Citrus Sinensis ID: 046199
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FL28 | 1173 | LRR receptor-like serine/ | yes | no | 0.952 | 0.732 | 0.353 | 1e-130 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.922 | 0.811 | 0.378 | 1e-122 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.883 | 0.789 | 0.350 | 1e-122 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.974 | 0.703 | 0.321 | 1e-120 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.970 | 0.698 | 0.317 | 1e-116 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.947 | 0.760 | 0.323 | 1e-113 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.901 | 0.725 | 0.333 | 1e-113 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.936 | 0.808 | 0.332 | 1e-112 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.964 | 0.789 | 0.330 | 1e-111 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.884 | 0.796 | 0.335 | 1e-109 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 357/1009 (35%), Positives = 523/1009 (51%), Gaps = 150/1009 (14%)
Query: 24 NWTSNTSV--CSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFS 81
+WT S+ C+W GITCD ST V ++++ + L G +S + NL+ LQ LDL+ N F+
Sbjct: 51 DWTIIGSLRHCNWTGITCD-STGHVVSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFT 109
Query: 82 GTIPSSIFSISTLKILILGDNQLSGSFPSFI-----------------------ISNTSS 118
G IP+ I ++ L LIL N SGS PS I I TSS
Sbjct: 110 GKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSS 169
Query: 119 LRAIDCNYNSLSGELPA--------NIFRA--------IPKDIGNLTKLKELYLGYNKLQ 162
L I +YN+L+G++P +F A IP IG L L +L L N+L
Sbjct: 170 LVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLT 229
Query: 163 GEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG----------- 211
G+IP++ GNL L+ L L + L G IP+ I N SSL++L+ +N LTG
Sbjct: 230 GKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQ 289
Query: 212 ---FYMTNNHFTGSIPRNLWQCE---------------IPHEIGNLPNLEVLGIDENHLV 253
+ N T SIP +L++ I EIG L +LEVL + N+
Sbjct: 290 LQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFT 349
Query: 254 GDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFN 313
G+ P +I N+ L L++ N +SG LP+ +L L N+ L+ N L+G IP I N
Sbjct: 350 GEFPQSITNLRNLTVLTVGFNNISGELPA---DLGLLTNLRNLSAHDNLLTGPIPSSISN 406
Query: 314 ASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYI 373
+ L LL+L+ N +G IP + NL + +G N+ T P+ F N S+ + +
Sbjct: 407 CTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPDDIF-----NCSNLETL 460
Query: 374 VLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSI 433
+A+N L G L IG L L + + + G IP+EIGNL +L L+L +N +G I
Sbjct: 461 SVADNNLTGTLKPLIGKLQ-KLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRI 519
Query: 434 PITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSELHVDHNKLSGPIPACFGNLNSLRN 490
P + L LQGL + +N LEGPIP+ D+ LS L + +NK SG IPA F L SL
Sbjct: 520 PREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTY 579
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFD--------------------------FSSNSLNG 524
LSL N+ + IP++ +L+ + +FD FS+N L G
Sbjct: 580 LSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTG 639
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG------------ 572
++P ++G +++V EI+LS N +G IP ++ N+ L N L G
Sbjct: 640 TIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDM 699
Query: 573 -------------PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619
IP+SFG +T L SLDLS NNL+G IP SL L LK L L+ N L+
Sbjct: 700 IISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLK 759
Query: 620 GEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLC---KSSPHQKSSKNV-ILLGVVLPLS 675
G +P G F N +A MGN LCGS P KSS K ++ + I+LG L
Sbjct: 760 GHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALL 819
Query: 676 VFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIG 735
+ ++ +L+ + + ++E S +++ + + +RF +EL ATD F+ ++IG
Sbjct: 820 LVLLLVLILTCCKKKEKKIENSSESSLPDLDSALK--LKRFEPKELEQATDSFNSANIIG 877
Query: 736 IGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIIS-SCS 792
S TVYKG+ DG +A+KV +L+ A K F E + L ++HRNLVKI+ +
Sbjct: 878 SSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWE 937
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSL-DIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+G KALVL +M NG+LE ++ S + + +++ + + +A ++YLH GY P+VHCD
Sbjct: 938 SGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCD 997
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLL----NGEESMRTQTL-GTIGYMAP 895
+KP+NILLD D VAH+SDFG A++L +G + T GTIGY+AP
Sbjct: 998 LKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 350/925 (37%), Positives = 500/925 (54%), Gaps = 93/925 (10%)
Query: 8 TDQQALLALKA------RITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTIS 61
TD+QALL K+ R+ +W + +CSW G+ C + RVT +++ LTG +S
Sbjct: 39 TDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVS 98
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRA 121
+GNLS L++L+L+ N F G IPS + ++ L+ L + +N G
Sbjct: 99 PFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGG--------------- 143
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
IP + N + L L L N L+ +P E G+L++L LSL
Sbjct: 144 ------------------VIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLG 185
Query: 182 RSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
R+ LTG P+S+ NL+SL LDF N + G EIP +I L
Sbjct: 186 RNNLTGKFPASLGNLTSLQMLDFIYNQIEG-------------------EIPGDIARLKQ 226
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
+ I N G P I+N+S+L LS+ N+ SG+L +L LPN++ L +G+N
Sbjct: 227 MIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSL--LPNLQILYMGIN 284
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS-STPELSF 360
+ +G IP + N S L L++ N +G IP + L+NL LGL N L + S+ +L F
Sbjct: 285 SFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDF 344
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
L +L N S +Y+ + N L G LP I NL L E+ L I G+IP IGNLV+L
Sbjct: 345 LGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQ 404
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS---ELHVDHNKLSGP 477
TL LG N L+G +P ++G L+ L+ + L +N L G IP L +S L++ +N G
Sbjct: 405 TLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGS 464
Query: 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
IP+ G+ + L +L+LG+N+L+ IP L +++ + S N L G L DIG +K ++
Sbjct: 465 IPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLL 524
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+++S N L+G IP T+ +L+ L L+ N GPIP+ G LT L LDLS NNLSG
Sbjct: 525 ALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGT 583
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS-PHLQVPLCKSS 656
IP + L++LNLS N +G +P+ G F N SA S GN LCG P LQ+ C
Sbjct: 584 IPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVE 643
Query: 657 -PHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSNIE--VNMSP-QAM 712
P + SS I+ V + ++ + L + + R + +N E + SP ++
Sbjct: 644 LPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSF 703
Query: 713 WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGALKSFD 770
+ + SY EL T FS +LIG G+FG V+KG FL VAIKV +L GA KSF
Sbjct: 704 YEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG-FLGSKNKAVAIKVLNLCKRGAAKSFI 762
Query: 771 AECEVLKSVRHRNLVKIISSCSNGNF-----KALVLEYMANGSLEKCLYSS--------N 817
AECE L +RHRNLVK+++ CS+ +F +ALV E+M NG+L+ L+ +
Sbjct: 763 AECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPS 822
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL- 876
R+L +F RL+I IDVA AL YLH NP+ HCDIKPSNILLD D+ AH+SDFG+A+LL
Sbjct: 823 RTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLL 882
Query: 877 -NGEESMRTQ-----TLGTIGYMAP 895
++ Q GTIGY AP
Sbjct: 883 KFDRDTFHIQFSSAGVRGTIGYAAP 907
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 337/962 (35%), Positives = 484/962 (50%), Gaps = 165/962 (17%)
Query: 6 NTTDQQALLALKA------RITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGT 59
+ TD+QALL K+ R+ +W + +C+W G+TC RVT L + L G
Sbjct: 22 DETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSL 119
IS +GNLS L +LDL N F GTIP + +S L+ L +G N L G P + N S L
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIP-LGLYNCSRL 140
Query: 120 RAIDCNYNSLSGELPA----------------NIFRAIPKDIGNLTKLKELYLGYNKLQG 163
+ + N L G +P+ N+ +P +GNLT L++L L +N L+G
Sbjct: 141 LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEG 200
Query: 164 EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG------------ 211
EIP ++ L ++ L L + +G P +++NLSSL L N +G
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260
Query: 212 ---FYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKA 268
F M N+FTGSIP L N+ LE LG++EN+L G +P T N+ LK
Sbjct: 261 LLSFNMGGNYFTGSIPTTL---------SNISTLERLGMNENNLTGSIP-TFGNVPNLKL 310
Query: 269 LSLLNNTLSGSLPSSSKNLIGLPN---IERLNLGLNNLSGRIPGFIFN-ASKLFLLELTG 324
L L N+L + L L N +E L +G N L G +P I N ++KL L+L G
Sbjct: 311 LFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGG 370
Query: 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVL 384
SG IP + NL NL+ L L N L+ P +SL + +Y+ L N L+G +
Sbjct: 371 TLISGSIPYDIGNLINLQKLILDQNMLSGPLP-----TSLGKLLNLRYLSLFSNRLSGGI 425
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
P+ IGN+ + LE + L N G +P +GN +L L +G+N+L+G+IP+ + ++ L
Sbjct: 426 PAFIGNMTM-LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL 484
Query: 445 GLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
L + N L G +P D+ G L +L LSLG N+LS +P
Sbjct: 485 RLDMSGNSLIGSLPQDI---------------------GALQNLGTLSLGDNKLSGKLPQ 523
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564
T N + S N G +P D+ + V E++LS N L+G IP
Sbjct: 524 TLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIP------------- 569
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624
E F + + LE L+LS NN LEG++P
Sbjct: 570 -----------EYFASFSKLEYLNLSFNN------------------------LEGKVPV 594
Query: 625 GGSFANFSAQSFMGNDLLCGSPH-LQVPLCKSSP------HQKSSKNVIL---LGVVLPL 674
G F N + S +GN+ LCG Q+ C S H K V++ +G+ L L
Sbjct: 595 KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLL 654
Query: 675 SVFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLI 734
+F+ ++ L + R RK N E +N + + + + SY +L AT+ FS +++
Sbjct: 655 LLFMASVTL-----IWLRKRKKNKETNN-PTPSTLEVLHEKISYGDLRNATNGFSSSNMV 708
Query: 735 GIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS- 792
G GSFGTVYK L + VA+KV ++Q GA+KSF AECE LK +RHRNLVK++++CS
Sbjct: 709 GSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSS 768
Query: 793 ---NGN-FKALVLEYMANGSLEKCLYSS--------NRSLDIFQRLSIMIDVALALEYLH 840
GN F+AL+ E+M NGSL+ L+ +R+L + +RL+I IDVA L+YLH
Sbjct: 769 IDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLH 828
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL--NGEESMRTQ-----TLGTIGYM 893
P+ HCD+KPSN+LLDDD+ AH+SDFG+A+LL EES Q GTIGY
Sbjct: 829 VHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYA 888
Query: 894 AP 895
AP
Sbjct: 889 AP 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 358/1115 (32%), Positives = 518/1115 (46%), Gaps = 236/1115 (21%)
Query: 9 DQQALLALKARITA--------KNWTS-NTSVCSWIGITCD-VSTHRVTALNISDFGLTG 58
D Q LL +K + + W S N + CSW G+TCD RV ALN++ GLTG
Sbjct: 26 DLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTG 85
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIIS--NT 116
+IS G +L LDLS N G IP+++ ++++L+ L L NQL+G PS + S N
Sbjct: 86 SISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNI 145
Query: 117 SSLRAID------------------------CNY---------------------NSLSG 131
SLR D C N L G
Sbjct: 146 RSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEG 205
Query: 132 ELPAN--------IFRA--------IPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
+PA +F A IP ++G L L+ L L N L GEIP +LG +++L
Sbjct: 206 PIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQL 265
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG--------------FYMTNNHFTG 221
++LSL + L G IP S+ +L +L LD S N+LTG + NNH +G
Sbjct: 266 QYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSG 325
Query: 222 SIPR-------NLWQC---------EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMST 265
S+P+ NL Q EIP E+ +L+ L + N L G +P +F +
Sbjct: 326 SLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVE 385
Query: 266 LKALSLLNNTLSGSLPSSSKNLI---------------------GLPNIERLNLGLNNLS 304
L L L NNTL G+L S NL L +E L L N S
Sbjct: 386 LTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFS 445
Query: 305 GRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
G IP I N + L ++++ GN F G IP ++ L+ L L L N L P +SL
Sbjct: 446 GEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLP-----ASL 500
Query: 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN---------------- 408
N + LA+N L+G +PSS G L LE++ L N ++GN
Sbjct: 501 GNCHQLNILDLADNQLSGSIPSSFGFLK-GLEQLMLYNNSLQGNLPDSLISLRNLTRINL 559
Query: 409 -------------------------------IPKEIGNLVNLTTLHLGNNQLSGSIPITV 437
IP E+GN NL L LG NQL+G IP T+
Sbjct: 560 SHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTL 619
Query: 438 GRLNTLQGLGLENNKLEGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLG 494
G++ L L + +N L G IP L +L+ + +++N LSGPIP G L+ L L L
Sbjct: 620 GKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLS 679
Query: 495 SNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV------------------- 535
SN+ +P+ +N +L NSLNGS+P +IGN+
Sbjct: 680 SNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAM 739
Query: 536 -----VVEINLSRNYLTGDIPTTIGGLTNLQ-LLSLENNRLHGPIPESFGALTSLESLDL 589
+ E+ LSRN LTG+IP IG L +LQ L L N G IP + G L+ LE+LDL
Sbjct: 740 GKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDL 799
Query: 590 SVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQ 649
S N L+G +P S+ + L LN+SFN L G++ F+ + A SF+GN LCGSP +
Sbjct: 800 SHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSR 857
Query: 650 VPLCKSSPHQK--SSKNVILLGVVLPLS-----VFIIAILLALGIGLITRYRKGNTELS- 701
+S+ Q+ S+++V+++ + L+ + +IA+ + G+T +
Sbjct: 858 CNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTS 917
Query: 702 -NIEVNMSPQAMWRR------FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVA 754
+ + + ++R + +++ AT + SE+ +IG G G VYK +G VA
Sbjct: 918 SSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVA 977
Query: 755 IKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FKALVLEYMANGSLEK 811
+K + D + KSF E + L +RHR+LVK++ CS+ + L+ EYM NGS+
Sbjct: 978 VKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWD 1037
Query: 812 CLY-------SSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864
L+ + LD RL I + +A +EYLH P+VH DIK SN+LLD +M
Sbjct: 1038 WLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNME 1097
Query: 865 AHLSDFGIAKLLNGEESMRTQT----LGTIGYMAP 895
AHL DFG+AK+L T + + GY+AP
Sbjct: 1098 AHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 353/1111 (31%), Positives = 518/1111 (46%), Gaps = 236/1111 (21%)
Query: 9 DQQALLALKARITA--------KNWTSNT-SVCSWIGITCDVSTHRVTALNISDFGLTGT 59
D Q LL LK ++W S + S C+W G+TC + LN+S GLTG+
Sbjct: 29 DLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTC--GGREIIGLNLSGLGLTGS 86
Query: 60 ISSQLGNLSSLQTLDLSHNRF-------------------------SGTIPSSIFSISTL 94
IS +G ++L +DLS NR SG IPS + S+ L
Sbjct: 87 ISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNL 146
Query: 95 KILILGDNQLSGSFPSFI--ISNTSSLRAIDCNY---------------------NSLSG 131
K L LGDN+L+G+ P + N L C N L G
Sbjct: 147 KSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEG 206
Query: 132 ELPANI--------FRA--------IPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
+PA I F A +P ++ L L+ L LG N GEIP +LG+L +
Sbjct: 207 PIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSI 266
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG-----FYMTN---------NHFTG 221
++L+L + L G IP + L++L LD S+N+LTG F+ N N +G
Sbjct: 267 QYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSG 326
Query: 222 SIPRNLWQ----------------CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMST 265
S+P+ + EIP EI N +L++L + N L G +P+++F +
Sbjct: 327 SLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVE 386
Query: 266 LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP---GF------------ 310
L L L NN+L G+L SS NL N++ L NNL G++P GF
Sbjct: 387 LTNLYLNNNSLEGTLSSSISNLT---NLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYEN 443
Query: 311 ---------IFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
I N ++L ++ GN SG IP ++ L++L L L N L + P
Sbjct: 444 RFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIP----- 498
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIG-----------------NLPITLEEIYLQNCK 404
+SL N I LA+N L+G +PSS G NLP +L I L+N
Sbjct: 499 ASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL--INLKNLT 556
Query: 405 -------------------------------IRGNIPKEIGNLVNLTTLHLGNNQLSGSI 433
G+IP E+G NL L LG NQ +G I
Sbjct: 557 RINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRI 616
Query: 434 PITVGRLNTLQGLGLENNKLEGPIPDDL--CQ-LSELHVDHNKLSGPIPACFGNLNSLRN 490
P T G+++ L L + N L G IP +L C+ L+ + +++N LSG IP G L L
Sbjct: 617 PRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGE 676
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDI 550
L L SN+ +P+ ++L NIL+ NSLNGS+P +IGN++ + +NL N L+G +
Sbjct: 677 LKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPL 736
Query: 551 PTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLES-LDLSVNNLSGVIPISLEKLVYLK 609
P+TIG L+ L L L N L G IP G L L+S LDLS NN +G IP ++ L L+
Sbjct: 737 PSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLE 796
Query: 610 DLNLSFNRLEGEIPS----------------------GGSFANFSAQSFMGNDLLCGSPH 647
L+LS N+L GE+P F+ + A +F+GN LCGSP
Sbjct: 797 SLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPL 856
Query: 648 LQVPLCKSSPHQK-SSKNVILLGVV-----LPLSVFIIAILLALGIGLITRYRKGNTELS 701
S + S K V+++ + + L V +I + L + R GN+ S
Sbjct: 857 SHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFS 916
Query: 702 NIEVN-----MSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIK 756
+ + S + +++ AT + +E+ +IG G G VYK +G +A+K
Sbjct: 917 SNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVK 976
Query: 757 VFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFKALVLEYMANGSLEKCL 813
+ D + KSF+ E + L ++RHR+LVK++ CS+ L+ EYMANGS+ L
Sbjct: 977 KILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWL 1036
Query: 814 YSSNRS-----LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLS 868
+++ + L RL I + +A +EYLH+ P+VH DIK SN+LLD ++ AHL
Sbjct: 1037 HANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLG 1096
Query: 869 DFGIAKLLNGEESMRTQT----LGTIGYMAP 895
DFG+AK+L G T++ G+ GY+AP
Sbjct: 1097 DFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 322/996 (32%), Positives = 477/996 (47%), Gaps = 141/996 (14%)
Query: 8 TDQQALLALKARI------TAKNWTS-NTSVCSWIGITCDVSTHR-------VTALNISD 53
+D Q LL LK R NW + + C+WIG+ C VT+L++S
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 54 FGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFII 113
L+G +S +G L +L L+L++N +G IP I + S L+++ L +NQ GS P I
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIP-VEI 153
Query: 114 SNTSSLRAIDCNYNSLSGELPA----------------NIFRAIPKDIGNLTKLKELYLG 157
+ S LR+ + N LSG LP N+ +P+ +GNL KL G
Sbjct: 154 NKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAG 213
Query: 158 YNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNN 217
N G IP E+G L+ L L ++F++G +P I L L E+ N +GF
Sbjct: 214 QNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGF----- 268
Query: 218 HFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLS 277
IP +IGNL +LE L + N LVG +P+ I NM +LK L L N L+
Sbjct: 269 --------------IPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLN 314
Query: 278 GSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
G++P K L L + ++ N LSG IP + S+L LL L N +G IP+ L
Sbjct: 315 GTIP---KELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSK 371
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
LRNL L L N LT P N +S + + L N L+GV+P +G L L
Sbjct: 372 LRNLAKLDLSINSLTGPIP-----PGFQNLTSMRQLQLFHNSLSGVIPQGLG-LYSPLWV 425
Query: 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPI 457
+ ++ G IP I NL L+LG+N++ G+IP V R +L L + N+L G
Sbjct: 426 VDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQF 485
Query: 458 PDDLCQL---SELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILS 514
P +LC+L S + +D N+ SGP+P G L+ L L +N+ SS +P+ L+N+++
Sbjct: 486 PTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVT 545
Query: 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI 574
F+ SSNSL G +P +I N K++ ++LSRN G +P +G L L++L L NR G I
Sbjct: 546 FNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNI 605
Query: 575 PESFGALTSLESLD---------------------------------------------- 588
P + G LT L L
Sbjct: 606 PFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLM 665
Query: 589 -LSVNN--LSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS 645
LS+NN LSG IP + E L L N S+N L G++P F N + SF+GN LCG
Sbjct: 666 YLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG 725
Query: 646 PHLQV--PLCKSSPHQKSSK-NVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTE--- 699
HL+ P S PH S K G ++ + +I + L I ++ + + E
Sbjct: 726 -HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTA 784
Query: 700 ---------LSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDG 750
++ P+ RF+ +++L AT F + ++G G+ GTVYK G
Sbjct: 785 PYVHDKEPFFQESDIYFVPK---ERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSG 841
Query: 751 MEVAIKVFHLQFDGALKS-------FDAECEVLKSVRHRNLVKIISSC--SNGNFKALVL 801
+A+K +G + F AE L +RHRN+V++ S C N L+
Sbjct: 842 KTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLY 901
Query: 802 EYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD 860
EYM+ GSL + L+ + S+D R +I + A L YLH ++H DIK +NIL+D
Sbjct: 902 EYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILID 961
Query: 861 DDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
++ AH+ DFG+AK+++ S + G+ GY+AP
Sbjct: 962 ENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAP 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-113, Method: Compositional matrix adjust.
Identities = 304/911 (33%), Positives = 456/911 (50%), Gaps = 98/911 (10%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+T L + LT I S+LGN+ S+ L LS N+ +G+IPSS+ ++ L +L L +N L+
Sbjct: 152 LTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLT 211
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFR----------------AIPKDIGNLT 149
G P + N S+ + + N L+G +P+ + IP +IGN+
Sbjct: 212 GVIPPEL-GNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNME 270
Query: 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSL 209
+ L L NKL G IP LGNL L LSL +++LTG IP + N+ S+++L+ SNN L
Sbjct: 271 SMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKL 330
Query: 210 TG--------------FYMTNNHFTGSIPRNLWQCE---------------IPHEIGNLP 240
TG Y+ N+ TG IP L E IP GNL
Sbjct: 331 TGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLK 390
Query: 241 NLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
NL L + N+L G +P + NM ++ L L N L+GS+P S N L E L L +
Sbjct: 391 NLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKL---ESLYLRV 447
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
N+LSG IP + N+S L L L N+F+GF P+T+ R L+++ L YN+L
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHL--------- 498
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
G +P S+ + + +L N K G+I + G +L
Sbjct: 499 --------------------EGPIPKSLRDCKSLIRARFLGN-KFTGDIFEAFGIYPDLN 537
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNKLSGP 477
+ +N+ G I + L L + NN + G IP + + QL EL + N L G
Sbjct: 538 FIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGE 597
Query: 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
+P GNL +L L L N+LS +P+ L N+ S D SSN+ + +P + +
Sbjct: 598 LPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLH 657
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
++NLSRN G IP + LT L L L +N+L G IP +L SL+ LDLS NNLSG+
Sbjct: 658 DMNLSRNKFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGL 716
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS-PHLQVPLCKSS 656
IP + E ++ L ++++S N+LEG +P +F +A + N LC + P ++ C+
Sbjct: 717 IPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCREL 776
Query: 657 PHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRK----GNTELSNIEVNMSPQAM 712
K + N+++ +V L V +I + A R RK NT+ E NMS ++
Sbjct: 777 KKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGE-NMSIFSV 835
Query: 713 WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL------ 766
+F Y++++ +T+ F LIG G + VY+ D + +A+K H D +
Sbjct: 836 DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVK 894
Query: 767 KSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN--RSLDIFQ 824
+ F E + L +RHRN+VK+ CS+ L+ EYM GSL K L + + L +
Sbjct: 895 QEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTK 954
Query: 825 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884
R++++ VA AL Y+H P+VH DI NILLD+D A +SDFG AKLL + S +
Sbjct: 955 RINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWS 1014
Query: 885 QTLGTIGYMAP 895
GT GY+AP
Sbjct: 1015 AVAGTYGYVAP 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-112, Method: Compositional matrix adjust.
Identities = 321/964 (33%), Positives = 472/964 (48%), Gaps = 119/964 (12%)
Query: 5 INTTDQQALLALKARITAKNWTSNTSVCSWI------------GITCDVSTHRVTALNIS 52
++ T ++A LK + T N TS++ + SW+ G+ C + + + LN++
Sbjct: 44 VSATVEEANALLKWKSTFTNQTSSSKLSSWVNPNTSSFCTSWYGVACSLGS--IIRLNLT 101
Query: 53 DFGLTGTISS-QLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSF 111
+ G+ GT +L +L +DLS NRFSGTI S L+ L NQL G P
Sbjct: 102 NTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPE 161
Query: 112 I--ISNTSSLRAIDCNYNSLSGELPANIFR----------------AIPKDIGNLTKLKE 153
+ +SN +L ++ N L+G +P+ I R IP GNLTKL
Sbjct: 162 LGDLSNLDTLHLVE---NKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVN 218
Query: 154 LYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFY 213
LYL N L G IP E+GNL L L L R+ LTG IPSS NL ++ L+ N L+G
Sbjct: 219 LYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSG-- 276
Query: 214 MTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLN 273
EIP EIGN+ L+ L + N L G +P+T+ N+ TL L L
Sbjct: 277 -----------------EIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYL 319
Query: 274 NTLSGSLPS-------------SSKNLIG--------LPNIERLNLGLNNLSGRIPGFIF 312
N L+GS+P S L G L +E L L N LSG IP I
Sbjct: 320 NQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIA 379
Query: 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKY 372
N+++L +L+L N+F+GF+PDT+ LE+L L N+ P+ SL + S
Sbjct: 380 NSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIR 434
Query: 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432
+ N +G + + G P TL I L N G + L L NN ++G+
Sbjct: 435 VRFKGNSFSGDISEAFGVYP-TLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGA 493
Query: 433 IPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLS 492
IP + ++ QLS+L + N+++G +P N+N + L
Sbjct: 494 IPPEIW---------------------NMTQLSQLDLSSNRITGELPESISNINRISKLQ 532
Query: 493 LGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPT 552
L N LS IPS L N+ D SSN + +P + N+ + +NLSRN L IP
Sbjct: 533 LNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPE 592
Query: 553 TIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 612
+ L+ LQ+L L N+L G I F +L +LE LDLS NNLSG IP S + ++ L ++
Sbjct: 593 GLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVD 652
Query: 613 LSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPL--CKSSPHQKSSKNV-ILLG 669
+S N L+G IP +F N +F GN LCGS + L C + +KS K+ +++
Sbjct: 653 VSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIY 712
Query: 670 VVLPLSVFIIAILLALGIGLITRYR-KGNTELSNIEVNMSPQAMWR---RFSYRELLLAT 725
+++P+ II + + GI + R R K E ++ E +++ + Y+E++ AT
Sbjct: 713 ILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKAT 772
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL------KSFDAECEVLKSV 779
F K LIG G G VYK + + + +A+K + D ++ + F E L +
Sbjct: 773 GEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEI 831
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALE 837
RHRN+VK+ CS+ LV EYM GSL K L + + + LD +R++++ VA AL
Sbjct: 832 RHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALS 891
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
Y+H S +VH DI NILL +D A +SDFG AKLL + S + GT GY+AP L
Sbjct: 892 YMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPEL 951
Query: 898 WVVL 901
+
Sbjct: 952 AYAM 955
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1038), Expect = e-111, Method: Compositional matrix adjust.
Identities = 319/965 (33%), Positives = 470/965 (48%), Gaps = 95/965 (9%)
Query: 9 DQQALLALK-----ARITAKNWTSNTSV-CSWIGITCD--VSTHRVTALNISDFGLTGTI 60
+ Q LL +K A+ +NW SN SV C W G+ C S V +LN+S L+G +
Sbjct: 30 EGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKL 89
Query: 61 SSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLR 120
S +G L L+ LDLS+N SG IP I + S+L+IL L +NQ G P I SL
Sbjct: 90 SPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIP-VEIGKLVSLE 148
Query: 121 AIDCNYNSLSGELPA----------------NIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
+ N +SG LP NI +P+ IGNL +L G N + G
Sbjct: 149 NLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGS 208
Query: 165 IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFY----------- 213
+P E+G L L L ++ L+G +P I L L ++ N +GF
Sbjct: 209 LPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLE 268
Query: 214 ---MTNNHFTGSIPRNLWQCE---------------IPHEIGNLPNLEVLGIDENHLVGD 255
+ N G IP+ L + IP EIGNL + EN L G+
Sbjct: 269 TLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGE 328
Query: 256 VPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP-GFIFNA 314
+P + N+ L+ L L N L+G++P L L N+ +L+L +N L+G IP GF +
Sbjct: 329 IPLELGNIEGLELLYLFENQLTGTIPVE---LSTLKNLSKLDLSINALTGPIPLGFQY-L 384
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIV 374
LF+L+L NS SG IP L +L L + N+L+ P S L S+ +
Sbjct: 385 RGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIP-----SYLCLHSNMIILN 439
Query: 375 LAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIP 434
L N L+G +P+ I TL ++ L + G P + VN+T + LG N+ GSIP
Sbjct: 440 LGTNNLSGNIPTGITTCK-TLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIP 498
Query: 435 ITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNKLSGPIPACFGNLNSLRNL 491
VG + LQ L L +N G +P + L QL L++ NKL+G +P+ N L+ L
Sbjct: 499 REVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRL 558
Query: 492 SLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551
+ N S +PS +L + S+N+L+G++P+ +GN+ + E+ + N G IP
Sbjct: 559 DMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIP 618
Query: 552 TTIGGLTNLQL-LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKD 610
+G LT LQ+ L+L N+L G IP L LE L L+ NNLSG IP S L L
Sbjct: 619 RELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLG 678
Query: 611 LNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKS-SPHQKSSK------ 663
N S+N L G IP N S SF+GN+ LCG P Q + +P Q + K
Sbjct: 679 YNFSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRS 735
Query: 664 -------NVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRF 716
++ GV L L I+ ++ + + + G ++++ P+ F
Sbjct: 736 SKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPK---EGF 792
Query: 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-----LKSFDA 771
++++L+ ATD+F E ++G G+ GTVYK G +A+K +G SF A
Sbjct: 793 TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMID 831
E L ++RHRN+VK+ C++ L+ EYM GSL + L+ + +LD +R I +
Sbjct: 853 EILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALG 912
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTI 890
A L YLH + H DIK +NILLDD AH+ DFG+AK+++ S + G+
Sbjct: 913 AAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSY 972
Query: 891 GYMAP 895
GY+AP
Sbjct: 973 GYIAP 977
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 396 bits (1017), Expect = e-109, Method: Compositional matrix adjust.
Identities = 311/927 (33%), Positives = 461/927 (49%), Gaps = 129/927 (13%)
Query: 8 TDQQALLALKARITAK-------NWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTI 60
T+ ALL+LK+ T +W +T+ CSW G+TCDVS VT+L++S L+GT+
Sbjct: 26 TELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTL 85
Query: 61 SSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLR 120
SS + +L LQ L L+ N+ SG IP I ++ L+ L L +N +GSFP + S +LR
Sbjct: 86 SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR 145
Query: 121 AIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSL 180
+D N+L+G+LP ++ NLT+L+ L+LG N G+IP G LE+L++
Sbjct: 146 VLDLYNNNLTGDLPVSL--------TNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAV 197
Query: 181 PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL-----------WQ 229
+ LTG IP I NL++L EL G+Y N F +P +
Sbjct: 198 SGNELTGKIPPEIGNLTTLREL------YIGYY---NAFENGLPPEIGNLSELVRFDAAN 248
Query: 230 C----EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
C EIP EIG L L+ L + N G + + +S+LK++ L NN +G +P+S
Sbjct: 249 CGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFS 308
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
L N+ LNL N L G IP FI +L +L+L N+F+G IP L L L
Sbjct: 309 QL---KNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILD 365
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
L N LT + P ++ + + ++ N L G +P S+G +L I + +
Sbjct: 366 LSSNKLTGTLP-----PNMCSGNRLMTLITLGNFLFGSIPDSLGKCE-SLTRIRMGENFL 419
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
G+IPKE+ L L+ + L +N L+G +PI+ G + DL Q+S
Sbjct: 420 NGSIPKELFGLPKLSQVELQDNYLTGELPIS-----------------GGGVSGDLGQIS 462
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
+ +N+LSG +PA GNL+ ++ L L N+ S IP L + DFS N +G
Sbjct: 463 ---LSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGR 519
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLE 585
+ +I K++ ++LSRN L+GDIP + G+ L L+L N L G IP + ++ SL
Sbjct: 520 IAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLT 579
Query: 586 SLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS 645
S+D S NNLSG+ +PS G F+ F+ SF+GN LCG
Sbjct: 580 SVDFSYNNLSGL------------------------VPSTGQFSYFNYTSFVGNSHLCG- 614
Query: 646 PHLQVPLCKSSPHQ-------KSSKNVILLGVVLPLSVF-IIAILLALGIGLITRYRKGN 697
P+L C HQ ++K +++LG++ VF I+AI+ A +
Sbjct: 615 PYLGP--CGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSL---------- 662
Query: 698 TELSNIEVNMSPQAMWRRFSYRELLLATDH----FSEKSLIGIGSFGTVYKGRFLDGMEV 753
N S WR +++ L D E ++IG G G VYKG G V
Sbjct: 663 -------RNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLV 715
Query: 754 AIKVFHLQFDGALKS--FDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEK 811
A+K G+ F+AE + L +RHR++V+++ CSN LV EYM NGSL +
Sbjct: 716 AVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE 775
Query: 812 CLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870
L+ L R I ++ A L YLH S +VH D+K +NILLD + AH++DF
Sbjct: 776 VLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADF 835
Query: 871 GIAKLLN--GEESMRTQTLGTIGYMAP 895
G+AK L G + G+ GY+AP
Sbjct: 836 GLAKFLQDSGTSECMSAIAGSYGYIAP 862
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.962 | 0.829 | 0.481 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.804 | 0.498 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.913 | 0.776 | 0.496 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.960 | 0.795 | 0.468 | 0.0 | |
| 359482811 | 1118 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.788 | 0.454 | 0.0 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.933 | 0.592 | 0.470 | 0.0 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.985 | 0.814 | 0.457 | 0.0 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.917 | 0.418 | 0.488 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.916 | 0.686 | 0.474 | 0.0 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.921 | 0.691 | 0.492 | 0.0 |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/955 (48%), Positives = 617/955 (64%), Gaps = 87/955 (9%)
Query: 4 NINTTDQQALLALKARIT-------AKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGL 56
+IN D+ AL+ALKA IT A NW++ +S C+W GI+C+ RV+A+N+S+ GL
Sbjct: 4 SINLVDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGL 63
Query: 57 TGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNT 116
GTI+ Q+GNLS L +LDL++N F+G+IP+ I ++ L+ L L +N L+G PS + S+
Sbjct: 64 EGTIAPQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNL-SHC 122
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176
LR + + N +G IP+ IG+L+ L+ELYL YNKL G IP+E+GNL+ L
Sbjct: 123 RELRGLSLSINQFTG--------GIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLN 174
Query: 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG---------------FYMTNNHFTG 221
L L + ++G IP+ IF +SSL + F+NNSL+G Y++ NH +G
Sbjct: 175 ILQLGSNGISGPIPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSG 234
Query: 222 SIPRNLWQCE---------------IPHEIGNLPNLEVLGIDENHLVGDVPNTI------ 260
+P L C IP EIGNL LE + + EN L+G +P +
Sbjct: 235 QLPTTLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTL 294
Query: 261 ----FNMSTLKALSLLNNTLSGSLPSSSKNLIG--LPNIERLNLGLNNLSGRIPGFIFNA 314
FN+S L+ L L+ N LSGSLPSS IG LP++E L +G+N SG IP I N
Sbjct: 295 KFLSFNISKLQTLGLVQNHLSGSLPSS----IGTWLPDLEGLYIGINEFSGTIPMSISNM 350
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSS--TPELSFLSSLANSSSSKY 372
SKL +L L+ NSF+G +P L NL L+ L L YN LT + FL+SL N +
Sbjct: 351 SKLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRN 410
Query: 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432
+ + NPL G LP+S+GNLPI LE C+ RG IP IGNL NL L LG N L+GS
Sbjct: 411 LWIGYNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGS 470
Query: 433 IPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSEL---HVDHNKLSGPIPACFGNLNSLR 489
IP T+G+L LQ L + N++ G IP+DLC L L + +NKLSG IP+CFG+L +LR
Sbjct: 471 IPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALR 530
Query: 490 NLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549
LSL SN L+ IP +FW+L ++L + SSN L G+LP ++GNMK + ++LS+N ++G
Sbjct: 531 ELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGY 590
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK 609
IP+ +G L NL LSL N+L GPIP FG L SLESLDLS NNLSG IP +LE L+YLK
Sbjct: 591 IPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLK 650
Query: 610 DLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSSPHQKS--SKNVIL 667
LN+SFN+L+GEIP+GG F F+A+SFM N+ LCG+PH QV C + +S +K+ IL
Sbjct: 651 YLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFIL 710
Query: 668 LGVVLPL-SVFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMW-----RRFSYREL 721
++LP+ S + + + L I R+ N E+ +P W + S+++L
Sbjct: 711 KYILLPVGSTVTLVVFIVLWI-----RRRDNMEIP------TPIDSWLPGTHEKISHQQL 759
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH 781
L AT+ F E +LIG GS G VYKG +G+ VAIKVF+L+F GAL+SF++ECEV++ +RH
Sbjct: 760 LYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRH 819
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
RNLV+II+ CSN +FKALVL+YM NGSLEK LYS LD+ QRL+IMIDVA ALEYLH
Sbjct: 820 RNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHH 879
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMAP 895
S+ VVHCD+KPSN+LLDDDMVAH++DFGIAKLL ESM +T+TL TIGYMAP
Sbjct: 880 DCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLSTIGYMAP 934
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/961 (49%), Positives = 612/961 (63%), Gaps = 86/961 (8%)
Query: 6 NTTDQQALLALKARIT-------AKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTG 58
N TDQ +LLALKA IT A NW++ TS C WIG++C+ RV AL++S+ GL G
Sbjct: 29 NFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRG 88
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFP-SFIISNTS 117
TI LGNLS L +LDLS N F G +P + +++L + L N LSG P SF N +
Sbjct: 89 TIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSF--GNLN 146
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
L+++ NS +G IP IGN++ L+ L LG N LQG IP+E+G L+ ++
Sbjct: 147 RLQSLFLGNNSFTG--------TIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKI 198
Query: 178 LSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG----------------FYMTNNHFTG 221
L + + L G IPS+IFN+SSL E+ + NSL+G ++ N FTG
Sbjct: 199 LDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTG 258
Query: 222 SIPRNLWQC---------------------------------------EIPHEIGNLPNL 242
IP NL +C E+P EIG+L L
Sbjct: 259 PIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTL 318
Query: 243 EVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNN 302
VL I++N L G +P IFN+S++ + SL N LSG+LP + + LPN+E L L +N
Sbjct: 319 NVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSY--LPNLENLILEINW 376
Query: 303 LSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLT--SSTPELSF 360
LSG IP I NASKL L+ N +G IP L +LR LE L LG N L S ELSF
Sbjct: 377 LSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSF 436
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
L+SL N + + L+ NPL G+LP SIGNL +L+ CK++GNIP EIGNL NL
Sbjct: 437 LTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLY 496
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS---ELHVDHNKLSGP 477
L L NN L+G+IP ++G+L LQGL L +NKL+G IP+D+CQL EL + +N+LSG
Sbjct: 497 LLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGS 556
Query: 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
IPAC G L LR+L LGSN+L+S IPST W+L +ILS D SSN L G LP D+GN+KV+V
Sbjct: 557 IPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLV 616
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+I+LSRN L+G+IP+ IGGL +L LSL +NR GPI SF L SLE +DLS N L G
Sbjct: 617 KIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGE 676
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSSP 657
IP SLE LVYLK L++SFN L GEIP G FANFSA+SFM N LCGSP L++P C++
Sbjct: 677 IPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGT 736
Query: 658 HQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFS 717
++ + +LL +LP ++ + LAL I + TR RK N L ++ A WRR S
Sbjct: 737 RWSTTISWLLLKYILP-AILSTLLFLAL-IFVWTRCRKRNAVLPTQSESLL-TATWRRIS 793
Query: 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK 777
Y+E+ AT+ FS +L+G GS G+VY+G DG AIKVF+LQ + A KSFDAECEV+
Sbjct: 794 YQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMH 853
Query: 778 SVRHRNLVKIISSCSNG--NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
+RHRNL+KI+SSCSN +FKALVLEY+ NGSLE+ LYS N LDI QRL+IMIDVALA
Sbjct: 854 HIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALA 913
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMA 894
+EYLH G S PVVHCD+KPSNILLD+D H+ DFGIAKLL EES+R TQTL TIGYMA
Sbjct: 914 MEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMA 973
Query: 895 P 895
P
Sbjct: 974 P 974
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/876 (49%), Positives = 571/876 (65%), Gaps = 52/876 (5%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+ LN+ + G IS ++ NLS+L+ LDL HN FSG I +F++ +L+++ L N LS
Sbjct: 90 LETLNLEGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLS 149
Query: 106 GSFPSFIISNT--SSLRAIDCNYNSLSGELPANIFR----------------AIPKDIGN 147
G +I + S+L ++ YN L G +P+N+ + +IPK+I
Sbjct: 150 GILQVVMIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICT 209
Query: 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN 207
LTKLKELYLG N L G+IP E+ L LE L L + L G IP I N + L+E+ NN
Sbjct: 210 LTKLKELYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENN 269
Query: 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLK 267
+LTG IP+E+GNL L+ L + N++ G +P+T FN S L+
Sbjct: 270 NLTGV-------------------IPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILR 310
Query: 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSF 327
+++ N LSG LPS++ +GLPN+E L L N LSG IP I NASKL +L+L+ NSF
Sbjct: 311 RVNMAYNYLSGHLPSNTG--LGLPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSF 368
Query: 328 SGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLA--NSSSSKYIVLAENPLNGVLP 385
SG IPD L NLRNL+ L L N LTS + + N S Y+ NPL G LP
Sbjct: 369 SGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP 428
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQG 445
SIGNL +LEE+Y +C+I GNIP+ IGNL NL L L N+L+G+IP +GRL LQ
Sbjct: 429 VSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQD 488
Query: 446 LGLENNKLEGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502
L +NKL+G IP+++C +LS L++ N SG +PAC N+ SLR L LGSN +S I
Sbjct: 489 FSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTS-I 547
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
P+TFW+L ++L + S NSL G+LPL+IGN+KVV I+ S N L+GDIPT+I L NL
Sbjct: 548 PTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAH 607
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622
SL +NR+ GPIP SFG L SLE LDLS N+LSG IP SLEKLV+LK N+SFNRL+GEI
Sbjct: 608 FSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEI 667
Query: 623 PSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKS-SPHQKSSK-NVILLGVVLPLSVFIIA 680
GG FANFS +SFM N+ LCG +QVP CKS S H++S + ++ ++P FII
Sbjct: 668 LDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFII- 726
Query: 681 ILLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFG 740
L L + +I R +LS E + P A WR+ SY EL AT+ F+E +L+G GS G
Sbjct: 727 --LVLALAVIIFRRSHKRKLSTQEDPLPP-ATWRKISYHELYRATEGFNETNLLGTGSCG 783
Query: 741 TVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800
+VYKG DG+ +A+KVFHLQ +G L FD+ECEVL+ +RHRNLVKIISSC N +FKAL+
Sbjct: 784 SVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALI 843
Query: 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD 860
LE++ +GSLEK LYS N LDI QRL+IMIDVA ALEYLH G + PVVHCD+KPSN+L++
Sbjct: 844 LEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLIN 903
Query: 861 DDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
+DMVAH+SDFGI++LL G+ +T TL TIGYMAP
Sbjct: 904 EDMVAHVSDFGISRLLGEGDAVTQTLTLATIGYMAP 939
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/967 (46%), Positives = 596/967 (61%), Gaps = 101/967 (10%)
Query: 6 NTTDQQALLALKAR-----ITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTI 60
N TD ALL LK +KNW+S TS C W G+TC +RV AL +S+ G+ G +
Sbjct: 28 NLTDLSALLVLKEHSNFDPFMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIV 87
Query: 61 SSQLGNLSSLQTLDLSHNRFSGTIP----------------------------------- 85
+GNLS L +D+S+N +SG +P
Sbjct: 88 PPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQH 147
Query: 86 ------------SSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGEL 133
SSIF+I+TL L L DN L G+ I N S+L+ ++ N LSG
Sbjct: 148 LLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSF 207
Query: 134 PANIF-----RAIPKDIGNLT------------KLKELYLGYNKLQGEIPQELGNLAELE 176
P I + I + NL+ KL+ L L N+L G+IP +L EL
Sbjct: 208 PPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELR 267
Query: 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEI 236
L+L + TG+IP +I NL+ L L N+LTG IP EI
Sbjct: 268 SLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTG-------------------RIPLEI 308
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
GNL NL+++ + N+L G +P+ +FN+ST+K +++ +N L G+LP+S + LPN+ L
Sbjct: 309 GNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLG--LHLPNLIWL 366
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS--S 354
LG+N LSG IP +I NASKL +LEL NSF+GFIPD+L +LRNL+ L LG N L+S +
Sbjct: 367 YLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKT 426
Query: 355 TPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIG 414
+ EL+ SSL N + KY+ L+ NPL+G LP S+GNL +LE + I+G++ + IG
Sbjct: 427 SQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIG 486
Query: 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELH---VDH 471
NL +LT L+LGNN L+G IP T+G L LQGL L N L+G IP +LC L L+ +
Sbjct: 487 NLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTG 546
Query: 472 NKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG 531
NKLSG IP CF NL SLRNL L SN S I ST W L +IL + +SN L GSLP +I
Sbjct: 547 NKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIE 606
Query: 532 NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591
N++ V IN+S+N L+G+IP +IGGL +L L L N+L GPIP+S G + SLE LDLS
Sbjct: 607 NLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSS 666
Query: 592 NNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVP 651
NNLSG+IP SL+ L+YLK N+SFN L+GEIP GGSF+NFSAQSF+GN+ LCGS LQV
Sbjct: 667 NNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVS 726
Query: 652 LCK--SSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSNIEVNMSP 709
CK +S ++ + I+L VLP VF + +L + ++ RY + + S IE +
Sbjct: 727 PCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAF--VIMLKRYCERKAKFS-IEDDFLA 783
Query: 710 QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSF 769
RR SY EL LAT+ F E + +G+GSFG+VYKG DG +A KVF+LQ + A KSF
Sbjct: 784 LTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSF 843
Query: 770 DAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIM 829
D ECEVL+++RHRNLVKII+SCS NFKALVLE+M N SLEK LYS + L+ QRL+IM
Sbjct: 844 DTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIM 903
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-MRTQTLG 888
+DVA LEYLH GY+ P+ HCDIKPSN+LL++DMVA L+DFGI+KLL E S M+T TL
Sbjct: 904 LDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLA 963
Query: 889 TIGYMAP 895
TIGYMAP
Sbjct: 964 TIGYMAP 970
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482811|ref|XP_002270207.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/986 (45%), Positives = 600/986 (60%), Gaps = 105/986 (10%)
Query: 1 AANNINTTDQQALLALKARIT-------AKNWTSNTSVCSWIGITCDVSTHRVTALNISD 53
AA+ N TDQ ALLA K+ I NWT TS C+W+G++C RVTAL +
Sbjct: 25 AASPSNFTDQSALLAFKSDIIDPTHSILGGNWTQETSFCNWVGVSCSRRRQRVTALRLQK 84
Query: 54 FGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFII 113
GL GT+S LGNLS + LDLS+N F G +P + + L+ILIL +NQL G P I
Sbjct: 85 RGLKGTLSPYLGNLSFIVLLDLSNNSFGGHLPYELGHLYRLRILILQNNQLEGKIPPS-I 143
Query: 114 SNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLA 173
S+ L I N LSG IP+++G L KL L LG N L+G IP LGN++
Sbjct: 144 SHCRRLEFISLASNWLSG--------GIPEELGILPKLDSLLLGGNNLRGTIPSSLGNIS 195
Query: 174 ELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG---------------FYMTNNH 218
LE L L + LTG+IPS IFN+SSLL + + NS++G T+N
Sbjct: 196 TLELLGLRETGLTGSIPSLIFNISSLLSIILTGNSISGSLSVDICQHSPNIEELLFTDNQ 255
Query: 219 FTGSIPRNLWQC---------------EIPHEIGNLPNLEVLGIDENHLVGDVPNT---- 259
+G +P + +C +IP EIG+L NLE L + NHL G +P++
Sbjct: 256 LSGQLPSGIHRCRELLFASLSYNRFDGQIPEEIGSLRNLEELYLGGNHLTGPIPSSIGNI 315
Query: 260 --------------------------------------------IFNMSTLKALSLLNNT 275
IFN+S+L+ LS++ N
Sbjct: 316 SSLQILFLEDNKIQGSIPSTLGNLLNLSYLVLELNELTGAIPQEIFNISSLQILSVVKNN 375
Query: 276 LSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTL 335
LSG+LPS++ +GLPN+ L L N LSG+IP + N S+L +++ N F+G IP +L
Sbjct: 376 LSGNLPSTTG--LGLPNLMVLFLAGNGLSGKIPPSLSNYSQLTKIDIGNNLFTGPIPPSL 433
Query: 336 VNLRNLEHLGLGYNYLT--SSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI 393
NL+ L+ L LG N L PELSF+++L N + I + NPL G++P+SIGNL
Sbjct: 434 GNLKFLQTLSLGENQLKVEPGRPELSFITALTNCRLLEEITMPNNPLGGIIPNSIGNLSN 493
Query: 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL 453
+ I C+++G+IP IG+L NL TL LG+N L+G+IP T+GRL LQ + + NN+L
Sbjct: 494 HVRNIVAFGCQLKGHIPSGIGSLKNLGTLELGDNNLNGNIPSTIGRLENLQRMNIFNNEL 553
Query: 454 EGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLN 510
EGPIP++LC L EL + +NKLSG IP C GNL+ L+ L L SN L+S IP+ W+L
Sbjct: 554 EGPIPEELCGLRDLGELSLYNNKLSGSIPHCIGNLSRLQKLFLSSNSLTSSIPTGLWSLG 613
Query: 511 NILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL 570
N+L + S NSL GSLP D+G + V+ +I+LS N L G+IP +G +L L+L N
Sbjct: 614 NLLFLNLSFNSLGGSLPSDMGTLTVIEDIDLSWNKLIGNIPGILGTFESLYSLNLSRNSF 673
Query: 571 HGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
IPE+ G L +LE +DLS NNLSG IP S E L +LK LNLSFN L GEIP+GG F N
Sbjct: 674 QEAIPETLGKLRALEFMDLSQNNLSGTIPKSFEALSHLKYLNLSFNNLSGEIPNGGPFVN 733
Query: 631 FSAQSFMGNDLLCGSPHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLI 690
F+AQSF+ N LCG L V C ++ Q+S +LL VLP + + + AL ++
Sbjct: 734 FTAQSFLENKALCGRSILLVSPCPTNRTQESKTKQVLLKYVLP-GIAAVVVFGAL-YYML 791
Query: 691 TRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDG 750
YRKG + N+ V++ P R SY EL AT+ F E +L+G+GSFG+VYKG DG
Sbjct: 792 KNYRKGKLRIQNL-VDLLPSIQHRMISYLELQRATNSFCETNLLGVGSFGSVYKGILSDG 850
Query: 751 MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLE 810
VA+KV +L+ +GA KSFDAEC+VL +RHRNL+K+ISSCSN + +ALVL+YM+NGSLE
Sbjct: 851 TTVAVKVLNLRLEGAFKSFDAECKVLARIRHRNLIKVISSCSNLDVRALVLQYMSNGSLE 910
Query: 811 KCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870
K LYS N L++FQR+SIM+DVALALEYLH S PVVHCD+KPSN+LLDDDMVAH+ DF
Sbjct: 911 KWLYSHNYCLNLFQRVSIMLDVALALEYLHHSQSEPVVHCDLKPSNVLLDDDMVAHVGDF 970
Query: 871 GIAKLL-NGEESMRTQTLGTIGYMAP 895
G+AK+L + +T+TLGT+GY+AP
Sbjct: 971 GLAKILVENKVVTQTKTLGTLGYIAP 996
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/930 (47%), Positives = 582/930 (62%), Gaps = 88/930 (9%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL 104
++ +++S TG+I +GNL LQ+L L +N +G IP S+F IS+L+ L LG+N L
Sbjct: 167 KLQGISLSYNEFTGSIPRAIGNLVELQSLSLXNNSLTGEIPQSLFKISSLRFLRLGENNL 226
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRA----------------IPKDIGNL 148
G P+ + + L ID + N GE+P+++ IP+ IG+L
Sbjct: 227 VGILPTGMGYDLPKLEMIDLSINQFKGEIPSSLSHCRQLRGLSLSLNQFTGGIPQAIGSL 286
Query: 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS 208
+ L+E+YL YN L G IP+E+GNL+ L L L ++G IP IFN+SSL +D ++NS
Sbjct: 287 SNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCGISGPIPPEIFNISSLQMIDLTDNS 346
Query: 209 L---------------TGFYMTNNHFTGSIPR-----------NLW-------------- 228
L G Y++ N +G +P +LW
Sbjct: 347 LHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSLCGQLLSLSLWGNRFTGNIPPSFGN 406
Query: 229 --------------QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
Q IP+E+GNL NL+ L + N+L G +P IFN+S L+ L L N
Sbjct: 407 LTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTLXLAQN 466
Query: 275 TLSGSLPSSSKNLIG--LPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIP 332
SGSLPSS IG LP++E L +G N SG IP I N S+L +L++ N F+G +P
Sbjct: 467 HFSGSLPSS----IGTQLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVP 522
Query: 333 DTLVNLRNLEHLGLGYNYLTS--STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390
L NLR LE L LG+N LT ST E+ FL+SL N + + + +NPL G+LP+S+GN
Sbjct: 523 KDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGILPNSLGN 582
Query: 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN 450
L I+LE C+ +G IP IGNL+NL L L +N L+G IPI+ G L LQ +
Sbjct: 583 LSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAISG 642
Query: 451 NKLEGPIPDDLCQLSEL---HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW 507
N++ G IP LC L L + NKLSG IP CFGNL +LRN+SL SN L+S IPS+ W
Sbjct: 643 NRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSLW 702
Query: 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567
L ++L + SSN LN LPL++GNMK ++ ++LS+N +G+IP+TI L NL L L +
Sbjct: 703 TLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSH 762
Query: 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGS 627
N+L G +P +FGAL SLE LDLS NN SG IP SLE L YLK LN+SFN+L+GEIP+ G
Sbjct: 763 NKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGP 822
Query: 628 FANFSAQSFMGNDLLCGSPHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGI 687
FANF+A+SF+ N LCG+P QV C+ + + +LL ++PLSV + ++L +
Sbjct: 823 FANFTAESFISNLALCGAPRFQVMACEKDARRNTKS--LLLKCIVPLSVSLSTMILVV-- 878
Query: 688 GLITRYRKGNTE-LSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGR 746
L T +++ TE S ++V++ M R S++ELL AT +F E++LIG GS G VYKG
Sbjct: 879 -LFTLWKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGV 937
Query: 747 FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806
DG+ VA+KVF+L+ GA KSF+ ECEV++++RHRNL KIISSCSN +FKALVLEYM N
Sbjct: 938 LSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPN 997
Query: 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866
SLEK LYS N LD QRL IMIDVA LEYLH YSNPVVHCD+KPSN+LLDDDMVAH
Sbjct: 998 ESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAH 1057
Query: 867 LSDFGIAKLLNGEESM-RTQTLGTIGYMAP 895
+SDFGIAKLL G E M RT+TLGTIGYMAP
Sbjct: 1058 ISDFGIAKLLMGSEFMKRTKTLGTIGYMAP 1087
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/981 (45%), Positives = 609/981 (62%), Gaps = 92/981 (9%)
Query: 2 ANNINTTDQQALLALKARITAK-------NWTSNTSVCSWIGITCDVSTHRVTALNISDF 54
A NI TTDQ ALLAL+A IT+ NW++ TSVC+W+GI C V RVT+LN S
Sbjct: 4 AQNI-TTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFSFM 62
Query: 55 GLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIIS 114
GLTGT ++G LS L + + +N F +P + ++ LK++ LG+N SG P++I
Sbjct: 63 GLTGTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWI-G 121
Query: 115 NTSSLRAIDCNYNSLSGELPANIFR----------------AIPKDIGNLTKLKELYLGY 158
+ + N SG +P ++F +IP++IGNLT L++LYL
Sbjct: 122 RLPRMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLNS 181
Query: 159 NKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN----------- 207
N+L EIP E+G L L L + + +G IP IFNLSSL+ L S N
Sbjct: 182 NQLT-EIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDIC 240
Query: 208 ----SLTGFYMTNNHFTGSIPRNLWQCE-------------------------------- 231
SL G Y++ N +G +P LW+CE
Sbjct: 241 EDLPSLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLG 300
Query: 232 -------IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSS 284
IP+E+G L NLE L + EN G +P TIFN+S L ++L+ N LSG+LP+
Sbjct: 301 VNYLSGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADL 360
Query: 285 KNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHL 344
+GLPN+ +L LG N L+G IP I N+S L L ++ NSFSG IP+ NL +
Sbjct: 361 G--VGLPNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWI 418
Query: 345 GLGYNYLTSSTP--ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQN 402
L N T+ +P E S L N +S + L+ NPLN LPSS N + + + + N
Sbjct: 419 NLELNNFTTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSMVN 478
Query: 403 CKIRGNIPKEIGN-LVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL 461
I+G IPK+IGN L +L L + +NQ++G+IP ++G+L LQGL L NN LEG IP ++
Sbjct: 479 TGIKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEI 538
Query: 462 CQLS---ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
CQL EL++ +NKLSG IP CF NL++LR LSLGSN L+S +PS+ W+L+ IL + S
Sbjct: 539 CQLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLS 598
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578
SNSL GSLP++IGN++VV++I++S+N L+G+IP++IGGL NL LSL +N L G IP+SF
Sbjct: 599 SNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSF 658
Query: 579 GALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMG 638
G L +LE LDLS NNL+GVIP SLEKL +L+ N+SFN+LEGEIP+GG F+NFSAQSF+
Sbjct: 659 GNLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFIS 718
Query: 639 NDLLC-GSPHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGN 697
N LC S QV C + Q S + L +LP S+ + + L L + +T YR
Sbjct: 719 NIGLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILP-SILLAMLSLILLLLFMT-YRHRK 776
Query: 698 TELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKV 757
E + + Q WRR +Y+EL ATD FSE +LIG GSFG+VYK DG A+K+
Sbjct: 777 KEQVREDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKI 836
Query: 758 FHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN 817
F L A KSF+ ECE+L ++RHRNLVKII+SCS+ +FKAL+LEYM NG+L+ LY+ +
Sbjct: 837 FDLLTQDANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHD 896
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
L++ +RL I+IDVALAL+YLH GY P+VHCD+KP+NILLD DMVAHL+DFGI+KLL
Sbjct: 897 CGLNMLERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKLLG 956
Query: 878 GEESM-RTQTLGTIGYMAPGL 897
G +S+ +T TL T+GYMAP L
Sbjct: 957 GGDSITQTITLATVGYMAPEL 977
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/937 (48%), Positives = 577/937 (61%), Gaps = 109/937 (11%)
Query: 6 NTTDQQALLALKARIT-------AKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTG 58
N TDQ +LLALKA IT A NW++ TS C WIG++C+ RV AL++S+ GL G
Sbjct: 504 NFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALDLSNLGLRG 563
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSS 118
TI LGNLS L +LDLS N F G IP S +++ L+ L LG+N +G+ P I N S
Sbjct: 564 TIPPDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGTIPPSI-GNMSM 622
Query: 119 LRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWL 178
L +D N L G +P+ IF N++ L+E+ L YN L G IP+E+ L LE+L
Sbjct: 623 LETLDIQSNQLVGAIPSAIF--------NISSLQEIALTYNSLSGTIPEEISFLPSLEYL 674
Query: 179 SLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG----------------FYMTNNHFTGS 222
L + T IPS+IF +S+L +D N +G + +N FTG+
Sbjct: 675 YLRSNSFTSPIPSAIFKISTLKAIDLGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFTGT 734
Query: 223 IPRNLWQC----------------EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTL 266
I + C E+P EIG+L L VL I++N L G +P IFN+S++
Sbjct: 735 IHGGIGNCTSLRELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSM 794
Query: 267 KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326
+ SL N LSG+LP + + LPN+E L L +N LSG IP I NASKL L+ N
Sbjct: 795 VSGSLTRNNLSGNLPPNFGSY--LPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNM 852
Query: 327 FSGFIPDTLVNLRNLEHLGLGYNYLT--SSTPELSFLSSLANSSSSKYIVLAENPLNGVL 384
+G IP L +LR LE L LG N L S ELSFL+SL N + + L+ NPL G+L
Sbjct: 853 LTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGIL 912
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
P SIGNL +L+ CK++GNIP EIGNL NL L L NN L+G+IP ++G+L LQ
Sbjct: 913 PISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQ 972
Query: 445 GLGLENNKLEGPIPDDLCQLS---ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF 501
GL L +NKL+G IP+D+CQL EL + +N+LSG IPAC G L LR+L LGSN+L+S
Sbjct: 973 GLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNST 1032
Query: 502 IPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ 561
IPST W+L +ILS D SSN L G LP D+GN+KV+V+I+LSRN L+G+IP+ IGGL +L
Sbjct: 1033 IPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLT 1092
Query: 562 LLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGE 621
LSL +NR GPI SF L SLE +DLS N L G IP SLE LVYLK L++SFN L GE
Sbjct: 1093 SLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGE 1152
Query: 622 IPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAI 681
IP G FANFSA+SFM N LC + +P S
Sbjct: 1153 IPPEGPFANFSAESFMMNKALCRKRNAVLPTQSES------------------------- 1187
Query: 682 LLALGIGLITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGT 741
L+T A WRR SY+E+ AT+ FS +L+G GS G+
Sbjct: 1188 -------LLT-------------------ATWRRISYQEIFQATNGFSAGNLLGRGSLGS 1221
Query: 742 VYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKAL 799
VY+G DG AIKVF+LQ + A KSFDAECEV+ +RHRNL+KI+SSCSN +FKAL
Sbjct: 1222 VYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKAL 1281
Query: 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859
VLEY+ NGSLE+ LYS N LDI QRL+IMIDVALA+EYLH G S PVVHCD+KPSNILL
Sbjct: 1282 VLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILL 1341
Query: 860 DDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAP 895
D+D H+ DFGIAKLL EES+R TQTL TIGYMAP
Sbjct: 1342 DEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAP 1378
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/921 (47%), Positives = 577/921 (62%), Gaps = 94/921 (10%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL 104
++ LN+S L+G I + LG LQ + L++N F+G+IP+ I ++ L+ L L +N L
Sbjct: 197 KLKELNLSSNHLSGKIPTGLGQCIKLQVISLAYNDFTGSIPNGIGNLVELQRLSLRNNSL 256
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
+G PS + S+ LR + ++N +G IP+ IG+L L+ELYL +NKL G
Sbjct: 257 TGEIPSNL-SHCRELRVLSSSFNQFTG--------GIPQAIGSLCNLEELYLAFNKLTGG 307
Query: 165 IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG------------- 211
IP+E+GNL+ L L L + ++G IP+ IFN+SSL +DF+NNSL+G
Sbjct: 308 IPREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQVIDFTNNSLSGSLPMGICKHLPNL 367
Query: 212 --FYMTNNHFTGSIPRNLWQC---------------EIPHEIGNLPNLEVLGIDENHLVG 254
Y+ NH +G +P L C IP EIGNL LE + + N LVG
Sbjct: 368 QGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVG 427
Query: 255 D------------------------VPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIG- 289
VP IFN+S L+ L+L+ N LSGSLPSS IG
Sbjct: 428 SIPTSFGNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQNHLSGSLPSS----IGT 483
Query: 290 -LPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
LP++E L +G N SG IP I N SKL +L L+ NSF+G +P L NL L+ L L +
Sbjct: 484 WLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAH 543
Query: 349 NYLTSS--TPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR 406
N LT + FL+SL N +Y+ + NPL G LP+S+GNLPI LE C+ R
Sbjct: 544 NQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFR 603
Query: 407 GNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSE 466
G IP IGNL NL L LG N L+GSIP T+GRL LQ L + N++ G IP+DLC L
Sbjct: 604 GTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKN 663
Query: 467 LH---VDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
L + NKLSG P+CFG+L +LR L L SN L+ IP++ W+L ++L + SSN L
Sbjct: 664 LGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLT 723
Query: 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTS 583
G+LP ++GNMK + ++LS+N ++G IP+ +G L L LSL NRL GPI FG L S
Sbjct: 724 GNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVS 783
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLC 643
LESLDLS NNLSG IP SLE L+YLK LN+SFN+L+GEIP+GG F F+A+SFM N+ LC
Sbjct: 784 LESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALC 843
Query: 644 GSPHLQVPLCKSSPHQKS--SKNVILLGVVLPL-SVFIIAILLALGIGLITRYRKGNTEL 700
G+PH QV C + +S +K+ IL ++LP+ S + + + L I R+ N E+
Sbjct: 844 GAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWI-----RRRDNMEI 898
Query: 701 SNIEVNMSPQAMW-----RRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAI 755
+P W + S+++LL AT+ F E +LIG GS G VYKG +G+ VAI
Sbjct: 899 P------TPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAI 952
Query: 756 KVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS 815
KVF+L+F GAL+SFD+ECEV++ +RHRNLV+II+ CSN +FKALVLEYM NGSLEK LYS
Sbjct: 953 KVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYS 1012
Query: 816 SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875
N LD+ QRL+IMIDVA ALEYLH S+ VVHCD+KPSN+LLDDDMVAH++DFGIAKL
Sbjct: 1013 HNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKL 1072
Query: 876 LNGEESM-RTQTLGTIGYMAP 895
L ESM +T+TLGTIGYMAP
Sbjct: 1073 LTETESMQQTKTLGTIGYMAP 1093
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1908), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/914 (49%), Positives = 587/914 (64%), Gaps = 83/914 (9%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL 104
+V L+ ++F TG+I +GNL L+ L L +N +G IP S+F+IS LK L L N L
Sbjct: 193 QVIYLSFNEF--TGSIPRAIGNLVELERLSLRNNSLTGEIPQSLFNISRLKFLSLAANNL 250
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
G PS ++ + LR +D + N +G IP+ IG+L+ L+ LYLG+N+L G
Sbjct: 251 KGEIPSSLL-HCRELRLLDLSINQFTG--------FIPQAIGSLSNLETLYLGFNQLAGG 301
Query: 165 IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG------------- 211
IP E+GNL+ L L+ S L+G IP+ IFN+SSL E+ F+NNSL+G
Sbjct: 302 IPGEIGNLSNLNLLNSASSGLSGPIPAEIFNISSLQEIGFANNSLSGSLPMDICKHLPNL 361
Query: 212 --------------------------FYMTNNHFTGSIPR---NLWQCE----------- 231
+ N+FTGSIPR NL + E
Sbjct: 362 QWLLLSLNQLSGQLPTTLSLCGELLTLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTG 421
Query: 232 -IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIG- 289
IP E+GNL NL+ L ++ N+L G VP IFN+S L+ LSL N LSGSLPSS IG
Sbjct: 422 NIPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSS----IGS 477
Query: 290 -LPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
LPN+E+L +G N SG IP I N S L L+++ N F G +P L NLR L+ LGL +
Sbjct: 478 WLPNLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSH 537
Query: 349 NYLTS--STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR 406
N LT+ S EL+FL+SL N + + +++NPL G++P+S+GNL I+LE IY +C++R
Sbjct: 538 NQLTNEHSASELAFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLR 597
Query: 407 GNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSE 466
G IP I NL NL L L +N L+G IP GRL LQ L + N++ G IP LC L+
Sbjct: 598 GTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTN 657
Query: 467 L---HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
L + NKLSG IP+C GNL LRN+ L SN L+S IPS+ NL +L + SSN LN
Sbjct: 658 LAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLN 717
Query: 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTS 583
LPL +GNMK +V ++LS+N +G+IP+TI L NL L L +N+L G IP +FG L S
Sbjct: 718 SQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVS 777
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLC 643
LESLDLS NNLSG IP SLE L YL+ LN+SFN+L+GEIP+GG FANF+A+SF+ N LC
Sbjct: 778 LESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALC 837
Query: 644 GSPHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSN- 702
G+P QV C+ + + +LL ++PLSV + I+L + L ++++ T+
Sbjct: 838 GAPRFQVMACEKDSRKNTKS--LLLKCIVPLSVSLSTIILVV---LFVQWKRRQTKSETP 892
Query: 703 IEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF 762
I+V++S M R ++ELL AT++F E +LIG GS G VYKG DG+ VA+KVF+L+
Sbjct: 893 IQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLEL 952
Query: 763 DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDI 822
GA KSF+ ECEV++++RHRNL KIISSCSN +FKALVLEYM NGSLEK LYS N LD
Sbjct: 953 QGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDF 1012
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882
QRL IMIDVA LEYLH YSNPVVHCD+KPSN+LLDDDMVAH+SDFGIAKLL G E M
Sbjct: 1013 VQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFM 1072
Query: 883 -RTQTLGTIGYMAP 895
RT+TLGT+GYMAP
Sbjct: 1073 KRTKTLGTVGYMAP 1086
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.850 | 0.748 | 0.381 | 4e-122 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.907 | 0.698 | 0.337 | 2.4e-108 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.779 | 0.685 | 0.344 | 1.4e-85 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.759 | 0.842 | 0.359 | 3e-101 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.666 | 0.534 | 0.332 | 6e-101 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.931 | 0.832 | 0.334 | 1.5e-99 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.919 | 0.740 | 0.315 | 2.8e-98 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.830 | 0.599 | 0.311 | 1.1e-80 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.943 | 0.814 | 0.314 | 1.2e-95 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.864 | 0.772 | 0.331 | 1.1e-94 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 321/841 (38%), Positives = 450/841 (53%)
Query: 97 LILGDNQLSGSF-PSFIISNTSSLRAIDCNYNSLSGELPANIFR---------------- 139
L+L + LSG PS + N S LR +D N LSGE+P + R
Sbjct: 84 LLLRSSNLSGIISPS--LGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQG 141
Query: 140 AIPKDIGNLTKLKELYLGYNKLQGEIPQELG-NLAELEWLSLPRSFLTGTIPSSIFNLSS 198
+IP IG TKL L L +N+L+G IP+E+G +L L L L ++ L+G IPS++ NL+S
Sbjct: 142 SIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTS 201
Query: 199 LLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPN 258
L E D S N L+G IP +G L +L + + +N+L G +PN
Sbjct: 202 LQEFDLSFNRLSG-------------------AIPSSLGQLSSLLTMNLGQNNLSGMIPN 242
Query: 259 TIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGLPNIERXXXXXXXXSGRIPGFIFNASKLF 318
+I+N+S+L+A + L +E G+IP + NAS L
Sbjct: 243 SIWNLSSLRAFSVRENKLGGMIPTNAFKTLHL--LEVIDMGTNRFHGKIPASVANASHLT 300
Query: 319 LLELTGNSFSGFIPDTLVNLRNLEHLGLGYN-YLTSSTPEXXXXXXXXXXXXXKYIVLAE 377
++++ GN FSG I LRNL L L N + T + + + L E
Sbjct: 301 VIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGE 360
Query: 378 NPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV 437
N L GVLP+S NL +L + L+ KI G+IPK+IGNL+ L L+L NN GS+P ++
Sbjct: 361 NNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSL 420
Query: 438 GRLNTLQGLGLENNKLEGPIPDDLCQLSELHV---DHNKLSGPIPACFGXXXXXXXXXXX 494
GRL L L N L G IP + L+EL++ NK SG IP
Sbjct: 421 GRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLS 480
Query: 495 XXXXXXFIPSTFWNLNNI-LSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553
IPS +N+ + + + S N+L GS+P +IG++K +VE + N L+G IP T
Sbjct: 481 TNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNT 540
Query: 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNL 613
+G L+ L L+NN L G IP + G L LE+LDLS NNLSG IP SL + L LNL
Sbjct: 541 LGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNL 600
Query: 614 SFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS-PHLQVPLCKSSPHQKSSKNVILLGVVL 672
SFN GE+P+ G+FA S S GN LCG P L +P C P ++ K+ VL
Sbjct: 601 SFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRC--CPLLENRKHF----PVL 654
Query: 673 PLSV-FXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEK 731
P+SV + K + + +M + SY +L+ ATD F+
Sbjct: 655 PISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPL---VSYSQLVKATDGFAPT 711
Query: 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 791
+L+G GSFG+VYKG+ VA+KV L+ ALKSF AECE L+++RHRNLVKI++ C
Sbjct: 712 NLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTIC 771
Query: 792 SN----GN-FKALVLEYMANGSLEKCLY------SSNRSLDIFQRLSIMIDVALALEYLH 840
S+ GN FKA+V ++M NGSLE ++ + R L++ +R++I++DVA AL+YLH
Sbjct: 772 SSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLH 831
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQT-----LGTIGYMA 894
PVVHCDIK SN+LLD DMVAH+ DFG+A++L +G ++ T +GTIGY A
Sbjct: 832 RHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAA 891
Query: 895 P 895
P
Sbjct: 892 P 892
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
Identities = 292/864 (33%), Positives = 433/864 (50%)
Query: 56 LTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISN 115
LTG+I +G L++L LDLS N+ +G IP ++ L+ L+L +N L G P+ I N
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEI-GN 262
Query: 116 TSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
SSL ++ N L+G++PA ++GNL +L+ L + NKL IP L L +L
Sbjct: 263 CSSLVQLELYDNQLTGKIPA--------ELGNLVQLQALRIYKNKLTSSIPSSLFRLTQL 314
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFY---MTN--NHFTGSIPRNLWQC 230
L L + L G I I L SL L +N+ TG + +TN N ++ N
Sbjct: 315 THLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISG 374
Query: 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGL 290
E+P ++G L NL L +N L G +P++I N + LK G
Sbjct: 375 ELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG----FGR 430
Query: 291 PNIERXXXXXXXXSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
N+ +G IP IFN S L L + N+ +G + + L+ L L + YN
Sbjct: 431 MNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNS 490
Query: 351 LTSSTPEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410
LT P + L N G +P + NL + L+ + + + + G IP
Sbjct: 491 LTGPIPREIGNLKDL-----NILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIP 544
Query: 411 KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELH-- 468
+E+ ++ L+ L L NN+ SG IP +L +L L L+ NK G IP L LS L+
Sbjct: 545 EEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTF 604
Query: 469 -VDHNKLSGPIPA--CFGXXXXXXXXXXXXXXXXXFIPSTFWNLNNILSFDFSSNSLNGS 525
+ N L+G IP IP L + D S+N +GS
Sbjct: 605 DISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGS 664
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPIPESFGALTSL 584
+P + K V ++ S+N L+G IP + G+ + L+L N G IP+SFG +T L
Sbjct: 665 IPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHL 724
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCG 644
SLDLS NNL+G IP SL L LK L L+ N L+G +P G F N +A MGN LCG
Sbjct: 725 VSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCG 784
Query: 645 SPHLQVPLC---KSSPHQKSSKNV-ILLGVVLPLSVFXXXXXXXXXXXXXTRYRKGNTEL 700
S P KSS K ++ + I+LG L + + + ++E
Sbjct: 785 SKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSES 844
Query: 701 SNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHL 760
S +++ + + +RF +EL ATD F+ ++IG S TVYKG+ DG +A+KV +L
Sbjct: 845 SLPDLDSALKL--KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNL 902
Query: 761 -QFDGAL-KSFDAECEVLKSVRHRNLVKIIS-SCSNGNFKALVLEYMANGSLEKCLYSSN 817
+F K F E + L ++HRNLVKI+ + +G KALVL +M NG+LE ++ S
Sbjct: 903 KEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSA 962
Query: 818 RSL-DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
+ + +++ + + +A ++YLH GY P+VHCD+KP+NILLD D VAH+SDFG A++L
Sbjct: 963 APIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022
Query: 877 ----NGEESMRTQTL-GTIGYMAP 895
+G + T GTIGY+AP
Sbjct: 1023 GFREDGSTTASTSAFEGTIGYLAP 1046
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 254/737 (34%), Positives = 358/737 (48%)
Query: 99 LGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGY 158
LG +L+G F+ N S LR+++ N G AIP ++GNL +L+ L +
Sbjct: 88 LGGLKLTGVVSPFV-GNLSFLRSLNLADNFFHG--------AIPSEVGNLFRLQYLNMSN 138
Query: 159 NKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG-FYMTNN 217
N G IP L N + L L L + L +P +LS L+ L N+LTG F +
Sbjct: 139 NLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLG 198
Query: 218 HFTG----SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKAXXXXX 273
+ T N + EIP +I L + I N G P I+N+S+L
Sbjct: 199 NLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITG 258
Query: 274 XXXXXXXXXXXXXXIGLPNIERXXXXXXXXSGRIPGFIFNASKLFLLELTGNSFSGFIPD 333
LPN++ +G IP + N S L L++ N +G IP
Sbjct: 259 NSFSGTLRPDFGSL--LPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPL 316
Query: 334 TLVNLRNLEHLGLGYNYLTS-STPEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLP 392
+ L+NL LGL N L + S+ + +Y+ + N L G LP I NL
Sbjct: 317 SFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLS 376
Query: 393 ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
L E+ L I G+IP IGNLV+L TL LG N L+G +P ++G L+ L+ + L +N
Sbjct: 377 TQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNG 436
Query: 453 LEGPIPDDLCQLSEL---HVDHNKLSGPIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNL 509
L G IP L +S L ++ +N G IP+ G IP L
Sbjct: 437 LSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMEL 496
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNR 569
+++ + S N L G L DIG +K ++ +++S N L+G IP T+ +L+ L L+ N
Sbjct: 497 PSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNS 556
Query: 570 LHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFA 629
GPIP+ G LT L LDLS NNLSG IP + L++LNLS N +G +P+ G F
Sbjct: 557 FVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFR 615
Query: 630 NFSAQSFMGNDLLCGS-PHLQVPLCKSS-PHQKSSKNVILLGVVLPLSVFXXXXXXXXXX 687
N SA S GN LCG P LQ+ C P + SS I+ V +
Sbjct: 616 NTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVY 675
Query: 688 XXXTRYRKGNTELSNIEVN--MSP-QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYK 744
+ R + +N E + SP ++ + + SY EL T FS +LIG G+FG V+K
Sbjct: 676 LCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFK 735
Query: 745 GRFLDGME--VAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GN-FK 797
G FL VAIKV +L GA KSF AECE L +RHRNLVK+++ CS+ GN F+
Sbjct: 736 G-FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFR 794
Query: 798 ALVLEYMANGSLEKCLY 814
ALV E+M NG+L+ L+
Sbjct: 795 ALVYEFMPNGNLDMWLH 811
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1004 (358.5 bits), Expect = 3.0e-101, P = 3.0e-101
Identities = 259/720 (35%), Positives = 378/720 (52%)
Query: 135 ANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF 194
+N+ I +GNL+ L+ L L N L G+IPQEL L+ L+ L L + L+G IP+++
Sbjct: 88 SNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALG 147
Query: 195 NLSSLLELDFSNNSLTGFYMTN-NHFTG----SIPRNLWQCEIPHEIGNLPNLEVLGIDE 249
NL+SL L+ +NN+L+G ++ TG ++ N IP G L L L +
Sbjct: 148 NLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAF 207
Query: 250 NHLVGDVPNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGLPNIERXXXXXXXXSGRIPG 309
N+L G +P+ I+N+S+L LP+++ GRIP
Sbjct: 208 NNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFS--NLPSLQEVYMYYNQFHGRIPA 265
Query: 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSS-TPEXXXXXXXXXXX 368
I NAS + + + NSFSG +P + +RNL+ L L + T +
Sbjct: 266 SIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCS 325
Query: 369 XXKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQ 428
+ + L GVLP S+ NL +L + +++ KI G++P++IGNLVNL L L NN
Sbjct: 326 NLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNS 385
Query: 429 LSGSIPITVGRLNTLQGLGLENNKLEGPIP---DDLCQLSELHVDHNKLSGPIPACFGXX 485
L+GS+P + +L L+ L ++NNKL G +P +L QL+ + V N G IP+ G
Sbjct: 386 LTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNL 445
Query: 486 XXXXXXXXXXXXXXXFIPSTFWNLNNILSF-DFSSNSLNGSLPLDIGNMKVVVEINLSRN 544
IP +++ + D S N+L GS+P +IG +K +VE + N
Sbjct: 446 TKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSN 505
Query: 545 YLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEK 604
L+G+ P+TIG LQ L L+NN L+G IP + L L++LDLS NNLSG IP+SL
Sbjct: 506 KLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGD 565
Query: 605 LVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS-PHLQVPLCKSSPHQKSSK 663
+ L LNLSFN GE+P+ G FAN S GN +CG P L +P C +K
Sbjct: 566 MPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKH 625
Query: 664 NVILLGVVLPLSVFXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYRELLL 723
++LL VV+ L T +++ E+ +M M +Y++L+
Sbjct: 626 QILLLVVVICL--VSTLAVFSLLYMLLTCHKRRKKEVP-ATTSMQGHPM---ITYKQLVK 679
Query: 724 ATDHFSEKSLIGIGSFGTVYKGRF--LDG---MEVAIKVFHLQFDGALKSFDAECEVLKS 778
ATD FS L+G GSFG+VYKG F DG VA++V L+ ALKSF AECE L++
Sbjct: 680 ATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRN 739
Query: 779 VRHRNLVKIISSCSN----GN-FKALVLEYMANGSLEKCLY------SSNRSLDIFQRLS 827
RHRNLVKI++ CS+ GN FKA+V ++M NGSLE L+ + R L + QR+S
Sbjct: 740 TRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 6.0e-101, Sum P(2) = 6.0e-101
Identities = 215/647 (33%), Positives = 320/647 (49%)
Query: 2 ANNINTTDQQALLALKAR------ITAKNWTS-NTSVCSWIGITCDV-----STHR--VT 47
+ ++N+ D Q LL LK R NW + + C+WIG+ C S++ VT
Sbjct: 30 SESLNS-DGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVT 88
Query: 48 ALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGS 107
+L++S L+G +S +G L +L L+L++N +G IP I + S L+++ L +NQ GS
Sbjct: 89 SLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGS 148
Query: 108 FPSFIISNTSSLRAID-CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
P I+ S LR+ + CN N LSG LP ++IG+L L+EL N L G +P
Sbjct: 149 IP-VEINKLSQLRSFNICN-NKLSGPLP--------EEIGDLYNLEELVAYTNNLTGPLP 198
Query: 167 QELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRN 226
+ LGNL +L ++ +G IP+ I +L L + N ++G +
Sbjct: 199 RSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEV 258
Query: 227 -LWQCE----IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKAXXXXXXXXXXXXX 281
LWQ + IP +IGNL +LE L + N LVG +P+ I NM +LK
Sbjct: 259 ILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIP 318
Query: 282 XXXXXXIGLPNIERXXXXXXXXSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNL 341
L + SG IP + S+L LL L N +G IP+ L LRNL
Sbjct: 319 KELGK---LSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNL 375
Query: 342 EHLGLGYNYLTSSTPEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNL-PITLEEIYL 400
L L N LT P + + L N L+GV+P +G P+ + + +
Sbjct: 376 AKLDLSINSLTGPIPPGFQNLTSM-----RQLQLFHNSLSGVIPQGLGLYSPLWVVD-FS 429
Query: 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD 460
+N ++ G IP I NL L+LG+N++ G+IP V R +L L + N+L G P +
Sbjct: 430 EN-QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTE 488
Query: 461 LCQL---SELHVDHNKLSGPIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNLNNILSFDF 517
LC+L S + +D N+ SGP+P G +P+ L+N+++F+
Sbjct: 489 LCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNV 548
Query: 518 SSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES 577
SSNSL G +P +I N K++ ++LSRN G +P +G L L++L L NR G IP +
Sbjct: 549 SSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFT 608
Query: 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLK-DLNLSFNRLEGEIP 623
G LT L L + N SG IP L L L+ +NLS+N GEIP
Sbjct: 609 IGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIP 655
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
Identities = 310/927 (33%), Positives = 451/927 (48%)
Query: 13 LLALKA--RITAKNWTSNTSVCSWIGITCDVSTHRVTALNI--SDFGLTGTISSQLGNLS 68
LLA A ++ A +T + + + I VS + AL+ + F L + G
Sbjct: 6 LLAFNALMQLEAYGFTDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKH 65
Query: 69 SLQT-LDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
T LDL + G I SI ++S L L L +N G+ P + N L+ + +N
Sbjct: 66 KRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEM-GNLFRLKYLAVGFN 124
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG 187
L GE+PA++ N ++L L L N L +P ELG+L +L +L L + L G
Sbjct: 125 YLEGEIPASL--------SNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKG 176
Query: 188 TIPSSIFNLSSLLELDFSNNSLTG-----FYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
P I NL+SL+ L+ N L G M + + ++ N + P NL +L
Sbjct: 177 KFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSL 236
Query: 243 EVLGIDENHLVGDVPNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGLPNIERXXXXXXX 302
E L + N G++ N+ L + +E
Sbjct: 237 ENLYLLGNGFSGNLKPDFGNL--LPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNR 294
Query: 303 XSGRI-PGFIFNASKLFLLELTGNSFSGF------IPDTLVNLRNLEHLGLGYNYLTSST 355
+G I P F L LEL NS + D L N +L L + YN L +
Sbjct: 295 MTGSISPNF-GKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGAL 353
Query: 356 PEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGN 415
P + L N + G +P IGNL I L+ + L + + G +P +GN
Sbjct: 354 PTSIVNMSTELTV----LNLKGNLIYGSIPHDIGNL-IGLQSLLLADNLLTGPLPTSLGN 408
Query: 416 LVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL--CQ-LSELHVDHN 472
LV L L L +N+ SG IP +G L L L L NN EG +P L C + +L + +N
Sbjct: 409 LVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYN 468
Query: 473 KLSGPIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGN 532
KL+G IP IP T +LN SNSL+GSLP DIG
Sbjct: 469 KLNGTIPK-----------------EIMQIP-TLVHLN------MESNSLSGSLPNDIGR 504
Query: 533 MKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
++ +VE+ L N L+G +P T+G +++++ L+ N G IP+ G L ++++DLS N
Sbjct: 505 LQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNN 563
Query: 593 NLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGS-PHLQVP 651
NLSG I E L+ LNLS N EG +P+ G F N + S GN LCGS L++
Sbjct: 564 NLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLK 623
Query: 652 LC-KSSPHQKSSKNVILLGVVLPLSV-FXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSP 709
C +P ++ +L V + +SV + RK N +++N +
Sbjct: 624 PCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINN-SAPFTL 682
Query: 710 QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKS 768
+ + SY +L ATD FS +++G GSFGTV+K + VA+KV ++Q GA+KS
Sbjct: 683 EIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKS 742
Query: 769 FDAECEVLKSVRHRNLVKIISSCSN----GN-FKALVLEYMANGSLEKCLYSS------- 816
F AECE LK +RHRNLVK++++C++ GN F+AL+ E+M NGSL+K L+
Sbjct: 743 FMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHR 802
Query: 817 -NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875
+R+L + +RL+I IDVA L+YLH P+ HCD+KPSNILLDDD+ AH+SDFG+A+L
Sbjct: 803 PSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARL 862
Query: 876 LN--GEESMRTQ-----TLGTIGYMAP 895
L +ES Q GTIGY AP
Sbjct: 863 LLKFDQESFFNQLSSAGVRGTIGYAAP 889
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 275/871 (31%), Positives = 416/871 (47%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+T L +S LTG+I S LGNL +L L L N +G IP + ++ ++ L L N+L+
Sbjct: 176 MTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLT 235
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
GS PS + N +L + N L+G IP +IGN+ + L L NKL G I
Sbjct: 236 GSIPS-TLGNLKNLMVLYLYENYLTG--------VIPPEIGNMESMTNLALSQNKLTGSI 286
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTN-----NHFT 220
P LGNL L LSL +++LTG IP + N+ S+++L+ SNN LTG ++ N
Sbjct: 287 PSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTI 346
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKAXXXXXXXXXXXX 280
+ N IP E+GN+ ++ L ++ N L G +P++ N+ L
Sbjct: 347 LYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVI 406
Query: 281 XXXXXXXIGLPNIERXXXXXXXXSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRN 340
+ N++ +G +P N +KL L L N SG IP + N +
Sbjct: 407 PQELGNMESMINLD---LSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSH 463
Query: 341 LEHLGLGYNYLTSSTPEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLPITLEEIYL 400
L L L N T PE Y N L G +P S+ + + +L
Sbjct: 464 LTTLILDTNNFTGFFPETVCKGRKLQNISLDY-----NHLEGPIPKSLRDCKSLIRARFL 518
Query: 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD 460
N K G+I + G +L + +N+ G I + L L + NN + G IP +
Sbjct: 519 GN-KFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTE 577
Query: 461 L---CQLSELHVDHNKLSGPIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNLNNILSFDF 517
+ QL EL + N L G +P G +P+ L N+ S D
Sbjct: 578 IWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDL 637
Query: 518 SSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES 577
SSN+ + +P + + ++NLSRN G IP + LT L L L +N+L G IP
Sbjct: 638 SSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQ 696
Query: 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFM 637
+L SL+ LDLS NNLSG+IP + E ++ L ++++S N+LEG +P +F +A +
Sbjct: 697 LSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALE 756
Query: 638 GNDLLCGS-PHLQVPLCKSSPHQKSSKNVILLGVVLPLSVFXXXXXXXXXXXXXTRYRK- 695
N LC + P ++ C+ K + N+++ +V L V R RK
Sbjct: 757 ENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKL 816
Query: 696 --G-NTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME 752
G NT+ E NMS ++ +F Y++++ +T+ F LIG G + VY+ D +
Sbjct: 817 QNGRNTDPETGE-NMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI- 874
Query: 753 VAIKVFHLQFDGAL------KSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806
+A+K H D + + F E + L +RHRN+VK+ CS+ L+ EYM
Sbjct: 875 IAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEK 934
Query: 807 GSLEKCLYSSNRS--LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864
GSL K L + + L +R++++ VA AL Y+H P+VH DI NILLD+D
Sbjct: 935 GSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYT 994
Query: 865 AHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
A +SDFG AKLL + S + GT GY+AP
Sbjct: 995 AKISDFGTAKLLKTDSSNWSAVAGTYGYVAP 1025
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 1.1e-80, P = 1.1e-80
Identities = 249/800 (31%), Positives = 375/800 (46%)
Query: 56 LTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISN 115
L G I L +L +LQTLDLS N +G IP +++S L L+L +N LSGS P I SN
Sbjct: 275 LQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSN 334
Query: 116 TSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
++L + + LSGE+P ++ LK+L L N L G IP+ L L EL
Sbjct: 335 NTNLEQLVLSGTQLSGEIPV--------ELSKCQSLKQLDLSNNSLAGSIPEALFELVEL 386
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIP-----RNLWQC 230
L L + L GT+ SI NL++L L +N+L G + N +
Sbjct: 387 TDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSG 446
Query: 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGL 290
EIP EIGN +L+++ + NH G++P +I + L L
Sbjct: 447 EIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQL 506
Query: 291 PNIERXXXXXXXXSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
NI SG IP L L L NS G +PD+L++LRNL + L +N
Sbjct: 507 -NI--LDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNR 563
Query: 351 LTSSTPEXXXXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410
L + + N +P +GN L+ + L ++ G IP
Sbjct: 564 LNGTIHPLCGSSSYLSFD------VTNNGFEDEIPLELGNSQ-NLDRLRLGKNQLTGKIP 616
Query: 411 KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSEL 467
+G + L+ L + +N L+G+IP+ + L + L NN L GPIP L QL EL
Sbjct: 617 WTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGEL 676
Query: 468 HVDHNKLSGPIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNLN--NILSFDFSSNSLNGS 525
+ N+ +P IP NL N+L+ D N +GS
Sbjct: 677 KLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLD--KNQFSGS 734
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ-LLSLENNRLHGPIPESFGALTSL 584
LP +G + + E+ LSRN LTG+IP IG L +LQ L L N G IP + G L+ L
Sbjct: 735 LPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKL 794
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCG 644
E+LDLS N L+G +P S+ + L LN+SFN L G++ F+ + A SF+GN LCG
Sbjct: 795 ETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCG 852
Query: 645 SPHLQVPLCKSSPHQK--SSKNVILLGVVLPLSVFXXXXXXXXXXXXXTR--YRK-GNTE 699
SP + +S+ Q+ S+++V+++ + L+ ++K G+
Sbjct: 853 SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGS 912
Query: 700 LSNIEVNMSPQA----MWRR------FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD 749
+ + S QA ++R + +++ AT + SE+ +IG G G VYK +
Sbjct: 913 TAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELEN 972
Query: 750 GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FKALVLEYMAN 806
G VA+K + D + KSF E + L +RHR+LVK++ CS+ + L+ EYM N
Sbjct: 973 GETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKN 1032
Query: 807 GSLEKCLYSSNRSLDIFQRL 826
GS+ L+ L+ ++L
Sbjct: 1033 GSIWDWLHEDKPVLEKKKKL 1052
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 1.2e-95, P = 1.2e-95
Identities = 284/903 (31%), Positives = 425/903 (47%)
Query: 24 NWTS-NTS-VC-SWIGITCDVSTHRVTALNISDFGLTGTISS-QLGNLSSLQTLDLSHNR 79
+W + NTS C SW G+ C + + + LN+++ G+ GT +L +L +DLS NR
Sbjct: 72 SWVNPNTSSFCTSWYGVACSLGS--IIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNR 129
Query: 80 FSGTIPSSIFSISTLKILILGDNQLSGSFPSFI--ISNTSSLRAIDCNYNSLSGELPANI 137
FSGTI S L+ L NQL G P + +SN +L ++ N L+G
Sbjct: 130 FSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVE---NKLNG------ 180
Query: 138 FRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLS 197
+IP +IG LTK+ E+ + N L G IP GNL +L L L + L+G+IPS I NL
Sbjct: 181 --SIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLP 238
Query: 198 SLLELDFSNNSLTG-----FYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHL 252
+L EL N+LTG F N ++ N EIP EIGN+ L+ L + N L
Sbjct: 239 NLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKL 298
Query: 253 VGDVPNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGLPNIERXXXXXXXXSGRIPGFIF 312
G +P+T+ N+ TL + ++E +G +P
Sbjct: 299 TGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLE---ISENKLTGPVPDSFG 355
Query: 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEXXXXXXXXXXXXXKY 372
+ L L L N SG IP + N L L L N T P+ +
Sbjct: 356 KLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKL-----EN 410
Query: 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432
+ L +N G +P S+ + +L + + G+I + G L + L NN G
Sbjct: 411 LTLDDNHFEGPVPKSLRDCK-SLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQ 469
Query: 433 IPITVGRLNTLQGLGLENNKLEGPIPDDL---CQLSELHVDHNKLSGPIPACFGXXXXXX 489
+ + L L NN + G IP ++ QLS+L + N+++G +P
Sbjct: 470 LSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRIS 529
Query: 490 XXXXXXXXXXXFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549
IPS L N+ D SSN + +P + N+ + +NLSRN L
Sbjct: 530 KLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQT 589
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK 609
IP + L+ LQ+L L N+L G I F +L +LE LDLS NNLSG IP S + ++ L
Sbjct: 590 IPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALT 649
Query: 610 DLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPL--CKSSPHQKSSKN--- 664
+++S N L+G IP +F N +F GN LCGS + L C + +KS K+
Sbjct: 650 HVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNL 709
Query: 665 --VILLGVVLPLSVFXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSPQAMWRRFSYRELL 722
IL+ ++ + + T+ + +T+ + +S + + Y+E++
Sbjct: 710 IIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEII 769
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS------FDAECEVL 776
AT F K LIG G G VYK + + + +A+K + D ++ + F E L
Sbjct: 770 KATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRAL 828
Query: 777 KSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN--RSLDIFQRLSIMIDVAL 834
+RHRN+VK+ CS+ LV EYM GSL K L + + + LD +R++++ VA
Sbjct: 829 TEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAH 888
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMA 894
AL Y+H S +VH DI NILL +D A +SDFG AKLL + S + GT GY+A
Sbjct: 889 ALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVA 948
Query: 895 PGL 897
P L
Sbjct: 949 PEL 951
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 286/863 (33%), Positives = 416/863 (48%)
Query: 73 LDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGE 132
L+L + G I SI ++S L L L +N G+ P + S L +D N L G
Sbjct: 71 LELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEV-GQLSRLEYLDMGINYLRGP 129
Query: 133 LPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSS 192
+P ++ N ++L L L N+L G +P ELG+L L L+L + + G +P+S
Sbjct: 130 IPLGLY--------NCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTS 181
Query: 193 IFNLSSLLELDFSNNSLTGFYMTN-----NHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247
+ NL+ L +L S+N+L G ++ ++ + N + P + NL +L++LGI
Sbjct: 182 LGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGI 241
Query: 248 DENHLVGDV-PNTIFNMSTLKAXXXXXXXXXXXXXXXXXXXIGLPNIERXXXXXXXXSGR 306
NH G + P+ + L + + +ER +G
Sbjct: 242 GYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLS---NISTLERLGMNENNLTGS 298
Query: 307 IPGFIFNASKLFLLELTGNSFSG-------FIPDTLVNLRNLEHLGLGYNYLTSSTPEXX 359
IP F N L LL L NS F+ +L N LE LG+G N L P
Sbjct: 299 IPTF-GNVPNLKLLFLHTNSLGSDSSRDLEFLT-SLTNCTQLETLGIGRNRLGGDLPISI 356
Query: 360 XXXXXXXXXXXKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNL 419
+ L ++G +P IGNL I L+++ L + G +P +G L+NL
Sbjct: 357 ANLSAKLVT----LDLGGTLISGSIPYDIGNL-INLQKLILDQNMLSGPLPTSLGKLLNL 411
Query: 420 TTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL--CQ-LSELHVDHNKLSG 476
L L +N+LSG IP +G + L+ L L NN EG +P L C L EL + NKL+G
Sbjct: 412 RYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNG 471
Query: 477 PIPACFGXXXXXXXXXXXXXXXXXFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVV 536
IP +P L N+ + N L+G LP +GN +
Sbjct: 472 TIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTM 531
Query: 537 VEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596
+ L N GDIP + GL ++ + L NN L G IPE F + + LE L+LS NNL G
Sbjct: 532 ESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEG 590
Query: 597 VIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSS 656
+P+ K ++ +S + G G F + C S Q P
Sbjct: 591 KVPV---KGIFENATTVS---IVGNNDLCGGIMGFQLKP-------CLS---QAPSVVKK 634
Query: 657 PHQKSSKNVIL---LGVVLPLSVFXXXXXXXXXXXXXTRYRKGNTELSNIEVNMSPQAMW 713
H K V++ +G+ L L +F R RK N E +N + + +
Sbjct: 635 -HSSRLKKVVIGVSVGITLLLLLFMASVTLIWL-----RKRKKNKETNN-PTPSTLEVLH 687
Query: 714 RRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAE 772
+ SY +L AT+ FS +++G GSFGTVYK L +V A+KV ++Q GA+KSF AE
Sbjct: 688 EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAE 747
Query: 773 CEVLKSVRHRNLVKIISSCSN----GN-FKALVLEYMANGSLEKCLYSS--------NRS 819
CE LK +RHRNLVK++++CS+ GN F+AL+ E+M NGSL+ L+ +R+
Sbjct: 748 CESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRT 807
Query: 820 LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN-- 877
L + +RL+I IDVA L+YLH P+ HCD+KPSN+LLDDD+ AH+SDFG+A+LL
Sbjct: 808 LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKF 867
Query: 878 GEESMRTQ-----TLGTIGYMAP 895
EES Q GTIGY AP
Sbjct: 868 DEESFFNQLSSAGVRGTIGYAAP 890
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 902 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-101 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 5e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 337 bits (867), Expect = e-101
Identities = 282/903 (31%), Positives = 425/903 (47%), Gaps = 136/903 (15%)
Query: 24 NWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGT 83
NW S+ VC W GITC+ S+ RV ++++S ++G ISS + L +QT++LS+N+ SG
Sbjct: 50 NWNSSADVCLWQGITCNNSS-RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGP 108
Query: 84 IPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANI----- 137
IP IF + S+L+ L L +N +GS P I N L +D + N LSGE+P +I
Sbjct: 109 IPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSS 165
Query: 138 -----------FRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
IP + NLT L+ L L N+L G+IP+ELG + L+W+ L + L+
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 187 GTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
G IP I L+SL LD N+LTG IP +GNL NL+ L
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTG-------------------PIPSSLGNLKNLQYLF 266
Query: 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306
+ +N L G +P +IF++ L +L L +N+LSG +P +I L N+E L+L NN +G+
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL---VIQLQNLEILHLFSNNFTGK 323
Query: 307 IPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLAN 366
IP + + +L +L+L N FSG IP L NL L L N LT PE L +
Sbjct: 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE-----GLCS 378
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
S + ++L N L G +P S+G +L + LQ+ G +P E L + L + N
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACR-SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLN 486
N L G I + K + P L L + NK G +P FG+
Sbjct: 438 NNLQGRI---------------NSRKWDMP------SLQMLSLARNKFFGGLPDSFGSKR 476
Query: 487 SLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546
L NL L N+ S +P +L+ ++ ++ LS N L
Sbjct: 477 -LENLDLSRNQFSGAVPRKLGSLSELM------------------------QLKLSENKL 511
Query: 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV 606
+G+IP + L L L +N+L G IP SF + L LDLS N LSG IP +L +
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 607 YLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQ-VPLCKSSPHQKSSKNV 665
L +N+S N L G +PS G+F +A + GN LCG +P CK S
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFY 631
Query: 666 I--LLGVVLPLSVFIIAILLALGIGLITRYRKGNTELSNIEVNMSPQAMW---------- 713
I LG L L++ + G + + N EL +E + W
Sbjct: 632 ITCTLGAFLVLAL--------VAFGFVFIRGRNNLELKRVE---NEDGTWELQFFDSKVS 680
Query: 714 RRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAE 772
+ + ++L + E+++I G G YKG+ + +GM+ +K + + S A+
Sbjct: 681 KSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD 736
Query: 773 CEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDV 832
+ ++H N+VK+I C + L+ EY+ +L + L R+L +R I I +
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGI 789
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
A AL +LH S VV ++ P I++D HL + LL T+ + Y
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL----CTDTKCFISSAY 844
Query: 893 MAP 895
+AP
Sbjct: 845 VAP 847
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 65/165 (39%), Positives = 93/165 (56%), Gaps = 6/165 (3%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G FGTVY R G +VAIK+ + L+ E E+LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ N LV+EY GSL+ L + L + L I++ + LEYLH SN ++H D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 852 IKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+KP NILLD D+ L+DFG++KLL ++S+ +GT YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 60/170 (35%), Positives = 86/170 (50%), Gaps = 7/170 (4%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLV 785
+ +G GSFG VY R G VAIKV + + E ++LK ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
++ + + LV+EY G L L L + + + ALEYLH S
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SK 116
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+VH D+KP NILLD+D L+DFG+A+ L+ E + T +GT YMAP
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-VGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 59/171 (34%), Positives = 89/171 (52%), Gaps = 7/171 (4%)
Query: 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL 784
+ +G GSFGTVYK + G VA+K+ + ++ E +L+ + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V++I + + + LV+EY G L S L + I + + LEYLH S
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N ++H D+KP NILLD++ V ++DFG+AK L S T +GT YMAP
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 6e-32
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 727 HFSEKSLIGIGSFGTVYKGR-----FLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVR 780
+K +G G+FG VYKG +VA+K + F E ++K +
Sbjct: 2 ELGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H N+V+++ C+ G +V EYM G L L L + L + + +A +EYL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
S VH D+ N L+ +++V +SDFG+++ + ++ R + G I +MAP
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 62/172 (36%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIIS 789
L+G GSFG+VY D G +A+K L D L++ + E +L S++H N+V+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 790 SCSN--GNFKALVLEYMANGSLEKCLYSSNRSLD--IFQRLSIMIDVALALEYLHFGYSN 845
S + N + LEY++ GSL L L + ++ + I L YLH SN
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SN 120
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAP 895
+VH DIK +NIL+D D V L+DFG AK L E+ GT +MAP
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 734 IGIGSFGTVYKGRFLD-----GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G+FG VYKG+ +EVA+K + ++ F E +++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
+ C+ +V+EYM G L L + L + LS + +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
+H D+ N L+ +++V +SDFG+++ L ++ R + I +MAP
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 11/170 (6%)
Query: 734 IGIGSFGTVYKGRFLDG-----MEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G+FG VYKG +EVA+K + ++ F E +++ + H N+VK+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCL-YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ C+ +V+EYM G L L + + L + LS + +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
+H D+ N L+ +++V +SDFG+++ L ++ + + I +MAP
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 63/170 (37%), Positives = 91/170 (53%), Gaps = 5/170 (2%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
F IG G FG VYK R G EVAIKV L+ + E ++LK +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
K S + +V+E+ + GSL+ L S+N++L Q + ++ LEYLH SN
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H DIK +NILL D L DFG++ L+ ++ R +GT +MAP
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 18/177 (10%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 788
+G G+FG VYKG+ EVA+K K F E V+K + H N+V+++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 789 SSCSNGNFKALVLEYMANGSLEKCL--------YSSNRSLDIFQRLSIMIDVALALEYLH 840
C+ LVLEYM G L L +L + LS I +A +EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
S VH D+ N L+ +D+V +SDFG+++ + ++ R +T G I +MAP
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 64/174 (36%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 727 HFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRN 783
++ LIG G+FG VYKG G VAIK L+ ALKS E ++LK+++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI--MIDVALALEYLHF 841
+VK I S + ++LEY NGSL + + + + L + V L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH- 116
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
V+H DIK +NIL D V L+DFG+A LN +GT +MAP
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRN 783
+ IG GSFG VY R DG +K L + DA E ++LK + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALEYLH 840
++K S +V+EY G L + + + F Q L + + LAL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
S ++H DIKP NI L + + L DFGI+K+L+ + +GT Y++P L
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 57/146 (39%), Positives = 83/146 (56%), Gaps = 8/146 (5%)
Query: 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIIS 789
+ IG G FG V G + G +VA+K L+ D A ++F AE V+ ++RH NLV+++
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF-QRLSIMIDVALALEYLHFGYSNPVV 848
GN +V EYMA GSL L S R++ Q+L +DV +EYL V
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAK 874
H D+ N+L+ +D+VA +SDFG+AK
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/172 (34%), Positives = 83/172 (48%), Gaps = 5/172 (2%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+ + IG G+ G VYK G EVAIK L+ + E ++K +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+V S G+ +V+EYM GSL + + ++ Q + +V LEYLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S V+H DIK NILL D L+DFG A L E+S R +GT +MAP
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 56/169 (33%), Positives = 85/169 (50%), Gaps = 6/169 (3%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
F +G GS+G+VYK + G VAIKV + + L+ E +LK +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
S +V+EY GS+ + +N++L + +I+ LEYLH SN
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H DIK NILL+++ A L+DFG++ L + R +GT +MAP
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 54/185 (29%), Positives = 82/185 (44%), Gaps = 31/185 (16%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRN 783
++G GS G VYK R G A+K H+ D K E + L+S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 784 LVKIISSCSNGNFK----ALVLEYMANGSLEKCLYSSNRSLDIFQRL---------SIMI 830
+VK C +K ++VLEYM GSL D+ +++ I
Sbjct: 61 VVK----CYGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIAR 106
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
+ L+YLH ++H DIKPSN+L++ ++DFGI+K+L +GT+
Sbjct: 107 QILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV 164
Query: 891 GYMAP 895
YM+P
Sbjct: 165 TYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 4/171 (2%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
+ + IG G++G VYK R G VAIKV L+ + E +LK RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V S + +V+EY GSL+ + L Q + + L YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---E 119
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H DIK +NILL +D L+DFG++ L + R +GT +MAP
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.0 bits (245), Expect = 5e-22
Identities = 67/177 (37%), Positives = 88/177 (49%), Gaps = 18/177 (10%)
Query: 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH-RNLVKI 787
+G GSFG VY R D VA+KV + ++ F E ++L S+ H N+VK+
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 788 ISSCSNGNFKALVLEYMANGSLEK--CLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ LV+EY+ GSLE L + L I+ + ALEYLH S
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 846 PVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQT------LGTIGYMAP 895
++H DIKP NILLD D V L DFG+AKLL S + +GT GYMAP
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 59/169 (34%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G GSFG V R D G A+KV ++ + E +L + H +VK+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPV 847
+ LVLEY G L L R S + + ++ LALEYLH S +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH---SLGI 114
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
++ D+KP NILLD D L+DFG+AK E RT T GT Y+AP
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFD-----AECEVLKSVR 780
+ IG GSFGTV K R DG + K G + + +E +L+ ++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELK 57
Query: 781 HRNLVKIISSCSNGNFKAL--VLEYMANGSL----EKCLYSSNRSLDIFQRLSIMIDVAL 834
H N+V+ + + + L V+EY G L +KC + ++ I+ + L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLL 116
Query: 835 ALEYLHFGY--SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
AL H N V+H D+KP+NI LD + L DFG+AK+L + S +GT Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 893 MAP 895
M+P
Sbjct: 177 MSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 53/168 (31%), Positives = 87/168 (51%), Gaps = 8/168 (4%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISS 790
IG G+ G V+K + + G VA+K L+ G E + L++ +H +VK++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 791 CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+G+ LV+EYM L + L R L Q S M + + Y+H +N ++H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAPGL 897
D+KP+N+L+ D V ++DFG+A+L + EE + + T Y AP L
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-20
Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 535 VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
+ + L L G IP I L +LQ ++L N + G IP S G++TSLE LDLS N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 595 SGVIPISLEKLVYLKDLNLSFNRLEGEIPS--GGSFANFSAQSFMGNDLLCGSPHLQVPL 652
+G IP SL +L L+ LNL+ N L G +P+ GG + ++ +F N LCG P L
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RA 536
Query: 653 CKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGN 697
C PH +G+ +SV A L + + R+ N
Sbjct: 537 C--GPHLSVGAK---IGIAFGVSV---AFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 59/175 (33%), Positives = 90/175 (51%), Gaps = 20/175 (11%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 786
IG G++G VYK R G VA+K ++ +G A++ E ++L+ +RH N+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 787 ---IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
I++S G+ +V EYM + L L S Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAPGL 897
SN ++H DIK SNIL+++D V L+DFG+A+ S T + T+ Y P L
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVRH 781
HF +IG G+FG V + D M+ K ++ G++++ E +L+ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNH 59
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
LV + S + LV++ + G L L S Q + ++ LALEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S ++H DIKP NILLD+ H++DF IA + + + T T GT GYMAP
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 59/171 (34%), Positives = 86/171 (50%), Gaps = 15/171 (8%)
Query: 734 IGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDA---ECEVLKSVRHRNLVKIIS 789
IG G+FG VY LD E+ A+K +Q D K+ E +VL+ ++H NLVK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 790 SCSNGNFKALVLEYMANGSLEK-CLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ + +EY + G+LE+ + + + ++ + LA YLH S+ +V
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA--YLH---SHGIV 121
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQ---TLGTIGYMAP 895
H DIKP+NI LD + V L DFG A L N +M + GT YMAP
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 4/144 (2%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
+G G FG V++G + + + VAIK+ + F E + LK +RH++L+ + + CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 794 GNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G ++ E M GSL L S + L + + + VA + YL +H D+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 853 KPSNILLDDDMVAHLSDFGIAKLL 876
NIL+ +D+V ++DFG+A+L+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 54/155 (34%), Positives = 87/155 (56%), Gaps = 10/155 (6%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH 781
LL + +IG G FG V +G + G +VA+K ++ D ++F E V+ + H
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHH 58
Query: 782 RNLVKIISSC-SNGNFKALVLEYMANGSLEKCLYSSNRSL-DIFQRLSIMIDVALALEYL 839
+NLV+++ NG + +V+E M+ G+L L + R+L + Q L +DVA +EYL
Sbjct: 59 KNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
S +VH D+ NIL+ +D VA +SDFG+A+
Sbjct: 117 E---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 56/170 (32%), Positives = 86/170 (50%), Gaps = 11/170 (6%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISSC 791
IG+G+ VY L +VAIK L + ++ E + + H N+VK +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRS--LDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
G+ LV+ Y++ GSL + SS LD +++ +V LEYLH SN +H
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLL--NGEES--MRTQTLGTIGYMAP 895
DIK NILL +D ++DFG++ L G+ + +R +GT +MAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 60/163 (36%), Positives = 86/163 (52%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G+ GTVY G EVAIK +LQ + E V++ +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH SN V+H DI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K NILL D L+DFG + E+S R+ +GT +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 15/169 (8%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 786
IG G++G VYK R L G VAIK L+F+ AL+ E ++LK + H N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ + LV E+M + L K + R L S + + L + H S+
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H D+KP N+L++ + V L+DFG+A+ T + T Y AP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 4e-18
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHL--QFDG----ALKSFDAECEVLKSVR 780
+ + +G G++G VYK R G VA+K L + +G AL+ E +LK ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H N+VK++ LV EY L+K L L SIM + L Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
S+ ++H D+KP NIL++ D V L+DFG+A+
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
D E+ ++G G++G VY R L + +AIK + ++ E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYS------SNRSLDIFQRLSIMIDVALALE 837
+V+ + S S F + +E + GSL L S N IF I+ L+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122
Query: 838 YLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
YLH N +VH DIK N+L++ V +SDFG +K L G GT+ YMAP
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 49/143 (34%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 791
IG G+FG VYKG EVA+K LK F E E+LK H N+VK+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+V+E + GSL L L + + L + +D A +EYL S +H D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N L+ ++ V +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 8/172 (4%)
Query: 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKII 788
++G G++G V K R G VAIK F D K+ E +VL+ +RH N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ LV EY+ LE L +S L S + + A+ Y H S+ ++
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAPGLWV 899
H DIKP NIL+ + V L DFG A+ L + T + T Y AP L V
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 11/177 (6%)
Query: 728 FSEKSLIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 784
F +G GS+G+VYK R D A+K L + DA E +L SV H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQR---LSIMIDVALALEYLHF 841
+ + +GN +V+EY G L K + + + I I + L+ LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
++H D+K +NILL + + + D GI+K+L + +TQ GT YMAP +W
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-KTQI-GTPHYMAPEVW 173
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 56/144 (38%), Positives = 78/144 (54%), Gaps = 10/144 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-- 791
IG G FG V G + G +VA+K ++ D ++F AE V+ +RH NLV+++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
G +V EYMA GSL L S RS L L +DV A+EYL +N VH
Sbjct: 71 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126
Query: 851 DIKPSNILLDDDMVAHLSDFGIAK 874
D+ N+L+ +D VA +SDFG+ K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/169 (35%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-----ALKSFDAECEVLKSVRHRNLVK 786
L+G GSFG+VY+G LD G A+K L DG A+K + E +L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ + + + LE + GSL K L S + L LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
VH DIK +NIL+D + V L+DFG+AK + E S G+ +MAP
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 7/174 (4%)
Query: 728 FSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 784
F + IG GSFG V+K R D A+K L + +A E VL + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGY 843
++ S + +V+EY NG L K L R L Q I + L L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
S ++H DIK N+ LD + D G+AKLL+ + +GT Y++P L
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 8/165 (4%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKIISSC 791
+G G+ G V K G +A+K L+ + A+ K E ++L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
N ++ +EYM GSL+K L + I + V L YLH + ++H D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 852 IKPSNILLDDDMVAHLSDFGIA-KLLNGEESMRTQTLGTIGYMAP 895
+KPSNIL++ L DFG++ +L+N S+ +GT YMAP
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 63/175 (36%), Positives = 84/175 (48%), Gaps = 13/175 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFD---AECEVLKSVRH 781
D F +G GSFG V R + A+K+ LK + E +L+S+RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
LV + S + + LV+EY+ G L L S R V LALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLH- 118
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
S +V+ D+KP N+LLD D ++DFG AK + G RT TL GT Y+AP
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 4/163 (2%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
+G G+FG VYK + + G+ A K+ ++ + L+ F E ++L +H N+V + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
N +++E+ G+L+ + R L Q + + AL +LH S+ V+H D+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K NILL D L+DFG++ R +GT +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 728 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRH 781
+ LIG G++G VY+G+ G VA+K+ +L D E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 782 ---RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS------IMIDV 832
N+ K S G +++EY GS+ R+L ++ I+ +V
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREV 110
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
+AL+Y+H V+H DIK +NIL+ + L DFG+A LLN S R+ +GT +
Sbjct: 111 LVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 893 MAP 895
MAP
Sbjct: 168 MAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK--SFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + +VA+K G + +F E +++K +RH LV++ + C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 792 SNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
S +V EYM+ GSL L S + L + Q + + +A + YL S +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
D+ NIL+ +++V ++DFG+A+L+ +E
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 55/154 (35%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVF---HLQFDGALKSFDAECEVL-KSVRHRNLVKI 787
+IG GSF TV + E AIK+ L + +K E EVL + H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
+ + VLEY NG L + + SLD ++ LALEYLH S +
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881
+H D+KP NILLD DM ++DFG AK+L+ S
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 58/175 (33%), Positives = 79/175 (45%), Gaps = 17/175 (9%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFD------AECEVLKSVR 780
F+ IG GSFG VYK VAIKV L+ ++ D E + L R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEIQFLSQCR 57
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+ K S G+ +++EY GS L LD I+ +V L LEYLH
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYLH 115
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H DIK +NILL ++ L+DFG++ L S R +GT +MAP
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 57/188 (30%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RH 781
T F +IG G++G VYK R G VAIK+ + D + E +L+ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNH 62
Query: 782 RNLVKIISSCSNGNFKA-----------LVLEYMANGS---LEKCLYSSNRSLDIFQRLS 827
N+ G F LV+E GS L K L + L
Sbjct: 63 PNIATFY-----GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 828 IMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887
I+ + L YLH N V+H DIK NILL + L DFG++ L+ R +
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 888 GTIGYMAP 895
GT +MAP
Sbjct: 175 GTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 732 SLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKS------FDA--ECEVLKSVRHR 782
+G G++ VYK R G VAIK L G K F A E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHP 62
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
N++ ++ + + LV E+M LEK + + L S M+ LEYLH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH-- 119
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
SN ++H D+KP+N+L+ D V L+DFG+A+
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 56/170 (32%), Positives = 80/170 (47%), Gaps = 7/170 (4%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIIS 789
L+G GS+G V K + + G VAIK F D + K E +LK +RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
LV E++ + L+ L LD + + + +E+ H S+ ++H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIH 123
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899
DIKP NIL+ V L DFG A+ L + T + T Y AP L V
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 791
IG G+ GTVYK G A+KV + + ++ E E+L+ V H N+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSL-DI-FQRLSIMIDVALALEYLHFGYSNPVVH 849
+ ++LE+M GSLE + + L D+ Q LS + YLH +VH
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-------GIAYLH---RRHIVH 191
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
DIKPSN+L++ ++DFG++++L ++GTI YM+P
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 58/163 (35%), Positives = 86/163 (52%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G+ GTVY G EVAI+ +LQ + E V++ ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH SN V+H DI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K NILL D L+DFG + E+S R+ +GT +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 734 IGIGSFGTVYKGR--FLD---GMEVAIKVF-HLQFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G FG V R L G +VA+K H + F+ E E+L+++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 788 ISSC--SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
C G L++EY+ +GSL L +++ + L + ++YL S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
+H D+ NIL++ + + +SDFG+AK+L
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 29/164 (17%)
Query: 734 IGIGSFGTVYKGRFL------DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRNLVK 786
+G G+FG V+ G D VA+K + A K F+ E E+L + +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRS-------------LDIFQRLSIMIDVA 833
C+ G+ +V EYM +G L K L S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 834 LALEYL---HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
+ YL HF VH D+ N L+ D+V + DFG+++
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 50/143 (34%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G++ ++VAIK+ +GA+ F E +V+ + H NLV++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ +V EYMANG L L L L + DV A+EYL SN +H D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N L+ +D V +SDFG+A+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 57/181 (31%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKS 778
+ + + S IG GS+G V+K R + G VAIK F D AL+ E +LK
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQ 56
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838
++H NLV +I LV EY + L + L + R + I+ A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
H + +H D+KP NIL+ L DFG A++L G T + T Y AP L
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 899 V 899
V
Sbjct: 173 V 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
I G++G V+ + G AIKV + + E ++L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
S LV+EY+ G L L + SLD + ++ LALEYLH SN ++H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESMR-------TQTLGTIGYMAP 895
D+KP NIL+D + L+DFG++K+ L + + +GT Y+AP
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 6e-16
Identities = 58/163 (35%), Positives = 86/163 (52%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G+ GTVY G EVAIK +LQ + E V++ ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G+ +V+EY+A GSL + + +D Q ++ + AL++LH SN V+H DI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K NILL D L+DFG + E+S R+ +GT +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 57/163 (34%), Positives = 88/163 (53%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G+ GTV+ + G EVAIK +LQ + E V+K +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G+ +V+EY+A GSL + + +D Q ++ + ALE+LH +N V+H DI
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K N+LL D L+DFG + E+S R+ +GT +MAP
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVR 780
+ IG G++G V G +VAIK FD DA E ++L+ +R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLR 57
Query: 781 HRNLVK---IISSCSNGNFKAL--VLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVAL 834
H N++ I+ S +F + V E M L K + S + D Q + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQ--YFLYQILR 114
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
L+YLH S V+H D+KPSNIL++ + + DFG+A+ ++ +E +
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 60/178 (33%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVRH 781
D +G G+FG V+ R + A+KV + LK E VLK V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR---SLDIFQRLSIMIDVALALEY 838
++++ + + F +++EY+ G L L +S R S +F I+ ALEY
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEY 116
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
LH S +V+ D+KP NILLD + L+DFG AK + RT TL GT Y+AP
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
IG G FG V+ G +L+ +VAIK +GA+ + F E +V+ + H LV++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ + LV E+M +G L L + L + +DV + YL S+ V+H D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLL 876
+ N L+ ++ V +SDFG+ + +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV 150
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-15
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS--FDAECEVLKSVRHRNLVKIISSC 791
+G G FG V G++ +VAIK+ +G++ F E +V+ + H LV++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ +V EYM+NG L L + Q L + DV + YL S +H D
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
+ N L+DD +SDFG+++ + +E T ++G+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGS 161
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 14/171 (8%)
Query: 734 IGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG V +GR ++VAIK D F E ++ H N++++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL-HFGYSNPV 847
+ ++ EYM NGSL+K L ++ + Q + ++ +A ++YL Y
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY---- 127
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
VH D+ NIL++ ++V +SDFG+++ L E+ T G I P W
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI----PIRW 174
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKII 788
K +G G +G VY+G + + VA+K L+ D ++ F E V+K ++H NLV+++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPV 847
C+ ++ E+M G+L L NR ++ L + ++ A+EYL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879
+H D+ N L+ ++ + ++DFG+++L+ G+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 9/170 (5%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVF--HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
++G G+FG V+ R D V IK + EC+VLK + H N+++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V+EY G+L + + S LD L + + LAL ++H + ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 849 HCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
H D+K NILLD MV + DFGI+K+L +S +GT Y++P L
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVVGTPCYISPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 20/180 (11%)
Query: 732 SLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGA---------LKSFDAECEVLKSVRH 781
+LIG GSFG+VY G G +A+K L A L + E +LK ++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
N+V+ + S + + + LEY+ GS+ L + + R + + + L YLH
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH- 123
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK------LLNGEESMRTQTLGTIGYMAP 895
+ ++H DIK +NIL+D+ +SDFGI+K L R G++ +MAP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIK--VFHLQFDGALKSFDAECEVLKSVR---H 781
+ E + IG G++GTVYK R L G VA+K L +G S E +LK + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 782 RNLVKIISSC-----SNGNFKALVLEYMA---NGSLEKCL---YSSNRSLDI-FQRLSIM 829
N+V+++ C LV E++ L KC D+ Q L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR-- 118
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
+++LH S+ +VH D+KP NIL+ D ++DFG+A++ E T + T
Sbjct: 119 -----GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVT 169
Query: 890 IGYMAP 895
+ Y AP
Sbjct: 170 LWYRAP 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 734 IGIGSFGTVYKGRFL--DG--MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKII 788
+G G+FG+V KG +L G +EVA+K + A K F E V+ + H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYSN 845
C LV+E G L K L R + + + VA+ + YL HF
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN-GEESMRTQTLG 888
VH D+ N+LL + A +SDFG+++ L G + R T G
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 45/171 (26%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 727 HFSEKSLIGIGSFGTVYKGRF-LDGME---VAIKVFHLQF-DGALKSFDAECEVLKSVRH 781
H +++ +IG G FG V++G + G + VAIK + + + F +E ++ H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL-H 840
N++++ + ++ EYM NG+L+K L + +Q + ++ +A ++YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE-ESMRTQTLGTI 890
Y VH D+ NIL++ ++ +SDFG++++L + E T + G I
Sbjct: 126 MNY----VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 733 LIGIGSFGTVYKGRF-LDG---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 787
+IG G FG V GR L G + VAIK + + + F +E ++ H N++ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-FGYSNP 846
+ +V EYM NGSL+ L + + Q + ++ +A ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE-ESMRTQTLGTI 890
VH D+ NIL++ ++V +SDFG++++L + E+ T G I
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 29/200 (14%)
Query: 720 ELLLATDHFSEKSLIGIGSFGTVYKGRF--LDGME----VAIKVFHLQFDGALKS-FDAE 772
E+ L+ F E+ +G G+FG VYKG + VAIK + ++ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 773 CEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN--------------- 817
E++ ++H N+V ++ C+ ++ EY+A+G L + L ++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
SLD L I I +A +EYL S+ VH D+ N L+ + + +SDFG+++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 878 GEESMRTQ--TLGTIGYMAP 895
+ R Q +L + +M P
Sbjct: 176 SADYYRVQSKSLLPVRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 4/143 (2%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIISSC 791
L+G G+FG V+KG D VA+K LK F +E +LK H N+VK+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ +V+E + G L L Q + +D A + YL S +H D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N L+ ++ V +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 53/178 (29%), Positives = 90/178 (50%), Gaps = 21/178 (11%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV-AIKVFHL----------QFDGALKSFDAECEVLKSVRH 781
LIG G++G VY + E+ A+K L + +K+ +E E LK + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
N+V+ + + + ++ LEY+ GS+ CL + R + R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK----LLNGEESMRTQTLGTIGYMAP 895
S ++H D+K N+L+D D + +SDFGI+K + + +++M Q G++ +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQ-FDGALKSFDAECEVLKSVRHRN 783
F++ IG GSFG V+KG +D VAIK+ L+ + ++ E VL
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+ K S G +++EY+ GS L + D FQ +++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH--- 118
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +H DIK +N+LL + L+DFG+A L + R +GT +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V++G + + VA+K G + K F AE +++K +RH L+++ + C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 792 SNGNFKALVLEYMANGSLEKCLY-SSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+ +V E M GSL + L + R+L + Q + + VA + YL + +H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
D+ N+L+ ++ + ++DFG+A+++ + R I + AP
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVA---IKVFHLQFDGALKSFDAECEVLKSVR 780
+F + IG G F VYK LDG VA +++F + A + E ++LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLE---KCLYSSNRSLDIFQRLSIMIDVALALE 837
H N++K ++S N +VLE G L K R + + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H S ++H DIKP+N+ + V L D G+ + + + + +GT YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 11/167 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
+G+G FG V + A+K H+ G + +E E+L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
+ + + +++EY G L L D + + V LA EYLH + +++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
D+KP N+LLD + L DFG AK L + +T T GT Y+AP
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGALKS-FDAECEVLK 777
+ + + IG G FG VY+G ++ + VA+K +++ F E +++
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALE 837
H ++VK+I + N +V+E G L L + SLD+ + ++ AL
Sbjct: 63 QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
YL S VH DI N+L+ L DFG+++ L +ES + G I +MAP
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 27/67 (40%), Positives = 45/67 (67%)
Query: 44 HRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQ 103
+ ++N+S + G I LG+++SL+ LDLS+N F+G+IP S+ +++L+IL L N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 104 LSGSFPS 110
LSG P+
Sbjct: 502 LSGRVPA 508
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 31/91 (34%), Positives = 53/91 (58%)
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDI 550
L L + L FIP+ L ++ S + S NS+ G++P +G++ + ++LS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 551 PTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581
P ++G LT+L++L+L N L G +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 5/163 (3%)
Query: 734 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G++G VYK R ++ E+A IKV L+ E ++K +H N+V S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
+ + +E+ GSL+ +Y L Q + + L YLH S +H DI
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K +NILL D+ L+DFG++ + + R +GT +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 733 LIGIGSFGTVYKGRFLDGME--VAIK---VFHLQFDGALKSFD-------AECEVLK-SV 779
+G G+FG VYK R + + +A+K V + F + D +E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF--QRL-SIMIDVALAL 836
RH N+V+ + + +V++ + L + S F +R+ +I + + LAL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
YLH +VH D+ P+NI+L +D ++DFG+AK ES T +GTI Y P
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 4/163 (2%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
+G G+FG VYK + + G+ A KV + + L+ + E ++L S H N+VK++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
N +++E+ A G+++ + R L Q + AL YLH N ++H D+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K NIL D L+DFG++ R +GT +MAP
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 10/176 (5%)
Query: 727 HFSEKSLIGIGSFGTVYKGRF-LDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRHR 782
+F + IG G F VY+ LDG+ VA+K +F L A E ++LK + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI---MIDVALALEYL 839
N++K +S N +VLE G L + + + + ++ + + ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H S V+H DIKP+N+ + V L D G+ + + + + +GT YM+P
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 39/106 (36%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 34 WIGITC--DVSTHR--VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIF 89
W G C D + + + L + + GL G I + + L LQ+++LS N G IP S+
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 90 SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPA 135
SI++L++L L N +GS P + +SLR ++ N NSLSG +PA
Sbjct: 464 SITSLEVLDLSYNSFNGSIPE-SLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 5/163 (3%)
Query: 734 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
+G G++G VYK R L E+A +K+ L+ E ++K +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
+ + +EY GSL+ +Y L Q + + L YLH S +H DI
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K +NILL D+ L+DFG+A + + R +GT +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 31/187 (16%)
Query: 734 IGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G+FG V+ D M VA+K + A + F E E+L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF--------------QRLSIMIDVA 833
C+ G +V EYM +G L + L S I Q L+I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 834 LALEY---LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLG 888
+ Y LHF VH D+ N L+ +V + DFG+++ + + R +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 889 TIGYMAP 895
I +M P
Sbjct: 187 PIRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL------KSFDAECEVLKSVRHRNLVK 786
++G G++GTVY G G +A+K L L + E ++LKS++H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDI-FQRLSIMIDVALALEYLHFGYSN 845
+ +C + N ++ +E++ GS+ L + F + + I +A YLH +N
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLH---NN 121
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLL-----NGEES-MRTQTLGTIGYMAP 895
VVH DIK +N++L + + L DFG A+ L +G S M GT +MAP
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 9/176 (5%)
Query: 727 HFSEKSLIGIGSFG--TVYKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHR 782
H+ ++G G+FG T+Y+ R D V K +L + DA E +L ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
N++ + + N + +EY G+L +K + + + L + + A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH- 118
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
++H DIK NI L + L DFGI+K+L E SM +GT YM+P L
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 24/153 (15%)
Query: 734 IGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAEC----EVLKSVR----HRNL 784
+G G+FG+VY R + E VAIK + S++ EC EV KS+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLH-F 841
VK+ + V EYM G+L + L + SI+ + L ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
G+ H D+KP N+L+ V ++DFG+A+
Sbjct: 119 GF----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 52/174 (29%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 734 IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKI 787
+G G FG V + G VA+K + S + E +LK++ H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 788 ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
CS K L++EY+ GSL Y L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAPGLW 898
+H D+ N+LLD+D + + DFG+AK + G E R + G +P W
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD----SPVFW 176
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 4/163 (2%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
+G G+FG VYK + + G A KV + + L+ + E E+L + H +VK++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
+++E+ G+++ + +R L I + LE L + +S ++H D+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K N+LL D L+DFG++ R +GT +MAP
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 734 IGIGSFGTVYKGRFLDGME-VAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISS 790
IG G++GTV+K + + E VA+K L D G S E +LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 791 CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+ LV EY + L+K S N +D S M + L + H S+ V+H
Sbjct: 68 LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 851 DIKPSNILLDDDMVAHLSDFGIAK 874
D+KP N+L++ + L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + VAIK G + ++F E +V+K +RH LV++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 792 SNGNFKALVLEYMANGSLEKCLY-SSNRSLDIFQRLSIMIDVALALEYLH-FGYSNPVVH 849
S +V EYM+ GSL L + L + Q + + +A + Y+ Y VH
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 125
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
D++ +NIL+ +++V ++DFG+A+L+ + E + R I + AP
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 733 LIGIGSFGTVYKGRF-LDGME---VAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 787
+IG G FG V +GR L G VAIK + + + F +E ++ H N++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL-HFGYSNP 846
+ ++ E+M NG+L+ L ++ + Q + ++ +A ++YL Y
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY--- 127
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
VH D+ NIL++ ++V +SDFG+++ L + S T T ++G P W
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT-SSLGGKIPIRW 177
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 733 LIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLVK 786
++G G FG+V +G+ DG ++ + V ++ D ++ F +E +K H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 787 IISSC----SNGNFKA--LVLEYMANGSLEKCLYSSN-----RSLDIFQRLSIMIDVALA 835
+I C S ++L +M +G L L S L + L M+D+AL
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+EYL + +H D+ N +L +DM ++DFG++K + + R G I M P
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ---GRIAKM-P 178
Query: 896 GLWVVL 901
W+ +
Sbjct: 179 VKWIAI 184
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 728 FSEKSLIGIGSFGTV----YKGRFLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVR 780
F +G GSFG V +KG G AIK + +K E +L +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYL 839
H +V ++ S + N +LE++ G L L + R D+ + ++ LA EYL
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYL 134
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
H S +++ D+KP N+LLD+ ++DFG AK + RT TL GT Y+AP
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAP 184
|
Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 20/178 (11%)
Query: 728 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL--QFDGALKSFDAECEVLKSVRHRNL 784
F + IG G++G VYK R L G VA+K L + +G + E +LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH---- 840
VK++ N LV E++ + L+K + +S S I + L YL
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLS---------GIPLPLIKSYLFQLLQ 111
Query: 841 ---FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
F +S+ V+H D+KP N+L++ + L+DFG+A+ T + T+ Y AP
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 734 IGIGSFGTVY--KGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIIS 789
IG GSFG +Y K + D IK L + ++ EV L ++H N+V +
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF----QRLSIMIDVALALEYLHFGYSN 845
S +V+EY G L K + NR + Q LS + ++L L+++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRI---NRQRGVLFSEDQILSWFVQISLGLKHIH---DR 120
Query: 846 PVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H DIK NI L + MVA L DFGIA+ LN + +GT Y++P
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
IG G F VY+ LD VA+K +F + A + E ++LK + H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI---MIDVALALEYLHFGYSNP 846
S N +VLE G L + + + + ++ + + A+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
V+H DIKP+N+ + V L D G+ + + + + +GT YM+P
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 27/179 (15%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA-----LKSFDAECEVLKSVRHRNLVK 786
L+G G+FG VY +D G E+A+K D + + + E ++LK+++H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 787 IISSCSNGNFKALVLEYMANGSLEK------CLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+ ++ +EYM GS++ L + Q L +EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-------GVEYLH 121
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN----GEESMRTQTLGTIGYMAP 895
SN +VH DIK +NIL D L DFG +K L M++ T GT +M+P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 731 KSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
K +G G+FG V+ D M VA+K A K F E E+L +++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYS---------------SNRSLDIFQRLSIM 829
VK C +G+ +V EYM +G L K L + + L + Q L I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTL 887
+A + YL S VH D+ N L+ +++ + DFG+++ + + R T+
Sbjct: 130 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 888 GTIGYMAP 895
I +M P
Sbjct: 187 LPIRWMPP 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 56/161 (34%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA--LKSFDAECEVLKS 778
H +G G+FG+V R+ D G VA+K LQ A L+ F+ E E+LKS
Sbjct: 5 HLKFIQQLGKGNFGSVELCRY-DPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKS 61
Query: 779 VRHRNLVKIISSC-SNG--NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
++H N+VK C S G N + LV+EY+ GSL L LD + L +
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
+EYL S VH D+ NIL++ + + DFG+ K+L
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKIISSC 791
IG G+FG V+ GR D VA+K LK+ F E +LK H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ +V+E + G L + L + + + ++ + A +EYL S +H D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N L+ + V +SDFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + +VA+K G + +SF E +++K +RH LV++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLH-FGYSNPVVH 849
S +V EYM+ GSL L R+L + + + VA + Y+ Y +H
Sbjct: 71 SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IH 125
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
D++ +NIL+ D +V ++DFG+A+L+ + E + R I + AP
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 734 IGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFDGALKSFDA---ECEVLKSVRHRNLV 785
+G G+FGTVYKG ++ +G + VAIKV L+ + + K+ E V+ SV H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+++ C + L+ + M G L + + ++ L+ + +A + YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
+VH D+ N+L+ ++DFG+AKLL+ +E G I +MA
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 58/179 (32%), Positives = 85/179 (47%), Gaps = 26/179 (14%)
Query: 728 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGAL---KSFDAECEV--LKSVRH 781
F++ IG GSFG VY R VAIK + + G K D EV L+ +RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 782 RNLVKIISSCSNGNFKALVL-EYMANGSLEKCLYSSNRSLDI----FQRLSIMIDVALAL 836
N ++ +K L E+ A +E CL S++ L++ Q + I AL
Sbjct: 75 PNTIE---------YKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGAL 125
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ L + +S+ +H DIK NILL + L+DFG A L++ S +GT +MAP
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----VGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 64/192 (33%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA----ECEVLKSVR 780
D F IG G++G VYK R D G VA+K L D + F E ++L+ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKILRQLN 64
Query: 781 HRNLVKIISSCSN-----------GNFKALVLEYMAN---GSLEKCLYSSNRSLDIFQRL 826
HRN+V + ++ G F LV EYM + G LE L +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAF-YLVFEYMDHDLMGLLESGLVHFSED----HIK 119
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-MRTQ 885
S M + L Y H +H DIK SNILL++ L+DFG+A+L N EES T
Sbjct: 120 SFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 886 TLGTIGYMAPGL 897
+ T+ Y P L
Sbjct: 177 KVITLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 727 HFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQ------FDGALKSFDAECEVLKSV 779
+ + +G G+F + Y+ R G +A+K + +++ E ++ +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 780 RHRNLVKII-SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI----DVAL 834
H ++++++ ++C + +F L +E+MA GS+ L F+ +++I +
Sbjct: 61 NHPHIIRMLGATCEDSHFN-LFVEWMAGGSVSHLL----SKYGAFKE-AVIINYTEQLLR 114
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLN----GEESMRTQTLGT 889
L YLH N ++H D+K +N+L+D ++DFG A L G + Q LGT
Sbjct: 115 GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 890 IGYMAP 895
I +MAP
Sbjct: 172 IAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 53/178 (29%), Positives = 87/178 (48%), Gaps = 12/178 (6%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLK 777
R L D+F + IG GS G V G +VA+K L+ + E +++
Sbjct: 18 RSYL---DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR 71
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALE 837
+H N+V++ SS G+ +V+E++ G+L + + ++ Q ++ + V AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALS 129
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+LH + V+H DIK +ILL D LSDFG ++ E R +GT +MAP
Sbjct: 130 FLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 734 IGIGSFGTVYKG---RFLDG---MEVAIK-VFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
+G GSFG VY+G + G VAIK V F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYS------SNRSLDIFQRLSIM---IDVALALE 837
++ S G +V+E MA G L+ L S +N L + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAP 895
YL + VH D+ N ++ +D+ + DFG+ + + + R + L + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 13/171 (7%)
Query: 734 IGIGSFGTVYKGRFLDGME-VAIKVFHL--QFDGALKSFDAECEVLKSVRHRNLVK---- 786
IG G++G VY+ R E VA+K + + DG S E +L ++RH N+V+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ + F LV+EY L L + Q +M+ + L+YLH N
Sbjct: 75 VVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENF 128
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
++H D+K SN+LL D ++DFG+A+ T + T+ Y AP L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQ-FDGALKSFDAECEVLKSVRHRN 783
F++ IG GSFG V+KG +D VAIK+ L+ + ++ E VL
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+ K S +++EY+ GS L LD Q +I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 118
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +H DIK +N+LL + L+DFG+A L + R +GT +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 7/170 (4%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLV 785
F++ IG GSFG VYKG EV AIK+ L+ + ++ E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ S G +++EY+ GS L L+ +I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SE 120
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H DIK +N+LL + L+DFG+A L + R +GT +MAP
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 734 IGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-L 784
+G G++G V+ R + G M+V K +Q + E +VL++VR L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V + + L+L+Y+ G L LY + R+ I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
+++ DIK NILLD + L+DFG++K EE R + GTI YMAP
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 23/185 (12%)
Query: 731 KSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
K +G G+FG V+ D + VA+K D A K F E E+L +++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSN------------RSLDIFQRLSIMIDV 832
VK C G+ +V EYM +G L K L + L Q L I +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLGTI 890
A + YL S VH D+ N L+ ++++ + DFG+++ + + R T+ I
Sbjct: 130 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 891 GYMAP 895
+M P
Sbjct: 187 RWMPP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 366 NSSSSKYIV----LAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421
+S+ K+ + L L G +P+ I L L+ I L IRGNIP +G++ +L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEV 470
Query: 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP 458
L L N +GSIP ++G+L +L+ L L N L G +P
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 42/188 (22%)
Query: 731 KSLIGIGSFGTVYKGRFLDGME----VAIKVFHL------QFDGALKSFDAECEVLKSVR 780
++G G +G V++ R + G + A+KV Q D A AE +L++V+
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVK 58
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSL----EK---------CLYSSNRSLDIFQRLS 827
H +V +I + G L+LEY++ G L E+ C Y S
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS----------- 107
Query: 828 IMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887
+++LALE+LH +++ D+KP NILLD L+DFG+ K E ++
Sbjct: 108 ---EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161
Query: 888 GTIGYMAP 895
GTI YMAP
Sbjct: 162 GTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 62/170 (36%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLVK 786
IG GSFG V + DG A+KV LQ LK + AE VL K+V+H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ S + VL+Y+ G L L + R ++A AL YLH S
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
+++ D+KP NILLD L+DFG+ K E S T T GT Y+AP
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 8/166 (4%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G++ TVYKGR G VA+K HL + G + E ++K ++H N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 792 SNGNFKALVLEYMANGSLEKCL--YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
N LV EYM + L+K + + +LD S + L+ + F + N V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
D+KP N+L++ L+DFG+A+ + + + T+ Y AP
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 23/181 (12%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDA----ECEVLKSVRHRNLVKII 788
IG G+FG V+K R VA+K + + + F E ++L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 789 SSCSN-----GNFKA---LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
C +K LV E+ + L L + N + + +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL----NGEESMRTQTLGTIGYMAPG 896
N ++H D+K +NIL+ D + L+DFG+A+ N + + T + T+ Y P
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 897 L 897
L
Sbjct: 194 L 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 30/191 (15%)
Query: 731 KSLIGIGSFGTVYKGRFL-DG--MEVAIKVF-HLQFDGALKSFDAECEVL-KSVRHRNLV 785
+ +IG G+FG V + DG M AIK+ + + F E EVL K H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMI 830
++ +C N + + +EY G+L L S +L Q L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
DVA ++YL +H D+ N+L+ +++ + ++DFG+++ GEE +T+G +
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 891 GYMAPGLWVVL 901
P W+ +
Sbjct: 181 ----PVRWMAI 187
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG GS G V R G +VA+K+ L+ + E +++ +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G +++E++ G+L + S L+ Q ++ V AL YLH S V+H DI
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K +ILL D LSDFG ++ + R +GT +MAP
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G++ ++VAIK + +GA+ + F E +V+ + H LV++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ +V E+M NG L L L LS+ DV +EYL N +H D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRD 125
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N L+ V +SDFG+ +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + +VAIK G++ ++F AE ++K ++H LV++ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+ ++ EYM NGSL L + L I + + + +A + ++ +H
Sbjct: 71 TQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
D++ +NIL+ + + ++DFG+A+L+ E
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 33/86 (38%), Positives = 44/86 (51%), Gaps = 3/86 (3%)
Query: 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHV---DHNKLSGPI 478
L L N L G IP + +L LQ + L N + G IP L ++ L V +N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 479 PACFGNLNSLRNLSLGSNELSSFIPS 504
P G L SLR L+L N LS +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 45/185 (24%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISS 790
IG G++G VYKGR G VA+K L+ +G + E +LK ++H N+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV----- 62
Query: 791 CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI-------------MIDVALALE 837
L+ L +R IF+ LS+ +D L
Sbjct: 63 -----------------CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 838 YLH-------FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
YL+ F +S V+H D+KP N+L+D+ V L+DFG+A+ + T + T+
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL 165
Query: 891 GYMAP 895
Y AP
Sbjct: 166 WYRAP 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK--VFHLQFDGALKSFDAECEVLKSVRHRN 783
K +G G+FG VYK R + G VA+K + H + DG + E ++LK ++H N
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 784 LVKII---------SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
+V +I S G+ +V YM + L L + + L Q M+ +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSV-YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879
+ YLH N ++H DIK +NIL+D+ + ++DFG+A+ +G
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + +VAIK G + ++F E +++K +RH LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLH-FGYSNPVVH 849
S +V E+M GSL L + + L + Q + + +A + Y+ Y +H
Sbjct: 71 SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY----IH 125
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
D++ +NIL+ D++V ++DFG+A+L+ + E + R I + AP
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 734 IGIGSFGTVYKG--RFLDG----MEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNL 784
+G G+FG VY+G R DG ++VA+K L + + F E ++ H+N+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKT--LPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-------SLDIFQRLSIMIDVALALE 837
V++I + ++LE MA G L+ L NR SL + L DVA +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 838 YLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIAKLLNGEESMRT--QTLGTIGY 892
YL N +H DI N LL VA ++DFG+A+ + R + + I +
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 893 MAP 895
M P
Sbjct: 188 MPP 190
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 733 LIGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
++G G++G V+ R + G M+V K +Q ++ E VL+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 785 VKIISSCSNGNFKA-LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI---DVALALEYLH 840
+ + K L+L+Y++ G + LY D F + ++ LALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122
Query: 841 -FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
G +V+ DIK NILLD + L+DFG++K EE RT + GTI YMAP
Sbjct: 123 KLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 35/203 (17%)
Query: 720 ELLLATDHFSEKSLIGIGSFGTVYKGR-FLDGME----VAIKVFHLQFDGALK--SFDAE 772
EL L+ F E+ +G +FG +YKG +L GM+ VAIK + + F E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQE 57
Query: 773 CEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLY----------SSNR---- 818
++ + H N+V ++ + ++ EY+ G L + L SS+
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 819 --SLDIFQRLSIMIDVALALEYL--HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
SLD L I I +A +EYL HF VH D+ NIL+ + + +SD G+++
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 875 LLNGEESMRTQ--TLGTIGYMAP 895
+ + R Q +L I +M P
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 21/113 (18%)
Query: 445 GLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
GLGL+N L G IP+D+ +L L ++++L N + IP
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHL---------------------QSINLSGNSIRGNIPP 460
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGL 557
+ ++ ++ D S NS NGS+P +G + + +NL+ N L+G +P +GG
Sbjct: 461 SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 40/164 (24%), Positives = 83/164 (50%), Gaps = 6/164 (3%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
+G G FG V+ G + + +VA+K ++++F E ++K+++H LV++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL-SIMIDVALALEYLHFGYSNPVVHCDI 852
++ EYMA GSL L S + +L +A + Y+ +H D+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
+ +N+L+ + ++ ++DFG+A+++ E + R I + AP
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRN 783
+ E S +G G+ G+V K R + GM A+K + L K E E+ KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 784 LVKIISSC---SNGNFKALVLEYMANGSLEKCLYSSNRSLD--IFQR--LSIMIDVALAL 836
+VK + S+ + + +EY GSL+ +Y + I ++ I V L
Sbjct: 61 IVKYYGAFLDESSSSIG-IAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE--ESMRTQTLGTIGYMA 894
YLH S ++H DIKPSNILL L DFG++ GE S+ GT YMA
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMA 171
Query: 895 P 895
P
Sbjct: 172 P 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 734 IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALK-SFDAECEVLKSVRHRNLVKIIS 789
+G G+FG V KG + ++VAIKV + + +++ E E++ + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
C LV+E + G L K L + + + +M V++ ++YL VH
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881
D+ N+LL + A +SDFG++K L ++S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 33/87 (37%), Positives = 51/87 (58%), Gaps = 3/87 (3%)
Query: 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459
L N +RG IP +I L +L +++L N + G+IP ++G + +L+ L L N G IP+
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 460 DLCQLSELHV---DHNKLSGPIPACFG 483
L QL+ L + + N LSG +PA G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 40/184 (21%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFD-----AECEVLKSVRHRN 783
++G GSFG V+ R + G + A+KV LK D E ++L V H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS--IMI----------D 831
+VK+ + L+L+++ G D+F RLS +M +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIG 891
+ALAL++LH S +++ D+KP NILLD++ L+DFG++K E GT+
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 892 YMAP 895
YMAP
Sbjct: 164 YMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRN 783
D + + +G GS+ TVYKG+ ++G VA+KV LQ + G + E +LK ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKC------LYSSNRSLDIFQRLSIMIDVALALE 837
+V + LV EY+ + L+ N L +FQ L L
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLS 117
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
Y+H Y ++H D+KP N+L+ D L+DFG+A+ + + + T+ Y P
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 734 IGIGSFGTV-YKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG GS G V G +VA+K L+ + E +++ H N+V + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
G+ +V+E++ G+L + ++ ++ Q ++ + V AL YLH + V+H DI
Sbjct: 90 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
K +ILL D LSDFG ++ E R +GT +MAP
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 14/172 (8%)
Query: 730 EKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVK 786
EK IG G++G VYK R L G VA+K L+ + G + E +LK + H N+V+
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
++ + N LV E++ + L+K + S LD S + + + Y H S+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT--LGTIGYMAP 895
V+H D+KP N+L+D + L+DFG+A+ +RT T + T+ Y AP
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFG--VPVRTYTHEVVTLWYRAP 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 716 FSYRELLLATDHFSEKS-------LIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALK 767
F Y +L + + + IG G++G VYK DG A+K+ D +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDE 63
Query: 768 SFDAECEVLKSV-RHRNLVKII------SSCSNGNFKALVLEYMANGS---LEKCLYSSN 817
+AE +L+S+ H N+VK G LVLE GS L K L
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICG 122
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
+ LD I+ L L++LH +N ++H D+K +NILL + L DFG++ L
Sbjct: 123 QRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 878 GEESMRTQTLGTIGYMAP 895
R ++GT +MAP
Sbjct: 180 STRLRRNTSVGTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 41/125 (32%), Positives = 65/125 (52%), Gaps = 5/125 (4%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMI 830
E ++L+ V + +V + + + LVL M G L+ +Y+ N + + L
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ LE LH V+ D+KP NILLDD +SD G+A + ES+R + +GT+
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTV 165
Query: 891 GYMAP 895
GYMAP
Sbjct: 166 GYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 700 LSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDG--MEVAIKV 757
L N++++ + + R+ + + F+ +G GSFG V + + VAIK
Sbjct: 4 LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63
Query: 758 FHLQFDGALKSFD---AECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLY 814
F K D +E ++L + H V + S + ++ LVLE++ G L
Sbjct: 64 FEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 815 SSNR---SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871
+ R + F I+ L EYL S +V+ D+KP N+LLD D ++DFG
Sbjct: 124 RNKRFPNDVGCFYAAQIV----LIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFG 176
Query: 872 IAKLLNGEESMRTQTL-GTIGYMAP 895
AK+++ RT TL GT Y+AP
Sbjct: 177 FAKVVD----TRTYTLCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/170 (35%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 733 LIGIGSFGTVY-KGRFLDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLV 785
+IG GSFG V R DG A+KV LQ LK + AE VL K+++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ S VL+Y+ G L L L+ R +VA A+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+++ D+KP NILLD L+DFG+ K E + GT Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 784
L+G G+FG VY +D G E+A K +QFD + + + E ++LK+++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 785 VKIISSCSNGNFKALV--LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
V+ + K L +EYM GS++ L + + R + + YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH-- 123
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN----GEESMRTQTLGTIGYMAP 895
SN +VH DIK +NIL D L DFG +K L +R+ T GT +M+P
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 34/193 (17%)
Query: 731 KSLIGIGSFGTVYKGRFL-DG--MEVAIKV---FHLQFDGALKSFDAECEVL-KSVRHRN 783
+ +IG G+FG V K R DG M+ AIK + + D + F E EVL K H N
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPN 69
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCL---------------YSSNRSLDIFQRLSI 828
++ ++ +C + + L +EY +G+L L S+ +L Q L
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
DVA ++YL +H D+ NIL+ ++ VA ++DFG+++ G+E +T+G
Sbjct: 130 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 183
Query: 889 TIGYMAPGLWVVL 901
+ P W+ +
Sbjct: 184 RL----PVRWMAI 192
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 734 IGIGSFGT--VYKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKIIS 789
IG GSFG + K + DG + IK ++ + ++ E VL +++H N+V+
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 790 SCSNGNFKALVLEYMANGSLEK-------CLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
S +V++Y G L K L+ ++ LD F + + LAL+++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH-- 118
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H DIK NI L D L DFGIA++LN + +GT Y++P
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 8e-10
Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 13/168 (7%)
Query: 737 GSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDA----ECEVLKSVRHRNLVKI--IS 789
G++G VY+ R E VA+K L+ + + F E +L ++H N+V + +
Sbjct: 16 GTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
SN + +V+EY+ + L+ + + + + +M+ + + +LH N ++H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILH 129
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
D+K SN+LL++ + + DFG+A+ TQ + T+ Y AP L
Sbjct: 130 RDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVR 780
L D F S +G G+ G V K + G+ +A K+ HL+ A+++ E +VL
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYL 839
+V + + ++ +E+M GSL++ L + R +I ++SI + LA YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YL 119
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H D+KPSNIL++ L DFG++ L +SM +GT YM+P
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISS 790
+G GS+G V R DG + IK +L+ K+ + E ++L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 791 CSNGN-FKALVLEYMANGSL-EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V+ + G L K + L Q + + +A+AL+YLH ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
H D+K N+ L + + D GIA++L + M + +GT YM+P L+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFDGALKSFDAECE-- 774
+L + L+G G FGTV+KG ++ +G + VAIK +Q ++F +
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHM 60
Query: 775 -VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
+ S+ H +V+++ C + + LV + GSL + SLD + L+ + +A
Sbjct: 61 LAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
+ YL + +VH ++ NILL D + ++DFG+A LL
Sbjct: 120 KGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 35/171 (20%)
Query: 734 IGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGAL---KSFDAECEVLKSVRHRNL 784
IG G+FG V++ R VA+K+ L+ + + F E ++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCL--------------------YSSNRS-LDIF 823
VK++ C+ G L+ EYMA G L + L N L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 824 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
++L I VA + YL VH D+ N L+ ++MV ++DFG+++
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 9/176 (5%)
Query: 723 LATDHFSEKSLIGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKS-FDAECEVLKSVR 780
L D F + S +G G+ G V+K G+ +A K+ HL+ A+++ E +VL
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLD-IFQRLSIMIDVALALEYL 839
+V + + ++ +E+M GSL++ L + R + I ++SI V L YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYL 119
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H D+KPSNIL++ L DFG++ L +SM +GT YM+P
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 56/181 (30%), Positives = 79/181 (43%), Gaps = 35/181 (19%)
Query: 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFH------------LQFDGALKSFDAECEVLKS 778
IG G+ G VYK RF G +A+K + D LKS D C
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD--CP---- 74
Query: 779 VRHRNLVKIISSCSNGNFKALV-LEYMANGSLEKCLYSSNRSL--DIFQRLSIMIDVALA 835
+VK + + +E M+ L+K L + DI ++++ I A
Sbjct: 75 ----YIVKCYG-YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAI--VKA 126
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMA 894
L YL + V+H D+KPSNILLD L DFGI+ L +S +T++ G YMA
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMA 182
Query: 895 P 895
P
Sbjct: 183 P 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 733 LIGIGSFGTVYKGRFLD------GMEVAIKVFHLQ-FDGALKSFDAECEVLKSV-RHRNL 784
+G G+FG V K + VA+K+ + L +E E++K + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCL---------YSSNRSLDIFQRL------SIM 829
+ ++ C+ +V+EY A+G+L L S + + L S
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG- 888
VA +E+L S +H D+ N+L+ +D V ++DFG+A+ ++ + R T G
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 889 -TIGYMAP 895
+ +MAP
Sbjct: 196 LPVKWMAP 203
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
D+F + IG GS G V G VA+K L+ + E +++ +H N+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V++ +S G+ +V+E++ G+L + ++ ++ Q ++ + V AL LH +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLH---A 134
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
V+H DIK +ILL D LSDFG ++ E R +GT +MAP L
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 54/188 (28%), Positives = 80/188 (42%), Gaps = 33/188 (17%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRN 783
+ + IG G+FGTV K G +A+K D K + +V+ R +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--RSSD 61
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL-----------SIMIDV 832
I+ + AL E G C+ + SLD F + I+ +
Sbjct: 62 CPYIVKF-----YGALFRE----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 833 AL----ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTL 887
A+ AL YL ++H D+KPSNILLD + L DFGI+ L +S+ +T+
Sbjct: 113 AVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDA 168
Query: 888 GTIGYMAP 895
G YMAP
Sbjct: 169 GCRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 56/173 (32%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 785
++G GSFG V EV AIKV L+ D L+ D +C + + + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ + V+EY+ G L + S R D + +V LAL +LH +
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAK--LLNGEESMRTQTL-GTIGYMAP 895
V++ D+K NILLD + L+DFG+ K +LNG + T T GT Y+AP
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 74/220 (33%), Positives = 114/220 (51%), Gaps = 9/220 (4%)
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQG 445
S + L + L ++R NI E+ L NLT+L L NN ++ P+ + L+
Sbjct: 86 SENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKE 144
Query: 446 LGLENNKLE--GPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
L L +NK+E +L L L + N LS +P NL++L NL L N++S +P
Sbjct: 145 LDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISD-LP 202
Query: 504 STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563
L+ + D S+NS+ L + N+K + + LS N L D+P +IG L+NL+ L
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL 260
Query: 564 SLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLE 603
L NN++ S G+LT+L LDLS N+LS +P+
Sbjct: 261 DLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 9/167 (5%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
+G G FG V + G A K L+ + E ++L+ V R +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ + LV+ M G L+ +Y+ + + + LE+LH +V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ D+KP N+LLDD +SD G+A L G + + GT GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI-KGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIK-VFHLQFDGALKSFDA-------------ECEVLKS 778
+G G++G V K L G VAIK V ++ + E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838
++H N++ ++ G+F LV++ MA L+K + R L Q I++ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQVKCILLQILNGLNV 134
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
LH Y +H D+ P+NI ++ + ++DFG+A+
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 18/181 (9%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLDG--------MEVAIKVFHLQFDGALKSFDAECEVLKS 778
+F ++G G++G V+ R + G M+V K +Q + E +VL+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 779 VRHRNLVKIISSCSNGNFKA-LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI-DVALAL 836
+R + + + K L+L+Y+ G L L R + Q + I ++ LAL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLAL 118
Query: 837 EYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMA 894
E+LH G +++ DIK NILLD + L+DFG++K + +E R + GTI YMA
Sbjct: 119 EHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 895 P 895
P
Sbjct: 175 P 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHR-NLVKII 788
I G+FG+VY + G AIKV + + + AE ++ + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
S + ++ LV+EY+ G L + L + +V L +E LH ++
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGII 119
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H DIKP N+L+D L+DFG+++ NG E+ + +GT Y+AP
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGLENKK--FVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 21/176 (11%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVR---HRNLVKI 787
IG+G++GTVYK R G VA+K +Q DG S E +LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 788 ISSCSNGNFK-----ALVLEYMAN---GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL 839
+ C+ LV E++ L+K + + + L M L++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK-VPPPGLPAETIKDL--MRQFLRGLDFL 124
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H +N +VH D+KP NIL+ L+DFG+A++ + + ++ T + T+ Y AP
Sbjct: 125 H---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-TPVVVTLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLV 785
F L+G G++G VYKGR + G AIKV + D + E +LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 786 KIISSCSNGNFKA------LVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEY 838
+ N LV+E+ GS+ + ++ +L I ++ L +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
LH + V+H DIK N+LL ++ L DFG++ L+ R +GT +MAP
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 101 DNQ-LSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN 159
DNQ L G P+ IS L++I+ + NS+ G IP +G++T L+ L L YN
Sbjct: 426 DNQGLRGFIPN-DISKLRHLQSINLSGNSIRGN--------IPPSLGSITSLEVLDLSYN 476
Query: 160 KLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSI 193
G IP+ LG L L L+L + L+G +P+++
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 734 IGIGSFGTVYKGRFL---DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKI 787
IG G++G VYK + DG E AIK F Q+ G +S E +L+ ++H N+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 788 ISSCSNGNFKA--LVLEYMANGSLEKCLY-SSNRSLDIFQRL--SIMIDVALALEYLHFG 842
+ K+ L+ +Y + + + + + I + S++ + + YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125
Query: 843 YSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLN 877
SN V+H D+KP+NIL+ + V + D G+A+L N
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 5/125 (4%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMI 830
E ++L+ V R +V + + + LVL M G L+ +Y+ N D + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ LE LH +V+ D+KP NILLDD +SD G+A + E++R + +GT+
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR-VGTV 165
Query: 891 GYMAP 895
GYMAP
Sbjct: 166 GYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 23/178 (12%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 784
L+G G+FG VY D G E+A+K +QFD + + + E ++LK++ H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 785 VKIISSCSNGNFKAL--VLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHF 841
V+ + + L +E+M GS++ L S + ++ ++ + I LE + +
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSY 121
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN----GEESMRTQTLGTIGYMAP 895
+SN +VH DIK +NIL D L DFG +K L M++ T GT +M+P
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 734 IGIGSFGTVY--------KGRFLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSV-RH 781
+G G FG V K + + + VA+K+ L+ D K +E E++K + +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCL-----------YSSNRSLD---IFQRL- 826
+N++ ++ +C+ +++EY + G+L + L Y R D F+ L
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
S VA +EYL S +H D+ N+L+ ++ V ++DFG+A+ +N + + T
Sbjct: 141 SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 887 LG--TIGYMAP 895
G + +MAP
Sbjct: 198 NGRLPVKWMAP 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 30/185 (16%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHR 782
D + S +G G++G V G +VAIK F A+ K E +LK + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 783 NLVKIIS----SCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLS------IMI 830
N++ ++ + S +F+ LV M L + Q+LS ++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKC--------QKLSDDHIQFLVY 125
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
+ L+Y+H S ++H D+KPSNI +++D + DFG+A+ + E M T + T
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--M-TGYVATR 179
Query: 891 GYMAP 895
Y AP
Sbjct: 180 WYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 787
F E + + + G +Y + LD + K K E E+L+ V +V +
Sbjct: 6 FGEVCAVQVKNTGKMYACKKLDKKRLKKK-------SGEKMALLEKEILEKVNSPFIVNL 58
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ + LV+ M G L+ +Y+ R L++ + + + + +LH S
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+V+ D+KP N+LLDD LSD G+A L +++ TQ GT GYMAP
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI-TQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQFDG--ALKSFDAECE 774
+L ++G G+FGTVYKG ++ E VAIK+ + + G A F E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
++ S+ H +LV+++ C + + LV + M +G L ++ ++ L+ + +A
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
+ YL +VH D+ N+L+ ++DFG+A+LL G+E
Sbjct: 121 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 732 SLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKS-----FDAECEVLKSVRHRNLV 785
+IG G+FG V+ R D +V A+KV L+ +K AE ++L +V
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-FGYS 844
K+ S + LV+EYM G L L + + R I ++ LAL+ +H G+
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF- 122
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
+H DIKP NIL+D D L+DFG+ K
Sbjct: 123 ---IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 34/191 (17%)
Query: 734 IGIGSFGTVY--------KGRFLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSV-RH 781
+G G FG V K + + VA+K+ L+ D K +E E++K + +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCL---------YS------SNRSLDIFQRL 826
+N++ ++ +C+ +++EY + G+L + L YS L +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
S VA +EYL S +H D+ N+L+ +D V ++DFG+A+ ++ + + T
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 887 LG--TIGYMAP 895
G + +MAP
Sbjct: 195 NGRLPVKWMAP 205
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 29/71 (40%), Positives = 42/71 (59%)
Query: 141 IPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLL 200
IP DI L L+ + L N ++G IP LG++ LE L L + G+IP S+ L+SL
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 201 ELDFSNNSLTG 211
L+ + NSL+G
Sbjct: 494 ILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 734 IGIGSFGTVYKGRFLDGME-VAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
+G G +G V+ + D E VA+K L ++ E ++L + + LVK++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-FGYSNPVV 848
+ + + L +EY+ G + L ++ L M ++ A++ LH GY +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAK-LLNGEESMRTQTLGTIGYMAP 895
H D+KP N L+D L+DFG++K ++ S+ +G+ YMAP
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAP 167
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRH 781
T+ + + +G+G+FG V R L G VAIK F + K E ++LK +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 782 RNLVKI----ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALE 837
N++ + IS + F V E + L + L S Q + + L+
Sbjct: 69 ENIISLSDIFISPLEDIYF---VTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRGLK 122
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
Y+H S VVH D+KPSNIL++++ + DFG+A++ ++ T + T Y AP
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHL---QFDGALKSFDAECEVLKSVRHRN 783
FS+ IG GSFG VY R + EV AIK Q + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL----ALEYL 839
++ + LV+EY CL S++ L++ ++ +++A AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ +S+ ++H D+K NILL + + L DFG A ++ +GT +MAP
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 7e-09
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 50/169 (29%)
Query: 734 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA------------ECEVLKS 778
+G G++G V+K +D VA+K K FDA E L+
Sbjct: 15 LGKGAYGIVWKA--IDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62
Query: 779 VR-HRNLVKIISSCSNGNFKA-------LVLEYMANGSLEKCLYSSNRS--LDIFQRLSI 828
+ H N+VK+++ KA LV EYM E L++ R+ L+ + I
Sbjct: 63 LGDHPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYI 112
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
M + AL+Y+H S V+H D+KPSNILL+ D L+DFG+A+ L+
Sbjct: 113 MYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 734 IGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKI 787
+G G FG V R+ G +VA+K + G + E E+L+++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 788 ISSCSN--GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
C+ GN L++E++ +GSL++ L + +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884
VH D+ N+L++ + + DFG+ K + ++ T
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 37/125 (29%), Positives = 65/125 (52%), Gaps = 5/125 (4%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMI 830
E ++L+ V R +V + + + LVL M G L+ +Y + + + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ LE LH +V+ D+KP NILLDD +SD G+A + ++++ + +GT+
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTV 165
Query: 891 GYMAP 895
GYMAP
Sbjct: 166 GYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 13/177 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGME-VAIKVFHL-QFDGALKSFDA-ECEVLKSVRHR 782
D + + IG G++G VYK R E +A+K L Q D + S E +LK ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYL 839
N+V++ + LV EY+ + L+K + SS ++ + + + + + + Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIK--TYLYQILRGIAYC 118
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVA-HLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H S+ V+H D+KP N+L+D A L+DFG+A+ T + T+ Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 13/177 (7%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLV 785
F ++G G++G VYKGR + G AIKV + D + E +LK HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 786 K----IISSCSNGNFKAL--VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEY 838
I G+ L V+E+ GS+ + ++ +L I ++ L +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
LH ++ V+H DIK N+LL ++ L DFG++ L+ R +GT +MAP
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-08
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 750 GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKIISS--CSNGNFKALVLEYM 804
G EVAIK+ + + F E + + H N+V ++ S G A V EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DD 861
+L + L +++ +L + +M+ V AL H + +VH D+KP NI++
Sbjct: 62 PGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 862 DMVAHLSDFGIAKLLNG-EESMRTQ------TLGTIGYMAP 895
A + DFGI LL G ++ LGT Y AP
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMI 830
E +L+ V R +V + + + LVL M G L+ +Y+ N D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ LE L +V+ D+KP NILLDD +SD G+A + E++R + +GT+
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-VGTV 165
Query: 891 GYMAP 895
GYMAP
Sbjct: 166 GYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 733 LIGIGSFGTVYKGRFLDG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKI 787
+IG G FG VY G +D + A+K + D ++ F E ++K H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 788 ISSC-SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ C + +VL YM +G L + S + + + + VA +EYL S
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKK 118
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAK 874
VH D+ N +LD+ ++DFG+A+
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 20/175 (11%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV--AIKV---FHLQFDGALKSFDAECEVLKSVR 780
HF + L+G G G V+ R L G A+KV + +K E E+L ++
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVR-LKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI------DVAL 834
H L + +S + LV++Y G L + L LS + +V L
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-----CLSEEVARFYAAEVLL 114
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
ALEYLH +V+ D+KP NILL + LSDF ++K + E ++ L
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 9/173 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRN 783
D F + +G G+ G V K G+ +A K+ HL+ A+++ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFG 842
+V + + ++ +E+M GSL++ L + R +I ++SI V L YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK 118
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H D+KPSNIL++ L DFG++ L +SM +GT YM+P
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 19/173 (10%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV-RHRNLV 785
++G GSFG V E+ A+KV L+ D L+ D EC VL +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
++ S + V+EY+ G L + S R D + ++ L L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLH---ER 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAK--LLNGEESMRTQTL-GTIGYMAP 895
+++ D+K N+LLD + ++DFG+ K +L G T T GT Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 731 KSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKII 788
+ ++G G+ GTVYK L +A+KV L L K +E E+L ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL------SIMIDVALALEYLHFG 842
+ N ++ E+M GSL D+++++ I + V L YL
Sbjct: 66 GAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL--- 111
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIA-KLLNGEESMRTQTLGTIGYMAP 895
+S ++H D+KPSN+L++ L DFG++ +L+N S+ +GT YMAP
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 734 IGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKII--- 788
IG G++G V+K +G + A+K+ D + +AE +LK++ H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 789 --SSCSNGNFKALVLEYMANGS---LEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
NG+ LVLE GS L K ++ I+ + + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N +H D+K +NILL + L DFG++ L R ++GT +MAP
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 30/189 (15%)
Query: 733 LIGIGSFGTVYKGRFL-DG--MEVAIKVF-HLQFDGALKSFDAECEVL-KSVRHRNLVKI 787
+IG G+FG V K R DG M+ AIK + F E EVL K H N++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDV 832
+ +C + + L +EY +G+L L S +L Q L DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
A ++YL +H D+ NIL+ ++ VA ++DFG+++ G+E +T+G +
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL-- 173
Query: 893 MAPGLWVVL 901
P W+ +
Sbjct: 174 --PVRWMAI 180
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 15/172 (8%)
Query: 733 LIGIGSFGTVYKGRF-LDG---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 787
++G G FG + +G L + VAI D + F AE L H N+V++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL-HFGYSNP 846
+ GN +V EYM+NG+L+ L L Q + ++ +A ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
VH + +L++ D+V +S F +E T+ +P LW
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLW 174
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/168 (35%), Positives = 78/168 (46%), Gaps = 9/168 (5%)
Query: 733 LIGIGSFGTVY-KGRFLDGMEVAIKVFHLQF---DGALKSFDAECEVL-KSVRHRNLVKI 787
+IG GSFG V R LDG A+KV + K AE VL K+V+H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
S VL+++ G L L RS + ++A AL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
V+ D+KP NILLD L+DFG+ K + T GT Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 35/184 (19%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNL 784
L+G G+FG VY D G E+A+K + FD + + + E ++LK++RH +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVK--QVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 785 VKIISSCSNGNFKALVL--EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
V+ + K L + EYM GS++ L + + R + + YLH
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH-- 123
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-----------GTIG 891
SN +VH DIK +NIL D L DFG +K R QT+ GT
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGIKSVTGTPY 174
Query: 892 YMAP 895
+M+P
Sbjct: 175 WMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHL---QFDGALKSFDAECEVLKSVRHRN 783
F++ IG GSFG VY R + EV AIK Q + + E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL----ALEYL 839
++ + LV+EY CL S++ L++ ++ +++A AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ +S+ ++H DIK NILL + L+DFG A + + S +GT +MAP
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----VGTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 734 IGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDG---ALKSFDAECEVLKSVRHRNLVKI-- 787
IG G++G V G +VAIK FD A ++ E ++L+ +H N++ I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRD 71
Query: 788 ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYS 844
I +FK +V++ M + L ++S + + + + + L+Y+H S
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYIH---S 125
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL--NGEESMR--TQTLGTIGYMAPGLWVV 900
V+H D+KPSN+L+++D + DFG+A+ L + E T+ + T Y AP L +
Sbjct: 126 ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 901 LN 902
L
Sbjct: 186 LP 187
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 298 LGLNN--LSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSST 355
LGL+N L G IP I L + L+GNS G IP +L ++ +LE L L YN S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 356 PELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI 393
PE SL +S + + L N L+G +P+++G +
Sbjct: 483 PE-----SLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 178 LSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIG 237
L L L G IP+ I L L ++ S NS+ G IP +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-------------------NIPPSLG 463
Query: 238 NLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSS 283
++ +LEVL + N G +P ++ +++L+ L+L N+LSG +P++
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 12/140 (8%)
Query: 762 FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS---SNR 818
++GA+ E +L V R +V + + LV+ M G L +Y+ N
Sbjct: 37 YEGAM----VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92
Query: 819 SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA-KLLN 877
+ + LE+LH +++ D+KP N+LLD+D +SD G+A +L +
Sbjct: 93 GFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149
Query: 878 GEESMRTQTLGTIGYMAPGL 897
G+ + GT G+MAP L
Sbjct: 150 GQSKTKGYA-GTPGFMAPEL 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DG----MEVAIKVF-HLQFDGALKSFDAECEV 775
+L F + ++G G+FGTVYKG ++ +G + VAIK A K E V
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 776 LKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
+ SV + ++ +++ C + L+ + M G L + ++ L+ + +A
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
+ YL +VH D+ N+L+ ++DFG+AKLL +E
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 51/151 (33%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDA--ECEVLKSVRHRNLVKIIS 789
+G GS+ TVYKGR L G VA+K L+ + GA F A E +LK ++H N+V +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHD 70
Query: 790 SCSNGNFKALVLEYMANG---SLEKC---LYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
LV EY+ ++ C L N L +FQ L L Y H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH--- 120
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
V+H D+KP N+L+ + L+DFG+A+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 17/163 (10%)
Query: 733 LIGIGSFGTVYKGRFL----DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRNLVKI 787
+G GSFG V +G + + VA+K + + F E ++ S+ H NL+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMID----VALALEYLHFGY 843
+V E GSL L +L F +S + D +A + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRL--RKDALGHFL-ISTLCDYAVQIANGMRYLE--- 114
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAK-LLNGEESMRTQ 885
S +H D+ NILL D + DFG+ + L E+ +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G++ TV+KGR L VA+K L+ + GA + E +LK+++H N+V +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
LV EY+ + L++ L + + + M + L Y H ++H D
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+KP N+L+++ L+DFG+A+ + + + T+ Y P
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 27/177 (15%)
Query: 734 IGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS 792
IG G+FG VY+ R D + A+KV + K A+ EV ++ RN++ + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL-VRTLLD 53
Query: 793 NGNFKA-------------LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL 839
F LV +YM+ G L L R + + I ++ LALE+L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
H +V+ D+KP NILLD L DFG++K N ++ T T GT Y+AP
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-08
Identities = 27/78 (34%), Positives = 50/78 (64%), Gaps = 3/78 (3%)
Query: 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLP 291
IP++I L +L+ + + N + G++P ++ ++++L+ L L N+ +GS+P S L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES---LGQLT 490
Query: 292 NIERLNLGLNNLSGRIPG 309
++ LNL N+LSGR+P
Sbjct: 491 SLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 16/273 (5%)
Query: 164 EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT-----GFYMTNNH 218
+ + L NL L L L + L I S + L++L LD NN++T + +N
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142
Query: 219 FTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG 278
+ N + +P + NLPNL+ L + N L D+P + N+S L L L N +S
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 279 SLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNL 338
LP + L L E L+L N++ + + N L LEL+ N +P+++ NL
Sbjct: 200 DLPPEIELLSAL---EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 339 RNLEHLGLGYNYLTSSTP--ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLE 396
NLE L L N ++S + L+ L L S +S L L +L + NL +TL+
Sbjct: 255 SNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314
Query: 397 EIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQL 429
+ L+ I N + L
Sbjct: 315 ALELKLNSILLNNNILSNGETSSPEALSILESL 347
|
Length = 394 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 48/192 (25%), Positives = 92/192 (47%), Gaps = 36/192 (18%)
Query: 734 IGIGSFGTVYKGRFLDGME---------VAIKVFHLQFDGALKSFD---AECEVLKSV-R 780
+G G FG V + G++ VA+K+ L+ D K +E E++K + +
Sbjct: 26 LGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGK 82
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCL---------YSSNRSLDIFQRLSI--- 828
H+N++ ++ +C+ +++EY + G+L + L Y N + ++LS
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 829 ---MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
VA +EYL S +H D+ N+L+ +D V ++DFG+A+ ++ + +
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 886 TLG--TIGYMAP 895
T G + +MAP
Sbjct: 200 TNGRLPVKWMAP 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 55/169 (32%), Positives = 77/169 (45%), Gaps = 10/169 (5%)
Query: 734 IGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
IG GSFG V + R D + I+ H+ + AE VL V +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
S + LVL ++ G L L R D+ + ++ ALE LH V++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAPGL 897
D+KP NILLD L DFG+ K LN ++ +T T GT Y+AP L
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPEL 164
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G++ TVYKGR L VA+K L+ + GA + E +LK ++H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
LV EY+ + L++ L S+++ + + L Y H V+H D
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRD 129
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+KP N+L+++ L+DFG+A+ + + + T+ Y P
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
LG+D L G +PN I + L++++L N++ G++P S ++ L E L+L N+ +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL---EVLDLSYNSFN 479
Query: 305 GRIPGFIFNASKLFLLELTGNSFSGFIPDTL 335
G IP + + L +L L GNS SG +P L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 25/172 (14%)
Query: 724 ATDHFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVR 780
AT + + + L G GS+ TVYKG ++G VA+KV ++ + + F A E +LK ++
Sbjct: 4 ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLK 61
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKC------LYSSNRSLDIFQRLSIMIDVAL 834
H N+V + V EYM + L+ N L +FQ L
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR------- 114
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
L Y+H ++H D+KP N+L+ L+DFG+A+ +S+ +QT
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 734 IGIGSFGTVYKG--RFLDGME-VAIKVFHLQF-DGALK-SFDAECEVLKSVRHRNLVKII 788
+G G+FGTV KG + + VA+K+ D ALK E V++ + + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
C ++ LV+E G L K L N+ + ++ V++ ++YL V
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-MRTQTLG 888
H D+ N+LL A +SDFG++K L +E+ + +T G
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 30/187 (16%)
Query: 733 LIGIGSFGTVYKGRFLD-------GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNL 784
+G G+FG VY+G D + VA+K D K F E ++ + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS------LDIFQRLSIMIDVALALEY 838
VK++ C + +++E M G L L + L + + L I +DVA Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 839 L---HFGYSNPVVHCDIKPSNILL-----DDDMVAHLSDFGIAKLL--NGEESMRTQTLG 888
L HF +H D+ N L+ D D V + DFG+A+ + + + L
Sbjct: 122 LEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 889 TIGYMAP 895
+ +MAP
Sbjct: 176 PVRWMAP 182
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 41/185 (22%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 727 HFSEKSLIGIGSFGTVY----KGRFLDGME--VAIKVF-HLQFDGALKSFDAECEVLKSV 779
+ E + +G G FG V+ KG +G E V +K + + F E ++ + +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS--------LDIFQRLSIMID 831
H+N+V+++ C ++LEY G L++ L ++ L Q++++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK-LLNGEESMRTQTLGTI 890
+AL +++L + VH D+ N L+ +S ++K + N E L +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 891 GYMAP 895
++AP
Sbjct: 183 RWLAP 187
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHR 782
+ S IG G++G V G++VAIK F+ E ++L+ +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHE 63
Query: 783 NLVKI---ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLD-----IFQRLSIMIDV 832
N++ I I S +F +V E M L K + + + S D ++Q L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE---SMRTQTLGT 889
L+Y+H S V+H D+KPSN+LL+ + + DFG+A++ + E T+ + T
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 890 IGYMAP 895
Y AP
Sbjct: 173 RWYRAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 731 KSLIGIGSFGTV-YKGRFLDGMEVAIKVFHLQ--FDGALKSFDAE------CEVLKSVR- 780
++G G+ GTV R DG A+KV ++ + AE C+ V+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 781 HRNLVKI-ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS---IMIDVALAL 836
H + K + N ALVL+Y G L + + S ++ F+ + I V LA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES---MRTQTLGTIGYM 893
++H S ++H DIK +NILL + + L DFG +K+ S RT GT Y+
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYV 212
Query: 894 APGLW 898
AP +W
Sbjct: 213 APEIW 217
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 20/151 (13%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFD-----AECEVLKSVR-HRNLVK 786
IG G+F V K + G AIK F KS + E + L+ + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSPHPNILR 62
Query: 787 ---IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
++ G ALV E M + +L + + R L + S M + +L+++H
Sbjct: 63 LIEVLFDRKTGRL-ALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
N + H DIKP NIL+ DD++ L+DFG +
Sbjct: 118 RNGIFHRDIKPENILIKDDIL-KLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 3/89 (3%)
Query: 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSF 327
L L N L G +P+ L L +I NL N++ G IP + + + L +L+L+ NSF
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSI---NLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 328 SGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356
+G IP++L L +L L L N L+ P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 83/331 (25%), Positives = 138/331 (41%), Gaps = 33/331 (9%)
Query: 264 STLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELT 323
+ + LS + + + L ++ L LN S + + S+L L+L
Sbjct: 16 TLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLL 75
Query: 324 GNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGV 383
S +L NL +L + + S +S L ++ + L N +
Sbjct: 76 SPS----GISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITD- 130
Query: 384 LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTL 443
+P IG L L+E+ L + KI ++P + NL NL L L N LS +P
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLP--------- 179
Query: 444 QGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
+ +L L+ L + NK+S +P L++L L L +N + +
Sbjct: 180 ------------KLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LL 225
Query: 504 STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563
S+ NL N+ + S+N L LP IGN+ + ++LS N ++ +++G LTNL+ L
Sbjct: 226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLREL 282
Query: 564 SLENNRLHGPIPESFGALTSLESLDLSVNNL 594
L N L +P L LE L + L
Sbjct: 283 DLSGNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 26/60 (43%), Positives = 35/60 (58%)
Query: 559 NLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618
NL+ L L NNRL +F L +L+ LDLS NNL+ + P + L L+ L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 781
F KSL+G G FG V R ++ A+KV L + F+ E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI---MIDVALALEY 838
+ ++ + + + LV+EY G L L NR D F + ++ LA+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 839 LH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMAPG 896
+H GY VH DIKP N+L+D L+DFG A L + + +GT Y+AP
Sbjct: 118 VHQMGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 897 LWVVLN 902
+ +N
Sbjct: 174 VLTTMN 179
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 785
++G GSFG V E AIK L+ D L+ D EC +++ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ + V+EY+ G L + SS R D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+++ D+K N+LLD D ++DFG+ K E + GT Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFD---AECEVLKSVRHRNLVKII 788
L+G G+FG V R G A+K+ + A E VL++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIM-IDVALALEYLHFGYSNPV 847
+ + V+EY ANG E + S + +R ++ ALEYLH S V
Sbjct: 62 YAFQTHDRLCFVMEY-ANGG-ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESMRTQTLGTIGYMAP 895
V+ DIK N++LD D ++DFG+ K ++ +M+T GT Y+AP
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 62/171 (36%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 733 LIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFD-----AECEVL-KSVRHRNLV 785
+IG GSFG V R + A+KV LQ LK + +E VL K+V+H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ S + VL+Y+ G L L L+ R ++A AL YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
+V+ D+KP NILLD L+DFG+ K N E + T T GT Y+AP
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 10/182 (5%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKS----FDAECE 774
R+L + + + +IG G+FG V R +V +F+ +S F E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
++ +V++ + + + +V+EYM G L + SN + +V L
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVL 153
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT-LGTIGYM 893
AL+ +H S +H D+KP N+LLD L+DFG +N E +R T +GT Y+
Sbjct: 154 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 894 AP 895
+P
Sbjct: 211 SP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 734 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKII 788
+G G FG+V +G+ ++VA+K + ++ F +E +K H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 789 SSCSNGNFK------ALVLEYMANGSLEK-CLYSSNRSLDIF---QRL-SIMIDVALALE 837
C ++L +M +G L LYS + Q L M D+A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA-KLLNGE 879
YL S +H D+ N +L+++M ++DFG++ K+ NG+
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 37/189 (19%)
Query: 734 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI--- 787
+G GS G V+ +D VA+K L ++K E ++++ + H N+VK+
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 788 -----------ISSCSNGNFKALVLEYMANG---SLEKCLYSSNRS-LDIFQRLSIMIDV 832
+ S + N +V EYM LE+ S + L ++Q L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR----- 125
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMR---TQTLG 888
L+Y+H S V+H D+KP+N+ ++ +D+V + DFG+A++++ S + ++ L
Sbjct: 126 --GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 889 TIGYMAPGL 897
T Y +P L
Sbjct: 181 TKWYRSPRL 189
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 10/123 (8%)
Query: 753 VAIKVFHL--QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLE 810
VA+K +L LK E + ++H N++ ++S + +V MA GS E
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 811 KCLYSSNRSLDIFQRLSI---MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL 867
L + L+I + DV AL+Y+H S +H +K S+ILL D L
Sbjct: 88 DLL--KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVL 142
Query: 868 SDF 870
S
Sbjct: 143 SGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 54/182 (29%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 732 SLIGIGSFGTV----YKGRFLDGMEVAIKVFHLQFDGA------LKSFDAECEVLKSVRH 781
+++G G FG V YK G AIK A L E S RH
Sbjct: 5 AVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI---DVALALEY 838
LV + + + V+EY A G L +++ D+F + V L L+Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQY 116
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM----RTQTL-GTIGYM 893
LH N +V+ D+K N+LLD + ++DFG+ K E M RT T GT ++
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFL 168
Query: 894 AP 895
AP
Sbjct: 169 AP 170
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGME-VAIKVFH--LQFDGALKSFDAECEVLKSVRHR 782
+ F ++G G++G V K R + E VAIK F + + ++ E ++L++++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
N+V++ + LV EY+ LE N R I ++ +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK-LLNGEESMRTQTLGTIGYMAPGL 897
+ N +VH DIKP N+L+ + V L DFG A+ L G + T+ + T Y +P L
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 785
++G GSFG V+ AIK L+ D L D EC +++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ + V+EY+ G L + S ++ D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLH---SK 115
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM----RTQTL-GTIGYMAP 895
+V+ D+K NILLD D ++DFG+ K E+M +T T GT Y+AP
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLDGMEV-AIK------VFHLQFDGALKSFDAECEVLKSV 779
F + IGIG+FG V R +D + A+K V +K AE ++L
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEA 58
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQ----RLSIMIDVALA 835
+ +VK+ S + + V++Y+ G + L L IF+ R I ++ A
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCA 113
Query: 836 LEYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872
+E +H G+ +H DIKP NIL+D D L+DFG+
Sbjct: 114 IESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 6/164 (3%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G++ TV+KGR L VA+K L+ + GA + E +LK ++H N+V +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
LV EY+ + L++ + + + + + L Y H V+H D
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRD 129
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+KP N+L+++ L+DFG+A+ + + + T+ Y P
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 14/184 (7%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKS----FDAEC 773
+L + + F +IG G+FG V R +V A+K+ +F+ +S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEER 94
Query: 774 EVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
+++ +V++ + + + +V+EYM G L L S+ + + R +V
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVV 152
Query: 834 LALEYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT-LGTIG 891
LAL+ +H G+ +H D+KP N+LLD L+DFG ++ +R T +GT
Sbjct: 153 LALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208
Query: 892 YMAP 895
Y++P
Sbjct: 209 YISP 212
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 24/166 (14%)
Query: 728 FSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRH 781
F+ ++G G FG+V + + +VA+K+ + ++ F E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 782 RNLVKIISSCSNGNFKA------LVLEYMANGSLEKCLYSS-------NRSLDIFQRLSI 828
N++K+I K ++L +M +G L L S L R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-- 118
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
MID+A +EYL S +H D+ N +L+++M ++DFG++K
Sbjct: 119 MIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
+G G FG V+ + +VA+K ++++F AE V+K+++H LVK+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 794 GNFKALVLEYMANGSLEKCLYSS--NRSLDIFQRLSIMIDVALAL-EYLHFGYSNPVVHC 850
++ E+MA GSL L S ++ Q L +ID + + E + F +H
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDEGSK-----QPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
D++ +NIL+ +V ++DFG+A+++ + E + R I + AP
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 734 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALKS---FDAECEVLKSVRHRNLVKIIS 789
IG G FG V G G A + V L+ +++ F E + +S++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRS------LDIFQRLSIMIDVALALEYLHFGY 843
C+ LV+E+ G L+ L S ++ QR++ ++AL L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH--- 117
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLGTIGYMAPGL 897
N +H D+ N LL D+ + D+G++ E+ T Q + ++AP L
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 29/69 (42%), Positives = 41/69 (59%), Gaps = 5/69 (7%)
Query: 828 IMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQT 886
I + + ALEYLH S V+H D+KPSN+L++ + L DFGI+ L +S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 887 LGTIGYMAP 895
G YMAP
Sbjct: 164 AGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 734 IGIGSFGTVYKGRFLD--GMEVAIKVFHLQF--DGALKSFDAECEVLK---SVRHRNLVK 786
IG G++G V+K R L G VA+K +Q +G S E VL+ + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 787 IISSCSNGNFK-----ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
+ C+ LV E++ + +M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 127
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S+ VVH D+KP NIL+ L+DFG+A++ + + ++ T + T+ Y AP
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAP 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 44/169 (26%), Positives = 59/169 (34%), Gaps = 33/169 (19%)
Query: 64 LGNLSSLQTLDLSHNRFSGTIP---SSIFSISTLKILILGDNQLSGSFPSFII----SNT 116
L LQ LDLS N S+ S+L+ L L +N L +
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 117 SSLRAIDCNYNSLSGELP---ANIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQEL 169
+L + N L G A RA LKEL L N + + + L
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANR-------DLKELNLANNGIGDAGIRALAEGL 189
Query: 170 GNLAELEWLSLPRSFLT--------GTIPSSIFNLSSLLELDFSNNSLT 210
LE L L + LT T+ S L SL L+ +N+LT
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLAS----LKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 19/97 (19%)
Query: 161 LQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFT 220
L+G IP ++ L L+ ++L + + G IP S+ +++SL LD S NS F
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS----------FN 479
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP 257
GSIP +L G L +L +L ++ N L G VP
Sbjct: 480 GSIPESL---------GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 734 IGIGSFGTVYKGRFLDGME-VAIKVFHL---QFDGALKSFDAECEVLKSVRHRNLVKIIS 789
IG GSFG VY E VA+K Q + + E + L+ ++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL----ALEYLHFGYSN 845
+ LV+EY CL S++ L++ ++ +++A AL+ L + +S+
Sbjct: 89 CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H DIK NILL + L+DFG A + S +GT +MAP
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF----VGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 17/173 (9%)
Query: 734 IGIGSFGTVY-----KGRFLDGMEV--AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
+G GSFGTVY K + ++V I V L + +++ + E ++L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 787 IISS-CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALEYLHFG 842
+S F ++ EY L+ L + Q I + L + Y+H
Sbjct: 67 FHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H D+K NI L ++++ + DFG+++LL G + T GT YM+P
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 31/181 (17%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLVK- 786
IG G++G V + + +VAIK FD + DA E ++L+ + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI---DAKRTLREIKLLRHLDHENVIAI 69
Query: 787 --IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLD------IFQRLSIMIDVALAL 836
I+ F +V E M + L + + SS D ++Q L L
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPG 896
+Y+H S V+H D+KPSN+LL+ + + DFG+A+ + + T+ + T Y AP
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 897 L 897
L
Sbjct: 179 L 179
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 704 EVNMSPQAMWR-RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFH 759
EVN + +W YR+L +G G++GTV LD G +VAIK +
Sbjct: 5 EVN---KTIWEVPDRYRDLKQ----------VGSGAYGTVCSA--LDRRTGAKVAIKKLY 49
Query: 760 LQFDGALKSFDA--ECEVLKSVRHRNLVKII------SSCSNGNFKALVLEYMANGSLEK 811
F L + A E +LK ++H N++ ++ S + LV+ +M L K
Sbjct: 50 RPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGK 108
Query: 812 CLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871
+ S D Q L + + L+Y+H + ++H D+KP N+ +++D + DFG
Sbjct: 109 LMKHEKLSEDRIQFL--VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163
Query: 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVVLN 902
+A+ + E T + T Y AP V+LN
Sbjct: 164 LARQTDSE---MTGYVVTRWYRAPE--VILN 189
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 32/190 (16%)
Query: 734 IGIGSFGTVYKGRFLDGME---------VAIKVFHLQ-FDGALKSFDAECEVLKSV-RHR 782
+G G FG V + G++ VA+K+ D L +E E++K + +H+
Sbjct: 20 LGEGCFGQVVRAEAY-GIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSS-----NRSLDI---------FQRL-S 827
N++ ++ C+ +++EY A G+L + L + + + DI F+ L S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 828 IMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887
VA +EYL S +H D+ N+L+ +D V ++DFG+A+ ++ + + +
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 888 G--TIGYMAP 895
G + +MAP
Sbjct: 196 GRLPVKWMAP 205
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 18/184 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHR 782
D + + IG G++G VYK R + G VA+K L+ D G + E +L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 783 N-LVKIIS--SCSNGNFKA---LVLEYMANGSLEKCLYSSNRS----LDIFQRLSIMIDV 832
+V+++ N K LV EY+ + L+K + S+ R L S M +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNGEESMRTQTLGTIG 891
+ + H + V+H D+KP N+L+D + ++D G+ + + T + T+
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 892 YMAP 895
Y AP
Sbjct: 177 YRAP 180
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 11/166 (6%)
Query: 734 IGIGSFGTVYK-GRFLDGMEVAIKVFHLQFDGAL-KSFDAECEVLKSVRHRNLVKIISSC 791
+G G+ G+V K G +A KV H+ ++ K E +++ R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
N N + +E+M GSL++ ++I + I + V L YL+ + ++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128
Query: 851 DIKPSNILLDDDMVAHLSDFGIA-KLLNGEESMRTQTLGTIGYMAP 895
DIKPSNIL++ L DFG++ +L+N S+ +GT YM+P
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 14/170 (8%)
Query: 733 LIGIGSFGTVY------KGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
L+G G+FG V G++ M++ K + D + E VLK+ RH L
Sbjct: 2 LLGKGTFGKVILVREKASGKYY-AMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTS 59
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ S + V+EY+ G L L S R + ++ AL+YLH S
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESMRTQTLGTIGYMAP 895
+V+ D+K N++LD D ++DFG+ K + +M+T GT Y+AP
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 734 IGIGSFGTVYKGRFLDGMEVA-IKVFHLQFDGALK---SFDAECEVLKSVRHRNLVKIIS 789
IG G FG V G GM A + V L+ F E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSL-------DIFQRLSIMIDVALALEYLHFG 842
C LVLE+ G L+ L SNR + D+ QR++ +VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMA--CEVASGLLWLH-- 117
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
+H D+ N L D+ + D+G+A
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 447 GLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTF 506
G EN P+P L+ L + ++L L +L +L L +N ++ P
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELL--------ELTNLTSLDLDNNNITDIPPLIG 136
Query: 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE 566
+N+ D S N + SLP + N+ + ++LS N L+ D+P + L+NL L L
Sbjct: 137 LLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194
Query: 567 NNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622
N++ +P L++LE LDLS NN + SL L L L LS N+LE
Sbjct: 195 GNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVR 780
+ F +IG G+FG V + D M+ +K + D L AE +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD-QLAHVKAERDVLAESD 59
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+V + S + + L++E++ G L L + + R M + LA+E +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH 118
Query: 841 -FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
G+ +H DIKP NIL+D LSDFG++
Sbjct: 119 KLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 47/194 (24%), Positives = 83/194 (42%), Gaps = 35/194 (18%)
Query: 734 IGIGSFGTVYKGRF--LDGM----EVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVK 786
+G G FG V K L G VA+K+ + L+ +E +LK V H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSN-----------------------RSLDIF 823
+ +CS L++EY GSL L S R+L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 824 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM- 882
+S ++ ++YL +VH D+ N+L+ + +SDFG+++ + E+S
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 883 -RTQTLGTIGYMAP 895
R++ + +MA
Sbjct: 185 KRSKGRIPVKWMAI 198
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 50/185 (27%), Positives = 92/185 (49%), Gaps = 16/185 (8%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKS----FDAEC 773
R+L + + + +IG G+FG V R +V A+K+ +F+ +S F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEER 94
Query: 774 EVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS--IMID 831
+++ +V++ + + + +V+EYM G L + SN D+ ++ + +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SN--YDVPEKWAKFYTAE 150
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT-LGTI 890
V LAL+ +H S ++H D+KP N+LLD L+DFG ++ +R T +GT
Sbjct: 151 VVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207
Query: 891 GYMAP 895
Y++P
Sbjct: 208 DYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 63/299 (21%)
Query: 10 QQALLALKARITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSS 69
L + +R+ + + S + + S G ++ + +L+++ L IS L L++
Sbjct: 59 LLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTN 117
Query: 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSL 129
L +LDL +N + P S LK L L DN++
Sbjct: 118 LTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI------------------------- 152
Query: 130 SGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTI 189
++P + NL LK L L +N L ++P+ L NL+ L L L + +
Sbjct: 153 ---------ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDL 201
Query: 190 PSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDE 249
P I LS+L ELD SNNS E+ + NL NL L +
Sbjct: 202 PPEIELLSALEELDLSNNS--------------------IIELLSSLSNLKNLSGLELSN 241
Query: 250 NHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP 308
N + D+P +I N+S L+ L L NN + SS +L L N+ L+L N+LS +P
Sbjct: 242 N-KLEDLPESIGNLSNLETLDLSNNQI-----SSISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 61/258 (23%), Positives = 93/258 (36%), Gaps = 45/258 (17%)
Query: 266 LKALSLLNNTLS-GSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324
L+ L L NTL + + + L P+++ L L LN GRIP
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIP---------------- 67
Query: 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNG-- 382
+ L L+ L L N L L SL SSS + + L N L
Sbjct: 68 -RGLQSLLQGLTKGCGLQELDLSDNALGPDGCG--VLESLLRSSSLQELKLNNNGLGDRG 124
Query: 383 --VLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLV----NLTTLHLGNNQLSGSIPIT 436
+L + +LP LE++ L ++ G + + + +L L+L NN + +
Sbjct: 125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRA 184
Query: 437 VGR----LNTLQGLGLENNKLE-------GPIPDDLCQLSELHVDHNKLSGPI-----PA 480
+ L+ L L NN L L L L++ N L+ A
Sbjct: 185 LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244
Query: 481 CFGNLNSLRNLSLGSNEL 498
SL LSL N++
Sbjct: 245 LLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 6e-06
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 463 QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522
L L + +N+L+ F L +L+ L L N L+S P F L ++ S D S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 21/180 (11%)
Query: 734 IGIGSFGTVY----KGRFLDGMEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNLVK 786
+G GSFG VY KG D E + + + +++ F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYS-----SNRSLDIFQRLSIMI----DVALALE 837
++ S G +++E M G L+ L S N + L MI ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLGTIGYMAP 895
YL+ +N VH D+ N ++ +D + DFG+ + + + R + L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
I G+FG VY GR + A+KV + + AE + L + +V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
S + N LV+EY+ G + K L D + + +VALAL+YLH + ++H
Sbjct: 72 SLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESM 882
D+KP N+L+ ++ L+DFG++K+ LN E +M
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKS-FDAE 772
E+ L+T F E+ +G FG VYKG VAIK + +G L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 773 CEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLY---------------SSN 817
+ ++H N+V ++ + +++ Y ++ L + L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
+L+ + I+ +A +E+L S+ VVH D+ N+L+ D + +SD G+ + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 878 GEE--SMRTQTLGTIGYMAP 895
+ + +L I +M+P
Sbjct: 176 AADYYKLMGNSLLPIRWMSP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 28/180 (15%)
Query: 734 IGIGSFGTVYK---GRFLDGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRN---LV 785
IG G+FG V+ R DG VA+K F + K E ++L +H N +
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 786 KIISSCSNGNFKAL-VLEYMANGSLEKCLYSSNRSLDIFQRLSI-MIDVAL-----ALEY 838
I+ F+ + V+ + L K + S Q LS + V L L+Y
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKY 118
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAPGL 897
LH S ++H DIKP N+L++ + V + DFG+A++ +ES TQ + T Y AP +
Sbjct: 119 LH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 23/150 (15%)
Query: 737 GSFGTVYKGRFLDGM-----EVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLVKI 787
G+FG ++ G +D EV +K D A + E +L + H+N++ I
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 788 ISSCSNGNFKALVLE-YMANGSL----EKCLYS---SNRSLDIFQRLSIMIDVALALEYL 839
+ C VL YM G+L ++C + ++L Q + + I +A + YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869
H V+H DI N ++D+++ ++D
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 32/128 (25%)
Query: 313 NASKLFL--LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS 370
K F+ L L GFIP+ + LR+L+
Sbjct: 414 TKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS--------------------------- 446
Query: 371 KYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS 430
I L+ N + G +P S+G++ +LE + L G+IP+ +G L +L L+L N LS
Sbjct: 447 --INLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 431 GSIPITVG 438
G +P +G
Sbjct: 504 GRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 734 IGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKIISSC 791
+G G++G+VYK G+ +A+K L+ D + E ++L +V +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALEYLHFGYSNPVV 848
+ +EYM GSL+K LY+ + + I V L++L ++ ++
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H D+KP+N+L++ + L DFG++ N S+ +G YMAP
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 25/181 (13%)
Query: 733 LIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKI 787
+G G++G+V +D G +VAIK F + + A E +LK ++H N++ +
Sbjct: 22 QVGSGAYGSVCSA--IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 788 I----SSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
+ S+ S F+ LV+ YM L+K + S D Q L + + L+Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYL--VYQMLCGLKYIH- 134
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVVL 901
S ++H D+KP N+ +++D + DFG+A+ + E T + T Y AP V+L
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPE--VIL 187
Query: 902 N 902
N
Sbjct: 188 N 188
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 734 IGIGSFGTVYK------GRFLDGMEVAIKVF----HLQFDGALKSFDAECEVLKSV-RHR 782
+G G+FG V + + M+VA+K+ H AL S E +++ + H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNHE 99
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHF 841
N+V ++ +C+ G ++ EY G L L S L + LS VA + +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA- 158
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
S +H D+ N+LL + + DFG+A+
Sbjct: 159 --SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 733 LIGIGSFGTVYKGRFL-DG----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVK 786
++G G+FGTVYKG ++ DG + VAIKV A K E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ C + LV + M G L + + + L+ + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881
+VH D+ N+L+ ++DFG+A+LL+ +E+
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 12/108 (11%)
Query: 771 AECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLS 827
AE ++L + +VK+ S + N+ L++EY+ G + L D F +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRF 105
Query: 828 IMIDVALALEYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
+ + LA++ +H GY +H DIKP N+LLD LSDFG+
Sbjct: 106 YIAETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVL-EYMANGSLEKCLYSSNRSLDIFQRLSIMI 830
E +L+++ H +++++ + + F L+L Y + C ++ R++ I L+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD---LYCYLAAKRNIAICDILAIER 189
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
V A++YLH N ++H DIK NI ++ L DFG A
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 4/128 (3%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLSIMI 830
E +L ++H N+V S +V+EY G L +K + L +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
+ L ++++H V+H DIK NI L + L DFG A+LL + +GT
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTP 164
Query: 891 GYMAPGLW 898
Y+ P +W
Sbjct: 165 YYVPPEIW 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 25/65 (38%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ L LE++H + VV+ D+KP+NILLD+ +SD G+A + + ++GT
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTH 159
Query: 891 GYMAP 895
GYMAP
Sbjct: 160 GYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 732 SLIGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI--- 787
++IG GSFG VY+ +D E VAIK LQ D K + E ++K++ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127
Query: 788 -ISSCSNGN----FKALVLEYMANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLH 840
+ C N F +V+E++ + + + N +L +F + AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 841 FGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAK-LLNGEESM 882
S + H D+KP N+L+D + L DFG AK LL G+ S+
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 37/163 (22%)
Query: 732 SLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLV 785
+IG GS+G V G +VAIK + F+ DA E ++L+ +RH ++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS---DATRILREIKLLRLLRHPDIV 62
Query: 786 K---IISSCSNGNFKAL--VLEYM---------ANGSLEKCLYSSNRSLDIFQRLSIMID 831
+ I+ S FK + V E M AN L + ++Q L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP----EHHQFFLYQLLR---- 114
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
AL+Y+H + V H D+KP NIL + D + DFG+A+
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 733 LIGIGSFGTVY----KGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK------SVRHR 782
++G GSFG V KG+ G A+K L+ D L D EC +++ + +
Sbjct: 2 VLGKGSFGKVLLAELKGK---GEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENP 56
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
L + + V+E++ G L + R D+++ ++ L++LH
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH-- 113
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +++ D+K N++LD D ++DFG+ K ++ + GT Y+AP
Sbjct: 114 -SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 43/131 (32%), Positives = 66/131 (50%), Gaps = 18/131 (13%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGS-----LEKC-LYSSNRSLDIFQR 825
E VL++ RH L + S + V+EY ANG L + ++S +R+ F
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRAR--FYG 101
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESMRT 884
I+ AL YLH S VV+ D+K N++LD D ++DFG+ K ++ +M+T
Sbjct: 102 AEIV----SALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 885 QTLGTIGYMAP 895
GT Y+AP
Sbjct: 155 -FCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 41/184 (22%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK-----SVRHRNLVKI 787
+IG G FG VY R D ++ A+K D + +K ++ R ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALNERIMLSL 50
Query: 788 ISS-------CSNGNFKA-----LVLEYMANGSLEKCLYS----SNRSLDIFQRLSIMID 831
+S+ C F +L+ M G L L S + + + +
Sbjct: 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA-----TE 105
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIG 891
+ L LE++H + VV+ D+KP+NILLD+ +SD G+A + + ++GT G
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHG 160
Query: 892 YMAP 895
YMAP
Sbjct: 161 YMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 34/134 (25%), Positives = 60/134 (44%), Gaps = 11/134 (8%)
Query: 734 IGIGSFGTVYKG---RFLDG-----MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+G G+F ++KG D EV +KV +SF ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
C G+ +V EY+ GSL+ L + ++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 846 PVVHCDIKPSNILL 859
+ H ++ N+LL
Sbjct: 120 GLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 734 IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVR-HRNLVKI 787
+G G++G V R + VAIK F + + A E ++L+ R H+N+ +
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 788 ISS--CSNGNFKALVL-EYMANGSLEKCLYSSNRSLDI-FQRLSIMIDVALALEYLHFGY 843
GNF L L E + L + + S D FQ S + + L+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQ--SFIYQILCGLKYIH--- 122
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG----EESMRTQTLGTIGYMAP 895
S V+H D+KP N+L++ D + DFG+A+ + T+ + T Y AP
Sbjct: 123 SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 26/82 (31%), Positives = 46/82 (56%), Gaps = 17/82 (20%)
Query: 809 LEKCLYSSNRSLDIFQRL---------SIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859
LEK + ++ IF+R+ +IM D+ LEY+H + + H DIKP NI++
Sbjct: 106 LEKLVENTKE---IFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159
Query: 860 DDDMVAHLSDFGIAK--LLNGE 879
D + ++ D+GIA +++G+
Sbjct: 160 DGNNRGYIIDYGIASHFIIHGK 181
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-05
Identities = 27/57 (47%), Positives = 32/57 (56%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
++LS N LT GL NL++L L N L PE+F L SL SLDLS NNL
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 732 SLIGIGSFGTVYKG-RFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 788
IG G+ G V + G VAIK F + A E ++K V H+N++ ++
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 789 ------SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL-ALEYLHF 841
S LV+E M + +L + + LD +R+S ++ L +++LH
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELM-DANLCQVI---QMDLD-HERMSYLLYQMLCGIKHLH- 135
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S ++H D+KPSNI++ D + DFG+A+ G M T + T Y AP
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 52/177 (29%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAEC-----EVLKSVR-HRNLV 785
++G GSFG V R G A+KV L+ D L+ D EC +L R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 786 KIISSCSNGNFKALVLEYMANGSL----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
++ + V+E++ G L +K R D + ++ AL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH- 113
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK--LLNGEESMRTQTL-GTIGYMAP 895
+++ D+K N+LLD + L+DFG+ K + NG T T GT Y+AP
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMID 831
E +L++V H +++++ + +G +VL + + L L +R L I Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
+ L YLH + ++H D+K NI ++D + D G A+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-05
Identities = 55/198 (27%), Positives = 78/198 (39%), Gaps = 41/198 (20%)
Query: 733 LIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF-DGAL--KSFDAECEVLKSVRHRNLVK 786
LIG G G VY D VA+K + L K F E ++ + H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQR-----------LSIMIDVALA 835
+ S CS+G+ + Y+ +L K L S + + LSI +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE--------------- 880
+EY+H S V+H D+KP NILL + D+G A EE
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 881 -SMRT--QTLGTIGYMAP 895
SM + +GT YMAP
Sbjct: 183 SSMTIPGKIVGTPDYMAP 200
|
Length = 932 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRN 783
F + +GIG+FG V +D A+K + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-FG 842
+VK+ S + + V++Y+ G + L ++ R I ++ LA+E +H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG 121
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872
+ +H DIKP NIL+D D L+DFG+
Sbjct: 122 F----IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 32/185 (17%)
Query: 728 FSEKSLIGIGSFGTVYK------GRFL-------DGMEVAIKVFHLQFD---GALKSFDA 771
EK +G G FG V+ FL DG V + V L+ D A F
Sbjct: 9 LKEK--LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL----------YSSN-RSL 820
E +++ +++ N+++++ C + + ++ EYM NG L + L +++N S+
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
I L + + +A ++YL S VH D+ N L+ + ++DFG+++ L +
Sbjct: 127 SIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 881 SMRTQ 885
R Q
Sbjct: 184 YYRIQ 188
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 734 IGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGALKS---FDAECEVLKSVRHRNLVK 786
+G GSFG VY+G D E + V + +L+ F E V+K ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYS--------SNRSLDIFQRLSIMI-DVALALE 837
++ S G +V+E MA+G L+ L S R Q + M ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLGTIGYMAP 895
YL+ + VH D+ N ++ D + DFG+ + + + R + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 35/198 (17%)
Query: 718 YRELLLAT-----DHFSEKSLIGIGSFGTV---YKGRFLDGMEVAIKVFHLQFDGAL--K 767
YR+ L T + + S +G G++G+V + + G+ VA+K F + K
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAK 61
Query: 768 SFDAECEVLKSVRHRNLVKII------SSCSNGNFKALVLEYMAN--GSLEKC--LYSSN 817
E +LK ++H N++ ++ S N LV M ++ KC L +
Sbjct: 62 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
I+Q L L+Y+H S ++H D+KPSN+ +++D + DFG+A+ +
Sbjct: 122 VQFLIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--H 169
Query: 878 GEESMRTQTLGTIGYMAP 895
++ M T + T Y AP
Sbjct: 170 TDDEM-TGYVATRWYRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 771 AECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI 830
+E L + H +VK + + L++EY + G L K + + FQ + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 831 ---DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT- 886
+ LAL+ +H S ++H D+K +NI L + L DFG +K + S+ +
Sbjct: 174 LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 887 -LGTIGYMAPGLW 898
GT Y+AP LW
Sbjct: 231 FCGTPYYLAPELW 243
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 33/142 (23%), Positives = 62/142 (43%), Gaps = 11/142 (7%)
Query: 742 VYKGRFLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKI----ISSCSNG 794
+YKG F + EV I+ F H + + E + L+ + N++KI I +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 854
+L+LEY G L + L + L +L + ID L L+ + P + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 855 SNILLDDDMVAHLSDFGIAKLL 876
+ L+ ++ + G+ K+L
Sbjct: 152 VSFLVTENYKLKIICHGLEKIL 173
|
Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 730 EKSLIGIGSFGTVYKGRFLDGM---EVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 784
E +G G++G VYK + DG E A+K Q +G S A E +L+ ++H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNV 60
Query: 785 V---KIISSCSNGNFKALVLEYMANG-----SLEKCLYSSNRSLDIFQRL--SIMIDVAL 834
+ K+ S S+ L+ +Y + + ++ + + + + + S++ +
Sbjct: 61 IALQKVFLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLN 877
+ YLH +N V+H D+KP+NIL+ + ++D G A+L N
Sbjct: 120 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 781
D F +IG G+FG V + + +V A+K+ + + F E +VL +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLH 840
R + + + + N LV++Y G L L +R + R + ++ LA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVH 119
Query: 841 -FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ-TLGTIGYMAP 895
GY VH DIKP N+LLD + L+DFG L + ++++ +GT Y++P
Sbjct: 120 QLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 30/120 (25%), Positives = 53/120 (44%), Gaps = 13/120 (10%)
Query: 763 DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-----SN 817
D A + F E ++L + N+ +++ C+ +++EYM NG L + L S
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 818 RSLDI----FQRLSIMI-DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872
+ + F L M +A + YL S VH D+ N L+ + ++DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 734 IGIGSFGTV---YKGRFLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 788
+G G++G+V Y R +VA+K F + + E +LK ++H N++ ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 789 ------SSCSNGNFKALVLEYMAN--GSLEKCLYSSNRSLD--IFQRLSIMIDVALALEY 838
+S N N LV M ++ KC S+ + I+Q L L+Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------GLKY 133
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H S ++H D+KPSN+ +++D + DFG+A+ + E T + T Y AP
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 733 LIGIGSFGTVY------KGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
L+G G+FG V GR+ M++ K + D + E VL++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTA 59
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ S + V+EY G L L S R + ++ AL+YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKL-LNGEESMRTQTLGTIGYMAP 895
VV+ D+K N++LD D ++DFG+ K + +M+T GT Y+AP
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 30/118 (25%), Positives = 50/118 (42%), Gaps = 27/118 (22%)
Query: 767 KSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL-----------EYMANGSLEKCLYS 815
K+ E ++LK++ HR ++ +I + + +V+ + LE+ +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 816 SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
R L+ AL YLH ++H D+K NI LD+ A L DFG A
Sbjct: 191 QRRLLE-------------ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRN 783
F + +GIG+FG V R +D A+K + + AE ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-FG 842
+V++ S + + V++Y+ G + L + R I ++ A+E +H G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG 121
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872
+ +H DIKP NIL+D D L+DFG+
Sbjct: 122 F----IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 2e-04
Identities = 15/40 (37%), Positives = 22/40 (55%), Gaps = 7/40 (17%)
Query: 8 TDQQALLALKARITA------KNWTSNTSV-CSWIGITCD 40
D+ ALLA K+ + +W ++S CSW G+TCD
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 27/77 (35%), Positives = 39/77 (50%), Gaps = 18/77 (23%)
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK--LLN-------------G 878
LALEYLH + +VH D+KP N+L+ L+DFG++K L++
Sbjct: 112 LALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 879 EESMRTQTLGTIGYMAP 895
E + Q GT Y+AP
Sbjct: 169 REFLDKQVCGTPEYIAP 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 734 IGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKII 788
IG G+ G V D G+ VA+K F + A E +LK V H+N++ ++
Sbjct: 29 IGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 789 S------SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI-DVALALEYLHF 841
+ S LV+E M + +L + ++ LD +R+S ++ + +++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH---MELD-HERMSYLLYQMLCGIKHLH- 140
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S ++H D+KPSNI++ D + DFG+A+ M T + T Y AP
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRYYRAP 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 4e-04
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 772 ECEVLKSVRHRNLVKIISSCSN-GNFKALVL-EYMANGSL----EKCLYSSNRSLDIFQR 825
E V++ ++H+N+V+ I N N K +L E+ G L +KC Y ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAI 120
Query: 826 LSIMIDVALALEYLHFGYSNP----VVHCDIKPSNILLDDDM-----------------V 864
+ I + AL Y H P V+H D+KP NI L + +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 865 AHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
A + DFG++K + G ESM +GT Y +P L
Sbjct: 181 AKIGDFGLSKNI-GIESMAHSCVGTPYYWSPEL 212
|
Length = 1021 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 12/34 (35%), Positives = 16/34 (47%), Gaps = 1/34 (2%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH 759
F E+ I S V++ DG EVA+KV
Sbjct: 12 AEFDEEP-IAAASIAQVHRAVLKDGEEVAVKVQR 44
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 8/175 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 781
D F +IG G+FG V + + A+K+ + + F E VL +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
+ + + + + N+ LV++Y G L L L + ++ LA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH- 119
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ-TLGTIGYMAP 895
VH DIKP N+LLD + L+DFG +N + ++++ +GT Y++P
Sbjct: 120 --QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 52/225 (23%), Positives = 73/225 (32%), Gaps = 54/225 (24%)
Query: 414 GNLVNLTTLHLGNNQLSGSIPITVGRL---NTLQGLGLENNKLEGPIPDDLCQLSELHVD 470
L L L +N L + L ++LQ L L NN L L + +
Sbjct: 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK-GLKDLP 136
Query: 471 HNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSN-SLNGSLPLD 529
L L LG N L + N L
Sbjct: 137 PA---------------LEKLVLGRN-----------RLEGASCEALAKALRANRDL--- 167
Query: 530 IGNMKVVVEINLSRNYLTGD-IPTTIGGL---TNLQLLSLENNRLH----GPIPESFGAL 581
E+NL+ N + I GL NL++L L NN L + E+ +L
Sbjct: 168 -------KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220
Query: 582 TSLESLDLSVNNLSGVI-----PISLEKLVYLKDLNLSFNRLEGE 621
SLE L+L NNL+ L + L L+LS N + +
Sbjct: 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 43/186 (23%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 728 FSEKSLIGIGSFGTVY----KG--RFLDG-----------MEVAIKVFHLQFD-GALKSF 769
F EK +G G FG V+ +G +F+D + VA+K+ + A F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 770 DAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL---------YSSNRSL 820
E +++ ++ N++++++ C + ++ EYM NG L + L ++
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 821 DIFQRLSIM-IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879
+ L M +A ++YL S VH D+ N L+ + ++DFG+++ L
Sbjct: 127 ISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 880 ESMRTQ 885
+ R Q
Sbjct: 184 DYYRIQ 189
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFH---LQFDGALKSFDAECEVLKSVRH 781
+ F +IG G+FG V + + +V A+K+ + + F E +VL + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQR--LSIMIDVALALEY 838
+ + + + + N LV++Y G L L +R + R L+ M+ ++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG-IAKLLNGEESMRTQTLGTIGYMAP 895
LH+ VH DIKP NIL+D + L+DFG KL+ + +GT Y++P
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 33/150 (22%), Positives = 65/150 (43%), Gaps = 15/150 (10%)
Query: 729 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV--K 786
S L+ G VY D + +K+ + GA + E +L+ + + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPK 57
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+++S + + L++E++ +L++ + ++ I +A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLL 108
Query: 847 VV-HCDIKPSNILLDDDMVAHLSDFGIAKL 875
V+ H D+ P NIL+DD + + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 14/166 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVR 780
D F +IG G+FG V + D M++ K L+ + + AE ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+VK+ S + L++E++ G + L + + + I + LA++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH 118
Query: 841 -FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
G+ +H DIKP N+LLD LSDFG+ L +++ RT+
Sbjct: 119 QLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGL--KKAHRTE 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 733 LIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAECEVLK------SVRHRNLV 785
++G GSFG V E+ AIK+ L+ D ++ D EC +++ S + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI---DVALALEYLHFG 842
++ S + V+EY+ G L + R F+ + ++A+ L +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLH-- 118
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAPGL 897
S +++ D+K N++LD + ++DFG+ K N + + T+T GT Y+AP +
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 730 EKSLIGIGSFGTVYKGRFLDGME---VAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNL 784
E +G G++G VYK + DG + A+K Q +G S A E +L+ ++H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKHPNV 60
Query: 785 VKIISS-CSNGNFKALVLEYMANGSLEKCL-----YSSNRSLDIFQRLSIMIDVALALEY 838
+ + S+ + K +L A L + +N+ R + + L+
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 839 LHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLN 877
+H+ ++N V+H D+KP+NIL+ + ++D G A+L N
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 27/182 (14%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSVRH 781
F+ ++G GSFG V E+ AIK+ L+ D ++ D EC VL
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 782 RNLVKIISSCSNGNFKAL-----VLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVAL 834
+ + SC F+ + V+EY+ G L +Y + Q + ++++
Sbjct: 60 PPFLTQLHSC----FQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISV 112
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYM 893
L +LH +++ D+K N++LD + ++DFG+ K + + + T+T GT Y+
Sbjct: 113 GLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYI 168
Query: 894 AP 895
AP
Sbjct: 169 AP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 18/60 (30%), Positives = 29/60 (48%)
Query: 292 NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351
N++ L+L N L+ G L +L+L+GN+ + P+ L +L L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 12/175 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRH 781
+ F +IG G+FG V + D G A+K+ + + AE ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH- 840
+VK+ S + L++E++ G + L + + + I + LA++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
G+ +H DIKP N+LLD LSDFG+ L +++ RT+ + + P
Sbjct: 120 LGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTEFYRNLNHSLP 168
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 753 VAIKVFHLQFDGALKSFDA--ECEVLKSVRHRNLVKIIS------SCSNGNFKALVLEYM 804
VAIK F + A E ++K V H+N++ +++ S LV+E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVAL-ALEYLHFGYSNPVVHCDIKPSNILLDDDM 863
+ +L + + LD +R+S ++ L +++LH S ++H D+KPSNI++ D
Sbjct: 105 -DANLCQVI---QMELD-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDC 156
Query: 864 VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ DFG+A+ G M T + T Y AP
Sbjct: 157 TLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 41/168 (24%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKV------FHLQFDGALKSFDAECEVLKSVRHRNLVK 786
LI G+ +Y G FL G++ IK H + D E ++ R RN +
Sbjct: 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELD----------ERIRRERTRNEAR 49
Query: 787 IISSC-SNG-----------NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
++S G + K +V+EY+ G K + ++ ++
Sbjct: 50 LLSRARKAGVNTPVVYDVDPDNKTIVMEYI-EGKPLKDVIEEGN-------DELLREIGR 101
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882
+ LH +VH D+ SNI++ DD + +L DFG+ K + E
Sbjct: 102 LVGKLH---KAGIVHGDLTTSNIIVRDDKL-YLIDFGLGKYSDEIEDK 145
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 29/116 (25%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+ N +K+ S + L+++Y+ +G L L L + I+ + AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 841 FGYSNPVVHCDIKPSNILLDDDMV-AHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H DIK N+L D +L D+G+ K++ GT+ Y +P
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSP 175
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.9 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.9 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.89 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.89 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.89 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.89 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.89 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.89 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.88 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.88 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.88 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.87 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.87 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.87 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.87 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.87 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.87 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.86 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.86 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.86 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.86 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.85 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.85 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.83 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.78 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.65 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.28 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.87 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.64 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.44 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.41 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-104 Score=995.29 Aligned_cols=814 Identities=33% Similarity=0.543 Sum_probs=625.0
Q ss_pred CChhHHHHHHHHHhcccc-----CCCCCCCCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccc
Q 046199 5 INTTDQQALLALKARITA-----KNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNR 79 (902)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~-----~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~ 79 (902)
.+++|++||++||+++.+ .+|+.+.|||.|.||+|+. .++|+.|||++++++|.+|+.+..+++|+.|||++|+
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 378999999999999965 5798778999999999985 4589999999999999999999999999999999999
Q ss_pred cccCCCcccc-CCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecc
Q 046199 80 FSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGY 158 (902)
Q Consensus 80 l~~~~p~~~~-~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~ 158 (902)
++|.+|..++ .+++|++|+|++|.++|.+|. +.+++|++||+++|.+++. +|..++++++|++|+|++
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~--------~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGE--------IPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCccccc--------CChHHhcCCCCCEEECcc
Confidence 9999999876 899999999999999998886 4578888888888888764 677788888888888888
Q ss_pred cccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccC
Q 046199 159 NKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGN 238 (902)
Q Consensus 159 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~ 238 (902)
|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+ ++.+| ..+++
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l----------~~~~p---------~~l~~ 234 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL----------SGEIP---------YEIGG 234 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc----------CCcCC---------hhHhc
Confidence 888888888888888888888888888888888888888888888888874 34443 77788
Q ss_pred CCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccccccccc
Q 046199 239 LPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLF 318 (902)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 318 (902)
+++|++|+|++|++++.+|..+.++++|+.|+|++|++++.+|.+ +.++++|++|++++|.+.+.+|..+..+++|+
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~---l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 311 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS---IFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh---HhhccCcCEEECcCCeeccCCChhHcCCCCCc
Confidence 888888888888888888888888888888888888888777766 56677777777777777777777777777777
Q ss_pred EEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEE
Q 046199 319 LLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEI 398 (902)
Q Consensus 319 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L 398 (902)
.|++++|.+.+..|..+..+++|+.|++++|.+.+..| ..+..+++|+.|++++|++.+.+|..+...+ +++.|
T Consensus 312 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-----~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-~L~~L 385 (968)
T PLN00113 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP-----KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-NLFKL 385 (968)
T ss_pred EEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC-----hHHhCCCCCcEEECCCCeeEeeCChhHhCcC-CCCEE
Confidence 77777777777777777777777777777777765555 3444555555555555555555555444444 45555
Q ss_pred EeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCC
Q 046199 399 YLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPI 478 (902)
Q Consensus 399 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~ 478 (902)
++++|.+.+.+|..+..+++|+.|++++|++++.+|..|..++ +|+.|++++|++++.+
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~---------------------~L~~L~Ls~N~l~~~~ 444 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP---------------------LVYFLDISNNNLQGRI 444 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCC---------------------CCCEEECcCCcccCcc
Confidence 5555555555555555555555555555555544444444444 4555555555566666
Q ss_pred CccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCC
Q 046199 479 PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLT 558 (902)
Q Consensus 479 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 558 (902)
|..+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|++++..|..+.++++|++|+|++|++++.+|..++.++
T Consensus 445 ~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 523 (968)
T PLN00113 445 NSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523 (968)
T ss_pred ChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence 7777788889999999999888777765 458899999999999999999999999999999999999999999999999
Q ss_pred ccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCcccccccccccC
Q 046199 559 NLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMG 638 (902)
Q Consensus 559 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~ 638 (902)
+|++|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..++|.++...++.|
T Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~ 603 (968)
T PLN00113 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603 (968)
T ss_pred CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCC-CCCCCCCCCCCCCccceeeehhhhhhHHHHHHHHHHHhhhheeecccCCccc-cc----cccccCcccc
Q 046199 639 NDLLCGSPHL-QVPLCKSSPHQKSSKNVILLGVVLPLSVFIIAILLALGIGLITRYRKGNTEL-SN----IEVNMSPQAM 712 (902)
Q Consensus 639 n~~lc~~~~~-~~~~c~~~~~~~~~~~~~~~~i~~~~~~~~~~~~l~~~~~~~~r~r~~~~~~-~~----~~~~~~~~~~ 712 (902)
|+.+||.+.. ..+.|..... +.. ++..++++++++++++++++++++++++++...+. .. ++........
T Consensus 604 n~~lc~~~~~~~~~~c~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (968)
T PLN00113 604 NIDLCGGDTTSGLPPCKRVRK---TPS-WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679 (968)
T ss_pred CccccCCccccCCCCCccccc---cce-eeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccccccccccc
Confidence 9999996532 3456743211 111 12222222222222223333333222222111110 00 0000000011
Q ss_pred ccccCHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 713 WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 713 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
...+.++++ ...|...+.||+|+||.||+|++. +++.||||+++.... ....|++++++++|||||++++++
T Consensus 680 ~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~ 752 (968)
T PLN00113 680 SKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLC 752 (968)
T ss_pred chhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEE
Confidence 122333333 345778889999999999999874 589999998864322 223568899999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.+++..|+||||+++|+|.++++ .+++..+.+++.|+++|++|||..++.+|+|||+||+||+++.++.+++. ||
T Consensus 753 ~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 753 RSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred EcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999999984 37899999999999999999996667799999999999999999888875 66
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.+...... ....+|+.|||||++..
T Consensus 828 ~~~~~~~~----~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 828 LPGLLCTD----TKCFISSAYVAPETRET 852 (968)
T ss_pred cccccccC----CCccccccccCcccccC
Confidence 65443221 22468899999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-64 Score=635.46 Aligned_cols=519 Identities=36% Similarity=0.579 Sum_probs=433.1
Q ss_pred CCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccC
Q 046199 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGN 147 (902)
Q Consensus 68 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~ 147 (902)
.+++.|||++|.++|.+|+.+..+++|++|+|++|+++|.+|..+..++++|++||+++|+++|.+ |. +.
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~--------p~--~~ 138 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI--------PR--GS 138 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCcccccc--------Cc--cc
Confidence 478999999999999999999999999999999999999999988889999999999999998764 33 45
Q ss_pred cCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccc
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~ 227 (902)
+++|++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|+|++|.+ ++.+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l----------~~~~---- 204 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL----------VGQI---- 204 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCC----------cCcC----
Confidence 77899999999999989999999999999999999999989999999999999999999984 3444
Q ss_pred cccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCC
Q 046199 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI 307 (902)
Q Consensus 228 ~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~ 307 (902)
|..++++++|+.|+|++|++++.+|..++++++|++|++++|++++.+|.. +.++++|++|++++|.+.+.+
T Consensus 205 -----p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~---l~~l~~L~~L~L~~n~l~~~~ 276 (968)
T PLN00113 205 -----PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS---LGNLKNLQYLFLYQNKLSGPI 276 (968)
T ss_pred -----ChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh---HhCCCCCCEEECcCCeeeccC
Confidence 488889999999999999999889999999999999999999998888876 677888888888888888888
Q ss_pred CccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcc
Q 046199 308 PGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSS 387 (902)
Q Consensus 308 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~ 387 (902)
|..+.++++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+..| ..+..+++|+.|++++|.+.+.+|..
T Consensus 277 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~p~~ 351 (968)
T PLN00113 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP-----VALTSLPRLQVLQLWSNKFSGEIPKN 351 (968)
T ss_pred chhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC-----hhHhcCCCCCEEECcCCCCcCcCChH
Confidence 8888888888888888888888888888888888888888888776655 44555566666666666555555555
Q ss_pred cccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeE
Q 046199 388 IGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSEL 467 (902)
Q Consensus 388 ~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L 467 (902)
+..++ +|+.|++++|++++.+|..++.+++|+.|++++|++.+.+|.++..++ +|+.|
T Consensus 352 l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~---------------------~L~~L 409 (968)
T PLN00113 352 LGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR---------------------SLRRV 409 (968)
T ss_pred HhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCC---------------------CCCEE
Confidence 55554 555555555555555555555555555555555555555555444444 55556
Q ss_pred eccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcccc
Q 046199 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLT 547 (902)
Q Consensus 468 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 547 (902)
++++|++++..|..|.++++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|+++
T Consensus 410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~ 488 (968)
T PLN00113 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFS 488 (968)
T ss_pred ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccC
Confidence 666666667788889999999999999999999999999999999999999999999888766 4589999999999999
Q ss_pred ccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCC-C
Q 046199 548 GDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG-G 626 (902)
Q Consensus 548 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~ 626 (902)
+..|..|.++++|+.|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|.. .
T Consensus 489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 568 (968)
T PLN00113 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568 (968)
T ss_pred CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999974 3
Q ss_pred cccccccccccCCcccCCCC
Q 046199 627 SFANFSAQSFMGNDLLCGSP 646 (902)
Q Consensus 627 ~~~~~~~~~~~~n~~lc~~~ 646 (902)
.+..+....+.+|+..+..|
T Consensus 569 ~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 569 NVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cCcccCEEeccCCcceeeCC
Confidence 45567777888898766444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=399.54 Aligned_cols=484 Identities=28% Similarity=0.422 Sum_probs=303.3
Q ss_pred EEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcc
Q 046199 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125 (902)
Q Consensus 46 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls 125 (902)
...+++++|.++ .+.+.+.+|..|..|++++|+++ ++|++++.+.+++.|+.|+|+++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-------------------- 104 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-------------------- 104 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh--------------------
Confidence 344455555554 34444555555555555555555 55555555555555555555554
Q ss_pred cCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeee
Q 046199 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFS 205 (902)
Q Consensus 126 ~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 205 (902)
.+|+.++.+.+|+.|+.++|.+. ++|++++.+..|+.|+..+|+++ ..|..++++.+|..|++.
T Consensus 105 --------------~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~ 168 (565)
T KOG0472|consen 105 --------------ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLE 168 (565)
T ss_pred --------------hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhcc
Confidence 25666666666666666666666 56666666666666666666666 556666666666666666
Q ss_pred eCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCc
Q 046199 206 NNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285 (902)
Q Consensus 206 ~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 285 (902)
+|+++. +|+..-+++.|+.||+-+|-++ .+|+.++.+.+|..|+|.+|++. .+|+
T Consensus 169 ~n~l~~--------------------l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPe--- 223 (565)
T KOG0472|consen 169 GNKLKA--------------------LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPE--- 223 (565)
T ss_pred ccchhh--------------------CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCCC---
Confidence 666552 2344444666666666666665 66666666666666666666665 4452
Q ss_pred ccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCccccccccc
Q 046199 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLA 365 (902)
Q Consensus 286 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~ 365 (902)
|.++..|.+|+++.|+|.....+...+++++.+|||..|++. ..|+.+.-+++|+.||+|+|.|++.++ +++
T Consensus 224 -f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~------sLg 295 (565)
T KOG0472|consen 224 -FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY------SLG 295 (565)
T ss_pred -CCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc------ccc
Confidence 566666666666666666333333346666777777777776 556666777777777777777766544 456
Q ss_pred CCCCCceeeeccCCCCcccCcccccccc--cccEEEe--ecCcccccCCcccCCCCCCcEEEeecceecccCCccccccc
Q 046199 366 NSSSSKYIVLAENPLNGVLPSSIGNLPI--TLEEIYL--QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLN 441 (902)
Q Consensus 366 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--~L~~L~L--~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 441 (902)
++ .|+.|.+.+|++.. +...+-+.++ -|++|.= ..-.++.. .. ..-..-++ ..+ .......+.
T Consensus 296 nl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~s-----e~-~~e~~~t~----~~~-~~~~~~~~i 362 (565)
T KOG0472|consen 296 NL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQS-----EG-GTETAMTL----PSE-SFPDIYAII 362 (565)
T ss_pred cc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCC-----cc-cccccCCC----CCC-cccchhhhh
Confidence 66 66666666766652 2222221110 0111110 00000000 00 00000000 000 001122344
Q ss_pred ccCeeecccccccCCCCCcCC------CCCeEeccCccccCCCCccccCCCcCce-EecCCCCccCcccccccCCCCceE
Q 046199 442 TLQGLGLENNKLEGPIPDDLC------QLSELHVDHNKLSGPIPACFGNLNSLRN-LSLGSNELSSFIPSTFWNLNNILS 514 (902)
Q Consensus 442 ~L~~L~L~~N~l~~~~p~~l~------~L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~ 514 (902)
+.+.|+++.-+++ .+|+..+ -....+++.|++. .+|..+..++.+.. +.+++|.+ +++|..++.+++|+.
T Consensus 363 ~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~ 439 (565)
T KOG0472|consen 363 TTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTF 439 (565)
T ss_pred hhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhccee
Confidence 4555555555555 4454332 2556777777777 56777766666544 45555555 467888888999999
Q ss_pred EEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccc
Q 046199 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594 (902)
Q Consensus 515 L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (902)
|+|++|-+. .+|.+++.+..|+.||+|.|++. .+|..+..+..++.+-.++|++..+.|..+.+|.+|.+|||.+|.+
T Consensus 440 L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdl 517 (565)
T KOG0472|consen 440 LDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDL 517 (565)
T ss_pred eecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCch
Confidence 999998888 58888999888999999999998 7899888888888888888999876677799999999999999999
Q ss_pred cccCCcccccccccccccccCCcce
Q 046199 595 SGVIPISLEKLVYLKDLNLSFNRLE 619 (902)
Q Consensus 595 ~~~~p~~l~~l~~L~~L~l~~N~l~ 619 (902)
. .+|+.++++++|++|+++||+|.
T Consensus 518 q-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 518 Q-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred h-hCChhhccccceeEEEecCCccC
Confidence 8 78889999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=380.98 Aligned_cols=485 Identities=27% Similarity=0.389 Sum_probs=335.1
Q ss_pred cEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEc
Q 046199 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124 (902)
Q Consensus 45 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldl 124 (902)
-.+.|+++++.++ ++|++++.+..++.|+.|+|+++ .+|++++++..|+.|+.++|.+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~e------------------ 128 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKE------------------ 128 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceee------------------
Confidence 3789999999998 89999999999999999999999 999999999999999999999874
Q ss_pred ccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEee
Q 046199 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDF 204 (902)
Q Consensus 125 s~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 204 (902)
+|++++.+..|+.|+..+|+++ ..|+.++.+.+|..|++.+|++. ..|...-+++.|++||.
T Consensus 129 ----------------l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~ 190 (565)
T KOG0472|consen 129 ----------------LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDC 190 (565)
T ss_pred ----------------cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhccc
Confidence 5566666666666666666666 56666666666666666666666 33433444666666666
Q ss_pred eeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCC
Q 046199 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSS 284 (902)
Q Consensus 205 s~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 284 (902)
-.|.++ .+|+.++.+.+|+.|+|.+|+|. .+| +|.+++.|++|+++.|+|+ .+|...
T Consensus 191 ~~N~L~--------------------tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~ 247 (565)
T KOG0472|consen 191 NSNLLE--------------------TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEH 247 (565)
T ss_pred chhhhh--------------------cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHH
Confidence 666544 23466666667777777777776 555 6777777777777777776 556553
Q ss_pred cccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccc
Q 046199 285 KNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364 (902)
Q Consensus 285 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l 364 (902)
+..+++|..|||..|+++ ..|+.+..+.+|.+||+|+|.|+ ..|.+++++ .|+.|-+.+|.+..+..++- .-
T Consensus 248 --~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii---~~ 319 (565)
T KOG0472|consen 248 --LKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREII---SK 319 (565)
T ss_pred --hcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHH---cc
Confidence 456777777777777776 56677777777777777777777 456667777 77777777777654322100 00
Q ss_pred cCCCCCceeee--ccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccc
Q 046199 365 ANSSSSKYIVL--AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNT 442 (902)
Q Consensus 365 ~~l~~L~~L~L--s~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 442 (902)
+.-.-|+||.= ..-.++.. .. + +-..-+ ... ..........+.+.|++++-+++ .+|+....-..
T Consensus 320 gT~~vLKyLrs~~~~dglS~s--e~-~----~e~~~t----~~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~ 386 (565)
T KOG0472|consen 320 GTQEVLKYLRSKIKDDGLSQS--EG-G----TETAMT----LPS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAK 386 (565)
T ss_pred cHHHHHHHHHHhhccCCCCCC--cc-c----ccccCC----CCC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhh
Confidence 00011222211 00011000 00 0 000000 001 11112334455666666666666 44544333222
Q ss_pred ---cCeeecccccccCCCCCcCCC----CCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEE
Q 046199 443 ---LQGLGLENNKLEGPIPDDLCQ----LSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515 (902)
Q Consensus 443 ---L~~L~L~~N~l~~~~p~~l~~----L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 515 (902)
....+++.|++. ++|..+.. .+.+.+++|.++ .+|..++.+++|..|+|++|-+.. +|..++.+..|+.|
T Consensus 387 ~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~L 463 (565)
T KOG0472|consen 387 SEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTL 463 (565)
T ss_pred hcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhhee
Confidence 566677777776 66666552 334556666665 788889999999999999999986 68889999999999
Q ss_pred EcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc
Q 046199 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595 (902)
Q Consensus 516 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 595 (902)
|+|.|+|. .+|..+..+..++.+-.++|++....|..+.++.+|+.|||.+|.+. .+|..+++|++|+.|+|++|+|+
T Consensus 464 nlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 464 NLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999999 68999998999999988999999777777999999999999999998 78999999999999999999999
Q ss_pred ccCCcccccccccccccccCCc
Q 046199 596 GVIPISLEKLVYLKDLNLSFNR 617 (902)
Q Consensus 596 ~~~p~~l~~l~~L~~L~l~~N~ 617 (902)
..+..+--......|.+-+++
T Consensus 542 -~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 542 -QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred -CCHHHHhccChHHHHHHhccc
Confidence 444444333444444444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.21 Aligned_cols=396 Identities=23% Similarity=0.282 Sum_probs=326.5
Q ss_pred cEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccC
Q 046199 200 LELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGS 279 (902)
Q Consensus 200 ~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 279 (902)
..||.+++.|+.++-. .+.|-+| +.-++||+++|+++..-+..|.++++|+++++.+|.++ .
T Consensus 55 ~lldcs~~~lea~~~~--~l~g~lp---------------~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~ 116 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKS--RLKGFLP---------------SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-R 116 (873)
T ss_pred eeeecCcccccccccc--ccCCcCc---------------cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-h
Confidence 4567777776654322 1444444 35677899999998777778888999999999999888 6
Q ss_pred CCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCccc
Q 046199 280 LPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELS 359 (902)
Q Consensus 280 ~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 359 (902)
+|.. .....+|+.|+|.+|.|+..-...+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+....
T Consensus 117 IP~f---~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~--- 190 (873)
T KOG4194|consen 117 IPRF---GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLET--- 190 (873)
T ss_pred cccc---cccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccc---
Confidence 6753 2334568888999998888888888888889999999999887666677777889999999999887766
Q ss_pred ccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCccccc
Q 046199 360 FLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGR 439 (902)
Q Consensus 360 ~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 439 (902)
..|.++.+|..|.|+.|+++...+..|..+| .|+.|+|..|+|.-.---.|.++++|+.|.|..|.++......|..
T Consensus 191 --~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~-~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~ 267 (873)
T KOG4194|consen 191 --GHFDSLNSLLTLKLSRNRITTLPQRSFKRLP-KLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYG 267 (873)
T ss_pred --ccccccchheeeecccCcccccCHHHhhhcc-hhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceee
Confidence 6777888888888999988877777788788 8999999999988555678889999999999999998777888999
Q ss_pred ccccCeeecccccccCCCCCcC---CCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEE
Q 046199 440 LNTLQGLGLENNKLEGPIPDDL---CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516 (902)
Q Consensus 440 l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 516 (902)
+.++++|+|+.|++...--.++ .+|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+...+..|..+..|++|.
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 9999999999998875444444 3788889999999988888888888999999999999999899999999999999
Q ss_pred cCCCccCCCCccccccccccceeccCCccccccCc---cccccCCccceEEccCcccCCCccccccccccCCeEeCcCcc
Q 046199 517 FSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP---TTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNN 593 (902)
Q Consensus 517 ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 593 (902)
|++|+++..-...|..+.+|++|||++|.|+..+. ..|.+|++|+.|+|.+|+|..+.-.+|.++++|+.|||.+|.
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCc
Confidence 99999998778888899999999999999887664 468889999999999999996666789999999999999999
Q ss_pred ccccCCcccccccccccccccCCcceecCC
Q 046199 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 594 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
|..+.|.+|..+ .|+.|-+..-.+-|.+-
T Consensus 428 iaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 428 IASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred ceeecccccccc-hhhhhhhcccceEEecc
Confidence 999999999998 89999887766665544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=354.05 Aligned_cols=363 Identities=23% Similarity=0.311 Sum_probs=257.3
Q ss_pred cceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC
Q 046199 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG 254 (902)
Q Consensus 175 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~ 254 (902)
-+.||+++|.++..-+..|.++++|+++++.+|.|+. +|...+...+|+.|+|.+|.|+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~--------------------IP~f~~~sghl~~L~L~~N~I~s 139 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR--------------------IPRFGHESGHLEKLDLRHNLISS 139 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhhh--------------------cccccccccceeEEeeecccccc
Confidence 4567777777776666777777777777777777662 33444445567777777777776
Q ss_pred cCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccc
Q 046199 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT 334 (902)
Q Consensus 255 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 334 (902)
.-.+++..++.|+.||||.|.|+ .+|... |..-.++++|+|++|.|+..-.+.|..+.+|..|.|++|+|+...+..
T Consensus 140 v~se~L~~l~alrslDLSrN~is-~i~~~s--fp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~ 216 (873)
T KOG4194|consen 140 VTSEELSALPALRSLDLSRNLIS-EIPKPS--FPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRS 216 (873)
T ss_pred ccHHHHHhHhhhhhhhhhhchhh-cccCCC--CCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHH
Confidence 66677777788888888888877 444332 555567888888888888777788888888888888888888777777
Q ss_pred ccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccC
Q 046199 335 LVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIG 414 (902)
Q Consensus 335 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~ 414 (902)
|.+|++|+.|+|..|+|.-..- ..|.+++ +|+.|.|..|.|.......|.
T Consensus 217 Fk~L~~L~~LdLnrN~irive~-----ltFqgL~-------------------------Sl~nlklqrN~I~kL~DG~Fy 266 (873)
T KOG4194|consen 217 FKRLPKLESLDLNRNRIRIVEG-----LTFQGLP-------------------------SLQNLKLQRNDISKLDDGAFY 266 (873)
T ss_pred hhhcchhhhhhccccceeeehh-----hhhcCch-------------------------hhhhhhhhhcCcccccCccee
Confidence 8888888888888888763211 2333444 455555555555555555566
Q ss_pred CCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCC---CCCeEeccCccccCCCCccccCCCcCceE
Q 046199 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNL 491 (902)
Q Consensus 415 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 491 (902)
.+.++++|+|+.|+++..-..|+.+++.|+.|+||+|.|...-++.+. +|++|+|++|+|+...+..|..+..|++|
T Consensus 267 ~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~L 346 (873)
T KOG4194|consen 267 GLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEEL 346 (873)
T ss_pred eecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhh
Confidence 666666666666666655555666666666666666666554454332 66666666666666777777777778888
Q ss_pred ecCCCCccCcccccccCCCCceEEEcCCCccCCCCc---cccccccccceeccCCccccccCccccccCCccceEEccCc
Q 046199 492 SLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP---LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENN 568 (902)
Q Consensus 492 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (902)
+|++|+++.+-..+|..+++|+.|||++|.|+..+. ..|..++.|+.|+|.+|+|..+.-.+|.++.+|+.|||.+|
T Consensus 347 nLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~N 426 (873)
T KOG4194|consen 347 NLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDN 426 (873)
T ss_pred cccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCC
Confidence 888888777766777778888888888887775443 34677888888888888888766778888899999999999
Q ss_pred ccCCCccccccccccCCeEeCcC
Q 046199 569 RLHGPIPESFGALTSLESLDLSV 591 (902)
Q Consensus 569 ~l~~~~p~~~~~l~~L~~L~Ls~ 591 (902)
.|..+-|++|..+ .|+.|-+..
T Consensus 427 aiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 427 AIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred cceeecccccccc-hhhhhhhcc
Confidence 8888888888888 888887643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=378.73 Aligned_cols=478 Identities=29% Similarity=0.374 Sum_probs=247.2
Q ss_pred EEeccCCcceecCcccCCCCCCCeeeccccccccCCCccc-cCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSI-FSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 49 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
+|.+++.++ .||..+..=..++.|+++.|-+. ..|-.+ .+.-+|+.||||+|++. .+|..+ ..++.|+.|.++.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~i-t~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQI-TLLSHLRQLNLSRN 78 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchh-hhHHHHhhcccchh
Confidence 456666665 56665555555777777777665 333322 23334777777777765 444432 44555666666655
Q ss_pred cccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeC
Q 046199 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 207 (902)
.+. +.|.+++++.+|++|.|.+|.++ ..|.++..+++|++|+++.|++. .+|..+..++.++.++.++|
T Consensus 79 ~i~---------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 79 YIR---------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hHh---------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcc
Confidence 543 45666666666666666666665 56666666666666666666665 56666666666666666666
Q ss_pred CCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCccc
Q 046199 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287 (902)
Q Consensus 208 ~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 287 (902)
. + + ..++... .+.++|..|.+.+.++..+..+.. .|||..|.+. ... +
T Consensus 148 ~-~-~---------------------~~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~d-----l 195 (1081)
T KOG0618|consen 148 E-K-I---------------------QRLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLD-----L 195 (1081)
T ss_pred h-h-h---------------------hhhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhh-----h
Confidence 2 1 0 1222222 555666666666666666665555 5666666665 211 4
Q ss_pred CCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCC
Q 046199 288 IGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANS 367 (902)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l 367 (902)
..+.+|+.|....|++... -...++|+.|+.++|.+....+ -..-.+|+++++++|++++.+ ++++.+
T Consensus 196 s~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp------~wi~~~ 263 (1081)
T KOG0618|consen 196 SNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNLP------EWIGAC 263 (1081)
T ss_pred hhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc--ccccccceeeecchhhhhcch------HHHHhc
Confidence 4556666666666665421 1123455666666666552211 122345556666666555432 344555
Q ss_pred CCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccc-cCee
Q 046199 368 SSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNT-LQGL 446 (902)
Q Consensus 368 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L 446 (902)
.+|+.+...+|.+. .+|..+.... +|+.|.+..|.+. .+|....+++.|++|+|..|+|....+..+..... |..|
T Consensus 264 ~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~l 340 (1081)
T KOG0618|consen 264 ANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTL 340 (1081)
T ss_pred ccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHH
Confidence 55555555555552 4444444444 5555555555555 34444445555555555555555222222222222 4444
Q ss_pred ecccccccCCCCC----cCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 447 GLENNKLEGPIPD----DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 447 ~L~~N~l~~~~p~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
..+.|+++ ..|. ..+.|+.|++.+|+++...-..+.++++|++|+|++|++..+....+.++..|++|+||+|++
T Consensus 341 n~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL 419 (1081)
T KOG0618|consen 341 NVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL 419 (1081)
T ss_pred hhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchh
Confidence 44555444 2221 112445555555555544434444555555555555555544444455555555555555555
Q ss_pred CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCc-cccccccccCCeEeCcCcc
Q 046199 523 NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI-PESFGALTSLESLDLSVNN 593 (902)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~ 593 (902)
+ .+|..+..+..|+.|...+|+|. ..| ++..++.|+.+|+|.|+|+... |...-. ++|++|||++|.
T Consensus 420 ~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 420 T-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred h-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 5 34455555555555555555554 344 4555555555555555554222 221111 455555555553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=366.12 Aligned_cols=482 Identities=29% Similarity=0.381 Sum_probs=406.7
Q ss_pred eeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCcc
Q 046199 72 TLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKL 151 (902)
Q Consensus 72 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L 151 (902)
.+|+|..++. .||..+..-..++.|+++.|.+-...-.++-+..+ |++||+|+|.++ ..|..+..+.+|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~-L~~l~lsnn~~~---------~fp~~it~l~~L 70 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVK-LKSLDLSNNQIS---------SFPIQITLLSHL 70 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheee-eEEeeccccccc---------cCCchhhhHHHH
Confidence 4688888888 89998887777999999999987544445555555 999999999987 488899999999
Q ss_pred ceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccC
Q 046199 152 KELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCE 231 (902)
Q Consensus 152 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~ 231 (902)
+.|+++.|.+. .+|.+..++.+|++|.|.+|++. ..|.++..+++|++|++|.|.+. .
T Consensus 71 ~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~--------------------~ 128 (1081)
T KOG0618|consen 71 RQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG--------------------P 128 (1081)
T ss_pred hhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC--------------------C
Confidence 99999999999 89999999999999999999998 89999999999999999999854 3
Q ss_pred CCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 232 lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
+|..+..++.++.+..++|.....++ ... .+.+++..|.+.+.++..+ ..+.+ .|+|++|.+. --.+
T Consensus 129 ~Pl~i~~lt~~~~~~~s~N~~~~~lg----~~~-ik~~~l~~n~l~~~~~~~i---~~l~~--~ldLr~N~~~---~~dl 195 (1081)
T KOG0618|consen 129 IPLVIEVLTAEEELAASNNEKIQRLG----QTS-IKKLDLRLNVLGGSFLIDI---YNLTH--QLDLRYNEME---VLDL 195 (1081)
T ss_pred CchhHHhhhHHHHHhhhcchhhhhhc----ccc-chhhhhhhhhcccchhcch---hhhhe--eeecccchhh---hhhh
Confidence 45788888999999999993332333 222 8899999999998888763 33444 6999999996 2246
Q ss_pred cccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccc
Q 046199 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNL 391 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 391 (902)
..+.+|+.|..+.|+++... -..++|+.|+.++|.++...+ -....+|+++++++|++++ +|+++..+
T Consensus 196 s~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~-------~p~p~nl~~~dis~n~l~~-lp~wi~~~ 263 (1081)
T KOG0618|consen 196 SNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV-------HPVPLNLQYLDISHNNLSN-LPEWIGAC 263 (1081)
T ss_pred hhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc-------ccccccceeeecchhhhhc-chHHHHhc
Confidence 78899999999999998432 235789999999999985433 2335678999999999995 56999999
Q ss_pred cccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCC-----CCCe
Q 046199 392 PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLC-----QLSE 466 (902)
Q Consensus 392 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~L~~ 466 (902)
+ +|+.+...+|+++ .+|..+....+|+.|.+.+|.++ .+|....+++.|++|+|..|+|. .+|+.+. .|..
T Consensus 264 ~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ 339 (1081)
T KOG0618|consen 264 A-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNT 339 (1081)
T ss_pred c-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHH
Confidence 9 9999999999996 78899999999999999999999 78888899999999999999998 6666432 5788
Q ss_pred EeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccc
Q 046199 467 LHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546 (902)
Q Consensus 467 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (902)
|+.+.|++.......=..++.|+.|++.+|+++...-..+.+..+|+.|+|++|+|.......+.++..|++|+||+|++
T Consensus 340 ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL 419 (1081)
T KOG0618|consen 340 LNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL 419 (1081)
T ss_pred HhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchh
Confidence 88899999854422223466799999999999987777889999999999999999977777788999999999999999
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcc
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 618 (902)
+ .+|+++..++.|++|...+|++. ..| .+..++.|+.+|+|.|+|+-..-.....-++|++|||+||..
T Consensus 420 ~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 420 T-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred h-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9 88999999999999999999998 678 899999999999999999865433333348999999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=342.12 Aligned_cols=367 Identities=28% Similarity=0.440 Sum_probs=226.2
Q ss_pred CcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhcc
Q 046199 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNL 196 (902)
Q Consensus 117 ~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 196 (902)
+-.+-+|+|+|.++|.. .|.++..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..|
T Consensus 7 pFVrGvDfsgNDFsg~~-------FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~L 77 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDR-------FPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDL 77 (1255)
T ss_pred ceeecccccCCcCCCCc-------CchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccc
Confidence 33455666666666542 5556666666666666666665 56666666666666666666665 444445555
Q ss_pred CcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCccc
Q 046199 197 SSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTL 276 (902)
Q Consensus 197 ~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 276 (902)
+.|+.+++.+|+|+. .-+|+.+..+..|+.||||+|++
T Consensus 78 p~LRsv~~R~N~LKn------------------------------------------sGiP~diF~l~dLt~lDLShNqL 115 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKN------------------------------------------SGIPTDIFRLKDLTILDLSHNQL 115 (1255)
T ss_pred hhhHHHhhhcccccc------------------------------------------CCCCchhcccccceeeecchhhh
Confidence 666666666665542 12444444445555555555554
Q ss_pred ccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCC
Q 046199 277 SGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356 (902)
Q Consensus 277 ~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 356 (902)
. ..|.. +..-+++..|+||+|+|..++...|.+++.|-.||||+|++. .+|..+..|.+|++|+|++|.+....
T Consensus 116 ~-EvP~~---LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ- 189 (1255)
T KOG0444|consen 116 R-EVPTN---LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ- 189 (1255)
T ss_pred h-hcchh---hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH-
Confidence 4 34433 334445555555555555444444556666777777777776 45555667777777777777665211
Q ss_pred cccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcc
Q 046199 357 ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPIT 436 (902)
Q Consensus 357 ~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 436 (902)
+..+-.+++|..|.+++.+-+ ...+|..+..+.+|..+|+|.|.+. .+|+.
T Consensus 190 ----LrQLPsmtsL~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 190 ----LRQLPSMTSLSVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred ----HhcCccchhhhhhhcccccch------------------------hhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 123333444444444443211 1245666677777777777777776 67777
Q ss_pred cccccccCeeecccccccCCCC--CcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceE
Q 046199 437 VGRLNTLQGLGLENNKLEGPIP--DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILS 514 (902)
Q Consensus 437 ~~~l~~L~~L~L~~N~l~~~~p--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 514 (902)
+.++++|+.|+||+|+|+..-. ....+|+.|+||+|+++ .+|.+++.+++|+.|++.+|+++-
T Consensus 241 ly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F-------------- 305 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF-------------- 305 (1255)
T ss_pred HhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc--------------
Confidence 7777777777777777762111 11225556666666665 566666667777776666666541
Q ss_pred EEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccc
Q 046199 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594 (902)
Q Consensus 515 L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (902)
.| +|..++.+.+|+.+..++|.+. ..|+.++.+.+|+.|.|++|++. .+|+.+.-|+.|+.|||..|.=
T Consensus 306 --------eG-iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 306 --------EG-IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred --------cC-CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 22 6777777777777778888777 78888888888888888888887 6888888888888888888854
Q ss_pred c
Q 046199 595 S 595 (902)
Q Consensus 595 ~ 595 (902)
-
T Consensus 375 L 375 (1255)
T KOG0444|consen 375 L 375 (1255)
T ss_pred c
Confidence 4
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.56 Aligned_cols=172 Identities=34% Similarity=0.544 Sum_probs=154.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|...+.||+|+||+||+|++++ +.+||||.+... .....+.+..|+++++.++|||||++++++..++++|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45789999999999999999999865 899999999766 345667789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC------CcEEEEeecCce
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD------MVAHLSDFGIAK 874 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~------~~~kL~DFG~a~ 874 (902)
||||+||||.+|++..+ .+++..++.++.|++.|+++|| +++||||||||.|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999997654 6999999999999999999999 9999999999999999764 468999999999
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...+ .....+.+|+|.|||||+++.
T Consensus 164 ~L~~-~~~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 164 FLQP-GSMAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred hCCc-hhHHHHhhCCccccCHHHHHh
Confidence 8874 344556899999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.47 Aligned_cols=364 Identities=29% Similarity=0.426 Sum_probs=255.6
Q ss_pred cCCCcceEEEecCccccC-CCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCch
Q 046199 89 FSISTLKILILGDNQLSG-SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ 167 (902)
Q Consensus 89 ~~l~~L~~L~ls~n~l~~-~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~ 167 (902)
+-|+-.|-.|+|+|.++| .+|..+ ..|++++-|-|....+. .+|+.++.|.+|++|.+++|++. .+-.
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v-~qMt~~~WLkLnrt~L~---------~vPeEL~~lqkLEHLs~~HN~L~-~vhG 72 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDV-EQMTQMTWLKLNRTKLE---------QVPEELSRLQKLEHLSMAHNQLI-SVHG 72 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhH-HHhhheeEEEechhhhh---------hChHHHHHHhhhhhhhhhhhhhH-hhhh
Confidence 445667889999999994 666654 78999999999888875 49999999999999999999999 7888
Q ss_pred hhccccccceeecccCcCCC-CCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEE
Q 046199 168 ELGNLAELEWLSLPRSFLTG-TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246 (902)
Q Consensus 168 ~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~ 246 (902)
.+..|+.|+.+++.+|++.. -||..+..|..|+.||||+|+|+ ++|..+..-+++-+|+
T Consensus 73 ELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~--------------------EvP~~LE~AKn~iVLN 132 (1255)
T KOG0444|consen 73 ELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR--------------------EVPTNLEYAKNSIVLN 132 (1255)
T ss_pred hhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh--------------------hcchhhhhhcCcEEEE
Confidence 99999999999999999863 47888999999999999999987 5678888899999999
Q ss_pred ccCccccCcCCCc-ccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCC
Q 046199 247 IDENHLVGDVPNT-IFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGN 325 (902)
Q Consensus 247 Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 325 (902)
||+|+|. .+|.. |-+++.|-.||||+|++. .+|+. ...+.+|++|+|++|.+....-..+..+++|++|.+++.
T Consensus 133 LS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ---~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~T 207 (1255)
T KOG0444|consen 133 LSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQ---IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNT 207 (1255)
T ss_pred cccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHH---HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccc
Confidence 9999998 56655 457888888888888887 45555 455667777777777665333233334555566666554
Q ss_pred ccc-CcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCc
Q 046199 326 SFS-GFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCK 404 (902)
Q Consensus 326 ~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~ 404 (902)
+=+ ..+|.++..+.+|..+|+|.|.+. .+|+.+..++ +|+.|+||+|+
T Consensus 208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp------------------------------~vPecly~l~-~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 208 QRTLDNIPTSLDDLHNLRDVDLSENNLP------------------------------IVPECLYKLR-NLRRLNLSGNK 256 (1255)
T ss_pred cchhhcCCCchhhhhhhhhccccccCCC------------------------------cchHHHhhhh-hhheeccCcCc
Confidence 332 234555555555555555555554 4455555555 56666666666
Q ss_pred ccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccccccc-CCCCCcCC---CCCeEeccCccccCCCCc
Q 046199 405 IRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE-GPIPDDLC---QLSELHVDHNKLSGPIPA 480 (902)
Q Consensus 405 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~---~L~~L~L~~N~l~~~~p~ 480 (902)
|+ .+........+|++|+||+|+++ .+|++++++++|+.|++.+|++. .-+|++++ +|+.+..++|.+. ..|.
T Consensus 257 it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPE 333 (1255)
T KOG0444|consen 257 IT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPE 333 (1255)
T ss_pred ee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCch
Confidence 65 23333444556666666666666 56666666666666666666654 23455444 4444555555554 6666
Q ss_pred cccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccC
Q 046199 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523 (902)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 523 (902)
.++.+.+|+.|.|+.|++-. .|+++.-++.|+.||+.+|.=-
T Consensus 334 glcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 334 GLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCc
Confidence 67777777777777777654 5666666677777777666533
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=291.01 Aligned_cols=172 Identities=31% Similarity=0.450 Sum_probs=150.6
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccch-------hhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-------ALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
..+.|.+.+.+|+|+||.|-+|..+ +|+.||||+++.+... .....++|+++|++++||+||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4678999999999999999999875 4999999999754311 2234579999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecC
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD---MVAHLSDFGI 872 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kL~DFG~ 872 (902)
..||||||++||+|.+.+... +.+.+.....+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999998654 45788888999999999999999 9999999999999999765 7899999999
Q ss_pred ceecCCCccceecccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+..+ ......+.||||.|.|||++..
T Consensus 326 AK~~g-~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 326 AKVSG-EGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred hhccc-cceehhhhcCCccccChhheec
Confidence 99876 4445566899999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=291.39 Aligned_cols=174 Identities=32% Similarity=0.454 Sum_probs=157.5
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||+||.++.++ ++.||+|++++.. ..+.+...+|..++..++||+||.++-.|++.+..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 456899999999999999999999876 8899999997653 345678889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|+||+.||.|..++.+ ++.+++..+..++.+|+.||.||| ++||||||+||+|||+|.+|+++|+|||+++....
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999999854 456999999999999999999999 99999999999999999999999999999997666
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
......+.+||+.|||||+++.
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred CCCccccccCCccccChHHHhc
Confidence 6556666899999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.85 Aligned_cols=189 Identities=47% Similarity=0.703 Sum_probs=166.7
Q ss_pred cccccCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 712 MWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 712 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
....|+++++..++++|.....||+|+||.||+|...+++.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999988999999987755432145599999999999999999999999
Q ss_pred ecCC-eeEEEEEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 792 SNGN-FKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 792 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
.+.+ ..++|+|||++|+|+++++.... .++|..+.+|+.++|+||+|||..+...||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999988766 899999999999999999999977777899999999999999999999999
Q ss_pred ecCceecCCCccceecc-cccccccccccccc
Q 046199 870 FGIAKLLNGEESMRTQT-LGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~~~~~-~gt~~y~APE~l~~ 900 (902)
||+|+............ .||.+|+|||++.+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhcc
Confidence 99997654312222223 79999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=298.58 Aligned_cols=170 Identities=27% Similarity=0.412 Sum_probs=158.6
Q ss_pred ccccccCeecccceeeEEEEEe-CCCcEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+|+..+.||+|+|+.||++++ ..|+.||+|++.+. .....+.+.+||++.++++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999999 56999999999753 3556788999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+|+.++|..+++ .++.+++.+++.+++||+.||.||| +++|+|||||..|++++++.+|||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999886 6677999999999999999999999 99999999999999999999999999999999987777
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
...+.||||.|.|||++.
T Consensus 174 rk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred ccceecCCCcccChhHhc
Confidence 777899999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.28 Aligned_cols=171 Identities=31% Similarity=0.380 Sum_probs=153.9
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+.|+....+|+|+||+||+|++++ |+.||||++.... +...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578889999999999999999976 9999999986443 3345677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
||+. ++.+-+.+....++...+.++++|++.|+.|+| ++++|||||||+||+|+.+|.+||||||+|+.+..+...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9987 554556666677999999999999999999999 999999999999999999999999999999999877777
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.+..+.|.+|+|||++++
T Consensus 158 YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVG 175 (396)
T ss_pred hhhhhhhhhccChhhhcc
Confidence 788899999999999865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=282.86 Aligned_cols=173 Identities=28% Similarity=0.399 Sum_probs=153.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-eeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-FKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 799 (902)
+..++.+..+.||+|..|+||+|+++. ++.+|+|++.... +...+++.+|+++++..+||+||.+||+|..++ ..++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 334566778899999999999999975 8889999996554 345688999999999999999999999999998 5999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
+||||++|+|++++... +.+++....+++.+|++||.|||. +++||||||||+|||++..|+|||||||.++.+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999988654 569999999999999999999993 399999999999999999999999999999887654
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
...+.+||..|||||.+.+
T Consensus 233 --~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISG 251 (364)
T ss_pred --hcccccccccccChhhhcC
Confidence 4566889999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=275.48 Aligned_cols=173 Identities=31% Similarity=0.419 Sum_probs=152.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceee-eeecCCe-eEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIIS-SCSNGNF-KAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 799 (902)
..+|++.+.||+|+||.||+|++. +|..||.|.++-. +....++...|+.++++++|||||++++ .+.++.. .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 457889999999999999999874 6999999998743 3456688999999999999999999998 4555544 899
Q ss_pred EEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCC--CC--eEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 800 VLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYS--NP--VVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~--~~--ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
|||||++|||..+++. .++.+++..+++++.|++.||.++| . .. |+||||||.||+++.+|.||++|||+
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH---~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH---SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh---ccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999988754 4567999999999999999999999 5 44 89999999999999999999999999
Q ss_pred ceecCCCccceecccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++.+....+.....+|||.||+||.+..
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhc
Confidence 9999887777777899999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=263.29 Aligned_cols=171 Identities=30% Similarity=0.481 Sum_probs=156.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|...+.+|+|.||.||+|++.. |+.||||+++... ++......+|+..++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578899999999999999999854 9999999998653 3334667899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
||+. +|+..++++...+...++..++.++++|++|+| ++.|+|||+||.|+|++.+|.+||+|||+|+.+..+...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9975 999999998889999999999999999999999 999999999999999999999999999999999887777
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.+..+.|.+|+|||++.+
T Consensus 158 ~~~~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFG 175 (318)
T ss_pred cccceeeeeccChHHhcc
Confidence 666789999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=285.62 Aligned_cols=173 Identities=33% Similarity=0.450 Sum_probs=154.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 798 (902)
..+.|+..++||+|.||.||+|++.. |+.||+|+++... +.......+||.|++++.||||+++.+...+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678889999999999999999864 8999999998664 44556778999999999999999999998776 7899
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|+|||+. ||.-++....-.+++.++..++.|++.||+|+| .+||+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999977 998888777778999999999999999999999 99999999999999999999999999999998766
Q ss_pred Cccc-eecccccccccccccccc
Q 046199 879 EESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
.... .+..+-|.+|+|||++++
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG 293 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLG 293 (560)
T ss_pred CCCcccccceEEeeccChHHhcC
Confidence 5543 455788999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=265.15 Aligned_cols=170 Identities=32% Similarity=0.424 Sum_probs=152.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|+..+.+|.|+||+|..++.+. |..||+|++..+. ....+....|..+++.+.||+++++++.+.+.+..|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34688999999999999999999865 8889999997653 2345677889999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||++||.|..++++. +++++..++.++.||+.|++||| +.+|++||+||+|||+|++|.+||+|||+|+.+.+.
T Consensus 122 vmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999999665 45999999999999999999999 999999999999999999999999999999987643
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
.-+.||||.|+|||+++.
T Consensus 198 ---T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred ---EEEecCCccccChHHhhc
Confidence 345799999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=287.37 Aligned_cols=174 Identities=34% Similarity=0.537 Sum_probs=150.4
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccch--hhhhHHHHHHHHHhCCCCCccceeeeeecCC-eeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGN-FKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l 799 (902)
+..++..+.+.+|+|+||+||+|.+.....||||++...... ..+.|.+|+.++.+++|||||+++|++.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 334455566679999999999999966555999999765322 2569999999999999999999999999887 7999
Q ss_pred EEEccCCCChHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCCCCCCEEEcCCC-cEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNP-VVHCDIKPSNILLDDDM-VAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~ 876 (902)
|||||++|+|.++++. .+..+++..+.+++.|||+||+||| +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999987 4678999999999999999999999 888 99999999999999998 9999999999876
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.......+...||+.|||||++.
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred ccccccccCCCCCccccChhhhc
Confidence 54333333467999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=282.87 Aligned_cols=173 Identities=26% Similarity=0.402 Sum_probs=153.9
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhh-hHHHHHHHHHhCC-CCCccceeeeeecCC-eeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALK-SFDAECEVLKSVR-HRNLVKIISSCSNGN-FKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 798 (902)
...++|.+.+.||.|+||.||+|+... +..||||+++.......+ .-.+|+..++++. ||||+++.+++.+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 446789999999999999999998754 889999999876544333 3468999999998 999999999998887 999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|||||+. +|+++++++++.+++..++.|++||++||+|+| ++|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999976 999999999999999999999999999999999 99999999999999999888999999999998865
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... .+..+.|.+|+|||+++.
T Consensus 163 kpP-YTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 163 KPP-YTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred CCC-cchhhhcccccchHHhhh
Confidence 443 455789999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=262.95 Aligned_cols=172 Identities=24% Similarity=0.362 Sum_probs=154.1
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 799 (902)
.+.|+....|++|+||.||+|+++. ++.||+|+++...+ +..-...+||.++.+++|||||.+-.+.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4678889999999999999999865 78899999986542 3345668999999999999999999987543 57999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|||||+. ||..++....+++...++..++.|+++|++||| ...|+|||+||+|+|+...|.+||+|||+|+.+..+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999976 999999888888999999999999999999999 999999999999999999999999999999999888
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
....+..+-|.+|+|||++++
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG 251 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLG 251 (419)
T ss_pred cccCcceEEEeeecCHHHhcC
Confidence 777777889999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=280.67 Aligned_cols=174 Identities=28% Similarity=0.436 Sum_probs=154.7
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeec----cc-hhhhhHHHHHHHHHhCC-CCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ----FD-GALKSFDAECEVLKSVR-HRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 795 (902)
.....|.+.+.||+|+||.|+.|++. +++.||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999875 4899999977654 12 23466778999999998 999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~ 874 (902)
..|+||||+.||+|.+++.+ .+.+.+.++.++++|++.|++|+| ++||+||||||+||+++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999987 677899999999999999999999 9999999999999999999 999999999999
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..........+.+||+.|+|||++..
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCC
Confidence 87434445566899999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=274.65 Aligned_cols=175 Identities=34% Similarity=0.467 Sum_probs=153.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 796 (902)
.....+|.+++.||+|+|++|++|+..+ +++||||++.+.. +...+.+.+|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4566799999999999999999998865 8999999986542 23345677899999999 89999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+|+||+++|+|.++|++. +.+++...+.++.||+.|++||| ++|||||||||+|||+|+||++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999665 56999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCccc-------------eecccccccccccccccc
Q 046199 877 NGEESM-------------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~-------------~~~~~gt~~y~APE~l~~ 900 (902)
.+.... ...++||..|.+||++..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~ 261 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND 261 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcC
Confidence 542211 134789999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=264.40 Aligned_cols=170 Identities=26% Similarity=0.407 Sum_probs=152.8
Q ss_pred cccccccCeecccceeeEEEEEe-CCCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..+|++.+.+|+|.||.|-+|.. ..|+.||||.+++.. +++.-.+++|++||..++||||+++|++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999986 459999999987553 34456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||..+|.|++|+.+. +.+++.++..+++||+.|+.|+| +++++|||+|.+|||+|+++++||+|||++..+....
T Consensus 132 MEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999654 56999999999999999999999 9999999999999999999999999999998776544
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
...++||+|-|.+||++.
T Consensus 208 -fLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVN 225 (668)
T ss_pred -HHHHhcCCcccCCccccC
Confidence 445689999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.29 Aligned_cols=169 Identities=31% Similarity=0.454 Sum_probs=144.7
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC--CCCCccceeeeeecCC----eeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV--RHRNLVKIISSCSNGN----FKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~ 798 (902)
.+.....+.||+|+||.||+|+. +++.||||++..+ ..+.|+.|.+|++.. +|+||++++++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45566778999999999999998 5699999999754 567888898888764 7999999999876554 889
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHc------cCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF------GYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~------~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
+|+||.+.|+|.+|++. ...+|....+++..+++||+|||. .++.+|+|||||.+||||..|+++.|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999965 458999999999999999999994 4577999999999999999999999999999
Q ss_pred ceecCCCccc--eeccccccccccccccc
Q 046199 873 AKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|.++...... ....+||.+|||||++-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLE 391 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLE 391 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHh
Confidence 9988643322 22368999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=272.93 Aligned_cols=169 Identities=37% Similarity=0.497 Sum_probs=153.6
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|.+.+.||+|+||+||+|+.+. .+.||+|.+.+.. +.+.+.+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578889999999999999998765 7889999987543 3456779999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+.| +|..++.. .+.++++.+..++.|++.||.||| +.+|.|||+||.||+++..|.+|+||||+|+.+......
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9977 99999865 456999999999999999999999 999999999999999999999999999999998877777
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.+...|||.|||||++.
T Consensus 157 ltsikGtPlYmAPElv~ 173 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVE 173 (808)
T ss_pred eeeccCcccccCHHHHc
Confidence 77788999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=269.55 Aligned_cols=150 Identities=29% Similarity=0.425 Sum_probs=138.0
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..+..++|+....||+|+||.||.|+.++ |..||+|++++.. ..+.+.++.|-.+|....+|.||++|..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 35688999999999999999999998876 9999999998654 3456778889999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
.|+||||++|||+..++... ..+++..+..++.+++.|++.+| +.|+|||||||+|+|||..|++||+|||++.
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999998654 56999999999999999999999 9999999999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=261.46 Aligned_cols=172 Identities=33% Similarity=0.482 Sum_probs=149.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC--eeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 801 (902)
..+|...+.||+|+||.||++...+ |..+|||.+........+.+.+|+.++++++||+||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4567889999999999999999866 8999999987664334677899999999999999999999754444 689999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++|+|.+++...+..+++..++++.+||++||+||| ++|||||||||+|||++. ++.+||+|||.|+......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999876657999999999999999999999 999999999999999999 7999999999998776311
Q ss_pred ---cceeccccccccccccccc
Q 046199 881 ---SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ---~~~~~~~gt~~y~APE~l~ 899 (902)
.......||+.|||||++.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ccccccccccCCccccCchhhc
Confidence 1123467999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.39 Aligned_cols=170 Identities=31% Similarity=0.451 Sum_probs=157.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
...|...+.||+|+.|.||.|+... ++.||||++........+-+..|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4568888899999999999998754 889999999988777788899999999999999999999999989999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
|+||+|.+.+.. ..+++.++..|++++++||+||| .+||+|||||.+||+++.+|.+||+|||++..+......+
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999998854 34899999999999999999999 9999999999999999999999999999999988877778
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
.+.+|||+|||||+..
T Consensus 427 ~TmVGTPYWMAPEVvt 442 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVT 442 (550)
T ss_pred ccccCCCCccchhhhh
Confidence 8899999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=257.45 Aligned_cols=172 Identities=30% Similarity=0.434 Sum_probs=151.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCC-ccceeeeeecCC-----
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRN-LVKIISSCSNGN----- 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 795 (902)
...|+..+.||+|+||+||+|+.. +|+.||+|+++...+ +......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456788889999999999999875 488999999987644 34567789999999999999 999999998776
Q ss_pred -eeEEEEEccCCCChHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 796 -FKALVLEYMANGSLEKCLYSSN---RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 796 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
..++|+||++. +|.+++.... ..++...++.+++||+.||+||| +++|+||||||.||+|+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 89999999965 9999997755 35788899999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+|+...-+....+..++|..|+|||+++.
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLG 194 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcC
Confidence 99977655555666789999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=258.20 Aligned_cols=176 Identities=29% Similarity=0.439 Sum_probs=154.9
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
+....++|++.+.||.|..++||+|+... +..||||++..+.. ...+.+++|+..|+.++||||++++..|..+...|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 34567899999999999999999999854 89999999987653 34688999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 799 LVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+||.||.+|++.+.++.. ...+++..+..|.+++++||.||| ++|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999998763 345899999999999999999999 9999999999999999999999999999887665
Q ss_pred CCccce----eccccccccccccccc
Q 046199 878 GEESMR----TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~----~~~~gt~~y~APE~l~ 899 (902)
+..... .+.+||+.|||||+++
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhh
Confidence 443322 3358999999999953
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=270.31 Aligned_cols=179 Identities=28% Similarity=0.458 Sum_probs=155.7
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.+.+.+..+.+...+.||+|-||.||.|.+....+||+|.++... ...++|.+|+++|++++|++||+++++|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 445566667778889999999999999999888899999998653 3347888999999999999999999999998999
Q ss_pred EEEEEccCCCChHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
|||||||+.|+|.++++. .+..+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999987 5567889999999999999999999 999999999999999999999999999999965
Q ss_pred CCCcccee-cccccccccccccccc
Q 046199 877 NGEESMRT-QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~-~~~gt~~y~APE~l~~ 900 (902)
.++..... ...-...|.|||.+..
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhh
Confidence 54443222 2345678999998853
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=259.72 Aligned_cols=174 Identities=32% Similarity=0.469 Sum_probs=144.5
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--------------chhhhhHHHHHHHHHhCCCCCccce
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--------------DGALKSFDAECEVLKSVRHRNLVKI 787 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l 787 (902)
...++|++.+.||+|.||.|-+|++. +++.||||++.+.. ....+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999985 48999999986431 1123578999999999999999999
Q ss_pred eeeeecC--CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 788 ISSCSNG--NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 788 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
+++..+. +.+|||+|||..|.+...= .....+++.++++++++++.||+||| .+|||||||||+|+|++++|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 9998654 6899999999998875432 22223889999999999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCC-----Cccceecccccccccccccccc
Q 046199 866 HLSDFGIAKLLNG-----EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 866 kL~DFG~a~~~~~-----~~~~~~~~~gt~~y~APE~l~~ 900 (902)
||+|||.+..+.. .+......+|||.|||||+..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 9999999987622 2222233689999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=253.44 Aligned_cols=171 Identities=28% Similarity=0.468 Sum_probs=144.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC--CCCCccceeeeeecC----Ce
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV--RHRNLVKIISSCSNG----NF 796 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 796 (902)
....+..+.+.||+|.||+||+|++ .|+.||||++... +.+.+.+|.++++.. +|+||..+++.-..+ ..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3445778899999999999999998 6889999999754 347788899998764 999999999876443 36
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHc-----cCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF-----GYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.|+|++|.+.|+|+||+.+ ..++.....+++..+|.||+|||. .-+..|.|||||.+||||.+++.+.|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 8999999999999999965 568899999999999999999993 236789999999999999999999999999
Q ss_pred CceecCCCcc----ceeccccccccccccccc
Q 046199 872 IAKLLNGEES----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~----~~~~~~gt~~y~APE~l~ 899 (902)
+|........ .....+||.+|||||++-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd 393 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD 393 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhh
Confidence 9988765422 223478999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=272.33 Aligned_cols=176 Identities=27% Similarity=0.364 Sum_probs=156.4
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCC
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 795 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 795 (902)
.....++|...++||+|+||+|+.|..+. ++.||||++++.. +++.+..+.|.+|+... +||+++.++..|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34567899999999999999999998865 7889999998764 45678888999998888 5999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
+.|+||||+.|||+..+ .....+++..+..|++.|+.||+||| ++||||||||.+|||+|.+|++||+|||+++.
T Consensus 443 ~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred eEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999995433 34466999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCccceeccccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
.-..+....+.+|||.|||||++...
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccC
Confidence 76566667779999999999999764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=267.79 Aligned_cols=179 Identities=30% Similarity=0.534 Sum_probs=156.0
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
+...++|.+..++..+.+.||+|+||+||+|+|. ..||||++.... +...+.|+.|+.++++-+|.||+-+.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3444778888888999999999999999999984 479999998664 456789999999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
.++. .||+.+|+|.+|+.+++..+..++......|++||++||.||| .++|||||||..||++++++.|||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 8887 9999999999999999888888999999999999999999999 99999999999999999999999999999
Q ss_pred ceecC--CCccceeccccccccccccccc
Q 046199 873 AKLLN--GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~--~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|..-. ..+.......|...|||||++.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIR 563 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIR 563 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHh
Confidence 85422 1122222345888999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-30 Score=249.92 Aligned_cols=171 Identities=29% Similarity=0.424 Sum_probs=156.4
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+-|++++.+|+|+||.||+|.++. |+.||+|.+..+ .+.+.+.+|+.+|++++.|+||++||.+......|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 347788999999999999998865 999999998654 45688999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
..|+..+.++.+++.+.+.++..+.+..+.||+||| ...-+|||||+.|||++.+|.+|++|||.|-.+.+.-..+.
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999999999999999999999999999999999 78889999999999999999999999999988776666667
Q ss_pred ccccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~~ 901 (902)
+..|||.|||||++..+
T Consensus 188 TVIGTPFWMAPEVI~EI 204 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEI 204 (502)
T ss_pred ccccCcccccHHHHHHh
Confidence 78999999999998754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=263.67 Aligned_cols=170 Identities=25% Similarity=0.355 Sum_probs=152.0
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.-|+.++.||.|+.|.|..|++. +|+.+|||++.... ......+++|+.+|+.+.||||+++|++|+...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788999999999999999985 49999999997652 334577899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||++||.|.+++..+ +++++.++.++++||+.|+.|+| ..+|+|||+||+|+++|..+.+||+|||+|..-. ++.
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGK 166 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc-CCc
Confidence 999999999999665 45889999999999999999999 9999999999999999999999999999998654 344
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.-.+.||+|.|+|||++++
T Consensus 167 lLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred cccccCCCcccCCchhhcC
Confidence 4556899999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=235.97 Aligned_cols=172 Identities=28% Similarity=0.405 Sum_probs=152.5
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|.||.||.|+.+. +..||+|++.+.. .....++.+|+++-..++||||.++|++|.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 35789999999999999999998765 7889999986542 2345788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
++||...|++...+.+.. ..+++.....+++|+|.|+.|+| .++|+||||||+|+|++..+.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999997543 45889999999999999999999 9999999999999999999999999999997643
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...+.+.+||..|.|||+...
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred -CCCceeeecccccCCHhhcCC
Confidence 455667899999999998754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=261.56 Aligned_cols=174 Identities=29% Similarity=0.452 Sum_probs=158.6
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe-eEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF-KALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 800 (902)
.++|+..+++|+|+||.++.++++ +.+.||+|.+.... ....+....|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999875 47899999997553 4455678899999999999999999999999888 9999
Q ss_pred EEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|+||+||++.+.+.+.+ ..++++.+.+|+.|++.|+.||| +.+|+|||||+.||+++.++.|||+|||+|+.+..+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999997765 67999999999999999999999 999999999999999999999999999999999888
Q ss_pred ccceeccccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~~ 901 (902)
.....+.+|||.||.||++.++
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~ 181 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDI 181 (426)
T ss_pred hhhhheecCCCcccCHHHhCCC
Confidence 7677778999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=249.65 Aligned_cols=166 Identities=32% Similarity=0.484 Sum_probs=138.9
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----eeEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FKAL 799 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 799 (902)
-.|+..+.+|.|+||.||+|.... +++||||++-.... --.+|.++|+.+.|||||++.-+|.... +..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357778999999999999998865 78999998854422 2247999999999999999998885432 3458
Q ss_pred EEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCcee
Q 046199 800 VLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKL 875 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~ 875 (902)
|||||+. +|.++++. .+..++...++-+++||.+|+.||| +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 99998874 2566888899999999999999999 9999999999999999976 8999999999998
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
....+.. .....|..|+|||++.+
T Consensus 176 L~~~epn-iSYicSRyYRaPELifg 199 (364)
T KOG0658|consen 176 LVKGEPN-ISYICSRYYRAPELIFG 199 (364)
T ss_pred eccCCCc-eeEEEeccccCHHHHcC
Confidence 8765544 33557899999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=240.91 Aligned_cols=172 Identities=26% Similarity=0.444 Sum_probs=149.7
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
...+.|++.+.||+|+|+.||++.+. .|+++|+|++... .....+.+.+|+++.+.++||||+++++.+.+.++.|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34678999999999999999999775 4899999988643 23466889999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 876 (902)
|+|+|.|++|..-+-.+ ..+++..+-.+++||++|+.|+| .++|||||+||+|+++. ...-+|++|||+|..+
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999996655433 45788999999999999999999 99999999999999994 3447999999999998
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
. ........+|||+|||||++.
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvr 185 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLK 185 (355)
T ss_pred C-CccccccccCCCcccCHHHhh
Confidence 8 555667789999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.88 Aligned_cols=168 Identities=30% Similarity=0.409 Sum_probs=148.1
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|.-.+.||.|+||.||-|++.. .+.||||++..... ..-+++.+|++++++++|||++.+-|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667889999999999999854 77899999864432 234688999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
||-| +-.|++.-.++++.+.++..|+.+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|..+.+.
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9955 777777666778999999999999999999999 999999999999999999999999999999876543
Q ss_pred eecccccccccccccccccC
Q 046199 883 RTQTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~~~ 902 (902)
..++|||.|||||+++.|.
T Consensus 180 -nsFvGTPywMAPEVILAMD 198 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMD 198 (948)
T ss_pred -hcccCCccccchhHheecc
Confidence 3478999999999999884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=279.13 Aligned_cols=181 Identities=27% Similarity=0.380 Sum_probs=162.3
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
..++....++|++.++||+|+||.|..++++. ++.||+|++.+. .......|..|-.+|.....+-|++++-+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45677888999999999999999999999865 888999998752 24455778889999999999999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
+.+.|+|||||+||||-.++.+.. .+++..+..+...|+.|+.-+| +.|+|||||||+|||+|..|++||+|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999997766 7999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCcccee-cccccccccccccccccC
Q 046199 874 KLLNGEESMRT-QTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 874 ~~~~~~~~~~~-~~~gt~~y~APE~l~~~~ 902 (902)
-.+...+.... ..+|||.|.+||++.+++
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~ 252 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQG 252 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhc
Confidence 88875555443 478999999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=269.36 Aligned_cols=179 Identities=28% Similarity=0.496 Sum_probs=153.6
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
+...+...+.+..+.||+|+||+||+|+... ...||||.++..... ..++|++|++++..++|||||+++|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 3344566677888999999999999997643 456999999877655 789999999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN-------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNIL 858 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (902)
.+++..|+|+|||..|||.++++... .+++..+.+.|+.|||.||+||- ++.+|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhce
Confidence 99999999999999999999996421 12778899999999999999999 999999999999999
Q ss_pred EcCCCcEEEEeecCceecCCCccceec--ccccccccccccccc
Q 046199 859 LDDDMVAHLSDFGIAKLLNGEESMRTQ--TLGTIGYMAPGLWVV 900 (902)
Q Consensus 859 l~~~~~~kL~DFG~a~~~~~~~~~~~~--~~gt~~y~APE~l~~ 900 (902)
|.++..|||+|||+++.+-..+.++.. ..-..+|||||.++.
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY 679 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence 999999999999999987655544332 345779999998863
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=253.29 Aligned_cols=172 Identities=33% Similarity=0.455 Sum_probs=154.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
....|...+.||+|+||.||+|.+.. ++.||+|++..+. ..+.+++++|+.++.+++++||.++|+.+..+...+++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34567778999999999999999865 8899999998664 456788999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||.||++.+.++. +..+++..+..++++++.|+.|+| .++.+|||||+.||++..+|.||++|||.+..+.....
T Consensus 91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999998854 344588888999999999999999 99999999999999999999999999999998877766
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
...+++|||.|||||++.
T Consensus 167 rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred ccccccccccccchhhhc
Confidence 667789999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=255.00 Aligned_cols=171 Identities=29% Similarity=0.387 Sum_probs=153.3
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch---hhhhHHHHHHHHHhCC-CCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG---ALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 797 (902)
...+.|++.+.||+|.||.||+|+.+. |+.||+|++.+.... ..+.+.+|+++|+++. |||||.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345689999999999999999999876 999999999765432 3468999999999998 99999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD----MVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~~~kL~DFG~a 873 (902)
++|||++.||.|.+.+... .+++..+..++.|++.|++|+| +.||+|||+||+|+++... +.+|++|||+|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999766 3999999999999999999999 9999999999999999543 57999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..... .......+||+.|+|||++.
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhc
Confidence 99876 44566689999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=260.48 Aligned_cols=147 Identities=27% Similarity=0.390 Sum_probs=132.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.+++.++||+|+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999998764 8899999997542 233457788999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||++||+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+..
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 999999999998654 46899999999999999999999 999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=242.00 Aligned_cols=173 Identities=28% Similarity=0.373 Sum_probs=147.8
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeec-----CC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSN-----GN 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 795 (902)
....|...+.||+|+||.|+.|.++. |+.||+|++... .....++..+|+.+++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566668999999999999998864 899999999743 34456888999999999999999999998865 35
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.+|+|+|+| +.+|...++. ++.++...+..+++|+++|++|+| +.+|+|||+||+|++++.+..+||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 789999999 5599998854 344899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCC--ccceeccccccccccccccccc
Q 046199 876 LNGE--ESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 876 ~~~~--~~~~~~~~gt~~y~APE~l~~~ 901 (902)
.... ....+..+.|.+|+|||+++..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhcc
Confidence 7542 2334557789999999998653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=259.98 Aligned_cols=177 Identities=24% Similarity=0.359 Sum_probs=151.7
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
++.....++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3445566889999999999999999999865 8899999986432 22345678899999999999999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
+..|+||||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999998543 4788999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccc-eecccccccccccccccc
Q 046199 875 LLNGEESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
........ .....||+.|||||++..
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhc
Confidence 76543322 234679999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=258.58 Aligned_cols=183 Identities=27% Similarity=0.398 Sum_probs=154.4
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEeCC--C---cEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccc
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD--G---MEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVK 786 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~ 786 (902)
.+....|++.-++....+.||+|+||.||+|+... + ..||+|..+.. .....+++.+|+++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34445566777788888999999999999998743 2 23899998852 3556789999999999999999999
Q ss_pred eeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 787 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
+||++..+...|+|||+|.||+|.+++++....++..+..+++.+.+.||+||| +++++||||.++|+|++.++.+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999999887778999999999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCccceecccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+|||+++.-...........-...|+|||.+.+
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~ 336 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT 336 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhcc
Confidence 9999998764311111111234678999998864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=252.69 Aligned_cols=175 Identities=26% Similarity=0.418 Sum_probs=152.9
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+.+.+...++++||+|-||.|..|....+..||||+.+..... ...+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 4566778889999999999999999877899999999877544 458999999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCC-CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSNRSL-DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~-~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
+|||++|+|.+++.+...+. ..+...+|+.||+.||+||. +.++||||+.++|+|+|.++++||+|||+++.+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999997764433 55667789999999999999 999999999999999999999999999999976555
Q ss_pred ccceec--cccccccccccccc
Q 046199 880 ESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~~~~--~~gt~~y~APE~l~ 899 (902)
+.+... .+-..+|||||.++
T Consensus 691 ~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred CceeeecceeeeeeehhHHHHH
Confidence 544332 45678999999875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=255.08 Aligned_cols=171 Identities=27% Similarity=0.379 Sum_probs=149.6
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.+++.++||+|+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999864 8899999987421 234466888999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++.+....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999765667899999999999999999999 99999999999999999999999999999987654333
Q ss_pred ce-eccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~ 899 (902)
.. ....||+.|||||++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred ccccceeccccccCHHHHh
Confidence 22 2246999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=253.79 Aligned_cols=165 Identities=28% Similarity=0.342 Sum_probs=143.0
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 48999999997542 234456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccc
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 887 (902)
+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+.............
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 999988653 46899999999999999999999 99999999999999999999999999999976433333334467
Q ss_pred ccccccccccccc
Q 046199 888 GTIGYMAPGLWVV 900 (902)
Q Consensus 888 gt~~y~APE~l~~ 900 (902)
||+.|||||++..
T Consensus 157 gt~~y~aPE~~~~ 169 (323)
T cd05571 157 GTPEYLAPEVLED 169 (323)
T ss_pred cCccccChhhhcC
Confidence 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=259.22 Aligned_cols=147 Identities=29% Similarity=0.415 Sum_probs=133.1
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.. ++.||||+++... ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478999999999999999999864 8899999997542 233456788999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.+
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999998654 45899999999999999999999 999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=254.10 Aligned_cols=169 Identities=27% Similarity=0.383 Sum_probs=148.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4689999999999999999999864 8899999987542 23446788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999998654 45788999999999999999999 9999999999999999999999999999998764332
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
....||+.|+|||++..
T Consensus 173 ---~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQS 189 (329)
T ss_pred ---ceecCChhhcCHHHHcC
Confidence 23579999999998753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=253.31 Aligned_cols=172 Identities=26% Similarity=0.359 Sum_probs=149.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999864 7889999986431 233456788999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||++||+|.+++......+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999775667899999999999999999999 99999999999999999999999999999987654433
Q ss_pred ce-ecccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~~ 900 (902)
.. ....||+.|||||++..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred eeeccccCCcccCCHHHHhc
Confidence 22 23569999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=249.03 Aligned_cols=171 Identities=25% Similarity=0.434 Sum_probs=148.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 367999999999999999999876 48899999987543 2234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++ +|.+++......+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9975 999988766666889999999999999999999 999999999999999999999999999999865443333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 160 ~~~~~~~~~y~aPE~~~ 176 (288)
T cd07871 160 YSNEVVTLWYRPPDVLL 176 (288)
T ss_pred ccCceecccccChHHhc
Confidence 33456899999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-28 Score=258.76 Aligned_cols=173 Identities=29% Similarity=0.410 Sum_probs=156.3
Q ss_pred hcccccccCeecccceeeEEEEEeCCC-cEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..+.|+++..||.|+||.||+|..++. --.|.|++........+++.-||+|+..+.||+||++++.|..++..||+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 446678888999999999999988763 3457788887777888999999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
||.||-.+.++-+-+..+.+.++..+++|++.||.||| ++.|||||+|+.|||++-+|.++++|||.+.........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99999999999888888999999999999999999999 999999999999999999999999999998776555555
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
...+.|||+|||||+.+
T Consensus 187 RDsFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVM 203 (1187)
T ss_pred hccccCCcccccchhee
Confidence 56689999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=231.62 Aligned_cols=170 Identities=31% Similarity=0.442 Sum_probs=148.1
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--------chhhhhHHHHHHHHHhC-CCCCccceeeeeec
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--------DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 793 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 793 (902)
.-..|+..+.+|+|..+.|.++.++ +++++|+|++.... ....+...+|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888899999999999998775 48999999986432 12235567899999998 69999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
+..+++|+|.|+.|.|.+++... -.++++...++++|+.+|++||| .+.|||||+||+|||+|++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999543 45899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccceecccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
..+...+. -...||||+|.|||.+
T Consensus 171 ~~l~~Gek-LrelCGTPgYLAPEti 194 (411)
T KOG0599|consen 171 CQLEPGEK-LRELCGTPGYLAPETI 194 (411)
T ss_pred eccCCchh-HHHhcCCCcccChhhe
Confidence 98875543 4558999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=258.29 Aligned_cols=174 Identities=26% Similarity=0.491 Sum_probs=152.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+......+.++||.|.||+||+|+.+. ...||||.++... +....+|..|+.||.++.||||+++.|+......+
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 344456788999999999999998753 4569999998775 45667899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+||+|||++|+|+.+++...+.+...+...+.++|+.||+||- +.++|||||.++|||++.+..+|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999998888999999999999999999999 9999999999999999999999999999999876
Q ss_pred CCccc-eecccc--ccccccccccc
Q 046199 878 GEESM-RTQTLG--TIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~-~~~~~g--t~~y~APE~l~ 899 (902)
++... .++..| ..+|.|||.+.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred cCCCccccccCCccceeecChhHhh
Confidence 55432 232333 46899999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=253.26 Aligned_cols=172 Identities=28% Similarity=0.383 Sum_probs=150.9
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||+|+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999886 48899999997542 234467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999776567999999999999999999999 99999999999999999999999999999987654433
Q ss_pred c-eecccccccccccccccc
Q 046199 882 M-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~-~~~~~gt~~y~APE~l~~ 900 (902)
. .....||+.|+|||++..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred eeeecccCCccccCHHHhcc
Confidence 2 223568999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=256.39 Aligned_cols=177 Identities=25% Similarity=0.356 Sum_probs=152.8
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
++++....++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45566777999999999999999999999864 8899999986432 2334567889999999999999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
++..|+||||+++|+|.+++... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999988543 4788889999999999999999 999999999999999999999999999999
Q ss_pred eecCCCcc-ceeccccccccccccccc
Q 046199 874 KLLNGEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
+....... ......||+.|||||++.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHh
Confidence 87654332 223467999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=249.55 Aligned_cols=171 Identities=27% Similarity=0.425 Sum_probs=148.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999986 488999999875432 233567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|++ +++.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 996 5888888766667899999999999999999999 999999999999999999999999999999765433333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....||+.|+|||++.
T Consensus 160 ~~~~~~~~~y~aPE~~~ 176 (303)
T cd07869 160 YSNEVVTLWYRPPDVLL 176 (303)
T ss_pred CCCCcccCCCCChHHHc
Confidence 33456899999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=253.84 Aligned_cols=171 Identities=27% Similarity=0.403 Sum_probs=148.4
Q ss_pred hhcccccccCeecccceeeEEEEEeCC--CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 345689999999999999999998644 4689999986432 23456788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999998654 45889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. .....||+.|||||++..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLN 202 (340)
T ss_pred CC---cceecCChhhcCHHHHhC
Confidence 32 233579999999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=257.81 Aligned_cols=146 Identities=28% Similarity=0.378 Sum_probs=131.5
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999875 48899999986432 234467888999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998653 45889999999999999999999 99999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=249.60 Aligned_cols=168 Identities=31% Similarity=0.409 Sum_probs=147.2
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999986 48899999987542 223467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999998654 45889999999999999999999 9999999999999999999999999999998764322
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
....||+.|+|||++..
T Consensus 156 --~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 156 --WTLCGTPEYLAPEVIQS 172 (291)
T ss_pred --ccccCChhhcCHHHHcC
Confidence 23568999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=253.41 Aligned_cols=168 Identities=25% Similarity=0.397 Sum_probs=147.9
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.+ ++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468999999999999999999865 8899999997542 234467888999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999998654 45889999999999999999999 99999999999999999999999999999986543
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 154 ~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred ccCCcccCccccChhHhcC
Confidence 2234579999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=251.15 Aligned_cols=165 Identities=29% Similarity=0.357 Sum_probs=142.2
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 48999999997542 234456778999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccc
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 887 (902)
+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 999888554 46899999999999999999999 99999999999999999999999999999876433333333467
Q ss_pred ccccccccccccc
Q 046199 888 GTIGYMAPGLWVV 900 (902)
Q Consensus 888 gt~~y~APE~l~~ 900 (902)
||+.|+|||++..
T Consensus 157 gt~~y~aPE~~~~ 169 (323)
T cd05595 157 GTPEYLAPEVLED 169 (323)
T ss_pred CCcCcCCcccccC
Confidence 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=250.62 Aligned_cols=165 Identities=28% Similarity=0.363 Sum_probs=142.7
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 48999999997542 234567788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccc
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL 887 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 887 (902)
+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 999888543 46899999999999999999999 99999999999999999999999999999976433333333467
Q ss_pred ccccccccccccc
Q 046199 888 GTIGYMAPGLWVV 900 (902)
Q Consensus 888 gt~~y~APE~l~~ 900 (902)
||+.|+|||++..
T Consensus 157 gt~~y~aPE~~~~ 169 (328)
T cd05593 157 GTPEYLAPEVLED 169 (328)
T ss_pred CCcCccChhhhcC
Confidence 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=256.78 Aligned_cols=145 Identities=26% Similarity=0.379 Sum_probs=131.0
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|++.+.||+|+||+||+|++.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999998754 8899999997542 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
|+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999998654 45889999999999999999999 99999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=249.28 Aligned_cols=163 Identities=31% Similarity=0.350 Sum_probs=141.8
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||.||+|++.+ ++.||+|+++... ......+.+|++++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999865 8899999987532 33456778899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccc
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt 889 (902)
.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.............||
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 9998654 45899999999999999999999 9999999999999999999999999999998644333333446799
Q ss_pred ccccccccccc
Q 046199 890 IGYMAPGLWVV 900 (902)
Q Consensus 890 ~~y~APE~l~~ 900 (902)
+.|+|||++..
T Consensus 157 ~~y~aPE~~~~ 167 (312)
T cd05585 157 PEYLAPELLLG 167 (312)
T ss_pred cccCCHHHHcC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=256.72 Aligned_cols=145 Identities=27% Similarity=0.380 Sum_probs=130.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||+|+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999998764 8899999986432 223466889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|.
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999998654 45788999999999999999999 9999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=257.19 Aligned_cols=145 Identities=26% Similarity=0.372 Sum_probs=130.7
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||+|+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999998854 8899999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
|+++|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|..
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999998654 45788999999999999999999 99999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=248.90 Aligned_cols=165 Identities=28% Similarity=0.340 Sum_probs=141.8
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|++. +++.||+|+++... ......+..|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 48999999997542 233456778999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
+|.+++... ..+++..+..++.||+.||+||| + .||+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 999888543 46899999999999999999999 7 799999999999999999999999999997644333333345
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05594 157 CGTPEYLAPEVLED 170 (325)
T ss_pred cCCcccCCHHHHcc
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=255.62 Aligned_cols=173 Identities=24% Similarity=0.349 Sum_probs=149.2
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4556789999999999999999998864 8899999986432 22345577899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999988543 4788889999999999999999 9999999999999999999999999999998765
Q ss_pred CCcc-ceeccccccccccccccc
Q 046199 878 GEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
.... ......||+.|||||++.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhc
Confidence 4322 223457999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=242.00 Aligned_cols=166 Identities=30% Similarity=0.499 Sum_probs=145.0
Q ss_pred cCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
.+.+|.|-||+||-|+++. |+.||||++.+.. ......+++|+.|++.++||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999998865 9999999997542 234478899999999999999999999999999999999999776
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceecCCCcccee
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD---MVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
-|+-.+....+.+++...+.+..||+.||.||| .++|+|+|+||+|||+... -.+||||||+|+.+.+ ...+.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksFRr 724 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSFRR 724 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch-hhhhh
Confidence 666666666778999999999999999999999 9999999999999999543 4899999999998864 44566
Q ss_pred cccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~ 900 (902)
..+|||.|.|||++..
T Consensus 725 sVVGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN 740 (888)
T ss_pred hhcCCccccCHHHHhh
Confidence 6899999999999853
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=250.01 Aligned_cols=171 Identities=25% Similarity=0.351 Sum_probs=148.4
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||++++.. ++.||+|++.... ....+.+..|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998865 7889999986421 223455788999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++.+....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999775667899999999999999999999 99999999999999999999999999999976543332
Q ss_pred ce-eccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~ 899 (902)
.. ....||+.|||||++.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred ceecccccCccccCHHHHh
Confidence 22 2357999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=253.51 Aligned_cols=175 Identities=23% Similarity=0.407 Sum_probs=143.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeec
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 793 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 793 (902)
.+..++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456789999999999999999999742 25689999987543 23456789999999999 89999999998865
Q ss_pred C-CeeEEEEEccCCCChHHHHhhCC-------------------------------------------------------
Q 046199 794 G-NFKALVLEYMANGSLEKCLYSSN------------------------------------------------------- 817 (902)
Q Consensus 794 ~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 817 (902)
. +..++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 46899999999999999986431
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc--eeccccc
Q 046199 818 ------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGT 889 (902)
Q Consensus 818 ------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt 889 (902)
..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23677788999999999999999 999999999999999999999999999999865432221 1123466
Q ss_pred cccccccccc
Q 046199 890 IGYMAPGLWV 899 (902)
Q Consensus 890 ~~y~APE~l~ 899 (902)
+.|||||++.
T Consensus 240 ~~y~aPE~~~ 249 (338)
T cd05102 240 LKWMAPESIF 249 (338)
T ss_pred ccccCcHHhh
Confidence 7899999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=253.54 Aligned_cols=147 Identities=28% Similarity=0.397 Sum_probs=132.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.++..++||+|+++++.+.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999998864 8899999997432 234567888999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||++||+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999999998654 45889999999999999999999 999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=212.00 Aligned_cols=170 Identities=29% Similarity=0.422 Sum_probs=153.4
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+.|+..+.||+|.||+||+|+..+ ++.||+|.++... +.......+|+-+++.++|.|||+++++...+....+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 457778999999999999998765 7889999998654 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
||+. +|.++.....+.++.+.+..++.|+++|+.|+| ++++.|||+||.|.+|+.+|++|++|||+|+.++-+-..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9965 999998888888999999999999999999999 999999999999999999999999999999988777666
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
....+-|..|++|.++-
T Consensus 158 ysaevvtlwyrppdvlf 174 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLF 174 (292)
T ss_pred eeceeeeeeccCcceee
Confidence 66678899999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=243.46 Aligned_cols=170 Identities=28% Similarity=0.377 Sum_probs=145.9
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999875 58999999986542 2233467889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998887543 345889999999999999999999 9999999999999999999999999999998764332
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|||||++..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred eecCCCCCCCccCHhhhcC
Confidence 2234579999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=247.33 Aligned_cols=165 Identities=31% Similarity=0.445 Sum_probs=141.8
Q ss_pred CeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.||+|+||.||+|+.. .++.||+|+++... ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 47899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++... ..+.+..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999988654 45788889999999999999999 9999999999999999999999999999998654433333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....||+.|+|||++..
T Consensus 158 ~~~~gt~~y~aPE~~~~ 174 (323)
T cd05584 158 HTFCGTIEYMAPEILMR 174 (323)
T ss_pred cccCCCccccChhhccC
Confidence 44679999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=247.21 Aligned_cols=174 Identities=30% Similarity=0.427 Sum_probs=153.9
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.....|.+.+.||+|.|++|..|++.. +.+||+|.++...- ...+.+.+|+++|+.+.|||||+++.+.+.....|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345679999999999999999998854 99999999976542 233558899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+.+|.+++++.+.+. +.+..+..++.|+.+|++|+| ++.|||||||++||+++.+.++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999999976654 556889999999999999999 99999999999999999999999999999998874
Q ss_pred ccceeccccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~~ 901 (902)
.....+.+|++.|+|||++...
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred cccccccCCCCCccChHhhcCc
Confidence 3344558999999999999764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=247.52 Aligned_cols=170 Identities=24% Similarity=0.291 Sum_probs=144.8
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCC-CCccceeeeeecCCeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 801 (902)
+|++.+.||+|+||.||+|++.+ ++.||+|+++... ....+.+..|+++++.+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58889999999999999998865 7889999987542 3345677889999999976 46888999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999988654 45889999999999999999999 99999999999999999999999999999875433333
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~ 175 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAY 175 (324)
T ss_pred ceeeecCCccccChhhhcC
Confidence 3344679999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=253.17 Aligned_cols=171 Identities=31% Similarity=0.428 Sum_probs=149.7
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999986 48999999997542 234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc-
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE- 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~- 880 (902)
||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998665 56899999999999999999999 9999999999999999999999999999998765433
Q ss_pred ----------------------------cceecccccccccccccccc
Q 046199 881 ----------------------------SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ----------------------------~~~~~~~gt~~y~APE~l~~ 900 (902)
.......||+.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 11223569999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=234.36 Aligned_cols=150 Identities=31% Similarity=0.404 Sum_probs=135.0
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
....++|+..+.||+|.-|+||.|+..+ +..+|+|++.+.. .....+.+.|.+|++.++||.++.+|+.|+.+++.
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3455788899999999999999999876 6889999997653 33456778899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 798 ALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
|+|||||+||+|....++. .+.+++..++.++.+++.||+||| ..|||+|||||+||||.++|++-|+||.++.
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 9999999999999887654 456999999999999999999999 9999999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=248.50 Aligned_cols=165 Identities=27% Similarity=0.475 Sum_probs=143.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++..+.....+.+|.|+.|.||+|+. .++.||||+++. .-+.+|+-+++++||||+.+.|+|.....+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 34444455678899999999999998 578999998752 2346788899999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||..|-|+.+++.. +.+.....+.|..+||.||.||| .+.|||||||.-||||..+..|||+|||.++...+. .
T Consensus 192 EfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S 266 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S 266 (904)
T ss_pred eccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-h
Confidence 999999999999654 56888889999999999999999 999999999999999999999999999999877654 3
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
....++||..|||||++.
T Consensus 267 TkMSFaGTVaWMAPEvIr 284 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIR 284 (904)
T ss_pred hhhhhhhhHhhhCHHHhh
Confidence 334488999999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=252.91 Aligned_cols=169 Identities=35% Similarity=0.543 Sum_probs=145.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC------CeeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------NFKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 798 (902)
-|...+.||+|+||.||+++++ .|+.||||.++... ....++..+|++++++++|||||+++++-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556788999999999999965 49999999997643 34568889999999999999999999886543 3568
Q ss_pred EEEEccCCCChHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCC--cEEEEeecC
Q 046199 799 LVLEYMANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDM--VAHLSDFGI 872 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~--~~kL~DFG~ 872 (902)
+|||||.||||+.++.+.. ..+++.+...+..+++.||.||| ++|||||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999997643 45999999999999999999999 99999999999999983 334 589999999
Q ss_pred ceecCCCccceeccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+...+.. .....+||+.|.|||++-
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHh
Confidence 99987665 455688999999999874
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=247.00 Aligned_cols=165 Identities=25% Similarity=0.335 Sum_probs=142.0
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|..+++.+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999998864 8899999997542 23345678899999988 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 9999888544 56899999999999999999999 9999999999999999999999999999997543333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (329)
T cd05588 157 CGTPNYIAPEILRG 170 (329)
T ss_pred cCCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=247.23 Aligned_cols=168 Identities=27% Similarity=0.395 Sum_probs=142.6
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHH---HhCCCCCccceeeeeecCCeeEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVL---KSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999875 48999999997542 23345677777665 456799999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|..++.. ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999888743 45899999999999999999999 9999999999999999999999999999987644333
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.......|++.|||||++..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTE 175 (324)
T ss_pred CcccccccCccccCHhHhcC
Confidence 33344679999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=245.83 Aligned_cols=165 Identities=29% Similarity=0.359 Sum_probs=141.5
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|.++++.+ +||+|+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 468999999999998865 7899999987542 23445677888888866 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
++|..++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 9999888654 45889999999999999999999 9999999999999999999999999999998654443334446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (321)
T cd05591 157 CGTPDYIAPEILQE 170 (321)
T ss_pred ccCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=247.04 Aligned_cols=169 Identities=30% Similarity=0.392 Sum_probs=144.9
Q ss_pred cccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
+|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|+.+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999763 47899999987432 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999998654 45889999999999999999999 9999999999999999999999999999998654
Q ss_pred CCcc-ceeccccccccccccccc
Q 046199 878 GEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
.... ......||+.|||||++.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~ 179 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIR 179 (332)
T ss_pred ccCCCccccccCCccccCHHHhc
Confidence 3322 222357999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=244.69 Aligned_cols=165 Identities=26% Similarity=0.365 Sum_probs=139.7
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.+ ++.||+|+++... ....+....|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998864 7889999997542 23344556677777654 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+............
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 9999988654 45899999999999999999999 9999999999999999999999999999998654433334446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05592 157 CGTPDYIAPEILKG 170 (316)
T ss_pred cCCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=245.10 Aligned_cols=165 Identities=26% Similarity=0.370 Sum_probs=141.3
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999864 8899999987532 23446677888888876 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 9999988654 45899999999999999999999 9999999999999999999999999999988654333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (320)
T cd05590 157 CGTPDYIAPEILQE 170 (320)
T ss_pred ccCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=245.40 Aligned_cols=165 Identities=27% Similarity=0.349 Sum_probs=141.2
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|+.++.++ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999864 7899999997542 23445677899888777 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|..++... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 9999887544 46899999999999999999999 9999999999999999999999999999997643333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (329)
T cd05618 157 CGTPNYIAPEILRG 170 (329)
T ss_pred cCCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=243.72 Aligned_cols=173 Identities=24% Similarity=0.440 Sum_probs=144.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-----------------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCcc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLV 785 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv 785 (902)
..++|++.+.||+|+||.||+|.+.+ +..||+|+++... .....++.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34689999999999999999997532 3469999987643 33456789999999999999999
Q ss_pred ceeeeeecCCeeEEEEEccCCCChHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 046199 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSN------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPV 847 (902)
Q Consensus 786 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 847 (902)
++++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.||+.||+||| +.||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 99999999999999999999999999885422 23567788999999999999999 9999
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 848 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
+||||||+||++++++.+||+|||+++......... ....++..|||||++.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 999999999999999999999999998764433211 1234578899999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=244.77 Aligned_cols=170 Identities=24% Similarity=0.304 Sum_probs=144.6
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 801 (902)
+|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58889999999999999998865 7899999987542 22334567788888777 5899999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999888554 45889999999999999999999 99999999999999999999999999999986543333
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAY 175 (323)
T ss_pred ccccCCCChhhcCHHHhcC
Confidence 3344679999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=229.47 Aligned_cols=174 Identities=28% Similarity=0.334 Sum_probs=153.2
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|+..+++|+|.||+|..++.+. ++.||+|+++++. ..+...-..|-++++..+||++..+.-.|+..+..|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 345688999999999999999998754 8999999998664 334455677999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||..||.|.-++.+ .+.+++.....+...|+.||.||| +++||.||+|.+|.++|.+|++||+|||+++.--.
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999888854 456899999999999999999999 99999999999999999999999999999987555
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
......+.||||.|.|||++-+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred ccceeccccCChhhcCchhhcc
Confidence 5555667899999999999865
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=244.36 Aligned_cols=170 Identities=23% Similarity=0.296 Sum_probs=144.2
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
+|+..+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 46788999999999999998764 8899999987542 233456778888888885 577888999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++|+|.+++... ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999988554 45899999999999999999999 99999999999999999999999999999986543333
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY 175 (323)
T ss_pred cccCccCCccccCHHHHcC
Confidence 3334569999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=244.47 Aligned_cols=165 Identities=34% Similarity=0.404 Sum_probs=138.5
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHH-HHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++. +++.||+|++.... ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 48999999987542 223345555554 46778999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|..++.. ...+++..+..++.||+.||+||| +.||+||||||+||++++++.+||+|||+++............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 999988854 346899999999999999999999 9999999999999999999999999999997643333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05604 157 CGTPEYLAPEVIRK 170 (325)
T ss_pred cCChhhCCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=243.20 Aligned_cols=165 Identities=23% Similarity=0.369 Sum_probs=140.5
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+....|.+++... +||+|+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999864 8899999997542 23345667788888755 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 9999988654 45889999999999999999999 9999999999999999999999999999987543333334456
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05620 157 CGTPDYIAPEILQG 170 (316)
T ss_pred CCCcCccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=237.88 Aligned_cols=172 Identities=24% Similarity=0.363 Sum_probs=154.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..-|+..+.||+|.|++|-.|++. .|.+||||++.+.. ......+.+|++.|+.++|||||++|++.......|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356888999999999999999875 59999999997654 334567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE-cCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL-DDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|.-++|+|++|+.+....+.+..+.++++||+.|+.|+| +..+||||+||+||++ ..-|-||+.|||++..+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999888888999999999999999999999 9999999999999887 567899999999998887554
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
. .++.||+..|.|||++++
T Consensus 174 k-L~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 174 K-LTTSCGSLAYSAPEILLG 192 (864)
T ss_pred h-hhcccchhhccCchhhhc
Confidence 3 456899999999999874
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=243.57 Aligned_cols=165 Identities=33% Similarity=0.406 Sum_probs=138.5
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHH-HHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++. +++.||+|++.... ....+.+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 48999999987542 222344555544 56789999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 9999988653 46889999999999999999999 9999999999999999999999999999997644333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (323)
T cd05575 157 CGTPEYLAPEVLRK 170 (323)
T ss_pred cCChhhcChhhhcC
Confidence 79999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=256.00 Aligned_cols=177 Identities=27% Similarity=0.360 Sum_probs=147.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCC-cEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeee-eec-----
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISS-CSN----- 793 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~----- 793 (902)
.+...++++.+.|.+|||+.||.|++..+ .+||+|++-..++...+.+.+|+++|+.|. |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 46677889999999999999999999775 999999998777778899999999999997 9999999993 321
Q ss_pred -CCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 794 -GNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 794 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.-++++.||||+||.|-+++..+ ...+++.++++|++|+++|+.+|| .++..|||||||-+||||+.+|..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 13578999999999999999753 334999999999999999999999 345669999999999999999999999999
Q ss_pred CceecCCCc-cc--------eeccccccccccccccc
Q 046199 872 IAKLLNGEE-SM--------RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~-~~--------~~~~~gt~~y~APE~l~ 899 (902)
.|....... .. ......|+-|+|||++-
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID 228 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence 986432222 11 01135799999999974
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=243.65 Aligned_cols=165 Identities=32% Similarity=0.376 Sum_probs=138.0
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHH-HHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.+ ++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999864 8899999987532 222344555554 57889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
++|...+.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 999888754 345888999999999999999999 9999999999999999999999999999987643333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (321)
T cd05603 157 CGTPEYLAPEVLRK 170 (321)
T ss_pred cCCcccCCHHHhcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=241.72 Aligned_cols=165 Identities=27% Similarity=0.379 Sum_probs=140.2
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.+ ++.||+|+++... ....+....|..+++.. +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 7899999997542 23345566788888764 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 9999988653 45889999999999999999999 9999999999999999999999999999997643333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (316)
T cd05619 157 CGTPDYIAPEILLG 170 (316)
T ss_pred cCCccccCHHHHcC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=243.22 Aligned_cols=165 Identities=30% Similarity=0.377 Sum_probs=142.7
Q ss_pred CeecccceeeEEEEEeC----CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 732 SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
+.||+|+||.||++++. .++.||+|+++.... .....+..|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999999763 478999999975432 234567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+++...........
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999988543 45899999999999999999999 999999999999999999999999999999876544333444
Q ss_pred ccccccccccccccc
Q 046199 886 TLGTIGYMAPGLWVV 900 (902)
Q Consensus 886 ~~gt~~y~APE~l~~ 900 (902)
..||+.|+|||++..
T Consensus 158 ~~g~~~y~aPE~~~~ 172 (318)
T cd05582 158 FCGTVEYMAPEVVNR 172 (318)
T ss_pred ccCChhhcCHHHHcC
Confidence 679999999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=255.58 Aligned_cols=172 Identities=23% Similarity=0.339 Sum_probs=148.1
Q ss_pred ccccccCeecccceeeEEEEEeCC--CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..|.+.+.||+|+||.||+|.... ++.||+|.+..........+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 459999999999999999997643 577899987655555556788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
+++|+|.+++.. ....+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988754 2345889999999999999999999 9999999999999999999999999999998765432
Q ss_pred c--ceecccccccccccccccc
Q 046199 881 S--MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~--~~~~~~gt~~y~APE~l~~ 900 (902)
. .....+||+.|||||++..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred ccccccccCCCccccCHhHhCC
Confidence 2 1233569999999998753
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=243.42 Aligned_cols=165 Identities=32% Similarity=0.370 Sum_probs=137.2
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHH-HHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAEC-EVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|++.... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999864 7889999987532 12223444444 456788999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
++|.+++... ..+.+..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+............
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 9999988654 45788888999999999999999 9999999999999999999999999999997654333333446
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (325)
T cd05602 157 CGTPEYLAPEVLHK 170 (325)
T ss_pred cCCccccCHHHHcC
Confidence 79999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=248.25 Aligned_cols=167 Identities=30% Similarity=0.424 Sum_probs=143.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|+..+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..|+|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356777889999999999999876 489999999865432 345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+.. ...+..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||+++........
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999986532 3467778899999999999999 999999999999999999999999999999876543333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....||..|+|||++.
T Consensus 225 ~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 CNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccccccCccccCccccc
Confidence 33467999999999873
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=243.19 Aligned_cols=165 Identities=27% Similarity=0.355 Sum_probs=142.2
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|+... ++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998865 7899999997542 23446678899999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++... +.+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 9999887543 46899999999999999999999 9999999999999999999999999999998643333334456
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
+||+.|+|||++..
T Consensus 157 ~gt~~y~aPE~~~~ 170 (327)
T cd05617 157 CGTPNYIAPEILRG 170 (327)
T ss_pred cCCcccCCHHHHCC
Confidence 79999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=237.32 Aligned_cols=176 Identities=26% Similarity=0.361 Sum_probs=152.7
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
+....+.|..-++||+|+||.||-++.++ |+-||+|++.+.. .........|..+++++..++||.+--+|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34455678889999999999999998765 8899999875331 2334566789999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 797 KALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.++|+..|.||||.-++...+ ..+++..+..++.+|+.||++|| ..+||.||+||+|||+|+.|+++|+|.|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999988887654 46999999999999999999999 99999999999999999999999999999999
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+...... ...+||.+|||||++..
T Consensus 337 i~~g~~~-~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 337 IPEGKPI-RGRVGTVGYMAPEVLQN 360 (591)
T ss_pred cCCCCcc-ccccCcccccCHHHHcC
Confidence 8765544 34589999999999853
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=237.74 Aligned_cols=164 Identities=27% Similarity=0.354 Sum_probs=140.9
Q ss_pred ecccceeeEEEEEeC-CCcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||+||+|.+. +++.||+|++..... ...+.+..|+++++.++||+|+++.+++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 488999999864421 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 810 EKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 810 ~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
.+++.. ....+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 887743 2345889999999999999999999 9999999999999999999999999999998765544333445
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|+|||++..
T Consensus 158 ~g~~~y~aPE~~~~ 171 (280)
T cd05608 158 AGTPGFMAPELLQG 171 (280)
T ss_pred CCCcCccCHHHhcC
Confidence 78999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=243.10 Aligned_cols=165 Identities=32% Similarity=0.475 Sum_probs=151.3
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChH
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLE 810 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 810 (902)
-++|+|.||+||.|++.+ ...+|||.+........+.+..||.+.++++|.|||+++|.+.+++++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999876 5578999998877778889999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceecCCCccceeccc
Q 046199 811 KCLYSSNRSL--DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQTL 887 (902)
Q Consensus 811 ~~l~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~ 887 (902)
++++.+-+++ .+..+..+.+||++||+||| +..|||||||-+||+|+ -.|.+||+|||.++++.+-.....++.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9998877776 78889999999999999999 99999999999999996 478999999999999887777777788
Q ss_pred cccccccccccc
Q 046199 888 GTIGYMAPGLWV 899 (902)
Q Consensus 888 gt~~y~APE~l~ 899 (902)
||..|||||++-
T Consensus 738 GTLQYMAPEvID 749 (1226)
T KOG4279|consen 738 GTLQYMAPEVID 749 (1226)
T ss_pred cchhhhChHhhc
Confidence 999999999974
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=241.87 Aligned_cols=171 Identities=27% Similarity=0.365 Sum_probs=148.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++.. +..||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 35789999999999999999999864 88899999876532 34567999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++++|.+++... ..+++..+..++.|++.|+.||| +. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 83 EHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999998654 45889999999999999999999 65 69999999999999999999999999997654322
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 159 --~~~~~g~~~y~aPE~~~~ 176 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQG 176 (331)
T ss_pred --cccCCCCcCcCCHhHhcC
Confidence 233568999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=240.45 Aligned_cols=171 Identities=25% Similarity=0.425 Sum_probs=147.6
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|.+.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 367999999999999999999876 478899999875432 233567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++ ++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9975 888888766666889999999999999999999 999999999999999999999999999999865443333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+|+.|+|||++.
T Consensus 161 ~~~~~~~~~y~aPE~~~ 177 (309)
T cd07872 161 YSNEVVTLWYRPPDVLL 177 (309)
T ss_pred cccccccccccCCHHHh
Confidence 33456899999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=259.48 Aligned_cols=172 Identities=29% Similarity=0.378 Sum_probs=145.1
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 589999999999999999999864 8999999987532 233567899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 802 EYMANGSLEKCLYSS----------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 802 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
||++|++|.+++... ....++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988542 123456778899999999999999 9999999999999999999999999999
Q ss_pred CceecCCCcc------------------ceecccccccccccccccc
Q 046199 872 IAKLLNGEES------------------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~------------------~~~~~~gt~~y~APE~l~~ 900 (902)
+|+....... .....+||+.|||||++..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g 205 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence 9987621110 0112469999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=238.21 Aligned_cols=171 Identities=27% Similarity=0.376 Sum_probs=145.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999864 7889999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 881 (902)
|++++.+..+. .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987766544 44456899999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG 175 (287)
T ss_pred cccccccccccCCcHHHcC
Confidence 2223568999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=243.71 Aligned_cols=168 Identities=27% Similarity=0.382 Sum_probs=145.4
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-C-----CCccceeeeeecCCeeE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H-----RNLVKIISSCSNGNFKA 798 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 798 (902)
-+|++.+.||+|+||.|.+|.+.. ++.||||+++... ....+...|+.++..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 389999999999999999999865 8999999998653 34466678999999996 4 47999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC--cEEEEeecCcee
Q 046199 799 LVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM--VAHLSDFGIAKL 875 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~ 875 (902)
||+|.++ .+|+++++..+ ..++...++.++.||+.||.+|| +.+|||+||||+|||+.+.+ .|||+|||.|..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999985 59999997754 45889999999999999999999 99999999999999996543 899999999987
Q ss_pred cCCCccceeccccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
..... .+.+.+..|+|||+++++
T Consensus 341 ~~q~v---ytYiQSRfYRAPEVILGl 363 (586)
T KOG0667|consen 341 ESQRV---YTYIQSRFYRAPEVILGL 363 (586)
T ss_pred cCCcc---eeeeeccccccchhhccC
Confidence 54322 256789999999999876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=259.12 Aligned_cols=175 Identities=29% Similarity=0.491 Sum_probs=151.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC--Cc----EEEEEEeeec-cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD--GM----EVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..+..+..+.||+|+||.||+|...+ +. .||+|.+++. +.+...+|.+|+.+|+.++|||||+++|++.+.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 35667788999999999999998754 43 4899988765 34567899999999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 797 KALVLEYMANGSLEKCLYSS------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
.++++|||+||||..++++. ...+...+...++.|||+|++||+ ++++|||||.++|+|+++...|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999887 556889999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCccceecc--ccccccccccccccc
Q 046199 871 GIAKLLNGEESMRTQT--LGTIGYMAPGLWVVL 901 (902)
Q Consensus 871 G~a~~~~~~~~~~~~~--~gt~~y~APE~l~~~ 901 (902)
|+|+.+...+..+... .-...|||||.++++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhc
Confidence 9999655444443332 234689999999863
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-26 Score=225.96 Aligned_cols=172 Identities=29% Similarity=0.378 Sum_probs=145.2
Q ss_pred cccccccCeecccceeeEEEEEeCC-----CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeec-CCe
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN-GNF 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 796 (902)
...|+....||+|.||.||+|...+ .+.+|+|+++.+.+ +.....-+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999996533 34799999986643 344667899999999999999999999877 789
Q ss_pred eEEEEEccCCCChHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC----CcEEEE
Q 046199 797 KALVLEYMANGSLEKCLYSS----NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD----MVAHLS 868 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~~~kL~ 868 (902)
+++++||.+. ||.+.++-. .+.++...+..+++||+.|+.||| +.-|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 898887542 245888999999999999999999 9999999999999999877 899999
Q ss_pred eecCceecCCCccce---ecccccccccccccccc
Q 046199 869 DFGIAKLLNGEESMR---TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 869 DFG~a~~~~~~~~~~---~~~~gt~~y~APE~l~~ 900 (902)
|||+|+.+.++-... ...+-|..|+|||++++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 999999887653322 22568999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=241.32 Aligned_cols=171 Identities=27% Similarity=0.372 Sum_probs=148.0
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999986 48889999887653 334567899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++++|.+++... ..+++..+..++.|++.|+.||| +. +|+||||||+||++++++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999998654 45888999999999999999999 64 79999999999999999999999999997653321
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.....|++.|+|||++..
T Consensus 159 --~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQG 176 (333)
T ss_pred --cccCCCCccccCHHHhcC
Confidence 223568999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=246.12 Aligned_cols=167 Identities=25% Similarity=0.307 Sum_probs=142.9
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
+...+|++.+.||+|+||.||+|.+.. ++.||+|... .+.+.+|+++++.++||||+++++++..++..++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 345689999999999999999999864 8899999643 245678999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc-
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE- 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~- 880 (902)
|++. ++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+......
T Consensus 163 e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 163 PRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9995 6888887554 45889999999999999999999 9999999999999999999999999999997543221
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.......||+.|+|||++..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR 257 (391)
T ss_pred cccccccCccCCCChhhhcC
Confidence 12233579999999998753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=247.26 Aligned_cols=176 Identities=25% Similarity=0.398 Sum_probs=146.0
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
+....++|++.+.||+|+||.||+|++. .+..||+|+++... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3455678999999999999999999742 25689999987543 33456788999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC-------------------------------------------------------
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------- 817 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 817 (902)
+.+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999886432
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 818 -------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 818 -------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 13677888999999999999999 99999999999999999999999999999987654
Q ss_pred Cccce--eccccccccccccccc
Q 046199 879 EESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~--~~~~gt~~y~APE~l~ 899 (902)
..... ....++..|||||++.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~ 289 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIF 289 (375)
T ss_pred cccccccCCCCCCcceeChhHhc
Confidence 33211 1133566899999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=234.06 Aligned_cols=173 Identities=24% Similarity=0.362 Sum_probs=146.2
Q ss_pred hcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...+|++.+.||+|+||.||+|++. .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3467899999999999999999763 356899999876532 33467889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999776667899999999999999999999 99999999999999999999999999998765432
Q ss_pred Ccccee-ccccccccccccccc
Q 046199 879 EESMRT-QTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~-~~~gt~~y~APE~l~ 899 (902)
...... ...++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred cchhcccCCCCceeecCHHHHh
Confidence 211111 123567899999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=267.89 Aligned_cols=355 Identities=22% Similarity=0.286 Sum_probs=267.2
Q ss_pred CcEEEEEeccCCcce-ec-CcccCCCCCCCeeeccccc------cccCCCccccCCC-cceEEEecCccccCCCCccccc
Q 046199 44 HRVTALNISDFGLTG-TI-SSQLGNLSSLQTLDLSHNR------FSGTIPSSIFSIS-TLKILILGDNQLSGSFPSFIIS 114 (902)
Q Consensus 44 ~~v~~l~l~~~~l~g-~~-~~~l~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~ 114 (902)
.+|..+.+.-..+.. .+ +.++..+++|+.|.+..+. +...+|..+..++ +|+.|++.+|.++ .+|..+
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-- 608 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-- 608 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--
Confidence 345555444333321 12 2457889999999997764 3346788887775 6999999999987 567654
Q ss_pred CCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhh
Q 046199 115 NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF 194 (902)
Q Consensus 115 ~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 194 (902)
...+|+.|++++|++. .+|.++..+++|++|+|+++...+.+|. ++.+++|++|+|++|.....+|..++
T Consensus 609 ~~~~L~~L~L~~s~l~---------~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~ 678 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE---------KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQ 678 (1153)
T ss_pred CccCCcEEECcCcccc---------ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhh
Confidence 5789999999999886 3788889999999999998865557774 88999999999999877779999999
Q ss_pred ccCcccEEeeeeCC-CCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccC
Q 046199 195 NLSSLLELDFSNNS-LTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLN 273 (902)
Q Consensus 195 ~l~~L~~L~Ls~N~-l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (902)
++++|+.|++++|. ++ .+| ..+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++
T Consensus 679 ~L~~L~~L~L~~c~~L~-----------~Lp---------~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~ 734 (1153)
T PLN03210 679 YLNKLEDLDMSRCENLE-----------ILP---------TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDE 734 (1153)
T ss_pred ccCCCCEEeCCCCCCcC-----------ccC---------CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCC
Confidence 99999999999875 33 333 444 7899999999999776667653 46789999999
Q ss_pred cccccCCCcCCcccCCCcccceeeccCccCC-------CCCCccccccccccEEEccCCcccCcccccccccccccEEec
Q 046199 274 NTLSGSLPSSSKNLIGLPNIERLNLGLNNLS-------GRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGL 346 (902)
Q Consensus 274 N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~-------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 346 (902)
|.++ .+|..+ .+++|++|++.++... ...+......++|+.|+|++|...+.+|..++++++|+.|++
T Consensus 735 n~i~-~lP~~~----~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 735 TAIE-EFPSNL----RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred Cccc-cccccc----cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 9987 667652 5788888888874432 122222334568999999999888788999999999999999
Q ss_pred ccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeec
Q 046199 347 GYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426 (902)
Q Consensus 347 s~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 426 (902)
++|..-+..| .. .++++|++|++++|.....+|.. +.+++.|+|++|.|+ .+|.++..+++|++|+|++
T Consensus 810 s~C~~L~~LP-----~~-~~L~sL~~L~Ls~c~~L~~~p~~----~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 810 ENCINLETLP-----TG-INLESLESLDLSGCSRLRTFPDI----STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCCCCcCeeC-----CC-CCccccCEEECCCCCcccccccc----ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 9875433344 22 26788888898887655555543 237888888888887 5677888888888888887
Q ss_pred -ceecccCCcccccccccCeeeccccc
Q 046199 427 -NQLSGSIPITVGRLNTLQGLGLENNK 452 (902)
Q Consensus 427 -N~l~~~~p~~~~~l~~L~~L~L~~N~ 452 (902)
|++. .+|..+..+++|+.++++++.
T Consensus 879 C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 879 CNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCcC-ccCcccccccCCCeeecCCCc
Confidence 4455 567777778888888887764
|
syringae 6; Provisional |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=223.26 Aligned_cols=165 Identities=24% Similarity=0.376 Sum_probs=141.8
Q ss_pred cCeecccceeeEEEEEe-CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEccCCCC
Q 046199 731 KSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEYMANGS 808 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 808 (902)
.+.||+|+|+.|--+.. ..+.+||||++.+.......++.+|++++.+++ |+||++++++|+++..+|+|||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 46799999999998875 459999999998887677889999999999995 9999999999999999999999999999
Q ss_pred hHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceecC--CCcc--
Q 046199 809 LEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAHLSDFGIAKLLN--GEES-- 881 (902)
Q Consensus 809 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~~--~~~~-- 881 (902)
|...+.+ ++.+++.++.++..+|+.||.||| .+||.|||+||+|||..... -||||||.++.-+. .+.+
T Consensus 163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQK-RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999865 456999999999999999999999 99999999999999996544 58999998875332 1111
Q ss_pred ---ceeccccccccccccccc
Q 046199 882 ---MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ---~~~~~~gt~~y~APE~l~ 899 (902)
.-.+.+|+..|||||+..
T Consensus 239 stP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCccccCcccchhhcchhHHh
Confidence 122367999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=246.59 Aligned_cols=177 Identities=24% Similarity=0.439 Sum_probs=146.5
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
.|....++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+++++.+ +||||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34566778999999999999999999753 24579999997543 33456788999999999 899999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC------------------------------------------------------
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------ 817 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 817 (902)
...+..|+||||+++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 818 ---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 818 ---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
..+++..+.+++.||+.||+||| ++||+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 23677888999999999999999 999999999999999999999999999999876433221
Q ss_pred e--eccccccccccccccc
Q 046199 883 R--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~--~~~~gt~~y~APE~l~ 899 (902)
. ....+++.|||||++.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 269 VVKGNARLPVKWMAPESIF 287 (374)
T ss_pred eeccCCCCccceeCHHHhc
Confidence 1 1233567899999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-25 Score=238.81 Aligned_cols=165 Identities=25% Similarity=0.348 Sum_probs=141.4
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|+++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998865 7899999997542 23446677899999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 9999888654 46899999999999999999999 9999999999999999999999999999997643333333345
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
+||+.|+|||++..
T Consensus 157 ~g~~~y~aPE~~~~ 170 (318)
T cd05570 157 CGTPDYIAPEILSY 170 (318)
T ss_pred ecCccccCHHHhcC
Confidence 79999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=240.76 Aligned_cols=162 Identities=30% Similarity=0.352 Sum_probs=136.2
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC---CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV---RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
||+|+||.||+|++.. ++.||+|++.... .........|..++... +||+|+++++++..++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999998864 8999999986432 12233445566666655 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++............
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 999988865 356899999999999999999999 9999999999999999999999999999997644333333446
Q ss_pred ccccccccccccc
Q 046199 887 LGTIGYMAPGLWV 899 (902)
Q Consensus 887 ~gt~~y~APE~l~ 899 (902)
+||+.|||||++.
T Consensus 157 ~gt~~y~aPE~~~ 169 (330)
T cd05586 157 CGTTEYLAPEVLL 169 (330)
T ss_pred cCCccccCHHHHc
Confidence 7999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=234.52 Aligned_cols=175 Identities=27% Similarity=0.393 Sum_probs=154.0
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
....+.|++.+.||+|+||.||+|++.. ++.||+|.+........+.+.+|+++++.++||||+++++.+..++..|+|
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 3455789999999999999999998865 889999999876666677889999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++++++..++.+....+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999999888666667899999999999999999999 9999999999999999999999999999987654333
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......+++.|+|||++.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred cccceecCCccccCceeec
Confidence 3333456889999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=231.05 Aligned_cols=171 Identities=26% Similarity=0.399 Sum_probs=147.1
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
.++|++.+.||+|+||.||+|++.++..+|+|.+.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35788899999999999999998888899999876432 23467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce-
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR- 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~- 883 (902)
++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.+|++|||.++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999998765556899999999999999999999 9999999999999999999999999999998654332221
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||++.
T Consensus 159 ~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 159 SGAKFPVKWSPPEVFN 174 (256)
T ss_pred CCCCCchhhCChhhcc
Confidence 1233566899999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=234.02 Aligned_cols=169 Identities=29% Similarity=0.390 Sum_probs=145.3
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||+|+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999875 48899999986532 1223457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999887653 346899999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
.....|++.|+|||++.
T Consensus 158 -~~~~~~~~~y~aPE~~~ 174 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVK 174 (285)
T ss_pred -cccccCCCCccCcHHhc
Confidence 23356899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=231.37 Aligned_cols=172 Identities=29% Similarity=0.420 Sum_probs=150.1
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++.........+.+|+.++++++||||+++++++..++..|+|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3467999999999999999999975 588999999876554455678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+++... ..+++..+..++.|++.|++||| +.+|+|||+||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999988643 46889999999999999999999 999999999999999999999999999999876543333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....|++.|+|||.+.
T Consensus 163 ~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 163 RKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cCccccCccccCHhHcc
Confidence 33456889999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=235.37 Aligned_cols=173 Identities=28% Similarity=0.428 Sum_probs=154.1
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++. +++.||+|.++.......+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3578999999999999999999875 488999999987666666789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+++.+....+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998776667999999999999999999999 999999999999999999999999999998765444333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 160 ~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 160 RDTFIGTPYWMAPEVVA 176 (280)
T ss_pred cceeecchhhcCHHHHh
Confidence 34456899999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=213.86 Aligned_cols=176 Identities=25% Similarity=0.300 Sum_probs=149.3
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec-----C
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN-----G 794 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 794 (902)
+.+..++|++.+.+|+|+|+.||.++.. +++.||+|++.....+..+..++|++..++++||||++++++... .
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3456789999999999999999999864 488899999988877788899999999999999999999988743 3
Q ss_pred CeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEe
Q 046199 795 NFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kL~D 869 (902)
...|++++|+..|+|.+.+.. ++..+++.++.+|+.++++||++|| +.. ++||||||.||++.+++.+++.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence 458999999999999998865 3456999999999999999999999 776 99999999999999999999999
Q ss_pred ecCceecCCCcc---------ceeccccccccccccccc
Q 046199 870 FGIAKLLNGEES---------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 870 FG~a~~~~~~~~---------~~~~~~gt~~y~APE~l~ 899 (902)
||.+....-.-. .......|..|+|||+|-
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 999875431110 111234789999999984
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=243.95 Aligned_cols=178 Identities=24% Similarity=0.421 Sum_probs=147.4
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSC 791 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 791 (902)
.+....++|++.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|+++++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 345567899999999999999999998632 3479999997543 234567899999999996 99999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC------------------------------------------------------
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------ 817 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 817 (902)
.+.+..|+||||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999875421
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 818 -----------------------------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 818 -----------------------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
..+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 23677788899999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
|++++++.+||+|||+++........ .....+++.|||||++..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 99999999999999999876433221 122456788999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=240.21 Aligned_cols=169 Identities=27% Similarity=0.380 Sum_probs=141.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----CeeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 798 (902)
+|++.+.||+|+||.||+|++. +++.||+|+++... .....++.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999876 48999999987432 23345688999999999999999999987543 3579
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||++ ++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6898888543 45899999999999999999999 99999999999999999999999999999986532
Q ss_pred Ccc---ceecccccccccccccccc
Q 046199 879 EES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
... ......||+.|+|||++..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhc
Confidence 221 1233579999999998743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=230.85 Aligned_cols=171 Identities=30% Similarity=0.422 Sum_probs=149.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|++.+ ++.||+|+++.........+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4578889999999999999998754 889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.+..........
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999988554 46899999999999999999999 9999999999999999999999999999998765433333
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....|++.|+|||++.
T Consensus 164 ~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 164 KSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCcccccChhhhc
Confidence 3457899999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=231.66 Aligned_cols=174 Identities=27% Similarity=0.472 Sum_probs=152.2
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.+..+|++.+.||.|+||.||+|.+.+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999998899999999987655556788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++..+..++.|++.|++||| ++||+||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999763 345889999999999999999999 99999999999999999999999999999987654333
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~ 177 (261)
T cd05148 160 LSSDKKIPYKWTAPEAAS 177 (261)
T ss_pred cccCCCCceEecCHHHHc
Confidence 233344677899999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=231.35 Aligned_cols=171 Identities=29% Similarity=0.433 Sum_probs=149.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+.|++.+.||+|+||.||+|.+.. +..+++|.+........+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 347888999999999999999865 7788999887655556678889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
+++++..++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.+|++|||++...........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999988665667899999999999999999999 99999999999999999999999999999976543333333
Q ss_pred ccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 ~~~gt~~y~APE~l~ 899 (902)
...+++.|+|||++.
T Consensus 162 ~~~~~~~y~aPE~~~ 176 (282)
T cd06643 162 SFIGTPYWMAPEVVM 176 (282)
T ss_pred cccccccccCHhhcc
Confidence 356899999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=232.13 Aligned_cols=169 Identities=30% Similarity=0.453 Sum_probs=139.1
Q ss_pred ccccccCeecccceeeEEEEEeC--CCcEEEEEEeeecc--chhhhhHHHHHHHHHhC---CCCCccceeeeee-----c
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQF--DGALKSFDAECEVLKSV---RHRNLVKIISSCS-----N 793 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 793 (902)
++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999874 36789999987543 22234566788777766 6999999999875 3
Q ss_pred CCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 794 GNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
....++||||++ ++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5898888653 345889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCccceeccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
++..... .......||+.|+|||++.
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred eEeccCC-cccccccccccccChHHHh
Confidence 9876533 2233456899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=234.50 Aligned_cols=170 Identities=24% Similarity=0.344 Sum_probs=144.8
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--------chhhhhHHHHHHHHHhCC---CCCccceeeeee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVR---HRNLVKIISSCS 792 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 792 (902)
..+|...+.+|+|+||.|+.|.++. ..+|++|.+.++. +.....+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3578999999999999999999865 6789999986542 122234556999999997 999999999999
Q ss_pred cCCeeEEEEEcc-CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 793 NGNFKALVLEYM-ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 793 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
+++++|++||-. +|.+|.+++. .+..+++.++..|++||+.|+++|| ++||||||||-+||.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999975 4558999984 4556999999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.|....... ....+||.+|+|||++.+
T Consensus 716 saa~~ksgp--fd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 716 SAAYTKSGP--FDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred chhhhcCCC--cceeeeeccccchhhhCC
Confidence 997654332 233679999999999854
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=240.35 Aligned_cols=167 Identities=28% Similarity=0.442 Sum_probs=140.9
Q ss_pred cccCeecccceeeEEEEEeCC-CcEEEEEEeee----ccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCe--eEEEE
Q 046199 729 SEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL----QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF--KALVL 801 (902)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 801 (902)
+..+.||+|+|-+||+|-+.. |.+||.-.++. ..+...++|..|+.+++.|+||||+++|.+|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456789999999999998854 77887544332 224456899999999999999999999999977654 77899
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~ 880 (902)
|.+..|+|..|.++. +.++...++.|++||++||.||| ++...|+|||||-+||+|+. .|.|||+|.|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999998654 45889999999999999999999 66889999999999999975 5899999999998765433
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
....+|||.|||||++-
T Consensus 201 --aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE 217 (632)
T ss_pred --cceeccCccccChHHHh
Confidence 33478999999999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=226.76 Aligned_cols=173 Identities=32% Similarity=0.463 Sum_probs=153.6
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|.+.. ++.+|+|++........+.+.+|++++++++||||+++++++...+..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4789999999999999999998854 788999999876655668899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+..........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999998776567899999999999999999999 9999999999999999999999999999998765433333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....++..|+|||++..
T Consensus 159 ~~~~~~~~y~~Pe~~~~ 175 (262)
T cd06613 159 KSFIGTPYWMAPEVAAV 175 (262)
T ss_pred ccccCCccccCchhhcc
Confidence 44568889999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=227.41 Aligned_cols=171 Identities=26% Similarity=0.417 Sum_probs=147.3
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
.++|++.+.||+|+||.||+|++.++..||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 45788999999999999999988777789999887442 23467889999999999999999999999989999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce-
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR- 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~- 883 (902)
++++|.+++......+++..+..++.||+.|++||| +.|++|+||||+||+++.++.+||+|||.++.........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999765557899999999999999999999 9999999999999999999999999999998764433211
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||++.
T Consensus 159 ~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 159 VGSKFPVRWSPPEVLL 174 (256)
T ss_pred CCCccChhhCCHHHHh
Confidence 1133567899999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=229.74 Aligned_cols=168 Identities=35% Similarity=0.522 Sum_probs=146.0
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhh--hhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
|++.+.||+|+||.||+|+... ++.||+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7788999999999999999876 67899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
++++|.+++. ....+++..+..++.|+++||++|| +.+|+||||||+||++++++.++|+|||.+...........
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 3455899999999999999999999 99999999999999999999999999999987533333344
Q ss_pred ccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 ~~~gt~~y~APE~l~ 899 (902)
...+++.|+|||++.
T Consensus 157 ~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQ 171 (260)
T ss_dssp SSSSSGGGSCHHHHT
T ss_pred ccccccccccccccc
Confidence 467899999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=235.02 Aligned_cols=172 Identities=27% Similarity=0.411 Sum_probs=144.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...+|++.+.||+|+||.||+|++.. ++ .||+|+++... ....+++..|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 45679999999999999999998643 33 48999987543 34457888999999999999999999998765 56
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++|+||+++|+|.+++......+++..+.+++.||+.||+||| +++|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 8999999999999999876667889999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcccee--ccccccccccccccc
Q 046199 878 GEESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~--~~~gt~~y~APE~l~ 899 (902)
....... ...++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred CCCcceeccCCccceeecChHHhc
Confidence 4333222 123467899999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=232.84 Aligned_cols=171 Identities=26% Similarity=0.438 Sum_probs=147.7
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467999999999999999999876 47899999987543 2334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|++ ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 997 5899888776667899999999999999999999 999999999999999999999999999999765433333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 161 ~~~~~~~~~y~~PE~~~ 177 (301)
T cd07873 161 YSNEVVTLWYRPPDILL 177 (301)
T ss_pred ccccceeecccCcHHHh
Confidence 33356789999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=248.49 Aligned_cols=176 Identities=28% Similarity=0.413 Sum_probs=147.1
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC---
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--- 795 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 795 (902)
....++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++..++|++|+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344579999999999999999999875 58999999987543 334567889999999999999999988765432
Q ss_pred -----eeEEEEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 046199 796 -----FKALVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL 867 (902)
Q Consensus 796 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (902)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999988653 245889999999999999999999 999999999999999999999999
Q ss_pred EeecCceecCCCc--cceecccccccccccccccc
Q 046199 868 SDFGIAKLLNGEE--SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 868 ~DFG~a~~~~~~~--~~~~~~~gt~~y~APE~l~~ 900 (902)
+|||+++...... .......||+.|+|||++..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCC
Confidence 9999998764322 12233579999999998754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=244.07 Aligned_cols=169 Identities=28% Similarity=0.419 Sum_probs=138.0
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC-------
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG------- 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 794 (902)
....+|++.+.||+|+||.||+|.+.+ ++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 345689999999999999999998864 8899999885432 3345799999999999999998876432
Q ss_pred -CeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEe
Q 046199 795 -NFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSD 869 (902)
Q Consensus 795 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~D 869 (902)
...++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +++|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence 256799999975 77666643 3456899999999999999999999 99999999999999998665 799999
Q ss_pred ecCceecCCCccceecccccccccccccccc
Q 046199 870 FGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
||+|+.+..... .....||+.|||||++..
T Consensus 215 FGla~~~~~~~~-~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 215 FGSAKNLLAGQR-SVSYICSRFYRAPELMLG 244 (440)
T ss_pred cccchhccCCCC-cccCCCCcCccCHHHhcC
Confidence 999987654332 233568999999998753
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=242.80 Aligned_cols=166 Identities=25% Similarity=0.319 Sum_probs=143.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..+|.+.+.||+|+||.||+|.+.. ++.||+|... ...+.+|++++++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc-
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM- 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~- 882 (902)
+. ++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6898888766567999999999999999999999 999999999999999999999999999999876433221
Q ss_pred -eecccccccccccccccc
Q 046199 883 -RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 -~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|||||++..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred cccccCCCcCCcCHHHHcC
Confidence 223569999999998754
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=227.38 Aligned_cols=171 Identities=29% Similarity=0.437 Sum_probs=145.9
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
..+|++.+.||+|+||.||+|++.++..+|+|++.... .....+.+|+++++.++||||+++++++...+..|+||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 35688999999999999999998777889999986432 23356888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999766667899999999999999999999 99999999999999999999999999999986643322111
Q ss_pred -ccccccccccccccc
Q 046199 885 -QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 -~~~gt~~y~APE~l~ 899 (902)
...++..|+|||++.
T Consensus 159 ~~~~~~~~y~~Pe~~~ 174 (256)
T cd05059 159 QGTKFPVKWAPPEVFD 174 (256)
T ss_pred CCCCCCccccCHHHhc
Confidence 122445799999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=264.24 Aligned_cols=124 Identities=22% Similarity=0.372 Sum_probs=67.8
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
+|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|++++|.....+|....+|+.|+|++|.
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~ 857 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTG 857 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCC
Confidence 56666666666555666666666666666666654333455444 45666666666654444444444455555555555
Q ss_pred ccCCCCccccCCCcCceEecCC-CCccCcccccccCCCCceEEEcCCC
Q 046199 474 LSGPIPACFGNLNSLRNLSLGS-NELSSFIPSTFWNLNNILSFDFSSN 520 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ls~N 520 (902)
++ .+|..+..+++|+.|+|++ |++.. +|..+..++.|+.++++++
T Consensus 858 i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 858 IE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred Cc-cChHHHhcCCCCCEEECCCCCCcCc-cCcccccccCCCeeecCCC
Confidence 55 3444555555555555555 23332 3444444555555554444
|
syringae 6; Provisional |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=226.97 Aligned_cols=173 Identities=25% Similarity=0.420 Sum_probs=147.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4567899999999999999999998778899999987543 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++.... ..+++..+..++.|++.|+.||| +.||+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999986543 45899999999999999999999 99999999999999999999999999999987653322
Q ss_pred cee-ccccccccccccccc
Q 046199 882 MRT-QTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~-~~~gt~~y~APE~l~ 899 (902)
... ....+..|+|||++.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 159 EAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred cccCCCcCceeccCccccc
Confidence 111 122345799999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=223.91 Aligned_cols=171 Identities=25% Similarity=0.409 Sum_probs=149.1
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+|++.+.||+|+||.||++++. +++.||+|.++... ....+.+.+|+.+++.++||||+++++.+.+++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999886 48899999986432 345577889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 805 ANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 805 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++.+++... ...+++..+..++.|++.|+.||| ++||+|+||||+||++++++.++++|||.+..........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999988653 345789999999999999999999 9999999999999999999999999999998775544444
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....|++.|+|||++..
T Consensus 158 ~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN 174 (255)
T ss_pred ccccCCccccCHHHHcc
Confidence 44678999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=227.05 Aligned_cols=163 Identities=30% Similarity=0.407 Sum_probs=138.7
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||.||+|+... ++.||+|++.... ....+.+..|+++++.++||||+++++++..+...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998754 8999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccc
Q 046199 810 EKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG 888 (902)
Q Consensus 810 ~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~g 888 (902)
.+++.... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++....... ......|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG 156 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence 88875533 35888999999999999999999 9999999999999999999999999999998765432 2233568
Q ss_pred cccccccccccc
Q 046199 889 TIGYMAPGLWVV 900 (902)
Q Consensus 889 t~~y~APE~l~~ 900 (902)
++.|+|||++..
T Consensus 157 ~~~y~aPE~~~~ 168 (277)
T cd05607 157 TNGYMAPEILKE 168 (277)
T ss_pred CCCccCHHHHcc
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-26 Score=234.96 Aligned_cols=411 Identities=22% Similarity=0.282 Sum_probs=257.7
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeee-CCCCccccccccccCCcccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSN-NSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
.-++++|..|+|+...|..|+.+++|+.||||+|+|+.+-|+.|.+|.+|..|-+.+ |+|+++ |+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l-----------~k--- 133 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDL-----------PK--- 133 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhh-----------hh---
Confidence 568899999999965667899999999999999999988899999999987776655 888843 31
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCC----
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS---- 304 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~---- 304 (902)
..|+.|..|+.|.+..|++.....+.|..+++|..|.+.+|.+. .++... |..+..++.+.+..|.+.
T Consensus 134 -----~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~t--f~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 134 -----GAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGT--FQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred -----hHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhcccc--ccchhccchHhhhcCccccccc
Confidence 46889999999999999999888889999999999999999998 455432 778889999999998832
Q ss_pred --------CCCCccccccccccEEEccCCcccCcccccccc-cccccEEecccccCCCCCCcccccccccCCCCCceeee
Q 046199 305 --------GRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN-LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVL 375 (902)
Q Consensus 305 --------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~L 375 (902)
...|-.++...-..-..+.++++..+.+..|.. +..+..=..+.+...+.-|. ..|..+++|+.|+|
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~----~cf~~L~~L~~lnl 281 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPA----KCFKKLPNLRKLNL 281 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChH----HHHhhcccceEecc
Confidence 122222333333333334444444333333321 11221112223333333342 45777888888888
Q ss_pred ccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccC
Q 046199 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG 455 (902)
Q Consensus 376 s~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 455 (902)
++|+++++-+.+|.... .+++|+|..|+|..+....|.++..|++|+|.+|+|+-..|.+|..+..|.+|.|-.|.+.-
T Consensus 282 snN~i~~i~~~aFe~~a-~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 282 SNNKITRIEDGAFEGAA-ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred CCCccchhhhhhhcchh-hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 88888887777888777 78888888888887777778888888888888888887778888888888888887776641
Q ss_pred CCCCcCCCCCeE--eccCccccCCCCccccCCCcCceEecCCCCccCc---ccccccCCCCceEEEcCCCccCCCCcccc
Q 046199 456 PIPDDLCQLSEL--HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF---IPSTFWNLNNILSFDFSSNSLNGSLPLDI 530 (902)
Q Consensus 456 ~~p~~l~~L~~L--~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 530 (902)
. +.|..| .|..+.-.|..|- +.-..++.+.++.+.+... .|+..+- .+ .+..-
T Consensus 361 n-----C~l~wl~~Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~--------------~~-s~~cP 418 (498)
T KOG4237|consen 361 N-----CRLAWLGEWLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGC--------------LT-SSPCP 418 (498)
T ss_pred c-----cchHHHHHHHhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCC--------------CC-CCCCC
Confidence 1 011111 1222222222211 1111344555555544322 1111100 00 00011
Q ss_pred ccccccc-eeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccc
Q 046199 531 GNMKVVV-EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK 609 (902)
Q Consensus 531 ~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 609 (902)
..++-+. ...-|++.+. .+|..+- ..-++|++.+|.++ .+|.. .+.+| .+|+|+|+++..--..|.++++|.
T Consensus 419 ~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~ 491 (498)
T KOG4237|consen 419 PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLS 491 (498)
T ss_pred CCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhh
Confidence 1122222 2223333333 4444332 14456666666666 45554 45556 667777776655555666777777
Q ss_pred cccccCC
Q 046199 610 DLNLSFN 616 (902)
Q Consensus 610 ~L~l~~N 616 (902)
+|-|++|
T Consensus 492 tlilsyn 498 (498)
T KOG4237|consen 492 TLILSYN 498 (498)
T ss_pred eeEEecC
Confidence 7766665
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=227.86 Aligned_cols=173 Identities=23% Similarity=0.439 Sum_probs=148.9
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4567899999999999999999998888899999876543 235788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ....++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999998653 345788899999999999999999 99999999999999999999999999999987654322
Q ss_pred c-eeccccccccccccccc
Q 046199 882 M-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~-~~~~~gt~~y~APE~l~ 899 (902)
. .....++..|+|||++.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 159 TAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred eccCCCccceecCCHHHhc
Confidence 1 12234567899999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=227.14 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=147.9
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999875 58999999876432 234467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||+++++|.+++.. ....+++..+..++.|++.|++||| +++++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2345788999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.........|++.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred hhHHHhcCCCCccccChhhhcc
Confidence 4333334568899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=237.07 Aligned_cols=168 Identities=23% Similarity=0.295 Sum_probs=143.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.....+|++.+.||+|+||.||+|++.. ++.||+|+... .....|+.++++++||||+++++++...+..++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3455689999999999999999999864 77899997532 2335699999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+. +++.+++......+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99995 5888888776677999999999999999999999 9999999999999999999999999999997543222
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 212 -~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred -ccccccccccccCCeecCC
Confidence 2233569999999998753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=224.49 Aligned_cols=171 Identities=30% Similarity=0.391 Sum_probs=150.1
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|++|.||+|++. +++.|++|.+... .....+.+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999885 4899999998643 234567888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++... ...+++..+..++.|++.|+.||| +.|++||||||+||+++.++.+||+|||.++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999998764 456889999999999999999999 999999999999999999999999999999877655444
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....|++.|+|||++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08529 158 ANTIVGTPYYLSPELCED 175 (256)
T ss_pred hhccccCccccCHHHhcC
Confidence 444568899999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=226.02 Aligned_cols=175 Identities=30% Similarity=0.443 Sum_probs=148.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+.+.+.+.....||+|+||.||+|++.+ +..||+|.+........+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3445566666789999999999998754 788999998766555667899999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSL--DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~ 877 (902)
|||+++++|.+++....... ++..+..++.|++.|++||| +.||+||||||+||+++. ++.+||+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997654445 78888999999999999999 999999999999999976 6799999999997664
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..........|++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVID 182 (268)
T ss_pred cCCCccccCCCCccccChhhhc
Confidence 4333333345889999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=238.53 Aligned_cols=169 Identities=29% Similarity=0.380 Sum_probs=142.5
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----eeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 798 (902)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999875 58999999986432 234467889999999999999999999998776 789
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||++ ++|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 588887744 346899999999999999999999 99999999999999999999999999999986543
Q ss_pred Ccc-ceecccccccccccccccc
Q 046199 879 EES-MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~-~~~~~~gt~~y~APE~l~~ 900 (902)
... ......+|+.|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC
Confidence 322 1223468899999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=227.49 Aligned_cols=168 Identities=29% Similarity=0.386 Sum_probs=144.2
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
|+..+.||+|+||+||+|.+. +++.||+|.+.... ....+.+.+|+++++.++|++|+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999885 48899999986542 22335577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++... ...+++..+..++.|++.|+.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999888653 346899999999999999999999 99999999999999999999999999999976543322
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....|+..|+|||++.
T Consensus 158 ~~~~~g~~~~~aPE~~~ 174 (285)
T cd05632 158 IRGRVGTVGYMAPEVLN 174 (285)
T ss_pred ccCCCCCcCccChHHhc
Confidence 23356899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=225.80 Aligned_cols=172 Identities=27% Similarity=0.446 Sum_probs=147.4
Q ss_pred cccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.++|++.+.||+|+||.||+|++.. ...||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4679999999999999999998743 4579999887543 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999999877532
Q ss_pred cccee--ccccccccccccccc
Q 046199 880 ESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~~~--~~~gt~~y~APE~l~ 899 (902)
..... ...+++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred ccceeccCCCCCccccChhhhc
Confidence 22211 123467899999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=227.41 Aligned_cols=170 Identities=27% Similarity=0.377 Sum_probs=144.7
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|+..+.||+|+||.||+|.+.. ++.||+|.+.... ......+.+|+.+++.++|++|+.+++.+.+++..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36778899999999999998864 8899999986432 1223457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999988543 345889999999999999999999 99999999999999999999999999999976543322
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....|++.|+|||++..
T Consensus 158 -~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred -ccCCCCCccccChHHHcC
Confidence 223578999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=225.42 Aligned_cols=174 Identities=24% Similarity=0.301 Sum_probs=150.3
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 796 (902)
++...+|....+||+|+||.|..|..+. .+.||||+++... +...+--+.|-++++.. +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5667789999999999999999997755 5679999987653 33445556788888777 57899999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+.||+|.-.+++- +.+.+..+..++..|+-||-||| ++||+.||+|.+|||+|.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999998888654 45888899999999999999999 999999999999999999999999999999875
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
--+.....+.+|||.|+|||++.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred ccCCcceeeecCCCcccccceEE
Confidence 55555566789999999999874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=229.51 Aligned_cols=171 Identities=34% Similarity=0.457 Sum_probs=150.5
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 368999999999999999999875 5899999999766555567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.+ ..+++..+..++.|++.|+.||| +.|++||||||+||+++.++.+||+|||.+..........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 999999998854 34788899999999999999999 9999999999999999999999999999998765444333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....+++.|+|||.+..
T Consensus 173 ~~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 173 STMVGTPYWMAPEVVTR 189 (297)
T ss_pred CcccCCccccCHHHHcC
Confidence 34568899999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=237.35 Aligned_cols=182 Identities=30% Similarity=0.437 Sum_probs=158.0
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeee-
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCS- 792 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 792 (902)
..++.....++.|++.+.||.|.+|.||+++..+ ++.+|+|+.....+ ..++++.|.++++.. .|||++.++|+|.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455556678899999999999999999998765 88899998875543 347788899999888 6999999999984
Q ss_pred ----cCCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 046199 793 ----NGNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL 867 (902)
Q Consensus 793 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (902)
.++..|+|||||.||+..|+++.. +..+.|..+..|++.++.|+.+|| ...++|||||=.||+++.++.||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 357899999999999999998653 456899999999999999999999 999999999999999999999999
Q ss_pred EeecCceecCCCccceeccccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
+|||.+.........+.+..|||.|||||++.-+
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecc
Confidence 9999999887766666778999999999998644
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=228.00 Aligned_cols=168 Identities=34% Similarity=0.440 Sum_probs=147.9
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|.+.. ++.||+|+++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 478999999999999999998864 8999999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998654 56899999999999999999999 999999999999999999999999999999876543
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....+++.|+|||.+..
T Consensus 155 -~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred -CCCCCCCccccChhhhcC
Confidence 233568999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=227.76 Aligned_cols=172 Identities=30% Similarity=0.450 Sum_probs=145.0
Q ss_pred cccccccCeecccceeeEEEEEeC-----CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec--CCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 797 (902)
..+|++.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357889999999999999999742 478999999876665566788999999999999999999998643 3468
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999999766566899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccce---eccccccccccccccc
Q 046199 878 GEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
...... ....++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLT 184 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhc
Confidence 433211 1122345699999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=226.08 Aligned_cols=173 Identities=25% Similarity=0.458 Sum_probs=146.6
Q ss_pred cccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..+|++.+.||+|+||.||+|++.. +..||+|.++... ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678899999999999999998742 3479999886543 3345688999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999999876543
Q ss_pred ccceec---ccccccccccccccc
Q 046199 880 ESMRTQ---TLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~---~~gt~~y~APE~l~~ 900 (902)
...... ..++..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc
Confidence 322111 223568999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=228.42 Aligned_cols=173 Identities=29% Similarity=0.481 Sum_probs=146.9
Q ss_pred hcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||+|+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3568899999999999999999752 2456899988766555667899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 798 ALVLEYMANGSLEKCLYSSN------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
++||||+++++|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 99999999999999986432 24889999999999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
||+|||.++........ .....+++.|+|||++.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 195 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 195 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhc
Confidence 99999999865433221 11234577899999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=228.22 Aligned_cols=174 Identities=24% Similarity=0.402 Sum_probs=144.6
Q ss_pred hhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
...++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999763 25679999886432 234467889999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 796 FKALVLEYMANGSLEKCLYSSN---------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
..++||||+++++|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999986532 23567788999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCcccee--ccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~l~ 899 (902)
++|||+++.......... ...+++.|||||++.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 999999976543322211 134577899999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=227.45 Aligned_cols=169 Identities=30% Similarity=0.445 Sum_probs=144.8
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|++|.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999885 48899999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
++ +++.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 58888875432 46889999999999999999999 99999999999999999999999999999986654433
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......+++.|+|||++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLL 174 (285)
T ss_pred cccCCcccccccChHHhc
Confidence 333346789999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=229.52 Aligned_cols=170 Identities=34% Similarity=0.464 Sum_probs=149.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..+|++.+.||+|+||.||+|++. +++.||+|.+........+.+.+|+.+++.+.||||+++++.+..+...|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999875 4889999998766555567888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.. ..+++.++..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+..........
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 999999998854 34788999999999999999999 9999999999999999999999999999988655433333
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 174 ~~~~~~~~y~aPE~~~ 189 (296)
T cd06654 174 STMVGTPYWMAPEVVT 189 (296)
T ss_pred CcccCCccccCHHHHc
Confidence 3456899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=228.83 Aligned_cols=180 Identities=27% Similarity=0.393 Sum_probs=150.2
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeee-
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCS- 792 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 792 (902)
+.++.+....++|++.+.||+|+||.||+|.+.. ++.||+|+++... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3345556678999999999999999999998854 7899999876432 2335678899999999 6999999999873
Q ss_pred ----cCCeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 793 ----NGNFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 793 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
.++..++||||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 44678999999999999988753 2345788899999999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCCCccceeccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
||+|||+++.............|++.|+|||++.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhc
Confidence 9999999987654433334456899999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=227.88 Aligned_cols=161 Identities=21% Similarity=0.313 Sum_probs=138.7
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccchh---hhhHHHHHHHHHhCCCCCccceeeeeec----CCeeEEEEEcc
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA---LKSFDAECEVLKSVRHRNLVKIISSCSN----GNFKALVLEYM 804 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 804 (902)
..||+|++|.||+|.+ +++.||||+++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78999999987543322 4678899999999999999999999876 35789999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
++|+|.+++... +.+++....+++.|++.|++|+| + .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999998654 46888999999999999999999 6 489999999999999999999999999998654322
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....|++.|+|||++..
T Consensus 178 ~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 FKNVNFMVYFSYKMLND 194 (283)
T ss_pred ccccCcccccCHHHhhh
Confidence 23468899999999854
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=227.31 Aligned_cols=172 Identities=26% Similarity=0.411 Sum_probs=145.8
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
+.++|.+.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999875 48899999987543 223346778999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||++ +++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6777777655556788889999999999999999 99999999999999999999999999999976543333
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......+++.|+|||++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~ 176 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLL 176 (291)
T ss_pred CCCCccccccccCCceee
Confidence 233355789999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=228.03 Aligned_cols=171 Identities=27% Similarity=0.449 Sum_probs=146.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999886 488999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9975 999988776667899999999999999999999 999999999999999999999999999998764332222
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||++.
T Consensus 160 ~~~~~~~~~~~aPE~~~ 176 (291)
T cd07844 160 YSNEVVTLWYRPPDVLL 176 (291)
T ss_pred ccccccccccCCcHHhh
Confidence 22345788999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=227.45 Aligned_cols=172 Identities=31% Similarity=0.508 Sum_probs=146.5
Q ss_pred cccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|.+.+.||+|+||.||+|++.+ ++.||+|+++..... ..+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4678899999999999999998643 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (902)
++||||+++++|.+++.... ..+++..+..++.|++.|++|+| ++|++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999986532 34778889999999999999999 999999999999999999999
Q ss_pred EEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 865 AHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 865 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
+||+|||.++........ .....+++.|+|||++.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 999999999865433221 12234678899999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=234.50 Aligned_cols=176 Identities=25% Similarity=0.428 Sum_probs=143.8
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
|..+.++|++.+.||+|+||.||+|.+.+ ++.||+|+++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 34566799999999999999999996432 4789999987543 23346778899999999 7999999999876
Q ss_pred c-CCeeEEEEEccCCCChHHHHhhCC------------------------------------------------------
Q 046199 793 N-GNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------ 817 (902)
Q Consensus 793 ~-~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 817 (902)
. +...+++|||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 457889999999999999885421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc--eeccccc
Q 046199 818 ------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGT 889 (902)
Q Consensus 818 ------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt 889 (902)
..+++..+..++.||+.|++||| +.+|+||||||+||++++++.+||+|||+++.+...... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788899999999999999999 999999999999999999999999999999876433221 1223456
Q ss_pred cccccccccc
Q 046199 890 IGYMAPGLWV 899 (902)
Q Consensus 890 ~~y~APE~l~ 899 (902)
..|||||++.
T Consensus 239 ~~y~aPE~~~ 248 (337)
T cd05054 239 LKWMAPESIF 248 (337)
T ss_pred ccccCcHHhc
Confidence 7899999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=228.42 Aligned_cols=169 Identities=27% Similarity=0.356 Sum_probs=146.2
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||.||+|++.. +..||+|.++.... ....++.+|++++++++||||+++++++..++..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468999999999999999998764 78899998875432 3446688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++... ..+++..+..++.|++.||.||| + .+++||||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999998654 55889999999999999999999 6 589999999999999999999999999987653322
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....|++.|+|||++..
T Consensus 155 ~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG 172 (308)
T ss_pred cccCCCCcCccChhHhcC
Confidence 233568999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=221.61 Aligned_cols=171 Identities=26% Similarity=0.375 Sum_probs=149.8
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|+..+.||+|+||.||.++... ++.|++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999998754 8899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999998764 345889999999999999999999 999999999999999999999999999999876554433
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....+++.|+|||++.+
T Consensus 158 ~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 158 AETVVGTPYYMSPELCQG 175 (256)
T ss_pred ccccCCCccccCHhhcCC
Confidence 344668999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=235.45 Aligned_cols=169 Identities=27% Similarity=0.347 Sum_probs=140.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----- 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 795 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999998854 8999999986542 234567789999999999999999999886443
Q ss_pred -eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 -FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
..|+||||+++ ++.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999976 5666553 24788889999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...... ......||+.|+|||++..
T Consensus 172 ~~~~~~-~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 172 TACTNF-MMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred ccccCc-cCCCCcccCCCCCchhccC
Confidence 653322 2233568999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=238.83 Aligned_cols=167 Identities=25% Similarity=0.318 Sum_probs=142.5
Q ss_pred hcccccccCeecccceeeEEEEEeCC---CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
...+|++.+.||+|+||.||+|...+ +++||+|.+... +...+|++++++++||||+++++++...+..|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 35689999999999999999997643 578999987543 3456899999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||++. +++.+++ .....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|.......
T Consensus 165 ~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99996 5888888 34456899999999999999999999 9999999999999999999999999999997665432
Q ss_pred cc--eecccccccccccccccc
Q 046199 881 SM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~--~~~~~gt~~y~APE~l~~ 900 (902)
.. .....||+.|+|||++..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred ccccccccccccCccCHhHhcC
Confidence 21 123569999999998753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=222.00 Aligned_cols=165 Identities=26% Similarity=0.426 Sum_probs=139.7
Q ss_pred CeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 732 SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999885 58899999876443 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee--ccc
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTL 887 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~--~~~ 887 (902)
.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766666899999999999999999999 99999999999999999999999999999876543211111 112
Q ss_pred cccccccccccc
Q 046199 888 GTIGYMAPGLWV 899 (902)
Q Consensus 888 gt~~y~APE~l~ 899 (902)
++..|+|||.+.
T Consensus 158 ~~~~y~aPE~~~ 169 (252)
T cd05084 158 IPVKWTAPEALN 169 (252)
T ss_pred CceeecCchhhc
Confidence 345799999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=226.22 Aligned_cols=172 Identities=26% Similarity=0.431 Sum_probs=144.0
Q ss_pred cccccccCeecccceeeEEEEEeC-----CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
.++|++.+.||+|+||.||+|+.. .++.||+|.++.... ...+.+.+|+++++.++||||+++++++..++..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 367888999999999999999852 367899999875432 33467889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 046199 799 LVLEYMANGSLEKCLYSSN----------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (902)
+||||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 9999999999999985321 23678888999999999999999 9999999999999999999
Q ss_pred CcEEEEeecCceecCCCcc--ceeccccccccccccccc
Q 046199 863 MVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 863 ~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
+.+||+|||+++....... ......++..|+|||++.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence 9999999999987643321 112244677899999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=227.40 Aligned_cols=169 Identities=31% Similarity=0.427 Sum_probs=146.7
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccch-----hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-----ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+|++.+.||+|+||.||+|.+. ++++||+|.++..... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 4899999999754322 345677899999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+ +++|.+++......+++..+..++.||++||+||| ++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999765546899999999999999999999 9999999999999999999999999999998776544
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......+++.|+|||++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLF 175 (298)
T ss_pred ccccccccceeeeCHHHHh
Confidence 3333445788999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=250.15 Aligned_cols=174 Identities=29% Similarity=0.424 Sum_probs=140.9
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeec---------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN--------- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 793 (902)
..+|+..+.||+||||.||+|+.+ ||+.||||++.... ......+.+|+.++++++|||||+++..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 357888899999999999999875 79999999997653 3345678899999999999999999854300
Q ss_pred ----------------------------------------------C---------------------------------
Q 046199 794 ----------------------------------------------G--------------------------------- 794 (902)
Q Consensus 794 ----------------------------------------------~--------------------------------- 794 (902)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC
Q 046199 795 -------------------------------NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843 (902)
Q Consensus 795 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 843 (902)
...||-||||+..++.+++.+....-.....++++++|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--- 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--- 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---
Confidence 1357899999987777777554332246778999999999999999
Q ss_pred CCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC------------------CCccceeccccccccccccccccc
Q 046199 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN------------------GEESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~------------------~~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
++|||||||||.||++|+++.|||+|||+|.... ......+..+||.-|+|||++...
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999999999999999999999999999998621 112234557899999999998653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.98 Aligned_cols=172 Identities=24% Similarity=0.470 Sum_probs=146.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
...+|++.+.||+|+||.||+|.+.+ ++.||+|+++.. ....+.+.+|+++++.++||+|+++++++..++..++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 44578889999999999999998765 888999998644 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999986543 45889999999999999999999 99999999999999999999999999999987654322
Q ss_pred cee-ccccccccccccccc
Q 046199 882 MRT-QTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~-~~~gt~~y~APE~l~ 899 (902)
... ...++..|+|||++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLA 178 (263)
T ss_pred eccCCCCCccccCCHHHhc
Confidence 111 123466899999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-26 Score=232.76 Aligned_cols=408 Identities=24% Similarity=0.212 Sum_probs=202.1
Q ss_pred eecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCc
Q 046199 155 YLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH 234 (902)
Q Consensus 155 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~ 234 (902)
|-++-.++ ++|..+- ..-..++|..|+|+...|..|+.+++|+.||||+|.|+.|. |+
T Consensus 52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~-------------------p~ 109 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIA-------------------PD 109 (498)
T ss_pred EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcC-------------------hH
Confidence 34444454 5555444 23445555666666444445555666666666666555321 34
Q ss_pred cccCCCCCCEEEccC-ccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccc
Q 046199 235 EIGNLPNLEVLGIDE-NHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFN 313 (902)
Q Consensus 235 ~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 313 (902)
.|..+++|..|-+.+ |+|+...-+.|.+|.+|+.|.+.-|++....... |..+++|..|.+..|.+..+.-..|..
T Consensus 110 AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~a---l~dL~~l~lLslyDn~~q~i~~~tf~~ 186 (498)
T KOG4237|consen 110 AFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDA---LRDLPSLSLLSLYDNKIQSICKGTFQG 186 (498)
T ss_pred hhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHH---HHHhhhcchhcccchhhhhhccccccc
Confidence 555555544443333 5555333344555555555555555554222222 444445555555555544333334444
Q ss_pred cccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccc
Q 046199 314 ASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI 393 (902)
Q Consensus 314 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 393 (902)
+..++.+.+..|.+-. ..+++.+..- +..|. ..++...-..-..+.++++..+-+..|.....
T Consensus 187 l~~i~tlhlA~np~ic-----dCnL~wla~~-~a~~~-----------ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~e 249 (498)
T KOG4237|consen 187 LAAIKTLHLAQNPFIC-----DCNLPWLADD-LAMNP-----------IETSGARCVSPYRLYYKRINQEDARKFLCSLE 249 (498)
T ss_pred hhccchHhhhcCcccc-----ccccchhhhH-Hhhch-----------hhcccceecchHHHHHHHhcccchhhhhhhHH
Confidence 4444444444444210 0111111100 00000 11122222222233333333333333322111
Q ss_pred cccEEEeecCcccccCC-cccCCCCCCcEEEeecceecccCCcccccccccCeeeccccccc---CCCCCcCCCCCeEec
Q 046199 394 TLEEIYLQNCKIRGNIP-KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE---GPIPDDLCQLSELHV 469 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~L~~L~L 469 (902)
.+..=..+.+...++-| ..|..+++|+.|+|++|+|+++-+.+|.+...+++|.|..|+|. +....++..|+.|+|
T Consensus 250 sl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L 329 (498)
T KOG4237|consen 250 SLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSL 329 (498)
T ss_pred hHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeee
Confidence 11111112222222333 35778888888888888888888888888888888888888775 223445557777777
Q ss_pred cCccccCCCCccccCCCcCceEecCCCCccCc-ccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccc
Q 046199 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSSF-IPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548 (902)
Q Consensus 470 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (902)
.+|+|+...|.+|..+.+|..|+|-.|.+.-- --.+++. +|..+.-.|. |.. +.-..++.++++++.+..
T Consensus 330 ~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~-~~C-q~p~~~~~~~~~dv~~~~ 400 (498)
T KOG4237|consen 330 YDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGN-PRC-QSPGFVRQIPISDVAFGD 400 (498)
T ss_pred cCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCC-CCC-CCCchhccccchhccccc
Confidence 77777777777777777777777776655310 0000000 0111111111 110 112234445555544321
Q ss_pred ---cCccccc---------cCCccc-eEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccC
Q 046199 549 ---DIPTTIG---------GLTNLQ-LLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 615 (902)
Q Consensus 549 ---~~p~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 615 (902)
..|++.+ ..+-+. +..-|++.++ .+|..+- ..-..|++.+|.++ .+|.+ .+.+| .+|+++
T Consensus 401 ~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~ 473 (498)
T KOG4237|consen 401 FRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSN 473 (498)
T ss_pred cccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hccccc
Confidence 1222221 223333 3345555565 6666553 34677899999999 67777 67788 899999
Q ss_pred Cccee
Q 046199 616 NRLEG 620 (902)
Q Consensus 616 N~l~~ 620 (902)
|+|..
T Consensus 474 n~i~~ 478 (498)
T KOG4237|consen 474 NRISS 478 (498)
T ss_pred Cceeh
Confidence 99983
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=222.19 Aligned_cols=171 Identities=29% Similarity=0.437 Sum_probs=148.8
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|++|+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999986 68999999886432 233578899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||+++++|.+++.. ....+++..+..++.|++.|+.||| +.||+||||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998854 2345789999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
.........+++.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccceecCCccccCHHHhc
Confidence 433333456889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.99 Aligned_cols=172 Identities=27% Similarity=0.452 Sum_probs=144.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|++.+...||+|+++.... ..+.+.+|+++++.++||||+++++.+.. +..|+|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 34568999999999999999999987777899999875332 34678999999999999999999998754 56799999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++..+..++.|++.||+|+| +.+++||||||+||++++++.+||+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999653 345788999999999999999999 99999999999999999999999999999987654332
Q ss_pred ce-eccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~ 899 (902)
.. ....++..|+|||+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 158 TARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred ccccCCcccceecCHhHhc
Confidence 21 1234667899999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=228.17 Aligned_cols=170 Identities=28% Similarity=0.413 Sum_probs=146.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|++. +|+.||+|+++... ......+.+|+++++.++||||+++++++.+.+..|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999986 48899999987542 22335678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++ ++.+++......+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||.++.........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 974 888887665667899999999999999999999 9999999999999999999999999999998765433333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....+++.|+|||++.+
T Consensus 157 ~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 157 SAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCCccccCCcChHHHhC
Confidence 34567899999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=223.76 Aligned_cols=165 Identities=28% Similarity=0.364 Sum_probs=142.8
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999875 48899999987543 33446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
++++++..+. .+++..+..++.|++.|++||| +.||+|+||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~ 150 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--A 150 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--c
Confidence 9999986542 3678889999999999999999 9999999999999999999999999999998664322 2
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....||..|+|||++..
T Consensus 151 ~~~~~~~~y~aPE~~~~ 167 (279)
T cd06619 151 KTYVGTNAYMAPERISG 167 (279)
T ss_pred cCCCCChhhcCceeecC
Confidence 33578999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=227.44 Aligned_cols=176 Identities=24% Similarity=0.404 Sum_probs=144.3
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
....++|++.+.||+|+||.||+|...+ +..||+|.++.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3567899999999999999999997532 45799998764432 2345678899999999999999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 795 NFKALVLEYMANGSLEKCLYSSN---------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
+..|+||||+++|+|.+++.... ...+...+..++.|++.|+.||| +++|+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999996532 22456778899999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCCCcccee--cccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESMRT--QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~l~~ 900 (902)
|++|||+++.......... ...++..|+|||.+..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 9999999986543322111 1235678999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=230.01 Aligned_cols=156 Identities=24% Similarity=0.358 Sum_probs=137.0
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeee
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISS 790 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~ 790 (902)
.+.++.-.....-|..++.||-|+||+|.+++..| ...||+|.+++.+ .......+.|-.||.....+-||++|-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 34455556667778899999999999999998766 5668999887553 3344667889999999999999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
|++++..|+||+|++||++..++.+. +.+++..+..++.++..|+++.| ..|+|||||||+|||||.+|++||.||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeec
Confidence 99999999999999999999998665 45888889999999999999999 999999999999999999999999999
Q ss_pred cCce
Q 046199 871 GIAK 874 (902)
Q Consensus 871 G~a~ 874 (902)
|++.
T Consensus 774 GLCT 777 (1034)
T KOG0608|consen 774 GLCT 777 (1034)
T ss_pred cccc
Confidence 9985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=228.25 Aligned_cols=173 Identities=24% Similarity=0.406 Sum_probs=143.5
Q ss_pred hcccccccCeecccceeeEEEEEeCC---------------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccce
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD---------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 787 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 787 (902)
..++|++.+.||+|+||.||+|++.+ ...||+|+++... ....+.+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34689999999999999999997642 2358999987543 3345678999999999999999999
Q ss_pred eeeeecCCeeEEEEEccCCCChHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSN-----------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 788 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
++++...+..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence 999999999999999999999999985432 13678889999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
|++++++.+||+|||++.......... ....++..|+|||++.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 999999999999999997654332211 1234567899999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=232.60 Aligned_cols=175 Identities=23% Similarity=0.416 Sum_probs=142.0
Q ss_pred HhhcccccccCeecccceeeEEEEEe------CCCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeec
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 793 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 793 (902)
....++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34567899999999999999999974 236789999997543 23446788999999999 68999999998765
Q ss_pred -CCeeEEEEEccCCCChHHHHhhCC-------------------------------------------------------
Q 046199 794 -GNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------- 817 (902)
Q Consensus 794 -~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 817 (902)
+...++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 456789999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc--ee
Q 046199 818 -----------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RT 884 (902)
Q Consensus 818 -----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~ 884 (902)
..+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 13567788899999999999999 999999999999999999999999999999865332221 11
Q ss_pred ccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 ~~~gt~~y~APE~l~ 899 (902)
...+++.|+|||++.
T Consensus 240 ~~~~~~~y~aPE~~~ 254 (343)
T cd05103 240 DARLPLKWMAPETIF 254 (343)
T ss_pred CCCCCcceECcHHhc
Confidence 234567899999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=225.61 Aligned_cols=172 Identities=28% Similarity=0.519 Sum_probs=145.1
Q ss_pred cccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|.+.. .+.||+|.++.... ...+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4578999999999999999998643 25799998875432 3456789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 046199 798 ALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (902)
|++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999986532 34778889999999999999999 9999999999999999999
Q ss_pred CcEEEEeecCceecCCCcc--ceeccccccccccccccc
Q 046199 863 MVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 863 ~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
+.+||+|||+++....... ......+++.|+|||++.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence 9999999999986543322 122345688999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=253.44 Aligned_cols=172 Identities=32% Similarity=0.429 Sum_probs=148.3
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.-+|.....||.|.||.||-|...+ |.-.|+|.++... ....+.+.+|..++..++|||+|++||+-..++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467778899999999999998765 8889999887553 334567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||++|+|.+.+.. ++..++.....+..|++.|+.||| +.|||||||||+||+++.+|.+|++|||.|+.+.+...
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999998854 445677778889999999999999 99999999999999999999999999999998876532
Q ss_pred c----eecccccccccccccccc
Q 046199 882 M----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~----~~~~~gt~~y~APE~l~~ 900 (902)
. .....||+.|||||++..
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcc
Confidence 1 123679999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=223.15 Aligned_cols=172 Identities=27% Similarity=0.460 Sum_probs=145.4
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|.+.++..||+|.++.... ..+.+.+|+.++++++||+++++++++. .+..|++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 34578999999999999999999988888999999875433 3467899999999999999999999885 456789999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999998653 345889999999999999999999 99999999999999999999999999999987654322
Q ss_pred ce-eccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~ 899 (902)
.. ....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 158 TARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred ccccCCCCCccccChHHHh
Confidence 11 1233566899999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=235.55 Aligned_cols=176 Identities=23% Similarity=0.412 Sum_probs=146.4
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 792 (902)
+.+..++|.+.+.||+|+||.||+|++. .++.||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 5667788999999999999999999863 24689999997543 233457889999999997 999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC-------------------------------------------------------
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN------------------------------------------------------- 817 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------- 817 (902)
..+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986432
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 818 ------------------------------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 818 ------------------------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
..+++..+..++.|++.||+||| +.+|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 12566778889999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCcc--ceeccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
||++++++.+||+|||+++....... ......+++.|||||++.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 99999999999999999986533221 112245778899999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=222.49 Aligned_cols=161 Identities=22% Similarity=0.350 Sum_probs=137.1
Q ss_pred CeecccceeeEEEEEeCC-------------CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 732 SLIGIGSFGTVYKGRFLD-------------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
+.||+|+||.||+|+... ..+||+|.+........+.+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358889877655555667888999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-------EEEEeec
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV-------AHLSDFG 871 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-------~kL~DFG 871 (902)
+||||+++++|..++......+++..+..++.||+.|++||| +++|+||||||+||+++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667899999999999999999999 999999999999999987664 8999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+...... ....++..|||||++.
T Consensus 158 ~~~~~~~~----~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 158 IPITVLSR----QECVERIPWIAPECVE 181 (262)
T ss_pred CCccccCc----ccccccccccChhhhc
Confidence 98765322 2245788999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=228.45 Aligned_cols=175 Identities=24% Similarity=0.465 Sum_probs=146.3
Q ss_pred HhhcccccccCeecccceeeEEEEEeC--------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
....++|.+.+.||+|+||.||+|++. ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 355788999999999999999999742 24579999886543 34457789999999999 899999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
...+..|+||||+++++|.+++.... ..+++..+..++.||+.|++||| ++||+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 99999999999999999999986532 24677889999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCcccee--ccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~l~ 899 (902)
|++++++.+||+|||.++.......... ...+++.|+|||++.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc
Confidence 9999999999999999987654332211 234567899999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=229.49 Aligned_cols=179 Identities=29% Similarity=0.460 Sum_probs=152.4
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCC---C--cEEEEEEeeec-cchhhhhHHHHHHHHHhCCCCCccceee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD---G--MEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIIS 789 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 789 (902)
.+..+..+........+.||+|-||.||+|.+.+ | -.||||.-+.. ..+..+.|..|+.+|+.++||||++++|
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 3444455566667778899999999999998754 2 34889988764 3455789999999999999999999999
Q ss_pred eeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 790 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
+|.+. ..|+|||.++-|.|..|++.....++......++.||+.||.||| +..+|||||..+|||+....-||++|
T Consensus 459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecc
Confidence 99764 679999999999999999988888999999999999999999999 99999999999999999999999999
Q ss_pred ecCceecCCCccceec-ccccccccccccc
Q 046199 870 FGIAKLLNGEESMRTQ-TLGTIGYMAPGLW 898 (902)
Q Consensus 870 FG~a~~~~~~~~~~~~-~~gt~~y~APE~l 898 (902)
||+++.+.+...+... ..-...|||||.+
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESI 564 (974)
T ss_pred cchhhhccccchhhccccccceeecCcccc
Confidence 9999998776554333 2345689999975
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=249.01 Aligned_cols=174 Identities=24% Similarity=0.387 Sum_probs=144.6
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec--CCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 796 (902)
....++|++.+.||+|+||.||+|++.. ++.||+|++.... ......+..|+.+++.++||||++++++|.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999999865 7789999887542 3345678899999999999999999998854 467
Q ss_pred eEEEEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCC-------CCeEEcCCCCCCEEEcC-----
Q 046199 797 KALVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYS-------NPVVHCDIKPSNILLDD----- 861 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~-------~~ivHrDlkp~NIll~~----- 861 (902)
+|+||||+++++|.+++... ...+++..++.|+.||+.||+||| . ++||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCcccc
Confidence 89999999999999988652 346899999999999999999999 5 45999999999999964
Q ss_pred ------------CCcEEEEeecCceecCCCccceeccccccccccccccc
Q 046199 862 ------------DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 862 ------------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+.+||+|||++..+.... ......||+.|+|||++.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHh
Confidence 2358999999998764332 223457999999999874
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=225.08 Aligned_cols=171 Identities=24% Similarity=0.465 Sum_probs=144.7
Q ss_pred ccccccCeecccceeeEEEEEeC-----CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC--Cee
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 797 (902)
.-|++.+.||+|+||.||+|++. +++.||+|.++... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788999999999999999742 37889999987553 33456789999999999999999999998775 568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++.+....+++..+..++.|++.||+|+| ++|++||||||+||+++.++.+||+|||.++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999998765556899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccc---eeccccccccccccccc
Q 046199 878 GEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
..... .....++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhc
Confidence 43321 11244677899999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=219.57 Aligned_cols=165 Identities=27% Similarity=0.432 Sum_probs=141.2
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChH
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLE 810 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 810 (902)
+.||+|+||.||+|...+++.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999987889999999875543 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee-ccccc
Q 046199 811 KCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT-QTLGT 889 (902)
Q Consensus 811 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~-~~~gt 889 (902)
+++......+++..+..++.|++.|+.|+| ++|++||||||+||++++++.+|++|||++........... ...++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998766666889999999999999999999 99999999999999999999999999999976443222111 12346
Q ss_pred cccccccccc
Q 046199 890 IGYMAPGLWV 899 (902)
Q Consensus 890 ~~y~APE~l~ 899 (902)
+.|+|||++.
T Consensus 158 ~~y~aPE~~~ 167 (250)
T cd05085 158 IKWTAPEALN 167 (250)
T ss_pred ccccCHHHhc
Confidence 7799999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=232.45 Aligned_cols=169 Identities=24% Similarity=0.370 Sum_probs=142.4
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC-----
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG----- 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 794 (902)
...++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999875 478999999875432 2345677899999999999999999987543
Q ss_pred -CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 795 -NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 795 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
...|++||++ +++|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3578999988 7799887743 45899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+..... .....||+.|+|||++..
T Consensus 166 ~~~~~~---~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 166 RQADDE---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred eecCCC---cCCccccccccCchHhcC
Confidence 876432 233568999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=220.53 Aligned_cols=171 Identities=29% Similarity=0.420 Sum_probs=146.3
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-----hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
++|++.+.||+|++|.||+|... ++++||+|.++.... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999875 489999999875421 234578889999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++... ..+++..+..++.|++.|+.||| +.||+||||+|+||++++++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988654 45788999999999999999999 999999999999999999999999999999865432
Q ss_pred ccce---ecccccccccccccccc
Q 046199 880 ESMR---TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~---~~~~gt~~y~APE~l~~ 900 (902)
.... ....++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred ccccccccCCCcCccccCcceecc
Confidence 2211 22457889999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=226.19 Aligned_cols=170 Identities=34% Similarity=0.473 Sum_probs=149.6
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..+|++.+.||.|+||.||+|.+. +++.||+|.+........+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357999999999999999999874 5899999998766555567888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.. ..+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++..........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 999999998854 35789999999999999999999 9999999999999999999999999999988765443333
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||.+.
T Consensus 173 ~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 173 STMVGTPYWMAPEVVT 188 (296)
T ss_pred CCcCCCccccCcchhc
Confidence 3456889999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=224.25 Aligned_cols=169 Identities=31% Similarity=0.472 Sum_probs=148.8
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999985 48999999987654 33457889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-c
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-M 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-~ 882 (902)
+ +++|.+++......+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999998776677999999999999999999999 99999999999999999999999999999987654332 1
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....|+..|+|||++.
T Consensus 157 ~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 157 YSHQVATRWYRAPELLY 173 (286)
T ss_pred cccccCcccccCceeee
Confidence 22356899999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=228.28 Aligned_cols=164 Identities=25% Similarity=0.328 Sum_probs=133.4
Q ss_pred cCeecccceeeEEEEEeC---CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec--CCeeEEEEEccC
Q 046199 731 KSLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFKALVLEYMA 805 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 805 (902)
.+.||+|+||.||+|++. +++.||+|.++... ....+.+|+++++.++||||+++++++.. +...|+||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 36789999886432 23557789999999999999999998854 467899999996
Q ss_pred CCChHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 046199 806 NGSLEKCLYSS--------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIA 873 (902)
Q Consensus 806 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~DFG~a 873 (902)
+ ++.+++... ...+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 888776432 124788999999999999999999 9999999999999999 45679999999999
Q ss_pred eecCCCcc---ceecccccccccccccccc
Q 046199 874 KLLNGEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
+....... ......||+.|||||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcC
Confidence 87654322 1223578999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=224.51 Aligned_cols=172 Identities=29% Similarity=0.436 Sum_probs=146.6
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecC------C
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG------N 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 795 (902)
+...|++.+.||+|+||.||+|.+.+ ++.||+|++.... .....+..|+.+++.+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45678999999999999999998764 8889999987543 3346788999999998 699999999998642 4
Q ss_pred eeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
..|+||||+++++|.+++... ...+++..+..++.|++.|++||| +++|+|||+||+||++++++.+||+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 689999999999999998764 345889999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceeccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.............|++.|+|||++.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred ecccccccCCcccccccccCHhHhc
Confidence 7654333334467899999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.32 Aligned_cols=167 Identities=36% Similarity=0.570 Sum_probs=139.5
Q ss_pred ccCeecccceeeEEEEEeC-----CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 730 EKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.+.||.|+||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999886 267899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++|+|.+++... ...+++..+..++.||+.||+||| +.+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999886 567999999999999999999999 899999999999999999999999999999887332221
Q ss_pred --eeccccccccccccccc
Q 046199 883 --RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 --~~~~~gt~~y~APE~l~ 899 (902)
.....+...|+|||++.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~ 178 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLK 178 (259)
T ss_dssp EESTTSESGGGGS-HHHHH
T ss_pred ccccccccccccccccccc
Confidence 12245778999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=220.98 Aligned_cols=171 Identities=33% Similarity=0.465 Sum_probs=152.1
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|+..+ ++.||+|.++.... .+.+.+|+++++.++||||+++++++..++..|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4689999999999999999999876 78999999875533 67899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++......+++..+..++.|++.|+.||| +.+++|||++|+||+++.++.+||+|||.+..........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999776677899999999999999999999 9999999999999999999999999999998765544333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....++..|+|||++..
T Consensus 157 ~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 157 NTVIGTPFWMAPEVIQE 173 (256)
T ss_pred ccccCCccccCHHHHhc
Confidence 34568899999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=234.04 Aligned_cols=170 Identities=26% Similarity=0.326 Sum_probs=141.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG----- 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 794 (902)
...++|++.+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345799999999999999999998754 8899999987542 23446778899999999999999999988543
Q ss_pred -CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 795 -NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 795 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
...|+||||+++ ++.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999976 6666663 24788899999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+...... ......||+.|+|||++..
T Consensus 167 ~~~~~~~-~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 167 RTAGTSF-MMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred ccCCCcc-ccCCccccCCccCHHHHcC
Confidence 8654332 2233578999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=223.16 Aligned_cols=165 Identities=24% Similarity=0.314 Sum_probs=134.7
Q ss_pred CeecccceeeEEEEEeCC---CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++.+...+..|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 4568888775443 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc-
Q 046199 808 SLEKCLYSSNR----SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM- 882 (902)
Q Consensus 808 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~- 882 (902)
+|.+++..... ..++.....++.||+.|++||| +++|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999866432 2457778899999999999999 999999999999999999999999999998754332211
Q ss_pred -eeccccccccccccccc
Q 046199 883 -RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 -~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 158 TKDCHAVPLRWLAPELVE 175 (269)
T ss_pred ccCCCCCcccccCHHHHh
Confidence 12234677899999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=221.98 Aligned_cols=172 Identities=25% Similarity=0.440 Sum_probs=146.2
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|...+++.||+|.+..... ..+++.+|+.+++.++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45678999999999999999999988899999999875432 3467889999999999999999999874 456899999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||++++++.++++|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999988653 346888999999999999999999 99999999999999999999999999999987653222
Q ss_pred -ceeccccccccccccccc
Q 046199 882 -MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 -~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 158 TAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred ccccCCcccccccCHHHhc
Confidence 122234677899999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=225.06 Aligned_cols=169 Identities=24% Similarity=0.396 Sum_probs=146.4
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||.||+|++. .++.||+|.++... ....+.+.+|+.++++++||||+++++.+..++..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47889999999999999999986 58999999887543 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
+++++|..++... ...+++..+..++.|++.|++||| + .+|+||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988653 236899999999999999999999 5 599999999999999999999999999997654322
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 158 --~~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 158 --AKTNIGCQSYMAPERIK 174 (286)
T ss_pred --cccCCCccCccCcchhc
Confidence 22345888999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=223.18 Aligned_cols=171 Identities=29% Similarity=0.437 Sum_probs=147.7
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +++.||||.+.... ....+++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57888999999999999999874 68999999886432 234467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998854 2345889999999999999999999 99999999999999999999999999999887654
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
.........|+..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccccccCCcCccCHHHhc
Confidence 433333456889999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=248.27 Aligned_cols=170 Identities=28% Similarity=0.383 Sum_probs=149.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|.+.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||+|+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999986 48899999987542 23346788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++... ..+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence 9999999999998653 45788999999999999999999 8999999999999999999999999999998766554
Q ss_pred cceecccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l 898 (902)
.......+|+.|+|||..
T Consensus 159 ~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 159 LNMMDILTTPSMAKPKND 176 (669)
T ss_pred ccccccccCccccCcccc
Confidence 444556789999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=221.84 Aligned_cols=173 Identities=28% Similarity=0.491 Sum_probs=148.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|+.+++.++||+|+++++++..+...++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4568899999999999999999998778899999987543 234678999999999999999999999998899999999
Q ss_pred ccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||.++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999986643 46899999999999999999999 99999999999999999999999999999987653221
Q ss_pred c-eeccccccccccccccc
Q 046199 882 M-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~-~~~~~gt~~y~APE~l~ 899 (902)
. .....++..|+|||.+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~ 177 (261)
T cd05034 159 TAREGAKFPIKWTAPEAAN 177 (261)
T ss_pred hhhhccCCCccccCHHHhc
Confidence 1 11223456899999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=223.61 Aligned_cols=170 Identities=32% Similarity=0.411 Sum_probs=146.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 478999999999999999999864 8999999986543 2234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|++++.+..++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9999888877643 345899999999999999999999 999999999999999999999999999999877554433
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||++.
T Consensus 157 ~~~~~~~~~~~aPE~~~ 173 (286)
T cd07847 157 YTDYVATRWYRAPELLV 173 (286)
T ss_pred ccCcccccccCCHHHHh
Confidence 33356788999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=227.01 Aligned_cols=176 Identities=23% Similarity=0.319 Sum_probs=151.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeec--cchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 798 (902)
.+....|++.+.||+||.+.||++...+.+.||+|++... +....+.|..|+..+.+++ |.+||++++|-..+++.|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3456679999999999999999999988888998877532 3456688999999999995 999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
|||||= ..||.+++.++....+...++.+..||+.|+.++| ..||||.||||.|+++-+ |.+||+|||.|..+..
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999975 45999999887766665688999999999999999 999999999999999875 5999999999998866
Q ss_pred Cccc--eecccccccccccccccccC
Q 046199 879 EESM--RTQTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 879 ~~~~--~~~~~gt~~y~APE~l~~~~ 902 (902)
+.+. ....+||+.|||||.+..|.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred cccceeeccccCcccccCHHHHhhcc
Confidence 5442 33478999999999998764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=218.89 Aligned_cols=171 Identities=27% Similarity=0.451 Sum_probs=146.5
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec-CCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 802 (902)
+|++.+.||+|++|.||+|++.. ++.||+|++.... ....+.+.+|++++++++||+++++++.+.. +...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58899999999999999998754 7889999987543 2345678899999999999999999998764 456899999
Q ss_pred ccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++... ...+++.++..++.|++.|++|+| +.|++||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998763 345899999999999999999999 99999999999999999999999999999987754444
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......+++.|+|||++..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN 176 (257)
T ss_pred ccccccCCcCccChhHhcC
Confidence 3444568999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=243.69 Aligned_cols=263 Identities=28% Similarity=0.357 Sum_probs=123.3
Q ss_pred ccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCc
Q 046199 292 NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSK 371 (902)
Q Consensus 292 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~ 371 (902)
.-..|+|+.|.++ .+|..+. ++|+.|++++|+++. +|. .+++|++|++++|+|+..++ ..++|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~---------lp~sL~ 265 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV---------LPPGLL 265 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccC---------cccccc
Confidence 3456677777776 4555443 356777777777763 343 24566777777776664322 124555
Q ss_pred eeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccc
Q 046199 372 YIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENN 451 (902)
Q Consensus 372 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 451 (902)
.|++++|.+.. +|. ++.+|+.|++++|+|+. +|.. .++|+.|+|++|+|++ +|... ..|+.|++++|
T Consensus 266 ~L~Ls~N~L~~-Lp~----lp~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N 332 (788)
T PRK15387 266 ELSIFSNPLTH-LPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNN 332 (788)
T ss_pred eeeccCCchhh-hhh----chhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccC
Confidence 66666665542 222 12245555666665553 2321 2455555555555553 23211 23445555555
Q ss_pred cccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccc
Q 046199 452 KLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG 531 (902)
Q Consensus 452 ~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 531 (902)
+++ .+|....+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|++++|+|++ +|..
T Consensus 333 ~L~-~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l-- 400 (788)
T PRK15387 333 QLT-SLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL-- 400 (788)
T ss_pred ccc-cccccccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc--
Confidence 554 244333345555555555543 2221 1234444555555543 2221 1234444444444442 2221
Q ss_pred cccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcc
Q 046199 532 NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPIS 601 (902)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 601 (902)
.++|+.|++++|+|++ +|..+ .+|+.|++++|+|+ .+|..|..+++|+.|+|++|+|++..|..
T Consensus 401 -~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 401 -PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred -ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 1234444444444442 33221 23344444444444 34444444444444444444444444333
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=221.76 Aligned_cols=165 Identities=26% Similarity=0.378 Sum_probs=136.7
Q ss_pred CeecccceeeEEEEEeCC---CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 46799998875532 33457888999999999999999999999999999999999999
Q ss_pred ChHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 808 SLEKCLYSSN----RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 808 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 23567778899999999999999 9999999999999999999999999999997544332211
Q ss_pred --eccccccccccccccc
Q 046199 884 --TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 --~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 158 TPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cCCCcCCcccccCHhHhc
Confidence 1245778899999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=222.79 Aligned_cols=172 Identities=27% Similarity=0.416 Sum_probs=142.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|.+.. ++ +|++|.+.... .....++..|+..++.+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 34678899999999999999998743 44 47777775332 2234677788889999999999999998754 457
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++++||+++|+|.+++......+++..+..++.||+.|++|+| +++++||||||+||++++++.+||+|||.++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 8899999999999999876677899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccc--eeccccccccccccccc
Q 046199 878 GEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
..... .....++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~ 184 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESIL 184 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhc
Confidence 33221 12245677899999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=219.99 Aligned_cols=165 Identities=34% Similarity=0.544 Sum_probs=144.6
Q ss_pred CeecccceeeEEEEEeCC----CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|.+.+ +..||+|+++..... ..+.+.+|+++++.++|++|+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998864 788999999765443 367889999999999999999999999999999999999999
Q ss_pred CChHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 807 GSLEKCLYSS--------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 807 g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
++|.+++... ...+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999775 467899999999999999999999 99999999999999999999999999999987755
Q ss_pred Cc--cceeccccccccccccccc
Q 046199 879 EE--SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~--~~~~~~~gt~~y~APE~l~ 899 (902)
.. .......+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~ 180 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLK 180 (262)
T ss_pred ccccccccCCCcCccccCHHHhc
Confidence 43 1222355788999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=219.95 Aligned_cols=168 Identities=33% Similarity=0.520 Sum_probs=146.7
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..++|++.+.||+|+||.||+|.. .++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 456889999999999999999987 478999999976544 567889999999999999999999999989999999999
Q ss_pred cCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999986544 25899999999999999999999 99999999999999999999999999999987633222
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
...++..|+|||++.
T Consensus 158 --~~~~~~~~~ape~~~ 172 (256)
T cd05039 158 --SGKLPVKWTAPEALR 172 (256)
T ss_pred --cCCCcccccCchhhc
Confidence 233566899999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=224.89 Aligned_cols=170 Identities=25% Similarity=0.391 Sum_probs=146.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKALV 800 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 800 (902)
++|++.+.||+|+||.||+|.+.. ++.||+|.++.... .....+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 579999999999999999999864 88999999875432 2234567899999999999999999998777 899999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++ +|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 999988765566899999999999999999999 9999999999999999999999999999998776543
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......+++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred cccccccccccccCchhhc
Confidence 3333456788999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=232.35 Aligned_cols=169 Identities=25% Similarity=0.323 Sum_probs=141.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 794 (902)
..++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999998754 8899999987542 33456788899999999999999999987543
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
...|+||||+++ ++.+.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999975 7777663 24788889999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...... ......||+.|+|||++..
T Consensus 175 ~~~~~~-~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 175 TAGTSF-MMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred ccCCCC-cccCCcccCCcCCHHHHhC
Confidence 654322 2233568999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=224.17 Aligned_cols=172 Identities=29% Similarity=0.478 Sum_probs=145.9
Q ss_pred cccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
..+|.+.+.||+|+||.||+|++. ++..|++|.++.......+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 456888999999999999999753 24568999887665555678999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 799 LVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
+||||+++++|.+++.... ..+++..+..++.||+.|++||| ++||+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 9999999999999986432 34788999999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
.+||+|||.+......... .....++..|+|||++.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 198 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence 9999999999765433221 12245678899999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=224.14 Aligned_cols=168 Identities=31% Similarity=0.475 Sum_probs=138.0
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhC---CCCCccceeeeeec-----CC
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCSN-----GN 795 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 795 (902)
+|++.+.||+|+||.||+|++.+ ++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58889999999999999998864 88999999875422 2234566787777665 69999999998754 34
Q ss_pred eeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
..++||||+++ ++.+++.... ..+++..+..++.|++.||+|+| +.||+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 68999999975 8888876533 35899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceeccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
....... .....||+.|+|||++.
T Consensus 157 ~~~~~~~-~~~~~~~~~y~aPE~~~ 180 (288)
T cd07863 157 IYSCQMA-LTPVVVTLWYRAPEVLL 180 (288)
T ss_pred cccCccc-CCCccccccccCchHhh
Confidence 7643322 23356899999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=227.51 Aligned_cols=175 Identities=24% Similarity=0.444 Sum_probs=144.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC--------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
.+..++|.+.+.||+|+||.||+|++.. ...||+|.++... ......+..|+++++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445789999999999999999997632 3569999987542 33456788899999999 799999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
...+..|+||||+++|+|.+++.... ..+++..+.+++.|++.|++||| +.|++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHh
Confidence 99999999999999999999996532 24788899999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccceec--cccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~--~~gt~~y~APE~l~ 899 (902)
|++++++.+||+|||.++........... ..+++.|+|||++.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence 99999999999999999765432221111 22456899999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=224.84 Aligned_cols=164 Identities=23% Similarity=0.250 Sum_probs=129.9
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC--CCcEEEEEEeeec-----cchhhhhHHHHHHHHHhCCCCCccc-eeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQ-----FDGALKSFDAECEVLKSVRHRNLVK-IISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 792 (902)
.....++|++.+.||+|+||+||+|++. +++.||||+.... .....+.+.+|+++++.++|++++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3456788999999999999999999875 4777899986533 1223567899999999999999985 4432
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCCEEEcCCCcEEEEeec
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI-KPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kL~DFG 871 (902)
+..|+||||++|++|.. .. . .. ...++.|+++||+|+| ++||+|||| ||+||+++.++.+||+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~-~---~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR-P---HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC-c---cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 21 1 11 1467899999999999 999999999 9999999999999999999
Q ss_pred CceecCCCccc--------eeccccccccccccccc
Q 046199 872 IAKLLNGEESM--------RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~--------~~~~~gt~~y~APE~l~ 899 (902)
+|+.+...... .+...+++.|+|||++.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99876543311 12356888899999874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=222.81 Aligned_cols=160 Identities=24% Similarity=0.390 Sum_probs=134.6
Q ss_pred eecccceeeEEEEEeCC-------------------------CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccce
Q 046199 733 LIGIGSFGTVYKGRFLD-------------------------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 787 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 787 (902)
.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999987421 23588898865544445678889999999999999999
Q ss_pred eeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----
Q 046199 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---- 863 (902)
Q Consensus 788 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---- 863 (902)
++++.++...++||||+++|+|..++......+++..+..++.|++.||+||| +++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999 99999999999999997654
Q ss_pred ---cEEEEeecCceecCCCccceeccccccccccccccc
Q 046199 864 ---VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 864 ---~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+|++|||.+...... ....++..|+|||++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVP 193 (274)
T ss_pred ccceeeecCCccccccccc----cccccCCcccCchhhc
Confidence 4899999998654322 1235788899999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=221.34 Aligned_cols=170 Identities=34% Similarity=0.441 Sum_probs=150.0
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||.|+||.||+|++.+ ++.||+|++.... ......+.+|+++++.++||||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 478889999999999999998864 8899999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++... .+++..+..++.|++.|+.||| +++++||||+|+||++++++.++++|||.++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999999998654 6899999999999999999999 9999999999999999999999999999998876543333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....+++.|+|||++..
T Consensus 156 ~~~~~~~~y~~PE~~~~ 172 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQ 172 (274)
T ss_pred ccccCCccccChhhhcc
Confidence 44568899999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=221.55 Aligned_cols=171 Identities=26% Similarity=0.475 Sum_probs=144.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-C---cEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.+|++.+.||+|+||.||+|++.. + ..||+|+++... ....+.+..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468899999999999999998753 3 369999987543 33457899999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++......+++..+..++.|++.|++||| ++|++||||||+||+++.++.+|++|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999776667899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccee--c-cc--cccccccccccc
Q 046199 881 SMRT--Q-TL--GTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~--~-~~--gt~~y~APE~l~ 899 (902)
.... . .. .+..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred cccccccccCCCcceeecCHhHhc
Confidence 2111 1 11 245799999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=225.09 Aligned_cols=176 Identities=27% Similarity=0.460 Sum_probs=147.1
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
+.+..++|++.+.||+|+||.||+|.+.+ ...||+|.++... ......+.+|+++++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45666789999999999999999998643 3679999887543 23446788999999999 7999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSS---------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNI 857 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 857 (902)
.++..+++|||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence 999999999999999999998642 245788999999999999999999 99999999999999
Q ss_pred EEcCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 858 LLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 858 ll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
++++++.+||+|||.++......... ....++..|+|||++.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 207 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence 99999999999999998765433211 1123467899999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=224.33 Aligned_cols=173 Identities=24% Similarity=0.368 Sum_probs=146.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-----------------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCcc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLV 785 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv 785 (902)
..++|++.+.||+|+||.||+|++.+ +..||+|++.... ....+.+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34689999999999999999997643 2458999987553 23457889999999999999999
Q ss_pred ceeeeeecCCeeEEEEEccCCCChHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSN----------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 786 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
++++++..++..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchh
Confidence 99999999999999999999999999986543 25889999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
||+++.++.++|+|||.++........ .....+++.|||||++.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 999999999999999999865433221 12245678899999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=242.48 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=153.9
Q ss_pred CceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEe
Q 046199 266 LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345 (902)
Q Consensus 266 L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 345 (902)
-..|+|++|.++ .+|..+ . ++|+.|++++|+++. +|.. +++|++|+|++|+|+. +|.. .++|+.|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l---~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~ 268 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCL---P--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELS 268 (788)
T ss_pred CcEEEcCCCCCC-cCCcch---h--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceee
Confidence 456677777666 456542 1 356667777777663 3332 4566777777777663 3432 35666677
Q ss_pred cccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEee
Q 046199 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLG 425 (902)
Q Consensus 346 Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 425 (902)
+++|.++..+. ...+|+.|++++|++.. +|.. +.+|+.|+|++|+|++ +|... .+|+.|+++
T Consensus 269 Ls~N~L~~Lp~---------lp~~L~~L~Ls~N~Lt~-LP~~----p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls 330 (788)
T PRK15387 269 IFSNPLTHLPA---------LPSGLCKLWIFGNQLTS-LPVL----PPGLQELSVSDNQLAS-LPALP---SELCKLWAY 330 (788)
T ss_pred ccCCchhhhhh---------chhhcCEEECcCCcccc-cccc----ccccceeECCCCcccc-CCCCc---ccccccccc
Confidence 77776664321 12456666777776663 3331 2266777777777664 33321 346666677
Q ss_pred cceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccccc
Q 046199 426 NNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPST 505 (902)
Q Consensus 426 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 505 (902)
+|+|++ +|.. ..+|++|+|++|+|+ .+|....+|+.|++++|+|++ +|.. ..+|+.|++++|+|++ +|..
T Consensus 331 ~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l 400 (788)
T PRK15387 331 NNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL 400 (788)
T ss_pred cCcccc-cccc---ccccceEecCCCccC-CCCCCCcccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc
Confidence 777663 4431 135667777777766 355544566667777777664 3432 2356667777777665 3332
Q ss_pred ccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccc
Q 046199 506 FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578 (902)
Q Consensus 506 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 578 (902)
.++|+.|++++|+|++ +|..+ .+|+.|++++|+|+ .+|..|+++++|+.|+|++|+|++..|..+
T Consensus 401 ---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 401 ---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 2456667777777664 44322 34566677777776 566666677777777777777776666555
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=220.33 Aligned_cols=160 Identities=26% Similarity=0.401 Sum_probs=136.5
Q ss_pred CeecccceeeEEEEEeCCCc-----------EEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 732 SLIGIGSFGTVYKGRFLDGM-----------EVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999886532 5778876644332 5788899999999999999999999887 778999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-------cEEEEeecCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-------VAHLSDFGIA 873 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-------~~kL~DFG~a 873 (902)
|||+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999776557899999999999999999999 99999999999999999887 7999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..... .....++..|+|||++..
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 156 ITVLS----REERVERIPWIAPECIRN 178 (259)
T ss_pred ccccc----ccccccCCCccChhhhcC
Confidence 87543 122456788999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=226.07 Aligned_cols=170 Identities=29% Similarity=0.385 Sum_probs=146.1
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+.|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..|+||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555677999999999999875 48899999987655555677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
++++|.+++.. ..+++..+..++.||+.|++||| +++|+||||||+||++++++.+||+|||++...........
T Consensus 102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99999998743 34788999999999999999999 99999999999999999999999999999876544333333
Q ss_pred cccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~ 900 (902)
...|++.|+|||++..
T Consensus 177 ~~~~~~~y~aPE~~~~ 192 (292)
T cd06658 177 SLVGTPYWMAPEVISR 192 (292)
T ss_pred eeecCccccCHHHHcc
Confidence 4568999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=221.92 Aligned_cols=172 Identities=27% Similarity=0.408 Sum_probs=144.1
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|++. +++ +||+|+++... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 4578999999999999999999864 343 58999987543 33456788999999999999999999998754 56
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+++|||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999776667899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcccee--ccccccccccccccc
Q 046199 878 GEESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~--~~~gt~~y~APE~l~ 899 (902)
....... ...+++.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred cccceeecCCCccchhhCCHHHhc
Confidence 4332211 123567899999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=219.03 Aligned_cols=171 Identities=28% Similarity=0.359 Sum_probs=143.3
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeecC--Cee
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 797 (902)
.+|++.+.||+|+||.||+|++.+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999998754 8999999886432 12346788899999999999999999988663 568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998654 44788889999999999999999 9999999999999999999999999999997654
Q ss_pred CCcc---ceecccccccccccccccc
Q 046199 878 GEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
.... ......|+..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred cccccccccccCCCCccccChhhhcC
Confidence 2211 1122458889999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=198.91 Aligned_cols=177 Identities=26% Similarity=0.332 Sum_probs=147.2
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeecCC
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 795 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 795 (902)
+......++....+.||+|+||.|-+.++.. |+..|+|.++... .+..++...|+.+..+. .+|++|.+||.+..++
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3456677788888999999999999988864 8999999998654 34556777888875554 7999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 796 FKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
..++.||.|+- +|..+.++ .+..+++..+-+|+..+.+||.|||. +..++|||+||+|||++.+|+||+||||.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999954 88776543 56779999999999999999999995 77999999999999999999999999999
Q ss_pred ceecCCCccceeccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+-.+.+.- ..+...|...|||||.+.
T Consensus 196 sG~L~dSi-Akt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 196 SGYLVDSI-AKTMDAGCKPYMAPERIN 221 (282)
T ss_pred ceeehhhh-HHHHhcCCCccCChhhcC
Confidence 98765432 223356888999999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=225.22 Aligned_cols=169 Identities=30% Similarity=0.382 Sum_probs=145.9
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
.|+....||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445567999999999999875 589999999876555556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+++|.+++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++............
T Consensus 102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999987744 45789999999999999999999 999999999999999999999999999998765443333334
Q ss_pred ccccccccccccccc
Q 046199 886 TLGTIGYMAPGLWVV 900 (902)
Q Consensus 886 ~~gt~~y~APE~l~~ 900 (902)
..|+..|+|||++..
T Consensus 177 ~~~~~~y~aPE~~~~ 191 (297)
T cd06659 177 LVGTPYWMAPEVISR 191 (297)
T ss_pred eecCccccCHHHHcc
Confidence 568999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=224.33 Aligned_cols=170 Identities=32% Similarity=0.445 Sum_probs=146.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|.+.+ ++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468899999999999999999864 89999998764322 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|++++++.++... ...+++..+..++.|++.|++||| +.+++|||++|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9999988887643 345899999999999999999999 999999999999999999999999999999876544433
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||++.
T Consensus 157 ~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 157 YTDYVATRWYRAPELLV 173 (286)
T ss_pred cCcccceeeccCcHHhc
Confidence 33456889999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=218.13 Aligned_cols=163 Identities=27% Similarity=0.474 Sum_probs=136.2
Q ss_pred eecccceeeEEEEEeC---CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCC
Q 046199 733 LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGS 808 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 808 (902)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 355799999875533 334678999999999999999999998864 56799999999999
Q ss_pred hHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec---
Q 046199 809 LEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ--- 885 (902)
Q Consensus 809 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~--- 885 (902)
|.+++......+++..+.+++.|++.|++||| ++|++||||||+||+++.++.+||+|||.+............
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766667899999999999999999999 999999999999999999999999999999865433322111
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
..+++.|+|||++.
T Consensus 158 ~~~~~~y~aPE~~~ 171 (257)
T cd05115 158 GKWPLKWYAPECIN 171 (257)
T ss_pred CCCCcccCCHHHHc
Confidence 22357899999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=222.59 Aligned_cols=162 Identities=25% Similarity=0.371 Sum_probs=138.4
Q ss_pred CeecccceeeEEEEEeCC--------CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.||+|+||.||+|.... ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998643 234888887655445567888999999999999999999999998999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--------EEEEeecCcee
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV--------AHLSDFGIAKL 875 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--------~kL~DFG~a~~ 875 (902)
+++|+|.+++......+++..+..++.||+.|++||| ++||+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776667899999999999999999999 999999999999999987765 69999999876
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... ....+++.|+|||++..
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIEN 178 (258)
T ss_pred cCCc----hhccccCCccCchhccC
Confidence 5432 22457889999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=226.21 Aligned_cols=175 Identities=25% Similarity=0.450 Sum_probs=144.6
Q ss_pred HhhcccccccCeecccceeeEEEEEeC--------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
....++|.+.+.||+|+||.||+|++. ....||+|.++... ....+.+.+|+++++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 455678999999999999999999752 24568999887543 33456788999999999 699999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
..++..|+||||+++|+|.+++.... ..+++..+.+++.|++.|++||| ++||+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccccee
Confidence 99999999999999999999986532 34788899999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccceec--cccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~--~~gt~~y~APE~l~ 899 (902)
|++++++.+||+|||.++........... ..++..|||||++.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence 99999999999999999876432221111 22446799999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=223.93 Aligned_cols=172 Identities=23% Similarity=0.380 Sum_probs=143.5
Q ss_pred cccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..+|++.+.||+|+||.||+|++.+ ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3568888999999999999998642 57899999875543 2346788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 046199 798 ALVLEYMANGSLEKCLYSS---------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (902)
++++||+++++|.+++... ...+++..+.+++.|++.|++|+| ++||+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCC
Confidence 9999999999999998532 124778889999999999999999 9999999999999999999
Q ss_pred CcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 863 MVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 863 ~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
+.+||+|||+++........ .....+++.|+|||++.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM 199 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence 99999999998865433221 12234678999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=217.70 Aligned_cols=171 Identities=26% Similarity=0.455 Sum_probs=146.8
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
..+|++.+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++||+|+++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 457888999999999999999887788999998864422 3467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc-e
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-R 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~ 883 (902)
++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999998766666889999999999999999999 999999999999999999999999999999865433221 1
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||++.
T Consensus 159 ~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 159 TGTKFPVKWSSPEVFS 174 (256)
T ss_pred CCCccchhhcCHhHhc
Confidence 1233567899999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=218.63 Aligned_cols=173 Identities=24% Similarity=0.421 Sum_probs=146.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+..++|++.+.||+|+||.||+|.+.++..||+|.++... ...+.+.+|+++++.++|++|+++++.+.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 35568899999999999999999998778889999886542 345678899999999999999999999887 7789999
Q ss_pred EccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++++|.+++... ....++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999998653 345788889999999999999999 9999999999999999999999999999998764332
Q ss_pred cc-eeccccccccccccccc
Q 046199 881 SM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~-~~~~~gt~~y~APE~l~ 899 (902)
.. .....++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred cccccCCcccccccCHhHhc
Confidence 21 12234567899999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=221.99 Aligned_cols=174 Identities=25% Similarity=0.394 Sum_probs=146.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+..++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 456789999999999999999998743 4689999986443 234567889999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 796 FKALVLEYMANGSLEKCLYSSN---------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
..++||||+++++|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 9999999999999999986432 23678889999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCccc--eeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|+|||+++........ .....++..|+|||++.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 9999999765433221 12245678999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=221.43 Aligned_cols=173 Identities=28% Similarity=0.462 Sum_probs=146.3
Q ss_pred cccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
.++|+..+.||+|+||.||+|... ++..||+|.+........+.+.+|+++++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467888999999999999999642 35679999887666666778999999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 046199 799 LVLEYMANGSLEKCLYSSN--------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (902)
+||||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999986543 24788999999999999999999 999999999999999999999
Q ss_pred EEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 865 AHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 865 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
+||+|||++......... .....+++.|+|||++..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 198 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence 999999999765432221 112345778999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=218.43 Aligned_cols=170 Identities=29% Similarity=0.442 Sum_probs=145.4
Q ss_pred cccccCeecccceeeEEEEEeCCCcEEEEEEeeecc------chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF------DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+|++.+.||+|+||.||+|...+++.+|+|.++... ....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 578899999999999999998789999999886432 12345688999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++.+. ..+++..+..++.|++.|++|+| +.+|+|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999998654 45789999999999999999999 9999999999999999999999999999987643211
Q ss_pred ------cceecccccccccccccccc
Q 046199 881 ------SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ------~~~~~~~gt~~y~APE~l~~ 900 (902)
.......|+..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred ccccccccccccCCCccccChhhhcC
Confidence 11122458899999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=220.14 Aligned_cols=172 Identities=28% Similarity=0.442 Sum_probs=144.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-C----cEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-G----MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|.+.+ + ..||+|....... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 44688999999999999999998643 3 3589998765533 345678899999999999999999999887 788
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.++...
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999776667899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccceec--cccccccccccccc
Q 046199 878 GEESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~--~~gt~~y~APE~l~ 899 (902)
........ ..++..|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESIL 184 (279)
T ss_pred CcccceecCCCcccccccCHHHhh
Confidence 43322211 22356899999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-25 Score=229.63 Aligned_cols=173 Identities=24% Similarity=0.352 Sum_probs=151.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCc-EEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGM-EVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
....+++++..||-|+||.|-.++....+ .+|+|++++. .....+.+..|-.+|..++.|+||++|..|.++.++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34456677888999999999999875433 4888887643 3455677889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+.||-|-||.+...++++ +.++......++..+++|++||| ++|||+||+||+|.++|.+|.+||.|||+|+.+..
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999999654 56899999999999999999999 99999999999999999999999999999999887
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.....+ ++|||.|.|||+++.
T Consensus 573 g~KTwT-FcGTpEYVAPEIILn 593 (732)
T KOG0614|consen 573 GRKTWT-FCGTPEYVAPEIILN 593 (732)
T ss_pred CCceee-ecCCcccccchhhhc
Confidence 665444 799999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=218.41 Aligned_cols=171 Identities=27% Similarity=0.448 Sum_probs=143.4
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..++|++.+.||+|+||.||+|.+..+..||+|.+.... ...+.+.+|+++++.++||+++++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 346799999999999999999998777789999876443 23467889999999999999999999875 4567899999
Q ss_pred cCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999986543 34788999999999999999999 999999999999999999999999999999876433221
Q ss_pred -eeccccccccccccccc
Q 046199 883 -RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 -~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||+..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 159 ARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred ccCCCccchhhCCHHHhc
Confidence 12234667899999764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=224.15 Aligned_cols=175 Identities=23% Similarity=0.405 Sum_probs=146.9
Q ss_pred HhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeec
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSN 793 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 793 (902)
....++|.+.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 455678999999999999999999752 25579999887543 33456789999999999 79999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
.+..|+||||+++|+|.+++.... ..+++.++..++.|++.|++||| +++|+|+||||+||+++.++.+|++|||.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999986543 33899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCccc--eeccccccccccccccc
Q 046199 873 AKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
++........ .....+++.|+|||++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 216 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIF 216 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhc
Confidence 9865433221 11234577899999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=222.15 Aligned_cols=179 Identities=30% Similarity=0.397 Sum_probs=149.7
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecC
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG 794 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 794 (902)
...++..+.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455567889999999999999999999885 48899999886432 2346678899999998 799999999998643
Q ss_pred -----CeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 795 -----NFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 795 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
+..|+||||+++++|.++++. ....+++..+..++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 468999999999999998753 3356889999999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCccceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||.+..............|+..|+|||++.
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhc
Confidence 999999987654333333456889999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=217.78 Aligned_cols=167 Identities=33% Similarity=0.468 Sum_probs=141.8
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeee-ecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|.. .+..||+|.++.. ...+.+.+|+.++++++|++++++++++ ..++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 456899999999999999999976 4788999988643 2346788999999999999999999975 45567899999
Q ss_pred ccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+++++|.+++..... .+++..+..++.|++.|++||| ++|++||||||+||++++++.+|++|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999999876443 4788999999999999999999 9999999999999999999999999999998654322
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||++.
T Consensus 157 --~~~~~~~~y~aPE~~~ 172 (256)
T cd05082 157 --DTGKLPVKWTAPEALR 172 (256)
T ss_pred --CCCccceeecCHHHHc
Confidence 2234567899999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=219.79 Aligned_cols=172 Identities=27% Similarity=0.417 Sum_probs=144.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
..++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34678899999999999999998743 3468999887554 3455788999999999999999999998875 4578
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++......+++..+..++.|++.|++|+| +.+++||||||+||+++.++.+|++|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999766666899999999999999999999 99999999999999999999999999999987654
Q ss_pred Ccccee-ccccccccccccccc
Q 046199 879 EESMRT-QTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~-~~~gt~~y~APE~l~ 899 (902)
...... ...++..|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred ccceecCCCCccccccChhhhc
Confidence 432211 223456899999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=222.09 Aligned_cols=170 Identities=35% Similarity=0.476 Sum_probs=149.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999875 4789999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.+. .+++..+..++.|++.|+.||| +.|++|||+||+||+++.++.+||+|||.+..........
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 9999999998543 4788899999999999999999 9999999999999999999999999999987665444333
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 173 ~~~~~~~~y~~PE~~~ 188 (293)
T cd06647 173 STMVGTPYWMAPEVVT 188 (293)
T ss_pred ccccCChhhcCchhhc
Confidence 4456889999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-23 Score=218.66 Aligned_cols=173 Identities=25% Similarity=0.488 Sum_probs=146.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-C---cEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
..++|+..+.||+|+||.||+|+... + ..||+|.++... ....+.+..|+++++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 34678889999999999999998753 3 379999887553 334577889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++......+++..+..++.|++.|++|+| +.+++||||||+||++++++.+|++|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999776667899999999999999999999 99999999999999999999999999999987643
Q ss_pred Cccceec---cccccccccccccc
Q 046199 879 EESMRTQ---TLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~---~~gt~~y~APE~l~ 899 (902)
....... ...++.|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred ccccceeccCCCcCceecCHHHhh
Confidence 3221111 12345799999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=220.70 Aligned_cols=169 Identities=30% Similarity=0.468 Sum_probs=145.1
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+|++.+.||+|++|.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999986 488999999875532 23466778999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 805 ANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 805 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
++ ++.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+|++|||.+.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 8888876543 45899999999999999999999 999999999999999999999999999999765443333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 157 ~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 157 FSNEVVTLWYRAPDVLL 173 (284)
T ss_pred cccccccccccChHHhc
Confidence 33356788999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=226.66 Aligned_cols=179 Identities=24% Similarity=0.456 Sum_probs=155.8
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
.+++|++...+......||.|-||.||.|.|+. .-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|..+-
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 346778888888889999999999999999976 678999998754 446689999999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
.+|||+|||..|+|.+|+++..+ .++....+.++.||..||+||. .+++|||||.++|.|+.++..||++|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999987654 4666777899999999999999 9999999999999999999999999999999
Q ss_pred ecCCCccceec-cccccccccccccc
Q 046199 875 LLNGEESMRTQ-TLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~~~~~-~~gt~~y~APE~l~ 899 (902)
.+.++...... ....+.|.|||-+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred hhcCCceecccCccCcccccCccccc
Confidence 98765443222 33567899999763
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=216.09 Aligned_cols=171 Identities=28% Similarity=0.415 Sum_probs=148.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999875 48899999987432 33456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999886543 35788999999999999999999 999999999999999999999999999999876554433
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....|++.|+|||++..
T Consensus 158 ~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN 175 (256)
T ss_pred hhhccCCccccCHHHhCC
Confidence 333568899999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=220.22 Aligned_cols=173 Identities=31% Similarity=0.427 Sum_probs=148.4
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCC-----
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN----- 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 795 (902)
.+.++|++.+.||+|+||.||+|.+. +++.|++|++..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999986 478999999875533 346789999999999 6999999999986543
Q ss_pred -eeEEEEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 796 -FKALVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 796 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
..|+||||+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999987653 356899999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+..............|+..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIA 186 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhc
Confidence 9987654444344466899999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=242.92 Aligned_cols=307 Identities=19% Similarity=0.309 Sum_probs=185.8
Q ss_pred CCChhHHHHHHHHHhcccc--------CCCCCCCCceeeee----------------EEeeCCCCcEEEEEeccCCccee
Q 046199 4 NINTTDQQALLALKARITA--------KNWTSNTSVCSWIG----------------ITCDVSTHRVTALNISDFGLTGT 59 (902)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~--------~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~l~g~ 59 (902)
+-+++|.+.+++..+.+.. .+|...+|.|.-.. |.| .++.|+.+..-+......
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~--~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEG--GGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEec--CCCccccccccccccccc
Confidence 3467899999999999876 34887788885443 445 445677776655322211
Q ss_pred cCcccCCCCCCCeeec----cccccccCCCc---c-----ccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 60 ISSQLGNLSSLQTLDL----SHNRFSGTIPS---S-----IFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 60 ~~~~l~~l~~L~~L~L----s~n~l~~~~p~---~-----~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
-. +.-..-.+-.. ..+.-.+.-+. . -+-..+.+.|+++++.++ .+|..+ .++|+.|++++|
T Consensus 137 ~~---~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N 209 (754)
T PRK15370 137 AS---GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACI---PEQITTLILDNN 209 (754)
T ss_pred CC---CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCccc---ccCCcEEEecCC
Confidence 10 00000000000 00000000000 0 011234567777777776 355543 245677777777
Q ss_pred cccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeC
Q 046199 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 207 (902)
+++. +|..+. ++|++|+|++|+++ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|
T Consensus 210 ~Lts---------LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N 272 (754)
T PRK15370 210 ELKS---------LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHN 272 (754)
T ss_pred CCCc---------CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence 7652 555443 47788888888877 5776554 46788888888887 6776664 47888888888
Q ss_pred CCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCccc
Q 046199 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287 (902)
Q Consensus 208 ~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 287 (902)
+|+. +| ..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+
T Consensus 273 ~L~~-----------LP---------~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l--- 323 (754)
T PRK15370 273 KISC-----------LP---------ENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETL--- 323 (754)
T ss_pred ccCc-----------cc---------cccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCccc---
Confidence 7652 22 3332 46888888888887 4555443 46888888888887 355442
Q ss_pred CCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCC
Q 046199 288 IGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANS 367 (902)
Q Consensus 288 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l 367 (902)
.++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+ .++|++|++++|+++..++. + .
T Consensus 324 --~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~LP~~------l--~ 387 (754)
T PRK15370 324 --PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTNLPEN------L--P 387 (754)
T ss_pred --cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCCCCHh------H--H
Confidence 2578888888888875 555443 67888999998887 456554 35788888888888754431 1 1
Q ss_pred CCCceeeeccCCCC
Q 046199 368 SSSKYIVLAENPLN 381 (902)
Q Consensus 368 ~~L~~L~Ls~N~l~ 381 (902)
.+|++|++++|++.
T Consensus 388 ~sL~~LdLs~N~L~ 401 (754)
T PRK15370 388 AALQIMQASRNNLV 401 (754)
T ss_pred HHHHHHhhccCCcc
Confidence 23555555555554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=224.11 Aligned_cols=172 Identities=28% Similarity=0.450 Sum_probs=140.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc--EEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 798 (902)
..++|++.+.||+|+||.||+|.+.+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++..++..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 34688999999999999999998754 44 45777765432 33456788999999999 8999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 799 LVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
+||||+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 9999999999999986532 24788899999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCccceeccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+||+|||++....... ......++..|+|||++.
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN 196 (303)
T ss_pred cEEeCccccCcccchhh-hcccCCCcccccCHHHHh
Confidence 99999999986432111 111123466799999764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=222.68 Aligned_cols=173 Identities=29% Similarity=0.410 Sum_probs=146.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 798 (902)
..++|++.+.||+|+||.||+|.+.. ++.||+|+++.... .....+.+|++++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 45789999999999999999999864 89999999875432 2234567899999999999999999998654 5689
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++ +|.+++......+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999965 888888765567899999999999999999999 99999999999999999999999999999987765
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.........+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred ccCCCCcccccccccChhhhcC
Confidence 4333333456888999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=215.76 Aligned_cols=169 Identities=33% Similarity=0.450 Sum_probs=146.8
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++||+|+++++++..++..|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999886 68999999987543 22456788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998654 35788999999999999999999 9999999999999999999999999999998764433
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
......|++.|+|||.+..
T Consensus 157 -~~~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred -cccccCCCcceeCHHHhcC
Confidence 2234568899999998743
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-24 Score=206.46 Aligned_cols=170 Identities=26% Similarity=0.325 Sum_probs=144.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 802 (902)
++.+....||.|+.|.|++++.+. |..+|||.+++.. ..+.+++...+.++.... +|+||+.+|+|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345566789999999999999875 8899999998664 345677888888776664 9999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
.|. ...+.+++.-.+++++..+-++...++.||.||.. +++|+|||+||+|||+|+.|++|+||||.+-++.+...+
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 984 46777777777889999999999999999999986 789999999999999999999999999999887654433
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
+...|.+.|||||.+-
T Consensus 249 -trsAGC~~YMaPERid 264 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERID 264 (391)
T ss_pred -ccccCCccccCccccC
Confidence 3467999999999863
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=219.37 Aligned_cols=168 Identities=32% Similarity=0.520 Sum_probs=147.1
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCC---CCCccceeeeeecCCeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 801 (902)
.|++.+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|+.+++.++ ||+++++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778899999999999999974 58999999987543 344567889999999996 999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++.. ..+++..+..++.|++.|+.||| +.||+||||+|+||++++++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998854 36889999999999999999999 99999999999999999999999999999988765544
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......|+..|+|||.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 157 KRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred ccccccCCcceeCHHHhc
Confidence 344457899999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=219.69 Aligned_cols=172 Identities=22% Similarity=0.382 Sum_probs=145.3
Q ss_pred cccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|+... .+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 3678999999999999999998642 467999988654433 457899999999999999999999999998999
Q ss_pred EEEEEccCCCChHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 798 ALVLEYMANGSLEKCLYSSN--------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
|+||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986543 15889999999999999999999 99999999999999999999999999
Q ss_pred ecCceecCCCcc-ceeccccccccccccccc
Q 046199 870 FGIAKLLNGEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 870 FG~a~~~~~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
||++........ ......++..|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhc
Confidence 999875432221 122245677899999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=217.66 Aligned_cols=169 Identities=31% Similarity=0.485 Sum_probs=143.6
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc---------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
+|.+.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999875 488999998864422 123568889999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||+|+||++++++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999998654 45788899999999999999999 999999999999999999999999999999876
Q ss_pred CCCcc------ceeccccccccccccccc
Q 046199 877 NGEES------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~------~~~~~~gt~~y~APE~l~ 899 (902)
..... ......|+..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 185 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVK 185 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhc
Confidence 53211 111235788999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=221.70 Aligned_cols=170 Identities=31% Similarity=0.441 Sum_probs=146.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.|+..+.||+|+||.||+|.+.. ++.||+|.++... ....+.+.+|+++++.++||||+++++++..++..|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 457778889999999999998754 7889999987443 34456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.. ..+++..+..++.|++.|+.||| +++++|+||+|+||++++++.+|++|||++..........
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999999998853 45788999999999999999999 9999999999999999999999999999998765443333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....++..|+|||++..
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hcccCcccccCHHHhCc
Confidence 33568899999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=215.57 Aligned_cols=169 Identities=29% Similarity=0.529 Sum_probs=145.5
Q ss_pred ccccCeecccceeeEEEEEeCC-----CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
+++.+.||+|+||.||+|++.+ +..||+|+++..... ..+.+..|+++++.++||+|+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998864 378999999755433 5678999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765444 899999999999999999999 9999999999999999999999999999998765443
Q ss_pred ccee-ccccccccccccccc
Q 046199 881 SMRT-QTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~-~~~gt~~y~APE~l~ 899 (902)
.... ...+++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~ 177 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLK 177 (258)
T ss_pred ccccccCCCcccccChHHhc
Confidence 2222 133678999999763
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=220.14 Aligned_cols=179 Identities=28% Similarity=0.413 Sum_probs=149.4
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeee--
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCS-- 792 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 792 (902)
++.+...+...|++.+.||+|+||.||+|++.. ++.||+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 445555667899999999999999999999854 8899999886543 3346688899999998 6999999999984
Q ss_pred ----cCCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 046199 793 ----NGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL 867 (902)
Q Consensus 793 ----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (902)
.....|++|||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+|||+||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 2467899999999999999886533 45788889999999999999999 999999999999999999999999
Q ss_pred EeecCceecCCCccceeccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+|||.+..............|++.|+|||++.
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcC
Confidence 99999876543333333456899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-24 Score=210.77 Aligned_cols=176 Identities=26% Similarity=0.319 Sum_probs=155.7
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec---cchhhhhHHHHHHHHHhC-CCCCccceeeeeecCC
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 795 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 795 (902)
+.....+|+..++||+|+|++|..++... .+.||+|+++++ .+...+-.+.|..+..+. +||++|.++.+|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 34567889999999999999999998865 778999999865 344566778898888887 6999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++|.||++||+|.-.+++ ++.++++.+..+...|+-||.||| ++||+.||+|.+||++|..|++|+.|+|+++.
T Consensus 325 rlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred eEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999877754 456999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
--.+.....+.+|||.|.|||++.+
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrg 425 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRG 425 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcc
Confidence 6666666777999999999999853
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=215.96 Aligned_cols=170 Identities=31% Similarity=0.424 Sum_probs=150.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|++|.||+|++.+ ++.||+|++..... ...+.+.+|++.++.++||+|+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999875 89999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++... ..+++..+..++.|+++|++|+| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999998654 56899999999999999999999 8 99999999999999999999999999999877654443
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||.+.
T Consensus 157 ~~~~~~~~~y~~pE~~~ 173 (264)
T cd06623 157 CNTFVGTVTYMSPERIQ 173 (264)
T ss_pred ccceeecccccCHhhhC
Confidence 33456889999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=225.94 Aligned_cols=176 Identities=24% Similarity=0.447 Sum_probs=145.1
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC--------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISS 790 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 790 (902)
+.....+|++.+.||+|+||.||+|++.. ...||+|.++... ....+.+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34555689999999999999999997532 2368999887543 33457889999999999 79999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
+..++..+++|||+++|+|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence 999999999999999999999986532 24678889999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccceec--cccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~--~~gt~~y~APE~l~ 899 (902)
||++++++.+||+|||.++........... ..++..|||||++.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF 209 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc
Confidence 999999999999999999876543222111 23456799999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=222.78 Aligned_cols=164 Identities=26% Similarity=0.333 Sum_probs=132.7
Q ss_pred cCeecccceeeEEEEEeCC---CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeee--cCCeeEEEEEccC
Q 046199 731 KSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFKALVLEYMA 805 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~ 805 (902)
...||+|+||.||+|+..+ ++.||+|.++... ....+.+|+++++.++||||+++++++. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999998753 5789999886442 2356788999999999999999999884 3567899999986
Q ss_pred CCChHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 046199 806 NGSLEKCLYSS--------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIA 873 (902)
Q Consensus 806 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~DFG~a 873 (902)
+ ++.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 777776421 124788899999999999999999 9999999999999999 56679999999999
Q ss_pred eecCCCcc---ceecccccccccccccccc
Q 046199 874 KLLNGEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
+....... ......||+.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcC
Confidence 87654322 1223568999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=221.87 Aligned_cols=148 Identities=32% Similarity=0.429 Sum_probs=133.2
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|...+ ++.||+|.+..... ...+.+..|+++++.++||+|+++++.+..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478899999999999999999865 89999999875532 24567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||+++++|.+++... ...+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999998653 346899999999999999999999 999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=221.52 Aligned_cols=172 Identities=21% Similarity=0.368 Sum_probs=142.4
Q ss_pred cccccccCeecccceeeEEEEEeCC-----------------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-----------------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVK 786 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 786 (902)
.++|++.+.||+|+||.||+|++.+ +..||+|+++... ....+++.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986432 3468999987543 334578899999999999999999
Q ss_pred eeeeeecCCeeEEEEEccCCCChHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSN----------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 787 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
+++++..++..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999986532 23667789999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|++++++.+|++|||.++.+...... .....+++.|+|||+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 99999999999999999865433221 11233467899999653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=216.18 Aligned_cols=165 Identities=25% Similarity=0.376 Sum_probs=141.2
Q ss_pred CeecccceeeEEEEEeCC--C--cEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD--G--MEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|++|.||+|.+.+ + ..||+|.++.... ...+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3699999876655 566789999999999999999999999988 889999999999
Q ss_pred CChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce--
Q 046199 807 GSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-- 883 (902)
Q Consensus 807 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-- 883 (902)
++|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||.++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997655 56899999999999999999999 9999999999999999999999999999998765432211
Q ss_pred -ecccccccccccccccc
Q 046199 884 -TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 -~~~~gt~~y~APE~l~~ 900 (902)
....++..|+|||++..
T Consensus 157 ~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT 174 (257)
T ss_pred ccCCCCCceecCHHHhcc
Confidence 12346788999998753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=223.99 Aligned_cols=168 Identities=22% Similarity=0.276 Sum_probs=139.6
Q ss_pred ccCeeccc--ceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 730 EKSLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 730 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+.+.||+| +|++||++++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78899999875 48999999987543 234467788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc--
Q 046199 805 ANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-- 881 (902)
Q Consensus 805 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-- 881 (902)
++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 345889999999999999999999 99999999999999999999999999987644322111
Q ss_pred -----ceecccccccccccccccc
Q 046199 882 -----MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 -----~~~~~~gt~~y~APE~l~~ 900 (902)
......++..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccceecccChHHhhc
Confidence 1112346778999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=208.90 Aligned_cols=166 Identities=27% Similarity=0.345 Sum_probs=137.3
Q ss_pred ccccccc-CeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeec----CCee
Q 046199 725 TDHFSEK-SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 725 ~~~y~~~-~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 797 (902)
+++|.+. ++||-|-.|.|..+.++. ++++|+|++... ...++|++..-.. .|||||+++++|+. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556543 678999999999998754 889999987533 5567888875554 69999999998853 3567
Q ss_pred EEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a 873 (902)
.+|||.|+||.|...+.+++ ..+++.++..|+.||+.|+.||| +.+|.||||||+|+|... +..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 79999999999999987654 46999999999999999999999 999999999999999954 458999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+....... -.+.+.||.|.|||++.
T Consensus 212 K~t~~~~~-L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 212 KETQEPGD-LMTPCFTPYYVAPEVLG 236 (400)
T ss_pred cccCCCcc-ccCCcccccccCHHHhC
Confidence 97654333 34478899999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=217.64 Aligned_cols=165 Identities=21% Similarity=0.351 Sum_probs=134.2
Q ss_pred CeecccceeeEEEEEeCCC---cEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 732 SLIGIGSFGTVYKGRFLDG---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.||+|+||.||+|+..++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3589999999999976443 345666665433 234578899999999999999999999999999999999999999
Q ss_pred ChHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc--c
Q 046199 808 SLEKCLYSSN---RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--M 882 (902)
Q Consensus 808 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--~ 882 (902)
+|.+++.+.. ...++..+..++.||+.||+||| +.+++||||||+||+++.++.+||+|||.+........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986532 33566778899999999999999 99999999999999999999999999999864322211 1
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||++.
T Consensus 158 ~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 158 EDDKCVPLRWLAPELVG 174 (268)
T ss_pred ccCCcCcccccCchhcc
Confidence 12346788999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=220.90 Aligned_cols=170 Identities=26% Similarity=0.448 Sum_probs=139.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-C--cEEEEEEeeec-cchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-G--MEVAIKVFHLQ-FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
++|++.+.||+|+||.||+|+..+ + ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998754 3 34788887643 233456788999999999 799999999999999999999
Q ss_pred EEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 801 LEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
|||+++++|.+++.... ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 24788899999999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCCCccceeccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
||+|||++........ ......+..|+|||++.
T Consensus 159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 191 (297)
T cd05089 159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLN 191 (297)
T ss_pred EECCcCCCccccceec-cCCCCcCccccCchhhc
Confidence 9999999864321111 11122355799999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=220.69 Aligned_cols=170 Identities=26% Similarity=0.424 Sum_probs=141.4
Q ss_pred cccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
+|++.+.||+|+||.||+|+... ...+|+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998632 35688888865432 345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 800 VLEYMANGSLEKCLYSSN-----------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999875421 24778889999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|++++++.+||+|||+++........ .....++..|+|||++.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 99999999999999999765433221 12234567899999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=218.80 Aligned_cols=169 Identities=28% Similarity=0.389 Sum_probs=148.0
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999986 48899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+++++|.+++......+++..+..++.|++.|++|+| + .+++||||||+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999999999766567899999999999999999999 8 99999999999999999999999999998765432221
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
...++..|+|||++.
T Consensus 158 --~~~~~~~y~~PE~~~ 172 (265)
T cd06605 158 --TFVGTSSYMAPERIQ 172 (265)
T ss_pred --cccCChhccCHHHHc
Confidence 156888999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=215.44 Aligned_cols=170 Identities=34% Similarity=0.479 Sum_probs=147.9
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+++++.++|++|+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 588999999876544 3567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++... ...++..+..++.|++.|++||| +.||+|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998654 34788899999999999999999 9999999999999999999999999999998765433322
Q ss_pred e----cccccccccccccccc
Q 046199 884 T----QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~----~~~gt~~y~APE~l~~ 900 (902)
. ...+++.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred cccccCCcCCcCccChhhccC
Confidence 1 2457889999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=219.11 Aligned_cols=173 Identities=28% Similarity=0.435 Sum_probs=143.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45679999999999999999998753 5678999876443 3334678899999999999999999999999899
Q ss_pred eEEEEEccCCCChHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEE
Q 046199 797 KALVLEYMANGSLEKCLYSSN------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAHL 867 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL 867 (902)
.++||||+++++|.+++.... ..+++..+.+++.||+.|++||| +++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986543 24788999999999999999999 99999999999999998754 6999
Q ss_pred EeecCceecCCCccce--eccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
+|||+++......... .....+..|+|||++.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence 9999998764322211 1123456899999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=220.49 Aligned_cols=170 Identities=27% Similarity=0.409 Sum_probs=143.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999998865 7899999987543 233467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||++|++|.+++... ..+++..+..++.|++.|++|+| +.+++||||||+||+++.++.+|++|||.++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999998654 45889999999999999999999 99999999999999999999999999999864211000
Q ss_pred ---------------ceeccccccccccccccc
Q 046199 882 ---------------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ---------------~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhcc
Confidence 011235788999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=233.79 Aligned_cols=172 Identities=30% Similarity=0.431 Sum_probs=156.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
...++|+..+++|.|.||.||||++.. ++..|+|+++.......+-+++|+-+++..+|||||.+++.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 456889999999999999999999864 8899999999887777788899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||.||+|++..+ ....+++.++..+++..++|++|+| ++|-+|||||-.||++++.|.+|++|||.+..+...-.
T Consensus 92 EycgggslQdiy~-~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EecCCCcccceee-ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999663 4567899999999999999999999 99999999999999999999999999999987766555
Q ss_pred ceecccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l 898 (902)
.+..+.||+.|||||+.
T Consensus 168 KrksfiGtpywmapEva 184 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVA 184 (829)
T ss_pred hhhcccCCccccchhHH
Confidence 56668899999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=217.11 Aligned_cols=169 Identities=34% Similarity=0.475 Sum_probs=148.0
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+|++.+.||.|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++.+.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48889999999999999999864 8999999987543 2345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+++... ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-L 155 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-c
Confidence 99999999998654 56889999999999999999999 9999999999999999999999999999998765432 2
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....|+..|+|||++..
T Consensus 156 ~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred ccccCCChhhcCHHHHcc
Confidence 233568889999998753
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.86 Aligned_cols=165 Identities=31% Similarity=0.464 Sum_probs=141.6
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChH
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLE 810 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 810 (902)
+.||+|+||.||+|.+.+++.||+|.++..... ..+.+.+|++++++++||+|+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765433 4578899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee--cccc
Q 046199 811 KCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT--QTLG 888 (902)
Q Consensus 811 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~--~~~g 888 (902)
+++......+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||.+........... ...+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667889999999999999999999 99999999999999999999999999999986542221111 1223
Q ss_pred ccccccccccc
Q 046199 889 TIGYMAPGLWV 899 (902)
Q Consensus 889 t~~y~APE~l~ 899 (902)
+..|+|||++.
T Consensus 158 ~~~y~~PE~~~ 168 (251)
T cd05041 158 PIKWTAPEALN 168 (251)
T ss_pred eeccCChHhhc
Confidence 56799999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=214.66 Aligned_cols=171 Identities=28% Similarity=0.392 Sum_probs=143.1
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeec--CCee
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 797 (902)
.+|+..+.||+|+||.||+|.+.+ ++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999998754 8899999886432 1234578889999999999999999998865 4678
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+++|||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999998654 34788999999999999999999 9999999999999999999999999999997654
Q ss_pred CCc---cceecccccccccccccccc
Q 046199 878 GEE---SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~---~~~~~~~gt~~y~APE~l~~ 900 (902)
... .......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC
Confidence 321 11122458889999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=236.01 Aligned_cols=171 Identities=23% Similarity=0.300 Sum_probs=137.3
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCC------CCccceeeeeec
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRH------RNLVKIISSCSN 793 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 793 (902)
+....++|++.+.||+|+||.||+|.+.. ++.||||+++... ........|+.+++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34567899999999999999999998854 7889999986432 233456678888777754 458888888865
Q ss_pred C-CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC--------
Q 046199 794 G-NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDM-------- 863 (902)
Q Consensus 794 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~-------- 863 (902)
+ +..|+|||++ +++|.+++.+. ..+++..+..++.||+.||+||| + .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5789999988 67888888654 46899999999999999999999 7 5999999999999998765
Q ss_pred --------cEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 864 --------VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 --------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.+||+|||.+..... .....+||+.|||||++..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhc
Confidence 499999998864322 2234679999999999854
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=218.45 Aligned_cols=169 Identities=28% Similarity=0.380 Sum_probs=144.2
Q ss_pred cccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
+|++.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+++++++ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999873 58899999987532 22346778899999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998654 45788999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccc-eeccccccccccccccc
Q 046199 878 GEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
..... .....|+..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred cccccccccccCCcccCChhhcc
Confidence 43221 12356889999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=216.81 Aligned_cols=169 Identities=24% Similarity=0.454 Sum_probs=144.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc------chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF------DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
+|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 48899999987433 1234678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~ 878 (902)
||||+++++|.+++.+. ..+++..+..++.|++.|++||| ++|++||||||+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998654 45889999999999999999999 99999999999999998776 699999999977654
Q ss_pred Ccc----ceeccccccccccccccc
Q 046199 879 EES----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~----~~~~~~gt~~y~APE~l~ 899 (902)
... ......++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred ccccCCccccccccccceeCHhHhc
Confidence 321 112245788999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=217.08 Aligned_cols=170 Identities=31% Similarity=0.464 Sum_probs=147.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..|+..+.||.|+||.||+|.+.. ++.||+|++.... ....+.+.+|+.+++.+.||+|+++++++.+++..|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 457788899999999999998754 8899999987543 34557888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++.. ..+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||.+..........
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999998854 45788899999999999999999 9999999999999999999999999999998765444333
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....++..|+|||++.+
T Consensus 159 ~~~~~~~~y~apE~~~~ 175 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ 175 (277)
T ss_pred ccccCcccccCHhHhcc
Confidence 33568889999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=216.62 Aligned_cols=169 Identities=27% Similarity=0.507 Sum_probs=139.7
Q ss_pred ccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe-----
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF----- 796 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 796 (902)
|++.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998643 4679999987543 2345678999999999999999999998865543
Q ss_pred -eEEEEEccCCCChHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 797 -KALVLEYMANGSLEKCLYSS-----NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 797 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
.++||||+++++|..++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999887542 235889999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCccceec--cccccccccccccc
Q 046199 871 GIAKLLNGEESMRTQ--TLGTIGYMAPGLWV 899 (902)
Q Consensus 871 G~a~~~~~~~~~~~~--~~gt~~y~APE~l~ 899 (902)
|.++.+......... ..++..|+|||++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcc
Confidence 999876544322211 23567899999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=208.84 Aligned_cols=172 Identities=28% Similarity=0.293 Sum_probs=141.6
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++.+-...||.|+||+|++..++. |+.+|||+++.... .+.+++..|.+...+- +.|+||++||+...++..|+.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3455566789999999999998865 99999999986654 5678888888865554 7999999999999999999999
Q ss_pred EccCCCChHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 802 EYMANGSLEKCLYS----SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 802 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|.|+- +++.+.+. .+..+++.-.-.|....+.||.||.. ...|||||+||+|||++..|.+|+||||.+-.+.
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99954 77665432 34458888888999999999999985 6789999999999999999999999999987664
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+. ...+..+|...|||||.+-.
T Consensus 220 ~S-iAkT~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 220 DS-IAKTVDAGCRPYMAPERIDP 241 (361)
T ss_pred HH-HHhhhccCCccccChhccCC
Confidence 32 23344679999999998754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=219.54 Aligned_cols=170 Identities=27% Similarity=0.396 Sum_probs=141.7
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCC-CCCccceeeeeecCCe-----
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVR-HRNLVKIISSCSNGNF----- 796 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 796 (902)
++|++.+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999986 489999998865432 23457888999999995 6999999999877655
Q ss_pred eEEEEEccCCCChHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeec
Q 046199 797 KALVLEYMANGSLEKCLYSS----NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFG 871 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG 871 (902)
.|+||||+++ ++.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 888887543 235799999999999999999999 999999999999999998 8899999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.++.............+++.|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhh
Confidence 9987644333333345788999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=217.74 Aligned_cols=169 Identities=27% Similarity=0.432 Sum_probs=140.1
Q ss_pred ccc-cccCeecccceeeEEEEEe-----CCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecC--Ce
Q 046199 726 DHF-SEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NF 796 (902)
Q Consensus 726 ~~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 796 (902)
++| ++.+.||+|+||+||++.. .+++.||+|.++.... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8899999999999988753 2477899999875532 3456788999999999999999999987653 46
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++++|.+++... .+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 89999999999999998653 4899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc---eeccccccccccccccc
Q 046199 877 NGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
...... .....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhc
Confidence 543221 11134566799999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=216.08 Aligned_cols=169 Identities=31% Similarity=0.435 Sum_probs=146.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
-|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999875 58899999886443 334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
++++|.+++.. ..+++..+..++.|++.|+.||| +.|++|+||||+||+++.++.++++|||++...........
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999998853 35789999999999999999999 99999999999999999999999999999987654433333
Q ss_pred cccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~ 900 (902)
...++..|+|||.+..
T Consensus 160 ~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ 175 (277)
T ss_pred cccCCccccChhhhcc
Confidence 3568889999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=216.40 Aligned_cols=169 Identities=24% Similarity=0.454 Sum_probs=137.2
Q ss_pred ccccCeecccceeeEEEEEeCC-C--cEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------Ce
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-G--MEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------NF 796 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 796 (902)
|.+.+.||+|+||.||+|++.+ + ..||+|.++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998765 3 268999886542 34457788999999999999999999976432 24
Q ss_pred eEEEEEccCCCChHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 797 KALVLEYMANGSLEKCLYS-----SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.+++|||+++|+|.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 2234789999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccce--eccccccccccccccc
Q 046199 872 IAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
+++.+....... ....+++.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLA 187 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHcc
Confidence 998765433211 1234677899999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=230.59 Aligned_cols=168 Identities=27% Similarity=0.414 Sum_probs=143.2
Q ss_pred cccccCeecccceeeEEEEEeC-C----CcEEEEEEeeec-cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-D----GMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..+..++||+|+||+||+|.+. + .-+||+|++... .....+++..|+-+|.+++|||++++++++.... ..+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3455789999999999999773 3 346899988644 3445688999999999999999999999998766 7899
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
++||++|.|.++++..+..+.....+.|..||++||.||| ++++|||||.++||||.+-..+||.|||+|+....+.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998888999999999999999999999 9999999999999999999999999999999877655
Q ss_pred cceecc--cccccccccccc
Q 046199 881 SMRTQT--LGTIGYMAPGLW 898 (902)
Q Consensus 881 ~~~~~~--~gt~~y~APE~l 898 (902)
...... .-.+.|||=|.+
T Consensus 853 ~ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred ccccccccccCcHHHHHHHh
Confidence 444432 235678887765
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=218.11 Aligned_cols=174 Identities=23% Similarity=0.384 Sum_probs=145.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeec-CC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 795 (902)
+..++|++.+.||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999998865 6889999886443 3345778899999999999999999998765 56
Q ss_pred eeEEEEEccCCCChHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 046199 796 FKALVLEYMANGSLEKCLYSSN-------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLS 868 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (902)
..++++||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 7899999999999999986532 35889999999999999999999 9999999999999999999999999
Q ss_pred eecCceecCCCccce--eccccccccccccccc
Q 046199 869 DFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 869 DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
|||+++.+....... ....++..|+|||++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 192 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence 999998664333221 1234567899999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-25 Score=210.53 Aligned_cols=173 Identities=26% Similarity=0.451 Sum_probs=144.8
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeee--ccchhhhhHHHHHHHHHhCCCCCccceeeeeec-------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL--QFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------- 793 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 793 (902)
....|+....||+|.||+||+|+.++ ++.||+|++-. +.++......+|+.++..++|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34567888899999999999998865 78899987643 234455677899999999999999999988742
Q ss_pred -CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 794 -GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 794 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
...+|+||.+|+. +|.-++......++..++.+++.++..||.|+| +..|+|||+||+|++|+.+|.+||+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 3458999999976 998888777678999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCcc----ceecccccccccccccccc
Q 046199 873 AKLLNGEES----MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~----~~~~~~gt~~y~APE~l~~ 900 (902)
|+.+...+. ..+..+-|.+|++||.+++
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 976643222 2334567999999999875
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=219.20 Aligned_cols=171 Identities=32% Similarity=0.413 Sum_probs=146.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|.+.+ ++.||+|+++... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 468999999999999999998864 8899999886532 3345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 881 (902)
|++++.+..+. .....+++..+..++.|++.|++||| +.+++|||++|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987776555 34455899999999999999999999 99999999999999999999999999999987655433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......++..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~ 175 (288)
T cd07833 157 PLTDYVATRWYRAPELLVG 175 (288)
T ss_pred cccCcccccCCcCCchhcC
Confidence 2233567889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=217.39 Aligned_cols=169 Identities=28% Similarity=0.368 Sum_probs=139.8
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHH-HHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEV-LKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+..|..+ ++..+||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999986 489999999875532 233455556665 566789999999999999999999999
Q ss_pred ccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 803 YMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 803 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
|++ |+|.+++.. ....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 588777654 2346899999999999999999999 76 999999999999999999999999999987643
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
.. ......++..|+|||++.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred cc-ccccccCCccccChhhcC
Confidence 22 122346889999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=215.40 Aligned_cols=169 Identities=29% Similarity=0.471 Sum_probs=143.5
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc----------hhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD----------GALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999875 488999998864211 12346788999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||+++++|.+++... ..+++..+..++.|++.|+.||| +++++||||+|+||+++.++.+|++|||.++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998655 46888999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCcc--ceeccccccccccccccc
Q 046199 876 LNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
...... ......|+..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIH 183 (272)
T ss_pred ccccccccccccccCCccccCHHHhc
Confidence 543211 122345888999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=216.87 Aligned_cols=171 Identities=27% Similarity=0.465 Sum_probs=145.6
Q ss_pred ccccccCeecccceeeEEEEEeC-----CCcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeec--CCee
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 797 (902)
++|++.+.||+|+||.||+|++. .++.||+|+++..... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788899999999999999853 3678999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999776656899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcccee---ccccccccccccccc
Q 046199 878 GEESMRT---QTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~---~~~gt~~y~APE~l~ 899 (902)
....... ...++..|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHc
Confidence 3322111 123456799999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=219.13 Aligned_cols=173 Identities=27% Similarity=0.450 Sum_probs=144.7
Q ss_pred hcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..++|++.+.||+|+||.||+|++. ++..||+|+++.... ...+.+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999863 367899999875533 345678899999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 797 KALVLEYMANGSLEKCLYSSN---------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|+| +++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 999999999999999986422 23677888999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
||++++++.+||+|||.+......... ......+..|+|||++.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 999999999999999999765433221 11233567899999764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=218.41 Aligned_cols=167 Identities=31% Similarity=0.414 Sum_probs=144.0
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.+.|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++..++..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456889999999999999999875 48999999986432 23345788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++ |++.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5777777655567899999999999999999999 999999999999999999999999999998765432
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 169 ---~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 169 ---NSFVGTPYWMAPEVIL 184 (307)
T ss_pred ---CCccCCccccCceeee
Confidence 2246788999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=218.55 Aligned_cols=170 Identities=27% Similarity=0.378 Sum_probs=146.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 34688999999999999999998864 8899999887543 334578899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++++|.+++... +.+++..+..++.|++.|+.||| + .+++||||||+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999988653 45889999999999999999999 5 589999999999999999999999999987653222
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.....|+..|+|||++.
T Consensus 159 --~~~~~~~~~~~aPE~~~ 175 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQ 175 (284)
T ss_pred --cCccccCcccCCHHHHc
Confidence 12356899999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=211.19 Aligned_cols=169 Identities=38% Similarity=0.502 Sum_probs=149.5
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|++|.||+|++. +++.||+|.+..... ...+.+.+|++++++++||+++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788999999999999999876 478999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++++|.+++... ..+++..+..++.|++.|+.||| +.||+||||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999999998654 56899999999999999999999 9999999999999999999999999999998876554433
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||.+.
T Consensus 157 ~~~~~~~~y~~pe~~~ 172 (254)
T cd06627 157 ASVVGTPYWMAPEVIE 172 (254)
T ss_pred cccccchhhcCHhhhc
Confidence 3456889999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=216.22 Aligned_cols=168 Identities=29% Similarity=0.389 Sum_probs=145.5
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
.|...+.||+|++|.||+|.+. +++.||+|+++.......+.+.+|+.+++.+.||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999874 588999999876554555678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+++|.+++.. ..+++..+..++.|++.|++|+| ++|++||||+|+||+++.++.++++|||.+............
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9999999865 45888999999999999999999 999999999999999999999999999988765443333333
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
..|++.|+|||++.
T Consensus 175 ~~~~~~y~aPE~~~ 188 (285)
T cd06648 175 LVGTPYWMAPEVIS 188 (285)
T ss_pred ccCCccccCHHHhc
Confidence 56899999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=213.37 Aligned_cols=170 Identities=28% Similarity=0.394 Sum_probs=143.1
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeecC--Cee
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 797 (902)
.+|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|++++++++||+|+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999998754 8999999875321 23446788999999999999999999998653 568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998654 34788999999999999999999 9999999999999999999999999999998654
Q ss_pred CCc---cceeccccccccccccccc
Q 046199 878 GEE---SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~---~~~~~~~gt~~y~APE~l~ 899 (902)
... .......++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred cccccCccccccCCcccccCHhhhc
Confidence 311 1112345889999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=212.10 Aligned_cols=170 Identities=29% Similarity=0.468 Sum_probs=145.8
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||+|+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999875 48899999987542 33457888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~ 881 (902)
+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||+++++ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 45889999999999999999999 9999999999999999865 4689999999987654332
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....++..|+|||.+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 158 -AYTVVGTPCYISPELCEG 175 (256)
T ss_pred -ccccccCCcccCchhccC
Confidence 223568899999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=214.26 Aligned_cols=172 Identities=33% Similarity=0.472 Sum_probs=148.7
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|++|+++++.+..++..|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999875 47889999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998653 245889999999999999999999 99999999999999999999999999999876654332
Q ss_pred c----eecccccccccccccccc
Q 046199 882 M----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~----~~~~~gt~~y~APE~l~~ 900 (902)
. .....|+..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~ 180 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQ 180 (267)
T ss_pred ccccccccccCChhhcChHHHcc
Confidence 2 122468899999998754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=217.79 Aligned_cols=169 Identities=30% Similarity=0.460 Sum_probs=144.3
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|+..+.||+|++|.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999886 48899999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
+. ++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5888887653 345889999999999999999999 999999999999999999999999999999766443333
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....+++.|+|||++.
T Consensus 157 ~~~~~~~~~y~aPE~~~ 173 (284)
T cd07860 157 YTHEVVTLWYRAPEILL 173 (284)
T ss_pred cccccccccccCCeEEe
Confidence 33345788999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=220.16 Aligned_cols=172 Identities=27% Similarity=0.438 Sum_probs=142.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|+..+.||+|+||.||+|++.. +. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45678899999999999999998743 43 578888765432 3345788999999999999999999998654 46
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++++||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence 7999999999999998776667899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccc--eeccccccccccccccc
Q 046199 878 GEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
..... .....++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~ 184 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIH 184 (303)
T ss_pred CcccccccCCCccccccCCHHHhc
Confidence 33221 11234567899999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=214.26 Aligned_cols=177 Identities=29% Similarity=0.438 Sum_probs=146.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-------hhhhhHHHHHHHHHhCCCCCccceeeeee-
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRHRNLVKIISSCS- 792 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~- 792 (902)
..-.++|-....||+|+|+.||+|-+.. .+.||||+-..... ...+...+|.+|.+.+.||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3445788899999999999999997754 78899998653321 22345678999999999999999999995
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEe
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSD 869 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~D 869 (902)
+.+.+|-|+|||+|.+|+-|++. .+.++++++..|+.||+.||.||. .-+..|||-|+||.|||+.. -|.+||.|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 45678999999999999988865 456999999999999999999998 44678999999999999954 47899999
Q ss_pred ecCceecCCCccc-------eecccccccccccccccc
Q 046199 870 FGIAKLLNGEESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
||+++.+.++... .....||.+|.+||.|.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV 654 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV 654 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeec
Confidence 9999998765432 223579999999999864
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=216.42 Aligned_cols=173 Identities=35% Similarity=0.441 Sum_probs=151.3
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
...+.|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+++++.++|+||+++++.+...+..|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888999999999999999986 588999999976544 4577889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++......+++..+..++.|++.|++||| +.|++|+|++|+||+++.++.+||+|||.+........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999776547899999999999999999999 99999999999999999999999999999876554333
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......+++.|+|||++.
T Consensus 172 ~~~~~~~~~~y~~PE~~~ 189 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIK 189 (286)
T ss_pred hhccccCCcccCCHhHhc
Confidence 333345788999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-23 Score=236.45 Aligned_cols=172 Identities=23% Similarity=0.266 Sum_probs=135.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC--CcEEEEE------------------EeeeccchhhhhHHHHHHHHHhCCCCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIK------------------VFHLQFDGALKSFDAECEVLKSVRHRN 783 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 783 (902)
..++|++.+.||+|+||.||+|..+. +..++.| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987542 2222222 111 11223456889999999999999
Q ss_pred ccceeeeeecCCeeEEEEEccCCCChHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 046199 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN----RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859 (902)
Q Consensus 784 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (902)
|+++++++...+..|+|+|++. +++.+++.... .......+..++.|++.||+||| ++|||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999995 47777764422 22345667889999999999999 9999999999999999
Q ss_pred cCCCcEEEEeecCceecCCCccc-eecccccccccccccccc
Q 046199 860 DDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 860 ~~~~~~kL~DFG~a~~~~~~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
+.++.+||+|||+++.+...... .....||+.|+|||++..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 99999999999999877543322 223579999999999753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=214.18 Aligned_cols=165 Identities=27% Similarity=0.452 Sum_probs=135.7
Q ss_pred CeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeee-cCCeeEEEEEccC
Q 046199 732 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS-NGNFKALVLEYMA 805 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 805 (902)
+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 4579999885432 334578889999999999999999999765 4567899999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc---
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--- 882 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--- 882 (902)
+++|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766556778888999999999999999 999999999999999999999999999999765432211
Q ss_pred -eeccccccccccccccc
Q 046199 883 -RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 -~~~~~gt~~y~APE~l~ 899 (902)
.....++..|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 158 NHTGAKLPVKWMALESLQ 175 (262)
T ss_pred ccccCcCCccccChhHhc
Confidence 11234577899999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=212.96 Aligned_cols=174 Identities=29% Similarity=0.418 Sum_probs=146.6
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec--CCeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 801 (902)
+|++.+.||.|+||.||+|.+. +++.||+|+++... ....+++..|+++++.++||||+++++++.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999875 47899999987442 3345678899999999999999999997753 45689999
Q ss_pred EccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC--CCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGY--SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||+++++|.+++... ...+++..+..++.|++.|++|+|... +.+++||||||+||+++.++.+|++|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 456889999999999999999999432 678999999999999999999999999999877
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...........+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred cCCcccccccccCCCccChhhhcC
Confidence 654433344568999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=211.36 Aligned_cols=170 Identities=32% Similarity=0.484 Sum_probs=149.8
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999986 488999999876533 4567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
+++++|.+++... ...+++..+..++.|++.|+.||| +.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998764 367899999999999999999999 9999999999999999999999999999998765544
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......|++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~ 176 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQ 176 (258)
T ss_pred ceecceeeeecccChhHhc
Confidence 3334457899999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=220.21 Aligned_cols=170 Identities=29% Similarity=0.414 Sum_probs=141.7
Q ss_pred cccccCeecccceeeEEEEEeCC---CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 798 (902)
+|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998854 7899999997633 33446778899999999999999999999888 8899
Q ss_pred EEEEccCCCChHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC----CCcEEEEee
Q 046199 799 LVLEYMANGSLEKCLYSS----NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD----DMVAHLSDF 870 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~----~~~~kL~DF 870 (902)
+||||+++ ++.+.+... ...+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676665332 235789999999999999999999 999999999999999999 899999999
Q ss_pred cCceecCCCcc---ceecccccccccccccccc
Q 046199 871 GIAKLLNGEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 871 G~a~~~~~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
|++........ ......+++.|+|||++..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC
Confidence 99987644322 1122467899999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=212.50 Aligned_cols=162 Identities=27% Similarity=0.425 Sum_probs=135.3
Q ss_pred eecccceeeEEEEEeC---CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 733 LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
.||+|+||.||+|.+. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 478899999865432 345678899999999999999999998864 4678999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce---e
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR---T 884 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~---~ 884 (902)
+|.+++... ..+++..+..++.|++.|++|+| ++||+||||||+||++++++.+||+|||.++......... .
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998643 45889999999999999999999 9999999999999999999999999999998765443221 1
Q ss_pred ccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 ~~~gt~~y~APE~l~ 899 (902)
...+++.|+|||++.
T Consensus 157 ~~~~~~~y~aPE~~~ 171 (257)
T cd05116 157 HGKWPVKWYAPECMN 171 (257)
T ss_pred CCCCCccccCHhHhc
Confidence 123457899999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=213.28 Aligned_cols=165 Identities=30% Similarity=0.501 Sum_probs=140.3
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
.++|++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.+++.++||||+++++++..++ .++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence 46799999999999999999975 67889999986542 3467889999999999999999999987654 69999999
Q ss_pred CCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 805 ANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
++++|.+++.... ..+++..+..++.|++.|+.|+| +.|++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999986543 35789999999999999999999 9999999999999999999999999999997643221
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
.....+..|+|||++.
T Consensus 155 ~~~~~~~~y~~pe~~~ 170 (254)
T cd05083 155 DNSKLPVKWTAPEALK 170 (254)
T ss_pred CCCCCCceecCHHHhc
Confidence 1233467899999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=209.75 Aligned_cols=170 Identities=37% Similarity=0.506 Sum_probs=151.0
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
+|+..+.||+|++|.||+|.+. +++.|++|+++.......+.+.+|+++++.++||+|+++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999986 588999999977655566889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+++|.+++......+++..+..++.|++.|++||| ..+++||||+|+||++++++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 156 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT 156 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence 99999998766567899999999999999999999 99999999999999999999999999999987655432 233
Q ss_pred ccccccccccccccc
Q 046199 886 TLGTIGYMAPGLWVV 900 (902)
Q Consensus 886 ~~gt~~y~APE~l~~ 900 (902)
..++..|+|||++..
T Consensus 157 ~~~~~~~~~PE~~~~ 171 (253)
T cd05122 157 MVGTPYWMAPEVING 171 (253)
T ss_pred eecCCcccCHHHHcC
Confidence 568899999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=217.03 Aligned_cols=170 Identities=28% Similarity=0.423 Sum_probs=141.4
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|++|.||+|.+. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999886 588999999865432 234568889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecCCCc
Q 046199 803 YMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~ 880 (902)
|++ +++.+++.... ...++..+..++.||+.||+||| +++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 47877775433 23678888899999999999999 999999999999999985 5579999999997654333
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......+++.|+|||++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred cccccCceeecccCHHHHh
Confidence 2223346788999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=213.76 Aligned_cols=161 Identities=28% Similarity=0.347 Sum_probs=132.3
Q ss_pred eecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHH---hCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLK---SVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
.||+|+||.||+|.+.+ ++.||+|.+..... .....+.+|..+++ ...||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998864 88999998865421 22233444544433 3479999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+++|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+|++|||++....... ...
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 154 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHA 154 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccC
Confidence 99999988644 45899999999999999999999 9999999999999999999999999999997654322 223
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
..|++.|+|||++.
T Consensus 155 ~~~~~~y~aPE~~~ 168 (279)
T cd05633 155 SVGTHGYMAPEVLQ 168 (279)
T ss_pred cCCCcCccCHHHhc
Confidence 46899999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=214.31 Aligned_cols=168 Identities=31% Similarity=0.462 Sum_probs=143.4
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
|++.+.||.|++|.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||+++++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999875 58999999987543 223356888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 805 ANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+ ++|.+++.... ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 58999886543 35899999999999999999999 9999999999999999999999999999997654333222
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 157 ~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 157 THEVVTLWYRAPEILL 172 (283)
T ss_pred CccccccCCCCCceee
Confidence 3345788999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=213.78 Aligned_cols=163 Identities=28% Similarity=0.368 Sum_probs=138.9
Q ss_pred ecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||.||+|.+. +++.||+|.+.... ....+.+..|+++++.++||+|+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 48899999986432 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccc
Q 046199 810 EKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG 888 (902)
Q Consensus 810 ~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~g 888 (902)
.+++.... ..+++..+..++.|++.|+.||| +.|++||||+|+||++++++.+||+|||.+...... .......+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG 156 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence 99986644 35899999999999999999999 999999999999999999999999999998765432 22223467
Q ss_pred cccccccccccc
Q 046199 889 TIGYMAPGLWVV 900 (902)
Q Consensus 889 t~~y~APE~l~~ 900 (902)
+..|+|||++..
T Consensus 157 ~~~y~~PE~~~~ 168 (277)
T cd05577 157 TPGYMAPEVLQG 168 (277)
T ss_pred CCCcCCHHHhcC
Confidence 889999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=212.63 Aligned_cols=164 Identities=29% Similarity=0.476 Sum_probs=134.4
Q ss_pred CeecccceeeEEEEEeCC-Cc--EEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|++.+ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 43 46888876432 34456788999999999 799999999999999999999999999
Q ss_pred CChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 807 GSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 807 g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
++|.+++.... ..+++..+..++.|++.|++||| +.|++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 24788899999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
++....... .......+..|+|||++.
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLN 184 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHc
Confidence 986432111 111123456799999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-23 Score=223.97 Aligned_cols=174 Identities=24% Similarity=0.381 Sum_probs=149.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCC--C--cEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD--G--MEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+..++....+.||+|.||+|++|.|.. | ..||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 344556677899999999999998854 3 45899999876544 67899999999999999999999999987 678
Q ss_pred EEEEEccCCCChHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.||||.++.|+|.+.+++ .+..+.......++.|||.||.||. .+++||||+.++|+++-....|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 899999999999999987 4556788889999999999999999 999999999999999998889999999999998
Q ss_pred CCCccceec---ccccccccccccccc
Q 046199 877 NGEESMRTQ---TLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~---~~gt~~y~APE~l~~ 900 (902)
...+.+... ..-...|+|||.+.+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc
Confidence 776665543 234567999998864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=214.33 Aligned_cols=168 Identities=33% Similarity=0.461 Sum_probs=144.9
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeEEEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKALVLE 802 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 802 (902)
|++.+.||+|+||.||+|++.+ ++.||+|+++... ....+.+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6778999999999999999865 8899999998653 33446788999999999999999999999888 89999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 881 (902)
|+++ ++.+++......+++..+..++.|++.|++||| +.|++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 898888665567899999999999999999999 99999999999999999999999999999987654432
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||.+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 157 DYTNRVITLWYRPPELLL 174 (287)
T ss_pred cccccccccccCCceeeE
Confidence 122345788899999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=216.35 Aligned_cols=173 Identities=35% Similarity=0.444 Sum_probs=144.9
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC----
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN---- 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 795 (902)
...++|++.+.||+|+||.||+|.+.. ++.||+|+++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999864 8899999987543 223456788999999999999999999886654
Q ss_pred ------eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 796 ------FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 796 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
..++||||+++ ++.+.+......+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 777777655556899999999999999999999 99999999999999999999999999
Q ss_pred ecCceecCCCcc-ceeccccccccccccccc
Q 046199 870 FGIAKLLNGEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 870 FG~a~~~~~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
||.+........ ......++..|+|||++.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhc
Confidence 999987654332 112234678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=217.09 Aligned_cols=171 Identities=27% Similarity=0.437 Sum_probs=141.9
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCC------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 795 (902)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++++||+|+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999886 488999998865432 22345678999999999999999999886543
Q ss_pred --eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 796 --FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 796 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
..++||||+++ ++.+++......+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 888888666557899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccc----eeccccccccccccccc
Q 046199 874 KLLNGEESM----RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~----~~~~~gt~~y~APE~l~ 899 (902)
......... .....++..|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhc
Confidence 766433221 12245788999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=215.35 Aligned_cols=164 Identities=30% Similarity=0.385 Sum_probs=142.4
Q ss_pred cCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 731 KSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999875 5889999998655555567789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccc
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt 889 (902)
.+++.. ..+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+..............|+
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 998743 35788999999999999999999 9999999999999999999999999999987665433333335688
Q ss_pred cccccccccc
Q 046199 890 IGYMAPGLWV 899 (902)
Q Consensus 890 ~~y~APE~l~ 899 (902)
+.|+|||++.
T Consensus 180 ~~y~~pE~~~ 189 (292)
T cd06657 180 PYWMAPELIS 189 (292)
T ss_pred ccccCHHHhc
Confidence 9999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=211.48 Aligned_cols=170 Identities=29% Similarity=0.425 Sum_probs=145.9
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 57889999999999999998864 8899999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~ 881 (902)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999986543 34789999999999999999999 99999999999999998886 569999999987654443
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......|++.|+|||++.
T Consensus 158 ~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred cccccCCCccccCHHHHc
Confidence 333356899999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=209.46 Aligned_cols=163 Identities=28% Similarity=0.432 Sum_probs=135.8
Q ss_pred CeecccceeeEEEEEeCC----CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|.+.. +..||+|.++.... ...+.+.+|+++++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997643 36899999875543 345678899999999999999999998764 467999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec-
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ- 885 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~- 885 (902)
++|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999996554 6899999999999999999999 999999999999999999999999999999876443322111
Q ss_pred --cccccccccccccc
Q 046199 886 --TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 --~~gt~~y~APE~l~ 899 (902)
..++..|+|||.+.
T Consensus 156 ~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 156 TAGRWPLKWYAPECIN 171 (257)
T ss_pred cCccccccccCHHHhc
Confidence 12346799999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=220.51 Aligned_cols=169 Identities=26% Similarity=0.326 Sum_probs=141.5
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 794 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999886 48999999986432 23345677899999999999999999988543
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
...|+||||+++ ++.+.+... +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999965 888877432 788899999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
....... .....+++.|+|||++..
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 167 TAGTSFM-MTPYVVTRYYRAPEVILG 191 (353)
T ss_pred eCCCCCC-CCCCcccccccCHHHHhC
Confidence 7644322 233468899999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=214.86 Aligned_cols=165 Identities=30% Similarity=0.399 Sum_probs=142.4
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.|+..+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|+++++.++|||++++++++.+++..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999875 48899999986432 2334578889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|++| ++.+.+......+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9975 787777665667899999999999999999999 999999999999999999999999999998754322
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
....|++.|+|||++.
T Consensus 179 -~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 179 -NSFVGTPYWMAPEVIL 194 (317)
T ss_pred -ccccCCccccChhhhh
Confidence 2346888999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=209.89 Aligned_cols=161 Identities=29% Similarity=0.446 Sum_probs=140.6
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||.|+||.||+|++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999865 8899999987543 23457789999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccc
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt 889 (902)
.+++... ..+++..+..++.|++.|++|+| +++++|+||+|+||+++.++.+||+|||.++...... ......++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 155 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGT 155 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCC
Confidence 9998654 45889999999999999999999 9999999999999999999999999999998765432 22235688
Q ss_pred cccccccccc
Q 046199 890 IGYMAPGLWV 899 (902)
Q Consensus 890 ~~y~APE~l~ 899 (902)
+.|+|||++.
T Consensus 156 ~~~~~PE~~~ 165 (262)
T cd05572 156 PEYVAPEIIL 165 (262)
T ss_pred cCccChhHhc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=219.29 Aligned_cols=169 Identities=27% Similarity=0.395 Sum_probs=140.9
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----Cee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 797 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++.... .....++.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999875 48999999986432 33456778899999999999999999887543 357
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++ ++.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 88877743 45899999999999999999999 9999999999999999999999999999998754
Q ss_pred CCccc---eeccccccccccccccc
Q 046199 878 GEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
..... .....|++.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhh
Confidence 33221 12246889999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=211.13 Aligned_cols=162 Identities=31% Similarity=0.447 Sum_probs=140.1
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||.||+|++.+ ++.||+|++..... ...+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999875432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc--------
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-------- 881 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-------- 881 (902)
.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99986644 6899999999999999999999 99999999999999999999999999999876443311
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 157 EDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred cccCcccCccccCHHHhc
Confidence 222346788999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=209.62 Aligned_cols=170 Identities=28% Similarity=0.461 Sum_probs=142.8
Q ss_pred cccccCeecccceeeEEEEEeCC--CcEEEEEEeeecc----------chhhhhHHHHHHHHHh-CCCCCccceeeeeec
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF----------DGALKSFDAECEVLKS-VRHRNLVKIISSCSN 793 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 793 (902)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999865 6889999875321 2234556778888765 799999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 794 GNFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
++..++||||+++++|.+++.. ....+++..++.++.|++.|+.||| + .+++||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3456889999999999999999999 6 6899999999999999999999999
Q ss_pred ecCceecCCCccceecccccccccccccccc
Q 046199 870 FGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
||.+....... ......|+..|+|||++..
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcC
Confidence 99998765443 2334568999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=210.77 Aligned_cols=161 Identities=27% Similarity=0.346 Sum_probs=132.4
Q ss_pred eecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHH---HHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECE---VLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
.||+|+||.||+|++.. ++.||+|.+..... .....+..|.. .++...||+|+++++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 47999999999998754 88999999865421 11122334433 3444579999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
|++|.+++.. ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+....... ...
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 154 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHA 154 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcC
Confidence 9999988854 356899999999999999999999 9999999999999999999999999999997654322 223
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
..|+..|+|||++.
T Consensus 155 ~~~~~~y~aPE~~~ 168 (278)
T cd05606 155 SVGTHGYMAPEVLQ 168 (278)
T ss_pred cCCCcCCcCcHHhc
Confidence 56899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=211.11 Aligned_cols=170 Identities=31% Similarity=0.355 Sum_probs=143.3
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeec--CCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 801 (902)
++|+..+.||.|++|.||+|.+.+ ++.||+|.+..... ....++.+|+++++.++||||+++++++.. .+..|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999999854 88899999875432 345778999999999999999999998854 34789999
Q ss_pred EccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 3345788999999999999999999 99999999999999999999999999999876543
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... ....++..|+|||.+..
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQG 177 (287)
T ss_pred ccc--ccccCCccccCHHHhcC
Confidence 221 22457889999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=207.29 Aligned_cols=167 Identities=23% Similarity=0.268 Sum_probs=136.5
Q ss_pred HHhhcccccccCee--cccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCe
Q 046199 721 LLLATDHFSEKSLI--GIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 796 (902)
Q Consensus 721 ~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 796 (902)
.....++|++.+.+ |+|+||.||+++.. +++.+|+|.+....... .|+.....+ +||||+++++.+..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677777776 99999999999875 48889999986542111 122222222 69999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCcee
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKL 875 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~ 875 (902)
.|+||||+++++|.+++.... .+++..+..++.|+++|++|+| +.|++||||||+||+++.++ .++|+|||.++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999999986553 7899999999999999999999 99999999999999999998 999999999987
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..... ...++..|+|||++..
T Consensus 160 ~~~~~----~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 160 IGTPS----CYDGTLDYFSPEKIKG 180 (267)
T ss_pred cCCCc----cCCCCCcccChhhhcC
Confidence 64332 2458899999998753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=212.88 Aligned_cols=170 Identities=36% Similarity=0.501 Sum_probs=146.5
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 800 (902)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999886 58999999986532 233467888999999998 99999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++.+. ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998654 46899999999999999999999 9999999999999999999999999999998665432
Q ss_pred c--------------------ceeccccccccccccccc
Q 046199 881 S--------------------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~--------------------~~~~~~gt~~y~APE~l~ 899 (902)
. ......++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 195 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence 1 112245788999999764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=210.92 Aligned_cols=166 Identities=28% Similarity=0.372 Sum_probs=139.1
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeeeecC--CeeEEEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCSNG--NFKALVLE 802 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 802 (902)
|++.+.||+|+||.||+|.+. +++.||+|+++... ........+|+.+++++. ||||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999875 48899999987542 222234457888898885 99999999999887 89999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++ ++.+.+......+++..+..++.|++.||+||| +.+++||||||+||+++. +.+||+|||.++........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9975 888888665567899999999999999999999 999999999999999999 99999999999876543322
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 156 -~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 156 -TEYISTRWYRAPECLL 171 (282)
T ss_pred -CCCCCCcccCChhHhh
Confidence 2245789999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=206.30 Aligned_cols=170 Identities=35% Similarity=0.453 Sum_probs=149.4
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKALVL 801 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 801 (902)
+|+..+.||+|++|.||+|.+. +++.|++|++..... ...+.+.+|++++++++||+|+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999986 589999999876542 4567889999999999999999999999888 8999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+|++|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999986654 7899999999999999999999 99999999999999999999999999999988765443
Q ss_pred --ceecccccccccccccccc
Q 046199 882 --MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 --~~~~~~gt~~y~APE~l~~ 900 (902)
......++..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred cccccCCCCCccccCHhhhcC
Confidence 1233568899999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=217.99 Aligned_cols=171 Identities=27% Similarity=0.377 Sum_probs=143.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec----CCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 797 (902)
.++|++.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3789999999999999999998764 8999999987543 2344677889999999999999999998753 3568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+. ++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||.+....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 5898888544 45899999999999999999999 9999999999999999999999999999997654
Q ss_pred CCccc----eecccccccccccccccc
Q 046199 878 GEESM----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~----~~~~~gt~~y~APE~l~~ 900 (902)
..... .....|+..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcC
Confidence 32211 123468899999998743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=217.84 Aligned_cols=170 Identities=28% Similarity=0.366 Sum_probs=143.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----Ce
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 796 (902)
.++|.+.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999875 48999999987532 23345677899999999999999999987644 35
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6898888543 56899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...........++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred CCCcccccccccccCccChHHHh
Confidence 54433333456888999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=217.81 Aligned_cols=169 Identities=29% Similarity=0.387 Sum_probs=145.4
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----eeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 798 (902)
+|++.+.||+|+||.||+|+..+ ++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58899999999999999999865 8999999987543 344578899999999999999999999987765 789
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||++ ++|.+++.... .+++..+..++.|++.|++||| +.||+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 48988885543 7899999999999999999999 99999999999999999999999999999987655
Q ss_pred Ccc---ceecccccccccccccccc
Q 046199 879 EES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
... ......+++.|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLS 180 (330)
T ss_pred cccccccccccccccCcCCceeeec
Confidence 431 2233567889999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=216.39 Aligned_cols=171 Identities=25% Similarity=0.379 Sum_probs=140.8
Q ss_pred ccccc-ccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchh--------------hhhHHHHHHHHHhCCCCCcccee
Q 046199 725 TDHFS-EKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA--------------LKSFDAECEVLKSVRHRNLVKII 788 (902)
Q Consensus 725 ~~~y~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 788 (902)
.++|. +.+.||+|+||.||+|.+. +++.||+|+++...... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 4577999999999999876 48999999986542211 12577899999999999999999
Q ss_pred eeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 046199 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLS 868 (902)
Q Consensus 789 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~ 868 (902)
+++..++..++||||++ ++|.+++.. ...+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence 99999999999999997 589988854 345889999999999999999999 9999999999999999999999999
Q ss_pred eecCceecCCC--------------ccceecccccccccccccccc
Q 046199 869 DFGIAKLLNGE--------------ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 869 DFG~a~~~~~~--------------~~~~~~~~gt~~y~APE~l~~ 900 (902)
|||.+...... ........+++.|+|||++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 99999766511 111122356888999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=221.68 Aligned_cols=174 Identities=22% Similarity=0.285 Sum_probs=132.1
Q ss_pred hhcccccccCeecccceeeEEEEEe-----------------CCCcEEEEEEeeeccchhhhh--------------HHH
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRF-----------------LDGMEVAIKVFHLQFDGALKS--------------FDA 771 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 771 (902)
...++|++.++||+|+||.||+|.+ .+++.||||++........++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999964 235679999987543322222 334
Q ss_pred HHHHHHhCCCCCc-----cceeeeeec--------CCeeEEEEEccCCCChHHHHhhCCC--------------------
Q 046199 772 ECEVLKSVRHRNL-----VKIISSCSN--------GNFKALVLEYMANGSLEKCLYSSNR-------------------- 818 (902)
Q Consensus 772 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------- 818 (902)
|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766544 667777643 3568999999999999998864221
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce-ecccccccccc
Q 046199 819 ---SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMA 894 (902)
Q Consensus 819 ---~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~gt~~y~A 894 (902)
..++..+..++.|++.|++|+| +.+|+||||||+||+++.++.+||+|||+++......... ....+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 2356678889999999999999 9999999999999999999999999999997654322211 11235889999
Q ss_pred ccccc
Q 046199 895 PGLWV 899 (902)
Q Consensus 895 PE~l~ 899 (902)
||++.
T Consensus 379 PE~l~ 383 (507)
T PLN03224 379 PEELV 383 (507)
T ss_pred hhhhc
Confidence 99875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=217.51 Aligned_cols=170 Identities=30% Similarity=0.406 Sum_probs=141.8
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeec--cchhhhhHHHHHHHHHhC-CCCCccceeeeeecC--Cee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNG--NFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 797 (902)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999886 4889999988543 223345677899999999 999999999988643 468
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||++ ++|..++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 4998888543 6788889999999999999999 9999999999999999999999999999998664
Q ss_pred CCcc-----ceeccccccccccccccc
Q 046199 878 GEES-----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~-----~~~~~~gt~~y~APE~l~ 899 (902)
.... ......|++.|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred cccccccCcchhcccccccccCceeee
Confidence 3321 122246889999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=210.64 Aligned_cols=169 Identities=31% Similarity=0.457 Sum_probs=146.0
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
|++.+.||+|++|.||+|... +++.+|+|.++.... .....+.+|+++++.++||+|+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999875 588999999875432 24567888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
++ ++.+++......+++..+..++.|++.|++||| +.+|+|+||||+||++++++.+||+|||.+...........
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 75 888888766567899999999999999999999 99999999999999999999999999999987755432223
Q ss_pred cccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~ 900 (902)
...++..|+|||.+..
T Consensus 157 ~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 157 HYVVTRWYRAPELLLG 172 (283)
T ss_pred CccCcccccCcHHHhc
Confidence 3557889999998753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=216.09 Aligned_cols=167 Identities=26% Similarity=0.387 Sum_probs=141.5
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----- 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 795 (902)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999875 58999999986432 223456889999999999999999999886543
Q ss_pred -eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 -FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
..++||||+ ++++.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+|++|||.+.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999999 7799888753 45889999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceeccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...... ....+++.|+|||++.
T Consensus 167 ~~~~~~---~~~~~~~~y~aPE~~~ 188 (343)
T cd07880 167 QTDSEM---TGYVVTRWYRAPEVIL 188 (343)
T ss_pred ccccCc---cccccCCcccCHHHHh
Confidence 654322 2345788999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=211.22 Aligned_cols=170 Identities=30% Similarity=0.403 Sum_probs=143.7
Q ss_pred cccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
+|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++++ +||+|+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999753 46889999987432 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988653 45889999999999999999999 9999999999999999999999999999987754
Q ss_pred CCccc-eecccccccccccccccc
Q 046199 878 GEESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
..... .....|+..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred cccccccccccCCccccCHHHhcC
Confidence 43322 222458899999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=206.73 Aligned_cols=169 Identities=31% Similarity=0.477 Sum_probs=146.2
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+++++.++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999875 47899999987543 33456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
+++++|.+++.+. ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 345788999999999999999999 999999999999999999999999999999876544
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
......+++.|+|||.+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred -CcccccCCccccCHHHHCC
Confidence 2223568899999998743
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-23 Score=203.39 Aligned_cols=169 Identities=27% Similarity=0.408 Sum_probs=138.6
Q ss_pred cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCC-----eeE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGN-----FKA 798 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 798 (902)
+.+..+.||-|+||+||.+.+. +|+.||.|++..-.. ...+++.+|+.++..++|.|+...++..+-.. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445678999999999999884 699999998864432 34578889999999999999999888765442 467
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+++|.|. .+|.+.+-. ...++...+.-+.+||++||+||| +.+|.||||||.|.+++.+..+||||||+|+....
T Consensus 134 V~TELmQ-SDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-hhhhheecc-CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 8899885 488877643 456888889999999999999999 99999999999999999999999999999987543
Q ss_pred Ccc-ceecccccccccccccccc
Q 046199 879 EES-MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~-~~~~~~gt~~y~APE~l~~ 900 (902)
.+. ..+..+-|..|+|||++++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc
Confidence 332 2334567899999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=209.60 Aligned_cols=164 Identities=29% Similarity=0.376 Sum_probs=140.9
Q ss_pred ccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
|...+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999875 48899999987432 23345788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+. +++.+++......+++..+..++.|++.|++||| +.|++||||+|+||+++.++.+||+|||.+..... .
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~ 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----A 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----C
Confidence 96 5787877666667899999999999999999999 99999999999999999999999999999865322 1
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....|+..|+|||++.
T Consensus 175 ~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 175 NSFVGTPYWMAPEVIL 190 (313)
T ss_pred CCccccccccChhhcc
Confidence 2356889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-22 Score=209.93 Aligned_cols=166 Identities=28% Similarity=0.460 Sum_probs=137.3
Q ss_pred CeecccceeeEEEEEeCC-------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFLD-------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.||+|+||.||+|++.+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998743 2579999876543 23457788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-----cEEEEeecC
Q 046199 804 MANGSLEKCLYSS------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-----VAHLSDFGI 872 (902)
Q Consensus 804 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-----~~kL~DFG~ 872 (902)
+++++|.+++... ...+++..+..++.|++.|++|+| +.+++|+||||+||+++.++ .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998652 234788899999999999999999 99999999999999999877 899999999
Q ss_pred ceecCCCccc--eecccccccccccccccc
Q 046199 873 AKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
++........ .....++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD 187 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc
Confidence 9765433221 112345788999998753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=215.25 Aligned_cols=175 Identities=25% Similarity=0.373 Sum_probs=144.9
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
....++....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344556667899999999999999999999874 58899999987542 223466788999999999999999999875
Q ss_pred cC------CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 793 NG------NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 793 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
.. ...|++++++ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+|
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 43 3468888887 7799887743 35889999999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCccceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||+++..... .....+++.|+|||++.
T Consensus 161 l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 161 ILDFGLARHTDDE---MTGYVATRWYRAPEIML 190 (345)
T ss_pred Eeccccccccccc---ccccccCCCccCHHHHh
Confidence 9999999764322 22346889999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=210.79 Aligned_cols=168 Identities=32% Similarity=0.452 Sum_probs=145.5
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
|+..+.||+|++|.||+|+..+ ++.||+|++.... ....+.+..|+++++.++||+++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5677889999999999999865 8999999987653 334467788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
+ ++|.+++......+++..+..++.|++.|++||| +.||+||||+|+||++++++.+||+|||.++..........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 7 5999999766457899999999999999999999 99999999999999999999999999999987654433333
Q ss_pred ccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 ~~~gt~~y~APE~l~ 899 (902)
...++..|+|||++.
T Consensus 157 ~~~~~~~~~aPE~~~ 171 (282)
T cd07829 157 HEVVTLWYRAPEILL 171 (282)
T ss_pred ccccCcCcCChHHhc
Confidence 345678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=210.66 Aligned_cols=167 Identities=30% Similarity=0.422 Sum_probs=142.8
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
...|+..+.||+|+||.||+|++.. ++.||+|.+... .....+++.+|+++++.++|+|++++++++...+..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3457778899999999999999864 788999988643 223345778899999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+. |++.+.+......+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+|++|||.+......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 5887777655566899999999999999999999 999999999999999999999999999998765432
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
....+++.|+|||++.
T Consensus 169 ---~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 ---NXFVGTPYWMAPEVIL 184 (308)
T ss_pred ---ccccCCccccCHHHHh
Confidence 2245888999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=208.52 Aligned_cols=167 Identities=27% Similarity=0.399 Sum_probs=142.2
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEcc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-GALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
|++.+.||+|++|.||+|+..+ ++.||+|++..... .......+|+..+++++ ||+|+++++++..++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6778999999999999999865 78899999865432 22234567899999998 999999999999999999999999
Q ss_pred CCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 805 ANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
++++.+++.... ..+++..+..++.|++.|+.||| +++++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-Y 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-c
Confidence 779988886654 46899999999999999999999 99999999999999999999999999999987654332 2
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....++..|+|||++.
T Consensus 156 ~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 156 TDYVSTRWYRAPEILL 171 (283)
T ss_pred CCCCCcccccCceeee
Confidence 2356888999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=204.81 Aligned_cols=161 Identities=27% Similarity=0.375 Sum_probs=133.6
Q ss_pred CeecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHH-HhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVL-KSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|.+.. ++.||+|+++.... .....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999998854 88999999865432 1223344555444 445899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
++|.+++... ..+++..+..++.|++.||.|+| +.+++||||+|+||++++++.+||+|||.++.... ....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~ 153 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKF 153 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccC
Confidence 9999998654 45889999999999999999999 99999999999999999999999999999876433 2234
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.+++.|+|||.+..
T Consensus 154 ~~~~~y~~pe~~~~ 167 (260)
T cd05611 154 VGTPDYLAPETILG 167 (260)
T ss_pred CCCcCccChhhhcC
Confidence 58889999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=210.40 Aligned_cols=173 Identities=28% Similarity=0.337 Sum_probs=143.9
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 798 (902)
....++|++.+.||+|+||.||+|++.+ ++.||||.++... ......+.+|+.++.... ||||+++++++.++...|
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3455789999999999999999999875 8999999987543 233455667777776665 999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+||||++ +++.+++......+++..+..++.|++.|++||| + .+|+||||+|+||++++++.+||+|||.+..+.
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999985 4787777665567899999999999999999999 6 599999999999999999999999999997664
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..... ....+++.|+|||++.
T Consensus 167 ~~~~~-~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 167 DSKAK-TRSAGCAAYMAPERID 187 (296)
T ss_pred CCCcc-cCCCCCccccCHhhcC
Confidence 33222 2245788999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=212.50 Aligned_cols=171 Identities=29% Similarity=0.440 Sum_probs=141.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecC-------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNG------- 794 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 794 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999876 488999999865432 2235678899999999999999999887443
Q ss_pred -CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 795 -NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 795 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
...++||||+++ ++...+......+++..+..++.|+++||+||| +.||+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 356999999965 777777655567999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccc-----------eeccccccccccccccc
Q 046199 874 KLLNGEESM-----------RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~-----------~~~~~gt~~y~APE~l~ 899 (902)
+........ .+...+++.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 765432211 11235688899999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-22 Score=202.15 Aligned_cols=171 Identities=23% Similarity=0.281 Sum_probs=144.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-C-C----CccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H-R----NLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 796 (902)
...+|.+...+|+|.||.|-++.+.. +..||+|+++.- ....+..+-|+++++++. + | -+|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 47899999999999999999998865 788999998743 345567788999999993 2 3 38888999999999
Q ss_pred eEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--------------
Q 046199 797 KALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-------------- 861 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------------- 861 (902)
.|+|+|.+ |-++.+++.+. ..+++...+..+++|++++++||| +.+++|-|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999988 66999999763 456999999999999999999999 999999999999999932
Q ss_pred ------CCcEEEEeecCceecCCCccceecccccccccccccccccC
Q 046199 862 ------DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 862 ------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 902 (902)
+..+|++|||.|+...... ...+.|..|+|||+++++.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLG 285 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccC
Confidence 2358999999998754333 4567899999999998863
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=210.71 Aligned_cols=170 Identities=28% Similarity=0.326 Sum_probs=139.9
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|+..+.||+|+||.||++.+.. ++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467778899999999999998864 8999999987543 334567889999999996 9999999999999999999999
Q ss_pred ccCCCChHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 803 YMANGSLEKCL---YS-SNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 803 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|++. ++.++. .. ....+++..+..++.|++.|++||| + .+++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 555432 22 2356899999999999999999999 5 599999999999999999999999999997654
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..... ....|++.|+|||++..
T Consensus 160 ~~~~~-~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 160 DSIAK-TRDAGCRPYMAPERIDP 181 (288)
T ss_pred cCCcc-ccccCccCccCHHHhcc
Confidence 33222 23468899999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=206.13 Aligned_cols=169 Identities=25% Similarity=0.458 Sum_probs=136.9
Q ss_pred ccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC------
Q 046199 728 FSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 795 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 795 (902)
|++.+.||+|+||.||+|.+. .++.||+|+++... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999763 36889999987543 334567889999999999999999999875432
Q ss_pred eeEEEEEccCCCChHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 796 FKALVLEYMANGSLEKCLYSS-----NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
..++++||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347889999999998876432 124788899999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCccce--eccccccccccccccc
Q 046199 871 GIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 871 G~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
|.++......... ....+++.|+|||.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA 188 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHh
Confidence 9998764332211 1234567899999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=211.03 Aligned_cols=168 Identities=22% Similarity=0.221 Sum_probs=137.7
Q ss_pred ccccCeecccceeeEEEEEeCCCcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
|.+.+.+|.|+++.||+++. +++.||+|+++.. .....+.+.+|+++++.++||||+++++++..++..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455556666666666554 6899999998754 23455789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc---
Q 046199 806 NGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--- 881 (902)
Q Consensus 806 ~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--- 881 (902)
++++.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998753 345889999999999999999999 99999999999999999999999999999876543221
Q ss_pred ----ceeccccccccccccccc
Q 046199 882 ----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ----~~~~~~gt~~y~APE~l~ 899 (902)
......++..|+|||++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred ccccccccccccccccCHHHhc
Confidence 112235778899999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-22 Score=232.47 Aligned_cols=213 Identities=28% Similarity=0.472 Sum_probs=121.5
Q ss_pred eeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcc
Q 046199 32 CSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSF 111 (902)
Q Consensus 32 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~ 111 (902)
+.|.-..|... ..+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+|+ .+|..
T Consensus 168 a~~r~~~Cl~~--~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~ 238 (754)
T PRK15370 168 AVQRMRDCLKN--NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPAT 238 (754)
T ss_pred HHHHHHhhccc--CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChh
Confidence 34444456433 4678888888887 5776554 47888888888888 7787665 57888888888887 44543
Q ss_pred cccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCCh
Q 046199 112 IISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPS 191 (902)
Q Consensus 112 ~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 191 (902)
+ ..+|+.|++++|.++ .+|..+. ++|++|+|++|+++ .+|..+. ++|++|+|++|+++ .+|.
T Consensus 239 l---~~~L~~L~Ls~N~L~---------~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~ 300 (754)
T PRK15370 239 L---PDTIQEMELSINRIT---------ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPA 300 (754)
T ss_pred h---hccccEEECcCCccC---------cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcc
Confidence 2 235666666666664 1444443 35666666666666 4555443 35666666666666 3444
Q ss_pred hhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEec
Q 046199 192 SIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSL 271 (902)
Q Consensus 192 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (902)
.+. ++|+.|++++|.++. +| ..+ .++|+.|++++|.++ .+|..+. ++|+.|+|
T Consensus 301 ~lp--~sL~~L~Ls~N~Lt~-----------LP---------~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~L 353 (754)
T PRK15370 301 HLP--SGITHLNVQSNSLTA-----------LP---------ETL--PPGLKTLEAGENALT-SLPASLP--PELQVLDV 353 (754)
T ss_pred cch--hhHHHHHhcCCcccc-----------CC---------ccc--cccceeccccCCccc-cCChhhc--CcccEEEC
Confidence 332 345666666665442 11 211 135555666666555 2444332 45555555
Q ss_pred cCcccccCCCcCCcccCCCcccceeeccCccCC
Q 046199 272 LNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304 (902)
Q Consensus 272 s~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~ 304 (902)
++|+++ .+|..+ .++|++|++++|+++
T Consensus 354 s~N~L~-~LP~~l-----p~~L~~LdLs~N~Lt 380 (754)
T PRK15370 354 SKNQIT-VLPETL-----PPTITTLDVSRNALT 380 (754)
T ss_pred CCCCCC-cCChhh-----cCCcCEEECCCCcCC
Confidence 555554 334321 134444444444444
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=201.90 Aligned_cols=163 Identities=34% Similarity=0.422 Sum_probs=141.6
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
||+|+||.||+|.+.+ ++.||+|+++.... ...+.+..|+.+++.++||+|+++++.+..++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999998864 88999999875432 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccc
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt 889 (902)
.+++... ..+++..+..++.|++.|+.|+| +.+++|+||+|+||+++.++.++|+|||.+..............++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 9998654 35889999999999999999999 9999999999999999999999999999998765443233345688
Q ss_pred ccccccccccc
Q 046199 890 IGYMAPGLWVV 900 (902)
Q Consensus 890 ~~y~APE~l~~ 900 (902)
..|+|||.+..
T Consensus 157 ~~~~~Pe~~~~ 167 (250)
T cd05123 157 PEYLAPEVLLG 167 (250)
T ss_pred ccccChHHhCC
Confidence 89999998753
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=211.19 Aligned_cols=170 Identities=29% Similarity=0.422 Sum_probs=142.6
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec-CCee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFK 797 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 797 (902)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446789999999999999999999876 58999999876432 2344678899999999999999999998865 5678
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+ +++|.+++.. ..+++..+..++.|++.|++||| +.+|+||||+|+||++++++.+||+|||.+....
T Consensus 86 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 9999998 5689888753 34788888899999999999999 9999999999999999999999999999997643
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. .....+++.|+|||++..
T Consensus 160 ~~---~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 160 PQ---MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CC---cCCCcccccccCceeeec
Confidence 22 123457889999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=211.13 Aligned_cols=168 Identities=26% Similarity=0.346 Sum_probs=137.6
Q ss_pred cccccCeecccceeeEEEEEeCC---CcEEEEEEeeecc--chhhhhHHHHHHHHHhC-CCCCccceeeeeec----CCe
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF--DGALKSFDAECEVLKSV-RHRNLVKIISSCSN----GNF 796 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 796 (902)
+|++.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 6789999986432 22346778899999999 59999999987532 245
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+++||++ ++|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 789999986 589888854 456899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCcc----ceeccccccccccccccc
Q 046199 877 NGEES----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~----~~~~~~gt~~y~APE~l~ 899 (902)
..... ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred ccccccccccccCcccCccccCcHHHh
Confidence 43221 112246899999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-22 Score=189.67 Aligned_cols=168 Identities=21% Similarity=0.427 Sum_probs=142.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecC--CeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNG--NFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 799 (902)
..++|++.+.+|+|.|++||.|... +.++++||++++. ..+.+.+|+.+++.+. ||||+++++...+. ...-+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678999999999999999999864 4788999998754 4578899999999997 99999999998765 45679
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~ 878 (902)
|+||+.+.+...+. ..++...+..++.+++.||.|+| +.||+|||+||.|++||.. -.++|+|+|+|.+..+
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999998877655 34677889999999999999999 9999999999999999875 4799999999988765
Q ss_pred CccceecccccccccccccccccC
Q 046199 879 EESMRTQTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~~~ 902 (902)
.... .-.+.+..|--||++.+++
T Consensus 186 ~~eY-nVRVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 186 GKEY-NVRVASRYFKGPELLVDYQ 208 (338)
T ss_pred Ccee-eeeeehhhcCCchheeech
Confidence 5433 3356788899999998764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=210.85 Aligned_cols=165 Identities=24% Similarity=0.336 Sum_probs=135.2
Q ss_pred Ceeccc--ceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
..||+| +||+||+|++. .++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999985 58999999987543 23457888999999999999999999999999999999999999
Q ss_pred CChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce--
Q 046199 807 GSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-- 883 (902)
Q Consensus 807 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-- 883 (902)
+++.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999886542 35889999999999999999999 9999999999999999999999999998654332211110
Q ss_pred -----eccccccccccccccc
Q 046199 884 -----TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 -----~~~~gt~~y~APE~l~ 899 (902)
....++..|||||++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~ 181 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLR 181 (328)
T ss_pred cccccccccCccCccChhhhc
Confidence 1123466799999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=204.23 Aligned_cols=169 Identities=27% Similarity=0.396 Sum_probs=140.0
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+|.+.+.||+|+||.||+|++.. +..+++|+.+... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998754 4456666554321 22334567899999999999999999999999999999
Q ss_pred EEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|||+++++|.+++.. ....+++..+..++.|++.|++||| +.|++|+|+||+||++++ +.+|++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988754 3356899999999999999999999 999999999999999975 579999999998765
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..........|++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred CCcccccCCCCCcCccCHHHHc
Confidence 5444334456889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=212.79 Aligned_cols=169 Identities=28% Similarity=0.415 Sum_probs=140.5
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC---------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG--------- 794 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 794 (902)
..+|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4789999999999999999998864 889999998766555567788999999999999999999876543
Q ss_pred -----CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEE
Q 046199 795 -----NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLS 868 (902)
Q Consensus 795 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~ 868 (902)
...|+||||++ ++|.+++.. ..+++..+..++.||+.|++||| +.||+||||||+||+++. ++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 589888743 35889999999999999999999 999999999999999974 5578999
Q ss_pred eecCceecCCCccc---eeccccccccccccccc
Q 046199 869 DFGIAKLLNGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 869 DFG~a~~~~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
|||.+......... .....++..|+|||++.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHh
Confidence 99999865432221 12235788999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=210.40 Aligned_cols=165 Identities=26% Similarity=0.419 Sum_probs=138.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------C
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------N 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 795 (902)
.++|.+.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999875 58999999986532 22345678999999999999999999988654 3
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+.. ++.++. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 777654 235889999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCccceeccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.... .....+++.|+|||++.
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~ 187 (342)
T cd07879 167 ADAE---MTGYVVTRWYRAPEVIL 187 (342)
T ss_pred CCCC---CCCceeeecccChhhhc
Confidence 5322 22345788999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=204.63 Aligned_cols=173 Identities=22% Similarity=0.313 Sum_probs=127.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeeccchhh-----------hhHHHHHHHHHhCCCCCccce
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFDGAL-----------KSFDAECEVLKSVRHRNLVKI 787 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 787 (902)
+..++|++.+.||+|+||.||+|++.+ +..+|+|+......... .....+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345789999999999999999998754 34566665433221110 111223344556789999999
Q ss_pred eeeeecCC----eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 788 ISSCSNGN----FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 788 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
++++.... ..++++|++.. ++.+.+... ...++..+..++.|++.|++||| +++|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 98765443 45788888744 666665432 33578888999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCcc-------ceecccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
.+||+|||+|+.+..... ......||+.|+|||++..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC
Confidence 999999999987643221 1122469999999998753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=203.37 Aligned_cols=167 Identities=32% Similarity=0.485 Sum_probs=138.9
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhC---CCCCccceeeeeecCCe-----
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCSNGNF----- 796 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 796 (902)
|++.+.||+|+||.||+|++.. +++||+|+++.... .....+.+|+.+++++ +||+|+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999865 89999999975432 2234566788777666 59999999999987776
Q ss_pred eEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 797 KALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.+++|||+++ ++.+++.... ..+++..+..++.|++.||+||| +.+++|+|++|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8988886543 35899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccceeccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...... .....++..|+|||++.
T Consensus 157 ~~~~~~-~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 157 YSFEMA-LTSVVVTLWYRAPEVLL 179 (287)
T ss_pred ccCCcc-cccccccccccChHHhc
Confidence 654322 22345788999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=220.89 Aligned_cols=169 Identities=22% Similarity=0.281 Sum_probs=121.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-----CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeee------ee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS------CS 792 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 792 (902)
..++|++.+.||+|+||.||+|++.+ +..||+|++...... +....| .++...+..++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999998854 688999987543211 111111 1122222222222221 24
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNRS-------------------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIK 853 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlk 853 (902)
.+...++||||+++++|.+++...... .....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 566889999999999999988654321 112345679999999999999 9999999999
Q ss_pred CCCEEEcC-CCcEEEEeecCceecCCCcc-ceeccccccccccccccc
Q 046199 854 PSNILLDD-DMVAHLSDFGIAKLLNGEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 854 p~NIll~~-~~~~kL~DFG~a~~~~~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
|+|||++. ++.+||+|||+|+.+..... ......+|+.|||||.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99999986 57999999999986543322 223467899999999653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-21 Score=189.49 Aligned_cols=141 Identities=18% Similarity=0.184 Sum_probs=111.0
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccch--h-------h-----------------hhHHHHHHHHHhCCCCCc
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG--A-------L-----------------KSFDAECEVLKSVRHRNL 784 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 784 (902)
.+.||+|+||.||+|...+|++||+|+++..... . . .....|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 0 1 122459999999988877
Q ss_pred cceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCCCCCEEEcCCC
Q 046199 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL-HFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 785 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
.....+... ..++||||++|+++...... ...++...+..++.|++.+++|+ | +.||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 544433222 23899999999877654322 34688899999999999999999 7 88999999999999998 47
Q ss_pred cEEEEeecCceecCC
Q 046199 864 VAHLSDFGIAKLLNG 878 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~ 878 (902)
.++++|||+|.....
T Consensus 155 ~v~LiDFG~a~~~~~ 169 (190)
T cd05147 155 KLYIIDVSQSVEHDH 169 (190)
T ss_pred cEEEEEccccccCCC
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=210.76 Aligned_cols=167 Identities=27% Similarity=0.396 Sum_probs=142.1
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF---- 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 796 (902)
..++|++.+.||+|++|.||+|++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46789999999999999999999864 7899999886532 2234667789999999999999999998866554
Q ss_pred --eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 797 --KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 797 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||||+||++++++.+||+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6699998854 45899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceeccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..... .....++..|+|||++.
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~ 188 (343)
T cd07851 167 HTDDE---MTGYVATRWYRAPEIML 188 (343)
T ss_pred ccccc---ccCCcccccccCHHHHh
Confidence 75433 22346788999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=196.06 Aligned_cols=151 Identities=19% Similarity=0.117 Sum_probs=127.6
Q ss_pred cceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChHHHHhh
Q 046199 737 GSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS 815 (902)
Q Consensus 737 G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 815 (902)
|.+|.||+|++.. ++.||+|+++... ...+|...+....||||+++++++...+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999864 8899999987542 233455555666799999999999999999999999999999998865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccccccccc
Q 046199 816 SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895 (902)
Q Consensus 816 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~AP 895 (902)
. ..+++..+..++.|++.|++|+| ++||+||||||+||+++.++.++++|||.+....... ....++..|+||
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aP 151 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAP 151 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCC
Confidence 4 35899999999999999999999 9999999999999999999999999999887654321 224467789999
Q ss_pred cccc
Q 046199 896 GLWV 899 (902)
Q Consensus 896 E~l~ 899 (902)
|++.
T Consensus 152 E~~~ 155 (237)
T cd05576 152 EVGG 155 (237)
T ss_pred cccC
Confidence 9864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-21 Score=213.00 Aligned_cols=165 Identities=34% Similarity=0.515 Sum_probs=133.8
Q ss_pred ccccCeeccccee-eEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEccC
Q 046199 728 FSEKSLIGIGSFG-TVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 728 y~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
|.-.+.+|.|+.| .||+|.. ++++||||++-.+ ..+..++|+..++.- +|||||++|+.-.++++.||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3445678899886 5899988 7889999987543 345678999999888 59999999999999999999999996
Q ss_pred CCChHHHHhhCCCC--CCH-HHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---C--CcEEEEeecCceecC
Q 046199 806 NGSLEKCLYSSNRS--LDI-FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---D--MVAHLSDFGIAKLLN 877 (902)
Q Consensus 806 ~g~L~~~l~~~~~~--~~~-~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~--~~~kL~DFG~a~~~~ 877 (902)
. +|+++++..... ... .....+..|++.||++|| +.+||||||||.||||+. + .+++|+|||+++++.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 999999763111 111 345778999999999999 999999999999999965 3 479999999999987
Q ss_pred CCccc---eecccccccccccccccc
Q 046199 878 GEESM---RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~---~~~~~gt~~y~APE~l~~ 900 (902)
..... ..+..||-+|+|||++..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~ 688 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLRE 688 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhc
Confidence 65443 223679999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=217.72 Aligned_cols=178 Identities=26% Similarity=0.462 Sum_probs=149.9
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCC--------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIIS 789 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 789 (902)
.+++..++..+.+.+|+|+||.|++|.... ...||||..+... ..+.+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455666667778899999999999996421 4569999987543 35678899999999999 5999999999
Q ss_pred eeecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCC
Q 046199 790 SCSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 854 (902)
Q Consensus 790 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (902)
++..++..++|+||++.|+|.++++..+ ..+...+...++.|||.|++||+ +.++||||+.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998766 34888899999999999999999 99999999999
Q ss_pred CCEEEcCCCcEEEEeecCceecCCCccce-ecccc--cccccccccccc
Q 046199 855 SNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLG--TIGYMAPGLWVV 900 (902)
Q Consensus 855 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~g--t~~y~APE~l~~ 900 (902)
+||++.++..+||+|||+|+......... ....| ...|||||.+.+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 99999999999999999999765544433 22233 345999998754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=182.41 Aligned_cols=142 Identities=20% Similarity=0.201 Sum_probs=113.1
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchh--------------------------hhhHHHHHHHHHhCCCCCc
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--------------------------LKSFDAECEVLKSVRHRNL 784 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 784 (902)
.+.||+|++|.||+|++.+|+.||||+++...... ...+.+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999998789999999987542110 1234678999999999987
Q ss_pred cceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC
Q 046199 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 785 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~ 863 (902)
.....+.... .|+||||++|+++...... ...++......++.|++.++.++| + .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 6555444332 4899999998855433212 245678889999999999999999 8 9999999999999999 78
Q ss_pred cEEEEeecCceecCCC
Q 046199 864 VAHLSDFGIAKLLNGE 879 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~ 879 (902)
.++|+|||+|.....+
T Consensus 155 ~~~liDFG~a~~~~~~ 170 (190)
T cd05145 155 KPYIIDVSQAVELDHP 170 (190)
T ss_pred CEEEEEcccceecCCC
Confidence 9999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=185.51 Aligned_cols=168 Identities=33% Similarity=0.468 Sum_probs=146.4
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccC
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
|++.+.||+|++|.||+|...+ ++++|+|.+...... ..+.+.+|++.++.++|++++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999876 889999999866544 56789999999999999999999999999899999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc-ccee
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRT 884 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~ 884 (902)
+++|.+++......+++..+..++.+++.++.++| +.+++|+|++|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998664433789999999999999999999 8999999999999999999999999999998775442 1122
Q ss_pred cccccccccccccc
Q 046199 885 QTLGTIGYMAPGLW 898 (902)
Q Consensus 885 ~~~gt~~y~APE~l 898 (902)
...++..|++||++
T Consensus 158 ~~~~~~~~~~pe~~ 171 (225)
T smart00221 158 TVKGTPFYLAPEVL 171 (225)
T ss_pred ceeccCCcCCHhHh
Confidence 34578889999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-20 Score=175.13 Aligned_cols=169 Identities=26% Similarity=0.359 Sum_probs=140.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCC-CCccceeeeeecCCeeEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 799 (902)
.+....|.+++.||.|+||.+|.|... .|.+||||+-.... ....+..|..+++.+++ ..|+.+..++.+..+-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 355678999999999999999999875 59999999865433 23567789999999975 678888888889999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~ 876 (902)
||+.. |.+|+++..-..+.++..++..++-|++.-++|+| .++++||||||+|+|+.- ...+.++|||+|+++
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99988 78999998777788999999999999999999999 999999999999999953 347899999999987
Q ss_pred CCCccc-------eecccccccccccc
Q 046199 877 NGEESM-------RTQTLGTIGYMAPG 896 (902)
Q Consensus 877 ~~~~~~-------~~~~~gt~~y~APE 896 (902)
.+..+. .....||..|++--
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred ccccccccCccccCCccceeeeehhhh
Confidence 654332 12245888887643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=180.03 Aligned_cols=168 Identities=20% Similarity=0.298 Sum_probs=135.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceee-eeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIIS-SCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv 800 (902)
..+.|.+.+.+|+|.||.+-.|+++. .+.+|+|.++.... ..++|.+|..---.+ .|.||+.-|+ .|+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 35789999999999999999999976 77899998876532 347788887654444 5899998776 56788899999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceecCC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL~DFG~a~~~~~ 878 (902)
+||++.|+|.+-+.. ..+.+....+++.|+++|++|+| ++.+||||||.+||||- +..+||+||||..+..+.
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999987744 44778889999999999999999 99999999999999993 334899999999886543
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.- ....-+..|.|||+...
T Consensus 176 tV---~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 176 TV---KYLEYVNNYHAPELCDT 194 (378)
T ss_pred ee---hhhhhhcccCCcHHHhh
Confidence 21 12234667999997643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-19 Score=179.72 Aligned_cols=164 Identities=39% Similarity=0.607 Sum_probs=142.2
Q ss_pred ecccceeeEEEEEeCC-CcEEEEEEeeeccch-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChHH
Q 046199 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEK 811 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 811 (902)
||+|++|.||+++..+ ++++++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999998765432 35789999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecCCCccceecccccc
Q 046199 812 CLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEESMRTQTLGTI 890 (902)
Q Consensus 812 ~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~gt~ 890 (902)
++.......++..+..++.+++.++++|| +.+++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 98765456889999999999999999999 999999999999999999 89999999999987654432223355788
Q ss_pred cccccccccc
Q 046199 891 GYMAPGLWVV 900 (902)
Q Consensus 891 ~y~APE~l~~ 900 (902)
.|++||.+..
T Consensus 158 ~~~~pe~~~~ 167 (215)
T cd00180 158 AYMAPEVLLG 167 (215)
T ss_pred CccChhHhcc
Confidence 9999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.9e-20 Score=199.87 Aligned_cols=164 Identities=27% Similarity=0.323 Sum_probs=136.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..+.|++...+|.|+|+.|-.+.+.. .+..++|++.... .+..+|+.++... +||||+++++.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 45678888889999999999998754 8889999997652 3345677665555 7999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE-cCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL-DDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|++.|+-+.+.+..... ...++..|+++|+.|+.||| ++|+||||+||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999988777754332 22677789999999999999 9999999999999999 58899999999999876544
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
..+.+-|..|.|||++.
T Consensus 470 --~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLA 486 (612)
T ss_pred --hcccchhhcccChhhhc
Confidence 22356788999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-20 Score=185.32 Aligned_cols=170 Identities=26% Similarity=0.352 Sum_probs=139.8
Q ss_pred hcccccccCeecccceeeEEEEEe-CCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 794 (902)
...+|.-.+.+|.|+- .|..|-+ ..+++||+|+..... ....++..+|..++..+.|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3457888888999988 5655654 348999999875443 23456778999999999999999999998543
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
...|+|||||.. +|...+. ...+-..+..+++|++.|++|+| +.||+||||||+||++..++.+||.|||+|+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence 467999999965 8888775 34677889999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccccC
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVVLN 902 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~~~ 902 (902)
.-... -.-+..+.|..|+|||++++++
T Consensus 167 ~e~~~-~~mtpyVvtRyyrapevil~~~ 193 (369)
T KOG0665|consen 167 TEDTD-FMMTPYVVTRYYRAPEVILGMG 193 (369)
T ss_pred ccCcc-cccCchhheeeccCchheeccC
Confidence 75433 2345577899999999998874
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-21 Score=174.88 Aligned_cols=165 Identities=32% Similarity=0.536 Sum_probs=104.8
Q ss_pred cCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcc
Q 046199 64 LGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143 (902)
Q Consensus 64 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~ 143 (902)
+..+++.+.|-||+|+++ .+|+.+..|.+|+.|++++|+++. +|.. ++.++.|+.|.++.|++. .+|.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~-issl~klr~lnvgmnrl~---------~lpr 96 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTS-ISSLPKLRILNVGMNRLN---------ILPR 96 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChh-hhhchhhhheecchhhhh---------cCcc
Confidence 344455555555555555 555555555555555555555542 2222 233444444444444442 2677
Q ss_pred cccCcCccceeeecccccCC-CCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCC
Q 046199 144 DIGNLTKLKELYLGYNKLQG-EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGS 222 (902)
Q Consensus 144 ~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ 222 (902)
+||.++.|+.|||.+|++.. .+|..|..++.|+.|+|++|.+. .+|..+++|++|+.|.+.+|.+-
T Consensus 97 gfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll------------ 163 (264)
T KOG0617|consen 97 GFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL------------ 163 (264)
T ss_pred ccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh------------
Confidence 88888888888888887763 37777778888888888888877 77777788888888877777753
Q ss_pred ccccccccCCCccccCCCCCCEEEccCccccCcCCCcccC
Q 046199 223 IPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFN 262 (902)
Q Consensus 223 ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 262 (902)
++|.+++.++.|+.|.+.+|+++ .+|+.+++
T Consensus 164 --------~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 164 --------SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred --------hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 34577777777777777777776 55655544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=176.66 Aligned_cols=167 Identities=25% Similarity=0.398 Sum_probs=143.0
Q ss_pred hhcccccccCeecccceeeEEEEEe-CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 800 (902)
+..-.|++.+.||+|+||+++.|+. ..+++||||.-....+ ..++..|.+.++.+. .+.|+.+|-+..++.+-.+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 4456899999999999999999975 4689999998665443 367888999999984 79999999888888888999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-----CcEEEEeecCcee
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-----MVAHLSDFGIAKL 875 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~kL~DFG~a~~ 875 (902)
+|.+ |.+|+|+..-.++.++.+++..+|.|++.-++|+| ++.+|.|||||+|+||... ..+.|+|||+|+.
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9988 78999998778889999999999999999999999 9999999999999999643 3689999999998
Q ss_pred cCCCcccee-------ccccccccccc
Q 046199 876 LNGEESMRT-------QTLGTIGYMAP 895 (902)
Q Consensus 876 ~~~~~~~~~-------~~~gt~~y~AP 895 (902)
+.++.+... ...||.+||+=
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSI 205 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSI 205 (449)
T ss_pred hcCccccccCccccccccccceeeeEe
Confidence 877665322 24599999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=182.12 Aligned_cols=157 Identities=37% Similarity=0.503 Sum_probs=137.5
Q ss_pred ceeeEEEEEeCC-CcEEEEEEeeeccchh-hhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChHHHHhh
Q 046199 738 SFGTVYKGRFLD-GMEVAIKVFHLQFDGA-LKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS 815 (902)
Q Consensus 738 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 815 (902)
+||.||+|.+.+ ++.||+|++....... .+.+.+|++.+++++|++|+++++.+......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999997655433 68899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceeccccccccccc
Q 046199 816 SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895 (902)
Q Consensus 816 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~AP 895 (902)
... +++..+..++.+++.++.||| +.+++|+||+|+||++++++.++++|||.+....... ......++..|+||
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 443 889999999999999999999 9999999999999999999999999999998765432 22335688899999
Q ss_pred cccc
Q 046199 896 GLWV 899 (902)
Q Consensus 896 E~l~ 899 (902)
|.+.
T Consensus 156 E~~~ 159 (244)
T smart00220 156 EVLL 159 (244)
T ss_pred HHHc
Confidence 9864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=189.14 Aligned_cols=173 Identities=31% Similarity=0.366 Sum_probs=145.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC------CCCccceeeeeecC
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR------HRNLVKIISSCSNG 794 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 794 (902)
+.--.+|.+....|+|-|+.|.+|.+.. |..||||+++... ...+.=.+|+++|++|. -.|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3456789999999999999999999865 8899999997552 23355578999999995 35799999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeec
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFG 871 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG 871 (902)
++.|+|+|-+. .+|.+++++.+. .+....+..++.|+..||..|. ..||+|.||||+||||++. ..+||||||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 99999999884 599999977543 4777889999999999999999 9999999999999999875 478999999
Q ss_pred CceecCCCccceeccccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
.|....... .+....+..|+|||+++++
T Consensus 583 SA~~~~ene--itPYLVSRFYRaPEIiLG~ 610 (752)
T KOG0670|consen 583 SASFASENE--ITPYLVSRFYRAPEIILGL 610 (752)
T ss_pred ccccccccc--ccHHHHHHhccCcceeecC
Confidence 998775443 3445567889999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=173.12 Aligned_cols=139 Identities=18% Similarity=0.306 Sum_probs=108.4
Q ss_pred ccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC-----CCCCccceeeeeecCC---eeE-
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-----RHRNLVKIISSCSNGN---FKA- 798 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 798 (902)
+.-.+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999995 544333479988765444567899999999999 5799999999998863 434
Q ss_pred EEEEc--cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHccCCCCeEEcCCCCCCEEEcC----CCcEEEEe-e
Q 046199 799 LVLEY--MANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL-EYLHFGYSNPVVHCDIKPSNILLDD----DMVAHLSD-F 870 (902)
Q Consensus 799 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~~~~ivHrDlkp~NIll~~----~~~~kL~D-F 870 (902)
+|||| +++++|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+||+++. ++.++|+| |
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999653 35544 35678888777 9999 999999999999999974 33799999 5
Q ss_pred cCcee
Q 046199 871 GIAKL 875 (902)
Q Consensus 871 G~a~~ 875 (902)
|.+..
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-21 Score=173.83 Aligned_cols=181 Identities=25% Similarity=0.433 Sum_probs=101.6
Q ss_pred ccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCch
Q 046199 88 IFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ 167 (902)
Q Consensus 88 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~ 167 (902)
+..+++.+.|-||+|.++- +|..|..+.+|+.|++++|++. ++|.
T Consensus 29 Lf~~s~ITrLtLSHNKl~~----------------------------------vppnia~l~nlevln~~nnqie-~lp~ 73 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTV----------------------------------VPPNIAELKNLEVLNLSNNQIE-ELPT 73 (264)
T ss_pred ccchhhhhhhhcccCceee----------------------------------cCCcHHHhhhhhhhhcccchhh-hcCh
Confidence 6678888999999999984 4555555555556666655555 5555
Q ss_pred hhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEc
Q 046199 168 ELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247 (902)
Q Consensus 168 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~L 247 (902)
+++.+++|+.|+++-|++. .+|..|+.++.|++|||++|.+.. . .+|..|.-+..|+.|+|
T Consensus 74 ~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e---------~---------~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 74 SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE---------N---------SLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc---------c---------cCCcchhHHHHHHHHHh
Confidence 5555666666666555555 555556656666666665555432 1 12334444455555555
Q ss_pred cCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccc---cccEEEccC
Q 046199 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS---KLFLLELTG 324 (902)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~---~L~~L~Ls~ 324 (902)
++|.+. .+|..++++++|+.|.+.+|.+- .+|.. ++.++.|++|++.+|+++ .+|..++++. +=+++.+.+
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke---ig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~ 208 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE---IGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEE 208 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH---HHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhh
Confidence 555555 55555555555555555555554 34444 445555555555555555 3333333321 223444555
Q ss_pred Cccc
Q 046199 325 NSFS 328 (902)
Q Consensus 325 N~l~ 328 (902)
|...
T Consensus 209 NPwv 212 (264)
T KOG0617|consen 209 NPWV 212 (264)
T ss_pred CCCC
Confidence 5544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=165.14 Aligned_cols=153 Identities=16% Similarity=0.111 Sum_probs=116.4
Q ss_pred cccCeecccceeeEEEEEeCCCcEEEEEEeeeccc----hhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEc
Q 046199 729 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----GALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.+...|++|+||+||.+.. ++.+++.+.+..... -....+.+|+++++++. |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998876 677888776654322 11236889999999995 5889999886 346899999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI-KPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-kp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
++|.+|.+.... ....++.|++.+++++| ++||+|||| ||+||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754311 12357889999999999 999999999 799999999999999999999865433321
Q ss_pred ----e---------eccccccccccccc
Q 046199 883 ----R---------TQTLGTIGYMAPGL 897 (902)
Q Consensus 883 ----~---------~~~~gt~~y~APE~ 897 (902)
. .....++.|++|+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~ 176 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVE 176 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHH
Confidence 0 01236777888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=179.84 Aligned_cols=145 Identities=29% Similarity=0.392 Sum_probs=126.5
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCC
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGN 795 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 795 (902)
+......|..++.||+|.|+.||+|.+. ..+.||+|.+.... ...++..|++.+..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345567899999999999999999764 36789999886553 3367889999999994 999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~ 874 (902)
...+|+||++..+..+++. .++..++..+++.+..||+++| ..|||||||||.|++.+. .+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999988888774 3668899999999999999999 999999999999999975 4678899999997
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=169.49 Aligned_cols=141 Identities=13% Similarity=0.121 Sum_probs=116.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhh---h------HHHHHHHHHhCCCCCccceeeeeec
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALK---S------FDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
.-..+|++.+.+|.|+||.||.+.. ++..+|+|+++........ . +++|+..+.+++||+|+.+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568999999999999999999766 6778999999755432222 2 6899999999999999999988653
Q ss_pred C--------CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 794 G--------NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 794 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
. +..++||||++|.+|.++.. .++ ....+++.++..+| +.|++|||+||+||+++.+| +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988631 222 34669999999999 99999999999999999998 9
Q ss_pred EEEeecCceecC
Q 046199 866 HLSDFGIAKLLN 877 (902)
Q Consensus 866 kL~DFG~a~~~~ 877 (902)
+++|||......
T Consensus 174 ~liDfg~~~~~~ 185 (232)
T PRK10359 174 RIIDLSGKRCTA 185 (232)
T ss_pred EEEECCCccccc
Confidence 999999887653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-20 Score=202.39 Aligned_cols=283 Identities=23% Similarity=0.255 Sum_probs=146.8
Q ss_pred eeeccCccCC-CCCCccccccccccEEEccCCcccCc----ccccccccccccEEecccccCCCCCCcccccccccCCCC
Q 046199 295 RLNLGLNNLS-GRIPGFIFNASKLFLLELTGNSFSGF----IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSS 369 (902)
Q Consensus 295 ~L~Ls~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~ 369 (902)
.|+|+.+.++ ......+..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+.....
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~----------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGL----------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHH-----------
Confidence 4667777776 44445556667777777777777432 3334445566777777766665311100
Q ss_pred CceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCC---CcEEEeecceecc----cCCcccccc-c
Q 046199 370 SKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN---LTTLHLGNNQLSG----SIPITVGRL-N 441 (902)
Q Consensus 370 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~ 441 (902)
..++..+..++ +|+.|++++|.+.+..+..+..+.. |++|++++|++++ .+...+..+ +
T Consensus 71 ------------~~~~~~l~~~~-~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~ 137 (319)
T cd00116 71 ------------QSLLQGLTKGC-GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137 (319)
T ss_pred ------------HHHHHHHHhcC-ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCC
Confidence 01112222222 3444444444443322222222222 5555555555542 111222333 3
Q ss_pred ccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCc----ccccccCCCCceEEEc
Q 046199 442 TLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF----IPSTFWNLNNILSFDF 517 (902)
Q Consensus 442 ~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l 517 (902)
+|+.|++++|.+++..+. .++..+..+++|+.|++++|.+++. ++..+..+++|+.|++
T Consensus 138 ~L~~L~L~~n~l~~~~~~-----------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L 200 (319)
T cd00116 138 ALEKLVLGRNRLEGASCE-----------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200 (319)
T ss_pred CceEEEcCCCcCCchHHH-----------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEec
Confidence 444444444444321110 1222344445555566665555531 2223334456666666
Q ss_pred CCCccCCC----CccccccccccceeccCCccccccCcccccc-----CCccceEEccCcccCC----CccccccccccC
Q 046199 518 SSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGDIPTTIGG-----LTNLQLLSLENNRLHG----PIPESFGALTSL 584 (902)
Q Consensus 518 s~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L 584 (902)
++|.+++. ++..+..+++|++|++++|.+++.....+.. .+.|+.|++++|.++. .++..+..+++|
T Consensus 201 ~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L 280 (319)
T cd00116 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280 (319)
T ss_pred cCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence 66655532 2223445566777777777666433333322 3688888888888862 234455666788
Q ss_pred CeEeCcCcccccc----CCcccccc-cccccccccCCcc
Q 046199 585 ESLDLSVNNLSGV----IPISLEKL-VYLKDLNLSFNRL 618 (902)
Q Consensus 585 ~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~l~~N~l 618 (902)
+.+|+++|.++.. ....+... +.|+.+|+.+|+|
T Consensus 281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 8888888888854 34444444 6788888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-18 Score=182.89 Aligned_cols=169 Identities=27% Similarity=0.352 Sum_probs=138.0
Q ss_pred cccccCeecccceeeEEEEEeCCC--cEEEEEEeeeccchhhhhHHHHHHHHHhCCC----CCccceeeee-ecCCeeEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLDG--MEVAIKVFHLQFDGALKSFDAECEVLKSVRH----RNLVKIISSC-SNGNFKAL 799 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 799 (902)
+|.+.+.||+|+||.||.|.+.+. ..+|+|............+..|+.++..+.. ++++.+++.+ ..+++.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998663 4789998776543333378889999999873 6899999999 57889999
Q ss_pred EEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-----CcEEEEeecCc
Q 046199 800 VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-----MVAHLSDFGIA 873 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~kL~DFG~a 873 (902)
||+.+ |.+|.++..... +.++..++.+++.|++.+|+++| +.|++||||||+|+.+... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 789999875544 67999999999999999999999 9999999999999999754 46999999999
Q ss_pred e--ecCCCcc-----c---eeccccccccccccccc
Q 046199 874 K--LLNGEES-----M---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~--~~~~~~~-----~---~~~~~gt~~y~APE~l~ 899 (902)
+ .+..... . .....||..|+++.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~ 210 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL 210 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhC
Confidence 8 4322211 1 12345999999988654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=171.64 Aligned_cols=150 Identities=19% Similarity=0.141 Sum_probs=115.8
Q ss_pred HhhcccccccCeecccceeeEEEEE--eCCCcEEEEEEeeeccch------------------------hhhhHHHHHHH
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQFDG------------------------ALKSFDAECEV 775 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~ 775 (902)
......|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|+..
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3334458899999999999999998 456999999998754210 11245789999
Q ss_pred HHhCCCC--CccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCC
Q 046199 776 LKSVRHR--NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP-VVHCDI 852 (902)
Q Consensus 776 l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDl 852 (902)
++++.+. .+++++++ +..++||||++|+++...... ........+..++.|++.+++++| ..| |+|||+
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di 175 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDL 175 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence 9999753 34445543 234899999999888665422 234556667899999999999999 999 999999
Q ss_pred CCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 853 KPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 853 kp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+||+++ ++.++++|||.|.....+.
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence 99999999 7899999999998665443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-19 Score=197.23 Aligned_cols=281 Identities=22% Similarity=0.233 Sum_probs=153.6
Q ss_pred eEeccCcccccCCCcCCcccCCCcccceeeccCccCCCC----CCccccccccccEEEccCCcccC------cccccccc
Q 046199 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR----IPGFIFNASKLFLLELTGNSFSG------FIPDTLVN 337 (902)
Q Consensus 268 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~ 337 (902)
.|+|..+.+++.- +...+..+.+|++|+++++.++.. ++..+...++++.|+++++.+.+ .++..+..
T Consensus 2 ~l~L~~~~l~~~~--~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~ 79 (319)
T cd00116 2 QLSLKGELLKTER--ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTK 79 (319)
T ss_pred ccccccCcccccc--hHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHh
Confidence 5788888887332 222256778899999999999542 45566677889999999998873 23345666
Q ss_pred cccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccc----cCCccc
Q 046199 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRG----NIPKEI 413 (902)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~----~~p~~~ 413 (902)
+++|+.|++++|.+.+..+ ..+..+.+ . + +|++|++++|++.+ .+...+
T Consensus 80 ~~~L~~L~l~~~~~~~~~~-----~~~~~l~~--------------------~-~-~L~~L~ls~~~~~~~~~~~l~~~l 132 (319)
T cd00116 80 GCGLQELDLSDNALGPDGC-----GVLESLLR--------------------S-S-SLQELKLNNNGLGDRGLRLLAKGL 132 (319)
T ss_pred cCceeEEEccCCCCChhHH-----HHHHHHhc--------------------c-C-cccEEEeeCCccchHHHHHHHHHH
Confidence 7788888888888765333 11111111 0 1 24444444444441 122233
Q ss_pred CCC-CCCcEEEeecceeccc----CCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcC
Q 046199 414 GNL-VNLTTLHLGNNQLSGS----IPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSL 488 (902)
Q Consensus 414 ~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 488 (902)
..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.... .++..+..+++|
T Consensus 133 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-----------------~l~~~l~~~~~L 195 (319)
T cd00116 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR-----------------ALAEGLKANCNL 195 (319)
T ss_pred HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH-----------------HHHHHHHhCCCC
Confidence 344 5666666666666632 223344445566566555555421100 111122223344
Q ss_pred ceEecCCCCccCcc----cccccCCCCceEEEcCCCccCCCCccccc-----cccccceeccCCcccc----ccCccccc
Q 046199 489 RNLSLGSNELSSFI----PSTFWNLNNILSFDFSSNSLNGSLPLDIG-----NMKVVVEINLSRNYLT----GDIPTTIG 555 (902)
Q Consensus 489 ~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~----~~~p~~~~ 555 (902)
++|++++|.+++.. +..+..+++|++|++++|.+++.....+. ..+.|++|++++|.++ ..+...+.
T Consensus 196 ~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~ 275 (319)
T cd00116 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA 275 (319)
T ss_pred CEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHh
Confidence 44444444443221 12233344455555555544432111111 1245666666666664 12334555
Q ss_pred cCCccceEEccCcccCCC----cccccccc-ccCCeEeCcCccc
Q 046199 556 GLTNLQLLSLENNRLHGP----IPESFGAL-TSLESLDLSVNNL 594 (902)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l 594 (902)
.+++|+++++++|.++.. ....+... +.|++||+.+|.+
T Consensus 276 ~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 276 EKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 667888888888888754 33344444 6788888887754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=163.26 Aligned_cols=141 Identities=23% Similarity=0.202 Sum_probs=112.0
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccch----------------------hhhhHHHHHHHHHhCCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG----------------------ALKSFDAECEVLKSVRH 781 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h 781 (902)
....|.+.+.||+|+||.||+|...+++.||||+++..... .......|+.++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33348889999999999999999878999999987643210 11236778889999887
Q ss_pred C--CccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 046199 782 R--NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859 (902)
Q Consensus 782 ~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (902)
+ .++..++. +..++||||++|+++.+.... .....++.+++.++.++| +.||+||||||+||++
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEE
Confidence 7 44554442 345899999999998765421 345678899999999999 9999999999999999
Q ss_pred cCCCcEEEEeecCceecCC
Q 046199 860 DDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 860 ~~~~~~kL~DFG~a~~~~~ 878 (902)
++++.++|+|||.|.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-17 Score=165.18 Aligned_cols=135 Identities=22% Similarity=0.308 Sum_probs=114.4
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccc--------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
+.||+|++|.||+|.+ .+..|++|+...... .....+.+|++++..++|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 677899998653321 1224678899999999999988887777777788999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
++|++|.+++.... . ....++.+++.++.++| +.+++|||++|+||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999885422 2 77889999999999999 99999999999999999 789999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-17 Score=166.75 Aligned_cols=181 Identities=20% Similarity=0.284 Sum_probs=146.9
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceee
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIIS 789 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 789 (902)
...++....++++....+.+|.||+||+|.+++ .++|.+|.++... +-....+..|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 355677788889999999999999999997653 4557777776442 334567888999999999999999999
Q ss_pred eeecC-CeeEEEEEccCCCChHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC
Q 046199 790 SCSNG-NFKALVLEYMANGSLEKCLYSS-------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD 861 (902)
Q Consensus 790 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (902)
++.++ ...++++.++.-|+|..++... .+.++..+...++.|++.|++||| ++||||.||.++|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence 88554 5778889999999999998732 234667788899999999999999 999999999999999999
Q ss_pred CCcEEEEeecCceecCCCccceec--ccccccccccccccc
Q 046199 862 DMVAHLSDFGIAKLLNGEESMRTQ--TLGTIGYMAPGLWVV 900 (902)
Q Consensus 862 ~~~~kL~DFG~a~~~~~~~~~~~~--~~gt~~y~APE~l~~ 900 (902)
.-+|||+|=.+++...+.+...-+ ......|||||.++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n 472 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN 472 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh
Confidence 999999999999887665543222 235668999998764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-17 Score=189.65 Aligned_cols=148 Identities=30% Similarity=0.522 Sum_probs=109.8
Q ss_pred CCChhHHHHHHHHHhcccc---CCCCCCCCce----eeeeEEeeCC--C--CcEEEEEeccCCcceecCcccCCCCCCCe
Q 046199 4 NINTTDQQALLALKARITA---KNWTSNTSVC----SWIGITCDVS--T--HRVTALNISDFGLTGTISSQLGNLSSLQT 72 (902)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~---~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l~~L~~ 72 (902)
...++|.+||++||+++.. .+|.. ..|| .|.||+|... + .+|+.|+|+++++.|.+|+.++.+++|+.
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 3467899999999999876 38974 3342 7999999632 2 25888888888888888888888888888
Q ss_pred eeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccc
Q 046199 73 LDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLK 152 (902)
Q Consensus 73 L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~ 152 (902)
|+|++|+++|.+|+.++.+++|++|+|++|+++|. +|+.++++++|+
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~---------------------------------iP~~l~~L~~L~ 493 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS---------------------------------IPESLGQLTSLR 493 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCC---------------------------------CchHHhcCCCCC
Confidence 88888888888888888888888888888888775 555666666677
Q ss_pred eeeecccccCCCCchhhccc-cccceeecccCcC
Q 046199 153 ELYLGYNKLQGEIPQELGNL-AELEWLSLPRSFL 185 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~n~l 185 (902)
+|+|++|+++|.+|..++.+ .++..+++++|..
T Consensus 494 ~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred EEECcCCcccccCChHHhhccccCceEEecCCcc
Confidence 77777777776666666543 3455555555543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=183.94 Aligned_cols=140 Identities=24% Similarity=0.303 Sum_probs=113.7
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEe-eecc-------chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVF-HLQF-------DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
....|...+.||+|+||.||+|.+.+.. +++|+. .... ....+++.+|+++++.++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445567899999999999999875443 444432 2111 112356889999999999999998887777777
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||++|++|.+++. ....++.|++.++.|+| +.+++|||+||+||++ +++.++|+|||+|+.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999998874 35678999999999999 9999999999999999 577999999999987
Q ss_pred cC
Q 046199 876 LN 877 (902)
Q Consensus 876 ~~ 877 (902)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=160.01 Aligned_cols=132 Identities=24% Similarity=0.355 Sum_probs=107.9
Q ss_pred eecccceeeEEEEEeCCCcEEEEEEeeecc-c-------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF-D-------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
.||+|+||.||+|.+ ++..|++|+..... . ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 67889999864321 1 12356778999999999887666655566666779999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+|++|.+++..... .++.|++.++.++| +.|++|||++|+||+++ ++.++++|||.+....
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988743211 78999999999999 99999999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-15 Score=167.52 Aligned_cols=168 Identities=40% Similarity=0.581 Sum_probs=144.1
Q ss_pred ccccCeecccceeeEEEEEeCCCcEEEEEEeeeccch---hhhhHHHHHHHHHhCCCC-CccceeeeeecCCeeEEEEEc
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG---ALKSFDAECEVLKSVRHR-NLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 803 (902)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+...+..+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999986 78999998755432 467899999999999988 799999999888888999999
Q ss_pred cCCCChHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~ 880 (902)
+.++++.+++.... ..+.......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775543 26889999999999999999999 99999999999999999988 79999999998665443
Q ss_pred c------ceecccccccccccccccc
Q 046199 881 S------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~------~~~~~~gt~~y~APE~l~~ 900 (902)
. ......||..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccccccCCHHHhcC
Confidence 2 2344679999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=161.39 Aligned_cols=134 Identities=26% Similarity=0.368 Sum_probs=113.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-----C---CCccceeeeeec--
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----H---RNLVKIISSCSN-- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 793 (902)
..+|.+.++||-|-|++||+|.+.. .+.||+|+.+.. ....+....||+++++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4789999999999999999999865 678999998754 344577788999999984 3 369999999965
Q ss_pred --CCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 046199 794 --GNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862 (902)
Q Consensus 794 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~ 862 (902)
+.++|||+|++ |.+|..+|+.. .+.++...+.+|++||+.||.|||. +.||||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeecc
Confidence 45899999999 66888887653 4569999999999999999999996 7899999999999999544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=146.05 Aligned_cols=136 Identities=21% Similarity=0.229 Sum_probs=114.5
Q ss_pred ccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCC--CCccceeeeeecCCeeEEEEEccCCC
Q 046199 730 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH--RNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
+.+.||+|.++.||++...+ ..+++|..+.... ...+.+|+.+++.++| +.+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899998865433 4678899999999976 58999999888888899999999987
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77543 45667788999999999999433358999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=150.82 Aligned_cols=137 Identities=24% Similarity=0.245 Sum_probs=99.6
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchh--hhh----------------------HHHHHHHHHhCCCC--Cc
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKS----------------------FDAECEVLKSVRHR--NL 784 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--ni 784 (902)
.+.||+|+||.||+|.+.++++||||+++...... ... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542111 111 13456666666443 24
Q ss_pred cceeeeeecCCeeEEEEEccCCCChHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCC
Q 046199 785 VKIISSCSNGNFKALVLEYMANGSLEK-CLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDD 862 (902)
Q Consensus 785 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~ 862 (902)
++.++. ...++||||++++++.. .+.... . ...+..++.+++.++.++| . .+|+|||+||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 455443 23589999999954321 111111 1 1567889999999999999 8 9999999999999999 8
Q ss_pred CcEEEEeecCceecCC
Q 046199 863 MVAHLSDFGIAKLLNG 878 (902)
Q Consensus 863 ~~~kL~DFG~a~~~~~ 878 (902)
+.++++|||.|.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-15 Score=177.11 Aligned_cols=172 Identities=24% Similarity=0.295 Sum_probs=132.9
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC---CCCccceeeeeecCCe
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNF 796 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 796 (902)
+.....+.|.+.+.||+|+||.||+|...+|+.||+|+-+.....+..-. .+++.+|+ -+-|..+..++...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34566788999999999999999999998899999999876654322111 12233333 2455666666667777
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-------CCcEEEEe
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-------DMVAHLSD 869 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------~~~~kL~D 869 (902)
.++|+||.+.|+|.+++. ..+.+++..++.++.|++..+++|| ..+|||+||||+|+|+.. ...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 899999999999999986 5567999999999999999999999 999999999999999932 34699999
Q ss_pred ecCceecC--CCccceecccccccccccccc
Q 046199 870 FGIAKLLN--GEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 870 FG~a~~~~--~~~~~~~~~~gt~~y~APE~l 898 (902)
||.+..+. .+.......++|-.+-.+|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~ 875 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR 875 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHh
Confidence 99996543 233344446677777777765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-15 Score=176.14 Aligned_cols=118 Identities=40% Similarity=0.607 Sum_probs=90.7
Q ss_pred ccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccccccccccc
Q 046199 535 VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614 (902)
Q Consensus 535 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 614 (902)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36677888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcceecCCCCC--cccccccccccCCcccCCCCCCCCCCCC
Q 046199 615 FNRLEGEIPSGG--SFANFSAQSFMGNDLLCGSPHLQVPLCK 654 (902)
Q Consensus 615 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~~~~~~~~c~ 654 (902)
+|+++|.+|... .+.......+.+|+.+|+.|.. +.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence 888888888631 1223345678899999997653 3674
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=147.82 Aligned_cols=136 Identities=20% Similarity=0.198 Sum_probs=105.4
Q ss_pred Ceec-ccceeeEEEEEeCCCcEEEEEEeeecc-------------chhhhhHHHHHHHHHhCCCCCc--cceeeeeecC-
Q 046199 732 SLIG-IGSFGTVYKGRFLDGMEVAIKVFHLQF-------------DGALKSFDAECEVLKSVRHRNL--VKIISSCSNG- 794 (902)
Q Consensus 732 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~- 794 (902)
..|| .|+.|+||.+.. .+..+++|.+.... .....++.+|++++..++|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 788888888876 47789999885421 1233567889999999998875 6677664332
Q ss_pred C---eeEEEEEccCC-CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 795 N---FKALVLEYMAN-GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 795 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
+ ..++||||++| .+|.+++.. ..+++. .+.|++.++.++| +.||+||||||+|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 689888754 234443 3678999999999 999999999999999999889999999
Q ss_pred cCceecC
Q 046199 871 GIAKLLN 877 (902)
Q Consensus 871 G~a~~~~ 877 (902)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9998754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.9e-16 Score=168.52 Aligned_cols=215 Identities=30% Similarity=0.401 Sum_probs=148.5
Q ss_pred EEeccCCcce-ecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 49 LNISDFGLTG-TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 49 l~l~~~~l~g-~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
|.|++..+.. ..+.+--.++.-...||+.|+|. ++|..+..+..|..|.|.+|.+. .+|.. +.++..|+.+|++.|
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~-i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEA-ICNLEALTFLDLSSN 131 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchh-hhhhhHHHHhhhccc
Confidence 4445544431 12222355666777888888887 78888888888888888888776 33332 356667777777777
Q ss_pred cccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeC
Q 046199 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 207 (902)
+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|
T Consensus 132 qlS---------~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn 199 (722)
T KOG0532|consen 132 QLS---------HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRN 199 (722)
T ss_pred hhh---------cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhh
Confidence 665 3777777776 888888888887 78888887788888888888887 77888888888888888888
Q ss_pred CCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCccc
Q 046199 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287 (902)
Q Consensus 208 ~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 287 (902)
++. .+|++++.| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.+. .-|..+..-
T Consensus 200 ~l~--------------------~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 200 HLE--------------------DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred hhh--------------------hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 765 345666654 4778888888887 77888888888888888888877 334443222
Q ss_pred CCCcccceeeccCc
Q 046199 288 IGLPNIERLNLGLN 301 (902)
Q Consensus 288 ~~l~~L~~L~Ls~N 301 (902)
+...=.++|+..-+
T Consensus 257 GkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 257 GKVHIFKYLSTQAC 270 (722)
T ss_pred cceeeeeeecchhc
Confidence 22223345555544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-14 Score=177.55 Aligned_cols=119 Identities=18% Similarity=0.228 Sum_probs=87.7
Q ss_pred hCCC-CCccceeeee-------ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 046199 778 SVRH-RNLVKIISSC-------SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849 (902)
Q Consensus 778 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (902)
.++| +||.+++++| ...+.++.+|||+ +++|.+++......+++.++..++.||++||+||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 3445 5777777776 2334567788987 56999999766667999999999999999999999 999999
Q ss_pred cCCCCCCEEEcC-------------------CCcEEEEeecCceecCCCc----------------cceecccccccccc
Q 046199 850 CDIKPSNILLDD-------------------DMVAHLSDFGIAKLLNGEE----------------SMRTQTLGTIGYMA 894 (902)
Q Consensus 850 rDlkp~NIll~~-------------------~~~~kL~DFG~a~~~~~~~----------------~~~~~~~gt~~y~A 894 (902)
|||||+|||++. ++.+|++|||+++...... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999955 3456666666665321100 00011357889999
Q ss_pred cccccc
Q 046199 895 PGLWVV 900 (902)
Q Consensus 895 PE~l~~ 900 (902)
||++..
T Consensus 184 PE~~~~ 189 (793)
T PLN00181 184 PEEDNG 189 (793)
T ss_pred hhhhcc
Confidence 999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=153.82 Aligned_cols=142 Identities=21% Similarity=0.271 Sum_probs=101.2
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchh----------------------------------------hhhHH
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA----------------------------------------LKSFD 770 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 770 (902)
.+.||.|++|.||+|+..+|++||||+.++..... .-++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 01244
Q ss_pred HHHHHHHhCC-----CCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHccCC
Q 046199 771 AECEVLKSVR-----HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL-ALEYLHFGYS 844 (902)
Q Consensus 771 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~-~L~~LH~~~~ 844 (902)
+|++.+.+++ +++|.-..-+....+..++||||++|+++.++........+ ...++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 5666555552 33332222222334457899999999999887643222222 3456666665 467888 8
Q ss_pred CCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 845 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
.|++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-14 Score=164.73 Aligned_cols=167 Identities=19% Similarity=0.268 Sum_probs=128.0
Q ss_pred cccCeecccceeeEEEEEeCC-CcEEEEEEeee---ccc--h-hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 729 SEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL---QFD--G-ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~--~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
...+.+|.|++|.|+.+.... .+.++.|.++. ... . ....+..|..+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 346789999999888776543 34444444331 111 1 1122556777778889999988888777666666669
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||++ ||..++... ..+...++..++.|+..|++|+| ..||.|||+|++|+++..+|.+||+|||.+..+..+..
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999988543 35788889999999999999999 99999999999999999999999999999976643332
Q ss_pred ----ceecccccccccccccccc
Q 046199 882 ----MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ----~~~~~~gt~~y~APE~l~~ 900 (902)
.....+|+.+|+|||++..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc
Confidence 2344789999999998754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.6e-15 Score=162.81 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=169.4
Q ss_pred CeeeccccccccCCCcc--ccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCc
Q 046199 71 QTLDLSHNRFSGTIPSS--IFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNL 148 (902)
Q Consensus 71 ~~L~Ls~n~l~~~~p~~--~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l 148 (902)
-.|.|++-++. ..|-. =..++--...||+.|++. .+|..++.+
T Consensus 53 g~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~----------------------------------elp~~~~~f 97 (722)
T KOG0532|consen 53 GRLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS----------------------------------ELPEEACAF 97 (722)
T ss_pred cccccccchhh-cCCCccccccccchhhhhccccccc----------------------------------cCchHHHHH
Confidence 35677777776 44432 234555566667666665 278888888
Q ss_pred CccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
..|+.|.|..|.+. .+|..+++|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++
T Consensus 98 ~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~------------------ 156 (722)
T KOG0532|consen 98 VSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT------------------ 156 (722)
T ss_pred HHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc------------------
Confidence 88999999999998 89999999999999999999998 8888888886 899999999977
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCC
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP 308 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 308 (902)
.+|++++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|+. +.. -.|..||+|.|+++ .+|
T Consensus 157 --~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~E---l~~-LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 157 --SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEE---LCS-LPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred --cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHH---HhC-CceeeeecccCcee-ecc
Confidence 34588888889999999999998 78888999999999999999988 55665 442 35888999999998 788
Q ss_pred ccccccccccEEEccCCcccCcccccccc---cccccEEeccccc
Q 046199 309 GFIFNASKLFLLELTGNSFSGFIPDTLVN---LRNLEHLGLGYNY 350 (902)
Q Consensus 309 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~---l~~L~~L~Ls~N~ 350 (902)
-.|.+++.|++|-|.+|.+. ..|..++. ..=-++|+..-++
T Consensus 228 v~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 88999999999999999998 45665543 3445667776664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1e-14 Score=160.13 Aligned_cols=159 Identities=28% Similarity=0.308 Sum_probs=132.2
Q ss_pred eecccceeeEEEEEeC----CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEccC
Q 046199 733 LIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEYMA 805 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 805 (902)
.+|+|+||.|+.++.. .+.-||+|+.+.... ........|..++...+ ||.+++++..++.++..+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3689999999987543 267789998765432 22235566888888887 9999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceec
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
||++...+.+. ..+.+.....+...++-|++++| +.+|+|||+|++||+++.+|++|+.|||.++..-....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99998877544 34677778888899999999999 99999999999999999999999999999987654332
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
.+||..|||||++.
T Consensus 153 ~cgt~eymApEI~~ 166 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN 166 (612)
T ss_pred cccchhhhhhHhhh
Confidence 28999999999975
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-13 Score=154.40 Aligned_cols=179 Identities=37% Similarity=0.512 Sum_probs=94.7
Q ss_pred cCccceeeecccccCCCCchhhcccc-ccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccc
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLA-ELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRN 226 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~ 226 (902)
++.++.|++.+|.++ .+|+..+.++ +|+.|++++|++. .+|..+.++++|+.|++++|++++
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~--------------- 177 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD--------------- 177 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhh---------------
Confidence 345555555555555 5555555553 5555555555555 444445555555555555555442
Q ss_pred ccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCC
Q 046199 227 LWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306 (902)
Q Consensus 227 ~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~ 306 (902)
+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+.. +.++.++..+.+..|++..
T Consensus 178 -----l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~---~~~~~~l~~l~l~~n~~~~- 246 (394)
T COG4886 178 -----LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS---LSNLKNLSGLELSNNKLED- 246 (394)
T ss_pred -----hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchh---hhhcccccccccCCceeee-
Confidence 2233334555555555555555 45554444555555566555322 11222 3445555555555555542
Q ss_pred CCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCC
Q 046199 307 IPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356 (902)
Q Consensus 307 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 356 (902)
.+..++.+++++.|++++|+++...+ ++.+.+++.|++++|.+....+
T Consensus 247 ~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 247 LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 24445555566666666666653322 5556666666666666654443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-13 Score=139.74 Aligned_cols=116 Identities=28% Similarity=0.354 Sum_probs=89.4
Q ss_pred CCCCccceeeeee---------------------------cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHH
Q 046199 780 RHRNLVKIISSCS---------------------------NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDV 832 (902)
Q Consensus 780 ~h~niv~l~~~~~---------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi 832 (902)
+|||||++.++|. +....|+||.-++. +|.+++.... .+.....-+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 5999999988763 23467899998865 9999986543 4666778899999
Q ss_pred HHHHHHHHccCCCCeEEcCCCCCCEEE--cCCC--cEEEEeecCceecCC------Cccceeccccccccccccccccc
Q 046199 833 ALALEYLHFGYSNPVVHCDIKPSNILL--DDDM--VAHLSDFGIAKLLNG------EESMRTQTLGTIGYMAPGLWVVL 901 (902)
Q Consensus 833 ~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~--~~kL~DFG~a~~~~~------~~~~~~~~~gt~~y~APE~l~~~ 901 (902)
++|+.||| ++||.|||+|.+||++ |+|+ .+.++|||++-.-.. ..+......|.-.-||||++.++
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999 9999999999999999 4444 678999998753222 12223335678889999998765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.9e-13 Score=150.93 Aligned_cols=200 Identities=35% Similarity=0.498 Sum_probs=143.2
Q ss_pred EEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC-ccceeeecccccCCCCchhhccccc
Q 046199 96 ILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT-KLKELYLGYNKLQGEIPQELGNLAE 174 (902)
Q Consensus 96 ~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~ 174 (902)
.|+++.|.+...+.. +..++.++.|++.+|.++ .||...+.+. +|++|++++|++. .+|..++.+++
T Consensus 97 ~l~~~~~~~~~~~~~--~~~~~~l~~L~l~~n~i~---------~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~ 164 (394)
T COG4886 97 SLDLNLNRLRSNISE--LLELTNLTSLDLDNNNIT---------DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN 164 (394)
T ss_pred eeeccccccccCchh--hhcccceeEEecCCcccc---------cCccccccchhhcccccccccchh-hhhhhhhcccc
Confidence 566666666332221 234456677777777665 3677777664 7888888888887 67777888888
Q ss_pred cceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC
Q 046199 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG 254 (902)
Q Consensus 175 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~ 254 (902)
|+.|++++|+++ .+|...+.+++|+.|++++|+++. +|...+.+..|++|.+++|++.
T Consensus 165 L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~--------------------l~~~~~~~~~L~~l~~~~N~~~- 222 (394)
T COG4886 165 LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD--------------------LPPEIELLSALEELDLSNNSII- 222 (394)
T ss_pred ccccccCCchhh-hhhhhhhhhhhhhheeccCCcccc--------------------CchhhhhhhhhhhhhhcCCcce-
Confidence 888888888888 667666677888888888888762 3455555666888888888654
Q ss_pred cCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccc
Q 046199 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT 334 (902)
Q Consensus 255 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 334 (902)
..+..+.++..+..|.+.+|++.. ++.. +..++.+++|++++|.++...+ ++.+.+++.|++++|.+....|..
T Consensus 223 ~~~~~~~~~~~l~~l~l~~n~~~~-~~~~---~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 223 ELLSSLSNLKNLSGLELSNNKLED-LPES---IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ecchhhhhcccccccccCCceeee-ccch---hccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 566777888888888888888763 2333 5677778888888888874433 778888999999999888666554
Q ss_pred c
Q 046199 335 L 335 (902)
Q Consensus 335 l 335 (902)
.
T Consensus 297 ~ 297 (394)
T COG4886 297 A 297 (394)
T ss_pred h
Confidence 3
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.3e-13 Score=156.77 Aligned_cols=167 Identities=24% Similarity=0.245 Sum_probs=129.3
Q ss_pred cccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc-hhhhhHH---HHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFD---AECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
+|...+.+|.+.|=+|.+|++.+|. |+||++-+..+ -..+.+. +|++ ...++|||++.+.-+-..+...|+|=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778899999999999999998777 99999876542 2223333 3444 566699999999988888888899999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC--CCc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN--GEE 880 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~--~~~ 880 (902)
|... +|+|.+.. +..+...+.+.|+.|++.|+..+| ..||+|||||.+||||+.-..+.|+||..-+..- .+.
T Consensus 102 yvkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9855 99998843 345777888999999999999999 9999999999999999999999999998765321 111
Q ss_pred c-cee----cccccccccccccccc
Q 046199 881 S-MRT----QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~-~~~----~~~gt~~y~APE~l~~ 900 (902)
. ..+ +...-..|.|||.|..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhc
Confidence 1 111 1223347999998864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-12 Score=144.80 Aligned_cols=146 Identities=20% Similarity=0.200 Sum_probs=94.8
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch----------------------------------hh----
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG----------------------------------AL---- 766 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~---- 766 (902)
.+|+. +.||+|++|.||+|+..+ |++||||+.++.... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 999999999754210 00
Q ss_pred --hhHHHHHHHHHhCC----CCCccceeeee-ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHH-HHHH
Q 046199 767 --KSFDAECEVLKSVR----HRNLVKIISSC-SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL-ALEY 838 (902)
Q Consensus 767 --~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~-~L~~ 838 (902)
-++.+|+..+.+++ +...+.+-.++ ......++||||++|+.+.++-.-.....+... ++...+. -+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 12344555554442 33323222222 224556899999999999775321112222222 2222221 1233
Q ss_pred HHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCceecCC
Q 046199 839 LHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGIAKLLNG 878 (902)
Q Consensus 839 LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a~~~~~ 878 (902)
+. ..|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 68999999999999999988 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3e-11 Score=119.08 Aligned_cols=139 Identities=19% Similarity=0.203 Sum_probs=102.1
Q ss_pred cCeecccceeeEEEEEeCC-------CcEEEEEEeeecc------------c----------hhhhhH----HHHHHHHH
Q 046199 731 KSLIGIGSFGTVYKGRFLD-------GMEVAIKVFHLQF------------D----------GALKSF----DAECEVLK 777 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 777 (902)
...||.|.-+.||.|...+ +..+|||+.+... + ...+.+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997653 4799999985321 0 011223 37999999
Q ss_pred hCCC--CCccceeeeeecCCeeEEEEEccCCCChHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCC
Q 046199 778 SVRH--RNLVKIISSCSNGNFKALVLEYMANGSLEK-CLYSSNRSLDIFQRLSIMIDVALALEYL-HFGYSNPVVHCDIK 853 (902)
Q Consensus 778 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHrDlk 853 (902)
++.. -.+++++++ ...++||||+.+..+.. .+++ ...+..+...+..+++.++..+ | +.|+||+|++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 9853 567777765 34589999997654321 2221 2345556778889999999999 8 8999999999
Q ss_pred CCCEEEcCCCcEEEEeecCceecCCC
Q 046199 854 PSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 854 p~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
+.||++++ +.++++|||.|.....+
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCCCC
Confidence 99999974 68999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.2e-11 Score=121.96 Aligned_cols=129 Identities=22% Similarity=0.213 Sum_probs=97.3
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC-ccceeeeeecCCeeEEEEEccCCCCh
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
.+.++.|.++.||+++.. ++.|++|+...... ....+.+|+.+++.+.+.. +++++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356889999999999874 77899998764432 2345678999999886544 445555543 234799999999887
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.+. . .....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.|...
T Consensus 79 ~~~-----~----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTE-----D----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc-----c----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 542 0 112345789999999999 666 59999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-12 Score=128.53 Aligned_cols=166 Identities=18% Similarity=0.364 Sum_probs=128.5
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.+.....+|.+...|+.|+|++ .|..+++|++.... .....+|..|.-.++.+.||||..+++.|.......++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3445566788999999999999 45666778775442 23446788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE--eecCceecCCCc
Q 046199 804 MANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLS--DFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~--DFG~a~~~~~~~ 880 (902)
|+.|+|+.++++... ..+..++.+++.+|++|++|||. .+.-|..--+....++||++.+++|. |--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999977543 36778899999999999999993 23445555788999999999887764 3222211
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.......|.||+||.++.
T Consensus 343 --e~gr~y~pawmspealqr 360 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQR 360 (448)
T ss_pred --ccccccCcccCCHHHHhc
Confidence 122346789999998863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=124.64 Aligned_cols=165 Identities=24% Similarity=0.337 Sum_probs=104.5
Q ss_pred cccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCC----------CCccceeeee-
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRH----------RNLVKIISSC- 791 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~- 791 (902)
.+...+.||.|+++.||.+++.+ ++++|+|++..... ...+.+++|.-....+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667899999999999999976 89999999865442 234566666655444322 1222222221
Q ss_pred --------ec---CCe-----eEEEEEccCCCChHHHHhh---CCCC---CCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 046199 792 --------SN---GNF-----KALVLEYMANGSLEKCLYS---SNRS---LDIFQRLSIMIDVALALEYLHFGYSNPVVH 849 (902)
Q Consensus 792 --------~~---~~~-----~~lv~e~~~~g~L~~~l~~---~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (902)
.. ... .+++|+-+. +||.+++.. .... .....+..+..|+++.++++| +.|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 11 112 257788774 588887542 2221 223344566789999999999 999999
Q ss_pred cCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccccccccccccc
Q 046199 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 850 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
+||||+|++++++|.++|+||+.....+.... ....+..|.+||+.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELE 214 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhh
Confidence 99999999999999999999998877543221 13456789999975
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=108.83 Aligned_cols=133 Identities=23% Similarity=0.349 Sum_probs=102.6
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEee-eccc-------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFH-LQFD-------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..+++|+-+.||.+.+. |.++++|.-. +... -...+..+|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999774 4446666432 2221 1235677899999999766666666666677777899999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++|..|.+.+... ...++..+-..+.-|| ..||||+|+.++||++..++ +.++|||++..-.
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999998888543 2457778888888999 99999999999999998774 9999999998644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.3e-10 Score=107.20 Aligned_cols=143 Identities=21% Similarity=0.255 Sum_probs=107.7
Q ss_pred ccCeecccceeeEEEEEeCCCcEEEEEEee-eccc-------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 730 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFH-LQFD-------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
....+-+|+-+.|+++.+ .|+.++||.-. +... -..++..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467889999999999987 57777777532 2221 12467788999999997666666555666666667999
Q ss_pred EccCC-CChHHHHhhCCCCCCH-HHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceec
Q 046199 802 EYMAN-GSLEKCLYSSNRSLDI-FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~-g~L~~~l~~~~~~~~~-~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~ 876 (902)
||++| .++.+++......-.+ .....++.+|-+.+.-|| ..+|+|+|+..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99987 4777877654332223 333788999999999999 99999999999999997665 4589999998654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=9e-13 Score=134.59 Aligned_cols=141 Identities=24% Similarity=0.265 Sum_probs=80.9
Q ss_pred cCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC----cCCCcccCCCCCceEec
Q 046199 196 LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG----DVPNTIFNMSTLKALSL 271 (902)
Q Consensus 196 l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L 271 (902)
-+.|+++...+|++.+.-.. .+...|...+.|+.+.++.|.|.. .+...+..+++|+.|||
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~---------------~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl 220 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGAT---------------ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDL 220 (382)
T ss_pred CcceEEEEeeccccccccHH---------------HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeec
Confidence 35688888888886532100 122456666788888888888742 12334667888888888
Q ss_pred cCcccccCCCcC-CcccCCCcccceeeccCccCCCCCCcccc-----ccccccEEEccCCcccCc----ccccccccccc
Q 046199 272 LNNTLSGSLPSS-SKNLIGLPNIERLNLGLNNLSGRIPGFIF-----NASKLFLLELTGNSFSGF----IPDTLVNLRNL 341 (902)
Q Consensus 272 s~N~l~~~~p~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L 341 (902)
.+|.++..-... ...++.+++|+.|++++|.+...-...+. ..++|++|.+.+|.|+.. +...+...+.|
T Consensus 221 ~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL 300 (382)
T KOG1909|consen 221 RDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDL 300 (382)
T ss_pred ccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhh
Confidence 888776321100 01255567777777777777643333222 245566666666666521 11223335555
Q ss_pred cEEecccccC
Q 046199 342 EHLGLGYNYL 351 (902)
Q Consensus 342 ~~L~Ls~N~l 351 (902)
+.|+|++|++
T Consensus 301 ~kLnLngN~l 310 (382)
T KOG1909|consen 301 EKLNLNGNRL 310 (382)
T ss_pred HHhcCCcccc
Confidence 5556655555
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.5e-12 Score=131.26 Aligned_cols=88 Identities=23% Similarity=0.320 Sum_probs=39.0
Q ss_pred CCCCEEEccCccccCcCC--CcccCCCCCceEeccCcccccC-CCcC--CcccCCCcccceeeccCccCCC-CCCccccc
Q 046199 240 PNLEVLGIDENHLVGDVP--NTIFNMSTLKALSLLNNTLSGS-LPSS--SKNLIGLPNIERLNLGLNNLSG-RIPGFIFN 313 (902)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~-~p~~--~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~ 313 (902)
..|+.|||++|++- ..+ ...+.++.|+.|.++.+.++.. .|+. ......+++|++|+++.|++.. ..-+.+..
T Consensus 246 ~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~ 324 (505)
T KOG3207|consen 246 QTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRT 324 (505)
T ss_pred hHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhc
Confidence 34555555555443 222 2344455555555555554421 1110 0112334555555555555531 11122334
Q ss_pred cccccEEEccCCccc
Q 046199 314 ASKLFLLELTGNSFS 328 (902)
Q Consensus 314 l~~L~~L~Ls~N~l~ 328 (902)
+.+|+.|....|.++
T Consensus 325 l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 325 LENLKHLRITLNYLN 339 (505)
T ss_pred cchhhhhhccccccc
Confidence 455666666666665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.9e-12 Score=141.68 Aligned_cols=177 Identities=28% Similarity=0.318 Sum_probs=114.2
Q ss_pred cccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCc
Q 046199 144 DIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSI 223 (902)
Q Consensus 144 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~i 223 (902)
.++.+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+... .+..++.|+.|++++|.|+.+
T Consensus 90 ~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~----------- 155 (414)
T KOG0531|consen 90 HLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI----------- 155 (414)
T ss_pred ccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc-----------
Confidence 3556677778888888777 45554777788888888888877432 256677788888888887643
Q ss_pred cccccccCCCccccCCCCCCEEEccCccccCcCC-CcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCcc
Q 046199 224 PRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP-NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNN 302 (902)
Q Consensus 224 p~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~ 302 (902)
..+..+.+|+.+++++|+++..-+ . ...+.+++.+++.+|.+... ..+..+..+..+++..|.
T Consensus 156 ----------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i-----~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 156 ----------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI-----EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred ----------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc-----cchHHHHHHHHhhccccc
Confidence 345557778888888888874433 2 46677777788888777621 113444555555777777
Q ss_pred CCCCCCccccccc--cccEEEccCCcccCcccccccccccccEEecccccCCC
Q 046199 303 LSGRIPGFIFNAS--KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 303 l~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 353 (902)
++..-+ +..+. .|+.+++++|.+. ..+..+..+.++..|++..|++..
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence 763222 11222 2677777777776 233455666777777777777664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.8e-11 Score=115.89 Aligned_cols=101 Identities=32% Similarity=0.524 Sum_probs=35.5
Q ss_pred cCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhh-hccCcccEEeeeeCCCCccccccccccCCcccc
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSI-FNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRN 226 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~ 226 (902)
+++|+.|||++|.++ .++ .+..+++|+.|++++|+|+ .++..+ ..+++|++|+|++|+|.++.
T Consensus 41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~------------- 104 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLN------------- 104 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCC-------------
T ss_pred hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChH-------------
Confidence 556666666666666 333 3556666666666666666 344334 34666667777666665421
Q ss_pred ccccCCCccccCCCCCCEEEccCccccCcCCC----cccCCCCCceEe
Q 046199 227 LWQCEIPHEIGNLPNLEVLGIDENHLVGDVPN----TIFNMSTLKALS 270 (902)
Q Consensus 227 ~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ 270 (902)
++ ..+..+++|++|+|.+|.++.. +. .+..+++|+.||
T Consensus 105 ----~l-~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 105 ----EL-EPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp ----CC-GGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred ----Hh-HHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 00 3455566666666666666522 22 133455555555
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-11 Score=117.72 Aligned_cols=116 Identities=31% Similarity=0.463 Sum_probs=33.6
Q ss_pred hhccCcccccCcCccceeeecccccCCCCchhhc-cccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccc
Q 046199 137 IFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELG-NLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMT 215 (902)
Q Consensus 137 ~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 215 (902)
.++.+|. +.+..++++|+|++|.|+ .| +.++ .+++|+.|+|++|.|+ .++ .+..++.|++|++++|+|+++
T Consensus 8 ~i~~~~~-~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i--- 79 (175)
T PF14580_consen 8 MIEQIAQ-YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSI--- 79 (175)
T ss_dssp -------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S----
T ss_pred ccccccc-cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCcc---
Confidence 3344553 334557889999999888 44 3555 5788888888888888 444 477788888888888887632
Q ss_pred cccccCCccccccccCCCccc-cCCCCCCEEEccCccccCcC-CCcccCCCCCceEeccCcccc
Q 046199 216 NNHFTGSIPRNLWQCEIPHEI-GNLPNLEVLGIDENHLVGDV-PNTIFNMSTLKALSLLNNTLS 277 (902)
Q Consensus 216 ~~~~~g~ip~~~~~~~lp~~l-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 277 (902)
++.+ ..+++|+.|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 80 -----------------~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 80 -----------------SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -----------------CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred -----------------ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 1333 24677888888888776321 123445666666666666665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.6e-10 Score=115.88 Aligned_cols=142 Identities=19% Similarity=0.185 Sum_probs=110.7
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCC--CCccceeeeeecC---CeeEEEEEccC
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH--RNLVKIISSCSNG---NFKALVLEYMA 805 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~ 805 (902)
+.++.|..+.||++...+|+.|++|+...... .....+.+|+++++.+.+ ..+++++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999886678999998764432 134678999999999975 4467788777654 36689999999
Q ss_pred CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 046199 806 NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG------------------------------------------- 842 (902)
Q Consensus 806 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------------- 842 (902)
|.++.+.+.. ...++.....++.++++++.++|..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888765421 3467777778888888888888831
Q ss_pred ----------CCCCeEEcCCCCCCEEEcC--CCcEEEEeecCcee
Q 046199 843 ----------YSNPVVHCDIKPSNILLDD--DMVAHLSDFGIAKL 875 (902)
Q Consensus 843 ----------~~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~ 875 (902)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999998 66789999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-11 Score=121.29 Aligned_cols=132 Identities=23% Similarity=0.284 Sum_probs=92.8
Q ss_pred CcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEc
Q 046199 486 NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSL 565 (902)
Q Consensus 486 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 565 (902)
..|+.+|||+|.|+. +.+...-.+.++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 446666777776664 344555566677777777776632 23666777777777777777 55556667788888888
Q ss_pred cCcccCCCccccccccccCCeEeCcCccccccC-CcccccccccccccccCCcceecCC
Q 046199 566 ENNRLHGPIPESFGALTSLESLDLSVNNLSGVI-PISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 566 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
+.|.|.. -..++.|-+|..||+++|+|...- -..++++|-|+.+.|.+|++.+...
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 8888762 245667778888999999887432 2568889999999999999986433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.7e-11 Score=120.64 Aligned_cols=130 Identities=24% Similarity=0.290 Sum_probs=105.5
Q ss_pred CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccC
Q 046199 463 QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLS 542 (902)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls 542 (902)
.|+++|||+|.|+ .+..+..-+|.++.|++|+|.|..+ +.+..+++|+.||||+|.++. +..+-..+.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence 5777788888777 5566777888999999999999865 337889999999999999883 55566677888999999
Q ss_pred CccccccCccccccCCccceEEccCcccCCCc-cccccccccCCeEeCcCccccccC
Q 046199 543 RNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI-PESFGALTSLESLDLSVNNLSGVI 598 (902)
Q Consensus 543 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (902)
.|.|.. -..++.+-+|..||+++|+|.... -..+++||-|+.|.|.+|.+.+..
T Consensus 361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999873 245778889999999999998433 357899999999999999999643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=129.13 Aligned_cols=163 Identities=25% Similarity=0.232 Sum_probs=80.0
Q ss_pred cccccceeecccCcCCCCCC--hhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEcc
Q 046199 171 NLAELEWLSLPRSFLTGTIP--SSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGID 248 (902)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls 248 (902)
++.+|+...|.++... ..+ +....|++++.||||.|-+..|. .+-.-...|++|+.|+|+
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~-----------------~v~~i~eqLp~Le~LNls 180 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWF-----------------PVLKIAEQLPSLENLNLS 180 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHH-----------------HHHHHHHhcccchhcccc
Confidence 4445555555555443 222 23445555555555555544321 111223445555555555
Q ss_pred CccccCcCCCc-ccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcc
Q 046199 249 ENHLVGDVPNT-IFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSF 327 (902)
Q Consensus 249 ~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 327 (902)
.|++..-.... -..+++|+.|.|+.|.++-.--.+ .+..+|+|+.|+|..|...........-+..|+.|||++|++
T Consensus 181 ~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~--~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~l 258 (505)
T KOG3207|consen 181 SNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQW--ILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNL 258 (505)
T ss_pred cccccCCccccchhhhhhhheEEeccCCCCHHHHHH--HHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcc
Confidence 55554211111 113555666666666655211111 134556666677766643223333334455677777777766
Q ss_pred cCcc-cccccccccccEEecccccCCC
Q 046199 328 SGFI-PDTLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 328 ~~~~-p~~l~~l~~L~~L~Ls~N~l~~ 353 (902)
.... -...+.++.|+.|+++.+.+.+
T Consensus 259 i~~~~~~~~~~l~~L~~Lnls~tgi~s 285 (505)
T KOG3207|consen 259 IDFDQGYKVGTLPGLNQLNLSSTGIAS 285 (505)
T ss_pred cccccccccccccchhhhhccccCcch
Confidence 5321 1234556666667766666654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-11 Score=137.14 Aligned_cols=214 Identities=29% Similarity=0.347 Sum_probs=141.6
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCC-CcCCCCCeEeccCc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHN 472 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~L~~L~L~~N 472 (902)
.++.+.++.|.|.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|+|+...+ ..+..|+.|++++|
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N 150 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGN 150 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccchhhccchhhheeccC
Confidence 44555555565552 23345566667777777777763 22225566777777777777764333 33446777777777
Q ss_pred cccCCCCccccCCCcCceEecCCCCccCccc-ccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCc
Q 046199 473 KLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551 (902)
Q Consensus 473 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 551 (902)
.|+.. ..+..++.|+.+++++|+++.+.+ . ...+.+++.+++++|.+.. ...+..+..+..+++..|.++..-+
T Consensus 151 ~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~ 225 (414)
T KOG0531|consen 151 LISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG 225 (414)
T ss_pred cchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC
Confidence 77643 235557788888888888887544 2 4667788888888888873 3445555666667888888873322
Q ss_pred cccccCC--ccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcce
Q 046199 552 TTIGGLT--NLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619 (902)
Q Consensus 552 ~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 619 (902)
+..+. .|+.+++++|++. ..+..+..+.++..||+++|++... ..+...+.+..+....|++.
T Consensus 226 --l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 226 --LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred --cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 22233 3888889998887 4556777888888899988888754 33555667777888888776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.3e-11 Score=139.01 Aligned_cols=174 Identities=26% Similarity=0.319 Sum_probs=139.9
Q ss_pred cccccccCeecccceeeEEEEEeCC--CcEEEEEEeeecc--chhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD--GMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 799 (902)
...|.+.+.||+|+|+.|-.+.... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4678888899999999998887643 4456666665432 233455566887777776 9999999999999999999
Q ss_pred EEEccCCCChHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecC
Q 046199 800 VLEYMANGSLEKCL-YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLN 877 (902)
Q Consensus 800 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~ 877 (902)
+++|.+|+++.+.+ .......+......++.|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998887 3333367778889999999999999995 68999999999999999999 99999999998765
Q ss_pred C-Cc--cceecccc-cccccccccccc
Q 046199 878 G-EE--SMRTQTLG-TIGYMAPGLWVV 900 (902)
Q Consensus 878 ~-~~--~~~~~~~g-t~~y~APE~l~~ 900 (902)
. .+ ......+| ++.|+|||....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccc
Confidence 5 22 22233678 999999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.9e-09 Score=104.76 Aligned_cols=127 Identities=24% Similarity=0.265 Sum_probs=85.3
Q ss_pred eEEEEEeCCCcEEEEEEeeecc--------------c------------hhhhhHHHHHHHHHhCCCC--Cccceeeeee
Q 046199 741 TVYKGRFLDGMEVAIKVFHLQF--------------D------------GALKSFDAECEVLKSVRHR--NLVKIISSCS 792 (902)
Q Consensus 741 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 792 (902)
.||.|...++.++|+|+.+... . ......++|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999985321 0 0123567899999999765 567777553
Q ss_pred cCCeeEEEEEccC--CCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 793 NGNFKALVLEYMA--NGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY-LHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 793 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
..++||||++ |..+..+. ... ++......++.+++..+.. +| ..||+|+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 2379999998 65554432 221 1133456677788775554 58 9999999999999999988 999999
Q ss_pred ecCceecCC
Q 046199 870 FGIAKLLNG 878 (902)
Q Consensus 870 FG~a~~~~~ 878 (902)
||.|.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=6e-10 Score=110.39 Aligned_cols=78 Identities=27% Similarity=0.228 Sum_probs=67.6
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecc
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 886 (902)
|+|.+++...+..+++..+..++.|++.||+||| +.+ ||+||+++.++.+|+ ||.++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----C
Confidence 6899999776677999999999999999999999 776 999999999999999 99998764322 2
Q ss_pred cccccccccccccc
Q 046199 887 LGTIGYMAPGLWVV 900 (902)
Q Consensus 887 ~gt~~y~APE~l~~ 900 (902)
.||+.|||||++..
T Consensus 65 ~g~~~y~aPE~~~~ 78 (176)
T smart00750 65 RVDPYFMAPEVIQG 78 (176)
T ss_pred CCcccccChHHhcC
Confidence 58999999999854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-11 Score=125.73 Aligned_cols=155 Identities=18% Similarity=0.214 Sum_probs=80.0
Q ss_pred ccCCCCCCEEEccCccccCcCCC----cccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 236 IGNLPNLEVLGIDENHLVGDVPN----TIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
+-..++|++||||+|-+.-.-+. .+.++..|++|.|.||.+.. ..-..++ ..|..|. .|+. .
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~---~ag~~l~--~al~~l~--~~kk-------~ 153 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGP---EAGGRLG--RALFELA--VNKK-------A 153 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCCh---hHHHHHH--HHHHHHH--HHhc-------c
Confidence 34455777777777777533333 24467778888888887751 1111111 1222222 2222 2
Q ss_pred cccccccEEEccCCcccCccc----ccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcc----
Q 046199 312 FNASKLFLLELTGNSFSGFIP----DTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGV---- 383 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~---- 383 (902)
+..++|++++..+|++..... ..|...+.|+.+.++.|.|..... ......+..++.|+.|+|.+|-++..
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~-~al~eal~~~~~LevLdl~DNtft~egs~~ 232 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV-TALAEALEHCPHLEVLDLRDNTFTLEGSVA 232 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchh-HHHHHHHHhCCcceeeecccchhhhHHHHH
Confidence 234567888888887763322 234455677777777777763222 11224455555555555555555422
Q ss_pred cCcccccccccccEEEeecCccc
Q 046199 384 LPSSIGNLPITLEEIYLQNCKIR 406 (902)
Q Consensus 384 ~p~~~~~l~~~L~~L~L~~N~l~ 406 (902)
+...+..++ +|++|++++|.+.
T Consensus 233 LakaL~s~~-~L~El~l~dcll~ 254 (382)
T KOG1909|consen 233 LAKALSSWP-HLRELNLGDCLLE 254 (382)
T ss_pred HHHHhcccc-hheeecccccccc
Confidence 222233333 4444444444444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-10 Score=132.29 Aligned_cols=136 Identities=31% Similarity=0.421 Sum_probs=92.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
....+|+.++.|..|+||.||.++++. .+.+|+|+-+ +. .+.+- ++.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee----------------
Confidence 345789999999999999999999875 6678885422 21 11110 22333344433
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc-
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE- 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~- 880 (902)
||-...++..+ .++. +++.+++|+| ..||+|||+||+|.+|..-|++|+.|||+.+......
T Consensus 136 -----gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -----chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 34444443322 2222 2277999999 9999999999999999999999999999986532100
Q ss_pred --------------cceeccccccccccccccc
Q 046199 881 --------------SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 --------------~~~~~~~gt~~y~APE~l~ 899 (902)
......+|||.|+|||++.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 0122358999999999974
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.8e-10 Score=134.21 Aligned_cols=131 Identities=27% Similarity=0.378 Sum_probs=99.0
Q ss_pred CCCCCeeeccccccccCCCccccCCCcceEEEecCccc-cCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccc
Q 046199 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL-SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDI 145 (902)
Q Consensus 67 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l-~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~ 145 (902)
....+...+-+|++. .++....+ ++|+.|-+..|.. -..++..++..++.|++||||+|.= ...+|++|
T Consensus 522 ~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~--------l~~LP~~I 591 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSS--------LSKLPSSI 591 (889)
T ss_pred hhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCc--------cCcCChHH
Confidence 366777777777776 55544333 3688888888762 2245555566788888888887542 12489999
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCC
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS 208 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 208 (902)
+.|.+|++|+|++..++ .+|..+++|++|.+|++..+.-...+|..+..|++|++|.+..-.
T Consensus 592 ~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 592 GELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 99999999999999998 899999999999999999887666677777779999999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=105.38 Aligned_cols=140 Identities=15% Similarity=0.086 Sum_probs=100.5
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccch-----------hhhhHHHHHHHHHhCCCCCc--cceeeeeec-----
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNL--VKIISSCSN----- 793 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 793 (902)
+.+-+.....|+++.. +|+.|.||........ ....+.+|.+.+..+...+| ++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445777765 6788999976432211 11247789999888854333 344445432
Q ss_pred CCeeEEEEEccCCC-ChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-------CCc
Q 046199 794 GNFKALVLEYMANG-SLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-------DMV 864 (902)
Q Consensus 794 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------~~~ 864 (902)
....++|||++++. +|.+++... ....+......++.+++..+.-|| ..||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 798887532 233556677889999999999999 999999999999999975 468
Q ss_pred EEEEeecCcee
Q 046199 865 AHLSDFGIAKL 875 (902)
Q Consensus 865 ~kL~DFG~a~~ 875 (902)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=102.51 Aligned_cols=139 Identities=24% Similarity=0.222 Sum_probs=104.1
Q ss_pred ccccCeecccceeeEEEEEeCCCcEEEEEEeeecc----------------------chhhhhHHHHHHHHHhCCCC--C
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF----------------------DGALKSFDAECEVLKSVRHR--N 783 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 783 (902)
+.+...||.|.-+.||.|...+|.++|||.=+... .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999753211 01123467899999999754 7
Q ss_pred ccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 784 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
|++.+++ +...+||||++|-.|...- ++......++..|+.-+...- ..||||+|+.+-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 7877765 3457999999996665421 123444455666666666666 68999999999999999999
Q ss_pred cEEEEeecCceecCCC
Q 046199 864 VAHLSDFGIAKLLNGE 879 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~ 879 (902)
.+.++||--+.....+
T Consensus 240 ~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 240 DIVVIDWPQAVPISHP 255 (304)
T ss_pred CEEEEeCcccccCCCC
Confidence 9999999887665443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-09 Score=120.53 Aligned_cols=172 Identities=26% Similarity=0.259 Sum_probs=138.2
Q ss_pred ccccccCeecc--cceeeEEEEEe--C-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 726 DHFSEKSLIGI--GSFGTVYKGRF--L-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 726 ~~y~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
..+.+.+.+|. |.+|.||.+.. . ++..+|+|.-+.... ....+-.+|+...+.+ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566788999 99999999987 3 488899998543322 3334445677666666 499999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL----ALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGI 872 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~ 872 (902)
|+-+|++. .++.++.+.....++....+....+... |+.++| ...++|-|+||.||+...+ ...+++|||.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 99999995 6888888776667888889999999999 999999 9999999999999999998 8999999999
Q ss_pred ceecCCCccceec-----cccccccccccccccc
Q 046199 873 AKLLNGEESMRTQ-----TLGTIGYMAPGLWVVL 901 (902)
Q Consensus 873 a~~~~~~~~~~~~-----~~gt~~y~APE~l~~~ 901 (902)
...+.+..-.... ..|...|+|||+...+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l 303 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL 303 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc
Confidence 9888765532222 2577789999987653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-09 Score=130.17 Aligned_cols=107 Identities=23% Similarity=0.322 Sum_probs=54.2
Q ss_pred CCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcc-cccCcCccceeeecccccCCCCchhh
Q 046199 91 ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK-DIGNLTKLKELYLGYNKLQGEIPQEL 169 (902)
Q Consensus 91 l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~-~~~~l~~L~~L~L~~n~l~~~~p~~l 169 (902)
....|...+-+|.+.- ++.. .+.+.|++|=+..|... +..++. .|..++.|+.|||++|.=-+.+|.++
T Consensus 522 ~~~~rr~s~~~~~~~~-~~~~--~~~~~L~tLll~~n~~~-------l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I 591 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIEH-IAGS--SENPKLRTLLLQRNSDW-------LLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSI 591 (889)
T ss_pred hhheeEEEEeccchhh-ccCC--CCCCccceEEEeecchh-------hhhcCHHHHhhCcceEEEECCCCCccCcCChHH
Confidence 3556666666666542 2211 12334555555555310 001222 23445556666666554444556666
Q ss_pred ccccccceeecccCcCCCCCChhhhccCcccEEeeeeCC
Q 046199 170 GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS 208 (902)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 208 (902)
+.|-+||+|+|++..+. .+|..+++|+.|.+|++..+.
T Consensus 592 ~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~ 629 (889)
T KOG4658|consen 592 GELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG 629 (889)
T ss_pred hhhhhhhcccccCCCcc-ccchHHHHHHhhheecccccc
Confidence 66666666666666555 555556666666666555443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-08 Score=113.20 Aligned_cols=124 Identities=18% Similarity=0.216 Sum_probs=105.3
Q ss_pred eCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHH
Q 046199 747 FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL 826 (902)
Q Consensus 747 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 826 (902)
..++.+|.|...+.......+...+-++.++.++||+|+++++.++.++..|+|+|-+. .|..++++.. ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34688899988877655445667788889999999999999999999999999999884 6777775533 56677
Q ss_pred HHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 827 ~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
..++||+.||.|||+ +.+++|++|.-.-|+|++.|..||++|..+....+
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 889999999999985 78999999999999999999999999998865543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-09 Score=117.55 Aligned_cols=122 Identities=34% Similarity=0.512 Sum_probs=102.1
Q ss_pred HHhCCCCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe-EEcCCCC
Q 046199 776 LKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV-VHCDIKP 854 (902)
Q Consensus 776 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i-vHrDlkp 854 (902)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.-...+.++|+.||+|+| ...| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 35788999999999999999999999999999999999887778999999999999999999999 4444 9999999
Q ss_pred CCEEEcCCCcEEEEeecCceecCC--Cccceecccccccccccccccc
Q 046199 855 SNILLDDDMVAHLSDFGIAKLLNG--EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 855 ~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.|.++|....+|++|||+...... .........-..-|.|||++..
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 999999999999999999876532 1111111234557999998754
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-09 Score=85.81 Aligned_cols=60 Identities=47% Similarity=0.636 Sum_probs=34.0
Q ss_pred ccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcc
Q 046199 559 NLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618 (902)
Q Consensus 559 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 618 (902)
+|++|++++|+|+...+.+|..+++|++|++++|+++...|..|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555555555555555555555555555555566666555543
|
... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.82 E-value=6e-10 Score=120.78 Aligned_cols=100 Identities=29% Similarity=0.455 Sum_probs=83.9
Q ss_pred CeeEEEEEccCCCChHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 795 NFKALVLEYMANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
.+.|+.|++|...+|.+++..+ ....++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4688999999999999999643 3446778889999999999998 6899999999999999999999999999
Q ss_pred ceecCCCc------cceecccccccccccccccc
Q 046199 873 AKLLNGEE------SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~------~~~~~~~gt~~y~APE~l~~ 900 (902)
........ ...+...||..||+||.+.+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhh
Confidence 98765544 12334679999999999864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3e-09 Score=84.44 Aligned_cols=60 Identities=42% Similarity=0.553 Sum_probs=42.9
Q ss_pred ccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccc
Q 046199 535 VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594 (902)
Q Consensus 535 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (902)
+|++|++++|+|+...+..|.++++|++|++++|++++..|.+|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 466677777777755556777777777777777777766667777777777777777764
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.2e-08 Score=109.08 Aligned_cols=141 Identities=21% Similarity=0.207 Sum_probs=97.5
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccch----------------------------------------hhhhHHH
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG----------------------------------------ALKSFDA 771 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 771 (902)
+.|+.++-|.||+|+..+|++||||+.++.... ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678999999999999999999999997543210 0012345
Q ss_pred HHHHHHhCC-----CCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHHccCCC
Q 046199 772 ECEVLKSVR-----HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA-LEYLHFGYSN 845 (902)
Q Consensus 772 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~-L~~LH~~~~~ 845 (902)
|+.-+.+++ .|.|.-..=+++..+...++|||++|..+.+....+....+...+ +..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHH---hc
Confidence 666555552 344433333444556678999999999888874333344554333 3333322 23333 57
Q ss_pred CeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 846 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
|++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999887654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.2e-10 Score=125.61 Aligned_cols=191 Identities=27% Similarity=0.334 Sum_probs=126.1
Q ss_pred chhhccccccceeecccCcCCCCCChhhhcc-CcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCE
Q 046199 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNL-SSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244 (902)
Q Consensus 166 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~ 244 (902)
|-.|....+|++|.|.++.|+. . ..+..+ .+|+.|- -+|.++.+......-.|.|. .++. --+|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~---------ns~~-Wn~L~~ 168 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDIS---------NSPV-WNKLAT 168 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccc---------cchh-hhhHhh
Confidence 5556667777777777777652 1 122222 2344443 23444332211111112221 1100 126778
Q ss_pred EEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccC
Q 046199 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324 (902)
Q Consensus 245 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 324 (902)
-+.++|+++ .+..++.-++.|+.|+|++|+++.. .++..+++|++|||++|.++. +|..=..--+|+.|.+++
T Consensus 169 a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-----~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~L~~L~lrn 241 (1096)
T KOG1859|consen 169 ASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-----DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCKLQLLNLRN 241 (1096)
T ss_pred hhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-----HHHHhcccccccccccchhcc-ccccchhhhhheeeeecc
Confidence 888899988 6777888889999999999999832 347788999999999999984 343222223499999999
Q ss_pred CcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCc
Q 046199 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNG 382 (902)
Q Consensus 325 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~ 382 (902)
|.++.. ..+.+|++|+.||+++|-|.+.. -+..+..+..|+.|+|.+|++..
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hs----eL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHS----ELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcch----hhhHHHHHHHHHHHhhcCCcccc
Confidence 998743 46788999999999999988543 24556777888999999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=93.63 Aligned_cols=108 Identities=23% Similarity=0.243 Sum_probs=85.5
Q ss_pred hhhHHHHHHHHHhCCCC--CccceeeeeecC----CeeEEEEEccCCC-ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 046199 766 LKSFDAECEVLKSVRHR--NLVKIISSCSNG----NFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838 (902)
Q Consensus 766 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~ 838 (902)
..+..+|...+..+... .+++.+++.+.. ...++|||++++. +|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 35678888888888533 355566665542 2458999999884 79998865333 5667788899999999999
Q ss_pred HHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceecC
Q 046199 839 LHFGYSNPVVHCDIKPSNILLDDDM---VAHLSDFGIAKLLN 877 (902)
Q Consensus 839 LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~~ 877 (902)
|| ..||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99 99999999999999999887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-09 Score=94.56 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=99.7
Q ss_pred CceEecCCCCccCccccc---ccCCCCceEEEcCCCccCCCCccccc-cccccceeccCCccccccCccccccCCccceE
Q 046199 488 LRNLSLGSNELSSFIPST---FWNLNNILSFDFSSNSLNGSLPLDIG-NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563 (902)
Q Consensus 488 L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 563 (902)
+..++|+++++-. +++. +.....|+..+|++|.+.. .|..|. ..+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4566777776653 3433 3445566777888888885 444443 4457888999999998 788889999999999
Q ss_pred EccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCc
Q 046199 564 SLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGS 627 (902)
Q Consensus 564 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 627 (902)
+++.|.|. ..|..|..|.+|..||..+|.+. .+|..+-.-+.....++.+++|.+..|.+.|
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 99999998 67888888999999999988887 5665554444555667788889888887543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.2e-10 Score=122.07 Aligned_cols=57 Identities=32% Similarity=0.388 Sum_probs=26.9
Q ss_pred cceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 151 LKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 151 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
|..-+.++|.+. .+..++.-++.|+.|+|++|+++.. . .+..|+.|++|||++|.|.
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~ 222 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR 222 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc
Confidence 444444455444 4444444445555555555554422 1 3444455555555555444
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.9e-08 Score=71.97 Aligned_cols=35 Identities=43% Similarity=0.957 Sum_probs=26.7
Q ss_pred ChhHHHHHHHHHhcccc------CCCCCC--CCceeeeeEEee
Q 046199 6 NTTDQQALLALKARITA------KNWTSN--TSVCSWIGITCD 40 (902)
Q Consensus 6 ~~~~~~~l~~~~~~~~~------~~w~~~--~~~c~w~gv~c~ 40 (902)
+++|++||++||+++.. .+|+.. .+||+|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 36899999999999984 689876 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.5e-07 Score=88.95 Aligned_cols=157 Identities=20% Similarity=0.171 Sum_probs=106.1
Q ss_pred cccCHHHHHhhcccccccC---eecccceeeEEEEEeCCCcEEEEEEeeeccchh------------------------h
Q 046199 714 RRFSYRELLLATDHFSEKS---LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA------------------------L 766 (902)
Q Consensus 714 ~~~~~~~~~~~~~~y~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~ 766 (902)
...+.+.+.....+..+.+ .|+.|.-+.||+|...++..||+|+++...... .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3445555555555555444 455777889999988789999999986432110 1
Q ss_pred hhHHHHHHHHHhCC--CCCccceeeeeecCCeeEEEEEccCCCC-hHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC
Q 046199 767 KSFDAECEVLKSVR--HRNLVKIISSCSNGNFKALVLEYMANGS-LEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843 (902)
Q Consensus 767 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 843 (902)
....+|..-|+++. +-.+++.+++.. -.+||||+.... -.-.+++ -.....+...+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 12356777777774 455666666643 369999996531 1111111 122333577788888888888871
Q ss_pred CCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 844 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
..++||+|+..-|||+. ++.+.|+|||-|.....+
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 48999999999999999 779999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=86.83 Aligned_cols=138 Identities=18% Similarity=0.102 Sum_probs=102.1
Q ss_pred ecccceeeEEEEEeCCCcEEEEEEeeecc------chhhhhHHHHHHHHHhCCCCC--ccceeeeeec----CCeeEEEE
Q 046199 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQF------DGALKSFDAECEVLKSVRHRN--LVKIISSCSN----GNFKALVL 801 (902)
Q Consensus 734 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----~~~~~lv~ 801 (902)
-|+|+.+.|++... +|+.|-+|.-.... +.....|.+|...+.++...+ ++++...... .-..++|+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36789999999876 44578888754110 334578999999999885322 4454422111 12467999
Q ss_pred EccCC-CChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecCcee
Q 046199 802 EYMAN-GSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV--AHLSDFGIAKL 875 (902)
Q Consensus 802 e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~ 875 (902)
|-++| .+|.+++.+.. ...+......+..+++.++.-|| +.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 58888875432 24577778899999999999999 999999999999999986666 99999987764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8e-08 Score=106.68 Aligned_cols=149 Identities=28% Similarity=0.248 Sum_probs=118.3
Q ss_pred hhcccccccCeecccceeeEEEEEeC--CCcEEEEEEeeeccchhhh--hHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGALK--SFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
....+|..+..||.|.|+.|+.+... ++..|++|........... .-..|+.+...+ .|.+++.++..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998654 4788999987644322222 223466555555 589999998888888888
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCcee
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKL 875 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~ 875 (902)
|+--|||++++..... .-...+++...+++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 8999999999887655 22344778889999999999999999 9999999999999999886 7889999999865
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=87.95 Aligned_cols=133 Identities=15% Similarity=0.146 Sum_probs=87.5
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCC--CccceeeeeecCCeeEEEEEccCCCC-
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR--NLVKIISSCSNGNFKALVLEYMANGS- 808 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~- 808 (902)
..||+|..+.||+. .+..+++|..+... ......+|.++++.+..- .+++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 35578889876533 335678999999998643 35788888888888899999999963
Q ss_pred hHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------c-cCCCCeE
Q 046199 809 LEKCLYSSNRSLDIFQRLSIMIDVALALEYLH---------------------------------------F-GYSNPVV 848 (902)
Q Consensus 809 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---------------------------------------~-~~~~~iv 848 (902)
+...+. .+......++.++++.+.-+| . .....++
T Consensus 82 ~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIIS-----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhc-----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 211110 000111111111111111111 0 1134678
Q ss_pred EcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 849 HCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
|+|+.|.||++++++ +.++||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2e-06 Score=85.31 Aligned_cols=139 Identities=14% Similarity=0.158 Sum_probs=92.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhH---------HHHHHHHHhCCC---CCccceeee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSF---------DAECEVLKSVRH---RNLVKIISS 790 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~ 790 (902)
+...+|.+.+.+.......|.+... +++.+++|..+.......+.+ .+++.....++. ...+.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4556788888888777777766654 689999998876543322222 233333334322 222232222
Q ss_pred e-----ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 791 C-----SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 791 ~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
. ......+++|||++|..+.++.. +++ .++..+.+++.-+| +.|++|+|..|.|++++++ .+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence 2 22345678999999988766431 222 24566778899999 9999999999999999866 59
Q ss_pred EEEeecCcee
Q 046199 866 HLSDFGIAKL 875 (902)
Q Consensus 866 kL~DFG~a~~ 875 (902)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.6e-06 Score=94.04 Aligned_cols=139 Identities=22% Similarity=0.219 Sum_probs=109.2
Q ss_pred eeeEEEEEe-CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec----CCeeEEEEEccCC-CChHHH
Q 046199 739 FGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFKALVLEYMAN-GSLEKC 812 (902)
Q Consensus 739 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~ 812 (902)
-.+.|+|.. .+|..|++|+++............-++.++++.|+|||++.+++.. +...++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888865 4799999999954433333333455778999999999999998863 4568899999987 477776
Q ss_pred Hhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 813 LYS--------------SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 813 l~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
... .+...++..++.++.|+..||.++| +.|..-+-+.|.+|+++.+.+++|...|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 533 1223678899999999999999999 99999999999999999999999988887766544
Q ss_pred Cc
Q 046199 879 EE 880 (902)
Q Consensus 879 ~~ 880 (902)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 43
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-08 Score=98.68 Aligned_cols=115 Identities=27% Similarity=0.364 Sum_probs=67.6
Q ss_pred ccccccceeecccCcCCCCC-Chhhh-ccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEc
Q 046199 170 GNLAELEWLSLPRSFLTGTI-PSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247 (902)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~-p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~L 247 (902)
..+.-++-|.+.++.|...- -..|+ ..+.+++|||.+|.|.+|. ++-.-+.+||.|++|+|
T Consensus 42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWs-----------------eI~~ile~lP~l~~LNl 104 (418)
T KOG2982|consen 42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWS-----------------EIGAILEQLPALTTLNL 104 (418)
T ss_pred ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHH-----------------HHHHHHhcCccceEeec
Confidence 33345556666666554211 11222 3567888888888877542 23345667888888888
Q ss_pred cCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccC
Q 046199 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNL 303 (902)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l 303 (902)
+.|++...+...-.-+.+|+.|-|.+..+.-.--.+ .+..+|.+++|++|.|++
T Consensus 105 s~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s--~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 105 SCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTS--SLDDLPKVTELHMSDNSL 158 (418)
T ss_pred cCCcCCCccccCcccccceEEEEEcCCCCChhhhhh--hhhcchhhhhhhhccchh
Confidence 888887443322234567777777776664221112 155667777777777754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 902 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-39 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-30 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-29 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-23 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 5e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-06 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 6e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 7e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 8e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 9e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 496 bits (1280), Expect = e-164
Identities = 181/631 (28%), Positives = 270/631 (42%), Gaps = 44/631 (6%)
Query: 37 ITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96
+ L IS ++G + + +L+ LD+S N FS IP + S L+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L + N+LSG F I S + L+ ++ + N G +P L L+ L L
Sbjct: 228 LDISGNKLSGDFSRAI-STCTELKLLNISSNQFVGPIPP----------LPLKSLQYLSL 276
Query: 157 GYNKLQGEIPQEL-GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMT 215
NK GEIP L G L L L + G +P + S L L S+N+ +G
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG---- 332
Query: 216 NNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMST-LKALSLLNN 274
+P + + L+VL + N G++P ++ N+S L L L +N
Sbjct: 333 ------ELP--------MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 275 TLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT 334
SG + + ++ L L N +G+IP + N S+L L L+ N SG IP +
Sbjct: 379 NFSGPILPNLCQNP-KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 335 LVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT 394
L +L L L L N L P L + + ++L N L G +PS + N
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIP-----QELMYVKTLETLILDFNDLTGEIPSGLSNCT-N 491
Query: 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
L I L N ++ G IPK IG L NL L L NN SG+IP +G +L L L N
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 455 GPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN--ELSSFIPSTFWNLNNI 512
G IP + + S + N ++G N + N E L+
Sbjct: 552 GTIPAAMFKQSGK-IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610
Query: 513 LSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG 572
+ +S G N ++ +++S N L+G IP IG + L +L+L +N + G
Sbjct: 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670
Query: 573 PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
IP+ G L L LDLS N L G IP ++ L L +++LS N L G IP G F F
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730
Query: 633 AQSFMGNDLLCGSPHLQVPLCKSSPHQKSSK 663
F+ N LCG P + + + +
Sbjct: 731 PAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-149
Identities = 165/643 (25%), Positives = 279/643 (43%), Gaps = 64/643 (9%)
Query: 1 AANNINTTDQQALLALKARIT----AKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGL 56
+ + + L++ K + +W+SN + C++ G+TC +VT++++S L
Sbjct: 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPL 62
Query: 57 T---GTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFI- 112
+SS L +L+ L++L LS++ +G++ ++L L L N LSG +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 113 ISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL--- 169
+ + S L+ ++ + N+L + L L+ L L N + G
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGG-------LKLNSLEVLDLSANSISGANVVGWVLS 174
Query: 170 GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229
EL+ L++ + ++G + + +L LD S +N+F+ IP
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVS----------SNNFSTGIP----- 217
Query: 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIG 289
+G+ L+ L I N L GD I + LK L++ +N G +P
Sbjct: 218 -----FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP----- 267
Query: 290 LPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
L +++ L+L N +G IP F+ L L+L+GN F G +P + LE L L
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 349 NYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
N + P +L K + L+ N +G LP S+ NL +L + L + G
Sbjct: 328 NNFSGELPM----DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383
Query: 409 IPKEIGN--LVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSE 466
I + L L+L NN +G IP T+ + L L L N L G IP L LS+
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443
Query: 467 L---HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
L + N L G IP + +L L L N+L+ IPS N N+ S+N L
Sbjct: 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
Query: 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTS 583
G +P IG ++ + + LS N +G+IP +G +L L L N +G IP +
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ-- 561
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN--RLEGEIPS 624
S ++ N ++G + ++ K+ + + N +G
Sbjct: 562 --SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 1e-93
Identities = 98/641 (15%), Positives = 199/641 (31%), Gaps = 120/641 (18%)
Query: 24 NWTSNTSVCSW---IGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRF 80
NW N + W G++ + S RVT L++ FG +G + +G L+ L+ L L +
Sbjct: 59 NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 81 SG----TIPSSIFSISTLKILILGDNQLSGSFPSFIIS-NTSSLRAIDCNYNSLSGELPA 135
P I + + + +F + + S L N + +
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 136 NIFR---------------AIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSL 180
+ + K + LTKL++ Y+G + E E E+
Sbjct: 178 SSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 181 PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLP 240
T NL L +++ N ++P + LP
Sbjct: 238 -----YKTEDLKWDNLKDLTDVEVYNCPNLT-------------------KLPTFLKALP 273
Query: 241 NLEVLGIDENHLV--------GDVPNTIFNMSTLKALSLLNNTL-SGSLPSSSKNLIGLP 291
++++ + N + ++ + + N L + + +S L +
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS---LQKMK 330
Query: 292 NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351
+ L N L G++P F + KL L L N + + +E+L +N L
Sbjct: 331 KLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389
Query: 352 TS--STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNI 409
+ + +S + I + N + V + +
Sbjct: 390 KYIPNIFDAKSVSVM------SAIDFSYNEIGSVDGKNFDP------------------L 425
Query: 410 PKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-------PIPDDLC 462
+N+++++L NNQ+S + L + L N L ++
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 463 QLS---ELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
+ + NKL+ L L + L N S P+ N + + F
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578
+ + N + P I +L L + +N + + E
Sbjct: 545 NQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 579 GALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619
++ LD+ N + + + L +++ +
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-80
Identities = 88/606 (14%), Positives = 175/606 (28%), Gaps = 99/606 (16%)
Query: 48 ALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGS 107
ALN ++ G + N + + LD+ + S+ S + L L SG
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDM----WGAQPGVSLNSNGRVTGLSLEGFGASGR 96
Query: 108 FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ 167
P I + L + + N PK I ++ Q
Sbjct: 97 VPDA-IGQLTELEVLALGSHGEKV----NERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151
Query: 168 ELGNLA--ELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
+L + +I S ++ +N++T
Sbjct: 152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-------------- 197
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
+ + L L + + V + +
Sbjct: 198 ------VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN---------------------- 229
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
N N L +E+ +P L L ++ +
Sbjct: 230 ----------ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 346 LGYNYLTSSTP---ELSFLSSLANSSSSKYIVLAENPL-NGVLPSSIGNLPITLEEIYLQ 401
+ N S + L+ + I + N L + +S+ + L +
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECL 338
Query: 402 NCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL 461
++ G +P G+ + L +L+L NQ++ G ++ L +NKL+ IP+
Sbjct: 339 YNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396
Query: 462 C-----QLSELHVDHNKLSG-------PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
+S + +N++ P+ ++ +++L +N++S F F
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 510 NNILSFDFSSNSLNG-------SLPLDIGNMKVVVEINLSRNYLTGDIPTTI--GGLTNL 560
+ + S + N L + N ++ I+L N LT + L L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 561 QLLSLENNRLHGPIPESFGALTSLESL------DLSVNNLSGVIPISLEKLVYLKDLNLS 614
+ L N P ++L+ D N P + L L +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 615 FNRLEG 620
N +
Sbjct: 575 SNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-50
Identities = 59/342 (17%), Positives = 130/342 (38%), Gaps = 17/342 (4%)
Query: 302 NLSGRIPG-FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
++ G PG + + ++ L L G SG +PD + L LE L LG + + L
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-LFG 125
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT-LEEIYLQNCKIRGNIPKEIGNLVNL 419
++ + S + + L + + + + +I K +
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 420 TTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIP 479
T + +N ++ + V RL L+ + N+ + + ++ +
Sbjct: 186 TQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS--EYAQQYKTED 242
Query: 480 ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL--------NGSLPLDIG 531
+ NL L ++ + + + +P+ L + + + N + D
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 532 NMKVVVEINLSRNYL-TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLS 590
+ + I + N L T + T++ + L +L N+L G +P FG+ L SL+L+
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLA 361
Query: 591 VNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
N ++ + +++L+ + N+L+ IP+ + S
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-41
Identities = 54/312 (17%), Positives = 105/312 (33%), Gaps = 42/312 (13%)
Query: 56 LTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSIST-LKILILGDNQLSGSFPSFIIS 114
L G + + G+ L +L+L++N+ + IP++ + ++ L N+L F
Sbjct: 342 LEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 115 NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAE 174
+ S + AID +YN + + F + + + L N++ + +
Sbjct: 400 SVSVMSAIDFSYNEIGS-VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 175 LEWLSLPRSFLTG-------TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227
L ++L + LT + N L +D N LT + +
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-----------KLSDDF 507
Query: 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLN------NTLSGSLP 281
LP L + + N P N STLK + N N P
Sbjct: 508 -------RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 282 SSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNL 341
+ P++ +L +G N++ + I + +L++ N +
Sbjct: 560 EG---ITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEA 613
Query: 342 EHLGLGYNYLTS 353
L Y+
Sbjct: 614 GMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 26/249 (10%), Positives = 69/249 (27%), Gaps = 29/249 (11%)
Query: 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSG----SIPITVGRLNTLQGLGLEN 450
+ + L+ G +P IG L L L LG++ P + + +
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 451 NKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLN 510
+ D + + + L + S+ I +
Sbjct: 143 MHYQKTFVDYDPRE-------------------DFSDLIKDCINSDPQQKSIKKSSRITL 183
Query: 511 NILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL 570
SN++ + + + + + + + + + + E +
Sbjct: 184 KDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQ 237
Query: 571 HGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
+ + L L +++ +P L+ L ++ +N++ NR +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 631 FSAQSFMGN 639
+
Sbjct: 298 LADAPVGEK 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 3e-92
Identities = 117/627 (18%), Positives = 203/627 (32%), Gaps = 79/627 (12%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
LN+ L+ ++L L L N + L L L N LS +
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
+L+ + + N + L + DI + LK+L L N+++ P
Sbjct: 138 LG-TQVQLENLQELLLSNNKIQA-LKSEEL-----DIFANSSLKKLELSSNQIKEFSPGC 190
Query: 169 LGNLAELEWLSLPRSFLTGTIPSSIF---NLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
+ L L L L ++ + +S+ L SN+ L+ +N F G
Sbjct: 191 FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT--SNTTFLGL--- 245
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
NL +L + N+L ++ + L+ L N + S
Sbjct: 246 ------------KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 286 NLIGL------PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLR 339
L + + + ++ L +L L L + N G + L
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIY 399
NL++L L ++ + T SLA+S L +
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSP--------------------------LHILN 387
Query: 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP 458
L KI L +L L LG N++ + L + + L NK
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 459 DDLC---QLSELHVDHNKLSG--PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNIL 513
+ L L + L P+ F L +L L L +N +++ L +
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 514 SFDFSSNSLN--------GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSL 565
D N+L G + + + +NL N L L+++ L
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567
Query: 566 ENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEK-LVYLKDLNLSFNRLEGEIPS 624
N L+ F SL+SL+L N ++ V L +L++ FN + S
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
Query: 625 GGSFANF-----SAQSFMGNDLLCGSP 646
F N+ + + + LC +P
Sbjct: 628 IAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 2e-91
Identities = 124/590 (21%), Positives = 209/590 (35%), Gaps = 53/590 (8%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
+++ L+L+HN+ ++ S L L +G N +S P + L+ ++ +
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE-LCQKLPMLKVLNLQH 82
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
N LS L F T L EL+L N +Q L L L + L+
Sbjct: 83 NELSQ-LSDKTFA-------FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 187 GTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
T + L +L EL SNN + L +I +L+ L
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQAL----------KSEEL-------DIFANSSLKKLE 177
Query: 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306
+ N + P + L L L N L SL + +I L+L + LS
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 307 IPGFIFN--ASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE----LSF 360
+ L +L+L+ N+ + D+ L LE+ L YN + L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
+ L S ++ L + S L LE + +++ I G L+NL
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLK-CLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 421 TLHLGNNQLSGSIPITVG----RLNTLQGLGLENNKLEGPIPD---DLCQLSELHVDHNK 473
L L N+ S + L L L NK+ D L L L + N+
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416
Query: 474 LSGPIPA-CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG--SLPLDI 530
+ + + L ++ + L N+ ++F + ++ +L S P
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 531 GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLH--------GPIPESFGALT 582
++ + ++LS N + + GL L++L L++N L G L+
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 583 SLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
L L+L N + + L LK ++L N L S F N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS--VFNNQV 584
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 5e-57
Identities = 87/479 (18%), Positives = 165/479 (34%), Gaps = 59/479 (12%)
Query: 36 GITCDVSTHRVTALNISDFGLTGTISSQLGNL--SSLQTLDLSHNRFSGTIPSSIFSIST 93
+ +++ + L++S+ L+ T ++ L ++L LDLS+N + S +
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 94 LKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPAN-IFRAIPKDIGNLTKLK 152
L+ L N + F + ++R ++ + + + + L L+
Sbjct: 274 LEYFFLEYNNIQHLFSHS-LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT-GTIPSSIF---NLSSLLELDFSNNS 208
L + N + G L L++LSL SF + T+ + F S L L+ + N
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392
Query: 209 LTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLK 267
++ L +LEVL + N + ++ + + +
Sbjct: 393 ISKI-------------------ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG--RIPGFIFNASKLFLLELTGN 325
+ L N +S +P+++RL L L P L +L+L+ N
Sbjct: 434 EIYLSYNKYLQLTRNS---FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 326 SFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLP 385
+ + D L L LE L L +N L L ++ G
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLAR---------------------LWKHANPGGPI 529
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQG 445
+ L L + L++ + +L L + LG N L+ +L+
Sbjct: 530 YFLKGLS-HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 446 LGLENNKLEGPIPDDLC----QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS 500
L L+ N + L+EL + N + +N + ELSS
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-39
Identities = 83/356 (23%), Positives = 131/356 (36%), Gaps = 45/356 (12%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFS-GTIPSSIFS---ISTLKILILGDNQL 104
LN+ D + G S+ L +L+ L LS++ S T+ + F S L IL L N++
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
S S S L +D N + EL + L + E+YL YNK
Sbjct: 394 SK-IESDAFSWLGHLEVLDLGLNEIGQELTGQEW-------RGLENIFEIYLSYNKYLQL 445
Query: 165 IPQELGNLAELEWLSLPRSFLTG--TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGS 222
+ L+ L L R L + PS L +L LD SNN++
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI---------- 495
Query: 223 IPRNLWQCEIPHEIGNLPNLEVLGIDENHL--------VGDVPNTIFNMSTLKALSLLNN 274
+ L LE+L + N+L G + +S L L+L +N
Sbjct: 496 ---------NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 275 TLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT 334
K+L ++ ++LGLNNL+ N L L L N +
Sbjct: 547 GFDEIPVEVFKDL---FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 335 L-VNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIG 389
RNL L + +N + +++ + N + + L+ + L P G
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG 659
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-37
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 11/240 (4%)
Query: 393 ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
++ E + K+ +P ++ N+T L+L +NQL R + L L + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 453 LEGPIPD---DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
+ P+ L L L++ HN+LS F +L L L SN + + F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIG--GLTNLQLLSLEN 567
N+++ D S N L+ + ++ + E+ LS N + + ++L+ L L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISL---EKLVYLKDLNLSFNRLEGEIPS 624
N++ P F A+ L L L+ L + L +++L+LS ++L +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 3/171 (1%)
Query: 462 CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNS 521
H KL+ +P ++ L+L N+L + F + + S D N+
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581
++ P + ++ +NL N L+ T TNL L L +N + F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
+L +LDLS N LS + +L L++L LS N+++ S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-85
Identities = 91/300 (30%), Positives = 133/300 (44%), Gaps = 14/300 (4%)
Query: 358 LSFLSSLAN----SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRG--NIPK 411
L L N SS GVL + + + L + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY-RVNNLDLSGLNLPKPYPIPS 70
Query: 412 EIGNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS---EL 467
+ NL L L++G N L G IP + +L L L + + + G IPD L Q+ L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF-DFSSNSLNGSL 526
+N LSG +P +L +L ++ N +S IP ++ + + + + S N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 527 PLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLES 586
P N+ + ++LSRN L GD G N Q + L N L + G +L
Sbjct: 191 PPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 587 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSP 646
LDL N + G +P L +L +L LN+SFN L GEIP GG+ F ++ N LCGSP
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-64
Identities = 88/376 (23%), Positives = 134/376 (35%), Gaps = 96/376 (25%)
Query: 6 NTTDQQALLALKARIT----AKNWTSNTSVC--SWIGITCDVSTH--RVTALNISDFGLT 57
N D+QALL +K + +W T C +W+G+ CD T RV L++S L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 58 GT--ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISN 115
I S L NL L L +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIG--------------------------------------- 84
Query: 116 TSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
N+L G IP I LT+L LY+ + + G IP L + L
Sbjct: 85 ---------GINNLVGP--------IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG---------------FYMTNNHFT 220
L + L+GT+P SI +L +L+ + F N ++G ++ N T
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSL 280
G IP NL NL + + N L GD + + + L N+L+ L
Sbjct: 188 GKIPP---------TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 281 PSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRN 340
+ N+ L+L N + G +P + L L ++ N+ G IP NL+
Sbjct: 238 GK----VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQR 292
Query: 341 LEHLGLGYNYLTSSTP 356
+ N +P
Sbjct: 293 FDVSAYANNKCLCGSP 308
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 7e-80
Identities = 116/621 (18%), Positives = 195/621 (31%), Gaps = 70/621 (11%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
L++S L S + LQ LDLS + S+S L LIL N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQG-E 164
S SSL+ + +L+ IG+L LKEL + +N +Q +
Sbjct: 90 S-LALGAFSGLSSLQKLVAVETNLASL--------ENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 165 IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL----LELDFSNNSLTGFYMTNNHFT 220
+P+ NL LE L L + + + + L + L LD S N +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF--------- 191
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGS 279
I L L + N +V T ++ L+ L+
Sbjct: 192 -----------IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 280 LPSSSKNLIGLPNIERLNLGLNNLS------GRIPGFIFNASKLFLLELTGNSFSGFIPD 333
+ L + L + L+ I + + L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299
Query: 334 TLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI 393
+HL L L G S +LP
Sbjct: 300 -FSYNFGWQHLELVNCKFGQ----------FPTLKLKSLKRLTFTSNKGGNAFSEVDLP- 347
Query: 394 TLEEIYLQNCKI--RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENN 451
+LE + L + +G + +L L L N + + L L+ L +++
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 452 KLEGPIPDDLCQ----LSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS-SFIPSTF 506
L+ + L L + H F L+SL L + N +F+P F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE 566
L N+ D S L P ++ + +N+S N L +LQ+L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526
Query: 567 NNRLHGPIPESFGAL-TSLESLDLSVNNLSGVIPIS--LEKLVYLKDLNLSFNRLEGEIP 623
N + + +SL L+L+ N+ + L+ + + L + R+E P
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
Query: 624 SGGSFANFSAQSFMGNDLLCG 644
S S ++ C
Sbjct: 587 S--DKQGMPVLSL---NITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 73/380 (19%), Positives = 124/380 (32%), Gaps = 55/380 (14%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
N +P + + L+L N L F+ +L +L+L+ +
Sbjct: 15 MELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS 74
Query: 338 LRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLE 396
L +L L L N + S S LSSL + +V E L + IG+L TL+
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSL------QKLVAVETNLASLENFPIGHLK-TLK 127
Query: 397 EIYLQNCKIRG-NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG 455
E+ + + I+ +P+ NL NL L L +N++ + L+ + L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS------ 181
Query: 456 PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPST-FWNLNNILS 514
L + N ++ P F + L L+L +N S + T L +
Sbjct: 182 -----------LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL---H 571
L + + GL NL + L
Sbjct: 230 HRLVLGEFRNE------------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 572 GPIPESFGALTSLESLDLSVNNLSGVIPIS-LEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
I + F LT++ S L + V S +L+ +N F +
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 631 FSAQSFMGNDLLCGSPHLQV 650
F++ P L+
Sbjct: 332 FTSNKGGNAFSEVDLPSLEF 351
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-36
Identities = 63/417 (15%), Positives = 129/417 (30%), Gaps = 58/417 (13%)
Query: 45 RVTALNISDFGLTGTISSQ-LGNLSSLQTLDLSHNRFSGTIPSSIFSIST---LKILILG 100
R+ L + + + + + L+ L+ L F F S L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 101 DNQL-----SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELY 155
+ +L + + +++ + ++ KD + L
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER----------VKDFSYNFGWQHLE 310
Query: 156 LGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMT 215
L K +L +L L + S G S +L SL LD S N L+
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSN-----KGGNAFSEVDLPSLEFLDLSRNGLS----- 360
Query: 216 NNHFTGSIPRNLWQC--------------EIPHEIGNLPNLEVLGIDENHLVGDVPNTIF 261
F G ++ + + L LE L ++L ++F
Sbjct: 361 ---FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 262 -NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFL 319
++ L L + + + GL ++E L + N+ IF L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGI---FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENP 379
L+L+ P +L +L+ L + +N S +S + + + N
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT-----FPYKCLNSLQVLDYSLNH 529
Query: 380 LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKE--IGNLVNLTTLHLGNNQLSGSIP 434
+ + + P +L + L + + + + L + ++ + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 7e-79
Identities = 93/671 (13%), Positives = 211/671 (31%), Gaps = 91/671 (13%)
Query: 8 TDQQALLALKARITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNL 67
D +AL A+ + KNW + + + + N L N
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLN------WNFNKELDMWGDQPGVDLDNN 322
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
+ L L+ G +P +I ++ LK+L G + + S + + +
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS-GRLFGDEELTPDMSEERKH 381
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG 187
+ +F + + L++ +++ +L + + +L +
Sbjct: 382 RIRMHYK-KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL--TNRIT 438
Query: 188 TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247
I +I L+ L + F+N+ T + + + NL +L + +
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498
Query: 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLSG------SLPSSSKNLIGLPNIERLNLGLN 301
+ +P+ ++++ L++L++ N + + P I+ +G N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 302 NLSG-RIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
NL + KL LL+ N + L L L YN +
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE------- 609
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPK--EIGNLVN 418
+P +E + + K++ IP ++
Sbjct: 610 -----------------------IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYV 645
Query: 419 LTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPI 478
+ ++ N++ ++ +G+ S + + +N++
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGI----------------NASTVTLSYNEIQKFP 689
Query: 479 PACFGNLNSLRNLSLGSNELSSF-------IPSTFWNLNNILSFDFSSNSLNGSLPLDI- 530
F + + + L +N ++S + N + + D N L SL D
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748
Query: 531 -GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE------NNRLHGPIPESFGALTS 583
+ + +++S N + PT + L+ + NR+ P S
Sbjct: 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL-EGEIPSGGSFANFSAQSFMGND-- 640
L L + N++ V +L L+++ N ++ S + + +
Sbjct: 808 LIQLQIGSNDIRKVDEKLTPQLYI---LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
Query: 641 LLCGSPHLQVP 651
+ G L +
Sbjct: 865 DIRGCDALGIE 875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-78
Identities = 103/567 (18%), Positives = 192/567 (33%), Gaps = 50/567 (8%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
+S + L+ S N ++ + L L L Q+ + L +
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTA 90
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
N L + LK L+ + L N LE L L + ++
Sbjct: 91 NPLIF-MAETALS-------GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 187 GTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
F L LDF NN++ ++ +L L
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYL-------------------SKEDMSSLQQATNLS 183
Query: 247 IDENHL-VGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
++ N + + F+ + ++L+ + KN + ++ +
Sbjct: 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS-TIQSLWLGTFEDMDDED 242
Query: 306 RIPGFIFNASKLFL--LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSS 363
P ++ + + L + F +T L+ L L +L+ L LS+
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLST 302
Query: 364 LANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKE-IGNLVNLTTL 422
L K +VL+ N + S N P +L + ++ R + + NL NL L
Sbjct: 303 L------KKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 423 HLGNNQL--SGSIPITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSELHVDHNKLSG- 476
L ++ + S + + L+ LQ L L N+ + + QL L + +L
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 477 PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG---NM 533
+ F NL+ L+ L+L + L F L + + N +
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 534 KVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNN 593
+ + LS L+ L + + L +NRL E+ L + L+L+ N+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNH 534
Query: 594 LSGVIPISLEKLVYLKDLNLSFNRLEG 620
+S ++P L L + +NL N L+
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-47
Identities = 85/489 (17%), Positives = 158/489 (32%), Gaps = 66/489 (13%)
Query: 42 STHRVTALNISDFGLTGTISSQLGNLSSLQ--TLDLSHNRFSGTIPSSIFSISTLKILIL 99
T ++ L+ + + + +L +L+L+ N + I F + + L
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNF 209
Query: 100 GDNQLSG-SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGY 158
G Q F S SL ++ +F + + ++ + L
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCE-----MSVESINLQK 263
Query: 159 NKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNH 218
+ + L+ L L + L+ +PS + LS+L +L S N
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC----- 317
Query: 219 FTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLS 277
N P+L L I N ++ N+ L+ L L ++ +
Sbjct: 318 --------------QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 278 GSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT-LV 336
+ + L L +++ LNL N +L LL+L +
Sbjct: 364 -TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 337 NLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP--I 393
NL L+ L L ++ L S+ + L +L +++ L N +L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPAL------QHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL 453
LE + L C + +L + + L +N+L+ S + L + L L +N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 454 EGPIPD---DLCQLSELHVDHNKLS--------------------GPIPACFGNLNSLRN 490
+P L Q +++ N L N LR
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595
Query: 491 LSLGSNELS 499
+ L LS
Sbjct: 596 VRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 39/202 (19%), Positives = 66/202 (32%), Gaps = 4/202 (1%)
Query: 448 LENNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTF 506
EN L IP L L N L F L +L L L ++ TF
Sbjct: 19 CENLGLNE-IPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE 566
+ + + + ++N L + K + + + ++ + L+ L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 567 NNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK--DLNLSFNRLEGEIPS 624
+N + L+ LD N + + + L LNL+ N + G P
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197
Query: 625 GGSFANFSAQSFMGNDLLCGSP 646
A F + +F G L
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIF 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 5e-69
Identities = 111/566 (19%), Positives = 184/566 (32%), Gaps = 55/566 (9%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
SS + +DLS N S + S L+ L L ++ + L + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGN 90
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG 187
+ F LT L+ L KL +G L L+ L++ +F+
Sbjct: 91 PIQS-FSPGSFS-------GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 188 TIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
+ F NL++L+ +D S N + T N N L
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTI--TVNDLQFLR-------------ENPQVNLSLD 187
Query: 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306
+ N + + + F L L+L N S ++ + L L + L L
Sbjct: 188 MSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTC--LQNLAGLHVHRLILGEFKDE 244
Query: 307 IPGFIFNAS--------KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
IF S + LT + L N+ + L +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY----- 299
Query: 359 SFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN 418
L + + + + L + L + + L K +I + L +
Sbjct: 300 --LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL----KSLTLTMNKG--SISFKKVALPS 351
Query: 419 LTTLHLGNNQLSGSIPITVGRLNT--LQGLGLENNKLEGPIPD--DLCQLSELHVDHNKL 474
L+ L L N LS S + L T L+ L L N + L +L L H+ L
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL 411
Query: 475 SGPIPA-CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDI-GN 532
F +L L L + F L ++ + + NS + ++ N
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 533 MKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
+ ++LS+ L L LQLL++ +N L + L SL +LD S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 593 NLSGVIPISLEKLVYLKDLNLSFNRL 618
+ I L NL+ N +
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-20
Identities = 38/157 (24%), Positives = 61/157 (38%), Gaps = 5/157 (3%)
Query: 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV 535
G + C + ++ +LS + NI D S N L N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFSE 57
Query: 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595
+ ++LSR + GL +L L L N + P SF LTSLE+L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 596 GVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
+ + +L+ LK LN++ N + F+N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 6e-62
Identities = 76/188 (40%), Positives = 110/188 (58%), Gaps = 5/188 (2%)
Query: 713 WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDA 771
+RFS REL +A+D+FS K+++G G FG VYKGR DG VA+K + G F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 772 ECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS---LDIFQRLSI 828
E E++ HRNL+++ C + LV YMANGS+ CL S LD +R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES-MRTQTL 887
+ A L YLH ++H D+K +NILLD++ A + DFG+AKL++ +++ + T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 888 GTIGYMAP 895
GTIG++AP
Sbjct: 197 GTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-61
Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 8/207 (3%)
Query: 694 RKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV 753
+ N+ + + R +L AT++F K LIG G FG VYKG DG +V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 754 AIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL 813
A+K + ++ F+ E E L RH +LV +I C N L+ +YM NG+L++ L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 814 YSSNR---SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870
Y S+ S+ QRL I I A L YLH + ++H D+K NILLD++ V ++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 871 GIAKL-LNGEES-MRTQTLGTIGYMAP 895
GI+K +++ + T GT+GY+ P
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDP 210
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-55
Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 18/196 (9%)
Query: 714 RRFSYRELLLATDHFSEK------SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-- 765
FS+ EL T++F E+ + +G G FG VYKG +++ VA+K D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 71
Query: 766 --LKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS--LD 821
+ FD E +V+ +H NLV+++ S+G+ LV YM NGSL L + + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 822 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL--NGE 879
R I A + +LH N +H DIK +NILLD+ A +SDFG+A+ +
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 880 ESMRTQTLGTIGYMAP 895
M ++ +GT YMAP
Sbjct: 189 TVMTSRIVGTTAYMAP 204
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-55
Identities = 125/602 (20%), Positives = 214/602 (35%), Gaps = 86/602 (14%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
L++ + L LS N T+ +S F + L++L LG + N +LR +D
Sbjct: 22 VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE--LGNLAELEWLSLPR 182
+ + L + F+ L L EL L + L + ++ NL L L L +
Sbjct: 81 GSSKIY-FLHPDAFQ-------GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 183 SFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
+ + F L+SL +DFS+N + + +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIF--LVCEHELEPL---------------QGKT 175
Query: 242 LEVLGIDENHLVGDVPNTIFNMS------TLKALSLLNNTLSGSLPSSSKN--------- 286
L + N L V L+ L + N + + + N
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 287 LIGLPNIERLNLGLNNLSGRIPGFIFNASKLFL--LELTGNSFSGFIPDTLVNLRNLEHL 344
LI +I G +N+ ++ + L+L+ L++L+ L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 345 GLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNC 403
L YN + E L +L + + L+ N L + S+ LP + I LQ
Sbjct: 296 NLAYNKINKIADEAFYGLDNL------QVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKN 348
Query: 404 KIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQ 463
I + L L TL L +N L+ T+ + ++ + L NKL +P
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINLT 402
Query: 464 LSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIPS-TFWNLNNILSFDFSSNS 521
+ +H+ N+L I + L+ L L N SS T ++ N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581
L + ++ GL++LQ+L L +N L+ P F L
Sbjct: 463 LQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDL 641
T+L L L+ N L+ + L L+ L++S N+L P+ F + S N
Sbjct: 504 TALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQL--LAPNPDVFVSLSVLDITHNKF 559
Query: 642 LC 643
+C
Sbjct: 560 IC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-27
Identities = 66/367 (17%), Positives = 122/367 (33%), Gaps = 34/367 (9%)
Query: 40 DVSTHRVTALNISDF--GLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI---STL 94
DVS + T +F ++ + + L + + + F+ S++
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSV 268
Query: 95 KILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKEL 154
+ L L + S S + L+ ++ YN ++ ++ F L L+ L
Sbjct: 269 RHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFY-------GLDNLQVL 319
Query: 155 YLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYM 214
L YN L L ++ ++ L ++ + + L L LD +N+LT +
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF 379
Query: 215 TNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLN 273
+ L ++ ++ + EN L + L+ L L
Sbjct: 380 IPSIPD----IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 274 NTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI-----PGFIFNASKLFLLELTGNSFS 328
N S P++E+L LG N L S L +L L N +
Sbjct: 436 NRFSSCSGDQ--TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 329 GFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSI 388
P +L L L L N LT ++L + + ++ N L P
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLTVL-SHNDLPANL------EILDISRNQLLAPNPDVF 546
Query: 389 GNLPITL 395
+L +
Sbjct: 547 VSLSVLD 553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-18
Identities = 50/250 (20%), Positives = 79/250 (31%), Gaps = 38/250 (15%)
Query: 402 NCKIRG--NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459
+ +P+ L L L N + + L LQ L L + I
Sbjct: 10 FYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 460 DLCQ----LSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI--PSTFWNLNNIL 513
+ + L L + +K+ P F L L L L LS + F NL +
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 514 SFDFSSNSLNG-SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE-----N 567
D S N + L G + + I+ S N + L LQ +L
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE---LEPLQGKTLSFFSLAA 183
Query: 568 NRLHGPIPESFGAL------TSLESLDLSVNNLSGVIP------------ISLEKLVYLK 609
N L+ + +G LE LD+S N + I SL ++
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 610 DLNLSFNRLE 619
F+ ++
Sbjct: 244 GAGFGFHNIK 253
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-53
Identities = 105/574 (18%), Positives = 189/574 (32%), Gaps = 55/574 (9%)
Query: 72 TLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSG 131
T F IP ++ + K L L N L S+ + L+ +D + +
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 132 ELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPS 191
+ ++ +L+ L L L N +Q L+ L+ L + L
Sbjct: 66 TIEDGAYQ-------SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 192 SIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH 251
I +L +L EL+ ++N + S +P NL NLE L + N
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-----------SFK-------LPEYFSNLTNLEHLDLSSNK 160
Query: 252 LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311
+ + + + L+L + + + +L L N S +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 312 FNA-SKLFLLELTGNSFSG------FIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
+ L + L F F L L NL YL ++ L +
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN- 279
Query: 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHL 424
++ L + V S LE + + + L +L L
Sbjct: 280 -CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTF 332
Query: 425 GNNQLSGSIPITVGRLNTLQGLGLENNKLEGP-----IPDDLCQLSELHVDHNKLSGPIP 479
+N+ + L +L+ L L N L L L + N + +
Sbjct: 333 TSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389
Query: 480 ACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVE 538
+ F L L +L + L S F +L N++ D S + + +
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 539 INLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+ ++ N + I L NL L L +L P +F +L+SL+ L+++ N L V
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANF 631
++L L+ + L N + P + +
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 61/330 (18%), Positives = 109/330 (33%), Gaps = 36/330 (10%)
Query: 56 LTGTISSQLGNLSSLQT--LDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFI 112
L S L L +L L++ + +F+ ++ + L +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 113 ISNTSSLRAIDCNYNSLSG---------ELPANIFRAIPKDIGNLTKLKELYLGYNKLQ- 162
L ++C + +N ++ +L L+ L L N L
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSF 361
Query: 163 -GEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTG 221
G Q L++L L + + T+ S+ L L LDF +++L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM--------- 411
Query: 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLP 281
+++ +L NL L I H +S+L+ L + N+ +
Sbjct: 412 -SEFSVFL--------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 282 SSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNL 341
L N+ L+L L P + S L +L + N L +L
Sbjct: 463 PDI--FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 342 EHLGLGYNYLTSSTPELSFLSSLANSSSSK 371
+ + L N S P + +LS N +S K
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSRWLNKNSQK 550
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-15
Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 1/123 (0%)
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNR 569
+ + D S N L + + ++LSR + L++L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 570 LHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFA 629
+ +F L+SL+ L NL+ + + L LK+LN++ N ++ F+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 630 NFS 632
N +
Sbjct: 147 NLT 149
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 6/174 (3%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRN 783
+ K IG GSFGTV++ + G +VA+K+ Q A + F E ++K +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHF 841
+V + + + ++V EY++ GSL + L+ S LD +RLS+ DVA + YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ P+VH ++K N+L+D + DFG+++L GT +MAP
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-49
Identities = 101/476 (21%), Positives = 188/476 (39%), Gaps = 62/476 (13%)
Query: 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDF 204
L + + LG + + Q +L ++ L L + L++L +++F
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQA--DRLGIKSIDGVEYLNNLTQINF 75
Query: 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMS 264
SNN LT I + NL L + ++ N + P + N++
Sbjct: 76 SNNQLT-----------DIT----------PLKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324
L L+L NN ++ L L N+ RL L N +S + + L L G
Sbjct: 113 NLTGLTLFNNQIT-----DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-G 164
Query: 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVL 384
N + P L NL LE L + N ++ +S LA ++ + ++ N ++ +
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDI- 214
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
+ +G L L+E+ L +++ + +L NLT L L NNQ+S P+ L L
Sbjct: 215 -TPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLT 268
Query: 445 GLGLENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
L L N++ P L L+ L ++ N+L P NL +L L+L N +S P
Sbjct: 269 ELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 504 STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563
+L + F +N ++ L N+ + ++ N ++ P + LT + L
Sbjct: 327 --VSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 564 SLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619
L + ++ ++ L + P ++ + ++++N
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-47
Identities = 106/543 (19%), Positives = 180/543 (33%), Gaps = 96/543 (17%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRA 121
L+ L + T+ ++ +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS---------------------------QTDLDQVTT 50
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
+ + + + L L ++ N+L P L NL +L + +
Sbjct: 51 LQADRLGIK----------SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 98
Query: 182 RSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
+ + P + NL++L L NN +T + NL N
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITD---------------------IDPLKNLTN 135
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
L L + N + + + +++L+ LS N + K L L +ERL++ N
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFGNQ------VTDLKPLANLTTLERLDISSN 187
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
+S + + L L T N S P L L NL+ L L N L +
Sbjct: 188 KVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-------I 236
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421
+LA+ ++ + LA N ++ + P + L L E+ L +I P + L LT
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNISP--LAGLTALTN 291
Query: 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPA 480
L L NQL PI L L L L N + P L +L L +NK+S
Sbjct: 292 LELNENQLEDISPI--SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSS- 348
Query: 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540
NL ++ LS G N++S P NL I + + + P++ +
Sbjct: 349 -LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTV 404
Query: 541 LSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPI 600
+ P TI + + N E + ++ SG +
Sbjct: 405 KNVTGAL-IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQ 462
Query: 601 SLE 603
L+
Sbjct: 463 PLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-43
Identities = 105/483 (21%), Positives = 187/483 (38%), Gaps = 70/483 (14%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
VT L G+ + L++L ++ S+N+ + P + +++ L +++ +NQ++
Sbjct: 48 VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
P ++N ++L + N ++ + NLT L L L N +
Sbjct: 104 DITP---LANLTNLTGLTLFNNQITD----------IDPLKNLTNLNRLELSSNTISD-- 148
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
L L L+ LS + NL++L LD S+N ++
Sbjct: 149 ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD-------------- 191
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
+ L NLE L N + P + ++ L LSL N L
Sbjct: 192 -------ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL-----KDIG 237
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
L L N+ L+L N +S P + +KL L+L N S P L L L +L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
L N L +P +S L +L Y+ L N ++ + P + +L L+ ++ N K+
Sbjct: 294 LNENQLEDISP-ISNLKNL------TYLTLYFNNISDISP--VSSLT-KLQRLFFYNNKV 343
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
+ NL N+ L G+NQ+S P+ L + LGL + + +S
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 466 ELHVDHNKLSGPI-PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG 524
+ N I PA + S + N L S+ + + ++ + + +G
Sbjct: 400 IPNTVKNVTGALIAPATISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSG 458
Query: 525 SLP 527
++
Sbjct: 459 TVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 36/194 (18%), Positives = 72/194 (37%), Gaps = 32/194 (16%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSG 106
T L +++ L + NL +L L L N S P + S++ L+ L +N++S
Sbjct: 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
++N +++ + +N +S P + NLT++ +L L
Sbjct: 346 VSS---LANLTNINWLSAGHNQISDLTP----------LANLTRITQLGLNDQAWTNAPV 392
Query: 167 QELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG-------------FY 213
N++ + L P++I + S E D + N +
Sbjct: 393 NYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIG 450
Query: 214 MTNNHFTGSIPRNL 227
F+G++ + L
Sbjct: 451 KGTTTFSGTVTQPL 464
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 23/196 (11%)
Query: 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV 775
L + + G FG V+K + VA+K+F +Q +S+ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEV 69
Query: 776 --LKSVRHRNLVKIISSCSNGNFKA----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIM 829
L ++H N+++ I + G L+ + GSL L + + I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIA 127
Query: 830 IDVALALEYLH------FGYSNP-VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881
+A L YLH P + H DIK N+LL +++ A ++DFG+A +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 882 --MRTQTLGTIGYMAP 895
Q GT YMAP
Sbjct: 188 GDTHGQV-GTRRYMAP 202
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 78/365 (21%), Positives = 158/365 (43%), Gaps = 29/365 (7%)
Query: 257 PNTIFNMSTLKALS-LLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS 315
P I + L+ + L + + L +I +L + ++ I G I +
Sbjct: 9 PAPINQIFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS-IQG-IEYLT 66
Query: 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVL 375
L L L GN + P L NL L +L +G N +T +S+L N ++ + + L
Sbjct: 67 NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISALQNLTNLRELYL 117
Query: 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPI 435
E+ ++ + S + NL + + L ++ + N+ L L + +++ PI
Sbjct: 118 NEDNISDI--SPLANLT-KMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTPI 173
Query: 436 TVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLG 494
L L L L N++E P L L N+++ P N+ L +L +G
Sbjct: 174 --ANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG 229
Query: 495 SNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554
+N+++ P NL+ + + +N ++ + + ++ + +N+ N ++ + +
Sbjct: 230 NNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVL 283
Query: 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
L+ L L L NN+L E G LT+L +L LS N+++ + P++ L + + +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFA 341
Query: 615 FNRLE 619
++
Sbjct: 342 NQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-41
Identities = 78/393 (19%), Positives = 151/393 (38%), Gaps = 62/393 (15%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRA 121
+L+ L + + ++ L++ +++ S I ++L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEEL--ESITKLVVAGEKVA-SIQG--IEYLTNLEY 70
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
++ N N ++ + NL KL LY+G NK+ L NL L L L
Sbjct: 71 LNLNGNQITD----------ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLN 118
Query: 182 RSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
++ S + NL+ + L+ N + N+
Sbjct: 119 EDNISD--ISPLANLTKMYSLNLGANHNLS--------------------DLSPLSNMTG 156
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
L L + E+ + DV I N++ L +LSL N + L L ++ +N
Sbjct: 157 LNYLTVTESKV-KDVTP-IANLTDLYSLSLNYNQI-----EDISPLASLTSLHYFTAYVN 209
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
++ P + N ++L L++ N + P L NL L L +G N ++ +
Sbjct: 210 QITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-------I 258
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421
+++ + + K + + N ++ + S + NL L ++L N ++ + IG L NLTT
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDI--SVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
L L N ++ P+ L+ + N ++
Sbjct: 316 LFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 75/407 (18%), Positives = 151/407 (37%), Gaps = 63/407 (15%)
Query: 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSL 129
TL + P + + +L ++ S+ + +
Sbjct: 2 AATLATLPAPINQIFPDADL--AEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKV 56
Query: 130 SGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTI 189
+ + I LT L+ L L N++ P L NL +L L + + + T
Sbjct: 57 AS----------IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TD 102
Query: 190 PSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDE 249
S++ NL++L EL + ++++ + NL + L +
Sbjct: 103 ISALQNLTNLRELYLNEDNISDI---------------------SPLANLTKMYSLNLGA 141
Query: 250 NHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPG 309
NH + D + + NM+ L L++ + + + L ++ L+L N + P
Sbjct: 142 NHNLSD-LSPLSNMTGLNYLTVTESKV-----KDVTPIANLTDLYSLSLNYNQIEDISP- 194
Query: 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSS 369
+ + + L N + P + N+ L L +G N +T +P L+ LS L
Sbjct: 195 -LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQL----- 245
Query: 370 SKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQL 429
++ + N ++ + +++ +L L+ + + + +I + NL L +L L NNQL
Sbjct: 246 -TWLEIGTNQISDI--NAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 430 SGSIPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLS 475
+G L L L L N + P L ++ + +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 71/338 (21%), Positives = 133/338 (39%), Gaps = 35/338 (10%)
Query: 289 GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
G + L +N + + ++ L S + + L ++ L +
Sbjct: 1 GAATLATLPAPINQIFP-----DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAG 53
Query: 349 NYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
+ S + +L++L +Y+ L N + + S + NL L +Y+ KI
Sbjct: 54 EKVAS-IQGIEYLTNL------EYLNLNGNQITDI--SPLSNLV-KLTNLYIGTNKI--T 101
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP--DDLCQLSE 466
+ NL NL L+L + +S P+ L + L L N + ++ L+
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLSPLSNMTGLNY 159
Query: 467 LHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSL 526
L V +K+ P NL L +LSL N++ P +L ++ F N +
Sbjct: 160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 527 PLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLES 586
P+ NM + + + N +T P + L+ L L + N++ + LT L+
Sbjct: 216 PV--ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKM 269
Query: 587 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624
L++ N +S + ++ L L L L+ N+L E
Sbjct: 270 LNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 50/270 (18%), Positives = 102/270 (37%), Gaps = 48/270 (17%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSG 106
L +++ ++ S L NL+ + +L+L N + S + +++ L L + ++++
Sbjct: 113 RELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
P I+N + L ++ NYN + P + +LT L N++ P
Sbjct: 170 VTP---IANLTDLYSLSLNYNQIEDISP----------LASLTSLHYFTAYVNQITDITP 216
Query: 167 QELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGF------------YM 214
+ N+ L L + + +T P + NLS L L+ N ++ +
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNV 272
Query: 215 TNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
+N + + NL L L ++ N L + I ++ L L L N
Sbjct: 273 GSNQISD-----------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 275 TLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
++ P L L ++ + +
Sbjct: 322 HITDIRP-----LASLSKMDSADFANQVIK 346
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-46
Identities = 61/201 (30%), Positives = 84/201 (41%), Gaps = 27/201 (13%)
Query: 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV 775
+ E L D+ LIG G +G VYKG LD VA+KVF ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFA---NRQNFINEKNI 58
Query: 776 --LKSVRHRNLVKIISSCSNGNFKA-----LVLEYMANGSLEKCLYSSNRSLDIFQRLSI 828
+ + H N+ + I LV+EY NGSL K Y S + D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRL 116
Query: 829 MIDVALALEYLH------FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882
V L YLH Y + H D+ N+L+ +D +SDFG++ L G +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 883 RTQTL--------GTIGYMAP 895
R GTI YMAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 11/173 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+ ++G G+FG V K ++ +VAIK + + K+F E L V H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGY 843
K+ +C N LV+EY GSL L+ + +S + + + YLH
Sbjct: 65 KLYGACLN-PV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 844 SNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H D+KP N+LL V + DFG A + + T G+ +MAP
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAP 172
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSC 791
IG GSFGTVYKG++ +VA+K+ ++ L++F E VL+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ A+V ++ SL L++S ++ + + I A ++YLH + ++H D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLN--GEESMRTQTLGTIGYMAP 895
+K +NI L +D + DFG+A + Q G+I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-45
Identities = 98/499 (19%), Positives = 179/499 (35%), Gaps = 37/499 (7%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQL 104
+ +L++S +T L ++LQ L L +R + TI F S+ +L+ L L DN L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK------------------DIG 146
S S S SSL+ ++ N ++F + D
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 147 NLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSN 206
LT L EL + L+ Q L ++ ++ L+L S + LSS+ L+ +
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 207 NSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTL 266
+L F + + + E+L + L ++ F+ TL
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL--ELSEVEFDDCTL 263
Query: 267 KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326
L N + S + K + I RL++ L + K+ + + +
Sbjct: 264 NGLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 327 FSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN--GVL 384
+L++LE L L N + + S + S + +VL++N L
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
+ L L + + +P + L+L + + + TL+
Sbjct: 380 GEILLTLK-NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLE 434
Query: 445 GLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
L + NN L+ L +L EL++ NKL +P L + + N+L S
Sbjct: 435 VLDVSNNNLDS-FSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDG 491
Query: 505 TFWNLNNILSFDFSSNSLN 523
F L ++ +N +
Sbjct: 492 IFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-45
Identities = 100/575 (17%), Positives = 187/575 (32%), Gaps = 90/575 (15%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125
+ + D F+ +IPS + + +K L L N+++
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKIT-------------------- 39
Query: 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFL 185
+ R L+ L L +++ +L LE L L + L
Sbjct: 40 ------YIGHGDLR-------ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 186 TGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
+ ++ SS F LSSL L+ N + NL NL+
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTL------------------GVTSLFPNLTNLQT 127
Query: 245 LGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNL 303
L I ++ F +++L L + +L + S S L + +I L L L+
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQS--LKSIRDIHHLTLHLSES 184
Query: 304 SGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE--LSFL 361
+ + F S + LEL + + F L + + T E L
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIGNLP----------ITLEEIYLQNCKIRGNIPK 411
L + + LNG+ + +T+ +++ + ++
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 412 EIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL-EGPIPDDLCQ-----LS 465
L + + + N+++ L +L+ L L N + E + + C+ L
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 466 ELHVDHNKLS--GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
L + N L L +L +L + N +P + + + SS +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR 423
Query: 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTS 583
+ I + +++S N L L LQ L + N+L S
Sbjct: 424 -VVKTCIPQT--LEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASL--FPV 474
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618
L + +S N L V ++L L+ + L N
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-33
Identities = 75/382 (19%), Positives = 138/382 (36%), Gaps = 39/382 (10%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
S++ +P ++ L+L N ++ G + + L +L L + + D +
Sbjct: 13 RSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS 72
Query: 338 LRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGV-LPSSIGNLPITL 395
L +LEHL L N+L+S + LSSL KY+ L NP + + S NL L
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSL------KYLNLMGNPYQTLGVTSLFPNLT-NL 125
Query: 396 EEIYLQNCKIRGNIPKE-IGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
+ + + N + I + L +L L + L ++ + + L L ++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 455 GPIP---DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF-------IPS 504
+ D L + L + L+ + + + S +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEI-----------NLSRNYLTGDIPTT 553
+ + +F +LNG + VV E+ ++ + YL D+ T
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVI---PISLEKLVYLKD 610
L ++ +++EN+++ L SLE LDLS N + L+
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 611 LNLSFNRLEGEIPSGGSFANFS 632
L LS N L +G
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 65/358 (18%), Positives = 127/358 (35%), Gaps = 40/358 (11%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQ----L 104
L + + LSS++ L+L + S + + +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 105 SGSFPSF-----IISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIG-NLTKLKELYLGY 158
SF I S + DC N L G+ + + + ++ L++
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGL-GDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 159 NKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNN 217
L ++ L +++ +++ S + +P S +L SL LD S N + Y+ N+
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 218 HFTGSIPR----NLWQCEI------PHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLK 267
G+ P L Q + + L NL L I N +P++ ++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMR 413
Query: 268 ALSLLNN---TLSGSLPSSSKNL-----------IGLPNIERLNLGLNNLSGRIPGFIFN 313
L+L + + +P + + L + LP ++ L + N L +P
Sbjct: 414 FLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASL- 471
Query: 314 ASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSK 371
L +++++ N L +L+ + L N S P + +LS N +S K
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK 529
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
D S S S+P + + ++LS N +T + NLQ+L L+++R++
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 576 ESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
++F +L SLE LDLS N+LS + L LK LNL N + + F N
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-------FDGALKS 768
R LA + + IG G FG V+KGR + D VAIK L +
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 769 FDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI 828
F E ++ ++ H N+VK+ N +V+E++ G L L + +L +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLD-----DDMVAHLSDFGIAKLLNGEESMR 883
M+D+AL +EY+ + P+VH D++ NI L + A ++DFG+++ S+
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSV- 183
Query: 884 TQTLGTIGYMAP 895
+ LG +MAP
Sbjct: 184 SGLLGNFQWMAP 195
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 34/167 (20%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSC 791
+ G ++KGR+ G ++ +KV ++ + F+ EC L+ H N++ ++ +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 792 SNGNFK--ALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ L+ +M GSL L+ +N +D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++++D+DM A +S + + ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAP 177
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 14/207 (6%)
Query: 697 NTELSNIEVNMSP-QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAI 755
LS + P +A +E + + LIG G FG VY GR+ EVAI
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAI 60
Query: 756 KVFHLQFDGA--LKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL 813
++ ++ D LK+F E + RH N+V + +C + A++ +L +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 814 YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
+ LD+ + I ++ + YLH + ++H D+K N+ D+ V ++DFG+
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLF 176
Query: 874 KL-----LNGEESMRTQTLGTIGYMAP 895
+ E G + ++AP
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----GALKSFDAECEVLKSVRHRNLVKIIS 789
IGIG FG VY+ + G EVA+K D +++ E ++ ++H N++ +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
C LV+E+ G L + L S + + ++ + +A + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 850 CDIKPSNILLDDDMVAH--------LSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
D+K SNIL+ + ++DFG+A+ + M G +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS--AAGAYAWMAP 183
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECE 774
R R++ L +G G +G V++G + G VA+K+F + KS+ E E
Sbjct: 4 RTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETE 52
Query: 775 V--LKSVRHRNLVKIISSCSNGNFKA----LVLEYMANGSLEKCLYSSNRSLDIFQRLSI 828
+ +RH N++ I+S + L+ Y GSL L +LD L I
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRI 110
Query: 829 MIDVALALEYLH-----FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM- 882
++ +A L +LH + H D+K NIL+ + ++D G+A + + +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 883 ---RTQTLGTIGYMAP 895
+GT YMAP
Sbjct: 171 DVGNNPRVGTKRYMAP 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-42
Identities = 104/547 (19%), Positives = 183/547 (33%), Gaps = 109/547 (19%)
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143
I S + L+ + + L+ P N S ++ P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 144 DIGNL-----TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSS 198
+ L + EL L L +P+ +L E L + LT +P +L S
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKS 115
Query: 199 LLELDFSNNSLTGF-------YMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH 251
LL + + +L+ ++NN +P E+ N L+++ +D N
Sbjct: 116 LLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP----------ELQNSSFLKIIDVDNNS 164
Query: 252 LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311
L +P+ + L+ ++ NN L LP L LP + + N+L ++P
Sbjct: 165 LK-KLPDLPPS---LEFIAAGNNQLE-ELP----ELQNLPFLTAIYADNNSLK-KLPDLP 214
Query: 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSK 371
+ L + N L NL L + N L +
Sbjct: 215 LS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT------------------ 251
Query: 372 YIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSG 431
LP +L E + +++ + ++P+ +L L + LS
Sbjct: 252 ------------LPDLPPSL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294
Query: 432 SIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNL 491
P L L +N++ + D L EL+V +NKL +PA L L
Sbjct: 295 LPP-------NLYYLNASSNEIRS-LCDLPPSLEELNVSNNKLIE-LPALPPRL---ERL 342
Query: 492 SLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551
N L+ +P NL + N L P +++ +L N ++P
Sbjct: 343 IASFNHLAE-VPELPQNLKQL---HVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVP 392
Query: 552 TTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDL 611
NL+ L +E N L P+ S+E L ++ + + E L+D
Sbjct: 393 ELPQ---NLKQLHVETNPLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDD 445
Query: 612 NLSFNRL 618
+
Sbjct: 446 VFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-42
Identities = 97/537 (18%), Positives = 179/537 (33%), Gaps = 108/537 (20%)
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSS 118
+ + N+ S + + + P + + L D
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQ 72
Query: 119 LRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWL 178
++ N LS ++P+ +L L N L E+P+ +L L
Sbjct: 73 AHELELNNLGLS---------SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 179 SLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGN 238
+ L+ P L L SNN L +P E+ N
Sbjct: 120 NNNLKALSDLPP-------LLEYLGVSNNQLE-----------KLP----------ELQN 151
Query: 239 LPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL 298
L+++ +D N L +P+ + L+ ++ NN L LP L LP + +
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELP----ELQNLPFLTAIYA 202
Query: 299 GLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
N+L ++P + L + N L NL L + N L +
Sbjct: 203 DNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLP 256
Query: 359 SFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN 418
L +L + +N L LP +L L+ + P N
Sbjct: 257 PSLEAL---------NVRDNYLTD-LPELPQSLT-FLDVSENIFSGLSELPP-------N 298
Query: 419 LTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPI 478
L L+ +N++ S+ +L+ L + NNKL +P +L L N L+ +
Sbjct: 299 LYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLAE-V 352
Query: 479 PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVE 538
P N L+ L + N L P ++ ++ ++ L +P N+K +
Sbjct: 353 PELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR----MNSHLA-EVPELPQNLK---Q 400
Query: 539 INLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595
+++ N L + P + +L++ + R+ P + LE ++
Sbjct: 401 LHVETNPLR-EFPDIPESVEDLRMN---SERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 108/484 (22%), Positives = 177/484 (36%), Gaps = 95/484 (19%)
Query: 136 NIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFN 195
+ +P + N+ E Y +++ + P G E+ L
Sbjct: 21 SNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR--------- 71
Query: 196 LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGD 255
EL+ +N L+ +P +LE L N L +
Sbjct: 72 --QAHELELNNLGLS--------------------SLPELPP---HLESLVASCNSLT-E 105
Query: 256 VPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS 315
+P ++ +L + LS LP P +E L + N L ++P + N+S
Sbjct: 106 LPELPQSLKSLLVDNNNLKALS-DLP---------PLLEYLGVSNNQLE-KLPE-LQNSS 153
Query: 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVL 375
L ++++ NS +PD +LE + G N L PEL L L I
Sbjct: 154 FLKIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQLE-ELPELQNLPFL------TAIYA 202
Query: 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPI 435
N L LP + LE I N + E+ NL LTT++ NN L ++P
Sbjct: 203 DNNSLK-KLPDLPLS----LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254
Query: 436 TVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS 495
L L + +N L +P+ L+ L V N SG + N L L+ S
Sbjct: 255 LPPSLEALN---VRDNYLTD-LPELPQSLTFLDVSENIFSG-LSELPPN---LYYLNASS 306
Query: 496 NELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIG 555
NE+ S ++ + S+N L LP ++ + S N+L ++P
Sbjct: 307 NEIRSLCDL----PPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQ 357
Query: 556 GLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSF 615
NL+ L +E N L P+ ++ L +N+ +P + LK L++
Sbjct: 358 ---NLKQLHVEYNPLRE-FPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVET 405
Query: 616 NRLE 619
N L
Sbjct: 406 NPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-37
Identities = 87/486 (17%), Positives = 158/486 (32%), Gaps = 93/486 (19%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNT--SSLRAID 123
+ + LQ + + +P ++ + ++ + P + R D
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 124 CNYNSLSG-ELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
C EL ++P+ +L L N L E+P+ +L L +
Sbjct: 68 CLDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 183 SFLTGTIPS---------------SIFNLSSLLELDFSNNSLTGF----------YMTNN 217
L+ P + N S L +D NNSL NN
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 183
Query: 218 HFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLS 277
E+P E+ NLP L + D N L +P+ + L+++ NN L
Sbjct: 184 QLE----------ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE 228
Query: 278 GSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
LP L LP + + N L +P + L + + +P+ +
Sbjct: 229 -ELPE----LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTD----LPELPQS 278
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS--------KYIVLAENPLNGVLPSSIG 389
L L+ ++ L+ P L +L++ +N S + + ++ N L LP+
Sbjct: 279 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 337
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNT------- 442
L E + + +P+ NL LH+ N L P +
Sbjct: 338 RL----ERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRMNSHL 388
Query: 443 ---------LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
L+ L +E N L PD + +L ++ ++ P + L +
Sbjct: 389 AEVPELPQNLKQLHVETNPLRE-FPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVF 447
Query: 494 GSNELS 499
+
Sbjct: 448 EHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 55/307 (17%), Positives = 92/307 (29%), Gaps = 42/307 (13%)
Query: 330 FIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIG 389
FI V+ L+ + LT E + S A + P G
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSK------TEYYNAWSEWERNAPPGNG 55
Query: 390 NL------------PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV 437
E+ L N + ++P+ +L +L N L+ +P
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110
Query: 438 GRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497
L +L L P L L V +N+L +P N + L+ + + +N
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP----LLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNS 164
Query: 498 LSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGL 557
L ++ +N L LP ++ N+ + I N L
Sbjct: 165 LKKLPDL----PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK----KLPDLP 214
Query: 558 TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR 617
+L+ + NN L L L ++ N L +P L L +
Sbjct: 215 LSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTD 271
Query: 618 LEGEIPS 624
L S
Sbjct: 272 LPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 48/245 (19%), Positives = 97/245 (39%), Gaps = 31/245 (12%)
Query: 383 VLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNT 442
+ P ++ N L+E + + +P E N+ + T + ++ + P G
Sbjct: 3 INPRNVSNT--FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 443 LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502
+ L + Q EL +++ LS +P +L +L N L+ +
Sbjct: 60 MAVSRLRDCLDR--------QAHELELNNLGLS-SLPELPPHL---ESLVASCNSLTE-L 106
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
P +L ++L + + +L+ PL + + +S N L +P + + L++
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622
+ ++NN L +P+ SLE + N L +P L+ L +L + N L+
Sbjct: 158 IDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLP 211
Query: 623 PSGGS 627
S
Sbjct: 212 DLPLS 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 79/439 (17%), Positives = 148/439 (33%), Gaps = 53/439 (12%)
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSL 280
PR I + + ID ++ K ++ N+T+ L
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KL 60
Query: 281 PSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLR 339
P++ L +E LNL + I + F A + L + N+ P N+
Sbjct: 61 PAAL--LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIY 399
L L L N L+S + N+ + ++ N L + + +L+ +
Sbjct: 118 LLTVLVLERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQ 171
Query: 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459
L + ++ ++ + + +L ++ N LS T+ ++ L +N +
Sbjct: 172 LSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGP 223
Query: 460 DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSS 519
+L+ L + HN L+ N L + L NEL + F + +
Sbjct: 224 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRL------- 274
Query: 520 NSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFG 579
+ +S N L + + L++L L +N L + +
Sbjct: 275 -----------------ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQP 315
Query: 580 ALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGN 639
LE+L L N++ + L LK+L LS N + F N + +
Sbjct: 316 QFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDA 371
Query: 640 DLLCGSPHLQVP--LCKSS 656
D C + CK S
Sbjct: 372 DQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 70/431 (16%), Positives = 155/431 (35%), Gaps = 86/431 (19%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGS 107
++I + L++ + + ++ +P+++ +++L L D Q+
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 108 FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ 167
++ + +++ + +N++ LP ++F+ N+ L L L N L +P+
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ-------NVPLLTVLVLERNDLS-SLPR 134
Query: 168 EL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
+ N +L LS+ + L I F +SL L S+N LT
Sbjct: 135 GIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV------------- 180
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
++ +P+L + N L +T+ ++ L +N+++ +
Sbjct: 181 ---------DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV- 224
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
+ L L NNL+ + N L ++L+ N + V ++ LE L
Sbjct: 225 ----NVELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
+ N L + L +P TL+ + L + +
Sbjct: 279 ISNNRLVA------------------------------LNLYGQPIP-TLKVLDLSHNHL 307
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQL 464
++ + L L+L +N + ++ + +TL+ L L +N + + +
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNV 363
Query: 465 SELHVDHNKLS 475
+ VD
Sbjct: 364 ARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 73/359 (20%), Positives = 139/359 (38%), Gaps = 55/359 (15%)
Query: 147 NLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFS 205
L K + + ++ L + ++E L+L + I + F ++ +L
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101
Query: 206 NNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMS 264
N++ +P +++Q N+P L VL ++ N L +P IF N
Sbjct: 102 FNAIR-----------YLPPHVFQ--------NVPLLTVLVLERNDLS-SLPRGIFHNTP 141
Query: 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324
L LS+ NN L + + +++ L L N L+ + + LF ++
Sbjct: 142 KLTTLSMSNNNLE-RIEDDT--FQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSY 195
Query: 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVL 384
N S TL +E L +N + + L + L N L
Sbjct: 196 NLLS-----TLAIPIAVEELDASHNSINVVRGPV--NVEL------TILKLQHNNLTDT- 241
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTL 443
+ + N P L E+ L ++ I + L L++ NN+L ++ + + TL
Sbjct: 242 -AWLLNYP-GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297
Query: 444 QGLGLENNKLEGPIPDD---LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS 499
+ L L +N L + + +L L++DHN + + ++L+NL+L N+
Sbjct: 298 KVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 33/181 (18%), Positives = 59/181 (32%), Gaps = 43/181 (23%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLR 120
+ L N L +DLS+N I F + L+ L + +N+L
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV--------------- 285
Query: 121 AIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSL 180
A+ + LK L L +N L + + LE L L
Sbjct: 286 -------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 181 PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMT---NNHFTGSIPRNLWQCEIPHEIG 237
+ + T+ S +L L S+N + N ++ C+I +++
Sbjct: 326 DHNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLE 382
Query: 238 N 238
+
Sbjct: 383 H 383
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 23/179 (12%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISS 790
IG G +G V+ G++ G +VA+KVF S+ E E+ +RH N++ I++
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 791 CSNGNFK----ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-----F 841
G L+ +Y NGSL L + +LD L + L +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE-----SMRTQTLGTIGYMAP 895
+ H D+K NIL+ + ++D G+A + T+ GT YM P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPP 215
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 20/192 (10%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLK 777
R + E +G G FG K + G + +K + ++F E +V++
Sbjct: 5 RIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALE 837
+ H N++K I + EY+ G+L + S + QR+S D+A +
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--------------R 883
YLH S ++H D+ N L+ ++ ++DFG+A+L+ E++ R
Sbjct: 123 YLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 884 TQTLGTIGYMAP 895
+G +MAP
Sbjct: 180 YTVVGNPYWMAP 191
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-40
Identities = 74/483 (15%), Positives = 143/483 (29%), Gaps = 66/483 (13%)
Query: 140 AIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL 199
AI + N + K + + L+ + + ++ L L + L+ + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 LELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNT 259
L+ S+N L ++ +L L L ++ N++
Sbjct: 61 ELLNLSSNVLYET---------------------LDLESLSTLRTLDLNNNYV-----QE 94
Query: 260 IFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFL 319
+ +++ L NN +S + S + + L N ++ S++
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSR-----GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 320 LELTGNSFSGFIPDTLV-NLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAEN 378
L+L N L + LEHL L YN++ + L K + L+ N
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL------KTLDLSSN 201
Query: 379 PLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS-GSIPITV 437
L + + + I L+N K+ I K + NL L N G++
Sbjct: 202 KLA-FMGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 438 GRLNTLQGLGLENNK-LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
+ +Q + + K L G ++ + H L +L+
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 497 ELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGG 556
S L + N EI+ + I
Sbjct: 319 SG--------------------QGSETERLECERENQARQREIDALKEQYRTVIDQVTLR 358
Query: 557 LTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
L + L + A L+ + + E+ L+ L
Sbjct: 359 KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVK 417
Query: 617 RLE 619
R E
Sbjct: 418 RYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-35
Identities = 67/541 (12%), Positives = 151/541 (27%), Gaps = 70/541 (12%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSL 119
I N + + ++ + + S S +K L L N LS + ++ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 120 RAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLS 179
++ + N L D+ +L+ L+ L L N + QEL +E L
Sbjct: 61 ELLNLSSNVLYE----------TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 180 LPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL 239
+ ++ + S + +NN +T + G
Sbjct: 106 AANNNIS-RVSCSRG--QGKKNIYLANNKITML-------------------RDLDEGCR 143
Query: 240 PNLEVLGIDENHLVG-DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL 298
++ L + N + + + TL+ L+L N + + + ++ L+L
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ----VVFAKLKTLDL 198
Query: 299 GLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
N L+ + +A+ + + L N I L +NLEH L N T
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 359 SFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN 418
F + + +A+ + + + + + L+
Sbjct: 257 FFSKNQRVQT------VAKQTVKKLTGQNEEECTV-PTLGHYGAYCCEDLPAPFADRLIA 309
Query: 419 LTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPI 478
L GS L+ + E+ + I
Sbjct: 310 LKRKEHALLSGQGS------ETERLECERENQARQR-----------EIDALKEQYRTVI 352
Query: 479 PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVE 538
+ L L + + + + + +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 539 INLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVI 598
+ + Y + ++ + ++ E+ DL++ + + +
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472
Query: 599 P 599
Sbjct: 473 Q 473
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-34
Identities = 63/400 (15%), Positives = 121/400 (30%), Gaps = 32/400 (8%)
Query: 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLP 291
I N ++ + ++ L + + + +K L L N LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD---LAPFT 58
Query: 292 NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351
+E LNL N L + + + S L L+L N L+ ++E L N +
Sbjct: 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 352 TSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRG-NIP 410
+ + K I LA N + + G ++ + L+ +I N
Sbjct: 112 SRVSCSR--GQGK------KNIYLANNKITMLRDLDEGCRS-RVQYLDLKLNEIDTVNFA 162
Query: 411 KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS---EL 467
+ + L L+L N + + V L+ L L +NKL + + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP 527
+ +NKL I +L + L N F++ N + + ++
Sbjct: 220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTG 277
Query: 528 LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG----PIPESFGALTS 583
+ V + L L+ G +
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623
+D VI + L L+ ++
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 64/483 (13%), Positives = 140/483 (28%), Gaps = 52/483 (10%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
L++S L+ ++ L + L+ L+LS N + S+STL+ L L +N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-- 94
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
+ S+ + N++S + + + K +YL NK+ +
Sbjct: 95 ----LLVGPSIETLHAANNNIS-RVSCSRGQ----------GKKNIYLANNKITMLRDLD 139
Query: 169 LGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227
G + +++L L + + + + + +L L+ N +
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY----------------- 182
Query: 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287
++ ++ L+ L + N L + + + + +SL NN L + + L
Sbjct: 183 ---DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA---L 233
Query: 288 IGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLG 347
N+E +L N F + + + + G
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 348 YNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRG 407
+ + + L N EI + R
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQA-RQREIDALKEQYRT 350
Query: 408 NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGL---GLENNKLEGPIPDDLCQL 464
I + TL L + L G + +L+ +
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410
Query: 465 SELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG 524
+ + N++R+ + ++ + D + S N
Sbjct: 411 LLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANA 470
Query: 525 SLP 527
+L
Sbjct: 471 TLQ 473
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 48/401 (11%), Positives = 99/401 (24%), Gaps = 66/401 (16%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSIST-LKILILGDNQLS 105
+ +++ +T G S +Q LDL N + + + S L+ L L N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
++ + KLK L L NKL +
Sbjct: 183 --------------------------DVKGQVV---------FAKLKTLDLSSNKLA-FM 206
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
E + A + W+SL + L I ++ +L D N
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-------------- 251
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
N V + + + + +
Sbjct: 252 ------GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 286 NLIGLPNIERLNLGL-NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHL 344
LI L E L + + R+ N ++ ++ + I + + L
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITL 365
Query: 345 GLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCK 404
L + + + L + +
Sbjct: 366 EQKKKALDEQVS-----NGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRY 419
Query: 405 IRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQG 445
+ ++ + + ++ + + RL L G
Sbjct: 420 EEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNG 459
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 3/103 (2%)
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSL 584
++ N ++ + L + + N++ L L N L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGS 627
E L+LS N L + + L L+ L+L+ N ++ E+ G S
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 53/329 (16%), Positives = 106/329 (32%), Gaps = 28/329 (8%)
Query: 280 LPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLR 339
+ SS + E L + + + + + N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIY 399
N + L ++ L + + L PL P L L+ +
Sbjct: 57 NPQIETRTGRALKATADLLEDATQP----GRVALELRSVPLP-QFPDQAFRL-SHLQHMT 110
Query: 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459
+ + +P + L TL L N L ++P ++ LN L+ L + +P+
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
Query: 460 DLCQ------------LSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW 507
L L L ++ + +PA NL +L++L + ++ LS+ +
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIH 226
Query: 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLS-RNYLTGDIPTTIGGLTNLQLLSLE 566
+L + D + + P G + + L + L +P I LT L+ L L
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 567 NNRLHGPIPESFGALTSLESLDLSVNNLS 595
+P L + + + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 69/384 (17%), Positives = 118/384 (30%), Gaps = 88/384 (22%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
L L D + + +S + +I L +
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGRALKATA 72
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
+ A++ L P L+ L+ + + L E+P
Sbjct: 73 DLLEDATQPGRVALELRSVPLP---------QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 169 LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFS-NNSLTGFYMTNNHFTGSIPRNL 227
+ A LE L+L R+ L +P+SI +L+ L EL LT +P L
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-----------ELPEPL 170
Query: 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287
+ E L NL+ L ++ + +P +I N+ LK+L + N+ LS +L +
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA---- 224
Query: 288 IGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGL- 346
I + KL L+L G + P L+ L L
Sbjct: 225 -----------------------IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 347 GYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR 406
+ L + LP I L LE++ L+ C
Sbjct: 262 DCSNLLT------------------------------LPLDIHRLT-QLEKLDLRGCVNL 290
Query: 407 GNIPKEIGNLVNLTTLHLGNNQLS 430
+P I L + + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 49/319 (15%), Positives = 101/319 (31%), Gaps = 34/319 (10%)
Query: 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSS 369
++S L G++ D L + + + + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 370 SKYIVLAENPLNGVLPSSIGNLP-ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQ 428
+ + + + L++ + P + L +L + +
Sbjct: 67 A----------LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 429 LSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS---ELHVDHNKLSGPIPACFGNL 485
L +P T+ + L+ L L N L +P + L+ EL + +P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 486 NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY 545
++ L N+ S + SLP I N++ + + + +
Sbjct: 174 DA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 546 LTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605
L+ + I L L+ L L P FG L+ L L + +P+ + +L
Sbjct: 218 LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 606 VYLKDLNLSFNRLEGEIPS 624
L+ L+L +PS
Sbjct: 277 TQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 56/352 (15%), Positives = 103/352 (29%), Gaps = 57/352 (16%)
Query: 233 PHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPN 292
H + E L + + + + + + + S+ N
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQ---WQRHYNADR----NRWHSAWRQANSNN 57
Query: 293 IERLNLGLNNLSGRIPGFIFNASKLFL--LELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
+ L + +A++ LEL PD L +L+H+ +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 351 LTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410
L LP ++ LE + L +R +P
Sbjct: 116 LME------------------------------LPDTMQQFA-GLETLTLARNPLR-ALP 143
Query: 411 KEIGNLVNLTTLHL-GNNQL--------SGSIPITVGRLNTLQGLGLENNKLEGPIPDDL 461
I +L L L + +L S L LQ L LE + +P +
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASI 202
Query: 462 CQLS---ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
L L + ++ LS + +L L L L P F +
Sbjct: 203 ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL 570
S +LPLDI + + +++L +P+ I L ++ + +
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISS 790
IG G FG V++G++ G EVA+K+F + +S+ E E+ +RH N++ I++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 791 CSNGNFKA----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-----F 841
+ N LV +Y +GSL L + ++ + + + + A L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR----TQTLGTIGYMAP 895
+ H D+K NIL+ + ++D G+A + +GT YMAP
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-37
Identities = 94/522 (18%), Positives = 180/522 (34%), Gaps = 75/522 (14%)
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
+D + N L +PKD+ K L + N + ++ +L++L L +
Sbjct: 5 VDRSKNGLI---------HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIIS 53
Query: 182 RSFLTGTIPSSIF-NLSSLLELDFSNNSLTGF-----------YMTNNHFTGSIPRNLWQ 229
+ + + S+F L LD S+N L ++ N F ++P
Sbjct: 54 HNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFD-ALPI---- 107
Query: 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIG 289
E GN+ L+ LG+ HL I +++ K L +L T
Sbjct: 108 ---CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG----- 159
Query: 290 LPNIERLNLGLNNLSGRIPGFIFNASKLFLLELT---------GNSFSGFIPDTLVNLRN 340
L + +L + + + FI + S + L N S F+ N
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 341 LEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYL 400
+ L N + ++ + L ++ Y ++ L G L + T
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT------ 273
Query: 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG---PI 457
+L L+ + ++ + + +
Sbjct: 274 --------------SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 458 PDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF--IPSTFWNLNNILSF 515
P + L +N L+ + G+L L L L N+L I + ++
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL 379
Query: 516 DFSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI 574
D S NS++ K ++ +N+S N LT I + +++L L +N++ I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-I 436
Query: 575 PESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
P+ L +L+ L+++ N L V ++L L+ + L N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 82/436 (18%), Positives = 144/436 (33%), Gaps = 48/436 (11%)
Query: 65 GNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAID 123
+L+ LDLS N F F +S LK L L L S I S +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS 183
E P + N L ++ + + + +A LE ++
Sbjct: 147 LGETYGEKEDPEGLQDF------NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 184 FLTGTIPSSIFNLSSLLELD-FSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
+ L+ L SN +L T N F I + +W +
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVW----------HTTV 249
Query: 243 EVLGIDENHLVGDVPNTIFNMST--LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
I L G + F+ S LKALS+ S N+ N +
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
+ S L+ + N + + + +L LE L L N L +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
+ + S + + +++N ++ + +L + + + + I + + +
Sbjct: 370 TTQM---KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIK 424
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPA 480
L L +N++ SIP V +L LQ L + +N+L+ +PD
Sbjct: 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPD--------------------G 462
Query: 481 CFGNLNSLRNLSLGSN 496
F L SL+ + L +N
Sbjct: 463 IFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 64/378 (16%), Positives = 120/378 (31%), Gaps = 39/378 (10%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
S LI +P LN+ N +S I + SKL +L ++ N
Sbjct: 8 SKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF 67
Query: 338 LRNLEHLGLGYNYLTSSTPELSF--LSSLANSSSSKYIVLAENPLNGV-LPSSIGNLPIT 394
+ LE+L L +N L +S +L K++ L+ N + + + GN+
Sbjct: 68 NQELEYLDLSHNKLVK----ISCHPTVNL------KHLDLSFNAFDALPICKEFGNMS-Q 116
Query: 395 LEEIYLQNCKIRGNIPKEIGNLVNLT-TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL 453
L+ + L + + I +L L LG P + NT +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 454 EGPIPDDLCQLSELHVDHNKLSG-----------PIPACFGNLNSLRNLSLGSNELSS-- 500
E D+ + +++ + + I A L NL+L + E +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 501 -FIPSTFWNLNNILSFDFSSNSLNGSLPLDIG-----NMKVVVEINLSRNYLTGDIPTTI 554
+ F S+ L G L ++K + + +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
+N+ + + + ++ LD S N L+ + + L L+ L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 615 FNRLEGEIPSGGSFANFS 632
N+L+
Sbjct: 357 MNQLKELSKIAEMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 74/400 (18%), Positives = 146/400 (36%), Gaps = 34/400 (8%)
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL--SGSFPSFIISNT 116
I + GN+S L+ L LS + I ++ K+L++ NT
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176
SL + L ++ ++ N+ + E L I +L +L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLS 223
Query: 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEI 236
L+L T I L + ++ F ++N G L + +
Sbjct: 224 NLTLNNIETTWNSFIRILQL-------VWHTTVWYFSISNVKLQG----QLDFRDFDYSG 272
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
+L L + + + + I+ +++ N T+SG+ + L
Sbjct: 273 TSLKALSIHQVVSDVFGFP-QSYIYE--IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLV--NLRNLEHLGLGYNYLTSS 354
+ N L+ + + ++L L L N + +++L+ L + N ++
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 355 TPELSF--LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKE 412
+ SL + ++ N L + LP ++ + L + KI+ +IPK+
Sbjct: 390 EKKGDCSWTKSL------LSLNMSSNILTDTIFRC---LPPRIKVLDLHSNKIK-SIPKQ 439
Query: 413 IGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENN 451
+ L L L++ +NQL S+P + RL +LQ + L N
Sbjct: 440 VVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 55/370 (14%), Positives = 117/370 (31%), Gaps = 54/370 (14%)
Query: 3 NNINTTDQQALLALKARITAKNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISS 62
++ T L +K + + S+ + + +S + + + +
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL-- 241
Query: 63 QLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAI 122
QL +++ +S+ + G + F S + L +Q+
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV----------------- 284
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
+ + G + I+ + + + + ++ L
Sbjct: 285 ----SDVFGFPQSYIYE-------IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 183 SFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
+ LT T+ + +L+ L L N L T + +L
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT-----------------QMKSL 376
Query: 243 EVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
+ L I +N + D +L +L++ +N L+ ++ P I+ L+L N
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC-----LPPRIKVLDLHSN 431
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
+ IP + L L + N L +L+ + L N S P + +L
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 490
Query: 362 SSLANSSSSK 371
S N +S K
Sbjct: 491 SRWLNKNSQK 500
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-36
Identities = 71/395 (17%), Positives = 134/395 (33%), Gaps = 30/395 (7%)
Query: 269 LSLLNNTLSGSLPSSSKNL--IGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGN 325
+ + I L N + + + + ++P + + ++ LL L
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 326 SFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLP 385
++ L +G+N + P + N +VL N L+ +
Sbjct: 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLERNDLSSLPR 140
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
N P L + + N + I + +L L L +N+L+ + + + +L
Sbjct: 141 GIFHNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLF 195
Query: 445 GLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
+ N L + EL HN ++ + L L L N L+ +
Sbjct: 196 HANVSYNLLS--TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTD--TA 248
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564
N ++ D S N L + M+ + + +S N L + + L++L
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624
L +N L + + LE+L L N++ + L LK+L LS N +
Sbjct: 308 LSHNHLLH-VERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD-CNSL 362
Query: 625 GGSFANFSAQSFMGNDLLCGSPHLQVP--LCKSSP 657
F N + + D C + CK S
Sbjct: 363 RALFRNVARPAVDDADQHCKIDYQLEHGLCCKESD 397
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 89/563 (15%), Positives = 188/563 (33%), Gaps = 100/563 (17%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGS 107
++I + L++ + + ++ +P+++ +++L L D Q+
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 108 FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ 167
++ + +++ + +N++ LP ++F+ N+ L L L N L +P+
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ-------NVPLLTVLVLERNDLS-SLPR 140
Query: 168 EL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
+ N +L LS+ + L I F +SL L S+N LT
Sbjct: 141 GIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV------------- 186
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
++ +P+L + N L +T+ ++ L +N+++ +
Sbjct: 187 ---------DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV- 230
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
+ L L NNL+ + N L ++L+ N + V ++ LE L
Sbjct: 231 ----NVELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
+ N L + L +P TL+ + L + +
Sbjct: 285 ISNNRLVA------------------------------LNLYGQPIP-TLKVLDLSHNHL 313
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQL 464
++ + L L+L +N + ++ + +TL+ L L +N + + +
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNV 369
Query: 465 SELHVDHNKLSGPIP-------ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDF 517
+ VD I C + + L L+S + + D
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429
Query: 518 SSNSLNGSLPLD-------IGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL 570
++ + S + GN ++ E+N R + I LQ L E +
Sbjct: 430 INSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTN 489
Query: 571 HGPIPESFGALTSLESLDLSVNN 593
L V
Sbjct: 490 LRRYRLPKDGLARSSDNLNKVFT 512
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-33
Identities = 67/376 (17%), Positives = 133/376 (35%), Gaps = 24/376 (6%)
Query: 271 LLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI--FNASKLFLLELTGNSFS 328
N + + ++ ++ + + + ++ ++
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 329 GFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSI 388
L + R +E L L + + A + + + + + N + + P
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHVF 119
Query: 389 GNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLG 447
N+P L + L+ + ++P+ I N LTTL + NN L T +LQ L
Sbjct: 120 QNVP-LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177
Query: 448 LENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW 507
L +N+L + L +V +N LS ++ L N ++
Sbjct: 178 LSSNRLTHVDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVNV 232
Query: 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567
L + N+L + N +VE++LS N L + + L+ L + N
Sbjct: 233 ELTIL---KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGS 627
NRL + + +L+ LDLS N+L + + + L++L L N + + +
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-ST 343
Query: 628 FANFSAQSFMGNDLLC 643
+ ND C
Sbjct: 344 HHTLKNLTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 93/564 (16%), Positives = 190/564 (33%), Gaps = 98/564 (17%)
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSS 118
I S L + + +++ KI+ ++ + P+ ++ +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 119 LRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWL 178
+ ++ N + E+ F +++LY+G+N ++
Sbjct: 77 VELLNLNDLQIE-EIDTYAFA-------YAHTIQKLYMGFNAIR---------------- 112
Query: 179 SLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIG 237
+P +F N+ L L N L+ S+PR ++
Sbjct: 113 ---------YLPPHVFQNVPLLTVLVLERNDLS-----------SLPRGIFH-------- 144
Query: 238 NLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLN 297
N P L L + N+L +T ++L+ L L +N L+ + S +P++ N
Sbjct: 145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-----IPSLFHAN 198
Query: 298 LGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE 357
+ N LS + + L+ + NS + V L L+ L +N LT T
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQHNNLT-DTAW 249
Query: 358 LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLV 417
L L + L+ N L ++ + LE +Y+ N ++ + +
Sbjct: 250 LLNYPGL------VEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLV-ALNLYGQPIP 301
Query: 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGP 477
L L L +N L + + + L+ L L++N + L L + HN
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD-- 358
Query: 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
C RN++ + + + + L + L S L I VV
Sbjct: 359 ---CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE 415
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN----N 593
++ ++ G + ++ + H + L E L+ VN
Sbjct: 416 KVQRAQ-----------GRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAE 464
Query: 594 LSGVIPISLEKLVYLKDLNLSFNR 617
+ + +++ L+ L+ +
Sbjct: 465 VQQLTNEQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 80/499 (16%), Positives = 169/499 (33%), Gaps = 59/499 (11%)
Query: 138 FRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF-NL 196
++ I ++ ++++ E L + ++ S + +P+++ +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74
Query: 197 SSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDV 256
+ L+ ++ + I ++ L + N +
Sbjct: 75 RQVELLNLNDLQIE-----------EIDTYA--------FAYAHTIQKLYMGFNAIRYLP 115
Query: 257 PNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NAS 315
P+ N+ L L L N LS SLP P + L++ NNL RI F +
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGI--FHNTPKLTTLSMSNNNLE-RIEDDTFQATT 171
Query: 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVL 375
L L+L+ N + + +L H + YN L++ L+ ++ + +
Sbjct: 172 SLQNLQLSSNRLTHVDLS---LIPSLFHANVSYNLLST----LAIPIAV------EELDA 218
Query: 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPI 435
+ N +N V L + LQ+ + + + N L + L N+L +
Sbjct: 219 SHNSINVVRGPVNVE----LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYH 272
Query: 436 TVGRLNTLQGLGLENNKLEG--PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
++ L+ L + NN+L + L L + HN L + + L NL L
Sbjct: 273 PFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 331
Query: 494 GSNELSSFIPSTFWNLNNILSFDFSSNSLNGS----LPLDIGNMKVV-VEINLSRNYLTG 548
N + + ST L N+ S N + + L ++ V + + +Y
Sbjct: 332 DHNSIVTLKLSTHHTLKNL---TLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLE 388
Query: 549 DIPTTIGG---LTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605
+ L + + + + G ++ ++++ + + L
Sbjct: 389 HGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPL 448
Query: 606 VYLKDLNLSFNRLEGEIPS 624
+ L N L E+
Sbjct: 449 QGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 52/392 (13%), Positives = 103/392 (26%), Gaps = 57/392 (14%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLR 120
+ L N L +DLS+N I F + L+ L + +N+L
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV--------------- 291
Query: 121 AIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSL 180
A+ + LK L L +N L + + LE L L
Sbjct: 292 -------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331
Query: 181 PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLP 240
+ + T+ S +L L S+N + ++ RN+ + + +
Sbjct: 332 DHNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLR------ALFRNVARPAVDDADQHCK 382
Query: 241 NLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
L D P + + S++ S+ + I +L
Sbjct: 383 IDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQ----SLSH 438
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
N + + + + L+ L +
Sbjct: 439 YITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRR------ 492
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
L ++ + L T + K + E N+
Sbjct: 493 -YRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEK 551
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
L + + T + ++ L + N+
Sbjct: 552 QLDNKRAKQAELRQETSLKRQKVKQLEAKKNR 583
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-35
Identities = 72/341 (21%), Positives = 133/341 (39%), Gaps = 44/341 (12%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQ 103
L++ + + + L+ L+L+ N S + F+ + L+ L L N+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 104 LSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQG 163
L P + + S+L +D + N + L +F+ +L LK L +G N L
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ-------DLYNLKSLEVGDNDLV- 141
Query: 164 EIPQE-LGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTG 221
I L LE L+L + LT +IP+ +L L+ L + ++
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN----------- 189
Query: 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLP 281
+I ++ L L+VL I + + L +LS+ + L+ ++P
Sbjct: 190 AIRDYSFKR--------LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
Query: 282 SSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRN 340
+ + L + LNL N +S I G + +L ++L G + P L
Sbjct: 241 YLA--VRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297
Query: 341 LEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN 381
L L + N LT+ + + + + ++L NPL
Sbjct: 298 LRVLNVSGNQLTTLEESV-----FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 65/322 (20%), Positives = 124/322 (38%), Gaps = 22/322 (6%)
Query: 331 IPDTLVNLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIG 389
+P+ + L LG N + + + + L + + L EN ++ V P +
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHL------EELELNENIVSAVEPGAFN 77
Query: 390 NLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGL 448
NL L + L++ +++ IP + L NLT L + N++ + L L+ L +
Sbjct: 78 NLF-NLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 449 ENNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
+N L I L L +L ++ L+ +L+ L L L +++
Sbjct: 136 GDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564
+F L + + S ++ + + ++++ LT + L L+ L+
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624
L N + L L+ + L L+ V P + L YL+ LN+S N+L +
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLE- 312
Query: 625 GGSFANFSAQ---SFMGNDLLC 643
F + N L C
Sbjct: 313 ESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 69/367 (18%), Positives = 136/367 (37%), Gaps = 48/367 (13%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
+ + + RF +P I + ++L LG N++ + ++ L ++ N N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEFASFPHLEELELNEN 66
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFLT 186
+S + F NL L+ L L N+L+ IP L+ L L + + +
Sbjct: 67 IVS-AVEPGAFN-------NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
Query: 187 GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
+ +F +L +L L+ +N L I L +LE L
Sbjct: 118 -ILLDYMFQDLYNLKSLEVGDNDLV-----------YISHRA--------FSGLNSLEQL 157
Query: 246 GIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
+++ +L + ++ L L L + ++ ++ S L ++ L +
Sbjct: 158 TLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYS--FKRLYRLKVLEISHWPYLD 214
Query: 306 RIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE-LSFLSSL 364
+ L L +T + + + +L L L L YN +++ L L L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLH 423
+ I L L V P + L L + + ++ + + + ++ NL TL
Sbjct: 275 ------QEIQLVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSVGNLETLI 326
Query: 424 LGNNQLS 430
L +N L+
Sbjct: 327 LDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-19
Identities = 35/179 (19%), Positives = 71/179 (39%), Gaps = 13/179 (7%)
Query: 33 SWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSIS 92
+ I H + L + + L L+ L++SH + T+ +
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 93 TLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLK 152
L L + L+ + P + + LR ++ +YN +S + ++ L +L+
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLH-------ELLRLQ 275
Query: 153 ELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSL 209
E+ L +L + L L L++ + LT T+ S+F ++ +L L +N L
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 730 EKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKII 788
++ ++G G++G VY GR L + +AIK + + E + K ++H+N+V+ +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL--SIMIDVALALEYLHFGYSNP 846
S S F + +E + GSL L S L ++ + L+YLH N
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142
Query: 847 VVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+VH DIK N+L++ V +SDFG +K L G GT+ YMAP
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 47/319 (14%), Positives = 107/319 (33%), Gaps = 19/319 (5%)
Query: 331 IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390
I + N + + + L + L ++ + K + L+ NPL+ + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLAP 56
Query: 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN 450
LE + L + + ++ +L L TL L NN + + +++ L N
Sbjct: 57 FT-KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAAN 108
Query: 451 NKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF-IPSTFWNL 509
N + +++ +NK++ G + ++ L L NE+ + +
Sbjct: 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNR 569
+ + + N + + + + ++LS N L + + +SL NN+
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 570 LHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFA 629
L I ++ +LE DL N + + ++ ++
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 630 NFSAQSFMGNDLLCGSPHL 648
G P
Sbjct: 284 TVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 62/362 (17%), Positives = 124/362 (34%), Gaps = 48/362 (13%)
Query: 140 AIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL 199
AI + N + K + + L+ + + ++ L L + L+ + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 LELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNT 259
L+ S+N L E ++ +L L L ++ N++
Sbjct: 61 ELLNLSSNVLY--------------------ETL-DLESLSTLRTLDLNNNYV-----QE 94
Query: 260 IFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFL 319
+ +++ L NN +S + S + + L N ++ S++
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSR-----GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 320 LELTGNSFSGF-IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAEN 378
L+L N + + LEHL L YN++ + L K + L+ N
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL------KTLDLSSN 201
Query: 379 PLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS-GSIPITV 437
L + + + I L+N K+ I K + NL L N G++
Sbjct: 202 KLA-FMGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 438 GRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497
+ +Q + + K ++ C + L +PA F R ++LG +
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHH 314
Query: 498 LS 499
Sbjct: 315 HH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 54/310 (17%), Positives = 106/310 (34%), Gaps = 46/310 (14%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSL 119
I N + + ++ + + S S +K L L N LS + ++ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 120 RAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLS 179
++ + N L E D+ +L+ L+ L L N + QEL +E L
Sbjct: 61 ELLNLSSNVLY-ETL---------DLESLSTLRTLDLNNNYV-----QELLVGPSIETLH 105
Query: 180 LPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL 239
+ ++ + S + +NN +T + + G
Sbjct: 106 AANNNIS-RVSCSRG--QGKKNIYLANNKIT-----------MLR--------DLDEGCR 143
Query: 240 PNLEVLGIDENHLVG-DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL 298
++ L + N + + + TL+ L+L N + + + ++ L+L
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG----QVVFAKLKTLDL 198
Query: 299 GLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
N L+ + +A+ + + L N I L +NLEH L N T
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 359 SFLSSLANSS 368
F + +
Sbjct: 257 FFSKNQRVQT 266
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 47/311 (15%), Positives = 95/311 (30%), Gaps = 51/311 (16%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
L++S L+ ++ L + L+ L+LS N + S+STL+ L L +N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-- 94
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRA--------------IPKDIGNLTKLKEL 154
+ S+ + N++S + + + D G ++++ L
Sbjct: 95 ----LLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 155 YLGYNKLQG-EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFY 213
L N++ + + LE L+L +F+ + + + L LD S+N L
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA--- 204
Query: 214 MTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLN 273
+ E + + + + N LV + + L+ L
Sbjct: 205 -----------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 274 NTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPD 333
N + N + + + L
Sbjct: 247 NGFH----CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
Query: 334 TLVNLRNLEHL 344
L L H
Sbjct: 303 FADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 31/165 (18%), Positives = 53/165 (32%), Gaps = 38/165 (23%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSIST-LKILILGDNQLS 105
+ +++ +T G S +Q LDL N + + + S L+ L L N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
++ + KLK L L NKL +
Sbjct: 183 --------------------------DVKGQVV---------FAKLKTLDLSSNKLA-FM 206
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210
E + A + W+SL + L I ++ +L D N
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 3/103 (2%)
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSL 584
++ N ++ + L + + N++ L L N L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGS 627
E L+LS N L + + L L+ L+L+ N ++ E+ G S
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 54/174 (31%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSV-RH 781
F S +G GS+G V+K R DG A+K F G AE + V +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
V++ + G L E SL++ + SL Q + D LAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +VH D+KP+NI L L DFG+ L + Q G YMAP
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIK---VFHLQFDGALKSFDAECEVLKSVRH 781
+F + IG G F VY+ L DG+ VA+K +F L A E ++LK + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALEY 838
N++K +S N +VLE G L + + + + + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
+H S V+H DIKP+N+ + V L D G+ + + + + +GT YM+P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 7/177 (3%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHL--QFDGALKSFDAECEVLKSVRHR 782
+ + IG GSFG + DG + IK ++ + E VL +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
N+V+ S +V++Y G L ++ Q L + + LAL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
++H DIK NI L D L DFGIA++LN + +GT Y++P +
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 76/425 (17%), Positives = 140/425 (32%), Gaps = 64/425 (15%)
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAEL 175
+ + +D + NS++ EL F L L+ L + I L+ L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFS-------RLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 176 EWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH 234
L L + + + F L++L L + +L G ++ N F
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK-------------- 126
Query: 235 EIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNI 293
L +LE+L + +N++ P + F NM L L N + S+ +
Sbjct: 127 ---PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHF 182
Query: 294 ERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353
L L L ++ ++ L L N
Sbjct: 183 TLLRLSSITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP---------ITLEEIYLQNCK 404
S + F + S + + N + ++ + ++ L K
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286
Query: 405 IRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP---- 458
I + K + + +L L L N+++ I L L L L N L I
Sbjct: 287 IF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMF 343
Query: 459 DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
++L +L L + +N + F L +L+ L+L +N+L S F L ++
Sbjct: 344 ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403
Query: 519 SNSLN 523
+N +
Sbjct: 404 TNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 85/442 (19%), Positives = 145/442 (32%), Gaps = 79/442 (17%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
+ + +DLS N + + + FS + L+ L + + SSL + +Y
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE--LGNLAELEWLSLPRSF 184
N +L F L L+ L L L G + L LE L L +
Sbjct: 89 NQFL-QLETGAFN-------GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 185 LTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ--CEIPHEIGNLPN 241
+ P+S F N+ LD + N + SI + L +
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK-----------SICEEDLLNFQGKHFTLLRLSS 189
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
+ + ++E L + F +++ L L N S+ + I I+ +L L+
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ--SLILS 247
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
N F + +F G ++ L + + +
Sbjct: 248 NSYNMGSSFGHTN----FKDPDNFTFKGL------EASGVKTCDLSKSKIFA-------- 289
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSI-GNLPITLEEIYLQNCKIRGNIPKEI-GNLVNL 419
L S+ + LE++ L +I I L +L
Sbjct: 290 ----------------------LLKSVFSHFT-DLEQLTLAQNEIN-KIDDNAFWGLTHL 325
Query: 420 TTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP----DDLCQLSELHVDHNKL 474
L+L N L SI + L+ L+ L L N + + L L EL +D N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 475 SGPIPACFGNLNSLRNLSLGSN 496
F L SL+ + L +N
Sbjct: 384 KSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 73/394 (18%), Positives = 145/394 (36%), Gaps = 35/394 (8%)
Query: 240 PNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299
++ + + N + + + L+ L + T + +++ GL ++ L L
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT--FRGLSSLIILKLD 87
Query: 300 LNNLSGRIPGFIFNA-SKLFLLELTGNSFSGFI--PDTLVNLRNLEHLGLGYNYLTSSTP 356
N ++ FN + L +L LT + G + + L +LE L L N + P
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 357 ELSF--LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT------LEEIYLQNCKIRGN 408
F + + L N + + + N L I LQ+
Sbjct: 147 ASFFLNMRRF------HVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 409 IPKEIGN---LVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
++ GN ++TTL L N S+ + + G +++ L
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMA--KRFFDAIAGTKIQSLILS------NSYNM 252
Query: 466 ELHVDHNKLSGPIPACFGNL--NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
H P F L + ++ L +++ + + S F + ++ + N +N
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN 312
Query: 524 GSLPLDI-GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALT 582
+ + + ++++NLS+N+L L L++L L N + +SF L
Sbjct: 313 -KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP 371
Query: 583 SLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
+L+ L L N L V ++L L+ + L N
Sbjct: 372 NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 69/380 (18%), Positives = 124/380 (32%), Gaps = 62/380 (16%)
Query: 264 STLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLEL 322
+ + + L N+++ L +S L +++ L + I F S L +L+L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETS--FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 323 TGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNG 382
N F L NLE L L L + +F L +
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS---------------- 130
Query: 383 VLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLN 441
LE + L++ I+ P N+ L L N++ I L
Sbjct: 131 ------------LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS---ICEEDLL 175
Query: 442 TLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF 501
QG L ++ ++ L S+ L L N
Sbjct: 176 NFQGKHFTLL--------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227
Query: 502 IPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV---------------VVEINLSRNYL 546
+ F++ S + ++ G+ V +LS++ +
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287
Query: 547 TGDIPTTI-GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605
+ ++ T+L+ L+L N ++ +F LT L L+LS N L + E L
Sbjct: 288 F-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENL 346
Query: 606 VYLKDLNLSFNRLEGEIPSG 625
L+ L+LS+N + +
Sbjct: 347 DKLEVLDLSYNHIR-ALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 49/264 (18%), Positives = 84/264 (31%), Gaps = 26/264 (9%)
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQ 444
+ LP + + L I L +L L + I L++L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 445 GLGLENNKLEGPIP----DDLCQLSELHVDHNKL-SGPIPA-CFGNLNSLRNLSLGSNEL 498
L L+ N+ + + L L L + L + F L SL L L N +
Sbjct: 83 ILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 499 SSFIPST-FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGL 557
P++ F N+ D + N + D+ N + L L
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------L 187
Query: 558 TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLS 614
+++ L + L + TS+ +LDLS N + ++ L LS
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 615 FNRLEGEIPSGGSFANFSAQSFMG 638
+ G +F + +F G
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 62/333 (18%), Positives = 116/333 (34%), Gaps = 33/333 (9%)
Query: 66 NLSSLQTLDLSHNRF-SGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAID 123
L++L+ L L+ + + F +++L++L+L DN + P+ N +D
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 124 CNYNSLSGELPANIFRAIPK---DIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSL 180
+N + + + L+ + + L E + L L
Sbjct: 161 LTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 181 PRSFLTGTIPSSIFNLSSL-----LELDFSNNSLTGF------YMTNNHFTGSIPRNLWQ 229
+ ++ F+ + L L S N + F N F G +
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279
Query: 230 C--------EIPHEI-GNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGS 279
C + + + +LE L + +N + + + F ++ L L+L N L S
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-S 337
Query: 280 LPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNL 338
+ S L +E L+L N++ + F L L L N L
Sbjct: 338 IDSRM--FENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394
Query: 339 RNLEHLGLGYNYLTSSTPELSFLSSLANSSSSK 371
+L+ + L N S P + +LS N +S K
Sbjct: 395 TSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK 427
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 10/183 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
+ + IG GS+G K R DG + K + + +E +L+ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 783 NLVKIISSCSNGNFKAL--VLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALE 837
N+V+ + L V+EY G L + + L +M + LAL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 838 YLH--FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H + V+H D+KP+N+ LD L DFG+A++LN + S +GT YM+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 896 GLW 898
Sbjct: 186 EQM 188
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 67/288 (23%), Positives = 119/288 (41%), Gaps = 28/288 (9%)
Query: 319 LLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAE 377
LL+L N + NL+NL L L N ++ +P + L L + + L++
Sbjct: 56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL------ERLYLSK 109
Query: 378 NPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPIT 436
N L LP +P TL+E+ + +I + K + L + + LG N L S I
Sbjct: 110 NQLK-ELPE---KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-SSGIE 163
Query: 437 VG---RLNTLQGLGLENNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLS 492
G + L + + + + IP L L+ELH+D NK++ A LN+L L
Sbjct: 164 NGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 493 LGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG---- 548
L N +S+ + N ++ ++N L +P + + K + + L N ++
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 549 --DIPTTIGGLTNLQLLSLENNRL-HGPIPES-FGALTSLESLDLSVN 592
P + +SL +N + + I S F + ++ L
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 70/370 (18%), Positives = 129/370 (34%), Gaps = 85/370 (22%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
LR + C+ L ++P ++ L L NK+ + NL L
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDT----------ALLDLQNNKITEIKDGDFKNLKNLHT 80
Query: 178 LSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEI 236
L L + ++ I F L L L S N L +P +
Sbjct: 81 LILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-----------ELPEKM--------- 119
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIER 295
L+ L + EN + V ++F ++ + + L N L S + G+ +
Sbjct: 120 --PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAFQGMKKLSY 175
Query: 296 LNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSST 355
+ + N++ IP + L L L GN + +L L NL LGL +N +++
Sbjct: 176 IRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-- 230
Query: 356 PELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGN 415
V S+ N P L E++L N K+ +P + +
Sbjct: 231 ---------------------------VDNGSLANTP-HLRELHLNNNKLV-KVPGGLAD 261
Query: 416 LVNLTTLHLGNNQLSGSIPITV-------GRLNTLQGLGLENNKLE-GPIP----DDLCQ 463
+ ++L NN +S +I + + G+ L +N ++ I +
Sbjct: 262 HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 464 LSELHVDHNK 473
+ + + + K
Sbjct: 321 RAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/279 (18%), Positives = 100/279 (35%), Gaps = 21/279 (7%)
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
+ + L N + + NL L + L N KI P LV L L+L
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD----LCQLSELHVDHNKL-SGPIPA- 480
NQL +P + TLQ L + N++ + L Q+ + + N L S I
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540
F + L + + +++ +L + N + + + + ++
Sbjct: 166 AFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLG 222
Query: 541 LSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV--- 597
LS N ++ ++ +L+ L L NN+L +P ++ + L NN+S +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 598 ---IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSA 633
P K ++L N ++ +F
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 70/368 (19%), Positives = 124/368 (33%), Gaps = 75/368 (20%)
Query: 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLK 267
L ++ +P++ +P P+ +L + N + N+ L
Sbjct: 32 HLRVVQCSDLGLE-KVPKD-----LP------PDTALLDLQNNKITEIKDGDFKNLKNLH 79
Query: 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSF 327
L L+NN +S + + L +ERL L N L +P + L L + N
Sbjct: 80 TLILINNKIS-KISPGA--FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI 133
Query: 328 SGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSS 387
+ L + + LG N L SS E +
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK--------------------- 172
Query: 388 IGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLG 447
L I + + I IP+ G +LT LHL N+++ ++ LN L LG
Sbjct: 173 -------LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 448 LENNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
L N + + + L ELH+++NKL +P + ++ + L +N +S+
Sbjct: 223 LSFNSISA-VDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 504 STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDI--PTTIGGLTNLQ 561
+ F P ++L N + P+T +
Sbjct: 281 NDF------------------CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322
Query: 562 LLSLENNR 569
+ L N +
Sbjct: 323 AVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 50/315 (15%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQL 104
L++ + +T NL +L TL L +N+ S I F+ + L+ L L NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQ-G 163
P + L+ + + N ++ ++ ++F L ++ + LG N L+
Sbjct: 113 K-ELPEKMPKT---LQELRVHENEIT-KVRKSVFN-------GLNQMIVVELGTNPLKSS 160
Query: 164 EIPQE-LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGS 222
I + +L ++ + + +T TIP + SL EL N +T
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-----------K 206
Query: 223 IPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPS 282
+ + L NL LG+ N + ++ N L+ L L NN L +P
Sbjct: 207 VDAASLK--------GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 283 SSKNLIGLPNIERLNLGLNNLSG------RIPGFIFNASKLFLLELTGN--SFSGFIPDT 334
L I+ + L NN+S PG+ + + L N + P T
Sbjct: 258 ---GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314
Query: 335 LVNLRNLEHLGLGYN 349
+ + LG
Sbjct: 315 FRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+LP + LQN KI + NL NL TL L NN++S P L L+ L L
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 450 NNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI--PSTF 506
N+L+ +P+ + L EL V N+++ + F LN + + LG+N L S F
Sbjct: 109 KNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE 566
+ + I ++ +T IP G +L L L+
Sbjct: 168 QGMKK------------------------LSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 567 NNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
N++ S L +L L LS N++S V SL +L++L+L+ N+L ++P G
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 66/365 (18%), Positives = 129/365 (35%), Gaps = 92/365 (25%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
LDL +N+ + I F + L LIL +N++S
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS--------------------- 89
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
++ F L KL+ LYL N+L+ E+P+++ L+ L + + +T
Sbjct: 90 -----KISPGAFA-------PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT 134
Query: 187 GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
+ S+F L+ ++ ++ N L + N F G + L +
Sbjct: 135 -KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG-----------------MKKLSYI 176
Query: 246 GIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
I + ++ +P + +L L L N ++ + ++S L GL N+ +L L N++S
Sbjct: 177 RIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAAS--LKGLNNLAKLGLSFNSIS- 229
Query: 306 RIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
+ N L L L N +P L + + ++ + L N ++ + F
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPG 287
Query: 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR-GNIPKEI-GNLVNLTTL 422
N+ + + L + ++ I + +
Sbjct: 288 YNTKKAS-----------------------YSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 423 HLGNN 427
LGN
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 7/153 (4%)
Query: 479 PAC-FGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
P C F LR + L +P + D +N + D N+K +
Sbjct: 23 PVCPFRCQCHLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLH 79
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+ L N ++ P L L+ L L N+L +PE +L+ L + N ++ V
Sbjct: 80 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKV 136
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
L + + L N L+ G+F
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 27/103 (26%)
Query: 59 TISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSS 118
+ L + +Q + L +N S I S+ F P + +S
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC------------------PPGYNTKKAS 294
Query: 119 LRAIDCNYNSLS-GELPANIFRAIPKDIGNLTKLKELYLGYNK 160
+ N + E+ + FR + + LG K
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFR-------CVYVRAAVQLGNYK 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 788
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V+E N L L +S+D ++R S ++ A+ +H + +V
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAP 895
H D+KP+N L+ D M+ L DFGIA + + + ++ +GT+ YM P
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 76/396 (19%), Positives = 138/396 (34%), Gaps = 76/396 (19%)
Query: 241 NLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
VL + E+ L +P+ + + L + +N L+ SLP+ P + L +
Sbjct: 41 GNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPAL------PPELRTLEVSG 90
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
N L+ +P +L + L L + N LTS
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTSLPVLPPG 142
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
L L +++N L LP+ L +++ N ++ ++P L
Sbjct: 143 LQEL---------SVSDNQLA-SLPALPSEL----CKLWAYNNQLT-SLPMLPSGL---Q 184
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPA 480
L + +NQL+ S+P L L NN+L +P L EL V N+L+ +P
Sbjct: 185 ELSVSDNQLA-SLPTLPSEL---YKLWAYNNRLT-SLPALPSGLKELIVSGNRLTS-LPV 238
Query: 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540
L + L + N L+S LP+ + ++
Sbjct: 239 LPSEL---KELMVSGNRLTS-------------------------LPMLPSGLL---SLS 267
Query: 541 LSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP- 599
+ RN LT +P ++ L++ ++LE N L ++ +TS +
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
Query: 600 -ISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQ 634
+ ++L + EGE + F +
Sbjct: 327 APRETRALHLAAADWLVPAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 76/434 (17%), Positives = 140/434 (32%), Gaps = 107/434 (24%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
+ L++ + + T+P + + + L++ DN L+ S P+ LR ++ +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALP----PELRTLEVSG 90
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
N L+ ++P L +L L L L + + LT
Sbjct: 91 NQLT---------SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT 134
Query: 187 GTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
++P L EL S+N L +P L L
Sbjct: 135 -SLPVLPPGLQ---ELSVSDNQLA--------------------SLPALPSELCKLWAYN 170
Query: 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306
N L +P L+ LS+ +N L+ SLP+ + +L N L+
Sbjct: 171 ---NQLT-SLPMLPSG---LQELSVSDNQLA-SLPTL------PSELYKLWAYNNRLT-S 215
Query: 307 IPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLAN 366
+P S L L ++GN + +P L+ L + N LTS
Sbjct: 216 LPALP---SGLKELIVSGNRLTS-LPVLPSELKELM---VSGNRLTS------------- 255
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
LP L + + ++ +P+ + +L + TT++L
Sbjct: 256 -----------------LPMLPSGL----LSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLN 486
N LS + + + G + + + LH+ +PA G
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL--VPAREGEPA 351
Query: 487 SLRNLSLGSNELSS 500
+ E ++
Sbjct: 352 PADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 76/392 (19%), Positives = 129/392 (32%), Gaps = 81/392 (20%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+T L I D LT ++ + L +TL++S N+ + ++P + L I L
Sbjct: 63 ITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
S L + N L+ ++P L EL + N+L +
Sbjct: 118 ALP--------SGLCKLWIFGNQLT---------SLPVLPPGLQ---ELSVSDNQLA-SL 156
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225
P L +L + LT ++P S L EL S+N L
Sbjct: 157 PALPSELCKLWAYNNQ---LT-SLPMLP---SGLQELSVSDNQLA--------------- 194
Query: 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSK 285
+P L L N L +P LK L + N L+ SLP
Sbjct: 195 -----SLPTLPSELYKLWAYN---NRLT-SLPALPSG---LKELIVSGNRLT-SLPVL-- 239
Query: 286 NLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345
++ L + N L+ +P S L L + N + +P++L++L + +
Sbjct: 240 ----PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 346 LGYNYLTSSTPELSF-LSSLANSS----SSKYIVLAENPLNGVLPSSIGNLPITLEEIYL 400
L N L+ T + ++S S + L + + + E
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
Query: 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432
G N L ++LS +
Sbjct: 351 APAD----RWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 22/148 (14%)
Query: 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVV 537
+ AC N L++G + L++ +P +I + N+L SLP ++
Sbjct: 34 MRACL--NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPELR--- 84
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+ +S N LT +P GL L + S L P + L L + N L+
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PAL---PSGLCKLWIFGNQLT-S 135
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+P+ L++L++S N+L +P+
Sbjct: 136 LPVLPPG---LQELSVSDNQLA-SLPAL 159
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 728 FSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
F E LIG G FG V+K + +DG IK + A + E + L + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 787 ----------------IISSCSNGNFKALVLEYMANGSLEKCL-YSSNRSLDIFQRLSIM 829
SS S + +E+ G+LE+ + LD L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
+ ++Y+H S +++ D+KPSNI L D + DFG+ L + RT++ GT
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSKGT 184
Query: 890 IGYMAPGLW 898
+ YM+P
Sbjct: 185 LRYMSPEQI 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-32
Identities = 101/519 (19%), Positives = 180/519 (34%), Gaps = 61/519 (11%)
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176
+D + +L+ +PKD+ + K L L N + ++ L+EL
Sbjct: 31 ELESMVDYSNRNLT---------HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELR 79
Query: 177 WLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHE 235
L L + + ++ +F L LD S+N L +I
Sbjct: 80 VLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-----------NISC---------- 117
Query: 236 IGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIE 294
+ +L L + N F N++ L L L L + L I
Sbjct: 118 -CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCIL 175
Query: 295 RLNLGLNNLSGRIPGFIF--NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLT 352
L+L ++ G + N + L L+ + FS + ++ L +L+ + N
Sbjct: 176 -LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 353 SSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNL--PITLEEIYLQNCKIRGNIP 410
++FLS L + + L + P +E + + N I I
Sbjct: 235 CQRL-MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 411 KEIGN-----LVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK---LEGPIPDDLC 462
+E L +L H+ N S + L + + P
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 463 QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522
+ L+ N + + L L+ L L N L + N+ S + SL
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSL 412
Query: 523 NGSLPLDIGNMKV-----VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES 577
N SL + ++ +NLS N LTG + + +++L L NNR+ IP+
Sbjct: 413 N-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKD 468
Query: 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
L +L+ L+++ N L V ++L L+ + L N
Sbjct: 469 VTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 79/436 (18%), Positives = 148/436 (33%), Gaps = 50/436 (11%)
Query: 65 GNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAID 123
++SL+ LDLS N F F ++ L L L + + S +D
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS 183
+ G ++ + L+L ++ Q ++ L L L
Sbjct: 178 LVSYHIKGGETESL---------QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 184 FLTGTIPSSIFNLSSLLELDFSNNSLTGFYM-TNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
L + S L + ++T ++ T + + + W +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW----------PRPV 278
Query: 243 EVLGIDENHLVGDVPNTIFNMS--TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
E L I + + F S LK+L + + L S + L +
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
++ + S L T N F+ + L+ L+ L L N L + +++
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF-FKVAL 397
Query: 361 LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420
+ N SS + + ++ N LN ++ + L + + G++ + + +
Sbjct: 398 M--TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVK 453
Query: 421 TLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPA 480
L L NN++ SIP V L LQ L + +N+L+ +PD
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPD--------------------G 491
Query: 481 CFGNLNSLRNLSLGSN 496
F L SL+ + L N
Sbjct: 492 VFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 58/363 (15%), Positives = 125/363 (34%), Gaps = 37/363 (10%)
Query: 283 SSKNL----IGLP-NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
S++NL LP + L+L N++S I S+L +L L+ N +
Sbjct: 39 SNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF 98
Query: 338 LRNLEHLGLGYNYLTSSTPELSF--LSSLANSSSSKYIVLAENPLNGV-LPSSIGNLPIT 394
++LE+L + +N L + +S ++SL +++ L+ N + + + GNL
Sbjct: 99 NQDLEYLDVSHNRLQN----ISCCPMASL------RHLDLSFNDFDVLPVCKEFGNLT-K 147
Query: 395 LEEIYLQNCKIRGNIPKEIGNL-VNLTTLHLGNNQLSGSIPITVGRLNT--LQGLGLENN 451
L + L K R + +L ++ L L + + G ++ NT L + N+
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207
Query: 452 KLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWN--- 508
+ + L L + + KL+ S ++ T W
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267
Query: 509 -------LNNILSFDFSSNSLNGSLPLDIGN-----MKVVVEINLSRNYLTGDIPTTIGG 556
+ + + ++ + + +K ++ ++
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 557 LTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
+ + L + + +S L+ + N + + L L+ L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 617 RLE 619
L+
Sbjct: 388 GLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 36/166 (21%), Positives = 68/166 (40%), Gaps = 11/166 (6%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL- 104
+ +S + SS L+ + N F+ ++ ++ L+ LIL N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
+ + + N SSL +D + NSL+ + L L N L G
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC-------AWAESILVLNLSSNMLTGS 443
Query: 165 IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210
+ + L +++ L L + + +IP + +L +L EL+ ++N L
Sbjct: 444 VFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 788
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V+E N L L +S+D ++R S ++ A+ +H + +V
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 130
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAP 895
H D+KP+N L+ D M+ L DFGIA + + + ++ +GT+ YM P
Sbjct: 131 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 16/178 (8%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+ + +G GSFG V++ + G + A+K L+ E +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPR 111
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+V + + G + + +E + GSL + + L + L + LEYLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLH--- 167
Query: 844 SNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNGEESMRTQTL-----GTIGYMAP 895
+ ++H D+K N+LL D A L DFG A L + ++ GT +MAP
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 732 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 788
I G G +Y ++G V +K D A AE + L V H ++V+I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 789 -------SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
+ +V+EY+ SL++ + L + + ++ ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGY--IVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH- 199
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYMAP 895
S +V+ D+KP NI+L ++ + L D G + GT G+ AP
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------NSFGYLYGTPGFQAP 246
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 43/189 (22%), Positives = 72/189 (38%), Gaps = 20/189 (10%)
Query: 727 HFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
H+ +G G F V DG A+K + E ++ + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 786 KIISSC---SNGNFKA-LVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALEY 838
++++ C +A L+L + G+L + + Q L +++ + LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL---------GT 889
+H + H D+KP+NILL D+ L D G Q L T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 890 IGYMAPGLW 898
I Y AP L+
Sbjct: 207 ISYRAPELF 215
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 12/169 (7%)
Query: 733 LIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNL--VKII 788
IG G V++ AIK +L+ + L S+ E L ++ + +++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V+E N L L +S+D ++R S ++ A+ +H + +V
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAP 895
H D+KP+N L+ D M+ L DFGIA + + + ++ +G + YM P
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 32/199 (16%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
F E +++G G+FG V K R LD AIK + L + +E +L S+ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63
Query: 784 LVKIISS-CSNGNFKA------------LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI 830
+V+ ++ NF + +EY NG+L ++S N + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN------------- 877
+ AL Y+H S ++H D+KP NI +D+ + DFG+AK ++
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 878 -GEESMRTQTLGTIGYMAP 895
G T +GT Y+A
Sbjct: 181 PGSSDNLTSAIGTAMYVAT 199
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 14/180 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRN 783
+ ++G G+ V++GR G AIKVF+ + F + E EVLK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 784 LVKI--ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQR--LSIMIDVALALEYL 839
+VK+ I + K L++E+ GSL L + + + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 840 HFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N +VH +IKP NI+ D V L+DFG A+ L +E + GT Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHP 184
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLK-SVRHRNLVK 786
F K ++G G+ GT+ D +VA+K + D E ++L+ S H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ + F+ + +E A +L++ + + + + ++++ L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 847 VVHCDIKPSNILL-----DDDMVAHLSDFGIAKLLNGEES---MRTQTLGTIGYMAP 895
+VH D+KP NIL+ + A +SDFG+ K L R+ GT G++AP
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 58/207 (28%), Positives = 84/207 (40%), Gaps = 30/207 (14%)
Query: 699 ELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD---GMEVAI 755
EL V MS + +F IG GSF TVYKG LD +EVA
Sbjct: 13 ELETKAVGMSNDGRFLKF--------------DIEIGRGSFKTVYKG--LDTETTVEVAW 56
Query: 756 KVFHL--QFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA----LVLEYMANGSL 809
+ F E E+LK ++H N+V+ S + LV E M +G+L
Sbjct: 57 CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLS 868
K + + I S + L++LH + P++H D+K NI + +
Sbjct: 117 -KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 869 DFGIAKLLNGEESMRTQTLGTIGYMAP 895
D G+A L S +GT +MAP
Sbjct: 175 DLGLATLKR--ASFAKAVIGTPEFMAP 199
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 14/180 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHRN 783
+ ++G G+ V++GR G AIKVF+ + F + E EVLK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 784 LVKI--ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQR--LSIMIDVALALEYL 839
+VK+ I + K L++E+ GSL L + + + + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 840 HFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N +VH +IKP NI+ D V L+DFG A+ L +E + GT Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHP 184
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 4/172 (2%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+ + +G G+FG VYK + + G A KV + + L+ + E E+L + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+VK++ + + +++E+ G+++ + +R L Q + + AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S ++H D+K N+L+ + L+DFG++ R +GT +MAP
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGL 448
+P + L I+ +L +L L LG N + I + L +L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130
Query: 449 ENNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS-NELSSFIP 503
+N L IP L +L EL + +N + F + SL L LG +L
Sbjct: 131 FDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189
Query: 504 STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563
F L N+ + ++ +P ++ + + E+ +S N+ P + GL++L+ L
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 564 SLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
+ N+++ +F L SL L+L+ NNLS + L YL +L+L N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 40/264 (15%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
S+ + L+L N I + F + L++L LG N + + +SL ++
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFL 185
N L+ +P+ F L+KL+EL+L N ++ IP + L L L
Sbjct: 133 NWLT-VIPSGAFE-------YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 186 TGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
I F L +L L+ ++ +P + L LE
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-----------DMP----------NLTPLVGLEE 222
Query: 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
L + NH P + +S+LK L ++N+ +S + ++ GL ++ LNL NNLS
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNA--FDGLASLVELNLAHNNLS 279
Query: 305 GRIPGFIFNA-SKLFLLELTGNSF 327
+P +F L L L N +
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 41/286 (14%)
Query: 291 PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
++ LS +P I + ++ L L N+ DT +L +LE L LG N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRY--LNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 351 LTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNI 409
+ + L+SL + L +N L + + L L E++L+N I +I
Sbjct: 111 IRQIEVGAFNGLASL------NTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-SI 162
Query: 410 PKEI-GNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD--DLCQLS 465
P + +L L LG +L L L+ L L ++ +P+ L L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLE 221
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
EL + N P F L+SL+ L + ++++S + F L +++ + + N+L+ S
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLH 571
LP L L L L +N +
Sbjct: 281 LP-----------------------HDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 64/252 (25%), Positives = 97/252 (38%), Gaps = 21/252 (8%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLV 336
+ + L +P N LNL NN+ I F + L +L+L NS
Sbjct: 62 TRRGLSEVPQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120
Query: 337 NLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395
L +L L L N+LT +LS L + + L NP+ + + +P +L
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKL------RELWLRNNPIESIPSYAFNRVP-SL 173
Query: 396 EEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
+ L K I + L NL L+LG + +P + L L+ L + N
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231
Query: 455 GPIPD---DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNN 511
P L L +L V ++++S F L SL L+L N LSS F L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291
Query: 512 ILSFDFSSNSLN 523
++ N N
Sbjct: 292 LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 56/212 (26%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAID- 123
L+SL TL+L N + IPS F +S L+ L L +N + S PS+ + SL +D
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDL 178
Query: 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS 183
L + F L LK L LG ++ ++P L L LE L + +
Sbjct: 179 GELKKLE-YISEGAFE-------GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN 228
Query: 184 FLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
I F LSSL +L N+ ++ I RN L +L
Sbjct: 229 HFP-EIRPGSFHGLSSLKKLWVMNSQVS-----------LIERNA--------FDGLASL 268
Query: 243 EVLGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
L + N+L + + L L L +N
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 48/217 (22%), Positives = 78/217 (35%), Gaps = 35/217 (16%)
Query: 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNKL 474
+ + LS +P + + + L L N ++ D L L L + N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 475 SGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMK 534
F L SL L L N L+ F L+ + +N + S+P
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP------- 163
Query: 535 VVVEINLSRNYLTGDIPTTIGGLTNLQLLSL-ENNRLHGPIPESFGALTSLESLDLSVNN 593
+ +L L L E +L +F L +L+ L+L + N
Sbjct: 164 ----------------SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207
Query: 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
+ +P +L LV L++L +S N EI GSF
Sbjct: 208 IK-DMP-NLTPLVGLEELEMSGNHFP-EIRP-GSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 30/146 (20%), Positives = 53/146 (36%), Gaps = 6/146 (4%)
Query: 486 NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY 545
N + LS +P +N + N++ ++ + + L RN
Sbjct: 54 NQFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 546 LTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605
+ GL +L L L +N L +F L+ L L L N + + + ++
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 606 VYLKDLNLS-FNRLEGEIPSGGSFAN 630
L L+L +LE I G+F
Sbjct: 171 PSLMRLDLGELKKLE-YISE-GAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 38/165 (23%)
Query: 47 TALNISDFGLTGTISSQ-LGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
L++ + IS L +L+ L+L
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK------------------------ 209
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
P+ + L ++ + N E+ F L+ LK+L++ +++
Sbjct: 210 -DMPNL--TPLVGLEELEMSGNHFP-EIRPGSFH-------GLSSLKKLWVMNSQVSLIE 258
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSL 209
LA L L+L + L+ ++P +F L L+EL +N
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 31/194 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNL 784
+ + ++G GS GTV G VA+K + F E ++L +S H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS------IMIDVALALEY 838
++ S + F + LE N +L+ + S N S + + ++ +A + +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 839 LHFGYSNPVVHCDIKPSNILLD-------------DDMVAHLSDFGIAKLLNGEESMRTQ 885
LH S ++H D+KP NIL+ +++ +SDFG+ K L+ +S
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 886 TL----GTIGYMAP 895
L GT G+ AP
Sbjct: 188 NLNNPSGTSGWRAP 201
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 6/172 (3%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
++ IG G+ GTVY + G EVAI+ +LQ + E V++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+V + S G+ +V+EY+A GSL + + +D Q ++ + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
SN V+H DIK NILL D L+DFG + E+S R+ +GT +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 31/198 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRN 783
F +G G FG V++ + +D AIK L + A + E + L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 784 LVKIISSCSNGNFKA------------LVLEYMANGSLEKCL--YSSNRSLDIFQRLSIM 829
+V+ ++ N + ++ +L+ + + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM------- 882
+ +A A+E+LH S ++H D+KPSNI D V + DFG+ ++ +E
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 883 -----RTQTLGTIGYMAP 895
T +GT YM+P
Sbjct: 182 PAYARHTGQVGTKLYMSP 199
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 33/197 (16%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA--ECEVLKSV-R 780
T F E IG G FG+V+K LDG AIK G++ +A E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF---QRLSIMIDVALALE 837
H ++V+ S+ + + + EY GSL + + R + F + +++ V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDD-------------------MVAHLSDFGIAKLLNG 878
Y+H S +VH DIKPSNI + ++ + D G ++
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 879 EESMRTQTLGTIGYMAP 895
+ G ++A
Sbjct: 187 PQVEE----GDSRFLAN 199
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 26/187 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA---------ECE 774
+++ K ++G G V + E A+K+ + G+ + + E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 775 VLKSV-RHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSI 828
+L+ V H N++++ + F LV + M G L EK S + I +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR---- 131
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
+ + LH +VH D+KP NILLDDDM L+DFG + L+ E +R G
Sbjct: 132 --ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCG 185
Query: 889 TIGYMAP 895
T Y+AP
Sbjct: 186 TPSYLAP 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 11/211 (5%)
Query: 689 LITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRF- 747
LI L S + R + +L + IG G+FG V+ GR
Sbjct: 81 LIDHLLSTQQPL----TKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR 136
Query: 748 LDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806
D VA+K F E +LK H N+V++I C+ +V+E +
Sbjct: 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196
Query: 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866
G L + L + L ++ D A +EYL S +H D+ N L+ + V
Sbjct: 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLK 253
Query: 867 LSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
+SDFG+++ + L + + AP
Sbjct: 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 6/172 (3%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
IG GS G V R G +VA+K+ L+ + E +++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+V++ S G +++E++ G+L + S L+ Q ++ V AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ V+H DIK +ILL D LSDFG ++ + R +GT +MAP
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 700 LSNIEVNMSPQAMWRRFSYRELLLATD---HFSEKSLIGIGSFGTVYKGRFLD-GMEVAI 755
L +++ P+ ++ E L F +G GS+G+VYK + G VAI
Sbjct: 2 LETVQLRNPPRRQLKK--LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 756 KVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYS 815
K ++ D L+ E +++ ++VK S +V+EY GS+ +
Sbjct: 60 KQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 816 SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875
N++L + +I+ LEYLH +H DIK NILL+ + A L+DFG+A
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 876 LNGEESMRTQTLGTIGYMAP 895
L + R +GT +MAP
Sbjct: 175 LTDTMAKRNTVIGTPFWMAP 194
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 732 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVK 786
+G G TVY L+ ++VAIK + + LK F+ E + H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+I + LV+EY+ +L S+ L + ++ + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYMAP 895
+VH DIKP NIL+D + + DFGIAK L+ E S+ TQT LGT+ Y +P
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSL-TQTNHVLGTVQYFSP 181
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 54/265 (20%), Positives = 92/265 (34%), Gaps = 38/265 (14%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVG---RLNTLQGL 446
+P + + L++ K++ L LT L L +N LS +L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYL 83
Query: 447 GLENNKLEGPIPDD---LCQLSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFI 502
L N + + + L QL L H+ L + F +L +L L +
Sbjct: 84 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
F L+++ + NS + P L NL
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFL-----------------------PDIFTELRNLTF 179
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622
L L +L P +F +L+SL+ L++S NN + + L L+ L+ S N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TS 238
Query: 623 PSGGSFANFSAQ----SFMGNDLLC 643
+F + + ND C
Sbjct: 239 KK-QELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 57/290 (19%), Positives = 95/290 (32%), Gaps = 45/290 (15%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
S I CN L+ +P I + L L NKLQ L +L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP----------SSATRLELESNKLQSLPHGVFDKLTQLTK 56
Query: 178 LSLPRSFLT-GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHE 235
LSL + L+ S +SL LD S N + +
Sbjct: 57 LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI--------------------TMSSN 96
Query: 236 IGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIE 294
L LE L ++L ++F ++ L L + + + GL ++E
Sbjct: 97 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI--FNGLSSLE 153
Query: 295 RLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353
L + N+ IF L L+L+ P +L +L+ L + +N S
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213
Query: 354 STPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQN 402
L+SL + + + N + + + P +L + L
Sbjct: 214 LDTFPYKCLNSL------QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/286 (20%), Positives = 93/286 (32%), Gaps = 59/286 (20%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
SS L+L N+ ++P +F ++ L L L N LS
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS--------------------- 65
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
+ T LK L L +N + + L +LE L S L
Sbjct: 66 ---FKGCCSQSDF-------GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
Query: 187 GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
S+F +L +L+ LD S+ ++ L +LEVL
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTR-----------VAFNGIFN--------GLSSLEVL 155
Query: 246 GIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
+ N + IF + L L L L L ++ L +++ LN+ NN
Sbjct: 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA--FNSLSSLQVLNMSHNNFF 212
Query: 305 GRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNL-RNLEHLGLGYN 349
+ L +L+ + N L + +L L L N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 14/170 (8%)
Query: 44 HRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDN 102
+ L++S G+ T+SS L L+ LD H+ S+F + L L +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 103 QLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQ 162
+ I + SSL + NS +IF L L L L +L+
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT-------ELRNLTFLDLSQCQLE 188
Query: 163 GEIPQE-LGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLT 210
++ +L+ L+ L++ + ++ + + L+SL LD+S N +
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 29/149 (19%), Positives = 45/149 (30%), Gaps = 37/149 (24%)
Query: 64 LGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAI 122
LSSL+ L ++ N F IF+ + L L L QL
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----------------- 188
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
+L F +L+ L+ L + +N L L+ L
Sbjct: 189 ---------QLSPTAFN-------SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 183 SFLTGTIPSSIFN--LSSLLELDFSNNSL 209
+ + T SSL L+ + N
Sbjct: 233 NHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 22/108 (20%), Positives = 41/108 (37%), Gaps = 10/108 (9%)
Query: 56 LTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIIS 114
+ L +L LDLS + + + F+ +S+L++L + N S +F
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
Query: 115 NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQ 162
+SL+ +D + N + + P + L L L N
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFP------SSLAFLNLTQNDFA 261
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-28
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 17/184 (9%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHR 782
+ K +G G FG V + G +VAIK + + + E +++K + H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 783 NLVKII------SSCSNGNFKALVLEYMANGSLEKCLYSSNRS--LDIFQRLSIMIDVAL 834
N+V + + L +EY G L K L L +++ D++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLNGEESMRTQTLGTIG 891
AL YLH N ++H D+KP NI+L ++ + D G AK L+ E +GT+
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQ 188
Query: 892 YMAP 895
Y+AP
Sbjct: 189 YLAP 192
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V G++ +VA+K+ +G++ F E + + + H LVK C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
S +V EY++NG L L S + L+ Q L + DV + +L S+ +H D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
+ N L+D D+ +SDFG+ + + + ++GT + + AP
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAP 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 8/232 (3%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+ + L +I+ +L +L L L N + L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 450 NNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS-NELSSFIPS 504
+N+L IP+ L +L EL + +N + F + SLR L LG LS
Sbjct: 121 DNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564
F L+N+ + + +L +P ++ + + E++LS N+L+ P + GL +LQ L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
+ +++ +F L SL ++L+ NNL+ + L +L+ ++L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 65/253 (25%), Positives = 94/253 (37%), Gaps = 23/253 (9%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLV 336
KNL +P N LNL N + I F + L +L+L+ N
Sbjct: 51 VRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFN 109
Query: 337 NLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395
L NL L L N LT+ +LS L K + L NP+ + + +P +L
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKL------KELWLRNNPIESIPSYAFNRIP-SL 162
Query: 396 EEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
+ L K I + L NL L+L L IP + L L L L N L
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS 220
Query: 455 GPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLN 510
I L L +L + +++ F NL SL ++L N L+ F L+
Sbjct: 221 A-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 511 NILSFDFSSNSLN 523
++ N N
Sbjct: 280 HLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 7/232 (3%)
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
S++++ + L EN + + +S +L LE + L IR L NL TL L +
Sbjct: 63 STNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKL---EGPIPDDLCQLSELHVDH-NKLSGPIPACF 482
N+L+ L+ L+ L L NN + + + L L + +LS F
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 483 GNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLS 542
L++LR L+L L IP L + D S N L+ P + + ++ +
Sbjct: 182 EGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 543 RNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
++ + L +L ++L +N L + F L LE + L N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 69/317 (21%), Positives = 110/317 (34%), Gaps = 70/317 (22%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
+ + +P I + ++L L +NQ+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ---------------------- 77
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG 187
+ N F+ +L L+ L L N ++ LA L L L + LT
Sbjct: 78 ----IIKVNSFK-------HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT- 125
Query: 188 TIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
TIP+ F LS L EL NN + SIP + +P+L L
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-----------SIPSYAFN--------RIPSLRRLD 166
Query: 247 IDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
+ E + + F +S L+ L+L L +P+ L L ++ L+L N+LS
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN----LTPLIKLDELDLSGNHLS- 220
Query: 306 RIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
I F L L + + + NL++L + L +N LT +L
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL-----F 275
Query: 365 ANSSSSKYIVLAENPLN 381
+ I L NP N
Sbjct: 276 TPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 61/262 (23%), Positives = 106/262 (40%), Gaps = 38/262 (14%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQ 103
LN+ + + + +L L+ L LS N TI F+ ++ L L L DN+
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123
Query: 104 LSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLG-YNKLQ 162
L+ + P+ S L+ + N + +P+ F + L+ L LG +L
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN-------RIPSLRRLDLGELKRLS 174
Query: 163 GEIPQE-LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTG 221
I + L+ L +L+L L IP ++ L L ELD S N L+
Sbjct: 175 -YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS----------- 220
Query: 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLP 281
+I L +L+ L + ++ + N N+ +L ++L +N L+ LP
Sbjct: 221 AIRPGS--------FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLP 271
Query: 282 SSSKNLIGLPNIERLNLGLNNL 303
L ++ER++L N
Sbjct: 272 HDL--FTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 457 IPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
+PD + L++ N++ F +L L L L N + + F L N+ +
Sbjct: 58 VPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117
Query: 516 DFSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPT-TIGGLTNLQLLSL-ENNRLHG 572
+ N L ++P + + E+ L N + IP+ + +L+ L L E RL
Sbjct: 118 ELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSY 175
Query: 573 PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFS 632
+F L++L L+L++ NL IP +L L+ L +L+LS N L I GSF
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRP-GSFQGLM 231
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 4/123 (3%)
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
PS N +L +P I +NL N + + L +L++
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622
L L N + +F L +L +L+L N L+ + + L LK+L L N +E I
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 623 PSG 625
PS
Sbjct: 152 PSY 154
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 32/151 (21%), Positives = 56/151 (37%), Gaps = 9/151 (5%)
Query: 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540
C + + L +P N + N + +++ + +
Sbjct: 41 CSNQFSKVI---CVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94
Query: 541 LSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPI 600
LSRN++ GL NL L L +NRL +F L+ L+ L L N + +
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY 154
Query: 601 SLEKLVYLKDLNLS-FNRLEGEIPSGGSFAN 630
+ ++ L+ L+L RL I G+F
Sbjct: 155 AFNRIPSLRRLDLGELKRLS-YISE-GAFEG 183
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 730 EKSLIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLV 785
+G G+FG+V +G + ++VAIKV + A E +++ + + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFG 842
++I C LV+E G L K L + + ++ V++ ++YL +F
Sbjct: 74 RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
VH D+ N+LL + A +SDFG++K L ++S T + + AP
Sbjct: 132 -----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
IG G FG V+ G +L+ +VAIK +GA+ + F E EV+ + H LV++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
LV E+M +G L L + L + +DV + YL V+H D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
+ N L+ ++ V +SDFG+ + + + T + GT + + +P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASP 174
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 52/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 689 LITRYRKGN----TELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYK 744
L+ Y+KGN +LS ++ PQ W + ++ + + + +G G FG V+
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWM 206
Query: 745 GRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804
+ +VA+K ++++F AE V+K+++H LVK+ + + ++ E+M
Sbjct: 207 ATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFM 264
Query: 805 ANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863
A GSL L S S + + + +A + ++ +H D++ +NIL+ +
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 864 VAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
V ++DFG+A+++ E + R I + AP
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 14/172 (8%)
Query: 734 IGIGSFGTVYKGRFL----DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVK 786
+G GSFG V +G + + VA+K L A+ F E + S+ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ K +V E GSL L + + VA + YL S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
+H D+ N+LL + + DFG+ + L + + AP
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 67/395 (16%), Positives = 128/395 (32%), Gaps = 55/395 (13%)
Query: 240 PNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299
N + + ++TL +L N++++ + L + +L
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-----DMTGIEKLTGLTKLICT 72
Query: 300 LNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELS 359
NN++ + + + L L N + + L L +L N LT +S
Sbjct: 73 SNNITT-LD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLD--VS 124
Query: 360 FLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNL 419
L Y+ A N L + + + L E+ K ++ L
Sbjct: 125 QNPLL------TYLNCARNTLTEI---DVSHNT-QLTELDCHLNKK--ITKLDVTPQTQL 172
Query: 420 TTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIP 479
TTL N+++ + V + L L + N + + QL+ L NKL+ I
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID 228
Query: 480 ACFGNLNSLRNLSLGSNELSSFIPSTFWNL-------NNILSFDFSSNS---------LN 523
L L N L+ ST L ++L D + N+
Sbjct: 229 --VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCR 286
Query: 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTS 583
LD+ + + ++ +T ++ + L L L N L + T
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTK 340
Query: 584 LESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618
L+SL ++ + K+ L + + +
Sbjct: 341 LKSLSCVNAHIQDFSSVG--KIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 75/476 (15%), Positives = 154/476 (32%), Gaps = 79/476 (16%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
+ F + T + L++L +LD ++ + + I ++ L LI N ++
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT--- 77
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
+ +S ++L + C+ N L+ D+ LTKL L NKL +
Sbjct: 78 -TLDLSQNTNLTYLACDSNKLTN-----------LDVTPLTKLTYLNCDTNKLT---KLD 122
Query: 169 LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228
+ L +L+ R+ LT I S + + L ELD N
Sbjct: 123 VSQNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKIT----------------- 162
Query: 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLI 288
++ L L N + + L L+ N + + +L
Sbjct: 163 ----KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI------TKLDLN 209
Query: 289 GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
+ L+ N L+ I + ++L + + N + L L L
Sbjct: 210 QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVS---TLSKLTTLHCIQ 263
Query: 349 NYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
L + + +++ I + + + L + Q I
Sbjct: 264 TDLL----------EIDLTHNTQLIYFQAEGCRKIKELDVTHNT-QLYLLDCQAAGIT-E 311
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQLSEL 467
+ + L L+L N +L+ + + L+ L N ++ + L+
Sbjct: 312 LD--LSQNPKLVYLYLNNTELT-ELDV--SHNTKLKSLSCVNAHIQDFSSVGKIPALNNN 366
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
+ +P NSL +++ + L F + +D ++N++
Sbjct: 367 FEAEGQTIT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 66/361 (18%), Positives = 120/361 (33%), Gaps = 42/361 (11%)
Query: 258 NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKL 317
N F + + + S + L + L+ ++++ + G I + L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQL---ATLTSLDCHNSSITD-MTG-IEKLTGL 66
Query: 318 FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAE 377
L T N+ + L NL +L N LT+ +++ L+ L Y+
Sbjct: 67 TKLICTSNNITTL---DLSQNTNLTYLACDSNKLTN--LDVTPLTKL------TYLNCDT 115
Query: 378 NPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV 437
N L + + P L + + ++ + LT L N+ + +T
Sbjct: 116 NKLTKL---DVSQNP-LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVT- 167
Query: 438 GRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497
L L NK+ L+ L+ D N ++ + L L SN+
Sbjct: 168 -PQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNK 223
Query: 498 LSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGL 557
L+ L + FD S N L LD+ + + ++ + L +I +
Sbjct: 224 LTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHN 274
Query: 558 TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNR 617
T L E R + T L LD ++ + L + L L L+
Sbjct: 275 TQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTE 329
Query: 618 L 618
L
Sbjct: 330 L 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 64/446 (14%), Positives = 137/446 (30%), Gaps = 66/446 (14%)
Query: 151 LKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210
++Q LA L L S +T + I L+ L +L ++N++T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 211 GFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALS 270
++ NL L D N L ++ + ++ L L+
Sbjct: 78 TL----------------------DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112
Query: 271 LLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGF 330
N L+ ++ P + LN N L+ I + + ++L L+ N
Sbjct: 113 CDTNKLT------KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163
Query: 331 IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390
+ + L L +N +T ++S L + N + + +
Sbjct: 164 LD--VTPQTQLTTLDCSFNKITEL--DVSQNKLL------NRLNCDTNNITKL---DLNQ 210
Query: 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN 450
L + + K+ I + L LT N L+ + V L+ L L
Sbjct: 211 NI-QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQ 263
Query: 451 NKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLN 510
L QL + + + + L L + ++
Sbjct: 264 TDLLEIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNP 318
Query: 511 NILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL 570
++ ++ L LD+ + + ++ ++ D + +G + L +
Sbjct: 319 KLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
Query: 571 HGPIPESFGALTSLESLDLSVNNLSG 596
E+ + ++ + + G
Sbjct: 374 ITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 53/333 (15%), Positives = 102/333 (30%), Gaps = 49/333 (14%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSG 106
T L+ + + + L TLD S N+ + + L L N ++
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT- 204
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
++ L +DC+ N L+ I D+ LT+L N L
Sbjct: 205 ---KLDLNQNIQLTFLDCSSNKLT-----EI------DVTPLTQLTYFDCSVNPLTELDV 250
Query: 167 QELGNLAELEWL-----SLPRSFLTGTIPSSIFNLSSLLELDFSNN-SLTGFYMTNNHFT 220
L L L + + + T I + ELD ++N L T
Sbjct: 251 STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSL 280
+ + P L L ++ L ++ + + + LK+LS +N +
Sbjct: 311 -ELD-----------LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DF 354
Query: 281 PSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSG---FIPDTLVN 337
S K +P + + N S + G I
Sbjct: 355 SSVGK----IPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS 370
+ + + + L++ P +++ + N +
Sbjct: 411 VYDQATNTITWENLSTDNPAVTYTFTSENGAIV 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 25/197 (12%)
Query: 710 QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-D 763
QA+ R E ++G G+FGTVYKG ++ E VAIK
Sbjct: 6 QALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58
Query: 764 GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF 823
A K E V+ SV + ++ +++ C + L+ + M G L + ++
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 824 QRLSIMIDVALALEYL---HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
L+ + +A + YL VH D+ N+L+ ++DFG+AKLL EE
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 881 SMRTQTLGT--IGYMAP 895
G I +MA
Sbjct: 172 KEYHAEGGKVPIKWMAL 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 7/173 (4%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHR 782
+ F++ IG GSFG V+KG VAIK+ L + + ++ E VL
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
+ K S +++EY+ GS L LD Q +I+ ++ L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH-- 136
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +H DIK +N+LL + L+DFG+A L + R +GT +MAP
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 40/176 (22%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 732 SLIGIGSFGTVYKGR--FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVK 786
++G G V+ R +VA+KV F E + ++ H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 787 I----ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
+ + G +V+EY+ +L + + + + + + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYMAP 895
N ++H D+KP+NI++ + DFGIA+ + + TQT +GT Y++P
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V G++ +VAIK+ +G++ F E +V+ ++ H LV++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+ ++ EYMANG L L Q L + DV A+EYL S +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
+ N L++D V +SDFG+++ + + T ++G+ + + P
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPP 190
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 79/342 (23%), Positives = 131/342 (38%), Gaps = 60/342 (17%)
Query: 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGL 290
+P EI P+ +L + N + + + L AL L+NN +S + + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKA--FSPL 101
Query: 291 PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
+++L + N+L IP + S L L + N LRN+ + +G N
Sbjct: 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158
Query: 351 LTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410
L +S E L Y+ ++E L G+ +LP TL E++L + KI+ I
Sbjct: 159 LENSGFEPGAFDGL----KLNYLRISEAKLTGIPK----DLPETLNELHLDHNKIQ-AIE 209
Query: 411 KEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHV 469
E L L LG+NQ+ I +L L L ELH+
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIE-----NGSLSFLP---------------TLRELHL 248
Query: 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLD 529
D+NKLS +PA +L L+ + L +N ++ + F + + N
Sbjct: 249 DNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR----AYYN------ 297
Query: 530 IGNMKVVVEINLSRNYLTGDI--PTTIGGLTNLQLLSLENNR 569
I+L N + P T +T+ + N +
Sbjct: 298 --------GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 69/323 (21%), Positives = 113/323 (34%), Gaps = 69/323 (21%)
Query: 319 LLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAE 377
LL+L N S D L++L L L N ++ + S L L + + +++
Sbjct: 58 LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL------QKLYISK 111
Query: 378 NPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQL-SGSIPI 435
N L + P NLP +L E+ + + +IR +PK + L N+ + +G N L +
Sbjct: 112 NHLVEIPP----NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 436 TVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS 495
L L + KL G D L+ELH+DHNK+ + L L LG
Sbjct: 167 GAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 496 NELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIG 555
N++ + L
Sbjct: 227 NQIRMIENGSLSFL---------------------------------------------- 240
Query: 556 GLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP------ISLEKLVYLK 609
L+ L L+NN+L +P L L+ + L NN++ V K Y
Sbjct: 241 --PTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 610 DLNLSFNRLEGEIPSGGSFANFS 632
++L N + +F +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 73/382 (19%), Positives = 123/382 (32%), Gaps = 88/382 (23%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
LR + C+ L +A+PK+I T L L L N + + L L
Sbjct: 34 HLRVVQCSDLGL---------KAVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYA 82
Query: 178 LSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEI 236
L L + ++ I F L L +L S N L IP NL
Sbjct: 83 LVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-----------EIPPNL--------- 121
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
+L L I +N + + + + + N L + GL + L
Sbjct: 122 --PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGL-KLNYL 177
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356
+ L+ IP + L L L N + L+ L LGLG+N +
Sbjct: 178 RISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM--- 231
Query: 357 ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNL 416
+ S+ LP TL E++L N K+ +P + +L
Sbjct: 232 --------------------------IENGSLSFLP-TLRELHLDNNKLS-RVPAGLPDL 263
Query: 417 VNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSG 476
L ++L N ++ + + N +G + + + +N +
Sbjct: 264 KLLQVVYLHTNNIT-KVGV-----NDFCPVGFGVK---------RAYYNGISLFNNPVPY 308
Query: 477 PI--PACFGNLNSLRNLSLGSN 496
PA F + + G+
Sbjct: 309 WEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/239 (23%), Positives = 88/239 (36%), Gaps = 33/239 (13%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+ + LQN I + L +L L L NN++S L LQ L +
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 450 NNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI--PSTF 506
N L IP +L L EL + N++ F L ++ + +G N L + P F
Sbjct: 111 KNHLVE-IPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLE 566
L + + +S LT IP L L L+
Sbjct: 170 DGLK-------------------------LNYLRISEAKLT-GIPK--DLPETLNELHLD 201
Query: 567 NNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+N++ E + L L L N + + SL L L++L+L N+L +P+G
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 61/316 (19%), Positives = 113/316 (35%), Gaps = 53/316 (16%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQL 104
T L++ + ++ L L L L +N+ S I FS + L+ L + N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQ-G 163
P + S+ L + + N + ++P +F L + + +G N L+
Sbjct: 115 V-EIPPNLPSS---LVELRIHDNRIR-KVPKGVFS-------GLRNMNCIEMGGNPLENS 162
Query: 164 EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSI 223
+ +L +L + + LT IP + +L EL +N + +I
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-----------AI 208
Query: 224 PRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPS 282
L LG+ N + + N + TL+ L L NN LS +P+
Sbjct: 209 ELEDLL--------RYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPA 258
Query: 283 SSKNLIGLPNIERLNLGLNNLSGRIPGFIF-------NASKLFLLELTGN--SFSGFIPD 333
L L ++ + L NN++ ++ F + + L N + P
Sbjct: 259 ---GLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
Query: 334 TLVNLRNLEHLGLGYN 349
T + + + G
Sbjct: 315 TFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 71/364 (19%), Positives = 117/364 (32%), Gaps = 89/364 (24%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
LDL +N S + F + L L+L +N++S
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS--------------------- 91
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
++ F L KL++LY+ N L EIP L + L L + + +
Sbjct: 92 -----KIHEKAFS-------PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR 136
Query: 187 GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
+P +F L ++ ++ N L F G L L
Sbjct: 137 -KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL------------------KLNYL 177
Query: 246 GIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
I E L +P + TL L L +N + ++ L+ + RL LG N +
Sbjct: 178 RISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELED--LLRYSKLYRLGLGHNQIR- 230
Query: 306 RIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
I L L L N S +P L +L+ L+ + L N +T F
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVG 288
Query: 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHL 424
+ Y + S+ N P+ E+ P + + +
Sbjct: 289 FGVKRAYYNGI-----------SLFNNPVPYWEVQ----------PATFRCVTDRLAIQF 327
Query: 425 GNNQ 428
GN +
Sbjct: 328 GNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 28/144 (19%), Positives = 49/144 (34%), Gaps = 6/144 (4%)
Query: 487 SLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546
LR + L + +P + D +N ++ D ++ + + L N +
Sbjct: 34 HLRVVQCSDLGLKA-VPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV 606
+ L LQ L + N L IP +SL L + N + V L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 607 YLKDLNLSFNRLEGEIPSGGSFAN 630
+ + + N LE G+F
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDG 171
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 7/167 (4%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 788
L+G GSF VY+ + G+EVAIK+ + G ++ E ++ ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ + N+ LVLE NG + + L + + + M + + YLH S+ ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H D+ SN+LL +M ++DFG+A L GT Y++P
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 17/173 (9%)
Query: 732 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLV 785
L+G G G VY+ D VA+K+ E ++ ++V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
I + + + L L L + ++I+ + AL+ H +
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYMAP 895
H D+KP NIL+ D A+L DFGIA +E + TQ +GT+ YMAP
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKL-TQLGNTVGTLYYMAP 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 727 HFSEKSL-----IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVL 776
F E+ L +G G+FG+V R+ G VA+K + L+ F+ E E+L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 777 KSVRHRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
KS++H N+VK C + + L++EY+ GSL L +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IG 891
+EYL + +H D+ NIL++++ + DFG+ K+L ++ I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 892 YMAP 895
+ AP
Sbjct: 183 WYAP 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVF--------HLQFDGALKSFDAECEV 775
+ K +IG G V + G E A+K+ Q + ++ E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 776 LKSVR-HRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIM 829
L+ V H +++ +I S + +F LV + M G L EK S + I +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR----- 207
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
+ A+ +LH +N +VH D+KP NILLDD+M LSDFG + L E +R GT
Sbjct: 208 -SLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGT 262
Query: 890 IGYMAP 895
GY+AP
Sbjct: 263 PGYLAP 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G G V GR + VAIK + + + F +E ++ H N++++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ G +V EYM NGSL+ L + + I Q + ++ V + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
H D+ N+L+D ++V +SDFG++++L + T G I + AP
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 23/175 (13%)
Query: 734 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQFD----GALKSFDAECEVLKSVRHRNLVK 786
+G G+FGTV KG + VA+K+ L+ + AE V++ + + +V+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGY 843
+I C ++ LV+E G L K L NR + + ++ V++ ++YL +F
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
VH D+ N+LL A +SDFG++K L +E+ + + AP
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 12/168 (7%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G G FG VY R +A+KV L+ G E E+ +RH N++++
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ L+LEY G++ + L ++ + + + ++A AL Y H S V+
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVI 131
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
H DIKP N+LL ++DFG + R L GT+ Y+ P
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPP 176
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 46/215 (21%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 689 LITRYRKGN----TELSNIEVNMSPQAMWRR-FSYRELLLATDHFSEKSLIGIGSFGTVY 743
L+ + T L + ++ +Y + + + K +G G +G VY
Sbjct: 178 LVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVY 237
Query: 744 KGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802
+G + + VA+K + ++ F E V+K ++H NLV+++ C+ ++ E
Sbjct: 238 EGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296
Query: 803 YMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD 861
+M G+L L NR + L + ++ A+EYL +H ++ N L+ +
Sbjct: 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGE 353
Query: 862 DMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
+ + ++DFG+++L+ G+ + I + AP
Sbjct: 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 734 IGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGALKS-FDAECEVLKSVRHRNLVKIIS 789
+G G+FG+V +G + ++VAIKV + A E +++ + + +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYSNP 846
C LV+E G L K L + + ++ V++ ++YL +F
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
VH ++ N+LL + A +SDFG++K L ++S T + + AP
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 727 HFSEKSL-----IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDGALKSFDAECEVL 776
F E+ L +G G+FG+V R+ G VA+K + L+ F+ E E+L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 777 KSVRHRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
KS++H N+VK C + + L++EY+ GSL L +D + L +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IG 891
+EYL + +H D+ NIL++++ + DFG+ K+L ++ I
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 892 YMAP 895
+ AP
Sbjct: 214 WYAP 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 64/189 (33%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 688 GLITRYRKGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRF 747
GL TR K +V A F L IG G FG V G +
Sbjct: 162 GLCTRLIK-------PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 748 LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA-LVLEYMAN 806
G +VA+K ++ D ++F AE V+ +RH NLV+++ +V EYMA
Sbjct: 215 -RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 807 GSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865
GSL L S RS L L +DV A+EYL N VH D+ N+L+ +D VA
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 328
Query: 866 HLSDFGIAK 874
+SDFG+ K
Sbjct: 329 KVSDFGLTK 337
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 706 NMSPQAMWRRFSYRELLLATD---HFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ 761
+M+ + R +L D F L+G G++G VYKGR + G AIKV +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 762 FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKA------LVLEYMANGSLEKCL- 813
D + E +LK HRN+ + N LV+E+ GS+ +
Sbjct: 61 GD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 814 YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
+ +L I ++ L +LH + V+H DIK N+LL ++ L DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 874 KLLNGEESMRTQTLGTIGYMAP 895
L+ R +GT +MAP
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAP 198
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 51/282 (18%), Positives = 102/282 (36%), Gaps = 32/282 (11%)
Query: 353 SSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCK---IRGN- 408
S + SF ++++ + + + + + + L+E + +
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLN 70
Query: 409 ---IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
+P + +T L + N L S+P L L +N+L +P+ L
Sbjct: 71 LSSLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDNRLST-LPELPASLK 123
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
L VD+N+L+ +P L ++ +N+L+ +P +L +N L
Sbjct: 124 HLDVDNNQLTM-LPELPALL---EYINADNNQLTM-LPELPTSLE---VLSVRNNQLT-F 174
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ----LLSLENNRLHGPIPESFGAL 581
LP +++ +++S N L +P + + NR+ IPE+ +L
Sbjct: 175 LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSL 229
Query: 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623
++ L N LS I SL + D +
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 72/456 (15%), Positives = 139/456 (30%), Gaps = 72/456 (15%)
Query: 141 IPKDIGNLTKLKELYLGYNKLQG---EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLS 197
I I N L + YN + G + + R+ + + ++
Sbjct: 3 IMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 198 SLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP 257
EL + +L+ +P + P + VL I +N L+ +P
Sbjct: 60 QFSELQLNRLNLS--------------------SLPDNLP--PQITVLEITQNALI-SLP 96
Query: 258 NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKL 317
+ L+ L +N LS +LP +++ L++ N L+ +P + L
Sbjct: 97 ELPAS---LEYLDACDNRLS-TLPEL------PASLKHLDVDNNQLT-MLPELP---ALL 142
Query: 318 FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAE 377
+ N + +P+ +LE L + N LT L +L ++
Sbjct: 143 EYINADNNQLT-MLPELP---TSLEVLSVRNNQLTFLPELPESLEAL---------DVST 189
Query: 378 NPLNGVLPSSIG---NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIP 434
N L LP+ + T + +I +IP+ I +L T+ L +N LS I
Sbjct: 190 NLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 435 ITVGRLNTLQGLGLENNKLEGPI-PDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
++ + + + +
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307
Query: 494 GSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553
+N S+F+ ++ + F + + + E+ + D +
Sbjct: 308 HANTFSAFLDRLSDTVSARNTSGFREQ-----VAAWLEKLSASAELRQQSFAVAADATES 362
Query: 554 IGGLTNLQLLSLENNRL-----HGPIPESFGALTSL 584
L +L L G GAL SL
Sbjct: 363 CEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 49/276 (17%), Positives = 87/276 (31%), Gaps = 57/276 (20%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
++ L L+ S ++P ++ + +L + N L S P +SL +D
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELP----ASLEYLDACD 109
Query: 127 NSLSGELPANI------------FRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAE 174
N LS LP +P+ L+ + N+L +P+ +
Sbjct: 110 NRLS-TLPELPASLKHLDVDNNQLTMLPELPAL---LEYINADNNQLT-MLPELPTS--- 161
Query: 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH 234
LE LS+ + LT +P +L LD S N L +P
Sbjct: 162 LEVLSVRNNQLT-FLPELPESLE---ALDVSTNLLE--------------------SLPA 197
Query: 235 EIGNLPNLE----VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGL 290
+ E EN + +P I ++ + L +N LS + S
Sbjct: 198 VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 291 PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326
P+ + + G+ + N
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-20
Identities = 60/323 (18%), Positives = 108/323 (33%), Gaps = 60/323 (18%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+T L I+ L ++ +L + LD NR S T+P ++LK L + +NQL+
Sbjct: 82 ITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPE---LPASLKHLDVDNNQLT 133
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
P + L I+ + N L+ LP T L+ L + N+L +
Sbjct: 134 -MLPELP----ALLEYINADNNQLT-MLPELP-----------TSLEVLSVRNNQLT-FL 175
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLE----LDFSNNSLTGFYMTNNHFTG 221
P+ + LE L + + L ++P+ E N +T
Sbjct: 176 PELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT----------- 220
Query: 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLP 281
IP I +L + +++N L + ++ + S S
Sbjct: 221 ---------HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
Query: 282 SSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNL 341
+ L + N S + F E N+FS D L + +
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIW-----HAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 342 EHLGLGYNYLTSSTPELSFLSSL 364
+ + + +LS + L
Sbjct: 326 RNTSGFREQVAAWLEKLSASAEL 348
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 7/164 (4%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
+G G FG V+ G + VAIK + ++F E +V+K +RH LV++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 794 GNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
+V EYM+ GSL L L + Q + + +A + Y+ VH D+
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
+ +NIL+ +++V ++DFG+A+L+ E + R I + AP
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEVLKSVR 780
L D F + S +G G+ G V+K G+ +A K+ HL+ A E +VL
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+V + + ++ +E+M GSL++ + + + I V L YL
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H D+KPSNIL++ L DFG++ L +SM +GT YM+P
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 60/231 (25%), Positives = 87/231 (37%), Gaps = 28/231 (12%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+P + I+L +I NLT L L +N L+ L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 450 NNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPST 505
+N + L +L LH+D L P F L +L+ L L N L + T
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 506 FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSL 565
F +L N+ N ++ S+P GL +L L L
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVP-----------------------ERAFRGLHSLDRLLL 184
Query: 566 ENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
NR+ P +F L L +L L NNLS + +L L L+ L L+ N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 59/264 (22%), Positives = 95/264 (35%), Gaps = 45/264 (17%)
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
C L +P I + ++L N++ L L L
Sbjct: 16 TSCPQQGLQ-AVPVGIP----------AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 182 RSFLTGTIPSSIF-NLSSLLELDFSNNS-LTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL 239
+ L I ++ F L+ L +LD S+N+ L S+ + L
Sbjct: 65 SNVLA-RIDAAAFTGLALLEQLDLSDNAQLR-----------SVDPATFH--------GL 104
Query: 240 PNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL 298
L L +D L ++ +F ++ L+ L L +N L +LP + L N+ L L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT--FRDLGNLTHLFL 160
Query: 299 GLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE 357
N +S +P F L L L N + P +L L L L N L++ E
Sbjct: 161 HGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 358 LSFLSSLANSSSSKYIVLAENPLN 381
LA + +Y+ L +NP
Sbjct: 220 A-----LAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 50/252 (19%), Positives = 81/252 (32%), Gaps = 43/252 (17%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
+ L +P +R+ L N +S L +L L N +
Sbjct: 19 PQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L LE L L N S +F L L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATF-HGLGR----------------------------LHT 109
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEG 455
++L C ++ + + L L L+L +N L ++P L L L L N++
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 456 PIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNN 511
+P+ L L L + N+++ P F +L L L L +N LS+ L
Sbjct: 168 -VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 512 ILSFDFSSNSLN 523
+ + N
Sbjct: 227 LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
++ Q + L NR S +P++ F L IL L N L+ + + + L +D +
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFL 185
N+ + F L +L L+L LQ E+ LA L++L L + L
Sbjct: 90 NAQLRSVDPATFH-------GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 186 TGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
+P F +L +L L N ++ S+P ++ L +L+
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-----------SVPERAFR--------GLHSLDR 181
Query: 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNL 303
L + +N + P+ ++ L L L N LS +LP+ + L L ++ L L N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA--LAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 48/232 (20%), Positives = 86/232 (37%), Gaps = 35/232 (15%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLS 105
+ + ++ ++ +L L L N + I ++ F+ ++ L+ L L DN
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQL 93
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
S L + + L EL +FR L L+ LYL N LQ +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR-------GLAALQYLYLQDNALQ-AL 144
Query: 166 PQE-LGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSI 223
P + +L L L L + ++ ++P F L SL L N + +
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-----------HV 192
Query: 224 PRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNN 274
+ ++ +L L L + N+L +P + L+ L L +N
Sbjct: 193 HPHAFR--------DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 5/172 (2%)
Query: 457 IPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
+P + + + N++S A F +L L L SN L+ + F L +
Sbjct: 26 VPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85
Query: 516 DFSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGP 573
D S N+ S+ + + ++L R L ++ + GL LQ L L++N L
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQAL 144
Query: 574 IPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
++F L +L L L N +S V + L L L L NR+ +
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 3/88 (3%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+ + L +P I Q + L NR+ SF A +L L L N L+ +
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+ L L+ L+LS N +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPA 99
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 19/175 (10%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG VY G LD + A+K + G + F E ++K H N++ ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 789 SSCSNGNFKAL-VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYS 844
C L VL YM +G L + + + + + + VA ++YL F
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF--- 149
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT----IGYMAP 895
VH D+ N +LD+ ++DFG+A+ + +E + +MA
Sbjct: 150 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDG---ALKSFDAECEVLK 777
+G G FG V R+ G +VA+K L+ + + E E+L+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILR 78
Query: 778 SVRHRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
++ H N+VK C+ L++E++ +GSL++ L + +++ Q+L + +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGY 892
++YL S VH D+ N+L++ + + DFG+ K + ++ T + +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 893 MAP 895
AP
Sbjct: 196 YAP 198
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 38/200 (19%), Positives = 67/200 (33%), Gaps = 26/200 (13%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGALKSFDAE 772
E L + L+G G+F VY+ D + +KV
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 773 CEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL----EKCLYSSNRSLDIFQRLSI 828
E LK +K S+ N LV E + G+L + + + +S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH-----------LSDFGIAKLLN 877
+ + +E +H ++H DIKP N +L + + L D G + +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 878 --GEESMRTQTLGTIGYMAP 895
+ ++ T T G+
Sbjct: 235 LFPKGTIFTAKCETSGFQCV 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 12/175 (6%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA---LKSFDAECEVLKSVR 780
FS+ IG GSFG VY R + VAIK + + E L+ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H N ++ + LV+EY GS L + L + ++ L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S+ ++H D+K NILL + + L DFG A ++ S +GT +MAP
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 709 PQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQF- 762
P +F E+ + + +IG G FG VYKG + VAIK +
Sbjct: 30 PNQAVLKF-TTEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86
Query: 763 DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDI 822
+ F E ++ H N++++ S ++ EYM NG+L+K L + +
Sbjct: 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 146
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882
Q + ++ +A ++YL + VH D+ NIL++ ++V +SDFG++++L +
Sbjct: 147 LQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203
Query: 883 RTQTLGT---IGYMAP 895
T G I + AP
Sbjct: 204 TYTTSGGKIPIRWTAP 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 24/192 (12%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNL 784
+ ++ G F VY+ + + G E A+K + ++ E +K + H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 785 VKIISSCS-------NGNFKALVLEYMANGSLEKCL--YSSNRSLDIFQRLSIMIDVALA 835
V+ S+ S G + L+L + G L + L S L L I A
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-------- 887
++++H P++H D+K N+LL + L DFG A ++
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 888 ----GTIGYMAP 895
T Y P
Sbjct: 208 ITRNTTPMYRTP 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 52/185 (28%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 728 FSEKSL-----IGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFDG--ALKSFDAECEV 775
F E+ L +G G+FG+V R+ G VA+K LQ G + F E ++
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQI 77
Query: 776 LKSVRHRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
LK++ +VK ++ LV+EY+ +G L L LD + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---I 890
+EYL S VH D+ NIL++ + ++DFG+AKLL ++ I
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 891 GYMAP 895
+ AP
Sbjct: 195 FWYAP 199
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 27/199 (13%), Positives = 61/199 (30%), Gaps = 43/199 (21%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKS----------------------- 768
++G + G + V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 769 -----FDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM-ANGSLEKCL------YSS 816
F +++K + + ++++ + + Y +L+ S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 817 NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
++SL RL + + V L LH +VH ++P +I+LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 877 NGEESMRTQTLGTIGYMAP 895
+ R + + G+ P
Sbjct: 255 --RDGARVVSSVSRGFEPP 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 734 IGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKI 787
+G G FGTV+KG ++ E V IKV + + ++ + S+ H ++V++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
+ C + + LV +Y+ GSL + +L L+ + +A + YL + +
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
VH ++ N+LL ++DFG+A LL ++ + I +MA
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 7/164 (4%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
+G G FG V+ G + VAIK + ++F E +V+K +RH LV++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 794 GNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDI 852
+V EYM+ GSL L L + Q + + +A + Y+ VH D+
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 853 KPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
+ +NIL+ +++V ++DFG+A+L+ E + R I + AP
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 39/151 (25%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 734 IGIGSFGTVYKGRFLDG-MEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISS 790
+G G +G VY+G + + VA+K + + + F E V+K ++H NLV+++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 791 CSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849
C+ ++ E+M G+L L NR + L + ++ A+EYL +H
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
D+ N L+ ++ + ++DFG+++L+ G+
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 19/194 (9%)
Query: 710 QAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGME-----VAIKVFHLQF-D 763
QA+ R E ++G G+FGTVYKG ++ E VAIK
Sbjct: 6 QALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58
Query: 764 GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF 823
A K E V+ SV + ++ +++ C + L+ + M G L + ++
Sbjct: 59 KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 824 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883
L+ + +A + YL +VH D+ N+L+ ++DFG+AKLL EE
Sbjct: 118 YLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 884 TQTLGT--IGYMAP 895
G I +MA
Sbjct: 175 HAEGGKVPIKWMAL 188
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 22/173 (12%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G G FG VY R +A+KV L+ +G E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNR-----SLDIFQRLSIMIDVALALEYLHFGY 843
+ + L+LE+ G L K L R S + L A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ADALHYCH--- 131
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
V+H DIKP N+L+ ++DFG + S+R +T+ GT+ Y+ P
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPP 181
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 20/173 (11%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
+G G FG VY+G + + + VA+K + F +E ++K++ H ++VK+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYSN 845
+++E G L L + SL + + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
VH DI NIL+ L DFG+++ + E+ + T I +M+P
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSP 183
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 64/313 (20%), Positives = 121/313 (38%), Gaps = 40/313 (12%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
++++LDLS+NR + I +S L+ L+L N ++ + S+ SL +D +Y
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE--LGNLAELEWLSLPRSF 184
N LS L ++ F+ L+ L L L N + + + +L +L+ L +
Sbjct: 110 NYLS-NLSSSWFK-------PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 185 LTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLE 243
I F L+ L EL+ + L S + ++ N+
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ-----------SYEPKSLK--------SIQNVS 201
Query: 244 VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG----SLPS-SSKNLIGLPNIERLNL 298
L + + + + S+++ L L + L L + + +LI + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 299 GLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
+L ++ + S L LE + N L +L+ + L N S P +
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320
Query: 359 SFLSSLANSSSSK 371
+LS N +S K
Sbjct: 321 DYLSRWLNKNSQK 333
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 49/265 (18%), Positives = 98/265 (36%), Gaps = 19/265 (7%)
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLG 425
+ + K + L+ N + + S + L+ + L + I I ++ +L +L L L
Sbjct: 51 TEAVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS 108
Query: 426 NNQLSGSIPITV-GRLNTLQGLGLENNKL----EGPIPDDLCQLSELHVDHNKLSGPIPA 480
N LS ++ + L++L L L N E + L +L L V + I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 481 -CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEI 539
F L L L + +++L S+ P + ++ N+ L + + V +
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227
Query: 540 NLSRNYLTGDIPTTI--------GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591
L L + + + + + + L + + ++ L L+ S
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 592 NNLSGVIPISLEKLVYLKDLNLSFN 616
N L V ++L L+ + L N
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/319 (18%), Positives = 113/319 (35%), Gaps = 51/319 (15%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
SS +L +P ++ L+L N ++ + L L LT N + D+ +
Sbjct: 39 SSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS 98
Query: 338 LRNLEHLGLGYNYLTSSTPEL-SFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLE 396
L +LEHL L YNYL++ + LSSL ++ L NP + +S+ + L+
Sbjct: 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSL------TFLNLLGNPYKTLGETSLFSHLTKLQ 152
Query: 397 EIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG 455
+ + N I ++ L L L + + L E
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ---------------------SYEP 191
Query: 456 PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
+ +S L + + + +S+ L L +L +F + + + +
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF------HFSELSTG 245
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
+ +S + + ++ L + + ++ L L N+L
Sbjct: 246 ETNSLIKKFTF----------RNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPD 294
Query: 576 ESFGALTSLESLDLSVNNL 594
F LTSL+ + L N
Sbjct: 295 GIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 47/258 (18%), Positives = 100/258 (38%), Gaps = 20/258 (7%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGL 448
L ++ + L N +I ++ VNL L L +N ++ +I L +L+ L L
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107
Query: 449 ENNKLEGPIP----DDLCQLSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIP 503
N L + L L+ L++ N + F +L L+ L +G+ + + I
Sbjct: 108 SYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 504 S-TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
F L + + ++ L P + +++ V + L + + ++++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 563 LSLENNRLHGP--------IPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
L L + L S + ++ ++ +L + L ++ L +L S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 615 FNRLEGEIPSGGSFANFS 632
N+L+ +P G F +
Sbjct: 286 RNQLKS-VPD-GIFDRLT 301
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 48/281 (17%), Positives = 101/281 (35%), Gaps = 23/281 (8%)
Query: 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA 314
+P+ + +K+L L NN ++ + +S L N++ L L N ++ I F++
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRIT-YISNSD--LQRCVNLQALVLTSNGIN-TIEEDSFSS 98
Query: 315 -SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYI 373
L L+L+ N S L +L L L N + F ++ + + +
Sbjct: 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLF----SHLTKLQIL 154
Query: 374 VLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSI 433
+ + LEE+ + ++ PK + ++ N++ L L Q +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214
Query: 434 PITVGRLNTLQGLGLENNKLEGP----IPD-------DLCQLSELHVDHNKLSGPIPACF 482
I V ++++ L L + L+ + + + L +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL 273
Query: 483 GNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
++ L L N+L S F L ++ +N +
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 26/149 (17%), Positives = 54/149 (36%), Gaps = 6/149 (4%)
Query: 64 LGNLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAI 122
L+ L+ L++ + + SI + LIL Q + TSS+ +
Sbjct: 170 FAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
+ L + + + + + + L ++ + L ++ L L R
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 183 SFLTGTIPSSIF-NLSSLLELDFSNNSLT 210
+ L ++P IF L+SL ++ N
Sbjct: 287 NQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 16/184 (8%)
Query: 725 TDHFSEKSLIGIG--SFGTVYKGRFLD-GMEVAIKVFHL--QFDGALKSFDAECEVLKSV 779
+ ++IG G TV R+ G V ++ +L + + E V K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL-YSSNRSLDIFQRLSIMIDVALALEY 838
H N+V ++ N +V +MA GS + + ++ I+ V AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT-------QTLGTIG 891
+H VH +K S+IL+ D +LS + + ++ +
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 892 YMAP 895
+++P
Sbjct: 201 WLSP 204
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
F ++G G+F V+ + G A+K S + E VLK ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEY 838
+V + + LV++ ++ G L E+ +Y+ + + Q V A++Y
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ------QVLSAVKY 121
Query: 839 LHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
LH N +VH D+KP N+L +++ ++DFG++K+ + + + GT GY+AP
Sbjct: 122 LH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTPGYVAP 176
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 734 IGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
+G G FG V GR + VAIK + + + + F E ++ H N++++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +V EYM NGSL+ L + + Q + ++ +A ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT---IGYMAP 895
H D+ NIL++ ++V +SDFG+ ++L + T G I + +P
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG VY G ++D ++ AIK +++F E +++ + H N++ +I
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 789 SSCSNGN-FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYS 844
++L YM +G L + + S R+ + +S + VA +EYL F
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF--- 145
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT----IGYMAP 895
VH D+ N +LD+ ++DFG+A+ + E Q + + A
Sbjct: 146 ---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 19/175 (10%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG VY G LD + A+K + G + F E ++K H N++ ++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 789 SSCSNGNFKAL-VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFGYS 844
C L VL YM +G L + + + + + + VA +++L F
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF--- 213
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT----IGYMAP 895
VH D+ N +LD+ ++DFG+A+ + +E + +MA
Sbjct: 214 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 21/182 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRH 781
+D++ K +G G+F V + G+E A K+ + + A + + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALAL 836
N+V++ S +F LV + + G L + YS + Q + ++
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESI 118
Query: 837 EYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
Y H SN +VH ++KP N+LL L+DFG+A +N E+ GT GY+
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYL 174
Query: 894 AP 895
+P
Sbjct: 175 SP 176
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 28/188 (14%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH--------LQFDGALKSFDAECEV 775
D + +G G+ G V +VAIK+ + + + E E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 776 LKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMI 830
LK + H ++KI + ++ +VLE M G L F
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------ 121
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTL 887
+ LA++YLH N ++H D+KP N+LL ++D + ++DFG +K+L MRT
Sbjct: 122 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LC 177
Query: 888 GTIGYMAP 895
GT Y+AP
Sbjct: 178 GTPTYLAP 185
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 46/191 (24%), Positives = 75/191 (39%), Gaps = 42/191 (21%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVR 780
TD + K IG+GS+ + ME A+K+ D E+ L+ +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQ 74
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL------------SI 828
H N++ + +G + +V E M G L ++ ++
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAV 121
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRT 884
+ + +EYLH + VVH D+KPSNIL + + DFG AK L E +
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 885 QTLGTIGYMAP 895
T ++AP
Sbjct: 179 TPCYTANFVAP 189
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 39/167 (23%), Positives = 70/167 (41%), Gaps = 8/167 (4%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G G F ++ D A K+ L + E + +S+ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +F +VLE SL + + R + + L +YLH N V+
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H D+K N+ L++D+ + DFG+A + + + GT Y+AP
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 20/173 (11%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G G F ++ D A K+ L + E + +S+ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS------IMIDVALALEYLHFG 842
+ +F +VLE SL + R + L+ + + L +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE--LHKRR-----KALTEPEARYYLRQIVLGCQYLH-- 158
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N V+H D+K N+ L++D+ + DFG+A + + + GT Y+AP
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGAL--KSFDAECEVLKSVRHRNLVKIISSC 791
+G G FG V+ G + +VA+K G++ +F AE ++K ++H+ LV++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+ ++ EYM NGSL L + + L I + L + +A + ++ +H
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
D++ +NIL+ D + ++DFG+A+L+ E
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 42/193 (21%), Positives = 75/193 (38%), Gaps = 35/193 (18%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKV-----FHLQFDGALKSFDAECEVLKS 778
D + +IG G F V + + G + A+K+ F + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLD-IFQRLS---------- 827
++H ++V+++ + S+ +V E+M L I +R
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----------CFEIVKRADAGFVYSEAVA 132
Query: 828 --IMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESM 882
M + AL Y H N ++H D+KP +LL ++ L FG+A L +
Sbjct: 133 SHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 883 RTQTLGTIGYMAP 895
+GT +MAP
Sbjct: 190 AGGRVGTPHFMAP 202
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRN 783
D + + +IG G+ V +VAIK +L + ++ E + + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-------EKCLYSSNRSLDIFQRLSIMIDVALAL 836
+V +S + LV++ ++ GS+ + LD +I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI-AKLLNGEESMRTQTLGT-IG--- 891
EYLH N +H D+K NILL +D ++DFG+ A L G + R + T +G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 892 YMAP 895
+MAP
Sbjct: 192 WMAP 195
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG V++G ++ + VAIK D + F E ++ H ++VK+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +++E G L L SLD+ + ++ AL YL S V
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE-SMRTQTLGTIGYMAP 895
H DI N+L+ + L DFG+++ + ++ I +MAP
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/143 (38%), Positives = 75/143 (52%), Gaps = 8/143 (5%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN 793
IG G FG V G G +VA+K ++ D ++F AE V+ +RH NLV+++
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 794 GNFKA-LVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
+V EYMA GSL L S RS L L +DV A+EYL N VH D
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 852 IKPSNILLDDDMVAHLSDFGIAK 874
+ N+L+ +D VA +SDFG+ K
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK 165
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 3e-24
Identities = 31/199 (15%), Positives = 57/199 (28%), Gaps = 43/199 (21%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFHLQF---DGALKSFDAECEVLKS---------- 778
++G + G + V + A+K E L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 779 ------------VRHRNLVKIISSCSNGN----FKALVLEYMANGSLEKCL------YSS 816
V+ K+I + L +L+ S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 817 NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
++SL RL + + V L LH +VH ++P +I+LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 877 NGEESMRTQTLGTIGYMAP 895
+ + G+ P
Sbjct: 260 --RDGASAVSPIGRGFAPP 276
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 17/183 (9%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEV-LKSV 779
+ + IG G++G+V K G +A+K D K + +V ++S
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS------IMIDVA 833
+V+ + + +E M+ S +K LD + I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATV 135
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGY 892
AL +L ++H DIKPSNILLD L DFGI+ L +S+ +T+ G Y
Sbjct: 136 KALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 191
Query: 893 MAP 895
MAP
Sbjct: 192 MAP 194
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH--LQFDGALKSFDAECEVLKSVRH 781
+ ++ ++G GSFG V K + E A+KV + + + E E+LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALAL 836
N++K+ + + +V E G L ++ +S + + I + V +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGI 134
Query: 837 EYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
Y+H + +VH D+KP NILL + D + DFG++ M+ +GT Y+
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYI 190
Query: 894 AP 895
AP
Sbjct: 191 AP 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 28/188 (14%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFH--------LQFDGALKSFDAECEV 775
D + +G G+ G V +VAI++ + + + E E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 776 LKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMI 830
LK + H ++KI + ++ +VLE M G L F
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------ 246
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTL 887
+ LA++YLH N ++H D+KP N+LL ++D + ++DFG +K+L MRT
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LC 302
Query: 888 GTIGYMAP 895
GT Y+AP
Sbjct: 303 GTPTYLAP 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 20/182 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVF--HLQFDGALKSFDAECEVLKSVRH 781
T+ + +G G+F V + + G E A + + + E + + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALAL 836
N+V++ S S L+ + + G L + YS + Q + A+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAV 123
Query: 837 EYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
+ H VVH ++KP N+LL L+DFG+A + GE+ GT GY+
Sbjct: 124 LHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 894 AP 895
+P
Sbjct: 181 SP 182
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+++ ++ IG GS+G V + A K F + F E E++KS+ H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEY 838
++++ + + LV+E G L K ++ + + I + DV A+ Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 121
Query: 839 LHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H V H D+KP N L D L DFG+A + MRT +GT Y++P
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYVSP 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+D++ K +G G+F V + G+E A K+ + + L + D E + +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRK 84
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVA 833
++H N+V++ S +F LV + + G L + YS + Q +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QIL 138
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTI 890
++ Y H SN +VH ++KP N+LL L+DFG+A +N E+ GT
Sbjct: 139 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTP 194
Query: 891 GYMAP 895
GY++P
Sbjct: 195 GYLSP 199
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 24/198 (12%), Positives = 47/198 (23%), Gaps = 42/198 (21%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKII 788
+ +G V+ R ++ + A+KVF + + L+ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 789 SSCSNGNFKA--------------------------LVLEYMA-----NGSLEKCLYSSN 817
L++ + S +Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 818 RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
I + + L S +VH P N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 878 GEESMRTQTLGTIGYMAP 895
+ R AP
Sbjct: 243 -KVGTRGPASSVPVTYAP 259
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 20/183 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG---ALKSFDAECEVLK 777
+ + +G G FG V + G VA+K L+ D + E ++L+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILR 88
Query: 778 SVRHRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
++ H +++K C + + LV+EY+ GSL L S+ + Q L +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEG 146
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES---MRTQTLGTIGY 892
+ YLH + +H D+ N+LLD+D + + DFG+AK + +R + +
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 893 MAP 895
AP
Sbjct: 204 YAP 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 43/185 (23%), Positives = 87/185 (47%), Gaps = 31/185 (16%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRNLV 785
+G G FG+V +G ++VA+K ++ D + ++ F +E +K H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 786 KIISSCSNGNFKA-----LVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALA 835
+++ C + + ++L +M G L L + + + + L M+D+AL
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 836 LEYL---HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--I 890
+EYL +F +H D+ N +L DDM ++DFG++K + + R + +
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 891 GYMAP 895
++A
Sbjct: 214 KWIAI 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 734 IGIGSFGTVYKGRF--------LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+G G+F ++KG L EV +KV +SF ++ + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL---HFG 842
C G+ LV E++ GSL+ L + ++I +L + +A A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 843 YSNPVVHCDIKPSNILLD--------DDMVAHLSDFGIAKLLNGEESMR 883
+H ++ NILL + LSD GI+ + ++ ++
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 40/197 (20%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 712 MWRRFSYRELLLATDHFSEK----SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGAL 766
+W+++ + + + + +G G+FG V++ G K + +
Sbjct: 33 IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92
Query: 767 KSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL------EKCLYSSNRSL 820
+ E ++ + H L+ + + + L+LE+++ G L E S +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL--SDFGIAKLLNG 878
+ M L+++H + +VH DIKP NI+ + + + DFG+A LN
Sbjct: 153 N------YMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 879 EESMRTQTLGTIGYMAP 895
+E ++ T T + AP
Sbjct: 204 DEIVKV-TTATAEFAAP 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 43/179 (24%), Positives = 67/179 (37%), Gaps = 36/179 (20%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSC 791
+G GSF K A+K+ + E LK H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL------------SIMIDVALALEYL 839
+ LV+E + G L F+R+ IM + A+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 840 HFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H VVH D+KP N+L +D++ + DFG A+L + T+ Y AP
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 12/180 (6%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEV-LKSV 779
+ D +G G++G V K R + G +A+K + K + ++ +++V
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL---YSSNRSLDIFQRLSIMIDVALAL 836
V + + +E M + SL+K +++ I + + AL
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT-LGTIGYMAP 895
E+LH S V+H D+KPSN+L++ + DFGI+ L + + G YMAP
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAP 178
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKII 788
IG G FG V++G ++ M VAIK D + F E ++ H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848
+ +++E G L L SLD+ + ++ AL YL S V
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 849 HCDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTLGTIGYMAP 895
H DI N+L+ + L DFG+++ + + ++ I +MAP
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 43/196 (21%), Positives = 82/196 (41%), Gaps = 27/196 (13%)
Query: 716 FSYRELLLATDHFSE------KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKS 768
F +R + + ++G G FG V+K G+++A K+ + +
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 769 FDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL------EKCLYSSNRSLDI 822
E V+ + H NL+++ + + N LV+EY+ G L E + ++
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL- 191
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGE 879
M + + ++H ++H D+KP NIL D + + DFG+A+
Sbjct: 192 -----FMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPR 242
Query: 880 ESMRTQTLGTIGYMAP 895
E ++ GT ++AP
Sbjct: 243 EKLKV-NFGTPEFLAP 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 36/186 (19%), Positives = 68/186 (36%), Gaps = 29/186 (15%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFH-----------------LQFDGALKSFDAECEVL 776
+ G F + D A+K + + F E +++
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 777 KSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLS------IM 829
+++ + +N + ++ EYM N S+ K + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT 889
V + Y+H + H D+KPSNIL+D + LSDFG ++ + + + GT
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGSRGT 213
Query: 890 IGYMAP 895
+M P
Sbjct: 214 YEFMPP 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 26/184 (14%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFD---AECEVLKSVRH 781
+ F ++G GSF TV R L E AIK+ + E +V+ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA-------- 833
VK+ + + L Y NG L K +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIV 140
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL-NGEESMRTQTL-GTIG 891
ALEYLH ++H D+KP NILL++DM ++DFG AK+L + R + GT
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 892 YMAP 895
Y++P
Sbjct: 198 YVSP 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 35/189 (18%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRH 781
+ ++ ++G GSFG V K + E A+KV + + + E E+LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL------------SIM 829
N++K+ + + +V E G L F + I+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARII 127
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQT 886
V + Y+H + +VH D+KP NILL + D + DFG++ M+ +
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183
Query: 887 LGTIGYMAP 895
+GT Y+AP
Sbjct: 184 IGTAYYIAP 192
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVR 780
+D + + ++G GSFG V + + G E A+KV ++ +S E ++LK +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALA 835
H N++K+ + + LV E G L + +S + I ++ V
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 138
Query: 836 LEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
+ Y+H N +VH D+KP N+LL D + DFG++ + M+ +GT Y
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KIGTAYY 194
Query: 893 MAP 895
+AP
Sbjct: 195 IAP 197
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA-LKSFDAECEVL-KSVRHR 782
+ +G G+ G V+K RF G +A+K + K + +V+ KS
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
+V+ + + +E M EK + + + + AL YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMAP 895
+ V+H D+KPSNILLD+ L DFGI+ L + + ++ G YMAP
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAP 193
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHR 782
D F K +G G+FG V+ G+E IK + + ++ +AE EVLKS+ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLS------IMIDVALA 835
N++KI + + +V+E G L E+ + + R + LS +M + A
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG----KALSEGYVAELMKQMMNA 136
Query: 836 LEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
L Y H S VVH D+KP NIL + DFG+A+L +E GT Y
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTALY 192
Query: 893 MAP 895
MAP
Sbjct: 193 MAP 195
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 21/180 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+D F +S +G G+ VY+ + A+KV D K E VL + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEY 838
++K+ +LVLE + G L EK YS + D + + A+ Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK------QILEAVAY 163
Query: 839 LHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
LH N +VH D+KP N+L D ++DFG++K++ + M+T GT GY AP
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAP 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 44/197 (22%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVF--------------------HLQFDGALKSFDA 771
IG GS+G V D A+KV G ++
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 772 ------ECEVLKSVRHRNLVK---IISSCSNGNFKALVLEYMANGSL----EKCLYSSNR 818
E +LK + H N+VK ++ + + +V E + G + S ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 819 SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878
+ FQ D+ +EYLH ++H DIKPSN+L+ +D ++DFG++ G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 879 EESMRTQTLGTIGYMAP 895
+++ + T+GT +MAP
Sbjct: 190 SDALLSNTVGTPAFMAP 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 39/181 (21%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 734 IGIGSFGTVYKGRFLDG----MEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKI 787
+G G FG+V + + ++VA+K+ ++ F E +K H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 788 ISSCSNGNFKA------LVLEYMANGSLEKCLYSS-----NRSLDIFQRLSIMIDVALAL 836
+ K ++L +M +G L L +S +L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMA 894
EYL S +H D+ N +L +DM ++DFG+++ + + R + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 895 P 895
Sbjct: 208 L 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 46/222 (20%), Positives = 70/222 (31%), Gaps = 54/222 (24%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+ K IG GS+G V AIK+ + + D E ++K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL----------------------------- 809
+ H N+ ++ + + LV+E G L
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 810 ----EKCLYSSNRSLDIFQRLS------IMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859
+ IM + AL YLH + + H DIKP N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201
Query: 860 DDDMVAHL--SDFGIAKLL----NGEESMRTQTLGTIGYMAP 895
+ + DFG++K NGE T GT ++AP
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 26/187 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 777
DH+ +G G F V K R G E A K + + + + E +L+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDV 832
+RH N++ + N L+LE ++ G L EK + + + + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQI 117
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
+ YLH S + H D+KP NI+L + L DFGIA + + G
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFG 173
Query: 889 TIGYMAP 895
T ++AP
Sbjct: 174 TPEFVAP 180
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRH 781
++ + +G G++G V R +E AIK+ + E VLK + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALAL 836
N++K+ + LV+E G L + ++ + I + V +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGV 149
Query: 837 EYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
YLH + +VH D+KP N+LL + D + + DFG++ + ++ M+ + LGT Y+
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-LGTAYYI 205
Query: 894 AP 895
AP
Sbjct: 206 AP 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 44/194 (22%), Positives = 70/194 (36%), Gaps = 40/194 (20%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 777
D + +G G F V K R G+E A K + + + E +L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL----------- 826
V H N++ + N L+LE ++ G L F L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEA 117
Query: 827 -SIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEES 881
S + + + YLH + + H D+KP NI+L L DFG+A +
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 882 MRTQTLGTIGYMAP 895
+ GT ++AP
Sbjct: 175 FKN-IFGTPEFVAP 187
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
DH+ +G G+FG V++ G A K + ++ E + + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL------EKCLYSSNRSLDIFQRLSIMIDVALALE 837
LV + + + N ++ E+M+ G L E S + +++ M V L
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE------YMRQVCKGLC 269
Query: 838 YLHFGYSNPVVHCDIKPSNILLDDDMVAHL--SDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H N VH D+KP NI+ L DFG+ L+ ++S++ T GT + AP
Sbjct: 270 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAP 325
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 43/187 (22%), Positives = 72/187 (38%), Gaps = 26/187 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 777
D + +G G F V K R G+E A K + + + + E +L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDV 832
V H N++ + N L+LE ++ G L +K S + + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQI 124
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
+ YLH + + H D+KP NI+L L DFG+A + + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFG 180
Query: 889 TIGYMAP 895
T ++AP
Sbjct: 181 TPEFVAP 187
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 46/200 (23%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKV-------------FHLQFDGALKSFD 770
+ + + +G G++G V + E AIKV + + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 771 AECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL---- 826
E +LKS+ H N++K+ + + LV E+ G L F+++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRH 141
Query: 827 --------SIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKL 875
+IM + + YLH + +VH DIKP NILL + + + DFG++
Sbjct: 142 KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 876 LNGEESMRTQTLGTIGYMAP 895
+ + +R + LGT Y+AP
Sbjct: 199 FSKDYKLRDR-LGTAYYIAP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 40/183 (21%), Positives = 74/183 (40%), Gaps = 27/183 (14%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
+G GSFG VY+G VAIK + + A F E V+K +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL---------EKCLYSSNRSLDIFQRLSIMIDVAL 834
+V+++ S G +++E M G L + + + + ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IGY 892
+ YL+ +N VH D+ N ++ +D + DFG+ + + + R G + +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 893 MAP 895
M+P
Sbjct: 207 MSP 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 39/187 (20%), Positives = 71/187 (37%), Gaps = 34/187 (18%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+ + +G G FG V++ K ++ E +L RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRN 62
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL-------------SIMI 830
++ + S + ++ E+++ DIF+R+ S +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVH 109
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL--SDFGIAKLLNGEESMRTQTLG 888
V AL++LH S+ + H DI+P NI+ + + +FG A+ L ++ R
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFT 165
Query: 889 TIGYMAP 895
Y AP
Sbjct: 166 APEYYAP 172
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 26/187 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFH------LQFDGALKSFDAECEVLK 777
D++ +G G F V K R G++ A K + + + + E +LK
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDV 832
++H N++ + N L+LE +A G L EK + + + + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQI 123
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
+ YLH S + H D+KP NI+L + DFG+A ++ + G
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFG 179
Query: 889 TIGYMAP 895
T ++AP
Sbjct: 180 TPEFVAP 186
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 44/192 (22%), Positives = 73/192 (38%), Gaps = 43/192 (22%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRH 781
D+ ++G+G G V + + A+K+ A EV ++ +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 114
Query: 782 RNLVKIISSCSNGNFKA----LVLEYMANGSLEKCLYSSNRSLD-IFQRLS--------- 827
++V+I+ N +V+E + G L I R
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREAS 164
Query: 828 -IMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMR 883
IM + A++YLH S + H D+KP N+L + + L+DFG AK S+
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 884 TQTLGTIGYMAP 895
T T Y+AP
Sbjct: 222 T-PCYTPYYVAP 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 43/190 (22%), Positives = 71/190 (37%), Gaps = 42/190 (22%)
Query: 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKII 788
+ ++G G+ V L E A+K+ Q E E+L + HRN++++I
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 789 SSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRL------------SIMIDVALAL 836
+ LV E M GS+ + ++ DVA AL
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASAL 124
Query: 837 EYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLN--------GEESMRTQ 885
++LH + + H D+KP NIL + + DF + + + T
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT- 180
Query: 886 TLGTIGYMAP 895
G+ YMAP
Sbjct: 181 PCGSAEYMAP 190
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 44/187 (23%)
Query: 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRHRNLVK 786
K ++G+G G V + G + A+K+ + S A EV ++ ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVC 86
Query: 787 IISSCSNGNFKA----LVLEYMANGSLEKCLYSSNRSLD-IFQRLS----------IMID 831
I+ N + +++E M G L I +R IM D
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRD 136
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
+ A+++LH S+ + H D+KP N+L + D V L+DFG AK + +++T
Sbjct: 137 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQT-PCY 191
Query: 889 TIGYMAP 895
T Y+AP
Sbjct: 192 TPYYVAP 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 24/176 (13%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHR-NLVKIIS 789
+G G F V + G E A K + G E VL+ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 790 SCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLS------IMIDVALALEYLHFG 842
N + L+LEY A G + CL ++ + +S ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL------PELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 843 YSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N +VH D+KP NILL + DFG+++ + +R +GT Y+AP
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE-IMGTPEYLAP 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 45/192 (23%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 781
DHF IG GSFG V + D ++ A+K +++ E ++++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 782 RNLVKIISSCSNGNFKA-----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMI------ 830
LV + S F+ +V++ + G D+ L +
Sbjct: 75 PFLVNLWYS-----FQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEET 116
Query: 831 ------DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884
++ +AL+YL + ++H D+KP NILLD+ H++DF IA +L E +
Sbjct: 117 VKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QI 171
Query: 885 QTL-GTIGYMAP 895
T+ GT YMAP
Sbjct: 172 TTMAGTKPYMAP 183
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 39/214 (18%), Positives = 75/214 (35%), Gaps = 11/214 (5%)
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP----DDLCQ 463
IP ++ N L +L I L+ + + N + I +L +
Sbjct: 24 IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 464 LSELHVDH-NKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522
L E+ ++ N L P F NL +L+ L + + + + + D N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 523 NGSLPLDI--GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGA 580
++ + G V + L++N + + G +L +NN L + F
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 581 LTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
+ LD+S + + LE L L+ +
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 47/262 (17%), Positives = 84/262 (32%), Gaps = 44/262 (16%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
S R C + ++ E+P+++ EL KL+ +LE
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP----------RNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 178 LSLPRSFLTGTIPSSIF-NLSSLLELDFSN-NSLTGFYMTNNHFTGSIPRNLWQCEIPHE 235
+ + ++ + I + +F NL L E+ N+L I +Q
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-----------YINPEAFQ------ 101
Query: 236 IGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLP-NIE 294
NLPNL+ L I + + L + +N ++ +S +GL
Sbjct: 102 --NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS--FVGLSFESV 157
Query: 295 RLNLGLNNLSGRIPGFIFNASKLF-LLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353
L L N + I FN ++L L N+ D L + + S
Sbjct: 158 ILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216
Query: 354 -------STPELSFLSSLANSS 368
+ +L S+
Sbjct: 217 LPSYGLENLKKLRARSTYNLKK 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 52/284 (18%)
Query: 31 VCSWIGITCDVSTHRVTA-----------LNISDFGLTGTISSQLGNLSSLQTLDLSHNR 79
+C +VT L L L+ +++S N
Sbjct: 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 80 FSGTIPSSIFS-ISTLKIL-ILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANI 137
I + +FS + L + I N L N +L+ + + + LP
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123
Query: 138 FRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL--GNLAELEWLSLPRSFLTGTIPSSIFN 195
+ + L + N I + G E L L ++ + I +S FN
Sbjct: 124 KI-------HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN 175
Query: 196 LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGD 255
+ L EL+ S+ NN+ +P +++ +L I +
Sbjct: 176 GTQLDELNLSD---------NNNLE-ELPNDVFH--------GASGPVILDISRTRIH-S 216
Query: 256 VPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL 298
+P+ N+ L+A S N LP+ L L + +L
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLPT----LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 45/271 (16%), Positives = 87/271 (32%), Gaps = 40/271 (14%)
Query: 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-N 313
++P+ + L + L + + G ++E++ + N++ I +F N
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLR-VIQKGA--FSGFGDLEKIEISQNDVLEVIEADVFSN 77
Query: 314 ASKLFLLELT-GNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKY 372
KL + + N+ P+ NL NL++L + + P++ + SL
Sbjct: 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL----QKVL 132
Query: 373 IVLAENPLNGVLPS-SIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHL-GNNQLS 430
+ + +N + S L ++L I+ I N L L+L NN L
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 431 GSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRN 490
+P + G L + ++ NL LR
Sbjct: 192 -ELPN-----DVFHGAS---------------GPVILDISRTRIHSLPSYGLENLKKLRA 230
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFDFSSNS 521
S L L ++ + S
Sbjct: 231 RST--YNLKKLPT--LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 45/236 (19%), Positives = 77/236 (32%), Gaps = 18/236 (7%)
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLG 425
++ + L + + LE+I + + I ++ NL L + +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 426 N-NQLSGSIPITV-GRLNTLQGLGLENNKLEGPIPDDLC----QLSELHVDHNKLSGPIP 479
N L I L LQ L + N ++ +PD Q L + N I
Sbjct: 88 KANNLL-YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 480 A-CFGNL-NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDI-GNMKVV 536
F L L L N + S F +N+L LP D+
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGP 204
Query: 537 VEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
V +++SR + + L L+ S N + +P + L +L L+
Sbjct: 205 VILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 20/106 (18%), Positives = 36/106 (33%), Gaps = 17/106 (16%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTL-KILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
L L+ N I +S F+ + L ++ + +N L P+ + S +D +
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 127 NSLSGELPANIFRAIPK-------------DIGNLTKLKELYLGYN 159
+ LP+ + K + L L E L Y
Sbjct: 212 TRIH-SLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYP 256
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 51/248 (20%), Positives = 84/248 (33%), Gaps = 51/248 (20%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
NLP + + + L +R + L L L ++ +I
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA------------ 71
Query: 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
L LS L + N + F L+SL+ L L+S +L
Sbjct: 72 --------YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNR 569
+ + + N + S L P LTNL+ L L +N+
Sbjct: 124 KTLKELNVAHNLIQ-SFKL----------------------PEYFSNLTNLEHLDLSSNK 160
Query: 570 LHGPIPESFGALTSLE----SLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+ L + SLDLS+N ++ I K + LK+L L N+L+ +P
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVP-D 217
Query: 626 GSFANFSA 633
G F ++
Sbjct: 218 GIFDRLTS 225
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 50/240 (20%), Positives = 87/240 (36%), Gaps = 39/240 (16%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
S + LDLS N + S F S L++L L ++ + + S L +
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186
N + L F L+ L++L L +G+L L+ L++ + +
Sbjct: 86 NPIQ-SLALGAFS-------GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 187 GTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV- 244
F NL++L LD S+N + SI + L + +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-----------SIYCTDLR--------VLHQMPLL 178
Query: 245 ---LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
L + N + + F LK L+L N L S+P L +++++ L N
Sbjct: 179 NLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGI--FDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 57/283 (20%), Positives = 100/283 (35%), Gaps = 61/283 (21%)
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143
IP ++ + K L L N L S+ + L+ +D + + + ++
Sbjct: 22 IPDNLPF--STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ---- 73
Query: 144 DIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLEL 202
+L+ L L L N +Q ++ F LSSL +L
Sbjct: 74 ---SLSHLSTLILTGNPIQ-------------------------SLALGAFSGLSSLQKL 105
Query: 203 DFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF- 261
+L S+ IG+L L+ L + N + F
Sbjct: 106 VAVETNLA-----------SLENFP--------IGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 262 NMSTLKALSLLNNTLSGSLPSSS-KNLIGLPNIE-RLNLGLNNLSGRIPGFIFNASKLFL 319
N++ L+ L L +N + S+ + + L +P + L+L LN ++ I F +L
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLS 362
L L N L +L+ + L N S P + +LS
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 247
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 47/253 (18%), Positives = 87/253 (34%), Gaps = 48/253 (18%)
Query: 283 SSKNL----IGLP-NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
N LP + + L+L N L F+ +L +L+L+ +
Sbjct: 15 MELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS 74
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L +L L L N + S L + +L++
Sbjct: 75 LSHLSTLILTGNPIQS------------------------------LALGAFSGLSSLQK 104
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPI--TVGRLNTLQGLGLENNKLE 454
+ + ++ G+L L L++ +N + S + L L+ L L +NK++
Sbjct: 105 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 455 GPIPDDLCQLS-------ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW 507
DL L L + N ++ P F + L+ L+L +N+L S F
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFD 221
Query: 508 NLNNILSFDFSSN 520
L ++ +N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 20/188 (10%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 774
+E+ L D F +IG G+F V + +V A+K+ + + G + F E +
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQ----RLSIMI 830
VL + R + ++ + + N+ LV+EY G L L ++ + R +
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLA- 169
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRTQTL- 887
++ +A++ +H VH DIKP NILLD H L+DFG L + ++R+
Sbjct: 170 EIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 888 GTIGYMAP 895
GT Y++P
Sbjct: 225 GTPDYLSP 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 33/186 (17%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
+G G+FG VY+G+ ++VA+K + F E ++ H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSS------NRSLDIFQRLSIMIDVALALE 837
+V+ I + +++E MA G L+ L + SL + L + D+A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 838 YL---HFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLNGEESMRTQTLGT-- 889
YL HF +H DI N LL VA + DFG+A+ + R
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 890 IGYMAP 895
+ +M P
Sbjct: 209 VKWMPP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 26/185 (14%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G+FG V+ + M VA+K A K F E E+L +++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 788 ISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQRLSIMIDV 832
C +G+ +V EYM +G L + + L + Q L I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--I 890
A + YL S VH D+ N L+ +++ + DFG+++ + + R I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 891 GYMAP 895
+M P
Sbjct: 200 RWMPP 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 12/178 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 781
D F + ++G G FG V+ + ++ A K L+ + E ++L V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF--QRLSIMI-DVALALEY 838
R +V + + LV+ M G + +Y+ + F R + LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
LH +++ D+KP N+LLDDD +SD G+A +T+ GT G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAP 358
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 774
R+L + + + +IG G+FG V R +V A+K+ F + F E +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA- 833
++ +V++ + + + +V+EYM G L +++ + A
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWAR 171
Query: 834 -------LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRT 884
LAL+ +H S +H D+KP N+LLD H L+DFG +N E +R
Sbjct: 172 FYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRC 226
Query: 885 QTL-GTIGYMAP 895
T GT Y++P
Sbjct: 227 DTAVGTPDYISP 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 31/180 (17%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDA-----ECEVLKSVRHRNL 784
+G G+FG V+ EV +K + D ++ E +L V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLY---SSNRSLD------IFQRLSIMIDVALA 835
+K++ N F LV+E +G L+ L+ + LD IF++L A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQL------VSA 142
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ YL ++H DIK NI++ +D L DFG A L + T GTI Y AP
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKV---FHLQFDGALKSFDAECE 774
+++ L + F +IG G+FG V + + +V A+K+ + + F E +
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQ----RLSIMI 830
VL + + + + + + N LV++Y G L L ++ D R +
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLA- 182
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRTQTL- 887
++ +A++ +H VH DIKP NIL+D + H L+DFG L + ++++
Sbjct: 183 EMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 888 GTIGYMAP 895
GT Y++P
Sbjct: 238 GTPDYISP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 41/197 (20%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
+G G FG V K VA+K+ + A L+ +E VLK V H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-----------------------EKCLYSSNRSL 820
++K+ +CS L++EY GSL + R+L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
+ +S ++ ++YL +VH D+ NIL+ + +SDFG+++ + E+
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 881 SMRTQTLGT--IGYMAP 895
S ++ G + +MA
Sbjct: 205 SYVKRSQGRIPVKWMAI 221
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 49/187 (26%), Positives = 77/187 (41%), Gaps = 9/187 (4%)
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQLSEL 467
+P ++ + T LHL N L T+ L L L+ +L + L L L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP 527
+ HN+L +P L +L L + N L+S L + N L +LP
Sbjct: 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLP 140
Query: 528 LDI-GNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPIPESFGALTSLE 585
+ + +++L+ N LT ++P + GL NL L L+ N L+ IP+ F L
Sbjct: 141 PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLP 198
Query: 586 SLDLSVN 592
L N
Sbjct: 199 FAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 52/214 (24%), Positives = 75/214 (35%), Gaps = 34/214 (15%)
Query: 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENN---KLEGPIPDDLCQLSELHVDH 471
+ + ++ L+ ++P L L N +L++L++D
Sbjct: 8 KVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 472 NKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG 531
+L+ + G L L L L N+L S +P L + D S N L SLP
Sbjct: 65 AELTK-LQV-DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLP---- 116
Query: 532 NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591
+ GL LQ L L+ N L P LE L L+
Sbjct: 117 -------------------LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 592 NNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
NNL+ + L L L L L N L IP G
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 49/210 (23%), Positives = 73/210 (34%), Gaps = 38/210 (18%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSIST-LKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
L LS N T + T L L L +L+ L +D ++
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVLGTLDLSH 86
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFL 185
N L +++P L L L + +N+L +P L EL+ L L + L
Sbjct: 87 NQL---------QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL 136
Query: 186 TGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
T+P + L +L +NN+LT +P L L NL+
Sbjct: 137 K-TLPPGLLTPTPKLEKLSLANNNLT-----------ELPAGLLN--------GLENLDT 176
Query: 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
L + EN L +P F L L N
Sbjct: 177 LLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 43/227 (18%)
Query: 114 SNTSSLRAIDCNYNSLSGELPANIFRAI--------------PKDIGNLTKLKELYLGYN 159
S +S ++C+ +L+ LP ++ + + T+L +L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 160 KLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHF 219
+L ++ G L L L L + L ++P L +L LD S N LT
Sbjct: 66 ELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT--------- 113
Query: 220 TGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSG 278
S+P + L L+ L + N L +P + L+ LSL NN L+
Sbjct: 114 --SLPLGALR--------GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT- 161
Query: 279 SLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGN 325
LP+ L GL N++ L L N+L IP F + L L GN
Sbjct: 162 ELPAGL--LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 38/163 (23%), Positives = 56/163 (34%), Gaps = 39/163 (23%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLS 105
L++S L ++ L +L LD+S NR + ++P + L+ L L N+L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
LP + KL++L L N L E+
Sbjct: 138 --------------------------TLPPGLLT-------PTPKLEKLSLANNNLT-EL 163
Query: 166 PQEL-GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN 207
P L L L+ L L + L TIP F L N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 786
IG GS+G V+K R D G VAIK F D AL+ E +LK ++H NLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ LV EY + ++ L R + SI A+ + H +
Sbjct: 67 LLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H D+KP NIL+ V L DFG A+LL G + T Y +P
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 25/184 (13%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKI 787
+G G+FG V+ + M VA+K + A + F E E+L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 788 ISSCSNGNFKALVLEYMANGSL--------------EKCLYSSNRSLDIFQRLSIMIDVA 833
C+ G +V EYM +G L + L + Q L++ VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGT--IG 891
+ YL VH D+ N L+ +V + DFG+++ + + R I
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 892 YMAP 895
+M P
Sbjct: 226 WMPP 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 39/192 (20%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
+G FG VYKG VAIK D A + F E + ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQRLSI 828
+V ++ + +++ Y ++G L + +L+ + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 829 MIDVALALEYL---HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+ +A +EYL H VH D+ N+L+ D + +SD G+ + + + +
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 886 TLGT--IGYMAP 895
I +MAP
Sbjct: 188 GNSLLPIRWMAP 199
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 33/186 (17%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
+G G+FG VY+G+ ++VA+K + F E ++ H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSS------NRSLDIFQRLSIMIDVALALE 837
+V+ I + ++LE MA G L+ L + SL + L + D+A +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 838 YL---HFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLNGEESMRTQTLGT-- 889
YL HF +H DI N LL VA + DFG+A+ + R
Sbjct: 196 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 890 IGYMAP 895
+ +M P
Sbjct: 250 VKWMPP 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 42/192 (21%), Positives = 84/192 (43%), Gaps = 36/192 (18%)
Query: 734 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 780
+G G+FG V + + VA+K+ D A L +E E++K + +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQR 825
H+N++ ++ +C+ +++EY + G+L +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+S +A +EYL S +H D+ N+L+ ++ V ++DFG+A+ +N + +
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 886 TLGT--IGYMAP 895
T G + +MAP
Sbjct: 217 TNGRLPVKWMAP 228
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 43/192 (22%), Positives = 85/192 (44%), Gaps = 36/192 (18%)
Query: 734 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 780
+G G+FG V + +VA+K+ A L +E E++K + +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQR 825
H+N++ ++ +C+ +++EY + G+L ++ L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+S VA +EYL S +H D+ N+L+ +D V ++DFG+A+ ++ + +
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 886 TLGT--IGYMAP 895
T G + +MAP
Sbjct: 251 TNGRLPVKWMAP 262
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 42/192 (21%), Positives = 83/192 (43%), Gaps = 36/192 (18%)
Query: 734 IGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-R 780
+G G FG V + + VA+K+ D A L +E E++K + +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQR 825
H+N++ ++ +C+ +++EY + G+L +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+S +A +EYL S +H D+ N+L+ ++ V ++DFG+A+ +N + +
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 886 TLGT--IGYMAP 895
T G + +MAP
Sbjct: 263 TNGRLPVKWMAP 274
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 39/188 (20%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 734 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 782
+G G+FG V + ++VA+K+ A ++ +E +++ + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL-------------EKCLYSSNRSLDIFQRLSIM 829
N+V ++ +C++G ++ EY G L + +N + L
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG- 888
VA + +L S +H D+ N+LL + VA + DFG+A+ + + + +
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 889 -TIGYMAP 895
+ +MAP
Sbjct: 228 LPVKWMAP 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVKI 787
+G G++G VYK + G VA+K L +G A++ E +LK + H N+V +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
I + LV E+M L+K L + L Q + + + + H + +
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+H D+KP N+L++ D L+DFG+A+ T + T+ Y AP
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 43/192 (22%), Positives = 77/192 (40%), Gaps = 36/192 (18%)
Query: 734 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 782
+G G+FG V + M VA+K+ A ++ +E +VL + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL-----------------EKCLYSSNRSLDIFQR 825
N+V ++ +C+ G ++ EY G L + +LD+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
LS VA + +L S +H D+ NILL + + DFG+A+ + + + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 886 TLGT--IGYMAP 895
+ +MAP
Sbjct: 205 GNARLPVKWMAP 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFH----LQFDGALKSFDAECEVLKSVRHRNLVKI 787
L+G GS+G V + A+K+ + + E ++L+ +RH+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 788 ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLD------IFQRLSIMIDVALALEYL 839
+ N + +V+EY G E + F +L ID LEYL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---ID---GLEYL 125
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN---GEESMRTQTLGTIGYMAP 895
H S +VH DIKP N+LL +S G+A+ L+ +++ RT + G+ + P
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISS 790
+G G++G V VA+K+ + + ++ E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
GN + L LEY + G L + F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH---GI 124
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKL--LNGEESMRTQTLGTIGYMAP 895
+ H DIKP N+LLD+ +SDFG+A + N E + + GT+ Y+AP
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 786
+G GS+G V K R D G VAIK F D A++ E ++LK +RH NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVN 88
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ C LV E++ + ++ L LD + + + + H S+
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H DIKP NIL+ V L DFG A+ L + + T Y AP
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 40/191 (20%), Positives = 76/191 (39%), Gaps = 35/191 (18%)
Query: 734 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 782
+G G+FG V + VA+K+ +GA ++ +E ++L + H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 783 NLVKIISSCSNGNFKALV-LEYMANGSL---------------EKCLYSSNRSLDIFQRL 826
N+V ++ +C+ +V +E+ G+L L + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
VA +E+L S +H D+ NILL + V + DFG+A+ + + +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 887 LGT--IGYMAP 895
+ +MAP
Sbjct: 209 DARLPLKWMAP 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 9e-19
Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 781
+ F + ++G G FG V + ++ A K ++ E ++L+ V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF--QRLSIMI-DVALALEY 838
R +V + + + LVL M G L+ +Y + F R ++ LE
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLED 301
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
LH +V+ D+KP NILLDD +SD G+A + E + GT+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAP 354
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 46/200 (23%), Positives = 77/200 (38%), Gaps = 47/200 (23%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSVRHRN 783
IG G+FG V++ R VA+K+ + A F E ++ + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 784 LVKIISSCSNGNFKALVLEYMANGSL-----------------------EKCLYSSNRSL 820
+VK++ C+ G L+ EYMA G L + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 821 DIFQRLSIMIDVALALEYL---HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877
++L I VA + YL F VH D+ N L+ ++MV ++DFG+++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 878 GEESMRTQTLGT--IGYMAP 895
+ + I +M P
Sbjct: 226 SADYYKADGNDAIPIRWMPP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 29/165 (17%)
Query: 733 LIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHRNL 784
+IG G+FG V K R M+ AIK + A + F E EVL + H N+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 785 VKIISSCSNGNFKALVLEYMANGSL---------------EKCLYSSNRSLDIFQRLSIM 829
+ ++ +C + + L +EY +G+L S+ +L Q L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
DVA ++YL +H D+ NIL+ ++ VA ++DFG+++
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGL 448
N+P +++ LQ+ K+ K L L L+L +N+L ++P + L L+ L +
Sbjct: 34 NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWV 92
Query: 449 ENNKLEG-P--IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPST 505
+NKL+ P + D L L+EL +D N+L P F +L L LSLG NEL S +P
Sbjct: 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKG 151
Query: 506 FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSL 565
FD LT+L+ L L
Sbjct: 152 --------VFD---------------------------------------KLTSLKELRL 164
Query: 566 ENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
NN+L +F LT L++L L N L V + + L LK L L N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
SSK L +P + ++L+L N LS +KL LL L N
Sbjct: 24 SSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE 83
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L+NLE L + N L + LP + + + L E
Sbjct: 84 LKNLETLWVTDNKLQA------------------------------LPIGVFDQLVNLAE 113
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEG 455
+ L +++ ++P + +L LT L LG N+L S+P V +L +L+ L L NN+L+
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR 171
Query: 456 PIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
+P D L +L L +D+N+L F +L L+ L L N
Sbjct: 172 -VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 36/211 (17%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
+ + LDL N+ S ++PS F ++ L++L L DN+L + P+ I +L +
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFL 185
N L LP +F L L EL L N+L+ +P + +L +L +LSL + L
Sbjct: 95 NKLQ-ALPIGVFD-------QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 186 TGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
++P +F L+SL EL NN L +P + L L+
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLK-----------RVPEGAFD--------KLTELKT 185
Query: 245 LGIDENHLVGDVPNTIF-NMSTLKALSLLNN 274
L +D N L VP F ++ LK L L N
Sbjct: 186 LKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 39/244 (15%)
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
+DC+ L+ +P+NI K+L L NKL + L +L L L
Sbjct: 21 VDCSSKKLT-AIPSNIP----------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 182 RSFLTGTIPSSIFN-LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLP 240
+ L T+P+ IF L +L L ++N L ++P ++ L
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-----------ALPIGVFD--------QLV 109
Query: 241 NLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299
NL L +D N L +P +F +++ L LSL N L SLP + L +++ L L
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD--KLTSLKELRLY 165
Query: 300 LNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPEL 358
N L R+P F ++L L+L N +L L+ L L N + +
Sbjct: 166 NNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGI 224
Query: 359 SFLS 362
+++
Sbjct: 225 IYMA 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 59/180 (32%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 457 IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516
IP D +L + NKLS F L LR L L N+L + F L N+ +
Sbjct: 35 IPADT---KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW 91
Query: 517 FSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPI 574
+ N L +LP+ + + + E+ L RN L +P + LT L LSL N L +
Sbjct: 92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-L 148
Query: 575 PE-SFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSA 633
P+ F LTSL+ L L N L V + +KL LK L L N+L+ +P G+F +
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGAFDSLEK 206
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 15/148 (10%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
L+ L+ L L+ N+ T+P+ IF + L+ L + DN+L + P + +L +
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRS 183
+ N L LP +F +LTKL L LGYN+LQ +P+ + L L+ L L +
Sbjct: 117 DRNQLK-SLPPRVFD-------SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNN 167
Query: 184 FLTGTIPSSIF-NLSSLLELDFSNNSLT 210
L +P F L+ L L NN L
Sbjct: 168 QLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 39/211 (18%), Positives = 72/211 (34%), Gaps = 22/211 (10%)
Query: 704 EVNMSPQAMWRRFSYRE--LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFH-- 759
+ + + + R RE L +H K +
Sbjct: 38 RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW 97
Query: 760 -LQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR 818
L + + + + +N V + S + + ++ +L+ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 819 --SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876
+ L I I +A A+E+LH S ++H D+KPSNI D V + DFG+ +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 877 NGEESM------------RTQTLGTIGYMAP 895
+ +E T +GT YM+P
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 726 DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIK-VFHLQFDGALKSFDAECEVLKSVRHRN 783
F +G G FG V++ + +D AIK + + A + E + L + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS 819
+V+ ++ + E ++ S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSS 101
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 733 LIGIGSFGTVYKGRFLD-GMEVAIKVFHL-QFDGALKSFDAECEVLKSVRHRNLVKIISS 790
+G G++G V VA+K+ + + ++ E + K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 791 CSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
GN + L LEY + G L + F +L + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA---GVVYLH---GI 124
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKL--LNGEESMRTQTLGTIGYMAP 895
+ H DIKP N+LLD+ +SDFG+A + N E + + GT+ Y+AP
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 734 IGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKI 787
IG G++G VYK + G A+K L+ + ++ E +LK ++H N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
LV E++ + L+K L L+ S ++ + + Y H V
Sbjct: 66 YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAK 874
+H D+KP N+L++ + ++DFG+A+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 786
IG G++GTV+K + + VA+K L +G AL+ E +LK ++H+N+V+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ + LV E+ + L+K S N LD S + + L + H S
Sbjct: 66 LHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
V+H D+KP N+L++ + L++FG+A+ + + T+ Y P
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKS---FDA--ECEVLKSVRHRNLVKI 787
+G G F TVYK R VAIK L K A E ++L+ + H N++ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPV 847
+ + + + +LV ++M LE + ++ L + M+ LEYLH + +
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133
Query: 848 VHCDIKPSNILLDDDMVAHLSDFGIAK 874
+H D+KP+N+LLD++ V L+DFG+AK
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/172 (29%), Positives = 89/172 (51%), Gaps = 19/172 (11%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G+G+FG V G L G +VA+K+ ++ + E + LK RH +++K+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 789 SSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
S +V+EY++ G L + + +FQ++ + A++Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LS---AVDYCH--- 128
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ VVH D+KP N+LLD M A ++DFG++ +++ E +RT + G+ Y AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 23/173 (13%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVF--HLQFDGALKSFDAECEVLKSVRHRNLVKIIS 789
IG G+FG R L VA+K D ++ E +S+RH N+V+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKE 83
Query: 790 SCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
A+++EY + G L +S + + FQ+L + + Y H S
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---LS---GVSYCH---S 134
Query: 845 NPVVHCDIKPSNILLDDDMVAHL--SDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ H D+K N LLD L DFG +K ++ T+GT Y+AP
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAP 186
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 37/187 (19%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 779
F +G GSFG V+ R A+KV L+ + ++ E +L V
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA------ 833
H ++++ + + ++++Y+ G L L S R F VA
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR----F-----PNPVAKFYAAE 114
Query: 834 --LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRTQTL-G 888
LALEYLH S +++ D+KP NILLD + H ++DFG AK T TL G
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK----YVPDVTYTLCG 165
Query: 889 TIGYMAP 895
T Y+AP
Sbjct: 166 TPDYIAP 172
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 38/197 (19%), Positives = 72/197 (36%), Gaps = 41/197 (20%)
Query: 734 IGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGA----LKSFDAECEVLKSV-RHR 782
+G G+FG V ++VA+K+ + A ++ +E +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSL----------------------EKCLYSSNRSL 820
N+V ++ +C+ L+ EY G L L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
L VA +E+L VH D+ N+L+ V + DFG+A+ + +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 881 SMRTQTLGT--IGYMAP 895
+ + + +MAP
Sbjct: 227 NYVVRGNARLPVKWMAP 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 23/148 (15%), Positives = 46/148 (31%), Gaps = 14/148 (9%)
Query: 732 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLV 785
G ++ D +VA+ Q D L+ + L + +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+++ +V E++ GSL++ + S + M +A A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIA 873
V PS + + D L+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 54/175 (30%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFD---AECEVLKSVRH 781
D F +G GSFG V + + A+K+ Q LK + E +L++V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
LVK+ S + + +V+EY+A G + L R + R + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH- 158
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
S +++ D+KP N+L+D ++DFG AK + G RT TL GT +AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 14/176 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF-LDGMEVAIKVFHLQF-DG----ALKSFDAECEVLKSV 779
+ + + +G G++ TVYKG+ L VA+K L+ +G A++ E +LK +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYL 839
+H N+V + LV EY+ + L++ L +++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 840 HFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H V+H D+KP N+L+++ L+DFG+A+ + + T+ Y P
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 56/286 (19%), Positives = 105/286 (36%), Gaps = 47/286 (16%)
Query: 335 LVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT 394
L +T + + L+S+ I+ + + V I LP
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT-QNELNSI------DQIIANNSDIKSV--QGIQYLP-N 66
Query: 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
+ +++L K+ +I K + NL NL L L N++ + L L+ L LE+N +
Sbjct: 67 VTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS 122
Query: 455 GPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNIL 513
L QL L++ +NK++ L L LSL N++S +P
Sbjct: 123 DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP---------- 170
Query: 514 SFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGP 573
+ + + + LS+N+++ D+ + GL NL +L L +
Sbjct: 171 ----------------LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNK 212
Query: 574 IPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619
L ++ + +L IS + N+ ++ E
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 50/278 (17%), Positives = 102/278 (36%), Gaps = 44/278 (15%)
Query: 37 ITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96
I D + N+ +T ++ L+S+ + +++ ++ I + +
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 69
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L L N+L+ P ++N +L + + N + ++ + +L KLK L L
Sbjct: 70 LFLNGNKLTDIKP---LTNLKNLGWLFLDENKIK-----DL-----SSLKDLKKLKSLSL 116
Query: 157 GYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNN--------- 207
+N + +I L +L +LE L L + + T + + L+ L L +N
Sbjct: 117 EHNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLA 172
Query: 208 ---SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMS 264
L Y++ NH + + + L NL+VL + + N N+
Sbjct: 173 GLTKLQNLYLSKNHIS-DLR----------ALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNN 302
+ + +L S PN++ N
Sbjct: 222 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 259
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 46/284 (16%)
Query: 147 NLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSN 206
+ + L + + Q L ++ + S + ++ I L ++ +L +
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 207 NSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTL 266
N LT + NL NL L +DEN + D+ + + ++ L
Sbjct: 75 NKLTDIK---------------------PLTNLKNLGWLFLDENKIK-DLSS-LKDLKKL 111
Query: 267 KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326
K+LSL +N +S L+ LP +E L LG N ++ + +KL L L N
Sbjct: 112 KSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQ 164
Query: 327 FSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPS 386
S +P L L L++L L N+++ L +LA + + L +
Sbjct: 165 ISDIVP--LAGLTKLQNLYLSKNHISD-------LRALAGLKNLDVLELFSQECLNKPIN 215
Query: 387 SIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS 430
NL + + + + P+ I + + ++ +
Sbjct: 216 HQSNLVV-PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 53/296 (17%), Positives = 89/296 (30%), Gaps = 38/296 (12%)
Query: 337 NLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNG-VLPSSIGNLPIT- 394
R+LE+L + + SL S K + + + +L ++ L I+
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSL----SLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 395 LEEIYLQNCKIRGNIPKEIGNLV--NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
L+E+ L+N ++ G P + +L L+L N + L LQ
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW----LAELQQWLKPG-- 150
Query: 453 LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS-------SFIPST 505
L L + +L L L N + P
Sbjct: 151 -----------LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 506 FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLS 564
F L + + + +G + ++LS N L + L L+
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620
L L L LDLS N L +L + +L+L N
Sbjct: 260 LSFTGLKQVPKGLP---AKLSVLDLSYNRLDRNPSPD--ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 55/342 (16%), Positives = 100/342 (29%), Gaps = 76/342 (22%)
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
G +L + I +LK L++ + + + ++G+ ++ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356
L ++G P + A+ L L NLRN+
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNIL--------------NLRNVSWATRD--------- 137
Query: 357 ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNL 416
++L+ L L+ + + +++
Sbjct: 138 --AWLAELQQWLKP-----------------------GLKVLSIAQAHSLNFSCEQVRVF 172
Query: 417 VNLTTLHLGNNQLSGSIPIT----VGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHN 472
L+TL L +N G + + TLQ L L N +
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM------------------E 214
Query: 473 KLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNGSLPLDIG 531
SG A L+ L L N L + + + S + S L +P +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 532 NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGP 573
+ ++LS N L P + L + LSL+ N
Sbjct: 274 AK--LSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 43/232 (18%), Positives = 79/232 (34%), Gaps = 21/232 (9%)
Query: 414 GNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD------DLCQLSEL 467
G L + + + + +L+ L + ++ I + L EL
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 468 HVDHNKLSG--PIPACFGNLNSLRNLSLGSNELSSFIPST----FWNLNNILSFDFSSNS 521
+++ +++G P P L L+L + ++ W + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI----GGLTNLQLLSLENNRLH---GPI 574
+ + ++LS N G+ LQ+L+L N + G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 575 PESFGALTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLEGEIPSG 625
A L+ LDLS N+L S + L LNLSF L+ ++P G
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 48/296 (16%), Positives = 91/296 (30%), Gaps = 31/296 (10%)
Query: 169 LGNLAELEWLSLPRSFLTGTIP-SSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227
G LE+L + I SL L + +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG----------- 87
Query: 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFN--MSTLKALSLLNNTLSGSLPSSSK 285
+ + L+ L ++ + G P + L L+L N + + ++
Sbjct: 88 -----ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAE 142
Query: 286 NLIGL-PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDT----LVNLRN 340
L P ++ L++ + + L L+L+ N G +
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 341 LEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYL 400
L+ L L + + + S L A + + L+ N L + + P L + L
Sbjct: 203 LQVLALRNAGMETPSGVCSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGP 456
++ +PK + L+ L L N+L P L + L L+ N
Sbjct: 261 SFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPSP-DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 49/292 (16%), Positives = 83/292 (28%), Gaps = 41/292 (14%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSS---IFSISTLKILILGDNQLS 105
L D + + SL+ L + R I + IS L+ L L + +++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 106 GSFPSFIISNT-SSLRAIDCNYNSLSGELPANIFRAIPKDIGNL--TKLKELYLGYNKLQ 162
G+ P ++ T L ++ S + A ++ LK L +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT------RDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 163 GEIPQELGNLAELEWLSLPRSFLTGTIPSSI----FNLSSLLELDFSNNSLTGFYMTNNH 218
+++ L L L + G +L L N +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG---- 218
Query: 219 FTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLS 277
L+ L + N L S L +L+L L
Sbjct: 219 ------------VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 278 GSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSG 329
+P + L+L N L R P ++ L L GN F
Sbjct: 267 -QVPKGL-----PAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 51/291 (17%), Positives = 83/291 (28%), Gaps = 38/291 (13%)
Query: 23 KNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSG 82
K + + + I +S R+T + ++ +S LQ L L + +G
Sbjct: 50 KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109
Query: 83 TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIP 142
T P + + + IL +S + ++ S++
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ----AHSLNFS 165
Query: 143 KD-IGNLTKLKELYLGYNKLQGEI-------PQELGNLAELEWLSLPRSFLTGTIPSSIF 194
+ + L L L N GE P + L L + +G +
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 195 NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG 254
L LD S+NSL L L + L
Sbjct: 226 ARVQLQGLDLSHNSLRDA------------------AGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305
VP + + L L L N L PS LP + L+L N
Sbjct: 268 -VPKGLP--AKLSVLDLSYNRLD-RNPS----PDELPQVGNLSLKGNPFLD 310
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC--------EVL 776
+ FS +IG G FG VY R D ++ A+K L ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 246
Query: 777 KSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
+ +V + + + + +L+ M G L L + R ++ L L
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGL 305
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
E++H + VV+ D+KP+NILLD+ +SD G+A + + + GT GYMAP
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 359
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 49/187 (26%), Positives = 72/187 (38%), Gaps = 21/187 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIK-VFHLQFDGAL-----KSFDA-----EC 773
++ + I GS+G V G +G+ VAIK VF+ DG SF E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 774 EVLKSVRHRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSI 828
+L H N++ I LV E M L + ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLG 888
M + L L LH VVH D+ P NILL D+ + DF +A+ + + T +
Sbjct: 140 MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVT 195
Query: 889 TIGYMAP 895
Y AP
Sbjct: 196 HRWYRAP 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 18/168 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
++ +IG GSFG V++ + ++ EVAIK + E ++++ V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 785 VK----IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSI---MIDVALA 835
V S+ + LVLEY+ ++ + + L I M + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEESM 882
L Y+H S + H DIKP N+LLD V L DFG AK+L E
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 50/172 (29%), Positives = 91/172 (52%), Gaps = 19/172 (11%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G+G+FG V G+ L G +VA+K+ + ++ + E + LK RH +++K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 789 SSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
S + +V+EY++ G L + S +FQ++ + ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LS---GVDYCH--- 133
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ VVH D+KP N+LLD M A ++DFG++ +++ E +RT + G+ Y AP
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 184
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 49/286 (17%), Positives = 108/286 (37%), Gaps = 25/286 (8%)
Query: 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKY 372
+ + ++ + + +L + L +T+ + + ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67
Query: 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432
+ L +N + + + + NL + E+ L ++ I L ++ TL L + Q++
Sbjct: 68 LELKDNQITDL--APLKNLT-KITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDV 122
Query: 433 IPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNL 491
P+ L+ LQ L L+ N++ P L L L + + ++S P NL+ L L
Sbjct: 123 TPL--AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 492 SLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551
N++S S +L N++ +N ++ PL N + + L+ +T
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTITNQPV 234
Query: 552 TTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
L ++ + P + + S +L+ N S +
Sbjct: 235 FYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 61/324 (18%), Positives = 115/324 (35%), Gaps = 52/324 (16%)
Query: 37 ITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96
I D + + +T T++ +L + TL T + ++ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIG 67
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L L DNQ++ P + N + + ++ + N L I L +K L L
Sbjct: 68 LELKDNQITDLAP---LKNLTKITELELSGNPLK----------NVSAIAGLQSIKTLDL 114
Query: 157 GYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTN 216
++ P L L+ L+ L L + +T S + L++L L N ++
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL---- 166
Query: 217 NHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTL 276
+ NL L L D+N + D+ + ++ L + L NN +
Sbjct: 167 -----------------TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQI 207
Query: 277 SGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLV 336
S L N+ + L ++ + +N + + + G S + P T+
Sbjct: 208 -----SDVSPLANTSNLFIVTLTNQTITNQPV--FYNNNLVVPNVVKGPSGAPIAPATIS 260
Query: 337 NLRNLEHLGLGYNYLTSSTPELSF 360
+ L +N LTS +S+
Sbjct: 261 DNGTYASPNLTWN-LTSFINNVSY 283
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 40/211 (18%), Positives = 66/211 (31%), Gaps = 55/211 (26%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEI--GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGL 446
+LP + L + + + E L NL +L L +N L+ I + L+ L
Sbjct: 36 SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 447 GLENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502
L +N L + DL L L + +N + F ++ L+ L L N++S F
Sbjct: 94 DLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
+ N L L L
Sbjct: 153 VELIKDGNK---------------------------------------------LPKLML 167
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNN 593
L L +N+L L + L ++N
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 41/210 (19%), Positives = 77/210 (36%), Gaps = 33/210 (15%)
Query: 69 SLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNS 128
+ L S + +P S+ S +L L N LS + + ++L ++ ++N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 129 LSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFLTG 187
L+ + + F + L+ L L N L + + +L LE L L + +
Sbjct: 76 LN-FISSEAFV-------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV- 125
Query: 188 TIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
+ + F +++ L +L S N ++ P L + LP L +L
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS-----------RFPVELI-----KDGNKLPKLMLLD 169
Query: 247 IDENHLVGDVPNTIFNMSTLKA--LSLLNN 274
+ N L + + L L NN
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 18/152 (11%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
L++L +L LSHN + I S F + L+ L L N L + F+ S+ +L +
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE----LGNLAELEWLSL 180
N + + N F ++ +L++LYL N++ P E L +L L L
Sbjct: 120 YNNHIV-VVDRNAFE-------DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170
Query: 181 PRSFLTGTIPSSIFNLSSLLE--LDFSNNSLT 210
+ L + + L + ++ L NN L
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 29/168 (17%)
Query: 457 IPDDL-CQLSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILS 514
+P L + L + HN LS L +L +L L N L+ F + N+
Sbjct: 33 VPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92
Query: 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI 574
D SSN L+ +L L L++L L NN +
Sbjct: 93 LDLSSNHLH-TLD-----------------------EFLFSDLQALEVLLLYNNHIVVVD 128
Query: 575 PESFGALTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLSFNRLE 619
+F + L+ L LS N +S KL L L+LS N+L+
Sbjct: 129 RNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 538 EINLSRNYLTGDIPT-TIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596
+ LS N+L I + + NL+ L L +N LH F L +LE L L N++
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV 126
Query: 597 VIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSA 633
V + E + L+ L LS N++ P + +
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPV-ELIKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/203 (22%), Positives = 72/203 (35%), Gaps = 43/203 (21%)
Query: 256 VPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NA 314
VP ++ S L L +N LS L + L N+ L L N+L+ I F
Sbjct: 33 VPQSLP--SYTALLDLSHNNLS-RLRAEW-TPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIV 374
L L+L+ N +L+ LE L L N++
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--------------------- 126
Query: 375 LAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI----GNLVNLTTLHLGNNQLS 430
V ++ ++ L+++YL +I P E+ L L L L +N+L
Sbjct: 127 --------VDRNAFEDMA-QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 431 GSIPITVGRLNTL--QGLGLENN 451
+ +L GL L NN
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 48/174 (27%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEV---LKSVRH 781
D+ ++G+G G V + + A+K+ A EV ++ +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 70
Query: 782 RNLVKIISSCSNGNFKA----LVLEYMANGSLEKCLYSSNRSLDIFQRL----------- 826
++V+I+ N +V+E + G L F R+
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTER 117
Query: 827 ---SIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAK 874
IM + A++YLH S + H D+KP N+L + + L+DFG AK
Sbjct: 118 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 24/173 (13%)
Query: 734 IGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKSVRHRNLVKI 787
IG G+F V R L G EVAIK+ L E ++K + H N+VK+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSNR-----SLDIFQRLSIMIDVALALEYLHFG 842
L++EY + G + L + R + F+++ A++Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH-- 131
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+VH D+K N+LLD DM ++DFG + + G Y AP
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAP 182
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 26/186 (13%)
Query: 730 EKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
E +G G++G VYK + D + A+K G S E +L+ ++H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVIS 82
Query: 787 ---IISSCSNGNFKALVLEYMA-------NGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
+ S ++ L+ +Y L S++ + +
Sbjct: 83 LQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAH----LSDFGIAKLLNGEESMRTQTLG---T 889
YLH +N V+H D+KP+NIL+ + ++D G A+L N T
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 890 IGYMAP 895
Y AP
Sbjct: 199 FWYRAP 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 33/187 (17%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVF---HLQFDGALKSFDAECEVLKSVRH 781
+ F L+G G+FG V + A+K+ + + E VL++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSI------------M 829
L + S + V+EY G ++F LS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGG-------------ELFFHLSRERVFSEDRARFYG 254
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-G 888
++ AL+YLH VV+ D+K N++LD D ++DFG+ K ++ +T G
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCG 311
Query: 889 TIGYMAP 895
T Y+AP
Sbjct: 312 TPEYLAP 318
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-16
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 16/170 (9%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DG----ALKSFDAECEVLKSVRHRNLVK 786
IG G++G VYK R G VA+K L +G A++ E +LK + H N+VK
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVK 66
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGYSN 845
++ N LV E++ + L+K + +S + + + S + + L + H S+
Sbjct: 67 LLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SH 122
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
V+H D+KP N+L++ + L+DFG+A+ T + T+ Y AP
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRHRNLVKII 788
+G GSFG V + +VA+K L+ + E LK +RH +++K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 789 SSCSNGNFKALVLEYMANGSL-----EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+ +V+EY A G L EK + + FQ++ I A+EY H
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI---IC---AIEYCH--- 125
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ +VH D+KP N+LLDD++ ++DFG++ ++ ++T + G+ Y AP
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAP 176
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 51/187 (27%), Positives = 68/187 (36%), Gaps = 41/187 (21%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIK------VFHLQFDGALKSFDAECEVLKSVR----H 781
L+G G FGTV+ G D ++VAIK V + E +L V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF------QRLS------IM 829
+++++ LVLE D+F L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEESMRTQTLG 888
V A+++ H S VVH DIK NIL+D A L DFG LL+ E G
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTD-FDG 200
Query: 889 TIGYMAP 895
T Y P
Sbjct: 201 TRVYSPP 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DG----ALKSFDAECEVLKSVRHRNLVKI 787
+G G++ TVYKG G+ VA+K L +G A++ E ++K ++H N+V++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 788 ISSCSNGNFKALVLEYMANGSLEKCLYSSN-----RSLDIFQRLSIMIDVALALEYLHFG 842
N LV E+M + L+K + S R L++ + L + H
Sbjct: 69 YDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-- 125
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
N ++H D+KP N+L++ L DFG+A
Sbjct: 126 -ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 44/192 (22%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 779
+ F L+G G+FG V R A+K+ L+ + + + VL++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 780 RHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQRL 826
RH L + + + V+EY G L E+ Y +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA---------- 112
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRT 884
++ ALEYLH S VV+ DIK N++LD D H ++DFG+ K +
Sbjct: 113 ----EIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK-EGISDGATM 162
Query: 885 QTL-GTIGYMAP 895
+T GT Y+AP
Sbjct: 163 KTFCGTPEYLAP 174
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 23/155 (14%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIK--VFHLQFDG----ALKSFDAECEVLKSVRHRNLVK 786
IG G+FG V+K R G +VA+K + + +G AL+ E ++L+ ++H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 787 ---IISSCSNGNFKA-----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838
I + ++ + LV ++ + L L + + + +M + L Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873
+H N ++H D+K +N+L+ D V L+DFG+A
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 45/176 (25%), Positives = 67/176 (38%), Gaps = 21/176 (11%)
Query: 733 LIGIGSFGTVYKGR-FLDGMEVAIK------VFHLQFDGALKSFDAECEVLKSVRHR--N 783
L+G G FG+VY G D + VAIK + E +LK V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLY---SSNRSLDIFQRLSIMIDVALALEYLH 840
+++++ + L+LE + L+ + +L S V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 841 FGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ V+H DIK NIL+D + L DFG LL GT Y P
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTD-FDGTRVYSPP 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 42/184 (22%), Positives = 82/184 (44%), Gaps = 21/184 (11%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
D + + LIG GS+G V + L+ VAIK F+ D E +L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNR 108
Query: 779 VRHRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDV 832
+ H ++VK I+ F +VLE + +K + + + +++ ++
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIK--TLLYNL 165
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
+ ++Y+H S ++H D+KP+N L++ D + DFG+A+ ++ E+ +Q +
Sbjct: 166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 893 MAPG 896
Sbjct: 223 DDMN 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 27/176 (15%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK-VF-HLQFDGALKSFDAECEVLKSVRH 781
D F + + G G+FGTV G+ GM VAIK V +F + + L + H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNREL-QIMQDLAVLHH 78
Query: 782 RNLVK---IISSCSNGNFK----ALVLEYMANGSLEKCLY-------SSNRSLDIFQRLS 827
N+V+ + + + +V+EY+ L+ +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 828 IMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESM 882
+ + ++ LH N V H DIKP N+L++ D L DFG AK L+ E
Sbjct: 134 FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 48/196 (24%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFD------AECEV 775
+ F ++G G +G V++ R + G A+KV L+ +++ AE +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNI 74
Query: 776 LKSVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDI 822
L+ V+H +V +I + G L+LEY++ G L E C Y +
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------ 128
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEE 880
++++AL +LH +++ D+KP NI+L+ H L+DFG+ K + +
Sbjct: 129 --------EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK-ESIHD 174
Query: 881 SMRTQTL-GTIGYMAP 895
T T GTI YMAP
Sbjct: 175 GTVTHTFCGTIEYMAP 190
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVK 786
+G G++G VYK VAIK L+ + A++ E +LK ++HRN+++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
+ S + + L+ EY N L+K + N + + S + + + + H S
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152
Query: 847 VVHCDIKPSNILLDDDMVAH-----LSDFGIAK 874
+H D+KP N+LL + + DFG+A+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+++ +IG GSFG VY+ + D G VAIK + E ++++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 784 LVK----IISSCSNGNFKAL--VLEYMANGSLEKCLY-------SSNRSLDIFQRLSIMI 830
+V+ SS + L VL+Y+ + +Y + ++L + M
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 831 DVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEESM 882
+ +L Y+H S + H DIKP N+LLD D V L DFG AK L E
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 54/200 (27%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFH----LQFDGALKSFDAECEVLK 777
++F ++G G++G V+ R + G + A+KV +Q + E +VL+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 778 SVRHRN-LVKIISSCSNGNFKA-----LVLEYMANGSL-----------EK--CLYSSNR 818
+R LV + + F+ L+L+Y+ G L E +Y
Sbjct: 114 HIRQSPFLVTLHYA-----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-- 166
Query: 819 SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLL 876
++ LALE+LH +++ DIK NILLD + H L+DFG++K
Sbjct: 167 ------------EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEF 209
Query: 877 NGEESMRTQTL-GTIGYMAP 895
+E+ R GTI YMAP
Sbjct: 210 VADETERAYDFCGTIEYMAP 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/235 (17%), Positives = 83/235 (35%), Gaps = 29/235 (12%)
Query: 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHL-GNNQLSGSIPITV-GRLNTL 443
I +LP + + + L +R NL N++ +++ + L + L+ +
Sbjct: 24 QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKV 82
Query: 444 QGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
+ + N + L+ + P L L+ L + + L F
Sbjct: 83 THIEIRNTR----------NLTYID----------PDALKELPLLKFLGIFNTGLKMFPD 122
Query: 504 STFWNLNNIL-SFDFSSNSLNGSLPLDI--GNMKVVVEINLSRNYLTGDIPTTIGGLTNL 560
T +I + + N S+P++ G + + L N T + T L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 561 QLLSLENNRLHGPIPE-SF-GALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNL 613
+ L N+ I + +F G + LD+S +++ + LE L L N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 42/233 (18%), Positives = 80/233 (34%), Gaps = 30/233 (12%)
Query: 264 STLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA-SKLFLLEL 322
+ + L L+ L ++PS + LPNI R+ + ++ ++ F SK+ +E+
Sbjct: 31 PSTQTLKLIETHLR-TIPSHA--FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 323 TGNSFSGFIP-DTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN 381
+I D L L L+ LG+ L P+L+ + S + + +NP
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF-PDLTKVYST---DIFFILEITDNPYM 143
Query: 382 GVLPS-SIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRL 440
+P + L + L N ++ N L ++L N+ I
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID-----K 197
Query: 441 NTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
+ G+ S L V ++ +L L +
Sbjct: 198 DAFGGVY--------------SGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 30/149 (20%), Positives = 54/149 (36%), Gaps = 12/149 (8%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFI-ISNTSSLRAID 123
NLS + +++ + R I + LK L + + L FP + +T ++
Sbjct: 78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136
Query: 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS 183
N +P N F+ + + L L N + N +L+ + L ++
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNE------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
Query: 184 FLTGTIPSSIF-NLSSLLE-LDFSNNSLT 210
I F + S LD S S+T
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 35/233 (15%), Positives = 70/233 (30%), Gaps = 33/233 (14%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQL 104
L + + L S NL ++ + +S + + S F +S + + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
+ L+ + L P + + L + N
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK------VYSTDIFFILEITDNPYMTS 145
Query: 165 IPQEL--GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFS-NNSLTGFYMTNNHFTG 221
IP G E L L + T ++ FN + L + + N LT
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT----------- 193
Query: 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
I ++ + G +L + + + +P+ LK L N
Sbjct: 194 VIDKDAFG-------GVYSGPSLLDVSQTSVT-ALPSKGL--EHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 37/204 (18%), Positives = 71/204 (34%), Gaps = 21/204 (10%)
Query: 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF--LSSLANSSSSKYIVLAE 377
L+L NL N+ + + + SF LS + +I +
Sbjct: 36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV------THIEIRN 89
Query: 378 NP-LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKE--IGNLVNLTTLHLGNNQLSGSIP 434
L + P ++ LP L+ + + N ++ P + + L + +N SIP
Sbjct: 90 TRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 435 ITV--GRLNTLQGLGLENNKLEGPIPD---DLCQLSELHVDHNKLSGPIPA-CFGNLNS- 487
+ G N L L NN + + +L ++++ NK I FG + S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 488 LRNLSLGSNELSSFIPSTFWNLNN 511
L + +++ +L
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKE 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 44/250 (17%), Positives = 89/250 (35%), Gaps = 40/250 (16%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
+ ++ IPS + + L L + L + PS SN ++ I + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAELEWLSLPRSFLT 186
+L ++ F NL+K+ + + + I + L L L++L + + L
Sbjct: 66 VTLQQLESHSFY-------NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 187 GTIP--SSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN-LE 243
P + +++ L+ ++N + T SIP N L N
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDN---------PYMT-SIPVNA--------FQGLCNETL 159
Query: 244 VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPN-IERLNLGLNN 302
L + N V FN + L A+ L N + + G+ + L++ +
Sbjct: 160 TLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDA--FGGVYSGPSLLDVSQTS 216
Query: 303 LSGRIPGFIF 312
++ +P
Sbjct: 217 VT-ALPSKGL 225
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSL-ENNRLHGPIPESFGALTSLESLDLSVNN-LS 595
+ L +L L N+ + + + L SF L+ + +++ L+
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 596 GVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
+ P +L++L LK L + L+ P +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 46/194 (23%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV----AIKVFHLQFDGALKSFDAEC----EVLK 777
F ++G GSFG V+ + + G + A+KV L+ ++L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILV 81
Query: 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQ 824
V H +VK+ + L+L+++ G L E+ Y +
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-------- 133
Query: 825 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESM 882
++ALAL++LH S +++ D+KP NILLD++ H L+DFG++K + +
Sbjct: 134 ------ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEK 181
Query: 883 RTQTL-GTIGYMAP 895
+ + GT+ YMAP
Sbjct: 182 KAYSFCGTVEYMAP 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 36/229 (15%), Positives = 75/229 (32%), Gaps = 35/229 (15%)
Query: 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL 453
E+ L+ + NIP LG + + IT ++N+L + L N +
Sbjct: 2 AAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV 56
Query: 454 EGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNI 512
+ + +L +++ + P L++L L + +++S L ++
Sbjct: 57 TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114
Query: 513 LSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG 572
+++S + I T I L + + L N
Sbjct: 115 ------------------------TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 573 PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGE 621
I L L+SL++ + + +E L L + G+
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 26/188 (13%), Positives = 60/188 (31%), Gaps = 35/188 (18%)
Query: 65 GNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
++SL + L++ + + I +K L + + + P IS S+L +
Sbjct: 41 AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP---ISGLSNLERLRI 95
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSF 184
++ + ++ LT L L + ++ I ++ L ++ + L +
Sbjct: 96 MGKDVTSD--------KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 185 LTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
I + L L L+ + + + I + P L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDY---------------------RGIEDFPKLNQ 185
Query: 245 LGIDENHL 252
L +
Sbjct: 186 LYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 31/192 (16%), Positives = 62/192 (32%), Gaps = 16/192 (8%)
Query: 240 PNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299
+ T M++L ++L N ++ + NI+ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTIN 74
Query: 300 LNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELS 359
+ + P I S L L + G + L L +L L + ++ S
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI---- 128
Query: 360 FLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNL 419
L+ + I L+ N + + LP L+ + +Q + I + L
Sbjct: 129 -LTKINTLPKVNSIDLSYNGAITDI-MPLKTLP-ELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 420 TTLHLGNNQLSG 431
L+ + + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 32/213 (15%), Positives = 64/213 (30%), Gaps = 38/213 (17%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125
+ L + T + +++L + L + ++ I +++ + N
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG---IEYAHNIKDLTIN 74
Query: 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFL 185
+ I L+ L+ L + + + L L L L + S
Sbjct: 75 NIHATN----------YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 186 TGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
+I + I L + +D S N + LP L+ L
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNG--------------------AITDIMPLKTLPELKSL 164
Query: 246 GIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG 278
I + + D I + L L + T+ G
Sbjct: 165 NIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 28/166 (16%), Positives = 68/166 (40%), Gaps = 16/166 (9%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
+T + +++ +T + + +++ L +++ + + I +S L+ L + ++
Sbjct: 46 LTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVT 101
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
+S +SL +D ++++ I I L K+ + L YN +I
Sbjct: 102 SDKIPN-LSGLTSLTLLDISHSAHDDS--------ILTKINTLPKVNSIDLSYNGAITDI 152
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG 211
L L EL+ L++ + I + L +L + ++ G
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 38/207 (18%), Positives = 74/207 (35%), Gaps = 18/207 (8%)
Query: 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI 307
++ L N ST KA S + + + ++ + L N++ +
Sbjct: 4 EQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL 59
Query: 308 PGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE-LSFLSSLAN 366
G I A + L + + + P + L NLE L + +TS LS L+SL
Sbjct: 60 TG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL-- 114
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
+ ++ + + + + I LP + I L +I + L L +L++
Sbjct: 115 ----TLLDISHSAHDDSILTKINTLP-KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKL 453
+ + I L L + +
Sbjct: 169 DGVHDYRGIE--DFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 28/185 (15%), Positives = 59/185 (31%), Gaps = 29/185 (15%)
Query: 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDF 204
+ L + L + ++ + ++ L++ T + I LS+L L
Sbjct: 40 EAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRI 95
Query: 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMS 264
+T + N + L +L +L I + + I +
Sbjct: 96 MGKDVTSDKIPN-------------------LSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324
+ ++ L N + L LP ++ LN+ + + I + KL L
Sbjct: 137 KVNSIDLSYNGAITDI----MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 325 NSFSG 329
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 20/107 (18%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578
+ + + M + I L+ +T D+ T I N++ L++ N
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPI 84
Query: 579 GALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
L++LE L + +++ +L L L L++S + + I +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 22/118 (18%), Positives = 46/118 (38%), Gaps = 12/118 (10%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSG 106
L I +T L L+SL LD+SH+ +I + I ++ + + L N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
+ L++++ ++ + + + I + KL +LY + G+
Sbjct: 151 DIMP--LKTLPELKSLNIQFDGVH-----DY-----RGIEDFPKLNQLYAFSQTIGGK 196
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSC 791
IG G+FG + G+ L VAIK+ + E K + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 792 SNGNFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
G + A+VLE + G SLE +R+ + L I I + +EY+H S +++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 851 DIKPSNILL-----DDDMVAHLSDFGIAK 874
D+KP N L+ V H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 62/193 (32%), Positives = 83/193 (43%), Gaps = 45/193 (23%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
F +IG GSFG V R A+KV LQ LK + + VL K+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKN 95
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
V+H LV + S + VL+Y+ G L E Y++
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------- 146
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMR 883
++A AL YLH S +V+ D+KP NILLD H L+DFG+ K N E +
Sbjct: 147 -----EIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK-ENIEHNST 195
Query: 884 TQTL-GTIGYMAP 895
T T GT Y+AP
Sbjct: 196 TSTFCGTPEYLAP 208
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 53/267 (19%), Positives = 110/267 (41%), Gaps = 19/267 (7%)
Query: 357 ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNL 416
++ + A + L + + + L ++++I N I+ ++ + I L
Sbjct: 16 QIFSDDAFAET---IKDNLKKKSVTDA--VTQNELN-SIDQIIANNSDIK-SV-QGIQYL 67
Query: 417 VNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLS 475
N+T L L N+L+ P+ L L L L+ NK++ DL +L L ++HN +S
Sbjct: 68 PNVTKLFLNGNKLTDIKPL--ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV 535
+L L +L LG+N+++ + L + + N ++ +PL +
Sbjct: 126 DING--LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA--GLTK 179
Query: 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595
+ + LS+N+++ D+ + GL NL +L L + L ++ + +L
Sbjct: 180 LQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 596 GVIPISLEKLVYLKDLNLSFNRLEGEI 622
IS + ++ E+
Sbjct: 238 TPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 24/281 (8%)
Query: 256 VPNTIFNMSTLKALS-LLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA 314
VP I + + A + + + L + + L +I+++ +++ + G I
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYL 67
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIV 374
+ L L GN + P L NL+NL L L N + LSSL + K +
Sbjct: 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-------LSSLKDLKKLKSLS 118
Query: 375 LAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIP 434
L N ++ + + + +LP LE +YL N KI + L L TL L +NQ+S +P
Sbjct: 119 LEHNGISDI--NGLVHLP-QLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 435 ITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
+ L LQ L L N + L L L + + NL +
Sbjct: 174 LA--GLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 494 GSNELSSFIP----STFWNLNNILSFDFSSNSLNGSLPLDI 530
L + + N +N ++ +
Sbjct: 232 TDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 272
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 46/261 (17%), Positives = 100/261 (38%), Gaps = 44/261 (16%)
Query: 37 ITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96
I D + N+ +T ++ L+S+ + +++ ++ I + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L L N+L+ P ++N +L + + N + ++ + +L KLK L L
Sbjct: 73 LFLNGNKLTDIKP---LANLKNLGWLFLDENKVK-----DL-----SSLKDLKKLKSLSL 119
Query: 157 GYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTN 216
+N + +I L +L +LE L L + + T + + L+ L L +N ++
Sbjct: 120 EHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS------ 169
Query: 217 NHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTL 276
I + L L+ L + +NH+ D+ + + L L L +
Sbjct: 170 -----DIV----------PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQEC 212
Query: 277 SGSLPSSSKNLIGLPNIERLN 297
+ NL+ ++ +
Sbjct: 213 LNKPINHQSNLVVPNTVKNTD 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 724 ATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL-QFDGALKSFDAEC--EV---- 775
AT + + IG+G++GTVYK R G VA+K + G EV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 776 -LKSVRHRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSN-RSLDIFQRLSI 828
L++ H N+V+ + ++ LV E++ L L + L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874
M L++LH +N +VH D+KP NIL+ L+DFG+A+
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 24/183 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+ + S +G G++G+V G+ VA+K F A E +LK
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKH 84
Query: 779 VRHRNLVKI----ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDV 832
++H N++ + + S F LV M L + + D Q ++ +
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ--FLIYQI 141
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
L+Y+H S ++H D+KPSN+ +++D + DFG+A+ T + T Y
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWY 195
Query: 893 MAP 895
AP
Sbjct: 196 RAP 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 49/181 (27%), Positives = 71/181 (39%), Gaps = 9/181 (4%)
Query: 420 TTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQLSELHVDHNKLSGPI 478
+L ++ LN++ + N+ ++ L + L + NKL I
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DI 78
Query: 479 PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV-VV 537
A L +L L L N+L S F L N+ N L SLP + + +
Sbjct: 79 SA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES-FGALTSLESLDLSVNNLSG 596
+NL+ N L LTNL L L N+L +PE F LT L+ L L N L
Sbjct: 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS 195
Query: 597 V 597
V
Sbjct: 196 V 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 20/216 (9%)
Query: 384 LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTL 443
P + L+ + + + L ++ + N+ + I L +
Sbjct: 13 FPDDA---FAETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNV 65
Query: 444 QGLGLENNKLEG-PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502
+ L L NKL +L L+ L + N+L F L +L+ L L N+L S
Sbjct: 66 RYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDI----GNMKVVVEINLSRNYLTGDIPTTI-GGL 557
F L N+ + + N L SLP + N+ E++LS N L +P + L
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLT---ELDLSYNQLQS-LPEGVFDKL 180
Query: 558 TNLQLLSLENNRLHGPIPE-SFGALTSLESLDLSVN 592
T L+ L L N+L +P+ F LTSL+ + L N
Sbjct: 181 TQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 15/145 (10%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
L++L L L+ N+ ++P+ +F ++ LK L+L +NQL S P + ++L ++
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRS 183
+N L LP +F D LT L EL L YN+LQ +P+ + L +L+ L L ++
Sbjct: 141 AHNQLQ-SLPKGVF-----D--KLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
Query: 184 FLTGTIPSSIF-NLSSLLELDFSNN 207
L ++P +F L+SL + +N
Sbjct: 192 QLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 59/265 (22%), Positives = 97/265 (36%), Gaps = 60/265 (22%)
Query: 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLS 130
+T+ +S P F+ L ++ + +S+ I N + +
Sbjct: 1 ETITVSTPIKQ-IFPDDAFA--ETIKANLKKKSVT-DAVTQN--ELNSIDQIIANNSDIK 54
Query: 131 GELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELG---NLAELEWLSLPRSFLTG 187
+ I L ++ L LG NKL ++ L L +L L + L
Sbjct: 55 -SVQG---------IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ- 98
Query: 188 TIPSSIFN-LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246
++P+ +F+ L++L EL N L S+P ++ L NL L
Sbjct: 99 SLPNGVFDKLTNLKELVLVENQLQ-----------SLPDGVFD--------KLTNLTYLN 139
Query: 247 IDENHLVGDVPNTIFNMST-LKALSLLNNTLSGSLPSSSKNLIG----LPNIERLNLGLN 301
+ N L +P +F+ T L L L N L SLP G L ++ L L N
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE------GVFDKLTQLKDLRLYQN 191
Query: 302 NLSGRIPGFIF-NASKLFLLELTGN 325
L +P +F + L + L N
Sbjct: 192 QLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 49/199 (24%), Positives = 73/199 (36%), Gaps = 40/199 (20%)
Query: 262 NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLE 321
++++ + N+ + S+ LPN+ L LG N L I + L L
Sbjct: 39 ELNSIDQIIANNSDIK-SVQGIQY----LPNVRYLALGGNKLH-DISAL-KELTNLTYLI 91
Query: 322 LTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN 381
LTGN L NL+ L L N L S
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQS---------------------------- 123
Query: 382 GVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRL 440
LP + + L + L + +++ L NLT L L NQL S+P V +L
Sbjct: 124 --LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 441 NTLQGLGLENNKLEGPIPD 459
L+ L L N+L+ +PD
Sbjct: 181 TQLKDLRLYQNQLKS-VPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 13/142 (9%)
Query: 487 SLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546
+L ++ + LN+I +++ + + + V + L N L
Sbjct: 20 ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY--LPNVRYLALGGNKL 75
Query: 547 TGDIPTTIG---GLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLE 603
I LTNL L L N+L F LT+L+ L L N L + +
Sbjct: 76 H-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD 130
Query: 604 KLVYLKDLNLSFNRLEGEIPSG 625
KL L LNL+ N+L+ +P G
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKG 151
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 19/173 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
D++ K LIG GS+G VY VAIK + F+ D E +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---DLIDCKRILREITILNR 81
Query: 779 VRHRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
++ +++ +I F +VLE + L+K + L +I+ ++
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF-LTEEHIKTILYNLL 139
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
L ++H + ++H D+KP+N LL+ D + DFG+A+ +N E+
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIK---VFHLQFDGALKSFDAECEVLKSVR 780
+ F KSL+G G++G V G VAIK F AL++ E ++LK +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTL-REIKILKHFK 67
Query: 781 HRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
H N++ I S NF ++ E M L + + S + L + A
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQMLSDDHIQYFIYQTLRA 124
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
++ LH + V+H D+KPSN+L++ + + DFG+A++++ + ++ G M
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 32/182 (17%)
Query: 734 IGIGSFGTVYKGR--FLDGMEVAIKVFHLQF--DGA----------LKSFDAECEVLKSV 779
IG G++G V+K R G VA+K +Q +G L+ L++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LETF 71
Query: 780 RHRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVA 833
H N+V+ + + LV E++ + L L + +M +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYM 893
L++LH S+ VVH D+KP NIL+ L+DFG+A++ + + ++ T + T+ Y
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYR 186
Query: 894 AP 895
AP
Sbjct: 187 AP 188
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 31/140 (22%), Positives = 62/140 (44%), Gaps = 8/140 (5%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLG 447
++P E+ L N + I L L ++ NN+++ I + + +
Sbjct: 29 HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEIL 87
Query: 448 LENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503
L +N+LE + L L L + N+++ F L+S+R LSL N++++ P
Sbjct: 88 LTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146
Query: 504 STFWNLNNILSFDFSSNSLN 523
F L+++ + + +N N
Sbjct: 147 GAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 31/143 (21%), Positives = 56/143 (39%), Gaps = 14/143 (9%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
L L++N F+ + IF + L+ + +N+++ S + I
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFL 185
N L + +F+ L LK L L N++ + + L+ + LSL + +
Sbjct: 91 NRLE-NVQHKMFK-------GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 186 TGTIPSSIF-NLSSLLELDFSNN 207
T T+ F L SL L+ N
Sbjct: 142 T-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 34/152 (22%), Positives = 61/152 (40%), Gaps = 25/152 (16%)
Query: 466 ELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG 524
EL +++N+ + F L LR ++ +N+++ F + + +SN L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSL 584
++ GL +L+ L L +NR+ +SF L+S+
Sbjct: 95 NVQ-----------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
L L N ++ V P + + L L LNL N
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 37/182 (20%), Positives = 71/182 (39%), Gaps = 38/182 (20%)
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQ-ELGNLAELEWLSLP 181
DC+ L+ IP+ I T EL L N+ L +L ++
Sbjct: 17 DCSNQKLN---------KIPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 182 RSFLTGTIPSSIFN-LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLP 240
+ +T I F S + E+ ++N L ++ +++ L
Sbjct: 66 NNKIT-DIEEGAFEGASGVNEILLTSNRLE-----------NVQHKMFK--------GLE 105
Query: 241 NLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299
+L+ L + N + V N F +S+++ LSL +N ++ ++ + L ++ LNL
Sbjct: 106 SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA--FDTLHSLSTLNLL 161
Query: 300 LN 301
N
Sbjct: 162 AN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 2/111 (1%)
Query: 516 DFSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI 574
++N I + + +IN S N +T G + + + L +NRL
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQ 97
Query: 575 PESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+ F L SL++L L N ++ V S L ++ L+L N++ + G
Sbjct: 98 HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125
S + + L+ NR + +F + +LK L+L N+++ + SS+R +
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN 159
N ++ + F L L L L N
Sbjct: 138 DNQIT-TVAPGAFD-------TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 35/176 (19%), Positives = 59/176 (33%), Gaps = 38/176 (21%)
Query: 256 VPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFN-A 314
+P I L L NN + L ++ LP + ++N N ++ I F A
Sbjct: 26 IPEHIP--QYTAELRLNNNEFT-VLEATGI-FKKLPQLRKINFSNNKIT-DIEEGAFEGA 80
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIV 374
S + + LT N L +L+ L L N +T SF L++
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF-IGLSS-------- 130
Query: 375 LAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQL 429
+ + L + +I + L +L+TL+L N
Sbjct: 131 --------------------VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 6e-14
Identities = 39/215 (18%), Positives = 68/215 (31%), Gaps = 17/215 (7%)
Query: 410 PKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHV 469
++ L L + + + + LQ L EN I + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSS-----FIPSTFWNLNNILSFDFSSNSLNG 524
+ L F L ++ + + ++ + L
Sbjct: 401 EKETLQY-----FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-- 453
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSL 584
++ + + +V ++LS N L +P + L L++L +N L + L L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRL 510
Query: 585 ESLDLSVNNLSGVIPI-SLEKLVYLKDLNLSFNRL 618
+ L L N L I L L LNL N L
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 9e-14
Identities = 43/336 (12%), Positives = 95/336 (28%), Gaps = 31/336 (9%)
Query: 168 ELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227
E ++ +S + L+ + S + L + + P ++
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNL 287
W C++P N + + + + T L ++
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE-QLFRCELSV 358
Query: 288 IGLPNIERLNLGLNNLSGRIPGFIFNASKL--FLLELTGNSFSGFIPDTLVNLRNLEHLG 345
++ L P + + + L + L+ ++ +
Sbjct: 359 EKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
Y S L + + + LA L + + L + + + L + ++
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLL-VTHLDLSHNRL 475
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
R +P + L L L +N L + G+ +L +L
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-----------NVDGVA------------NLPRLQ 511
Query: 466 ELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSS 500
EL + +N+L + L L+L N L
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 2e-13
Identities = 47/251 (18%), Positives = 78/251 (31%), Gaps = 9/251 (3%)
Query: 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKI 405
L L P+ +F S S K VL + +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDSATDEQLFRCEL--SVEK 360
Query: 406 RGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465
+ E+ + L L N +I + + L+ L D + +
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
L +K +R L L +L+ L + D S N L +
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR-A 477
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG-PIPESFGALTSL 584
LP + ++ + + S N L ++ + L LQ L L NNRL + + L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 585 ESLDLSVNNLS 595
L+L N+L
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 45/264 (17%), Positives = 78/264 (29%), Gaps = 10/264 (3%)
Query: 360 FLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNL 419
L+ + + +V N P + L + +P+ ++
Sbjct: 264 PLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWT 323
Query: 420 TTLHLGNNQLS----GSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLS 475
+ L L L K + +L EL +
Sbjct: 324 GSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK 382
Query: 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV 535
+ + +L L L F + D + +
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442
Query: 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595
V ++L+ LT + + L + L L +NRL +P + AL LE L S N L
Sbjct: 443 VRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
Query: 596 GVIPISLEKLVYLKDLNLSFNRLE 619
V + L L++L L NRL+
Sbjct: 500 NVDG--VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 5e-10
Identities = 43/224 (19%), Positives = 71/224 (31%), Gaps = 37/224 (16%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTI-------------PSSIFSISTLKILILGDNQLSGSF 108
S+L + LQ L+ + TI ++ STLK +
Sbjct: 366 SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
S + S L+ + L L + + L + L L +N+L+ +P
Sbjct: 426 RSKFLLENSVLKMEYADVRVLH--LAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPA 481
Query: 169 LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228
L L LE L + L + + NL L EL NN L
Sbjct: 482 LAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQS---------------- 523
Query: 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLL 272
+ + P L +L + N L + L ++S +
Sbjct: 524 --AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 38/216 (17%), Positives = 69/216 (31%), Gaps = 47/216 (21%)
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELY----------------LGYNKLQGEI 165
+ EL + ++ + +L+EL L + E
Sbjct: 345 SATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404
Query: 166 PQELGNLAELEWLSL-----PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGF-------- 212
Q L ++ + RS + + L ++ LT
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLL 464
Query: 213 ----YMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKA 268
+++N +P + L LEVL +N L +V + N+ L+
Sbjct: 465 VTHLDLSHNRLR----------ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQE 512
Query: 269 LSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
L L NN L ++ + L+ P + LNL N+L
Sbjct: 513 LLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 4e-05
Identities = 26/131 (19%), Positives = 44/131 (33%), Gaps = 36/131 (27%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL 104
VT L++S L + L L L+ L S N + + ++ L+ L+L +N+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
Query: 105 SGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE 164
AI + + + +L L L N L +
Sbjct: 521 ------------QQSAAI--------------------QPLVSCPRLVLLNLQGNSLC-Q 547
Query: 165 IPQELGNLAEL 175
LAE+
Sbjct: 548 EEGIQERLAEM 558
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 41/191 (21%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
D+F ++G GSFG V R + ++ A+KV L+ D L+ D EC +L +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
H L ++ + V+E++ G L E Y++
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------- 131
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
++ AL +LH +++ D+K N+LLD + L+DFG+ K + T
Sbjct: 132 -----EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTA 182
Query: 886 TL-GTIGYMAP 895
T GT Y+AP
Sbjct: 183 TFCGTPDYIAP 193
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 13/147 (8%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSC 791
IG GSFG +Y G + G EVAIK+ ++ E ++ K ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 792 SNGNFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
+ G++ +V+E + G SLE +R + L + + +EY+H S +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 851 DIKPSNILL---DDDMVAHLSDFGIAK 874
D+KP N L+ + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 58/212 (27%), Positives = 80/212 (37%), Gaps = 56/212 (26%)
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTL 443
PS I P E++ LQ+ + L LT L+L NQL ++ V L L
Sbjct: 30 PSGI---PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 444 QGLGLENN---KLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS 500
LGL NN L + D L QL +L++ N+L F L L+ L L +N+L S
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145
Query: 501 FIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNL 560
IP+ +FD LTNL
Sbjct: 146 -IPAG--------AFD---------------------------------------KLTNL 157
Query: 561 QLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
Q LSL N+L +F L L+++ L N
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLS 105
L++ GL + L+ L L+L +N+ T+ + +F ++ L L L +NQL+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
S P + + + L + N L LP+ +F LTKLKEL L N+LQ I
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD-------RLTKLKELRLNTNQLQ-SI 146
Query: 166 PQEL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNN 207
P L L+ LSL + L ++P F L L + N
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 457 IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516
IP D +L + L+ A F L L L+L N+L + F +L + +
Sbjct: 33 IPADT---EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG 89
Query: 517 FSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPI 574
++N L SLPL + ++ + ++ L N L +P+ + LT L+ L L N+L I
Sbjct: 90 LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-I 146
Query: 575 PES-FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
P F LT+L++L LS N L V + ++L L+ + L N
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 52/221 (23%), Positives = 75/221 (33%), Gaps = 60/221 (27%)
Query: 283 SSKNLIGLP-NI----ERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
K+L +P I E+L+L L+ +KL L L N +
Sbjct: 22 QGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L L LGL N L S LP + + L++
Sbjct: 82 LTELGTLGLANNQLAS------------------------------LPLGVFDHLTQLDK 111
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEG 455
+YL +++ +P + L L L L NQL SIP +L LQ L L N+L+
Sbjct: 112 LYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ- 168
Query: 456 PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
S P A F L L+ ++L N
Sbjct: 169 -------------------SVPHGA-FDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 36/137 (26%), Positives = 54/137 (39%), Gaps = 25/137 (18%)
Query: 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548
L L S L++ +TF L + + N L +L + +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFD---------------- 80
Query: 549 DIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYL 608
LT L L L NN+L F LT L+ L L N L + ++L L
Sbjct: 81 -------DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133
Query: 609 KDLNLSFNRLEGEIPSG 625
K+L L+ N+L+ IP+G
Sbjct: 134 KELRLNTNQLQ-SIPAG 149
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 56/261 (21%), Positives = 81/261 (31%), Gaps = 90/261 (34%)
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
DC SL ++P I T+ +L L L
Sbjct: 20 DCQGKSLD---------SVPSGIPADTE--KLDLQSTGLA-------------------- 48
Query: 183 SFLTGTIPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
T+ + F L+ L L+ N L ++ ++ +L
Sbjct: 49 -----TLSDATFRGLTKLTWLNLDYNQLQ-----------TLSAGVFD--------DLTE 84
Query: 242 LEVLGIDENHLVGDVPNTIFNMST-LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300
L LG+ N L +P +F+ T L L L N L SLPS + L ++ L L
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD--RLTKLKELRLNT 140
Query: 301 NNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSF 360
N L IP F+ L NL+ L L N L S P +F
Sbjct: 141 NQLQ-SIPAGAFD-----------------------KLTNLQTLSLSTNQLQ-SVPHGAF 175
Query: 361 LSSLANSSSSKYIVLAENPLN 381
+ I L N +
Sbjct: 176 ----DRLGKLQTITLFGNQFD 192
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 34/151 (22%), Positives = 60/151 (39%), Gaps = 24/151 (15%)
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
E+ ++ N + P F LR + L +N++S P F L ++ S N +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLE 585
LP + GL +LQLL L N+++ ++F L +L
Sbjct: 95 LP-----------------------KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131
Query: 586 SLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
L L N L + + L ++ ++L+ N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 15/143 (10%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126
++ + L N IP F L+ + L +NQ+S SL ++
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFL 185
N ++ ELP ++F L L+ L L NK+ + + +L L LSL + L
Sbjct: 90 NKIT-ELPKSLFE-------GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 186 TGTIPSSIF-NLSSLLELDFSNN 207
TI F L ++ + + N
Sbjct: 141 Q-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 10/135 (7%)
Query: 368 SSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGN 426
+ I L +N + + P + L I L N +I + + L +L +L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYK-KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 427 NQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPAC 481
N+++ +P ++ L +LQ L L NK+ + DL L+ L + NKL
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 482 FGNLNSLRNLSLGSN 496
F L +++ + L N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 42/208 (20%), Positives = 71/208 (34%), Gaps = 59/208 (28%)
Query: 69 SLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNS 128
S +D + IP+++ T+ + L N + P S LR ID + N
Sbjct: 12 SNNIVDCRGKGLT-EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQ 67
Query: 129 LSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGT 188
+S EL + F+ L L L L NK+
Sbjct: 68 IS-ELAPDAFQ-------GLRSLNSLVLYGNKIT-------------------------E 94
Query: 189 IPSSIF-NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247
+P S+F L SL L + N + + + +Q +L NL +L +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-----------CLRVDAFQ--------DLHNLNLLSL 135
Query: 248 DENHLVGDVPNTIF-NMSTLKALSLLNN 274
+N L + F + ++ + L N
Sbjct: 136 YDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 30/139 (21%), Positives = 51/139 (36%), Gaps = 25/139 (17%)
Query: 487 SLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546
++ + L N + P F + D S+N ++ L
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELA------------------- 72
Query: 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV 606
P GL +L L L N++ F L SL+ L L+ N ++ + + + L
Sbjct: 73 ----PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128
Query: 607 YLKDLNLSFNRLEGEIPSG 625
L L+L N+L+ I G
Sbjct: 129 NLNLLSLYDNKLQ-TIAKG 146
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 19/154 (12%)
Query: 283 SSKNL----IGLP-NIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLV 336
K L LP I + L N + IP F KL ++L+ N S PD
Sbjct: 19 RGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ 77
Query: 337 NLRNLEHLGLGYNYLTSSTPELSF--LSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT 394
LR+L L L N +T L F L SL + ++L N +N + + +L
Sbjct: 78 GLRSLNSLVLYGNKITELPKSL-FEGLFSL------QLLLLNANKINCLRVDAFQDLH-N 129
Query: 395 LEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNN 427
L + L + K++ I K L + T+HL N
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 39/207 (18%), Positives = 70/207 (33%), Gaps = 61/207 (29%)
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182
DC L+ E+P N+ P+ I E+ L N ++ P +L + L
Sbjct: 17 DCRGKGLT-EIPTNL----PETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSN 65
Query: 183 SFLTGTIPSSIFN-LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
+ ++ + F L SL L N +T +P++L++ L +
Sbjct: 66 NQIS-ELAPDAFQGLRSLNSLVLYGNKIT-----------ELPKSLFE--------GLFS 105
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
L++L ++ N + + F L N+ L+L N
Sbjct: 106 LQLLLLNANKINC-LRVDAFQ--------------------------DLHNLNLLSLYDN 138
Query: 302 NLSGRIPGFIFNA-SKLFLLELTGNSF 327
L I F+ + + L N F
Sbjct: 139 KLQ-TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 20/94 (21%), Positives = 41/94 (43%), Gaps = 11/94 (11%)
Query: 67 LSSLQTLDLSHNRFSGTIPSSIF-SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125
L SL +L L N+ + +P S+F + +L++L+L N+++ + +L +
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN 159
N L + F L ++ ++L N
Sbjct: 137 DNKLQ-TIAKGTFS-------PLRAIQTMHLAQN 162
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 28/206 (13%)
Query: 707 MSPQAMWRRFSYRELLLAT-----DHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL 760
M ++ Y + + + IG G+ G V + VAIK
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 761 QFDGALKSFDA-----ECEVLKSVRHRNLVKI----ISSCSNGNFKA--LVLEYMANGSL 809
F A E ++K V H+N++ + S F+ +V+E M + +L
Sbjct: 61 PFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 116
Query: 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869
+ + + ++ + +++LH S ++H D+KPSNI++ D + D
Sbjct: 117 CQVI-QMELDHERMS--YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 170
Query: 870 FGIAKLLNGEESMRTQTLGTIGYMAP 895
FG+A+ M T + T Y AP
Sbjct: 171 FGLARTAGTSFMM-TPYVVTRYYRAP 195
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 36/149 (24%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSC 791
IG GSFG +++G L + +VAIK + D E K + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 792 SNGNFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850
G LV++ + G SLE L R + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 851 DIKPSNILLDDDM-----VAHLSDFGIAK 874
DIKP N L+ + ++ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 41/191 (21%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVLKSV 779
F+ ++G GSFG V E+ A+K+ L+ D ++ D EC VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 398
Query: 780 -RHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
+ L ++ S + V+EY+ G L E Y++
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------- 449
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
++A+ L +L S +++ D+K N++LD + ++DFG+ K N + + T+
Sbjct: 450 -----EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTK 500
Query: 886 TL-GTIGYMAP 895
T GT Y+AP
Sbjct: 501 TFCGTPDYIAP 511
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 41/191 (21%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
F +IG GS+ V R + A+KV ++ + D + V ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
H LV + S + V+EY+ G L E+ YS+
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 117
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+++LAL YLH +++ D+K N+LLD + L+D+G+ K T
Sbjct: 118 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS 168
Query: 886 TL-GTIGYMAP 895
T GT Y+AP
Sbjct: 169 TFCGTPNYIAP 179
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 27/206 (13%)
Query: 706 NMSPQAMWRRFSYRELL----LATDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL 760
NMS + +F E+ + IG G+ G V + VAIK
Sbjct: 38 NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97
Query: 761 QFDGALKSFDA-----ECEVLKSVRHRNLVKII----SSCSNGNFKA--LVLEYMANGSL 809
F A E ++K V H+N++ ++ + F+ LV+E M + +L
Sbjct: 98 PFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 153
Query: 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869
+ + LD + ++ + +++LH S ++H D+KPSNI++ D + D
Sbjct: 154 CQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 870 FGIAKLLNGEESMRTQTLGTIGYMAP 895
FG+A+ M T + T Y AP
Sbjct: 208 FGLARTAGTSFMM-TPYVVTRYYRAP 232
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 45/193 (23%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
F+ ++G GSFG V E+ A+K+ L+ D ++ D EC VL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 77
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
+ L ++ S + V+EY+ G L E Y++
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------- 128
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMR 883
++A+ L +L S +++ D+K N++LD + H ++DFG+ K N + +
Sbjct: 129 -----EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVT 177
Query: 884 TQTL-GTIGYMAP 895
T+T GT Y+AP
Sbjct: 178 TKTFCGTPDYIAP 190
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 54/193 (27%), Positives = 79/193 (40%), Gaps = 45/193 (23%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
+ F ++G GSFG V+ F + AIK L+ D L D EC VL +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
H L + + V+EY+ G L Y++
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------- 125
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMR 883
++ L L++LH S +V+ D+K NILLD D H ++DFG+ K N +
Sbjct: 126 -----EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK-ENMLGDAK 174
Query: 884 TQTL-GTIGYMAP 895
T T GT Y+AP
Sbjct: 175 TNTFCGTPDYIAP 187
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 41/191 (21%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEV-AIKVFHLQFDGALKSFDAEC-----EVL-KS 778
F +IG GS+ V R + A++V ++ + D + V ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSL-----------EK--CLYSSNRSLDIFQR 825
H LV + S + V+EY+ G L E+ YS+
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------- 160
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
+++LAL YLH +++ D+K N+LLD + L+D+G+ K T
Sbjct: 161 -----EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS 211
Query: 886 TL-GTIGYMAP 895
T GT Y+AP
Sbjct: 212 TFCGTPNYIAP 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIK---VFHLQFDGALKSFDAECEVLKSVR 780
++ S IG G++G V L+ + VAIK F Q ++ E ++L R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTL-REIKILLRFR 83
Query: 781 HRNLVK---IISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
H N++ II + + K +V + M L K L + + S D + +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHIC--YFLYQILRG 140
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR---TQTLGTIGY 892
L+Y+H S V+H D+KPSN+LL+ + DFG+A++ + + T+ + T Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 893 MAP 895
AP
Sbjct: 198 RAP 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 42/197 (21%), Positives = 70/197 (35%), Gaps = 43/197 (21%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
+ +S +G GSFG V + ++ G A+K + E +++K + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 784 LVKIIS---SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY-- 838
++K++ + + K N K +N + S + + +EY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 839 --LH--------------------FGY----------SNPVVHCDIKPSNILLD-DDMVA 865
LH + Y S + H DIKP N+L++ D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 866 HLSDFGIAKLLNGEESM 882
L DFG AK L E
Sbjct: 182 KLCDFGSAKKLIPSEPS 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 25/183 (13%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+ + +G G++G+V G +VAIK F A E +LK
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKH 79
Query: 779 VRHRNLVKI----ISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDV 832
++H N++ + + S NF LV+ +M L+K + S + Q ++ +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQ--YLVYQM 135
Query: 833 ALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGY 892
L+Y+H S VVH D+KP N+ +++D + DFG+A+ + E M T + T Y
Sbjct: 136 LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--M-TGYVVTRWY 189
Query: 893 MAP 895
AP
Sbjct: 190 RAP 192
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGL 448
+P + +YL + +I P +L+NL L+LG+NQL ++P+ V L L L L
Sbjct: 37 GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL 95
Query: 449 ENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS 504
N+L +P D L L EL + NKL+ +P L L +L+L N+L S
Sbjct: 96 GTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHG 153
Query: 505 TFWNLNNI 512
F L+++
Sbjct: 154 AFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLS 130
Q L L N+ + P S+ LK L LG NQL + P + + + L +D N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 131 GELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIP 190
LP+ +F L LKEL++ NKL E+P+ + L L L+L ++ L +IP
Sbjct: 102 -VLPSAVF-------DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
Query: 191 SSIF-NLSSLLELDFSNN 207
F LSSL N
Sbjct: 152 HGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 38/160 (23%), Positives = 61/160 (38%), Gaps = 28/160 (17%)
Query: 457 IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516
IP + L++ N+++ P F +L +L+ L LGSN+L + F +L + D
Sbjct: 38 IPTNA---QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94
Query: 517 FSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPE 576
+N L LP L +L+ L + N+L +P
Sbjct: 95 LGTNQLT-VLP-----------------------SAVFDRLVHLKELFMCCNKLTE-LPR 129
Query: 577 SFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
LT L L L N L + + ++L L L N
Sbjct: 130 GIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 39/175 (22%)
Query: 116 TSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
+ S +DC + ++P I + LYL N++ P +L L
Sbjct: 18 SCSGTTVDCRSKRHA---------SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINL 66
Query: 176 EWLSLPRSFLTGTIPSSIFN-LSSLLELDFSNN--------------SLTGFYMTNNHFT 220
+ L L + L +P +F+ L+ L LD N L +M N T
Sbjct: 67 KELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125
Query: 221 GSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIF-NMSTLKALSLLNN 274
E+P I L +L L +D+N L +P+ F +S+L L N
Sbjct: 126 ----------ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 28/154 (18%)
Query: 442 TLQGLGLENNKLEGPIP---DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNEL 498
Q L L +N++ P D L L EL++ N+L F +L L L LG+N+L
Sbjct: 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL 100
Query: 499 SSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLT 558
+ + F L ++ E+ + N LT +P I LT
Sbjct: 101 TVLPSAVFDRLVHL------------------------KELFMCCNKLTE-LPRGIERLT 135
Query: 559 NLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
+L L+L+ N+L +F L+SL L N
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/177 (22%), Positives = 59/177 (33%), Gaps = 52/177 (29%)
Query: 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENP 379
L L N + P +L NL+ L LG N L +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------------------------- 78
Query: 380 LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGR 439
LP + + L + L ++ LV+L L + N+L+ +P + R
Sbjct: 79 ----LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133
Query: 440 LNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
L L L L+ N+L+ S P A F L+SL + L N
Sbjct: 134 LTHLTHLALDQNQLK--------------------SIPHGA-FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 29/165 (17%)
Query: 462 CQLSELHVD-HNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSN 520
C S VD +K +PA G + + L L N+++ P F +L N+ SN
Sbjct: 17 CSCSGTTVDCRSKRHASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74
Query: 521 SLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGA 580
L +LP+ + + LT L +L L N+L F
Sbjct: 75 QLG-ALPVGVFDS-----------------------LTQLTVLDLGTNQLTVLPSAVFDR 110
Query: 581 LTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625
L L+ L + N L+ +P +E+L +L L L N+L+ IP G
Sbjct: 111 LVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 42/157 (26%), Positives = 58/157 (36%), Gaps = 24/157 (15%)
Query: 283 SSKNLIGLP-NI----ERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGF---IPDT 334
SK +P I + L L N ++ PG + L L L N + D+
Sbjct: 27 RSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS 86
Query: 335 LVNLRNLEHLGLGYNYLTSSTPELSF--LSSLANSSSSKYIVLAENPLNGVLPSSIGNLP 392
L L L LG N LT P F L L K + + N L LP I L
Sbjct: 87 LTQL---TVLDLGTNQLTV-LPSAVFDRLVHL------KELFMCCNKLTE-LPRGIERLT 135
Query: 393 ITLEEIYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQ 428
L + L +++ +IP L +LT +L N
Sbjct: 136 -HLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNP 170
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 707 MSPQAMWRRFSYRELLLATD-----HFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHL 760
MS R YR+ + T + + +G G++G V G +VAIK +
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60
Query: 761 QFDGALKSFDA-----ECEVLKSVRHRNLVKII----SSCSNGNFKA--LVLEYMANGSL 809
F A E +LK +RH N++ ++ + +F LV+ +M L
Sbjct: 61 PFQ---SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL 116
Query: 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869
K + D Q ++ + L Y+H + ++H D+KP N+ +++D + D
Sbjct: 117 GKLMKHEKLGEDRIQ--FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD 171
Query: 870 FGIAKLLNGEESMRTQTLGTIGYMAP 895
FG+A+ + E M T + T Y AP
Sbjct: 172 FGLARQADSE--M-TGYVVTRWYRAP 194
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 30/168 (17%), Positives = 60/168 (35%), Gaps = 35/168 (20%)
Query: 734 IGIGSFGTVYKGR---------FLDGMEVAIKV----------FHLQFDGALKSFDAECE 774
+ G +Y+ + ++K+ + A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 775 VLKSVRHRNLVKIISSCSN-GNFKALVLEYMANG-SLEKCLYSSNR---SLDIFQRLSI- 828
L S + + + ++ LVL + G SL+ L S + S +++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILL--DDDMVAHLSDFGIAK 874
++D ALE+LH N VH ++ NI + +D L+ +G A
Sbjct: 168 LLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 18/171 (10%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+ +G G++G V+K G VA+K F S DA E +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTE 64
Query: 779 VR-HRNLVKIISSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835
+ H N+V +++ N + LV +YM L + ++ Q ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ--YVVYQLIKV 121
Query: 836 LEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT 886
++YLH S ++H D+KPSNILL+ + ++DFG+++ +
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 42/195 (21%), Positives = 79/195 (40%), Gaps = 35/195 (17%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGR-FLDGMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
+ + +G G G V+ VAIK + E ++++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLT---DPQSVKHALREIKIIRR 64
Query: 779 VRHRNLVKII------------SSCSNGNFKA--LVLEYMANGSLEKCLYSSNRSLDIFQ 824
+ H N+VK+ S + +V EYM L L + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR 123
Query: 825 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMR 883
M + L+Y+H S V+H D+KP+N+ ++ +D+V + DFG+A++++ S +
Sbjct: 124 --LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 884 ---TQTLGTIGYMAP 895
++ L T Y +P
Sbjct: 179 GHLSEGLVTKWYRSP 193
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 734 IGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV-KIISSC 791
IG GSFG +Y G + EVAIK+ ++ E ++ + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851
G++ LV++ + SLE +R L + L + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 852 IKPSNILLDDDMVAH---LSDFGIAK 874
IKP N L+ A+ + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 32/170 (18%), Positives = 63/170 (37%), Gaps = 37/170 (21%)
Query: 733 LIGIGSFGTVYKGRFLDG------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
IG G FG +Y +KV +G L + E + + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEP-SDNGPLFT---ELKFYQRAAKPEQIQ 97
Query: 787 IISS-------------------CSNGNFKALVLEYMANG-SLEKCLYSSNRSLDIFQRL 826
+ +++ ++++ G L+K ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVL 155
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSDFGIAK 874
+ + + LEY+H + VH DIK SN+LL+ + +L D+G+A
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 41/260 (15%), Positives = 90/260 (34%), Gaps = 39/260 (15%)
Query: 357 ELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNL 416
++ + +++ L + + + S L ++ N I+ ++ +
Sbjct: 8 PINQVFPDPGLANAVKQNLGKQSVTDL--VSQKELS-GVQNFNGDNSNIQ-SL-AGMQFF 62
Query: 417 VNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSG 476
NL LHL +NQ+S P+ L L+ L + N+L+ LS L +D+N+L
Sbjct: 63 TNLKELHLSHNQISDLSPL--KDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRD 120
Query: 477 PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVV 536
+L +L LS+ +N+L S + +G + +
Sbjct: 121 TDS--LIHLKNLEILSIRNNKLKSIVM--------------------------LGFLSKL 152
Query: 537 VEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596
++L N +T + + L + + L + + L ++
Sbjct: 153 EVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-- 208
Query: 597 VIPISLEKLVYLKDLNLSFN 616
+ P + D + +
Sbjct: 209 ISPYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 40/239 (16%), Positives = 80/239 (33%), Gaps = 49/239 (20%)
Query: 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRA 121
L++ +L T S +S ++ ++ + + ++L+
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG---MQFFTNLKE 67
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
+ ++N +S ++ + +LTKL+EL + N+L+ NL + L
Sbjct: 68 LHLSHNQIS-----DL-----SPLKDLTKLEELSVNRNRLK--------NLNGIPSACLS 109
Query: 182 RSFLTG---TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGN 238
R FL S+ +L +L L NN L SI +G
Sbjct: 110 RLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-----------SIV----------MLGF 148
Query: 239 LPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLN 297
L LEVL + N + + + + + + L L ++ +
Sbjct: 149 LSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 38/213 (17%), Positives = 80/213 (37%), Gaps = 37/213 (17%)
Query: 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDF 204
L + LG + + Q+ L+ ++ + S + + + ++L EL
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMS 264
S+N ++ ++ + +L LE L ++ N + N++
Sbjct: 71 SHNQIS--------------------DLSP-LKDLTKLEELSVNRNR--------LKNLN 101
Query: 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTG 324
+ + L L + + +LI L N+E L++ N L I + SKL +L+L G
Sbjct: 102 GIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHG 159
Query: 325 NSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE 357
N + L L+ + + L + +
Sbjct: 160 NEITNTGG--LTRLKKVNWIDLTGQKCVNEPVK 190
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 9/112 (8%)
Query: 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567
L N + + S+ + + V N + + + + TNL+ L L +
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72
Query: 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619
N++ LT LE L ++ N L + I L L L N L
Sbjct: 73 NQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNELR 119
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 34/170 (20%), Positives = 68/170 (40%), Gaps = 28/170 (16%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGA---------LKSFDAECEVL 776
+ IG G FG +Y + A V +++ + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 777 KSVRHRNLVKI---------ISSCSNGNFKALVLEYMANG-SLEKCLYSSNRSLDIFQRL 826
K + + L + ++ +++ +V+E + G L+K + N + L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVL 154
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSDFGIAK 874
+ I + LEY+H N VH DIK +N+LL + +L+D+G++
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 2e-11
Identities = 33/201 (16%), Positives = 56/201 (27%), Gaps = 54/201 (26%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAEC 773
L T+ IG G FG V++ D VAIK+ ++ + E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 774 EVLKSV---------RHRNLVKIISSC------------------------------SNG 794
+ K + R + + S
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 795 NFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIK 853
+ +VLE+ G LE+ + + SI+ + +L H D+
Sbjct: 135 DQLFIVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 854 PSNILLDDDMVAHLSDFGIAK 874
N+LL + L K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 384 LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNT 442
S +P + L+ ++ L +LT L+LG N+L S+P V +L +
Sbjct: 19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 443 LQGLGLENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPA-CFGNLNSLRNLSLGSNE 497
L L L N+L+ +P D L QL EL ++ N+L +P F L L++L L N+
Sbjct: 78 LTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQ 135
Query: 498 LSSFIPSTFWNLNNI 512
L S F L ++
Sbjct: 136 LKSVPDGVFDRLTSL 150
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 13/142 (9%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127
+ LDL N +++L L LG N+L S P+ + + +SL ++ + N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFLT 186
L LP +F D LT+LKEL L N+LQ +P + L +L+ L L ++ L
Sbjct: 87 QLQ-SLPNGVF-----D--KLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 187 GTIPSSIF-NLSSLLELDFSNN 207
++P +F L+SL + +N
Sbjct: 138 -SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 46/195 (23%), Positives = 65/195 (33%), Gaps = 53/195 (27%)
Query: 402 NCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL---EGPIP 458
C +G G T L L N L L +L L L NKL +
Sbjct: 13 ECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 459 DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
+ L L+ L++ N+L F L L+ L+L +N+L S +P FD
Sbjct: 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDG--------VFD-- 121
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPE-S 577
LT L+ L L N+L +P+
Sbjct: 122 -------------------------------------KLTQLKDLRLYQNQLKS-VPDGV 143
Query: 578 FGALTSLESLDLSVN 592
F LTSL+ + L N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/161 (27%), Positives = 62/161 (38%), Gaps = 29/161 (18%)
Query: 457 IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516
IP + L ++ N L F L SL L LG N+L S F L ++ +
Sbjct: 26 IPAQT---TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82
Query: 517 FSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPE 576
S+N L SLP LT L+ L+L N+L +P+
Sbjct: 83 LSTNQLQ-SLP-----------------------NGVFDKLTQLKELALNTNQLQS-LPD 117
Query: 577 -SFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
F LT L+ L L N L V ++L L+ + L N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 1/86 (1%)
Query: 540 NLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599
+L N L LT+L L L N+L F LTSL L+LS N L +
Sbjct: 34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93
Query: 600 ISLEKLVYLKDLNLSFNRLEGEIPSG 625
+KL LK+L L+ N+L+ +P G
Sbjct: 94 GVFDKLTQLKELALNTNQLQ-SLPDG 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 41/176 (23%), Positives = 63/176 (35%), Gaps = 39/176 (22%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
S+ +P L+L N+L G + L L L GN
Sbjct: 15 YSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L +L +L L N L S LP+ + + L+E
Sbjct: 75 LTSLTYLNLSTNQLQS------------------------------LPNGVFDKLTQLKE 104
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENN 451
+ L +++ ++P + L L L L NQL S+P V RL +LQ + L +N
Sbjct: 105 LALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 385 PSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTL 443
P+ I P + + L++ K++ L LT L L NQ+ S+P V +L L
Sbjct: 23 PTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 444 QGLGLENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
L L NKL+ +P D L QL EL +D N+L F L SL+ + L +N
Sbjct: 79 TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 15/126 (11%)
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143
+P+ I S + L L N+L S P + + L + + N + LP +F
Sbjct: 22 VPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVF----- 72
Query: 144 DIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLE 201
D LTKL LYL NKLQ +P + L +L+ L+L + L ++P IF L+SL +
Sbjct: 73 D--KLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQK 128
Query: 202 LDFSNN 207
+ N
Sbjct: 129 IWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 28/86 (32%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 540 NLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599
L N L LT L LSL N++ F LT L L L N L +
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPN 93
Query: 600 ISLEKLVYLKDLNLSFNRLEGEIPSG 625
+KL LK+L L N+L+ +P G
Sbjct: 94 GVFDKLTQLKELALDTNQLKS-VPDG 118
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 35/136 (25%), Positives = 49/136 (36%), Gaps = 27/136 (19%)
Query: 457 IPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFD 516
IP + L ++ NKL F L L LSL N++ S F L +
Sbjct: 26 IPSSA---TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82
Query: 517 FSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPE 576
N L SLP + + LT L+ L+L+ N+L
Sbjct: 83 LHENKLQ-SLPNGVFDK-----------------------LTQLKELALDTNQLKSVPDG 118
Query: 577 SFGALTSLESLDLSVN 592
F LTSL+ + L N
Sbjct: 119 IFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 442 TLQGLGLENN---KLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNEL 498
+ L LE+N L + D L QL++L + N++ F L L L L N+L
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88
Query: 499 SSFIPSTFWNLNNILSFDFSSNSL 522
S F L + +N L
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQL 112
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 73/452 (16%), Positives = 146/452 (32%), Gaps = 58/452 (12%)
Query: 68 SSLQTLDLSHNRFSGT-IPSSIFSISTLKILILGDNQLSGSFP---SFIISNTSSLRAID 123
+Q+LD+ S + + +++ L D L+ + S + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELGNLAELEWLS 179
N L + + + K+++L L L G + L L L+ L
Sbjct: 63 LRSNELGDVGVHCVLQGLQT---PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 180 LPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL 239
L + L + + L L L + + + L +
Sbjct: 120 LSDNLLG---DAGLQLLCEGLL--DPQCRLEKLQLEYCSLSAASCEPLASV-----LRAK 169
Query: 240 PNLEVLGIDENHLVGDVPNTI-----FNMSTLKALSLLNNTLSG-SLPSSSKNLIGLPNI 293
P+ + L + N + + + L+AL L + ++ + + ++
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 294 ERLNLGLNNLSGR-----IPGFIFNASKLFLLELTGNSFS----GFIPDTLVNLRNLEHL 344
L LG N L PG + +S+L L + + G + L +L+ L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 345 GLGYNYLTSSTPELSFLSSLANSSSS-KYIVLAENPLNGVLPSSIGNLPI---TLEEIYL 400
L N L L +L + + + S ++ L E+ +
Sbjct: 290 SLAGNELGDEGARL-LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348
Query: 401 QNCKIRGNIPKEIG-----NLVNLTTLHLGNNQLS----GSIPITVGRLNTLQGLGLENN 451
N ++ +E+ L L L + +S S+ T+ ++L+ L L NN
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408
Query: 452 KLEGP--------IPDDLCQLSELHVDHNKLS 475
L + C L +L + S
Sbjct: 409 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 77/439 (17%), Positives = 146/439 (33%), Gaps = 58/439 (13%)
Query: 241 NLEVLGIDENHL-VGDVPNTIFNMSTLKALSLLNNTLS-GSLPSSSKNLIGLPNIERLNL 298
+++ L I L + + + + L + L+ S L P + LNL
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 299 GLNNLSGR-----IPGFIFNASKLFLLELTGNSFS----GFIPDTLVNLRNLEHLGLGYN 349
N L + G + K+ L L + G + TL L L+ L L N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 350 YLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI---TLEEIYLQNCKIR 406
L + +L L + + L L+ + ++ +E+ + N I
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 407 GNIPKEIG-----NLVNLTTLHLGNNQLS----GSIPITVGRLNTLQGLGLENNKLEGP- 456
+ + + L L L + ++ + V +L+ L L +NKL
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243
Query: 457 -------IPDDLCQLSELHVDHNKLSGP----IPACFGNLNSLRNLSLGSNELS-----S 500
+ +L L + ++ + SL+ LSL NEL
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303
Query: 501 FIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNM----KVVVEINLSRNYLTGDIPTTIG- 555
+ + S S S + ++ + ++E+ +S N L +
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363
Query: 556 ----GLTNLQLLSLENNRLH----GPIPESFGALTSLESLDLSVNNL--SGVIPIS--LE 603
+ L++L L + + + + A SL LDLS N L +G++ + +
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423
Query: 604 KLVY-LKDLNLSFNRLEGE 621
+ L+ L L E
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 86/451 (19%), Positives = 156/451 (34%), Gaps = 59/451 (13%)
Query: 46 VTALNISDFGLTGT-ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI----STLKILILG 100
+ +L+I L+ + L L Q + L + I S L L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 101 DNQLSGS----FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
N+L + + + ++ + L+G + + L L+EL+L
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST----LRTLPTLQELHL 120
Query: 157 GYNKLQGEIPQELGNLAE-----LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG 211
N L Q L LE L L L+ +S L+S+L +
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---AASCEPLASVLR---AKPDFKE 174
Query: 212 FYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHL----VGDVPNTIFNMSTLK 267
++NN + R L C+ + + LE L ++ + D+ + + ++L+
Sbjct: 175 LTVSNNDINEAGVRVL--CQGLKD--SPCQLEALKLESCGVTSDNCRDLCGIVASKASLR 230
Query: 268 ALSLLNNTL--SGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA----SKLFLLE 321
L+L +N L G L + L + ++ + G + L L
Sbjct: 231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290
Query: 322 LTGNSFSG----FIPDTLVN-LRNLEHLGLGYNYLTS-STPELSFLSSLANSSSSKYIVL 375
L GN + +TL+ LE L + T+ S S LA + + +
Sbjct: 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS--SVLAQNRFLLELQI 348
Query: 376 AENPL--NGV--LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLV----NLTTLHLGNN 427
+ N L GV L +G L ++L +C + + + + +L L L NN
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408
Query: 428 QL--SGSIPITVGRLN---TLQGLGLENNKL 453
L +G + + L+ L L +
Sbjct: 409 CLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 50/302 (16%), Positives = 97/302 (32%), Gaps = 37/302 (12%)
Query: 50 NISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI-----STLKILILGDNQL 104
++S ++S L + L +S+N + + L+ L L +
Sbjct: 153 SLSAASCEP-LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
Query: 105 SG---SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKL 161
+ I+++ +SLR + N L A + + ++L+ L++ +
Sbjct: 212 TSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH---PSSRLRTLWIWECGI 268
Query: 162 QGE----IPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNN 217
+ + + L L+ LSL + L L L L ++ +
Sbjct: 269 TAKGCGDLCRVLRAKESLKELSLAGNELG---DEGARLLCETLL--EPGCQLESLWVKSC 323
Query: 218 HFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTI-----FNMSTLKALSLL 272
FT + + + L L I N L + S L+ L L
Sbjct: 324 SFTAACCSHFSSV-----LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 273 NNTLSG-SLPSSSKNLIGLPNIERLNLGLNNLSGR-----IPGFIFNASKLFLLELTGNS 326
+ +S S S + L+ ++ L+L N L + L L L
Sbjct: 379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438
Query: 327 FS 328
+S
Sbjct: 439 WS 440
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 6e-10
Identities = 55/453 (12%), Positives = 129/453 (28%), Gaps = 141/453 (31%)
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG-SLPLDIGNMKVVVEINLSRNYLTGD 549
L+L + + L + +++S S + ++ L I +++ L R +
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ----AELRRLLKSKP 242
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPESF--GALTSLESLDLSVNNLSGVIPISLEKLVY 607
LL L N + + +F L + V + + + +
Sbjct: 243 YENC--------LLVLLNVQ-NAKAWNAFNLSCKILLTTRFKQVTD---FLSAATTTHIS 290
Query: 608 LKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSSPHQKSSKNVIL 667
L +++ E + + DL P + + N
Sbjct: 291 LDHHSMTLTPDEVK----SLLLKYLDCRP--QDL---------------PREVLTTN--- 326
Query: 668 LGVVLPLSVFIIAILLALGIGLITRYRKGNTE-LSNI----------------------- 703
P + IIA + G+ ++ N + L+ I
Sbjct: 327 -----PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381
Query: 704 --EVNMSPQAM---WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVF 758
++ + W ++++ + + SL+ E I +
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV------------EKQPKESTISIP 429
Query: 759 HLQFDGALKSFDAECEVLKSVRHRNLV---KIISSCSNGNFKALVLE-YMAN--GS-LEK 811
+ + + E ++ HR++V I + + + L+ Y + G L+
Sbjct: 430 SIYLE-----LKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 812 CLYSSNRSLDIFQRLSIMIDVALALEYLHFG-------YSNPVVHCDIKPSNILLD---- 860
+ + +F+ + +L F + + + N L
Sbjct: 484 IEHP--ERMTLFRMV-----------FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 861 -----------DDMVAHLSDFGIAKLLNGEESM 882
+ +V + DF L EE++
Sbjct: 531 KPYICDNDPKYERLVNAILDF----LPKIEENL 559
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 88/534 (16%), Positives = 163/534 (30%), Gaps = 144/534 (26%)
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTK-LKEL----YL------G 157
PS + R D YN N+ R + L + L EL + G
Sbjct: 105 PSMMTRMYIEQR--DRLYNDNQVFAKYNVSR--LQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 158 YNK--LQGEIPQELGNLAELE----WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG 211
K + ++ +++ WL+L T+ + L ++ ++++ S
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 212 F-YMTNNHFTGSIPRNLWQCEIPHEIGNLPN-LEVLGIDENHLVGDV--PNTI--FNMS- 264
H + R L + + N L VL +V FN+S
Sbjct: 221 SNIKLRIHSIQAELRRLLKSK------PYENCLLVL--L------NVQNAKAWNAFNLSC 266
Query: 265 -TL-----KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKL- 317
L K ++ + + + S + + L E +L L L R L
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP-------QDLP 319
Query: 318 --------FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSS 369
L + S T N ++ N +T S L+ L +
Sbjct: 320 REVLTTNPRRLSIIAESIRDG-LATWDNWKH-------VNCDKLTTIIESSLNVLEPAEY 371
Query: 370 SK-YIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGN-LVNLTTLHLGNN 427
K + L+ V P S ++P L + + + + + N L + +
Sbjct: 372 RKMFDRLS------VFPPSA-HIPTILLSLIWFD--VIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 428 QLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELH---VDHNKLSGPIPACFGN 484
+ + SIP + LE L+ + ++ LH VDH IP F +
Sbjct: 423 ESTISIP----------SIYLE---LKVKLENEY----ALHRSIVDHYN----IPKTFDS 461
Query: 485 LNS----------------LRNLSLGSNELSSFIPSTFWNLNNILSFDF-------SSNS 521
+ L+N+ E + F L F F S +
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHP--ERMTLFRMVF------LDFRFLEQKIRHDSTA 513
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ--LLSLENNRLHGP 573
N S + + + ++ + Y+ + P + + L +E N +
Sbjct: 514 WNASGSI----LNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 47/344 (13%), Positives = 97/344 (28%), Gaps = 108/344 (31%)
Query: 617 RLEGEIPSGGSFANFSAQSFMGNDLLCGSPH----------LQVPLCKSSPHQKSSKNVI 666
+ E PS + + + ND + + L+ L + P KNV+
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA----KNVL 154
Query: 667 LLGV------VL--------------PLSVF------------IIAILLALGIGLITRYR 694
+ GV + +F ++ +L L + +
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL----LYQID 210
Query: 695 KGNTELSNIEVNMSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVA 754
T S+ N+ + + R LL + + E L+ + L
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCLL-V-----------LLN---- 252
Query: 755 IKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG-----SL 809
V + + A +F+ C++L + R + + + S + L++ +
Sbjct: 253 --VQNAK---AWNAFNLSCKILLTTRFKQVTDFL---SAATTTHISLDHHSMTLTPDEVK 304
Query: 810 E---KCLYSSNRSL-----DIFQRLSIMI------DVALALEYLHFGYSNPVVHCDIKPS 855
K L + L R +I +A + H + I+ S
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESS 362
Query: 856 -NILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
N+L + + + T L +W
Sbjct: 363 LNVLEPAEYRKMFDRLSV---FPPSAHIPTILLSL-------IW 396
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 22/123 (17%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+P + E+YL + +PKE+ N +LT + L NN++S
Sbjct: 28 GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS------------------- 67
Query: 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
L ++ QL L + +N+L P F L SLR LSL N++S F +L
Sbjct: 68 --TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL 125
Query: 510 NNI 512
+ +
Sbjct: 126 SAL 128
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
E+ L N T +P + +L L+ L NNR+ +SF +T L +L LS N L +
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
P + + L L+ L+L N + +P G+F +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPE-GAFND 124
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 37/126 (29%), Positives = 52/126 (41%), Gaps = 16/126 (12%)
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143
+P I + L L NQ + SN L ID + N +S L F
Sbjct: 25 LPKGIPR--DVTELYLDGNQFTLVPKEL--SNYKHLTLIDLSNNRIS-TLSNQSFS---- 75
Query: 144 DIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLE 201
N+T+L L L YN+L+ IP L L LSL + ++ +P F +LS+L
Sbjct: 76 ---NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH 130
Query: 202 LDFSNN 207
L N
Sbjct: 131 LAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 35/163 (21%), Positives = 54/163 (33%), Gaps = 58/163 (35%)
Query: 433 IPITVGRLNTLQGLGLENNKL--EGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRN 490
IP V L L+ N+ + L+ + + +N++S F N+ L
Sbjct: 29 IPRDVTELY------LDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82
Query: 491 LSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDI 550
L L N L IP +FD
Sbjct: 83 LILSYNRLRC-IPP--------RTFD---------------------------------- 99
Query: 551 PTTIGGLTNLQLLSLENNRLHGPIPE-SFGALTSLESLDLSVN 592
GL +L+LLSL N + +PE +F L++L L + N
Sbjct: 100 -----GLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 8/76 (10%)
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK 609
IP + L L+ N+ +P+ L +DLS N +S + S + L
Sbjct: 29 IPRDV------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 610 DLNLSFNRLEGEIPSG 625
L LS+NRL IP
Sbjct: 82 TLILSYNRLR-CIPPR 96
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 35/153 (22%), Positives = 54/153 (35%), Gaps = 38/153 (24%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
S+K L LP ++ L L N + +P + N L L++L+ N S + N
Sbjct: 18 SNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSN 76
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
+ L L L YN L P +F L + L
Sbjct: 77 MTQLLTLILSYNRLR-CIPPRTF-DGLKS----------------------------LRL 106
Query: 398 IYLQNCKIRGNIPKEI-GNLVNLTTLHLGNNQL 429
+ L I +P+ +L L+ L +G N L
Sbjct: 107 LSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 36/175 (20%), Positives = 76/175 (43%), Gaps = 39/175 (22%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDA-----ECEVLKS 778
D + +G G + V++ + +V +K+ LK E ++L++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILEN 86
Query: 779 VR-HRNLVK---IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLS------I 828
+R N++ I+ + ALV E++ N ++ ++Q L+
Sbjct: 87 LRGGPNIITLADIVKDPVSRT-PALVFEHVNNTDFKQ----------LYQTLTDYDIRFY 135
Query: 829 MIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESM 882
M ++ AL+Y H S ++H D+KP N+++D + L D+G+A+ + +
Sbjct: 136 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 39/170 (22%)
Query: 726 DHFSEK----SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECE 774
DH + + +IG GSFG V K VA+K+ FH Q A + E
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ---AAE----EIR 145
Query: 775 VLKSVRHR------NLVKIISSCSNGNFKALVLEYMANGSLEKCLY-----SSNRSLDIF 823
+L+ +R + N++ ++ + + N + E L LY + + +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLP 200
Query: 824 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFG 871
+ L+ LH N ++HCD+KP NILL + + DFG
Sbjct: 201 LVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 27/116 (23%), Positives = 40/116 (34%), Gaps = 21/116 (18%)
Query: 408 NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSEL 467
+ + NLT L++ N Q + L L+GLG +L L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLE-----LRDLRGLG---------------ELRNL 61
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523
+ + L P F L L+L N L S T L ++ S N L+
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 21/101 (20%), Positives = 42/101 (41%), Gaps = 2/101 (1%)
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPT-TIGGLTNLQLLSLENNRLHGPIPES 577
+ + + + E+ + + + GL L+ L++ + L P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618
F L L+LS N L + +++ L L++L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 22/104 (21%), Positives = 36/104 (34%), Gaps = 7/104 (6%)
Query: 279 SLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVN 337
S +L G N+ L + + +L L + + PD
Sbjct: 19 GALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHF 78
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN 381
L L L +N L S + + SL + +VL+ NPL+
Sbjct: 79 TPRLSRLNLSFNALESLSWKTVQGLSL------QELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 16/126 (12%)
Query: 38 TCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTLKI 96
S+ L + G ++ L +L L + + + + + L+
Sbjct: 6 CPHGSS----GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L + + L T L ++ ++N+L L + + L+EL L
Sbjct: 61 LTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS--------LQELVL 110
Query: 157 GYNKLQ 162
N L
Sbjct: 111 SGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 19/134 (14%), Positives = 33/134 (24%), Gaps = 33/134 (24%)
Query: 77 HNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPAN 136
+ + L L + + Q + LR + + L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 137 IFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNL 196
F +L L L +N L+ ++
Sbjct: 75 AFH-------FTPRLSRLNLSFNALE-------------------------SLSWKTVQG 102
Query: 197 SSLLELDFSNNSLT 210
SL EL S N L
Sbjct: 103 LSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 20/119 (16%), Positives = 33/119 (27%), Gaps = 25/119 (21%)
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE-LGNLAEL 175
+ C + + L ELY+ + + L L EL
Sbjct: 8 HGSSGLRCTRDGAL---------DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL 58
Query: 176 EWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNN-------------SLTGFYMTNNHFT 220
L++ +S L + F L L+ S N SL ++ N
Sbjct: 59 RNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 24/140 (17%), Positives = 34/140 (24%), Gaps = 46/140 (32%)
Query: 188 TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247
+ +L EL N H + + L L L I
Sbjct: 22 DSLHHLPGAENLTELYIENQ---------QHLQ-HLELRD--------LRGLGELRNLTI 63
Query: 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI 307
++ L V F+ P + RLNL N L +
Sbjct: 64 VKSGLR-FVAPDAFH--------------------------FTPRLSRLNLSFNALE-SL 95
Query: 308 PGFIFNASKLFLLELTGNSF 327
L L L+GN
Sbjct: 96 SWKTVQGLSLQELVLSGNPL 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 14/126 (11%)
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143
IP I L+L DN+L + L ++ N L+ + N F
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFE---- 75
Query: 144 DIGNLTKLKELYLGYNKLQGEIPQEL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLE 201
+ ++EL LG NK++ EI ++ L +L+ L+L + ++ + F +L+SL
Sbjct: 76 ---GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTS 130
Query: 202 LDFSNN 207
L+ ++N
Sbjct: 131 LNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 538 EINLSRNYLTGDIPTTI-GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596
E+ L+ N L + G L +L L L+ N+L G P +F + ++ L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92
Query: 597 VIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
+ L LK LNL N++ + GSF +
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC-VMP-GSFEH 124
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 29/79 (36%), Positives = 43/79 (54%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
++ L RN LTG P G +++Q L L N++ + F L L++L+L N +S V
Sbjct: 58 KLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117
Query: 598 IPISLEKLVYLKDLNLSFN 616
+P S E L L LNL+ N
Sbjct: 118 MPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 35/165 (21%), Positives = 56/165 (33%), Gaps = 60/165 (36%)
Query: 433 IPITVGRLNTLQGLGLENNKLEGPIP----DDLCQLSELHVDHNKLSGPIPACFGNLNSL 488
IP+ L L +N+L L L +L + N+L+G P F + +
Sbjct: 27 IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548
+ L LG N++ I + F
Sbjct: 81 QELQLGENKIKE-ISNK--------MFL-------------------------------- 99
Query: 549 DIPTTIGGLTNLQLLSLENNRLHGPIPE-SFGALTSLESLDLSVN 592
GL L+ L+L +N++ + SF L SL SL+L+ N
Sbjct: 100 -------GLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 26/130 (20%), Positives = 51/130 (39%), Gaps = 23/130 (17%)
Query: 368 SSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNN 427
+ ++L +N L + + L ++ L+ ++ G P ++ L LG N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 428 QLSGSIPITV-GRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLN 486
++ I + L+ L+ L L +N++ + F +LN
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISC-VMP--------------------GSFEHLN 126
Query: 487 SLRNLSLGSN 496
SL +L+L SN
Sbjct: 127 SLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 23/78 (29%), Positives = 37/78 (47%), Gaps = 8/78 (10%)
Query: 549 DIPTTIGGLTNLQLLSLENNRLHGPIPE-SFGALTSLESLDLSVNNLSGVIPISLEKLVY 607
DIP L L +N L + FG L L L+L N L+G+ P + E +
Sbjct: 26 DIPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 608 LKDLNLSFNRLEGEIPSG 625
+++L L N+++ EI +
Sbjct: 80 IQELQLGENKIK-EISNK 96
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 37/170 (21%)
Query: 732 SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECEVLKSVR---- 780
+G G F TV+ + ++ VA+K+ + A E ++L+ V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AED----EIKLLQRVNDADN 77
Query: 781 -------HRNLVKIISS----CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIM 829
+++K++ NG +V E + L +R + + I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH------LSDFGIA 873
+ L L+Y+H ++H DIKP N+L++ ++D G A
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 51/387 (13%), Positives = 113/387 (29%), Gaps = 91/387 (23%)
Query: 64 LGNLSSLQTLDLSHNRFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFI---ISNT 116
+ S ++ L + + ++ + + ++K ++L N + ++ I++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 117 SSLRAID--CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAE 174
L + + + R + + + KL + L N + L +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH 234
+ L L NN L I R L + +
Sbjct: 120 --------------------KHTPLEHLYLHNNGLG------PQAGAKIARALQELAVNK 153
Query: 235 EIGNLPNLEVLGIDENHL----VGDVPNTIFNMSTLKALSLLNNTLS--GSLPSSSKNLI 288
+ N P L + N L + + T + L + ++ N + G + L
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 289 GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
++ L+L N + S + L + NL LGL
Sbjct: 214 YCQELKVLDLQDNTF--------------------THLGSSALAIALKSWPNLRELGLND 253
Query: 349 NYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
L++ + + + + + L+ + LQ +I +
Sbjct: 254 CLLSARGAA-AVVDAFSKLENI-----------------------GLQTLRLQYNEIELD 289
Query: 409 IPKEIG-----NLVNLTTLHLGNNQLS 430
+ + + +L L L N+ S
Sbjct: 290 AVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 53/359 (14%), Positives = 102/359 (28%), Gaps = 82/359 (22%)
Query: 293 IERLNLGLNNLSGR----IPGFIFNASKLFLLELTGNSFSG----FIPDTLVNLRNLEHL 344
IE +L L+ ++ + + + + L+GN+ ++ + + + ++LE
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 345 GLGYNYLTSSTPE-LSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNC 403
+ E L L + L + P L + L +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQA-------LLKCP--------------KLHTVRLSDN 104
Query: 404 KIRGNIPKEIGNL----VNLTTLHLGNNQLS--GSIPITVGRLNTLQGLGLENNKLEGPI 457
+ + + L L+L NN L I +N
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP----- 159
Query: 458 PDDLCQLSELHVDHNKLSGP----IPACFGNLNSLRNLSLGSNEL-----SSFIPSTFWN 508
L + N+L F + L + + N + +
Sbjct: 160 -----PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 509 LNNILSFDFSSNSL--NGSLPL--DIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564
+ D N+ GS L + + + E+ L+ L+ G + S
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR-----GAAAVVDAFS 269
Query: 565 LENNRLHGPIPESFGALTSLESLDLSVNNLS--GVIPIS---LEKLVYLKDLNLSFNRL 618
N L++L L N + V + EK+ L L L+ NR
Sbjct: 270 KLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 34/176 (19%), Positives = 61/176 (34%), Gaps = 29/176 (16%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGT----IPSSIFSISTLKILILGDNQ------------ 103
+ L L T+ LS N F T + + + L+ L L +N
Sbjct: 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA 145
Query: 104 LSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQG 163
L + N LR+I C N L + K + L + + N ++
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNRL-ENGSM---KEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 164 E-----IPQELGNLAELEWLSLPRSFLTGT----IPSSIFNLSSLLELDFSNNSLT 210
E + + L EL+ L L + T + ++ + +L EL ++ L+
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 26/131 (19%), Positives = 47/131 (35%), Gaps = 14/131 (10%)
Query: 50 NISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGT----IPSSIFSISTLKILILGDNQLS 105
I G+ + L L+ LDL N F+ + ++ S L+ L L D LS
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 106 GS-----FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNK 160
+F L+ + YN + + + I + + L L L N+
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE---KMPDLLFLELNGNR 314
Query: 161 L--QGEIPQEL 169
+ ++ E+
Sbjct: 315 FSEEDDVVDEI 325
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 44/169 (26%), Positives = 66/169 (39%), Gaps = 33/169 (19%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKV------FHLQFDGALKSFDAECEVLK 777
D + SLIG GSFG V K + VAIK+ F Q A E +L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQI----EVRLLE 105
Query: 778 SVRHR------NLVKIISSCSNGNFKALVLEYMANGSLEKCLY-----SSNRSLDIFQRL 826
+ +V + N LV E L LY ++ R + +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTR 160
Query: 827 SIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH--LSDFGIA 873
+ AL +L + ++HCD+KP NILL + + + DFG +
Sbjct: 161 KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 37/186 (19%), Positives = 60/186 (32%), Gaps = 36/186 (19%)
Query: 726 DHFSEK----SLIGIGSFGTVYKGR-FLDGMEVAIKV------FHLQFDGALKSFDAECE 774
+ +G G+FG V + + A+KV + A E +
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS---AKI----EAD 83
Query: 775 VLKSVRHR-----NLVKIISSCSNGNFKALVLEYMANGSLEKCLY-----SSNRSLDIFQ 824
+LK +++ N+VK + L+ E L LY ++ I
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIED 138
Query: 825 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884
I++ AL YL + H D+KP NILLDD + +
Sbjct: 139 IKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 885 QTLGTI 890
I
Sbjct: 196 TKSTGI 201
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 31/160 (19%), Positives = 56/160 (35%), Gaps = 38/160 (23%)
Query: 726 DHFSEK----SLIGIGSFGTVYKG--RFLDGMEVAIKV------FHLQFDGALKSFDAEC 773
D E+ +G G+FG V + +VA+K+ + A E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---ARL----EI 67
Query: 774 EVLKSVRHR------NLVKIISSCSNGNFKALVLEYMANGSLEKCLY-----SSNRSLDI 822
VLK ++ + V + + + E L K + ++ + +
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPL 122
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862
+ + AL +LH N + H D+KP NIL +
Sbjct: 123 PHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 31/160 (19%), Positives = 55/160 (34%), Gaps = 38/160 (23%)
Query: 726 DHFSEK----SLIGIGSFGTVYKGRFL--DGMEVAIKV------FHLQFDGALKSFDAEC 773
D S + +G G+FG V + G VA+K+ + A E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---ARS----EI 62
Query: 774 EVLKSVRHR------NLVKIISSCSNGNFKALVLEYMANGSLEKCLY-----SSNRSLDI 822
+VL+ + V+++ + +V E L Y + +
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRL 117
Query: 823 FQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862
+ + ++ +LH SN + H D+KP NIL
Sbjct: 118 DHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 18/142 (12%)
Query: 732 SLIGIGSFGTVYKGRFLDGME-VAIKVFHLQFDGALKSFDAECEVLKSVR-----HRNLV 785
+G G F TV+ + G + VA+KV + D E +LKSVR N
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNRE 101
Query: 786 KIIS-------SCSNGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALE 837
++ S NG +V E + + L K + SN + L + I+ V L+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 838 YLHFGYSNPVVHCDIKPSNILL 859
YLH ++H DIKP NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILL 180
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD 862
E L + + VA +E+L S +H D+ NILL +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229
Query: 863 MVAHLSDFGIAKLLNGEESMRTQTLGT--IGYMAP 895
V + DFG+A+ + + + + +MAP
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 20/96 (20%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 734 IGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLV 785
+G G+FG V + VA+K+ ++ +E ++L + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 786 KIISSCSNGNFKALV-LEYMANGSLEKCLYSSNRSL 820
++ +C+ +V +E+ G+L L S
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 125
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 30/166 (18%), Positives = 60/166 (36%), Gaps = 31/166 (18%)
Query: 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS 525
ELH + + A L + ++L+L +N + ++++
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK--------ISSL------------- 66
Query: 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLE 585
M+ + ++L RN + I L+ L + N++ L +L
Sbjct: 67 -----SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLR 118
Query: 586 SLDLSVNNLSGVIPIS-LEKLVYLKDLNLSFNRLEGEIPSGGSFAN 630
L +S N ++ I L L L+DL L+ N L + + +
Sbjct: 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 41/186 (22%), Positives = 69/186 (37%), Gaps = 46/186 (24%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSL 119
+ + L L + + L LS N I SS+ + L+IL LG N + + + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK--IENLDAVADTL 95
Query: 120 RAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLS 179
+ +YN ++ ++ I L L+ LY+ NK+ N E++ L+
Sbjct: 96 EELWISYNQIA-----SL-----SGIEKLVNLRVLYMSNNKIT--------NWGEIDKLA 137
Query: 180 LPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL 239
L L +L + N L Y NN + + L
Sbjct: 138 ---------------ALDKLEDLLLAGNPLYNDYKENNATSEYRIEV---------VKRL 173
Query: 240 PNLEVL 245
PNL+ L
Sbjct: 174 PNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 15/120 (12%)
Query: 389 GNLPITLEEIYLQNC--KIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGL 446
+ E++ L I + + L L L N + I ++ + L+ L
Sbjct: 19 SVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75
Query: 447 GLENNKLE--GPIPDDLCQLSELHVDHN---KLSGPIPACFGNLNSLRNLSLGSNELSSF 501
L N ++ + L EL + +N LSG L +LR L + +N+++++
Sbjct: 76 SLGRNLIKKIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNW 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 12/124 (9%)
Query: 331 IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390
+ TL L+ +HL L N + +S LS + N + + L N + + ++
Sbjct: 40 MDATLSTLKACKHLALSTNNIEK----ISSLSGMEN---LRILSLGRNLIKKI--ENLDA 90
Query: 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPI-TVGRLNTLQGLGLE 449
+ TLEE+++ +I ++ I LVNL L++ NN+++ I + L+ L+ L L
Sbjct: 91 VADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148
Query: 450 NNKL 453
N L
Sbjct: 149 GNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 17/86 (19%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP--ESFGALTSLESLDLSVNN 593
VE++ + + T+ L + L+L N I S + +L L L N
Sbjct: 27 KVELHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNL 81
Query: 594 LSGVIPISLEKLVYLKDLNLSFNRLE 619
+ + + L++L +S+N++
Sbjct: 82 IKKIENLD-AVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 30/126 (23%), Positives = 51/126 (40%), Gaps = 12/126 (9%)
Query: 255 DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA 314
+ T+ + K L+L N + +L G+ N+ L+LG N + +I A
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIV 374
L L ++ N + + L NL L + N +T + LA + ++
Sbjct: 93 DTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLL 146
Query: 375 LAENPL 380
LA NPL
Sbjct: 147 LAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 30/129 (23%), Positives = 46/129 (35%), Gaps = 23/129 (17%)
Query: 141 IPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLL 200
+ + L K L L N ++ +I L + L LSL R+ + I + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 201 ELDFSNN------------SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGID 248
EL S N +L YM+NN + ++ L LE L +
Sbjct: 97 ELWISYNQIASLSGIEKLVNLRVLYMSNN--------KITNWGEIDKLAALDKLEDLLLA 148
Query: 249 ENHLVGDVP 257
N L D
Sbjct: 149 GNPLYNDYK 157
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 26/114 (22%)
Query: 384 LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNT 442
+P+ I P T + +YL + +I P L LT L L NNQL+ +P V +L
Sbjct: 24 VPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 443 LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
L L L +N+L+ IP F NL SL ++ L +N
Sbjct: 80 LTQLSLNDNQLKS-IPR--------------------GAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 33/89 (37%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENN---KLEGPIPDDLCQLSELHVDHNKL 474
+ TT+ L+ S+P G T Q L L +N KLE + D L QL+ L +D+N+L
Sbjct: 10 SGTTVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL 66
Query: 475 SGPIPACFGNLNSLRNLSLGSNELSSFIP 503
+ F L L LSL N+L S IP
Sbjct: 67 TVLPAGVFDKLTQLTQLSLNDNQLKS-IP 94
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
++ S L +PT I T Q+L L +N++ P F LT L LDL N L+ +
Sbjct: 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL 69
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+KL L L+L+ N+L+ IP G
Sbjct: 70 PAGVFDKLTQLTQLSLNDNQLKS-IPRG 96
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 15/103 (14%)
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
S P+ I + T L N ++ +L +F LT+L L L N+L +P
Sbjct: 23 SVPTGIPTTTQVL---YLYDNQIT-KLEPGVFD-------RLTQLTRLDLDNNQLT-VLP 70
Query: 167 QEL-GNLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNN 207
+ L +L LSL + L +IP F NL SL + NN
Sbjct: 71 AGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 26/114 (22%)
Query: 384 LPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNT 442
+P+ I P + ++L N +I P +LVNL L+ +N+L+ +IP V +L
Sbjct: 27 VPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 443 LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
L L L +N L+ IP F NL SL ++ L +N
Sbjct: 83 LTQLDLNDNHLKS-IPR--------------------GAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP---DDLCQLSELHVDHNKL 474
+ T ++ N +L+ S+P G Q L L NN++ P D L L +L+ + NKL
Sbjct: 13 DQTLVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL 69
Query: 475 SGPIPACFGNLNSLRNLSLGSNELSSFIP 503
+ F L L L L N L S IP
Sbjct: 70 TAIPTGVFDKLTQLTQLDLNDNHLKS-IP 97
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 19/105 (18%)
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
S P+ I ++ L N N ++ +L +F +L L++LY NKL IP
Sbjct: 26 SVPAGIPTDKQRL---WLNNNQIT-KLEPGVFD-------HLVNLQQLYFNSNKLT-AIP 73
Query: 167 QELG---NLAELEWLSLPRSFLTGTIPSSIF-NLSSLLELDFSNN 207
G L +L L L + L +IP F NL SL + NN
Sbjct: 74 T--GVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597
+N L +P I T+ Q L L NN++ P F L +L+ L + N L+ +
Sbjct: 16 LVNCQNIRLAS-VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI 72
Query: 598 IPISLEKLVYLKDLNLSFNRLEGEIPSG 625
+KL L L+L+ N L+ IP G
Sbjct: 73 PTGVFDKLTQLTQLDLNDNHLKS-IPRG 99
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 3/88 (3%)
Query: 532 NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591
N E++L + I L + +N + + + F L L++L ++
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 592 NNLSGVIPISLEKLVYLKDLNLSFNRLE 619
N + + + L L +L L+ N L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP--DDLCQLSELHVDHN 472
N V L L ++ I L+ + +N++ + L +L L V++N
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNN 74
Query: 473 KLSGPIPACFGNLNSLRNLSLGSNELSSF 501
++ L L L L +N L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 20/112 (17%), Positives = 40/112 (35%), Gaps = 6/112 (5%)
Query: 459 DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
+ + EL + K+ I L+ + NE+ F L + + +
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVN 72
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLT--GDIPTTIGGLTNLQLLSLENN 568
+N + + + E+ L+ N L GD+ + L +L L + N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/126 (24%), Positives = 43/126 (34%), Gaps = 29/126 (23%)
Query: 380 LNGVLPSSIGNLPIT---LEEIYLQNCKIR--GNIPKEIGNLVNLTTLHLGNNQLSGSIP 434
L G I NL T + I + +IR P L L TL + NN++
Sbjct: 26 LRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPL----LRRLKTLLVNNNRICRIGE 81
Query: 435 ITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLG 494
L L L L NN L +L L L +L SL L +
Sbjct: 82 GLDQALPDLTELILTNNSLV-----ELGDLDPLA---------------SLKSLTYLCIL 121
Query: 495 SNELSS 500
N +++
Sbjct: 122 RNPVTN 127
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 29/85 (34%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 536 VVEINLSRNYLT-GDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
V E+ L G I NL+ LSL N L + L L+ L+LS N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRI 83
Query: 595 SGVIPISLEKLVYLKDLNLSFNRLE 619
G + + EKL L LNLS N+L+
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 28/108 (25%), Positives = 44/108 (40%), Gaps = 26/108 (24%)
Query: 395 LEEIYLQNCKIR--GNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
LE + L N + N+PK L L L L N++ G + + +L L L L NK
Sbjct: 51 LEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 453 LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS 500
L+ D+ L L L L++L L + E+++
Sbjct: 107 LK-----DISTLEPLK---------------KLECLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 7/114 (6%)
Query: 238 NLPNLEVLGIDENHL-VGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
+ L +D G + L+ LSL+N L S NL LP +++L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGF-IPDTLVNLRNLEHLGLGYN 349
L N + G + L L L+GN + L L L+ L L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 56/346 (16%), Positives = 107/346 (30%), Gaps = 57/346 (16%)
Query: 335 LVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS-KYIVLAENPLN----GVLPSSIG 389
+ L L N L S + + + AN+ +S + L+ N L L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTV-ELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLV-----NLTTLHLGNNQLS--GSIPITVGRLNT 442
+P + + L + E+ + +T L LG N S S
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF------- 129
Query: 443 LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGP----IPACFGNLN-SLRNLSLGSNE 497
N ++ L++ N L + + ++ +L+L N
Sbjct: 130 --KQAFSNLP---------ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 498 LSS----FIPSTFWNLN-NILSFDFSSNSLNGSLPLDIG-----NMKVVVEINLSRNYLT 547
L+S + ++ ++ S D S+N L ++ VV +NL N L
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 548 GD----IPTTIGGLTNLQLLSLENNRLHGPIPESFGAL-------TSLESLDLSVNNLSG 596
G + L +LQ + L+ + + E AL + +D + +
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298
Query: 597 VIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLL 642
I + L+ L + + + D L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 49/399 (12%), Positives = 112/399 (28%), Gaps = 87/399 (21%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI-----STLKILILGDNQLS----GSFPS 110
+ + +LDLS N + +++ L L N L
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73
Query: 111 FIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELG 170
+ + +++ +++ + N LS + + + + + L LG+N + E
Sbjct: 74 ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAA---IPFTITVLDLGWNDFSSKSSSEFK 130
Query: 171 NLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQC 230
+S+ L+ N L +++ +
Sbjct: 131 QAFS-------------------NLPASITSLNLRGNDLG--IKSSDELIQILAAI--PA 167
Query: 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGL 290
N+ L + N+L L+ L S ++
Sbjct: 168 ----------NVNSLNLRGNNL-AS--------KNCAE-------LAKFLASIPASV--- 198
Query: 291 PNIERLNLGLNNLSGR-----IPGFIFNASKLFLLELTGNSFSG----FIPDTLVNLRNL 341
L+L N L + F + + L L N G + +L++L
Sbjct: 199 ---TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 342 EHLGLGYNYLTSSTPEL--SFLSSLANSSSSKYIVLAENPLNG----VLPSSIGNLPITL 395
+ + L Y+ + + + E + ++ N + ++ + + I L
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 396 EEIYLQNCKI-----RGNIPKEIGNLVNLTTLHLGNNQL 429
+ L N + +++ L L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 46/327 (14%), Positives = 96/327 (29%), Gaps = 64/327 (19%)
Query: 337 NLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS-KYIVLAENPLNG----VLPSSIGNL 391
++ L L N L + + LA ++ + L+ N L+ L ++ +
Sbjct: 49 TPASVTSLNLSGNSLGFKNSD-ELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 392 PITLEEIYLQNCKIRGNIPKEIGNLV-----NLTTLHLGNNQLS--GSIPITVGRLN--- 441
P T+ + L E ++T+L+L N L S +
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 442 TLQGLGLENNKLEGP--------IPDDLCQLSELHVDHNKLSGP-----IPACFGNLNSL 488
+ L L N L + ++ L + N L N +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 489 RNLSLGSNELSS----FIPSTFWNLNNILSFDFSSNSLNG-------SLPLDIGNMKVVV 537
+L+L N L + +L ++ + + + +L N++ ++
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 538 EINLSRNYLTGDIPTTIGGL-----TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592
++ + + I L + SL N L F DL++
Sbjct: 288 LVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCL------IFAQKHQTNIEDLNIP 341
Query: 593 NLSGVIPISLEKLVYLKDLNLSFNRLE 619
+ L++ + L
Sbjct: 342 D-------------ELRESIQTCKPLL 355
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 238 NLPNLEVLGIDENHL-VGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
+++ L +D + G + L+ LS +N L+ S NL L +++L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGF-IPDTLVNLRNLEHLGLGYN 349
L N +SG + L L L+GN + L L NL+ L L
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/117 (18%), Positives = 40/117 (34%), Gaps = 28/117 (23%)
Query: 388 IGNLPITLEEIYLQNCKIRGNIPKEIGN---LVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
P ++E+ L N + N K G L L N L+ ++
Sbjct: 12 RNRTPSDVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLT-----------SIA 58
Query: 445 GLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF 501
L L +L +L + N++SG + +L +L+L N++
Sbjct: 59 NL------------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 26/107 (24%)
Query: 395 LEEIYLQNCKIR--GNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
LE + N + N+PK L L L L +N++SG + + + L L L NK
Sbjct: 44 LEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99
Query: 453 LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS 499
++ DL + L L +L++L L + E++
Sbjct: 100 IK-----DLSTIEPLK---------------KLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 536 VVEINLSRNYLT-GDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
V E+ L + G + L+ LS N L + L L+ L+LS N +
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRV 76
Query: 595 SGVIPISLEKLVYLKDLNLSFNRLE 619
SG + + EK L LNLS N+++
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/135 (19%), Positives = 49/135 (36%), Gaps = 28/135 (20%)
Query: 460 DLCQLSELHVDHNKLS-GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFS 518
+ EL +D+++ + G + L LS + L+S + N+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------IANL------ 60
Query: 519 SNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGP-IPES 577
+ + ++ LS N ++G + NL L+L N++ E
Sbjct: 61 ------------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 578 FGALTSLESLDLSVN 592
L +L+SLDL
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 28/119 (23%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 262 NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLE 321
S +K L L N+ + +E L+ L+ I +KL LE
Sbjct: 15 TPSDVKELVLDNS--RSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLP-KLNKLKKLE 70
Query: 322 LTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPL 380
L+ N SG + NL HL L N + +LS + L + K + L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 22/133 (16%), Positives = 43/133 (32%), Gaps = 12/133 (9%)
Query: 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI------STLKILI 98
+ + + D + + S L NL L + + + LK L
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 99 LGDNQLSGSFPSFIIS--NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
+ D + + L +D + L+ E + + + LK + +
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD----KIKHLKFINM 314
Query: 157 GYNKLQGEIPQEL 169
YN L E+ +EL
Sbjct: 315 KYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 7/74 (9%)
Query: 555 GGLTNLQLLSLENNRLHGPIPESFGA---LTSLESLDLSVNNLS--GVIPI--SLEKLVY 607
NL+ L + + + E F L LE++D+S L+ G + ++K+ +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 608 LKDLNLSFNRLEGE 621
LK +N+ +N L E
Sbjct: 309 LKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 34/244 (13%), Positives = 76/244 (31%), Gaps = 34/244 (13%)
Query: 115 NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAE 174
SL+ I GE ++I I ++ + L+ + E +
Sbjct: 105 KLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFW-GDIDFEEQEISWIEQVD 163
Query: 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH 234
L + L I ++L +L + + S+ ++ ++P
Sbjct: 164 LSPVLDAMPLLNNL---KIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP- 219
Query: 235 EIGNLPNLEVLGIDENHLVGDVPNTIF------NMSTLKALSLLNNTLSGSLPSSSKNLI 288
NL L + E++ N LK L +++ +
Sbjct: 220 ---NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 289 GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGY 348
LP +E +++ L + + + D + +++L+ + + Y
Sbjct: 277 ILPQLETMDISAGVL--------------------TDEGARLLLDHVDKIKHLKFINMKY 316
Query: 349 NYLT 352
NYL+
Sbjct: 317 NYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 21/183 (11%), Positives = 47/183 (25%), Gaps = 24/183 (13%)
Query: 431 GSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFG--NLNSL 488
+ + + L L ++ L L + L + +L +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548
L L + FD N + + +
Sbjct: 222 EKLVL-------------YVGVEDYGFDGDMNVFRPLFSK--DRFPNLKWLGIVDAEEQN 266
Query: 549 DIPTTIGG---LTNLQLLSLENNRLHG----PIPESFGALTSLESLDLSVNNLSGVIPIS 601
+ L L+ + + L + + + L+ +++ N LS +
Sbjct: 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326
Query: 602 LEK 604
L+K
Sbjct: 327 LQK 329
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.98 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.93 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.93 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.96 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.92 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.52 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.52 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.0 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.72 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.85 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-88 Score=829.85 Aligned_cols=621 Identities=32% Similarity=0.498 Sum_probs=487.6
Q ss_pred CCCCChhHHHHHHHHHhcccc----CCCCCCCCceeeeeEEeeCCCCcEEEEEeccCCccee---cC-------------
Q 046199 2 ANNINTTDQQALLALKARITA----KNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGT---IS------------- 61 (902)
Q Consensus 2 ~~~~~~~~~~~l~~~~~~~~~----~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~------------- 61 (902)
++...++|++||++||+++++ ++|..++|||+|.||+|+ ++||+.|||+++++.|. +|
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 344468899999999999975 689888899999999999 68999999999999987 55
Q ss_pred ----------cccCCCCCCCeeeccccccccCCCc--cccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcc
Q 046199 62 ----------SQLGNLSSLQTLDLSHNRFSGTIPS--SIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSL 129 (902)
Q Consensus 62 ----------~~l~~l~~L~~L~Ls~n~l~~~~p~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l 129 (902)
+.++.+++|++|||++|+++|.+|. .++++++|++|+|++|.+++.+|....+++++|++||+++|++
T Consensus 84 ~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 163 (768)
T 3rgz_A 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163 (768)
T ss_dssp CTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCC
T ss_pred CcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCcc
Confidence 4677888999999999999988888 8899999999999999999888887778888999999999988
Q ss_pred cCcCCcc------------------hhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCCh
Q 046199 130 SGELPAN------------------IFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPS 191 (902)
Q Consensus 130 ~~~~~~~------------------~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~ 191 (902)
++..+.. .+...+ .++.+++|++|+|++|++++.+|. ++.+++|++|+|++|++++.+|.
T Consensus 164 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 164 SGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp EEETHHHHHHTTCCTTCCEEECCSSEEESCC-BCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred CCcCChhhhhhccCCCCCEEECCCCcccccC-CcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 8653321 011110 113444555555555555544444 55555555555555555555555
Q ss_pred hhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCC-CCCceEe
Q 046199 192 SIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNM-STLKALS 270 (902)
Q Consensus 192 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ 270 (902)
.++++++|++|+|++|. ++|.+| .. .+++|++|+|++|++++.+|..+..+ ++|++|+
T Consensus 242 ~l~~l~~L~~L~Ls~n~----------l~~~~~---------~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~ 300 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQ----------FVGPIP---------PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLD 300 (768)
T ss_dssp HTTTCSSCCEEECCSSC----------CEESCC---------CC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEE
T ss_pred HHhcCCCCCEEECCCCc----------ccCccC---------cc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEE
Confidence 55555555555555554 334443 22 56677777777777776677666654 7777777
Q ss_pred ccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcc-ccccccccEEEccCCcccCcccccccccc-cccEEeccc
Q 046199 271 LLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGF-IFNASKLFLLELTGNSFSGFIPDTLVNLR-NLEHLGLGY 348 (902)
Q Consensus 271 Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~ 348 (902)
|++|++++.+|.. +..+++|++|++++|.+++.+|.. +..+++|++|++++|++++.+|..+..++ +|++|++++
T Consensus 301 Ls~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~ 377 (768)
T 3rgz_A 301 LSGNHFYGAVPPF---FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377 (768)
T ss_dssp CCSSEEEECCCGG---GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCS
T ss_pred CcCCcCCCccchH---HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccC
Confidence 7777777666665 566677777777777776666654 66777777777777777766777776665 777777777
Q ss_pred ccCCCCCCcccccccccC--CCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeec
Q 046199 349 NYLTSSTPELSFLSSLAN--SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426 (902)
Q Consensus 349 N~l~~~~~~~~~l~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 426 (902)
|++++..| ..+.. +++|++|++++|.+.+.+|..+..++ +|++|++++|++++.+|..|..+++|++|++++
T Consensus 378 N~l~~~~~-----~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 451 (768)
T 3rgz_A 378 NNFSGPIL-----PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451 (768)
T ss_dssp SEEEEECC-----TTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CCcCCCcC-----hhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCC
Confidence 77766554 33444 67788888888888888888888887 888888888888888888888888888888888
Q ss_pred ceecccCCcccccccccCeeecccccccCCCCCcCC---CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccc
Q 046199 427 NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP 503 (902)
Q Consensus 427 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 503 (902)
|++++.+|..+..+++|++|++++|++++.+|..+. +|++|++++|++++.+|..|+++++|++|++++|++++.+|
T Consensus 452 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 531 (768)
T 3rgz_A 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred CcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence 888888888888888888888888888888886654 78888888888888888888888888888888888888888
Q ss_pred ccccCCCCceEEEcCCCccCCCCcccc-----------------------------------------------------
Q 046199 504 STFWNLNNILSFDFSSNSLNGSLPLDI----------------------------------------------------- 530 (902)
Q Consensus 504 ~~~~~l~~L~~L~ls~N~l~~~~~~~~----------------------------------------------------- 530 (902)
..++.+++|++|++++|+++|.+|..+
T Consensus 532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (768)
T 3rgz_A 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 888888888888888888887766543
Q ss_pred -----------------ccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcc
Q 046199 531 -----------------GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNN 593 (902)
Q Consensus 531 -----------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 593 (902)
+.+++|+.|||++|+++|.+|.+|+++++|+.|+|++|+++|.+|..|+.+++|++|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 345778999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCCCCCCCCCCCCCCC
Q 046199 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCKSSPHQ 659 (902)
Q Consensus 594 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~c~~~~~~ 659 (902)
++|.+|..+..+++|++||+++|+++|.||.+++|+++...+|.|||++||.|+. .|......
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~~~~ 754 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPSNAD 754 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSCC--
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCCccC
Confidence 9999999999999999999999999999999999999999999999999999874 68655433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-71 Score=675.74 Aligned_cols=547 Identities=33% Similarity=0.490 Sum_probs=454.1
Q ss_pred CcEEEEEeccCCcceecCc--ccCCCCCCCeeeccccccccCCCccc-cCCCcceEEEecCccccCCCCccc--ccCCCc
Q 046199 44 HRVTALNISDFGLTGTISS--QLGNLSSLQTLDLSHNRFSGTIPSSI-FSISTLKILILGDNQLSGSFPSFI--ISNTSS 118 (902)
Q Consensus 44 ~~v~~l~l~~~~l~g~~~~--~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~ls~n~l~~~~~~~~--~~~~~~ 118 (902)
.+++.|||++|.++|.+|. .++.+++|++|||++|++++.+|..+ +++++|++|||++|++++..|..+ ++++++
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 4689999999999999998 99999999999999999999998876 789999999999999998776543 567777
Q ss_pred ccEEEcccCcccCcCCc-------------chhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcC
Q 046199 119 LRAIDCNYNSLSGELPA-------------NIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFL 185 (902)
Q Consensus 119 L~~ldls~n~l~~~~~~-------------~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 185 (902)
|++|++++|.+++..+. |.+...++.++++++|++|+|++|++++.+|..++.+++|++|+|++|++
T Consensus 180 L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 259 (768)
T 3rgz_A 180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259 (768)
T ss_dssp CCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCC
T ss_pred CCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcc
Confidence 77777777777764432 23333333499999999999999999999999999999999999999999
Q ss_pred CCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCC-CCCCEEEccCccccCcCCCcccCCC
Q 046199 186 TGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL-PNLEVLGIDENHLVGDVPNTIFNMS 264 (902)
Q Consensus 186 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~ 264 (902)
++.+|.. .+++|++|+|++|.+ +|.+| ..+..+ ++|++|+|++|++++.+|..+++++
T Consensus 260 ~~~~~~~--~l~~L~~L~L~~n~l----------~~~ip---------~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 260 VGPIPPL--PLKSLQYLSLAENKF----------TGEIP---------DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp EESCCCC--CCTTCCEEECCSSEE----------EESCC---------CCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred cCccCcc--ccCCCCEEECcCCcc----------CCccC---------HHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 9988875 899999999999984 44454 555554 7888888888888888888888888
Q ss_pred CCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccc-cccEEEccCCcccCcccccccc--cccc
Q 046199 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS-KLFLLELTGNSFSGFIPDTLVN--LRNL 341 (902)
Q Consensus 265 ~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~--l~~L 341 (902)
+|++|+|++|+++|.+|... +..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+.. +++|
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~--l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDT--LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp TCCEEECCSSEEEEECCHHH--HTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CccEEECCCCcccCcCCHHH--HhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 88888888888887777542 56778888888888888877887777776 7888888888887777777766 7778
Q ss_pred cEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcE
Q 046199 342 EHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421 (902)
Q Consensus 342 ~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 421 (902)
++|++++|++++..| ..+.++++|++|++++|++.+.+|..+..++ +|+.|++++|.+++.+|..+..+++|++
T Consensus 397 ~~L~L~~n~l~~~~p-----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 470 (768)
T 3rgz_A 397 QELYLQNNGFTGKIP-----PTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLET 470 (768)
T ss_dssp CEEECCSSEEEEECC-----GGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred cEEECCCCccccccC-----HHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceE
Confidence 888888888877666 6677778888888888888877787777777 7888888888888778888888888888
Q ss_pred EEeecceecccCCcccccccccCeeecccccccCCCCCcCC---CCCeEeccCccccCCCCccccCCCcCceEecCCCCc
Q 046199 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNEL 498 (902)
Q Consensus 422 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 498 (902)
|++++|++++.+|.++..+++|++|++++|++++.+|.++. +|++|++++|++++.+|..+.++++|+.|++++|++
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 550 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCcc
Confidence 88888888877788888888888888888888877776543 777888888888877888888888888888888877
Q ss_pred cCccccc----------------------------------------------------------------------ccC
Q 046199 499 SSFIPST----------------------------------------------------------------------FWN 508 (902)
Q Consensus 499 ~~~~~~~----------------------------------------------------------------------~~~ 508 (902)
++.+|.. |..
T Consensus 551 ~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~ 630 (768)
T 3rgz_A 551 NGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630 (768)
T ss_dssp ESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSS
T ss_pred CCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhc
Confidence 7666543 444
Q ss_pred CCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEe
Q 046199 509 LNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLD 588 (902)
Q Consensus 509 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 588 (902)
+++|++||+++|+++|.+|..+++++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..|+.+++|++||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCccccccCCcccccccccccccccCCccee
Q 046199 589 LSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 589 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
|++|+++|.+|.. ..+..+....+.+|+--|
T Consensus 711 ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 711 LSNNNLSGPIPEM-GQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp CCSSEEEEECCSS-SSGGGSCGGGGCSCTEEE
T ss_pred CcCCcccccCCCc-hhhccCCHHHhcCCchhc
Confidence 9999999999965 456667778888997444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-62 Score=593.57 Aligned_cols=544 Identities=21% Similarity=0.226 Sum_probs=348.8
Q ss_pred CcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEE
Q 046199 44 HRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAID 123 (902)
Q Consensus 44 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ld 123 (902)
.+++.|+|+++.+++..+..++.+++|++|||++|++++..|..++++++|++|+|++|.++ .+|...++++++|++||
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEE
Confidence 46999999999999877778999999999999999999888989999999999999999999 46776678999999999
Q ss_pred cccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhh--ccCcccE
Q 046199 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIF--NLSSLLE 201 (902)
Q Consensus 124 ls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~ 201 (902)
+++|++++. .|..++++++|++|+|++|++++..|..++.+++|++|++++|.+++..|..+. .+++|++
T Consensus 104 L~~n~l~~~--------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 175 (680)
T 1ziw_A 104 LMSNSIQKI--------KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175 (680)
T ss_dssp CCSSCCCCC--------CSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred CCCCccCcc--------ChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence 999999742 346789999999999999999988899999999999999999999977777665 4589999
Q ss_pred EeeeeCCCCccccccccccCCccccccccCCCccccCC---------------------------CCCCEEEccCccccC
Q 046199 202 LDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL---------------------------PNLEVLGIDENHLVG 254 (902)
Q Consensus 202 L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l---------------------------~~L~~L~Ls~N~l~~ 254 (902)
|++++|.++.+ . |..+..+ ++|+.|++++|++++
T Consensus 176 L~L~~n~l~~~----------~---------~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~ 236 (680)
T 1ziw_A 176 LELSSNQIKEF----------S---------PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236 (680)
T ss_dssp EECTTCCCCCB----------C---------TTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCE
T ss_pred EECCCCccccc----------C---------hhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccc
Confidence 99999986642 1 2334444 445555555555555
Q ss_pred cCCCcccCCCC--CceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccC---
Q 046199 255 DVPNTIFNMST--LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSG--- 329 (902)
Q Consensus 255 ~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~--- 329 (902)
..|..+..++. |+.|+|++|++++..|.. +..+++|++|++++|++.+..|..+..+++|++|++++|...+
T Consensus 237 ~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~ 313 (680)
T 1ziw_A 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS---FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313 (680)
T ss_dssp ECTTTTGGGGGSCCCEEECTTSCCCEECTTT---TTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC---
T ss_pred cChhHhhccCcCCCCEEECCCCCcCccCccc---ccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc
Confidence 55555555543 666666666555444443 4455556666666666555555555555566666665554332
Q ss_pred --cccc----cccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcc--cCccccccc-ccccEEEe
Q 046199 330 --FIPD----TLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGV--LPSSIGNLP-ITLEEIYL 400 (902)
Q Consensus 330 --~~p~----~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~-~~L~~L~L 400 (902)
.+|. .|..+++|++|++++|++++..+ ..+.++++|++|++++|.+... .+..+..+. .+|+.|++
T Consensus 314 ~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L 388 (680)
T 1ziw_A 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-----NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388 (680)
T ss_dssp ---CCEECTTTTTTCTTCCEEECCSCCBCCCCT-----TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEEC
T ss_pred cccccccChhhcccCCCCCEEECCCCccCCCCh-----hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEEC
Confidence 1111 44555556666666665555544 4455555566666655553321 111122111 14555666
Q ss_pred ecCcccccCCcccCCCCCCcEEEeecceecccCC-cccccccccCeeecccccccCCCCCcC---CCCCeEeccCcccc-
Q 046199 401 QNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIP-ITVGRLNTLQGLGLENNKLEGPIPDDL---CQLSELHVDHNKLS- 475 (902)
Q Consensus 401 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~L~~N~l~- 475 (902)
++|++++..|.+|..+++|++|++++|++++.+| ..|..+++|++|++++|++.+..+..+ .+|+.|++++|.++
T Consensus 389 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 468 (680)
T 1ziw_A 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBC
T ss_pred CCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccc
Confidence 6666655555555556666666666666554443 455555666666666665554433332 25556666665554
Q ss_pred -CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCc--------cccccccccceeccCCccc
Q 046199 476 -GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP--------LDIGNMKVVVEINLSRNYL 546 (902)
Q Consensus 476 -~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l 546 (902)
+..|..|.++++|+.|++++|+++++.+..|.++++|++|++++|++++..+ ..|.++++|++|+|++|++
T Consensus 469 ~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 548 (680)
T 1ziw_A 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548 (680)
T ss_dssp TTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCC
T ss_pred cccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCC
Confidence 3455555556666666666666655555555556666666666665553211 1245555566666666666
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccc-cccccccccccCCcceecCC
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLE-KLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p 623 (902)
+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+. .+++|+.|++++|+|.|.++
T Consensus 549 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 533334455566666666666666554445555556666666666666655554454 45556666666666655554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=587.13 Aligned_cols=563 Identities=23% Similarity=0.258 Sum_probs=483.1
Q ss_pred EEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 48 ALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 48 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
.+|.++++++ .+|..+. +++++|||++|++++..|..|+++++|++|+|++|.+++..|. .++++++|++||+++|
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE-LCQKLPMLKVLNLQHN 83 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTT-HHHHCTTCCEEECCSS
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHH-HHhcccCcCEEECCCC
Confidence 4667777776 6887665 7999999999999966666799999999999999999976554 4688999999999999
Q ss_pred cccCcCCcchhccCcc-cccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeee
Q 046199 128 SLSGELPANIFRAIPK-DIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSN 206 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 206 (902)
.+++ +|. .|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++
T Consensus 84 ~l~~---------l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (680)
T 1ziw_A 84 ELSQ---------LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154 (680)
T ss_dssp CCCC---------CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCS
T ss_pred ccCc---------cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccC
Confidence 9974 665 589999999999999999976778999999999999999999998899999999999999999
Q ss_pred CCCCccccccccccCCccccccccCCCccc--cCCCCCCEEEccCccccCcCCCcccCC---------------------
Q 046199 207 NSLTGFYMTNNHFTGSIPRNLWQCEIPHEI--GNLPNLEVLGIDENHLVGDVPNTIFNM--------------------- 263 (902)
Q Consensus 207 N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l--~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------------------- 263 (902)
|.++.+ .| ..+ ..+++|+.|++++|++++..|..+..+
T Consensus 155 n~l~~~----------~~---------~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~ 215 (680)
T 1ziw_A 155 NKIQAL----------KS---------EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215 (680)
T ss_dssp SCCCCB----------CH---------HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHH
T ss_pred Cccccc----------CH---------HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHH
Confidence 996632 11 333 356899999999999998888877655
Q ss_pred ------CCCceEeccCcccccCCCcCCcccCCCcc--cceeeccCccCCCCCCccccccccccEEEccCCcccCcccccc
Q 046199 264 ------STLKALSLLNNTLSGSLPSSSKNLIGLPN--IERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTL 335 (902)
Q Consensus 264 ------~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~--L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l 335 (902)
++|+.|++++|.+++..|.. +..++. |++|++++|++++..|..+..+++|++|++++|++.+..|..|
T Consensus 216 ~~~l~~~~L~~L~L~~n~l~~~~~~~---~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (680)
T 1ziw_A 216 CLELANTSIRNLSLSNSQLSTTSNTT---FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292 (680)
T ss_dssp HHHHTTSCCCEEECTTSCCCEECTTT---TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTT
T ss_pred HHHhhhccccEEEccCCcccccChhH---hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhh
Confidence 45777888888888777766 555544 9999999999998888889999999999999999998888899
Q ss_pred cccccccEEecccccCCCCC-----CcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCccc--cc
Q 046199 336 VNLRNLEHLGLGYNYLTSST-----PELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR--GN 408 (902)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~--~~ 408 (902)
..+++|++|++++|...+.. |.+.. ..+..+++|++|++++|.+.+..|..+..++ +|++|++++|.+. ..
T Consensus 293 ~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l 370 (680)
T 1ziw_A 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDD-FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTL 370 (680)
T ss_dssp TTCTTCCEEECTTCBCCC------CCEECT-TTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEE
T ss_pred cCCCCccEEeccchhhhcccccccccccCh-hhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhc
Confidence 99999999999987665422 11100 2577899999999999999998888899998 9999999999854 33
Q ss_pred CCcccCCC--CCCcEEEeecceecccCCcccccccccCeeecccccccCCCCC----cCCCCCeEeccCccccCCCCccc
Q 046199 409 IPKEIGNL--VNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD----DLCQLSELHVDHNKLSGPIPACF 482 (902)
Q Consensus 409 ~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~L~~L~L~~N~l~~~~p~~~ 482 (902)
.+..|..+ ++|+.|++++|++++..|.+|..+++|++|++++|++.+.+|. .+.+|++|++++|++.+..+..|
T Consensus 371 ~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 450 (680)
T 1ziw_A 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450 (680)
T ss_dssp CTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTT
T ss_pred chhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhh
Confidence 34445443 5899999999999999999999999999999999999876663 34589999999999999999999
Q ss_pred cCCCcCceEecCCCCcc--CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCc--------c
Q 046199 483 GNLNSLRNLSLGSNELS--SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP--------T 552 (902)
Q Consensus 483 ~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~ 552 (902)
..+++|+.|++++|.+. +..|..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+ .
T Consensus 451 ~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 530 (680)
T 1ziw_A 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530 (680)
T ss_dssp TTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCC
T ss_pred hcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcch
Confidence 99999999999999987 5688999999999999999999999888889999999999999999996532 3
Q ss_pred ccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCC--cccc
Q 046199 553 TIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGG--SFAN 630 (902)
Q Consensus 553 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~--~~~~ 630 (902)
.|.++++|+.|+|++|+++...+..|..+++|+.|||++|++++..+..|..+++|+.|+|++|++++..|... .+..
T Consensus 531 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 610 (680)
T 1ziw_A 531 FLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTT
T ss_pred hhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccc
Confidence 48899999999999999996556689999999999999999998777788999999999999999998776532 4677
Q ss_pred cccccccCCcccCCCCC
Q 046199 631 FSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 631 ~~~~~~~~n~~lc~~~~ 647 (902)
+....+.+||+.|.++.
T Consensus 611 L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 611 LTELDMRFNPFDCTCES 627 (680)
T ss_dssp CSEEECTTCCCCBCCCC
T ss_pred cCEEEccCCCcccCCcc
Confidence 88889999999999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=585.87 Aligned_cols=529 Identities=23% Similarity=0.213 Sum_probs=431.6
Q ss_pred EEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 48 ALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 48 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
..|.++++++ .+|. ..++|++||||+|++++..|..|.++++|++|+|++|.+.+.++...++++++|++|||++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 3455566666 4565 44678888888888876667778888888888888887777776666778888888888888
Q ss_pred cccCcCCcchhccCcccccCcCccceeeecccccCCCCchh--hccccccceeecccCcCCCCCC-hhhhccCcccEEee
Q 046199 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE--LGNLAELEWLSLPRSFLTGTIP-SSIFNLSSLLELDF 204 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L 204 (902)
.+++. .|..++++++|++|+|++|.+++.+|.. ++.+++|++|+|++|.+++..| ..|+++++|++|+|
T Consensus 84 ~l~~~--------~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~L 155 (844)
T 3j0a_A 84 KIYFL--------HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155 (844)
T ss_dssp CCCEE--------CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEE
T ss_pred cCccc--------CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEEC
Confidence 77643 5777888888888888888888766665 7788888888888888876544 56788888888888
Q ss_pred eeCCCCccccccccccCCccccccccCCCccccCC--CCCCEEEccCccccCcCCCcccCCCC------CceEeccCccc
Q 046199 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNL--PNLEVLGIDENHLVGDVPNTIFNMST------LKALSLLNNTL 276 (902)
Q Consensus 205 s~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l 276 (902)
++|.++. .. |..++.+ ++|+.|+|++|.+.+..|..+..+.+ |+.|++++|.+
T Consensus 156 s~N~i~~----------~~---------~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 216 (844)
T 3j0a_A 156 SSNQIFL----------VC---------EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216 (844)
T ss_dssp ESSCCCC----------CC---------SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCS
T ss_pred CCCcCCe----------eC---------HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcC
Confidence 8887542 22 3566666 77888888888888777777666655 88888888888
Q ss_pred ccCCCcCCcccCCCcccceeeccC---------ccCCCCCCcccccc--ccccEEEccCCcccCcccccccccccccEEe
Q 046199 277 SGSLPSSSKNLIGLPNIERLNLGL---------NNLSGRIPGFIFNA--SKLFLLELTGNSFSGFIPDTLVNLRNLEHLG 345 (902)
Q Consensus 277 ~~~~p~~~~~l~~l~~L~~L~Ls~---------N~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 345 (902)
++.+|..+.......+++.|.++. +.+.+..+..|..+ ++|+.|+|++|.+.+..|..|..+++|+.|+
T Consensus 217 ~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 296 (844)
T 3j0a_A 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296 (844)
T ss_dssp STTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEE
T ss_pred chhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEE
Confidence 877776654444456677777663 33433444445443 6899999999999988889999999999999
Q ss_pred cccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEee
Q 046199 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLG 425 (902)
Q Consensus 346 Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 425 (902)
|++|++++..+ ..+..+++|++|++++|.+.+..|..+..++ +|+.|++++|++++..+..|..+++|++|+|+
T Consensus 297 L~~n~i~~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls 370 (844)
T 3j0a_A 297 LAYNKINKIAD-----EAFYGLDNLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370 (844)
T ss_dssp EESCCCCEECT-----TTTTTCSSCCEEEEESCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEE
T ss_pred CCCCcCCCCCh-----HHhcCCCCCCEEECCCCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECC
Confidence 99999998777 6788899999999999999988899999998 99999999999998888899999999999999
Q ss_pred cceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCC-ccccCCCcCceEecCCCCccCcccc
Q 046199 426 NNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIP-ACFGNLNSLRNLSLGSNELSSFIPS 504 (902)
Q Consensus 426 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~ 504 (902)
+|.+++. + .+++|+.|++++|+++ .+|....+++.|++++|++++... ..+.++++|+.|+|++|++++..+.
T Consensus 371 ~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 444 (844)
T 3j0a_A 371 DNALTTI-H----FIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD 444 (844)
T ss_dssp TCCSCCC-S----SCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSS
T ss_pred CCCCCcc-c----CCCCcchhccCCCCcc-cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccc
Confidence 9999843 2 3789999999999998 778777899999999999997533 2456899999999999999986554
Q ss_pred -cccCCCCceEEEcCCCccC-----CCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccc
Q 046199 505 -TFWNLNNILSFDFSSNSLN-----GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578 (902)
Q Consensus 505 -~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 578 (902)
.+..+++|+.|++++|.++ +..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+
T Consensus 445 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~ 524 (844)
T 3j0a_A 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524 (844)
T ss_dssp SSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCC
T ss_pred cccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhh
Confidence 5667899999999999997 4455678899999999999999999999999999999999999999998877777
Q ss_pred cccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 579 GALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 579 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
. ++|+.|||++|+|++.+|..+. +|+.|++++|++.|.++.
T Consensus 525 ~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 525 P--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECEL 565 (844)
T ss_dssp C--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSC
T ss_pred h--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCccccccc
Confidence 6 8999999999999999997764 788999999999998885
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-61 Score=572.50 Aligned_cols=504 Identities=20% Similarity=0.279 Sum_probs=309.3
Q ss_pred ChhHHHHHHHHHhcccc-------------CCCCCCCCceee---eeEEeeCCCCcEEEEEeccCCcceecCcccCCCCC
Q 046199 6 NTTDQQALLALKARITA-------------KNWTSNTSVCSW---IGITCDVSTHRVTALNISDFGLTGTISSQLGNLSS 69 (902)
Q Consensus 6 ~~~~~~~l~~~~~~~~~-------------~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~ 69 (902)
...|+.||.+||+++.. .+|+.++|||.| .||+|+.. +||+.|+|++++++|.+|+++++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 35799999999999765 268878899999 99999865 79999999999999999999999999
Q ss_pred CCeeecccccc------cc------CCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcch
Q 046199 70 LQTLDLSHNRF------SG------TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANI 137 (902)
Q Consensus 70 L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~ 137 (902)
|++|||++|.+ .| .+|+.. +..|+ +++++|.+.+.+|..+-..+..+..+++....+..
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------ 177 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------ 177 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------
Confidence 99999999987 33 556544 67788 88888888887665543333333333333322211
Q ss_pred hccCcccccCcCccceeee--cccccCCCCchhhccccccceeecccCcCCCC-----------------CChhhh--cc
Q 046199 138 FRAIPKDIGNLTKLKELYL--GYNKLQGEIPQELGNLAELEWLSLPRSFLTGT-----------------IPSSIF--NL 196 (902)
Q Consensus 138 ~~~ip~~~~~l~~L~~L~L--~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l 196 (902)
.....++.+.+ .+|+++| +|+.++++++|++|+|++|.++|. +|..++ ++
T Consensus 178 --------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l 248 (636)
T 4eco_A 178 --------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248 (636)
T ss_dssp --------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred --------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhccc
Confidence 01112233323 2466665 666666666666666666666654 555555 56
Q ss_pred CcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCcc-ccC-cCCCcccCC------CCCce
Q 046199 197 SSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH-LVG-DVPNTIFNM------STLKA 268 (902)
Q Consensus 197 ~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~ 268 (902)
++|++|+|++|. +.|.+| +.++++++|++|+|++|+ +++ .+|..++++ ++|++
T Consensus 249 ~~L~~L~L~~n~----------l~~~~p---------~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~ 309 (636)
T 4eco_A 249 KDLTDVEVYNCP----------NLTKLP---------TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309 (636)
T ss_dssp TTCCEEEEECCT----------TCSSCC---------TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred CCCCEEEecCCc----------CCccCh---------HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence 666666666555 233333 555556666666666665 555 555555554 55555
Q ss_pred EeccCcccccCCCc--CCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccccccc-ccEEe
Q 046199 269 LSLLNNTLSGSLPS--SSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRN-LEHLG 345 (902)
Q Consensus 269 L~Ls~N~l~~~~p~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~ 345 (902)
|+|++|+++ .+|. . +..+++|++|++++|+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|+
T Consensus 310 L~L~~n~l~-~ip~~~~---l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~ 383 (636)
T 4eco_A 310 IYIGYNNLK-TFPVETS---LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLS 383 (636)
T ss_dssp EECCSSCCS-SCCCHHH---HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEE
T ss_pred EECCCCcCC-ccCchhh---hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEE
Confidence 555555555 4444 3 4445555555555555554555 4555555555555555555 44445555555 55555
Q ss_pred cccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccccc-ccccEEEeecCcccccCCcccC-------CCC
Q 046199 346 LGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP-ITLEEIYLQNCKIRGNIPKEIG-------NLV 417 (902)
Q Consensus 346 Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~~L~~L~L~~N~l~~~~p~~~~-------~l~ 417 (902)
+++|+++ .+|..+.... .+|+.|++++|++++..|..|. .++
T Consensus 384 Ls~N~l~------------------------------~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~ 433 (636)
T 4eco_A 384 FAHNKLK------------------------------YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433 (636)
T ss_dssp CCSSCCS------------------------------SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCC
T ss_pred ccCCcCc------------------------------ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCC
Confidence 5555554 3333333221 1566666666666666666666 666
Q ss_pred CCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCC
Q 046199 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497 (902)
Q Consensus 418 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 497 (902)
+|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..... ..+..+.++++|+.|+|++|+
T Consensus 434 ~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~-------------~~~~~~~~l~~L~~L~Ls~N~ 499 (636)
T 4eco_A 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLK-------------DENENFKNTYLLTSIDLRFNK 499 (636)
T ss_dssp CEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSE-------------ETTEECTTGGGCCEEECCSSC
T ss_pred CCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhc-------------cccccccccCCccEEECcCCc
Confidence 7777777777777443344556777888888877777 44443210 001113344566777777777
Q ss_pred ccCccccccc--CCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcc
Q 046199 498 LSSFIPSTFW--NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575 (902)
Q Consensus 498 l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 575 (902)
++. +|..+. .+++|++|++++|++++ +|..+..+++|++|+|++|+ ++++|++.+.+|
T Consensus 500 l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p 559 (636)
T 4eco_A 500 LTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR------------------DAQGNRTLREWP 559 (636)
T ss_dssp CCB-CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB------------------CTTCCBCCCCCC
T ss_pred CCc-cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc------------------ccccCcccccCh
Confidence 763 455554 66677777777777665 56666666666666665554 445555555555
Q ss_pred ccccccccCCeEeCcCccccccCCcccccccccccccccCCccee
Q 046199 576 ESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 576 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
..|+.+++|++|+|++|++ +.+|..+. ++|+.|++++|++.+
T Consensus 560 ~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 560 EGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred HHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 5555555555555555555 34555443 455566666665554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=556.20 Aligned_cols=530 Identities=21% Similarity=0.232 Sum_probs=438.6
Q ss_pred EEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCc
Q 046199 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNS 128 (902)
Q Consensus 49 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~ 128 (902)
++.++.+++ .+|..+.. ++++|||++|++++..|..|+++++|++|+|++|++++..|. .++++++|++||+++|+
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED-TFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTT-TTTTCTTCCEEECTTCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChh-hccCccccCeeeCCCCc
Confidence 455666666 67776654 789999999999977788999999999999999999875454 45789999999999998
Q ss_pred ccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCC
Q 046199 129 LSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS 208 (902)
Q Consensus 129 l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 208 (902)
+++. .|..++++++|++|+|++|++++..|..++.+++|++|+|++|++++..+..+..+++|++|++++|.
T Consensus 93 l~~~--------~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 93 LIFM--------AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp CSEE--------CTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred cccc--------ChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 8753 57788999999999999999997667889999999999999999997443445559999999999998
Q ss_pred CCccccccccccCCccccccccCCCccccCCCCCC--EEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcc
Q 046199 209 LTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLE--VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKN 286 (902)
Q Consensus 209 l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 286 (902)
++.+ .|..++.+++|+ .|++++|++++..|..+. ..+|+.|++++|... +..
T Consensus 165 l~~~-------------------~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~---~~~--- 218 (606)
T 3t6q_A 165 IHYL-------------------SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNL---LVI--- 218 (606)
T ss_dssp CCEE-------------------CHHHHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCH---HHH---
T ss_pred cccc-------------------ChhhhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhH---HHH---
Confidence 6632 136788889998 899999999976666554 468999999988622 222
Q ss_pred cCCCcccceeeccCcc-----CCCCCCccccccc--cccEEEccCCcccCcccccccccccccEEecccccCCCCCCccc
Q 046199 287 LIGLPNIERLNLGLNN-----LSGRIPGFIFNAS--KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELS 359 (902)
Q Consensus 287 l~~l~~L~~L~Ls~N~-----l~~~~~~~l~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 359 (902)
+..+.++....+..+. .....+..+..+. +|+.|++++|.+++..+..|..+++|++|++++|+++.. |
T Consensus 219 ~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l-p--- 294 (606)
T 3t6q_A 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-P--- 294 (606)
T ss_dssp HHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC-C---
T ss_pred hhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC-C---
Confidence 2222222222222111 1122233344433 789999999999988888899999999999999999854 3
Q ss_pred ccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCc-ccCCCCCCcEEEeecceecccC--Ccc
Q 046199 360 FLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPK-EIGNLVNLTTLHLGNNQLSGSI--PIT 436 (902)
Q Consensus 360 ~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~ 436 (902)
..+..+++|++|++++|.+.+..|..+..++ +|++|++++|.+.+.+|. .+..+++|++|++++|++++.. |..
T Consensus 295 --~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 371 (606)
T 3t6q_A 295 --SGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371 (606)
T ss_dssp --SSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTT
T ss_pred --hhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchh
Confidence 4578889999999999999988888888888 899999999998866654 5889999999999999998766 778
Q ss_pred cccccccCeeecccccccCCCCCcC---CCCCeEeccCccccCCCCc-cccCCCcCceEecCCCCccCcccccccCCCCc
Q 046199 437 VGRLNTLQGLGLENNKLEGPIPDDL---CQLSELHVDHNKLSGPIPA-CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNI 512 (902)
Q Consensus 437 ~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 512 (902)
+..+++|++|++++|++.+..|..+ .+|+.|++++|++++..|. .|.++++|+.|++++|++++..|..|..+++|
T Consensus 372 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 451 (606)
T 3t6q_A 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451 (606)
T ss_dssp TTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC
T ss_pred cccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC
Confidence 9999999999999999987766654 4899999999999887665 48999999999999999999999999999999
Q ss_pred eEEEcCCCccCCC---CccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeC
Q 046199 513 LSFDFSSNSLNGS---LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDL 589 (902)
Q Consensus 513 ~~L~ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 589 (902)
++|++++|++++. .+..+..+++|++|++++|++++..|..|+.+++|+.|+|++|++++..|..|..+++| .|+|
T Consensus 452 ~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L 530 (606)
T 3t6q_A 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530 (606)
T ss_dssp CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEEC
T ss_pred CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEEC
Confidence 9999999999863 33668899999999999999999999999999999999999999999999999999999 9999
Q ss_pred cCccccccCCcccccccccccccccCCcceecCCC
Q 046199 590 SVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 590 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
++|++++.+|..+..+++|+.|++++|++.|.++.
T Consensus 531 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99999999899999999999999999999998885
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-59 Score=562.16 Aligned_cols=530 Identities=20% Similarity=0.253 Sum_probs=280.2
Q ss_pred CCChhHHHHHHHHHhccccCCCCCCC-----Cc--eee------------eeEEeeCCCCcEEEEEeccCCcceecCccc
Q 046199 4 NINTTDQQALLALKARITAKNWTSNT-----SV--CSW------------IGITCDVSTHRVTALNISDFGLTGTISSQL 64 (902)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l 64 (902)
....+|++||++||+++.+.+|+.+. +| |.| .||+|+. .+||+.|+|++++++|.+|+++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l 343 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAI 343 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGG
T ss_pred ccchHHHHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHH
Confidence 34568999999999999888996543 55 999 9999987 6799999999999999999999
Q ss_pred CCCCCCCeeec-cccccccCCCccccCC----C-----cceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCC
Q 046199 65 GNLSSLQTLDL-SHNRFSGTIPSSIFSI----S-----TLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELP 134 (902)
Q Consensus 65 ~~l~~L~~L~L-s~n~l~~~~p~~~~~l----~-----~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~ 134 (902)
++|++|++||| ++|.++|..|...... + .++..++. .+....|. .++..+..-.+..+..
T Consensus 344 ~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~--~~l~~~~~---~~~s~l~~~~l~~~~~----- 413 (876)
T 4ecn_A 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK--MFLDYDQR---LNLSDLLQDAINRNPE----- 413 (876)
T ss_dssp GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHH--HHTCCCGG---GGSCHHHHHHHHTCTT-----
T ss_pred hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhh--hhhccCcc---hhhhHHHHHHhhhCcc-----
Confidence 99999999999 9999998865432211 0 01100000 00000000 0000000000000000
Q ss_pred cchhccCcccccCcCccceeeecc--cccCCCCchhhccccccceeecccCcCCC-----------------CCChhhh-
Q 046199 135 ANIFRAIPKDIGNLTKLKELYLGY--NKLQGEIPQELGNLAELEWLSLPRSFLTG-----------------TIPSSIF- 194 (902)
Q Consensus 135 ~~~~~~ip~~~~~l~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----------------~~p~~~~- 194 (902)
..+........++.+.+.. |+++| +|..|+++++|++|+|++|+++| .+|..++
T Consensus 414 -----~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f 487 (876)
T 4ecn_A 414 -----MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487 (876)
T ss_dssp -----SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred -----ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhh
Confidence 0000001111222222222 44443 44444444444444444444443 2444444
Q ss_pred -ccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCcc-ccC-cCCCcccCCC-------
Q 046199 195 -NLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH-LVG-DVPNTIFNMS------- 264 (902)
Q Consensus 195 -~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~------- 264 (902)
++++|++|+|++|. +.|.+| ..|+++++|+.|+|++|+ +++ .+|..+++++
T Consensus 488 ~~L~~L~~L~Ls~N~----------l~~~iP---------~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~ 548 (876)
T 4ecn_A 488 SNLKDLTDVELYNCP----------NMTQLP---------DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548 (876)
T ss_dssp GGCTTCCEEEEESCT----------TCCSCC---------GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTT
T ss_pred ccCCCCCEEECcCCC----------CCccCh---------HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccC
Confidence 45555555555444 222222 444445555555555554 444 4444333333
Q ss_pred CCceEeccCcccccCCCc--CCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccccccc-c
Q 046199 265 TLKALSLLNNTLSGSLPS--SSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRN-L 341 (902)
Q Consensus 265 ~L~~L~Ls~N~l~~~~p~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L 341 (902)
+|+.|+|++|+++ .+|. . +.++++|++|+|++|+++ .+| .+..+++|+.|+|++|+++ .+|..+..+++ |
T Consensus 549 ~L~~L~Ls~N~L~-~ip~~~~---l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L 621 (876)
T 4ecn_A 549 KIQIFYMGYNNLE-EFPASAS---LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQV 621 (876)
T ss_dssp TCCEEECCSSCCC-BCCCHHH---HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTC
T ss_pred CccEEEeeCCcCC-ccCChhh---hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccC
Confidence 5555555555554 4443 3 444455555555555554 444 4455555555555555555 44445555555 5
Q ss_pred cEEecccccCCCCCCcccccccccCCC--CCceeeeccCCCCcccCccc---c--cccccccEEEeecCcccccCCcccC
Q 046199 342 EHLGLGYNYLTSSTPELSFLSSLANSS--SSKYIVLAENPLNGVLPSSI---G--NLPITLEEIYLQNCKIRGNIPKEIG 414 (902)
Q Consensus 342 ~~L~Ls~N~l~~~~~~~~~l~~l~~l~--~L~~L~Ls~N~l~~~~p~~~---~--~l~~~L~~L~L~~N~l~~~~p~~~~ 414 (902)
++|++++|+++. .| ..+..++ +|+.|++++|++.+.+|... . ..+ +|+.|+|++|+++...+..+.
T Consensus 622 ~~L~Ls~N~L~~-lp-----~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~-~L~~L~Ls~N~L~~lp~~~~~ 694 (876)
T 4ecn_A 622 EGLGFSHNKLKY-IP-----NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI-NASTVTLSYNEIQKFPTELFA 694 (876)
T ss_dssp CEEECCSSCCCS-CC-----SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCC-CEEEEECCSSCCCSCCHHHHH
T ss_pred CEEECcCCCCCc-Cc-----hhhhccccCCCCEEECcCCcCCCccccchhhhccccCC-CcCEEEccCCcCCccCHHHHc
Confidence 555555555542 22 1122221 13333333333333222111 1 111 344444444444422222223
Q ss_pred CCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCcccc--CCCcCceEe
Q 046199 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFG--NLNSLRNLS 492 (902)
Q Consensus 415 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ 492 (902)
.+++|+.|+|++|+++ .+|..+..... .....+.+|+.|+|++|+++ .+|..+. .+++|+.|+
T Consensus 695 ~l~~L~~L~Ls~N~L~-~ip~~~~~~~~-------------~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~ 759 (876)
T 4ecn_A 695 TGSPISTIILSNNLMT-SIPENSLKPKD-------------GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD 759 (876)
T ss_dssp TTCCCSEEECCSCCCS-CCCTTSSSCTT-------------SCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEE
T ss_pred cCCCCCEEECCCCcCC-ccChHHhcccc-------------ccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEE
Confidence 4444444454444444 22222111000 00000114444555555554 3444444 566666666
Q ss_pred cCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCC
Q 046199 493 LGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHG 572 (902)
Q Consensus 493 L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 572 (902)
|++|+|++ +|..+..+++|+.|+|++|+ ++++|++.+.+|..|..+++|+.|+|++|+| +
T Consensus 760 Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~ 819 (876)
T 4ecn_A 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-R 819 (876)
T ss_dssp CCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-C
T ss_pred eCCCCCCc-cchhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-C
Confidence 66666665 45556666666666666654 4566888888888888888888888888888 5
Q ss_pred CccccccccccCCeEeCcCccccccCCcccccccccccccccCCccee
Q 046199 573 PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 573 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
.+|..+. ++|+.|||++|++....+..+.....+..+.|.+|++..
T Consensus 820 ~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 820 KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp BCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred ccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 7787765 588888888888887777777777777777788776653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=544.18 Aligned_cols=526 Identities=21% Similarity=0.205 Sum_probs=450.6
Q ss_pred EEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccC
Q 046199 48 ALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYN 127 (902)
Q Consensus 48 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n 127 (902)
.++.++++++ .+|..+. ++|++|||++|++++..|..|.++++|++|+|++|++++..|. .++++++|++||+++|
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~-~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK-AWHGLHHLSNLILTGN 90 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT-TTTTCTTCCEEECTTC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHH-HhhchhhcCEeECCCC
Confidence 4677788887 6787665 7899999999999977777899999999999999999965444 4588999999999999
Q ss_pred cccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCC-CCChhhhccCcccEEeeee
Q 046199 128 SLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG-TIPSSIFNLSSLLELDFSN 206 (902)
Q Consensus 128 ~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~ 206 (902)
++++. .|..|+++++|++|+|++|++++..|..++.+++|++|+|++|++++ .+|..|+++++|++|+|++
T Consensus 91 ~l~~~--------~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 91 PIQSF--------SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CCCCC--------CTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred ccccc--------ChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 99853 58889999999999999999997777889999999999999999986 6799999999999999999
Q ss_pred CCCCccccccccccCCccccccccCCCccccCCCCCC----EEEccCccccCcCCCcccCCCCCceEeccCccccc-CCC
Q 046199 207 NSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLE----VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG-SLP 281 (902)
Q Consensus 207 N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p 281 (902)
|.++.+ .|..++.+++|+ +|++++|++++..+..+.. .+|+.|++++|.+++ .+|
T Consensus 163 n~l~~~-------------------~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~ 222 (606)
T 3vq2_A 163 NYIQTI-------------------TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMK 222 (606)
T ss_dssp SCCCEE-------------------CTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSCHHHHH
T ss_pred Ccceec-------------------ChhhhhhhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccchhHHH
Confidence 997642 135566666654 8999999999655555544 499999999999874 344
Q ss_pred cCCcccCCCcccceeeccCccCCC------CCCccccccc--cccEEEc-cCCcccCcccccccccccccEEecccccCC
Q 046199 282 SSSKNLIGLPNIERLNLGLNNLSG------RIPGFIFNAS--KLFLLEL-TGNSFSGFIPDTLVNLRNLEHLGLGYNYLT 352 (902)
Q Consensus 282 ~~~~~l~~l~~L~~L~Ls~N~l~~------~~~~~l~~l~--~L~~L~L-s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 352 (902)
.. +.+++.|+.+++..+.+.+ ..+..+..+. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.
T Consensus 223 ~~---~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~ 298 (606)
T 3vq2_A 223 TC---LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK 298 (606)
T ss_dssp HH---HHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC
T ss_pred HH---hccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch
Confidence 44 6778888888887665542 1222233322 4677777 78899988887 999999999999999997
Q ss_pred CCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceeccc
Q 046199 353 SSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS 432 (902)
Q Consensus 353 ~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 432 (902)
.. +.+..+++|++|++++|.+ +.+|. + .++ +|++|++++|...+.. .+..+++|++|++++|++++.
T Consensus 299 ~l-------~~l~~~~~L~~L~l~~n~l-~~lp~-~-~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~ 365 (606)
T 3vq2_A 299 YL-------EDVPKHFKWQSLSIIRCQL-KQFPT-L-DLP-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFS 365 (606)
T ss_dssp CC-------CCCCTTCCCSEEEEESCCC-SSCCC-C-CCS-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEE
T ss_pred hh-------hhccccccCCEEEcccccC-ccccc-C-CCC-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCC
Confidence 54 2577889999999999999 67884 4 777 9999999999666544 678999999999999999976
Q ss_pred --CCcccccccccCeeecccccccCCCCCc---CCCCCeEeccCccccCCCC-ccccCCCcCceEecCCCCccCcccccc
Q 046199 433 --IPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNKLSGPIP-ACFGNLNSLRNLSLGSNELSSFIPSTF 506 (902)
Q Consensus 433 --~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~ 506 (902)
.|..+..+++|++|++++|.+++ +|.. +.+|+.|++++|++.+..| ..|.++++|++|++++|++++..|..|
T Consensus 366 ~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 444 (606)
T 3vq2_A 366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444 (606)
T ss_dssp EECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred cchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhh
Confidence 48899999999999999999985 4443 4589999999999999888 689999999999999999999999999
Q ss_pred cCCCCceEEEcCCCccCC-CCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCC
Q 046199 507 WNLNNILSFDFSSNSLNG-SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLE 585 (902)
Q Consensus 507 ~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 585 (902)
..+++|++|++++|++++ .+|..+..+++|++|++++|++++..|..|+++++|+.|+|++|++++.+|..|+.+++|+
T Consensus 445 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 524 (606)
T 3vq2_A 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524 (606)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred cCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence 999999999999999998 4788999999999999999999999999999999999999999999999999999999999
Q ss_pred eEeCcCccccccCCccccccc-ccccccccCCcceecCCC
Q 046199 586 SLDLSVNNLSGVIPISLEKLV-YLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 586 ~L~Ls~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~ 624 (902)
.|||++|+++ .+|..+..++ +|+.|++++|++.|.++.
T Consensus 525 ~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 525 TLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred EEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999999 6777799997 599999999999998886
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-57 Score=537.98 Aligned_cols=514 Identities=20% Similarity=0.195 Sum_probs=442.5
Q ss_pred CcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEE
Q 046199 44 HRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAID 123 (902)
Q Consensus 44 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ld 123 (902)
..++.|||+++.+++..|..++.+++|++|||++|++++..|..|+++++|++|+|++|++++..|. .++++++|++||
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-ALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-TTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-hhcccccccEee
Confidence 4689999999999988889999999999999999999988899999999999999999999976554 468999999999
Q ss_pred cccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCccc--E
Q 046199 124 CNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLL--E 201 (902)
Q Consensus 124 ls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~--~ 201 (902)
+++|.+++. .|..++++++|++|+|++|++++..++.+..+++|++|+|++|.+++..|..++.+++|+ .
T Consensus 112 L~~n~i~~l--------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~ 183 (606)
T 3t6q_A 112 FIQTGISSI--------DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183 (606)
T ss_dssp CTTSCCSCG--------GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEE
T ss_pred ccccCcccC--------CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeE
Confidence 999999852 256789999999999999999974434455599999999999999988889999999999 8
Q ss_pred EeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCccccc---
Q 046199 202 LDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG--- 278 (902)
Q Consensus 202 L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--- 278 (902)
|++++|.++.+ +.......+|+.|++++|. .++..+..+..++...+.-+.+..
T Consensus 184 L~l~~n~l~~~--------------------~~~~~~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~ 240 (606)
T 3t6q_A 184 LNLNGNDIAGI--------------------EPGAFDSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDD 240 (606)
T ss_dssp EECTTCCCCEE--------------------CTTTTTTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCC
T ss_pred EecCCCccCcc--------------------ChhHhhhccccccccCCch---hHHHHhhhccccchhheechhhccccc
Confidence 99999997632 1233344689999999987 334455555555544443332221
Q ss_pred -CCCcCCcccCCCc--ccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCC
Q 046199 279 -SLPSSSKNLIGLP--NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSST 355 (902)
Q Consensus 279 -~~p~~~~~l~~l~--~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 355 (902)
.++.. .+..+. +|++|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..
T Consensus 241 ~~i~~~--~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~ 317 (606)
T 3t6q_A 241 EDISPA--VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317 (606)
T ss_dssp CCCCGG--GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG
T ss_pred cccChh--HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc
Confidence 11111 133333 7899999999999888888999999999999999998 67888999999999999999998776
Q ss_pred CcccccccccCCCCCceeeeccCCCCcccCcc-cccccccccEEEeecCcccccC--CcccCCCCCCcEEEeecceeccc
Q 046199 356 PELSFLSSLANSSSSKYIVLAENPLNGVLPSS-IGNLPITLEEIYLQNCKIRGNI--PKEIGNLVNLTTLHLGNNQLSGS 432 (902)
Q Consensus 356 ~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~ 432 (902)
| ..+..+++|++|++++|.+.+.+|.. +..++ +|++|++++|.+++.. +..+..+++|++|++++|++.+.
T Consensus 318 ~-----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 391 (606)
T 3t6q_A 318 Q-----ISASNFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391 (606)
T ss_dssp G-----GCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEE
T ss_pred h-----hhhhccCcCCEEECCCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcC
Confidence 6 67888999999999999998777655 77787 9999999999999776 78899999999999999999999
Q ss_pred CCcccccccccCeeecccccccCCCCCc----CCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCc---cccc
Q 046199 433 IPITVGRLNTLQGLGLENNKLEGPIPDD----LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF---IPST 505 (902)
Q Consensus 433 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~----l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~ 505 (902)
.|..|..+++|++|++++|++.+..|.. +.+|+.|++++|.+++..|..|.++++|++|++++|++++. .+..
T Consensus 392 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 471 (606)
T 3t6q_A 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471 (606)
T ss_dssp CTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCG
T ss_pred CHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchh
Confidence 9999999999999999999998776543 45899999999999999999999999999999999999873 3367
Q ss_pred ccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCC
Q 046199 506 FWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLE 585 (902)
Q Consensus 506 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 585 (902)
+..+++|++|++++|++++..|..|..+++|++|+|++|++++..|..|..+++| .|+|++|++++.+|..|..+++|+
T Consensus 472 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~ 550 (606)
T 3t6q_A 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQR 550 (606)
T ss_dssp GGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSS
T ss_pred hccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCC
Confidence 8999999999999999999889999999999999999999999999999999999 999999999999999999999999
Q ss_pred eEeCcCccccccCC
Q 046199 586 SLDLSVNNLSGVIP 599 (902)
Q Consensus 586 ~L~Ls~N~l~~~~p 599 (902)
.|++++|+++...+
T Consensus 551 ~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 551 TINLRQNPLDCTCS 564 (606)
T ss_dssp EEECTTCCEECSGG
T ss_pred EEeCCCCCccccCC
Confidence 99999999987554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=552.07 Aligned_cols=527 Identities=22% Similarity=0.237 Sum_probs=458.8
Q ss_pred CeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccC-cccccCcC
Q 046199 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAI-PKDIGNLT 149 (902)
Q Consensus 71 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~i-p~~~~~l~ 149 (902)
+..|.++++++ .+|. -.++|++||||+|.+++..|. .++++++|++||+++|...+. + |..+++++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~--------i~~~~f~~L~ 73 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLT--------IDKEAFRNLP 73 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCE--------ECTTTTSSCT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccc--------cCHHHhcCCC
Confidence 46788999998 8897 458999999999999976554 468999999999999976544 4 77899999
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChh--hhccCcccEEeeeeCCCCccccccccccCCccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSS--IFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~ 227 (902)
+|++|+|++|.+++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.++++ .
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~----------~---- 139 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL----------Y---- 139 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCC----------C----
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccc----------c----
Confidence 9999999999999888999999999999999999999877765 99999999999999996532 1
Q ss_pred cccCCCccccCCCCCCEEEccCccccCcCCCcccCC--CCCceEeccCcccccCCCcCCcccCCCc------ccceeecc
Q 046199 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNM--STLKALSLLNNTLSGSLPSSSKNLIGLP------NIERLNLG 299 (902)
Q Consensus 228 ~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~l~------~L~~L~Ls 299 (902)
.+..|+++++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+..|.. +..++ .|++|+++
T Consensus 140 ----~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~---~~~~~~~~~~~~L~~L~Ls 212 (844)
T 3j0a_A 140 ----LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD---WGKCMNPFRNMVLEILDVS 212 (844)
T ss_dssp ----CCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCC---CCSSSCTTTTCCBSEEBCS
T ss_pred ----cchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccc---hhhcCCccccCceeEEecC
Confidence 23679999999999999999999999999988 89999999999999888776 33343 49999999
Q ss_pred CccCCCCCCcccccc---ccccEEEccC---------CcccCccccccccc--ccccEEecccccCCCCCCccccccccc
Q 046199 300 LNNLSGRIPGFIFNA---SKLFLLELTG---------NSFSGFIPDTLVNL--RNLEHLGLGYNYLTSSTPELSFLSSLA 365 (902)
Q Consensus 300 ~N~l~~~~~~~l~~l---~~L~~L~Ls~---------N~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~l~ 365 (902)
+|.+++..+..+... ++++.|+++. |.+.+..+..|..+ ++|+.|++++|.+.+..+ ..+.
T Consensus 213 ~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~-----~~~~ 287 (844)
T 3j0a_A 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFE 287 (844)
T ss_dssp SCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS-----CCSS
T ss_pred CCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccCh-----hhhh
Confidence 999998888877654 6788888873 44444555566655 789999999999998777 7789
Q ss_pred CCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCe
Q 046199 366 NSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQG 445 (902)
Q Consensus 366 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 445 (902)
.+++|+.|++++|++.+..|..|..++ +|++|+|++|.+++..|..|..+++|++|++++|++++..+..|..+++|++
T Consensus 288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 288 TLKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SCCCCCEEEEESCCCCEECTTTTTTCS-SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred cCCCCCEEECCCCcCCCCChHHhcCCC-CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 999999999999999999999999998 9999999999999999999999999999999999999888889999999999
Q ss_pred eecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccc-ccccCCCCceEEEcCCCccCC
Q 046199 446 LGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNG 524 (902)
Q Consensus 446 L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~ 524 (902)
|+|++|.+++ ++. +.+|+.|++++|+++. +|.. ..+++.|++++|++++... ..+..+++|++|++++|++++
T Consensus 367 L~Ls~N~l~~-i~~-~~~L~~L~l~~N~l~~-l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~ 440 (844)
T 3j0a_A 367 LDLRDNALTT-IHF-IPSIPDIFLSGNKLVT-LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440 (844)
T ss_dssp EEEETCCSCC-CSS-CCSCSEEEEESCCCCC-CCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCC
T ss_pred EECCCCCCCc-ccC-CCCcchhccCCCCccc-cccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccc
Confidence 9999999984 333 7799999999999994 4543 4679999999999998533 245689999999999999997
Q ss_pred CCcc-ccccccccceeccCCcccc-----ccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccC
Q 046199 525 SLPL-DIGNMKVVVEINLSRNYLT-----GDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVI 598 (902)
Q Consensus 525 ~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (902)
..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..
T Consensus 441 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~ 520 (844)
T 3j0a_A 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS 520 (844)
T ss_dssp CCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCC
T ss_pred cccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccC
Confidence 5443 4667899999999999997 455677999999999999999999999999999999999999999999877
Q ss_pred CcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCCC
Q 046199 599 PISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 599 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
|..+. ++|+.|+|++|++++.+|. .|..+....+.+||+.|.++.
T Consensus 521 ~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 521 HNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSSC
T ss_pred hhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCccccccc
Confidence 77776 8999999999999999986 477888889999999997765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=528.39 Aligned_cols=529 Identities=22% Similarity=0.218 Sum_probs=454.1
Q ss_pred CCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT 149 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~ 149 (902)
.+.++.+++.++ .+|..+. ++|++|+|++|.+++. +...++++++|++||+++|.+++. .|..|++++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~i--------~~~~~~~l~ 80 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKIL-KSYSFSNFSELQWLDLSRCEIETI--------EDKAWHGLH 80 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTCCCCEE--------CTTTTTTCT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEe-ChhhccCCccCcEEeCCCCccccc--------CHHHhhchh
Confidence 467999999998 8998776 8999999999999965 444578999999999999999752 467889999
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~ 229 (902)
+|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|.++++
T Consensus 81 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------- 143 (606)
T 3vq2_A 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC----------------- 143 (606)
T ss_dssp TCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCC-----------------
T ss_pred hcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccce-----------------
Confidence 999999999999987899999999999999999999977778899999999999999997632
Q ss_pred cCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCc----eEeccCcccccCCCcCCcccCCCcccceeeccCccCC-
Q 046199 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLK----ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS- 304 (902)
Q Consensus 230 ~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~- 304 (902)
.+|..++++++|++|+|++|++++..|..+..+++|+ .|++++|.+++..+.. +. ..+|++|++++|.+.
T Consensus 144 -~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~---~~-~~~L~~L~L~~n~~~~ 218 (606)
T 3vq2_A 144 -KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA---FQ-GIKLHELTLRGNFNSS 218 (606)
T ss_dssp -CCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTT---TT-TCEEEEEEEESCCSCH
T ss_pred -echHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCccc---cc-CceeeeeeccCCccch
Confidence 3458999999999999999999988888888887776 7999999999654443 33 348999999999987
Q ss_pred CCCCccccccccccEEEccCCcccC------cccccccccc--cccEEec-ccccCCCCCCcccccccccCCCCCceeee
Q 046199 305 GRIPGFIFNASKLFLLELTGNSFSG------FIPDTLVNLR--NLEHLGL-GYNYLTSSTPELSFLSSLANSSSSKYIVL 375 (902)
Q Consensus 305 ~~~~~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~--~L~~L~L-s~N~l~~~~~~~~~l~~l~~l~~L~~L~L 375 (902)
+..|..+.+++.|+.+++..+.+.+ ..+..+..+. +++.+++ ..|.+.+..| . +..+++|+.|++
T Consensus 219 ~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~-----~-~~~l~~L~~L~l 292 (606)
T 3vq2_A 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV-----K-FHCLANVSAMSL 292 (606)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGG-----S-CGGGTTCSEEEE
T ss_pred hHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccccccccccc-----c-cccCCCCCEEEe
Confidence 5677888999999999987665542 1222233332 4666677 6777776655 3 788899999999
Q ss_pred ccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccC
Q 046199 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG 455 (902)
Q Consensus 376 s~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 455 (902)
++|.+.. +| .+..++ +|++|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++
T Consensus 293 ~~~~~~~-l~-~l~~~~-~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 364 (606)
T 3vq2_A 293 AGVSIKY-LE-DVPKHF-KWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSF 364 (606)
T ss_dssp ESCCCCC-CC-CCCTTC-CCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEE
T ss_pred cCccchh-hh-hccccc-cCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCC
Confidence 9999974 55 788887 999999999999 5777 45 9999999999999766444 67899999999999999986
Q ss_pred CC--CC---cCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccc-ccccCCCCceEEEcCCCccCCCCccc
Q 046199 456 PI--PD---DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNGSLPLD 529 (902)
Q Consensus 456 ~~--p~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~ 529 (902)
.. |. .+.+|++|++++|.+++ +|..|.++++|+.|++++|++.+..| ..|..+++|++|++++|.+++..|..
T Consensus 365 ~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 443 (606)
T 3vq2_A 365 SGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443 (606)
T ss_dssp EEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred CcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhh
Confidence 52 43 45699999999999986 56889999999999999999999888 78999999999999999999999999
Q ss_pred cccccccceeccCCccccc-cCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccccc
Q 046199 530 IGNMKVVVEINLSRNYLTG-DIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYL 608 (902)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 608 (902)
+..+++|++|++++|++++ .+|..|+.+++|+.|+|++|++++..|..|+.+++|++|+|++|++++.+|..+..+++|
T Consensus 444 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 523 (606)
T 3vq2_A 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523 (606)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTC
T ss_pred hcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcC
Confidence 9999999999999999998 479999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcceecCCCC-Cccc-ccccccccCCcccCCCCCC
Q 046199 609 KDLNLSFNRLEGEIPSG-GSFA-NFSAQSFMGNDLLCGSPHL 648 (902)
Q Consensus 609 ~~L~l~~N~l~~~~p~~-~~~~-~~~~~~~~~n~~lc~~~~~ 648 (902)
+.|++++|+++ .+|.. ..+. ++....+.+||+.|+++..
T Consensus 524 ~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 524 STLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 99999999999 56653 3343 4677889999999998874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=498.15 Aligned_cols=497 Identities=19% Similarity=0.195 Sum_probs=325.1
Q ss_pred CceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCC
Q 046199 30 SVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFP 109 (902)
Q Consensus 30 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~ 109 (902)
-.|.|.|+ |+.. +++++ .+|+.+. ++|++|||++|++++..|..|+++++|++|+|++|++++.
T Consensus 2 ~~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-- 65 (549)
T 2z81_A 2 LSCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI-- 65 (549)
T ss_dssp CEECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEE--
T ss_pred ccCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCcc--
Confidence 35999999 9654 44555 6777665 7899999999999977788899999999999999998864
Q ss_pred cccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCC-C
Q 046199 110 SFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG-T 188 (902)
Q Consensus 110 ~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~ 188 (902)
.|..++++++|++|+|++|++++..|..|+.+++|++|+|++|.+++ .
T Consensus 66 -------------------------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 114 (549)
T 2z81_A 66 -------------------------------EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114 (549)
T ss_dssp -------------------------------CTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSC
T ss_pred -------------------------------ChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccc
Confidence 33455556666666666666665444456666666666666666654 2
Q ss_pred CChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCce
Q 046199 189 IPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKA 268 (902)
Q Consensus 189 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (902)
+|..++++++|++|++++|.+ .+.+| +..++.+++|++|++++|++++..|..+..+++|+.
T Consensus 115 ~~~~~~~l~~L~~L~L~~n~~----------~~~~~--------~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 115 VTSLFPNLTNLQTLRIGNVET----------FSEIR--------RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp SSCSCTTCTTCCEEEEEESSS----------CCEEC--------TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred hhhhhhccCCccEEECCCCcc----------ccccC--------HhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 455566666666666666651 12222 235566666666666666666666666666666666
Q ss_pred EeccCcccccCCCcCCcccCCCcccceeeccCccCCCCC---CccccccccccEEEccCCcccCccccc----ccccccc
Q 046199 269 LSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI---PGFIFNASKLFLLELTGNSFSGFIPDT----LVNLRNL 341 (902)
Q Consensus 269 L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~l~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L 341 (902)
|++++|.+. .+|..+ +..+++|++|++++|++++.. ......+++|+.|++++|.+.+..+.. +..+++|
T Consensus 177 L~l~~n~~~-~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L 253 (549)
T 2z81_A 177 LTLHLSESA-FLLEIF--ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253 (549)
T ss_dssp EEEECSBST-THHHHH--HHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTC
T ss_pred EecccCccc-ccchhh--HhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccc
Confidence 666666654 333321 234566666666666666431 112234567777777777776544433 3456777
Q ss_pred cEEecccccCCCCCCcc-cccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCc
Q 046199 342 EHLGLGYNYLTSSTPEL-SFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLT 420 (902)
Q Consensus 342 ~~L~Ls~N~l~~~~~~~-~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 420 (902)
+.+++++|.+.+..... .....+..+.+++.|++.++.+.... .+. ..+..+...++|+
T Consensus 254 ~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~------------------~l~~~~~~~~~L~ 313 (549)
T 2z81_A 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY--LFY------------------DLSTVYSLLEKVK 313 (549)
T ss_dssp CEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG--GSC------------------CCCHHHHHSTTCC
T ss_pred cccccccccccccccccccchhhhhhhcccccccccccccchhh--hcc------------------cchhhhhhcccce
Confidence 88888877776532200 00122334445555555554433210 000 0111112233455
Q ss_pred EEEeecceecccCCccc-ccccccCeeecccccccCCCC------CcCCCCCeEeccCccccCCCC--ccccCCCcCceE
Q 046199 421 TLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIP------DDLCQLSELHVDHNKLSGPIP--ACFGNLNSLRNL 491 (902)
Q Consensus 421 ~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p------~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L 491 (902)
.|++++|+++ .+|..+ ..+++|++|++++|++++.+| ..+.+|+.|++++|++++..+ ..+..+++|++|
T Consensus 314 ~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L 392 (549)
T 2z81_A 314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392 (549)
T ss_dssp EEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEE
T ss_pred EEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEE
Confidence 5555555554 334333 345555555555555544332 223466666666666665432 457888899999
Q ss_pred ecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccC
Q 046199 492 SLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLH 571 (902)
Q Consensus 492 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (902)
++++|++++ +|..+..+++|++|++++|++++ +|..+ .++|++|++++|+|++.. ..+++|++|+|++|+|+
T Consensus 393 ~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~ 464 (549)
T 2z81_A 393 DISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK 464 (549)
T ss_dssp ECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS
T ss_pred ECCCCCCcc-CChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC
Confidence 999999985 67788888999999999999884 44433 258999999999998643 57899999999999998
Q ss_pred CCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCC
Q 046199 572 GPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625 (902)
Q Consensus 572 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 625 (902)
.+|. .+.+++|+.|||++|++++.+|..+..+++|+.|++++|++.|.+|..
T Consensus 465 -~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 516 (549)
T 2z81_A 465 -TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516 (549)
T ss_dssp -SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred -cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence 6776 568999999999999999988888999999999999999999998853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=495.27 Aligned_cols=528 Identities=20% Similarity=0.217 Sum_probs=374.4
Q ss_pred EEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCc
Q 046199 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNS 128 (902)
Q Consensus 49 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~ 128 (902)
++.++.+++ .+|..+. +++++|||++|++++..|..|+++++|++|+|++|++++ ++...++++++|++|++++|+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~ 87 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNP 87 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc-cCcccccCchhCCEEeCcCCc
Confidence 344455565 5676553 578999999999987667789999999999999999885 444456778888888888888
Q ss_pred ccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCC-CCChhhhccCcccEEeeeeC
Q 046199 129 LSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG-TIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 129 l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N 207 (902)
+++. .|..|+.+++|++|+|++|++++..+..++.+++|++|+|++|.+++ .+|..|+++++|++|++++|
T Consensus 88 l~~~--------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n 159 (570)
T 2z63_A 88 IQSL--------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (570)
T ss_dssp CCEE--------CTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTS
T ss_pred CCcc--------CHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCC
Confidence 7642 34678888888888888888885444468888888888888888876 46888888888888888888
Q ss_pred CCCccccccccccCCccccccccCCCccccCCCCC----CEEEccCccccCcCCCcccCCCCCceEeccCcccccC-CCc
Q 046199 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL----EVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGS-LPS 282 (902)
Q Consensus 208 ~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~ 282 (902)
.++.+ .|..++.+++| +.|++++|.+++..|..+..+ +|+.|++++|..... +|.
T Consensus 160 ~l~~~-------------------~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~ 219 (570)
T 2z63_A 160 KIQSI-------------------YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219 (570)
T ss_dssp CCCEE-------------------CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHH
T ss_pred cccee-------------------cHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhh
Confidence 86532 13566667777 788888888887767666655 788888888754321 122
Q ss_pred CCcccCCCcccceeeccCccCC------CCCCccccccc--cccEEEccCC-cccCcccccccccccccEEecccccCCC
Q 046199 283 SSKNLIGLPNIERLNLGLNNLS------GRIPGFIFNAS--KLFLLELTGN-SFSGFIPDTLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 283 ~~~~l~~l~~L~~L~Ls~N~l~------~~~~~~l~~l~--~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 353 (902)
. +..++.++.+.+....+. ......+..+. .++.+++++| .+.+..|..+..+++|++|++++|.+++
T Consensus 220 ~---~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~ 296 (570)
T 2z63_A 220 C---IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296 (570)
T ss_dssp H---HHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS
T ss_pred h---hcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh
Confidence 2 344555555444432221 11122222222 2456666666 5666666666667777777777776664
Q ss_pred CCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccC
Q 046199 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSI 433 (902)
Q Consensus 354 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 433 (902)
. | ..+..+ +|++|++++|.+. .+|. ..++ +|+.|++++|.+.+..+. ..+++|++|++++|++++..
T Consensus 297 l-~-----~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~-~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~ 363 (570)
T 2z63_A 297 V-K-----DFSYNF-GWQHLELVNCKFG-QFPT--LKLK-SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKG 363 (570)
T ss_dssp C-C-----BCCSCC-CCSEEEEESCBCS-SCCB--CBCS-SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEE
T ss_pred h-h-----hhhccC-CccEEeeccCccc-ccCc--cccc-ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccc
Confidence 2 2 233444 5666666666555 3333 2333 555566666555544433 45555555555555555332
Q ss_pred --CcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccc-ccccCCC
Q 046199 434 --PITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLN 510 (902)
Q Consensus 434 --p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~ 510 (902)
|..+..++ +|++|++++|.+++..+. +..+++|+.|++++|++.+..+ ..|..++
T Consensus 364 ~~~~~~~~~~---------------------~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 421 (570)
T 2z63_A 364 CCSQSDFGTT---------------------SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421 (570)
T ss_dssp EEEHHHHTCS---------------------CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCT
T ss_pred cccccccccC---------------------ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCC
Confidence 34444444 455555555555554444 8889999999999999988766 5788999
Q ss_pred CceEEEcCCCccCCCCccccccccccceeccCCcccc-ccCccccccCCccceEEccCcccCCCccccccccccCCeEeC
Q 046199 511 NILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLT-GDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDL 589 (902)
Q Consensus 511 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 589 (902)
+|++|++++|.+++..|..+..+++|++|++++|+++ +.+|..|..+++|++|+|++|++++..|..|+.+++|+.|+|
T Consensus 422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 501 (570)
T 2z63_A 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501 (570)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence 9999999999999888999999999999999999998 678999999999999999999999888999999999999999
Q ss_pred cCccccccCCcccccccccccccccCCcceecCCCCCcc-ccccc--ccccCCcccCCCCC
Q 046199 590 SVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSF-ANFSA--QSFMGNDLLCGSPH 647 (902)
Q Consensus 590 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-~~~~~--~~~~~n~~lc~~~~ 647 (902)
++|++++..|..+..+++|+.|++++|+++|.+|....+ .++.. ..+.+.+ .|+.|.
T Consensus 502 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~~ 561 (570)
T 2z63_A 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGSG 561 (570)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTTC
T ss_pred CCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCCC
Confidence 999999988888999999999999999999999975443 33322 2344544 676654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=480.51 Aligned_cols=513 Identities=22% Similarity=0.230 Sum_probs=367.8
Q ss_pred CCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT 149 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~ 149 (902)
.+.++.++.+++ .+|..+. +++++|+|++|++++. +...+.++++|++||+++|++++. .|..+++++
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~i--------~~~~~~~l~ 76 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTI--------EDGAYQSLS 76 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEE-CTTTTTTCSSCCEEECTTCCCCEE--------CTTTTTTCT
T ss_pred CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCcc-ChhHhhCCCCceEEECCCCcCCcc--------CcccccCch
Confidence 356777787887 7887654 5788999999988853 333345566666666666655431 234455566
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~ 229 (902)
+|++|+|++|++++..|..|+.+++|++|++++|++++..+..++++++|++|+|++|.++.+
T Consensus 77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~----------------- 139 (570)
T 2z63_A 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF----------------- 139 (570)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCC-----------------
T ss_pred hCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCcccee-----------------
Confidence 666666666666544445566666666666666666543333455566666666666554321
Q ss_pred cCCCccccCCCCCCEEEccCccccCcCCCcccCCCCC----ceEeccCcccccCCCcCCcccCCCcccceeeccCccCCC
Q 046199 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTL----KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305 (902)
Q Consensus 230 ~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (902)
.+|..++++++|++|++++|++++..|..+..+++| +.|++++|.+++.
T Consensus 140 -~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~-------------------------- 192 (570)
T 2z63_A 140 -KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-------------------------- 192 (570)
T ss_dssp -CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEE--------------------------
T ss_pred -cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceec--------------------------
Confidence 123555555556666666555555445555555555 4555555555544
Q ss_pred CCCccccccccccEEEccCCcccC-cccccccccccccEEecccccCCCCCC----cccccccccCCCCCceeeeccC-C
Q 046199 306 RIPGFIFNASKLFLLELTGNSFSG-FIPDTLVNLRNLEHLGLGYNYLTSSTP----ELSFLSSLANSSSSKYIVLAEN-P 379 (902)
Q Consensus 306 ~~~~~l~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~l~~l~~l~~L~~L~Ls~N-~ 379 (902)
.|+.+... +|+.|++++|.... ..+..+..+++++.+.+..+.+..... ....+..+..+ .++.++++++ .
T Consensus 193 -~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~~l~l~~~~~ 269 (570)
T 2z63_A 193 -QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL-TIEEFRLAYLDY 269 (570)
T ss_dssp -CTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS-EEEEEEEEETTE
T ss_pred -CHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc-chhhhhhhcchh
Confidence 33333332 44444444443221 223334444444444443322221100 00001122222 3567777777 6
Q ss_pred CCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCC
Q 046199 380 LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459 (902)
Q Consensus 380 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 459 (902)
+.+..|..+..++ +|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+.
T Consensus 270 ~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~ 343 (570)
T 2z63_A 270 YLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE 343 (570)
T ss_dssp EESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC
T ss_pred hhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc
Confidence 7778888888888 9999999999998 578888888 9999999999998 5665 5788999999999999877664
Q ss_pred -cCCCCCeEeccCccccCCC--CccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCc-cccccccc
Q 046199 460 -DLCQLSELHVDHNKLSGPI--PACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP-LDIGNMKV 535 (902)
Q Consensus 460 -~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~ 535 (902)
.+.+|+.|++++|++++.. |..+.++++|++|++++|++++..+. +..+++|++|++++|.+++..| ..+..+++
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 422 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence 5669999999999998765 77899999999999999999986555 9999999999999999998766 57899999
Q ss_pred cceeccCCccccccCccccccCCccceEEccCcccC-CCccccccccccCCeEeCcCccccccCCccccccccccccccc
Q 046199 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLH-GPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614 (902)
Q Consensus 536 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 614 (902)
|++|++++|++++..|..|.++++|+.|+|++|+++ +.+|..|+.+++|+.|+|++|++++..|..+..+++|+.|+++
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 502 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCC
Confidence 999999999999999999999999999999999998 6789999999999999999999999999999999999999999
Q ss_pred CCcceecCCCC-CcccccccccccCCcccCCCCCC
Q 046199 615 FNRLEGEIPSG-GSFANFSAQSFMGNDLLCGSPHL 648 (902)
Q Consensus 615 ~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~~ 648 (902)
+|++++..|.. ..+..+....+.+|+..|..|..
T Consensus 503 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999887753 56677888899999999987753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=494.36 Aligned_cols=358 Identities=19% Similarity=0.267 Sum_probs=247.8
Q ss_pred CccccCcCCCcccCCCCCceEeccCcccccC-----------------CCcCCcccC--CCcccceeeccCccCCCCCCc
Q 046199 249 ENHLVGDVPNTIFNMSTLKALSLLNNTLSGS-----------------LPSSSKNLI--GLPNIERLNLGLNNLSGRIPG 309 (902)
Q Consensus 249 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~~l~--~l~~L~~L~Ls~N~l~~~~~~ 309 (902)
.|++++ +|..++++++|++|+|++|++++. +|.. +. ++++|++|+|++|++.+.+|.
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~---l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED---LKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC---CCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh---hhhcccCCCCEEEecCCcCCccChH
Confidence 355554 555555555555555555555553 5655 44 566677777777776667777
Q ss_pred cccccccccEEEccCCc-ccC-ccccccccc------ccccEEecccccCCCCCCcccccc--cccCCCCCceeeeccCC
Q 046199 310 FIFNASKLFLLELTGNS-FSG-FIPDTLVNL------RNLEHLGLGYNYLTSSTPELSFLS--SLANSSSSKYIVLAENP 379 (902)
Q Consensus 310 ~l~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~~~~~~l~--~l~~l~~L~~L~Ls~N~ 379 (902)
.++++++|++|+|++|+ +++ .+|..++.+ ++|++|++++|+++ ..| . .+.++++|++|++++|.
T Consensus 268 ~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip-----~~~~l~~l~~L~~L~L~~N~ 341 (636)
T 4eco_A 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP-----VETSLQKMKKLGMLECLYNQ 341 (636)
T ss_dssp TTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCC-----CHHHHTTCTTCCEEECCSCC
T ss_pred HHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccC-----chhhhccCCCCCEEeCcCCc
Confidence 77777777777777776 776 667766665 77777777777776 333 3 45555666666666666
Q ss_pred CCcccCcccccccccccEEEeecCcccccCCcccCCCCC-CcEEEeecceecccCCccccccc--ccCeeecccccccCC
Q 046199 380 LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN-LTTLHLGNNQLSGSIPITVGRLN--TLQGLGLENNKLEGP 456 (902)
Q Consensus 380 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~ 456 (902)
+.|.+| .+..++ +|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..+. +|++|++++|+++
T Consensus 342 l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~-- 415 (636)
T 4eco_A 342 LEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG-- 415 (636)
T ss_dssp CEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT--
T ss_pred Cccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC--
Confidence 665555 555555 6666666666666 55555666666 666666666666 4555554433 4555555555554
Q ss_pred CCCcCCCCCeEeccCccccCCCCcccc-------CCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccc
Q 046199 457 IPDDLCQLSELHVDHNKLSGPIPACFG-------NLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLD 529 (902)
Q Consensus 457 ~p~~l~~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~ 529 (902)
+..|..|. .+++|+.|+|++|+++++.+..+..+++|++|++++|+++ .+|..
T Consensus 416 -------------------~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 475 (636)
T 4eco_A 416 -------------------SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKN 475 (636)
T ss_dssp -------------------TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSS
T ss_pred -------------------CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHH
Confidence 44444444 5667777777777777655555666777777777777777 34443
Q ss_pred ccc--------ccccceeccCCccccccCccccc--cCCccceEEccCcccCCCccccccccccCCeEeC------cCcc
Q 046199 530 IGN--------MKVVVEINLSRNYLTGDIPTTIG--GLTNLQLLSLENNRLHGPIPESFGALTSLESLDL------SVNN 593 (902)
Q Consensus 530 ~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~ 593 (902)
+.. +++|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|+
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~ 553 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCB
T ss_pred HhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCc
Confidence 322 238888888888888 6777776 88888899999998886 7888888888999988 6788
Q ss_pred ccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCC
Q 046199 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSP 646 (902)
Q Consensus 594 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 646 (902)
+.+.+|..+..+++|+.|+|++|++ +.+|.. -+..+....+.+|+..|-..
T Consensus 554 l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 554 TLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred ccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccH
Confidence 9999999999999999999999999 788875 33778888999999887543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=475.36 Aligned_cols=463 Identities=20% Similarity=0.226 Sum_probs=316.4
Q ss_pred eeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCcc
Q 046199 72 TLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKL 151 (902)
Q Consensus 72 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L 151 (902)
+||+++|+++ .+|..+. ++|++|+|++|.+++..| ..++++++|++||+++|++++. .|..++++++|
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~--------~~~~~~~l~~L 71 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWT-SDILSLSKLRILIISHNRIQYL--------DISVFKFNQEL 71 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCH-HHHTTCTTCCEEECCSSCCCEE--------EGGGGTTCTTC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccCh-hhccccccccEEecCCCccCCc--------ChHHhhcccCC
Confidence 4455555554 4444443 455555555555543222 1223344444444444444321 35667777777
Q ss_pred ceeeecccccCCCCchhhccccccceeecccCcCCC-CCChhhhccCcccEEeeeeCCCCccccccccccCCcccccccc
Q 046199 152 KELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG-TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQC 230 (902)
Q Consensus 152 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~ 230 (902)
++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|.++.
T Consensus 72 ~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~------------------- 129 (520)
T 2z7x_B 72 EYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK------------------- 129 (520)
T ss_dssp CEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-------------------
T ss_pred CEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch-------------------
Confidence 77777777777 56665 67777777777777775 466777777777777777777542
Q ss_pred CCCccccCCCCC--CEEEccCccc--cCcCCCcccCCC-CCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCC
Q 046199 231 EIPHEIGNLPNL--EVLGIDENHL--VGDVPNTIFNMS-TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305 (902)
Q Consensus 231 ~lp~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (902)
..+..+++| +.|++++|++ .+..|..+..+. +...+++++|++.+.++... +.++++|+.|++++|.-..
T Consensus 130 ---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~--~~~l~~L~~L~l~~n~~~~ 204 (520)
T 2z7x_B 130 ---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS--VKTVANLELSNIKCVLEDN 204 (520)
T ss_dssp ---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCC--CTTCSEEEECCEEECCSTT
T ss_pred ---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhh--hhcccceeecccccccccc
Confidence 234445555 7777777777 666666666554 23345566666655544432 4445555555555544100
Q ss_pred CCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccC
Q 046199 306 RIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLP 385 (902)
Q Consensus 306 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p 385 (902)
... .+.+.+| .+..+++|+.|++++|.+++..+ .+..
T Consensus 205 ~~~-----------------~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~------------------------~~~~- 241 (520)
T 2z7x_B 205 KCS-----------------YFLSILA-KLQTNPKLSNLTLNNIETTWNSF------------------------IRIL- 241 (520)
T ss_dssp TTH-----------------HHHHHHH-GGGGCTTCCEEEEEEEEEEHHHH------------------------HHHH-
T ss_pred ccc-----------------eeecchh-hhccccchhhccccccccCHHHH------------------------HHHH-
Confidence 000 0333333 45566666666666665543111 0000
Q ss_pred cccccccccccEEEeecCcccccCCccc-----CCCCCCcEEEeecceecccCC-cccccc---cccCeeecccccccCC
Q 046199 386 SSIGNLPITLEEIYLQNCKIRGNIPKEI-----GNLVNLTTLHLGNNQLSGSIP-ITVGRL---NTLQGLGLENNKLEGP 456 (902)
Q Consensus 386 ~~~~~l~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~ 456 (902)
..+ ..+ +|++|++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.
T Consensus 242 ~~~-~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~ 317 (520)
T 2z7x_B 242 QLV-WHT-TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317 (520)
T ss_dssp HHH-HTS-SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC
T ss_pred HHh-hhC-cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc
Confidence 000 012 56677777777776666666 7777888888888887 344 455544 5688888888887654
Q ss_pred C-CCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccC--cccccccCCCCceEEEcCCCccCCCCcc-cccc
Q 046199 457 I-PDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS--FIPSTFWNLNNILSFDFSSNSLNGSLPL-DIGN 532 (902)
Q Consensus 457 ~-p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~ 532 (902)
. +..+.+|++|++++|++++..|..+.++++|+.|++++|++++ .+|..|..+++|++|++++|++++.+|. .+..
T Consensus 318 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~ 397 (520)
T 2z7x_B 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397 (520)
T ss_dssp CCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCC
T ss_pred cchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhcc
Confidence 3 3667789999999999998889999999999999999999997 4567899999999999999999985565 4888
Q ss_pred ccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcc-cccccccccc
Q 046199 533 MKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPIS-LEKLVYLKDL 611 (902)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L 611 (902)
+++|++|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++ +|.. +..+++|+.|
T Consensus 398 l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 398 TKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKI 473 (520)
T ss_dssp CTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEE
Confidence 99999999999999988887775 79999999999999 788888899999999999999995 5654 8999999999
Q ss_pred cccCCcceecCCC
Q 046199 612 NLSFNRLEGEIPS 624 (902)
Q Consensus 612 ~l~~N~l~~~~p~ 624 (902)
++++|+++|.++.
T Consensus 474 ~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 474 WLHTNPWDCSCPR 486 (520)
T ss_dssp ECCSSCBCCCHHH
T ss_pred ECcCCCCcccCCc
Confidence 9999999998874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=467.87 Aligned_cols=479 Identities=23% Similarity=0.260 Sum_probs=334.3
Q ss_pred eeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccc
Q 046199 73 LDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLK 152 (902)
Q Consensus 73 L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~ 152 (902)
.|+++|.++ .+|+.+. ++|++|+|++|++++. .|..++++++|+
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~---------------------------------~~~~~~~l~~L~ 53 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYI---------------------------------GHGDLRACANLQ 53 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEE---------------------------------CSSTTSSCTTCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCcc---------------------------------ChhhhhcCCccc
Confidence 456666666 6666544 5666666666665532 355666777777
Q ss_pred eeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCC
Q 046199 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEI 232 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~l 232 (902)
+|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|.++.+ ..
T Consensus 54 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~------------------~~ 115 (549)
T 2z81_A 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL------------------GV 115 (549)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSS------------------CS
T ss_pred EEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCccccc------------------ch
Confidence 777777777766667777777777777777777766666677777777777777775421 12
Q ss_pred CccccCCCCCCEEEccCccccCcCC-CcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 233 PHEIGNLPNLEVLGIDENHLVGDVP-NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 233 p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
|..++++++|++|++++|++.+.+| ..+.++++|++|++++|++++..|.. +..+++|++|+++.|.+....+..+
T Consensus 116 ~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---l~~l~~L~~L~l~~n~~~~~~~~~~ 192 (549)
T 2z81_A 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS---LKSIRDIHHLTLHLSESAFLLEIFA 192 (549)
T ss_dssp SCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT---TTTCSEEEEEEEECSBSTTHHHHHH
T ss_pred hhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhh---hhccccCceEecccCcccccchhhH
Confidence 3556667777777777776433443 45666666666666666666555544 4445555555555555542222222
Q ss_pred cccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCc----c
Q 046199 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPS----S 387 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~----~ 387 (902)
..+++|++|++++|++++.... + ......+++|+.|++++|.+.+..+. .
T Consensus 193 ~~l~~L~~L~L~~n~l~~~~~~----------------------~----~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 246 (549)
T 2z81_A 193 DILSSVRYLELRDTNLARFQFS----------------------P----LPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246 (549)
T ss_dssp HSTTTBSEEEEESCBCTTCCCC----------------------C----CSSCCCCCCCCEEEEESCEEEHHHHHHHHGG
T ss_pred hhcccccEEEccCCcccccccc----------------------c----cchhhhhhcccceeccccccchhHHHHHHHH
Confidence 3344555555555554432100 0 01122344555555555555443222 2
Q ss_pred cccccccccEEEeecCcccccC------CcccCCCCCCcEEEeecceeccc-----CCcccccccccCeeecccccccCC
Q 046199 388 IGNLPITLEEIYLQNCKIRGNI------PKEIGNLVNLTTLHLGNNQLSGS-----IPITVGRLNTLQGLGLENNKLEGP 456 (902)
Q Consensus 388 ~~~l~~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~ 456 (902)
+..++ +++.+++++|.+.+.. ...+..+++|+.|+++++.+... ++..+....+|+.|++++|++. .
T Consensus 247 ~~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ 324 (549)
T 2z81_A 247 LRYIL-ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324 (549)
T ss_dssp GGGCT-TCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-C
T ss_pred hhhhc-cccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-c
Confidence 23334 6777777777776531 23456778899999999887632 2223445678999999999997 6
Q ss_pred CCCc----CCCCCeEeccCccccCCCC---ccccCCCcCceEecCCCCccCccc--ccccCCCCceEEEcCCCccCCCCc
Q 046199 457 IPDD----LCQLSELHVDHNKLSGPIP---ACFGNLNSLRNLSLGSNELSSFIP--STFWNLNNILSFDFSSNSLNGSLP 527 (902)
Q Consensus 457 ~p~~----l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~ls~N~l~~~~~ 527 (902)
+|.. +.+|++|++++|++++..| ..++.+++|+.|++++|++++..+ ..+..+++|++|++++|+++ .+|
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 7753 5699999999999998764 357889999999999999998654 56899999999999999999 578
Q ss_pred cccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccc
Q 046199 528 LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVY 607 (902)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 607 (902)
..+..+++|++|++++|+++ .+|..+. ++|++|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~ 474 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPV 474 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTT
T ss_pred hhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCcc
Confidence 89999999999999999998 4555442 68999999999999753 57899999999999999 6776 567999
Q ss_pred cccccccCCcceecCCCC-CcccccccccccCCcccCCCC
Q 046199 608 LKDLNLSFNRLEGEIPSG-GSFANFSAQSFMGNDLLCGSP 646 (902)
Q Consensus 608 L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~ 646 (902)
|+.|+|++|++++.+|.. ..+..+....+.+|++.|..|
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 999999999999888763 566778888999999988766
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=466.48 Aligned_cols=527 Identities=21% Similarity=0.222 Sum_probs=403.8
Q ss_pred EeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcc
Q 046199 50 NISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSL 129 (902)
Q Consensus 50 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l 129 (902)
|-++.+|+ .+|+.+- +++++||||+|++++..|.+|.++++|++|||++|++++ +|...++++++|++|||++|++
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~-i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC-cChhHhcCCCCCCEEEccCCcC
Confidence 33455665 6776553 468889999998885445678888999999999998884 5555668888888888888888
Q ss_pred cCcCCcchhccCc-ccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCC-CCChhhhccCcccEEeeeeC
Q 046199 130 SGELPANIFRAIP-KDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG-TIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 130 ~~~~~~~~~~~ip-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N 207 (902)
++ +| ..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..++++++|++|+|++|
T Consensus 113 ~~---------l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 183 (635)
T 4g8a_A 113 QS---------LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 183 (635)
T ss_dssp CE---------ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CC---------CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence 64 44 457888889999999998886555678888889999999888875 46778888888999999888
Q ss_pred CCCccccccccccCCccccccccCCCccccCCCC----CCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcC
Q 046199 208 SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN----LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSS 283 (902)
Q Consensus 208 ~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~----L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 283 (902)
+|+.+. |..+..+.+ +..++++.|.++. ++........++.+++++|..+..++..
T Consensus 184 ~l~~~~-------------------~~~l~~L~~l~~~~~~~~ls~n~l~~-i~~~~~~~~~~~~l~l~~n~~~~~~~~~ 243 (635)
T 4g8a_A 184 KIQSIY-------------------CTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 243 (635)
T ss_dssp CCCEEC-------------------GGGGHHHHTCTTCCCEEECTTCCCCE-ECTTTTTTCEEEEEEEESCCSSHHHHHH
T ss_pred cccccc-------------------cccccchhhhhhhhhhhhcccCcccc-cCcccccchhhhhhhhhcccccccccch
Confidence 866431 234444433 3467888888874 4444445556778888888665332222
Q ss_pred CcccCCCcccceeeccCcc------CCCCCCccccccccccEEEccCCcccCc---ccccccccccccEEecccccCCCC
Q 046199 284 SKNLIGLPNIERLNLGLNN------LSGRIPGFIFNASKLFLLELTGNSFSGF---IPDTLVNLRNLEHLGLGYNYLTSS 354 (902)
Q Consensus 284 ~~~l~~l~~L~~L~Ls~N~------l~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~~~ 354 (902)
. +..+..++...+..+. +.......+.....+...++..+..... .+..+..+.+++.+++..+.+...
T Consensus 244 ~--~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~ 321 (635)
T 4g8a_A 244 C--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV 321 (635)
T ss_dssp H--HHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC
T ss_pred h--hcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc
Confidence 1 4455555555554332 3333444555666777777766554322 234456678888888888877654
Q ss_pred CCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceec--cc
Q 046199 355 TPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS--GS 432 (902)
Q Consensus 355 ~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~ 432 (902)
..+....+++.|++.+|.+.+..+..+ + .++.+++..|.+... ..+..+++|+.|++++|.+. +.
T Consensus 322 -------~~~~~~~~L~~L~l~~~~~~~~~~~~l---~-~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~ 388 (635)
T 4g8a_A 322 -------KDFSYNFGWQHLELVNCKFGQFPTLKL---K-SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGC 388 (635)
T ss_dssp -------GGGGSCCCCSEEEEESCEESSCCCCBC---T-TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEE
T ss_pred -------cccccchhhhhhhcccccccCcCcccc---h-hhhhcccccccCCCC--cccccccccccchhhccccccccc
Confidence 334566788889999988876544333 3 788899999987743 33557889999999999886 34
Q ss_pred CCcccccccccCeeecccccccCCCCC--cCCCCCeEeccCccccCCCC-ccccCCCcCceEecCCCCccCcccccccCC
Q 046199 433 IPITVGRLNTLQGLGLENNKLEGPIPD--DLCQLSELHVDHNKLSGPIP-ACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509 (902)
Q Consensus 433 ~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 509 (902)
.+..+..+.+|+.++++.|.+....+. .+.+|+.+++++|......+ ..|..+++++.++++.|++.+..+..+..+
T Consensus 389 ~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 389 CSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 468 (635)
T ss_dssp CCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred cccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccc
Confidence 566777888999999999987643332 34589999999888776654 478899999999999999999999999999
Q ss_pred CCceEEEcCCCcc-CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEe
Q 046199 510 NNILSFDFSSNSL-NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLD 588 (902)
Q Consensus 510 ~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 588 (902)
+.++.|++++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++||
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 9999999999985 445788899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCccccccCCcccccc-cccccccccCCcceecCCC
Q 046199 589 LSVNNLSGVIPISLEKL-VYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 589 Ls~N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~ 624 (902)
|++|+|++..|..+..+ ++|+.|+|++|+|.|.+.-
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999999999999988 6899999999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=456.18 Aligned_cols=456 Identities=20% Similarity=0.248 Sum_probs=353.4
Q ss_pred EEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCccc
Q 046199 121 AIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLL 200 (902)
Q Consensus 121 ~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 200 (902)
+||+++|.++. +|..+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|+
T Consensus 4 ~l~ls~n~l~~---------ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 72 (520)
T 2z7x_B 4 LVDRSKNGLIH---------VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72 (520)
T ss_dssp EEECTTSCCSS---------CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCC
T ss_pred eEecCCCCccc---------cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCC
Confidence 45555555542 565555 6889999999999877778888999999999999999877788888999999
Q ss_pred EEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC-cCCCcccCCCCCceEeccCcccccC
Q 046199 201 ELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG-DVPNTIFNMSTLKALSLLNNTLSGS 279 (902)
Q Consensus 201 ~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~ 279 (902)
+|+|++|+|+. +| .. .+++|++|+|++|++++ .+|..++++++|++|++++|++++.
T Consensus 73 ~L~Ls~N~l~~-----------lp---------~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 130 (520)
T 2z7x_B 73 YLDLSHNKLVK-----------IS---------CH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS 130 (520)
T ss_dssp EEECCSSCCCE-----------EE---------CC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG
T ss_pred EEecCCCceee-----------cC---------cc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh
Confidence 99999998663 22 44 68889999999998886 4678888888888888888888751
Q ss_pred CCcCCcccCCCccc--ceeeccCccC--CCCCCccccccc-cccEEEccCCcccCcccc-cccccccccEEecccccCCC
Q 046199 280 LPSSSKNLIGLPNI--ERLNLGLNNL--SGRIPGFIFNAS-KLFLLELTGNSFSGFIPD-TLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 280 ~p~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~ 353 (902)
. +..+++| ++|++++|.+ .+..|..+..+. +...+++++|++.+.++. .+..+++|+.|++++|.-..
T Consensus 131 ---~---~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 204 (520)
T 2z7x_B 131 ---S---VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204 (520)
T ss_dssp ---G---GGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTT
T ss_pred ---h---ccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccc
Confidence 2 4455555 7777777777 666666665544 334556666666544333 34455555555555554110
Q ss_pred CCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccC---CCCCCcEEEeecceec
Q 046199 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIG---NLVNLTTLHLGNNQLS 430 (902)
Q Consensus 354 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~ 430 (902)
... .+.+.+| .+..++ +|+.|++++|.+++..+..+. ..++|++|++++|+++
T Consensus 205 ~~~----------------------~~~~~~~-~l~~l~-~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 260 (520)
T 2z7x_B 205 KCS----------------------YFLSILA-KLQTNP-KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260 (520)
T ss_dssp TTH----------------------HHHHHHH-GGGGCT-TCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEE
T ss_pred ccc----------------------eeecchh-hhcccc-chhhccccccccCHHHHHHHHHHhhhCcccEEEeeccccc
Confidence 000 0333444 556666 788888888877754322221 2468999999999999
Q ss_pred ccCCccc-----ccccccCeeecccccccCCCCC-cC------CCCCeEeccCccccCCCCccccCCCcCceEecCCCCc
Q 046199 431 GSIPITV-----GRLNTLQGLGLENNKLEGPIPD-DL------CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNEL 498 (902)
Q Consensus 431 ~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~-~l------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 498 (902)
|.+|..+ ..+++|+.+++++|.+ .+|. .+ .+|+.|++++|.+.+.. .+..+++|++|++++|++
T Consensus 261 ~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l 336 (520)
T 2z7x_B 261 GQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLL 336 (520)
T ss_dssp SCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCC
T ss_pred CccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCcc
Confidence 9999998 9999999999999999 5662 22 36999999999987543 236889999999999999
Q ss_pred cCcccccccCCCCceEEEcCCCccCC--CCccccccccccceeccCCccccccCcc-ccccCCccceEEccCcccCCCcc
Q 046199 499 SSFIPSTFWNLNNILSFDFSSNSLNG--SLPLDIGNMKVVVEINLSRNYLTGDIPT-TIGGLTNLQLLSLENNRLHGPIP 575 (902)
Q Consensus 499 ~~~~~~~~~~l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p 575 (902)
++..|..+..+++|++|++++|++++ .+|..+..+++|++|++++|++++.+|. .|..+++|+.|++++|++++.+|
T Consensus 337 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 416 (520)
T 2z7x_B 337 TDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416 (520)
T ss_dssp CTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGG
T ss_pred ChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchh
Confidence 99999999999999999999999997 4567899999999999999999985665 48899999999999999998888
Q ss_pred ccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCC--CcccccccccccCCcccCCCCC
Q 046199 576 ESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG--GSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 576 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
..+. ++|+.|||++|+++ .+|..+..+++|+.|++++|+++ .+|.. ..+..+....+.+|+..|.++.
T Consensus 417 ~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 417 RCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp GSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 7775 79999999999999 78988889999999999999999 46653 4566777888999999887664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=467.84 Aligned_cols=452 Identities=18% Similarity=0.225 Sum_probs=354.9
Q ss_pred CccceeeecccccCCCCchhhccccccceeec-ccCcCCCCCChhhhccCcccEEeeeeCCCCccc----------cccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSL-PRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFY----------MTNN 217 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----------~~~~ 217 (902)
..++.|+|++|.++|.+|++|++|++|++|+| ++|.++|..|-..... .++++...+..+. ....
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~----~~~l~~~~l~~lr~~~~~~~l~~~~~~ 398 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL----TPDMSEERKHRIRMHYKKMFLDYDQRL 398 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCC----CSSCCHHHHHHHHTHHHHHHTCCCGGG
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeeccccccccccccccccc----ccccchhHHHHHHHhhhhhhhccCcch
Confidence 35788888888888888888888888888888 7887777644221111 0011000000000 0000
Q ss_pred cccCCccccccc--cCCCccccCCCCCCEEEccC--ccccCcCCCcccCCCCCceEeccCccccc---------------
Q 046199 218 HFTGSIPRNLWQ--CEIPHEIGNLPNLEVLGIDE--NHLVGDVPNTIFNMSTLKALSLLNNTLSG--------------- 278 (902)
Q Consensus 218 ~~~g~ip~~~~~--~~lp~~l~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--------------- 278 (902)
.+++.++..+-. ...+........++.+.++. |++++ +|..++++++|+.|+|++|++++
T Consensus 399 ~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~ 477 (876)
T 4ecn_A 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA 477 (876)
T ss_dssp GSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred hhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccc
Confidence 011101000000 00011112233444455544 88887 88889999999999999999987
Q ss_pred --CCCcCCcccC--CCcccceeeccCccCCCCCCccccccccccEEEccCCc-ccC-cccccccccc-------cccEEe
Q 046199 279 --SLPSSSKNLI--GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS-FSG-FIPDTLVNLR-------NLEHLG 345 (902)
Q Consensus 279 --~~p~~~~~l~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~-------~L~~L~ 345 (902)
.+|.. +. ++++|++|+|++|++.+.+|..++++++|+.|+|++|+ +++ .+|..+..++ +|++|+
T Consensus 478 ~g~iP~~---l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~ 554 (876)
T 4ecn_A 478 KQYENEE---LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554 (876)
T ss_dssp HHHTTSC---CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred cccCChh---hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence 37877 55 89999999999999999999999999999999999998 988 7888777776 999999
Q ss_pred cccccCCCCCCcccccc--cccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCC-CcEE
Q 046199 346 LGYNYLTSSTPELSFLS--SLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVN-LTTL 422 (902)
Q Consensus 346 Ls~N~l~~~~~~~~~l~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L 422 (902)
+++|+++ ..| . .+.++++|++|++++|.+. .+| .+..++ +|+.|+|++|+++ .+|..+..+++ |+.|
T Consensus 555 Ls~N~L~-~ip-----~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L 624 (876)
T 4ecn_A 555 MGYNNLE-EFP-----ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624 (876)
T ss_dssp CCSSCCC-BCC-----CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTCCEE
T ss_pred eeCCcCC-ccC-----ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHHhhccccCCEE
Confidence 9999999 555 4 6889999999999999998 788 888888 9999999999999 88889999999 9999
Q ss_pred EeecceecccCCcccccccc--cCeeecccccccCCCCCcC--------CCCCeEeccCccccCCCCccccCCCcCceEe
Q 046199 423 HLGNNQLSGSIPITVGRLNT--LQGLGLENNKLEGPIPDDL--------CQLSELHVDHNKLSGPIPACFGNLNSLRNLS 492 (902)
Q Consensus 423 ~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~l--------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 492 (902)
+|++|+++ .+|..+..+.. |+.|++++|++.+.+|... .+|+.|+|++|+++...+..+..+++|+.|+
T Consensus 625 ~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~ 703 (876)
T 4ecn_A 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703 (876)
T ss_dssp ECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred ECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence 99999999 78888887755 9999999999998776422 2799999999999965555566899999999
Q ss_pred cCCCCccCcccccccCC-------CCceEEEcCCCccCCCCccccc--cccccceeccCCccccccCccccccCCccceE
Q 046199 493 LGSNELSSFIPSTFWNL-------NNILSFDFSSNSLNGSLPLDIG--NMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563 (902)
Q Consensus 493 L~~N~l~~~~~~~~~~l-------~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 563 (902)
|++|+|+.+.+..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|
T Consensus 704 Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L 781 (876)
T 4ecn_A 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781 (876)
T ss_dssp CCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEE
T ss_pred CCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEE
Confidence 99999996544444433 39999999999999 6788887 99999999999999997 79999999999999
Q ss_pred EccC------cccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 564 SLEN------NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 564 ~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
+|++ |++.+.+|..|..+++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+.
T Consensus 782 ~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp ECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred ECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChH
Confidence 9977 889999999999999999999999999 68898876 6999999999999865553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=450.69 Aligned_cols=439 Identities=21% Similarity=0.229 Sum_probs=307.6
Q ss_pred CccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|++|+|++|.|+.
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------- 114 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN----------------- 114 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-----------------
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-----------------
Confidence 355566666666654444556666666666666666665555556666666666666665442
Q ss_pred ccCCCccccCCCCCCEEEccCccccC-cCCCcccCCCCCceEeccCcccccCCCcCCcccCCCccc--ceeeccCccC--
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVG-DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNI--ERLNLGLNNL-- 303 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L--~~L~Ls~N~l-- 303 (902)
+|.. .+++|++|+|++|++++ .+|..+.++++|++|+|++|++++. . +..+++| ++|++++|.+
T Consensus 115 ---lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~---~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 115 ---ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---D---LLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp ---ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---T---TGGGTTSCEEEEEEEESSCCC
T ss_pred ---cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---c---hhhhhhceeeEEEeecccccc
Confidence 1233 45566666666666654 2345566666666666666666531 2 2223333 6666666666
Q ss_pred CCCCCccccccc-cccEEEccCCcccCcccc-cccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCC
Q 046199 304 SGRIPGFIFNAS-KLFLLELTGNSFSGFIPD-TLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLN 381 (902)
Q Consensus 304 ~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~ 381 (902)
++..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|+..... -...+..+..+++++.++++++.+.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~-l~~~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR-LMTFLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHH-HHHHHHHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccch-HHHHHHHHhccCcceEEEecCCcCc
Confidence 556666655543 122456666666654443 3456677777777776421000 0011234556666777777666655
Q ss_pred ccc----CcccccccccccEEEeecCcccccCCccc-----CCCCCCcEEEeecceecccCC-cccccc---cccCeeec
Q 046199 382 GVL----PSSIGNLPITLEEIYLQNCKIRGNIPKEI-----GNLVNLTTLHLGNNQLSGSIP-ITVGRL---NTLQGLGL 448 (902)
Q Consensus 382 ~~~----p~~~~~l~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L 448 (902)
+.. +..+ ..+ +|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+| .++..+ .+|++|++
T Consensus 263 ~~~~~~~~~~~-~~~-~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l 338 (562)
T 3a79_B 263 WKCSVKLFQFF-WPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSI 338 (562)
T ss_dssp HHHHHHHHHHH-TTS-SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEE
T ss_pred HHHHHHHHHhh-hcc-cccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEc
Confidence 421 1111 123 79999999999998888877 6777777777777777 344 333333 67999999
Q ss_pred ccccccCCCC-CcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcc--cccccCCCCceEEEcCCCccCCC
Q 046199 449 ENNKLEGPIP-DDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI--PSTFWNLNNILSFDFSSNSLNGS 525 (902)
Q Consensus 449 ~~N~l~~~~p-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~ls~N~l~~~ 525 (902)
++|.+..... ..+.+|++|++++|++++..|..|.++++|++|++++|+++++. |..|..+++|++|++++|++++.
T Consensus 339 ~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (562)
T 3a79_B 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418 (562)
T ss_dssp ESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred cCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence 9999875433 67779999999999999999999999999999999999999843 56799999999999999999984
Q ss_pred Cc-cccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcc-cc
Q 046199 526 LP-LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPIS-LE 603 (902)
Q Consensus 526 ~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~ 603 (902)
+| ..+..+++|++|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. +.
T Consensus 419 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~ 494 (562)
T 3a79_B 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFD 494 (562)
T ss_dssp CSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTT
T ss_pred cChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHh
Confidence 55 4588999999999999999988877665 79999999999999 688777799999999999999995 5655 99
Q ss_pred cccccccccccCCcceecCCC
Q 046199 604 KLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 604 ~l~~L~~L~l~~N~l~~~~p~ 624 (902)
.+++|+.|++++|+|.|.+|.
T Consensus 495 ~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 495 RLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TCTTCCCEECCSCCBCCCHHH
T ss_pred cCCCCCEEEecCCCcCCCcch
Confidence 999999999999999998885
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=445.47 Aligned_cols=509 Identities=22% Similarity=0.223 Sum_probs=416.1
Q ss_pred cEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEc
Q 046199 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124 (902)
Q Consensus 45 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldl 124 (902)
.++.|||++|.|++..+.++..+++|++|||++|++++..|..|.++++|++|+|++|+|++ +|...++++++|++||+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC-CCHHHhcCCCCCCEEEC
Confidence 58999999999997666789999999999999999996556679999999999999999985 67677899999999999
Q ss_pred ccCcccCcCCcchhccCc-ccccCcCccceeeecccccCC-CCchhhccccccceeecccCcCCCCCChhhhccCccc--
Q 046199 125 NYNSLSGELPANIFRAIP-KDIGNLTKLKELYLGYNKLQG-EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLL-- 200 (902)
Q Consensus 125 s~n~l~~~~~~~~~~~ip-~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-- 200 (902)
++|++++ +| ..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|++++..|..+..+++++
T Consensus 132 s~N~l~~---------l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~ 202 (635)
T 4g8a_A 132 VETNLAS---------LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 202 (635)
T ss_dssp TTSCCCC---------STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CCCcCCC---------CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhh
Confidence 9999985 44 468999999999999999985 4789999999999999999999988888888877654
Q ss_pred --EEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCc-CCCcccCCCCCceEeccCcccc
Q 046199 201 --ELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGD-VPNTIFNMSTLKALSLLNNTLS 277 (902)
Q Consensus 201 --~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~ 277 (902)
.++++.|.++.+ +........++.|++++|..... .+..+..+..++...+..+...
T Consensus 203 ~~~~~ls~n~l~~i--------------------~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~ 262 (635)
T 4g8a_A 203 NLSLDLSLNPMNFI--------------------QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 262 (635)
T ss_dssp CCEEECTTCCCCEE--------------------CTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCT
T ss_pred hhhhhcccCccccc--------------------CcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccc
Confidence 678888886632 23444445678888888876532 3445667788877776544332
Q ss_pred cCCC---cCCcccCCCcccceeeccCccCC---CCCCccccccccccEEEccCCcccCcccccccccccccEEecccccC
Q 046199 278 GSLP---SSSKNLIGLPNIERLNLGLNNLS---GRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351 (902)
Q Consensus 278 ~~~p---~~~~~l~~l~~L~~L~Ls~N~l~---~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 351 (902)
.... .....+..+..+...++..+... ...+..+....+++.+++.+|.+.... .+....+|+.|++++|.+
T Consensus 263 ~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~ 340 (635)
T 4g8a_A 263 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKF 340 (635)
T ss_dssp TSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEE
T ss_pred cccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccc
Confidence 1110 11112444556666666555443 223445667788999999999887543 456678899999999998
Q ss_pred CCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCccc--ccCCcccCCCCCCcEEEeeccee
Q 046199 352 TSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIR--GNIPKEIGNLVNLTTLHLGNNQL 429 (902)
Q Consensus 352 ~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l 429 (902)
....+ ..+..|+.+++++|...... ....++ +|+.|++++|.+. +..+..+..+.+|+.++++.|.+
T Consensus 341 ~~~~~--------~~l~~L~~l~l~~n~~~~~~--~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~ 409 (635)
T 4g8a_A 341 GQFPT--------LKLKSLKRLTFTSNKGGNAF--SEVDLP-SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGV 409 (635)
T ss_dssp SSCCC--------CBCTTCCEEEEESCCSCCBC--CCCBCT-TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSE
T ss_pred cCcCc--------ccchhhhhcccccccCCCCc--cccccc-ccccchhhccccccccccccchhhhhhhhhhhcccccc
Confidence 86544 34678889999999876533 344666 8999999999986 34566778889999999999999
Q ss_pred cccCCcccccccccCeeecccccccCCCCC----cCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCc-cCcccc
Q 046199 430 SGSIPITVGRLNTLQGLGLENNKLEGPIPD----DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNEL-SSFIPS 504 (902)
Q Consensus 430 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~~~ 504 (902)
.. .+..+..+++|+.++++.|+.....+. .+.+++.++++.|.+.+..+..+..+++|+.|++++|++ .+..|.
T Consensus 410 ~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~ 488 (635)
T 4g8a_A 410 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 488 (635)
T ss_dssp EE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred cc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCch
Confidence 84 566788999999999999988765553 345899999999999999999999999999999999974 556888
Q ss_pred cccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccccccc-cc
Q 046199 505 TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL-TS 583 (902)
Q Consensus 505 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~ 583 (902)
.|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+ ++
T Consensus 489 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~ 568 (635)
T 4g8a_A 489 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 568 (635)
T ss_dssp CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTT
T ss_pred hhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988 68
Q ss_pred CCeEeCcCcccccc
Q 046199 584 LESLDLSVNNLSGV 597 (902)
Q Consensus 584 L~~L~Ls~N~l~~~ 597 (902)
|+.|+|++|+++-.
T Consensus 569 L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 569 LAFLNLTQNDFACT 582 (635)
T ss_dssp CCEEECTTCCBCCS
T ss_pred CCEEEeeCCCCccc
Confidence 99999999999853
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=438.79 Aligned_cols=462 Identities=21% Similarity=0.221 Sum_probs=268.3
Q ss_pred EEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEccc
Q 046199 47 TALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNY 126 (902)
Q Consensus 47 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~ 126 (902)
+.+|++++++++ +|..+. ++|++|||++|++++..|..|+++++|++|+|++|++++..|. .++++++|++||+++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH-VFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT-TTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH-HhCCCCCCCEEECCC
Confidence 678888888884 777654 7888888888888865566788888888888888888754332 234455555555555
Q ss_pred CcccCcCCcchhccCcccccCcCccceeeecccccCC-CCchhhccccccceeecccCcCCCCCChhhhccCcc--cEEe
Q 046199 127 NSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQG-EIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL--LELD 203 (902)
Q Consensus 127 n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~ 203 (902)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|+
T Consensus 110 N~l~---------~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~ 175 (562)
T 3a79_B 110 NRLQ---------NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCIL 175 (562)
T ss_dssp SCCC---------EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEE
T ss_pred CcCC---------ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEE
Confidence 5554 13433 45555555555555553 2334555555555555555555431 23333333 5555
Q ss_pred eeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCC--CCceEeccCcccccCCC
Q 046199 204 FSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMS--TLKALSLLNNTLSGSLP 281 (902)
Q Consensus 204 Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 281 (902)
+++|.+. . ++..|..+..+. .+ .+++++|.+.+.++
T Consensus 176 L~~n~l~--------~---------------------------------~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~ 213 (562)
T 3a79_B 176 LDLVSYH--------I---------------------------------KGGETESLQIPNTTVL-HLVFHPNSLFSVQV 213 (562)
T ss_dssp EEESSCC--------C---------------------------------CSSSCCEEEECCEEEE-EEEECSSSCCCCCC
T ss_pred eeccccc--------c---------------------------------cccCcccccccCcceE-EEEecCccchhhhh
Confidence 5555431 0 333444333322 11 23444444443333
Q ss_pred cCCcccCCCcccceeeccCccC-----CCCCCccccccccccEEEccCCcccCccccc---ccccccccEEecccccCCC
Q 046199 282 SSSKNLIGLPNIERLNLGLNNL-----SGRIPGFIFNASKLFLLELTGNSFSGFIPDT---LVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 282 ~~~~~l~~l~~L~~L~Ls~N~l-----~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~---l~~l~~L~~L~Ls~N~l~~ 353 (902)
... +..+++|+.|++++|+. .+. ...+..+++|+.|+++++.+++..... .....+|++|++++|.+++
T Consensus 214 ~~~--~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 290 (562)
T 3a79_B 214 NMS--VNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290 (562)
T ss_dssp EEE--ESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECS
T ss_pred hhc--ccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeec
Confidence 221 33444444444444421 111 112333444444444444433211100 0112355555555555554
Q ss_pred CCCcccccccccCCCCCceeeeccCCCCcccC-cccccc---cccccEEEeecCcccccCCcccCCCCCCcEEEeeccee
Q 046199 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLP-SSIGNL---PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQL 429 (902)
Q Consensus 354 ~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 429 (902)
..|...+.....+++.|+.++++.|.+ .+| ..+..+ + +++.|++++|.+.... ....+++|++|++++|++
T Consensus 291 ~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l 365 (562)
T 3a79_B 291 RIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEM-NIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVF 365 (562)
T ss_dssp CCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTC-CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCC
T ss_pred cccchhhhcccccchheehhhccccee--ecChhhhhhhhccC-cceEEEccCCCccccc--CccCCCCceEEECCCCcc
Confidence 444110000013344444444444443 222 111111 2 4666666666664221 114566666666666666
Q ss_pred cccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccC-cccccccC
Q 046199 430 SGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS-FIPSTFWN 508 (902)
Q Consensus 430 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~ 508 (902)
++..|..+..+++|++|++++|++++. + ..|..|.++++|++|++++|++++ +.+..|..
T Consensus 366 ~~~~~~~~~~l~~L~~L~L~~N~l~~~-~------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 426 (562)
T 3a79_B 366 TDSVFQGCSTLKRLQTLILQRNGLKNF-F------------------KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426 (562)
T ss_dssp CTTTTTTCCSCSSCCEEECCSSCCCBT-T------------------HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCC
T ss_pred ccchhhhhcccCCCCEEECCCCCcCCc-c------------------cchhhhcCCCCCCEEECCCCcCCCccChhhhcC
Confidence 666666666666665555555555421 0 234567888888999999998888 44456888
Q ss_pred CCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccc-ccccccCCeE
Q 046199 509 LNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES-FGALTSLESL 587 (902)
Q Consensus 509 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L 587 (902)
+++|++|++++|++++..|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. |..+++|+.|
T Consensus 427 l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L 502 (562)
T 3a79_B 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYI 502 (562)
T ss_dssp CTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCE
T ss_pred cccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEE
Confidence 88999999999998877666554 68999999999999 678777799999999999999995 5554 9999999999
Q ss_pred eCcCccccccCC
Q 046199 588 DLSVNNLSGVIP 599 (902)
Q Consensus 588 ~Ls~N~l~~~~p 599 (902)
+|++|++++..|
T Consensus 503 ~l~~N~~~c~c~ 514 (562)
T 3a79_B 503 WLHDNPWDCTCP 514 (562)
T ss_dssp ECCSCCBCCCHH
T ss_pred EecCCCcCCCcc
Confidence 999999997655
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=413.33 Aligned_cols=239 Identities=29% Similarity=0.328 Sum_probs=113.2
Q ss_pred cccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccc
Q 046199 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395 (902)
Q Consensus 316 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 395 (902)
+|++|++++|++++ +| .+..+++|++|++++|++++.+. ..+ +|
T Consensus 174 ~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~---------~~~-------------------------~L 217 (454)
T 1jl5_A 174 SLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD---------LPL-------------------------SL 217 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC---------CCT-------------------------TC
T ss_pred cccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC---------CcC-------------------------cc
Confidence 55555555555554 33 35555666666666665554211 001 44
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcccc
Q 046199 396 EEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLS 475 (902)
Q Consensus 396 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~ 475 (902)
++|++++|.++ .+| .++.+++|++|++++|++++ +|.. .++|++|++++|++++ +|..+.+|+.|++++|+++
T Consensus 218 ~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~~~L~~L~ls~N~l~ 290 (454)
T 1jl5_A 218 ESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFS 290 (454)
T ss_dssp CEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred cEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcccCcCCEEECcCCccC
Confidence 45555555554 333 24555555555555555553 2321 2455555555555553 4444456666666666665
Q ss_pred CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccc
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIG 555 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 555 (902)
+. |.. .++|+.|++++|+++++ +. -.++|++|++++|++++ +|.. +++|++|++++|+++ .+|.
T Consensus 291 ~l-~~~---~~~L~~L~l~~N~l~~i-~~---~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~--- 354 (454)
T 1jl5_A 291 GL-SEL---PPNLYYLNASSNEIRSL-CD---LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE--- 354 (454)
T ss_dssp EE-SCC---CTTCCEEECCSSCCSEE-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---
T ss_pred cc-cCc---CCcCCEEECcCCcCCcc-cC---CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---
Confidence 42 111 14566666666666652 11 11466677777777665 4433 356677777777776 3454
Q ss_pred cCCccceEEccCcccCC--CccccccccccCCeEeCcCccccccCCcccccccccccccccCCccee--cCCC
Q 046199 556 GLTNLQLLSLENNRLHG--PIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG--EIPS 624 (902)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~ 624 (902)
.+++|++|++++|++++ .+|.+++.+ +.|++.|.+|.. +++|+.|++++|++++ .+|.
T Consensus 355 ~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 355 LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---------------------------------
T ss_pred hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence 35677777777777776 556555432 335555555543 3566666666666665 5553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=390.94 Aligned_cols=289 Identities=29% Similarity=0.471 Sum_probs=234.0
Q ss_pred CCChhHHHHHHHHHhcccc----CCCCCCCCcee--eeeEEeeCCC--CcEEEEEeccCCcce--ecCcccCCCCCCCee
Q 046199 4 NINTTDQQALLALKARITA----KNWTSNTSVCS--WIGITCDVST--HRVTALNISDFGLTG--TISSQLGNLSSLQTL 73 (902)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~----~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 73 (902)
.|+++|++||++||+++.+ ++|..+.|||. |.||+|+..+ ++|+.|+|++++++| .+|+.++.+++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 5899999999999999976 68988889998 9999998765 799999999999999 999999999999999
Q ss_pred eccc-cccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccc
Q 046199 74 DLSH-NRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLK 152 (902)
Q Consensus 74 ~Ls~-n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~ 152 (902)
+|++ |.+++.+|..++++++|++|+|++|.+++. +|..++++++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~---------------------------------~p~~~~~l~~L~ 128 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA---------------------------------IPDFLSQIKTLV 128 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE---------------------------------CCGGGGGCTTCC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc---------------------------------CCHHHhCCCCCC
Confidence 9995 999999999999999999999999999865 566677777788
Q ss_pred eeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccC-cccEEeeeeCCCCccccccccccCCccccccccC
Q 046199 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLS-SLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCE 231 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~ 231 (902)
+|+|++|.+++.+|..++.+++|++|+|++|++++.+|..+++++ +|++|+|++|.++ |.+|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~----------~~~~------- 191 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT----------GKIP------- 191 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE----------EECC-------
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeee----------ccCC-------
Confidence 888888888777787788888888888888888777777777777 7788888777743 3333
Q ss_pred CCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 232 lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
..++.++ |+.|+|++|++++..|..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+
T Consensus 192 --~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 192 --PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK----VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp --GGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG----CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred --hHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc----ccccCCCCEEECcCCcccCcCChHH
Confidence 6666665 78888888888777777777788888888888887755543 4556777777777777777777777
Q ss_pred cccccccEEEccCCcccCcccccccccccccEEeccccc
Q 046199 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 350 (902)
..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 77777777777777777777665 667777777777776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=405.87 Aligned_cols=398 Identities=26% Similarity=0.306 Sum_probs=247.2
Q ss_pred cCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccc
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~ 227 (902)
.+.|++|++++|++ |.+|++++++++|++|++++|.+.|.+|.+++++++|+.+++++|.
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~------------------- 69 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL------------------- 69 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHH-------------------
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhh-------------------
Confidence 35566666666666 4666666666666666666666666666666666665555444432
Q ss_pred cccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCC
Q 046199 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRI 307 (902)
Q Consensus 228 ~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~ 307 (902)
..+++.|++++|++++ +|.. .++|+.|++++|++++ +|.. .++|++|++++|++++.
T Consensus 70 -----------~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~------~~~L~~L~l~~n~l~~l- 126 (454)
T 1jl5_A 70 -----------DRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL------PQSLKSLLVDNNNLKAL- 126 (454)
T ss_dssp -----------HHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC------CTTCCEEECCSSCCSCC-
T ss_pred -----------ccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc------cCCCcEEECCCCccCcc-
Confidence 0244555555555542 2321 2455555555555554 4432 24555666666655532
Q ss_pred CccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcc
Q 046199 308 PGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSS 387 (902)
Q Consensus 308 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~ 387 (902)
|.. .++|++|++++|++++ +| .+.++++|++|++++|++++.+. ...+|++|++++|++.+ +| .
T Consensus 127 ~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~---------~~~~L~~L~L~~n~l~~-l~-~ 190 (454)
T 1jl5_A 127 SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD---------LPPSLEFIAAGNNQLEE-LP-E 190 (454)
T ss_dssp CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSS-CC-C
T ss_pred cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCC---------CcccccEEECcCCcCCc-Cc-c
Confidence 211 1466777777777765 44 46677777777777777765322 12467777777777776 45 4
Q ss_pred cccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeE
Q 046199 388 IGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSEL 467 (902)
Q Consensus 388 ~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L 467 (902)
+..++ +|++|++++|++++ +|... ++|++|++++|+++ .+| .++.+++|++|++++|++++ +|..+.+|+.|
T Consensus 191 ~~~l~-~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L 262 (454)
T 1jl5_A 191 LQNLP-FLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL 262 (454)
T ss_dssp CTTCT-TCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCCTTCCEE
T ss_pred ccCCC-CCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccccccccCEE
Confidence 77777 88999999998886 44432 58999999999999 677 48999999999999999995 77777899999
Q ss_pred eccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccc-cccceeccCCccc
Q 046199 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNM-KVVVEINLSRNYL 546 (902)
Q Consensus 468 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l 546 (902)
++++|++++ +|.. .++|+.|++++|+++++ |.. .++|++|++++|++++ ++ .+ ++|++|++++|++
T Consensus 263 ~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l 329 (454)
T 1jl5_A 263 NVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKL 329 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCC
T ss_pred ECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcc
Confidence 999999997 4543 37899999999999984 221 2689999999999986 22 23 5899999999999
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccc--cCCcccccccccccccccCCcceecCCC
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG--VIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
++ +|.. +++|+.|++++|+++ .+|. .+++|++|+|++|++++ .+|.++.. ++.|.+.|.+|.
T Consensus 330 ~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~ 393 (454)
T 1jl5_A 330 IE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPE 393 (454)
T ss_dssp SC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------
T ss_pred cc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccccc
Confidence 96 6654 589999999999999 4666 47899999999999998 67776654 346888888887
Q ss_pred CCcccccccccccCCcccC
Q 046199 625 GGSFANFSAQSFMGNDLLC 643 (902)
Q Consensus 625 ~~~~~~~~~~~~~~n~~lc 643 (902)
.+..+....+.+|+...
T Consensus 394 --~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 394 --LPQNLKQLHVETNPLRE 410 (454)
T ss_dssp -------------------
T ss_pred --ccCcCCEEECCCCcCCc
Confidence 34667777888887643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=403.15 Aligned_cols=372 Identities=19% Similarity=0.230 Sum_probs=324.6
Q ss_pred CCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccE
Q 046199 240 PNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFL 319 (902)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 319 (902)
++|++|+|++|++++..|..+.++++|++|+|++|.+.+.++... |.++++|++|+|++|++++..|..+..+++|++
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 107 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT--FRGLSSLIILKLDYNQFLQLETGAFNGLANLEV 107 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTT--TTTCTTCCEEECTTCTTCEECTTTTTTCTTCCE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccc--ccccccCCEEeCCCCccCccChhhccCcccCCE
Confidence 689999999999998889999999999999999999986665443 788999999999999999999999999999999
Q ss_pred EEccCCcccCccccc--ccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccccc-cccc
Q 046199 320 LELTGNSFSGFIPDT--LVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP-ITLE 396 (902)
Q Consensus 320 L~Ls~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~~L~ 396 (902)
|+|++|++++..|.. +..+++|++|++++|++++..|. ..+.++++|++|++++|.+.+..|..+..+. .+++
T Consensus 108 L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~ 183 (455)
T 3v47_A 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA----SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183 (455)
T ss_dssp EECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC----GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEE
T ss_pred EeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc----cccCCCCcccEEeCCCCcccccChhhhhcccccccc
Confidence 999999999866555 89999999999999999988762 2378899999999999999999888887762 2899
Q ss_pred EEEeecCcccccCCccc--------CCCCCCcEEEeecceecccCCcccccc---cccCeeecccccccCCCCCcCCCCC
Q 046199 397 EIYLQNCKIRGNIPKEI--------GNLVNLTTLHLGNNQLSGSIPITVGRL---NTLQGLGLENNKLEGPIPDDLCQLS 465 (902)
Q Consensus 397 ~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~L~ 465 (902)
.|++++|.+.+..+..+ ..+++|++|++++|++++..|..+... ++|+.|++++|.+.+..
T Consensus 184 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------- 255 (455)
T 3v47_A 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------- 255 (455)
T ss_dssp EEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------
T ss_pred ccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------
Confidence 99999999997666543 366889999999999998888877665 88999999998876432
Q ss_pred eEeccCccccCCCCccccCC--CcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCC
Q 046199 466 ELHVDHNKLSGPIPACFGNL--NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSR 543 (902)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (902)
+..+.+.+..+..+..+ ++|+.|++++|++++..|..|..+++|++|++++|++++..|..|..+++|++|+|++
T Consensus 256 ---~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 332 (455)
T 3v47_A 256 ---FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQ 332 (455)
T ss_dssp ---TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ---cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCC
Confidence 22334444444444444 6899999999999999999999999999999999999988888999999999999999
Q ss_pred ccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 544 NYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 544 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
|++++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|+++|.+|
T Consensus 333 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 333 NFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp SCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99998889999999999999999999998889999999999999999999998777788999999999999999999999
Q ss_pred CCCcc
Q 046199 624 SGGSF 628 (902)
Q Consensus 624 ~~~~~ 628 (902)
....+
T Consensus 413 ~~~~l 417 (455)
T 3v47_A 413 RIDYL 417 (455)
T ss_dssp TTHHH
T ss_pred cchHH
Confidence 64443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=399.19 Aligned_cols=330 Identities=21% Similarity=0.282 Sum_probs=219.3
Q ss_pred cccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcc-ccc
Q 046199 235 EIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGF-IFN 313 (902)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-l~~ 313 (902)
.|..+++|++|+|++|++++..|..+.++++|++|+|++|++++.+|.. ..+..+++|++|+|++|++++..|.. +..
T Consensus 74 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 152 (455)
T 3v47_A 74 TFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG-NFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152 (455)
T ss_dssp TTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS-STTTTCTTCCEEECCSSBCCSCCCCGGGGG
T ss_pred cccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCc-ccccCcccCCEEECCCCccCccCcccccCC
Confidence 3444445555555555554444555555555555555555554322211 11444555555555555555554543 556
Q ss_pred cccccEEEccCCcccCccccccccc--ccccEEecccccCCCCCCcccc---cccccCCCCCceeeeccCCCCcccCccc
Q 046199 314 ASKLFLLELTGNSFSGFIPDTLVNL--RNLEHLGLGYNYLTSSTPELSF---LSSLANSSSSKYIVLAENPLNGVLPSSI 388 (902)
Q Consensus 314 l~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~---l~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 388 (902)
+++|++|++++|++.+..|..+..+ .+|+.|++++|.+.+..+.... ...+..++
T Consensus 153 l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~-------------------- 212 (455)
T 3v47_A 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT-------------------- 212 (455)
T ss_dssp CTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC--------------------
T ss_pred CCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc--------------------
Confidence 6666666666666666666666554 5677777777776654431100 01112233
Q ss_pred ccccccccEEEeecCcccccCCcccCCC---CCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCC
Q 046199 389 GNLPITLEEIYLQNCKIRGNIPKEIGNL---VNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465 (902)
Q Consensus 389 ~~l~~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~ 465 (902)
+|++|++++|++++..|..+... ++|+.|++++|.+.+... ....+..+....+.+. ...+|+
T Consensus 213 -----~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~-~~~~~~~~~~~~~~~~--------~~~~L~ 278 (455)
T 3v47_A 213 -----SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-GHTNFKDPDNFTFKGL--------EASGVK 278 (455)
T ss_dssp -----EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-TCCSSCCCCTTTTGGG--------TTSCCC
T ss_pred -----eeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-chhhhccCcccccccc--------cccCce
Confidence 44444444444444444433322 556666666665543211 0111111110000000 123788
Q ss_pred eEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcc
Q 046199 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY 545 (902)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (902)
.|++++|++++..|..|..+++|++|++++|++++..|..|.++++|++|++++|++++..|..|..+++|++|+|++|+
T Consensus 279 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 358 (455)
T 3v47_A 279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358 (455)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC
T ss_pred EEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc
Confidence 89999999988899999999999999999999999989999999999999999999998889999999999999999999
Q ss_pred ccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCC
Q 046199 546 LTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599 (902)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 599 (902)
+++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 359 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 359 IRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999999999999999999998777888999999999999999998876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=385.01 Aligned_cols=365 Identities=20% Similarity=0.234 Sum_probs=181.5
Q ss_pred cceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCc
Q 046199 56 LTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPA 135 (902)
Q Consensus 56 l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~ 135 (902)
..+..+..++.+++|++|||++|++++ +| .++.+++|++|+|++|++++. | ++++++|++||+++|.+++
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~---- 99 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTN---- 99 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSC----
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCce----
Confidence 334444566677777777777777774 45 577777777777777777652 2 3455555555555555543
Q ss_pred chhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccc
Q 046199 136 NIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMT 215 (902)
Q Consensus 136 ~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 215 (902)
+| ++++++|++|+|++|++++ +| ++.+++|++|++++|++++ +| ++++++|++|++++|...
T Consensus 100 -----~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~----- 161 (457)
T 3bz5_A 100 -----LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKI----- 161 (457)
T ss_dssp -----CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCC-----
T ss_pred -----ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcc-----
Confidence 22 4455555555555555553 33 4555555555555555553 22 444555555555554310
Q ss_pred cccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccce
Q 046199 216 NNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIER 295 (902)
Q Consensus 216 ~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 295 (902)
+.+ .++.+++|+.|++++|++++ +| +..+++|+.|++++|+
T Consensus 162 -----~~~-----------~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~-------------------- 202 (457)
T 3bz5_A 162 -----TKL-----------DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNN-------------------- 202 (457)
T ss_dssp -----CCC-----------CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSC--------------------
T ss_pred -----ccc-----------ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCc--------------------
Confidence 110 13334444444444444443 22 3444444444444444
Q ss_pred eeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeee
Q 046199 296 LNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVL 375 (902)
Q Consensus 296 L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~L 375 (902)
+++. .+..+++|++|++++|++++ +| +..+++|++|++++|++++.++ ..+++|+.|++
T Consensus 203 -------l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~--------~~l~~L~~L~l 261 (457)
T 3bz5_A 203 -------ITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV--------STLSKLTTLHC 261 (457)
T ss_dssp -------CSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC--------TTCTTCCEEEC
T ss_pred -------CCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH--------HHCCCCCEEec
Confidence 4432 13344445555555555544 22 4445555555555555544221 12233333333
Q ss_pred ccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccC
Q 046199 376 AENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG 455 (902)
Q Consensus 376 s~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 455 (902)
++| +|+.|++++|. +.+.+| ++.+++|+.|++++|...+
T Consensus 262 ~~n---------------~L~~L~l~~n~------------------------~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 262 IQT---------------DLLEIDLTHNT------------------------QLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp TTC---------------CCSCCCCTTCT------------------------TCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred cCC---------------CCCEEECCCCc------------------------cCCccc--ccccccCCEEECCCCcccc
Confidence 322 22233333333 333333 2334444444444444444
Q ss_pred CCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccc
Q 046199 456 PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKV 535 (902)
Q Consensus 456 ~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 535 (902)
.+|....+|+.|++++| ++|++|++++|+++++ + ++.+++|+.|++++|++++ ++.
T Consensus 301 ~l~~~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~ 356 (457)
T 3bz5_A 301 LLDCQAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSS 356 (457)
T ss_dssp EEECTTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTT
T ss_pred eeccCCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccc
Confidence 44433334444443333 4566666666666653 2 5566666666666666654 234
Q ss_pred cceeccCCccccccCccccccCCccceEEccCcccCCCccccc
Q 046199 536 VVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF 578 (902)
Q Consensus 536 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 578 (902)
|..|++++|+++|. +.+..|+.+++++|+++|.+|..+
T Consensus 357 L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 357 VGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp GGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred cccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 55556666666654 234455556666666666665543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=373.54 Aligned_cols=368 Identities=20% Similarity=0.197 Sum_probs=254.7
Q ss_pred ecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCcc
Q 046199 156 LGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHE 235 (902)
Q Consensus 156 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~ 235 (902)
.......+..+..++.+++|++|++++|.+++ +| .++.+++|++|+|++|.+++ +|
T Consensus 25 ~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~--------------------~~-- 80 (457)
T 3bz5_A 25 AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT--------------------LD-- 80 (457)
T ss_dssp HHHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC--------------------CC--
T ss_pred HHhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe--------------------Ec--
Confidence 33334444455556666666666666666664 34 45666666666666666442 11
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccc
Q 046199 236 IGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS 315 (902)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 315 (902)
++.+++|++|+|++|++++. | ++++++|++|++++|++++ +| +..+++|++|++++|++++. + ++.++
T Consensus 81 ~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~-----~~~l~~L~~L~l~~N~l~~l-~--l~~l~ 148 (457)
T 3bz5_A 81 LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD-----VSQNPLLTYLNCARNTLTEI-D--VSHNT 148 (457)
T ss_dssp CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC-----CTTCTTCCEEECTTSCCSCC-C--CTTCT
T ss_pred cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec-----CCCCCcCCEEECCCCcccee-c--cccCC
Confidence 45556666666666666642 2 5566666666666666654 22 45566666666666666653 2 55666
Q ss_pred cccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccc
Q 046199 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395 (902)
Q Consensus 316 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 395 (902)
+|++|++++|+..+.+ .+..+++|++|++++|++++.. +..+++|++|++++|++.+. .+..++ +|
T Consensus 149 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~--------l~~l~~L~~L~l~~N~l~~~---~l~~l~-~L 214 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD--------VSQNKLLNRLNCDTNNITKL---DLNQNI-QL 214 (457)
T ss_dssp TCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC--------CTTCTTCCEEECCSSCCSCC---CCTTCT-TC
T ss_pred cCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec--------cccCCCCCEEECcCCcCCee---ccccCC-CC
Confidence 6666666666444333 3556666777777777666531 44566666777777766654 255666 78
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcccc
Q 046199 396 EEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLS 475 (902)
Q Consensus 396 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~ 475 (902)
++|++++|++++ +| +..+++|+.|++++|++++.. ++.+++|+.|++++|++ +.|++++|.+.
T Consensus 215 ~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L-----------~~L~l~~n~~~ 277 (457)
T 3bz5_A 215 TFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL-----------LEIDLTHNTQL 277 (457)
T ss_dssp SEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC-----------SCCCCTTCTTC
T ss_pred CEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC-----------CEEECCCCccC
Confidence 888888888886 44 778888888888888888653 45677888888887654 47888888888
Q ss_pred CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccc
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIG 555 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 555 (902)
+.+| +..+++|+.|++++|++.+.+|. ...+|+.|++++| ++|++|++++|+|++. + ++
T Consensus 278 ~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~ 336 (457)
T 3bz5_A 278 IYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VS 336 (457)
T ss_dssp CEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CT
T ss_pred Cccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cc
Confidence 7776 56788999999999988777664 3455666655554 6789999999999974 3 89
Q ss_pred cCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 556 GLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
.+++|+.|++++|+|++ ++.|+.|++++|+++|. ..+..|..+++++|+++|.+|.
T Consensus 337 ~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 337 HNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp TCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred cCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 99999999999999986 35677888999999986 3567888999999999999997
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=367.22 Aligned_cols=343 Identities=28% Similarity=0.449 Sum_probs=276.0
Q ss_pred cEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEc
Q 046199 45 RVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124 (902)
Q Consensus 45 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldl 124 (902)
+++.|+++++++.. +| .+..+++|++|||++|+++ .+|+ ++++++|++|++++|++++..| ++++++|++||+
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~L 119 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTL 119 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG---GTTCTTCCEEEC
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccC-Cchh-hhccccCCEEECCCCccccChh---hcCCCCCCEEEC
Confidence 58889999988873 55 4788899999999999998 4555 8899999999999999987544 688999999999
Q ss_pred ccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEee
Q 046199 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDF 204 (902)
Q Consensus 125 s~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 204 (902)
++|.+++ +|. ++++++|++|+|++|.+++ +| .++.+++|++|+++ |.+.+. + .+.++++|++|++
T Consensus 120 ~~n~l~~---------~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~L~~L~l 184 (466)
T 1o6v_A 120 FNNQITD---------IDP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL-K-PLANLTTLERLDI 184 (466)
T ss_dssp CSSCCCC---------CGG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTTCCEEEC
T ss_pred CCCCCCC---------ChH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc-h-hhccCCCCCEEEC
Confidence 9998874 443 7888899999999999884 54 48889999999996 555533 3 3888999999999
Q ss_pred eeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCC
Q 046199 205 SNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSS 284 (902)
Q Consensus 205 s~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 284 (902)
++|.++.+ ..+..+++|+.|++++|++++..| ++.+++|+.|++++|++++. +
T Consensus 185 ~~n~l~~~---------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~--- 237 (466)
T 1o6v_A 185 SSNKVSDI---------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G--- 237 (466)
T ss_dssp CSSCCCCC---------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G---
T ss_pred cCCcCCCC---------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-h---
Confidence 99986632 347788899999999999886655 77888999999999988742 2
Q ss_pred cccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccc
Q 046199 285 KNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364 (902)
Q Consensus 285 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l 364 (902)
.+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +
T Consensus 238 -~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-------~ 305 (466)
T 1o6v_A 238 -TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-------I 305 (466)
T ss_dssp -GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-------G
T ss_pred -hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-------h
Confidence 26778889999999999886655 7788889999999999886654 7888899999999998886532 5
Q ss_pred cCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccC
Q 046199 365 ANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444 (902)
Q Consensus 365 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 444 (902)
..+++|++|++++|++.+..| +..++ +|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+
T Consensus 306 ~~l~~L~~L~L~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 378 (466)
T 1o6v_A 306 SNLKNLTYLTLYFNNISDISP--VSSLT-KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRIT 378 (466)
T ss_dssp GGCTTCSEEECCSSCCSCCGG--GGGCT-TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCC
T ss_pred cCCCCCCEEECcCCcCCCchh--hccCc-cCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCC
Confidence 678888888888888887665 66666 888888888888865 467888888888888888887766 77888888
Q ss_pred eeecccccccC
Q 046199 445 GLGLENNKLEG 455 (902)
Q Consensus 445 ~L~L~~N~l~~ 455 (902)
.|++++|++++
T Consensus 379 ~L~l~~n~~~~ 389 (466)
T 1o6v_A 379 QLGLNDQAWTN 389 (466)
T ss_dssp EEECCCEEEEC
T ss_pred EEeccCCcccC
Confidence 88888888875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=361.90 Aligned_cols=106 Identities=26% Similarity=0.379 Sum_probs=47.3
Q ss_pred cCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCe
Q 046199 507 WNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLES 586 (902)
Q Consensus 507 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 586 (902)
..+++|++|++++|++++..+ +..+++|++|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.
T Consensus 284 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 357 (466)
T 1o6v_A 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINW 357 (466)
T ss_dssp TTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred cCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCE
Confidence 333344444444444433222 3344444444444444443332 34444455555555544432 23444555555
Q ss_pred EeCcCccccccCCcccccccccccccccCCccee
Q 046199 587 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 587 L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
|++++|++++..| +..+++|+.|++++|++++
T Consensus 358 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp EECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred EeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555555554443 4445555555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=369.34 Aligned_cols=348 Identities=20% Similarity=0.199 Sum_probs=194.7
Q ss_pred CEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEc
Q 046199 243 EVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLEL 322 (902)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 322 (902)
+.++.++++++ .+|..+. ++++.|+|++|++++..|.. |.++++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 87 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDE---FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTT---TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhH---ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEEC
Confidence 46677777776 4555443 45666666666666544443 455555666666666555555555555555555555
Q ss_pred cCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeec
Q 046199 323 TGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQN 402 (902)
Q Consensus 323 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~ 402 (902)
++|++++..+..|.++++|++|++++|++++ ..|..+..++ +|++|++++
T Consensus 88 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-----------------------------~~~~~~~~l~-~L~~L~l~~ 137 (477)
T 2id5_A 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIVI-----------------------------LLDYMFQDLY-NLKSLEVGD 137 (477)
T ss_dssp CSSCCCSCCTTSSTTCTTCCEEECTTSCCCE-----------------------------ECTTTTTTCT-TCCEEEECC
T ss_pred CCCcCCccCcccccCCCCCCEEECCCCcccc-----------------------------CChhHccccc-cCCEEECCC
Confidence 5555554444445555555555555555544 3344444444 555555555
Q ss_pred CcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccc
Q 046199 403 CKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACF 482 (902)
Q Consensus 403 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~ 482 (902)
|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+. +..+..|
T Consensus 138 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~---------------------~~~~~~~ 196 (477)
T 2id5_A 138 NDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN---------------------AIRDYSF 196 (477)
T ss_dssp TTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC---------------------EECTTCS
T ss_pred CccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc---------------------EeChhhc
Confidence 5555555555555555555555555555444444444444444444444433 3333345
Q ss_pred cCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccce
Q 046199 483 GNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562 (902)
Q Consensus 483 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 562 (902)
..+++|+.|++++|.+.+.+|.......+|++|++++|++++..+..+..+++|++|+|++|++++..+..|.++++|+.
T Consensus 197 ~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (477)
T 2id5_A 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQE 276 (477)
T ss_dssp CSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCE
T ss_pred ccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCE
Confidence 55555555555555554444444444445666666666665444445556666666666666666555666666666666
Q ss_pred EEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCccc
Q 046199 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLL 642 (902)
Q Consensus 563 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~l 642 (902)
|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.++....+.+.....+.++...
T Consensus 277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~ 356 (477)
T 2id5_A 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPT 356 (477)
T ss_dssp EECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCB
T ss_pred EECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCce
Confidence 66666666666666666666666666666666665555666666666777777766665543222222223345556666
Q ss_pred CCCCC
Q 046199 643 CGSPH 647 (902)
Q Consensus 643 c~~~~ 647 (902)
|+.|.
T Consensus 357 C~~p~ 361 (477)
T 2id5_A 357 CATPE 361 (477)
T ss_dssp EEESG
T ss_pred eCCch
Confidence 65543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=356.26 Aligned_cols=336 Identities=21% Similarity=0.221 Sum_probs=246.5
Q ss_pred CCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 232 lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++..|.. |.++++|++|+|++|++++..+..|
T Consensus 26 ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~ 100 (477)
T 2id5_A 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA---FNNLFNLRTLGLRSNRLKLIPLGVF 100 (477)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT---TTTCTTCCEEECCSSCCCSCCTTSS
T ss_pred CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhh---hhCCccCCEEECCCCcCCccCcccc
Confidence 445443 58999999999999888899999999999999999999877776 7889999999999999998888889
Q ss_pred cccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccc
Q 046199 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNL 391 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 391 (902)
..+++|++|+|++|++.+..|..|..+++|++|++++|.+++..+ ..+.+++
T Consensus 101 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~l~----------------------- 152 (477)
T 2id5_A 101 TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH-----RAFSGLN----------------------- 152 (477)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT-----TSSTTCT-----------------------
T ss_pred cCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh-----hhccCCC-----------------------
Confidence 999999999999999998888899999999999999998876544 3344444
Q ss_pred cccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccC
Q 046199 392 PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDH 471 (902)
Q Consensus 392 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~ 471 (902)
+|++|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.
T Consensus 153 --~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~------------ 218 (477)
T 2id5_A 153 --SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP------------ 218 (477)
T ss_dssp --TCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT------------
T ss_pred --CCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc------------
Confidence 555555555555554455566666666666666666666566666666666666666555433332
Q ss_pred ccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCc
Q 046199 472 NKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551 (902)
Q Consensus 472 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 551 (902)
.+....+|+.|++++|+++++.+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..|
T Consensus 219 ---------~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (477)
T 2id5_A 219 ---------NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289 (477)
T ss_dssp ---------TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred ---------ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence 22222356666666666665544556666666666666666666556666777777777777777777778
Q ss_pred cccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 552 TTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...-+. ..-...+..+++.++...|..|.
T Consensus 290 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESG
T ss_pred HHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCch
Confidence 8888888888888888888877777788888888888888888754332 11122344566777777777775
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.09 Aligned_cols=170 Identities=29% Similarity=0.372 Sum_probs=156.2
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+.|++.+.||+|+||+||+|++.. |+.||||+++.......+.+.+|+++++.++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 569999999999999999999864 9999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT 884 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 884 (902)
+||+|.+++.. ..+++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+........
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999865 35899999999999999999999 99999999999999999999999999999998876655566
Q ss_pred cccccccccccccccc
Q 046199 885 QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 885 ~~~gt~~y~APE~l~~ 900 (902)
+.+||+.|||||++..
T Consensus 229 ~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 229 SLVGTPYWMAPELISR 244 (346)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred ccccCcCcCCHHHHCC
Confidence 6899999999999854
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.69 Aligned_cols=337 Identities=21% Similarity=0.213 Sum_probs=234.3
Q ss_pred CCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccc
Q 046199 262 NMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNL 341 (902)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 341 (902)
.+++++.|++++|.++ .+|..+ +..+++|++|++++|.+++..+..|..+++|++|+|++|++.+..|..|..+++|
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~--~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 119 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAAL--LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHH--HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCCceEEEecCCchh-hCChhH--hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence 3566666666666665 333322 4455666666666666665555556666666666666666665555555556666
Q ss_pred cEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcE
Q 046199 342 EHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421 (902)
Q Consensus 342 ~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 421 (902)
++|++++|+++..++ ..+..++ +|++|++++|.+++..|..|..+++|++
T Consensus 120 ~~L~L~~n~l~~l~~-----------------------------~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 169 (390)
T 3o6n_A 120 TVLVLERNDLSSLPR-----------------------------GIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQN 169 (390)
T ss_dssp CEEECCSSCCCCCCT-----------------------------TTTTTCT-TCCEEECCSSCCCBCCTTTTSSCTTCCE
T ss_pred CEEECCCCccCcCCH-----------------------------HHhcCCC-CCcEEECCCCccCccChhhccCCCCCCE
Confidence 666666655554332 2234444 5666666666666555666666666666
Q ss_pred EEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCc
Q 046199 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF 501 (902)
Q Consensus 422 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 501 (902)
|++++|++++. .+..+++|+.|++++|.+++. ....+|+.|++++|+++..... ..++|+.|++++|++++.
T Consensus 170 L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~--~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~ 241 (390)
T 3o6n_A 170 LQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL--AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT 241 (390)
T ss_dssp EECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE--ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC
T ss_pred EECCCCcCCcc---ccccccccceeeccccccccc--CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc
Confidence 66666666643 244556666667776666531 1123677777777777754322 246788888888888864
Q ss_pred ccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccccccc
Q 046199 502 IPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581 (902)
Q Consensus 502 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 581 (902)
..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+
T Consensus 242 --~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l 317 (390)
T 3o6n_A 242 --AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317 (390)
T ss_dssp --GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred --HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccccc
Confidence 578888889999999998888778888889999999999999984 5777788999999999999998 577788999
Q ss_pred ccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCCC
Q 046199 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 582 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
++|+.|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|+.+.
T Consensus 318 ~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 318 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred CcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 9999999999999854 3 77788999999999999986543 3455666667788888887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.13 Aligned_cols=173 Identities=27% Similarity=0.416 Sum_probs=148.4
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++|++.+.||+|+||+||+|++.. ++.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4789999999999999999999864 9999999997653 345678999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+||+|.+++...+ ..+++..+..|+.||+.||+||| ++|||||||||+|||++++|.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999997544 45789999999999999999999 9999999999999999999999999999998765443
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
......+||+.|||||++..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTT
T ss_pred ccccccCCCccccCHHHHCC
Confidence 33445689999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.05 Aligned_cols=172 Identities=31% Similarity=0.466 Sum_probs=153.4
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||+||+|++.. ++.||||+++... ....+.+.+|++++++++|||||++++++++++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999864 8999999997542 33457899999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||||+||+|.+++.+. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999999654 46999999999999999999999 9999999999999999999999999999999875433
Q ss_pred --cceecccccccccccccccc
Q 046199 881 --SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 --~~~~~~~gt~~y~APE~l~~ 900 (902)
....+.+||+.|||||++..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcC
Confidence 23345789999999999853
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.21 Aligned_cols=171 Identities=29% Similarity=0.372 Sum_probs=156.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.+.|++.+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3579999999999999999999864 899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
|+||+|.+++... .+++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+.......
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999998653 5899999999999999999999 9999999999999999999999999999999887665556
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
...+||+.|||||++..
T Consensus 305 ~~~~GTp~YmAPEvl~~ 321 (423)
T 4fie_A 305 KSLVGTPYWMAPELISR 321 (423)
T ss_dssp CCCEECTTTCCHHHHTT
T ss_pred cccccCcCcCCHHHHCC
Confidence 66889999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=356.12 Aligned_cols=337 Identities=21% Similarity=0.215 Sum_probs=232.9
Q ss_pred CCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccccccccc
Q 046199 263 MSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLE 342 (902)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 342 (902)
+++++.|++++|.+.. +|..+ +..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|+
T Consensus 50 l~~l~~l~l~~~~l~~-lp~~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 126 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRK-LPAAL--LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126 (597)
T ss_dssp GCCCSEEEESSCEESE-ECTHH--HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCceEEEeeCCCCCC-cCHHH--HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCC
Confidence 4455566666665553 23221 34455555555555555555554555555555555555555554444455555555
Q ss_pred EEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEE
Q 046199 343 HLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTL 422 (902)
Q Consensus 343 ~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 422 (902)
+|+|++|.+++ ..+..|..++ +|++|+|++|.+++..|..|..+++|++|
T Consensus 127 ~L~L~~n~l~~-----------------------------l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 176 (597)
T 3oja_B 127 VLVLERNDLSS-----------------------------LPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNL 176 (597)
T ss_dssp EEECCSSCCCC-----------------------------CCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred EEEeeCCCCCC-----------------------------CCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence 55555555543 3333344555 66666666666666666666666666666
Q ss_pred EeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcc
Q 046199 423 HLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502 (902)
Q Consensus 423 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 502 (902)
+|++|.+++. .+..+++|+.|++++|.+++. ....+|+.|++++|.++...+.. .++|+.|+|++|.+++
T Consensus 177 ~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l--~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~-- 246 (597)
T 3oja_B 177 QLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL--AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD-- 246 (597)
T ss_dssp ECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE--ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--
T ss_pred ECcCCCCCCc---ChhhhhhhhhhhcccCccccc--cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--
Confidence 6666666643 244556666777777666532 11236777777777776544332 2578888888888886
Q ss_pred cccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccc
Q 046199 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALT 582 (902)
Q Consensus 503 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 582 (902)
+..+..+++|+.|++++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..++
T Consensus 247 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~ 324 (597)
T 3oja_B 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324 (597)
T ss_dssp CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHT
T ss_pred ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCC
Confidence 4678888899999999999988888888899999999999999985 5777888999999999999999 6888899999
Q ss_pred cCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCCCC
Q 046199 583 SLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHL 648 (902)
Q Consensus 583 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~ 648 (902)
+|+.|+|++|++++. | +..+++|+.|++++|+|+|..+. ..+..+....+.+++..|+.+..
T Consensus 325 ~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~ 386 (597)
T 3oja_B 325 RLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQ 386 (597)
T ss_dssp TCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCE
T ss_pred CCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchh
Confidence 999999999999865 3 67788999999999999987653 34666777778899999987543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.74 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=156.4
Q ss_pred CChhHHHHHHHHHhcccc------CCC----CCCCCceeeeeEEeeC--------CCCcEEEEEeccCCcceecCcccCC
Q 046199 5 INTTDQQALLALKARITA------KNW----TSNTSVCSWIGITCDV--------STHRVTALNISDFGLTGTISSQLGN 66 (902)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~------~~w----~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~~~~~l~~ 66 (902)
.-.+|++||++||+++.. .+| ....++|.|.|++|+. ...+|+.|+|++++++ .+|+.++.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 446899999999998853 357 4567899999999953 3456778888888777 77777777
Q ss_pred CCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCccccc
Q 046199 67 LSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIG 146 (902)
Q Consensus 67 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~ 146 (902)
+++|++|+|++|+++ .+|..++.+++|++|+|++|.++ . +|..++
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~---------------------------------lp~~l~ 147 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-A---------------------------------LPASIA 147 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-C---------------------------------CCGGGG
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-c---------------------------------CcHHHh
Confidence 777777777777777 77777777777777777777776 3 555666
Q ss_pred CcCccceeeecccccCCCCchhhcc---------ccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccc
Q 046199 147 NLTKLKELYLGYNKLQGEIPQELGN---------LAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNN 217 (902)
Q Consensus 147 ~l~~L~~L~L~~n~l~~~~p~~l~~---------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 217 (902)
++++|++|+|++|++.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|.++
T Consensus 148 ~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~------- 219 (328)
T 4fcg_A 148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS------- 219 (328)
T ss_dssp GCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-------
T ss_pred cCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-------
Confidence 6666666666666666666665543 555555555555555 44555555555555555555533
Q ss_pred cccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceee
Q 046199 218 HFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLN 297 (902)
Q Consensus 218 ~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 297 (902)
.+|..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|.. +..+++|++|+
T Consensus 220 -------------~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~---~~~l~~L~~L~ 283 (328)
T 4fcg_A 220 -------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD---IHRLTQLEKLD 283 (328)
T ss_dssp -------------CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT---GGGCTTCCEEE
T ss_pred -------------cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh---hhcCCCCCEEe
Confidence 12234444555555555555555455554545555555555544444444433 33334444444
Q ss_pred ccCccCCCCCCccccccccccEEEccC
Q 046199 298 LGLNNLSGRIPGFIFNASKLFLLELTG 324 (902)
Q Consensus 298 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 324 (902)
|++|.+.+.+|..++.+++|+.+++..
T Consensus 284 L~~n~~~~~iP~~l~~L~~L~~l~l~~ 310 (328)
T 4fcg_A 284 LRGCVNLSRLPSLIAQLPANCIILVPP 310 (328)
T ss_dssp CTTCTTCCCCCGGGGGSCTTCEEECCG
T ss_pred CCCCCchhhccHHHhhccCceEEeCCH
Confidence 444444444444444444444444333
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.67 Aligned_cols=253 Identities=33% Similarity=0.564 Sum_probs=210.8
Q ss_pred cccEEEeecCcccc--cCCcccCCCCCCcEEEeec-ceecccCCcccccccccCeeecccccccCCCCCcC---CCCCeE
Q 046199 394 TLEEIYLQNCKIRG--NIPKEIGNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL---CQLSEL 467 (902)
Q Consensus 394 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L 467 (902)
+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|..+++|++|++++|++++.+|..+ .+|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45556666666655 5555666666666666663 56655566666666666666666666655555433 366677
Q ss_pred eccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCC-CceEEEcCCCccCCCCccccccccccceeccCCccc
Q 046199 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLN-NILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546 (902)
Q Consensus 468 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (902)
++++|++++.+|..|.++++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |++|++++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 7777777778888899999999999999999988999999998 999999999999999999999987 99999999999
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCC
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGG 626 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 626 (902)
++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999977666 8899999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCcccCCCCCC
Q 046199 627 SFANFSAQSFMGNDLLCGSPHL 648 (902)
Q Consensus 627 ~~~~~~~~~~~~n~~lc~~~~~ 648 (902)
++.++....+.+|+++||.|+.
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS
T ss_pred cccccChHHhcCCCCccCCCCC
Confidence 9999999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=328.10 Aligned_cols=336 Identities=18% Similarity=0.186 Sum_probs=261.3
Q ss_pred CCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccc
Q 046199 238 NLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKL 317 (902)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 317 (902)
.++++++|++++|.++...+..+..+++|++|+|++|.+++..+.. +..+++|++|++++|.+++..|..+..+++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 119 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYA---FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTT---TTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhh---ccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence 4689999999999998544445788999999999999999765555 7889999999999999999999999999999
Q ss_pred cEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccE
Q 046199 318 FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397 (902)
Q Consensus 318 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~ 397 (902)
++|+|++|+++...+..|..+++|++|++++|.+++..+ ..+..+++|++|++++|++.+.. +..++ +|+.
T Consensus 120 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~---~~~l~-~L~~ 190 (390)
T 3o6n_A 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED-----DTFQATTSLQNLQLSSNRLTHVD---LSLIP-SLFH 190 (390)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT-----TTTSSCTTCCEEECCSSCCSBCC---GGGCT-TCSE
T ss_pred CEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh-----hhccCCCCCCEEECCCCcCCccc---ccccc-ccce
Confidence 999999999997666667999999999999999987766 55666777777777777666431 23333 5555
Q ss_pred EEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCC
Q 046199 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGP 477 (902)
Q Consensus 398 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~ 477 (902)
|++++|.+++. ...++|+ +|++++|.+.........+|+.|++++|++++.
T Consensus 191 L~l~~n~l~~~-----~~~~~L~------------------------~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~ 241 (390)
T 3o6n_A 191 ANVSYNLLSTL-----AIPIAVE------------------------ELDASHNSINVVRGPVNVELTILKLQHNNLTDT 241 (390)
T ss_dssp EECCSSCCSEE-----ECCSSCS------------------------EEECCSSCCCEEECCCCSSCCEEECCSSCCCCC
T ss_pred eeccccccccc-----CCCCcce------------------------EEECCCCeeeeccccccccccEEECCCCCCccc
Confidence 55555555432 1223444 444554444422222234677777777777754
Q ss_pred CCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccC
Q 046199 478 IPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGL 557 (902)
Q Consensus 478 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 557 (902)
..+..+++|++|++++|++++..|..|..+++|++|++++|++++ +|..+..+++|++|++++|+++ .+|..+..+
T Consensus 242 --~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l 317 (390)
T 3o6n_A 242 --AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317 (390)
T ss_dssp --GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHH
T ss_pred --HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccccc
Confidence 468889999999999999999889999999999999999999985 6777788999999999999999 678889999
Q ss_pred CccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 558 TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
++|+.|+|++|++++. | +..+++|+.|++++|+++..-... -+..+....+.++...+..|
T Consensus 318 ~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~--~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 318 DRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA--LFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp TTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH--HTTTCCTTTBCCCCSCCCTT
T ss_pred CcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHH--HHHHHHhhcccccCceeccc
Confidence 9999999999999854 3 778899999999999998753322 23445555666666655544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.79 Aligned_cols=175 Identities=29% Similarity=0.490 Sum_probs=152.0
Q ss_pred hhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
+..++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34578999999999999999999874 367899999987766677889999999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 046199 797 KALVLEYMANGSLEKCLYSS------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (902)
.|+|||||++|+|.++++.. ...+++.++..++.||+.||+||| +++||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCc
Confidence 99999999999999999753 246899999999999999999999 999999999999999999999
Q ss_pred EEEEeecCceecCCCcccee--cccccccccccccccc
Q 046199 865 AHLSDFGIAKLLNGEESMRT--QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 865 ~kL~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~l~~ 900 (902)
+||+|||+|+.......... ...||+.|||||++..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 99999999987654433222 2469999999999853
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=347.24 Aligned_cols=345 Identities=20% Similarity=0.233 Sum_probs=184.0
Q ss_pred CCCCCCCCcee----eeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCcc-ccCCCcceEE
Q 046199 23 KNWTSNTSVCS----WIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSS-IFSISTLKIL 97 (902)
Q Consensus 23 ~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L 97 (902)
++|.++.+||. |.++.|+. ++ +....+.. .+..-..+++++.|++++|.+. .+|+. +..+++|++|
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~---~i---~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L 80 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDV---HI---DMQTQDVY--FGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 80 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSC---EE---CSSCCCCE--ESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEE
T ss_pred cCCCCCCcCcccCcCceeEecCc---ee---cccccccc--cCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEE
Confidence 78988878874 66665542 11 11111111 1111123556667777777665 34443 4556666666
Q ss_pred EecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccce
Q 046199 98 ILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177 (902)
Q Consensus 98 ~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 177 (902)
+|++|.+++. .|..++.+++|++|+|++|.+++..|..|+.+++|++
T Consensus 81 ~L~~n~l~~~---------------------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 81 NLNDLQIEEI---------------------------------DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp ECTTSCCCEE---------------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ECCCCCCCCC---------------------------------ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 6666666542 2335555566666666666666545555566666666
Q ss_pred eecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCC
Q 046199 178 LSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP 257 (902)
Q Consensus 178 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p 257 (902)
|+|++|.+++..+..|+++++|++|+|++|.++. .. |..|+.+++|++|+|++|++++.
T Consensus 128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~----------~~---------~~~~~~l~~L~~L~L~~N~l~~~-- 186 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER----------IE---------DDTFQATTSLQNLQLSSNRLTHV-- 186 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB----------CC---------TTTTTTCTTCCEEECTTSCCSBC--
T ss_pred EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC----------CC---------hhhhhcCCcCcEEECcCCCCCCc--
Confidence 6666666653333334555555555555555331 11 23445555555555555555432
Q ss_pred CcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccc
Q 046199 258 NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337 (902)
Q Consensus 258 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 337 (902)
.+..+++|+.|++++|.+++ +...++|+.|++++|.+....+. +
T Consensus 187 -~~~~l~~L~~L~l~~n~l~~--------------------------------l~~~~~L~~L~ls~n~l~~~~~~-~-- 230 (597)
T 3oja_B 187 -DLSLIPSLFHANVSYNLLST--------------------------------LAIPIAVEELDASHNSINVVRGP-V-- 230 (597)
T ss_dssp -CGGGCTTCSEEECCSSCCSE--------------------------------EECCTTCSEEECCSSCCCEEECS-C--
T ss_pred -ChhhhhhhhhhhcccCcccc--------------------------------ccCCchhheeeccCCcccccccc-c--
Confidence 13334444555555444432 11223344444444444422211 1
Q ss_pred cccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCC
Q 046199 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLV 417 (902)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~ 417 (902)
.++|+.|++++|.+++. ..+..+++|++|++++|.+.+..|..+..++ +|+.|+|++|.+++ +|..+..++
T Consensus 231 ~~~L~~L~L~~n~l~~~-------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~-l~~~~~~l~ 301 (597)
T 3oja_B 231 NVELTILKLQHNNLTDT-------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLVA-LNLYGQPIP 301 (597)
T ss_dssp CSCCCEEECCSSCCCCC-------GGGGGCTTCSEEECCSSCCCEEESGGGTTCS-SCCEEECTTSCCCE-EECSSSCCT
T ss_pred CCCCCEEECCCCCCCCC-------hhhccCCCCCEEECCCCccCCCCHHHhcCcc-CCCEEECCCCCCCC-CCcccccCC
Confidence 13455555555555532 2344445555555555555555555566665 66666666666664 345556667
Q ss_pred CCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCC
Q 046199 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497 (902)
Q Consensus 418 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 497 (902)
+|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.. +..+++|+.|++++|.
T Consensus 302 ~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~------------------------~~~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK------------------------LSTHHTLKNLTLSHND 356 (597)
T ss_dssp TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC------------------------CCTTCCCSEEECCSSC
T ss_pred CCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC------------------------hhhcCCCCEEEeeCCC
Confidence 7777777777777 45666666666666666666665322 3445666667777776
Q ss_pred ccC
Q 046199 498 LSS 500 (902)
Q Consensus 498 l~~ 500 (902)
+.+
T Consensus 357 ~~~ 359 (597)
T 3oja_B 357 WDC 359 (597)
T ss_dssp EEH
T ss_pred CCC
Confidence 654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.69 Aligned_cols=169 Identities=23% Similarity=0.432 Sum_probs=136.8
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||+||+|++. +++.||+|+++... ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999985 48999999997542 234567899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+ +|+|.+++.+. ..+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 67999998664 46999999999999999999999 9999999999999999999999999999998765433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
...+.+||+.|||||++..
T Consensus 167 ~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp --------CTTSCHHHHSS
T ss_pred ccCCeeECcccCChhhhcC
Confidence 3344789999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.12 Aligned_cols=172 Identities=28% Similarity=0.351 Sum_probs=144.5
Q ss_pred cccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
.++|++.+.||+|+||+||+|++. .++.||+|+++... .....++.+|++++++++|||||++++++.+++..|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 368999999999999999999873 36889999997542 223457889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|||||+||+|.+++.+. +.+++..+..++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999999654 46999999999999999999999 99999999999999999999999999999987665
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
......+.+||+.|||||++..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~ 200 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR 200 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT
T ss_pred CCccccccccCcccCCHHHhcc
Confidence 5555556789999999999853
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.31 Aligned_cols=174 Identities=28% Similarity=0.458 Sum_probs=145.8
Q ss_pred hcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++++|.+++..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4467888999999999999999864 3788999999877666778899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 798 ALVLEYMANGSLEKCLYSSN--------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
|+|||||++|+|.++++... ..+++.++..|+.||+.||+||| +++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence 99999999999999987532 35899999999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
.+||+|||+|+........ .....||+.|||||++..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 234 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence 9999999999876543322 233679999999998864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.30 Aligned_cols=173 Identities=28% Similarity=0.494 Sum_probs=147.4
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
|++..+++++.+.||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||++++++.+ +..|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 4566788999999999999999999874 369999987543 3456789999999999999999999998865 5689
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|||||+||+|.++++.....+++..+..|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999877778999999999999999999999 99999999999999999999999999999987643
Q ss_pred Ccc--ceeccccccccccccccc
Q 046199 879 EES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~--~~~~~~gt~~y~APE~l~ 899 (902)
... .....+||+.|||||++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~ 207 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIR 207 (307)
T ss_dssp ---------CCCCTTSCCHHHHH
T ss_pred CCcceeecccccCCCccCHHHhh
Confidence 222 233468999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.87 Aligned_cols=168 Identities=26% Similarity=0.337 Sum_probs=145.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..+.|++.+.||+|+||.||+|++.. |+.||||+++... ...+|+.+++.++|||||++++++.+++..|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34678899999999999999999865 8999999997542 22479999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCCCcc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~ 881 (902)
||+||+|.+++++. +.+++..+..++.||+.||+||| +++||||||||+|||++.+| .+||+|||+|+.+.....
T Consensus 131 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999764 46999999999999999999999 99999999999999999988 699999999998754332
Q ss_pred c-----eecccccccccccccccc
Q 046199 882 M-----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~-----~~~~~gt~~y~APE~l~~ 900 (902)
. ....+||+.|||||++..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTT
T ss_pred ccceecCCccccCccccCHHHHCC
Confidence 1 122579999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.37 Aligned_cols=166 Identities=30% Similarity=0.435 Sum_probs=143.7
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec----CCeeEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFKALV 800 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 800 (902)
|++.+.||+|+||+||+|++.. ++.||+|++.... ....+++.+|++++++++|||||+++++|.+ ++.+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4677889999999999999865 8899999997543 3445789999999999999999999999864 3568999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcC-CCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDD-DMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~ 877 (902)
||||+||+|.+++.+. ..+++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999654 46899999999999999999999 888 999999999999974 7899999999998643
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
. ....+.+||+.|||||++.
T Consensus 184 ~--~~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 184 A--SFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp T--TSBEESCSSCCCCCGGGGG
T ss_pred C--CccCCcccCccccCHHHcC
Confidence 2 2334578999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.75 Aligned_cols=174 Identities=24% Similarity=0.390 Sum_probs=148.9
Q ss_pred hcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..+++++.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|++.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3456788899999999999999863 36789999997543 3345789999999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC
Q 046199 797 KALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD 861 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (902)
.++|||||++|+|.+++.... ..+++..+.+++.||+.||+||| +++||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence 999999999999999996532 35889999999999999999999 999999999999999999
Q ss_pred CCcEEEEeecCceecCCCcc--ceecccccccccccccccc
Q 046199 862 DMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 862 ~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~~ 900 (902)
++.+||+|||+|+....... .....+||+.|||||++..
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 99999999999987644332 2233679999999998753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.85 Aligned_cols=307 Identities=24% Similarity=0.366 Sum_probs=207.9
Q ss_pred ccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccc
Q 046199 260 IFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLR 339 (902)
Q Consensus 260 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 339 (902)
+..+++|+.|++++|.+.. +|. +..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+..++
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~~----~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~ 110 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQG----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLT 110 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CTT----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred chhcccccEEEEeCCcccc-chh----hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence 4567788888888888763 332 5667778888888887775443 67777777777777777753 3577777
Q ss_pred cccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCC
Q 046199 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNL 419 (902)
Q Consensus 340 ~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L 419 (902)
+|++|++++|.+++.. .+..+++|++|++++|.....++. +..++ +|++|++++|.+.+..+ +..+++|
T Consensus 111 ~L~~L~l~~n~i~~~~-------~~~~l~~L~~L~l~~n~~~~~~~~-~~~l~-~L~~L~l~~~~~~~~~~--~~~l~~L 179 (347)
T 4fmz_A 111 NLRELYLNEDNISDIS-------PLANLTKMYSLNLGANHNLSDLSP-LSNMT-GLNYLTVTESKVKDVTP--IANLTDL 179 (347)
T ss_dssp TCSEEECTTSCCCCCG-------GGTTCTTCCEEECTTCTTCCCCGG-GTTCT-TCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred cCCEEECcCCcccCch-------hhccCCceeEEECCCCCCcccccc-hhhCC-CCcEEEecCCCcCCchh--hccCCCC
Confidence 7777777777776432 245555566666666544332222 44444 44455555444443222 4444444
Q ss_pred cEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCcc
Q 046199 420 TTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS 499 (902)
Q Consensus 420 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 499 (902)
++|++++|.+.+..+ +..++ +|+.|++++|.+++..+ +..+++|+.|++++|+++
T Consensus 180 ~~L~l~~n~l~~~~~--~~~l~---------------------~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 180 YSLSLNYNQIEDISP--LASLT---------------------SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp SEEECTTSCCCCCGG--GGGCT---------------------TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CEEEccCCccccccc--ccCCC---------------------ccceeecccCCCCCCch--hhcCCcCCEEEccCCccC
Confidence 444444444442211 33333 55666666666655443 677788888888888888
Q ss_pred CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccccc
Q 046199 500 SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFG 579 (902)
Q Consensus 500 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 579 (902)
+..+ +..+++|++|++++|.+++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..|+
T Consensus 235 ~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 308 (347)
T 4fmz_A 235 DLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG 308 (347)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred CCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence 7544 77888888888888888753 4577888888888888888854 4588888999999999998888888888
Q ss_pred ccccCCeEeCcCccccccCCcccccccccccccccCCcce
Q 046199 580 ALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLE 619 (902)
Q Consensus 580 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 619 (902)
.+++|+.|+|++|++++..| +..+++|+.|++++|+++
T Consensus 309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 88999999999999887666 788888999999998875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=310.72 Aligned_cols=172 Identities=26% Similarity=0.402 Sum_probs=138.1
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCC--------
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGN-------- 795 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 795 (902)
++|++.+.||+|+||+||+|++. +++.||||+++.... ...+.+.+|++++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999986 489999999976543 34578899999999999999999999986543
Q ss_pred ----eeEEEEEccCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 796 ----FKALVLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 796 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
+.|+|||||+||+|.+++..... ..++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999975432 2456678899999999999999 99999999999999999999999999
Q ss_pred ecCceecCCCccc------------eecccccccccccccccc
Q 046199 870 FGIAKLLNGEESM------------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~------------~~~~~gt~~y~APE~l~~ 900 (902)
||+|+........ .++.+||+.|||||++..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 204 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTT
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcC
Confidence 9999876543221 123579999999999864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.98 Aligned_cols=308 Identities=26% Similarity=0.388 Sum_probs=257.9
Q ss_pred cccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccccc
Q 046199 235 EIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA 314 (902)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l 314 (902)
.+..+++|+.|++++|.++ .+| .+..+++|++|++++|++++. |. +..+++|++|++++|.++.. + .+..+
T Consensus 39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~----~~~l~~L~~L~L~~n~i~~~-~-~~~~l 109 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP----LSNLVKLTNLYIGTNKITDI-S-ALQNL 109 (347)
T ss_dssp CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG----GTTCTTCCEEECCSSCCCCC-G-GGTTC
T ss_pred cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh----hhcCCcCCEEEccCCcccCc-h-HHcCC
Confidence 3557889999999999998 455 488999999999999999843 32 77899999999999999863 3 58899
Q ss_pred ccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccccccc
Q 046199 315 SKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPIT 394 (902)
Q Consensus 315 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~ 394 (902)
++|++|++++|++.+..+ +..+++|++|++++|...... ..+..+++|++|++++|.+.+..+ +..++ +
T Consensus 110 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~------~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~-~ 178 (347)
T 4fmz_A 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL------SPLSNMTGLNYLTVTESKVKDVTP--IANLT-D 178 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC------GGGTTCTTCCEEECCSSCCCCCGG--GGGCT-T
T ss_pred CcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc------cchhhCCCCcEEEecCCCcCCchh--hccCC-C
Confidence 999999999999996544 889999999999999766544 347899999999999999986654 77777 9
Q ss_pred ccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccc
Q 046199 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKL 474 (902)
Q Consensus 395 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l 474 (902)
|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|+++
T Consensus 179 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~-------------------- 234 (347)
T 4fmz_A 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT-------------------- 234 (347)
T ss_dssp CSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC--------------------
T ss_pred CCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC--------------------
Confidence 9999999999996544 8899999999999999996544 677777777777777665
Q ss_pred cCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcccc
Q 046199 475 SGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554 (902)
Q Consensus 475 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 554 (902)
+..+ +..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++|++++..|..|
T Consensus 235 -~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 235 -DLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp -CCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred -CCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 2222 77788888888888888874 4688888999999999988864 457888999999999999998889999
Q ss_pred ccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc
Q 046199 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595 (902)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 595 (902)
+.+++|+.|++++|++++..| +..+++|+.||+++|+|+
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999997766 889999999999999886
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=303.18 Aligned_cols=292 Identities=22% Similarity=0.282 Sum_probs=176.6
Q ss_pred CCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEE
Q 046199 265 TLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHL 344 (902)
Q Consensus 265 ~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 344 (902)
+++.+++++|.++ .+|..+ .++|++|++++|.+++..|..+..+++|++|+|++|++++..|..|..+++|++|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~-----~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI-----SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC-----CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred cCCEEECCCCCcc-ccCCCC-----CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 4566666666665 445432 1456666666666665556666666777777777777766666667777777777
Q ss_pred ecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEe
Q 046199 345 GLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHL 424 (902)
Q Consensus 345 ~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 424 (902)
++++|+++..+ ..+. + +|++|++++|++++..+..|..+++|++|++
T Consensus 108 ~L~~n~l~~l~------------------------------~~~~--~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 154 (332)
T 2ft3_A 108 YISKNHLVEIP------------------------------PNLP--S-SLVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154 (332)
T ss_dssp ECCSSCCCSCC------------------------------SSCC--T-TCCEEECCSSCCCCCCSGGGSSCSSCCEEEC
T ss_pred ECCCCcCCccC------------------------------cccc--c-cCCEEECCCCccCccCHhHhCCCccCCEEEC
Confidence 77776665322 2222 2 7788888888888776777888888888888
Q ss_pred ecceec--ccCCcccccccccCeeecccccccCCCCCcC-CCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCc
Q 046199 425 GNNQLS--GSIPITVGRLNTLQGLGLENNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF 501 (902)
Q Consensus 425 ~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 501 (902)
++|.++ +..|..+..+ +|++|++++|++++ +|..+ .+|++|++++|++++..+..|.++++|+.|++++|++++.
T Consensus 155 ~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 155 GGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232 (332)
T ss_dssp CSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC
T ss_pred CCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC
Confidence 888886 3667777777 88888888888874 44433 2666666666666666556666666666666666666665
Q ss_pred ccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccccccc
Q 046199 502 IPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581 (902)
Q Consensus 502 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 581 (902)
.+..|..+++|++|++++|+++ .+|..+..+++|++|++++|+|++..+..|..... -...
T Consensus 233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~ 293 (332)
T 2ft3_A 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKR 293 (332)
T ss_dssp CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSS
T ss_pred ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------cccc
Confidence 5555555566666666555555 34444444555555555555554443333332100 0002
Q ss_pred ccCCeEeCcCcccc--ccCCcccccccccccccccCC
Q 046199 582 TSLESLDLSVNNLS--GVIPISLEKLVYLKDLNLSFN 616 (902)
Q Consensus 582 ~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~l~~N 616 (902)
++|+.|++++|.+. +..|..+..+++|+.+++++|
T Consensus 294 ~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp CCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 34555555555554 444555555555555555555
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.09 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=150.1
Q ss_pred cccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccC
Q 046199 142 PKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTG 221 (902)
Q Consensus 142 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g 221 (902)
|..++++++|++|+|++|++++..|..++.+++|++|+|++|+++ .+|..+. ++|++|++++|.++.
T Consensus 71 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~---------- 137 (332)
T 2ft3_A 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRK---------- 137 (332)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCC----------
T ss_pred HhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCc----------
Confidence 445666667777777777776555666777777777777777766 5555444 566667766666542
Q ss_pred CccccccccCCCccccCCCCCCEEEccCcccc--CcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeecc
Q 046199 222 SIPRNLWQCEIPHEIGNLPNLEVLGIDENHLV--GDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLG 299 (902)
Q Consensus 222 ~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls 299 (902)
+| +..++.+++|+.|++++|+++ +..|..+..+ +|+.|++++|++++ +|..+ .++|++|+++
T Consensus 138 -~~--------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~-----~~~L~~L~l~ 201 (332)
T 2ft3_A 138 -VP--------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDL-----PETLNELHLD 201 (332)
T ss_dssp -CC--------SGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSS-----CSSCSCCBCC
T ss_pred -cC--------HhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccc-----cCCCCEEECC
Confidence 11 234566666666666666664 2455555555 66666666666653 44331 1455566666
Q ss_pred CccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCC
Q 046199 300 LNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENP 379 (902)
Q Consensus 300 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~ 379 (902)
+|.+++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|+++
T Consensus 202 ~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------------- 254 (332)
T 2ft3_A 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS--------------------------- 254 (332)
T ss_dssp SSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC---------------------------
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe---------------------------
Confidence 66665555555555555555555555555554445555555555555555554
Q ss_pred CCcccCcccccccccccEEEeecCcccccCCcccCC------CCCCcEEEeecceec--ccCCcccccccccCeeecccc
Q 046199 380 LNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGN------LVNLTTLHLGNNQLS--GSIPITVGRLNTLQGLGLENN 451 (902)
Q Consensus 380 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N 451 (902)
.+|..+..++ +|++|++++|+|++..+..|+. ...|+.|++++|.+. +..|.+|..+++|+.+++++|
T Consensus 255 ---~lp~~l~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 255 ---RVPAGLPDLK-LLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp ---BCCTTGGGCT-TCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ---ecChhhhcCc-cCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 3444455555 6666666666666555555544 356778888888776 566777778888888888777
Q ss_pred c
Q 046199 452 K 452 (902)
Q Consensus 452 ~ 452 (902)
+
T Consensus 331 ~ 331 (332)
T 2ft3_A 331 K 331 (332)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.30 Aligned_cols=168 Identities=27% Similarity=0.411 Sum_probs=138.9
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC----eeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 800 (902)
.++|.+.+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+.+++|||||++++++.+++ ..|+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35788999999999999999998 689999999865422 1223345666667889999999999997653 67999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN--------PVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~--------~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
||||++|+|.++++.. .+++..+.+++.|++.||+||| ++ +||||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999754 5889999999999999999999 55 999999999999999999999999999
Q ss_pred ceecCCCccce----eccccccccccccccc
Q 046199 873 AKLLNGEESMR----TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~~----~~~~gt~~y~APE~l~ 899 (902)
|+......... ...+||+.|||||++.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~ 185 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHT
T ss_pred CccccCCCCceeeecccccccccccCHHHhc
Confidence 98775443321 2357999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.33 Aligned_cols=183 Identities=22% Similarity=0.389 Sum_probs=156.4
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCC-CCccc
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH-RNLVK 786 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~ 786 (902)
.+..++|++..++|++.+.||+|+||+||+|++.. ++.||||+++.... ...+.+.+|+++++++.| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 45677899999999999999999999999998643 46799999975543 345789999999999965 99999
Q ss_pred eeeeeec-CCeeEEEEEccCCCChHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 046199 787 IISSCSN-GNFKALVLEYMANGSLEKCLYSS---------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850 (902)
Q Consensus 787 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 850 (902)
++|+|.+ ++..|+|||||++|+|.++++.. ...+++..+..++.||+.||+||| +++||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence 9999866 46789999999999999999753 234789999999999999999999 9999999
Q ss_pred CCCCCCEEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 851 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
||||+|||+++++.+||+|||+|+.+...... ....+||+.|||||++..
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 99999999999999999999999876544332 233679999999998853
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=297.18 Aligned_cols=290 Identities=22% Similarity=0.295 Sum_probs=181.2
Q ss_pred CCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccccccccc
Q 046199 263 MSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLE 342 (902)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 342 (902)
..+++.++++++.++ .+|..+ .+++++|++++|++++..+..|..+++|++|+|++|++++..|..|..+++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~-----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDL-----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSC-----CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred cCCCeEEEecCCCcc-ccCccC-----CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCC
Confidence 346788888888877 456542 25677777777777766666677777777777777777766677777777777
Q ss_pred EEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEE
Q 046199 343 HLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTL 422 (902)
Q Consensus 343 ~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 422 (902)
+|++++|+++.. |..+. + +|++|++++|++++..+..|.++++|++|
T Consensus 104 ~L~Ls~n~l~~l------------------------------~~~~~--~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (330)
T 1xku_A 104 RLYLSKNQLKEL------------------------------PEKMP--K-TLQELRVHENEITKVRKSVFNGLNQMIVV 150 (330)
T ss_dssp EEECCSSCCSBC------------------------------CSSCC--T-TCCEEECCSSCCCBBCHHHHTTCTTCCEE
T ss_pred EEECCCCcCCcc------------------------------Chhhc--c-cccEEECCCCcccccCHhHhcCCccccEE
Confidence 777777766532 22222 2 77888888888887777778888888888
Q ss_pred Eeecceecc--cCCcccccccccCeeecccccccCCCCCcC-CCCCeEeccCccccCCCCccccCCCcCceEecCCCCcc
Q 046199 423 HLGNNQLSG--SIPITVGRLNTLQGLGLENNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELS 499 (902)
Q Consensus 423 ~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 499 (902)
++++|++.. ..+..+..+++|++|++++|+++. +|..+ .+|++|++++|++++..|..|.++++|+.|++++|+++
T Consensus 151 ~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp ECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 888888853 667778888888888888888773 44332 35555555555555555555555555555555555555
Q ss_pred CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccccc
Q 046199 500 SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFG 579 (902)
Q Consensus 500 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 579 (902)
+..+..|..+++|++|++++|+++ .+|..+..+++|++|+|++|+|++..+..|.
T Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 230 AVDNGSLANTPHLRELHLNNNKLV-------------------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-------------------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred eeChhhccCCCCCCEEECCCCcCc-------------------------cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 554445555555555555555554 3444444555555555555555544444443
Q ss_pred c------cccCCeEeCcCccccc--cCCcccccccccccccccCCc
Q 046199 580 A------LTSLESLDLSVNNLSG--VIPISLEKLVYLKDLNLSFNR 617 (902)
Q Consensus 580 ~------l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~ 617 (902)
. .+.|+.|++++|.+.. ..|..+..+.+|+.++|++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 2 2455666666666542 344556666666666666653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-32 Score=296.89 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=143.1
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~ 229 (902)
.|++|+|++|++++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|.++.
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~------------------ 114 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE------------------ 114 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB------------------
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc------------------
Confidence 44555555555553333345555555555555555554445555555555555555554431
Q ss_pred cCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCccccc--CCCcCCcccCCCcccceeeccCccCCCCC
Q 046199 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG--SLPSSSKNLIGLPNIERLNLGLNNLSGRI 307 (902)
Q Consensus 230 ~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~ 307 (902)
+|..+. ++|+.|++++|++++..+..+.++++|+.|++++|.++. ..+.. +.++++|++|++++|.++. +
T Consensus 115 --l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~~~l~~L~~L~l~~n~l~~-l 186 (330)
T 1xku_A 115 --LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA---FQGMKKLSYIRIADTNITT-I 186 (330)
T ss_dssp --CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG---GGGCTTCCEEECCSSCCCS-C
T ss_pred --cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhh---ccCCCCcCEEECCCCcccc-C
Confidence 112221 345555555555554444445555555555555555532 22222 4445555555555555543 2
Q ss_pred CccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcc
Q 046199 308 PGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSS 387 (902)
Q Consensus 308 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~ 387 (902)
|..+. ++|++|++++|++++..|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|++. .+|..
T Consensus 187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~L~~N~l~-~lp~~ 258 (330)
T 1xku_A 187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN-----GSLANTPHLRELHLNNNKLV-KVPGG 258 (330)
T ss_dssp CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT-----TTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh-----hhccCCCCCCEEECCCCcCc-cCChh
Confidence 22221 455555555555555555555555556666666665554443 34455555555555555555 45555
Q ss_pred cccccccccEEEeecCcccccCCcccCCC------CCCcEEEeecceecc--cCCcccccccccCeeeccccc
Q 046199 388 IGNLPITLEEIYLQNCKIRGNIPKEIGNL------VNLTTLHLGNNQLSG--SIPITVGRLNTLQGLGLENNK 452 (902)
Q Consensus 388 ~~~l~~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~ 452 (902)
+..++ +|++|++++|+|++..+..|+.. +.++.|++++|.+.. ..|..|..+..++.++|++|+
T Consensus 259 l~~l~-~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 259 LADHK-YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTTCS-SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hccCC-CcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 66665 67777777777776666666433 667788888888753 456677777888888887774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-36 Score=343.95 Aligned_cols=367 Identities=20% Similarity=0.177 Sum_probs=240.4
Q ss_pred CcEEEEEeccCCcceecCc-ccCCCCCCCeeecccccccc----CCCccccCCCcceEEEecCccccCCCCcccccCCC-
Q 046199 44 HRVTALNISDFGLTGTISS-QLGNLSSLQTLDLSHNRFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTS- 117 (902)
Q Consensus 44 ~~v~~l~l~~~~l~g~~~~-~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~- 117 (902)
.+++.|||+++.++..... .+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+...++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 3689999999998754333 37788999999999999874 56777888899999999999998755555555555
Q ss_pred ---cccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhcc-----ccccceeecccCcCCCC-
Q 046199 118 ---SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGN-----LAELEWLSLPRSFLTGT- 188 (902)
Q Consensus 118 ---~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-----l~~L~~L~L~~n~l~~~- 188 (902)
+|++||+++|.++.. ....+|..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++.
T Consensus 83 ~~~~L~~L~L~~n~i~~~----~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGA----GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TTCCCCEEECTTSCCBGG----GHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred CCCceeEEEccCCCCCHH----HHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 699999999988632 11236778888889999999999887555554442 45799999999988863
Q ss_pred ---CChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCcccc-CCCCCCEEEccCccccCc----CCCcc
Q 046199 189 ---IPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIG-NLPNLEVLGIDENHLVGD----VPNTI 260 (902)
Q Consensus 189 ---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~-~l~~L~~L~Ls~N~l~~~----~p~~~ 260 (902)
++..+..+++|++|+|++|.++..... .+...+. .+++|+.|+|++|++++. ++..+
T Consensus 159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 223 (461)
T 1z7x_W 159 CEPLASVLRAKPDFKELTVSNNDINEAGVR---------------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHH---------------HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCEEECcCCCcchHHHH---------------HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence 356667788899999998886531100 0111111 356888888888888753 56667
Q ss_pred cCCCCCceEeccCcccccCCCcCC--cccCCCcccceeeccCccCCCC----CCccccccccccEEEccCCcccCccccc
Q 046199 261 FNMSTLKALSLLNNTLSGSLPSSS--KNLIGLPNIERLNLGLNNLSGR----IPGFIFNASKLFLLELTGNSFSGFIPDT 334 (902)
Q Consensus 261 ~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 334 (902)
..+++|++|++++|++++.....+ ..+..+++|++|++++|.++.. ++..+..+++|++|+|++|.+.+..+..
T Consensus 224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 303 (461)
T 1z7x_W 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303 (461)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence 778888888888888764211000 0022456677777777766643 3444555666666666666665443333
Q ss_pred cccc-----ccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccC
Q 046199 335 LVNL-----RNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNI 409 (902)
Q Consensus 335 l~~l-----~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~ 409 (902)
+... ++|++|++++|.+++.... .++..+..++ +|++|++++|.+++..
T Consensus 304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~-------------------------~l~~~l~~~~-~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 304 LCETLLEPGCQLESLWVKSCSFTAACCS-------------------------HFSSVLAQNR-FLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHH-------------------------HHHHHHHHCS-SCCEEECCSSBCHHHH
T ss_pred HHHHhccCCccceeeEcCCCCCchHHHH-------------------------HHHHHHhhCC-CccEEEccCCcccccc
Confidence 3322 3555555555555432100 1233344444 6666666666665544
Q ss_pred CcccCC-----CCCCcEEEeecceecc----cCCcccccccccCeeecccccccC
Q 046199 410 PKEIGN-----LVNLTTLHLGNNQLSG----SIPITVGRLNTLQGLGLENNKLEG 455 (902)
Q Consensus 410 p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 455 (902)
+..+.. .++|++|+|++|++++ .+|..+..+++|++|++++|++++
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 433332 5677777777777775 566677777777777777777653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=305.01 Aligned_cols=171 Identities=29% Similarity=0.401 Sum_probs=146.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec------CC
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN------GN 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 795 (902)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++++.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999986 49999999997543 2345678899999999999999999998753 36
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+|||||+ |+|.+++.. .+.+++..+..+++||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 689998865 456999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCc----cceecccccccccccccccc
Q 046199 876 LNGEE----SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~----~~~~~~~gt~~y~APE~l~~ 900 (902)
+.... ....+.+||+.|||||++..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~ 236 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLS 236 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTT
T ss_pred cccCccccccccccceeChHhcCHHHhcC
Confidence 64322 22334689999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=315.07 Aligned_cols=171 Identities=27% Similarity=0.354 Sum_probs=147.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHH---HHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDA---ECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
...++|++.+.||+|+||+||+|++.. |+.||||+++... ........+ ++.+++.++|||||+++++|++++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 345789999999999999999999865 8999999997532 112233333 456677789999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+|||||+||+|.+++.+. +.+++..+..++.||+.||+||| ++|||||||||+|||++.+|++||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999999764 45999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCccceeccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+.... ..+.+||+.|||||++.
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHS
T ss_pred cCCCC--CCCccCCcCccCHHHHh
Confidence 75433 34478999999999985
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-35 Score=340.66 Aligned_cols=378 Identities=21% Similarity=0.202 Sum_probs=233.5
Q ss_pred CcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC----cCCCcccCCCCCceEecc
Q 046199 197 SSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG----DVPNTIFNMSTLKALSLL 272 (902)
Q Consensus 197 ~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls 272 (902)
++|++|+|++|.++... ....+..+++|++|+|++|+++. .++..+..+++|++|+|+
T Consensus 3 ~~l~~L~Ls~~~l~~~~------------------~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls 64 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDAR------------------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64 (461)
T ss_dssp EEEEEEEEESCCCCHHH------------------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECT
T ss_pred ccceehhhhhcccCchh------------------HHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCC
Confidence 46788888888765321 11336677888888888888874 346667777888888888
Q ss_pred CcccccCCCcCCcccCCCc----ccceeeccCccCCC----CCCccccccccccEEEccCCcccCcccccccc-----cc
Q 046199 273 NNTLSGSLPSSSKNLIGLP----NIERLNLGLNNLSG----RIPGFIFNASKLFLLELTGNSFSGFIPDTLVN-----LR 339 (902)
Q Consensus 273 ~N~l~~~~p~~~~~l~~l~----~L~~L~Ls~N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~ 339 (902)
+|.++...+..+ +..++ +|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+.. .+
T Consensus 65 ~n~l~~~~~~~l--~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 142 (461)
T 1z7x_W 65 SNELGDVGVHCV--LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142 (461)
T ss_dssp TCCCHHHHHHHH--HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCcCChHHHHHH--HHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCC
Confidence 888765333221 12233 57777777777763 34666667777777777777776544433322 34
Q ss_pred cccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccC-----
Q 046199 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIG----- 414 (902)
Q Consensus 340 ~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~----- 414 (902)
+|++|++++|++++.... .....+..+++ |++|++++|.++...+..+.
T Consensus 143 ~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~-------------------------L~~L~L~~n~i~~~~~~~l~~~l~~ 196 (461)
T 1z7x_W 143 RLEKLQLEYCSLSAASCE-PLASVLRAKPD-------------------------FKELTVSNNDINEAGVRVLCQGLKD 196 (461)
T ss_dssp CCCEEECTTSCCBGGGHH-HHHHHHHHCTT-------------------------CCEEECCSSBCHHHHHHHHHHHHHH
T ss_pred cceEEECCCCCCCHHHHH-HHHHHHhhCCC-------------------------CCEEECcCCCcchHHHHHHHHHHhc
Confidence 567777766666542210 00122333344 44444444444433222222
Q ss_pred CCCCCcEEEeecceeccc----CCcccccccccCeeecccccccCCC--------CCcCCCCCeEeccCccccCC----C
Q 046199 415 NLVNLTTLHLGNNQLSGS----IPITVGRLNTLQGLGLENNKLEGPI--------PDDLCQLSELHVDHNKLSGP----I 478 (902)
Q Consensus 415 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~--------p~~l~~L~~L~L~~N~l~~~----~ 478 (902)
..++|++|++++|.+++. ++..+..+++|++|++++|++++.. .....+|++|++++|++++. +
T Consensus 197 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 276 (461)
T 1z7x_W 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276 (461)
T ss_dssp SCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred CCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHH
Confidence 134555555555555532 3444555556666666666554321 11234667777777776653 4
Q ss_pred CccccCCCcCceEecCCCCccCcccccccC-----CCCceEEEcCCCccCCC----CccccccccccceeccCCcccccc
Q 046199 479 PACFGNLNSLRNLSLGSNELSSFIPSTFWN-----LNNILSFDFSSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGD 549 (902)
Q Consensus 479 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (902)
+..+.++++|++|++++|++++..+..+.. .++|++|++++|.+++. ++..+..+++|++|++++|++++.
T Consensus 277 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356 (461)
T ss_dssp HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred HHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence 666777888888888888887654444432 36888888888888764 455566678888888888888876
Q ss_pred Ccccccc-----CCccceEEccCcccCC----CccccccccccCCeEeCcCccccccCCcccc-----cccccccccccC
Q 046199 550 IPTTIGG-----LTNLQLLSLENNRLHG----PIPESFGALTSLESLDLSVNNLSGVIPISLE-----KLVYLKDLNLSF 615 (902)
Q Consensus 550 ~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~l~~ 615 (902)
.+..+.. .++|+.|+|++|++++ .+|..+..+++|++|||++|++++.-...+. ...+|+.|++.+
T Consensus 357 ~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~ 436 (461)
T 1z7x_W 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred cHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecc
Confidence 6665554 6788888888888885 6788888888888999988888764222221 122455666666
Q ss_pred Cccee
Q 046199 616 NRLEG 620 (902)
Q Consensus 616 N~l~~ 620 (902)
+.+..
T Consensus 437 ~~~~~ 441 (461)
T 1z7x_W 437 IYWSE 441 (461)
T ss_dssp CCCCH
T ss_pred cccCH
Confidence 55543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=299.46 Aligned_cols=169 Identities=24% Similarity=0.324 Sum_probs=145.1
Q ss_pred hhcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||+||+|+++ .++.||+|++.... ...++.+|+++++.+ .||||+++++++.+++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 44678999999999999999999863 36789999886543 346788999999998 699999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~ 876 (902)
|+||||++||+|.+++. .+++.++..+++|++.||+||| ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999983 4899999999999999999999 9999999999999999876 79999999999865
Q ss_pred CCCcc----------------------------ceecccccccccccccccc
Q 046199 877 NGEES----------------------------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~----------------------------~~~~~~gt~~y~APE~l~~ 900 (902)
.+... ..+..+||+.|||||++..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 220 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC
Confidence 43221 1123579999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=314.22 Aligned_cols=172 Identities=25% Similarity=0.374 Sum_probs=155.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|+++. |+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999999864 899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--CcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD--MVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL~DFG~a~~~~~~~~ 881 (902)
|+||+|.+++......+++.++..+++||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999776677999999999999999999999 9999999999999999854 8999999999998765443
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
....+||+.|||||++..
T Consensus 313 -~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 313 -VKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp -EEEECSSGGGCCHHHHTT
T ss_pred -eeeeEECccccCHHHhCC
Confidence 344689999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.51 Aligned_cols=287 Identities=21% Similarity=0.223 Sum_probs=172.9
Q ss_pred CCCCCCCCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCc
Q 046199 23 KNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDN 102 (902)
Q Consensus 23 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n 102 (902)
..|....++|.|.|+ |+. ++++++ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 456666788999998 865 445555 6776655 48999999999998554557889999999999999
Q ss_pred cccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCccc-ccCcCccceeeecccccCCCCch--hhccccccceee
Q 046199 103 QLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKD-IGNLTKLKELYLGYNKLQGEIPQ--ELGNLAELEWLS 179 (902)
Q Consensus 103 ~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~-~~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~ 179 (902)
++++..| ..++++++|++||+++|++++ +|.. ++++++|++|+|++|+++ .+|. .+..+++|++|+
T Consensus 87 ~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~---------~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~ 155 (353)
T 2z80_A 87 GINTIEE-DSFSSLGSLEHLDLSYNYLSN---------LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155 (353)
T ss_dssp CCCEECT-TTTTTCTTCCEEECCSSCCSS---------CCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEE
T ss_pred ccCccCH-hhcCCCCCCCEEECCCCcCCc---------CCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEE
Confidence 9886433 334667777777777777653 4443 666777777777777776 4544 566777777777
Q ss_pred cccC-cCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCC
Q 046199 180 LPRS-FLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPN 258 (902)
Q Consensus 180 L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~ 258 (902)
+++| .+.+..|..|+++++|++|++++|.++. . .|..++.+++|+.|++++|+++...+.
T Consensus 156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~----------~---------~~~~l~~l~~L~~L~l~~n~l~~~~~~ 216 (353)
T 2z80_A 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS----------Y---------EPKSLKSIQNVSHLILHMKQHILLLEI 216 (353)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCE----------E---------CTTTTTTCSEEEEEEEECSCSTTHHHH
T ss_pred CCCCccccccCHHHccCCCCCCEEECCCCCcCc----------c---------CHHHHhccccCCeecCCCCccccchhh
Confidence 7776 3554445667777777777777776542 1 235666677777777777776532222
Q ss_pred cccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCC----CCCccccccccccEEEccCCcccCccccc
Q 046199 259 TIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG----RIPGFIFNASKLFLLELTGNSFSGFIPDT 334 (902)
Q Consensus 259 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 334 (902)
.+..+++|+.|++++|++++..+..+......+.++.++++++.+.+ .+|..+..+++|++|+|++|+++...+..
T Consensus 217 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~ 296 (353)
T 2z80_A 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGI 296 (353)
T ss_dssp HHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTT
T ss_pred hhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHH
Confidence 33346677777777777765444333223334445555555555442 23444444555555555555555322222
Q ss_pred ccccccccEEecccccCCC
Q 046199 335 LVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 335 l~~l~~L~~L~Ls~N~l~~ 353 (902)
|..+++|++|++++|++.+
T Consensus 297 ~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 297 FDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp TTTCTTCCEEECCSSCBCC
T ss_pred HhcCCCCCEEEeeCCCccC
Confidence 3445555555555555444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=295.07 Aligned_cols=181 Identities=24% Similarity=0.342 Sum_probs=159.9
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
..+.++....++|++.+.||+|+||+||+|++.. ++.||+|+++... ....+.+.+|+.+++.++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456777888999999999999999999999875 7889999997532 22345588999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.+++..|+||||++||+|.+++......+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999876677999999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccce-eccccccccccccccc
Q 046199 872 IAKLLNGEESMR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~-~~~~gt~~y~APE~l~ 899 (902)
+|+......... ...+||+.|||||++.
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHh
Confidence 998775544332 3368999999999985
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=329.14 Aligned_cols=431 Identities=13% Similarity=0.077 Sum_probs=206.6
Q ss_pred ceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeecccccc---ccCCCcccc------------CCCcce
Q 046199 31 VCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRF---SGTIPSSIF------------SISTLK 95 (902)
Q Consensus 31 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~ 95 (902)
|++|.++.+.. . ..+.+.. .+....+..+..+++|++|+|+++.. .|.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~--~--~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET--R--EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH--C--CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc--c--cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 45899885432 1 2222332 23333445567788899999988532 245665544 567777
Q ss_pred EEEecCccccCCCCcccccCCCc-ccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCC----Cchhhc
Q 046199 96 ILILGDNQLSGSFPSFIISNTSS-LRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELG 170 (902)
Q Consensus 96 ~L~ls~n~l~~~~~~~~~~~~~~-L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~----~p~~l~ 170 (902)
+|+|++|.+++..+..+...++. |++|++++|.-.. ...++..+..+++|++|+|++|.+++. ++..+.
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~------~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT------TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE------HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC------HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 77777777665433332222223 5555555554100 001222223445555555555555433 223334
Q ss_pred cccccceeecccCcCC----CCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEE
Q 046199 171 NLAELEWLSLPRSFLT----GTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246 (902)
Q Consensus 171 ~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~ 246 (902)
.+++|++|+|++|.++ +.++..+.++++|++|+|++|
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~--------------------------------------- 230 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF--------------------------------------- 230 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC---------------------------------------
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc---------------------------------------
Confidence 4455555555555554 122333344455555555544
Q ss_pred ccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCc
Q 046199 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326 (902)
Q Consensus 247 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 326 (902)
.+.+ +|..+..+++|+.|+++.+......+.....+..+++|+.|+++++.. ..+|..+..+++|++|+|++|.
T Consensus 231 ----~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 231 ----EILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp ----BGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCC
T ss_pred ----cHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCc
Confidence 4442 334444444444444443221111111112234445555555554322 2344445555555555555555
Q ss_pred ccCccc-ccccccccccEEecccccCCCCCCcccccccccCCCCCceeeecc-----------CCCCcc-cCcccccccc
Q 046199 327 FSGFIP-DTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAE-----------NPLNGV-LPSSIGNLPI 393 (902)
Q Consensus 327 l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~-----------N~l~~~-~p~~~~~l~~ 393 (902)
+++... ..+..+++|++|+++ +.+.... .......+++|++|++++ |.++.. ++.....++
T Consensus 305 l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~----l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~- 378 (592)
T 3ogk_B 305 LETEDHCTLIQKCPNLEVLETR-NVIGDRG----LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ- 378 (592)
T ss_dssp CCHHHHHHHHTTCTTCCEEEEE-GGGHHHH----HHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCT-
T ss_pred CCHHHHHHHHHhCcCCCEEecc-CccCHHH----HHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCc-
Confidence 443322 223455566666655 2222110 001123445566666662 344332 111123344
Q ss_pred cccEEEeecCcccccCCcccCC-CCCCcEEEee----cceeccc-----CCcccccccccCeeeccccc--ccCCCCC--
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGN-LVNLTTLHLG----NNQLSGS-----IPITVGRLNTLQGLGLENNK--LEGPIPD-- 459 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~--l~~~~p~-- 459 (902)
+|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|+++.+. +++..+.
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 7777777777777665555554 7778888885 5667653 33346667888888886432 4422221
Q ss_pred --cCCCCCeEeccCccccC-CCCccccCCCcCceEecCCCCccCc-ccccccCCCCceEEEcCCCccC
Q 046199 460 --DLCQLSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSF-IPSTFWNLNNILSFDFSSNSLN 523 (902)
Q Consensus 460 --~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~ 523 (902)
.+.+|+.|++++|++++ .++..+.++++|++|++++|.+++. ++..+..+++|++|++++|+++
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 12244444444444443 1223334445555555555554332 1222233444444444444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=277.40 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=214.4
Q ss_pred CCCC--CCCceeeeeEEeeCCCCcEEEEEeccCCccee----cCccc--CCCCCCCeeeccccccccCCCccccCCCcce
Q 046199 24 NWTS--NTSVCSWIGITCDVSTHRVTALNISDFGLTGT----ISSQL--GNLSSLQTLDLSHNRFSGTIPSSIFSISTLK 95 (902)
Q Consensus 24 ~w~~--~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~----~~~~l--~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 95 (902)
.|.. ..|+|.|.++-|...... -..+...|. ++..+ ...+.+++|+|++|+++ .+|+.++++++|+
T Consensus 34 ~~k~~~~~~~~~~~~~w~~~~~~~-----~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~ 107 (328)
T 4fcg_A 34 QWQRHYNADRNRWHSAWRQANSNN-----PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ 107 (328)
T ss_dssp HHHHHHHHCCTTHHHHHHHHTTTC-----TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCS
T ss_pred HHHHhccCCchhhhhhhccccccc-----ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCC
Confidence 4643 257899998877433221 111222221 12211 23578899999999998 8898888899999
Q ss_pred EEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhcccccc
Q 046199 96 ILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175 (902)
Q Consensus 96 ~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 175 (902)
+|+|++|.++ . +|..++.+++|++|+|++|+++ .+|..++.+++|
T Consensus 108 ~L~L~~n~l~-~---------------------------------lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L 152 (328)
T 4fcg_A 108 HMTIDAAGLM-E---------------------------------LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152 (328)
T ss_dssp EEEEESSCCC-C---------------------------------CCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTC
T ss_pred EEECCCCCcc-c---------------------------------hhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCC
Confidence 9999998887 3 7788889999999999999999 899999999999
Q ss_pred ceeecccCcCCCCCChhhhc---------cCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEE
Q 046199 176 EWLSLPRSFLTGTIPSSIFN---------LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLG 246 (902)
Q Consensus 176 ~~L~L~~n~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~ 246 (902)
++|+|++|++.+.+|..++. +++|++|+|++|.++ .+|..++++++|++|+
T Consensus 153 ~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~--------------------~lp~~l~~l~~L~~L~ 212 (328)
T 4fcg_A 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR--------------------SLPASIANLQNLKSLK 212 (328)
T ss_dssp CEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC--------------------CCCGGGGGCTTCCEEE
T ss_pred CEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC--------------------cchHhhcCCCCCCEEE
Confidence 99999999998899987765 889999999999865 3457788899999999
Q ss_pred ccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCc
Q 046199 247 IDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326 (902)
Q Consensus 247 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 326 (902)
|++|+++ .+|..+..+++|++|+|++|++.+.+|.. +..+++|++|++++|.+.+.+|..+..+++|++|+|++|+
T Consensus 213 L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~---~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 288 (328)
T 4fcg_A 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI---FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288 (328)
T ss_dssp EESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCC---TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred ccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHH---hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCC
Confidence 9999998 46677888999999999999888888876 6778889999999988888888888888899999999988
Q ss_pred ccCcccccccccccccEEecccccCCC
Q 046199 327 FSGFIPDTLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 327 l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 353 (902)
+.+.+|..+..+++|+.+++..+.+..
T Consensus 289 ~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 289 NLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp TCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred chhhccHHHhhccCceEEeCCHHHHHH
Confidence 888888888888888888888776654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=279.26 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=140.0
Q ss_pred CCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCcc-ccCCCcceEEEecCccccCC
Q 046199 29 TSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSS-IFSISTLKILILGDNQLSGS 107 (902)
Q Consensus 29 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~ls~n~l~~~ 107 (902)
.+.|.|.+|.|+.. +++ .+|..+. ++|++|+|++|+++ .+|.. +.++++|++|+|++|.++..
T Consensus 4 ~C~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 4 RCSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp TCEEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred CCeeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcc
Confidence 45589988888643 333 4565443 68899999999998 66664 67899999999999988732
Q ss_pred --CCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCc-hhhccccccceeecccCc
Q 046199 108 --FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP-QELGNLAELEWLSLPRSF 184 (902)
Q Consensus 108 --~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~ 184 (902)
.|.. ..++++|++||+++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.
T Consensus 68 ~~~~~~-~~~~~~L~~L~Ls~n~i~---------~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~ 137 (306)
T 2z66_A 68 GCCSQS-DFGTTSLKYLDLSFNGVI---------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137 (306)
T ss_dssp EEEEHH-HHSCSCCCEEECCSCSEE---------EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC
T ss_pred cCcccc-cccccccCEEECCCCccc---------cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc
Confidence 1111 223555555555555543 144445555555555555555553222 345555555555555555
Q ss_pred CCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC-cCCCcccCC
Q 046199 185 LTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG-DVPNTIFNM 263 (902)
Q Consensus 185 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l 263 (902)
+.+..|..+.++++|++|+|++|. +++ .+|..+..+
T Consensus 138 l~~~~~~~~~~l~~L~~L~l~~n~-------------------------------------------l~~~~~~~~~~~l 174 (306)
T 2z66_A 138 TRVAFNGIFNGLSSLEVLKMAGNS-------------------------------------------FQENFLPDIFTEL 174 (306)
T ss_dssp CEECSTTTTTTCTTCCEEECTTCE-------------------------------------------EGGGEECSCCTTC
T ss_pred CCccchhhcccCcCCCEEECCCCc-------------------------------------------cccccchhHHhhC
Confidence 554444445555555555555554 443 234444444
Q ss_pred CCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccccc-cccc
Q 046199 264 STLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNL-RNLE 342 (902)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~ 342 (902)
++|++|++++|++++..|.. +..+++|++|++++|.+++..+..+..+++|++|+|++|++++..|..+..+ ++|+
T Consensus 175 ~~L~~L~Ls~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 251 (306)
T 2z66_A 175 RNLTFLDLSQCQLEQLSPTA---FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251 (306)
T ss_dssp TTCCEEECTTSCCCEECTTT---TTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCC
T ss_pred cCCCEEECCCCCcCCcCHHH---hcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCC
Confidence 44444444444444333333 3344444444444444444444444555555555555555555555555555 2556
Q ss_pred EEecccccCCC
Q 046199 343 HLGLGYNYLTS 353 (902)
Q Consensus 343 ~L~Ls~N~l~~ 353 (902)
+|++++|.+++
T Consensus 252 ~L~L~~N~~~~ 262 (306)
T 2z66_A 252 FLNLTQNDFAC 262 (306)
T ss_dssp EEECTTCCEEC
T ss_pred EEEccCCCeec
Confidence 66666665554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-31 Score=290.30 Aligned_cols=253 Identities=22% Similarity=0.222 Sum_probs=164.0
Q ss_pred cCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccc-cCCCCcccc------cCCCcccEEEcccCcccCcCCcc
Q 046199 64 LGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQL-SGSFPSFII------SNTSSLRAIDCNYNSLSGELPAN 136 (902)
Q Consensus 64 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l-~~~~~~~~~------~~~~~L~~ldls~n~l~~~~~~~ 136 (902)
.+..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|.... .++++|++||+++|++++.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 110 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT---- 110 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSC----
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccch----
Confidence 34455677777777777 666665543 77777777777 334443321 1466666666666666654
Q ss_pred hhccCcccc--cCcCccceeeecccccCCCCchhhccc-----cccceeecccCcCCCCCChhhhccCcccEEeeeeCCC
Q 046199 137 IFRAIPKDI--GNLTKLKELYLGYNKLQGEIPQELGNL-----AELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSL 209 (902)
Q Consensus 137 ~~~~ip~~~--~~l~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 209 (902)
+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 111 ----~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 185 (312)
T 1wwl_A 111 ----APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185 (312)
T ss_dssp ----CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred ----hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence 44444 6677777777777777754 7777766 7777777777777766667777777777777777774
Q ss_pred CccccccccccCCccccccccCCCccc--cCCCCCCEEEccCccccC--cCC-CcccCCCCCceEeccCcccccCCCcCC
Q 046199 210 TGFYMTNNHFTGSIPRNLWQCEIPHEI--GNLPNLEVLGIDENHLVG--DVP-NTIFNMSTLKALSLLNNTLSGSLPSSS 284 (902)
Q Consensus 210 ~~~~~~~~~~~g~ip~~~~~~~lp~~l--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 284 (902)
. |.++ +|..+ +.+++|++|+|++|++++ .++ ..+.++++|++|+|++|++++..|...
T Consensus 186 ~----------~~~~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 248 (312)
T 1wwl_A 186 L----------GERG-------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248 (312)
T ss_dssp C----------HHHH-------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSC
T ss_pred C----------cchH-------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhh
Confidence 3 2111 11233 667777777777777762 122 233466777777777777776554322
Q ss_pred cccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCC
Q 046199 285 KNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353 (902)
Q Consensus 285 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 353 (902)
+..+++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus 249 --~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 249 --CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp --CCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred --hhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 455677777777777777 5555554 6777777777777765 44 7777777777777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=276.34 Aligned_cols=230 Identities=23% Similarity=0.254 Sum_probs=168.2
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceeccc--CCcccccccccCeeecccccccCCCCC---cCCCCCeEe
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGS--IPITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSELH 468 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~---~l~~L~~L~ 468 (902)
++++|+|++|+++...+..|.++++|++|+|++|+++.. .|..+..+++|++|++++|.+++ +|. .+.+|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEE
Confidence 566666666666644444456666666666666666522 24455556666666666666652 332 233666677
Q ss_pred ccCccccCCCC-ccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCC-CCccccccccccceeccCCccc
Q 046199 469 VDHNKLSGPIP-ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNG-SLPLDIGNMKVVVEINLSRNYL 546 (902)
Q Consensus 469 L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l 546 (902)
+++|++++..+ ..|..+++|++|++++|++++..+..|..+++|++|++++|.+++ ..|..+..+++|++|++++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 77777766554 567788888888888888887777788888888888888888876 4677788888888888888888
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccc-ccccccccCCcceecCCC
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV-YLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~ 624 (902)
++..|..|..+++|+.|+|++|++++..+..|..+++|+.|||++|++++..|..+..++ +|+.|+|++|+++|.++.
T Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 877788888888888888888888877777788888888888888888888888888874 888888888888876553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=296.46 Aligned_cols=290 Identities=26% Similarity=0.332 Sum_probs=162.4
Q ss_pred CCCCCCCCceeeeeEEe------eCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceE
Q 046199 23 KNWTSNTSVCSWIGITC------DVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96 (902)
Q Consensus 23 ~~w~~~~~~c~w~gv~c------~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 96 (902)
++|..+.+||.|.|..| ......++.|++++++++ .+|..+. ++|++|+|++|+++ .+|. .+++|++
T Consensus 13 ~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~ 85 (622)
T 3g06_A 13 SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRT 85 (622)
T ss_dssp HHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCE
T ss_pred HHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCE
Confidence 35877788999987432 222224677888888887 7777665 67888888888877 6776 4677888
Q ss_pred EEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccc
Q 046199 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176 (902)
Q Consensus 97 L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 176 (902)
|+|++|++++ +|. .+++|++|++++|.+++ +|. .+++|++|+|++|+++ .+|.. +++|+
T Consensus 86 L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~---------l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~ 144 (622)
T 3g06_A 86 LEVSGNQLTS-LPV----LPPGLLELSIFSNPLTH---------LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQ 144 (622)
T ss_dssp EEECSCCCSC-CCC----CCTTCCEEEECSCCCCC---------CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCC
T ss_pred EEcCCCcCCc-CCC----CCCCCCEEECcCCcCCC---------CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCC
Confidence 8888887763 343 45566666666666553 333 2345666666666665 34443 25555
Q ss_pred eeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcC
Q 046199 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDV 256 (902)
Q Consensus 177 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~ 256 (902)
+|+|++|+++ .+|. .+++|+.|++++|.|+. +| ..+++|+.|+|++|++++ +
T Consensus 145 ~L~Ls~N~l~-~l~~---~~~~L~~L~L~~N~l~~--------------------l~---~~~~~L~~L~Ls~N~l~~-l 196 (622)
T 3g06_A 145 ELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTS--------------------LP---MLPSGLQELSVSDNQLAS-L 196 (622)
T ss_dssp EEECCSSCCS-CCCC---CCTTCCEEECCSSCCSC--------------------CC---CCCTTCCEEECCSSCCSC-C
T ss_pred EEECcCCcCC-CcCC---ccCCCCEEECCCCCCCC--------------------Cc---ccCCCCcEEECCCCCCCC-C
Confidence 5666666555 2333 12445555555555442 11 223455555555555552 3
Q ss_pred CCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCccccccc
Q 046199 257 PNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLV 336 (902)
Q Consensus 257 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 336 (902)
|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| .
T Consensus 197 ~~~---~~~L~~L~L~~N~l~-~l~~~------------------------------~~~L~~L~Ls~N~L~~-lp---~ 238 (622)
T 3g06_A 197 PTL---PSELYKLWAYNNRLT-SLPAL------------------------------PSGLKELIVSGNRLTS-LP---V 238 (622)
T ss_dssp CCC---CTTCCEEECCSSCCS-SCCCC------------------------------CTTCCEEECCSSCCSC-CC---C
T ss_pred CCc---cchhhEEECcCCccc-ccCCC------------------------------CCCCCEEEccCCccCc-CC---C
Confidence 321 244555555555554 22221 2445555555555543 22 2
Q ss_pred ccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCC
Q 046199 337 NLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNL 416 (902)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l 416 (902)
.+++|+.|++++|+|++.++ .+++|++|++++|++. .+|..+..++ +|+.|+|++|.+++..|..+..+
T Consensus 239 ~l~~L~~L~Ls~N~L~~lp~---------~~~~L~~L~Ls~N~L~-~lp~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 239 LPSELKELMVSGNRLTSLPM---------LPSGLLSLSVYRNQLT-RLPESLIHLS-SETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCC-SCCGGGGGSC-TTCEEECCSCCCCHHHHHHHHHH
T ss_pred CCCcCcEEECCCCCCCcCCc---------ccccCcEEeCCCCCCC-cCCHHHhhcc-ccCEEEecCCCCCCcCHHHHHhc
Confidence 33455555555555553221 3345555555555555 4455666666 67777777777766666655544
Q ss_pred C
Q 046199 417 V 417 (902)
Q Consensus 417 ~ 417 (902)
+
T Consensus 308 ~ 308 (622)
T 3g06_A 308 T 308 (622)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.68 Aligned_cols=172 Identities=34% Similarity=0.458 Sum_probs=155.4
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3468999999999999999999975 489999999987666666788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|.........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999998654 5899999999999999999999 999999999999999999999999999999887665555
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 173 ~~~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR 190 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC
T ss_pred cCCccCCcCccChhhhcC
Confidence 555789999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=284.05 Aligned_cols=181 Identities=27% Similarity=0.395 Sum_probs=160.1
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
+.+++.....++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.++..++||+|+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456677788899999999999999999999986 48999999997532 23346688999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
.+++..|+||||++||+|.+++.+.+..+++..+..++.||+.||+||| ++||+||||||+||+++.++++||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999776667999999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccce-eccccccccccccccc
Q 046199 872 IAKLLNGEESMR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~-~~~~gt~~y~APE~l~ 899 (902)
+|+......... ...+||+.|||||++.
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHh
Confidence 998876544322 2368999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-32 Score=321.01 Aligned_cols=298 Identities=14% Similarity=0.042 Sum_probs=158.5
Q ss_pred ccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccccc
Q 046199 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP 392 (902)
Q Consensus 313 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 392 (902)
.+++|+.|++++|.+.+ +|..+..+++|++|+++..... .+.......+..+++|+.|+++++. .+.+|..+..++
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~--~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~ 293 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNED--IGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAA 293 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCC--TTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGG
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccc--cchHHHHHHhhccccccccCccccc-hhHHHHHHhhcC
Confidence 34455555555555443 3344555555555555432111 0001111344455555666655532 224455555555
Q ss_pred ccccEEEeecCcccccCC-cccCCCCCCcEEEeecceecccCCcccccccccCeeeccc-----------ccccCCCC--
Q 046199 393 ITLEEIYLQNCKIRGNIP-KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN-----------NKLEGPIP-- 458 (902)
Q Consensus 393 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-----------N~l~~~~p-- 458 (902)
+|++|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|++|++++ |.+++...
T Consensus 294 -~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~ 372 (592)
T 3ogk_B 294 -QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372 (592)
T ss_dssp -GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHH
T ss_pred -CCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHH
Confidence 67777777776554332 2346677777777773322233344445566777777772 44442211
Q ss_pred --CcCCCCCeEeccCccccCCCCccccC-CCcCceEecC----CCCccCc-----ccccccCCCCceEEEcCCC--ccCC
Q 046199 459 --DDLCQLSELHVDHNKLSGPIPACFGN-LNSLRNLSLG----SNELSSF-----IPSTFWNLNNILSFDFSSN--SLNG 524 (902)
Q Consensus 459 --~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~ls~N--~l~~ 524 (902)
..+.+|++|+++.|.+++..+..+.. +++|+.|+++ .|++++. ++..+.++++|++|+++++ .+++
T Consensus 373 l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~ 452 (592)
T 3ogk_B 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452 (592)
T ss_dssp HHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH
T ss_pred HHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH
Confidence 12346666666666666555554544 6667777774 5666653 2333555677777777543 2444
Q ss_pred CCcccccc-ccccceeccCCccccc-cCccccccCCccceEEccCcccCCCc-cccccccccCCeEeCcCccccccCCcc
Q 046199 525 SLPLDIGN-MKVVVEINLSRNYLTG-DIPTTIGGLTNLQLLSLENNRLHGPI-PESFGALTSLESLDLSVNNLSGVIPIS 601 (902)
Q Consensus 525 ~~~~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 601 (902)
..+..+.. +++|++|++++|++++ .++..+..+++|+.|+|++|++++.. +..+..+++|+.|+|++|++++.-...
T Consensus 453 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~ 532 (592)
T 3ogk_B 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDL 532 (592)
T ss_dssp HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTG
T ss_pred HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHH
Confidence 33333332 5667777777777664 23444566677777777777765432 333456677777777777766543322
Q ss_pred c-ccccccccccccC
Q 046199 602 L-EKLVYLKDLNLSF 615 (902)
Q Consensus 602 l-~~l~~L~~L~l~~ 615 (902)
+ ..++.+....+..
T Consensus 533 l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 533 MQMARPYWNIELIPS 547 (592)
T ss_dssp GGGCCTTEEEEEECC
T ss_pred HHHhCCCcEEEEecC
Confidence 3 2345554444443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=274.33 Aligned_cols=173 Identities=28% Similarity=0.350 Sum_probs=152.8
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++...+..|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 35789999999999999999999864 8999999997542 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+.....
T Consensus 83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999988654 45899999999999999999999 999999999999999999999999999999875444
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
.......+||+.|+|||++..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS
T ss_pred CCcccccccChhhCChhhhcC
Confidence 444455789999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=270.13 Aligned_cols=174 Identities=24% Similarity=0.396 Sum_probs=154.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 45789999999999999999999864 89999999876666677889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999999887778999999999999999999999 999999999999999999999999999999876543321
Q ss_pred e--------------ecccccccccccccccc
Q 046199 883 R--------------TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~--------------~~~~gt~~y~APE~l~~ 900 (902)
. ....||+.|+|||++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC
Confidence 1 13579999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=281.04 Aligned_cols=179 Identities=25% Similarity=0.357 Sum_probs=157.0
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
.+.++....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 345677888999999999999999999999865 8899999997532 223456889999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
+++..|+||||++||+|.+++... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999998653 5899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCccc-eecccccccccccccccc
Q 046199 873 AKLLNGEESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
|+........ ....+||+.|||||++..
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHT
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhc
Confidence 9887654332 234689999999998753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=275.05 Aligned_cols=283 Identities=17% Similarity=0.165 Sum_probs=200.1
Q ss_pred cCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccccccc
Q 046199 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASK 316 (902)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 316 (902)
..++...+.++++|+++ .+|..+. ++|++|++++|++++..+.. +.++++|++|++++|++++..|..|..+++
T Consensus 28 ~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSD---LQRCVNLQALVLTSNGINTIEEDSFSSLGS 101 (353)
T ss_dssp CEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTT---TTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHH---hccCCCCCEEECCCCccCccCHhhcCCCCC
Confidence 34455667899999998 6777665 48999999999998654444 778899999999999999888888999999
Q ss_pred ccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccC-CCCcccCcccccccccc
Q 046199 317 LFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAEN-PLNGVLPSSIGNLPITL 395 (902)
Q Consensus 317 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~~L 395 (902)
|++|+|++|++++..+..|..+++|++|++++|++++..+. ..+..+++|++|++++| .+....+..+..++ +|
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L 176 (353)
T 2z80_A 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET----SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT-FL 176 (353)
T ss_dssp CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS----CSCTTCTTCCEEEEEESSSCCEECTTTTTTCC-EE
T ss_pred CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch----hhhccCCCCcEEECCCCccccccCHHHccCCC-CC
Confidence 99999999999977666688999999999999999864431 25678888999999988 46666677788887 88
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcccc
Q 046199 396 EEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLS 475 (902)
Q Consensus 396 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~ 475 (902)
++|++++|++++..|..|..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+..
T Consensus 177 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------ 244 (353)
T 2z80_A 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------ 244 (353)
T ss_dssp EEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----------------
T ss_pred CEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc------------
Confidence 99999999988888888888889999999998887544444556788888888888887654433220
Q ss_pred CCCCccccCCCcCceEecCCCCccC----cccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccc
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSS----FIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (902)
....+.++.+++++|.+++ .+|..+..+++|++|++++|+++...+..|..+++|++|++++|++.+
T Consensus 245 ------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 245 ------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp --------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 0112233334444443332 134444555555555555555553222223455555555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=280.18 Aligned_cols=229 Identities=24% Similarity=0.280 Sum_probs=196.0
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCc---CCCCCeEecc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVD 470 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~L~ 470 (902)
+++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+.. +.+|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 6777777777777777777777788888888888887777777777888888888888777544433 3478888888
Q ss_pred CccccCCCCccccCCCcCceEecCC-CCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcccccc
Q 046199 471 HNKLSGPIPACFGNLNSLRNLSLGS-NELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549 (902)
Q Consensus 471 ~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (902)
+|++++..+..|.++++|+.|++++ |.+..+.+..|.++++|++|++++|++++. | .+..+++|++|+|++|++++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 8888877778899999999999998 566666666899999999999999999964 4 588899999999999999999
Q ss_pred CccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
.|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..+..+++|+.|+|++|+|.|.+..
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 999999999999999999999998899999999999999999999988888889999999999999999987764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=275.95 Aligned_cols=173 Identities=27% Similarity=0.375 Sum_probs=146.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 456899999999999999999999865 8999999997542 23456778899999988 699999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999998654 45899999999999999999999 9999999999999999999999999999998655
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.........+||+.|+|||++.
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp C---------CCGGGCCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcC
Confidence 4444445578999999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=267.06 Aligned_cols=221 Identities=24% Similarity=0.290 Sum_probs=121.6
Q ss_pred ceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccc
Q 046199 371 KYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN 450 (902)
Q Consensus 371 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 450 (902)
+.++.+++.+.. +|..+ +.++++|++++|.+++..+..|..+++|++|++++|.+++..|..|..+++|++|++++
T Consensus 14 ~~~~c~~~~l~~-ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSS-CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCccc-CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 345555555542 33322 23788888888888877777788888888888888888877777888777777777777
Q ss_pred cc-ccCCCCCcC---CCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCC
Q 046199 451 NK-LEGPIPDDL---CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSL 526 (902)
Q Consensus 451 N~-l~~~~p~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 526 (902)
|+ +....|..+ .+|++|++++|++++..|..|.++++|++|++++|++++..+..|..+++|++|++++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 76 553323222 24444444444444444444445555555555555555444444444455555555555444433
Q ss_pred ccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc
Q 046199 527 PLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595 (902)
Q Consensus 527 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 595 (902)
+..|..+++|++|++++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 333444444444444444444444444444444444444444444433344444444444444444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=278.38 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=207.9
Q ss_pred eeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccc
Q 046199 372 YIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENN 451 (902)
Q Consensus 372 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 451 (902)
.++.+++.+. .+|..+. .+++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 47 ~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4444444444 3444333 37788888888888877888888888888888888888777788888888888888888
Q ss_pred cccCCCCCc---CCCCCeEeccCccccCCCCccccCCCcCceEecCC-CCccCcccccccCCCCceEEEcCCCccCCCCc
Q 046199 452 KLEGPIPDD---LCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS-NELSSFIPSTFWNLNNILSFDFSSNSLNGSLP 527 (902)
Q Consensus 452 ~l~~~~p~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 527 (902)
++++..+.. +.+|++|+|++|++++..+..|.++++|+.|++++ |.+..+.+..|.++++|++|++++|+++. +|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence 887544433 34888888889988888888999999999999999 55666666689999999999999999995 45
Q ss_pred cccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccc
Q 046199 528 LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVY 607 (902)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 607 (902)
.+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..+..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 5888999999999999999999999999999999999999999988999999999999999999999888888999999
Q ss_pred cccccccCCcceecCCC
Q 046199 608 LKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 608 L~~L~l~~N~l~~~~p~ 624 (902)
|+.|+|++|+|.|.+..
T Consensus 281 L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCEEECCSSCEECSSTT
T ss_pred CCEEEcCCCCccCCCCc
Confidence 99999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=271.98 Aligned_cols=174 Identities=26% Similarity=0.390 Sum_probs=153.6
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
....++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345678999999999999999999984 59999999997543 334567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999998654 45899999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. .....+||+.|+|||++..
T Consensus 167 ~~-~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 167 GG-KLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp SC-GGGTTSSSGGGCCHHHHHT
T ss_pred CC-ccccccCCcceeCcccccC
Confidence 33 2344679999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=277.48 Aligned_cols=175 Identities=26% Similarity=0.340 Sum_probs=152.2
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 796 (902)
....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+++.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 3456789999999999999999999865 7889999997543 23345688999999887 89999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999998654 45899999999999999999999 999999999999999999999999999999875
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..........+||+.|+|||++..
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~ 227 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRG 227 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTT
T ss_pred ccCCCccccccCCcccCCchhhcC
Confidence 444444555789999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=272.39 Aligned_cols=176 Identities=27% Similarity=0.404 Sum_probs=151.7
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCC
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGN 795 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 795 (902)
.....++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 34567899999999999999999999864 8899999997542 23456678899999877 8999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+.
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999998654 45899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...........+||+.|+|||++..
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cccCCCcccCCCCCcccCChhhhcC
Confidence 5444444455789999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=267.51 Aligned_cols=173 Identities=27% Similarity=0.413 Sum_probs=151.2
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++.+++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999987543 233567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++ ++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99985 888888777777999999999999999999999 99999999999999999999999999999998765544
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp ---CCCCCCTTCCHHHHTT
T ss_pred cccCCcccCCcCCHHHhcC
Confidence 4455679999999998753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=278.36 Aligned_cols=268 Identities=18% Similarity=0.185 Sum_probs=209.5
Q ss_pred cccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccc
Q 046199 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395 (902)
Q Consensus 316 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 395 (902)
+++.++++.+.+.......+..+++|++|++++|.+++..+ ..+..++ +|
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~-----~~~~~l~-------------------------~L 60 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-----ADLAPFT-------------------------KL 60 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCH-----HHHTTCT-------------------------TC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCH-----HHhhCCC-------------------------cC
Confidence 45667777777765555556666777777777777776544 3344444 55
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcccc
Q 046199 396 EEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLS 475 (902)
Q Consensus 396 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~ 475 (902)
++|+|++|++++..+ |..+++|++|++++|++++.. ..++|++|++++|++++..+..+.+|+.|++++|+++
T Consensus 61 ~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133 (317)
T ss_dssp CEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCC
T ss_pred CEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCC
Confidence 555555555554433 666677777777777776432 2367777777777777666666778899999999999
Q ss_pred CCCCccccCCCcCceEecCCCCccCccccccc-CCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcccc
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFW-NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 554 (902)
+..+..|..+++|++|++++|++++..+..+. .+++|++|++++|++++. + ....+++|++|+|++|++++ +|..|
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~ 210 (317)
T 3o53_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEF 210 (317)
T ss_dssp SGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGG
T ss_pred CccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhh
Confidence 88888899999999999999999998887774 789999999999999865 3 33458999999999999995 45569
Q ss_pred ccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc-ccCCccccccccccccccc-CCcceecCCC
Q 046199 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS-GVIPISLEKLVYLKDLNLS-FNRLEGEIPS 624 (902)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~-~N~l~~~~p~ 624 (902)
..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.++++ .+.++|..|.
T Consensus 211 ~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp GGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 99999999999999999 57888999999999999999999 7888899999999999999 5567776665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=293.93 Aligned_cols=236 Identities=18% Similarity=0.179 Sum_probs=145.8
Q ss_pred CCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCee
Q 046199 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGL 446 (902)
Q Consensus 367 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 446 (902)
+++|++|++++|.+.+..|..|..++ +|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34667777777777666666666666 67777777777665544 6666677777777776664322 2566666
Q ss_pred ecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccccccc-CCCCceEEEcCCCccCCC
Q 046199 447 GLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW-NLNNILSFDFSSNSLNGS 525 (902)
Q Consensus 447 ~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~ 525 (902)
++++|.+++..+..+.+|+.|++++|.+++..|..|.++++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.
T Consensus 105 ~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 105 HAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp ECCSSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred ECcCCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 6666666655555555666666666666666666666666666666666666665555554 566666666666666643
Q ss_pred CccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc-ccCCccccc
Q 046199 526 LPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS-GVIPISLEK 604 (902)
Q Consensus 526 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~ 604 (902)
| ....+++|+.|+|++|+|++. |..|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.+. +.+|..+..
T Consensus 185 -~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 -K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp -E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred -c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 2 222456666666666666643 3336666666666666666663 5555666666666666666665 455555566
Q ss_pred cccccccccc
Q 046199 605 LVYLKDLNLS 614 (902)
Q Consensus 605 l~~L~~L~l~ 614 (902)
++.|+.++++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 6666665554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=278.79 Aligned_cols=246 Identities=21% Similarity=0.195 Sum_probs=111.2
Q ss_pred CCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT 149 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~ 149 (902)
...++.+++.++ .+|..+. ++|++|+|++|++++..| ..++++++|++||+++|.+++. .|..++.++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~--------~~~~~~~l~ 123 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQI--------EVGAFNGLA 123 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEE--------CTTTTTTCT
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCc--------ChhhccCcc
Confidence 345555555555 5555443 455666666666554211 1122333333333333333211 233444555
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCC-CCccccccccccCCcccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS-LTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~g~ip~~~~ 228 (902)
+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|. ++ .+|
T Consensus 124 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~-----------~i~---- 188 (452)
T 3zyi_A 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-----------YIS---- 188 (452)
T ss_dssp TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCC-----------EEC----
T ss_pred cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcc-----------ccC----
Confidence 55555555555553333345555555555555555553333445555555555555532 21 111
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCC
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP 308 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 308 (902)
+..|..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..|.. |.++++|++|+|++|++++..+
T Consensus 189 ----~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 189 ----EGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGS---FHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp ----TTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGG---GTTCTTCCEEECTTSCCCEECT
T ss_pred ----hhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCccc---ccCccCCCEEEeCCCcCceECH
Confidence 1234445555555555555542 22 2444444444444444444333333 3344444444444444444444
Q ss_pred ccccccccccEEEccCCcccCcccccccccccccEEecccccC
Q 046199 309 GFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351 (902)
Q Consensus 309 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 351 (902)
..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 302 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCc
Confidence 4444444444444444444444334444444444444444443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=270.32 Aligned_cols=173 Identities=26% Similarity=0.341 Sum_probs=152.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 798 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.+++++ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 35789999999999999999999865 8899999997543 23456788999999988 8999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+....
T Consensus 87 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999998654 45899999999999999999999 99999999999999999999999999999986544
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
........+||+.|+|||++..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTT
T ss_pred CCCcccccCCCccccCccccCC
Confidence 4444455789999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=265.28 Aligned_cols=181 Identities=28% Similarity=0.346 Sum_probs=157.6
Q ss_pred ccCHHHHHhhcc----------cccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC
Q 046199 715 RFSYRELLLATD----------HFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783 (902)
Q Consensus 715 ~~~~~~~~~~~~----------~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 783 (902)
.++++++..+.+ .|+..+.||+|+||.||+|++. +++.||||+++.......+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 455555554443 3777889999999999999986 59999999998766666678999999999999999
Q ss_pred ccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 784 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
|+++++++...+..|+||||+++++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999998854 45899999999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.+||+|||++..............||+.|+|||++..
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcC
Confidence 9999999999887655444455679999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=271.53 Aligned_cols=172 Identities=30% Similarity=0.428 Sum_probs=152.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
+..++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345789999999999999999999865 8899999997542 234567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||++||+|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.+|.+||+|||+|+....
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999865 456999999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
.. .....+||+.|+|||++.
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTC
T ss_pred CC-ceeccCCCccccCCeeec
Confidence 33 334578999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=270.80 Aligned_cols=174 Identities=22% Similarity=0.288 Sum_probs=151.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+..|..+++.+ +||+|+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 456789999999999999999999875 7899999997542 23456788899999988 799999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999998654 45899999999999999999999 9999999999999999999999999999998754
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.........+||+.|+|||++..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT
T ss_pred cCCcccccccCCccccChhhhcC
Confidence 44444455789999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=264.73 Aligned_cols=171 Identities=21% Similarity=0.305 Sum_probs=152.4
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|+++.. ....+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4789999999999999999999864 889999998754 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--CCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD--DMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~~~ 881 (902)
++|++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999776667999999999999999999999 999999999999999987 78999999999988764433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 160 -~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp -EEEEESCGGGSCHHHHTT
T ss_pred -cccccCChhhcCcHHhcC
Confidence 344679999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=261.78 Aligned_cols=171 Identities=27% Similarity=0.399 Sum_probs=151.5
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 589999999999999999999864 8999999997553 2344778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++ ++.+.+......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|+........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9976 676777666677999999999999999999999 999999999999999999999999999999987655555
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 158 ~~~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred ccCCccccCCcChHHHcC
Confidence 555679999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=264.06 Aligned_cols=170 Identities=28% Similarity=0.398 Sum_probs=150.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3578999999999999999999986 48999999997542 2345678889999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+.....
T Consensus 84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999999654 45899999999999999999999 999999999999999999999999999999876432
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
....+||+.|+|||++..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTT
T ss_pred ---cccccCCccccCHhHhcC
Confidence 234679999999998753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=257.83 Aligned_cols=265 Identities=20% Similarity=0.202 Sum_probs=183.2
Q ss_pred cEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccE
Q 046199 318 FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397 (902)
Q Consensus 318 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~ 397 (902)
+.++.+++.++. +|..+ .++|++|++++|.+++..+ ..+..++ +|++
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~-----~~~~~~~-------------------------~L~~ 60 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPA-----ASFRACR-------------------------NLTI 60 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECT-----TTTTTCT-------------------------TCCE
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCH-----HHcccCC-------------------------CCCE
Confidence 566777777763 34333 3466666666666665443 3344444 4555
Q ss_pred EEeecCcccccCCcccCCCCCCcEEEeecce-ecccCCcccccccccCeeecccccccCCCCCc---CCCCCeEeccCcc
Q 046199 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQ-LSGSIPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNK 473 (902)
Q Consensus 398 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~L~~L~L~~N~ 473 (902)
|++++|.+++..|..|..+++|++|++++|+ ++...|..|..+++|++|++++|++++..|.. +.+|++|++++|+
T Consensus 61 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 140 (285)
T 1ozn_A 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140 (285)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCc
Confidence 5555555554445555555555555555554 44444555555555555555555555443432 2356666666666
Q ss_pred ccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (902)
+++..+..|.++++|+.|++++|+++++.+..|..+++|++|++++|++++..|..|..+++|++|++++|++++..+..
T Consensus 141 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 220 (285)
T 1ozn_A 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220 (285)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHH
T ss_pred ccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHH
Confidence 66677778999999999999999999988888999999999999999999988999999999999999999999877788
Q ss_pred cccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccc--ccccccccccCC
Q 046199 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEK--LVYLKDLNLSFN 616 (902)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~--l~~L~~L~l~~N 616 (902)
|..+++|+.|+|++|++....+.. .-...++.+..+.|.+....|..+.+ +..++..+++++
T Consensus 221 ~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 221 LAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp HTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred cccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence 999999999999999998544321 22244566667788888888877654 344555454443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=267.20 Aligned_cols=172 Identities=27% Similarity=0.397 Sum_probs=151.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch------hhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35789999999999999999999864 899999999765321 34678999999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecC
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGI 872 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~ 872 (902)
.|+||||++||+|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999855 456899999999999999999999 99999999999999998877 799999999
Q ss_pred ceecCCCccceecccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++....... ....+||+.|+|||++..
T Consensus 166 a~~~~~~~~-~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 166 AHEIEDGVE-FKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp CEECCTTCC-CCCCCSCGGGCCHHHHTT
T ss_pred ceEcCCCCc-cccCCCCccEECchHHcC
Confidence 988755332 334679999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=267.26 Aligned_cols=184 Identities=41% Similarity=0.673 Sum_probs=160.4
Q ss_pred ccccCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 713 WRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 713 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
...+++.++....++|++.+.||+|+||.||+|++.+++.||+|+++.... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356889999999999999999999999999999987899999999875532 2334789999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCC---CeEEcCCCCCCEEEcCCCcE
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN---RSLDIFQRLSIMIDVALALEYLHFGYSN---PVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~---~ivHrDlkp~NIll~~~~~~ 865 (902)
...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999997643 34899999999999999999999 77 99999999999999999999
Q ss_pred EEEeecCceecCCCccc-eeccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
||+|||+|+........ .....||+.|+|||++.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhc
Confidence 99999999877544333 23356999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=265.95 Aligned_cols=182 Identities=30% Similarity=0.471 Sum_probs=144.1
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
.....++.+..++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 344455667788999999999999999999987 68899999987553 234567899999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEE
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDDDMVAHLS 868 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kL~ 868 (902)
..+..++||||+++|+|.+++..... .+++..+..++.|++.||+||| ++| |+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999965432 3889999999999999999999 999 9999999999999999999999
Q ss_pred eecCceecCCCccceecccccccccccccccc
Q 046199 869 DFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 869 DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|||+++.............||+.|+|||++..
T Consensus 182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp CCC-----------------CCTTSCHHHHTT
T ss_pred CCCCCccccccccccccCCCCccccChhhhcC
Confidence 99999865544333445679999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=269.69 Aligned_cols=174 Identities=22% Similarity=0.332 Sum_probs=150.8
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-----chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568999999999999999999886 48999999986432 12357789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeec
Q 046199 798 ALVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV---AHLSDFG 871 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kL~DFG 871 (902)
|+||||+++++|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998877542 345899999999999999999999 999999999999999987654 9999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+++.............||+.|+|||++..
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence 99987665544455689999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=267.53 Aligned_cols=181 Identities=39% Similarity=0.647 Sum_probs=157.6
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+.+.++....++|++.+.||+|+||.||+|++.+++.||+|++........+.+.+|+++++.++||||+++++++..++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34444556788999999999999999999998889999999988766666788999999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 796 FKALVLEYMANGSLEKCLYSSN---RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999986543 34899999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCcc--ceeccccccccccccccc
Q 046199 873 AKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
++....... ......||+.|+|||++.
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHH
T ss_pred ccccccccccccccccCCCccccCHHHhc
Confidence 987543222 122356899999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=261.48 Aligned_cols=172 Identities=27% Similarity=0.433 Sum_probs=146.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--------------------------hhhhhHHHHHHHH
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--------------------------GALKSFDAECEVL 776 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l 776 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45789999999999999999998854 88999999865421 1236788999999
Q ss_pred HhCCCCCccceeeeeec--CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCC
Q 046199 777 KSVRHRNLVKIISSCSN--GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKP 854 (902)
Q Consensus 777 ~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp 854 (902)
+.++||||+++++++.+ .+..|+||||+++++|.+++. ...+++..+..++.|++.||+||| ++||+||||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 165 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP 165 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 99999999999999976 578999999999999988653 346899999999999999999999 99999999999
Q ss_pred CCEEEcCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 855 SNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 855 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+||+++.++.+||+|||+++.............||+.|+|||++..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCT
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhcc
Confidence 9999999999999999999987655544455689999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=263.26 Aligned_cols=171 Identities=26% Similarity=0.420 Sum_probs=147.4
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||.||+|++.+++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999997799999999975432 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+.........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 976 999998776677999999999999999999999 9999999999999999999999999999998765444444
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....||+.|+|||++..
T Consensus 158 ~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMG 174 (288)
T ss_dssp ----CCCTTCCHHHHTT
T ss_pred ccccccccccCchheeC
Confidence 44678999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=268.54 Aligned_cols=172 Identities=22% Similarity=0.343 Sum_probs=153.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999986 4889999999876655667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--CCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD--DMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~~~ 881 (902)
+++|+|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|+.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999766667999999999999999999999 999999999999999974 56899999999998764433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 207 -~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp -EEEECSSGGGCCHHHHTT
T ss_pred -eeeeccCCCccCchhccC
Confidence 334579999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=266.75 Aligned_cols=174 Identities=27% Similarity=0.418 Sum_probs=141.5
Q ss_pred hhcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
+..++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.++||||+++++++..+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45678999999999999999999873 58999999997542 23346678899999999999999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
+..|+||||+++++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999998654 45889999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
............+||+.|+|||++..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTT
T ss_pred ccccCCccccccCCCcCccCHhhCcC
Confidence 65444444445679999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=260.47 Aligned_cols=175 Identities=26% Similarity=0.415 Sum_probs=153.9
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+.+..++|++.+.||+|+||.||+|++.+++.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456689999999999999999999998899999999975533 346789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999999877777999999999999999999999 9999999999999999999999999999998664332
Q ss_pred cc-eeccccccccccccccc
Q 046199 881 SM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~-~~~~~gt~~y~APE~l~ 899 (902)
.. .....+|+.|+|||++.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~ 180 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFS 180 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHH
T ss_pred cccccCcccccccCCHHHhc
Confidence 21 22245778899999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=264.33 Aligned_cols=174 Identities=26% Similarity=0.491 Sum_probs=149.2
Q ss_pred hhcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+..++|++.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44678999999999999999999985 34569999997653 34457899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999777677999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCccce---eccccccccccccccc
Q 046199 878 GEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
...... ....+|+.|+|||++.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHH
T ss_pred cCccceeeccCCCCcccccCHhHhc
Confidence 433221 2234678899999874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=268.87 Aligned_cols=248 Identities=21% Similarity=0.247 Sum_probs=121.3
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcC-CCCCChhhh-------ccCcccEEeeeeCCCCccccccc
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFL-TGTIPSSIF-------NLSSLLELDFSNNSLTGFYMTNN 217 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~ 217 (902)
+..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|.++
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~------- 108 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT------- 108 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB-------
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc-------
Confidence 3444566666666666 455555533 56666666665 334554444 4556666666665532
Q ss_pred cccCCccccccccCCCccc--cCCCCCCEEEccCccccCcCCCcccCC-----CCCceEeccCcccccCCCcCCcccCCC
Q 046199 218 HFTGSIPRNLWQCEIPHEI--GNLPNLEVLGIDENHLVGDVPNTIFNM-----STLKALSLLNNTLSGSLPSSSKNLIGL 290 (902)
Q Consensus 218 ~~~g~ip~~~~~~~lp~~l--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~l 290 (902)
|.+| ..+ +.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|.. +..+
T Consensus 109 ---~~~~---------~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~---~~~l 172 (312)
T 1wwl_A 109 ---GTAP---------PPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ---VRVF 172 (312)
T ss_dssp ---SCCC---------CCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTT---CCCC
T ss_pred ---chhH---------HHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHH---hccC
Confidence 2233 332 5555566666666665544 5555544 55555555555555443333 4445
Q ss_pred cccceeeccCccCCCC--CCccc--cccccccEEEccCCcccCc---ccccccccccccEEecccccCCCCCCccccccc
Q 046199 291 PNIERLNLGLNNLSGR--IPGFI--FNASKLFLLELTGNSFSGF---IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSS 363 (902)
Q Consensus 291 ~~L~~L~Ls~N~l~~~--~~~~l--~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~ 363 (902)
++|++|++++|++.+. .+..+ ..+++|++|+|++|++++. ....+..+++|++|++++|++++..|. ..
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~ 248 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA----PS 248 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC----SC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch----hh
Confidence 5555555555554432 11122 4555566666666665521 112233455666666666666554321 22
Q ss_pred ccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceec
Q 046199 364 LANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS 430 (902)
Q Consensus 364 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 430 (902)
+..+++|++|++++|+++ .+|..+. + +|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus 249 ~~~l~~L~~L~Ls~N~l~-~ip~~~~--~-~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--A-KLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CCCCTTCCEEECTTSCCS-SCCSSCC--S-EEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred hhhcCCCCEEECCCCccC-hhhhhcc--C-CceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 233344444444444444 3333333 2 444444444444433 32 444444444444444444
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=273.63 Aligned_cols=173 Identities=23% Similarity=0.347 Sum_probs=151.3
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 48999999997653 23456789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~~ 877 (902)
|||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+|+...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999998664 45899999999999999999999 99999999999999998 56789999999998876
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..........||+.|+|||++..
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTT
T ss_pred CCCceeecccCCcccCCHHHhcC
Confidence 65554455789999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=257.58 Aligned_cols=174 Identities=26% Similarity=0.424 Sum_probs=153.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+..++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 356689999999999999999999998888999999976533 3467899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++......+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999999776667999999999999999999999 99999999999999999999999999999987654433
Q ss_pred ce-eccccccccccccccc
Q 046199 882 MR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~-~~~~gt~~y~APE~l~ 899 (902)
.. ....+|+.|+|||++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~ 178 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFH 178 (268)
T ss_dssp EECCSCCCCGGGCCHHHHH
T ss_pred hcccCCCcCcccCCHHHHh
Confidence 22 2245677899999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=269.36 Aligned_cols=175 Identities=23% Similarity=0.462 Sum_probs=150.3
Q ss_pred hhcccccccCeecccceeeEEEEEeC--------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
...++|++.+.||+|+||.||+|++. ++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 45688999999999999999999863 25679999997553 33457889999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNI 857 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 857 (902)
.++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence 9999999999999999999997643 24789999999999999999999 99999999999999
Q ss_pred EEcCCCcEEEEeecCceecCCCccce--ecccccccccccccccc
Q 046199 858 LLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 858 ll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~~ 900 (902)
+++.++.+||+|||+|+......... ....+|+.|+|||++..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 99999999999999998765443222 22457889999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=265.62 Aligned_cols=170 Identities=28% Similarity=0.375 Sum_probs=150.8
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3478999999999999999999986 48999999997542 2345678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 119 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999999654 45899999999999999999999 999999999999999999999999999999876543
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
....+||+.|+|||++..
T Consensus 195 ---~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTT
T ss_pred ---cccccCCccccCHHHhcC
Confidence 234679999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=260.83 Aligned_cols=173 Identities=27% Similarity=0.414 Sum_probs=146.0
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999986 48999999986443 2345788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998654 45899999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc-eecccccccccccccccc
Q 046199 880 ESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~-~~~~~gt~~y~APE~l~~ 900 (902)
... .....||+.|+|||++..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp ----------CCSSCCHHHHHT
T ss_pred cccccCccccCccccCHhHhcC
Confidence 322 223569999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=268.43 Aligned_cols=174 Identities=20% Similarity=0.267 Sum_probs=149.2
Q ss_pred HHhhcccccccCeecccceeeEEEEE------eCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC---CCCccceeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGR------FLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSC 791 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 791 (902)
+....++|.+.+.||+|+||.||+|. ...++.||+|+++.. ....+.+|+++++.++ |++|+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34567899999999999999999994 335889999998754 3456778888888887 99999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC------
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYS----SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD------ 861 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~------ 861 (902)
..++..|+||||+++|+|.+++.. ....+++..+..++.||+.||+||| ++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999965 3456999999999999999999999 999999999999999998
Q ss_pred -----CCcEEEEeecCceecC--CCccceecccccccccccccccc
Q 046199 862 -----DMVAHLSDFGIAKLLN--GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 862 -----~~~~kL~DFG~a~~~~--~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++.+||+|||+|+.+. .........+||+.|||||++..
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 8999999999998654 22333445679999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=270.35 Aligned_cols=174 Identities=32% Similarity=0.369 Sum_probs=143.2
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHH-HHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEV-LKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345789999999999999999999865 8899999997553 2233556667776 5678999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999998654 45889999999999999999999 9999999999999999999999999999998754
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.........+||+.|+|||++..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTT
T ss_pred cCCCccccccCCccccCHHHhCC
Confidence 44444455789999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=261.90 Aligned_cols=173 Identities=27% Similarity=0.442 Sum_probs=136.6
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35689999999999999999998864 8999999997553 234467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSSN-----RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||++ ++|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886532 45889999999999999999999 999999999999999999999999999999887
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...........||+.|+|||++..
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred CCCcccCCCCcccccccCchHhhC
Confidence 654444445679999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=277.19 Aligned_cols=175 Identities=26% Similarity=0.397 Sum_probs=154.3
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 345789999999999999999999864 8999999997542 233467889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 799 LVLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
+||||++||+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999999998654 245899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+..........+||+.|||||++..
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT
T ss_pred ccCCCcccccccCCccccChhhhcC
Confidence 7655444444689999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=262.35 Aligned_cols=173 Identities=26% Similarity=0.394 Sum_probs=145.0
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC-------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------- 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 795 (902)
.++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 468999999999999999999986 59999999997543 345678999999999999999999999885433
Q ss_pred --------------------------------------------------eeEEEEEccCCCChHHHHhhCCC--CCCHH
Q 046199 796 --------------------------------------------------FKALVLEYMANGSLEKCLYSSNR--SLDIF 823 (902)
Q Consensus 796 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~ 823 (902)
..++||||+++++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999976432 35566
Q ss_pred HHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc------------ceeccccccc
Q 046199 824 QRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES------------MRTQTLGTIG 891 (902)
Q Consensus 824 ~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~------------~~~~~~gt~~ 891 (902)
.+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....... ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 99999999999999999999999999999988765421 1223569999
Q ss_pred ccccccccc
Q 046199 892 YMAPGLWVV 900 (902)
Q Consensus 892 y~APE~l~~ 900 (902)
|+|||++..
T Consensus 242 y~aPE~~~~ 250 (332)
T 3qd2_B 242 YMSPEQIHG 250 (332)
T ss_dssp GSCHHHHHC
T ss_pred ccChHHhcC
Confidence 999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=262.60 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=148.0
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999986 58999999987543 2334678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 881 (902)
|+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999998854 345899999999999999999999 99999999999999999999999999999986543222
Q ss_pred -ceecccccccccccccccc
Q 046199 882 -MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 -~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHC
T ss_pred cccCCCccCcCccCcHHhcc
Confidence 2234679999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=259.75 Aligned_cols=170 Identities=26% Similarity=0.388 Sum_probs=149.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch------hhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4679999999999999999999864 899999999754321 356789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a 873 (902)
|+||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+||+|||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999864 356899999999999999999999 99999999999999999887 8999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+....... .....||+.|+|||++.
T Consensus 166 ~~~~~~~~-~~~~~gt~~y~aPE~~~ 190 (326)
T 2y0a_A 166 HKIDFGNE-FKNIFGTPEFVAPEIVN 190 (326)
T ss_dssp EECCTTSC-CCCCCSCTTTCCHHHHT
T ss_pred eECCCCCc-cccccCCcCcCCceeec
Confidence 88754332 23467999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=276.47 Aligned_cols=174 Identities=26% Similarity=0.374 Sum_probs=153.0
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999986 48999999997542 233466889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 799 LVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+||||++||+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+|+...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999986643 34899999999999999999999 9999999999999999999999999999998875
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... ....+||+.|+|||++..
T Consensus 338 ~~~~-~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 338 EGQT-IKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp TTCC-EECCCSCGGGCCHHHHTT
T ss_pred cCcc-ccccCCCccccCHHHHcC
Confidence 4432 344689999999998754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-26 Score=271.47 Aligned_cols=269 Identities=26% Similarity=0.314 Sum_probs=177.9
Q ss_pred cccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCC
Q 046199 291 PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSS 370 (902)
Q Consensus 291 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L 370 (902)
.+++.|++++|.++ .+|..+. ++|++|+|++|+|+. +|. .+++|++|+|++|++++.++ .+++|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---------~l~~L 103 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV---------LPPGL 103 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC---------CCTTC
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC---------CCCCC
Confidence 35888999999988 5565554 788899999998884 444 46888888888888875332 46777
Q ss_pred ceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccc
Q 046199 371 KYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLEN 450 (902)
Q Consensus 371 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 450 (902)
++|++++|++.+. |. .+ .+|+.|++++|+|++ +|.. +++|++|+|++|++++ +|. .+.+|+.|++++
T Consensus 104 ~~L~Ls~N~l~~l-~~---~l-~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~ 170 (622)
T 3g06_A 104 LELSIFSNPLTHL-PA---LP-SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYN 170 (622)
T ss_dssp CEEEECSCCCCCC-CC---CC-TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CEEECcCCcCCCC-CC---CC-CCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCC
Confidence 8888888877753 33 22 377777777777774 3432 3677777777777774 333 235677777777
Q ss_pred ccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCcccc
Q 046199 451 NKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDI 530 (902)
Q Consensus 451 N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 530 (902)
|++++ +|..+.+|+.|++++|++++. |.. +++|+.|++++|+++.+ |.. +++|+.|++++|+|++ +|
T Consensus 171 N~l~~-l~~~~~~L~~L~Ls~N~l~~l-~~~---~~~L~~L~L~~N~l~~l-~~~---~~~L~~L~Ls~N~L~~-lp--- 237 (622)
T 3g06_A 171 NQLTS-LPMLPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTS-LP--- 237 (622)
T ss_dssp SCCSC-CCCCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSC-CC---
T ss_pred CCCCC-CcccCCCCcEEECCCCCCCCC-CCc---cchhhEEECcCCccccc-CCC---CCCCCEEEccCCccCc-CC---
Confidence 77763 555556777777777777653 322 35677777777777653 322 3567777777777765 34
Q ss_pred ccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccc
Q 046199 531 GNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV 606 (902)
Q Consensus 531 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 606 (902)
..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++.+|..+..++
T Consensus 238 ~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 238 VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 34466667777777766 3444 4566667777777776 5566666677777777777777766666655544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-27 Score=267.13 Aligned_cols=249 Identities=22% Similarity=0.240 Sum_probs=169.6
Q ss_pred cceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCce
Q 046199 293 IERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKY 372 (902)
Q Consensus 293 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~ 372 (902)
...++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------- 102 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT------------------- 102 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-------------------
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-------------------
Confidence 445566666665 3333332 455566666666655555555555555555555555543
Q ss_pred eeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccccc
Q 046199 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452 (902)
Q Consensus 373 L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 452 (902)
..+..|..++ +|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 103 ----------i~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 103 ----------IEIGAFNGLA-NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp ----------ECGGGGTTCS-SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT
T ss_pred ----------cChhhccCCc-cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC
Confidence 3334444454 56666666666665555566666677777777777665555566666666666665533
Q ss_pred ccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCcccccc
Q 046199 453 LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGN 532 (902)
Q Consensus 453 l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 532 (902)
.. ....+..|.++++|+.|+|++|+++.+ | .+..+++|++|++++|++++..|..|.+
T Consensus 172 ~l--------------------~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 229 (440)
T 3zyj_A 172 RL--------------------SYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229 (440)
T ss_dssp TC--------------------CEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTT
T ss_pred Cc--------------------ceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhcc
Confidence 22 223344567777777777777777754 3 4677788888888888888777888888
Q ss_pred ccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccc
Q 046199 533 MKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596 (902)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (902)
+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.-
T Consensus 230 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 8888888888888888888888999999999999999998778888899999999999998863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=262.75 Aligned_cols=170 Identities=25% Similarity=0.425 Sum_probs=149.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999985 58999999997542 22346789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+ +|+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 67998888654 45899999999999999999999 9999999999999999999999999999998765443
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
. ....+||+.|+|||++..
T Consensus 163 ~-~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 163 F-LKTSCGSPNYAAPEVING 181 (336)
T ss_dssp T-TCCCTTSTTTSCGGGSCC
T ss_pred c-cccccCCcCcCCHHHHcC
Confidence 2 344679999999999753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=278.71 Aligned_cols=216 Identities=19% Similarity=0.214 Sum_probs=195.8
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
+|+.|+|++|.|++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+. .+|+.|++++|.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~--~~L~~L~L~~N~ 110 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG--PSIETLHAANNN 110 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC--TTCCEEECCSSC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC--CCcCEEECcCCc
Confidence 89999999999999888999999999999999999997766 99999999999999999854332 799999999999
Q ss_pred ccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccc-cccccceeccCCccccccCcc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG-NMKVVVEINLSRNYLTGDIPT 552 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~ 552 (902)
|++..+.. +++|+.|+|++|++++..|..|+.+++|++|++++|.+++..|..+. .+++|++|+|++|.|++..+
T Consensus 111 l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~- 186 (487)
T 3oja_A 111 ISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG- 186 (487)
T ss_dssp CCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-
T ss_pred CCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-
Confidence 99877654 57899999999999999999999999999999999999998888886 79999999999999997633
Q ss_pred ccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCccee
Q 046199 553 TIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 553 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
+..+++|+.|+|++|+|++ +|..|..+++|+.|||++|+|++ +|..+..+++|+.|++++|++.+
T Consensus 187 -~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 187 -QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp -CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred -cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 4469999999999999997 45559999999999999999995 78889999999999999999983
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=263.78 Aligned_cols=172 Identities=25% Similarity=0.442 Sum_probs=150.1
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|++.+.||+|+||.||+|.+.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35789999999999999999999864 8999999997543 23456789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD---MVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kL~DFG~a~~~~ 877 (902)
|||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.+ +.+||+|||+|+...
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999988653 46899999999999999999999 9999999999999999765 459999999998765
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 183 ~~~~-~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 183 DSEA-WHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp TCCS-CCCSCSCTTTCCHHHHTT
T ss_pred CCcc-cccCCCCccccCHHHHcc
Confidence 4332 334679999999998753
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=267.08 Aligned_cols=265 Identities=19% Similarity=0.152 Sum_probs=171.2
Q ss_pred eeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCC
Q 046199 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEI 232 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~l 232 (902)
.++++.+.+...++..+..+++|++|+|++|++++..|..|.++++|++|+|++|.++++
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-------------------- 73 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-------------------- 73 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEE--------------------
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcc--------------------
Confidence 334444444322223333444555555555555544444555555555555555553311
Q ss_pred CccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccc
Q 046199 233 PHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF 312 (902)
Q Consensus 233 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~ 312 (902)
..+..+++|++|+|++|++++. | ..++|+.|++++|++++..+. .+++|++|++++|++++..+..+.
T Consensus 74 -~~~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~------~~~~L~~L~l~~N~l~~~~~~~~~ 141 (317)
T 3o53_A 74 -LDLESLSTLRTLDLNNNYVQEL-L----VGPSIETLHAANNNISRVSCS------RGQGKKNIYLANNKITMLRDLDEG 141 (317)
T ss_dssp -EEETTCTTCCEEECCSSEEEEE-E----ECTTCCEEECCSSCCSEEEEC------CCSSCEEEECCSSCCCSGGGBCTG
T ss_pred -hhhhhcCCCCEEECcCCccccc-c----CCCCcCEEECCCCccCCcCcc------ccCCCCEEECCCCCCCCccchhhh
Confidence 1144455555555555555422 1 225566666666666543222 245677777777777766666677
Q ss_pred ccccccEEEccCCcccCccccccc-ccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccc
Q 046199 313 NASKLFLLELTGNSFSGFIPDTLV-NLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNL 391 (902)
Q Consensus 313 ~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 391 (902)
.+++|++|+|++|++++..+..+. .+++|++|++++|++++.. ....+++|++|++++|++.+. |..+..+
T Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-------~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l 213 (317)
T 3o53_A 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-------GQVVFAKLKTLDLSSNKLAFM-GPEFQSA 213 (317)
T ss_dssp GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-------CCCCCTTCCEEECCSSCCCEE-CGGGGGG
T ss_pred ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-------cccccccCCEEECCCCcCCcc-hhhhccc
Confidence 777788888888887776666653 6778888888888877542 233477888888888888754 4457777
Q ss_pred cccccEEEeecCcccccCCcccCCCCCCcEEEeecceec-ccCCcccccccccCeeeccc-ccccCCCCC
Q 046199 392 PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS-GSIPITVGRLNTLQGLGLEN-NKLEGPIPD 459 (902)
Q Consensus 392 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~ 459 (902)
+ +|++|+|++|+|++ +|..+..+++|+.|++++|++. +.+|.++..+++|+.|++++ +.++|..|.
T Consensus 214 ~-~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 214 A-GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp T-TCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred C-cccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 7 89999999999994 6778899999999999999998 78888999999999999984 456655444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=260.29 Aligned_cols=172 Identities=27% Similarity=0.405 Sum_probs=147.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC----ee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FK 797 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 797 (902)
.+..++|++.+.||+|+||.||+|++. ++.||||+++... .......+|+.++++++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 456689999999999999999999885 7899999987543 33455667899999999999999999997643 47
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC----------CeEEcCCCCCCEEEcCCCcEEE
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN----------PVVHCDIKPSNILLDDDMVAHL 867 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~----------~ivHrDlkp~NIll~~~~~~kL 867 (902)
|+||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999999653 4899999999999999999999 88 9999999999999999999999
Q ss_pred EeecCceecCCCccc--eecccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
+|||+|+........ .....||+.|+|||++..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred ccCCcccccccccCccccccCccCccccCHhhccc
Confidence 999999877544332 223579999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=270.43 Aligned_cols=176 Identities=26% Similarity=0.397 Sum_probs=152.5
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
+.+..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++..++..|
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 4566789999999999999999999986 58999999987543 234567889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999876667899999999999999999999 99999999999999999999999999999987543
Q ss_pred Ccccee--ccccccccccccccc
Q 046199 879 EESMRT--QTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~--~~~gt~~y~APE~l~ 899 (902)
...... ...+++.|+|||++.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~ 288 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALN 288 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhc
Confidence 322111 123577899999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=264.48 Aligned_cols=167 Identities=25% Similarity=0.406 Sum_probs=143.3
Q ss_pred cccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCCC
Q 046199 729 SEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANG 807 (902)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 807 (902)
...+.||+|+||.||+|++. +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..|+||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999885 48999999998766566788999999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE--cCCCcEEEEeecCceecCCCccceec
Q 046199 808 SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL--DDDMVAHLSDFGIAKLLNGEESMRTQ 885 (902)
Q Consensus 808 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~~ 885 (902)
+|.+++......+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++....... ...
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~~~ 247 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKV 247 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-CCC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-ccc
Confidence 999998776667999999999999999999999 9999999999999999 5678999999999998754433 233
Q ss_pred cccccccccccccc
Q 046199 886 TLGTIGYMAPGLWV 899 (902)
Q Consensus 886 ~~gt~~y~APE~l~ 899 (902)
..||+.|+|||++.
T Consensus 248 ~~gt~~y~aPE~~~ 261 (373)
T 2x4f_A 248 NFGTPEFLAPEVVN 261 (373)
T ss_dssp CCSSCTTCCHHHHT
T ss_pred ccCCCcEeChhhcc
Confidence 57999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=257.87 Aligned_cols=176 Identities=26% Similarity=0.415 Sum_probs=151.5
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.+.+..++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 44567789999999999999999999998888999999975533 34678999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999999775667999999999999999999999 999999999999999999999999999999866443
Q ss_pred ccc-eeccccccccccccccc
Q 046199 880 ESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~-~~~~~gt~~y~APE~l~ 899 (902)
... .....+|+.|+|||++.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~ 194 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLM 194 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHH
T ss_pred ccccccCCccCcccCCHHHhc
Confidence 221 12245778899999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=253.20 Aligned_cols=173 Identities=27% Similarity=0.475 Sum_probs=137.8
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3468999999999999999999985 58999999997542 2234678999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999876677999999999999999999999 999999999999999999999999999999877544
Q ss_pred ccceeccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~ 899 (902)
........||+.|+|||++.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~ 185 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIAT 185 (278)
T ss_dssp --------------------
T ss_pred CCcceeccCCCCcCCcchhc
Confidence 43334467999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=270.40 Aligned_cols=172 Identities=28% Similarity=0.480 Sum_probs=152.3
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999986 59999999997542 2234678999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999864 356899999999999999999999 999999999999999999999999999999887543
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
. .....+||+.|+|||++..
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTT
T ss_pred c-cccccCCCcCeEChhhccC
Confidence 3 2344679999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=260.54 Aligned_cols=171 Identities=26% Similarity=0.373 Sum_probs=149.9
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. +++.||||++.... ..+.+.+|+++++.+ +||||+++++++..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3578999999999999999999974 58999999987543 235788999999999 8999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-----EEEEeecCceec
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV-----AHLSDFGIAKLL 876 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-----~kL~DFG~a~~~ 876 (902)
||+ +++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||+|+..
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 89999999876678999999999999999999999 999999999999999998887 999999999876
Q ss_pred CCCccc-------eecccccccccccccccc
Q 046199 877 NGEESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
...... .....||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLG 191 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcC
Confidence 543321 134679999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=259.48 Aligned_cols=171 Identities=31% Similarity=0.337 Sum_probs=143.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||+||+|++. +++.||||++..... ........|+..+..+ +||||+++++++.+++..|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999987 599999999865432 2334455566555555 89999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999 66999998777777999999999999999999999 999999999999999999999999999999876543
Q ss_pred ccceeccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~ 899 (902)
.. .....||+.|+|||++.
T Consensus 211 ~~-~~~~~gt~~y~aPE~~~ 229 (311)
T 3p1a_A 211 GA-GEVQEGDPRYMAPELLQ 229 (311)
T ss_dssp -----CCCCCGGGCCGGGGG
T ss_pred CC-CcccCCCccccCHhHhc
Confidence 32 33456999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=259.56 Aligned_cols=174 Identities=28% Similarity=0.485 Sum_probs=147.4
Q ss_pred hhcccccccCeecccceeeEEEEEe-----CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC--C
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG--N 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 795 (902)
...++|++.+.||+|+||.||+|++ .+++.||||+++.......+.+.+|++++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4568999999999999999999984 24889999999876666678899999999999999999999998543 5
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 689999999999999999877667999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccc---eeccccccccccccccc
Q 046199 876 LNGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
....... .....+++.|+|||++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp ------------CTTCGGGGCCHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhc
Confidence 6543321 22245778899999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=276.09 Aligned_cols=175 Identities=27% Similarity=0.325 Sum_probs=142.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
....++|++.+.||+|+||.||+|++.. ++.||+|+++.. .......+.+|+++++.++||||+++++++...+..
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 3456789999999999999999999864 899999999754 233446678899999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
|+||||+++|+|.+++... ..+++..+..++.||+.||+||| + +||+||||||+||+++.++.+||+|||+|+..
T Consensus 224 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999988654 46899999999999999999999 8 89999999999999999999999999999865
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..........+||+.|+|||++..
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHT
T ss_pred cCCCcccccccCCccccCHhhcCC
Confidence 544444455789999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-28 Score=266.91 Aligned_cols=174 Identities=25% Similarity=0.486 Sum_probs=140.8
Q ss_pred hhcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+..++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34578999999999999999999875 46789999997653 34457899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++|+|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999999877677999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcccee---ccccccccccccccc
Q 046199 878 GEESMRT---QTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~---~~~gt~~y~APE~l~ 899 (902)
....... ...+++.|+|||++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIA 223 (373)
T ss_dssp ---------------CTTSCHHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhc
Confidence 4332211 123577899999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=257.43 Aligned_cols=172 Identities=31% Similarity=0.455 Sum_probs=149.1
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC--eeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 799 (902)
..++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 35789999999999999999999865 8999999997543 234577889999999999999999999987655 7899
Q ss_pred EEEccCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 046199 800 VLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIA 873 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~DFG~a 873 (902)
||||+++++|.+++..... .+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+|
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976432 3899999999999999999999 9999999999999999 77888999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+....... .....||+.|+|||++.
T Consensus 164 ~~~~~~~~-~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 164 RELEDDEQ-FVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp EECCTTCC-BCCCCSCGGGCCHHHHH
T ss_pred eecCCCCc-eeecccCCCccCHHHhh
Confidence 88765433 23467999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=264.59 Aligned_cols=183 Identities=22% Similarity=0.376 Sum_probs=154.8
Q ss_pred cccCHHHHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCcc
Q 046199 714 RRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLV 785 (902)
Q Consensus 714 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv 785 (902)
..+...++.+..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++++++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 44667788899999999999999999999999742 36789999997643 33456799999999999 799999
Q ss_pred ceeeeeecCC-eeEEEEEccCCCChHHHHhhCCC----------------------------------------------
Q 046199 786 KIISSCSNGN-FKALVLEYMANGSLEKCLYSSNR---------------------------------------------- 818 (902)
Q Consensus 786 ~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------- 818 (902)
++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999987754 58999999999999999976432
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 819 -------------------SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 819 -------------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1888999999999999999999 999999999999999999999999999999876443
Q ss_pred cc--ceeccccccccccccccc
Q 046199 880 ES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~--~~~~~~gt~~y~APE~l~ 899 (902)
.. ......||+.|+|||++.
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHH
T ss_pred ccchhccccCCCceeEChhhhc
Confidence 32 223356899999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=257.39 Aligned_cols=167 Identities=26% Similarity=0.340 Sum_probs=128.6
Q ss_pred ccccc---CeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 727 HFSEK---SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 727 ~y~~~---~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
+|++. +.||+|+||.||+|++.. ++.||||++... ....+.+|+.+++.+. ||||+++++++.+++..|+||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45543 789999999999999864 899999998643 3467789999999997 999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFG~a~~~~~ 878 (902)
||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 86 ELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999999999999764 56899999999999999999999 99999999999999998766 899999999987765
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
........+||+.|+|||++..
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQ 183 (325)
T ss_dssp ----------------------
T ss_pred CCCcccccCCCcCccCHHHhcC
Confidence 5544555778999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=250.48 Aligned_cols=170 Identities=27% Similarity=0.377 Sum_probs=152.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|++.. +..||+|++........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4689999999999999999999865 779999999876656678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~ 880 (902)
+++++|.+++... ..+++..+..++.|++.|++||| ++||+||||||+||++ +.++.+||+|||.+.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999988654 45899999999999999999999 9999999999999999 788899999999998776443
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
. .....||+.|+|||++.
T Consensus 164 ~-~~~~~~t~~y~aPE~~~ 181 (277)
T 3f3z_A 164 M-MRTKVGTPYYVSPQVLE 181 (277)
T ss_dssp C-BCCCCSCTTTCCHHHHT
T ss_pred c-hhccCCCCCccChHHhc
Confidence 3 33467999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=262.40 Aligned_cols=172 Identities=24% Similarity=0.294 Sum_probs=141.9
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34678999999999999999999986 58999999997543 23467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecCceecCCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV--AHLSDFGIAKLLNGE 879 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~ 879 (902)
||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 96 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 96 EYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999998654 45899999999999999999999 999999999999999987765 999999999754332
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
. ......||+.|+|||++..
T Consensus 172 ~-~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 172 S-QPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp ----------CTTSCHHHHHC
T ss_pred C-CCCCCcCCCCcCChhhhcC
Confidence 2 2234579999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=255.60 Aligned_cols=171 Identities=32% Similarity=0.429 Sum_probs=143.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999865 89999999865432 23567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||++++++.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999887754 456899999999999999999999 99999999999999999999999999999988765554
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......||+.|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLV 175 (311)
T ss_dssp --------GGGCCHHHHH
T ss_pred ccCCCcCCccccChHHHh
Confidence 445567999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=268.01 Aligned_cols=168 Identities=20% Similarity=0.226 Sum_probs=138.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc--------hhhhhHHHHHHHHHhCC---------CCCcc
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVR---------HRNLV 785 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv 785 (902)
...++|++.+.||+|+||.||+|++ +++.||||+++.... ...+.+.+|+++++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4467899999999999999999998 789999999986532 23377889999998886 55555
Q ss_pred ceee-----------------eeec-------------CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHH
Q 046199 786 KIIS-----------------SCSN-------------GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALA 835 (902)
Q Consensus 786 ~l~~-----------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~ 835 (902)
++.+ ++.+ ++..|+||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 5544 4443 6889999999999976666633 458999999999999999
Q ss_pred HHHHHccCCCCeEEcCCCCCCEEEcCCC--------------------cEEEEeecCceecCCCccceeccccccccccc
Q 046199 836 LEYLHFGYSNPVVHCDIKPSNILLDDDM--------------------VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895 (902)
Q Consensus 836 L~~LH~~~~~~ivHrDlkp~NIll~~~~--------------------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~AP 895 (902)
|+|||. ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.||||
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 999992 47999999999999999887 8999999999876532 24799999999
Q ss_pred ccccc
Q 046199 896 GLWVV 900 (902)
Q Consensus 896 E~l~~ 900 (902)
|++..
T Consensus 247 E~~~g 251 (336)
T 2vuw_A 247 DLFTG 251 (336)
T ss_dssp GGGCC
T ss_pred hhhcC
Confidence 99864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=271.66 Aligned_cols=170 Identities=26% Similarity=0.374 Sum_probs=134.5
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec-----CCe
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-----GNF 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 796 (902)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+++.+|+++++.++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999886 48999999986543 2345788999999999999999999999843 357
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||++ ++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999984 699998854 456999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCcc---------------------------ceeccccccccccccccc
Q 046199 877 NGEES---------------------------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~---------------------------~~~~~~gt~~y~APE~l~ 899 (902)
..... ..+..+||+.|||||++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 43211 123357899999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=260.73 Aligned_cols=171 Identities=25% Similarity=0.423 Sum_probs=141.8
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 589999999875432 2223556799999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++ +|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 974 999998877777999999999999999999999 9999999999999999999999999999998765444444
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....||+.|+|||++..
T Consensus 158 ~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLG 174 (324)
T ss_dssp -----CGGGCCHHHHTT
T ss_pred ccccCcccccChhhhcC
Confidence 45678999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=280.83 Aligned_cols=175 Identities=22% Similarity=0.282 Sum_probs=152.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 796 (902)
....++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3456789999999999999999999865 8889999997542 33456788899999988 79999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999764 45899999999999999999999 999999999999999999999999999999875
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..........+||+.|||||++..
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTC
T ss_pred ccCCcccccccCCCcccCHhhhcC
Confidence 544444555789999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=256.51 Aligned_cols=171 Identities=25% Similarity=0.387 Sum_probs=151.0
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-C-------cEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-G-------MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
+..++|++.+.||+|+||.||+|++.. + +.||+|+++.......+.+.+|++++++++||||+++++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 345789999999999999999998754 3 57999999776666678899999999999999999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--------EE
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV--------AH 866 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--------~k 866 (902)
+..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999877666999999999999999999999 999999999999999998887 99
Q ss_pred EEeecCceecCCCccceecccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+|||.+...... ....||+.|+|||++..
T Consensus 162 l~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 162 LSDPGISITVLPK----DILQERIPWVPPECIEN 191 (289)
T ss_dssp ECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC
T ss_pred eccCcccccccCc----cccCCcCcccCHHHhCC
Confidence 9999998754322 22458899999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=258.48 Aligned_cols=169 Identities=28% Similarity=0.436 Sum_probs=146.2
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+|++++.++ +||||+++++++.+++..|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 345789999999999999999999864 8899999997543 2345788888888 799999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCceec
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD----MVAHLSDFGIAKLL 876 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~----~~~kL~DFG~a~~~ 876 (902)
|||++||+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||++.++ +.+||+|||+++..
T Consensus 95 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp ECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999998654 56899999999999999999999 9999999999999998443 35999999999987
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..........+||+.|+|||++.
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~ 193 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLE 193 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHH
T ss_pred cCCCCceeccCCCccccCHHHhc
Confidence 65554445578999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=262.40 Aligned_cols=175 Identities=21% Similarity=0.271 Sum_probs=151.9
Q ss_pred hhcccccccCeeccc--ceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIG--SFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+| +||.||+|++. +++.||||+++... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 456789999999999 99999999986 48999999997653 33457788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
|+||||+++|+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999998764 356899999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcc-------ceecccccccccccccccc
Q 046199 877 NGEES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
..... ......||+.|+|||++..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccccccCHHHHhc
Confidence 32211 1122478999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=258.63 Aligned_cols=172 Identities=28% Similarity=0.383 Sum_probs=149.9
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--------hhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999875 488999999975531 2345678899999999999999999999999
Q ss_pred CeeEEEEEccCCC-ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 795 NFKALVLEYMANG-SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 795 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 999988654 46899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+....... .....||+.|+|||++..
T Consensus 178 ~~~~~~~~-~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 178 AYLERGKL-FYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp EECCTTCC-BCEECSCGGGCCHHHHTT
T ss_pred eECCCCCc-eeccCCCccccChhhhcC
Confidence 88755433 334679999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=252.43 Aligned_cols=174 Identities=26% Similarity=0.412 Sum_probs=153.2
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+..++|++.+.||+|+||.||+|++.+++.||+|+++.... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 455689999999999999999999998889999999976533 3467899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999877677899999999999999999999 99999999999999999999999999999986643221
Q ss_pred c-eeccccccccccccccc
Q 046199 882 M-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~-~~~~~gt~~y~APE~l~ 899 (902)
. .....+++.|+|||++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~ 178 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFS 178 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHH
T ss_pred cccccccccccccChhhhc
Confidence 1 12245788999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=250.39 Aligned_cols=173 Identities=22% Similarity=0.345 Sum_probs=152.6
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++.+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 45789999999999999999999865 8899999987542 2345778899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 93 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999988653 45899999999999999999999 999999999999999999999999999999887644
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
........||+.|+|||++..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTT
T ss_pred ccccccccCCCCcCCcchhcc
Confidence 444445679999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=261.43 Aligned_cols=173 Identities=29% Similarity=0.448 Sum_probs=145.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-----hhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999864 89999999875322 123578899999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++ ++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 899988776667899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...........||+.|+|||++.
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~ 185 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLF 185 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHT
T ss_pred cCCcccCCcccccccccCchHhh
Confidence 65544445567999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=266.59 Aligned_cols=171 Identities=27% Similarity=0.381 Sum_probs=144.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----C
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----N 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 795 (902)
..++|++.+.||+|+||.||+|++.. ++.||||+++... ....+++.+|+++++.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35789999999999999999999865 8889999997543 23457889999999999999999999999766 5
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||++ ++|.+++.. ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 7899999996 599998864 456899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCcc----------------------ceeccccccccccccccc
Q 046199 876 LNGEES----------------------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~----------------------~~~~~~gt~~y~APE~l~ 899 (902)
...... ..+..+||+.|+|||++.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 654321 124467999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=261.50 Aligned_cols=178 Identities=26% Similarity=0.426 Sum_probs=152.4
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeee
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSC 791 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 791 (902)
..+....++|++.+.||+|+||.||+|++.+ ++.||+|+++... ....+.+.+|+++++.++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455677899999999999999999998753 4789999997653 33457899999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeE
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN-----------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVV 848 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~iv 848 (902)
.+++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 99999999999999999999997642 46899999999999999999999 99999
Q ss_pred EcCCCCCCEEEcCCCcEEEEeecCceecCCCcc--ceeccccccccccccccc
Q 046199 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 249 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 249 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc
Confidence 999999999999999999999999987643321 122356889999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=255.80 Aligned_cols=173 Identities=22% Similarity=0.345 Sum_probs=152.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|.+.+.||+|+||.||+|++.+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999865 7899999987542 2345778899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 119 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999988654 46899999999999999999999 999999999999999999999999999999887644
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
........||+.|+|||++..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHT
T ss_pred cccccccCCCccccCHHHhcc
Confidence 444445679999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=253.12 Aligned_cols=173 Identities=24% Similarity=0.462 Sum_probs=148.2
Q ss_pred hcccccccCeecccceeeEEEEEe-----CCCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC--C
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--N 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 795 (902)
..++|++.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|+++++.++||||+++++++... .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 356799999999999999999983 348899999997543 33457889999999999999999999999876 6
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 689999999999999999776677999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCccc---eeccccccccccccccc
Q 046199 876 LNGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
....... .....||+.|+|||++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeec
Confidence 7654422 22356888999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=262.96 Aligned_cols=176 Identities=25% Similarity=0.436 Sum_probs=151.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeC--------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
.+..++|++.+.||+|+||.||+|++. .+..||+|+++... ....+.+.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 456689999999999999999999863 24579999997653 33457889999999999 899999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSN 856 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~N 856 (902)
..++..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 99999999999999999999997653 35899999999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 857 ILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 857 Ill~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
|+++.++.+||+|||+|+........ .....+|+.|+|||++..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 99999999999999999876543322 223457889999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=249.40 Aligned_cols=183 Identities=36% Similarity=0.557 Sum_probs=158.6
Q ss_pred ccccCHHHHHhhccccccc------CeecccceeeEEEEEeCCCcEEEEEEeeecc----chhhhhHHHHHHHHHhCCCC
Q 046199 713 WRRFSYRELLLATDHFSEK------SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHR 782 (902)
Q Consensus 713 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 782 (902)
...+++.++..++++|... +.||+|+||.||+|++ +++.||+|++.... ....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568888998888888777 8999999999999987 68899999986532 33457889999999999999
Q ss_pred CccceeeeeecCCeeEEEEEccCCCChHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc
Q 046199 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSS--NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD 860 (902)
Q Consensus 783 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (902)
||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 345899999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 861 DDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 861 ~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
.++.+||+|||+++........ .....||+.|+|||++.
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhc
Confidence 9999999999999876543322 22356999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=259.08 Aligned_cols=177 Identities=23% Similarity=0.407 Sum_probs=149.7
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
++.+..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35667789999999999999999999862 35689999997543 33457899999999999 899999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNR----------------------SLDIFQRLSIMIDVALALEYLHFGYSNPVVH 849 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 849 (902)
...+..|+||||+++|+|.+++..... .+++..+..++.||+.||+||| ++||+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 999999999999999999999976543 2788999999999999999999 999999
Q ss_pred cCCCCCCEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 850 CDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 850 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|||||+||+++.++.+||+|||++......... .....||+.|+|||++.
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 247 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence 999999999999999999999999876443322 22356788999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=253.76 Aligned_cols=174 Identities=26% Similarity=0.387 Sum_probs=138.9
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
.+..++|++.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4556899999999999999999998753 4579999886543 334578899999999999999999999985 456
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 89999999999999999877667999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc-eeccccccccccccccc
Q 046199 877 NGEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
...... .....+|+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp ------------CCGGGCCHHHHH
T ss_pred CcccccccccCCCcccccChhhcc
Confidence 543322 12245778999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=259.28 Aligned_cols=173 Identities=23% Similarity=0.418 Sum_probs=140.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCC----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN---- 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 795 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999984 58999999997643 233467889999999999999999999987654
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 349999999999999998654 45899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccc---eecccccccccccccccc
Q 046199 876 LNGEESM---RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~---~~~~~gt~~y~APE~l~~ 900 (902)
....... .....||+.|+|||++..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp ----------------CCTTCCHHHHHT
T ss_pred ccccccccccccccCcCcccCCHHHhcC
Confidence 6543221 223568999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=258.47 Aligned_cols=170 Identities=27% Similarity=0.392 Sum_probs=133.6
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45789999999999999999999865 8899999997543 34678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceecCCC
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~~~~ 879 (902)
|+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999998654 45899999999999999999999 999999999999999975 889999999999876443
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
. ......||+.|+|||++..
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 205 V-LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp ---------CGGGSCHHHHTT
T ss_pred c-ccccccCCCCccCHHHhcC
Confidence 2 2234679999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=259.30 Aligned_cols=181 Identities=27% Similarity=0.366 Sum_probs=156.8
Q ss_pred cccccCHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-----CCCcc
Q 046199 712 MWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----HRNLV 785 (902)
Q Consensus 712 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 785 (902)
....+++++.....++|++.+.||+|+||.||+|++. +++.||||+++.. ....+.+..|+++++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3456777777788899999999999999999999985 4889999998743 334567788999999996 99999
Q ss_pred ceeeeeecCCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---
Q 046199 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD--- 861 (902)
Q Consensus 786 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~--- 861 (902)
++++++...+..|+||||+ +++|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999 889999987654 35899999999999999999999 999999999999999975
Q ss_pred ----------------------CCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 862 ----------------------DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 862 ----------------------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++.+||+|||+|+...... ....||+.|+|||++..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILN 233 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTT
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcC
Confidence 7899999999998754322 34679999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=258.23 Aligned_cols=167 Identities=30% Similarity=0.423 Sum_probs=147.2
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.+.|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++..++..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356899999999999999999974 58999999997543 23346788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++ |++.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 5888888666677999999999999999999999 999999999999999999999999999999875432
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
....||+.|+|||++.
T Consensus 208 ---~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp ---CCCCSCGGGCCHHHHH
T ss_pred ---CcccCCcceeCHhhhc
Confidence 2357999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=255.24 Aligned_cols=176 Identities=26% Similarity=0.396 Sum_probs=151.5
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
+....++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3456789999999999999999999862 35789999997543 3445788999999999999999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNR-----------------------SLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 850 (902)
++..++||||+++++|.+++..... .+++..+..++.|++.||+||| ++||+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccc
Confidence 9999999999999999999976432 3789999999999999999999 9999999
Q ss_pred CCCCCCEEEcCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 851 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
||||+||+++.++.+||+|||+++......... ....+|+.|+|||++.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 999999999999999999999998775443322 2245788999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=252.71 Aligned_cols=170 Identities=27% Similarity=0.406 Sum_probs=150.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccch------hhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDG------ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4689999999999999999999864 899999999754321 356789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a 873 (902)
|+||||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999865 456899999999999999999999 99999999999999999888 7999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+....... .....||+.|+|||++.
T Consensus 167 ~~~~~~~~-~~~~~gt~~y~aPE~~~ 191 (321)
T 2a2a_A 167 HEIEDGVE-FKNIFGTPEFVAPEIVN 191 (321)
T ss_dssp EECCTTCC-CCCCCSCGGGCCHHHHT
T ss_pred eecCcccc-ccccCCCCCccCccccc
Confidence 87754332 23457999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=255.35 Aligned_cols=174 Identities=28% Similarity=0.405 Sum_probs=151.8
Q ss_pred hhcccccccCeecccceeeEEEEEe-----CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeee--cCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~ 795 (902)
+..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++. ..+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 3457899999999999999999984 348899999998776666778999999999999999999999886 456
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 789999999999999999775566999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccc---eeccccccccccccccc
Q 046199 876 LNGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
....... .....||+.|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhc
Confidence 7544332 12245888899999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=256.05 Aligned_cols=173 Identities=25% Similarity=0.395 Sum_probs=147.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|++........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999864 89999999976665667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.........
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 99999999998776677999999999999999999999 999999999999999999999999999987643222222
Q ss_pred eeccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~ 899 (902)
.....||+.|+|||++.
T Consensus 174 ~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp -----CCGGGCCHHHHH
T ss_pred cccccCChhhcCCeeec
Confidence 23356899999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=251.04 Aligned_cols=173 Identities=30% Similarity=0.405 Sum_probs=148.5
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ..+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 456789999999999999999999865 8999999987543 3467899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999766677999999999999999999999 99999999999999999999999999999988765544
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 181 ~~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS
T ss_pred ccCccCCCCCccChhhcCC
Confidence 4445679999999998753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=243.03 Aligned_cols=217 Identities=27% Similarity=0.362 Sum_probs=128.7
Q ss_pred CCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCC
Q 046199 29 TSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108 (902)
Q Consensus 29 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~ 108 (902)
.|+|.|.|+.|.... .++.+++++++++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|.++ .+
T Consensus 2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TL 76 (270)
T ss_dssp CCCBGGGTCSBEEET-TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CC
T ss_pred CccCCCCCCCCEeCC-CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-ee
Confidence 589999999987654 3568999999998 5777655 67899999999998555557889999999999999987 44
Q ss_pred CcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCC
Q 046199 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGT 188 (902)
Q Consensus 109 ~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 188 (902)
|...+.++++|++|++++|++++. .|..++.+++|++|+|++|++++..|..|+.+++|++|+|++|.+++.
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQAL--------PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCC--------CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcC--------CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 444445555555555555555421 122334455555555555555544444455555555555555555533
Q ss_pred CChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCce
Q 046199 189 IPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKA 268 (902)
Q Consensus 189 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (902)
.+..|..+++|++|+|++|.++.+ | +..|..+++|++|+|++|++++..+..+..+++|+.
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~-----------~--------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 209 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRV-----------P--------EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCC-----------C--------TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CHhHccCCcccceeEecCCcCcEe-----------C--------hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCE
Confidence 333345555555555555544321 1 123444455555555555554333333444444444
Q ss_pred EeccCcccc
Q 046199 269 LSLLNNTLS 277 (902)
Q Consensus 269 L~Ls~N~l~ 277 (902)
|+|++|.+.
T Consensus 210 L~l~~N~~~ 218 (270)
T 2o6q_A 210 LQLQENPWD 218 (270)
T ss_dssp EECCSSCBC
T ss_pred EEecCCCee
Confidence 444444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=247.51 Aligned_cols=172 Identities=23% Similarity=0.318 Sum_probs=150.5
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+++++.+ +|++++++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 34678999999999999999999974 58999999986543 346788999999999 799999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-----EEEEeecCcee
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV-----AHLSDFGIAKL 875 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-----~kL~DFG~a~~ 875 (902)
|||+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+|+.
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 99999999877777999999999999999999999 999999999999999987776 99999999987
Q ss_pred cCCCccc-------eecccccccccccccccc
Q 046199 876 LNGEESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
....... .....||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccCccCCCCCcccCCchhhcC
Confidence 7544321 233579999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=249.25 Aligned_cols=171 Identities=33% Similarity=0.465 Sum_probs=144.7
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|.+.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3689999999999999999999854 8899999987653 3345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceec
Q 046199 803 YMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 803 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 876 (902)
|+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 356899999999999999999999 9999999999999999 45678999999999876
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.... ......||+.|+|||++.
T Consensus 178 ~~~~-~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 178 KSDE-HSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp ----------CTTGGGCCHHHHT
T ss_pred CCcc-cCcCcccccCcCChHHhc
Confidence 5433 233467999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=271.94 Aligned_cols=175 Identities=23% Similarity=0.446 Sum_probs=152.3
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
+.+..++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++...+..|+
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34566789999999999999999999875 8899999987543 345789999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999764 345899999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccc-eeccccccccccccccc
Q 046199 879 EESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~-~~~~~gt~~y~APE~l~ 899 (902)
.... .....+++.|+|||++.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHH
T ss_pred CceeecCCCcCCcceeCHhHHh
Confidence 3322 12245678999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=260.08 Aligned_cols=171 Identities=25% Similarity=0.405 Sum_probs=136.5
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCC-CCCccceeeeeecCC--ee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCSNGN--FK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 797 (902)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999885 48999999986442 344567889999999997 999999999997543 78
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||++ ++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 589998865 35889999999999999999999 9999999999999999999999999999998764
Q ss_pred CC---------------------ccceecccccccccccccccc
Q 046199 878 GE---------------------ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~---------------------~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. ....+..+||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 31 111233579999999998854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=253.20 Aligned_cols=177 Identities=23% Similarity=0.452 Sum_probs=154.4
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+++.+..++|++.+.||+|+||.||+|++.. ++.||+|+++.. ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3455678899999999999999999999865 889999998754 33457889999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
|+||||+++++|.+++... ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999764 345899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc-eeccccccccccccccc
Q 046199 877 NGEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
...... .....+|+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~ 185 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLA 185 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHH
T ss_pred cCCccccccCCccccCcCChhhhc
Confidence 544322 22345788999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=248.18 Aligned_cols=172 Identities=31% Similarity=0.433 Sum_probs=152.6
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..+.|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999875 48999999997553 345678999999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999854 46899999999999999999999 99999999999999999999999999999988765544
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred ccCccCCCcCccCHHHHhc
Confidence 4445679999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=249.73 Aligned_cols=175 Identities=26% Similarity=0.441 Sum_probs=150.3
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
++.+..++|++.+.||+|+||.||+|++.+++.||+|+++... ...+.+.+|+++++.++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4556778999999999999999999999888899999987543 235788999999999999999999999864 45899
Q ss_pred EEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999986432 25899999999999999999999 99999999999999999999999999999988754
Q ss_pred Cccc-eeccccccccccccccc
Q 046199 879 EESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~-~~~~~gt~~y~APE~l~ 899 (902)
.... .....+++.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHH
T ss_pred cccccccCCCCccCccChhhhc
Confidence 3322 22245788999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=246.56 Aligned_cols=168 Identities=30% Similarity=0.498 Sum_probs=146.4
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccch-------hhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG-------ALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44578999999999999999999985 5899999998654321 126789999999999999999999999766
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCc-----EEE
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDDDMV-----AHL 867 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~-----~kL 867 (902)
. ++||||+++++|.+++......+++..+..++.|++.|++||| +++ |+||||||+||+++.++. +||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 5 6999999999999998777778999999999999999999999 899 999999999999988776 999
Q ss_pred EeecCceecCCCccceecccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
+|||+|+.... ......||+.|+|||++
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGS
T ss_pred CCCCccccccc---cccccCCCccccCchhh
Confidence 99999986433 23446799999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=253.88 Aligned_cols=176 Identities=25% Similarity=0.419 Sum_probs=151.9
Q ss_pred HHhhcccccccCeecccceeeEEEEEe------CCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
+....++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345678999999999999999999985 2367899999975543 3457889999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSNR-----------------SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
.++..++||||+++|+|.+++..... .+++..+..++.|++.||+||| ++||+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence 99999999999999999999976543 4899999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
||+++.++.+||+|||+++........ .....+|+.|+|||++.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc
Confidence 999999999999999999876554332 22345788999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=253.88 Aligned_cols=176 Identities=23% Similarity=0.461 Sum_probs=150.3
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC--------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISS 790 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 790 (902)
+....++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++++ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3456789999999999999999999874 36789999997553 33457789999999999 89999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
+..++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccc
Confidence 999999999999999999999997643 23889999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
||+++.++.+||+|||+++......... ....+|+.|+|||++.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 232 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc
Confidence 9999999999999999998776543322 2245788999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=262.93 Aligned_cols=174 Identities=26% Similarity=0.411 Sum_probs=146.9
Q ss_pred hhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+..++|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.++++++||||+++++++...+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34578999999999999999999853 36789999986543 344567889999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEE
Q 046199 796 FKALVLEYMANGSLEKCLYSSN------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAH 866 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~k 866 (902)
..|+||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999997643 35889999999999999999999 99999999999999999555 599
Q ss_pred EEeecCceecCCCc--cceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEE--SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~--~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||+|+...... .......||+.|+|||++.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 259 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence 99999997543211 1223356899999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=257.24 Aligned_cols=174 Identities=26% Similarity=0.415 Sum_probs=139.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
....++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+++..|
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 456679999999999999999999875 488999999975432 23456789999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE-----cCCCcEEEEeecCc
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL-----DDDMVAHLSDFGIA 873 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll-----~~~~~~kL~DFG~a 873 (902)
+||||+++ +|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+||+|||+|
T Consensus 110 lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999975 999998654 45899999999999999999999 9999999999999999 44556999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+.............||+.|+|||++..
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcC
Confidence 877654444455678999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=259.85 Aligned_cols=172 Identities=28% Similarity=0.390 Sum_probs=149.5
Q ss_pred hcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhC-CCCCccceeeeeecC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSV-RHRNLVKIISSCSNG 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 794 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++++.+ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4578999999999999999999883 58999999986432 23446677899999999 699999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
+..|+||||+++++|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999998654 45899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCcc-ceeccccccccccccccc
Q 046199 875 LLNGEES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 875 ~~~~~~~-~~~~~~gt~~y~APE~l~ 899 (902)
....... ......||+.|+|||++.
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVR 233 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred ecccCCCCcccCcccCcCccChhhhc
Confidence 7643322 223357999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=261.48 Aligned_cols=172 Identities=31% Similarity=0.451 Sum_probs=148.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC--eeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--FKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 799 (902)
..++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..|+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35789999999999999999999865 8999999997543 234567889999999999999999999987654 7899
Q ss_pred EEEccCCCChHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 046199 800 VLEYMANGSLEKCLYSSN--RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAHLSDFGIA 873 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~kL~DFG~a 873 (902)
||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+||+|||+|
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986543 23899999999999999999999 9999999999999999 77788999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+....... .....||+.|+|||++.
T Consensus 164 ~~~~~~~~-~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 164 RELEDDEQ-FVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp EECCCGGG-SSCSSSCCTTCCHHHHH
T ss_pred eEccCCCc-cccccCCccccCHHHhh
Confidence 88754432 33467999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=256.86 Aligned_cols=178 Identities=22% Similarity=0.449 Sum_probs=135.3
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCCC----cEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDG----MEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
+++.+..++|++.+.||+|+||.||+|++... ..||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34456678999999999999999999987653 37999998754 3445678999999999999999999999998
Q ss_pred cCCee------EEEEEccCCCChHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC
Q 046199 793 NGNFK------ALVLEYMANGSLEKCLYSSN-----RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD 861 (902)
Q Consensus 793 ~~~~~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 861 (902)
..+.. ++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||++++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcC
Confidence 77655 99999999999999985422 25899999999999999999999 999999999999999999
Q ss_pred CCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 862 DMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 862 ~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
++.+||+|||+|+........ .....+++.|+|||++.
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA 212 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhc
Confidence 999999999999876543322 12245788999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=254.03 Aligned_cols=172 Identities=32% Similarity=0.452 Sum_probs=144.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 35789999999999999999999865 89999999865432 2346678999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++++++.++.. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.++......
T Consensus 103 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999988888764 3456899999999999999999999 9999999999999999999999999999998766554
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
.......||+.|+|||++.
T Consensus 179 ~~~~~~~~t~~y~aPE~~~ 197 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLV 197 (331)
T ss_dssp -----CCCCCTTCCHHHHT
T ss_pred cccCCCcCCccccCccccc
Confidence 4445567999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=271.08 Aligned_cols=175 Identities=23% Similarity=0.412 Sum_probs=150.6
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.+.+..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..|+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3456778999999999999999999999888999999997543 34578999999999999999999999986 567899
Q ss_pred EEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999996532 35788999999999999999999 99999999999999999999999999999987643
Q ss_pred Cccc-eeccccccccccccccc
Q 046199 879 EESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~-~~~~~gt~~y~APE~l~ 899 (902)
.... .....+|+.|+|||++.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHH
T ss_pred CceeccCCCcccccccCHHHhc
Confidence 2211 12245678999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=248.56 Aligned_cols=171 Identities=28% Similarity=0.441 Sum_probs=142.8
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHh--CCCCCccceeeeeec----CCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 797 (902)
..++|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. .+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 467899999999999999999988 6899999998644 33556667777766 789999999998643 3568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
|+||||+++|+|.++++. ..+++..+..++.|++.||+|||.. ++++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999999999943 4689999999999999999999932 167999999999999999999999999999
Q ss_pred ceecCCCccce----ecccccccccccccccc
Q 046199 873 AKLLNGEESMR----TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~----~~~~gt~~y~APE~l~~ 900 (902)
|+......... ....||+.|+|||++..
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred eeecccccccccccccccccccceeChhhhcC
Confidence 98765443322 22479999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=250.86 Aligned_cols=171 Identities=26% Similarity=0.356 Sum_probs=143.8
Q ss_pred ccccccc-CeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++|++. +.||+|+||.||+|++. +++.||||+++.......+.+.+|+++++++ +||||+++++++.+++..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999975 5899999999876555667899999999985 7999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV---AHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kL~DFG~a~~~~~ 878 (902)
||+++++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998664 45899999999999999999999 999999999999999988775 99999999976542
Q ss_pred Ccc-------ceeccccccccccccccc
Q 046199 879 EES-------MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~-------~~~~~~gt~~y~APE~l~ 899 (902)
... ......||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp ---------------CCSGGGCCHHHHH
T ss_pred CCccccccccccccccCCcCccChHHhh
Confidence 211 112346999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=245.51 Aligned_cols=172 Identities=25% Similarity=0.438 Sum_probs=150.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|++.+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999864 8999999997543 33457788999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV---AHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kL~DFG~a~~~~ 877 (902)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++. +||+|||.+....
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999998888654 45899999999999999999999 999999999999999986655 9999999998765
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 160 DSEA-WHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp SSCB-CCCSCSCGGGCCHHHHTT
T ss_pred cCcc-ccCCCCCcCCcCchhhcC
Confidence 4332 234679999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=255.11 Aligned_cols=172 Identities=27% Similarity=0.433 Sum_probs=147.0
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeec--------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSN-------- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 793 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999985 589999999865432 234578899999999999999999999876
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
.+..|+||||+++ ++.+.+......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999975 888888776677999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCc----cceecccccccccccccccc
Q 046199 874 KLLNGEE----SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~----~~~~~~~gt~~y~APE~l~~ 900 (902)
+.+.... .......||+.|+|||++..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred ccccccccccccccCCcccccCccCchhhcC
Confidence 8765322 12233578999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=246.53 Aligned_cols=171 Identities=30% Similarity=0.452 Sum_probs=145.7
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
++|.....||+|+||.||+|++. +++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44555669999999999999985 48899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceecCCCcc
Q 046199 805 ANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 805 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~ 881 (902)
++++|.+++..... ..++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||.+........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976533 4668889999999999999999 999999999999999987 89999999999988765443
Q ss_pred ceeccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~ 899 (902)
......||+.|+|||++.
T Consensus 179 ~~~~~~~~~~y~aPE~~~ 196 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIID 196 (295)
T ss_dssp --CCCCCCGGGCCHHHHH
T ss_pred cccccCCCccccChhhhc
Confidence 344467999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=264.87 Aligned_cols=172 Identities=33% Similarity=0.442 Sum_probs=147.4
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC-eeE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-FKA 798 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 798 (902)
.+.+..++|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..|
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34566789999999999999999999884 7899999997543 4578999999999999999999999986654 789
Q ss_pred EEEEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 799 LVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
+||||+++|+|.+++..... .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999976544 3689999999999999999999 9999999999999999999999999999998653
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... ....+++.|+|||++..
T Consensus 341 ~~~---~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 341 STQ---DTGKLPVKWTAPEALRE 360 (450)
T ss_dssp ---------CCCTTTSCHHHHHS
T ss_pred ccc---cCCCCCcceeCHHHhcC
Confidence 321 22357889999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=246.78 Aligned_cols=172 Identities=28% Similarity=0.432 Sum_probs=146.6
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 345789999999999999999998865 7799999986542 223467889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999998654 45899999999999999999999 99999999999999999999999999999865433
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
. ......||+.|+|||++..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp --------CCCCTTCCHHHHTT
T ss_pred c--cccccCCCCCccCHhHhcc
Confidence 2 2234579999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=258.79 Aligned_cols=167 Identities=24% Similarity=0.333 Sum_probs=135.0
Q ss_pred ccccccc-CeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHH-hCCCCCccceeeeeec----CCee
Q 046199 725 TDHFSEK-SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLK-SVRHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 725 ~~~y~~~-~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 797 (902)
.++|.+. +.||+|+||.||+|++.. ++.||||+++.. ..+.+|++++. ..+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567666 789999999999999864 889999998632 45678888874 4589999999998865 5678
Q ss_pred EEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a 873 (902)
|+||||++||+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++. ++.+||+|||+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999997643 35899999999999999999999 999999999999999987 789999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+...... .....+||+.|+|||++..
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp EECC------------CTTCCGGGSCC
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCC
Confidence 8765433 2344679999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=265.53 Aligned_cols=169 Identities=25% Similarity=0.311 Sum_probs=139.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec--cchhhhhHHHHHHHHHhCCCCCccceeeeeecC------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ--FDGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 794 (902)
..++|++.+.||+|+||.||+|++.. ++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999998864 889999999754 234457888999999999999999999998654
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
...|+||||+++ ++.+.+. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 467999999976 5666663 24889999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...... .....+||+.|+|||++..
T Consensus 213 ~~~~~~-~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 213 TAGTSF-MMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp ----CC-CC----CCCTTCCHHHHTT
T ss_pred ecCCCc-ccCCCcccccccCHHHHcC
Confidence 765432 2344679999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=245.85 Aligned_cols=169 Identities=25% Similarity=0.360 Sum_probs=147.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999986 58999999997543 33457788999999999 899999999999999999999
Q ss_pred EEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---------------
Q 046199 801 LEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD--------------- 862 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--------------- 862 (902)
|||+++++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999998653 255899999999999999999999 9999999999999999844
Q ss_pred ----CcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 863 ----MVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 863 ----~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..+||+|||.+....... ...||+.|+|||++..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQE 204 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTT
T ss_pred cCCceEEEEcccccccccCCcc----ccCCCccccChhHhcC
Confidence 479999999998865432 2458999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=249.44 Aligned_cols=173 Identities=30% Similarity=0.459 Sum_probs=142.7
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-----hhhhhHHHHHHHHHhCC---CCCccceeeeeec
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-----GALKSFDAECEVLKSVR---HRNLVKIISSCSN 793 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 793 (902)
...++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34679999999999999999999975 489999999875431 22356778888877764 9999999999976
Q ss_pred CC-----eeEEEEEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 046199 794 GN-----FKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHL 867 (902)
Q Consensus 794 ~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 867 (902)
.. ..++||||++ ++|.+++..... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 54 5899999997 599999876543 3899999999999999999999 999999999999999999999999
Q ss_pred EeecCceecCCCccceecccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+|||+|+...... ......||+.|+|||++..
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHT
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcC
Confidence 9999998764333 2344679999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=256.13 Aligned_cols=175 Identities=26% Similarity=0.335 Sum_probs=145.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeec-----cchhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ-----FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
....++|++.+.||+|+||.||+|++.. ++.||+|+++.. .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 4556899999999999999999998854 889999998754 2345578999999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 046199 796 FKALVLEYMANGSLEKCLYSS---------------------------------------NRSLDIFQRLSIMIDVALAL 836 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~L 836 (902)
..++||||+++|+|.+++... ...+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988420 11135677889999999999
Q ss_pred HHHHccCCCCeEEcCCCCCCEEEcCCC--cEEEEeecCceecCCCcc----ceeccccccccccccccc
Q 046199 837 EYLHFGYSNPVVHCDIKPSNILLDDDM--VAHLSDFGIAKLLNGEES----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 837 ~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~----~~~~~~gt~~y~APE~l~ 899 (902)
+||| +.+|+||||||+||+++.++ .+||+|||+|+.+..... ......||+.|+|||++.
T Consensus 182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 9999 99999999999999998776 899999999987643221 123467999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=256.31 Aligned_cols=180 Identities=26% Similarity=0.301 Sum_probs=146.6
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccch-----------hhhhHHHHHHHHHhCCCCCc
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNL 784 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni 784 (902)
....++....++|++.+.||+|+||.||+|.+.+++.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4466778888999999999999999999999988999999998653221 23778999999999999999
Q ss_pred cceeeeee-----cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 046199 785 VKIISSCS-----NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859 (902)
Q Consensus 785 v~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (902)
+++++++. .....|+||||++ |++.+++......+++..+..++.||+.||+||| +.||+||||||+||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 99999984 3347899999997 5888888777667999999999999999999999 9999999999999999
Q ss_pred cCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 860 DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 860 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+.++.+||+|||+++...... ......||+.|+|||++..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTT
T ss_pred cCCCCEEEEecCccccccccc-ccceecccceecCcHHhcC
Confidence 999999999999998654332 2334678999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=248.13 Aligned_cols=173 Identities=25% Similarity=0.447 Sum_probs=148.5
Q ss_pred hhcccccccC-eecccceeeEEEEEeC---CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...++|.+.+ .||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+++++.++||||+++++++. .+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence 4456777777 9999999999999864 47789999997653 345678999999999999999999999994 5568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999999776677999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCccce---eccccccccccccccc
Q 046199 878 GEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
...... ....+|+.|+|||++.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECIN 186 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred cCcceeeccccccccccccCHHHhc
Confidence 443322 1235688999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=253.90 Aligned_cols=174 Identities=32% Similarity=0.470 Sum_probs=152.0
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--------hhhhhHHHHHHHHHhC-CCCCccceeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--------GALKSFDAECEVLKSV-RHRNLVKIISS 790 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~ 790 (902)
.....++|++.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999986 599999999875431 1245678999999999 79999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
+...+..|+||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998654 45899999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCccceeccccccccccccccc
Q 046199 871 GIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 871 G~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|++..+..... .....||+.|+|||++.
T Consensus 245 G~~~~~~~~~~-~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 245 GFSCHLEPGEK-LRELCGTPGYLAPEILK 272 (365)
T ss_dssp TTCEECCTTCC-BCCCCSCGGGCCHHHHH
T ss_pred CcccccCCCcc-cccCCCCCCccChhhcc
Confidence 99988764432 33467999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=254.48 Aligned_cols=171 Identities=25% Similarity=0.389 Sum_probs=144.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCC--CCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRH--RNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|.+.+++.||||+++... ....+.+.+|+++++.++| |||+++++++..++..|
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3567899999999999999999999889999999997553 2345778999999999976 99999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|||+ .+++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++ ++.+||+|||+|+....
T Consensus 86 lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99995 578999999764 46899999999999999999999 99999999999999997 57899999999987654
Q ss_pred Cccc--eeccccccccccccccc
Q 046199 879 EESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~--~~~~~gt~~y~APE~l~ 899 (902)
.... .....||+.|+|||++.
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp ----------CCCCSSCCHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHh
Confidence 3322 23467999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=251.13 Aligned_cols=173 Identities=28% Similarity=0.425 Sum_probs=143.3
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC--CCCCccceeeeeecC--
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV--RHRNLVKIISSCSNG-- 794 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 794 (902)
.......++|++.+.||+|+||.||+|++. ++.||||++... ......+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344455689999999999999999999985 899999998643 234455566666554 899999999999877
Q ss_pred --CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEEcCCCCCCEEEcCCCc
Q 046199 795 --NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN--------PVVHCDIKPSNILLDDDMV 864 (902)
Q Consensus 795 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~--------~ivHrDlkp~NIll~~~~~ 864 (902)
+..|+||||+++|+|.++++.. .+++..+..++.|++.||+||| +. ||+||||||+||+++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7899999999999999999654 5899999999999999999999 77 9999999999999999999
Q ss_pred EEEEeecCceecCCCccce----ecccccccccccccccc
Q 046199 865 AHLSDFGIAKLLNGEESMR----TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 865 ~kL~DFG~a~~~~~~~~~~----~~~~gt~~y~APE~l~~ 900 (902)
+||+|||+|+......... ....||+.|+|||++..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 9999999998765433221 23579999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=250.39 Aligned_cols=175 Identities=24% Similarity=0.305 Sum_probs=148.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeee----cCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS----NGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~ 796 (902)
.+..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 355689999999999999999999984 58999999998766666788999999999999999999999986 3457
Q ss_pred eEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 797 KALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
.|+||||+++++|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999865 3566899999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCccc---------eeccccccccccccccc
Q 046199 874 KLLNGEESM---------RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~---------~~~~~gt~~y~APE~l~ 899 (902)
......... .....||+.|+|||++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhc
Confidence 765321110 11235799999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=261.45 Aligned_cols=170 Identities=28% Similarity=0.411 Sum_probs=137.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--------chhhhhHHHHHHHHHhCCCCCccceeeeeecC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVRHRNLVKIISSCSNG 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 794 (902)
..++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45789999999999999999998865 8999999987542 1223468899999999999999999999864
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeec
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAHLSDFG 871 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~DFG 871 (902)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 457999999999999998854 356899999999999999999999 99999999999999996544 59999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+|+...... .....+||+.|+|||++.
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC
T ss_pred cceecCCCc-cccccCCCCCccCceeee
Confidence 998765432 233467999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=265.68 Aligned_cols=170 Identities=26% Similarity=0.421 Sum_probs=144.7
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999986 48899999997543 334577899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~~~ 878 (902)
||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|+....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 45899999999999999999999 999999999999999976 44599999999988764
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
... ....+||+.|+|||++.
T Consensus 192 ~~~-~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 192 QKK-MKERLGTAYYIAPEVLR 211 (494)
T ss_dssp TBC-BCCCCSCTTTCCHHHHT
T ss_pred Ccc-ccccCCCcCeeCHHHHc
Confidence 432 34467999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=257.57 Aligned_cols=174 Identities=20% Similarity=0.251 Sum_probs=142.5
Q ss_pred hhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccchh-----------hhhHHHHHHHHHhCCCCCcc
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFDGA-----------LKSFDAECEVLKSVRHRNLV 785 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 785 (902)
...++|++.+.||+|+||.||+|++.. ++.||||++....... ......|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345699999999999999999998864 4789999987543211 12234456667788899999
Q ss_pred ceeeeeecC----CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-
Q 046199 786 KIISSCSNG----NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD- 860 (902)
Q Consensus 786 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~- 860 (902)
++++++... ...|+||||+ +++|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence 999998764 5689999999 99999999887678999999999999999999999 99999999999999998
Q ss_pred -CCCcEEEEeecCceecCCCccc-------eecccccccccccccccc
Q 046199 861 -DDMVAHLSDFGIAKLLNGEESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 861 -~~~~~kL~DFG~a~~~~~~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
.++.+||+|||+|+.+...... .....||+.|||||++..
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 235 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG 235 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC
Confidence 8899999999999876533221 122459999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=243.34 Aligned_cols=173 Identities=25% Similarity=0.386 Sum_probs=150.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3478999999999999999999986 58999999997543 344578899999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+........
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998854 345899999999999999999999 99999999999999999999999999999986543221
Q ss_pred --ceecccccccccccccccc
Q 046199 882 --MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 --~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKR 181 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTC
T ss_pred hhcccCCccccCccChHHHhc
Confidence 2233578999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=255.88 Aligned_cols=181 Identities=24% Similarity=0.394 Sum_probs=153.1
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCcccee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKII 788 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 788 (902)
+..+++....++|++.+.||+|+||.||+|++. .++.||+|++..... .....+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344456677889999999999999999999764 267899999875432 3456788999999999999999999
Q ss_pred eeeecCCeeEEEEEccCCCChHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 046199 789 SSCSNGNFKALVLEYMANGSLEKCLYSSN---------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859 (902)
Q Consensus 789 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (902)
+++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence 99999999999999999999999986522 34689999999999999999999 9999999999999999
Q ss_pred cCCCcEEEEeecCceecCCCccce--eccccccccccccccc
Q 046199 860 DDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 860 ~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~ 899 (902)
+.++.+||+|||+++......... ....+|+.|+|||++.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence 999999999999998664333221 2245788999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=253.77 Aligned_cols=173 Identities=27% Similarity=0.412 Sum_probs=142.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|++.. ++ +||+|.++... ....+.+.+|+.++++++||||+++++++..++ .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 45789999999999999999998753 43 46888775432 344578999999999999999999999998765 6
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++|+||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8899999999999999887778999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccce--ecccccccccccccccc
Q 046199 878 GEESMR--TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~--~~~~gt~~y~APE~l~~ 900 (902)
...... ....+|+.|+|||++..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHH
T ss_pred CCcccccccCCCccccccChHHhcc
Confidence 443322 22457889999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=248.14 Aligned_cols=174 Identities=28% Similarity=0.424 Sum_probs=139.1
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4568999999999999999999975 58999999997532 3445778999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
||||+++++|.+++.. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999998864 3456899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
...........|++.|+|||++..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp ------------CCSSCCHHHHTT
T ss_pred cCCCccccccCCCeeEeChHHhCC
Confidence 554443444678999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=243.51 Aligned_cols=170 Identities=28% Similarity=0.412 Sum_probs=146.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999986 489999999875432 1357789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a 873 (902)
++||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999998653 45899999999999999999999 99999999999999998877 8999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
........ .....||+.|+|||++.
T Consensus 160 ~~~~~~~~-~~~~~~~~~y~aPE~~~ 184 (283)
T 3bhy_A 160 HKIEAGNE-FKNIFGTPEFVAPEIVN 184 (283)
T ss_dssp EECC---------CCCGGGCCHHHHT
T ss_pred eeccCCCc-ccccCCCcCccCcceec
Confidence 87654332 23356999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=264.25 Aligned_cols=171 Identities=27% Similarity=0.419 Sum_probs=147.2
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-------------hhhhhHHHHHHHHHhCCCCCccceee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-------------GALKSFDAECEVLKSVRHRNLVKIIS 789 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 789 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999865 88999999875421 23467889999999999999999999
Q ss_pred eeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEE
Q 046199 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM---VAH 866 (902)
Q Consensus 790 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~k 866 (902)
++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988654 45899999999999999999999 99999999999999998776 699
Q ss_pred EEeecCceecCCCccceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||+|+....... .....||+.|+|||++.
T Consensus 190 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp ECCCTTCEECCTTSC-BCCCCSCTTTCCHHHHT
T ss_pred EEECCCCEEcCCCCc-cccccCCcCCCCHHHhc
Confidence 999999988754432 34467999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=251.62 Aligned_cols=182 Identities=22% Similarity=0.384 Sum_probs=154.3
Q ss_pred ccCHHHHHhhcccccccCeecccceeeEEEEEe------CCCcEEEEEEeeeccc-hhhhhHHHHHHHHHhC-CCCCccc
Q 046199 715 RFSYRELLLATDHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVK 786 (902)
Q Consensus 715 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 786 (902)
.+...++....++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 456677788899999999999999999999985 2368899999976533 3456789999999999 7999999
Q ss_pred eeeeeecC-CeeEEEEEccCCCChHHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 046199 787 IISSCSNG-NFKALVLEYMANGSLEKCLYSSNRS---------------LDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850 (902)
Q Consensus 787 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 850 (902)
+++++... +..++||||+++++|.+++...... +++..+..++.|++.||+||| ++||+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 99998765 4589999999999999999765432 789999999999999999999 9999999
Q ss_pred CCCCCCEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 851 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
||||+||+++.++.+||+|||+++........ .....||+.|+|||++.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc
Confidence 99999999999999999999999876543322 22356889999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=256.42 Aligned_cols=171 Identities=25% Similarity=0.379 Sum_probs=145.2
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCC--CCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR--HRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|+++++.++ ||||+++++++..++..|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 345799999999999999999998889999999997553 334578899999999996 5999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||| +.+++|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++ ++.+||+|||+|+.+...
T Consensus 134 v~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 999 5678999999765 46889999999999999999999 99999999999999996 579999999999876543
Q ss_pred cc--ceecccccccccccccccc
Q 046199 880 ES--MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~--~~~~~~gt~~y~APE~l~~ 900 (902)
.. .....+||+.|+|||++..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhh
Confidence 32 1234679999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=265.16 Aligned_cols=171 Identities=26% Similarity=0.407 Sum_probs=148.0
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999986 58999999986432 33457889999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~~ 877 (902)
|||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+|+...
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988654 45899999999999999999999 99999999999999995 45689999999998765
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
... ......||+.|+|||++.
T Consensus 176 ~~~-~~~~~~gt~~y~aPE~~~ 196 (486)
T 3mwu_A 176 QNT-KMKDRIGTAYYIAPEVLR 196 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGG
T ss_pred CCC-ccCCCcCCCCCCCHHHhC
Confidence 433 233467999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=248.67 Aligned_cols=171 Identities=28% Similarity=0.420 Sum_probs=143.5
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec----------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN---------- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 793 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999985 5899999999654 3345788999999999999999999998754
Q ss_pred ---CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 794 ---GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 794 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
.+..|+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45789999999999999999876667888999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCc--------------cceeccccccccccccccc
Q 046199 871 GIAKLLNGEE--------------SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 871 G~a~~~~~~~--------------~~~~~~~gt~~y~APE~l~ 899 (902)
|.++...... .......||+.|+|||++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHT
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence 9998654321 1123356899999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=253.71 Aligned_cols=180 Identities=28% Similarity=0.417 Sum_probs=147.5
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeec
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN 793 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 793 (902)
+++.++....++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445567789999999999999999999985 58999999987543 3457889999999999 79999999999976
Q ss_pred ------CCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 794 ------GNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 794 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
.+..|+||||+++++|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence 568899999999999999997643 46899999999999999999999 99999999999999999999999
Q ss_pred EEeecCceecCCCccceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||++..............||+.|+|||++.
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhc
Confidence 999999987654433334467999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=249.74 Aligned_cols=174 Identities=28% Similarity=0.473 Sum_probs=151.0
Q ss_pred hhcccccccCeecccceeeEEEEEe-----CCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC--
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRF-----LDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN-- 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 795 (902)
...++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4567899999999999999999984 358899999998766666788999999999999999999999986654
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 789999999999999999887677999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCccce---eccccccccccccccc
Q 046199 876 LNGEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
........ ....++..|+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhc
Confidence 75443221 2245778899999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=255.23 Aligned_cols=167 Identities=25% Similarity=0.368 Sum_probs=139.8
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 795 (902)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999985 48999999986543 234567889999999999999999999997653
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 7899999865 45899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 178 ~~~~---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 178 ADSE---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHT
T ss_pred cccc---cCcCcCCCCcCCHHHHhC
Confidence 6432 234678999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-27 Score=267.08 Aligned_cols=175 Identities=27% Similarity=0.447 Sum_probs=145.6
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.+.+..++|++.+.||+|+||.||+|++.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..|+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34566789999999999999999999998888899999975432 34789999999999999999999999876 67899
Q ss_pred EEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999999653 345899999999999999999999 99999999999999999999999999999987654
Q ss_pred Ccc-ceeccccccccccccccc
Q 046199 879 EES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~-~~~~~~gt~~y~APE~l~ 899 (902)
... ......+++.|+|||++.
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~ 354 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAAL 354 (452)
T ss_dssp ----------CCGGGSCHHHHH
T ss_pred CceecccCCcccccccCHhHHh
Confidence 322 122345788999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=254.26 Aligned_cols=177 Identities=22% Similarity=0.415 Sum_probs=151.2
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhC-CCCCccceeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISSC 791 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 791 (902)
++....++|++.+.||+|+||.||+|++.. .+.||+|+++.... ...+.+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456778899999999999999999998753 34799999975532 3457789999999999 899999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSS-------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNIL 858 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (902)
..++..|+||||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 9999999999999999999998653 235789999999999999999999 999999999999999
Q ss_pred EcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 859 LDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 859 l~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
++.++.+||+|||+++........ .....+|+.|+|||++.
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 239 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc
Confidence 999999999999999866433322 22345788999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=243.74 Aligned_cols=172 Identities=28% Similarity=0.426 Sum_probs=150.3
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999864 7889999986542 223467899999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++... ..+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999998654 35899999999999999999999 99999999999999999999999999999977643
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. .....|++.|+|||++..
T Consensus 167 ~~--~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 167 LR--RRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp SC--BCCCCSCGGGCCHHHHTT
T ss_pred cc--cccccCCCCcCCHHHhcc
Confidence 22 234579999999998753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=240.70 Aligned_cols=210 Identities=20% Similarity=0.210 Sum_probs=168.6
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
++++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------------- 89 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ------------------- 89 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-------------------
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC-------------------
Confidence 6788888888888777777888888888888888887666667776666666666655554
Q ss_pred ccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCC-CccccccccccceeccCCccccccCcc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGS-LPLDIGNMKVVVEINLSRNYLTGDIPT 552 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 552 (902)
+..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++. +|..+..+++|++|++++|++++..+.
T Consensus 90 --~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 90 --SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp --EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred --ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 45556777888888888888888887777788888888888888888764 578888888888889998888887778
Q ss_pred ccccCCccc----eEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCC
Q 046199 553 TIGGLTNLQ----LLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625 (902)
Q Consensus 553 ~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 625 (902)
.|..+.+|+ .|++++|++++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|++++|+++|.+|.-
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 888877777 8999999999665655554 48999999999999777777899999999999999999988864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=254.01 Aligned_cols=172 Identities=24% Similarity=0.402 Sum_probs=143.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|++.. ++ +||+|.+.... ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 45789999999999999999998754 44 37888775432 2344677889999999999999999999864 568
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+...
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 8999999999999999776667899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcc--ceeccccccccccccccc
Q 046199 878 GEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
.... ......||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~ 190 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIH 190 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHH
T ss_pred cccccccccCCCCcccccChHHhc
Confidence 4332 223356788999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=253.29 Aligned_cols=171 Identities=22% Similarity=0.336 Sum_probs=150.7
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchh-----------------hhhHHHHHHHHHhCCCCCccc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA-----------------LKSFDAECEVLKSVRHRNLVK 786 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 786 (902)
..++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|+++++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999999999 89999999997542111 178999999999999999999
Q ss_pred eeeeeecCCeeEEEEEccCCCChHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEE
Q 046199 787 IISSCSNGNFKALVLEYMANGSLEKC------LYSS-NRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNIL 858 (902)
Q Consensus 787 l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIl 858 (902)
+++++.+.+..|+||||+++++|.++ +... ...+++..+..++.|++.||+||| + +||+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 99999999999999999999999998 5432 466899999999999999999999 8 99999999999999
Q ss_pred EcCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 859 LDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 859 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++.++.+||+|||.+...... ......||+.|+|||++..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 224 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSN 224 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSS
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcC
Confidence 999999999999999876543 3344679999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=247.49 Aligned_cols=171 Identities=25% Similarity=0.399 Sum_probs=146.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++.......+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468999999999999999999986 589999999986654455778999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceecCCC
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~ 879 (902)
|+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||.++.....
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999988654 45899999999999999999999 9999999999999999 78889999999999764332
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSS
T ss_pred --ccccccCCCCccChHHhcc
Confidence 2233568999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=243.96 Aligned_cols=172 Identities=28% Similarity=0.388 Sum_probs=150.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---------chhhhhHHHHHHHHHhCC-CCCccceeeee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---------DGALKSFDAECEVLKSVR-HRNLVKIISSC 791 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 791 (902)
...++|++.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999864 8899999997543 123467789999999995 99999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
..++..++||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999998654 45899999999999999999999 9999999999999999999999999999
Q ss_pred CceecCCCccceeccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+........ .....||+.|+|||++.
T Consensus 170 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 170 FSCQLDPGEK-LREVCGTPSYLAPEIIE 196 (298)
T ss_dssp TCEECCTTCC-BCCCCSCGGGCCHHHHH
T ss_pred chhhcCCCcc-cccccCCccccCHHHhc
Confidence 9987654332 33467999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=246.61 Aligned_cols=173 Identities=25% Similarity=0.432 Sum_probs=145.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeee-ecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~ 797 (902)
...+|++.+.||+|+||.||+|++.+ ...||+|.++... ....+.+.+|+.++++++||||+++++++ ..++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578999999999999999998753 3358999887543 34557889999999999999999999985 556788
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|+...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999999877777899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcc----ceeccccccccccccccc
Q 046199 878 GEES----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~----~~~~~~gt~~y~APE~l~ 899 (902)
.... ......+|+.|+|||++.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQ 205 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHH
T ss_pred ccchhccccccCCCCCccccChHHhc
Confidence 4322 122356788999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=243.44 Aligned_cols=168 Identities=26% Similarity=0.504 Sum_probs=135.3
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc----hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. ++.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578999999999999999999984 88999999875432 234678899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC---eEEcCCCCCCEEEcC--------CCcEEEE
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP---VVHCDIKPSNILLDD--------DMVAHLS 868 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~---ivHrDlkp~NIll~~--------~~~~kL~ 868 (902)
||||+++++|.+++. ...+++..+..++.|++.|++||| ++| |+||||||+||+++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999884 346899999999999999999999 888 999999999999986 6789999
Q ss_pred eecCceecCCCccceeccccccccccccccc
Q 046199 869 DFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 869 DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|||.++....... ....||+.|+|||++.
T Consensus 159 Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 159 DFGLAREWHRTTK--MSAAGAYAWMAPEVIR 187 (271)
T ss_dssp CCCC---------------CCGGGSCHHHHH
T ss_pred cCCcccccccccc--cCCCCccceeCHHHhc
Confidence 9999987644322 2357999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=243.59 Aligned_cols=173 Identities=27% Similarity=0.466 Sum_probs=143.7
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 45578999999999999999999986 58999999997542 233467889999999999999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999998654 45899999999999999999999 99999999999999999999999999999987654
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... .....||+.|+|||++..
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 164 GEF-LRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp --------------CCTGGGTT
T ss_pred Ccc-eecccCCccccCHHHHcC
Confidence 322 233568999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=251.08 Aligned_cols=174 Identities=26% Similarity=0.484 Sum_probs=143.8
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
+..++|++.+.||+|+||.||+|++.. +..||+|+++... ......+.+|+++++.++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 455788899999999999999998743 2469999997553 2345678999999999999999999999999999
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++..
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999877777999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc---eeccccccccccccccc
Q 046199 877 NGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
...... .....+|+.|+|||++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp -------------CCCGGGSCHHHHH
T ss_pred ccccccccccCCCCccccccCchhcc
Confidence 543221 11234678999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-26 Score=247.19 Aligned_cols=172 Identities=24% Similarity=0.309 Sum_probs=142.3
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999986 588999999875432 234778999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998654 45899999999999999999999 999999999999999999999999999999876543
Q ss_pred cc-ceeccccccccccccccc
Q 046199 880 ES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~-~~~~~~gt~~y~APE~l~ 899 (902)
.. ......||+.|+|||++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp ---------CCGGGCCGGGTC
T ss_pred ccccccccCCCcCccCHHHHc
Confidence 22 222356899999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=253.69 Aligned_cols=170 Identities=28% Similarity=0.405 Sum_probs=140.5
Q ss_pred HhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec-------
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------- 793 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 793 (902)
....++|++.+.||+|+||.||+|++. +++.||+|++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456789999999999999999999885 58999999986542 223479999999999999999999843
Q ss_pred -------------------------------CCeeEEEEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH
Q 046199 794 -------------------------------GNFKALVLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYL 839 (902)
Q Consensus 794 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~L 839 (902)
....++||||+++ +|.+.+.. ....+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999985 87776653 456799999999999999999999
Q ss_pred HccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 840 HFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 840 H~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
| ++||+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++..
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLG 215 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTT
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcC
Confidence 9 99999999999999997 688999999999987654433 334578999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=265.80 Aligned_cols=171 Identities=27% Similarity=0.444 Sum_probs=150.5
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999986 58999999986542 3345788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 876 (902)
||||+++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+||+|||+|+..
T Consensus 104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999988654 46899999999999999999999 9999999999999999 56789999999999876
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..... .....||+.|+|||++.
T Consensus 180 ~~~~~-~~~~~gt~~y~aPE~~~ 201 (484)
T 3nyv_A 180 EASKK-MKDKIGTAYYIAPEVLH 201 (484)
T ss_dssp CCCCS-HHHHTTGGGTCCHHHHH
T ss_pred ccccc-cccCCCCccccCceeec
Confidence 54432 33467999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=244.04 Aligned_cols=168 Identities=29% Similarity=0.490 Sum_probs=146.6
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec---------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN--------- 793 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 793 (902)
...+|++.+.||+|+||.||+|++. +++.||+|+++... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3468999999999999999999986 58999999987543 467789999999999999999998854
Q ss_pred -------CCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 046199 794 -------GNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 794 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 865 (902)
....|+||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 45689999999999999999654 356899999999999999999999 9999999999999999999999
Q ss_pred EEEeecCceecCCCccceeccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
||+|||.+........ .....||+.|+|||++.
T Consensus 162 kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 194 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQIS 194 (284)
T ss_dssp EECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHH
T ss_pred EECcchhheecccccc-ccccCCcccccChhhhc
Confidence 9999999988765432 33456999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=249.66 Aligned_cols=170 Identities=33% Similarity=0.504 Sum_probs=138.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHH--HHhCCCCCccceeeeee-----cC
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEV--LKSVRHRNLVKIISSCS-----NG 794 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~ 794 (902)
.+..++|++.+.||+|+||.||+|++ +++.||||+++... .+.+..|.++ +..++||||+++++.+. ..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 34568999999999999999999987 68999999987542 2344445444 44589999999997542 33
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC---------CeEEcCCCCCCEEEcCCCcE
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN---------PVVHCDIKPSNILLDDDMVA 865 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~---------~ivHrDlkp~NIll~~~~~~ 865 (902)
...|+||||+++|+|.+++.... .++..+..++.||+.||+||| +. ||+||||||+||+++.++.+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence 46789999999999999996543 488899999999999999999 88 99999999999999999999
Q ss_pred EEEeecCceecCCCcc--------ceecccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEES--------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~--------~~~~~~gt~~y~APE~l~~ 900 (902)
||+|||+|+.+..... ......||+.|+|||++..
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9999999987653221 1223569999999998853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=247.37 Aligned_cols=173 Identities=29% Similarity=0.472 Sum_probs=138.6
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
.++..++|++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3566789999999999999999999864 369999987553 33457889999999999999999999965 455689
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999999777777999999999999999999999 99999999999999999999999999999976543
Q ss_pred Cc--cceeccccccccccccccc
Q 046199 879 EE--SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~--~~~~~~~gt~~y~APE~l~ 899 (902)
.. .......||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -----------CCCTTCCHHHHC
T ss_pred ccccccccccCCCccccCchhhc
Confidence 22 1223356999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=244.84 Aligned_cols=173 Identities=25% Similarity=0.420 Sum_probs=145.5
Q ss_pred hhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
...++|++.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+++++.++||||+++++++.++ ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 456889999999999999999998643 3469999987653 34567899999999999999999999998754 56
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 8999999999999999877677999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccc-eeccccccccccccccc
Q 046199 878 GEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
..... .....+|+.|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~ 187 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESIN 187 (281)
T ss_dssp --------CCCCCGGGCCHHHHH
T ss_pred cccccccccCCCCcceeCchhhc
Confidence 43322 22345788999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=242.87 Aligned_cols=169 Identities=20% Similarity=0.400 Sum_probs=147.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC--CeeE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG--NFKA 798 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 798 (902)
+..++|++.+.||+|+||.||+|++ +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3457899999999999999999998 48899999997653 33456799999999999999999999999877 7889
Q ss_pred EEEEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 799 LVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
+||||+++|+|.+++..... .+++..+..++.|++.||+||| +++ |+||||||+||+++.++.++++|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999976543 5899999999999999999999 889 99999999999999999999999998765
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... ....||+.|+|||++..
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHS
T ss_pred ecc-----cCccCCccccChhhhcc
Confidence 332 22468999999998753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=246.29 Aligned_cols=172 Identities=29% Similarity=0.455 Sum_probs=147.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 368999999999999999999986 58999999987543 223467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||++ ++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.......
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 157 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence 9997 59999987653 45889999999999999999999 9999999999999999999999999999998765444
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.......||+.|+|||++..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 158 RTYTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp BCTTSCBCCCTTCCHHHHTT
T ss_pred cccCcccccccccCcHHhhc
Confidence 33344578999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=255.41 Aligned_cols=172 Identities=28% Similarity=0.392 Sum_probs=149.0
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
...++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34578999999999999999999986 48999999998653 34457889999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|||+++++|.+++... ..+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++......
T Consensus 110 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999998654 35899999999999999999999 75 9999999999999999999999999999765321
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
......||+.|+|||++..
T Consensus 186 --~~~~~~gt~~y~aPE~~~~ 204 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQG 204 (360)
T ss_dssp --C----CCCCTTCCHHHHTT
T ss_pred --cccCCCCCCCeECHHHHcC
Confidence 2233579999999998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-29 Score=295.29 Aligned_cols=351 Identities=13% Similarity=0.081 Sum_probs=172.4
Q ss_pred CCCCCceEeccCcccccCCCcCCccc-CCCcccceeeccCcc--CCC-CCCccccccccccEEEccCC-cccCccccccc
Q 046199 262 NMSTLKALSLLNNTLSGSLPSSSKNL-IGLPNIERLNLGLNN--LSG-RIPGFIFNASKLFLLELTGN-SFSGFIPDTLV 336 (902)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~l~~L~~L~Ls~N~--l~~-~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~ 336 (902)
++++|++|+|++|.+++..+.++..+ ..+++|++|++++|. +.. .++..+..+++|++|++++| .+.+ ++..+.
T Consensus 154 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~ 232 (594)
T 2p1m_B 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQ 232 (594)
T ss_dssp HCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHH
T ss_pred hCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHh
Confidence 34444444444444443322222111 134455555555554 110 01111223456666666665 3332 455555
Q ss_pred ccccccEEecccccCCCCCCcc-cccccccCCCCCcee-eeccCCCCcccCcccccccccccEEEeecCcccccCC-ccc
Q 046199 337 NLRNLEHLGLGYNYLTSSTPEL-SFLSSLANSSSSKYI-VLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP-KEI 413 (902)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~~~~-~~l~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p-~~~ 413 (902)
.+++|++|+++.+...-..... .....+.++++|+.| .+.+... ..++..+..++ +|++|+|++|.+++... ..+
T Consensus 233 ~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~-~L~~L~L~~~~l~~~~l~~~~ 310 (594)
T 2p1m_B 233 RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCS-RLTTLNLSYATVQSYDLVKLL 310 (594)
T ss_dssp HCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHT-TCCEEECTTCCCCHHHHHHHH
T ss_pred cCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-hhHHHHHHhhC-CCCEEEccCCCCCHHHHHHHH
Confidence 5666666664433210000000 001234555566655 2332221 23344444455 77777777777654322 224
Q ss_pred CCCCCCcEEEeecceeccc-CCcccccccccCeeeccc---------ccccCCCC----CcCCCCCeEeccCccccCCCC
Q 046199 414 GNLVNLTTLHLGNNQLSGS-IPITVGRLNTLQGLGLEN---------NKLEGPIP----DDLCQLSELHVDHNKLSGPIP 479 (902)
Q Consensus 414 ~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~p----~~l~~L~~L~L~~N~l~~~~p 479 (902)
..+++|++|++++| +... ++.....+++|++|++++ +.+++... ..+.+|+.|.++.|.+++..+
T Consensus 311 ~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~ 389 (594)
T 2p1m_B 311 CQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389 (594)
T ss_dssp TTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH
T ss_pred hcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH
Confidence 56778888888877 4322 222333467777777743 33332111 123466666666666655444
Q ss_pred cccc-CCCcCceEecC--C----CCccCc-----ccccccCCCCceEEEcCCCccCCCCcccccc-ccccceeccCCccc
Q 046199 480 ACFG-NLNSLRNLSLG--S----NELSSF-----IPSTFWNLNNILSFDFSSNSLNGSLPLDIGN-MKVVVEINLSRNYL 546 (902)
Q Consensus 480 ~~~~-~l~~L~~L~L~--~----N~l~~~-----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l 546 (902)
..+. .+++|+.|+++ + |+++.. ++..+..+++|+.|++++ .+++..+..+.. +++|++|+|++|.+
T Consensus 390 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp HHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred HHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 4443 46667777776 3 444421 112245566667777655 444433333433 56666666666666
Q ss_pred cccCcccc-ccCCccceEEccCcccCCCccc-cccccccCCeEeCcCccccccCCccc-ccccccccccccCCc
Q 046199 547 TGDIPTTI-GGLTNLQLLSLENNRLHGPIPE-SFGALTSLESLDLSVNNLSGVIPISL-EKLVYLKDLNLSFNR 617 (902)
Q Consensus 547 ~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~l~~N~ 617 (902)
++..+..+ ..+++|+.|+|++|++++..+. .+..+++|+.|++++|+++......+ ..++.|+...+..+.
T Consensus 469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 55444444 4566677777777766543333 23346667777777766643333333 334555544444443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=244.74 Aligned_cols=170 Identities=25% Similarity=0.425 Sum_probs=145.3
Q ss_pred ccc-cccCeecccceeeEEEEEeC-----CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeec--CCe
Q 046199 726 DHF-SEKSLIGIGSFGTVYKGRFL-----DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSN--GNF 796 (902)
Q Consensus 726 ~~y-~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 796 (902)
++| ++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++++.++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 444 99999999999999998653 478899999976532 445778999999999999999999999987 467
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 89999999999999999654 4899999999999999999999 999999999999999999999999999999887
Q ss_pred CCCccc---eecccccccccccccccc
Q 046199 877 NGEESM---RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~---~~~~~gt~~y~APE~l~~ 900 (902)
...... .....+|+.|+|||++..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcC
Confidence 654322 223568889999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=250.63 Aligned_cols=177 Identities=27% Similarity=0.385 Sum_probs=132.2
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.+.+..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 34567789999999999999999999875 48899999886543 33456788999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 798 ALVLEYMANGSLEKCLYS-------SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
++||||+++++|.+++.. ....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999864 2455899999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCcc-----ceeccccccccccccccc
Q 046199 871 GIAKLLNGEES-----MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 871 G~a~~~~~~~~-----~~~~~~gt~~y~APE~l~ 899 (902)
|.+........ ......||+.|+|||++.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHH
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhc
Confidence 99876543221 122356899999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=255.40 Aligned_cols=171 Identities=25% Similarity=0.420 Sum_probs=136.3
Q ss_pred ccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeee-cCCeeEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS-NGNFKAL 799 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l 799 (902)
..|++.+.||+|+||.||+|++.+ +..||+|.++... ....+.+.+|+.++++++||||+++++++. .++..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998642 2468999886543 345678999999999999999999999864 4568899
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+++|+|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877777899999999999999999999 999999999999999999999999999999866433
Q ss_pred ccc----eeccccccccccccccc
Q 046199 880 ESM----RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~----~~~~~gt~~y~APE~l~ 899 (902)
... .....+|+.|+|||++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~ 269 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQ 269 (373)
T ss_dssp ------------CCGGGSCHHHHH
T ss_pred ccccccccCCCCCcccccChHHhc
Confidence 211 12345788999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=246.45 Aligned_cols=173 Identities=28% Similarity=0.437 Sum_probs=147.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeee--cCCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 799 (902)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++. .++..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 578999999999999999999986 48999999997543 344577899999999999999999999874 4678999
Q ss_pred EEEccCCCChHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 800 VLEYMANGSLEKCLYSS---NRSLDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
||||+++++|.+++... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998653 345899999999999999999999 888 9999999999999999999999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.++.............||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred hheeeccccccccccCCCccccChHHhcc
Confidence 99876544333334578999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=269.94 Aligned_cols=160 Identities=19% Similarity=0.167 Sum_probs=126.4
Q ss_pred eecccceeeEEEEEeC-CCcEEEEEEeeecc----------chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF----------DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 733 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
..+.|++|.+..++.. -|+.||+|++.... +...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666666655432 38889999997542 22346799999999999 699999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++|++|.+++.+. ..+++. +|+.||+.||+|+| ++|||||||||+|||++++|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999654 446653 58999999999999 9999999999999999999999999999999876655
Q ss_pred cceeccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~ 899 (902)
....+.+||++|||||++.
T Consensus 394 ~~~~t~vGTp~YmAPE~l~ 412 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFA 412 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-
T ss_pred ccccCceechhhccHHHhC
Confidence 5556678999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=247.78 Aligned_cols=169 Identities=28% Similarity=0.409 Sum_probs=142.4
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--------chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--------DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
.++|++.+.||+|+||.||+|++.. ++.||||++.... ......+.+|+++++.++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4689999999999999999999865 8899999986432 122356889999999999999999999997665
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecC
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV---AHLSDFGI 872 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kL~DFG~ 872 (902)
.|+||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7999999999999998854 456899999999999999999999 999999999999999987654 99999999
Q ss_pred ceecCCCccceeccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
++....... .....||+.|+|||++.
T Consensus 164 ~~~~~~~~~-~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 164 SKILGETSL-MRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CEECCCCHH-HHHHHSCCTTCCHHHHH
T ss_pred ceecccccc-cccccCCcCccCchhhc
Confidence 987654322 23356999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=245.49 Aligned_cols=166 Identities=22% Similarity=0.396 Sum_probs=145.3
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeec--CCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSN--GNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++.. ..+.+.+|+++++.++ ||||+++++++.+ ....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 3478999999999999999999875 5899999998743 3467899999999997 9999999999987 667899
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~ 878 (902)
||||+++++|.+++. .+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+|+....
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999874 3789999999999999999999 99999999999999999776 899999999987654
Q ss_pred Cccceecccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... .....||+.|+|||++..
T Consensus 184 ~~~-~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 184 GQE-YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp TCC-CCSCCSCGGGCCHHHHTT
T ss_pred CCc-cccccccccccChhhhcC
Confidence 433 334679999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=257.95 Aligned_cols=169 Identities=17% Similarity=0.197 Sum_probs=137.2
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeec---cchhhhhHHHHHH---HHHhCCCCCcccee-------e
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ---FDGALKSFDAECE---VLKSVRHRNLVKII-------S 789 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~ 789 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++.. .....+.+.+|+. +++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4578999999999999999999974 5899999999743 3345678899995 45555799999998 5
Q ss_pred eeecCC-----------------eeEEEEEccCCCChHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 046199 790 SCSNGN-----------------FKALVLEYMANGSLEKCLYSSNR------SLDIFQRLSIMIDVALALEYLHFGYSNP 846 (902)
Q Consensus 790 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (902)
++..++ ..|+||||+ +|+|.+++..... .+++..+..++.||+.||+||| ++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 555443 278999999 5799999875322 1224778889999999999999 999
Q ss_pred eEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++..
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcc
Confidence 99999999999999999999999999986432 3344567 99999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=245.19 Aligned_cols=171 Identities=25% Similarity=0.314 Sum_probs=134.1
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
+..++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.++...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45689999999999999999999985 589999999975532 223344455556888899999999999999999999
Q ss_pred EEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 800 VLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
||||+++ ++.+++.. ....+++..+..++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||.|+.
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999975 88777654 4567999999999999999999999 87 999999999999999999999999999987
Q ss_pred cCCCccceecccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l 898 (902)
...... .....||+.|+|||++
T Consensus 160 ~~~~~~-~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 160 LVDDVA-KDIDAGCKPYMAPERI 181 (290)
T ss_dssp -----------CCCCCCSCHHHH
T ss_pred cccccc-ccccCCCccccChhhc
Confidence 654332 2335799999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=243.54 Aligned_cols=175 Identities=26% Similarity=0.413 Sum_probs=145.9
Q ss_pred HHHhhcccccccC-eecccceeeEEEEEeC---CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 720 ELLLATDHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 720 ~~~~~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
++....++|++.+ .||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 4445667899988 9999999999999653 36889999997543 23457899999999999999999999999 5
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 56789999999999999999764 45899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCcccee---ccccccccccccccc
Q 046199 874 KLLNGEESMRT---QTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~---~~~gt~~y~APE~l~ 899 (902)
........... ...+++.|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred eeeccCCCcccccccCCCCceeeChHHhc
Confidence 87754433221 234678999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=239.97 Aligned_cols=170 Identities=28% Similarity=0.416 Sum_probs=145.7
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec----CCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 796 (902)
..+.|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34568899999999999999998864 8899999987543 3456788999999999999999999998864 466
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEc-CCCcEEEEeecCc
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLD-DDMVAHLSDFGIA 873 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a 873 (902)
.++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 89999999999999999654 45899999999999999999999 888 99999999999997 7889999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...... ......||+.|+|||++.
T Consensus 180 ~~~~~~--~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 180 TLKRAS--FAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp GGCCTT--SBEESCSSCCCCCGGGGG
T ss_pred cccccc--ccccccCCcCcCCHHHHh
Confidence 754432 233457999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=247.16 Aligned_cols=180 Identities=23% Similarity=0.463 Sum_probs=140.9
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeee
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISS 790 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~ 790 (902)
.++++.+..++|.+.+.||+|+||.||+|++.. ++.||+|+++... ....+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345556778899999999999999999997642 4589999987543 3345778999999999999999999999
Q ss_pred eecCC-----eeEEEEEccCCCChHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc
Q 046199 791 CSNGN-----FKALVLEYMANGSLEKCLYS-----SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD 860 (902)
Q Consensus 791 ~~~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~ 860 (902)
+.+.+ ..++||||+++++|.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEc
Confidence 97654 35999999999999999843 3356899999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 861 DDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 861 ~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
.++.+||+|||+++........ .....+++.|+|||++.
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 222 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 222 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhc
Confidence 9999999999999876543321 22245788999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=247.44 Aligned_cols=177 Identities=22% Similarity=0.309 Sum_probs=147.5
Q ss_pred HHHhhccccccc-CeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCC-CCCccceeeeeecC
Q 046199 720 ELLLATDHFSEK-SLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVR-HRNLVKIISSCSNG 794 (902)
Q Consensus 720 ~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 794 (902)
......++|.+. +.||+|+||.||+|++.. ++.||+|+++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556778887 899999999999999864 8999999987543 234578899999999995 69999999999999
Q ss_pred CeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEee
Q 046199 795 NFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDF 870 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DF 870 (902)
+..|+||||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999988543 356899999999999999999999 999999999999999988 789999999
Q ss_pred cCceecCCCccceecccccccccccccccc
Q 046199 871 GIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 871 G~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+++....... .....||+.|+|||++..
T Consensus 179 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~ 207 (327)
T 3lm5_A 179 GMSRKIGHACE-LREIMGTPEYLAPEILNY 207 (327)
T ss_dssp GGCEEC----------CCCGGGCCHHHHTT
T ss_pred ccccccCCccc-cccccCCcCccCCeeecC
Confidence 99987654332 233679999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=248.68 Aligned_cols=172 Identities=27% Similarity=0.420 Sum_probs=140.0
Q ss_pred hcccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeec-cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..++|++.+.||+|+||.||+|++.. ++ +||+|.++.. .....+.+.+|+.+++.++||||+++++++..++ .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 45789999999999999999998754 44 3577776543 2345678999999999999999999999998765 7
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++|+||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8999999999999999887778999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccc--eeccccccccccccccc
Q 046199 878 GEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
..... .....+|+.|+|||++.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~ 192 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESIL 192 (327)
T ss_dssp -----------CCCGGGSCHHHHH
T ss_pred CccccccccCCCccccccCHHHHc
Confidence 43322 22245788999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=244.44 Aligned_cols=169 Identities=29% Similarity=0.456 Sum_probs=137.0
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..++|++.+.||+|+||.||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 457899999999999999999988 4788999998643 345788999999999999999999999874 47899999
Q ss_pred cCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-EEEEeecCceecCCCc
Q 046199 804 MANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV-AHLSDFGIAKLLNGEE 880 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~~ 880 (902)
+++++|.+++..... .+++..+..++.|++.||+|||..+.+||+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999976443 4788999999999999999999221289999999999999998886 799999999765432
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 160 --~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp -------CCTTSSCHHHHTC
T ss_pred --cccCCCCCceEChhhhCC
Confidence 223469999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=269.87 Aligned_cols=175 Identities=27% Similarity=0.447 Sum_probs=150.4
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
.+.+..++|++.+.||+|+||.||+|++.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..|+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 34567789999999999999999999998888899999976532 34789999999999999999999999876 67899
Q ss_pred EEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999653 345899999999999999999999 99999999999999999999999999999987643
Q ss_pred Ccc-ceeccccccccccccccc
Q 046199 879 EES-MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~-~~~~~~gt~~y~APE~l~ 899 (902)
... ......++..|+|||++.
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~ 437 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAAL 437 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHH
T ss_pred CceecccCCcCcccccCHHHhc
Confidence 221 112245678999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=249.43 Aligned_cols=174 Identities=23% Similarity=0.302 Sum_probs=136.2
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeee-------
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSC------- 791 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~------- 791 (902)
+.....+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3456679999999999999999999985 48999999997776666778899999999996 99999999998
Q ss_pred -ecCCeeEEEEEccCCCChHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEE
Q 046199 792 -SNGNFKALVLEYMANGSLEKCLYS--SNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 792 -~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~~~~~~k 866 (902)
......++||||++ |+|.+++.. ....+++..+..++.||+.||+||| +.+ |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence 34456899999996 699888865 3456999999999999999999999 888 99999999999999999999
Q ss_pred EEeecCceecCCCccc------------eecccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESM------------RTQTLGTIGYMAPGLW 898 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~------------~~~~~gt~~y~APE~l 898 (902)
|+|||+++........ .....||+.|+|||++
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp BCCCTTCBCCSSCC------------------------------
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999999876543221 1134589999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=242.86 Aligned_cols=171 Identities=25% Similarity=0.405 Sum_probs=145.2
Q ss_pred cccccCeecccceeeEEEEEeCC----CcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee-EEE
Q 046199 727 HFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK-ALV 800 (902)
Q Consensus 727 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 800 (902)
.|+..+.||+|+||.||+|++.+ +..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999998643 33799999875433 4457889999999999999999999999766554 999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+.+++|.+++......+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999877777899999999999999999999 9999999999999999999999999999998654322
Q ss_pred c----ceecccccccccccccccc
Q 046199 881 S----MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~----~~~~~~gt~~y~APE~l~~ 900 (902)
. ......+|+.|+|||++..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred ccccccCcCCCCCccccChhhhcc
Confidence 1 1223568899999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=250.05 Aligned_cols=168 Identities=26% Similarity=0.324 Sum_probs=135.7
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 795 (902)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 578999999999999999999886 48899999997543 334567889999999999999999999997654
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+++ +|.+++. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999975 7888774 34889999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..... ......||+.|+|||++..
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~ 200 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILG 200 (371)
T ss_dssp --------------CTTCCHHHHTT
T ss_pred ccccc-ccCCceecCCccCHHHhcC
Confidence 64332 2334679999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=241.51 Aligned_cols=172 Identities=24% Similarity=0.379 Sum_probs=144.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc----chhhhhHHHHHHHHHhCCCCCccceeeee--ecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF----DGALKSFDAECEVLKSVRHRNLVKIISSC--SNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|.+.. ++.||+|+++... ....+.+.+|+++++.++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999854 8899999997542 23457889999999999999999999998 445688
Q ss_pred EEEEEccCCCChHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 798 ALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
|+||||++++ +.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7666654 3456899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCc--cceecccccccccccccccc
Q 046199 877 NGEE--SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~--~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .......||+.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred CccccccccccCCCCCCCcChhhccC
Confidence 5322 22234569999999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=252.30 Aligned_cols=168 Identities=26% Similarity=0.390 Sum_probs=128.4
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG------ 794 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 794 (902)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999875 48899999987543 23457788999999999999999999998654
Q ss_pred CeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 795 NFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 795 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
...|+||||+ +++|.+++.. ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+|+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5689999999 6799998854 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..... .....||+.|+|||++..
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 181 HTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp -------------CCCTTCCHHHHTT
T ss_pred ccccc---CCCcCcCcCccChHHHcC
Confidence 75432 234679999999998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-29 Score=294.00 Aligned_cols=163 Identities=10% Similarity=0.026 Sum_probs=99.1
Q ss_pred CCCCcEEEeecceecccCCcccc-cccccCeeecccccccCCCCCcCCCCCeEeccCccccC-----CCCccccCCCcCc
Q 046199 416 LVNLTTLHLGNNQLSGSIPITVG-RLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSG-----PIPACFGNLNSLR 489 (902)
Q Consensus 416 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~ 489 (902)
+++|+.|+++.|.+++..+..+. .+++|+.|+++.|...+ -|.+++ .++..+..+++|+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~---------------~~~l~~~~~~~~~~~l~~~~~~L~ 435 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKA---------------PDYLTLEPLDIGFGAIVEHCKDLR 435 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTC---------------CCTTTCCCTHHHHHHHHHHCTTCC
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCC---------------cccccCCchhhHHHHHHhhCCCcc
Confidence 56666666666666654444443 35666666666211000 022221 1122355667788
Q ss_pred eEecCCCCccCcccccccC-CCCceEEEcCCCccCCCCcccc-ccccccceeccCCccccccCcc-ccccCCccceEEcc
Q 046199 490 NLSLGSNELSSFIPSTFWN-LNNILSFDFSSNSLNGSLPLDI-GNMKVVVEINLSRNYLTGDIPT-TIGGLTNLQLLSLE 566 (902)
Q Consensus 490 ~L~L~~N~l~~~~~~~~~~-l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 566 (902)
.|++++ .+++..+..+.. +++|++|++++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+.|+++
T Consensus 436 ~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~ 514 (594)
T 2p1m_B 436 RLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514 (594)
T ss_dssp EEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEE
T ss_pred EEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeee
Confidence 888866 666555555554 7778888888888765444444 5578888888888888654444 34458899999999
Q ss_pred CcccCCCccccc-cccccCCeEeCcCccc
Q 046199 567 NNRLHGPIPESF-GALTSLESLDLSVNNL 594 (902)
Q Consensus 567 ~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l 594 (902)
+|+++......+ ..+++|+...+..+.-
T Consensus 515 ~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 515 SCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp SSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred CCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 998854434444 4567777766665543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=248.49 Aligned_cols=170 Identities=26% Similarity=0.342 Sum_probs=145.6
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----Ce
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 796 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999986 48889999997543 33457889999999999999999999998654 46
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+++ +|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++..
T Consensus 105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 8999999975 99998865 35899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc---eeccccccccccccccc
Q 046199 877 NGEESM---RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~---~~~~~gt~~y~APE~l~ 899 (902)
...... .....||+.|+|||++.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 204 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIML 204 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhc
Confidence 533221 23357999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=250.33 Aligned_cols=172 Identities=22% Similarity=0.226 Sum_probs=139.1
Q ss_pred hcccccccCeecccceeeEEEEEeC----CCcEEEEEEeeeccch-----------hhhhHHHHHHHHHhCCCCCcccee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQFDG-----------ALKSFDAECEVLKSVRHRNLVKII 788 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~ 788 (902)
..++|++.+.||+|+||.||+|++. .+..||+|++...... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4578999999999999999999986 4778999998755321 123466788899999999999999
Q ss_pred eeeec----CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-
Q 046199 789 SSCSN----GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM- 863 (902)
Q Consensus 789 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~- 863 (902)
+++.. .+..|+||||+ +++|.+++.... .+++..+..++.||+.||+||| ++||+||||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence 99877 78899999999 999999986544 6899999999999999999999 99999999999999998887
Q ss_pred -cEEEEeecCceecCCCcc-------ceecccccccccccccccc
Q 046199 864 -VAHLSDFGIAKLLNGEES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 -~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
.+||+|||+|+.+..... ......||+.|+|||++..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG 234 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC
Confidence 999999999987643221 1133579999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=246.59 Aligned_cols=172 Identities=28% Similarity=0.445 Sum_probs=142.9
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcE--EEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GME--VAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 798 (902)
..++|++.+.||+|+||.||+|++.. +.. ||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..|
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 34789999999999999999998754 554 4999887532 33457789999999999 8999999999999999999
Q ss_pred EEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 799 LVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
+||||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCC
Confidence 9999999999999997543 36899999999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCccceeccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+||+|||+++...... ......+++.|+|||++.
T Consensus 180 ~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 214 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLN 214 (327)
T ss_dssp CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHH
T ss_pred eEEEcccCcCccccccc-cccCCCCCccccChhhhc
Confidence 99999999997533211 122245788999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=240.23 Aligned_cols=171 Identities=26% Similarity=0.427 Sum_probs=142.2
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeee-ecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+++++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999974 58899999876543 235688999999999988877666655 6778889999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 878 (902)
||+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||+|+....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 89999999876777999999999999999999999 9999999999999999 7889999999999987654
Q ss_pred Ccc-------ceecccccccccccccccc
Q 046199 879 EES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
... ......||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTT
T ss_pred cccCccCCCCcccccCCCccccchHHhcC
Confidence 432 1223579999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-26 Score=267.59 Aligned_cols=172 Identities=24% Similarity=0.436 Sum_probs=142.1
Q ss_pred hcccccccC-eecccceeeEEEEEeC---CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 724 ATDHFSEKS-LIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 724 ~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
..+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..|
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344555555 7999999999999874 36679999997653 3456789999999999999999999999976 5689
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+||||+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999999777777999999999999999999999 99999999999999999999999999999987643
Q ss_pred Cccce---eccccccccccccccc
Q 046199 879 EESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~---~~~~gt~~y~APE~l~ 899 (902)
..... ....+|+.|+|||++.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp -------------CCTTSCHHHHH
T ss_pred CCceeeeccCCCCccceeCHhhhc
Confidence 33211 1234568999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=242.06 Aligned_cols=173 Identities=24% Similarity=0.359 Sum_probs=139.2
Q ss_pred hhcccccccCeecccceeeEEEEEeC--CCc--EEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL--DGM--EVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+..++|++.+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|+++++.++||||+++++++..++
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34578999999999999999999863 233 68999987542 345678899999999999999999999998765
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 78999999999999999776667899999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCccce---eccccccccccccccc
Q 046199 876 LNGEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
........ ....+|+.|+|||++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred ccccccchhhhccCCCCceeeCchhhc
Confidence 75443321 2245788999999874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=231.19 Aligned_cols=206 Identities=27% Similarity=0.290 Sum_probs=136.7
Q ss_pred ccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccc
Q 046199 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKL 474 (902)
Q Consensus 395 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l 474 (902)
.+.++++++.++ .+|..+. +++++|+|++|++++..+..|..+++|++|++++|+++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------- 74 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-------------------- 74 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS--------------------
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC--------------------
Confidence 445555555555 2333332 35556666666655444445555555554444444443
Q ss_pred cCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcccc
Q 046199 475 SGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554 (902)
Q Consensus 475 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 554 (902)
+..+..|.++++|++|++++|+++++.+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|
T Consensus 75 -~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 153 (270)
T 2o6q_A 75 -TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153 (270)
T ss_dssp -CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred -eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHc
Confidence 2333445566666666666666666655666666667777777777766666666777777777777777776666667
Q ss_pred ccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|.+.++.
T Consensus 154 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 7888888888888888876677788888888888888888876666778888888888888888877653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=238.69 Aligned_cols=171 Identities=26% Similarity=0.429 Sum_probs=145.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeee-ecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC-SNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 3578999999999999999999974 58999999987543 235788999999999988866665554 6678889999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 878 (902)
||+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 88999999866677999999999999999999999 9999999999999999 4888999999999987755
Q ss_pred Cccc-------eecccccccccccccccc
Q 046199 879 EESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLG 189 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccccccccccCChhhhcC
Confidence 4321 233579999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=253.42 Aligned_cols=170 Identities=21% Similarity=0.314 Sum_probs=145.7
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhC------CCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSV------RHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 795 (902)
....+|++.+.||+|+||.||+|++.. ++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++...+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 345689999999999999999998865 889999999754 23446777888888877 5779999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecC
Q 046199 796 FKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV--AHLSDFGI 872 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~--~kL~DFG~ 872 (902)
..++||||++ ++|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999996 58999887654 45899999999999999999999 999999999999999999887 99999999
Q ss_pred ceecCCCccceecccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|+..... .....||+.|+|||++..
T Consensus 249 a~~~~~~---~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 249 SCYEHQR---VYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHHT
T ss_pred ceecCCc---ccccCCCCCccChHHHhC
Confidence 9865432 234679999999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-26 Score=246.84 Aligned_cols=174 Identities=25% Similarity=0.412 Sum_probs=144.0
Q ss_pred hhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
+..++|++.+.||+|+||.||+|++. +++.||+|++.... .....++.+|+.++++++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45689999999999999999999842 37789999987443 344567899999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEE
Q 046199 796 FKALVLEYMANGSLEKCLYSSN------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAH 866 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~k 866 (902)
..|+||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997654 34889999999999999999999 999999999999999984 44699
Q ss_pred EEeecCceecCCCcc--ceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~l~ 899 (902)
|+|||+++....... ......||+.|+|||++.
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 218 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence 999999976543322 122356789999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=250.90 Aligned_cols=169 Identities=30% Similarity=0.423 Sum_probs=138.9
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC------Cee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG------NFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 797 (902)
...+|++.+.||+|+||.||+|++..+..||+|++.... ....+|+++++.++||||+++++++... ...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 346799999999999999999999887789999886432 2234799999999999999999998543 348
Q ss_pred EEEEEccCCCChHHHH--hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCce
Q 046199 798 ALVLEYMANGSLEKCL--YSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAK 874 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~ 874 (902)
++||||++++.+.... ......+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+|+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8999999875433322 123566899999999999999999999 99999999999999999 79999999999998
Q ss_pred ecCCCccceecccccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
....... .....||+.|+|||++..
T Consensus 191 ~~~~~~~-~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 191 ILIAGEP-NVSYICSRYYRAPELIFG 215 (394)
T ss_dssp ECCTTCC-CCSSCSCGGGCCHHHHTT
T ss_pred cccCCCC-CcccccCcCccCHHHHcC
Confidence 7654333 234678999999998743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=242.49 Aligned_cols=169 Identities=28% Similarity=0.405 Sum_probs=138.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeee-----------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS----------- 792 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 792 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4789999999999999999999875 8999999998766666788999999999999999999998873
Q ss_pred ---cCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEE
Q 046199 793 ---NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLS 868 (902)
Q Consensus 793 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~ 868 (902)
+.+..|+||||++ |+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4468899999997 599998853 45899999999999999999999 99999999999999997 56799999
Q ss_pred eecCceecCCCcc---ceeccccccccccccccc
Q 046199 869 DFGIAKLLNGEES---MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 869 DFG~a~~~~~~~~---~~~~~~gt~~y~APE~l~ 899 (902)
|||.++....... ......+|+.|+|||++.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhc
Confidence 9999987643221 122346799999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=251.27 Aligned_cols=167 Identities=31% Similarity=0.456 Sum_probs=138.1
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec------CCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 797 (902)
..+|++.+.||+|+||.||+|++.. ++.||||++.... ....+|+++++.++||||+++++++.. ..+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4579999999999999999999864 8999999986542 233479999999999999999998843 2246
Q ss_pred EEEEEccCCCChHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLY---SSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a 873 (902)
++||||+++ ++.+.+. .....+++..+..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999976 6665553 34567999999999999999999999 9999999999999999965 57899999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+....... .....||+.|+|||++..
T Consensus 205 ~~~~~~~~-~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 205 KQLVRGEP-NVSYICSRYYRAPELIFG 230 (420)
T ss_dssp EECCTTCC-CCSCCSCTTSCCHHHHTT
T ss_pred hhcccCCC-ceeeeeCCCcCCHHHHcC
Confidence 87654332 234678999999998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=252.04 Aligned_cols=171 Identities=25% Similarity=0.378 Sum_probs=146.5
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCC-CCccceeeeeecCCeeEEEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 801 (902)
..++|++.+.||+|+||.||+|++. +++.||||++..... .+.+.+|+++++.++| ++|+.+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3578999999999999999999975 489999998765432 3568899999999986 56666667778888999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceecCC
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL---DDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 878 (902)
||+ +++|.+++......+++..+..++.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 89999999876778999999999999999999999 9999999999999999 6889999999999988765
Q ss_pred Cccc-------eecccccccccccccccc
Q 046199 879 EESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred CccccccccccccccCCCccccCHHHhcC
Confidence 4322 124679999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-26 Score=252.78 Aligned_cols=169 Identities=12% Similarity=0.090 Sum_probs=127.4
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc---hhhhhHHHHHHHHHhC--CCCCcccee-------eee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSV--RHRNLVKII-------SSC 791 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 791 (902)
..+|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999986 589999999987542 3456777886555544 699988755 333
Q ss_pred ecC-----------------CeeEEEEEccCCCChHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHccCCCCeE
Q 046199 792 SNG-----------------NFKALVLEYMANGSLEKCLYSSNRSLDIFQR------LSIMIDVALALEYLHFGYSNPVV 848 (902)
Q Consensus 792 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~~~~iv 848 (902)
... ...|+||||++ |+|.+++...+...++..+ ..++.||+.||+||| ++||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 322 34799999998 7999999764444455555 677899999999999 99999
Q ss_pred EcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 849 HCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 849 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
||||||+||+++.++.+||+|||+|+..... .....+|+.|+|||++..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccC
Confidence 9999999999999999999999999876432 224567799999999853
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-26 Score=242.78 Aligned_cols=169 Identities=33% Similarity=0.460 Sum_probs=138.4
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecC-CeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNG-NFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv 800 (902)
....++|++.+.||+|+||.||+|++ +++.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..|+|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 45568999999999999999999987 48899999987543 457889999999999999999999987544 578999
Q ss_pred EEccCCCChHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|||+++++|.+++..... .+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999865432 3788999999999999999999 999999999999999999999999999999865432
Q ss_pred ccceeccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~ 899 (902)
. ....+++.|+|||++.
T Consensus 171 ~---~~~~~~~~y~aPE~~~ 187 (278)
T 1byg_A 171 Q---DTGKLPVKWTAPEALR 187 (278)
T ss_dssp --------CCTTTSCHHHHH
T ss_pred c---cCCCccccccCHHHhC
Confidence 2 2245788999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=241.76 Aligned_cols=177 Identities=27% Similarity=0.416 Sum_probs=149.3
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHh--CCCCCccceeeeeecCC
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKS--VRHRNLVKIISSCSNGN 795 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 795 (902)
........++|++.+.||+|+||.||+|++ +++.||+|+++.. ..+.+.+|+++++. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445568999999999999999999998 5899999998643 34667789998887 78999999999998775
Q ss_pred ----eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcEE
Q 046199 796 ----FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNILLDDDMVAH 866 (902)
Q Consensus 796 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~k 866 (902)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||.. ++.+|+||||||+||+++.++.+|
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred CccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999653 589999999999999999999921 147999999999999999999999
Q ss_pred EEeecCceecCCCccc----eecccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESM----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~----~~~~~gt~~y~APE~l~~ 900 (902)
|+|||+++........ .....||+.|+|||++..
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 9999999876554322 233579999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=244.30 Aligned_cols=170 Identities=25% Similarity=0.353 Sum_probs=143.7
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----Ce
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 796 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+++++.++||||+++++++..+ ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999986 48899999996543 33456788999999999999999999987654 67
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||++ ++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|+..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999997 599998865 45899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc----------eeccccccccccccccc
Q 046199 877 NGEESM----------RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~----------~~~~~gt~~y~APE~l~ 899 (902)
...... .....||+.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeec
Confidence 532211 11246899999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=251.64 Aligned_cols=170 Identities=25% Similarity=0.328 Sum_probs=129.1
Q ss_pred cccccc-cCeecccceeeEEEEEeC---CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeee--cCCeeE
Q 046199 725 TDHFSE-KSLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCS--NGNFKA 798 (902)
Q Consensus 725 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 798 (902)
.+.|++ .++||+|+||.||+|++. +++.||+|++.... ..+.+.+|+++++.++||||+++++++. .+...|
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345766 558999999999999975 47889999986442 2357889999999999999999999994 477899
Q ss_pred EEEEccCCCChHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEE
Q 046199 799 LVLEYMANGSLEKCLYSS--------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL----DDDMVAH 866 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll----~~~~~~k 866 (902)
+||||+++ +|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 887776421 124899999999999999999999 9999999999999999 6778999
Q ss_pred EEeecCceecCCCcc---ceecccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 867 L~DFG~a~~~~~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
|+|||+|+....... .....+||+.|+|||++..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 999999987654321 2233679999999998864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=265.13 Aligned_cols=177 Identities=27% Similarity=0.400 Sum_probs=147.7
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
.+..+..++|++.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3445567889999999999999999998743 4679999887543 334578899999999999999999999985
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
++..|+||||+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 45689999999999999999877667999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccce-eccccccccccccccc
Q 046199 874 KLLNGEESMR-TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~-~~~~gt~~y~APE~l~ 899 (902)
+......... ....+|+.|||||++.
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhc
Confidence 8765433222 2245778999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-26 Score=249.60 Aligned_cols=167 Identities=20% Similarity=0.241 Sum_probs=142.1
Q ss_pred cccccccCeecccceeeEEEEEeCC---------CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccc---------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD---------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK--------- 786 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 786 (902)
.++|++.+.||+|+||.||+|++.. ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999864 788999998744 57889999999999999887
Q ss_pred ------eeeeeec-CCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 046199 787 ------IISSCSN-GNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNIL 858 (902)
Q Consensus 787 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIl 858 (902)
+++++.. ++..|+||||+ +++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5666655 78899999999 99999999765 356999999999999999999999 999999999999999
Q ss_pred EcCCC--cEEEEeecCceecCCCcc-------ceecccccccccccccccc
Q 046199 859 LDDDM--VAHLSDFGIAKLLNGEES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 859 l~~~~--~~kL~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
++.++ .+||+|||+|+.+..... ......||+.|+|||++..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 99998 999999999987653321 1123479999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=250.17 Aligned_cols=169 Identities=27% Similarity=0.364 Sum_probs=142.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC--------CCCccceeeeee--
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR--------HRNLVKIISSCS-- 792 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 792 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++.. ....+.+.+|+++++.++ ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 35789999999999999999998754 889999998744 334577889999999985 788999999987
Q ss_pred --cCCeeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCC-----
Q 046199 793 --NGNFKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDM----- 863 (902)
Q Consensus 793 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~----- 863 (902)
.....|+||||+. +++.+++... ...+++..+..++.||+.||+||| ++ ||+||||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence 5568999999994 5665655443 356999999999999999999999 88 999999999999999775
Q ss_pred --------------------------------------------cEEEEeecCceecCCCccceeccccccccccccccc
Q 046199 864 --------------------------------------------VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 864 --------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.+||+|||.|+..... .....||+.|+|||++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc
Confidence 7999999999876433 23357999999999875
Q ss_pred c
Q 046199 900 V 900 (902)
Q Consensus 900 ~ 900 (902)
.
T Consensus 267 ~ 267 (397)
T 1wak_A 267 G 267 (397)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=240.64 Aligned_cols=172 Identities=30% Similarity=0.437 Sum_probs=145.0
Q ss_pred hcccccccCeecccceeeEEEEEeC--CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhC---CCCCccceeeeee----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFD--GALKSFDAECEVLKSV---RHRNLVKIISSCS---- 792 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 792 (902)
..++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999984 488999999875432 2235677888887776 8999999999987
Q ss_pred -cCCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 046199 793 -NGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDF 870 (902)
Q Consensus 793 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 870 (902)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678899999998 59999987643 34899999999999999999999 999999999999999999999999999
Q ss_pred cCceecCCCccceecccccccccccccccc
Q 046199 871 GIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 871 G~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
|.++...... ......||+.|+|||++..
T Consensus 165 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 165 GLARIYSFQM-ALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp CSCCCCCGGG-GGCCCCCCCTTCCHHHHTT
T ss_pred cccccccCCC-CccccccccceeCHHHHhc
Confidence 9998754322 2334678999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=246.25 Aligned_cols=166 Identities=26% Similarity=0.379 Sum_probs=140.3
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee----
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK---- 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 797 (902)
.++|.+.+.||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4789999999999999999999864 8999999997543 23457888999999999999999999999877654
Q ss_pred --EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 798 --ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 798 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
|+||||++ ++|.+++. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|+.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 58888763 34899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSC
T ss_pred cccC---cCCcccCccccCHHHhcC
Confidence 5432 234678999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=236.17 Aligned_cols=172 Identities=25% Similarity=0.397 Sum_probs=148.5
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
...++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..|+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 58999999987543 2345788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceec
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD---MVAHLSDFGIAKLL 876 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~kL~DFG~a~~~ 876 (902)
||||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.+ +.+||+|||.+...
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999888654 35899999999999999999999 9999999999999999764 47999999999876
Q ss_pred CCCccceeccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
..... .....||+.|+|||++.
T Consensus 175 ~~~~~-~~~~~~~~~y~aPE~~~ 196 (287)
T 2wei_A 175 QQNTK-MKDRIGTAYYIAPEVLR 196 (287)
T ss_dssp CCCSS-CSCHHHHHTTCCHHHHT
T ss_pred cCCCc-cccccCcccccChHHhc
Confidence 54332 23346899999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=264.12 Aligned_cols=164 Identities=27% Similarity=0.427 Sum_probs=136.0
Q ss_pred CeecccceeeEEEEEeC---CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFL---DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 36789999997543 2345789999999999999999999999975 457899999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc---e
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM---R 883 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~---~ 883 (902)
|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.+...... .
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999654 46899999999999999999999 999999999999999999999999999999876543321 2
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....+|+.|+|||++..
T Consensus 530 ~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 530 THGKWPVKWYAPECINY 546 (635)
T ss_dssp -----CGGGSCHHHHHH
T ss_pred cCCCCceeeeChhhhcC
Confidence 22457789999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=246.52 Aligned_cols=179 Identities=24% Similarity=0.418 Sum_probs=148.8
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN 793 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 793 (902)
....++.+..++|++.+.||+|+||.||+|++.+ .||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4455667788999999999999999999998754 59999987543 2334677889999999999999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
.+..++||||+++++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++ ++.+||+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999999776667999999999999999999999 99999999999999998 679999999998
Q ss_pred eecCCCc-----cceecccccccccccccccc
Q 046199 874 KLLNGEE-----SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~ 900 (902)
+...... .......||+.|+|||++..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccccccCCCcccccChHHhhh
Confidence 7643211 11223468999999998853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.8e-25 Score=240.11 Aligned_cols=169 Identities=21% Similarity=0.320 Sum_probs=145.3
Q ss_pred hcccccccCeecccceeeEEEEEeC--CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCC------CccceeeeeecCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR------NLVKIISSCSNGN 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~ 795 (902)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.. ....+.+.+|+++++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 4578999999999999999999873 4889999998744 33457788999999988765 4999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-------------
Q 046199 796 FKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD------------- 861 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~------------- 861 (902)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999987654 35889999999999999999999 999999999999999987
Q ss_pred ------CCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 862 ------DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 862 ------~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++.+||+|||.++..... .....||+.|+|||++..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT
T ss_pred ccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC
Confidence 668999999999875432 234579999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=253.32 Aligned_cols=171 Identities=26% Similarity=0.430 Sum_probs=139.3
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 800 (902)
.+...+|.+.+.||+|+||.||.....+++.||||++.... ...+.+|+++++.+ +||||+++++++.+.+..|+|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 45566899999999999999766555679999999986432 24467899999999 799999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-----CCcEEEEeecCcee
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-----DMVAHLSDFGIAKL 875 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~kL~DFG~a~~ 875 (902)
|||++ |+|.+++........+..+..++.||+.||+||| ++||+||||||+||+++. ...+||+|||+|+.
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99996 5999999776655666677899999999999999 999999999999999953 23688999999987
Q ss_pred cCCCc---cceeccccccccccccccc
Q 046199 876 LNGEE---SMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~---~~~~~~~gt~~y~APE~l~ 899 (902)
..... .......||+.|+|||++.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp C------------CCSCTTSCCGGGTS
T ss_pred ccCCCcceeeccccCCCcCccChhhhh
Confidence 65432 1223467999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=266.52 Aligned_cols=165 Identities=27% Similarity=0.371 Sum_probs=141.8
Q ss_pred hcccccccCeecccceeeEEEEEeC--CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe----
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF---- 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 796 (902)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999985 58999999986543 3445678899999999999999999999987654
Q ss_pred -eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 797 -KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 797 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.|+||||++|++|.+++.. .+++..+..++.||+.||+||| ++||+||||||+||+++.+ .+||+|||+++.
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987743 6899999999999999999999 9999999999999999986 999999999988
Q ss_pred cCCCccceeccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.... ....||+.|||||++.
T Consensus 231 ~~~~----~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 231 INSF----GYLYGTPGFQAPEIVR 250 (681)
T ss_dssp TTCC----SCCCCCTTTSCTTHHH
T ss_pred cccC----CccCCCccccCHHHHc
Confidence 6543 3357999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=241.97 Aligned_cols=176 Identities=28% Similarity=0.344 Sum_probs=134.2
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC---
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN--- 795 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 795 (902)
......++|++.+.||+|+||.||+|++. +++.||||++.... .......+|++.++.++||||+++++++...+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999985 48999999986542 33456677888889999999999999986533
Q ss_pred ----eeEEEEEccCCCChHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEE
Q 046199 796 ----FKALVLEYMANGSLEKCLY---SSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHL 867 (902)
Q Consensus 796 ----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL 867 (902)
..++||||+++ ++.+.+. .....+++..+..++.|++.|++||| .+++||+||||||+||+++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 37899999987 5544433 24556889999999999999999999 45789999999999999997 899999
Q ss_pred EeecCceecCCCccceeccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+|||+|+....... .....||+.|+|||++.
T Consensus 174 ~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~ 204 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP-NVAYICSRYYRAPELIF 204 (360)
T ss_dssp CCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHT
T ss_pred eeCCCceecCCCCC-cccccCCcceeCHHHHc
Confidence 99999987654432 33457899999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-25 Score=240.00 Aligned_cols=175 Identities=27% Similarity=0.292 Sum_probs=148.2
Q ss_pred HHHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc------hhhhhHHHHHHHHHhCC--CCCccceee
Q 046199 719 RELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVR--HRNLVKIIS 789 (902)
Q Consensus 719 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~ 789 (902)
.+.....++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344556789999999999999999999875 488999999975432 12356778999999996 599999999
Q ss_pred eeecCCeeEEEEEccCC-CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEE
Q 046199 790 SCSNGNFKALVLEYMAN-GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHL 867 (902)
Q Consensus 790 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL 867 (902)
++..++..++||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999999986 8999998654 45899999999999999999999 99999999999999999 7889999
Q ss_pred EeecCceecCCCccceeccccccccccccccc
Q 046199 868 SDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 868 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+|||+++...... .....||+.|+|||++.
T Consensus 192 ~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~ 221 (320)
T 3a99_A 192 IDFGSGALLKDTV--YTDFDGTRVYSPPEWIR 221 (320)
T ss_dssp CCCTTCEECCSSC--BCCCCSCGGGSCHHHHH
T ss_pred eeCcccccccccc--ccCCCCCccCCChHHhc
Confidence 9999998765432 23456999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=241.25 Aligned_cols=179 Identities=24% Similarity=0.377 Sum_probs=146.3
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCC--CCCccceeeee
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVR--HRNLVKIISSC 791 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 791 (902)
+.+..+....++|++.+.||+|+||.||+|++.+++.||+|++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33344456678899999999999999999999889999999997543 334578899999999997 59999999999
Q ss_pred ecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 792 SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 792 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
..++..|+||| +.+++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||++++ +.+||+|||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence 99999999999 5578999999764 46899999999999999999999 999999999999999975 799999999
Q ss_pred CceecCCCccc--eecccccccccccccccc
Q 046199 872 IAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
+++........ .....||+.|+|||++..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTT
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 99876543321 223568999999999754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=227.33 Aligned_cols=207 Identities=27% Similarity=0.318 Sum_probs=154.1
Q ss_pred CCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeec
Q 046199 369 SSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGL 448 (902)
Q Consensus 369 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 448 (902)
++++|++++|.+.+..+..+..++ +|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCT-TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccCHhHhcccc-CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 344455555555444445566666 7777788878777777777888888888888888888777777777777777776
Q ss_pred ccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCc-ccccccCCCCceEEEcCCCccCCCCc
Q 046199 449 ENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSF-IPSTFWNLNNILSFDFSSNSLNGSLP 527 (902)
Q Consensus 449 ~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~~ 527 (902)
++|++. +..+..+.++++|++|++++|++++. +|..|..+++|++|++++|++++..+
T Consensus 108 ~~n~l~---------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 108 VETNLA---------------------SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp TTSCCC---------------------CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CCCCcc---------------------ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 666665 23333466777777777777777764 47777777888888888888877666
Q ss_pred cccccccccc----eeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccC
Q 046199 528 LDIGNMKVVV----EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVI 598 (902)
Q Consensus 528 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (902)
..+..+..|+ +|++++|++++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 7777777666 7889999998665555544 48999999999999877777899999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=240.82 Aligned_cols=174 Identities=30% Similarity=0.336 Sum_probs=139.2
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc------hhhhhHHHHHHHHHhC----CCCCcccee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSV----RHRNLVKII 788 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~ 788 (902)
+.....++|++.+.||+|+||.||+|++. +++.||+|+++.... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556788999999999999999999875 488999999865432 2234566799999998 899999999
Q ss_pred eeeecCCeeEEEEEc-cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEE
Q 046199 789 SSCSNGNFKALVLEY-MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAH 866 (902)
Q Consensus 789 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~k 866 (902)
+++...+..++|||| +++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 7899999998764 45899999999999999999999 99999999999999999 889999
Q ss_pred EEeecCceecCCCccceeccccccccccccccc
Q 046199 867 LSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 867 L~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
|+|||+++...... .....||+.|+|||++.
T Consensus 181 l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~ 211 (312)
T 2iwi_A 181 LIDFGSGALLHDEP--YTDFDGTRVYSPPEWIS 211 (312)
T ss_dssp ECCCSSCEECCSSC--BCCCCSCTTTSCHHHHH
T ss_pred EEEcchhhhcccCc--ccccCCcccccCceeee
Confidence 99999998765432 23456999999999874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=229.30 Aligned_cols=137 Identities=26% Similarity=0.199 Sum_probs=84.3
Q ss_pred CCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceE
Q 046199 484 NLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLL 563 (902)
Q Consensus 484 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 563 (902)
.+++|+.|++++|+++. +|..+..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 34444555555555443 34444555555555555555554444555555566666666666665555556667777777
Q ss_pred EccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecC
Q 046199 564 SLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622 (902)
Q Consensus 564 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 622 (902)
+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.++|++|+|.|.+
T Consensus 154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 77777777555556667777777777777777 56666666677777777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=231.42 Aligned_cols=180 Identities=22% Similarity=0.226 Sum_probs=105.3
Q ss_pred CccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
.++..+++..+.+.+. ..+..+++|+.|++++|.++ .++ .++.+++|++|+|++|.++.+
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~---------------- 78 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI---------------- 78 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC----------------
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc----------------
Confidence 3455566666665532 33456666677777766665 333 366666667777666665421
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCC
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP 308 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 308 (902)
..++.+++|++|+|++|++++..+..+..+++|++|+|++|++++..+.. +..+++|++|++++|++++..+
T Consensus 79 -----~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~ 150 (272)
T 3rfs_A 79 -----SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV---FDKLTNLTYLNLAHNQLQSLPK 150 (272)
T ss_dssp -----GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT---TTTCTTCCEEECCSSCCCCCCT
T ss_pred -----hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHH---hccCCCCCEEECCCCccCccCH
Confidence 34556666666666666666555555666666666666666666443333 4555666666666666665555
Q ss_pred ccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCC
Q 046199 309 GFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356 (902)
Q Consensus 309 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 356 (902)
..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+
T Consensus 151 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 151 GVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred HHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 555556666666666666655555555555555555555555554433
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=242.81 Aligned_cols=166 Identities=26% Similarity=0.377 Sum_probs=139.9
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe-----
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF----- 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 796 (902)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999986 48999999997543 2335678899999999999999999999977654
Q ss_pred -eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 797 -KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 797 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.|+||||++ ++|.+++. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 58887763 34899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|+|||++..
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp -----------CCSBCCSCHHHHSC
T ss_pred CCCC---ccccccCcCcCCHHHHhC
Confidence 5432 234578999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=238.03 Aligned_cols=171 Identities=27% Similarity=0.336 Sum_probs=128.6
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-hhhhhHHHHHH-HHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECE-VLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
...++|++.+.||+|+||.||+|.+. +++.||||+++.... .....+..|+. +++.++||||+++++++..++..++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 45689999999999999999999985 589999999976532 33445556665 6777899999999999999999999
Q ss_pred EEEccCCCChHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 800 VLEYMANGSLEKCLYS----SNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
||||+++ +|.+++.. ....+++..+..++.|++.|++||| +. ||+||||||+||+++.++.+||+|||+++
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999986 88777653 2456899999999999999999999 88 99999999999999999999999999998
Q ss_pred ecCCCccceecccccccccccccc
Q 046199 875 LLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 875 ~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
....... .....||+.|+|||++
T Consensus 175 ~~~~~~~-~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 175 QLVDSIA-KTRDAGCRPYMAPERI 197 (327)
T ss_dssp C-----------------------
T ss_pred ecccccc-cccCCCCccccCceee
Confidence 7654322 2334699999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=242.77 Aligned_cols=175 Identities=27% Similarity=0.320 Sum_probs=146.1
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CC-----Cccceeeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HR-----NLVKIISSCS 792 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~ 792 (902)
......++|++.+.||+|+||.||+|++.. ++.||||+++.. ....+.+..|+++++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 334456899999999999999999999864 889999999743 234567788999988885 44 4999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEe
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSD 869 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL~D 869 (902)
..+..|+||||+++ +|.+++.... ..+++..+..++.|++.||+||| .++.||+||||||+||+++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT-STTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc-cCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999965 9999987654 45899999999999999999999 2347999999999999994 477899999
Q ss_pred ecCceecCCCccceecccccccccccccccc
Q 046199 870 FGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 870 FG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
||+|+..... .....||+.|+|||++..
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTT
T ss_pred ccCceecccc---cccccCCccccChHHHcC
Confidence 9999886433 234679999999999864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=230.20 Aligned_cols=202 Identities=24% Similarity=0.263 Sum_probs=155.2
Q ss_pred CCCCCcEEEeecceecccCCcccccccccCeeecccccccCCC-CCcCCCCCeEeccCccccCCCCccccCCCcCceEec
Q 046199 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPI-PDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493 (902)
Q Consensus 415 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 493 (902)
.+++|+.|++++|.++. + ..+..+++|++|++++|++++.- ...+.+|++|++++|++++..+..|.++++|++|++
T Consensus 39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 33444444444444441 1 12444444444444444444311 012335666666666666777777888999999999
Q ss_pred CCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCC
Q 046199 494 GSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGP 573 (902)
Q Consensus 494 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 573 (902)
++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|+.+++|+.|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 99999988888889999999999999999987777788999999999999999988888889999999999999999988
Q ss_pred ccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCC
Q 046199 574 IPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSG 625 (902)
Q Consensus 574 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 625 (902)
.|..|+.+++|+.|+|++|++.+. +++|+.+++++|.++|.+|..
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred CHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 888899999999999999998865 447899999999999999973
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-24 Score=227.55 Aligned_cols=206 Identities=28% Similarity=0.279 Sum_probs=176.0
Q ss_pred cccccccCeeecccccccCCCCCcCC-CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEE
Q 046199 437 VGRLNTLQGLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515 (902)
Q Consensus 437 ~~~l~~L~~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 515 (902)
+..+++++++++++|.++ .+|..+. +++.|++++|++++..|..|.++++|+.|+|++|+|+++.+. ..+++|++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L 82 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTL 82 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEE
T ss_pred ccccCCccEEECCCCCCC-cCCCCCCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEE
Confidence 445566666666666666 4454443 788888888988888888999999999999999999986443 789999999
Q ss_pred EcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc
Q 046199 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595 (902)
Q Consensus 516 ~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 595 (902)
++++|+++ .+|..+..+++|++|++++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus 83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 99999999 57888999999999999999999888899999999999999999999888888999999999999999999
Q ss_pred ccCCcccccccccccccccCCcceecCCC-CCcccccccccccCCcccCCCCC
Q 046199 596 GVIPISLEKLVYLKDLNLSFNRLEGEIPS-GGSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 596 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
+..+..+..+++|+.|+|++|+++ .+|. ......+....+.+||+.|.+..
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence 776677899999999999999999 4554 34455677788999999988643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=236.21 Aligned_cols=167 Identities=25% Similarity=0.353 Sum_probs=121.9
Q ss_pred hcccccccC-eecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec----CCee
Q 046199 724 ATDHFSEKS-LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 724 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 797 (902)
..++|.+.+ .||+|+||.||+|++. +++.||+|++.... .........++.++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457898854 6999999999999987 48999999986531 112222334567799999999999875 4568
Q ss_pred EEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a 873 (902)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999997654 46899999999999999999999 999999999999999976 456999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+...... .....||+.|+|||++.
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 179 KETTQNA--LQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp EEC-----------------------
T ss_pred eeccccc--cccCCCCcCccChhhhC
Confidence 8764322 23457899999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=238.39 Aligned_cols=169 Identities=22% Similarity=0.327 Sum_probs=143.1
Q ss_pred hcccccccCeecccceeeEEEEEeCC-C-cEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC------ccceeeeeecCC
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-G-MEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN------LVKIISSCSNGN 795 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 795 (902)
..++|++.+.||+|+||.||+|++.. + +.||+|+++.. ....+.+.+|+++++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 45799999999999999999999854 4 68999998743 334577889999999997665 899999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---------------
Q 046199 796 FKALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL--------------- 859 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll--------------- 859 (902)
..++||||+ ++++.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 556766665543 56899999999999999999999 9999999999999999
Q ss_pred ----cCCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 860 ----DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 860 ----~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+.++.+||+|||+++..... .....||+.|+|||++..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE 213 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT
T ss_pred cccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec
Confidence 56789999999999875432 234579999999998753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-26 Score=251.56 Aligned_cols=269 Identities=18% Similarity=0.237 Sum_probs=172.2
Q ss_pred CCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCC--CCCCeeeccccccccCCCccccCCCcceEEEecCccccC
Q 046199 29 TSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNL--SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSG 106 (902)
Q Consensus 29 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~ 106 (902)
.-|.+|.++.|+.. .++.+|++++.+. +..++.+ +.++.|++++|.+++..|. ++.+++|++|+|++|.+++
T Consensus 34 ~vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~ 107 (336)
T 2ast_B 34 GVCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 107 (336)
T ss_dssp SSCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred HHHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence 34668999988643 4788999998876 4556666 8899999999999866554 6789999999999999876
Q ss_pred C-CCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeeccc-ccCCC-CchhhccccccceeecccC
Q 046199 107 S-FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN-KLQGE-IPQELGNLAELEWLSLPRS 183 (902)
Q Consensus 107 ~-~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~n 183 (902)
. +|. .++++++|++|++++|.+++. +|..++.+++|++|+|++| .+++. +|..+..+++|++|++++|
T Consensus 108 ~~~~~-~~~~~~~L~~L~L~~~~l~~~--------~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 108 STLHG-ILSQCSKLQNLSLEGLRLSDP--------IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp HHHHH-HHTTBCCCSEEECTTCBCCHH--------HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred HHHHH-HHhhCCCCCEEeCcCcccCHH--------HHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 5 333 346677777777777776543 4556666777777777777 56542 5666677777777777777
Q ss_pred -cCCCC-CChhhhccC-cccEEeeeeCCCCcccccccccc-CCccccccccCCCccccCCCCCCEEEccCcc-ccCcCCC
Q 046199 184 -FLTGT-IPSSIFNLS-SLLELDFSNNSLTGFYMTNNHFT-GSIPRNLWQCEIPHEIGNLPNLEVLGIDENH-LVGDVPN 258 (902)
Q Consensus 184 -~l~~~-~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~-g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~-l~~~~p~ 258 (902)
.+++. ++..+..++ +|++|+|++|.+. ++ +. +|..+..+++|+.|+|++|. +++..+.
T Consensus 179 ~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~--------~~~~~---------l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKN--------LQKSD---------LSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp TTCCHHHHHHHHHHSCTTCCEEECCSCGGG--------SCHHH---------HHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred CCcChHHHHHHHHhcccCCCEEEeCCCccc--------CCHHH---------HHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 77643 566667777 7777777777321 11 11 23455666777777777777 5555666
Q ss_pred cccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccccc-ccccEEEccCCcccCcccccc
Q 046199 259 TIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA-SKLFLLELTGNSFSGFIPDTL 335 (902)
Q Consensus 259 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~l 335 (902)
.+..+++|+.|++++|. +..+..+..+..+++|++|++++| ++ ...+..+ ..+..|+++.|++++..|..+
T Consensus 242 ~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 242 EFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred HHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 66667777777777764 222333333455555666666555 22 1122222 124444455555554444433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=235.42 Aligned_cols=172 Identities=26% Similarity=0.327 Sum_probs=130.5
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccch--hhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDG--ALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
...++|++.+.||+|+||.||+|++. +++.||||+++..... ..+.+..+..+++.++||||+++++++..++..|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578999999999999999999986 5899999999765332 22344455567888899999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+ ++.+..+.......+++..+..++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 55666666555567899999999999999999999 75 999999999999999999999999999977654
Q ss_pred Cccceeccccccccccccccc
Q 046199 879 EESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~~~~~~~gt~~y~APE~l~ 899 (902)
... .....||+.|+|||++.
T Consensus 178 ~~~-~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 178 DKA-KDRSAGCAAYMAPERID 197 (318)
T ss_dssp ----------CCTTCCHHHHC
T ss_pred Ccc-ccccCCCccccChhhcc
Confidence 322 23356999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=245.58 Aligned_cols=168 Identities=28% Similarity=0.390 Sum_probs=132.1
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEEEEEcc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++.+ +||||+++++++.+++..|+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776678999999998654 235678899999876 8999999999999999999999999
Q ss_pred CCCChHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-------------CcE
Q 046199 805 ANGSLEKCLYSSNRS------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD-------------MVA 865 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-------------~~~ 865 (902)
+ |+|.+++...... .++..+..++.||+.||+||| ++||+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999999654321 122345789999999999999 9999999999999999754 489
Q ss_pred EEEeecCceecCCCccc----eecccccccccccccccc
Q 046199 866 HLSDFGIAKLLNGEESM----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 866 kL~DFG~a~~~~~~~~~----~~~~~gt~~y~APE~l~~ 900 (902)
||+|||+|+........ .....||+.|+|||++..
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 99999999987654321 223579999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=255.17 Aligned_cols=172 Identities=30% Similarity=0.441 Sum_probs=145.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeec------CCe
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNF 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 796 (902)
.++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999885 48999999987543 3446788999999999999999999998765 677
Q ss_pred eEEEEEccCCCChHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeec
Q 046199 797 KALVLEYMANGSLEKCLYSSNR--SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV---AHLSDFG 871 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~---~kL~DFG 871 (902)
.|+||||++||+|.+++..... .+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976432 5888999999999999999999 999999999999999997764 9999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.+........ .....||+.|+|||++..
T Consensus 170 ~a~~~~~~~~-~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 170 YAKELDQGEL-CTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp CCCBTTSCCC-CCCCCSCCTTCSSCSSCC
T ss_pred cccccccccc-cccccCCcccCChHHhcc
Confidence 9987654432 334679999999998753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=221.12 Aligned_cols=192 Identities=22% Similarity=0.281 Sum_probs=130.5
Q ss_pred CCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCC
Q 046199 29 TSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108 (902)
Q Consensus 29 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~ 108 (902)
.+||.|.|++|... .+.+++++++++ .+|+.+. ++|++|+|++|++++..|..++.+++|++|+|++|.+++.
T Consensus 2 ~~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~- 74 (251)
T 3m19_A 2 KTCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL- 74 (251)
T ss_dssp --CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC-
T ss_pred ccCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc-
Confidence 36999999999643 345788888887 6676655 5788888888888866666777888888888888877753
Q ss_pred CcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCC
Q 046199 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGT 188 (902)
Q Consensus 109 ~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 188 (902)
.|..+..+++|++|+|++|++++..|..++.+++|++|+|++|++++.
T Consensus 75 --------------------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 122 (251)
T 3m19_A 75 --------------------------------SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSL 122 (251)
T ss_dssp --------------------------------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred --------------------------------CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCc
Confidence 334455666777777777777755555666777777777777777755
Q ss_pred CChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCce
Q 046199 189 IPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKA 268 (902)
Q Consensus 189 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (902)
.+..|.++++|++|+|++|+|+.+ | |..|+.+++|++|+|++|++++..+..+..+++|+.
T Consensus 123 ~~~~~~~l~~L~~L~Ls~N~l~~~-----------~--------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 183 (251)
T 3m19_A 123 PSGVFDRLTKLKELRLNTNQLQSI-----------P--------AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT 183 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCC-----------C--------TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred ChhHhccCCcccEEECcCCcCCcc-----------C--------HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 555566677777777777765421 1 234666667777777777776555556666667777
Q ss_pred EeccCccccc
Q 046199 269 LSLLNNTLSG 278 (902)
Q Consensus 269 L~Ls~N~l~~ 278 (902)
|+|++|.+++
T Consensus 184 L~l~~N~~~c 193 (251)
T 3m19_A 184 ITLFGNQFDC 193 (251)
T ss_dssp EECCSCCBCT
T ss_pred EEeeCCceeC
Confidence 7777776653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=218.12 Aligned_cols=182 Identities=22% Similarity=0.280 Sum_probs=160.1
Q ss_pred ccCeeecccccccCCCCCcCC-CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCC
Q 046199 442 TLQGLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSN 520 (902)
Q Consensus 442 ~L~~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N 520 (902)
..++++++++.++ .+|..+. +++.|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CCeEEecCCCCcc-ccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 4556666666666 4555444 7888888888888888888999999999999999999988888999999999999999
Q ss_pred ccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCc
Q 046199 521 SLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPI 600 (902)
Q Consensus 521 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 600 (902)
++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|+.+++|+.|+|++|++++..|.
T Consensus 94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 99988888889999999999999999987777889999999999999999987777899999999999999999988888
Q ss_pred ccccccccccccccCCcceecCCC
Q 046199 601 SLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 601 ~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
.+..+++|+.|++++|+|+|..+.
T Consensus 174 ~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 174 AFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTCTTCCEEECCSCCBCTTSTT
T ss_pred HHhCCCCCCEEEeeCCceeCCccc
Confidence 899999999999999999987554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=239.30 Aligned_cols=169 Identities=21% Similarity=0.380 Sum_probs=143.0
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-----------CCCccceeeee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----------HRNLVKIISSC 791 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 791 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++.. ....+.+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3578999999999999999999985 5889999998743 234567889999998886 89999999998
Q ss_pred ecCC----eeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEc-----
Q 046199 792 SNGN----FKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLD----- 860 (902)
Q Consensus 792 ~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~----- 860 (902)
...+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+||| ++ ||+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence 7654 789999999 88999998764 345899999999999999999999 87 999999999999994
Q ss_pred -CCCcEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 861 -DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 861 -~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
..+.+||+|||+|+..... .....||+.|+|||++..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC
Confidence 4458999999999876432 233579999999998753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=228.05 Aligned_cols=207 Identities=18% Similarity=0.192 Sum_probs=110.1
Q ss_pred CcccEEEcccCcccCcCCcchhccCcccc--cCcCccceeeecccccCCCCc----hhhccccccceeecccCcCCCCCC
Q 046199 117 SSLRAIDCNYNSLSGELPANIFRAIPKDI--GNLTKLKELYLGYNKLQGEIP----QELGNLAELEWLSLPRSFLTGTIP 190 (902)
Q Consensus 117 ~~L~~ldls~n~l~~~~~~~~~~~ip~~~--~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n~l~~~~p 190 (902)
++|++|++++|.+++. +|..+ +.+++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|
T Consensus 91 ~~L~~L~l~~n~l~~~--------~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~ 162 (310)
T 4glp_A 91 SRLKELTLEDLKITGT--------MPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSC 162 (310)
T ss_dssp SCCCEEEEESCCCBSC--------CCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCT
T ss_pred CceeEEEeeCCEeccc--------hhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhH
Confidence 3355555555555433 33343 555666666666666665444 233456666666666666665555
Q ss_pred hhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCC----cccCCCCC
Q 046199 191 SSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPN----TIFNMSTL 266 (902)
Q Consensus 191 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L 266 (902)
..|+++++|++|+|++|++... ..++ .+..++.+++|++|+|++|+++ .+|. .+..+++|
T Consensus 163 ~~~~~l~~L~~L~Ls~N~l~~~--------~~~~-------~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L 226 (310)
T 4glp_A 163 EQVRAFPALTSLDLSDNPGLGE--------RGLM-------AALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQP 226 (310)
T ss_dssp TSCCCCTTCCEEECCSCTTCHH--------HHHH-------TTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCC
T ss_pred HHhccCCCCCEEECCCCCCccc--------hhhh-------HHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCC
Confidence 5666666666666666654310 0000 0122345566666666666665 2222 13455666
Q ss_pred ceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEec
Q 046199 267 KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGL 346 (902)
Q Consensus 267 ~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 346 (902)
++|+|++|++++..|..+..+..+++|++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|++
T Consensus 227 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L 301 (310)
T 4glp_A 227 HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTL 301 (310)
T ss_dssp SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEEC
T ss_pred CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEEC
Confidence 66666666666555555433333456666666666665 3344332 4566666666666543 22 445556666666
Q ss_pred ccccCC
Q 046199 347 GYNYLT 352 (902)
Q Consensus 347 s~N~l~ 352 (902)
++|+++
T Consensus 302 ~~N~l~ 307 (310)
T 4glp_A 302 DGNPFL 307 (310)
T ss_dssp SSTTTS
T ss_pred cCCCCC
Confidence 666554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=248.50 Aligned_cols=157 Identities=20% Similarity=0.233 Sum_probs=123.3
Q ss_pred cccCeecccceeeEEEEEeCCCcEEEEEEeeeccc--------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 729 SEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 729 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
...+.||+|+||.||+|+. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999954 578899998643221 1235689999999999999999666666667778999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++|++|.+++.. +..++.|++.||+||| +++|+||||||+||+++. .+||+|||+|+......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999854 5689999999999999 999999999999999998 99999999999876543
Q ss_pred cce-------ecccccccccccccccc
Q 046199 881 SMR-------TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~-------~~~~gt~~y~APE~l~~ 900 (902)
... ....||+.|||||++..
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 221 24679999999999864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-25 Score=244.76 Aligned_cols=181 Identities=18% Similarity=0.186 Sum_probs=87.9
Q ss_pred EEeccCCcceecCcccCCCCCCCeeeccccccccCCC----ccccCCC-cceEEEecCccccCCCCcccccCCCcccEEE
Q 046199 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIP----SSIFSIS-TLKILILGDNQLSGSFPSFIISNTSSLRAID 123 (902)
Q Consensus 49 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ld 123 (902)
.+++.++++|.+|..+...++|++|||++|++++.-+ ..+..++ +|++|+|++|.+++..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~-------------- 68 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-------------- 68 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH--------------
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH--------------
Confidence 3455556666555555555556666666666653333 3444555 55566665555554322
Q ss_pred cccCcccCcCCcchhccCcccccCc-----CccceeeecccccCCCCchhhccc-----cccceeecccCcCCCCCChhh
Q 046199 124 CNYNSLSGELPANIFRAIPKDIGNL-----TKLKELYLGYNKLQGEIPQELGNL-----AELEWLSLPRSFLTGTIPSSI 193 (902)
Q Consensus 124 ls~n~l~~~~~~~~~~~ip~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~p~~~ 193 (902)
..++.+ ++|++|+|++|++++..+..++.. ++|++|+|++|++++..+..+
T Consensus 69 -------------------~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 129 (362)
T 3goz_A 69 -------------------DELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF 129 (362)
T ss_dssp -------------------HHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred -------------------HHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH
Confidence 222222 455555555555554444433332 555666666665554444333
Q ss_pred hc-----cCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCC-CCCEEEccCccccCcCCCcccC----C
Q 046199 194 FN-----LSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLP-NLEVLGIDENHLVGDVPNTIFN----M 263 (902)
Q Consensus 194 ~~-----l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l 263 (902)
.. .++|++|+|++|.+++.. + ..++..+..++ +|++|+|++|++++..+..+.. +
T Consensus 130 ~~~l~~~~~~L~~L~Ls~N~l~~~~----------~-----~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 194 (362)
T 3goz_A 130 KQAFSNLPASITSLNLRGNDLGIKS----------S-----DELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194 (362)
T ss_dssp HHHHTTSCTTCCEEECTTSCGGGSC----------H-----HHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTS
T ss_pred HHHHHhCCCceeEEEccCCcCCHHH----------H-----HHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhC
Confidence 22 135555555555543210 0 01113333333 5555555555555444333222 2
Q ss_pred -CCCceEeccCcccc
Q 046199 264 -STLKALSLLNNTLS 277 (902)
Q Consensus 264 -~~L~~L~Ls~N~l~ 277 (902)
++|++|+|++|.++
T Consensus 195 ~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 195 PASVTSLDLSANLLG 209 (362)
T ss_dssp CTTCCEEECTTSCGG
T ss_pred CCCCCEEECCCCCCC
Confidence 35555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-24 Score=229.27 Aligned_cols=198 Identities=19% Similarity=0.153 Sum_probs=144.3
Q ss_pred CCCcEEEeecceecccCCccc--ccccccCeeecccccccCCCCC-------cCCCCCeEeccCccccCCCCccccCCCc
Q 046199 417 VNLTTLHLGNNQLSGSIPITV--GRLNTLQGLGLENNKLEGPIPD-------DLCQLSELHVDHNKLSGPIPACFGNLNS 487 (902)
Q Consensus 417 ~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 487 (902)
++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+. .+.+|++|++++|++++..|..|+++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 446666666666665555555 5566666666666666544331 2446777777777777777778888888
Q ss_pred CceEecCCCCccCc---c-cccccCCCCceEEEcCCCccCCCCcc----ccccccccceeccCCccccccCccccccC--
Q 046199 488 LRNLSLGSNELSSF---I-PSTFWNLNNILSFDFSSNSLNGSLPL----DIGNMKVVVEINLSRNYLTGDIPTTIGGL-- 557 (902)
Q Consensus 488 L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-- 557 (902)
|++|+|++|++.+. . +..+..+++|++|++++|+++. ++. .+..+++|++|+|++|+|++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 88888888887652 2 2234678888888888888873 333 24677888899999999988778777776
Q ss_pred -CccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCccee
Q 046199 558 -TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 558 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|+|++|+++.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999998 5677664 7899999999999864 43 6778899999999998873
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.8e-25 Score=242.29 Aligned_cols=250 Identities=17% Similarity=0.188 Sum_probs=166.8
Q ss_pred eeeccCCCCcccCcccccccccccEEEeecCcccccCC----cccCCCC-CCcEEEeecceecccCCcccccc-----cc
Q 046199 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP----KEIGNLV-NLTTLHLGNNQLSGSIPITVGRL-----NT 442 (902)
Q Consensus 373 L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 442 (902)
..++.|.+++.+|..+.... +|++|+|++|.|++..+ ..|..++ +|++|+|++|++++..+..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~-~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPH-GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCT-TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCC-CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 34555555555554443333 57777777777765555 5566666 67777777777776666666554 67
Q ss_pred cCeeecccccccCCCCC-------cC-CCCCeEeccCccccCCCCcccc----C-CCcCceEecCCCCccCccc----cc
Q 046199 443 LQGLGLENNKLEGPIPD-------DL-CQLSELHVDHNKLSGPIPACFG----N-LNSLRNLSLGSNELSSFIP----ST 505 (902)
Q Consensus 443 L~~L~L~~N~l~~~~p~-------~l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~~----~~ 505 (902)
|++|+|++|++++..+. .. .+|++|++++|++++..+..+. . .++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 77777777777654443 12 4677777777777766554433 3 2578888888888875333 33
Q ss_pred ccCCC-CceEEEcCCCccCCCCccccccc-----cccceeccCCcccccc----CccccccC-CccceEEccCcccCCCc
Q 046199 506 FWNLN-NILSFDFSSNSLNGSLPLDIGNM-----KVVVEINLSRNYLTGD----IPTTIGGL-TNLQLLSLENNRLHGPI 574 (902)
Q Consensus 506 ~~~l~-~L~~L~ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~~ 574 (902)
+..++ +|++|++++|++++..+..+... ++|++|+|++|+|++. ++..+..+ ++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 44554 88888888888877666554433 5888888888888853 45555553 58888888888888655
Q ss_pred c----ccccccccCCeEeCcCccccccC-------CcccccccccccccccCCcceecCC
Q 046199 575 P----ESFGALTSLESLDLSVNNLSGVI-------PISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 575 p----~~~~~l~~L~~L~Ls~N~l~~~~-------p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
+ ..+..+++|+.|+|++|++.+.. +..+..+++|+.||+++|++.+..|
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 33466788888888888855433 3456777888888888888876543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-25 Score=248.48 Aligned_cols=197 Identities=22% Similarity=0.221 Sum_probs=146.0
Q ss_pred CcccccCcCccceeeecccccCC----CCchhhccccccceeecccCcCCCCCChhh----hcc---------CcccEEe
Q 046199 141 IPKDIGNLTKLKELYLGYNKLQG----EIPQELGNLAELEWLSLPRSFLTGTIPSSI----FNL---------SSLLELD 203 (902)
Q Consensus 141 ip~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~----~~l---------~~L~~L~ 203 (902)
+...+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+
T Consensus 86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 44455788899999999999986 478888899999999999999875444433 344 8999999
Q ss_pred eeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCcccc--C---cCCCcccCCCCCceEeccCcccc-
Q 046199 204 FSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLV--G---DVPNTIFNMSTLKALSLLNNTLS- 277 (902)
Q Consensus 204 Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~- 277 (902)
|++|.++. +.+| .+...+..+++|+.|+|++|+++ | ..|..+..+++|+.|+|++|.++
T Consensus 166 L~~n~l~~---------~~~~------~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~ 230 (386)
T 2ca6_A 166 CGRNRLEN---------GSMK------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230 (386)
T ss_dssp CCSSCCTG---------GGHH------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred CCCCCCCc---------HHHH------HHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCc
Confidence 99998652 1222 12246778889999999999987 2 34557888899999999999885
Q ss_pred ---cCCCcCCcccCCCcccceeeccCccCCCC----CCcccc--ccccccEEEccCCcccC----cccccc-cccccccE
Q 046199 278 ---GSLPSSSKNLIGLPNIERLNLGLNNLSGR----IPGFIF--NASKLFLLELTGNSFSG----FIPDTL-VNLRNLEH 343 (902)
Q Consensus 278 ---~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~--~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~ 343 (902)
+.+|.. +..+++|++|+|++|.+++. ++..+. .+++|++|+|++|.+++ .+|..+ .++++|++
T Consensus 231 ~g~~~l~~~---l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~ 307 (386)
T 2ca6_A 231 LGSSALAIA---LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307 (386)
T ss_dssp HHHHHHHHH---GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHH---HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceE
Confidence 455554 66778888888888888754 445553 37788888888888876 366666 55788888
Q ss_pred EecccccCCCCC
Q 046199 344 LGLGYNYLTSST 355 (902)
Q Consensus 344 L~Ls~N~l~~~~ 355 (902)
|++++|++++..
T Consensus 308 L~l~~N~l~~~~ 319 (386)
T 2ca6_A 308 LELNGNRFSEED 319 (386)
T ss_dssp EECTTSBSCTTS
T ss_pred EEccCCcCCcch
Confidence 888888877654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=213.99 Aligned_cols=197 Identities=18% Similarity=0.202 Sum_probs=131.8
Q ss_pred ccccEEEeecCcccccCCcccCCCCCCcEEEeecce-ecccCCcccccccccCeeeccc-ccccCCCCCcCCCCCeEecc
Q 046199 393 ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQ-LSGSIPITVGRLNTLQGLGLEN-NKLEGPIPDDLCQLSELHVD 470 (902)
Q Consensus 393 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~L~~L~L~ 470 (902)
.++++|++++|+|++..+..|.++++|++|++++|+ +++..+..|..+++|++|++++ |+++
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~---------------- 94 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT---------------- 94 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC----------------
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee----------------
Confidence 378888888888887777778888888888888886 7766666777777777777666 6665
Q ss_pred CccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCce---EEEcCCC-ccCCCCccccccccccc-eeccCCcc
Q 046199 471 HNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNIL---SFDFSSN-SLNGSLPLDIGNMKVVV-EINLSRNY 545 (902)
Q Consensus 471 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~ 545 (902)
+..+..|.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+
T Consensus 95 -----~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~ 167 (239)
T 2xwt_C 95 -----YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167 (239)
T ss_dssp -----EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred -----EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence 3334456666666666666666665 333 55666665 6666666 66655555566667777 77777777
Q ss_pred ccccCccccccCCccceEEccCcc-cCCCcccccccc-ccCCeEeCcCccccccCCcccccccccccccccCC
Q 046199 546 LTGDIPTTIGGLTNLQLLSLENNR-LHGPIPESFGAL-TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616 (902)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 616 (902)
++...+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|||++|++++. |.. .+++|+.|+++++
T Consensus 168 l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 168 FTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 76333333444 677777777774 775556667777 7777777777777743 333 4556666666665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-24 Score=245.71 Aligned_cols=205 Identities=24% Similarity=0.379 Sum_probs=160.7
Q ss_pred CCCCCCCCce-----eeeeE-EeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceE
Q 046199 23 KNWTSNTSVC-----SWIGI-TCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96 (902)
Q Consensus 23 ~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 96 (902)
.+|..+.++| .|.|+ .|.. .+++.|+|+++++++ +|+.+. ++|++|+|++|+++ .+| ..+++|++
T Consensus 34 ~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 34 DKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 3576666778 79999 7864 368999999999987 888764 88999999999998 888 45789999
Q ss_pred EEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccc
Q 046199 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176 (902)
Q Consensus 97 L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 176 (902)
|+|++|.|++ +|. +.+ +|++|++++|++++ +|. .+++|++|+|++|++++ +|. .+++|+
T Consensus 105 L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~---------lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~ 163 (571)
T 3cvr_A 105 LDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM---------LPE---LPALLEYINADNNQLTM-LPE---LPTSLE 163 (571)
T ss_dssp EECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC---------CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred EEccCCCCCC-cch--hhc--CCCEEECCCCcCCC---------CCC---cCccccEEeCCCCccCc-CCC---cCCCcC
Confidence 9999999997 676 333 88999999998875 555 46788999999999885 776 578888
Q ss_pred eeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccC-----CCCCCEEEccCcc
Q 046199 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGN-----LPNLEVLGIDENH 251 (902)
Q Consensus 177 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~-----l~~L~~L~Ls~N~ 251 (902)
+|+|++|++++ +|. |. ++|++|+|++|.|+. +| . +.. .+.|+.|+|++|+
T Consensus 164 ~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-----------lp---------~-~~~~L~~~~~~L~~L~Ls~N~ 218 (571)
T 3cvr_A 164 VLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-----------LP---------A-VPVRNHHSEETEIFFRCRENR 218 (571)
T ss_dssp EEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-----------CC---------C-CC--------CCEEEECCSSC
T ss_pred EEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-----------hh---------h-HHHhhhcccccceEEecCCCc
Confidence 89999998885 776 65 788888888888663 22 3 222 1223888888888
Q ss_pred ccCcCCCcccCCCCCceEeccCcccccCCCcC
Q 046199 252 LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSS 283 (902)
Q Consensus 252 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 283 (902)
|+ .+|..+..+++|+.|+|++|.+++.+|..
T Consensus 219 l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp CC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred ce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 87 57777777888888888888888777665
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.4e-23 Score=218.63 Aligned_cols=145 Identities=15% Similarity=0.071 Sum_probs=129.3
Q ss_pred hcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD---GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++.. ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34789999999999999999999865 89999999975532 334788999999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
||||++|++|.+++... ....++.+++.|++.||+||| ++||+||||||+||+++.++.+||+++|...
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999998432 356678999999999999999 9999999999999999999999999887653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-24 Score=236.16 Aligned_cols=126 Identities=17% Similarity=0.164 Sum_probs=63.8
Q ss_pred CCeeeccccccccCCCccccCC--CcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSI--STLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGN 147 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~ 147 (902)
++.+|+++|.+. |..++.+ +++++|++++|.+++..+. ..++++|++||+++|.+++. .+|..++.
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~-------~~~~~~~~ 116 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVS-------TLHGILSQ 116 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHH-------HHHHHHTT
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHH-------HHHHHHhh
Confidence 566667666665 4445555 6666666666666655443 22445555555555544321 13334444
Q ss_pred cCccceeeecccccCCCCchhhccccccceeecccC-cCCCC-CChhhhccCcccEEeeeeC
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS-FLTGT-IPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~N 207 (902)
+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++|
T Consensus 117 ~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 455555555555544444444545555555555555 34431 3344444445555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-25 Score=244.62 Aligned_cols=236 Identities=21% Similarity=0.262 Sum_probs=158.7
Q ss_pred ccccccccccEEEeecCcccccCC----cccCCCCCCcEEEeecc---eecccCCccc-------ccccccCeeeccccc
Q 046199 387 SIGNLPITLEEIYLQNCKIRGNIP----KEIGNLVNLTTLHLGNN---QLSGSIPITV-------GRLNTLQGLGLENNK 452 (902)
Q Consensus 387 ~~~~l~~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~N~ 452 (902)
.+..++ +|+.|+|++|.|+...+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|+
T Consensus 27 ~l~~~~-~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 27 VLLEDD-SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHCS-CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHhcCC-CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 333344 45555555555554322 23445556666666553 3333344333 455666666666666
Q ss_pred ccCC----CCCc---CCCCCeEeccCccccCCCCcc----ccCC---------CcCceEecCCCCcc-Cccc---ccccC
Q 046199 453 LEGP----IPDD---LCQLSELHVDHNKLSGPIPAC----FGNL---------NSLRNLSLGSNELS-SFIP---STFWN 508 (902)
Q Consensus 453 l~~~----~p~~---l~~L~~L~L~~N~l~~~~p~~----~~~l---------~~L~~L~L~~N~l~-~~~~---~~~~~ 508 (902)
+.+. +|.. +.+|+.|+|++|.+++..+.. +..+ ++|++|++++|+++ +..+ ..+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 6542 2322 235666666666665433333 3333 78888888888887 3344 46667
Q ss_pred CCCceEEEcCCCccC--C---CCccccccccccceeccCCcccc----ccCccccccCCccceEEccCcccCCC----cc
Q 046199 509 LNNILSFDFSSNSLN--G---SLPLDIGNMKVVVEINLSRNYLT----GDIPTTIGGLTNLQLLSLENNRLHGP----IP 575 (902)
Q Consensus 509 l~~L~~L~ls~N~l~--~---~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 575 (902)
+++|++|++++|+++ | ..|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++. +|
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 888888999888887 2 34447788888999999999986 57788888999999999999999865 56
Q ss_pred cccc--ccccCCeEeCcCccccc----cCCccc-ccccccccccccCCcceecCC
Q 046199 576 ESFG--ALTSLESLDLSVNNLSG----VIPISL-EKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 576 ~~~~--~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~L~l~~N~l~~~~p 623 (902)
..+. .+++|+.|+|++|++++ .+|..+ .++++|+.|++++|++++..|
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 6663 38899999999999997 477777 668999999999999886554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=218.53 Aligned_cols=148 Identities=25% Similarity=0.403 Sum_probs=129.3
Q ss_pred ccccccc-CeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHH-HhCCCCCccceeeeeec----CCee
Q 046199 725 TDHFSEK-SLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 725 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 797 (902)
.++|.+. +.||+|+||.||+|++. +++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999985 4899999998643 5677888887 56689999999999876 6788
Q ss_pred EEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a 873 (902)
|+||||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999997654 46899999999999999999999 999999999999999998 789999999999
Q ss_pred eecCCCc
Q 046199 874 KLLNGEE 880 (902)
Q Consensus 874 ~~~~~~~ 880 (902)
.......
T Consensus 168 ~~~~~~~ 174 (299)
T 3m2w_A 168 KETTGEK 174 (299)
T ss_dssp EECTTCG
T ss_pred ccccccc
Confidence 8776443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-22 Score=207.63 Aligned_cols=196 Identities=21% Similarity=0.282 Sum_probs=134.8
Q ss_pred CCceeeeccCCCCcccCcccccccccccEEEeecCc-ccccCCcccCCCCCCcEEEeec-ceecccCCcccccccccCee
Q 046199 369 SSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCK-IRGNIPKEIGNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGL 446 (902)
Q Consensus 369 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 446 (902)
++++|++++|++.+..+..|..++ +|++|++++|+ ++++.+..|.++++|++|++++ |++++..+..|..+++|++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~-~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCT-TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCC-CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 344445555555444444566666 77777777775 7766666777888888888887 78876666777777777777
Q ss_pred ecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCc---eEecCCC-CccCcccccccCCCCce-EEEcCCCc
Q 046199 447 GLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLR---NLSLGSN-ELSSFIPSTFWNLNNIL-SFDFSSNS 521 (902)
Q Consensus 447 ~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~ls~N~ 521 (902)
++++|++++ +|. |..+++|+ +|++++| +++++.+..|.++++|+ +|++++|+
T Consensus 111 ~l~~n~l~~----------------------lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~ 167 (239)
T 2xwt_C 111 GIFNTGLKM----------------------FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167 (239)
T ss_dssp EEEEECCCS----------------------CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred eCCCCCCcc----------------------ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence 777777662 222 44455555 7777777 77766666677777777 77777777
Q ss_pred cCCCCccccccccccceeccCCcc-ccccCccccccC-CccceEEccCcccCCCccccccccccCCeEeCcCc
Q 046199 522 LNGSLPLDIGNMKVVVEINLSRNY-LTGDIPTTIGGL-TNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592 (902)
Q Consensus 522 l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 592 (902)
++...+..|.. ++|++|++++|+ +++..+..|.++ ++|+.|++++|++++ +|.. .+++|+.|+++++
T Consensus 168 l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 168 FTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 77333333433 778888888884 876667778888 888888888888885 4443 5678888888776
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=215.73 Aligned_cols=190 Identities=21% Similarity=0.342 Sum_probs=119.8
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
+|++|++++|.++. +| .+..+++|++|++++|++++..+ +..+++|++|++++|++++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~------------------ 99 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN------------------ 99 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC------------------
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC------------------
Confidence 56666666666663 23 46666777777777777764333 6666666666666665552
Q ss_pred ccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (902)
. + .+..+++|++|++++|++++.. .+..+++|++|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 100 ---~-~-~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 100 ---V-S-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp ---C-G-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred ---c-h-hhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 1 1 3555666666666666666532 26666666666666666665332 6666666777777776664332
Q ss_pred cccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCccee
Q 046199 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 620 (902)
+..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++
T Consensus 169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 6677777777777777765433 6677777777777777775442 6677777777777777764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-23 Score=231.29 Aligned_cols=167 Identities=19% Similarity=0.200 Sum_probs=128.2
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc---hhhhhHHHHHHHHHhCCC-CCcccee----------
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---GALKSFDAECEVLKSVRH-RNLVKII---------- 788 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~---------- 788 (902)
....|...+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+.+++.++| ++.....
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888899999999999999975 489999999874332 235789999999999987 3221111
Q ss_pred -----------eeeec-----CCeeEEEEEccCCCChHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 046199 789 -----------SSCSN-----GNFKALVLEYMANGSLEKCLY------SSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846 (902)
Q Consensus 789 -----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 846 (902)
.++.. ....+++|+++ +++|.+++. .....+++..+..++.||+.||+||| ++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 11111 12356777766 679998884 22344777889999999999999999 999
Q ss_pred eEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccceecccccccccccccc
Q 046199 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
|+||||||+|||++.++.+||+|||+|+..... ....+| +.|||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETT 279 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhh
Confidence 999999999999999999999999999875432 344567 999999998
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-22 Score=215.18 Aligned_cols=151 Identities=30% Similarity=0.446 Sum_probs=81.5
Q ss_pred ccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcc
Q 046199 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIP 224 (902)
Q Consensus 145 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip 224 (902)
++.+++|++|+|++|++++ +| .+..+++|++|+|++|++++ +|. +..+++|++|++++|.++.+
T Consensus 81 ~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~------------ 144 (308)
T 1h6u_A 81 LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI------------ 144 (308)
T ss_dssp GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC------------
T ss_pred HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC------------
Confidence 4455555555555555552 22 35555555555555555553 232 55555555555555554321
Q ss_pred ccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCC
Q 046199 225 RNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304 (902)
Q Consensus 225 ~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~ 304 (902)
..++.+++|+.|+|++|++++. +. +..+++|+.|++++|++++..+ +..+++|++|++++|+++
T Consensus 145 ---------~~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-----l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 145 ---------SPLAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP-----LASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp ---------GGGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-----GGGCTTCCEEECTTSCCC
T ss_pred ---------ccccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh-----hcCCCCCCEEEccCCccC
Confidence 1144555555555555555532 22 5555666666666666553221 445566666666666666
Q ss_pred CCCCccccccccccEEEccCCcccC
Q 046199 305 GRIPGFIFNASKLFLLELTGNSFSG 329 (902)
Q Consensus 305 ~~~~~~l~~l~~L~~L~Ls~N~l~~ 329 (902)
+..+ +..+++|+.|+|++|++++
T Consensus 209 ~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 209 DVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp BCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cccc--ccCCCCCCEEEccCCeeec
Confidence 4442 5666677777777777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=213.89 Aligned_cols=152 Identities=14% Similarity=0.102 Sum_probs=121.4
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc------------------hhhhhHHHHHHHHHhC
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD------------------GALKSFDAECEVLKSV 779 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 779 (902)
+.........|.+.+.||+|+||.||+|++.+++.||+|+++.... .....+.+|+++++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667778899999999999999996699999999864321 1346788999999999
Q ss_pred CCCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 046199 780 RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILL 859 (902)
Q Consensus 780 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll 859 (902)
+ | +++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||+||| ++||+||||||+||++
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl 226 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence 9 4 566665543 55699999999999988 421 224579999999999999 9999999999999999
Q ss_pred cCCCcEEEEeecCceecCCCccceecccccccccccccc
Q 046199 860 DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898 (902)
Q Consensus 860 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l 898 (902)
+ ++.+||+|||+|+.. ..|+|||++
T Consensus 227 ~-~~~vkl~DFG~a~~~-------------~~~~a~e~l 251 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV-------------GEEGWREIL 251 (282)
T ss_dssp E-TTEEEECCCTTCEET-------------TSTTHHHHH
T ss_pred E-CCcEEEEECCCCeEC-------------CCCCHHHHH
Confidence 9 999999999999743 346777765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.9e-22 Score=199.54 Aligned_cols=156 Identities=25% Similarity=0.320 Sum_probs=93.1
Q ss_pred CCCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCC
Q 046199 28 NTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGS 107 (902)
Q Consensus 28 ~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~ 107 (902)
..+.|.|.+|.|+... ++ .+|..+ .++|++|+|++|++++..+..+..+++|++|+|++|++++
T Consensus 3 ~~C~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~- 66 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS- 66 (208)
T ss_dssp TTCEEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-
T ss_pred CCCEECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-
Confidence 3456999999996432 32 445444 3589999999999985555567889999999999999884
Q ss_pred CCcccccCCCcccEEEcccCcccCcCCcchhccCc-ccccCcCccceeeecccccCCCCchhhccccccceeecccCcCC
Q 046199 108 FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIP-KDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLT 186 (902)
Q Consensus 108 ~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 186 (902)
+|...++++++|++||+++|++++ +| ..++.+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 67 ~~~~~~~~l~~L~~L~Ls~n~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 67 LPNGVFNKLTSLTYLNLSTNQLQS---------LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCC---------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cChhhcCCCCCcCEEECCCCcCCc---------cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 344444555555555555555542 22 22345555555555555555433334455555555555555555
Q ss_pred CCCChhhhccCcccEEeeeeCC
Q 046199 187 GTIPSSIFNLSSLLELDFSNNS 208 (902)
Q Consensus 187 ~~~p~~~~~l~~L~~L~Ls~N~ 208 (902)
+..+..+..+++|++|+|++|.
T Consensus 138 ~~~~~~~~~l~~L~~L~l~~N~ 159 (208)
T 2o6s_A 138 SVPDGVFDRLTSLQYIWLHDNP 159 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSCC
T ss_pred eeCHHHhccCCCccEEEecCCC
Confidence 4333344455555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.8e-21 Score=209.86 Aligned_cols=224 Identities=16% Similarity=0.171 Sum_probs=152.5
Q ss_pred cccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCC-ccccc
Q 046199 235 EIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP-GFIFN 313 (902)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~ 313 (902)
.++.+. -++++.++++++ .+|..+. +++++|+|++|+|+. +|... |.++++|++|+|++|++.+.+| +.|.+
T Consensus 5 ~~C~C~-~~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~-i~~~~--f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 5 RICHCS-NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV-IQKGA--FSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp SSSEEE-TTEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSE-ECTTS--STTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred CccEee-CCEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCC-cCHHH--HcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 344443 367888899988 6777663 678899999999984 45432 7788899999999998865544 56778
Q ss_pred ccccc-EEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeecc-CCCCcccCcccccc
Q 046199 314 ASKLF-LLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAE-NPLNGVLPSSIGNL 391 (902)
Q Consensus 314 l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l 391 (902)
++++. .++++.|+++...|..|..+++|++|++++|+++...+ ..+....++..+++.+ +.+....+..|..+
T Consensus 78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~-----~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD-----VHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC-----CTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCc-----hhhcccchhhhhhhccccccccccccchhhc
Confidence 87765 46677788888878888889999999999998887665 4445556667777755 45555445556666
Q ss_pred cccccEEEeecCcccccCCcccCCCCCCcEEEeec-ceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEecc
Q 046199 392 PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVD 470 (902)
Q Consensus 392 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~ 470 (902)
+..++.|+|++|+|+.+.+..| ...+|+.|++++ |.++...+..|..+++|++|||++|+|+...+..+.+|+.|.+.
T Consensus 153 ~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l 231 (350)
T 4ay9_X 153 SFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 231 (350)
T ss_dssp BSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECT
T ss_pred chhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhc
Confidence 5567777777777775544444 345677777764 55664444567777777777777777763222334445555443
Q ss_pred C
Q 046199 471 H 471 (902)
Q Consensus 471 ~ 471 (902)
+
T Consensus 232 ~ 232 (350)
T 4ay9_X 232 S 232 (350)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=213.14 Aligned_cols=215 Identities=18% Similarity=0.177 Sum_probs=121.3
Q ss_pred ceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCC-cccccccccCe-eec
Q 046199 371 KYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIP-ITVGRLNTLQG-LGL 448 (902)
Q Consensus 371 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 448 (902)
+.++.++++++ .+|..+ |.++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| .+|.+++++.+ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 56777788777 456544 3478888888888887666778888888888888888765444 45666666554 344
Q ss_pred ccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCC-CccCCCCc
Q 046199 449 ENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSS-NSLNGSLP 527 (902)
Q Consensus 449 ~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~ 527 (902)
+.|+++ ++.|..|.++++|++|++++|+++...+..+....++..|++.+ |++....+
T Consensus 88 ~~N~l~---------------------~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~ 146 (350)
T 4ay9_X 88 KANNLL---------------------YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146 (350)
T ss_dssp EETTCC---------------------EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT
T ss_pred cCCccc---------------------ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc
Confidence 445554 44455555555555555555555555444555555555555533 34443333
Q ss_pred ccccccc-ccceeccCCccccccCccccccCCccceEEccC-cccCCCccccccccccCCeEeCcCccccccCCcccccc
Q 046199 528 LDIGNMK-VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN-NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605 (902)
Q Consensus 528 ~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 605 (902)
..|..+. .++.|+|++|+|+. +|.......+|+.|++++ |+++...++.|+.+++|+.|||++|+|+...+..+.++
T Consensus 147 ~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L 225 (350)
T 4ay9_X 147 NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225 (350)
T ss_dssp TSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTC
T ss_pred cchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccc
Confidence 4444443 35555555555553 333333334555555553 44443333445556666666666666654333344444
Q ss_pred cccccc
Q 046199 606 VYLKDL 611 (902)
Q Consensus 606 ~~L~~L 611 (902)
++|+.+
T Consensus 226 ~~L~~l 231 (350)
T 4ay9_X 226 KKLRAR 231 (350)
T ss_dssp CEEECT
T ss_pred hHhhhc
Confidence 444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=244.44 Aligned_cols=214 Identities=26% Similarity=0.293 Sum_probs=104.3
Q ss_pred CChhHHHHHHHHHhccccC------CCC-CCCCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccc
Q 046199 5 INTTDQQALLALKARITAK------NWT-SNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSH 77 (902)
Q Consensus 5 ~~~~~~~~l~~~~~~~~~~------~w~-~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~ 77 (902)
+...+++||+++..+.... +|. ..+..+.|.++++.. .+++.|+|.++++.+ ++..+ |+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-----LQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhH-----hhcCccCc
Confidence 4567889999999887653 452 234567898888754 568999998888875 23322 33444444
Q ss_pred ccccc---------CCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCc
Q 046199 78 NRFSG---------TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNL 148 (902)
Q Consensus 78 n~l~~---------~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l 148 (902)
|.+.+ ..|..+..++.|++|+|++|.+. .+|..+..+
T Consensus 201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~----------------------------------~l~~~~~~l 246 (727)
T 4b8c_D 201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF----------------------------------NISANIFKY 246 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS----------------------------------CCCGGGGGC
T ss_pred ccccCccccccceecChhhhccCCCCcEEECCCCCCC----------------------------------CCChhhcCC
Confidence 44431 23444444555555555555443 155666667
Q ss_pred CccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~------------------ 306 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT------------------ 306 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC------------------
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC------------------
Confidence 77777777777777 67777777777777777777777 66777777777777777777654
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCC-CceEeccCcccccCCCc
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMST-LKALSLLNNTLSGSLPS 282 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 282 (902)
.+|..|+++++|++|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 307 --~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 307 --TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp --CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred --ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 23466777777777777777777766666654322 22366777777666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=6e-21 Score=193.77 Aligned_cols=172 Identities=24% Similarity=0.263 Sum_probs=146.8
Q ss_pred eeecccccccCCCCCcC-CCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccC
Q 046199 445 GLGLENNKLEGPIPDDL-CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN 523 (902)
Q Consensus 445 ~L~L~~N~l~~~~p~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 523 (902)
.++.+++.++ .+|..+ .+|++|++++|++++..+..|.++++|++|++++|+++++.+..|..+++|++|++++|+++
T Consensus 11 ~v~c~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 89 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89 (208)
T ss_dssp EEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEEecCCCcc-CCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC
Confidence 4455555554 334333 37888888888888777778899999999999999999887788899999999999999999
Q ss_pred CCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccc
Q 046199 524 GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLE 603 (902)
Q Consensus 524 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 603 (902)
+..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+.
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------ 163 (208)
T 2o6s_A 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------ 163 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------
T ss_pred ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC------
Confidence 87777789999999999999999987777899999999999999999987777799999999999999988754
Q ss_pred cccccccccccCCcceecCCC
Q 046199 604 KLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 604 ~l~~L~~L~l~~N~l~~~~p~ 624 (902)
+++|+.|++++|.++|.+|.
T Consensus 164 -~~~l~~L~~~~n~~~g~ip~ 183 (208)
T 2o6s_A 164 -CPGIRYLSEWINKHSGVVRN 183 (208)
T ss_dssp -TTTTHHHHHHHHHCTTTBBC
T ss_pred -CCCHHHHHHHHHhCCceeec
Confidence 45799999999999999996
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-21 Score=221.38 Aligned_cols=189 Identities=23% Similarity=0.328 Sum_probs=107.1
Q ss_pred CCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeec
Q 046199 369 SSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGL 448 (902)
Q Consensus 369 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 448 (902)
+++.|++++|.+.+ +|..+. + +|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +..
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~-~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--------- 120 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--P-QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--------- 120 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--T-TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT---------
T ss_pred CccEEEeCCCCCCc-cCHhHc--C-CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc---------
Confidence 45555555555554 343332 2 4555555555555 233 223455555555555553 333 322
Q ss_pred ccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCcc
Q 046199 449 ENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPL 528 (902)
Q Consensus 449 ~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~ 528 (902)
+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|++++|+|++ +|.
T Consensus 121 --------------~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 121 --------------SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp --------------TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred --------------CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch
Confidence 45555555555554 333 35566666666666665 333 34566666666666665 444
Q ss_pred ccccccccceeccCCccccccCccccccCCcc-------ceEEccCcccCCCccccccccccCCeEeCcCccccccCCcc
Q 046199 529 DIGNMKVVVEINLSRNYLTGDIPTTIGGLTNL-------QLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPIS 601 (902)
Q Consensus 529 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 601 (902)
|. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..
T Consensus 178 -l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 178 -LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp -CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred -hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 44 56666666666666 4454 443 55 77788888777 46777777778888888888887777777
Q ss_pred cccccc
Q 046199 602 LEKLVY 607 (902)
Q Consensus 602 l~~l~~ 607 (902)
+..++.
T Consensus 250 l~~l~~ 255 (571)
T 3cvr_A 250 LSQQTA 255 (571)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 766554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-21 Score=198.22 Aligned_cols=156 Identities=26% Similarity=0.298 Sum_probs=106.6
Q ss_pred eEeccCccccCCCCccccCCCcCceEecCCCCccCccc-ccccCCCCceEEEcCCCccCCCCccccccccccceeccCCc
Q 046199 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIP-STFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRN 544 (902)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 544 (902)
.+++++|.+++ +|..+. +.+++|+|++|+|++..+ ..|..+++|++|++++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 44555555543 333221 234566666666665533 34566666666666666666655556666777777777777
Q ss_pred cccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCC
Q 046199 545 YLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 545 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|.|.++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 77766666777777888888888888777777788888888888888888877777788888888888888888877664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.8e-21 Score=211.29 Aligned_cols=178 Identities=26% Similarity=0.248 Sum_probs=149.0
Q ss_pred eeecccccccCCCCCcCC-CCCeEeccCccccCCCCcccc-CCCcCceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 445 GLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFG-NLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 445 ~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
.+++++|+++ .+|..+. .++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|
T Consensus 22 ~l~c~~~~l~-~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l 100 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100 (361)
T ss_dssp EEECCSSCCS-SCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEEeCCCCcC-ccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcC
Confidence 4555555555 3454444 577888888888888788887 899999999999999998888899999999999999999
Q ss_pred CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccc---cccccCCeEeCcCccccccCC
Q 046199 523 NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESF---GALTSLESLDLSVNNLSGVIP 599 (902)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p 599 (902)
++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++..+
T Consensus 101 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 180 (361)
T 2xot_A 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180 (361)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCH
T ss_pred CcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCH
Confidence 98777789999999999999999998889999999999999999999997555556 679999999999999997666
Q ss_pred cccccccc--cccccccCCcceecCC
Q 046199 600 ISLEKLVY--LKDLNLSFNRLEGEIP 623 (902)
Q Consensus 600 ~~l~~l~~--L~~L~l~~N~l~~~~p 623 (902)
..+..++. |+.|+|++|+|.|.+.
T Consensus 181 ~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 181 TDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp HHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred HHhhhccHhhcceEEecCCCccCCcC
Confidence 77888887 4899999999998654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.8e-21 Score=195.34 Aligned_cols=138 Identities=21% Similarity=0.294 Sum_probs=88.0
Q ss_pred CcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEc
Q 046199 486 NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSL 565 (902)
Q Consensus 486 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 565 (902)
++|+.|++++|+|+++.+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 34555555555555555555555555555555555555555555666666666666666666444455666677777777
Q ss_pred cCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 566 ENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 566 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.+.++
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 7777776666677777777777777777776666667777777777777777776544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.6e-20 Score=189.98 Aligned_cols=163 Identities=26% Similarity=0.341 Sum_probs=139.1
Q ss_pred CCCCCCCCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCccccCCCcceEEEecCc
Q 046199 23 KNWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDN 102 (902)
Q Consensus 23 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n 102 (902)
.-|..+.+.|+|.+|.|... +++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 10 ~~~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 10 SAACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp -CCCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 34555678999999999642 232 6676554 89999999999999877889999999999999999
Q ss_pred cccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeeccc
Q 046199 103 QLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPR 182 (902)
Q Consensus 103 ~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 182 (902)
+++ .+|...++++++|++||+++|++++. .|..++.+++|++|+|++|+++ .+|..+..+++|++|+|++
T Consensus 75 ~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l--------~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 144 (229)
T 3e6j_A 75 QLG-ALPVGVFDSLTQLTVLDLGTNQLTVL--------PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144 (229)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCS
T ss_pred CCC-CcChhhcccCCCcCEEECCCCcCCcc--------ChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCC
Confidence 996 56777778999999999999999842 2345688999999999999999 8999999999999999999
Q ss_pred CcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 183 SFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 183 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
|++++..+..|..+++|++|+|++|.+.
T Consensus 145 N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 145 NQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 9999776678999999999999999854
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.7e-20 Score=186.98 Aligned_cols=154 Identities=23% Similarity=0.322 Sum_probs=135.2
Q ss_pred eeecccccccCCCCCcCC-CCCeEeccCccccCCCC-ccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 445 GLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIP-ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 445 ~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
.+++++|.++ .+|..+. .++.|+|++|+|++..| ..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l 93 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93 (220)
T ss_dssp EEECCSSCCS-SCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EeEeCCCCcc-cCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCcc
Confidence 5555555555 3454444 56788888888887754 5689999999999999999998888999999999999999999
Q ss_pred CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCC
Q 046199 523 NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599 (902)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 599 (902)
++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99888889999999999999999999989999999999999999999999889999999999999999999987654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-22 Score=232.79 Aligned_cols=204 Identities=25% Similarity=0.209 Sum_probs=120.0
Q ss_pred CCCCCCCeeeccccccccCCCccccCCCcceEEEecCcc-------------ccCCCCcccccCCCcccEEE-cccCccc
Q 046199 65 GNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQ-------------LSGSFPSFIISNTSSLRAID-CNYNSLS 130 (902)
Q Consensus 65 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~-------------l~~~~~~~~~~~~~~L~~ld-ls~n~l~ 130 (902)
..+++|+.|+|++|+++ .+|++++++++|+.|++++|. +.+.+| ..++++++|+.|| ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~-~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEK-ETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHH-HHHHHHHHHHHHCGGGHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCH-HHHHHHHhcccCcchhhcccc
Confidence 67899999999999998 899999999999999998775 233222 2234455555555 3433321
Q ss_pred CcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 131 GELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 131 ~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
.|+.+.+++|.++ .+|. ..|+.|+|++|++++ +|. |+++++|++|+|++|.|+
T Consensus 424 -------------------~L~~l~l~~n~i~-~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 424 -------------------DLRSKFLLENSVL-KMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp -------------------HHHHHHHHHHHHH-HHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC
T ss_pred -------------------hhhhhhhhccccc-ccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc
Confidence 1111222222222 1111 135666666666663 454 666666666666666644
Q ss_pred ccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCC-CcCCcccCC
Q 046199 211 GFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSL-PSSSKNLIG 289 (902)
Q Consensus 211 ~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~ 289 (902)
.+|..++++++|+.|+|++|+|++ +| .++.+++|+.|+|++|++++.. |.. +..
T Consensus 477 --------------------~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~---l~~ 531 (567)
T 1dce_A 477 --------------------ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQP---LVS 531 (567)
T ss_dssp --------------------CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGG---GGG
T ss_pred --------------------ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHH---Hhc
Confidence 233556666666666666666664 44 5666666666666666666544 544 555
Q ss_pred CcccceeeccCccCCCCCCcc---ccccccccEEEc
Q 046199 290 LPNIERLNLGLNNLSGRIPGF---IFNASKLFLLEL 322 (902)
Q Consensus 290 l~~L~~L~Ls~N~l~~~~~~~---l~~l~~L~~L~L 322 (902)
+++|++|+|++|.+++.+|.. +..+++|+.|++
T Consensus 532 l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 666666666666666544322 223566666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=216.95 Aligned_cols=173 Identities=24% Similarity=0.338 Sum_probs=106.5
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccc
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~ 225 (902)
..+++|++|+|++|.+. .+| .++.+++|+.|+|++|++++..| +..+++|++|+|++|.|+.+
T Consensus 40 ~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l------------- 102 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL------------- 102 (605)
T ss_dssp HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-------------
T ss_pred hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-------------
Confidence 34556666666666665 333 46666666666666666664333 66666666666666665421
Q ss_pred cccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCC
Q 046199 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305 (902)
Q Consensus 226 ~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (902)
+.++.+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+.+
T Consensus 103 --------~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-----~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 103 --------SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-----TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp --------TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-----GGGGSCTTCSEEECCSSCCCC
T ss_pred --------hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-----hhhcccCCCCEEECcCCcCCC
Confidence 245566666666666666663 2 3466666666666666666643 125566667777777777665
Q ss_pred CCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCC
Q 046199 306 RIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSS 354 (902)
Q Consensus 306 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 354 (902)
..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 554 66667777777777777653 2466677777777777777653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=194.31 Aligned_cols=126 Identities=24% Similarity=0.348 Sum_probs=61.5
Q ss_pred CCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccc
Q 046199 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDI 145 (902)
Q Consensus 66 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~ 145 (902)
.+++|++|++++|.++ .+|. +..+++|++|+|++|++++..+ ++++++|++|++++|++++ +| .+
T Consensus 44 ~l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~~~~---l~~l~~L~~L~l~~n~l~~---------~~-~l 108 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP---LANLKNLGWLFLDENKVKD---------LS-SL 108 (291)
T ss_dssp HHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCC---------GG-GG
T ss_pred hcCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCCCcc---cccCCCCCEEECCCCcCCC---------Ch-hh
Confidence 4455555566655555 3332 5555555666665555554322 3444555555555554432 22 24
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
+.+++|++|+|++|++++ + +.+..+++|++|+|++|++++. ..+..+++|++|+|++|.++
T Consensus 109 ~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 109 KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp TTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence 445555555555555542 2 2344455555555555555432 23444555555555555433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=184.55 Aligned_cols=152 Identities=22% Similarity=0.325 Sum_probs=134.9
Q ss_pred CeeecccccccCCCCCcCC-CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 444 QGLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 444 ~~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
+.+++++|.++ .+|..++ +++.|++++|+|+++.+..|.++++|+.|+|++|+|+++.|..|.++++|++|+|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 34555555555 4455444 788888888888888888999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccc
Q 046199 523 NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596 (902)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (902)
++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 98777778999999999999999999999999999999999999999998888889999999999999999975
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=184.29 Aligned_cols=157 Identities=22% Similarity=0.244 Sum_probs=114.1
Q ss_pred CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccC
Q 046199 463 QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLS 542 (902)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls 542 (902)
+-+.++.++++++. +|..+. ++|++|+|++|+|+++.|..|..+++|++|+|++|+|+...+..|..+++|++|+|+
T Consensus 20 s~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 44556666666653 333222 567777777777777667777777777777777777766555666777777777777
Q ss_pred CccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecC
Q 046199 543 RNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622 (902)
Q Consensus 543 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 622 (902)
+|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++.|.+
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 77777666666777888888888888887 67777888888888888888888766667788888888888888888776
Q ss_pred C
Q 046199 623 P 623 (902)
Q Consensus 623 p 623 (902)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 6
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=210.22 Aligned_cols=173 Identities=22% Similarity=0.333 Sum_probs=114.3
Q ss_pred cCCCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcc
Q 046199 64 LGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPK 143 (902)
Q Consensus 64 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~ 143 (902)
+..|++|++|+|++|.++ .+| .+..+++|++|+|++|.+++..| +.++++|+.|+|++|.+++ +|
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~---------l~- 103 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKIKD---------LS- 103 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG---GGGCTTCCEEECCSSCCCC---------CT-
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh---hccCCCCCEEECcCCCCCC---------Ch-
Confidence 456777778888888776 555 47777888888888888776433 5667777777777777653 23
Q ss_pred cccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCc
Q 046199 144 DIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSI 223 (902)
Q Consensus 144 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~i 223 (902)
.++.+++|++|+|++|.+++ + +.+..+++|+.|+|++|.+++. ..+..+++|++|+|++|.|+++
T Consensus 104 ~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~----------- 168 (605)
T 1m9s_A 104 SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI----------- 168 (605)
T ss_dssp TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC-----------
T ss_pred hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc-----------
Confidence 56667777777777777763 3 3466677777777777777643 4566677777777777765421
Q ss_pred cccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCccccc
Q 046199 224 PRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG 278 (902)
Q Consensus 224 p~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 278 (902)
+. +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|.+++
T Consensus 169 ---------~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 169 ---------VP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp ---------GG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred ---------hh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 12 56666777777777777642 246666677777777776663
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-22 Score=231.77 Aligned_cols=166 Identities=23% Similarity=0.227 Sum_probs=120.4
Q ss_pred ecccCCcccccccccCeee-cccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCccccccc
Q 046199 429 LSGSIPITVGRLNTLQGLG-LENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFW 507 (902)
Q Consensus 429 l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 507 (902)
+.+..|..++.+++|+.|+ ++.|.+. +|+.+.+++|.+++..+. .|+.|+|++|+|++ +|. |+
T Consensus 397 ~~~~~~~~l~~l~~L~~L~~l~~n~~~--------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~ 460 (567)
T 1dce_A 397 PLLYEKETLQYFSTLKAVDPMRAAYLD--------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LE 460 (567)
T ss_dssp TGGGHHHHHHHHHHHHHHCGGGHHHHH--------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GG
T ss_pred cccCCHHHHHHHHhcccCcchhhcccc--------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-cc
Confidence 4556677777888888887 6777654 566667777777654332 47778888888877 354 77
Q ss_pred CCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCc-cccccccccCCe
Q 046199 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI-PESFGALTSLES 586 (902)
Q Consensus 508 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~ 586 (902)
.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.+ |..|+.+++|+.
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~ 537 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCE
Confidence 7888888888888887 567778888888888888888875 56 7778888888888888888766 778888888888
Q ss_pred EeCcCccccccCCcc---cccccccccccc
Q 046199 587 LDLSVNNLSGVIPIS---LEKLVYLKDLNL 613 (902)
Q Consensus 587 L~Ls~N~l~~~~p~~---l~~l~~L~~L~l 613 (902)
|+|++|+|++.+|.. +..+++|+.||+
T Consensus 538 L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 538 LNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp EECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 888888887655422 233667777653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=190.04 Aligned_cols=167 Identities=26% Similarity=0.415 Sum_probs=79.5
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
+|+.|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|++|++++|+++
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~------------------- 103 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK------------------- 103 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-------------------
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-------------------
Confidence 455555555555432 2 24555555555555555553322 444444444444444433
Q ss_pred ccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (902)
+ +| .+..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++|++++..|
T Consensus 104 --~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 104 --D-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp --C-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred --C-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence 1 11 245555555555555555543 2345555555555555555532 334444444444444444443322
Q ss_pred cccCCccceEEccCcccCCCccccccccccCCeEeCcCcccc
Q 046199 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595 (902)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 595 (902)
+..+++|+.|+|++|++++ +| .+..+++|+.|++++|+++
T Consensus 174 l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 4444555555555555543 22 2444455555555555444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=191.15 Aligned_cols=170 Identities=21% Similarity=0.279 Sum_probs=99.8
Q ss_pred CCCCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccc
Q 046199 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDI 145 (902)
Q Consensus 66 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~ 145 (902)
.+.+++.+++++|.++ .++ .+..+++|++|++++|.++. +| .++.+++|++|++++|++++ +|. +
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~L~~N~i~~---------~~~-l 81 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQS-LA--GMQFFTNLKELHLSHNQISD---------LSP-L 81 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCC---------CGG-G
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCccc-ch--HHhhCCCCCEEECCCCccCC---------Chh-h
Confidence 3556667777777776 444 46677777777777777763 33 24455666666666665543 333 5
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccc
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~ 225 (902)
+.+++|++|+|++|++++ +|.... ++|++|+|++|++++ +| .+.++++|++|+|++|+|+++
T Consensus 82 ~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~------------- 143 (263)
T 1xeu_A 82 KDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI------------- 143 (263)
T ss_dssp TTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-------------
T ss_pred ccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-------------
Confidence 566666666666666663 443222 666666666666663 23 356666666666666665421
Q ss_pred cccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCccccc
Q 046199 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG 278 (902)
Q Consensus 226 ~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 278 (902)
..++.+++|+.|+|++|++++. ..+..+++|+.|++++|.+++
T Consensus 144 --------~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 144 --------VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp --------GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred --------hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 2355556666666666666543 445566666666666666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.3e-19 Score=195.54 Aligned_cols=121 Identities=23% Similarity=0.191 Sum_probs=77.3
Q ss_pred CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcccc-
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI- 554 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~- 554 (902)
+..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 157 (361)
T 2xot_A 78 FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157 (361)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC
T ss_pred ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhc
Confidence 3344455555566666666666655555556666666666666666665555666666666666666666664333334
Q ss_pred --ccCCccceEEccCcccCCCcccccccccc--CCeEeCcCccccc
Q 046199 555 --GGLTNLQLLSLENNRLHGPIPESFGALTS--LESLDLSVNNLSG 596 (902)
Q Consensus 555 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~ 596 (902)
..+++|+.|+|++|+|++..+..|..++. |+.|+|++|.+.-
T Consensus 158 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp ----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 56788888888888888666667777776 4788888888763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=176.80 Aligned_cols=153 Identities=20% Similarity=0.278 Sum_probs=94.2
Q ss_pred cCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchh
Q 046199 89 FSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168 (902)
Q Consensus 89 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~ 168 (902)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..++.+++|++|++++|++++..|..
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~----------~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 107 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT----------NYNPISGLSNLERLRIMGKDVTSDKIPN 107 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS----------CCGGGTTCTTCCEEEEECTTCBGGGSCC
T ss_pred hhcCCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC----------cchhhhcCCCCCEEEeECCccCcccChh
Confidence 45556666666666665 333 1344555555555555443 2335666777777777777777666777
Q ss_pred hccccccceeecccCcCCCCCChhhhccCcccEEeeeeCC-CCccccccccccCCccccccccCCCccccCCCCCCEEEc
Q 046199 169 LGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNS-LTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGI 247 (902)
Q Consensus 169 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~L 247 (902)
++.+++|++|+|++|++++..|..++.+++|++|+|++|. ++. +| .+..+++|+.|++
T Consensus 108 l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~--------------------~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD--------------------IM-PLKTLPELKSLNI 166 (197)
T ss_dssp CTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC--------------------CG-GGGGCSSCCEEEC
T ss_pred hcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc--------------------cH-hhcCCCCCCEEEC
Confidence 7777777777777777776666667777777777777776 442 12 4556666777777
Q ss_pred cCccccCcCCCcccCCCCCceEeccCcccc
Q 046199 248 DENHLVGDVPNTIFNMSTLKALSLLNNTLS 277 (902)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 277 (902)
++|++++ ++ .+..+++|+.|++++|++.
T Consensus 167 ~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 167 QFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 7777663 33 5666666666666666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=189.42 Aligned_cols=148 Identities=19% Similarity=0.221 Sum_probs=112.6
Q ss_pred HHHhhcccccccCeecccceeeEEEEEe-CCCcE--EEEEEeeeccch------------------------hhhhHHHH
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRF-LDGME--VAIKVFHLQFDG------------------------ALKSFDAE 772 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E 772 (902)
.+.....-|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|
T Consensus 41 ~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 120 (258)
T 1zth_A 41 KLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKE 120 (258)
T ss_dssp HHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHH
T ss_pred HHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHH
Confidence 3333444578889999999999999998 67888 999987543111 11367899
Q ss_pred HHHHHhCCCCCc--cceeeeeecCCeeEEEEEccCC-C----ChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 046199 773 CEVLKSVRHRNL--VKIISSCSNGNFKALVLEYMAN-G----SLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845 (902)
Q Consensus 773 ~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~ 845 (902)
+++++.+.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.|+.|||. +.
T Consensus 121 ~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~ 190 (258)
T 1zth_A 121 FRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EA 190 (258)
T ss_dssp HHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TS
T ss_pred HHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HC
Confidence 999999988764 444432 346899999942 3 67665432 2244678899999999999994 57
Q ss_pred CeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 846 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||+||||||+|||++. .++|+|||+|.....+
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 9999999999999998 9999999999876543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-19 Score=218.23 Aligned_cols=196 Identities=21% Similarity=0.163 Sum_probs=118.3
Q ss_pred CCCCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccC
Q 046199 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGN 147 (902)
Q Consensus 68 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~ 147 (902)
+.++.|+|++|.+.+ +|. ..|+.++|+.|.+.+ ++++.|+++ ..|..+..
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~---------------~~~~~n~~~---------~~~~~~~~ 222 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE---------------DDDIENRMV---------MPKDSKYD 222 (727)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC---------------cccccccee---------cChhhhcc
Confidence 457788888888873 444 345666777776653 344455543 25777888
Q ss_pred cCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccc
Q 046199 148 LTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNL 227 (902)
Q Consensus 148 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~ 227 (902)
++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~----------------- 283 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT----------------- 283 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-----------------
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-----------------
Confidence 999999999999998 89999999999999999999999 89999999999999999999965
Q ss_pred cccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCC-cccceeeccCccCCCC
Q 046199 228 WQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGL-PNIERLNLGLNNLSGR 306 (902)
Q Consensus 228 ~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~~L~~L~Ls~N~l~~~ 306 (902)
.+|..|++|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+ ..+ ..+..|+|++|.+++.
T Consensus 284 ---~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~~~~~~~~l~l~~N~l~~~ 356 (727)
T 4b8c_D 284 ---SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL---TEKSVTGLIFYLRDNRPEIP 356 (727)
T ss_dssp ---SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH---HHHHHHHHHHHHHHCCCCCC
T ss_pred ---ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH---hhcchhhhHHhhccCcccCc
Confidence 34588999999999999999997 788889999999999999999998877663 222 2233578888888877
Q ss_pred CCccccccccccEEEccCC
Q 046199 307 IPGFIFNASKLFLLELTGN 325 (902)
Q Consensus 307 ~~~~l~~l~~L~~L~Ls~N 325 (902)
+|. .|..|+++.|
T Consensus 357 ~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 357 LPH------ERRFIEINTD 369 (727)
T ss_dssp CCC------C---------
T ss_pred Ccc------ccceeEeecc
Confidence 775 3556667766
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.8e-19 Score=184.01 Aligned_cols=171 Identities=23% Similarity=0.311 Sum_probs=126.6
Q ss_pred CcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccc
Q 046199 147 NLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRN 226 (902)
Q Consensus 147 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~ 226 (902)
.+.+++.+++++|.++ .++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|+|++
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~--------------- 77 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD--------------- 77 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC---------------
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC---------------
Confidence 4667778888888887 455 5778888888888888887 556 57788888888888888663
Q ss_pred ccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCC
Q 046199 227 LWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGR 306 (902)
Q Consensus 227 ~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~ 306 (902)
+|. ++.+++|+.|+|++|++++ +|.... ++|+.|+|++|++++. + .+..+++|++|++++|++++.
T Consensus 78 -----~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~-~----~l~~l~~L~~L~Ls~N~i~~~ 143 (263)
T 1xeu_A 78 -----LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDT-D----SLIHLKNLEILSIRNNKLKSI 143 (263)
T ss_dssp -----CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBS-G----GGTTCTTCCEEECTTSCCCBC
T ss_pred -----Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCCC-h----hhcCcccccEEECCCCcCCCC
Confidence 223 7778888888888888874 443332 7888888888888753 2 266778888888888888754
Q ss_pred CCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCC
Q 046199 307 IPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSS 354 (902)
Q Consensus 307 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 354 (902)
+ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|.++..
T Consensus 144 -~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 -V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 3 577788888888888888765 5677788888888888887765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=5.8e-19 Score=176.39 Aligned_cols=131 Identities=25% Similarity=0.338 Sum_probs=78.4
Q ss_pred CeEeccCccccCCCCccccCCCcCceEecCCCCccCcccc-cccCCCCceEEEcCCCccCCCCccccccccccceeccCC
Q 046199 465 SELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS-TFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSR 543 (902)
Q Consensus 465 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (902)
+.+++++|+++ .+|..+.. +|++|++++|+|+++.+. .|..+++|++|++++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56667777665 33443322 566666666666665543 356666666666666666665566666666666666666
Q ss_pred ccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccC
Q 046199 544 NYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVI 598 (902)
Q Consensus 544 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (902)
|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 6666555555666666666666666666555556666666666666666665543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-18 Score=169.76 Aligned_cols=156 Identities=26% Similarity=0.331 Sum_probs=100.4
Q ss_pred ceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCcc-ccccccccceeccCCccccccCccccccCCccceEEccC
Q 046199 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPL-DIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567 (902)
Q Consensus 489 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (902)
+.+++++|+++. +|..+.. ++++|++++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 566777777754 3443322 677777777777655443 366777777777777777766677777777777777777
Q ss_pred cccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCCcccccccccccCCcccCCCCC
Q 046199 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
|+|++..|..|..+++|++|+|++|+|++.+|..+..+++|+.|+|++|+|+|.++......++....+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 77776666667777777777777777777667777777777777777777776665422222233334445555565553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-18 Score=170.04 Aligned_cols=153 Identities=18% Similarity=0.257 Sum_probs=96.6
Q ss_pred ccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccC
Q 046199 170 GNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDE 249 (902)
Q Consensus 170 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~ 249 (902)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~---------------------~~~l~~l~~L~~L~l~~ 97 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN---------------------YNPISGLSNLERLRIMG 97 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC---------------------CGGGTTCTTCCEEEEEC
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc---------------------chhhhcCCCCCEEEeEC
Confidence 56667777777777776 555 46667777777777775442 13556667777777777
Q ss_pred ccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCcc-CCCCCCccccccccccEEEccCCccc
Q 046199 250 NHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNN-LSGRIPGFIFNASKLFLLELTGNSFS 328 (902)
Q Consensus 250 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~Ls~N~l~ 328 (902)
|++++..|..+..+++|++|++++|++++..|.. +..+++|++|++++|. ++ .+| .+..+++|++|++++|+++
T Consensus 98 n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~---l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK---INTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp TTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHH---HTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred CccCcccChhhcCCCCCCEEEecCCccCcHhHHH---HhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc
Confidence 7776666666777777777777777776544443 5566666666666666 44 333 4566666677777776666
Q ss_pred CcccccccccccccEEecccccCC
Q 046199 329 GFIPDTLVNLRNLEHLGLGYNYLT 352 (902)
Q Consensus 329 ~~~p~~l~~l~~L~~L~Ls~N~l~ 352 (902)
+. + .+..+++|++|++++|++.
T Consensus 173 ~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 173 DY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CC-T-TGGGCSSCCEEEECBC---
T ss_pred Ch-H-HhccCCCCCEEEeeCcccC
Confidence 43 2 5666666666666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-17 Score=180.30 Aligned_cols=87 Identities=13% Similarity=0.044 Sum_probs=51.6
Q ss_pred CCCCccccCCCcCceEecCCCCccCcccccccCCCCce-EEEcCCCccCCCCccccccccccceeccCCccccccCcccc
Q 046199 476 GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNIL-SFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554 (902)
Q Consensus 476 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 554 (902)
.+.+.+|.++++|+.++|.+| ++.+.+.+|.++++|+ .+++.+ +++.+.+..|.++++|+.++++.|+++...+.+|
T Consensus 240 ~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF 317 (329)
T 3sb4_A 240 TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELF 317 (329)
T ss_dssp EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTT
T ss_pred eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhh
Confidence 344445555666666666555 5555555566666665 666655 4554445566666666666666666665555666
Q ss_pred ccCCccceEE
Q 046199 555 GGLTNLQLLS 564 (902)
Q Consensus 555 ~~l~~L~~L~ 564 (902)
.++++|+.++
T Consensus 318 ~~~~~L~~ly 327 (329)
T 3sb4_A 318 GNGVPSKLIY 327 (329)
T ss_dssp CTTCCCCEEE
T ss_pred cCCcchhhhc
Confidence 6666666665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-17 Score=165.11 Aligned_cols=131 Identities=24% Similarity=0.310 Sum_probs=102.4
Q ss_pred ceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCc
Q 046199 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENN 568 (902)
Q Consensus 489 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (902)
+.+++++|+++.+ |..+ .++|++|++++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~i-p~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVL-PKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSC-CSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcC-CCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4566777776653 3333 246777777777777 46677777888888888888888777778888888888888888
Q ss_pred ccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 569 RLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 569 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 8888778888888889999999998887666678888889999999999987665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.1e-18 Score=183.56 Aligned_cols=102 Identities=16% Similarity=0.108 Sum_probs=61.3
Q ss_pred CCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccc-eEEccCcccCCCccccccccccCCeE
Q 046199 509 LNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ-LLSLENNRLHGPIPESFGALTSLESL 587 (902)
Q Consensus 509 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 587 (902)
+++|+.|++++|+++.+.+..|.++.+|++++|++| ++...+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 455555555555555444455555555555666555 5545555666666666 666666 5554455666666666666
Q ss_pred eCcCccccccCCccccccccccccc
Q 046199 588 DLSVNNLSGVIPISLEKLVYLKDLN 612 (902)
Q Consensus 588 ~Ls~N~l~~~~p~~l~~l~~L~~L~ 612 (902)
++++|+++.+.+.+|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 6666666655555666666666654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-17 Score=177.89 Aligned_cols=148 Identities=14% Similarity=0.135 Sum_probs=106.6
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc--------------hhhh--------hHHHHHHHHH
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD--------------GALK--------SFDAECEVLK 777 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~ 777 (902)
.+.....-|++.+.||+|++|.||+|.+.+|++||||+++.... .... ...+|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33444445999999999999999999998899999998753210 0001 1235666677
Q ss_pred hCCCCCccceeeeeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 046199 778 SVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNI 857 (902)
Q Consensus 778 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NI 857 (902)
++.+..+....-+... ..++||||++|+++.++.. . .....++.|++.+|.|+| +.|||||||||.||
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNI 236 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHE
Confidence 7655444322222222 2379999999988866431 1 234568899999999999 99999999999999
Q ss_pred EEcCCC----------cEEEEeecCceecCCC
Q 046199 858 LLDDDM----------VAHLSDFGIAKLLNGE 879 (902)
Q Consensus 858 ll~~~~----------~~kL~DFG~a~~~~~~ 879 (902)
|+++++ .+.|+||+-+.....+
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp 268 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSMDHP 268 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred EEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence 998876 3899999988765543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=155.52 Aligned_cols=132 Identities=20% Similarity=0.194 Sum_probs=83.3
Q ss_pred CcCceEecCCCCcc-CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEE
Q 046199 486 NSLRNLSLGSNELS-SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564 (902)
Q Consensus 486 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 564 (902)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34555555555554 33444455555555555555555543 4555566666666666666655666666677777777
Q ss_pred ccCcccCCCc-cccccccccCCeEeCcCccccccCC---cccccccccccccccCCcce
Q 046199 565 LENNRLHGPI-PESFGALTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLSFNRLE 619 (902)
Q Consensus 565 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~l~~N~l~ 619 (902)
|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777777532 2567777777777777777775544 36677777777777777766
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=154.34 Aligned_cols=137 Identities=26% Similarity=0.222 Sum_probs=118.4
Q ss_pred CCCCeEeccCcccc-CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceec
Q 046199 462 CQLSELHVDHNKLS-GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540 (902)
Q Consensus 462 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 540 (902)
.+|+.|++++|+++ +.+|..+..+++|++|++++|++++. ..|..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 47888888888887 67788889999999999999999886 7888999999999999999987888888899999999
Q ss_pred cCCccccccC-ccccccCCccceEEccCcccCCCcc---ccccccccCCeEeCcCccccccCCcc
Q 046199 541 LSRNYLTGDI-PTTIGGLTNLQLLSLENNRLHGPIP---ESFGALTSLESLDLSVNNLSGVIPIS 601 (902)
Q Consensus 541 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~ 601 (902)
+++|++++.. +..+..+++|+.|++++|++++..+ ..|..+++|+.|++++|.+. .+|.+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999998642 2789999999999999999996555 48899999999999999988 45543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=151.31 Aligned_cols=128 Identities=17% Similarity=0.193 Sum_probs=90.4
Q ss_pred CcCceEecCCCCcc-CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEE
Q 046199 486 NSLRNLSLGSNELS-SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLS 564 (902)
Q Consensus 486 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 564 (902)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666666 45566666666666666666666654 5566677777777777777766777777778888888
Q ss_pred ccCcccCCC-ccccccccccCCeEeCcCccccccCC---cccccccccccccccC
Q 046199 565 LENNRLHGP-IPESFGALTSLESLDLSVNNLSGVIP---ISLEKLVYLKDLNLSF 615 (902)
Q Consensus 565 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~l~~ 615 (902)
+++|++++. .|..++.+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888887753 34677788888888888888876555 4677788888887764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-16 Score=153.50 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=83.3
Q ss_pred ceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCc
Q 046199 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENN 568 (902)
Q Consensus 489 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (902)
+.+++++|+++.+ |..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4455555555443 2222 245556666666665544455556666666666666666555555667777777777777
Q ss_pred ccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 569 RLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 569 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+++|.+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7776666666777777777777777775555556677777777777777777666
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.2e-16 Score=149.45 Aligned_cols=128 Identities=23% Similarity=0.265 Sum_probs=112.7
Q ss_pred CCCCeEeccCcccc-CCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceec
Q 046199 462 CQLSELHVDHNKLS-GPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEIN 540 (902)
Q Consensus 462 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 540 (902)
.+|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46788888888887 67788889999999999999999986 7888999999999999999987888888899999999
Q ss_pred cCCcccccc-CccccccCCccceEEccCcccCCCcc---ccccccccCCeEeCcC
Q 046199 541 LSRNYLTGD-IPTTIGGLTNLQLLSLENNRLHGPIP---ESFGALTSLESLDLSV 591 (902)
Q Consensus 541 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 591 (902)
+++|++++. .+..++.+++|++|++++|++++..+ ..++.+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999964 35889999999999999999997665 5789999999999974
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-17 Score=166.61 Aligned_cols=151 Identities=24% Similarity=0.314 Sum_probs=97.0
Q ss_pred cCCCCCCCeeeccccccccCCCc------cccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcch
Q 046199 64 LGNLSSLQTLDLSHNRFSGTIPS------SIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANI 137 (902)
Q Consensus 64 l~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~ 137 (902)
+.....++.++++.+.++|.+|. .++.+++|++|+|++|.+++
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~------------------------------- 62 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK------------------------------- 62 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-------------------------------
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-------------------------------
Confidence 44566778888888888877776 67777777777777777764
Q ss_pred hccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccc
Q 046199 138 FRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNN 217 (902)
Q Consensus 138 ~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 217 (902)
+| .++.+++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +| .+.++++|++|+|++|.++.+
T Consensus 63 ---l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~----- 130 (198)
T 1ds9_A 63 ---IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNW----- 130 (198)
T ss_dssp ---CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCH-----
T ss_pred ---cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCch-----
Confidence 44 4555666666666666666 566666666667777777776664 44 466666777777777765531
Q ss_pred cccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCc----------ccCCCCCceEe
Q 046199 218 HFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNT----------IFNMSTLKALS 270 (902)
Q Consensus 218 ~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~ 270 (902)
| ....+..+++|++|++++|++++..|.. +..+++|+.||
T Consensus 131 ------~-------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 131 ------G-------EIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ------H-------HHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred ------h-------HHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence 1 0024566666777777777666554442 55556666555
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=148.14 Aligned_cols=133 Identities=24% Similarity=0.270 Sum_probs=104.1
Q ss_pred CCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCC
Q 046199 464 LSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSR 543 (902)
Q Consensus 464 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 543 (902)
.+.+++++|+++.. |..+ .++|+.|++++|+++++.+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 45566666666543 3322 25778888888888877777777888888888888888876666678888888888888
Q ss_pred ccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCC
Q 046199 544 NYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599 (902)
Q Consensus 544 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 599 (902)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88887777778899999999999999997767778889999999999999987654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=149.30 Aligned_cols=127 Identities=25% Similarity=0.355 Sum_probs=92.5
Q ss_pred eEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcc
Q 046199 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY 545 (902)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (902)
.+++++|+++. +|..+. ++|+.|++++|+|+. +|..|.++++|++|++++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 44444444442 333221 356677777777764 45667777777777777777776666677777777788888888
Q ss_pred ccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccc
Q 046199 546 LTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596 (902)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (902)
|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 887777788888999999999999987667778889999999999998875
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=3e-15 Score=147.12 Aligned_cols=135 Identities=19% Similarity=0.161 Sum_probs=108.2
Q ss_pred cccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCcc
Q 046199 481 CFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNL 560 (902)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (902)
.+.++++|+.|++++|+++.+ |......++|++|++++|.+++. ..+..+++|++|++++|+|++..+..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 456777888888888888864 44333334888888888888864 678888889999999999986655666899999
Q ss_pred ceEEccCcccCCCccc--cccccccCCeEeCcCccccccCCcc----cccccccccccccCCccee
Q 046199 561 QLLSLENNRLHGPIPE--SFGALTSLESLDLSVNNLSGVIPIS----LEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 561 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~l~~N~l~~ 620 (902)
++|+|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|....
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999999996 5665 7889999999999999998 45654 8889999999999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-14 Score=159.07 Aligned_cols=130 Identities=9% Similarity=0.139 Sum_probs=71.1
Q ss_pred CcCceEecCCCCccCcccccccCCCCceEEEcCCCccC-----CCCccccccccccceeccCCccccccCccccccCCcc
Q 046199 486 NSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLN-----GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNL 560 (902)
Q Consensus 486 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (902)
.+|+.+.+ .|.++.+.+.+|.++++|+.+++.+|.+. ...+..|.++++|+.+++. |.++.....+|.++++|
T Consensus 248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSC
T ss_pred CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCc
Confidence 34444444 23344444445555555555555444433 2334455556666666665 33554555666666666
Q ss_pred ceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccc-ccccccccCCcce
Q 046199 561 QLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV-YLKDLNLSFNRLE 619 (902)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~ 619 (902)
+.++|.+| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+.
T Consensus 326 ~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 326 TQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 66666444 554445666666 677777766666655555565553 4556655555433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.7e-14 Score=157.88 Aligned_cols=174 Identities=10% Similarity=0.133 Sum_probs=113.3
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCcc
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNK 473 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~ 473 (902)
+|+.+.|.++ ++.+...+|.++++|+.+++.+| ++.+...+|.+ . +|+.+.+ .+.
T Consensus 204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~---------------------~L~~i~l-p~~ 258 (401)
T 4fdw_A 204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-S---------------------GITTVKL-PNG 258 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-C---------------------CCSEEEE-ETT
T ss_pred ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-C---------------------CccEEEe-CCC
Confidence 5555555533 55455556666666666666553 33233334433 3 3344444 233
Q ss_pred ccCCCCccccCCCcCceEecCCCCcc-----CcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccc
Q 046199 474 LSGPIPACFGNLNSLRNLSLGSNELS-----SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 548 (902)
++.+.+.+|.++++|+.+++.+|.+. .+.+.+|.++++|+.+++. +.++.+....|.++++|+.++|..| ++.
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~ 336 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQ 336 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCE
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccE
Confidence 44455567777777777777776654 4556677777778887777 3466566677777788888888554 665
Q ss_pred cCccccccCCccceEEccCcccCCCccccccccc-cCCeEeCcCcccc
Q 046199 549 DIPTTIGGLTNLQLLSLENNRLHGPIPESFGALT-SLESLDLSVNNLS 595 (902)
Q Consensus 549 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 595 (902)
..+.+|.++ +|+.+++++|.+....+..|.+++ +++.|.+..|.+.
T Consensus 337 I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 337 INFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 667788888 888888888888766677787774 6788888777654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=8.1e-15 Score=144.01 Aligned_cols=134 Identities=23% Similarity=0.289 Sum_probs=110.8
Q ss_pred cccCCCCCCCeeeccccccccCCCccccCCC-cceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhcc
Q 046199 62 SQLGNLSSLQTLDLSHNRFSGTIPSSIFSIS-TLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRA 140 (902)
Q Consensus 62 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ 140 (902)
+.+.++++|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..++++++|+.||+++|.+++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~---~~l~~l~~L~~L~Ls~N~l~~--------- 78 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL---DGFPLLRRLKTLLVNNNRICR--------- 78 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE---CCCCCCSSCCEEECCSSCCCE---------
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc---cccccCCCCCEEECCCCcccc---------
Confidence 34567788999999999988 6665 55554 899999999998864 346788899999999998873
Q ss_pred Ccccc-cCcCccceeeecccccCCCCch--hhccccccceeecccCcCCCCCChh----hhccCcccEEeeeeCCCCc
Q 046199 141 IPKDI-GNLTKLKELYLGYNKLQGEIPQ--ELGNLAELEWLSLPRSFLTGTIPSS----IFNLSSLLELDFSNNSLTG 211 (902)
Q Consensus 141 ip~~~-~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~ 211 (902)
+|..+ +.+++|++|+|++|+++ .+|. .++.+++|++|++++|.++ .+|.. +..+++|++||+++|.++.
T Consensus 79 ~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 79 IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 55444 78899999999999997 6787 8899999999999999998 66764 8999999999999998654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=8e-17 Score=161.73 Aligned_cols=133 Identities=23% Similarity=0.302 Sum_probs=104.1
Q ss_pred ccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCc
Q 046199 480 ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTN 559 (902)
Q Consensus 480 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 559 (902)
..|..+++|++|++++|++++ +| .+..+++|++|++++|.++ .+|..+..+++|++|++++|++++ +| .+..+++
T Consensus 42 ~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHH
T ss_pred HHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCC
Confidence 378888888888888888887 45 7788888888888888888 467777777888888888888885 44 6888888
Q ss_pred cceEEccCcccCCCcc-ccccccccCCeEeCcCccccccCCcc----------cccccccccccccCCcce
Q 046199 560 LQLLSLENNRLHGPIP-ESFGALTSLESLDLSVNNLSGVIPIS----------LEKLVYLKDLNLSFNRLE 619 (902)
Q Consensus 560 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~L~l~~N~l~ 619 (902)
|+.|++++|++++..+ ..+..+++|+.|++++|++++.+|.. +..+++|+.|| +|+++
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 8888888888885332 46788888888888888888776653 77788888776 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=140.56 Aligned_cols=108 Identities=28% Similarity=0.291 Sum_probs=68.1
Q ss_pred eEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCc
Q 046199 513 LSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592 (902)
Q Consensus 513 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 592 (902)
+.+++++|+++. +|..+. +.|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 345555555543 343332 45566666666666556666666677777777777776655566666777777777777
Q ss_pred cccccCCcccccccccccccccCCcceecCC
Q 046199 593 NLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 593 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
+|++..+..|..+++|+.|+|++|+|++.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 7776555566677777777777777776655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.7e-13 Score=150.46 Aligned_cols=237 Identities=13% Similarity=0.073 Sum_probs=129.7
Q ss_pred cccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccc
Q 046199 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIG 389 (902)
Q Consensus 310 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 389 (902)
.|.++++|+.+.+.++.. ......|.++.+|+.+++..| ++.... ..+.++..|+.+.+..+... +.+...
T Consensus 157 aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~-----~~F~~~~~L~~i~~~~~~~~--i~~~~~ 227 (394)
T 4fs7_A 157 AFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRD-----YCFAECILLENMEFPNSLYY--LGDFAL 227 (394)
T ss_dssp TTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECT-----TTTTTCTTCCBCCCCTTCCE--ECTTTT
T ss_pred hhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCc-----hhhccccccceeecCCCceE--eehhhc
Confidence 444555555555544322 233445555566666655544 222222 34555555555555544322 222223
Q ss_pred cccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEec
Q 046199 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHV 469 (902)
Q Consensus 390 ~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L 469 (902)
... .|+.+.+... ++.+....|..+..|+.+.+..+... .....|..+..++.+....+.+..
T Consensus 228 ~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~-------------- 290 (394)
T 4fs7_A 228 SKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE-------------- 290 (394)
T ss_dssp TTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--------------
T ss_pred ccC-CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--------------
Confidence 333 6667766543 33355567777788888887776554 555666666666666655444332
Q ss_pred cCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcccccc
Q 046199 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549 (902)
Q Consensus 470 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (902)
..|..+.+|+.+.+.++ ++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+++..| ++..
T Consensus 291 ----------~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I 357 (394)
T 4fs7_A 291 ----------KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKI 357 (394)
T ss_dssp ----------TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEE
T ss_pred ----------ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEe
Confidence 24555555555555443 44444555666666666666533 44344555666666666666655 5545
Q ss_pred CccccccCCccceEEccCcccCCCccccccccccCCeE
Q 046199 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESL 587 (902)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 587 (902)
...+|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 358 ~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 358 GANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred hHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 5667777777777777654 33 234566666666553
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.8e-13 Score=147.80 Aligned_cols=327 Identities=13% Similarity=0.090 Sum_probs=191.6
Q ss_pred ccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccc
Q 046199 234 HEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFN 313 (902)
Q Consensus 234 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 313 (902)
.+|.++.+|+.+.|.. .++..-..+|.++++|+.+++.++ ++ .++.. +|.+++.|+.+.+..+ +.......|..
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~--aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRC--TFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTT--TTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-Eccch--hhcccccchhhcccCc-eeeecceeeec
Confidence 4677788888888874 466555667888888998888765 43 23332 2777778887776654 33344445555
Q ss_pred cccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccc
Q 046199 314 ASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPI 393 (902)
Q Consensus 314 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 393 (902)
...+......... .....+|.++++|+.+.+..+. ..... ..+.++.+|+.+.+..+ +
T Consensus 139 ~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~-~~I~~-----~~F~~c~~L~~i~l~~~-~------------- 196 (394)
T 4fs7_A 139 CDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSM-ETLHN-----GLFSGCGKLKSIKLPRN-L------------- 196 (394)
T ss_dssp CCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTC-CEECT-----TTTTTCTTCCBCCCCTT-C-------------
T ss_pred ccccccccCcccc--ccchhhhcccCCCcEEecCCcc-ceecc-----ccccCCCCceEEEcCCC-c-------------
Confidence 5443333322222 2334566677777777765442 21222 34555555555555443 2
Q ss_pred cccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccccc--ccCCCCCcCCCCCeEeccC
Q 046199 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK--LEGPIPDDLCQLSELHVDH 471 (902)
Q Consensus 394 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~l~~L~~L~L~~ 471 (902)
+.+...+|.++..|+.+.+..+... +...+.....|+.+.+..+. +..........++.+.+..
T Consensus 197 ------------~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~ 262 (394)
T 4fs7_A 197 ------------KIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQN 262 (394)
T ss_dssp ------------CEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECC
T ss_pred ------------eEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCceecccccccccccceeEEcCC
Confidence 2233344444455554444443322 11222223344444443221 1111112222455555544
Q ss_pred ccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCc
Q 046199 472 NKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIP 551 (902)
Q Consensus 472 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 551 (902)
+... +....|..+..++.+....+.+ ....|..+.+|+.+.+.++ ++.+....|.++.+|+.+++.++ ++....
T Consensus 263 ~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~ 336 (394)
T 4fs7_A 263 NKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGK 336 (394)
T ss_dssp TTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT
T ss_pred Ccce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhH
Confidence 4332 5556777888888887776643 3457778888888888765 55455667888888888888654 665667
Q ss_pred cccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccc
Q 046199 552 TTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDL 611 (902)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 611 (902)
.+|.++.+|+.+++..| ++.+...+|.++++|+.+++..+ ++ .+...|.+.++|+.+
T Consensus 337 ~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 337 RSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred HhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 78888888888888776 66555678888888888888654 33 345567777777653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=137.90 Aligned_cols=107 Identities=27% Similarity=0.284 Sum_probs=59.2
Q ss_pred EEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcc
Q 046199 514 SFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNN 593 (902)
Q Consensus 514 ~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 593 (902)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4444444443 2333332 445555555555555555556666666666666666665444455566666666666666
Q ss_pred ccccCCcccccccccccccccCCcceecCC
Q 046199 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 594 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
|++..+..|..+++|+.|+|++|+|.+.++
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred cceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 665444446666666666666666665443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=131.74 Aligned_cols=108 Identities=21% Similarity=0.214 Sum_probs=83.6
Q ss_pred CceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccC
Q 046199 488 LRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567 (902)
Q Consensus 488 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (902)
.+.+++++|+++. +|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566777777765 34433 26677777777777777777777788888888888888877777788889999999999
Q ss_pred cccCCCccccccccccCCeEeCcCccccccC
Q 046199 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVI 598 (902)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (902)
|+|++..+..|..+++|+.|+|++|+++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9998777778889999999999999888543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.3e-13 Score=130.44 Aligned_cols=105 Identities=20% Similarity=0.196 Sum_probs=78.0
Q ss_pred ceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCc
Q 046199 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENN 568 (902)
Q Consensus 489 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (902)
+.+++++|+++. +|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 556666666654 344332 56777777777777666777777777777777777777666666788888888888888
Q ss_pred ccCCCccccccccccCCeEeCcCccccc
Q 046199 569 RLHGPIPESFGALTSLESLDLSVNNLSG 596 (902)
Q Consensus 569 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (902)
+|++..+..|..+++|+.|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 8887666678888889999999998884
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.9e-12 Score=134.63 Aligned_cols=144 Identities=15% Similarity=0.106 Sum_probs=115.3
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.+.|++....+.|+.+.||++.. +++.+++|+.+.........+.+|+++++.+. +..++++++++...+..|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 35788888899999999999975 46899999987543233467899999999984 67888999999988999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG----------------------------------------- 842 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------------------------------------- 842 (902)
++|.++.+... +......++.++++++..||..
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99999887531 1122347889999999999941
Q ss_pred ---------------CCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 843 ---------------YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 843 ---------------~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
....++|+|++|.||++++++.+.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 015689999999999998765667999998864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=9.8e-13 Score=144.43 Aligned_cols=132 Identities=17% Similarity=0.086 Sum_probs=82.5
Q ss_pred eEecCCC-CccCcccccccCCCCceEEEcCC-CccCCCCccccccccccceeccCCccccccCccccccCCccceEEccC
Q 046199 490 NLSLGSN-ELSSFIPSTFWNLNNILSFDFSS-NSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567 (902)
Q Consensus 490 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (902)
.++.+++ +|++ +|. +..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4567776 7776 455 77777777777775 777766666677777777777777777776677777777777777777
Q ss_pred cccCCCccccccccccCCeEeCcCccccccCC-cccccccccccccccCCcceecCCC
Q 046199 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIP-ISLEKLVYLKDLNLSFNRLEGEIPS 624 (902)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~ 624 (902)
|+|++..|..|..++ |+.|+|++|++...-. ..|..+.......+..+.+++..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 777765555555555 7777777777664322 1222222223333444555555554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.8e-12 Score=138.89 Aligned_cols=107 Identities=22% Similarity=0.274 Sum_probs=83.8
Q ss_pred EEEcCCC-ccCCCCccccccccccceeccCC-ccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcC
Q 046199 514 SFDFSSN-SLNGSLPLDIGNMKVVVEINLSR-NYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591 (902)
Q Consensus 514 ~L~ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 591 (902)
.++++++ +|++ +|. +..+++|++|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|+.|++|+.|||++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 7874 666 88888888888885 888877777888888888888888888887778888888888888888
Q ss_pred ccccccCCcccccccccccccccCCcceecCC
Q 046199 592 NNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 592 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
|+|++..+..+..++ |+.|+|++|+|.+.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 888866555666655 8888888888887654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.4e-10 Score=127.50 Aligned_cols=328 Identities=11% Similarity=0.138 Sum_probs=176.8
Q ss_pred cccCCC-CCCEEEccCccccCcCCCcccCCCCCceEeccCcc---cccCCCcCCcccCCCcccceeeccCccCCCCCCcc
Q 046199 235 EIGNLP-NLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNT---LSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGF 310 (902)
Q Consensus 235 ~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 310 (902)
+|.+.. .|+.+.+-.+ ++.+-..+|.++++|+.+.+++|. ++ .++.. +|..+.+|+.+.+..+ ++......
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~--aF~~c~~L~~i~~~~~-~~~I~~~a 132 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQ--AFMFCSELTDIPILDS-VTEIDSEA 132 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTT--TTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-Eechh--hchhcccceeeccCCc-cceehhhh
Confidence 355543 4666666543 544445566666667666666553 22 12211 2455555555554433 22233344
Q ss_pred ccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccc
Q 046199 311 IFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390 (902)
Q Consensus 311 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 390 (902)
|..+.+|+.+.+..+- .......|....+|+.+.+ .++ +..+-...|.
T Consensus 133 F~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~-----------------------------~~~-~~~I~~~aF~- 180 (394)
T 4gt6_A 133 FHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTL-----------------------------PDS-VTAIEERAFT- 180 (394)
T ss_dssp TTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEEC-----------------------------CTT-CCEECTTTTT-
T ss_pred hhhhccccccccccee-eeecccceecccccccccc-----------------------------cce-eeEecccccc-
Confidence 4445555555554322 2123333444444444443 322 1111122222
Q ss_pred ccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCccc-ccccccCeeecccccccCCCCCcCCCCCeEec
Q 046199 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITV-GRLNTLQGLGLENNKLEGPIPDDLCQLSELHV 469 (902)
Q Consensus 391 l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L 469 (902)
.. .|+.+.+..+-.. ....+|.++..++......+.... ....+ ........-... .+ ....+..+.+
T Consensus 181 ~~-~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~~i 249 (394)
T 4gt6_A 181 GT-ALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIR-------YP-SQREDPAFKI 249 (394)
T ss_dssp TC-CCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEE-------CC-TTCCCSEEEC
T ss_pred cc-ceeEEEECCcccc-cccchhhhccccceeccccccccc-ccceeecccccccccccc-------cc-cccccceEEc
Confidence 22 5666666544333 555667777777777666555442 11111 111100000000 00 0012333333
Q ss_pred cCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcccccc
Q 046199 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549 (902)
Q Consensus 470 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 549 (902)
. +.+..+...+|.++..|+.+.+.++.. .+...+|.++++|+.+.+. +.++......|.++.+|+.+++..+ ++..
T Consensus 250 p-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I 325 (394)
T 4gt6_A 250 P-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQI 325 (394)
T ss_dssp C-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEE
T ss_pred C-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEe
Confidence 2 234445566788888888888876543 4566788888889888886 4455556677888888888888765 6656
Q ss_pred CccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcc
Q 046199 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRL 618 (902)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 618 (902)
...+|.++.+|+.+.+..+ ++.+-..+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 326 ~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 326 LDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred hHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 6778888899999988655 665567788889999999998876542 4566677788877766644
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-13 Score=150.85 Aligned_cols=158 Identities=20% Similarity=0.220 Sum_probs=98.3
Q ss_pred CCCeEeccCccccCCCCccccC-----CCcCceEecCCCCccCccccccc-CCCCceEEEcCCCccCCCCcccc-----c
Q 046199 463 QLSELHVDHNKLSGPIPACFGN-----LNSLRNLSLGSNELSSFIPSTFW-NLNNILSFDFSSNSLNGSLPLDI-----G 531 (902)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~~~~~-----~ 531 (902)
.|+.|+|++|.++......+.. .++|+.|+|++|.++......+. .+.+|+.|+|++|.++......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 4555555555554332222222 25677777777776543333332 34567777777777764333333 2
Q ss_pred cccccceeccCCcccccc----CccccccCCccceEEccCcccCCC----ccccccccccCCeEeCcCcccccc----CC
Q 046199 532 NMKVVVEINLSRNYLTGD----IPTTIGGLTNLQLLSLENNRLHGP----IPESFGALTSLESLDLSVNNLSGV----IP 599 (902)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 599 (902)
..+.|++|+|++|.|+.. ++..+...++|++|+|++|+|++. ++..+...++|+.|||++|.|+.. ++
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~ 232 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence 346677888888877642 344456678888888888887643 245566777888888888888753 33
Q ss_pred cccccccccccccccCCccee
Q 046199 600 ISLEKLVYLKDLNLSFNRLEG 620 (902)
Q Consensus 600 ~~l~~l~~L~~L~l~~N~l~~ 620 (902)
..+...++|+.|||++|+++.
T Consensus 233 ~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 233 RAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHhCCCCCEEeccCCCCCH
Confidence 344456788888888888764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-13 Score=152.29 Aligned_cols=110 Identities=20% Similarity=0.168 Sum_probs=59.7
Q ss_pred CCceEEEcCCCccCCC----CccccccccccceeccCCcccccc----CccccccCCccceEEccCcccCCC----cccc
Q 046199 510 NNILSFDFSSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGD----IPTTIGGLTNLQLLSLENNRLHGP----IPES 577 (902)
Q Consensus 510 ~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 577 (902)
++|++|+|++|.|+.. ++..+..+++|++|+|++|+|++. ++..+...++|+.|+|++|.|++. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 3444444444444321 222223445555555555555532 245566677788888888888743 2334
Q ss_pred ccccccCCeEeCcCccccccCCcccccccc-----ccccc--ccCCcce
Q 046199 578 FGALTSLESLDLSVNNLSGVIPISLEKLVY-----LKDLN--LSFNRLE 619 (902)
Q Consensus 578 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-----L~~L~--l~~N~l~ 619 (902)
+...++|++|||++|.|+..-...+..+.. |+.+. +.+|.++
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 445678888888888887655555544321 55555 5555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.22 E-value=5.1e-10 Score=124.89 Aligned_cols=307 Identities=10% Similarity=0.125 Sum_probs=175.8
Q ss_pred ccccCCCCCCEEEccCcc---ccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcc
Q 046199 234 HEIGNLPNLEVLGIDENH---LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGF 310 (902)
Q Consensus 234 ~~l~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 310 (902)
.+|.++++|+.+.++.|. ++..-..+|..+.+|+.+.+.++ ++ .++.. +|..+.+|+.+.+..+ +.......
T Consensus 81 ~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~--aF~~c~~L~~i~lp~~-~~~I~~~~ 155 (394)
T 4gt6_A 81 NAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSE--AFHHCEELDTVTIPEG-VTSVADGM 155 (394)
T ss_dssp TTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTT--TTTTCTTCCEEECCTT-CCEECTTT
T ss_pred HHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhh--hhhhhcccccccccce-eeeecccc
Confidence 468899999999999875 66455678889999999998766 33 23332 3788999999999754 44466677
Q ss_pred ccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccc
Q 046199 311 IFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390 (902)
Q Consensus 311 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 390 (902)
|..+.+|+.+.+..+ +..+...+|.+ .+|+.+.+..+-.. ... ..+.++.+++......+..... ...+..
T Consensus 156 F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~-----~af~~c~~l~~~~~~~~~~~~~-~~~~~~ 226 (394)
T 4gt6_A 156 FSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGT-----NAFSECFALSTITSDSESYPAI-DNVLYE 226 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECT-----TTTTTCTTCCEEEECCSSSCBS-SSCEEE
T ss_pred eecccccccccccce-eeEeccccccc-cceeEEEECCcccc-ccc-----chhhhccccceecccccccccc-cceeec
Confidence 889999999999876 44344555654 67888888654322 122 4566677777766655544311 111111
Q ss_pred ccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEecc
Q 046199 391 LPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVD 470 (902)
Q Consensus 391 l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~ 470 (902)
. +.........+.....+..+.+.+ .++..-..+|..+..|+.+.+.++..+
T Consensus 227 ~-----------~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~---------------- 278 (394)
T 4gt6_A 227 K-----------SANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS---------------- 278 (394)
T ss_dssp E-----------CTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE----------------
T ss_pred c-----------cccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce----------------
Confidence 0 000000000111222333333322 233233445555555555554433221
Q ss_pred CccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccC
Q 046199 471 HNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDI 550 (902)
Q Consensus 471 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 550 (902)
+...+|.++++|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+....|.++.+|+.+.+..+ ++..-
T Consensus 279 ------I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~ 349 (394)
T 4gt6_A 279 ------IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP 349 (394)
T ss_dssp ------ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred ------ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence 334456666666666664 3455555556666666666666654 44344556666777777777544 55455
Q ss_pred ccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccc
Q 046199 551 PTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594 (902)
Q Consensus 551 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (902)
..+|.++++|+.+++.+|.... ..|....+|+.+.+..|.+
T Consensus 350 ~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 350 ESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred HhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 6677777777777777765431 3556667777777766654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=4.1e-11 Score=125.61 Aligned_cols=139 Identities=16% Similarity=0.047 Sum_probs=103.4
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC--ccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 803 (902)
.+|.+....+.|..+.||++...+|+.|++|+.... ....+.+|+++++.+.+.. +++++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444466679999998767888999987543 3367889999999885434 66788888888889999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----------------------------------------
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY---------------------------------------- 843 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------- 843 (902)
++|.++. ... .. ...++.++++.+..+|...
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 12 2357788888888888311
Q ss_pred ---------------CCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 844 ---------------SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 844 ---------------~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
..+++|+|++|.||++++++.++|+|||.|...
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999988766779999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=120.29 Aligned_cols=142 Identities=13% Similarity=0.160 Sum_probs=107.5
Q ss_pred ccCeecccceeeEEEEEeCCCcEEEEEEee--ecc-chhhhhHHHHHHHHHhCC--CCCccceeeeeecC---CeeEEEE
Q 046199 730 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFH--LQF-DGALKSFDAECEVLKSVR--HRNLVKIISSCSNG---NFKALVL 801 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 801 (902)
..+.++.|.++.||++... +..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999874 4688888775 332 123467889999999997 45688999888766 5589999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY-------------------------------------- 843 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------- 843 (902)
||++|..+.+.. ...++......++.+++++|..||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998774421 233678888899999999999999410
Q ss_pred -----------------CCCeEEcCCCCCCEEEcCCCc--EEEEeecCcee
Q 046199 844 -----------------SNPVVHCDIKPSNILLDDDMV--AHLSDFGIAKL 875 (902)
Q Consensus 844 -----------------~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~ 875 (902)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-10 Score=125.16 Aligned_cols=13 Identities=23% Similarity=0.378 Sum_probs=6.5
Q ss_pred CcceEEEecCccc
Q 046199 92 STLKILILGDNQL 104 (902)
Q Consensus 92 ~~L~~L~ls~n~l 104 (902)
..++.|.+....+
T Consensus 107 ~~v~~L~lg~~~~ 119 (362)
T 2ra8_A 107 PSLKQITIGXWGY 119 (362)
T ss_dssp GGCSEEEECCCCS
T ss_pred hhcceEEEccccc
Confidence 3455566554443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-11 Score=127.65 Aligned_cols=162 Identities=20% Similarity=0.169 Sum_probs=109.9
Q ss_pred ceeeeeEEeeCCCCcEEEEEecc---CCcceecCc-ccCCCCCCCeeeccccccccCCCcc-ccCCCcceE--EEecCcc
Q 046199 31 VCSWIGITCDVSTHRVTALNISD---FGLTGTISS-QLGNLSSLQTLDLSHNRFSGTIPSS-IFSISTLKI--LILGDNQ 103 (902)
Q Consensus 31 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~--L~ls~n~ 103 (902)
.|+|.|+.|+..+.+|+.+...+ ..+.|.+++ .+..++. .|...+|..++.++-+ +...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 48999999998777887665544 334455543 2333332 3444555555544432 555666666 7777774
Q ss_pred ccCCCCc---ccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhcccc--cccee
Q 046199 104 LSGSFPS---FIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLA--ELEWL 178 (902)
Q Consensus 104 l~~~~~~---~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~--~L~~L 178 (902)
.. .++. .+..++++|++||||+|+|++- ..+|..++.+++|++|+|++|+|++. ..+..++ +|++|
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l------~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRL------DDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCC------GGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCC------ccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 33 2221 1235678888888888888752 23667778889999999999999853 4566666 89999
Q ss_pred ecccCcCCCCCCh-------hhhccCcccEEe
Q 046199 179 SLPRSFLTGTIPS-------SIFNLSSLLELD 203 (902)
Q Consensus 179 ~L~~n~l~~~~p~-------~~~~l~~L~~L~ 203 (902)
+|++|.+.+.+|. .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999999887763 467889999887
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.92 E-value=4e-08 Score=108.87 Aligned_cols=112 Identities=12% Similarity=0.132 Sum_probs=57.8
Q ss_pred CCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcccccc
Q 046199 477 PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGG 556 (902)
Q Consensus 477 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 556 (902)
+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++......|.++.+|+.+.+.++.++.....+|.+
T Consensus 231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcC
Confidence 33445555566666666544 44444555556666666655433 33233344555555555555555555444455555
Q ss_pred CCccceEEccCcccCCCccccccccccCCeEeCcC
Q 046199 557 LTNLQLLSLENNRLHGPIPESFGALTSLESLDLSV 591 (902)
Q Consensus 557 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 591 (902)
+.+|+.+.|..+ ++.+-..+|.++++|+.+.+..
T Consensus 309 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 309 CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 555555555433 4433344555555555555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.88 E-value=6.2e-08 Score=107.34 Aligned_cols=302 Identities=9% Similarity=0.065 Sum_probs=184.1
Q ss_pred cCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccC
Q 046199 287 LIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLAN 366 (902)
Q Consensus 287 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~ 366 (902)
+....+|+.+.+.. .++.+...+|.++++|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.... ..+..
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~-----~aF~~ 112 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGD-----YVFQG 112 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECT-----TTTTT
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEecc-----ceecc
Confidence 44456777777754 355555667777778888877644 554555566665 5666655432 322222 22332
Q ss_pred CCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCee
Q 046199 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGL 446 (902)
Q Consensus 367 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 446 (902)
.+|+.+.+.++- .......|.. . +++.+.+..+ ++.+....|..+..++.+.+..+.........+ ........
T Consensus 113 -~~L~~i~lp~~~-~~i~~~~F~~-~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~ 186 (379)
T 4h09_A 113 -TDLDDFEFPGAT-TEIGNYIFYN-S-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-LYNKNKTI 186 (379)
T ss_dssp -CCCSEEECCTTC-CEECTTTTTT-C-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-EEETTSSE
T ss_pred -CCcccccCCCcc-cccccccccc-c-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-ecccccce
Confidence 255666554432 1111122222 1 3444444332 333444555555666655555433321111000 00000000
Q ss_pred ecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCC
Q 046199 447 GLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSL 526 (902)
Q Consensus 447 ~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 526 (902)
. .....-..+..+.+..+. .......+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++...
T Consensus 187 ~--------~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~ 255 (379)
T 4h09_A 187 L--------ESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIG 255 (379)
T ss_dssp E--------EECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEEC
T ss_pred e--------ccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeC
Confidence 0 000011134444443322 2244567778888999988765 55566778999999999999876 66566
Q ss_pred ccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccc
Q 046199 527 PLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLV 606 (902)
Q Consensus 527 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 606 (902)
...|.++..|+.+.+..+ +.......|.++.+|+.+.+.++.++.+.+.+|.++.+|+.++|..+ ++.+-..+|.+++
T Consensus 256 ~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 333 (379)
T 4h09_A 256 SFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK 333 (379)
T ss_dssp TTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred ccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence 778889999999999765 66566788999999999999999998667789999999999999765 7766677899999
Q ss_pred ccccccccCC
Q 046199 607 YLKDLNLSFN 616 (902)
Q Consensus 607 ~L~~L~l~~N 616 (902)
+|+.+.+..+
T Consensus 334 ~L~~i~ip~~ 343 (379)
T 4h09_A 334 ALSTISYPKS 343 (379)
T ss_dssp TCCCCCCCTT
T ss_pred CCCEEEECCc
Confidence 9999987554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.80 E-value=3.4e-09 Score=115.64 Aligned_cols=34 Identities=32% Similarity=0.442 Sum_probs=15.7
Q ss_pred CCCCCEEEccCccccCcCCCccc--CCCCCceEecc
Q 046199 239 LPNLEVLGIDENHLVGDVPNTIF--NMSTLKALSLL 272 (902)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls 272 (902)
+++|+.|+|..|.++......+. .+++|+.|+|+
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 44555555555554322222222 45555555553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=3e-09 Score=104.73 Aligned_cols=127 Identities=14% Similarity=0.147 Sum_probs=76.7
Q ss_pred CcceecCcccCCCCCCCeeecccc-cccc----CCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcc
Q 046199 55 GLTGTISSQLGNLSSLQTLDLSHN-RFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSL 129 (902)
Q Consensus 55 ~l~g~~~~~l~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l 129 (902)
++...+...+...+.|++|+|++| .+.. .+...+...++|++|+|++|.+...-
T Consensus 23 ~~~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g--------------------- 81 (185)
T 1io0_A 23 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPV--------------------- 81 (185)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHH---------------------
T ss_pred HHHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHH---------------------
Confidence 334445566777888888888888 7752 23444556677888888888775320
Q ss_pred cCcCCcchhccCcccccCcCccceeeecccccCCC----Cchhhccccccceeec--ccCcCCCC----CChhhhccCcc
Q 046199 130 SGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELGNLAELEWLSL--PRSFLTGT----IPSSIFNLSSL 199 (902)
Q Consensus 130 ~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L--~~n~l~~~----~p~~~~~l~~L 199 (902)
...+...+...+.|++|+|++|.|... +...+...++|++|+| ++|.+... +...+...++|
T Consensus 82 --------~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L 153 (185)
T 1io0_A 82 --------AFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTL 153 (185)
T ss_dssp --------HHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSC
T ss_pred --------HHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCc
Confidence 111333444445666666666666532 3444555566777777 66666532 23344455677
Q ss_pred cEEeeeeCCCC
Q 046199 200 LELDFSNNSLT 210 (902)
Q Consensus 200 ~~L~Ls~N~l~ 210 (902)
++|+|++|.+.
T Consensus 154 ~~L~L~~n~i~ 164 (185)
T 1io0_A 154 LKFGYHFTQQG 164 (185)
T ss_dssp CEEECCCSSHH
T ss_pred CEEeccCCCCC
Confidence 77777777653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.4e-08 Score=103.20 Aligned_cols=41 Identities=29% Similarity=0.327 Sum_probs=24.5
Q ss_pred cccccceeecccCcCCC--CCChhhhccCcccEEeeeeCCCCc
Q 046199 171 NLAELEWLSLPRSFLTG--TIPSSIFNLSSLLELDFSNNSLTG 211 (902)
Q Consensus 171 ~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~ 211 (902)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 45566666666666665 344555566666666666666553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.4e-07 Score=100.89 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=100.8
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCC--ccceeeeeecCC---eeEEEEEcc
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRN--LVKIISSCSNGN---FKALVLEYM 804 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 804 (902)
.+.++.|....||++. ..+++|+.+.. .....+.+|+++++.+. +.. +++++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 56889986432 34577899999998883 333 455655544333 458999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc------------------------------------------
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG------------------------------------------ 842 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 842 (902)
+|.++.+... ..++..+...++.+++..+..||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865332 2356777788888888888888831
Q ss_pred -------------CCCCeEEcCCCCCCEEEcC--CCcEEEEeecCceec
Q 046199 843 -------------YSNPVVHCDIKPSNILLDD--DMVAHLSDFGIAKLL 876 (902)
Q Consensus 843 -------------~~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~~ 876 (902)
....++|+|++|.||++++ +..+.++||+.+..-
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 0145899999999999998 456889999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.2e-06 Score=93.68 Aligned_cols=137 Identities=13% Similarity=0.085 Sum_probs=96.9
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCC---Cccceeeeee-cCCeeEEEEEccCC
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR---NLVKIISSCS-NGNFKALVLEYMAN 806 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 806 (902)
.+.++.|....||+. ++.+++|+.+ .......+.+|+++++.+.+. .|++++.+.. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888999988 5678888843 223457889999999999642 3667777764 45678899999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc--------------------------------------------
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG-------------------------------------------- 842 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------------------------------------------- 842 (902)
.++.+... ..++......++.++++.+..||..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88866321 1234445555555555555555521
Q ss_pred -------------CCCCeEEcCCCCCCEEEcC---CCc-EEEEeecCceec
Q 046199 843 -------------YSNPVVHCDIKPSNILLDD---DMV-AHLSDFGIAKLL 876 (902)
Q Consensus 843 -------------~~~~ivHrDlkp~NIll~~---~~~-~kL~DFG~a~~~ 876 (902)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 455 489999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.6e-06 Score=90.89 Aligned_cols=136 Identities=18% Similarity=0.080 Sum_probs=99.5
Q ss_pred eeccccee-eEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 733 LIGIGSFG-TVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 733 ~lg~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
.+..|..+ .||+..... +..+++|+.+.. ....+.+|...++.+. +--|+++++++.+.+..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 699987654 678999986533 3467888999998884 44478899999999999999999999888
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------------
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG----------------------------------------------- 842 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------------------------------------------- 842 (902)
.+..... ......+..+++..+..||..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7765321 122345666777777777720
Q ss_pred --------CCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 843 --------YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 843 --------~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
....++|+|+.+.||+++.++.+-|+||+.+..-
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 0123799999999999998877779999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=7.9e-08 Score=94.46 Aligned_cols=114 Identities=13% Similarity=0.178 Sum_probs=53.3
Q ss_pred cccCCCcCceEecCCC-CccCc----ccccccCCCCceEEEcCCCccCCC----CccccccccccceeccCCcccccc--
Q 046199 481 CFGNLNSLRNLSLGSN-ELSSF----IPSTFWNLNNILSFDFSSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGD-- 549 (902)
Q Consensus 481 ~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-- 549 (902)
.+...++|++|+|++| .+... +...+...+.|++|+|++|.|... +...+...+.|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4455566666667666 66532 223344455666666666665531 111222234455555555554432
Q ss_pred --CccccccCCccceEEc--cCcccCCCc----cccccccccCCeEeCcCccc
Q 046199 550 --IPTTIGGLTNLQLLSL--ENNRLHGPI----PESFGALTSLESLDLSVNNL 594 (902)
Q Consensus 550 --~p~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l 594 (902)
+...+...+.|++|+| ++|.|.... ...+...++|+.|+|++|.+
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 2333444445555555 445554321 12222334455555555544
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.2e-06 Score=96.13 Aligned_cols=80 Identities=11% Similarity=0.007 Sum_probs=57.9
Q ss_pred cCee-cccceeeEEEEEeC-------CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCC-C--CCccceeeeeecC--
Q 046199 731 KSLI-GIGSFGTVYKGRFL-------DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR-H--RNLVKIISSCSNG-- 794 (902)
Q Consensus 731 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 794 (902)
.+.| +.|....+|++... +++.+++|+..... ......+.+|+++++.+. + ..++++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999998764 26789999765432 111357889999998884 3 3577888887655
Q ss_pred -CeeEEEEEccCCCChH
Q 046199 795 -NFKALVLEYMANGSLE 810 (902)
Q Consensus 795 -~~~~lv~e~~~~g~L~ 810 (902)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4578999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=2e-05 Score=85.59 Aligned_cols=139 Identities=17% Similarity=0.117 Sum_probs=81.2
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC--CCCccceee------eeecCCeeEEEEEc
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR--HRNLVKIIS------SCSNGNFKALVLEY 803 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~ 803 (902)
+.++.|..+.||++...++ .+++|+.... ...+..|.++++.+. .-.+++++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4456677899999987544 5999988652 134445666666553 113444443 12346778999999
Q ss_pred cCCCChH-----H---------HHhh--CCC--C---------CCHHH-------------------------------H
Q 046199 804 MANGSLE-----K---------CLYS--SNR--S---------LDIFQ-------------------------------R 825 (902)
Q Consensus 804 ~~~g~L~-----~---------~l~~--~~~--~---------~~~~~-------------------------------~ 825 (902)
++|..+. . .++. ... . ..+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1111 100 0 11111 0
Q ss_pred HHHHHHHHHHHHHHHc----------cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 826 LSIMIDVALALEYLHF----------GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 826 ~~i~~qi~~~L~~LH~----------~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..+..++..++++++. ....+++|+|+++.||+++.++.+.++||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223345566641 0257899999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.1e-05 Score=87.40 Aligned_cols=75 Identities=15% Similarity=0.047 Sum_probs=50.6
Q ss_pred cCeecccceeeEEEEEeC-CCcEEEEEEeeeccc-------hhhhhHHHHHHHHHhCCC---CCccceeeeeecCCeeEE
Q 046199 731 KSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-------GALKSFDAECEVLKSVRH---RNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~l 799 (902)
.+.+|.|..+.||+++.. +++.|++|....... ...+++..|+++++.+.. ..+++++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999764 468899998653211 123567889999887742 3455666543 344689
Q ss_pred EEEccCCC
Q 046199 800 VLEYMANG 807 (902)
Q Consensus 800 v~e~~~~g 807 (902)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00012 Score=77.68 Aligned_cols=137 Identities=14% Similarity=0.097 Sum_probs=92.9
Q ss_pred ccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC---CCCccceeeeeecCCeeEEEEEccCC
Q 046199 730 EKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
-.+.|+.|....+|+... +++.+++|+.... ....+..|++.++.+. ...+++++++....+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999986 5778999987643 3567889999998884 36688999988888899999999998
Q ss_pred CChH--------H---HHhhCCC--C-------------------CCHHHHH---HHHH----------------HHHHH
Q 046199 807 GSLE--------K---CLYSSNR--S-------------------LDIFQRL---SIMI----------------DVALA 835 (902)
Q Consensus 807 g~L~--------~---~l~~~~~--~-------------------~~~~~~~---~i~~----------------qi~~~ 835 (902)
..+. + .++.... . -+|.... ++.. +++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1222111 0 1233211 1111 11111
Q ss_pred H-HHHH-ccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 836 L-EYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 836 L-~~LH-~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
+ ..|. ......++|+|+.+.|++++.++ +.|+||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 2332 12257899999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00015 Score=76.36 Aligned_cols=80 Identities=14% Similarity=0.102 Sum_probs=59.5
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-C--CCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-H--RNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e 802 (902)
....-.+.+|.|..+.||+++..+|+.|++|+...........+..|++.|+.+. . -.+++++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3455567889999999999999999999999876544444467889999999884 2 2355666543 2378999
Q ss_pred ccCCCCh
Q 046199 803 YMANGSL 809 (902)
Q Consensus 803 ~~~~g~L 809 (902)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00019 Score=80.25 Aligned_cols=73 Identities=11% Similarity=0.086 Sum_probs=45.8
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeecc----ch-----hhhhHHHHHHHHH-hCCCCCccceeeeeecCCeeEEE
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF----DG-----ALKSFDAECEVLK-SVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~-----~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.+.+|.|..+.||++.. +++.|+||...... .. ....++.|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 56789999999999965 56789999432210 11 1223344443322 12335677777765 4567899
Q ss_pred EEcc-CC
Q 046199 801 LEYM-AN 806 (902)
Q Consensus 801 ~e~~-~~ 806 (902)
|||+ +|
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.52 E-value=1.8e-05 Score=75.56 Aligned_cols=83 Identities=12% Similarity=0.065 Sum_probs=41.8
Q ss_pred CCceEEEcCCCccCCCCccccccccccceeccCCcc-ccccCccccccC----CccceEEccCcc-cCCCcccccccccc
Q 046199 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY-LTGDIPTTIGGL----TNLQLLSLENNR-LHGPIPESFGALTS 583 (902)
Q Consensus 510 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 583 (902)
..|+.||++++.++..--..+..+++|++|+|+++. |+...-..++.+ ++|+.|+|+++. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 456666666666654433444555555555555553 443333333332 245555555542 44333334445555
Q ss_pred CCeEeCcCc
Q 046199 584 LESLDLSVN 592 (902)
Q Consensus 584 L~~L~Ls~N 592 (902)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00026 Score=75.91 Aligned_cols=156 Identities=13% Similarity=0.132 Sum_probs=86.7
Q ss_pred CHHHHHhhcccccc-----cCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC--ccceee
Q 046199 717 SYRELLLATDHFSE-----KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKIIS 789 (902)
Q Consensus 717 ~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 789 (902)
+.+++.....+|.+ .+.|+.|....+|++...++ .+++|+.... ...+.+..|.++++.+.... +++++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444333344543 34566788889999987555 6889988652 12345667888887774212 344443
Q ss_pred e------eecCCeeEEEEEccCCCChHH-----H---------HhhC--C--CC----CC---HHHHHH-----------
Q 046199 790 S------CSNGNFKALVLEYMANGSLEK-----C---------LYSS--N--RS----LD---IFQRLS----------- 827 (902)
Q Consensus 790 ~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~--~--~~----~~---~~~~~~----------- 827 (902)
. ....+..+++|+|++|..+.. + ++.. . .. .. +.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 2 123466789999999865321 0 1111 0 00 01 111000
Q ss_pred -HHHHHHHHHHHHHc----cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 828 -IMIDVALALEYLHF----GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 828 -i~~qi~~~L~~LH~----~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
+...+...+++++. ....+++|+|+.+.||++++++.+.++||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113344455541 1245899999999999999876668999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.40 E-value=3.6e-05 Score=73.48 Aligned_cols=82 Identities=11% Similarity=0.114 Sum_probs=38.1
Q ss_pred cCceEecCCCCccCcccccccCCCCceEEEcCCCc-cCCCCccccccc----cccceeccCCcc-ccccCccccccCCcc
Q 046199 487 SLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNS-LNGSLPLDIGNM----KVVVEINLSRNY-LTGDIPTTIGGLTNL 560 (902)
Q Consensus 487 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 560 (902)
.|+.||++++.++...-..+.++++|+.|+|+++. ++..--..+..+ ++|++|+|+++. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555544433444455555555555553 332222222222 245555555542 443333344455555
Q ss_pred ceEEccCc
Q 046199 561 QLLSLENN 568 (902)
Q Consensus 561 ~~L~Ls~N 568 (902)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00048 Score=74.27 Aligned_cols=140 Identities=14% Similarity=0.065 Sum_probs=76.4
Q ss_pred Ceecccceee-EEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCC--CCccceeeeeecCCeeEEEEEccCCCC
Q 046199 732 SLIGIGSFGT-VYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRH--RNLVKIISSCSNGNFKALVLEYMANGS 808 (902)
Q Consensus 732 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~ 808 (902)
+.++.|.... +|+....+++.+++|...... .+.+..|+.+++.+.. -.+++++.+....+ +++||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555444 678765447788887654321 1445667777777742 23567777644444 68999997766
Q ss_pred hHHHHhhC-------------------------CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 046199 809 LEKCLYSS-------------------------NRSLDIFQRL-------S-I------------MIDVALALEYLH--- 840 (902)
Q Consensus 809 L~~~l~~~-------------------------~~~~~~~~~~-------~-i------------~~qi~~~L~~LH--- 840 (902)
+.+++... ...++..... . + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433210 0112221110 0 0 001111222221
Q ss_pred ccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCceec
Q 046199 841 FGYSNPVVHCDIKPSNILLDDD----MVAHLSDFGIAKLL 876 (902)
Q Consensus 841 ~~~~~~ivHrDlkp~NIll~~~----~~~kL~DFG~a~~~ 876 (902)
......++|+|+.+.||+++.+ +.+.++||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1125689999999999999874 68999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00052 Score=72.81 Aligned_cols=137 Identities=12% Similarity=0.095 Sum_probs=77.4
Q ss_pred cCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCc-cceeeeeecCCeeEEEEEcc-CCCC
Q 046199 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL-VKIISSCSNGNFKALVLEYM-ANGS 808 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 808 (902)
.+.|+.|....+|++ +.+++|+....... .....+|+.+++.+....+ +++++...+ .-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 678889999999999 56888987643221 2234568888877742222 566665433 346899999 6654
Q ss_pred hHHH------------------HhhCCCC----CCH-HHHHHHHHH--------------HHHHHH----HHH-ccCCCC
Q 046199 809 LEKC------------------LYSSNRS----LDI-FQRLSIMID--------------VALALE----YLH-FGYSNP 846 (902)
Q Consensus 809 L~~~------------------l~~~~~~----~~~-~~~~~i~~q--------------i~~~L~----~LH-~~~~~~ 846 (902)
+... ++..... ... ..+..+..+ +...+. .+. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 1111110 011 111111110 111111 111 112456
Q ss_pred eEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 847 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
++|+|+.|.||+ ..++.+.++||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56668899999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00094 Score=71.71 Aligned_cols=140 Identities=11% Similarity=0.109 Sum_probs=82.2
Q ss_pred CeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCC--Cccceeee-----eecCCeeEEEEEcc
Q 046199 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHR--NLVKIISS-----CSNGNFKALVLEYM 804 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 804 (902)
+.++ |....||++...+|+.+++|+.+... ...+.+..|..+++.+... .+++++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77789999887677789999986431 1235677788888777422 24444443 22356678999999
Q ss_pred CCCChH-----HH---------Hhh--C------CCCCCHHHH----HHH---------------HHHHHHHHHHHHc--
Q 046199 805 ANGSLE-----KC---------LYS--S------NRSLDIFQR----LSI---------------MIDVALALEYLHF-- 841 (902)
Q Consensus 805 ~~g~L~-----~~---------l~~--~------~~~~~~~~~----~~i---------------~~qi~~~L~~LH~-- 841 (902)
+|..+. .+ ++. . ....+.... ..+ ...+...++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885432 11 111 0 011221111 000 1111112222221
Q ss_pred --cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 842 --GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 842 --~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1256789999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00098 Score=72.66 Aligned_cols=140 Identities=13% Similarity=0.130 Sum_probs=84.6
Q ss_pred cCeecccceeeEEEEEeC--------CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 731 KSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+.+..|-...+|++... +++.|++|+..... .......+|.++++.+. +.-.+++++.+.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888999999864 25789999863321 23456678999998884 3334677776653 2999
Q ss_pred EccCCCChHH--------------H---HhhC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 046199 802 EYMANGSLEK--------------C---LYSS----NRSLD--IFQRLSIMIDVAL-------------------ALEYL 839 (902)
Q Consensus 802 e~~~~g~L~~--------------~---l~~~----~~~~~--~~~~~~i~~qi~~-------------------~L~~L 839 (902)
||++|.++.. . ++.. .+... +.++.++..++.. .++++
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865431 0 1111 11122 3445555544322 22333
Q ss_pred H-----ccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCcee
Q 046199 840 H-----FGYSNPVVHCDIKPSNILLDDD----MVAHLSDFGIAKL 875 (902)
Q Consensus 840 H-----~~~~~~ivHrDlkp~NIll~~~----~~~kL~DFG~a~~ 875 (902)
. ......++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1124578999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00064 Score=61.81 Aligned_cols=61 Identities=25% Similarity=0.317 Sum_probs=42.1
Q ss_pred ceEEccCcccC-CCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCC
Q 046199 561 QLLSLENNRLH-GPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 561 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
..++.+++.|+ ..+|..+. ++|+.|||++|+|+...+..|..+++|+.|+|++|+|.+..-
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 36677777775 24554332 357888888888886666677778888888888888876544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0043 Score=66.85 Aligned_cols=67 Identities=10% Similarity=0.118 Sum_probs=44.3
Q ss_pred ccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC---CCCccceeee------eecCCeeEEEEEccCC
Q 046199 736 IGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR---HRNLVKIISS------CSNGNFKALVLEYMAN 806 (902)
Q Consensus 736 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~ 806 (902)
.|....||++...++ .+++|+...... ..|..+++.+. -|.+++++.. ....+..++||+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333678999987666 999998765431 35666666553 2335555532 2345788999999998
Q ss_pred CCh
Q 046199 807 GSL 809 (902)
Q Consensus 807 g~L 809 (902)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0015 Score=72.74 Aligned_cols=73 Identities=18% Similarity=0.172 Sum_probs=50.1
Q ss_pred cCeecccceeeEEEEEeCC--------CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 731 KSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+.|+.|....||++...+ ++.|++|+.... ...+.+..|..+++.+. +.-.+++++.+.. .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998753 578999988432 11145567999888884 3334677776542 3899
Q ss_pred EccCCCCh
Q 046199 802 EYMANGSL 809 (902)
Q Consensus 802 e~~~~g~L 809 (902)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.003 Score=70.80 Aligned_cols=74 Identities=16% Similarity=0.160 Sum_probs=48.9
Q ss_pred cCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC-ccceeeeeecCCeeEEEEEccCCCC
Q 046199 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFKALVLEYMANGS 808 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~ 808 (902)
.+.|+.|-...+|++...+ ++.|++|+....... .-.-.+|..+++.+...+ .+++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence 4568888889999998765 578999987543221 122368999999886443 467777763 2 25999998854
Q ss_pred h
Q 046199 809 L 809 (902)
Q Consensus 809 L 809 (902)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0003 Score=68.45 Aligned_cols=85 Identities=15% Similarity=0.204 Sum_probs=38.3
Q ss_pred CCCcCceEecCCC-CccCc----ccccccCCCCceEEEcCCCccCCC----CccccccccccceeccCCccccccCc---
Q 046199 484 NLNSLRNLSLGSN-ELSSF----IPSTFWNLNNILSFDFSSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGDIP--- 551 (902)
Q Consensus 484 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p--- 551 (902)
+-+.|+.|+|++| +|... +.+.+..-+.|+.|+|++|+|... +...+..-+.|++|+|++|+|....-
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3445566666553 54321 223334445555555555555422 11122223445555555555543221
Q ss_pred -cccccCCccceEEccCc
Q 046199 552 -TTIGGLTNLQLLSLENN 568 (902)
Q Consensus 552 -~~~~~l~~L~~L~Ls~N 568 (902)
+.+..-+.|+.|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 22333345555565543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0023 Score=69.91 Aligned_cols=74 Identities=15% Similarity=0.231 Sum_probs=45.8
Q ss_pred cCeecccceeeEEEEEeCC---------CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC-ccceeeeeecCCeeEEE
Q 046199 731 KSLIGIGSFGTVYKGRFLD---------GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN-LVKIISSCSNGNFKALV 800 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 800 (902)
.+.++.|....+|++...+ ++.|++|+...... .......|.++++.+.... ++++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 3467788888999998654 26889998754322 1223467888888875333 55677654 22 689
Q ss_pred EEccCCCCh
Q 046199 801 LEYMANGSL 809 (902)
Q Consensus 801 ~e~~~~g~L 809 (902)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00026 Score=68.91 Aligned_cols=17 Identities=12% Similarity=0.264 Sum_probs=7.3
Q ss_pred ccccccCeeeccccccc
Q 046199 438 GRLNTLQGLGLENNKLE 454 (902)
Q Consensus 438 ~~l~~L~~L~L~~N~l~ 454 (902)
.....|+.|+|++|+|.
T Consensus 67 ~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 67 CNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TTCSCCCEEECTTSCCB
T ss_pred hhCCCcCEEEccCCCCC
Confidence 33344444444444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0029 Score=57.44 Aligned_cols=35 Identities=20% Similarity=0.284 Sum_probs=17.5
Q ss_pred CceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 488 LRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 488 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44445555555444444445555555555555544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.044 Score=60.42 Aligned_cols=74 Identities=11% Similarity=0.176 Sum_probs=49.7
Q ss_pred cCeecccceeeEEEEEeCC--------CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 731 KSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
.+.+..|-...+|++...+ ++.|++|+...... ..-+..+|.++++.+. +.-.+++++.+. + +.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence 3456778888999998753 57899998654322 2234467888888874 333556665442 2 6899
Q ss_pred EccCCCCh
Q 046199 802 EYMANGSL 809 (902)
Q Consensus 802 e~~~~g~L 809 (902)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.85 E-value=0.15 Score=56.03 Aligned_cols=30 Identities=30% Similarity=0.394 Sum_probs=25.5
Q ss_pred CeEEcCCCCCCEEE------cCCCcEEEEeecCcee
Q 046199 846 PVVHCDIKPSNILL------DDDMVAHLSDFGIAKL 875 (902)
Q Consensus 846 ~ivHrDlkp~NIll------~~~~~~kL~DFG~a~~ 875 (902)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4566899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 902 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-47
Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVR 780
L D F + S +G G+ G V+K G+ +A K+ HL+ E +VL
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
+V + + ++ +E+M GSL++ L + R + + I V L YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ ++H D+KPSNIL++ L DFG++ L +SM +GT YM+P
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 172
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 4/175 (2%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
D + +G G+FG VYK + + + A KV + + L+ + E ++L S H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+VK++ + N +++E+ A G+++ + R L Q + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
N ++H D+K NIL D L+DFG++ R +GT +MAP +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 10/174 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGA--LKSFDAECEVLKSVRHRN 783
+ IG GSFGTVYKG++ +VA+K+ ++ L++F E VL+ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
++ + + A+V ++ SL L+ ++ + + I A ++YLH
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE--SMRTQTLGTIGYMAP 895
++H D+K +NI L +D+ + DFG+A + + Q G+I +MAP
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-46
Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 12/188 (6%)
Query: 719 RELLLATDHFSEKSL-IGIGSFGTVYKGRFL---DGMEVAIKVFHLQFD-GALKSFDAEC 773
++L L D+ + +G G+FG+V +G + ++VAIKV + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 774 EVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
+++ + + +V++I C LV+E G L K L + + ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM---RTQTLGTI 890
+ ++YL VH D+ N+LL + A +SDFG++K L ++S R+ +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 891 GYMAPGLW 898
+ AP
Sbjct: 177 KWYAPECI 184
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 6e-45
Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 716 FSYRELLLATDHFSEK---------SLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF 762
F++ + A F+++ +IG G FG V G + VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 763 -DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLD 821
+ + F +E ++ H N++ + + ++ E+M NGSL+ L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 822 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881
+ Q + ++ +A ++YL VH D+ NIL++ ++V +SDFG+++ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 882 MRTQT-----LGTIGYMAP 895
T T I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-44
Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 12/175 (6%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR 780
FS+ IG GSFG VY R + + VAIK + + E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H N ++ + LV+EY + + + L + ++ L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S+ ++H D+K NILL + + L DFG A ++ S GT +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAP 180
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+ +G G FG V+ G + +VA+K +F AE ++K ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQRLSIMIDVALALEYLHFGYS 844
++ + + ++ EYM NGSL L + + L I + L + +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-RTQTLGTIGYMAP 895
+H D++ +NIL+ D + ++DFG+A+L+ E R I + AP
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 10/183 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
+ + IG GS+G K R DG + K + + +E +L+ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 783 NLVKIISSCSNGNFKAL--VLEYMANGSLEKCLYSSNRS---LDIFQRLSIMIDVALALE 837
N+V+ + L V+EY G L + + LD L +M + LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 838 YLH--FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
H + V+H D+KP+N+ LD L DFG+A++LN + S +GT YM+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 896 GLW 898
Sbjct: 184 EQM 186
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-42
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 5/171 (2%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+ +G G FG V G++ +VAIK+ F E +V+ ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
++ C+ ++ EYMANG L L Q L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR-TQTLGTIGYMAP 895
+H D+ N L++D V +SDFG+++ + +E + + + P
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 3e-42
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 707 MSPQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGA 765
M P +Y + + + K +G G +G VY+G + + VA+K
Sbjct: 2 MDPS----SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TME 56
Query: 766 LKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNR-SLDIFQ 824
++ F E V+K ++H NLV+++ C+ ++ E+M G+L L NR +
Sbjct: 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116
Query: 825 RLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR- 883
L + ++ A+EYL +H D+ N L+ ++ + ++DFG+++L+ G+
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173
Query: 884 TQTLGTIGYMAPGLW 898
I + AP
Sbjct: 174 AGAKFPIKWTAPESL 188
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-42
Identities = 57/172 (33%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN 783
++ IG G+ GTVY + G EVAI+ +LQ + E V++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+V + S G+ +V+EY+A GSL + + Q ++ + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
SN V+H DIK NILL D L+DFG + E+S R+ +GT +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 5/171 (2%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+ IG G FG V+ G +L+ +VAIK + F E EV+ + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
++ C LV E+M +G L L + L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 846 PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
V+H D+ N L+ ++ V +SDFG+ + + ++ + + + +P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-41
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 8/174 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRN 783
+ + +G G++G V VA+K+ ++ ++ E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+VK GN + L LEY + G L + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL--NGEESMRTQTLGTIGYMAP 895
+ H DIKP N+LLD+ +SDFG+A + N E + + GT+ Y+AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (386), Expect = 3e-41
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 7/173 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
DH+ +G G+FG V++ G A K + ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V + + + N ++ E+M+ G L + + + + + + M V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 845 NPVVHCDIKPSNILL--DDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N VH D+KP NI+ L DFG+ L+ ++S++ T GT + AP
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAP 194
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 10/174 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH---LQFDGALKSFDAECEVLKSVRH 781
+ F +G G FG VY R +A+KV L+ G E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
N++++ + L+LEY G++ + L ++ D + + + ++A AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S V+H DIKP N+LL ++DFG + GT+ Y+ P
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC--GTLDYLPP 173
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 7/172 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
+ + +G G FG V+ G + VAIK ++F E +V+K +RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 786 KIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIF-QRLSIMIDVALALEYLHFGYS 844
++ + S +V EYM+ GSL L Q + + +A + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTL-GTIGYMAP 895
VH D++ +NIL+ +++V ++DFG+A+L+ E Q I + AP
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 58/172 (33%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLV 785
IG G FG V G G +VA+K ++ D ++F AE V+ +RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 786 KIISSCSNGNFK-ALVLEYMANGSLEKCLYSSNRS-LDIFQRLSIMIDVALALEYLHFGY 843
+++ +V EYMA GSL L S RS L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
N VH D+ N+L+ +D VA +SDFG+ K + S + + + AP
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAP 169
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-40
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 734 IGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISS 790
IG GSF TVYKG + +EVA + + F E E+LK ++H N+V+ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 791 C----SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
LV E M +G+L+ L + + I S + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 847 VVHCDIKPSNILLDD-DMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H D+K NI + + D G+A L S +GT +MAP
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAP 182
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (374), Expect = 1e-39
Identities = 37/173 (21%), Positives = 76/173 (43%), Gaps = 7/173 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
D++ +G G+FG V++ G K + + + E ++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
+ + + + L+LE+++ G L + + + + + ++ M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 845 NPVVHCDIKPSNILLD--DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ +VH DIKP NI+ + + DFG+A LN + + T T + AP
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAP 197
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 730 EKSLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNL 784
E +G G+FGTV KG + VA+K+ + + AE V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
V++I C ++ LV+E G L K L NR + + ++ V++ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 845 NPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYMAP 895
+ VH D+ N+LL A +SDFG++K L +E+ + + AP
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-39
Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVF---HLQFDGALKSFDAECEVLKSVRH 781
+ F ++G GSF TV R L E AIK+ H+ + + E +V+ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
VK+ + + L Y NG L K + D ++ ALEYLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH- 125
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT--LGTIGYMAP 895
++H D+KP NILL++DM ++DFG AK+L+ E +GT Y++P
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 5e-39
Identities = 46/182 (25%), Positives = 84/182 (46%), Gaps = 12/182 (6%)
Query: 723 LATDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQF-DGALKSFDAECEVL 776
+ + + +IG G FG VYKG + VAIK + + F E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 777 KSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
H N++++ S ++ EYM NG+L+K L + + Q + ++ +A +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYM 893
+YL + VH D+ NIL++ ++V +SDFG++++L + T I +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 894 AP 895
AP
Sbjct: 181 AP 182
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-39
Identities = 40/202 (19%), Positives = 77/202 (38%), Gaps = 35/202 (17%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQFD-GALKSFDAECEVLKS 778
++ ++G G+FG V ++VA+K+ + D ++ +E +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 779 V-RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS------------------ 819
+ H N+V ++ +C+ L+ EY G L L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 820 ----LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875
L L VA +E+L VH D+ N+L+ V + DFG+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 876 LNGEESMRTQT--LGTIGYMAP 895
+ + + + + +MAP
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAP 235
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 17/181 (9%)
Query: 731 KSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISS 790
+ IG G FG V++G+ G EVA+K+F + + + +AE +RH N++ I++
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 791 CSNGNFKA----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH-----F 841
+ N LV +Y +GSL L + ++ + + + + A L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES----MRTQTLGTIGYMAPGL 897
+ H D+K NIL+ + ++D G+A + +GT YMAP +
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 898 W 898
Sbjct: 184 L 184
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 43/187 (22%), Positives = 69/187 (36%), Gaps = 14/187 (7%)
Query: 722 LLATDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF---DGALKSFDAECE 774
L+ +G GSFG V +G + + VA+K A+ F E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 775 VLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
+ S+ HRNL+++ K +V E GSL L + + VA
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES---MRTQTLGTIG 891
+ YL S +H D+ N+LL + + DFG+ + L + M+
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 892 YMAPGLW 898
+ AP
Sbjct: 180 WCAPESL 186
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 10/175 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVR 780
+ IG G FG V++G ++ + VAIK D + F E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H ++VK+I + +++E G L L SLD+ + ++ AL YL
Sbjct: 67 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT-LGTIGYMA 894
S VH DI N+L+ + L DFG+++ + + I +MA
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 2e-37
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 35/211 (16%)
Query: 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSF 769
L ++ IG G+FG V++ R VA+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 770 DAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS---------- 819
E ++ + N+VK++ C+ G L+ EYMA G L + L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 820 -------------LDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAH 866
L ++L I VA + YL VH D+ N L+ ++MV
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 867 LSDFGIAKLLNGEESMRTQT--LGTIGYMAP 895
++DFG+++ + + + I +M P
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 13/184 (7%)
Query: 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLD-----GMEVAIKVFHLQFDG-ALKSFDAEC 773
+L T+ F + ++G G+FGTVYKG ++ + VAIK A K E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 774 EVLKSVRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVA 833
V+ SV + ++ +++ C + L+ + M G L + ++ L+ + +A
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 834 LALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT--LGTIG 891
+ YL +VH D+ N+L+ ++DFG+AKLL EE I
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 892 YMAP 895
+MA
Sbjct: 179 WMAL 182
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-37
Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 30/197 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKS 778
+ S +G G+FG V + M VA+K+ ++ +E +VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 779 V-RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS-----------------L 820
+ H N+V ++ +C+ G ++ EY G L L S L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
D+ LS VA + +L S +H D+ NILL + + DFG+A+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 881 SMRTQT--LGTIGYMAP 895
+ + + +MAP
Sbjct: 200 NYVVKGNARLPVKWMAP 216
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 1e-36
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGAL---------KSFDAECEV 775
+++ K ++G G V + E A+K+ + G+ ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 776 LKSVR-HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
L+ V H N++++ + F LV + M G L L + +L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMA 894
+ LH +VH D+KP NILLDDDM L+DFG + L+ E +R GT Y+A
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSYLA 177
Query: 895 PGLW 898
P +
Sbjct: 178 PEII 181
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 727 HFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQFD-GALKSFDAECEVLKSVRH 781
HF+E +IG G FG VY G LD + A+K + D G + F E ++K H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 782 RNLVKIISSCSNGNFKA-LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
N++ ++ C +VL YM +G L + + + + + + VA +++L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE----SMRTQTLGTIGYMAP 895
VH D+ N +LD+ ++DFG+A+ + +E +T + +MA
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 24/190 (12%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDG---MEVAIKVFHLQFD-GALKSFDAECEVLKSV-R 780
+ + +IG G+FG V K R M+ AIK + F E EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLY---------------SSNRSLDIFQR 825
H N++ ++ +C + + L +EY +G+L L S+ +L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 826 LSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQ 885
L DVA ++YL +H D+ NIL+ ++ VA ++DFG+++
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 886 TLGTIGYMAP 895
+ +MA
Sbjct: 187 R-LPVRWMAI 195
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 4e-35
Identities = 41/176 (23%), Positives = 74/176 (42%), Gaps = 4/176 (2%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHR 782
D + + ++G G+F V VAIK + +G S + E VL ++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
N+V + +G L+++ ++ G L + ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
LD+D +SDFG++K+ + S+ + GT GY+AP +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVL 181
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (329), Expect = 2e-34
Identities = 42/182 (23%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVR 780
+D + ++G G V+ R L +VA+KV F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 781 HRNLVKIISSC----SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
H +V + + G +V+EY+ +L +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT---LGTIGYM 893
+ H N ++H D+KP+NI++ + DFGIA+ + + TQT +GT Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 894 AP 895
+P
Sbjct: 182 SP 183
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 2e-34
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 11/174 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 781
F +G GSFG V+ R +G A+KV + ++ + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
++++ + + ++++Y+ G L L S R +V LALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH- 121
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +++ D+KP NILLD + ++DFG AK + + GT Y+AP
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAP 170
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 9/175 (5%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH---LQFDGALKSFDAECEVL-KSVR 780
+ F ++G GSFG V+ F AIK + D ++ E VL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 781 HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
H L + + V+EY+ G L + S ++ D+ + ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +V+ D+K NILLD D ++DFG+ K ++ GT Y+AP
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 4e-34
Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHL------QFDGALKSFDAECEVLKS 778
+ FS +IG G FG VY R D G A+K Q + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838
+V + + + + +L+ M G L L S + ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMA 894
+H + VV+ D+KP+NILLD+ +SD G+A + ++GT GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMA 173
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (326), Expect = 5e-34
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 6/175 (3%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRN 783
+ + IG G++G VYK + G A+K L+ +G + E +LK ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 784 LVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+VK+ LV E++ + L+K L L+ S ++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 844 SNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
V+H D+KP N+L++ + ++DFG+A+ T + T+ Y AP +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 6/173 (3%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
++F + IG G++G VYK R G VA+K L +G + E +LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
N+VK++ N LV E++ + S+ + + S + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S+ V+H D+KP N+L++ + L+DFG+A+ T + T+ Y AP
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 10/169 (5%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-----DGALKSFDAECEVLKSVRHRNLVK 786
+G G F TVYK R VAIK L DG ++ E ++L+ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 787 IISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP 846
++ + + + +LV ++M LE + ++ L + M+ LEYLH +
Sbjct: 65 LLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 847 VVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++H D+KP+N+LLD++ V L+DFG+AK T + T Y AP
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-34
Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFH-LQFDGALKSFDAECEVLKSVRHR 782
++ S IG G++G V + + VAIK + + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYS--SNRSLDIFQRLSIMIDVALALEYLH 840
N++ I + + Y+ + LY + L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE---SMRTQTLGTIGYMAP 895
S V+H D+KPSN+LL+ + DFG+A++ + + T+ + T Y AP
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 41/188 (21%), Positives = 78/188 (41%), Gaps = 21/188 (11%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRF------LDGMEVAIKVFHLQFD-GALKSFDAECEVLKS 778
+ + +G GSFG VY+G VAIK + F E V+K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRS---------LDIFQRLSIM 829
++V+++ S G +++E M G L+ L S + + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 830 IDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQT--L 887
++A + YL+ +N VH D+ N ++ +D + DFG+ + + + R L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 888 GTIGYMAP 895
+ +M+P
Sbjct: 197 LPVRWMSP 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 37/173 (21%), Positives = 74/173 (42%), Gaps = 8/173 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
+ + +G G FG V++ K ++ E +L RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
+ + S + ++ E+++ + + + +S L+ + +S + V AL++LH S
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 845 NPVVHCDIKPSNILLDDDMVAH--LSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ + H DI+P NI+ + + +FG A+ L ++ R Y AP
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAP 172
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 15/180 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ------FDGALKSFDAECEVLKS 778
+ L+G G FG+VY G + D + VAIK E +LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 779 VR--HRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
V +++++ + L+LE + +L S V A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 837 EYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ H + V+H DIK NIL+D + L DFG LL +++ T GT Y P
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPP 178
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 42/197 (21%), Positives = 86/197 (43%), Gaps = 30/197 (15%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL--------DGMEVAIKVFHLQF-DGALKSFDAECEVL 776
D +G G+FG V + +VA+K+ + L +E E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 777 KSV-RHRNLVKIISSCSNGNFKALVLEYMANGSLEKCL---------------YSSNRSL 820
K + +H+N++ ++ +C+ +++EY + G+L + L ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 821 DIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880
+S VA +EYL S +H D+ N+L+ +D V ++DFG+A+ ++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 881 SMRT--QTLGTIGYMAP 895
+ + +MAP
Sbjct: 190 YYKKTTNGRLPVKWMAP 206
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 16/181 (8%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF------DGALKSFDAECEVLKS 778
D++ +G G F V K R G++ A K + + + + E +LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 779 VRHRNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEY 838
++H N++ + N L+LE +A G L + SL + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 839 LHFGYSNPVVHCDIKPSNILLDDDMVA----HLSDFGIAKLLNGEESMRTQTLGTIGYMA 894
LH S + H D+KP NI+L D V + DFG+A ++ + GT ++A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVA 184
Query: 895 P 895
P
Sbjct: 185 P 185
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-31
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 8/177 (4%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 781
+ F L+G G+FG V R G A+K+ + + E VL++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
L + + + V+EY G L L S R + ++ ALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
S VV+ DIK N++LD D ++DFG+ K + + GT Y+AP +
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 7/176 (3%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHR 782
+ + IG G++GTV+K + VA+K L D G S E +LK ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 783 NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG 842
N+V++ + LV E+ + S N LD S + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119
Query: 843 YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLW 898
V+H D+KP N+L++ + L++FG+A+ + + T+ Y P +
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 29/196 (14%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKS 778
D +G G+FG V + VA+K+ ++ +E ++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 779 VRHRNLVKII--SSCSNGNFKALVLEYMANGSLEKCLYSSNRS---------------LD 821
+ H V + + G +++E+ G+L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 822 IFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881
+ + VA +E+L S +H D+ NILL + V + DFG+A+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 882 --MRTQTLGTIGYMAP 895
+ + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 724 ATDHFSEKSLIGIGSFGTVYKGRFL--DGMEVAIKVFHLQF--DGALKSFDAECEVLK-- 777
A + + IG G++G V+K R L G VA+K +Q +G S E VL+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 778 -SVRHRNLVKIISSCSNGNFKA-----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMID 831
+ H N+V++ C+ LV E++ + +M
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 832 VALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIG 891
+ L++LH S+ VVH D+KP NIL+ L+DFG+A++ + + ++ + + T+
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLW 180
Query: 892 YMAPGLW 898
Y AP +
Sbjct: 181 YRAPEVL 187
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 2e-30
Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
+ + IG GSFG +Y G + G EVAIK+ ++ E ++ K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64
Query: 785 VKIISSC-SNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGY 843
+ I C + G++ +V+E + SLE +R + L + + +EY+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120
Query: 844 SNPVVHCDIKPSNIL---LDDDMVAHLSDFGIAKLLNGEES-------MRTQTLGTIGYM 893
S +H D+KP N L + ++ DFG+AK + GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 894 AP 895
+
Sbjct: 181 SI 182
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVK 786
+++ +IG GSFG VY+ + D G VAIK + + E ++++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 787 IISSC------SNGNFKALVLEYMANGSLEKCLY--SSNRSLDIFQRLSIMIDVALALEY 838
+ + + LVL+Y+ + + ++L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 839 LHFGYSNPVVHCDIKPSNILLDDD-MVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGL 897
+H S + H DIKP N+LLD D V L DFG AK L E + + + Y AP L
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPEL 193
Query: 898 W 898
Sbjct: 194 I 194
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-29
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 19/173 (10%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVL-KSVRHRNLVKIISS 790
++G+G G V + + A+K+ E E+ ++ + ++V+I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 791 C----SNGNFKALVLEYMANGSLEKCLYS-SNRSLDIFQRLSIMIDVALALEYLHFGYSN 845
+ +V+E + G L + +++ + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 846 PVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
+ H D+KP N+L + + L+DFG AK S+ T T Y+AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVAP 182
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (297), Expect = 1e-29
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 11/174 (6%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRH 781
D F +G GSFG V + G A+K+ Q ++ E +L++V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHF 841
LVK+ S + + +V+EY+A G + L R + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158
Query: 842 GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
S +++ D+KP N+L+D ++DFG AK + G GT +AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAP 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 43/188 (22%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
+ + + IG G+FG V+K R G +VA+K ++ +G + E ++L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 783 NLVKIISSCSNGNFKA--------LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVAL 834
N+V +I C LV ++ + + + + +M +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML-- 126
Query: 835 ALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES----MRTQTLGTI 890
L L++ + N ++H D+K +N+L+ D V L+DFG+A+ + ++ T + T+
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 891 GYMAPGLW 898
Y P L
Sbjct: 186 WYRPPELL 193
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (290), Expect = 8e-29
Identities = 40/201 (19%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 704 EVNMS-PQAMWRRFSYRELLLATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQ 761
+VN P+ W S+ D + +G G + V++ + + +V +K+
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 762 FDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFK--ALVLEYMANGSLEKCLYSSNR 818
K E ++L+++R N++ + + + ALV E++ N ++ +
Sbjct: 72 K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----Q 124
Query: 819 SLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLN 877
+L + M ++ AL+Y H S ++H D+KP N+++D + L D+G+A+ +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 878 GEESMRTQTLGTIGYMAPGLW 898
+ + + + P L
Sbjct: 182 PGQEY-NVRVASRYFKGPELL 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (285), Expect = 2e-28
Identities = 37/183 (20%), Positives = 65/183 (35%), Gaps = 18/183 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL 784
H+ IG GSFG +++G L + +VAIK + D E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 785 VKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYS 844
+ + +++ + SLE L R + + ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 845 NPVVHCDIKPSNILLDDDMVAH-----LSDFGIAKLLNGEES-------MRTQTLGTIGY 892
+V+ DIKP N L+ + + DFG+ K + + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 893 MAP 895
M+
Sbjct: 180 MSI 182
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 8e-28
Identities = 40/179 (22%), Positives = 77/179 (43%), Gaps = 18/179 (10%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
+ + +G G++G V G +VAIK + F + K E +LK +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 783 NLVKIISSCSNGNFKA------LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
N++ ++ + LV+ +M + + L + ++ + L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGL 134
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
Y+H + ++H D+KP N+ +++D + DFG+A+ + S T + T Y AP
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAP 187
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 4e-26
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 14/179 (7%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFH----LQFDGALKSFDAECEVLK 777
++F ++G G++G V+ R + G A+KV +Q + E +VL+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 778 SVRHR-NLVKIISSCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
+R LV + + L+L+Y+ G L L R F + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT-QTLGTIGYMA 894
L + +++ DIK NILLD + L+DFG++K +E+ R GTI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 7e-25
Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 17/179 (9%)
Query: 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHR 782
+ IG G+ G V VAIK F K E ++K V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 783 NLVKIISSCS------NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
N++ +++ + LV+E M + + + ++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGI 132
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAP 895
++LH S ++H D+KPSNI++ D + DFG+A+ G M T + T Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 187
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 6e-24
Identities = 38/183 (20%), Positives = 78/183 (42%), Gaps = 16/183 (8%)
Query: 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRH 781
+ + S +G G++G+V G+ VA+K F K E +LK ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 782 RNLVKIISSCSNGNFKA-----LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
N++ ++ + ++ ++ L + L ++ + L
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGL 134
Query: 837 EYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPG 896
+Y+H S ++H D+KPSN+ +++D + DFG+A+ + E + T Y AP
Sbjct: 135 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR---WYRAPE 188
Query: 897 LWV 899
+ +
Sbjct: 189 IML 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.7 bits (244), Expect = 5e-23
Identities = 71/318 (22%), Positives = 113/318 (35%), Gaps = 28/318 (8%)
Query: 6 NTTDQQALLALKARITA----KNWTSNTSVC--SWIGITCDVST--HRVTALNISDFGLT 57
N D+QALL +K + +W T C +W+G+ CD T +RV L++S L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 58 G--TISSQLGNLSSLQTLDLSHN-RFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIIS 114
I S L NL L L + G IP +I ++ L L + +S
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLS 122
Query: 115 NTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAE 174
+L +D +YN + +P I +L L + N++ G IP G+ ++
Sbjct: 123 QIKTLVTLDFSYN--------ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 175 LEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTG----SIPRNLWQC 230
L F +L +D S N L G
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGL 290
++G NL L + N + G +P + + L +L++ N L G +P L
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN----L 290
Query: 291 PNIERLNLGLNNLSGRIP 308
+ N P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.9 bits (216), Expect = 2e-19
Identities = 78/307 (25%), Positives = 118/307 (38%), Gaps = 17/307 (5%)
Query: 358 LSFLSSLANSSSSKYIVLAENPLN----GVLPSSIGNLPITLEEIYLQNCKIRGN--IPK 411
L L N ++ + + N GVL + + + L + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQT-YRVNNLDLSGLNLPKPYPIPS 70
Query: 412 EIGNLVNLTTLHL-GNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSEL 467
+ NL L L++ G N L G IP + +L L L + + + G IPD + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI-PSTFWNLNNILSFDFSSNSLNGSL 526
+N LSG +P +L +L ++ N +S I S S S N L G
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG-- 188
Query: 527 PLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLES 586
+ + + + + + G G +L
Sbjct: 189 KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 587 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSP 646
LDL N + G +P L +L +L LN+SFN L GEIP GG+ F ++ N LCGSP
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 647 HLQVPLC 653
+P C
Sbjct: 309 ---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 28/251 (11%)
Query: 146 GNLTKLKELYLGYNKLQG--EIPQELGNLAELEWLSLPRS-FLTGTIPSSIFNLSSLLEL 202
++ L L L IP L NL L +L + L G IP +I L+ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 203 DFSNNSLTGFYMTNNHFTGSIPR-----NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP 257
++ +++G ++ N +P I +LPNL + D N + G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 258 NTIFNMSTLKA-LSLLNNTLSGSLPSSSKNLIGLPN-------------------IERLN 297
++ + S L +++ N L+G +P + NL +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 298 LGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPE 357
N G + + L L+L N G +P L L+ L L + +N L P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 358 LSFLSSLANSS 368
L S+
Sbjct: 287 GGNLQRFDVSA 297
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 4e-22
Identities = 24/163 (14%), Positives = 48/163 (29%), Gaps = 20/163 (12%)
Query: 732 SLIGIGSFGTVYKGRFLDGMEVAIKVFHL----------QFDGALKSFDAECEVLKSVRH 781
L+G G V+ E +K + + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 782 RNLVKIISSCSNGNFKALVLEYMANGSL-EKCLYSSNRSLDIFQRLSIMIDVALALEYLH 840
R L K+ G V + N L E + + ++ + + +
Sbjct: 66 RALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 841 FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883
+VH D+ N+L+ ++ + + DF + + E
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 4e-22
Identities = 75/387 (19%), Positives = 145/387 (37%), Gaps = 31/387 (8%)
Query: 238 NLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLN 297
L + + ++ V + ++ + L + S + L N+ ++N
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-----SIDGVEYLNNLTQIN 72
Query: 298 LGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLE-------HLGLGYNY 350
N L+ P + N +KL + + N + P +
Sbjct: 73 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 351 LTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410
LT+ +++++ S+ + + G + + L L + +
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 411 KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP-DDLCQLSELHV 469
+ L NL +L NNQ+S P+ + L L L N+L+ L L++L +
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGTLASLTNLTDLDL 248
Query: 470 DHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLD 529
+N++S P L L L LG+N++S+ P L + + + + N L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISP 302
Query: 530 IGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDL 589
I N+K + + L N ++ P + LT LQ L NN++ S LT++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSA 358
Query: 590 SVNNLSGVIPISLEKLVYLKDLNLSFN 616
N +S + P++ L + L L+
Sbjct: 359 GHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 3e-18
Identities = 79/434 (18%), Positives = 148/434 (34%), Gaps = 69/434 (15%)
Query: 40 DVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILIL 99
D + + +T T+S +L + TL I SI ++ L
Sbjct: 18 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--------GIKSIDGVEYL-- 65
Query: 100 GDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN 159
++L I+ + N L+ P + NLTKL ++ + N
Sbjct: 66 -----------------NNLTQINFSNNQLTDITP----------LKNLTKLVDILMNNN 98
Query: 160 KLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHF 219
++ P L + + + + S+N+++ +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL----ELSSNTISDISALSGLT 154
Query: 220 TGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGS 279
+ Q + NL LE L I N + + ++ L++L NN +S
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKLTNLESLIATNNQISDI 212
Query: 280 LPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLR 339
P N++ L+L N L G + + + L L+L N S P L L
Sbjct: 213 TPLGIL-----TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLT 263
Query: 340 NLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIY 399
L L LG N +++ +P + E N + S + L +
Sbjct: 264 KLTELKLGANQISNISPLAGL----------TALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP- 458
L I P + +L L L NN++S ++ L + L +N++ P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 369
Query: 459 DDLCQLSELHVDHN 472
+L ++++L ++
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 72/374 (19%), Positives = 134/374 (35%), Gaps = 26/374 (6%)
Query: 258 NTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKL 317
N IF + L + L + + + + L + L + I G + + L
Sbjct: 13 NQIFTDTALA--EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDG-VEYLNNL 68
Query: 318 FLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAE 377
+ + N + P L NL L + + N + TP + + + + I +
Sbjct: 69 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 378 NPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTL-------HLGNNQLS 430
N + + T+ +I + + +L L L +
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 431 GSIPITVGRLNTLQGLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFGNLNSLR 489
S + +L L+ L NN++ P + L EL ++ N+L +L +L
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT--LASLTNLT 244
Query: 490 NLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549
+L L +N++S+ P L + +N ++ PL + NL N +
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL----AGLTALTNLELNENQLE 298
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLK 609
+ I L NL L+L N + P +LT L+ L + N +S SL L +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 610 DLNLSFNRLEGEIP 623
L+ N++ P
Sbjct: 355 WLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 81.2 bits (199), Expect = 8e-17
Identities = 75/402 (18%), Positives = 143/402 (35%), Gaps = 42/402 (10%)
Query: 147 NLTKLKELYLGYNKLQGEIPQ-ELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFS 205
L + + LG + + Q +L + L+ L + G + L++L +++FS
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 206 NNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMST 265
NN LT + NL L + ++ N + P T
Sbjct: 75 NNQLTDI---------------------TPLKNLTKLVDILMNNNQIADITPLANLTNLT 113
Query: 266 LKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGN 325
L T L + + + ++ + +++ L+ N
Sbjct: 114 GLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN 173
Query: 326 SFSGFIPDTLVNLRNLEHLGLG---YNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNG 382
+ D N + + L ++ ++S ++ L ++ + L N L
Sbjct: 174 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD 233
Query: 383 VLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNT 442
++ +L L ++ L N +I P + L LT L LG NQ+S P+ G
Sbjct: 234 --IGTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA-GLTAL 287
Query: 443 LQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI 502
EN + +L L+ L + N +S P +L L+ L +N++S
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 503 PSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRN 544
S+ NL NI N ++ PL N+ + ++ L+
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.9 bits (237), Expect = 8e-22
Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 22/182 (12%)
Query: 733 LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSC 791
+G G F TV+ + + + VA+K+ ++ + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 792 S---------------NGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALAL 836
+ NG +V E + L +R + + I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 837 EYLHFGYSNPVVHCDIKPSNILLD-DDMVAHLSDFGIAKLLNGEESMRT--QTLGTIGYM 893
+Y+H ++H DIKP N+L++ D +L IA L N ++ T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 894 AP 895
+P
Sbjct: 197 SP 198
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.4 bits (228), Expect = 6e-21
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 6/233 (2%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+LP + LQN KI + NL NL TL L NN++S P L L+ L L
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGS--NELSSFIPSTFW 507
N+L+ L EL V N+++ + F LN + + LG+ + S F
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 508 NLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567
+ + + ++ + G + E++L N +T ++ GL NL L L
Sbjct: 148 GMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 568 NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEG 620
N + S L L L+ N L +P L Y++ + L N +
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.0 bits (227), Expect = 8e-21
Identities = 51/270 (18%), Positives = 95/270 (35%), Gaps = 13/270 (4%)
Query: 367 SSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGN 426
+ + L N + + NL L + L N KI P LV L L+L
Sbjct: 30 PPDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSK 88
Query: 427 NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL--CQLSELHVDHNKLSGPIPACFGN 484
NQL L L+ E K+ + + L + EL + K SG F
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
Query: 485 LNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRN 544
+ L + + +++ +L + N + + + + ++ LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 545 YLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV------I 598
++ ++ +L+ L L NN+L +P ++ + L NN+S +
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 599 PISLEKLVYLKDLNLSFNRLEGEIPSGGSF 628
P K ++L N ++ +F
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.5 bits (197), Expect = 5e-17
Identities = 52/295 (17%), Positives = 93/295 (31%), Gaps = 27/295 (9%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
LR + C+ L +PKD+ L L NK+ + NL L
Sbjct: 11 HLRVVQCSDLGL---------EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 178 LSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT----GFYMTNNHFTGSIPRNLWQCEIP 233
L L + ++ P + L L L S N L T +
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
Query: 234 HEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNI 293
N + LG + G M L + + + ++ ++P P++
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-----PPSL 173
Query: 294 ERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353
L+L N ++ + + L L L+ NS S +L N +L L L N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
L+ + + + L N ++ + + ++ + N
Sbjct: 234 VPGGLADHKYI------QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 6e-16
Identities = 50/259 (19%), Positives = 86/259 (33%), Gaps = 30/259 (11%)
Query: 291 PNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350
P+ L+L N ++ G N L L L N S P L LE L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 351 LTSSTPELSFLSSLANSSSSKYIVLAENPLN------------------GVLPSSIGNLP 392
L ++ ++ + ++ N G+ + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 393 ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452
L I + + I IP+ G +LT LHL N+++ ++ LN L LGL N
Sbjct: 151 -KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 453 LEGPIPDDLCQLSELH--VDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTF---- 506
+ L L +N +P + ++ + L +N +S+ + F
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 507 --WNLNNILSFDFSSNSLN 523
+ SN +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 6e-16
Identities = 53/240 (22%), Positives = 87/240 (36%), Gaps = 10/240 (4%)
Query: 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDD---LCQLSELHVDHNKL 474
+L + + L +P + L L+NNK+ D L L L + +NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 475 SGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMK 534
S P F L L L L N+L L + + + S+ + N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQM 126
Query: 535 VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNL 594
+VVE+ + +G G+ L + + + + IP+ G SL L L N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 595 SGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQVPLCK 654
+ V SL+ L L L LSFN + + + + N+ L P
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 6e-16
Identities = 47/257 (18%), Positives = 91/257 (35%), Gaps = 29/257 (11%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
L++ + +T NL +L TL L +N+ S P + + L+ L L NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGEL---------------PANIFRAIPKDIGNLTK 150
P + LR + + + P + K
Sbjct: 93 -ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 151 LKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210
L + + + IPQ G L L L + +T +S+ L++L +L S NS++
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 211 GFYMTNNHFTGSI----PRNLWQCEIPHEIGNLPNLEVLGIDENHL------VGDVPNTI 260
+ T + N ++P + + ++V+ + N++ P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 268
Query: 261 FNMSTLKALSLLNNTLS 277
++ +SL +N +
Sbjct: 269 TKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 1e-08
Identities = 28/140 (20%), Positives = 47/140 (33%), Gaps = 2/140 (1%)
Query: 525 SLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSL 584
+P D+ ++L N +T L NL L L NN++ P +F L L
Sbjct: 24 KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 585 ESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLCG 644
E L LS N L + + L L+ ++ + +G +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 645 SPHLQVPLCKSSPHQKSSKN 664
+ K S + + N
Sbjct: 142 ENGAFQGMKKLSYIRIADTN 161
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 4e-18
Identities = 53/261 (20%), Positives = 97/261 (37%), Gaps = 12/261 (4%)
Query: 339 RNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEI 398
+ + L N ++ S + + L N L + ++ L + +
Sbjct: 32 AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86
Query: 399 YLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP 458
N ++R P L L TLHL L P L LQ L L++N L+
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146
Query: 459 DDLC---QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
D L+ L + N++S F L+SL L L N ++ P F +L +++
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
+N+L+ + ++ + + L+ N D LQ ++ + +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP 265
Query: 576 ESFGALTSLESLDLSVNNLSG 596
+ L + L+ N+L G
Sbjct: 266 QR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 56/251 (22%), Positives = 88/251 (35%), Gaps = 8/251 (3%)
Query: 402 NCKIRG--NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD 459
+C +G +P I + L N++S + L L L +N L
Sbjct: 17 SCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 460 DLCQLSELHVDHN----KLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
L+ L +L PA F L L L L L P F L +
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
N+L ++ + + L N ++ GL +L L L NR+ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 576 ESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQS 635
+F L L +L L NNLS + +L L L+ L L+ N + + +A
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254
Query: 636 FMGNDLLCGSP 646
+++ C P
Sbjct: 255 GSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (158), Expect = 4e-12
Identities = 58/274 (21%), Positives = 91/274 (33%), Gaps = 17/274 (6%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
+ L +P +R+ L N +S L +L L N +
Sbjct: 19 PQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78
Query: 338 LRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEE 397
L LE L L N S +F + L + L + L+
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATF----HGLGRLHTLHL-DRCGLQELGPGLFRGLAALQY 133
Query: 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPI 457
+YLQ+ ++ +L NLT L L N++S L++L L L N++
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 458 PDDLCQLSELH---VDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILS 514
P L L + N LS L +L+ L L N + +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQK 252
Query: 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548
F SS+ + SLP + + L+ N L G
Sbjct: 253 FRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 2e-11
Identities = 47/295 (15%), Positives = 76/295 (25%), Gaps = 42/295 (14%)
Query: 188 TIPSSIFNLSSLLELDFSNNSLTGF------YMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
+P I ++ + N ++ N L + + G
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
++ D L P T + L L L L P + L L + L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL---YLQDN 139
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
L + L L L GN S L +L+ L L N +
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA--------- 190
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTT 421
V P + +L + N + + L L
Sbjct: 191 --------------------HVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQY 229
Query: 422 LHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSG 476
L L +N LQ ++++ +P L + N L G
Sbjct: 230 LRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 46/301 (15%), Positives = 90/301 (29%), Gaps = 46/301 (15%)
Query: 24 NWTSNTSVCSWIGIT---CDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRF 80
N T+ C G+ + + + ++ ++ +L L L N
Sbjct: 10 NEPKVTTSCPQQGLQAVPVGIPAA-SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 81 SGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPA----- 135
+ ++ ++ L+ L L DN S L + + L P
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 136 -----------NIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSF 184
+ +L L L+L N++ + L L+ L L ++
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 185 LTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEV 244
+ P + +L L+ L N+ + L L+
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANN-------------------LSALPTEALAPLRALQY 229
Query: 245 LGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLS 304
L +++N V D + L+ ++ + SLP L + L N+L
Sbjct: 230 LRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQR------LAGRDLKRLAANDLQ 282
Query: 305 G 305
G
Sbjct: 283 G 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 43/200 (21%), Positives = 69/200 (34%), Gaps = 4/200 (2%)
Query: 395 LEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLE 454
E+ + +P ++ + T LHL N L T+ L L L+ +L
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 455 GPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILS 514
D + + +P L +L L + N L+S L +
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 515 FDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPI 574
N L P + + +++L+ N LT + GL NL L L+ N L+ I
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 575 PESFGALTSLESLDLSVNNL 594
P+ F L L N
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 34/182 (18%), Positives = 59/182 (32%), Gaps = 1/182 (0%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+LP ++L + + LT L+L +L+ + L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHN 87
Query: 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
+ + L L+ L V N+L+ L L+ L L NEL + P
Sbjct: 88 QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 510 NNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNR 569
+ ++N+L + ++ + + L N L IP G L L N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206
Query: 570 LH 571
Sbjct: 207 WL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 35/214 (16%), Positives = 59/214 (27%), Gaps = 19/214 (8%)
Query: 65 GNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDC 124
++S ++ + +P + IL L +N L F + + L ++
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYT-FSLATLMPYTRLTQLNL 62
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSF 184
+ + G L L L L +N+LQ A
Sbjct: 63 D----------RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL 112
Query: 185 LTGTIPSSIFNLSSLLELDFSNNSLT----GFYMTNNHFTGSIPRNLWQCEIPHEIGNLP 240
+ + + N T T S+ N + L
Sbjct: 113 TSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 241 NLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNN 274
NL+ L + EN L +P F L L N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 51/209 (24%), Positives = 74/209 (35%), Gaps = 5/209 (2%)
Query: 436 TVGRLNTLQGLGLENNKLEGPIPDDLCQ-LSELHVDHNKLSGPIPACFGNLNSLRNLSLG 494
V ++ + + + L +P DL + + LH+ N L A L L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 495 SNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTI 554
E +L S++ SLPL + + +++S N LT +
Sbjct: 64 RAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 555 GGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
GL LQ L L+ N L P LE L L+ NNL+ + L L L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 615 FNRLEGEIPSGGSFANFSAQSFMGNDLLC 643
N L GN LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 36/208 (17%), Positives = 53/208 (25%), Gaps = 41/208 (19%)
Query: 39 CDVS-THRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKIL 97
C+VS +N LT + L L LS N +++ + L L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 98 ILGDNQLSGSFPSFIISN-----------------------------------TSSLRAI 122
L +L+ + + L A+
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 123 DCNYNSLSGELPANIFRAIPKDIGNLTKLKEL-YLGYNKLQGEIPQELGNLAELEWLSLP 181
L N + +P + T E L N L L L L+ L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL- 179
Query: 182 RSFLTGTIPSSIFNLSSLLELDFSNNSL 209
+ TIP F L N
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 9e-06
Identities = 44/238 (18%), Positives = 78/238 (32%), Gaps = 35/238 (14%)
Query: 192 SIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH 251
+ ++S LE++ +LT +P ++ + +L + EN
Sbjct: 5 EVSKVASHLEVNCDKRNLT--------------------ALPPDLP--KDTTILHLSENL 42
Query: 252 LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311
L T+ + L L+ L + + + LP + L+L N L
Sbjct: 43 LYTFSLATLMPYTRLTQLN-----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ 97
Query: 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSK 371
+ +L+++ N + L L L+ L L N L + P L + S
Sbjct: 98 TLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156
Query: 372 YIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQL 429
N L + + L L+ + LQ + IPK L L N
Sbjct: 157 N-----NNLTELPAGLLNGLE-NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 38/193 (19%), Positives = 55/193 (28%), Gaps = 25/193 (12%)
Query: 283 SSKNLIGLP-----NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVN 337
+NL LP + L+L N L + ++L L L +
Sbjct: 18 DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGT 75
Query: 338 LRNLEHLGLGYNYLTSSTPE-----------------LSFLSSLANSSSSKYIVLAENPL 380
L L L L +N L S S + +
Sbjct: 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 381 NGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRL 440
LP + LE++ L N + + L NL TL L N L +IP
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 441 NTLQGLGLENNKL 453
+ L L N
Sbjct: 195 HLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 18/81 (22%), Positives = 28/81 (34%), Gaps = 1/81 (1%)
Query: 24 NWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGT 83
+ + T ++ L++++ LT + L L +L TL L N T
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 84 IPSSIFSISTLKILILGDNQL 104
IP F L L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 42/210 (20%), Positives = 65/210 (30%), Gaps = 16/210 (7%)
Query: 290 LPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYN 349
+ + +N NL+ +P + +L L+ N F TL+ L L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD-R 64
Query: 350 YLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNI 409
+ L L S + + L L + + ++
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG--------QTLPALTVLDVSFNRLTSLP 116
Query: 410 PKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPD---DLCQLSE 466
+ L L L+L N+L P + L+ L L NN L L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 467 LHVDHNKLSGPIPACFGNLNSLRNLSLGSN 496
L + N L IP F + L L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 40/287 (13%), Positives = 86/287 (29%), Gaps = 27/287 (9%)
Query: 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLS 130
QTLDL+ + + S ++ + P + ++ +D + + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS---QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 131 GELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIP 190
+ + +KL+ L L +L I L + L L+L
Sbjct: 60 VS-------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 112
Query: 191 SSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDEN 250
+S + N + Q + H + L + G +N
Sbjct: 113 LQTL-----------LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161
Query: 251 HLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNL-GLNNLSGRIPG 309
D+ + L L L ++ + + L ++ L+L ++
Sbjct: 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLK--NDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219
Query: 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356
+ L L++ G G + L HL + ++ T+
Sbjct: 220 ELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 39/258 (15%), Positives = 82/258 (31%), Gaps = 19/258 (7%)
Query: 381 NGVLPSSIGNL-PITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSG-SIPITVG 438
+ P G L + + + E + + + L N+ + ++ +
Sbjct: 10 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILS 68
Query: 439 RLNTLQGLGLENNKLEGPIPDDLCQLSEL-----HVDHNKLSGPIPACFGNLNSLRNLSL 493
+ + LQ L LE +L PI + L + S L + + + L L+L
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 128
Query: 494 GSNELSS------FIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL- 546
+ + + + + N L + +V ++LS + +
Sbjct: 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 188
Query: 547 TGDIPTTIGGLTNLQLLSLEN-NRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKL 605
D L LQ LSL + G + +L++L + G + + E
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA- 247
Query: 606 VYLKDLNLSFNRLEGEIP 623
L L ++ +
Sbjct: 248 --LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 9e-05
Identities = 40/280 (14%), Positives = 92/280 (32%), Gaps = 28/280 (10%)
Query: 36 GITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFS-ISTL 94
+T + + V A + ++ +Q +DLS++ + I S S L
Sbjct: 15 DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 95 KILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKEL 154
+ L L +LS + ++ S+L ++ + S E + + L
Sbjct: 74 QNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 155 YLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYM 214
+Q + + +L ++ + + + +L+ LD S++
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS------- 185
Query: 215 TNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDE-NHLVGDVPNTIFNMSTLKALSLLN 273
+ + + E L L+ L + ++ + + + TLK L +
Sbjct: 186 -----------VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 274 NTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFN 313
G+L + L L + ++ + I N
Sbjct: 235 IVPDGTLQLLKEAL------PHLQINCSHFTTIARPTIGN 268
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.1 bits (123), Expect = 3e-08
Identities = 40/184 (21%), Positives = 79/184 (42%), Gaps = 12/184 (6%)
Query: 402 NCKIRG--NIPKEIGNLVNLTTLHLGNNQLSGSIPITVG----RLNTLQGLGLENNKLEG 455
+C RG IP++I + T L L +N+L + L L+ + +E
Sbjct: 14 DCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71
Query: 456 PIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSF 515
+ + EL + NK+ F L+ L+ L+L N++S +P +F +LN++ S
Sbjct: 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
+ +SN N + L + + + +L+ P+ + ++Q+ L ++
Sbjct: 132 NLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187
Query: 576 ESFG 579
S G
Sbjct: 188 NSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 31/207 (14%), Positives = 57/207 (27%), Gaps = 42/207 (20%)
Query: 69 SLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNS 128
T+D + IP I L+L DN+L + L ++ N
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 129 LSGELPANIFRA----------------IPKDIGNLTKLKELYLGYNKLQGEIPQELGNL 172
L+G P A K L +LK L L N++ +P +
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH- 124
Query: 173 AELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEI 232
SL L + +L+ E + + P +
Sbjct: 125 ----LNSLTSLNLASNPFNCNCHLAWFAEWLRKKS------LNGGAARCGAPSKVR---- 170
Query: 233 PHEIGNLPNLEVLGIDENHLVGDVPNT 259
++++ + + N+
Sbjct: 171 --------DVQIKDLPHSEFKCSSENS 189
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 5e-08
Identities = 22/91 (24%), Positives = 34/91 (37%), Gaps = 6/91 (6%)
Query: 399 YLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP 458
I +L L++ NN+L +P RL L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VP 320
Query: 459 DDLCQLSELHVDHNKLSGPIPACFGNLNSLR 489
+ L +LHV++N L P ++ LR
Sbjct: 321 ELPQNLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 20/95 (21%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP 527
N S I + SL L++ +N+L +P+ L + S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVP 320
Query: 528 LDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
N+K ++++ N L P + +L++
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 50/329 (15%), Positives = 99/329 (30%), Gaps = 28/329 (8%)
Query: 292 NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYL 351
L L LS +P + L L + NS + +P+ +L++L + N L
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLL---VDNNNL 90
Query: 352 TSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPK 411
+ + L L S++ + + + + N + + +
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 412 EIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSEL---- 467
++ L L L + + + L + +L L L
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 468 -------HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSN 520
+ S N + S + F L+ + + N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 521 SLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGA 580
+ + + + E+N+S N L ++P L+ L N L +PE
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPEL--- 322
Query: 581 LTSLESLDLSVNNLSGVIPISLEKLVYLK 609
+L+ L + N L P E + L+
Sbjct: 323 PQNLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 9e-06
Identities = 52/326 (15%), Positives = 96/326 (29%), Gaps = 23/326 (7%)
Query: 46 VTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLS 105
L +++ GL+ ++ +L ++L S N + +P S+ +L + LS
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 106 GSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEI 165
P S+ + S L ++ Q E
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 166 PQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTN-------NH 218
EL NL L + + L + S + + + N+
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 219 FTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSG 278
++P E + N + N +S L N S
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 279 SLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNL 338
+ P++E LN+ N L +P +L L + N + +P+
Sbjct: 275 EIR---SLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE-VPEL---P 323
Query: 339 RNLEHLGLGYNYLTSSTPELSFLSSL 364
+NL+ L + YN L + L
Sbjct: 324 QNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 9/85 (10%)
Query: 540 NLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIP 599
N + +I + +L+ L++ NN+L +P LE L S N+L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE-VP 320
Query: 600 ISLEKLVYLKDLNLSFNRLEGEIPS 624
+ L K L++ +N L E P
Sbjct: 321 ELPQNL---KQLHVEYNPLR-EFPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 44/341 (12%), Positives = 93/341 (27%), Gaps = 31/341 (9%)
Query: 68 SSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTS------SLRA 121
L+L++ S ++P L+ L+ N L+ P S S +L+A
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 122 IDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLP 181
+ L +N ++ N + LK + + N L+ +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 182 RSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPN 241
+ + + L + + +P +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 242 LEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLN 301
+L + + + L + + + + + L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL--N 270
Query: 302 NLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFL 361
S I L L ++ N +P LE L +N+L L
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAEVPELPQNL 326
Query: 362 SSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQN 402
L + NPL ++P ++E++ + +
Sbjct: 327 KQL---------HVEYNPL-----REFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 50/336 (14%), Positives = 109/336 (32%), Gaps = 31/336 (9%)
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELE 176
++ N LS ++P+ +L L N L E+P+ +L L
Sbjct: 38 RQAHELELNNLGLS---------SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLL 84
Query: 177 WLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEI 236
+ L+ P + S +L+ ++ + + L E
Sbjct: 85 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 237 GNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
N ++ + E + + + ++LK L L +L + ++
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 297 NLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTP 356
L + + + +++ +P+ +L L+ ++ L+ P
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 357 ELSFLSSLANS--------SSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGN 408
L +L++ +N S + + ++ N L LP+ LE + +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR----LERLIASFNHL-AE 318
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQ 444
+P+ NL LH+ N L P + L+
Sbjct: 319 VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 20/97 (20%), Positives = 32/97 (32%), Gaps = 10/97 (10%)
Query: 24 NWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGT 83
+ S + + LN+S+ L + + L + L S N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-E 318
Query: 84 IPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLR 120
+P LK L + N L FP I + LR
Sbjct: 319 VPE---LPQNLKQLHVEYNPLR-EFPD-IPESVEDLR 350
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 9e-08
Identities = 40/217 (18%), Positives = 74/217 (34%), Gaps = 15/217 (6%)
Query: 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPI 457
I + + + +L +TTL ++ + LN L GL L++N++
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGV--QYLNNLIGLELKDNQITDLA 79
Query: 458 PDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDF 517
P + L S++ L L S +++ P + +L D
Sbjct: 80 PLKNLTKITELELSGN-PLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 518 SSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES 577
+ + L LS T + L+ L L ++N++ P
Sbjct: 139 NQITNISPLAGLTNLQ------YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
+L +L + L N +S V P L L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 39/218 (17%), Positives = 71/218 (32%), Gaps = 15/218 (6%)
Query: 147 NLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSN 206
L ++ G + + + Q +L + LS + +T + L++L+ L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 207 NSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTL 266
N +T N + ++ D+ +T T
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIA--------GLQSIKTLDLTSTQITDVTP 124
Query: 267 KALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNS 326
A L L + L + N + N SKL L+ N
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 327 FSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSL 364
S P L +L NL + L N ++ +P L+ S+L
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNL 219
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 38/237 (16%), Positives = 76/237 (32%), Gaps = 22/237 (9%)
Query: 37 ITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKI 96
I D + + +T T++ +L + TL + + ++ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67
Query: 97 LILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
L L DNQ++ P ++ + L ++S + + +T + L
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 157 GYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTN 216
N + ++ +S S S L + + LT +
Sbjct: 128 LSNLQVLYLDLN-----QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 217 NHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLN 273
N + P + +LPNL + + N + P + N S L ++L N
Sbjct: 183 NKISDISP-----------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 32/210 (15%), Positives = 60/210 (28%), Gaps = 15/210 (7%)
Query: 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQLSELHVDHNK 473
L N + G + ++ ++ L+ + L + L L L + N+
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74
Query: 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNM 533
+ A NL + L L N L + L + + L
Sbjct: 75 I--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 534 KVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNN 593
+ I L L L+ L +L N
Sbjct: 133 VL--------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 594 LSGVIPISLEKLVYLKDLNLSFNRLEGEIP 623
+S + P++ L L +++L N++ P
Sbjct: 185 ISDISPLA--SLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 21/213 (9%)
Query: 409 IPKEIG------NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIP-DDL 461
+P I +L ++ +T LN++ + N+ ++ L
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYL 67
Query: 462 CQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNS 521
+++L ++ NKL+ NL +L L L N++ LS + + S
Sbjct: 68 PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581
L + + N + T + LT L LSLE+N++ +P L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDI------TVLSRLTKLDTLSLEDNQISDIVP--LAGL 177
Query: 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLS 614
T L++L LS N++S + L L L L L
Sbjct: 178 TKLQNLYLSKNHISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 36/214 (16%), Positives = 66/214 (30%), Gaps = 16/214 (7%)
Query: 133 LPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSS 192
+P I + D + + L + + Q L ++ + S +
Sbjct: 10 VPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG-- 63
Query: 193 IFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHL 252
I L ++ +L + N LT N E++
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 253 VGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF 312
+ D+ + N + L L ++ L+L N +S +P +
Sbjct: 124 ISDINGLVHLPQLESLYLGNNK------ITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175
Query: 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGL 346
+KL L L+ N S L L+NL+ L L
Sbjct: 176 GLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 33/174 (18%), Positives = 66/174 (37%), Gaps = 11/174 (6%)
Query: 394 TLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKL 453
++++I N I+ I L N+T L L N+L+ P+ L+ LG
Sbjct: 47 SIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDE 99
Query: 454 EGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNIL 513
+ + + I G ++ + SL + L +
Sbjct: 100 NKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLD 159
Query: 514 SFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567
+ N ++ +PL + + + LS+N+++ D+ + GL NL +L L +
Sbjct: 160 TLSLEDNQISDIVPL--AGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 22/208 (10%), Positives = 55/208 (26%), Gaps = 20/208 (9%)
Query: 66 NLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCN 125
+ +L + + + ++++ +I ++ + I ++ + N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLN 76
Query: 126 YNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFL 185
N L+ I L LK L + +
Sbjct: 77 GNKLTD-------------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 186 TGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVL 245
I + +N ++ ++ Q + L L+ L
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNL 183
Query: 246 GIDENHLVGDVPNTIFNMSTLKALSLLN 273
+ +NH+ + + L L L +
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 7/92 (7%)
Query: 69 SLQTLDLSHNRFSGTIPSSIFS-ISTLKILILGDNQLSGSFPSFI---ISNTSSLRAIDC 124
+Q+LD+ S + + + +++ L D L+ + I + +L ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 125 NYNSLSGELPANIFRAIPKDIGNLTKLKELYL 156
N L + + + K+++L L
Sbjct: 63 RSNELGDVGVHCVLQGLQT---PSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 5/88 (5%)
Query: 538 EINLSRNYLT-GDIPTTIGGLTNLQLLSLENNRLHG----PIPESFGALTSLESLDLSVN 592
+++ L+ + L Q++ L++ L I + +L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 593 NLSGVIPISLEKLVYLKDLNLSFNRLEG 620
L V + + + + L+
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/92 (15%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 94 LKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKE 153
++ L + +LS + + ++ + + + L+ + I + L E
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA----RCKDISSALRVNPALAE 59
Query: 154 LYLGYNKLQGEIPQELG-----NLAELEWLSL 180
L L N+L + +++ LSL
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 15/71 (21%), Positives = 24/71 (33%), Gaps = 5/71 (7%)
Query: 559 NLQLLSLENNRL-HGPIPESFGALTSLESLDLSVNNLSGV----IPISLEKLVYLKDLNL 613
++Q L ++ L E L + + L L+ I +L L +LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 614 SFNRLEGEIPS 624
N L
Sbjct: 63 RSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 16/98 (16%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 24 NWTSNTSVCSWIGITCDVSTHRVTALNISDFGLTGT----ISSQLGNLSSLQTLDLSHNR 79
N + + + L ++D ++ + +++ L SL+ LDLS+N
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 80 FSGTIPSSIFSI-----STLKILILGDNQLSGSFPSFI 112
+ L+ L+L D S +
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 9/76 (11%)
Query: 558 TNLQLLSLENNRLHG----PIPESFGALTSLESLDLSVNNLSGVIPISLEKLV-----YL 608
+ L++L L + + + + A SL LDLS N L + L + V L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 609 KDLNLSFNRLEGEIPS 624
+ L L E+
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 16/83 (19%), Positives = 27/83 (32%), Gaps = 9/83 (10%)
Query: 532 NMKVVVEINLSRNYLTGD----IPTTIGGLTNLQLLSLENNRLHGPIPESFGA-----LT 582
V+ + L+ ++ + T+ +L+ L L NN L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 583 SLESLDLSVNNLSGVIPISLEKL 605
LE L L S + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 15/100 (15%), Positives = 35/100 (35%), Gaps = 8/100 (8%)
Query: 417 VNLTTLHLGNNQLSGS-IPITVGRLNTLQGLGLENNKLEGPIPDDLCQ-------LSELH 468
+++ +L + +LS + + L Q + L++ L D+ L+EL+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 469 VDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWN 508
+ N+L C + + L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 394 TLEEIYLQNCKIRGN----IPKEIGNLVNLTTLHLGNNQLSGSIPITVGR-----LNTLQ 444
L ++L +C + + + + +L L L NN L + + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 445 GLGLENNKLEGPIPDDLCQLSELH 468
L L + + D L L +
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 10/90 (11%)
Query: 511 NILSFDFSSNSLNGS-LPLDIGNMKVVVEINLSRNYLTGD----IPTTIGGLTNLQLLSL 565
+I S D L+ + + ++ + L LT I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 566 ENNRLHGPIPESFGAL-----TSLESLDLS 590
+N L ++ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 9/91 (9%)
Query: 46 VTALNISDFGLTGT-ISSQLGNLSSLQTLDLSHNRFSG----TIPSSIFSISTLKILILG 100
+ +L+I L+ + L L Q + L + I S++ L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 101 DNQLSG----SFPSFIISNTSSLRAIDCNYN 127
N+L + + + ++ +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 19/109 (17%), Positives = 31/109 (28%), Gaps = 15/109 (13%)
Query: 107 SFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIP 166
+ S LR + +S ++ + L+EL L N L
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDS----SCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 167 QELG-----NLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210
+L LE L L + + + L L+ SL
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 5/66 (7%)
Query: 151 LKELYLGYNKLQGE-IPQELGNLAELEWLSLPRSFLTG----TIPSSIFNLSSLLELDFS 205
++ L + +L + L L + + + L LT I S++ +L EL+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 206 NNSLTG 211
+N L
Sbjct: 64 SNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 16/84 (19%), Positives = 25/84 (29%), Gaps = 6/84 (7%)
Query: 292 NIERLNLGLNNLS-GRIPGFIFNASKLFLLELTGNSFSG----FIPDTLVNLRNLEHLGL 346
+I+ L++ LS R + + ++ L + I L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 347 GYNYLTSSTPELSFLSSLANSSSS 370
N L L L S
Sbjct: 63 RSNELGDVGVH-CVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 20/84 (23%), Positives = 32/84 (38%), Gaps = 6/84 (7%)
Query: 262 NMSTLKALSLLNNTLSGSLPSS-SKNLIGLPNIERLNLGLNNLSGRIPGFIFNA-----S 315
S L+ L L + +S S SS + L+ ++ L+L N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 316 KLFLLELTGNSFSGFIPDTLVNLR 339
L L L +S + D L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 17/89 (19%), Positives = 30/89 (33%), Gaps = 6/89 (6%)
Query: 308 PGFIFNASKLFLLELTGNSFSG----FIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSS 363
G S L +L L S + TL+ +L L L N L + + S
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL-QLVES 420
Query: 364 LANSSSS-KYIVLAENPLNGVLPSSIGNL 391
+ + +VL + + + + L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 17/99 (17%), Positives = 40/99 (40%), Gaps = 13/99 (13%)
Query: 479 PACFGNLNSLRNLSLGSNELS----SFIPSTFWNLNNILSFDFSSNSLNGSLPLDIG--- 531
+ LR L L ++S S + +T +++ D S+N L + L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 532 --NMKVVVEINLSRNYLTGDIPTTIGGL----TNLQLLS 564
++ ++ L Y + ++ + L +L+++S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 32/251 (12%), Positives = 63/251 (25%), Gaps = 18/251 (7%)
Query: 32 CSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSI 91
CS C + +T I S L + L + +
Sbjct: 8 CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 92 STLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKL 151
L+ + + N + + + SN L I + + F+ +P L
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 152 KELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTG 211
+ + + Q++ + + S + L +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 212 FYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSL 271
F T N + +L I + + N+ L+A S
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 272 LNNTLSGSLPS 282
N LP+
Sbjct: 233 YNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (110), Expect = 3e-06
Identities = 31/223 (13%), Positives = 63/223 (28%), Gaps = 12/223 (5%)
Query: 409 IPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELH 468
IP ++ N L +L L+ + + N + I D+
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 469 VDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFI-------PSTFWNLNNILSFDFSSNS 521
+ +L +S+ +L + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 522 LNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGAL 581
+G V + L++N + G +L +NN L + F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 582 TSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPS 624
+ LD+S + + LE L L+ + + ++P+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 35/235 (14%), Positives = 70/235 (29%), Gaps = 17/235 (7%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEW 177
S R C + ++ E+P+++ EL KL+ +LE
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP----------RNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 178 LSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIG 237
+ + ++ + I + +F+ L + Y+ F
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 238 NLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIE--- 294
++ + + L I + + L ++ L + I
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 295 --RLNLGLNNLSGRIPGFIF-NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGL 346
LNL NN +P +F AS +L+++ L NL+ L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 26/213 (12%), Positives = 55/213 (25%), Gaps = 9/213 (4%)
Query: 390 NLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449
+LP E+ K+R +L + + N + I V
Sbjct: 26 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85
Query: 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNL 509
+ + ++ + +S +++ + +L ++ I
Sbjct: 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145
Query: 510 NNILSFDFSSNSLN-------GSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562
N+ + F S L ++ N L G + +
Sbjct: 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 205
Query: 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLS 595
L + R+H L L + NL
Sbjct: 206 LDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 5e-06
Identities = 22/124 (17%), Positives = 46/124 (37%), Gaps = 9/124 (7%)
Query: 398 IYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPI 457
++L + + + + L+ +T L L +N+L P +N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 458 PDDLCQLSELHVDHNKL-SGPIPACFGNLNSLRNLSLGSNELS------SFIPSTFWNLN 510
+L +L EL + +N+L + L L+L N L + +++
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
Query: 511 NILS 514
+IL+
Sbjct: 121 SILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 27/131 (20%), Positives = 46/131 (35%), Gaps = 16/131 (12%)
Query: 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLS 130
+ L L+H T+ + + + L L N+L P+ L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL------------AALRCLE 46
Query: 131 GELPANIFRAIPKDIGNLTKLKELYLGYNKLQG-EIPQELGNLAELEWLSLPRSFLTGTI 189
++ + NL +L+EL L N+LQ Q L + L L+L + L
Sbjct: 47 VLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-E 105
Query: 190 PSSIFNLSSLL 200
L+ +L
Sbjct: 106 EGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 28/127 (22%), Positives = 49/127 (38%), Gaps = 14/127 (11%)
Query: 49 LNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSF 108
L+++ LT + L L + LDLSHNR P +++ L+ L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56
Query: 109 PSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQE 168
++N L+ + N L A + + + +L L L N L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQS-------AAIQPLVSCPRLVLLNLQGNSLC-QEEGI 108
Query: 169 LGNLAEL 175
LAE+
Sbjct: 109 QERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 28/125 (22%), Positives = 42/125 (33%), Gaps = 6/125 (4%)
Query: 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTG 548
R L L +L+ L + D S N L P + ++ + + S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 549 DIPTTIGGLTNLQLLSLENNRL-HGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVY 607
LQ L L NNRL + + L L+L N+L I
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 608 LKDLN 612
L ++
Sbjct: 116 LPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 12/113 (10%)
Query: 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENP 379
L L + + L L + HL L +N L + P L+ L L +S + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 380 LNGVLPSSIGNLPITLEEIYLQNCKIRG-NIPKEIGNLVNLTTLHLGNNQLSG 431
L+E+ L N +++ + + + L L+L N L
Sbjct: 61 ---------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 516 DFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP 575
+ L ++ + + +V ++LS N L P + L L++L +
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALENV 58
Query: 576 ESFGALTSLESLDLSVNNLSGVIPI-SLEKLVYLKDLNLSFNRLEGE 621
+ L L+ L L N L I L L LNL N L E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 21/112 (18%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 188 TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPH--EIGNLPNLEVL 245
T+ + L + LD S+N L + + + NLP L+ L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 246 GIDENHLVG-DVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296
+ N L + + L L+L N+L + LP++ +
Sbjct: 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 7e-06
Identities = 41/340 (12%), Positives = 97/340 (28%), Gaps = 30/340 (8%)
Query: 118 SLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELGNLA 173
S+ ++++ +++ + +KE+ L N + E + + + +
Sbjct: 4 SIEGKSLKLDAIT----TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 174 ELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIP 233
+LE F L LL+ L +++N F + L
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 234 HEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNI 293
H L G+ +++I N
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELA----------VNKKAKNAPPLRSIICGRNR 169
Query: 294 ERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTS 353
+ + K+ + + + L + L+ L L N T
Sbjct: 170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229
Query: 354 STPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP-----ITLEEIYLQNCKIRGN 408
+L + + + + L + L+ +++ + I L+ + LQ +I +
Sbjct: 230 LGSSALA-IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 288
Query: 409 IPKEI-----GNLVNLTTLHLGNNQLSGSIPITVGRLNTL 443
+ + + +L L L N+ V + +
Sbjct: 289 AVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 43/318 (13%), Positives = 82/318 (25%), Gaps = 38/318 (11%)
Query: 60 ISSQLGNLSSLQTLDLSHNRFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFIISN 115
+ + L S++ + LS N + +I S L+I D I
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-RVKDEIPEA 81
Query: 116 TSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAEL 175
L L + + + +L + + L
Sbjct: 82 LRLLLQALLKCPKLH-----TVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 136
Query: 176 EWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHE 235
+ R+ + N L + N L M T R L ++
Sbjct: 137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 196
Query: 236 IGNLPNLE------------------VLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLS 277
+E + + + + L+ L L + LS
Sbjct: 197 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 278 G---SLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNA-----SKLFLLELTGNSFS- 328
+ + + + ++ L L N + + L LEL GN FS
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316
Query: 329 -GFIPDTLVNLRNLEHLG 345
+ D + + + G
Sbjct: 317 EDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 43/341 (12%), Positives = 88/341 (25%), Gaps = 19/341 (5%)
Query: 310 FIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSS 369
F L L +T + L+ +++ + L N + + ++A+
Sbjct: 3 FSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKD 60
Query: 370 SKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQL 429
+ ++ + I L + L+ K+ + +
Sbjct: 61 LEIAEFSDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 430 SGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLR 489
+ L GL + I L +
Sbjct: 120 HTPLEH-----LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 174
Query: 490 NLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGD 549
S + T + N + + + L L + ++ N + +
Sbjct: 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234
Query: 550 IPTTIGGLTNLQLLSLENNRLHGPIPE------SFGALTSLESLDLSVNNLSGVIPISL- 602
+ + NL+ L L + L S L++L L N + +L
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294
Query: 603 ----EKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGN 639
EK+ L L L+ NR E + G
Sbjct: 295 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 6e-05
Identities = 27/107 (25%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 538 EINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIP-ESFGALTSLESLDLSVNNLSG 596
+ +R+ D + G NL L +EN + + L L +L + + L
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 597 VIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSFMGNDLLC 643
V P + L LNLSFN LE + GN L C
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 24/156 (15%), Positives = 40/156 (25%), Gaps = 39/156 (25%)
Query: 117 SSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQEL-GNLAEL 175
+ C + + L ELY+ + + L EL
Sbjct: 8 HGSSGLRCTRDGAL---------DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL 58
Query: 176 EWLSLPRSFLTG-----------------------TIPSSIFNLSSLLELDFSNN----- 207
L++ +S L ++ SL EL S N
Sbjct: 59 RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118
Query: 208 -SLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNL 242
+L G +P QC + ++PN
Sbjct: 119 CALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 20/146 (13%), Positives = 40/146 (27%), Gaps = 10/146 (6%)
Query: 61 SSQLGNLSSLQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLR 120
++Q N + LDL + I + ++ + DN++ L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG---FPLLRRLK 66
Query: 121 AIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLS- 179
+ N N + LT + LG + +
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-----LTYLCILR 121
Query: 180 LPRSFLTGTIPSSIFNLSSLLELDFS 205
P + I+ + + LDF
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 3/93 (3%)
Query: 557 LTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616
+ L L ++ I L +++D S N + + L LK L ++ N
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 617 RLEGEIPSGGSFANFSAQSFMGNDLLCGSPHLQ 649
R+ + + N+ L L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLD 106
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 19/114 (16%), Positives = 36/114 (31%), Gaps = 2/114 (1%)
Query: 415 NLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEG-PIPDDLCQLSELHVDHNK 473
N V L L ++ I L+ + +N++ L +L L V++N+
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNR 74
Query: 474 LSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLP 527
+ L L L L +N L L++ + +
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 3/110 (2%)
Query: 529 DIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRL--HGPIPESFGALTSLES 586
D+ + V +N + + + L L+L NNRL + +L+
Sbjct: 37 DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 587 LDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGGSFANFSAQSF 636
L+LS N L + K + L++L L N L ++ + + F
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 29/139 (20%), Positives = 54/139 (38%), Gaps = 2/139 (1%)
Query: 485 LNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRN 544
++ + S + +L NI +S+ +L + N+ ++ +NLS N
Sbjct: 16 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNN 75
Query: 545 YLTG--DIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISL 602
L D+ + + NL++L+L N L LE L L N+LS
Sbjct: 76 RLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135
Query: 603 EKLVYLKDLNLSFNRLEGE 621
+ +++ RL+G
Sbjct: 136 TYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 6e-04
Identities = 23/132 (17%), Positives = 44/132 (33%), Gaps = 11/132 (8%)
Query: 331 IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGN 390
+ + + L L S P+L + + + + L N
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRR-------SSMAATLRIIEEN 63
Query: 391 LPITLEEIYLQNCKIRG--NIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGL 448
+P L + L N ++ ++ + NL L+L N+L + + L+ L L
Sbjct: 64 IP-ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122
Query: 449 ENNKLEGPIPDD 460
+ N L D
Sbjct: 123 DGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 32/170 (18%), Positives = 53/170 (31%), Gaps = 24/170 (14%)
Query: 132 ELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPS 191
EL + + + L L+ +L L+ S T+
Sbjct: 3 ELKPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRI 59
Query: 192 SIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENH 251
N+ LL L+ SNN L ++ + PNL++L + N
Sbjct: 60 IEENIPELLSLNLSNNRLY-----------------RLDDMSSIVQKAPNLKILNLSGNE 102
Query: 252 LVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKN----LIGLPNIERLN 297
L + L+ L L N+LS + S P + RL+
Sbjct: 103 LKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 33/214 (15%), Positives = 65/214 (30%), Gaps = 16/214 (7%)
Query: 374 VLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSI 433
+ + P+N + + L + L + + + +L +TTL +
Sbjct: 2 ITQDTPINQIFTDT--ALA-EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSID 56
Query: 434 PITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSL 493
+ LN L + NN+L P + +N I N
Sbjct: 57 GV--EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 114
Query: 494 GSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTT 553
+ NLN + + + ++ L ++
Sbjct: 115 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKP 167
Query: 554 IGGLTNLQLLSLENNRLHGPIPESFGALTSLESL 587
+ LT L+ L + +N++ LT+LESL
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.98 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.98 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.98 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.46 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.03 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.5e-44 Score=384.94 Aligned_cols=289 Identities=29% Similarity=0.465 Sum_probs=214.1
Q ss_pred CCChhHHHHHHHHHhcccc----CCCCCCCCce--eeeeEEeeCCC--CcEEEEEeccCCcce--ecCcccCCCCCCCee
Q 046199 4 NINTTDQQALLALKARITA----KNWTSNTSVC--SWIGITCDVST--HRVTALNISDFGLTG--TISSQLGNLSSLQTL 73 (902)
Q Consensus 4 ~~~~~~~~~l~~~~~~~~~----~~w~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 73 (902)
-|+++|++||++||+++++ ++|..++||| .|.||+|+..+ +||+.|||++++++| ++|+++++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 4899999999999999987 7899889999 59999999754 489999999999998 689999999999999
Q ss_pred eccc-cccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccc
Q 046199 74 DLSH-NRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLK 152 (902)
Q Consensus 74 ~Ls~-n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~ 152 (902)
||++ |+++|.+|++|++|++|++|+|++|++.+. .|..+..+..|+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~---------------------------------~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA---------------------------------IPDFLSQIKTLV 128 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE---------------------------------CCGGGGGCTTCC
T ss_pred ccccccccccccccccccccccchhhhcccccccc---------------------------------ccccccchhhhc
Confidence 9997 899999999999999999999999999875 333445555666
Q ss_pred eeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcc-cEEeeeeCCCCccccccccccCCccccccccC
Q 046199 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL-LELDFSNNSLTGFYMTNNHFTGSIPRNLWQCE 231 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~ 231 (902)
++++++|.+.+.+|..++.++.|+++++++|.++|.+|+.+..+.++ +.+++++|+++ |..|
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~----------~~~~------- 191 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT----------GKIP------- 191 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE----------EECC-------
T ss_pred ccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccc----------cccc-------
Confidence 66666666666666666666666666666666666666666666554 56666666533 2222
Q ss_pred CCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccc
Q 046199 232 IPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFI 311 (902)
Q Consensus 232 lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 311 (902)
..++++.. ..++++++...+.+|..+..+++|+.+++++|.+++.+|. +..+++|++|+|++|+++|.+|..+
T Consensus 192 --~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~----~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 192 --PTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK----VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp --GGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG----CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred --cccccccc-cccccccccccccccccccccccccccccccccccccccc----cccccccccccCccCeecccCChHH
Confidence 44444433 3566666666666666666777777777777777655442 4556667777777777776677777
Q ss_pred cccccccEEEccCCcccCcccccccccccccEEeccccc
Q 046199 312 FNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNY 350 (902)
Q Consensus 312 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 350 (902)
+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 7777777777777777776663 4666777777777765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=312.84 Aligned_cols=171 Identities=34% Similarity=0.457 Sum_probs=155.6
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999985 4999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
|+||+|.+++.+ ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999999998765 35899999999999999999999 9999999999999999999999999999999876655555
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
...+||+.|||||++..
T Consensus 174 ~~~~gt~~Y~aPE~~~~ 190 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR 190 (293)
T ss_dssp CCCCSCGGGCCHHHHSS
T ss_pred cccccCCCccChhhhcC
Confidence 66789999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-36 Score=315.16 Aligned_cols=172 Identities=28% Similarity=0.424 Sum_probs=156.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.+.|++.+.||+|+||.||+|++.. ++.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3679999999999999999999864 889999999877667778999999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
|++|+|.+++.+..+.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999998776677999999999999999999999 9999999999999999999999999999998764433333
Q ss_pred eccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~ 899 (902)
....||+.|||||++.
T Consensus 168 ~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVM 183 (288)
T ss_dssp TCCCSCCTTCCHHHHT
T ss_pred cccccccccCCHHHHh
Confidence 4567999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=310.17 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=149.7
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 578999999999999999999986 48999999997553 2345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc-
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES- 881 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 881 (902)
|+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999854 456999999999999999999999 99999999999999999999999999999987643322
Q ss_pred -ceecccccccccccccccc
Q 046199 882 -MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 -~~~~~~gt~~y~APE~l~~ 900 (902)
.....+||+.|||||++..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHC
T ss_pred ccccceeeCcCccCHhHhcC
Confidence 2334679999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=301.56 Aligned_cols=170 Identities=28% Similarity=0.436 Sum_probs=151.3
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||+||+|++.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999999864 8899999987432 33456789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||||++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999998654 45899999999999999999999 9999999999999999999999999999998765432
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|||||++..
T Consensus 161 --~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp --CEETTEEGGGCCHHHHTT
T ss_pred --ccccCCCCcccCHHHHcC
Confidence 344679999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-35 Score=308.55 Aligned_cols=180 Identities=23% Similarity=0.454 Sum_probs=157.3
Q ss_pred CHHHHHhhcccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC
Q 046199 717 SYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN 795 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 795 (902)
.+++|++..++|++.+.||+|+||+||+|++.+ ++.||||+++... ...+++.+|++++++++|||||++++++.+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 445567778899999999999999999999865 8899999987543 34578999999999999999999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 046199 796 FKALVLEYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAK 874 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 874 (902)
..|+|||||++|+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999998754 456899999999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCccc-eecccccccccccccccc
Q 046199 875 LLNGEESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 875 ~~~~~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
........ .....||+.|||||++..
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~ 190 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAY 190 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHH
T ss_pred ecCCCCceeeccccccccccChHHHcC
Confidence 76544332 233568999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=303.74 Aligned_cols=173 Identities=28% Similarity=0.440 Sum_probs=138.5
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec--CCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN--GNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 799 (902)
.++|++.+.||+|+||+||+|++. +|+.||+|+++... +...+.+.+|++++++++||||+++++++.+ ++..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999986 48999999997653 3445778999999999999999999999864 456899
Q ss_pred EEEccCCCChHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeec
Q 046199 800 VLEYMANGSLEKCLYS---SNRSLDIFQRLSIMIDVALALEYLHFGYSNP-----VVHCDIKPSNILLDDDMVAHLSDFG 871 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~~~~kL~DFG 871 (902)
|||||++|+|.+++.+ ....+++..++.++.||+.||+||| +++ |+||||||+|||++.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 9999999999999864 3456999999999999999999999 654 9999999999999999999999999
Q ss_pred CceecCCCccceecccccccccccccccc
Q 046199 872 IAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 872 ~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+|+............+||+.|||||++..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTT
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcC
Confidence 99887655555555789999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=304.36 Aligned_cols=173 Identities=28% Similarity=0.489 Sum_probs=147.0
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
|++..++|++.+.||+|+||+||+|++. ..||||+++... ....+.+.+|++++++++|||||++++++.+ +..+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 4566789999999999999999999864 469999987542 4456789999999999999999999998754 5689
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
+|||||++|+|.+++...+..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999877777999999999999999999999 99999999999999999999999999999987653
Q ss_pred Ccc--ceeccccccccccccccc
Q 046199 879 EES--MRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 879 ~~~--~~~~~~gt~~y~APE~l~ 899 (902)
... ......||+.|||||++.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~ 179 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIR 179 (276)
T ss_dssp ---------CCCCGGGCCHHHHT
T ss_pred cCCcccccccccCcccCCHHHHh
Confidence 322 223467999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=301.26 Aligned_cols=173 Identities=26% Similarity=0.411 Sum_probs=144.8
Q ss_pred hcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..++|++.+.||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++||||++++|++.+++..|+||||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 356899999999999999999999888899999987543 3447899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+++|+|.+++......+++..+..++.||+.||+|+| +++|+||||||+||++++++.+||+|||+|+.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999999877777999999999999999999999 9999999999999999999999999999998765443322
Q ss_pred -ecccccccccccccccc
Q 046199 884 -TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 -~~~~gt~~y~APE~l~~ 900 (902)
....||+.|||||++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF 176 (263)
T ss_dssp ------CTTSCCHHHHTT
T ss_pred ecceecCcccCChHHhcC
Confidence 23578999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=302.84 Aligned_cols=172 Identities=31% Similarity=0.465 Sum_probs=149.3
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 368999999999999999999985 48999999997542 33456789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||++||+|.+++... +.+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999988654 46899999999999999999999 9999999999999999999999999999999875432
Q ss_pred c--ceecccccccccccccccc
Q 046199 881 S--MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~--~~~~~~gt~~y~APE~l~~ 900 (902)
. .....+||+.|||||++..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp -------CCCCGGGCCHHHHHT
T ss_pred cccccccccCCccccCceeecc
Confidence 2 2334679999999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-34 Score=309.68 Aligned_cols=172 Identities=25% Similarity=0.374 Sum_probs=155.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999986 4899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+||+|.+++.+....+++..+..++.||+.||+||| ++|||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999766677999999999999999999999 99999999999999995 467899999999998765443
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|||||++..
T Consensus 182 -~~~~~gT~~Y~aPEv~~~ 199 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEG 199 (350)
T ss_dssp -EEEECSCTTTCCHHHHHT
T ss_pred -cceecCcccccCHHHHcC
Confidence 344689999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-34 Score=307.72 Aligned_cols=173 Identities=28% Similarity=0.351 Sum_probs=155.0
Q ss_pred hcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3578999999999999999999985 59999999997542 3345778899999999999999999999999999999
Q ss_pred EEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 800 VLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|||||+||+|.+++... +.+++..++.++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999998654 45899999999999999999999 999999999999999999999999999999977655
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
.......+||+.|||||++..
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS
T ss_pred CcccccceeCHHHhhhhhccC
Confidence 555556789999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-35 Score=313.58 Aligned_cols=172 Identities=28% Similarity=0.395 Sum_probs=151.2
Q ss_pred hhcccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
+..++|++.+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|+.++++++|||||+++++|.+++..|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45789999999999999999999986 48999999997653 34457889999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSN-PVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
||||+||+|.+++.+. +.+++..+..++.|++.||+||| ++ ||+||||||+|||+++++.+||+|||+|+...+
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999999654 45899999999999999999999 74 899999999999999999999999999987643
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
....+.+||+.|||||++.+
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHC
T ss_pred -CccccccCCccccCchHHcC
Confidence 22344689999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-33 Score=306.93 Aligned_cols=172 Identities=22% Similarity=0.344 Sum_probs=155.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||.||+|++. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999985 4999999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD--DDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~--~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|+||+|.+++......+++.++..++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999988776667999999999999999999999 99999999999999997 578999999999998765433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|||||++..
T Consensus 185 -~~~~~gt~~y~aPE~~~~ 202 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDR 202 (352)
T ss_dssp -EEEECSSGGGCCHHHHTT
T ss_pred -eeeccCcccccCHHHHcC
Confidence 344679999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-34 Score=300.27 Aligned_cols=176 Identities=26% Similarity=0.437 Sum_probs=151.9
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEE
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 799 (902)
+|++..++|++.+.||+|+||.||+|++.+++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..|+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4456678999999999999999999999888999999997543 345789999999999999999999998865 55799
Q ss_pred EEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 800 VLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
||||+++|+|.+++.... ..+++..+.+++.||++||+||| +++|+||||||+||++++++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence 999999999998775432 35899999999999999999999 99999999999999999999999999999998765
Q ss_pred Cccc-eecccccccccccccccc
Q 046199 879 EESM-RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~-~~~~~gt~~y~APE~l~~ 900 (902)
.... .....||+.|||||++..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHH
T ss_pred CccccccccCCcccccChHHHhC
Confidence 4332 233578999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-33 Score=301.94 Aligned_cols=167 Identities=28% Similarity=0.399 Sum_probs=147.4
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
+.|+..+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999985 48899999997553 233467889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
|||++|++..++.. ...+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999998766544 456999999999999999999999 999999999999999999999999999999875432
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
....||+.|||||++..
T Consensus 169 --~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp --CCCCSCGGGCCHHHHTT
T ss_pred --CccccCccccCHHHHhc
Confidence 33679999999999853
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-33 Score=298.72 Aligned_cols=169 Identities=28% Similarity=0.395 Sum_probs=150.5
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 800 (902)
.++|++.+.||+|+||+||+|+++. |+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 3689999999999999999999854 8999999997542 33457789999999999999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||||+||++..++... ..+++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999999888654 45788999999999999999999 9999999999999999999999999999999865432
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
...+||+.|||||++..
T Consensus 159 ---~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVST 175 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTT
T ss_pred ---ccccCcccccCHHHHcC
Confidence 34679999999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6e-33 Score=299.24 Aligned_cols=255 Identities=33% Similarity=0.579 Sum_probs=221.5
Q ss_pred cccEEEeecCcccc--cCCcccCCCCCCcEEEeec-ceecccCCcccccccccCeeecccccccCCCCCcC---CCCCeE
Q 046199 394 TLEEIYLQNCKIRG--NIPKEIGNLVNLTTLHLGN-NQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDL---CQLSEL 467 (902)
Q Consensus 394 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~L~~L 467 (902)
.++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+ .+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46777777777766 3677777777777777775 67777777777777777777777777776555433 377888
Q ss_pred eccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCc-eEEEcCCCccCCCCccccccccccceeccCCccc
Q 046199 468 HVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNI-LSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYL 546 (902)
Q Consensus 468 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 546 (902)
++++|.+.+.+|..+.+++.|+.+++++|++.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 888888888899999999999999999999999999999888876 899999999999999888887655 699999999
Q ss_pred cccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceecCCCCC
Q 046199 547 TGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEIPSGG 626 (902)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 626 (902)
.+.+|..++.+++++.+++++|.+.+.+| .++.+++|+.|||++|+++|.+|..+.++++|++|||++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997655 68899999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCcccCCCCCCCCCCC
Q 046199 627 SFANFSAQSFMGNDLLCGSPHLQVPLC 653 (902)
Q Consensus 627 ~~~~~~~~~~~~n~~lc~~~~~~~~~c 653 (902)
.+..+...++.+|+.+||.|++ +|
T Consensus 289 ~L~~L~~l~l~~N~~l~g~plp---~c 312 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPLP---AC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS---CC
T ss_pred cCCCCCHHHhCCCccccCCCCC---CC
Confidence 9999999999999999999874 57
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-33 Score=300.40 Aligned_cols=171 Identities=26% Similarity=0.414 Sum_probs=134.2
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
.+.|++.+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4679999999999999999999864 8999999997553 3344678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceecCCC
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLD---DDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~~~~ 879 (902)
||+||+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||++. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999965 456999999999999999999999 99999999999999994 5789999999999876543
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
. .....+||+.|||||++..
T Consensus 164 ~-~~~~~~GT~~y~APE~~~~ 183 (307)
T d1a06a_ 164 S-VLSTACGTPGYVAPEVLAQ 183 (307)
T ss_dssp ----------CTTSCHHHHTT
T ss_pred C-eeeeeeeCccccCcHHHcC
Confidence 3 2344679999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-33 Score=290.00 Aligned_cols=166 Identities=29% Similarity=0.430 Sum_probs=143.0
Q ss_pred ccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec----CCeeEEE
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN----GNFKALV 800 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 800 (902)
|++.+.||+|+||+||+|++.. ++.||+|++.... ....+.+.+|++++++++|||||++++++.+ +...|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677789999999999999864 8899999987543 3445788999999999999999999999864 4568999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEc-CCCcEEEEeecCceecC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNP--VVHCDIKPSNILLD-DDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~ 877 (902)
|||+++|+|.+++.+. ..+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998654 45899999999999999999999 888 99999999999996 57899999999998643
Q ss_pred CCccceeccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~ 899 (902)
.. .....+||+.|||||++.
T Consensus 167 ~~--~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 167 AS--FAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp TT--SBEESCSSCCCCCGGGGG
T ss_pred CC--ccCCcccCccccCHHHhC
Confidence 32 234568999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-33 Score=289.08 Aligned_cols=172 Identities=27% Similarity=0.424 Sum_probs=154.1
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEcc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYM 804 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 804 (902)
.++|++.+.||+|+||+||+|+++++++||||+++.... ..+.+.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 478999999999999999999998888999999986533 3478999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce-
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR- 883 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~- 883 (902)
++|++.+++......+++..+.+++.|+++||+||| ++||+||||||+||++++++.+||+|||+|+.........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999998777778999999999999999999999 9999999999999999999999999999998765443322
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....||+.|||||++..
T Consensus 159 ~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp CCSCCCGGGCCHHHHHH
T ss_pred cccCCCCCcCCcHHhcC
Confidence 23668999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.8e-33 Score=295.21 Aligned_cols=173 Identities=25% Similarity=0.446 Sum_probs=148.9
Q ss_pred hhcccccccCe-ecccceeeEEEEEeCC---CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSL-IGIGSFGTVYKGRFLD---GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~-lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+..++|.+.+. ||+|+||.||+|.+.. +..||||+++... ....+++.+|++++++++|||||++++++.++ ..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 44567888885 9999999999998743 5579999997554 34567899999999999999999999998754 57
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+|||||++|+|.+++...+..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 8999999999999998777778999999999999999999999 9999999999999999999999999999999876
Q ss_pred CCccce---eccccccccccccccc
Q 046199 878 GEESMR---TQTLGTIGYMAPGLWV 899 (902)
Q Consensus 878 ~~~~~~---~~~~gt~~y~APE~l~ 899 (902)
...... ....||+.|||||++.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred ccccccccccccccCccccChHHHh
Confidence 543322 2346899999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=2.8e-33 Score=297.80 Aligned_cols=175 Identities=25% Similarity=0.445 Sum_probs=141.1
Q ss_pred hhcccccccCeecccceeeEEEEEeCC-C---cEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 723 LATDHFSEKSLIGIGSFGTVYKGRFLD-G---MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 723 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
+..++|++.+.||+|+||+||+|++.. + ..||||++.... ....+.+.+|++++++++|||||++++++.+++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 345678999999999999999998753 2 358899886543 34557899999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+|||||++|+|.+++......+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999998877777999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccce-----ecccccccccccccccc
Q 046199 878 GEESMR-----TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~-----~~~~gt~~y~APE~l~~ 900 (902)
...... ....||+.|||||++..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp ----------------CGGGSCHHHHHS
T ss_pred CCCCcceeeecccccCCccccCHHHHhc
Confidence 433221 12457899999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.7e-32 Score=291.63 Aligned_cols=171 Identities=26% Similarity=0.377 Sum_probs=150.8
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc------hhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999985 489999999975421 2357799999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM----VAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~kL~DFG~a 873 (902)
|+|||||+||+|.+++... +.+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998664 46999999999999999999999 99999999999999998876 5999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+....... .....||+.|||||++..
T Consensus 165 ~~~~~~~~-~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 165 HKIDFGNE-FKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp EECTTSCB-CSCCCCCGGGCCHHHHTT
T ss_pred hhcCCCcc-ccccCCCCcccCHHHHcC
Confidence 88754433 344679999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-32 Score=291.57 Aligned_cols=174 Identities=26% Similarity=0.479 Sum_probs=144.3
Q ss_pred hcccccccCeecccceeeEEEEEeCCC-----cEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCee
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLDG-----MEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
..+.|++.+.||+|+||.||+|.+... ..||||+++... ....+++.+|++++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 446788999999999999999987542 479999987543 33456789999999999999999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
++||||++++++.+++......+++..+..++.||+.|++||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999998887788999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccc---eecccccccccccccccc
Q 046199 878 GEESM---RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~---~~~~~gt~~y~APE~l~~ 900 (902)
..... .....||+.|||||++..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp ------------CCCGGGSCHHHHHS
T ss_pred CCCccceEeccCCCCccccCHHHHcc
Confidence 43221 222468999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.2e-32 Score=296.93 Aligned_cols=168 Identities=28% Similarity=0.383 Sum_probs=150.9
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999986 49999999987532 234567889999999999999999999999999999999
Q ss_pred EccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcc
Q 046199 802 EYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 802 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 881 (902)
||+.+|++.+++... +.+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 999999999998654 45899999999999999999999 9999999999999999999999999999999875432
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
....||+.|||||++..
T Consensus 196 --~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILS 212 (350)
T ss_dssp --CCCEECGGGCCHHHHTT
T ss_pred --ccccCccccCCHHHHcC
Confidence 34679999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=296.61 Aligned_cols=177 Identities=23% Similarity=0.407 Sum_probs=148.8
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
|++..++|++.+.||+|+||+||+|++.. ...||+|++.... ......+.+|+.+++++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 44667899999999999999999998743 2369999886443 34557889999999998 8999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN----------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHC 850 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 850 (902)
+.+..|+|||||++|+|.++++... ..+++..+..++.||+.||+||| +++||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 9999999999999999999997643 23788999999999999999999 9999999
Q ss_pred CCCCCCEEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 851 DIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 851 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
||||+||+++.++.+||+|||+|+........ .....||+.|||||++..
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 99999999999999999999999876544332 223568999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=4.1e-32 Score=284.93 Aligned_cols=170 Identities=28% Similarity=0.403 Sum_probs=151.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc---------hhhhhHHHHHHHHHhCC-CCCccceeeeeec
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD---------GALKSFDAECEVLKSVR-HRNLVKIISSCSN 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 793 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++.... ...+++.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999985 589999999975431 12346889999999997 9999999999999
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
++..|+|||||++|+|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999999764 46999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+.+.... ......||+.|+|||++.
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 158 CQLDPGE-KLREVCGTPSYLAPEIIE 182 (277)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred eEccCCC-ceeeeeccCCCCCHHHhh
Confidence 9876533 334467999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-33 Score=292.26 Aligned_cols=174 Identities=28% Similarity=0.448 Sum_probs=145.0
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 801 (902)
++..++|++.+.||+|+||.||+|++.++++||||+++... ...+.+.+|+.++++++|||||++++++.+ +..|+||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 35568999999999999999999999888899999997543 345789999999999999999999999865 5579999
Q ss_pred EccCCCChHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 802 EYMANGSLEKCLYSS-NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 802 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
||+++|++..++... ...+++.++..++.||+.||+||| +++|+||||||+|||+++++++||+|||+|+......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999888653 345899999999999999999999 9999999999999999999999999999998765433
Q ss_pred c-ceecccccccccccccccc
Q 046199 881 S-MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~-~~~~~~gt~~y~APE~l~~ 900 (902)
. ......||+.|||||++..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp --------CCGGGSCHHHHHH
T ss_pred ceeeccccccccccChHHHhC
Confidence 2 2333679999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-32 Score=290.39 Aligned_cols=171 Identities=21% Similarity=0.294 Sum_probs=151.3
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
.++|++.+.||+|+||+||+|++.. ++.||||+++... .....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4789999999999999999999864 8899999997653 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--CcEEEEeecCceecCCCcc
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDD--MVAHLSDFGIAKLLNGEES 881 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~--~~~kL~DFG~a~~~~~~~~ 881 (902)
|+||+|.+++...+..+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999999999776667999999999999999999999 9999999999999999854 4899999999988754433
Q ss_pred ceecccccccccccccccc
Q 046199 882 MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 882 ~~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 160 -~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp -EEEEESCGGGSCHHHHTT
T ss_pred -ccccccccccccchhccC
Confidence 344679999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-32 Score=291.72 Aligned_cols=171 Identities=27% Similarity=0.410 Sum_probs=150.6
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHHHHHHHH-hCCCCCccceeeeeecCCeeEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDAECEVLK-SVRHRNLVKIISSCSNGNFKALV 800 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 800 (902)
++|++.+.||+|+||+||+|++.. ++.||||+++... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 689999999999999999999864 8999999997542 334456677777665 68999999999999999999999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCc
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEE 880 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 880 (902)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999654 45899999999999999999999 9999999999999999999999999999998776555
Q ss_pred cceecccccccccccccccc
Q 046199 881 SMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 881 ~~~~~~~gt~~y~APE~l~~ 900 (902)
.......||+.|||||++..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~ 177 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLG 177 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTT
T ss_pred ccccccCCCCCcCCHHHHcC
Confidence 55555789999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=4.7e-32 Score=295.94 Aligned_cols=170 Identities=26% Similarity=0.344 Sum_probs=146.0
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc---chhhhhHHH---HHHHHHhCCCCCccceeeeeecCCee
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF---DGALKSFDA---ECEVLKSVRHRNLVKIISSCSNGNFK 797 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 797 (902)
.++|++.+.||+|+||.||+|++.. |+.||||++.... ......+.+ |+++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4789999999999999999999864 8999999986432 112233333 46677778899999999999999999
Q ss_pred EEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecC
Q 046199 798 ALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLN 877 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 877 (902)
|+|||||+||+|.+++... ..+++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999998654 45889999999999999999999 9999999999999999999999999999999775
Q ss_pred CCccceecccccccccccccccc
Q 046199 878 GEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
... ....+||+.|||||++..
T Consensus 159 ~~~--~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 159 KKK--PHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp SSC--CCSCCSCGGGCCHHHHST
T ss_pred CCc--ccccccccccchhHHhhc
Confidence 432 334679999999999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-32 Score=284.58 Aligned_cols=163 Identities=27% Similarity=0.417 Sum_probs=138.3
Q ss_pred CeecccceeeEEEEEeCC---CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEccCC
Q 046199 732 SLIGIGSFGTVYKGRFLD---GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEYMAN 806 (902)
Q Consensus 732 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 806 (902)
+.||+|+||+||+|.+.+ ++.||||+++... ....+++.+|++++++++|||||++++++..+ ..|+||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998643 5689999986542 34457899999999999999999999999754 56899999999
Q ss_pred CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCcccee--
Q 046199 807 GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMRT-- 884 (902)
Q Consensus 807 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~-- 884 (902)
|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.+........
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998654 45899999999999999999999 99999999999999999999999999999998755433222
Q ss_pred -ccccccccccccccc
Q 046199 885 -QTLGTIGYMAPGLWV 899 (902)
Q Consensus 885 -~~~gt~~y~APE~l~ 899 (902)
...||+.|||||++.
T Consensus 168 ~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 168 THGKWPVKWYAPECIN 183 (277)
T ss_dssp ---CCCGGGCCHHHHH
T ss_pred cccCCCceecCchhhc
Confidence 256899999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-32 Score=290.00 Aligned_cols=172 Identities=28% Similarity=0.413 Sum_probs=148.5
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc--hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD--GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
|+|++.+.||+|+||+||+|++. +++.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999985 489999999975432 335788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
|+.++.+..........+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||.|+........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 99765444444445567999999999999999999999 999999999999999999999999999999887665555
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 159 ~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp TTCCBCCCTTCCHHHHTT
T ss_pred ceeecccceeeehhhhcc
Confidence 555789999999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-32 Score=285.19 Aligned_cols=174 Identities=26% Similarity=0.387 Sum_probs=139.8
Q ss_pred HhhcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
++..++|++.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|++++++++||||+++++++. ++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 3556899999999999999999998753 3568899886443 344578999999999999999999999996 467
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+++|++.+++......+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence 89999999999999998777778999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCccc-eeccccccccccccccc
Q 046199 877 NGEESM-RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 877 ~~~~~~-~~~~~gt~~y~APE~l~ 899 (902)
...... .....||+.|||||++.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp ------------CCGGGCCHHHHH
T ss_pred cCCcceeccceecCcccchhhHhc
Confidence 543332 23356899999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.6e-32 Score=288.39 Aligned_cols=167 Identities=29% Similarity=0.413 Sum_probs=142.6
Q ss_pred ccCeecccceeeEEEEEeCC-CcEEEEEEeeeccc-----hhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 730 EKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFD-----GALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 730 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
..+.||+|+||+||+|++.. ++.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999864 89999999865432 2245788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
++++++..+. .....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.|+.........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 9887766554 45566899999999999999999999 9999999999999999999999999999998876655555
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
...+||+.|||||++..
T Consensus 158 ~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFG 174 (299)
T ss_dssp CCSCCCCTTCCHHHHTT
T ss_pred cceecChhhccHHHHcc
Confidence 55789999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=286.78 Aligned_cols=167 Identities=25% Similarity=0.344 Sum_probs=143.1
Q ss_pred cccccccC-eecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhC-CCCCccceeeeeec----CCee
Q 046199 725 TDHFSEKS-LIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSV-RHRNLVKIISSCSN----GNFK 797 (902)
Q Consensus 725 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 797 (902)
.++|++.+ .||+|+||.||+|++. +++.||||+++.. +.+.+|++++.++ +|||||+++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 6999999999999985 4899999998643 5677899987654 89999999999865 4678
Q ss_pred EEEEEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 046199 798 ALVLEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIA 873 (902)
Q Consensus 798 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a 873 (902)
|+|||||+||+|.+++.+.. ..+++.++..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 99999999999999997643 46999999999999999999999 999999999999999975 567999999999
Q ss_pred eecCCCccceecccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
+....... ....+||+.|||||++..
T Consensus 162 ~~~~~~~~-~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 162 KETTSHNS-LTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp EECCCCCC-CCCCSCCCSSCCCCCCCG
T ss_pred eeccCCCc-cccccCCcccCCcHHHcC
Confidence 88765443 344679999999999854
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=2.5e-31 Score=280.42 Aligned_cols=172 Identities=22% Similarity=0.407 Sum_probs=141.6
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc---chhhhhHHHHHHHHHhCCCCCccceeeeeecCC----e
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF---DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----F 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 796 (902)
.++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999985 58999999997543 234567899999999999999999999987543 4
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||++|++|.+++... +.+++.++..++.||+.||+||| ++||+||||||+||+++.++.++++|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 89999999999999988654 46899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcc---ceecccccccccccccccc
Q 046199 877 NGEES---MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~---~~~~~~gt~~y~APE~l~~ 900 (902)
..... .....+||+.|||||++..
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp C----------------TTCCHHHHTT
T ss_pred ccccccccccccccCcccccCHHHHcC
Confidence 43322 2334679999999999854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=284.57 Aligned_cols=182 Identities=23% Similarity=0.395 Sum_probs=143.9
Q ss_pred cCHHHHHhhcccccccCeecccceeeEEEEEeCC------CcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccce
Q 046199 716 FSYRELLLATDHFSEKSLIGIGSFGTVYKGRFLD------GMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKI 787 (902)
Q Consensus 716 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 787 (902)
++.++|++..++|++.+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|..++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 4566777888999999999999999999998642 4689999987543 33456778888888777 68999999
Q ss_pred eeeeec-CCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcC
Q 046199 788 ISSCSN-GNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCD 851 (902)
Q Consensus 788 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 851 (902)
++++.. ++..++|||||++|+|.++++... ..+++..+..++.||+.||+||| +++|||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence 998765 456899999999999999986532 34789999999999999999999 99999999
Q ss_pred CCCCCEEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 852 IKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 852 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
|||+|||+++++.+||+|||+|+........ .....||+.|||||++..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence 9999999999999999999999876543332 233579999999998753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2e-29 Score=279.72 Aligned_cols=358 Identities=27% Similarity=0.387 Sum_probs=195.1
Q ss_pred eeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCC
Q 046199 153 ELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEI 232 (902)
Q Consensus 153 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~l 232 (902)
...++.+.+++.++. ..+.+|++|++++|.++ .+ +.+..+++|++|+|++|+|+++
T Consensus 26 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~l-------------------- 81 (384)
T d2omza2 26 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-------------------- 81 (384)
T ss_dssp HHHTTCSSTTSEECH--HHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCCC--------------------
T ss_pred HHHhCCCCCCCccCH--HHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCCC--------------------
Confidence 345666666654432 45667777777777776 34 3467777777777777776532
Q ss_pred CccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCcccc
Q 046199 233 PHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIF 312 (902)
Q Consensus 233 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~ 312 (902)
..++++++|++|++++|++++.. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+
T Consensus 82 -~~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~---- 149 (384)
T d2omza2 82 -TPLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP-----LKNLTNLNRLELSSNTISDISA---- 149 (384)
T ss_dssp -GGGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-----GTTCTTCSEEEEEEEEECCCGG----
T ss_pred -ccccCCccccccccccccccccc--ccccccccccccccccccccccc-----cccccccccccccccccccccc----
Confidence 23666777777777777776432 25666666666666666653222 1223344444444444432221
Q ss_pred ccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCccccccc
Q 046199 313 NASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLP 392 (902)
Q Consensus 313 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 392 (902)
..................+ ..+.............|... .+..+..++
T Consensus 150 --------------------~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 197 (384)
T d2omza2 150 --------------------LSGLTSLQQLSFGNQVTDL----------KPLANLTTLERLDISSNKVS--DISVLAKLT 197 (384)
T ss_dssp --------------------GTTCTTCSEEEEEESCCCC----------GGGTTCTTCCEEECCSSCCC--CCGGGGGCT
T ss_pred --------------------ccccccccccccccccchh----------hhhccccccccccccccccc--ccccccccc
Confidence 1111111111111111100 11111222222222222221 112222233
Q ss_pred ccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCc
Q 046199 393 ITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHN 472 (902)
Q Consensus 393 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N 472 (902)
+++.+++++|.+++..| +...++|++|++++|+++. +..+..++ +|+.|++++|
T Consensus 198 -~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~---------------------~L~~L~l~~n 251 (384)
T d2omza2 198 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT---------------------NLTDLDLANN 251 (384)
T ss_dssp -TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCT---------------------TCSEEECCSS
T ss_pred -ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhccc---------------------ccchhccccC
Confidence 44444444444443322 2333445555555554442 12333444 4444444444
Q ss_pred cccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCcc
Q 046199 473 KLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPT 552 (902)
Q Consensus 473 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 552 (902)
++++..+ +..+++|+.|++++|++++.. .+..+..++.++++.|++++ ...+..+++++.|++++|++++..
T Consensus 252 ~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-- 323 (384)
T d2omza2 252 QISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-- 323 (384)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--
T ss_pred ccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--
Confidence 4444332 556667777777777776543 35666777777777777764 234666777777777777777543
Q ss_pred ccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCC
Q 046199 553 TIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFN 616 (902)
Q Consensus 553 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 616 (902)
.+..+++|++|++++|+|++ +| .|+.+++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 324 ~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 37777888888888888874 33 57778888888888888886554 777788888888877
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-31 Score=284.46 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=143.9
Q ss_pred cccccccCeecccceeeEEEEEeCC-Cc----EEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GM----EVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 798 (902)
.++|++.+.||+|+||+||+|++.. ++ +||+|+++... ....+.+.+|++++++++|||||++++++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 3579999999999999999998753 43 68888886432 34567899999999999999999999999875 467
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
++|||+.+|+|.+++......+++..+.+++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 888999999999998888888999999999999999999999 99999999999999999999999999999987754
Q ss_pred Cccce--ecccccccccccccccc
Q 046199 879 EESMR--TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~~--~~~~gt~~y~APE~l~~ 900 (902)
..... ....||+.|||||++..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp TCC--------CCTTTSCHHHHHH
T ss_pred ccccccccccccCccccChHHHhc
Confidence 43322 22468999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3e-31 Score=283.07 Aligned_cols=180 Identities=26% Similarity=0.421 Sum_probs=153.4
Q ss_pred HHHHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeeccc-hhhhhHHHHHHHHHhCCCCCccceeee
Q 046199 718 YRELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQFD-GALKSFDAECEVLKSVRHRNLVKIISS 790 (902)
Q Consensus 718 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 790 (902)
+.+++...++|++.+.||+|+||+||+|++. +++.||||+++.... ...+++.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667889999999999999999999864 257899999875543 345789999999999999999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSN-----------------------RSLDIFQRLSIMIDVALALEYLHFGYSNPV 847 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~i 847 (902)
+.+.+..++||||+++|+|.++++... ..+++..+..++.|++.||+||| +++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 999999999999999999999986532 23788899999999999999999 9999
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc--eecccccccccccccccc
Q 046199 848 VHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 848 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~~ 900 (902)
|||||||+||+++.++.+||+|||+|+...+.... .....||+.|||||++..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 99999999999999999999999999876443322 233578999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=4.2e-31 Score=280.26 Aligned_cols=171 Identities=25% Similarity=0.383 Sum_probs=146.8
Q ss_pred ccccccCeecccceeeEEEEEeCCCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEEc
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
++|++.+.||+|+||+||+|++.+++.||||+++... ....+++.+|+.++++++||||+++++++..++..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999997653 23357899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccce
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESMR 883 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 883 (902)
+.++.+..+. ...+.+++..+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.|..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9876665554 55567999999999999999999999 9999999999999999999999999999998876555444
Q ss_pred ecccccccccccccccc
Q 046199 884 TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 884 ~~~~gt~~y~APE~l~~ 900 (902)
....|++.|+|||++..
T Consensus 158 ~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMG 174 (286)
T ss_dssp ----CCCTTCCHHHHTT
T ss_pred ceecccchhhhHHHHhC
Confidence 55679999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-31 Score=275.38 Aligned_cols=173 Identities=23% Similarity=0.334 Sum_probs=139.4
Q ss_pred hcccccccCeecccceeeEEEEEeCC----CcEEEEEEeeec---cchhhhhHHHHHHHHHhCCCCCccceeeeeecCCe
Q 046199 724 ATDHFSEKSLIGIGSFGTVYKGRFLD----GMEVAIKVFHLQ---FDGALKSFDAECEVLKSVRHRNLVKIISSCSNGNF 796 (902)
Q Consensus 724 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 796 (902)
..++|++.+.||+|+||.||+|++.. ..+||||+++.. .+...+++.+|++++++++||||++++|++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 35789999999999999999998632 247899998654 23445789999999999999999999999976 46
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.++||||+++|++.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 78999999999999988777677999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCccce---ecccccccccccccccc
Q 046199 877 NGEESMR---TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~---~~~~gt~~y~APE~l~~ 900 (902)
....... ....||..|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred ccCCCcceecCccccCcccCCHHHHhC
Confidence 5543322 22467889999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=276.73 Aligned_cols=172 Identities=27% Similarity=0.392 Sum_probs=139.7
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeecCC----eeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 800 (902)
..+|.+.+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+.+++||||+++++++.+++ ..|+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45788899999999999999997 688999999865422 1222334555556789999999999997643 68999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG-----YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
||||++|+|.+++++. .+++..+.+++.|++.||+|+|.. +++|||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999764 588999999999999999999921 236999999999999999999999999999988
Q ss_pred cCCCccc----eecccccccccccccccc
Q 046199 876 LNGEESM----RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~----~~~~~gt~~y~APE~l~~ 900 (902)
....... .....||+.|||||++..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred ccCCCcceeccccceecccCcCChhhccc
Confidence 7544322 223679999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.9e-31 Score=275.89 Aligned_cols=169 Identities=27% Similarity=0.301 Sum_probs=144.8
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccc------hhhhhHHHHHHHHHhCC--CCCccceeeeeecCC
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFD------GALKSFDAECEVLKSVR--HRNLVKIISSCSNGN 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 795 (902)
.++|++.+.||+|+||.||+|++. +++.||||+++.... ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999985 589999999875421 12345778999999986 899999999999999
Q ss_pred eeEEEEEccCC-CChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCc
Q 046199 796 FKALVLEYMAN-GSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-DMVAHLSDFGIA 873 (902)
Q Consensus 796 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a 873 (902)
..|+||||+.+ +++.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 5777777543 46899999999999999999999 999999999999999985 479999999999
Q ss_pred eecCCCccceeccccccccccccccc
Q 046199 874 KLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 874 ~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+..... ..+...||+.|||||++.
T Consensus 159 ~~~~~~--~~~~~~GT~~y~aPE~~~ 182 (273)
T d1xwsa_ 159 ALLKDT--VYTDFDGTRVYSPPEWIR 182 (273)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHH
T ss_pred eecccc--cccccccCCCcCCHHHHc
Confidence 875433 234567999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-31 Score=275.61 Aligned_cols=170 Identities=32% Similarity=0.448 Sum_probs=139.7
Q ss_pred HhhcccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec-CCeeEEE
Q 046199 722 LLATDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFKALV 800 (902)
Q Consensus 722 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 800 (902)
++..++|++.+.||+|+||.||+|++ .+++||||+++.. ...+.+.+|++++++++||||++++|++.+ ++..|+|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 45567899999999999999999998 5789999999654 345789999999999999999999998854 4668999
Q ss_pred EEccCCCChHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSN-RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 879 (902)
|||+++|+|.+++.... ..+++..+.+++.||+.||+||| +++|+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999986543 34899999999999999999999 999999999999999999999999999999875432
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
.....+|+.|||||++..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALRE 174 (262)
T ss_dssp --------CCTTTSCHHHHHH
T ss_pred ---CccccccccCCChHHHhC
Confidence 233568999999998754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.4e-28 Score=272.96 Aligned_cols=343 Identities=25% Similarity=0.349 Sum_probs=225.7
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccc
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPR 225 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~ 225 (902)
..+.+|++|++++++++ .+ +.++.+++|++|+|++|+|++ +|. ++++++|++|++++|.++++
T Consensus 41 ~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i------------- 103 (384)
T d2omza2 41 TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI------------- 103 (384)
T ss_dssp HHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-------------
T ss_pred HHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccccc-------------
Confidence 35678999999999998 45 578999999999999999995 453 99999999999999997642
Q ss_pred cccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCC
Q 046199 226 NLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSG 305 (902)
Q Consensus 226 ~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 305 (902)
..++++++|+.|++++|.+++..+ ......+..+....|.+....+.. ...............
T Consensus 104 --------~~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~---- 166 (384)
T d2omza2 104 --------TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLTSLQQLSFGNQVT---- 166 (384)
T ss_dssp --------GGGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT---TCTTCSEEEEEESCC----
T ss_pred --------cccccccccccccccccccccccc--cccccccccccccccccccccccc---ccccccccccccccc----
Confidence 347889999999999999985433 445677888888888876432222 111111111111111
Q ss_pred CCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccC
Q 046199 306 RIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLP 385 (902)
Q Consensus 306 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p 385 (902)
....+...+.........|... ....+..+++++.+++++|.+++..+
T Consensus 167 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~----------------------------- 214 (384)
T d2omza2 167 -DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP----------------------------- 214 (384)
T ss_dssp -CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG-----------------------------
T ss_pred -hhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc-----------------------------
Confidence 1122333444445555555443 23344555666666666665554322
Q ss_pred cccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCC
Q 046199 386 SSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLS 465 (902)
Q Consensus 386 ~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~ 465 (902)
+...+ +|++|++++|+++.. ..+..+++|+.|++++|++++..+ +..+++|++|++++|++++
T Consensus 215 --~~~~~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~---------- 277 (384)
T d2omza2 215 --LGILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN---------- 277 (384)
T ss_dssp --GGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC----------
T ss_pred --ccccC-CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCC----------
Confidence 12223 667777777777642 356777788888888888875432 5566666666666666552
Q ss_pred eEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCcc
Q 046199 466 ELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNY 545 (902)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 545 (902)
.. .+..++.++.+++++|++++. ..+..+++++.|++++|++++.. .+..+++|++|++++|+
T Consensus 278 -----------~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~ 340 (384)
T d2omza2 278 -----------IS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNK 340 (384)
T ss_dssp -----------CG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSC
T ss_pred -----------CC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCC
Confidence 21 244556666666666666652 34566666777777777776542 26667777777777777
Q ss_pred ccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCc
Q 046199 546 LTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVN 592 (902)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 592 (902)
|++ ++ .|+++++|++|++++|+|++..| +.++++|++|+|++|
T Consensus 341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 341 VSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 763 33 57788888888888888886554 778888888888887
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=278.27 Aligned_cols=177 Identities=25% Similarity=0.399 Sum_probs=152.9
Q ss_pred HHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhC-CCCCccceeeeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSV-RHRNLVKIISSCS 792 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 792 (902)
|++..++|++.+.||+|+||.||+|++. .++.||||+++... ......+.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4566789999999999999999999862 36789999997654 34556789999999999 6999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN-----------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
+++..|+|||||++|+|.++++... ..+++..+..++.||+.|++||| +++||||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence 9999999999999999999987543 24889999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccce--ecccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESMR--TQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~l~~ 900 (902)
||+++.++.+|++|||.++......... ....||+.|||||++..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence 9999999999999999998776543322 23678999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.3e-31 Score=279.85 Aligned_cols=178 Identities=24% Similarity=0.389 Sum_probs=152.1
Q ss_pred HHHhhcccccccCeecccceeeEEEEEeC------CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeee
Q 046199 720 ELLLATDHFSEKSLIGIGSFGTVYKGRFL------DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCS 792 (902)
Q Consensus 720 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 792 (902)
+|++..++|++.+.||+|+||.||+|.+. +++.||||+++... ......+.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45667789999999999999999999874 25789999997543 334567899999999999999999999999
Q ss_pred cCCeeEEEEEccCCCChHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 046199 793 NGNFKALVLEYMANGSLEKCLYSSN---------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM 863 (902)
Q Consensus 793 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~ 863 (902)
.++..++||||+++|+|.+++.... ...++..+.+++.|+++||.||| +++|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 9999999999999999999886421 34688999999999999999999 99999999999999999999
Q ss_pred cEEEEeecCceecCCCcccee--cccccccccccccccc
Q 046199 864 VAHLSDFGIAKLLNGEESMRT--QTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 ~~kL~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~l~~ 900 (902)
++||+|||+|+.......... ...||+.|||||.+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~ 209 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHcc
Confidence 999999999987654433222 2468999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-30 Score=275.56 Aligned_cols=171 Identities=28% Similarity=0.453 Sum_probs=143.2
Q ss_pred cccccccCeecccceeeEEEEEeCC-Cc--EEEEEEeeec-cchhhhhHHHHHHHHHhC-CCCCccceeeeeecCCeeEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GM--EVAIKVFHLQ-FDGALKSFDAECEVLKSV-RHRNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 799 (902)
.++|++.+.||+|+||+||+|++.+ +. .||||+++.. .....+.+.+|+++++++ +|||||++++++.+++..|+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 4789999999999999999998864 43 5788887643 334567899999999998 79999999999999999999
Q ss_pred EEEccCCCChHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 046199 800 VLEYMANGSLEKCLYSS---------------NRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMV 864 (902)
Q Consensus 800 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~ 864 (902)
||||+++|+|.++++.. ...+++..+.+++.||+.||+|+| +++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence 99999999999998643 356899999999999999999999 999999999999999999999
Q ss_pred EEEEeecCceecCCCccceeccccccccccccccc
Q 046199 865 AHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 865 ~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
+||+|||+|+....... .....||+.|+|||.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~ 199 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLN 199 (309)
T ss_dssp EEECCTTCEESSCEECC-C----CCTTTCCHHHHH
T ss_pred eEEcccccccccccccc-ccceecCCcccchHHhc
Confidence 99999999986543222 22356899999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-30 Score=275.10 Aligned_cols=176 Identities=25% Similarity=0.435 Sum_probs=146.3
Q ss_pred HHhhcccccccCeecccceeeEEEEEeCC--------CcEEEEEEeeeccc-hhhhhHHHHHHHHHhC-CCCCccceeee
Q 046199 721 LLLATDHFSEKSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFD-GALKSFDAECEVLKSV-RHRNLVKIISS 790 (902)
Q Consensus 721 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~ 790 (902)
|.+..++|++.+.||+|+||.||+|++.. +..||||+++.... .....+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44677899999999999999999998643 34799999976543 3457788899888888 89999999999
Q ss_pred eecCCeeEEEEEccCCCChHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 046199 791 CSNGNFKALVLEYMANGSLEKCLYSSN---------------RSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPS 855 (902)
Q Consensus 791 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~ 855 (902)
+.+++..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +++||||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence 999999999999999999999996543 34899999999999999999999 999999999999
Q ss_pred CEEEcCCCcEEEEeecCceecCCCccc--eeccccccccccccccc
Q 046199 856 NILLDDDMVAHLSDFGIAKLLNGEESM--RTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 856 NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~l~ 899 (902)
|||++.++.+||+|||+++........ .....||+.|||||++.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 210 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc
Confidence 999999999999999999876543322 22356899999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.3e-30 Score=271.80 Aligned_cols=167 Identities=26% Similarity=0.448 Sum_probs=143.6
Q ss_pred cCeecccceeeEEEEEeCCC----cEEEEEEeeec-cchhhhhHHHHHHHHHhCCCCCccceeeeeec-CCeeEEEEEcc
Q 046199 731 KSLIGIGSFGTVYKGRFLDG----MEVAIKVFHLQ-FDGALKSFDAECEVLKSVRHRNLVKIISSCSN-GNFKALVLEYM 804 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 804 (902)
.++||+|+||+||+|++.++ ..||||+++.. .....+++.+|++++++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 35899998753 34456889999999999999999999999765 56899999999
Q ss_pred CCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc--
Q 046199 805 ANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM-- 882 (902)
Q Consensus 805 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-- 882 (902)
++|+|.+++.......++..+.+++.|++.||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877777889999999999999999999 999999999999999999999999999999876543322
Q ss_pred --eecccccccccccccccc
Q 046199 883 --RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 --~~~~~gt~~y~APE~l~~ 900 (902)
.....||+.|+|||++..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH
T ss_pred eecccccccccccChHHHhc
Confidence 122568999999998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=2.7e-29 Score=266.57 Aligned_cols=170 Identities=23% Similarity=0.312 Sum_probs=147.5
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCC-CCccceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRH-RNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||+||+|++.. ++.||||+++... ..+.+.+|+++++.++| ++|+.+++++..++..|+|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999864 8899999886543 33567889999999975 899999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-----CCcEEEEeecCceecC
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD-----DMVAHLSDFGIAKLLN 877 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~-----~~~~kL~DFG~a~~~~ 877 (902)
|+ +++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 67999999887778999999999999999999999 999999999999999964 5789999999998865
Q ss_pred CCcc-------ceecccccccccccccccc
Q 046199 878 GEES-------MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 878 ~~~~-------~~~~~~gt~~y~APE~l~~ 900 (902)
.... .....+||+.|||||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC
Confidence 4322 1223579999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.6e-30 Score=272.98 Aligned_cols=172 Identities=28% Similarity=0.410 Sum_probs=144.1
Q ss_pred cccccccCeecccceeeEEEEEeC-C-CcEEEEEEeeecc--chhhhhHHHHHHHHHhC---CCCCccceeeeeec----
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-D-GMEVAIKVFHLQF--DGALKSFDAECEVLKSV---RHRNLVKIISSCSN---- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 793 (902)
.++|++.+.||+|+||+||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999984 3 5679999997543 22345677888887766 79999999999852
Q ss_pred -CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 046199 794 -GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGI 872 (902)
Q Consensus 794 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 872 (902)
....|++|||++++.+..........+++..++.++.|++.||+||| +++||||||||+|||++.++.+||+|||.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 35789999999988776666556677999999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCccceecccccccccccccccc
Q 046199 873 AKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 873 a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
++..... .......||+.|||||++..
T Consensus 163 ~~~~~~~-~~~~~~~gT~~Y~APE~~~~ 189 (305)
T d1blxa_ 163 ARIYSFQ-MALTSVVVTLWYRAPEVLLQ 189 (305)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTT
T ss_pred hhhhccc-ccCCCcccChhhcCcchhcC
Confidence 9865433 23344789999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=2.3e-29 Score=272.43 Aligned_cols=165 Identities=22% Similarity=0.405 Sum_probs=142.8
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeec--CCeeEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSN--GNFKALV 800 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 800 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++.. ..+++.+|+++++.++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 468999999999999999999985 4899999998754 3467889999999995 9999999999874 4568999
Q ss_pred EEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceecCCC
Q 046199 801 LEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKLLNGE 879 (902)
Q Consensus 801 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 879 (902)
|||+++++|..+. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987754 45899999999999999999999 99999999999999998655 6999999999877544
Q ss_pred ccceecccccccccccccccc
Q 046199 880 ESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. ....+||+.|+|||++..
T Consensus 184 ~~-~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 184 QE-YNVRVASRYFKGPELLVD 203 (328)
T ss_dssp CC-CCSCCSCGGGCCHHHHTT
T ss_pred Cc-ccccccCccccCcccccC
Confidence 32 344679999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=273.44 Aligned_cols=171 Identities=25% Similarity=0.328 Sum_probs=141.1
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc-chhhhhHHHHHHHHHhCCCCCccceeeeeecCC----eeE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF-DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN----FKA 798 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 798 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++... ....+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999875 59999999997543 344578899999999999999999999986543 234
Q ss_pred EEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCC
Q 046199 799 LVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNG 878 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 878 (902)
++++|+.+|+|.+++... .+++..+..++.|++.||+||| ++|||||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 445566789999999653 5899999999999999999999 99999999999999999999999999999987644
Q ss_pred Cccc---eecccccccccccccccc
Q 046199 879 EESM---RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 879 ~~~~---~~~~~gt~~y~APE~l~~ 900 (902)
.... ....+||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred CCccceeeccccccceechHHHhhc
Confidence 3221 233579999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.7e-29 Score=264.94 Aligned_cols=171 Identities=25% Similarity=0.352 Sum_probs=152.3
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCCeeEEEEE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGNFKALVLE 802 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 802 (902)
++|++.+.||+|+||+||+|++. +++.||||+++... ....+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999985 48899999997553 3446788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceecCCCccc
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLLNGEESM 882 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 882 (902)
++.++++..++. ..+.+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|+........
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999988877764 4566899999999999999999999 999999999999999999999999999999987665555
Q ss_pred eecccccccccccccccc
Q 046199 883 RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 883 ~~~~~gt~~y~APE~l~~ 900 (902)
.....+++.|+|||++..
T Consensus 158 ~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT
T ss_pred ceeeccccchhhhhHhcc
Confidence 555678899999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-29 Score=272.80 Aligned_cols=167 Identities=25% Similarity=0.367 Sum_probs=139.8
Q ss_pred cccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecCC------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNGN------ 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 795 (902)
.++|++.+.||+|+||+||+|++.. ++.||||+++... ....+.+.+|+++++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5789999999999999999999864 9999999997543 334567889999999999999999999997654
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..|+||||+ +.++..+.+. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 579999999 5688877654 45899999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCccceecccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... .+...||+.|||||++..
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 171 ADSE---MTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHT
T ss_pred cCCc---cccccccccccCHHHHcC
Confidence 6543 244679999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-29 Score=271.21 Aligned_cols=166 Identities=31% Similarity=0.450 Sum_probs=138.3
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCccceeeeeec------CCeeE
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNFKA 798 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 798 (902)
-+|+..++||+|+||+||+|++.. ++.||||+++... +...+|++++++++||||++++++|.. ..+.|
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 378999999999999999999864 8999999997543 233479999999999999999999843 34578
Q ss_pred EEEEccCCCChHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCcee
Q 046199 799 LVLEYMANGSLEKCLY--SSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDM-VAHLSDFGIAKL 875 (902)
Q Consensus 799 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~ 875 (902)
+|||||+++....+.. .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998764433322 34556999999999999999999999 99999999999999999775 899999999988
Q ss_pred cCCCccceeccccccccccccccc
Q 046199 876 LNGEESMRTQTLGTIGYMAPGLWV 899 (902)
Q Consensus 876 ~~~~~~~~~~~~gt~~y~APE~l~ 899 (902)
...... .....||+.|+|||++.
T Consensus 173 ~~~~~~-~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 173 LVRGEP-NVSYICSRYYRAPELIF 195 (350)
T ss_dssp CCTTSC-CCSCCSCTTSCCHHHHT
T ss_pred ccCCcc-cccccccccccChHHhh
Confidence 754433 33467999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8e-29 Score=266.97 Aligned_cols=172 Identities=26% Similarity=0.418 Sum_probs=141.9
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec--------
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN-------- 793 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 793 (902)
.++|++.+.||+|+||+||+|++. +++.||||++.... +...+++.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 479999999999999999999985 59999999986542 3445778999999999999999999998854
Q ss_pred CCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 046199 794 GNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIA 873 (902)
Q Consensus 794 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 873 (902)
++..|+||||++++.+.. .......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+|++|||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 346899999998766554 4455567899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCcc----ceecccccccccccccccc
Q 046199 874 KLLNGEES----MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 874 ~~~~~~~~----~~~~~~gt~~y~APE~l~~ 900 (902)
+.+..... .....+||+.|+|||++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcC
Confidence 87654322 1223579999999998753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2.2e-28 Score=260.87 Aligned_cols=170 Identities=25% Similarity=0.384 Sum_probs=141.7
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCc-cceeeeeecCCeeEEEEE
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL-VKIISSCSNGNFKALVLE 802 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 802 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++... ..+++.+|+++++.++|+++ +.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999985 48999999987543 33568899999999987664 555666678889999999
Q ss_pred ccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceecCCC
Q 046199 803 YMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDD---DMVAHLSDFGIAKLLNGE 879 (902)
Q Consensus 803 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~~~~ 879 (902)
|+ ++++.+.+......+++..+..++.|++.||+||| ++||+||||||+||+++. +..+|++|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 55777777777778999999999999999999999 999999999999999854 457999999999987543
Q ss_pred ccc-------eecccccccccccccccc
Q 046199 880 ESM-------RTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 880 ~~~-------~~~~~gt~~y~APE~l~~ 900 (902)
... .....||+.|||||++..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred ccccceeccccCCcCCCccccCHHHHhC
Confidence 321 223579999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.3e-29 Score=267.24 Aligned_cols=172 Identities=28% Similarity=0.393 Sum_probs=149.2
Q ss_pred cccccccCeecccceeeEEEEEeC----CCcEEEEEEeeecc----chhhhhHHHHHHHHHhCCC-CCccceeeeeecCC
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL----DGMEVAIKVFHLQF----DGALKSFDAECEVLKSVRH-RNLVKIISSCSNGN 795 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 795 (902)
.++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999863 37899999986432 2345678899999999976 89999999999999
Q ss_pred eeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 796 FKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 796 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
..++||||+.+|+|.+++.... .+++..+..++.||+.|++|+| +++|+||||||+||+++.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999986554 4788999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCcc-ceecccccccccccccccc
Q 046199 876 LNGEES-MRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 876 ~~~~~~-~~~~~~gt~~y~APE~l~~ 900 (902)
+..... ......|++.|+|||.+..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred hcccccccccccccccccchhHHhhc
Confidence 654332 2344679999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.4e-28 Score=263.44 Aligned_cols=167 Identities=26% Similarity=0.319 Sum_probs=132.7
Q ss_pred ccccccCeecccceeeEEEEEeCC-CcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeec------CCe
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSN------GNF 796 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 796 (902)
++|++.+.||+|+||+||+|++.. |+.||||+++... ....+++.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999864 9999999997553 3345678899999999999999999999853 468
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.|+||||+.++.+ +.+. ..+++..++.++.||+.||+||| ++||+||||||+||+++.++.+|++|||.++..
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 8999999976544 4442 45899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.... ......||+.|+|||++..
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 170 GTSF-MMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp ------------CCTTCCHHHHTT
T ss_pred cccc-ccccccccccccChhhhcC
Confidence 5433 3344679999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.4e-28 Score=264.71 Aligned_cols=168 Identities=23% Similarity=0.367 Sum_probs=140.0
Q ss_pred cccccccCeecccceeeEEEEEeC-CCcEEEEEEeeecc--chhhhhHHHHHHHHHhCCCCCccceeeeeecC-----Ce
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQF--DGALKSFDAECEVLKSVRHRNLVKIISSCSNG-----NF 796 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 796 (902)
.++|++.+.||+|+||+||+|++. +++.||||+++... ....+++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999985 49999999997553 23456788999999999999999999998532 34
Q ss_pred eEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceec
Q 046199 797 KALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKLL 876 (902)
Q Consensus 797 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 876 (902)
.+++|+|+.+|+|.+++.. +.+++..+..++.||+.||+||| ++||+||||||+||+++.++.+|++|||.|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 4666777889999999854 45999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCccceecccccccccccccccc
Q 046199 877 NGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 877 ~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.. ......||+.|+|||++..
T Consensus 172 ~~---~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 172 DD---EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp TG---GGSSSCHHHHTSCHHHHTT
T ss_pred Cc---ccccccccccccCchhhcC
Confidence 32 2334679999999998653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=6.9e-26 Score=242.51 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=159.2
Q ss_pred CCceeeeeEEeeCCCCcEEEEEeccCCcceecCcccCCCCCCCeeeccccccccCCCc-cccCCCcceEEEecCccccCC
Q 046199 29 TSVCSWIGITCDVSTHRVTALNISDFGLTGTISSQLGNLSSLQTLDLSHNRFSGTIPS-SIFSISTLKILILGDNQLSGS 107 (902)
Q Consensus 29 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~ls~n~l~~~ 107 (902)
.+-|.|.+|.|.. .+|+ ++|+.+. +++++|||++|+++ .+|+ +|.++++|++|++++|.++..
T Consensus 7 ~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i 70 (305)
T d1xkua_ 7 RCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKI 70 (305)
T ss_dssp TCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred CCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhcccccccccccccccccc
Confidence 4457888888853 3454 6676653 57888888888887 5554 677888888888888887742
Q ss_pred CCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCC
Q 046199 108 FPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTG 187 (902)
Q Consensus 108 ~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 187 (902)
.|..|.++++|++|++++|+++ .+|..+. ..|+.|++++|.+.+
T Consensus 71 ---------------------------------~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 71 ---------------------------------SPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITK 114 (305)
T ss_dssp ---------------------------------CTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCB
T ss_pred ---------------------------------chhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhh
Confidence 2444556666666666666666 4554332 456666666666664
Q ss_pred CCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCc
Q 046199 188 TIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLK 267 (902)
Q Consensus 188 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 267 (902)
..+..+.....++.++...|.... .+ ..+..+..+++|+.+++++|.++ .+|..+ +++|+
T Consensus 115 l~~~~~~~~~~~~~l~~~~n~~~~--------~~---------~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~ 174 (305)
T d1xkua_ 115 VRKSVFNGLNQMIVVELGTNPLKS--------SG---------IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT 174 (305)
T ss_dssp BCHHHHTTCTTCCEEECCSSCCCG--------GG---------BCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCS
T ss_pred hhhhhhhccccccccccccccccc--------cC---------CCccccccccccCccccccCCcc-ccCccc--CCccC
Confidence 444445555666666666655321 11 11245556666777777777665 344332 45667
Q ss_pred eEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecc
Q 046199 268 ALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLG 347 (902)
Q Consensus 268 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 347 (902)
.|++++|..++..+.. +.+++.+++|++++|.+.+..+.++..+++|++|+|++|+|+ .+|.+|..+++|++|+|+
T Consensus 175 ~L~l~~n~~~~~~~~~---~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 175 ELHLDGNKITKVDAAS---LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp EEECTTSCCCEECTGG---GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred EEECCCCcCCCCChhH---hhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECC
Confidence 7777777666555544 556666667777777776666666667777777777777776 346667777777777777
Q ss_pred cccCCCCC
Q 046199 348 YNYLTSST 355 (902)
Q Consensus 348 ~N~l~~~~ 355 (902)
+|+|+...
T Consensus 251 ~N~i~~i~ 258 (305)
T d1xkua_ 251 NNNISAIG 258 (305)
T ss_dssp SSCCCCCC
T ss_pred CCccCccC
Confidence 77776543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=7.9e-26 Score=242.07 Aligned_cols=220 Identities=24% Similarity=0.301 Sum_probs=115.5
Q ss_pred cceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCce
Q 046199 293 IERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKY 372 (902)
Q Consensus 293 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~ 372 (902)
+++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|++++|+++..+.
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~---------------- 96 (305)
T d1xkua_ 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE---------------- 96 (305)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCS----------------
T ss_pred CCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCcc----------------
Confidence 3334444444433333344445555555555555554445555555555555555555543221
Q ss_pred eeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceec--ccCCcccccccccCeeeccc
Q 046199 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLS--GSIPITVGRLNTLQGLGLEN 450 (902)
Q Consensus 373 L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~ 450 (902)
.+. + .+..|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++
T Consensus 97 --------------~~~--~-~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~ 159 (305)
T d1xkua_ 97 --------------KMP--K-TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159 (305)
T ss_dssp --------------SCC--T-TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred --------------chh--h-hhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccccc
Confidence 111 1 4445555555555444445555556666666665443 23345566666666677766
Q ss_pred ccccCCCCC-cCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccc
Q 046199 451 NKLEGPIPD-DLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLD 529 (902)
Q Consensus 451 N~l~~~~p~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~ 529 (902)
|++. .+|. .+.+|+.|++++|.+++..+..|.+++.++.|++++|++++..+..|.++++|++|+|++|+|+. +|..
T Consensus 160 n~l~-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~ 237 (305)
T d1xkua_ 160 TNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGG 237 (305)
T ss_dssp SCCC-SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTT
T ss_pred CCcc-ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccc
Confidence 6665 2332 22355666666666655555566666666666666666666555555555555555555555552 3444
Q ss_pred cccccccceeccCCcccc
Q 046199 530 IGNMKVVVEINLSRNYLT 547 (902)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~ 547 (902)
|..+++|++|+|++|+|+
T Consensus 238 l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTTCSSCCEEECCSSCCC
T ss_pred cccccCCCEEECCCCccC
Confidence 444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.5e-26 Score=241.99 Aligned_cols=250 Identities=24% Similarity=0.280 Sum_probs=186.0
Q ss_pred eeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeeccccc
Q 046199 373 IVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNK 452 (902)
Q Consensus 373 L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 452 (902)
++.+++.+. .+|..+ |.++++|+|++|+|+++.+.+|.++++|++|++++|++.+..+..+..+..+..++..
T Consensus 16 v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~--- 88 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS--- 88 (284)
T ss_dssp EECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC---
T ss_pred EEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc---
Confidence 344444444 344433 3477888888888887777788888888888888888887777666666666655443
Q ss_pred ccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCcccccc
Q 046199 453 LEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGN 532 (902)
Q Consensus 453 l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 532 (902)
..|.++...|..|+++++|++|++++|.+....+..+....+|+.+++++|++++..+..|..
T Consensus 89 -----------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~ 151 (284)
T d1ozna_ 89 -----------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151 (284)
T ss_dssp -----------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred -----------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhcc
Confidence 233444455667888888888888888888777777888888888888888888776777888
Q ss_pred ccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccccccccccccc
Q 046199 533 MKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLN 612 (902)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 612 (902)
++.|++|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|+.||+++|++++..|..|..+++|+.|+
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~ 231 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEE
Confidence 88888888888888877788888888888888888888888888888888888888888888887778888888888888
Q ss_pred ccCCcceecCCCCCcccccccccccCCcccCCCC
Q 046199 613 LSFNRLEGEIPSGGSFANFSAQSFMGNDLLCGSP 646 (902)
Q Consensus 613 l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 646 (902)
+++|+|.|.++...-..++.......+...|..|
T Consensus 232 l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 232 LNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (284)
T ss_dssp CCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred ecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence 8888888877653323334444444455555443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.5e-25 Score=231.24 Aligned_cols=179 Identities=23% Similarity=0.236 Sum_probs=88.5
Q ss_pred CcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccc
Q 046199 403 CKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACF 482 (902)
Q Consensus 403 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~ 482 (902)
|.++...+..|+++++|++|++++|.+....+..+....+|+ .+++++|+|+++.+..|
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~---------------------~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ---------------------YLYLQDNALQALPDDTF 149 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC---------------------EEECCSSCCCCCCTTTT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccc---------------------hhhhccccccccChhHh
Confidence 344444444555555555555555555433333333333333 33333333333444455
Q ss_pred cCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccce
Q 046199 483 GNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQL 562 (902)
Q Consensus 483 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 562 (902)
..+++|+.|++++|+++++.+.+|.++++|+++++++|++++..|..|..+++|++|++++|++.+..|..|+.+++|++
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 55566666666666666555555555555665555555555555555555555555555555555555555555555555
Q ss_pred EEccCcccCCCccccccccccCCeEeCcCccccccCCcccc
Q 046199 563 LSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLE 603 (902)
Q Consensus 563 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 603 (902)
|+|++|.+...-+. -.-...++.+....++++...|..+.
T Consensus 230 L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 230 LRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp EECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred EEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHc
Confidence 55555555432210 00112234444444555544444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.4e-24 Score=220.97 Aligned_cols=180 Identities=27% Similarity=0.220 Sum_probs=113.2
Q ss_pred CCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCC
Q 046199 418 NLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNE 497 (902)
Q Consensus 418 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 497 (902)
++++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~----------------------~l~-~~~~l~~L~~L~Ls~N~ 88 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT----------------------KLQ-VDGTLPVLGTLDLSHNQ 88 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC----------------------EEE-CCSCCTTCCEEECCSSC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc----------------------ccc-ccccccccccccccccc
Confidence 4555555555555444444555555554444444443 111 12344555555555555
Q ss_pred ccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCcccc
Q 046199 498 LSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPES 577 (902)
Q Consensus 498 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 577 (902)
++. .+..+.++++|++|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++++|+|++..+..
T Consensus 89 l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 89 LQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp CSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred ccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccc
Confidence 554 2444555555566666666555555555566666666666666666666666777777888888888887777777
Q ss_pred ccccccCCeEeCcCccccccCCcccccccccccccccCCcceecC
Q 046199 578 FGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622 (902)
Q Consensus 578 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 622 (902)
|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|.|.+
T Consensus 168 ~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 788888888888888887 67777777888888888888887654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=6.1e-23 Score=214.35 Aligned_cols=204 Identities=27% Similarity=0.287 Sum_probs=179.4
Q ss_pred cccccCeeecccccccCCCCCcCC-CCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEc
Q 046199 439 RLNTLQGLGLENNKLEGPIPDDLC-QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDF 517 (902)
Q Consensus 439 ~l~~L~~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 517 (902)
....+.+++.+++.++ .+|..++ ++++|+|++|+|++..+..|.++++|++|+|++|+|+.+. .++.+++|++|++
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL 84 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred ccCCCeEEEccCCCCC-eeCcCcCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccc
Confidence 3445566677777777 5677665 7999999999999888889999999999999999998753 4678999999999
Q ss_pred CCCccCCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCcccccc
Q 046199 518 SSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGV 597 (902)
Q Consensus 518 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 597 (902)
++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++.
T Consensus 85 s~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred ccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 9999995 577899999999999999999988899999999999999999999988888899999999999999999988
Q ss_pred CCcccccccccccccccCCcceecCCCC-CcccccccccccCCcccCCCCC
Q 046199 598 IPISLEKLVYLKDLNLSFNRLEGEIPSG-GSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 598 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
.+..|..+++|++|+|++|+|+ .+|.+ ..+..+....+.+||+.|++..
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 8889999999999999999999 67763 4456778889999999998654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=1.6e-23 Score=229.81 Aligned_cols=168 Identities=21% Similarity=0.320 Sum_probs=133.0
Q ss_pred ccccccCeecccceeeEEEEEeC-CCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-----------CCCccceeeeeec
Q 046199 726 DHFSEKSLIGIGSFGTVYKGRFL-DGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-----------HRNLVKIISSCSN 793 (902)
Q Consensus 726 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 793 (902)
.+|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999985 58999999997542 23467788999888775 5789999988754
Q ss_pred --CCeeEEEEEccCCCChHHH--HhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC-----
Q 046199 794 --GNFKALVLEYMANGSLEKC--LYSSNRSLDIFQRLSIMIDVALALEYLHFGYS-NPVVHCDIKPSNILLDDDM----- 863 (902)
Q Consensus 794 --~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~----- 863 (902)
....+++|+++..+..... .......+++..+..++.||+.|++||| + .||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence 3566677776655443222 2234456889999999999999999999 5 8999999999999998665
Q ss_pred -cEEEEeecCceecCCCccceecccccccccccccccc
Q 046199 864 -VAHLSDFGIAKLLNGEESMRTQTLGTIGYMAPGLWVV 900 (902)
Q Consensus 864 -~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~APE~l~~ 900 (902)
.+|++|||.|...... ....+||+.|+|||++..
T Consensus 169 ~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT
T ss_pred ceeeEeecccccccccc---cccccccccccChhhccc
Confidence 4999999999875432 234679999999998753
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=7.2e-21 Score=207.22 Aligned_cols=136 Identities=27% Similarity=0.398 Sum_probs=72.1
Q ss_pred CCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT 149 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~ 149 (902)
|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++. +..+| +
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~------l~~lp------~ 98 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA------LSDLP------P 98 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC------CCSCC------T
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch------hhhhc------c
Confidence 445555555554 45532 234555555555554 33321 2344444444444431 11122 2
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~ 229 (902)
.|++|+|++|.++ .+|. ++.+++|++|++++|.+.. .|.. ...+..+.+.++....
T Consensus 99 ~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~------------------ 154 (353)
T d1jl5a_ 99 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE------------------ 154 (353)
T ss_dssp TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS------------------
T ss_pred ccccccccccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhccccccc------------------
Confidence 5777888888777 5664 5677777777777777763 3322 3345555555544221
Q ss_pred cCCCccccCCCCCCEEEccCcccc
Q 046199 230 CEIPHEIGNLPNLEVLGIDENHLV 253 (902)
Q Consensus 230 ~~lp~~l~~l~~L~~L~Ls~N~l~ 253 (902)
+..++.++.++.|++++|.+.
T Consensus 155 ---~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 155 ---LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp ---CCCCTTCTTCCEEECCSSCCS
T ss_pred ---cccccccccceeccccccccc
Confidence 134555666667777766665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=4.5e-20 Score=200.84 Aligned_cols=304 Identities=26% Similarity=0.339 Sum_probs=185.4
Q ss_pred CCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccE
Q 046199 240 PNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFL 319 (902)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 319 (902)
.++++|||++|+++ .+|+. .++|++|+|++|+|+ .+|.. ..+|+.|++++|+++. +++. .+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~------~~~L~~L~l~~n~l~~-l~~l---p~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL------PQSLKSLLVDNNNLKA-LSDL---PPLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC------CTTCCEEECCSSCCSC-CCSC---CTTCCE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc------hhhhhhhhhhhcccch-hhhh---cccccc
Confidence 36889999999998 67764 468899999999998 66754 3578899999998873 3332 246899
Q ss_pred EEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEE
Q 046199 320 LELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIY 399 (902)
Q Consensus 320 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 399 (902)
|++++|.+.. +|. ++.+++|++|++++|.+..... ....+..+.+..+... .+..+..++ .++.++
T Consensus 103 L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~---------~~~~l~~l~~~~~~~~--~~~~l~~l~-~l~~L~ 168 (353)
T d1jl5a_ 103 LGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPD---------LPPSLEFIAAGNNQLE--ELPELQNLP-FLTAIY 168 (353)
T ss_dssp EECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCS--SCCCCTTCT-TCCEEE
T ss_pred cccccccccc-ccc-hhhhccceeecccccccccccc---------ccccccchhhcccccc--ccccccccc-cceecc
Confidence 9999999984 453 5788999999999998875433 2345556666555443 234455555 777788
Q ss_pred eecCcccccCCcccCCCCCCcEEEeecceecccCCcccccccccCeeecccccccCCCCCcCCCCCeEeccCccccCCCC
Q 046199 400 LQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLENNKLEGPIPDDLCQLSELHVDHNKLSGPIP 479 (902)
Q Consensus 400 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p 479 (902)
+++|.+... +.. ....+.+..+++.+. .++ .+..++.|+.+++++|... .+|....++..+.+.+|.+... +
T Consensus 169 l~~n~~~~~-~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~~~~l~~~~~~~~~~~~~-~ 240 (353)
T d1jl5a_ 169 ADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-P 240 (353)
T ss_dssp CCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSCCTTCCEEECCSSCCSCC-C
T ss_pred ccccccccc-ccc---ccccccccccccccc-ccc-ccccccccccccccccccc-cccccccccccccccccccccc-c
Confidence 888777632 221 233456666666555 333 3456777777777777765 4555556677777777766532 2
Q ss_pred ccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCc
Q 046199 480 ACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTN 559 (902)
Q Consensus 480 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 559 (902)
. ....+...++..|.+.+.. .. .......++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++
T Consensus 241 ~---~~~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~ 305 (353)
T d1jl5a_ 241 E---LPQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPR 305 (353)
T ss_dssp C---CCTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTT
T ss_pred c---ccccccccccccccccccc-cc---cchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCC
Confidence 1 1234555555555554321 10 12334455555554421 122345566666666665 34432 345
Q ss_pred cceEEccCcccCCCccccccccccCCeEeCcCccccccCCc
Q 046199 560 LQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPI 600 (902)
Q Consensus 560 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 600 (902)
|+.|+|++|+|+ .+|+. +++|+.|+|++|+|+ .+|.
T Consensus 306 L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 306 LERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 556666666665 34432 345556666666655 3443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=2.1e-21 Score=191.54 Aligned_cols=136 Identities=16% Similarity=0.182 Sum_probs=108.4
Q ss_pred ccccCeecccceeeEEEEEeCCCcEEEEEEeeeccc------------------hhhhhHHHHHHHHHhCCCCCccceee
Q 046199 728 FSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFD------------------GALKSFDAECEVLKSVRHRNLVKIIS 789 (902)
Q Consensus 728 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~ 789 (902)
+.+.+.||+|+||.||+|++.+|++||||+++.... .......+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999998899999998753210 11234456888999999999999886
Q ss_pred eeecCCeeEEEEEccCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 046199 790 SCSNGNFKALVLEYMANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFGYSNPVVHCDIKPSNILLDDDMVAHLSD 869 (902)
Q Consensus 790 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 869 (902)
+.. .+++|||+++....+ ++...+..++.|++.|++||| ++||+||||||+|||++++ .++++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 642 379999998865543 233445679999999999999 9999999999999999976 589999
Q ss_pred ecCceecCCC
Q 046199 870 FGIAKLLNGE 879 (902)
Q Consensus 870 FG~a~~~~~~ 879 (902)
||.|+....+
T Consensus 146 FG~a~~~~~~ 155 (191)
T d1zara2 146 FPQSVEVGEE 155 (191)
T ss_dssp CTTCEETTST
T ss_pred CCCcccCCCC
Confidence 9999876543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=1.8e-19 Score=177.63 Aligned_cols=174 Identities=19% Similarity=0.222 Sum_probs=109.8
Q ss_pred eeecccccccCCCCCcCC-CCCeEeccCccccC-CCCccccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCcc
Q 046199 445 GLGLENNKLEGPIPDDLC-QLSELHVDHNKLSG-PIPACFGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSL 522 (902)
Q Consensus 445 ~L~L~~N~l~~~~p~~l~-~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 522 (902)
+++.++++++ .+|..++ ++++|+|++|+|++ ..+..|.++++|+.|+|++|++.++.+..|..+++|++|+|++|+|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp EEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence 4555555555 4555544 66677777777765 3345667777777777777777777777777777777777777777
Q ss_pred CCCCccccccccccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCccc
Q 046199 523 NGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISL 602 (902)
Q Consensus 523 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 602 (902)
++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+. ..-...++.+.+..|.++...|..+
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCChhh
Confidence 766666677777777777777777766666677777777777777766543221 1112335555666666665555443
Q ss_pred ccccccccccccCCcceecCC
Q 046199 603 EKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 603 ~~l~~L~~L~l~~N~l~~~~p 623 (902)
..++.++|+.|.+.+..+
T Consensus 170 ---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 170 ---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp ---TTSBGGGSCTTTCCCCCC
T ss_pred ---cCCEeeecCHhhCcCCCC
Confidence 334556666666665444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.1e-22 Score=227.99 Aligned_cols=116 Identities=22% Similarity=0.127 Sum_probs=64.6
Q ss_pred cCceEecCCCCccCcccc----cccCCCCceEEEcCCCccCCC----Cccccc-cccccceeccCCcccccc----Cccc
Q 046199 487 SLRNLSLGSNELSSFIPS----TFWNLNNILSFDFSSNSLNGS----LPLDIG-NMKVVVEINLSRNYLTGD----IPTT 553 (902)
Q Consensus 487 ~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~p~~ 553 (902)
.|+.+++++|.++..... .+...++|++|+|++|++++. ++..+. ..+.|++|+|++|.|+.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 455555555555433222 223344566666666665432 122221 234566777777776532 3445
Q ss_pred cccCCccceEEccCcccCCCcccccc-----ccccCCeEeCcCccccccCCccc
Q 046199 554 IGGLTNLQLLSLENNRLHGPIPESFG-----ALTSLESLDLSVNNLSGVIPISL 602 (902)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~l 602 (902)
+...++|++|+|++|+|+......|. ....|+.|++++|.+....+..+
T Consensus 393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 56677888888888887753333332 22368888888888876554444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1e-21 Score=222.10 Aligned_cols=382 Identities=21% Similarity=0.198 Sum_probs=219.9
Q ss_pred cccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccC----cCCCcccCCCCCceEeccC
Q 046199 198 SLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVG----DVPNTIFNMSTLKALSLLN 273 (902)
Q Consensus 198 ~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~ 273 (902)
+|++||+++|++++.. +.+-+..++++++|+|++|+++. .++..+..+++|++|||++
T Consensus 3 ~l~~ld~~~~~i~~~~------------------~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~ 64 (460)
T d1z7xw1 3 DIQSLDIQCEELSDAR------------------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64 (460)
T ss_dssp EEEEEEEESCCCCHHH------------------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTT
T ss_pred CCCEEEeeCCcCChHH------------------HHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcC
Confidence 5788888888876421 11345567888889999988863 3345567788888888888
Q ss_pred cccccCCCcCC-cccC-CCcccceeeccCccCCCC----CCccccccccccEEEccCCcccCcccccccc-----ccccc
Q 046199 274 NTLSGSLPSSS-KNLI-GLPNIERLNLGLNNLSGR----IPGFIFNASKLFLLELTGNSFSGFIPDTLVN-----LRNLE 342 (902)
Q Consensus 274 N~l~~~~p~~~-~~l~-~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~ 342 (902)
|+|+..-...+ ..+. ...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+.. .....
T Consensus 65 N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~ 144 (460)
T d1z7xw1 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 144 (460)
T ss_dssp CCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred CcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccc
Confidence 88752100000 0011 234677777777777633 2344556667777777777765332222211 11112
Q ss_pred EEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccC----Cccc-CCCC
Q 046199 343 HLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNI----PKEI-GNLV 417 (902)
Q Consensus 343 ~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~----p~~~-~~l~ 417 (902)
........+.... .......+.... .++.++++++.+.... ...+ ....
T Consensus 145 ~~~~~~~~~~~~~-~~~~~~~l~~~~-------------------------~~~~~~ls~~~~~~~~~~~~~~~l~~~~~ 198 (460)
T d1z7xw1 145 KLQLEYCSLSAAS-CEPLASVLRAKP-------------------------DFKELTVSNNDINEAGVRVLCQGLKDSPC 198 (460)
T ss_dssp EEECTTSCCBGGG-HHHHHHHHHHCT-------------------------TCCEEECCSSBCHHHHHHHHHHHHHHSCC
T ss_pred cccccccccchhh-hccccccccccc-------------------------ccccccccccccccccccccccccccccc
Confidence 2222222111100 000011122223 3444444444332110 0000 1112
Q ss_pred CCcEEEeecceeccc----CCcccccccccCeeecccccccCC--------CCCcCCCCCeEeccCccccCC----CCcc
Q 046199 418 NLTTLHLGNNQLSGS----IPITVGRLNTLQGLGLENNKLEGP--------IPDDLCQLSELHVDHNKLSGP----IPAC 481 (902)
Q Consensus 418 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--------~p~~l~~L~~L~L~~N~l~~~----~p~~ 481 (902)
....+++..+.+... ....+...+.++.+++++|++... .......++.+++++|.+... ....
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 344555555544321 112233455666666666654321 112233677778887777543 2234
Q ss_pred ccCCCcCceEecCCCCccCcccccc-----cCCCCceEEEcCCCccCCCCcccc----ccccccceeccCCcccccc---
Q 046199 482 FGNLNSLRNLSLGSNELSSFIPSTF-----WNLNNILSFDFSSNSLNGSLPLDI----GNMKVVVEINLSRNYLTGD--- 549 (902)
Q Consensus 482 ~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~--- 549 (902)
+...+.++.+++++|.++......+ .....|+.+++++|.++......+ ....+|++|+|++|+|++.
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc
Confidence 5567889999999999864322222 235689999999999885533333 3456899999999999754
Q ss_pred -Cccccc-cCCccceEEccCcccCCC----ccccccccccCCeEeCcCccccccCCcccc-----cccccccccccCCcc
Q 046199 550 -IPTTIG-GLTNLQLLSLENNRLHGP----IPESFGALTSLESLDLSVNNLSGVIPISLE-----KLVYLKDLNLSFNRL 618 (902)
Q Consensus 550 -~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~l~~N~l 618 (902)
++..+. ..+.|++|+|++|+|+.. +++.+..+++|++|||++|+|+......+. +...|+.|++++|.+
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 333343 467799999999999743 445567779999999999999865443332 334799999999998
Q ss_pred eecCC
Q 046199 619 EGEIP 623 (902)
Q Consensus 619 ~~~~p 623 (902)
....+
T Consensus 439 ~~~~~ 443 (460)
T d1z7xw1 439 SEEME 443 (460)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 85443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=6.5e-19 Score=178.77 Aligned_cols=145 Identities=26% Similarity=0.351 Sum_probs=67.6
Q ss_pred ccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccc
Q 046199 236 IGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNAS 315 (902)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 315 (902)
+..+++|+++++++|.++ .++ .+..+++|+.+++++|...+..+ +...+.++.+.++.+.+.... .+...+
T Consensus 81 l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~-----~~~~~~~~~l~~~~~~~~~~~--~~~~~~ 151 (227)
T d1h6ua2 81 LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP-----LAGLSNLQVLYLDLNQITNIS--PLAGLT 151 (227)
T ss_dssp GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGG-----GTTCTTCCEEECCSSCCCCCG--GGGGCT
T ss_pred cccccccccccccccccc-ccc-cccccccccccccccccccccch-----hccccchhhhhchhhhhchhh--hhcccc
Confidence 344444445555444444 222 24444455555555444432211 333444555555555443221 234445
Q ss_pred cccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccc
Q 046199 316 KLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITL 395 (902)
Q Consensus 316 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 395 (902)
+|+.|++++|.+.+.. .+.++++|++|++++|++++. ..++++++|++|++++|++++.. .+..++ +|
T Consensus 152 ~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-------~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~-~L 219 (227)
T d1h6ua2 152 NLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-------SPLASLPNLIEVHLKNNQISDVS--PLANTS-NL 219 (227)
T ss_dssp TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-------GGGGGCTTCCEEECTTSCCCBCG--GGTTCT-TC
T ss_pred ccccccccccccccch--hhcccccceecccCCCccCCC-------hhhcCCCCCCEEECcCCcCCCCc--ccccCC-CC
Confidence 5555555555554321 244555555555555555432 12444555555555555555332 244555 66
Q ss_pred cEEEee
Q 046199 396 EEIYLQ 401 (902)
Q Consensus 396 ~~L~L~ 401 (902)
++|+++
T Consensus 220 ~~L~ls 225 (227)
T d1h6ua2 220 FIVTLT 225 (227)
T ss_dssp CEEEEE
T ss_pred CEEEee
Confidence 666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.7e-18 Score=175.66 Aligned_cols=209 Identities=24% Similarity=0.318 Sum_probs=130.7
Q ss_pred cccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCc
Q 046199 171 NLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDEN 250 (902)
Q Consensus 171 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N 250 (902)
.+.++..++++.+.+++.+ .+..+++|++|++++|.|+++ +++..+++|++|++++|
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l---------------------~~l~~l~~L~~L~ls~n 73 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI---------------------EGVQYLNNLIGLELKDN 73 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC---------------------TTGGGCTTCCEEECCSS
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc---------------------hhHhcCCCCcEeecCCc
Confidence 3444455566666666543 345667777777777776532 34667778888888888
Q ss_pred cccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCCccccccccccEEEccCCcccCc
Q 046199 251 HLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGF 330 (902)
Q Consensus 251 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 330 (902)
++++..| +..+++|+.+++++|.++. ++ .+..+++|++++++++...+.. .+...+.+..+.++++.+...
T Consensus 74 ~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~----~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~ 144 (227)
T d1h6ua2 74 QITDLAP--LKNLTKITELELSGNPLKN-VS----AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI 144 (227)
T ss_dssp CCCCCGG--GTTCCSCCEEECCSCCCSC-CG----GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred eeecccc--ccccccccccccccccccc-cc----cccccccccccccccccccccc--hhccccchhhhhchhhhhchh
Confidence 8875433 7888999999999998872 32 3677888888888888876433 255667777888877777643
Q ss_pred ccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeeccCCCCcccCcccccccccccEEEeecCcccccCC
Q 046199 331 IPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIP 410 (902)
Q Consensus 331 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p 410 (902)
..+...++|++|++++|.+.+. ..+.++++|++|++++|++ ++.
T Consensus 145 --~~~~~~~~L~~L~l~~n~~~~~-------~~l~~l~~L~~L~Ls~n~l-------------------------~~l-- 188 (227)
T d1h6ua2 145 --SPLAGLTNLQYLSIGNAQVSDL-------TPLANLSKLTTLKADDNKI-------------------------SDI-- 188 (227)
T ss_dssp --GGGGGCTTCCEEECCSSCCCCC-------GGGTTCTTCCEEECCSSCC-------------------------CCC--
T ss_pred --hhhccccccccccccccccccc-------hhhcccccceecccCCCcc-------------------------CCC--
Confidence 2356667777777777776542 2234445555555555544 432
Q ss_pred cccCCCCCCcEEEeecceecccCCcccccccccCeeecc
Q 046199 411 KEIGNLVNLTTLHLGNNQLSGSIPITVGRLNTLQGLGLE 449 (902)
Q Consensus 411 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 449 (902)
..++++++|++|+|++|++++.. .+..+++|++|+++
T Consensus 189 ~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 189 SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 12445555555555555555322 24555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.5e-18 Score=176.40 Aligned_cols=221 Identities=17% Similarity=0.165 Sum_probs=154.0
Q ss_pred ceeeeccCCCCcccCcccccccccccEEEeecCcccccCCcccCCCCCCcEEEeecceecccC-CcccccccccCeeecc
Q 046199 371 KYIVLAENPLNGVLPSSIGNLPITLEEIYLQNCKIRGNIPKEIGNLVNLTTLHLGNNQLSGSI-PITVGRLNTLQGLGLE 449 (902)
Q Consensus 371 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~ 449 (902)
+.++.++..++ .+|+.+. .++++|+|++|+|+...+.+|.++++|++|++++|.+...+ +.+|..++.++++++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 56777777776 4555443 37788888888888666667888888888888888776543 4456667766666654
Q ss_pred cccccCCCCCcCCCCCeEeccCccccCCCCccccCCCcCceEecCCCCccCcccc-cccCCCCceEEEcCCCccCCCCcc
Q 046199 450 NNKLEGPIPDDLCQLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSSFIPS-TFWNLNNILSFDFSSNSLNGSLPL 528 (902)
Q Consensus 450 ~N~l~~~~p~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~ 528 (902)
. .|.+....+..|.++++|+++++++|++....+. .+..+..+..+..+++.+....+.
T Consensus 87 ~--------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~ 146 (242)
T d1xwdc1 87 K--------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 146 (242)
T ss_dssp C--------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTT
T ss_pred c--------------------cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccc
Confidence 3 2333345566777888888888888887764333 234456666777777777766566
Q ss_pred cccccc-ccceeccCCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccc
Q 046199 529 DIGNMK-VVVEINLSRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVY 607 (902)
Q Consensus 529 ~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 607 (902)
.|..+. .++.|++++|+++...+..|.....++.+++++|+|+...+..|.++++|+.|||++|+|+...+..|.++++
T Consensus 147 ~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 226 (242)
T d1xwdc1 147 SFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 226 (242)
T ss_dssp SSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCE
T ss_pred ccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcc
Confidence 666654 6778888888888555555544333444567888888655667888999999999999998665667888888
Q ss_pred cccccccC
Q 046199 608 LKDLNLSF 615 (902)
Q Consensus 608 L~~L~l~~ 615 (902)
|+.+++.+
T Consensus 227 L~~l~~~~ 234 (242)
T d1xwdc1 227 LRARSTYN 234 (242)
T ss_dssp EESSSEES
T ss_pred cccCcCCC
Confidence 88887754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.7e-18 Score=170.45 Aligned_cols=179 Identities=22% Similarity=0.283 Sum_probs=148.3
Q ss_pred CCCeEeccCccccCCCCccccCCCcCceEecCCCCccC-cccccccCCCCceEEEcCCCccCCCCccccccccccceecc
Q 046199 463 QLSELHVDHNKLSGPIPACFGNLNSLRNLSLGSNELSS-FIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINL 541 (902)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L 541 (902)
+.+.++.++++++. +|..+- +++++|+|++|+|++ ..+..|.++++|+.|++++|.+++..+..|..+++|++|+|
T Consensus 9 ~~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 45789999999995 555442 579999999999986 44667899999999999999999999999999999999999
Q ss_pred CCccccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccccCCcccccccccccccccCCcceec
Q 046199 542 SRNYLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSGVIPISLEKLVYLKDLNLSFNRLEGE 621 (902)
Q Consensus 542 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 621 (902)
++|+|++..|..|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+....+.. .-...++.+.+..|.+++.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeC
Confidence 999999888899999999999999999999888899999999999999999998644322 2234577888899999988
Q ss_pred CCCCCcccccccccccCCcccCCCCC
Q 046199 622 IPSGGSFANFSAQSFMGNDLLCGSPH 647 (902)
Q Consensus 622 ~p~~~~~~~~~~~~~~~n~~lc~~~~ 647 (902)
.|. .+....-..+..|..-|..+-
T Consensus 165 ~p~--~l~~~~l~~L~~n~l~C~~~~ 188 (192)
T d1w8aa_ 165 APS--KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp SST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred CCh--hhcCCEeeecCHhhCcCCCCC
Confidence 885 345555556777777776553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.1e-18 Score=172.39 Aligned_cols=185 Identities=26% Similarity=0.348 Sum_probs=127.5
Q ss_pred CccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccc
Q 046199 149 TKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLW 228 (902)
Q Consensus 149 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~ 228 (902)
.+....+++.+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|+|+++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l---------------- 83 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI---------------- 83 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC----------------
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc----------------
Confidence 3445566777777755543 356788888888888873 33 377788888888888886632
Q ss_pred ccCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccCccCCCCCC
Q 046199 229 QCEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGLNNLSGRIP 308 (902)
Q Consensus 229 ~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 308 (902)
..++.+++|++|++++|++++ +| .+..+++|+.|++++|.+.. ++ .+..+++++.+++++|.+++.
T Consensus 84 -----~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~----~l~~l~~l~~l~~~~n~l~~~-- 149 (210)
T d1h6ta2 84 -----KPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN----GLVHLPQLESLYLGNNKITDI-- 149 (210)
T ss_dssp -----GGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG----GGGGCTTCCEEECCSSCCCCC--
T ss_pred -----cccccCccccccccccccccc-cc-cccccccccccccccccccc-cc----ccccccccccccccccccccc--
Confidence 245677888888888888873 44 47778888888888887762 22 266677788888888877642
Q ss_pred ccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCCCcccccccccCCCCCceeeec
Q 046199 309 GFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSSTPELSFLSSLANSSSSKYIVLA 376 (902)
Q Consensus 309 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~l~~l~~L~~L~Ls 376 (902)
..+..+++|+++++++|++++.. .+.++++|++|++++|++++. +.+.++++|++|+|+
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l-------~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDL-------RALAGLKNLDVLELF 208 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-------GGGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCC-------hhhcCCCCCCEEEcc
Confidence 34566777888888888777542 267777777777777777642 235556666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.1e-18 Score=170.25 Aligned_cols=184 Identities=23% Similarity=0.379 Sum_probs=118.1
Q ss_pred CCeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcC
Q 046199 70 LQTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLT 149 (902)
Q Consensus 70 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~ 149 (902)
....+++.+.+++.++. ..+..|++|++++|.+++. +. ++.+++|++|++++|++++ +| .++.++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~~--l~~l~~L~~L~L~~n~i~~---------l~-~~~~l~ 90 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-QG--IQYLPNVTKLFLNGNKLTD---------IK-PLANLK 90 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-TT--GGGCTTCCEEECCSSCCCC---------CG-GGTTCT
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-hh--HhhCCCCCEEeCCCccccC---------cc-ccccCc
Confidence 33445555555544432 2455666666666666542 22 4566666777777666653 33 356677
Q ss_pred ccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCccccccc
Q 046199 150 KLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQ 229 (902)
Q Consensus 150 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~ 229 (902)
+|++|++++|+++ .+| .+..+++|+.|++++|.+. .++ .+.++++|+.+++++|.+++.
T Consensus 91 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~----------------- 149 (210)
T d1h6ta2 91 NLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI----------------- 149 (210)
T ss_dssp TCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC-----------------
T ss_pred ccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccccccccccc-----------------
Confidence 7777777777777 355 4677777777777777766 333 467777777777777775531
Q ss_pred cCCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCcccceeeccC
Q 046199 230 CEIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERLNLGL 300 (902)
Q Consensus 230 ~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~ 300 (902)
..+..+++|+++++++|++++ ++ .+.++++|+.|+|++|+++. +| .+.++++|++|+|++
T Consensus 150 ----~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~----~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 150 ----TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR----ALAGLKNLDVLELFS 209 (210)
T ss_dssp ----GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG----GGTTCTTCSEEEEEE
T ss_pred ----ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch----hhcCCCCCCEEEccC
Confidence 345566777788888887774 33 26777788888888887763 33 266777888887764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=9.5e-18 Score=171.96 Aligned_cols=218 Identities=19% Similarity=0.152 Sum_probs=122.1
Q ss_pred cEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCC-hhhhccCc
Q 046199 120 RAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIP-SSIFNLSS 198 (902)
Q Consensus 120 ~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~ 198 (902)
+++++++..++ .+|..+. +++++|+|++|+++...+..|.++++|++|+|++|.+...+| ..|.++++
T Consensus 11 ~~i~c~~~~l~---------~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~ 79 (242)
T d1xwdc1 11 RVFLCQESKVT---------EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79 (242)
T ss_dssp SEEEEESCSCS---------SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred CEEEEeCCCCC---------CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccc
Confidence 67888877776 2555442 467888888888873333457778888888888887765443 45677777
Q ss_pred ccEEeeee-CCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCcCCC-cccCCCCCceEeccCccc
Q 046199 199 LLELDFSN-NSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVPN-TIFNMSTLKALSLLNNTL 276 (902)
Q Consensus 199 L~~L~Ls~-N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l 276 (902)
+++|++.. |.+..+ .+..|..+++|+.|++++|++....+. .+..+..++.+..+++.+
T Consensus 80 l~~l~~~~~n~l~~~-------------------~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l 140 (242)
T d1xwdc1 80 LHEIRIEKANNLLYI-------------------NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140 (242)
T ss_dssp CCEEEEECCTTCCEE-------------------CTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTC
T ss_pred ccccccccccccccc-------------------ccccccccccccccccchhhhccccccccccccccccccccccccc
Confidence 77777654 444321 135566777777777777777633221 233455555555566665
Q ss_pred ccCCCcCCcccCCCc-ccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCCCCC
Q 046199 277 SGSLPSSSKNLIGLP-NIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLTSST 355 (902)
Q Consensus 277 ~~~~p~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 355 (902)
...-+.. +.+++ .++.|++++|+++...+..+.....++.+++++|+++...+..|.++++|++|++++|+|+..+
T Consensus 141 ~~i~~~~---~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 217 (242)
T d1xwdc1 141 HTIERNS---FVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217 (242)
T ss_dssp CEECTTS---STTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCC
T ss_pred ccccccc---cccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccC
Confidence 5332222 33332 5555666666665433333322222233344555555444444555556666666555555443
Q ss_pred CcccccccccCCCCCceeee
Q 046199 356 PELSFLSSLANSSSSKYIVL 375 (902)
Q Consensus 356 ~~~~~l~~l~~l~~L~~L~L 375 (902)
+ ..+.++++|+++++
T Consensus 218 ~-----~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 218 S-----YGLENLKKLRARST 232 (242)
T ss_dssp S-----SSCTTCCEEESSSE
T ss_pred H-----HHHcCCcccccCcC
Confidence 3 33444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.1e-17 Score=163.61 Aligned_cols=179 Identities=24% Similarity=0.381 Sum_probs=106.9
Q ss_pred CeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCc
Q 046199 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTK 150 (902)
Q Consensus 71 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~ 150 (902)
..++++.+.+++.++ ...+.++++|++++|.++. ++. ++.+++|++||+++|++++ ++. ++++++
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~--l~~l~nL~~L~Ls~N~l~~---------~~~-l~~l~~ 85 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDG--VEYLNNLTQINFSNNQLTD---------ITP-LKNLTK 85 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCC---------CGG-GTTCTT
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-ccc--cccCCCcCcCccccccccC---------ccc-ccCCcc
Confidence 344455555543322 2344555555555555542 221 3455566666666665542 332 666777
Q ss_pred cceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccccCCcccccccc
Q 046199 151 LKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHFTGSIPRNLWQC 230 (902)
Q Consensus 151 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~ 230 (902)
|++|++++|.+. .+| .++.+++|+.|++++|.+... ..+..+++|+.|++++|++..+
T Consensus 86 L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~------------------ 143 (199)
T d2omxa2 86 LVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI------------------ 143 (199)
T ss_dssp CCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC------------------
T ss_pred cccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc------------------
Confidence 777777777766 344 366777777777777776632 2366677777777777765421
Q ss_pred CCCccccCCCCCCEEEccCccccCcCCCcccCCCCCceEeccCcccccCCCcCCcccCCCccccee
Q 046199 231 EIPHEIGNLPNLEVLGIDENHLVGDVPNTIFNMSTLKALSLLNNTLSGSLPSSSKNLIGLPNIERL 296 (902)
Q Consensus 231 ~lp~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L 296 (902)
+.+..+++|+.|++++|++++. + .++++++|++|++++|+++. ++ . +.++++|++|
T Consensus 144 ---~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~---l~~L~~L~~L 199 (199)
T d2omxa2 144 ---SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-V---LAKLTNLESL 199 (199)
T ss_dssp ---GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-G---GGGCTTCSEE
T ss_pred ---ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-c---ccCCCCCCcC
Confidence 3456677777777777777643 2 36777777777777777763 32 1 5566666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.6e-17 Score=162.86 Aligned_cols=60 Identities=30% Similarity=0.453 Sum_probs=25.9
Q ss_pred CCcccceeeccCccCCCCCCccccccccccEEEccCCcccCcccccccccccccEEecccccCC
Q 046199 289 GLPNIERLNLGLNNLSGRIPGFIFNASKLFLLELTGNSFSGFIPDTLVNLRNLEHLGLGYNYLT 352 (902)
Q Consensus 289 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 352 (902)
.+++|+.|++++|++.. + +.+..+++|+.|++++|++++.. .+.++++|++|++++|+++
T Consensus 126 ~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 126 NLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp TCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred hhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 34444444444444432 1 12334444444444444444321 2444455555555555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=7.4e-15 Score=132.18 Aligned_cols=78 Identities=28% Similarity=0.367 Sum_probs=42.2
Q ss_pred cEEEcccCcccCcCCcchhccCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcc
Q 046199 120 RAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSL 199 (902)
Q Consensus 120 ~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 199 (902)
++|||++|+++. +| .++.+++|++|++++|+++ .+|+.++.+++|++|++++|+++ .+| .+.++++|
T Consensus 1 R~L~Ls~n~l~~---------l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L 67 (124)
T d1dcea3 1 RVLHLAHKDLTV---------LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 67 (124)
T ss_dssp SEEECTTSCCSS---------CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSC
T ss_pred CEEEcCCCCCCC---------Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-cccccccc
Confidence 345666665541 32 3555555666666666655 45555555555555555555555 333 25555555
Q ss_pred cEEeeeeCCCC
Q 046199 200 LELDFSNNSLT 210 (902)
Q Consensus 200 ~~L~Ls~N~l~ 210 (902)
++|++++|+|+
T Consensus 68 ~~L~l~~N~i~ 78 (124)
T d1dcea3 68 QELLLCNNRLQ 78 (124)
T ss_dssp CEEECCSSCCC
T ss_pred CeEECCCCccC
Confidence 55555555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=5.1e-16 Score=162.58 Aligned_cols=160 Identities=18% Similarity=0.172 Sum_probs=72.5
Q ss_pred ccCcCccceeeecccccCCCCchhhccccccceeecccC-cCCCC-CChhhhccCcccEEeeeeCC-CCccccccccccC
Q 046199 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRS-FLTGT-IPSSIFNLSSLLELDFSNNS-LTGFYMTNNHFTG 221 (902)
Q Consensus 145 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~g 221 (902)
+.++++|++|+|+++.+++..+..++.+++|++|+|++| .++.. +...+.++++|++|+++++. +++-
T Consensus 67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~--------- 137 (284)
T d2astb2 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK--------- 137 (284)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH---------
T ss_pred HHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccc---------
Confidence 344455555555555555444455555555555555553 33311 11122345555555555532 2110
Q ss_pred CccccccccCCCccccC-CCCCCEEEccCcc--ccC-cCCCcccCCCCCceEeccCcc-cccCCCcCCcccCCCccccee
Q 046199 222 SIPRNLWQCEIPHEIGN-LPNLEVLGIDENH--LVG-DVPNTIFNMSTLKALSLLNNT-LSGSLPSSSKNLIGLPNIERL 296 (902)
Q Consensus 222 ~ip~~~~~~~lp~~l~~-l~~L~~L~Ls~N~--l~~-~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~l~~L~~L 296 (902)
.++..+.. .++|+.|+++++. ++. .+.....++++|++|++++|. +++.... .+..+++|++|
T Consensus 138 ---------~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~---~l~~~~~L~~L 205 (284)
T d2astb2 138 ---------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ---EFFQLNYLQHL 205 (284)
T ss_dssp ---------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG---GGGGCTTCCEE
T ss_pred ---------cchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhh---hhcccCcCCEE
Confidence 00011111 2345555555432 221 111222345556666665542 4332222 24455666666
Q ss_pred eccCc-cCCCCCCccccccccccEEEccCC
Q 046199 297 NLGLN-NLSGRIPGFIFNASKLFLLELTGN 325 (902)
Q Consensus 297 ~Ls~N-~l~~~~~~~l~~l~~L~~L~Ls~N 325 (902)
++++| .+++.....++++++|+.|+++++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66663 454444445556666666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=8.3e-15 Score=131.84 Aligned_cols=102 Identities=24% Similarity=0.325 Sum_probs=68.4
Q ss_pred CeeeccccccccCCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCc
Q 046199 71 QTLDLSHNRFSGTIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTK 150 (902)
Q Consensus 71 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~ 150 (902)
|.|||++|+++ .+|. +.++++|++||+++|+++. +|+.++.+++
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~~----------------------------------lp~~~~~l~~ 44 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA----------------------------------LPPALAALRC 44 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCC----------------------------------CCGGGGGCTT
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccCc----------------------------------chhhhhhhhc
Confidence 45677777776 5553 6667777777777777652 5666666777
Q ss_pred cceeeecccccCCCCchhhccccccceeecccCcCCCCC-ChhhhccCcccEEeeeeCCCC
Q 046199 151 LKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTI-PSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 151 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
|++|++++|+++ .+| .++.+++|++|++++|+++... ...+..+++|++|++++|.++
T Consensus 45 L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 45 LEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 777777777776 344 3677777777777777776322 245677777777777777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6.3e-16 Score=161.84 Aligned_cols=86 Identities=20% Similarity=0.137 Sum_probs=39.1
Q ss_pred CCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcchhccCcccccCcCccceeeeccc-ccCCC-Cch
Q 046199 90 SISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANIFRAIPKDIGNLTKLKELYLGYN-KLQGE-IPQ 167 (902)
Q Consensus 90 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~~~~ip~~~~~l~~L~~L~L~~n-~l~~~-~p~ 167 (902)
...+|++|||++|.++......++.++++|++|+++++.+++. .+..++.+++|++|+|+++ .++.. +..
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~--------~~~~l~~~~~L~~L~Ls~c~~itd~~l~~ 115 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDP--------IVNTLAKNSNLVRLNLSGCSGFSEFALQT 115 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHH--------HHHHHTTCTTCSEEECTTCBSCCHHHHHH
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcH--------HHHHHhcCCCCcCccccccccccccccch
Confidence 3345555555555554433333444555555555555554422 2334444555555555553 33311 112
Q ss_pred hhccccccceeecccC
Q 046199 168 ELGNLAELEWLSLPRS 183 (902)
Q Consensus 168 ~l~~l~~L~~L~L~~n 183 (902)
.+..+++|++|+++++
T Consensus 116 l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 116 LLSSCSRLDELNLSWC 131 (284)
T ss_dssp HHHHCTTCCEEECCCC
T ss_pred hhHHHHhccccccccc
Confidence 2234455555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=8.2e-15 Score=138.79 Aligned_cols=127 Identities=20% Similarity=0.173 Sum_probs=100.1
Q ss_pred ccCCCcCceEecCCCCccCcccccccCCCCceEEEcCCCccCCCCccccccccccceeccCCccccccCccccccCCccc
Q 046199 482 FGNLNSLRNLSLGSNELSSFIPSTFWNLNNILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQ 561 (902)
Q Consensus 482 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 561 (902)
|.+..++++|+|++|+|+.+ +..+..+++|+.||+++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 56777888888888888875 5667778888888888888884 3 3577888888999999998866666677889999
Q ss_pred eEEccCcccCCCcc-ccccccccCCeEeCcCccccccCC----ccccccccccccc
Q 046199 562 LLSLENNRLHGPIP-ESFGALTSLESLDLSVNNLSGVIP----ISLEKLVYLKDLN 612 (902)
Q Consensus 562 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~ 612 (902)
.|++++|+|+.... ..+..+++|+.|++++|+++. .| ..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 99999999884322 467888999999999998874 34 2467788888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.2e-14 Score=137.61 Aligned_cols=63 Identities=21% Similarity=0.214 Sum_probs=33.1
Q ss_pred cCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 146 GNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 146 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
..+++|++|||++|+++ .++ .+..+++|++|++++|+++...+..+..+++|++|++++|+|+
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~ 100 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred cccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc
Confidence 34455555555555555 332 3455555555555555555333333445555566666555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.3e-15 Score=164.71 Aligned_cols=255 Identities=21% Similarity=0.148 Sum_probs=134.4
Q ss_pred cCcccCCCCCCCeeecccccccc----CCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCc
Q 046199 60 ISSQLGNLSSLQTLDLSHNRFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPA 135 (902)
Q Consensus 60 ~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~ 135 (902)
+...+...+.|++|+|++|++.. .+-..+...++|+.|+++++..... ... .+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~-~~~---------------------~~- 79 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRV-KDE---------------------IP- 79 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSC-GGG---------------------SH-
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccccc-ccc---------------------cc-
Confidence 44456667777777777777642 2333455667777777776654321 000 00
Q ss_pred chhccCcccccCcCccceeeecccccCCC----CchhhccccccceeecccCcCCCCCChh-------------hhccCc
Q 046199 136 NIFRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELGNLAELEWLSLPRSFLTGTIPSS-------------IFNLSS 198 (902)
Q Consensus 136 ~~~~~ip~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~-------------~~~l~~ 198 (902)
..+..+...+...++|++|+|++|.++.. +...+...++|++|++++|.+...-... ....+.
T Consensus 80 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~ 159 (344)
T d2ca6a1 80 EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP 159 (344)
T ss_dssp HHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred hHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcc
Confidence 11122334455566777777777777643 2334445667777777777664211111 123456
Q ss_pred ccEEeeeeCCCCccccccccccCCccccccccCCCccccCCCCCCEEEccCccccCc-----CCCcccCCCCCceEeccC
Q 046199 199 LLELDFSNNSLTGFYMTNNHFTGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGD-----VPNTIFNMSTLKALSLLN 273 (902)
Q Consensus 199 L~~L~Ls~N~l~~~~~~~~~~~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~ 273 (902)
|+.|++++|.++.-.. ..+...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++
T Consensus 160 L~~l~l~~n~i~~~~~---------------~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~ 224 (344)
T d2ca6a1 160 LRSIICGRNRLENGSM---------------KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 224 (344)
T ss_dssp CCEEECCSSCCTGGGH---------------HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCS
T ss_pred cceeeccccccccccc---------------ccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccc
Confidence 7777777777542100 01123455566777888877777531 334456667777777777
Q ss_pred cccccCCCcC-CcccCCCcccceeeccCccCCCCCCccc----c--ccccccEEEccCCcccCcccc----ccc-ccccc
Q 046199 274 NTLSGSLPSS-SKNLIGLPNIERLNLGLNNLSGRIPGFI----F--NASKLFLLELTGNSFSGFIPD----TLV-NLRNL 341 (902)
Q Consensus 274 N~l~~~~p~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~l----~--~l~~L~~L~Ls~N~l~~~~p~----~l~-~l~~L 341 (902)
|.++..-... ...+..+++|++|+|++|.|++.....+ . ....|++|++++|+|...... .+. ++++|
T Consensus 225 N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L 304 (344)
T d2ca6a1 225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304 (344)
T ss_dssp SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred ccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCC
Confidence 7765221000 0124455666666666666653221112 1 123466666666665432211 121 34455
Q ss_pred cEEecccccCC
Q 046199 342 EHLGLGYNYLT 352 (902)
Q Consensus 342 ~~L~Ls~N~l~ 352 (902)
++|++++|++.
T Consensus 305 ~~L~l~~N~~~ 315 (344)
T d2ca6a1 305 LFLELNGNRFS 315 (344)
T ss_dssp CEEECTTSBSC
T ss_pred CEEECCCCcCC
Confidence 55666555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=5.9e-15 Score=159.35 Aligned_cols=38 Identities=26% Similarity=0.284 Sum_probs=23.2
Q ss_pred CccceEEccCcccCCCc----ccccc-ccccCCeEeCcCcccc
Q 046199 558 TNLQLLSLENNRLHGPI----PESFG-ALTSLESLDLSVNNLS 595 (902)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~ 595 (902)
..|+.|++++|+|+... ...+. .+++|+.|+|++|++.
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 45677777777765322 22232 4567777777777775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=7.1e-15 Score=144.35 Aligned_cols=63 Identities=27% Similarity=0.309 Sum_probs=32.1
Q ss_pred ccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCC
Q 046199 145 IGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLT 210 (902)
Q Consensus 145 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 210 (902)
++.+++|++|+|++|.++ .+|..+..+++|++|++++|+++ .++ .+.++++|++|++++|+|+
T Consensus 66 l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC
T ss_pred ccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhc
Confidence 444455555555555554 44444444445555555555555 222 2455555555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=5.3e-15 Score=145.29 Aligned_cols=118 Identities=25% Similarity=0.316 Sum_probs=91.0
Q ss_pred cCcccccCcCccceeeecccccCCCCchhhccccccceeecccCcCCCCCChhhhccCcccEEeeeeCCCCccccccccc
Q 046199 140 AIPKDIGNLTKLKELYLGYNKLQGEIPQELGNLAELEWLSLPRSFLTGTIPSSIFNLSSLLELDFSNNSLTGFYMTNNHF 219 (902)
Q Consensus 140 ~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 219 (902)
.+|.+++.+++|++|+|++|+|+ .++ .+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|+++
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l------- 108 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL------- 108 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-------
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-------
Confidence 46778888889999999999988 565 5888899999999999887 6676666677889999998887642
Q ss_pred cCCccccccccCCCccccCCCCCCEEEccCccccCcCC-CcccCCCCCceEeccCcccccCCC
Q 046199 220 TGSIPRNLWQCEIPHEIGNLPNLEVLGIDENHLVGDVP-NTIFNMSTLKALSLLNNTLSGSLP 281 (902)
Q Consensus 220 ~g~ip~~~~~~~lp~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 281 (902)
+.+..+++|++|+|++|+++.... ..+..+++|+.|+|++|.+....+
T Consensus 109 --------------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 109 --------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp --------------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred --------------ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 346677888888888888874321 357788888888888888764433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.1e-12 Score=121.01 Aligned_cols=109 Identities=19% Similarity=0.192 Sum_probs=76.8
Q ss_pred ceEEEcCCCccCCCCccccccccccceeccCCc-cccccCccccccCCccceEEccCcccCCCccccccccccCCeEeCc
Q 046199 512 ILSFDFSSNSLNGSLPLDIGNMKVVVEINLSRN-YLTGDIPTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLS 590 (902)
Q Consensus 512 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 590 (902)
...++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+++.|.+|..+++|++|||+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344566666665 34566666777777777655 4776666778888888888888888887667778888888888888
Q ss_pred CccccccCCcccccccccccccccCCcceecC
Q 046199 591 VNNLSGVIPISLEKLVYLKDLNLSFNRLEGEI 622 (902)
Q Consensus 591 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 622 (902)
+|+|+...+..+.. .+|+.|+|++|+|.+.+
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCCCCG
T ss_pred CCCCcccChhhhcc-ccccccccCCCcccCCc
Confidence 88888444444443 46888888888887544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=8.4e-12 Score=116.83 Aligned_cols=133 Identities=16% Similarity=0.039 Sum_probs=72.2
Q ss_pred ceEecCCCCccCcccccccCCCCceEEEcCCC-ccCCCCccccccccccceeccCCccccccCccccccCCccceEEccC
Q 046199 489 RNLSLGSNELSSFIPSTFWNLNNILSFDFSSN-SLNGSLPLDIGNMKVVVEINLSRNYLTGDIPTTIGGLTNLQLLSLEN 567 (902)
Q Consensus 489 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (902)
+.++.+++.+.. .|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 334444444443 2444445555555555443 35544445566666666666666666666666777777777777777
Q ss_pred cccCCCccccccccccCCeEeCcCcccccc-CCcccccccccccccccCCcceecCC
Q 046199 568 NRLHGPIPESFGALTSLESLDLSVNNLSGV-IPISLEKLVYLKDLNLSFNRLEGEIP 623 (902)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p 623 (902)
|+|+...+..|..+ +|+.|+|++|.+.-. .-.++..........+..+.+++.-|
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p 145 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred CCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcC
Confidence 77774444444443 577777777776411 11122222222333444555655555
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.2e-07 Score=96.56 Aligned_cols=144 Identities=15% Similarity=0.103 Sum_probs=103.1
Q ss_pred cccccccCeecccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEEEc
Q 046199 725 TDHFSEKSLIGIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVLEY 803 (902)
Q Consensus 725 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 803 (902)
...|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+++++++...++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34566666555555678999864 67778899887665555567888999888774 44578888888888999999999
Q ss_pred cCCCChHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------
Q 046199 804 MANGSLEKCLYSSNRSLDIFQRLSIMIDVALALEYLHFG----------------------------------------- 842 (902)
Q Consensus 804 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------------------------------------- 842 (902)
++|.++.+..... .....++.++++.+..||..
T Consensus 92 l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9998876544211 11233455666666666620
Q ss_pred ---------------CCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 843 ---------------YSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 843 ---------------~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012479999999999999876677999998865
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=6e-09 Score=97.66 Aligned_cols=64 Identities=28% Similarity=0.228 Sum_probs=28.5
Q ss_pred ccccceeccCCccccccC--ccccccCCccceEEccCcccCCCccccccccccCCeEeCcCccccc
Q 046199 533 MKVVVEINLSRNYLTGDI--PTTIGGLTNLQLLSLENNRLHGPIPESFGALTSLESLDLSVNNLSG 596 (902)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (902)
++.|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|+++.
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 444444444444444221 2334445555555555555553222222233345555555555543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=6.7e-09 Score=97.34 Aligned_cols=16 Identities=44% Similarity=0.540 Sum_probs=8.0
Q ss_pred CCCCCceEeccCcccc
Q 046199 262 NMSTLKALSLLNNTLS 277 (902)
Q Consensus 262 ~l~~L~~L~Ls~N~l~ 277 (902)
.+++|++|+|++|+|+
T Consensus 63 ~~~~L~~L~Ls~N~i~ 78 (162)
T d1koha1 63 NIPELLSLNLSNNRLY 78 (162)
T ss_dssp HCTTCCCCCCCSSCCC
T ss_pred hCCCCCEeeCCCcccc
Confidence 4445555555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=2.4e-06 Score=86.05 Aligned_cols=131 Identities=18% Similarity=0.128 Sum_probs=88.7
Q ss_pred eecccc-eeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCC--CCCccceeeeeecCCeeEEEEEccCCCCh
Q 046199 733 LIGIGS-FGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVR--HRNLVKIISSCSNGNFKALVLEYMANGSL 809 (902)
Q Consensus 733 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 809 (902)
.+..|. -+.||+....++..+++|..... ....+..|++.++.+. .-.+++++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 36799998877888999976543 3356778888888774 33467888888888899999999998665
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 046199 810 EKCLYSSNRSLDIFQRLSIMIDVALALEYLHF------------------------------------------------ 841 (902)
Q Consensus 810 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------------ 841 (902)
.+.. ... ...+.++...+.-||.
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3310 111 1122233333333331
Q ss_pred -------cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 842 -------GYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 842 -------~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0122479999999999999876678999999865
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=7.5e-05 Score=79.80 Aligned_cols=76 Identities=16% Similarity=0.102 Sum_probs=50.4
Q ss_pred cCeecccceeeEEEEEeCC-CcEEEEEEeeec-------cchhhhhHHHHHHHHHhCC-C--CCccceeeeeecCCeeEE
Q 046199 731 KSLIGIGSFGTVYKGRFLD-GMEVAIKVFHLQ-------FDGALKSFDAECEVLKSVR-H--RNLVKIISSCSNGNFKAL 799 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 799 (902)
.+.||.|....||++...+ ++.|++|..... .+....+...|.+.++.+. + ..+++++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 4468999999999998755 678999975421 1123355677888887663 2 3466676654 344579
Q ss_pred EEEccCCCC
Q 046199 800 VLEYMANGS 808 (902)
Q Consensus 800 v~e~~~~g~ 808 (902)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.46 E-value=2.5e-05 Score=72.67 Aligned_cols=109 Identities=16% Similarity=0.166 Sum_probs=49.4
Q ss_pred CCcCceEecCCC-CccCc----ccccccCCCCceEEEcCCCccCCC----CccccccccccceeccCCccccccC----c
Q 046199 485 LNSLRNLSLGSN-ELSSF----IPSTFWNLNNILSFDFSSNSLNGS----LPLDIGNMKVVVEINLSRNYLTGDI----P 551 (902)
Q Consensus 485 l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p 551 (902)
.++|++|+|+++ .++.. +...+...+.|++|++++|.++.. +...+...+.|++|+|++|.|+... -
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355666666543 34321 112334445566666666555421 1112223344555555555554321 1
Q ss_pred cccccCCccceEEccCcccCCC-------ccccccccccCCeEeCcCcc
Q 046199 552 TTIGGLTNLQLLSLENNRLHGP-------IPESFGALTSLESLDLSVNN 593 (902)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 593 (902)
..+...+.|++|+|++|++... +...+...++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2333445566666666554321 12223334555666555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=2.3e-05 Score=72.95 Aligned_cols=41 Identities=12% Similarity=0.260 Sum_probs=23.0
Q ss_pred CCCCCCCeeecccc-cccc----CCCccccCCCcceEEEecCcccc
Q 046199 65 GNLSSLQTLDLSHN-RFSG----TIPSSIFSISTLKILILGDNQLS 105 (902)
Q Consensus 65 ~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~ls~n~l~ 105 (902)
.+.++|++|+|+++ .++. .+-..+...+.|++|+|++|.+.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 34566777777753 3431 12223445566777777777665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.03 E-value=0.001 Score=68.68 Aligned_cols=133 Identities=14% Similarity=0.138 Sum_probs=78.6
Q ss_pred eeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCCc--ccee-----eeeecCCeeEEEEEccCCCChH--
Q 046199 740 GTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRNL--VKII-----SSCSNGNFKALVLEYMANGSLE-- 810 (902)
Q Consensus 740 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~-- 810 (902)
-.||+++..+|+.|++|+.+... ...+++..|...+..+....+ +... ..+..++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999899999999987542 234667788888887742222 2111 1234567789999999874321
Q ss_pred ---HH------H---hh----C----CCCCCHH----------------------HHHHHHHHHHHHHHHH-HccCCCCe
Q 046199 811 ---KC------L---YS----S----NRSLDIF----------------------QRLSIMIDVALALEYL-HFGYSNPV 847 (902)
Q Consensus 811 ---~~------l---~~----~----~~~~~~~----------------------~~~~i~~qi~~~L~~L-H~~~~~~i 847 (902)
.+ + +. . ....+.. .....+.++...+.-. ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 0 00 0 0111111 1112222232222221 11224689
Q ss_pred EEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 848 VHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 848 vHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
||+|+.|.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.79 E-value=5.7e-05 Score=70.05 Aligned_cols=117 Identities=15% Similarity=0.157 Sum_probs=59.3
Q ss_pred ccCCCCCCCeeeccc-ccccc----CCCccccCCCcceEEEecCccccCCCCcccccCCCcccEEEcccCcccCcCCcch
Q 046199 63 QLGNLSSLQTLDLSH-NRFSG----TIPSSIFSISTLKILILGDNQLSGSFPSFIISNTSSLRAIDCNYNSLSGELPANI 137 (902)
Q Consensus 63 ~l~~l~~L~~L~Ls~-n~l~~----~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~L~~ldls~n~l~~~~~~~~ 137 (902)
...+.+.|++|+|++ +.++. .+-..+...++|++|+|++|.++..--
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~---------------------------- 63 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVA---------------------------- 63 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHH----------------------------
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHH----------------------------
Confidence 344566777777776 44541 122334456677777777776653210
Q ss_pred hccCcccccCcCccceeeecccccCCC----Cchhhccccccceeec--ccCcCCC----CCChhhhccCcccEEeeeeC
Q 046199 138 FRAIPKDIGNLTKLKELYLGYNKLQGE----IPQELGNLAELEWLSL--PRSFLTG----TIPSSIFNLSSLLELDFSNN 207 (902)
Q Consensus 138 ~~~ip~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L--~~n~l~~----~~p~~~~~l~~L~~L~Ls~N 207 (902)
..+-+.+...+.++.|++++|.+... +-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+
T Consensus 64 -~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 64 -FALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp -HHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred -HHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 11222333345566666666555422 2233444555554333 3445532 23334455667777776655
Q ss_pred C
Q 046199 208 S 208 (902)
Q Consensus 208 ~ 208 (902)
.
T Consensus 143 ~ 143 (166)
T d1io0a_ 143 Q 143 (166)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.73 E-value=0.0027 Score=65.13 Aligned_cols=156 Identities=13% Similarity=0.088 Sum_probs=84.3
Q ss_pred CHHHHHhhcccccccCee-----cccceeeEEEEEeCCCcEEEEEEeeeccchhhhhHHHHHHHHHhCCCCC--ccceee
Q 046199 717 SYRELLLATDHFSEKSLI-----GIGSFGTVYKGRFLDGMEVAIKVFHLQFDGALKSFDAECEVLKSVRHRN--LVKIIS 789 (902)
Q Consensus 717 ~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 789 (902)
+.+++.....+|.+.+.. ..|---+.|+++..+| .|++|++.... ..+.+..|.+++..+.... ++....
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 445565566677765444 3555577899987555 58999986432 2355666777777774322 222221
Q ss_pred ------eeecCCeeEEEEEccCCCChHH-----H---------Hhh----CC----CCCCHH------------------
Q 046199 790 ------SCSNGNFKALVLEYMANGSLEK-----C---------LYS----SN----RSLDIF------------------ 823 (902)
Q Consensus 790 ------~~~~~~~~~lv~e~~~~g~L~~-----~---------l~~----~~----~~~~~~------------------ 823 (902)
+....+..+.++.++.+..... . ++. .. ......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1233456667777777643311 0 000 00 000000
Q ss_pred HHHHHHHHHHHHHHHHH-ccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 046199 824 QRLSIMIDVALALEYLH-FGYSNPVVHCDIKPSNILLDDDMVAHLSDFGIAKL 875 (902)
Q Consensus 824 ~~~~i~~qi~~~L~~LH-~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 875 (902)
.....+......+...+ .....|+||+|+.++||+++.+...-++||+.|..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 01112222222222222 12357899999999999999987778999998854
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.63 E-value=7.8e-05 Score=69.11 Aligned_cols=111 Identities=14% Similarity=0.198 Sum_probs=48.9
Q ss_pred cCCCcCceEecCC-CCccCc----ccccccCCCCceEEEcCCCccCCCCc----cccccccccceeccCCcccccc----
Q 046199 483 GNLNSLRNLSLGS-NELSSF----IPSTFWNLNNILSFDFSSNSLNGSLP----LDIGNMKVVVEINLSRNYLTGD---- 549 (902)
Q Consensus 483 ~~l~~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~---- 549 (902)
.+.++|++|+|++ +.++.. +..++...+.|++|++++|.++.... ..+...+.++.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456666666665 344322 11233455566666666665543211 1122234445555555544322
Q ss_pred CccccccCCccceEEc--cCcccCC----CccccccccccCCeEeCcCcc
Q 046199 550 IPTTIGGLTNLQLLSL--ENNRLHG----PIPESFGALTSLESLDLSVNN 593 (902)
Q Consensus 550 ~p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~L~Ls~N~ 593 (902)
+...+...++|+.++| ++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 1233344455554333 3344432 122333344555555554443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0025 Score=67.70 Aligned_cols=73 Identities=18% Similarity=0.181 Sum_probs=50.7
Q ss_pred cCeecccceeeEEEEEeCC--------CcEEEEEEeeeccchhhhhHHHHHHHHHhCC-CCCccceeeeeecCCeeEEEE
Q 046199 731 KSLIGIGSFGTVYKGRFLD--------GMEVAIKVFHLQFDGALKSFDAECEVLKSVR-HRNLVKIISSCSNGNFKALVL 801 (902)
Q Consensus 731 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 801 (902)
++.|+.|-.-.+|++...+ .+.|++++.- .... .....+|..+++.+. +.-.+++++++.. .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888889999998643 3567777764 2222 345668999988884 4445678887753 5899
Q ss_pred EccCCCCh
Q 046199 802 EYMANGSL 809 (902)
Q Consensus 802 e~~~~g~L 809 (902)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|